TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219488_at	30	0.633333	0.0366046	0.403944	0.878561	0.23855	1.38515	4.00 [0.40 - 39.99]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1735045	165	0.430303	0.0376349	0.411266	-0.496495	0.102617	-0.21328	0.81 [0.63 - 1.04]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1735045	165	0.8	0.0353752	0.395063	-1.41567	0.0869135	-0.347443	0.71 [0.47 - 1.05]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219488_at	163	0.104294	0.00271157	0.0580482	-0.845637	0.859234	-0.117147	0.89 [0.24 - 3.25]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219488_at	79	0.265823	0.0371958	0.408158	-0.63195	0.136437	-1.32995	0.26 [0.05 - 1.52]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219488_at	58	0.896552	0.0896082	-	-0.800699	0.641751	-0.0919718	0.91 [0.62 - 1.34]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219488_at	34	0.441176	0.0125194	0.190932	-0.959195	0.0801504	-0.930274	0.39 [0.14 - 1.12]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219488_at	158	0.493671	0.216725	-	0.287987	0.760803	0.152491	1.16 [0.44 - 3.11]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219488_at	53	0.679245	0.248577	-	0.412538	0.843016	0.0520327	1.05 [0.63 - 1.76]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219488_at	53	0.679245	0.168159	-	0.522148	0.74902	0.0905448	1.09 [0.63 - 1.91]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219488_at	180	0.755556	0.0121631	0.186895	-0.680979	0.341805	-0.157209	0.85 [0.62 - 1.18]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219488_at	559	0.477639	0.00145719	0.0348873	-0.648464	0.0175249	-0.565442	0.57 [0.36 - 0.91]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219488_at	77	0.636364	0.086509	-	0.441595	0.997135	0.00090009	1.00 [0.61 - 1.64]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219488_at	70	0.828571	0.0104149	0.16647	0.828582	0.227326	0.871671	2.39 [0.58 - 9.84]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219488_at	74	0.121622	0.0821846	-	0.887896	0.247996	0.269166	1.31 [0.83 - 2.07]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219488_at	67	0.477612	0.013364	0.200347	2.17494	0.535203	1.00042	2.72 [0.12 - 64.24]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219488_at	115	0.608696	0.0456398	0.464757	-1.40868	0.284521	-0.665335	0.51 [0.15 - 1.74]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219488_at	204	0.480392	0.000315577	0.00954438	-0.517795	0.0060039	-0.280024	0.76 [0.62 - 0.92]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219488_at	87	0.804598	0.0649484	-	-1.26959	0.506408	-0.479092	0.62 [0.15 - 2.55]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219488_at	87	0.804598	0.0649484	-	-1.26959	0.506408	-0.479092	0.62 [0.15 - 2.55]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219488_at	77	0.571429	0.10354	-	0.899159	0.380866	1.01438	2.76 [0.29 - 26.66]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219488_at	77	0.207792	0.144087	-	-0.911974	0.690254	0.532308	1.70 [0.12 - 23.34]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219488_at	136	0.889706	0.0213676	0.280708	1.14393	0.828773	0.0751719	1.08 [0.55 - 2.13]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219488_at	200	0.825	0.0558846	-	0.654809	0.180877	0.363166	1.44 [0.84 - 2.45]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8624	60	0.783333	0.0225825	0.291763	-1.3127	0.0748779	-0.542003	0.58 [0.32 - 1.06]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8624	60	0.566667	0.196305	-	0.486806	0.825613	-0.0815798	0.92 [0.45 - 1.90]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219488_at	286	0.164336	0.0031703	0.0658554	-0.654165	0.165417	-0.20828	0.81 [0.60 - 1.09]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219488_at	159	0.433962	0.310282	-	-0.319892	0.83158	-0.0705178	0.93 [0.49 - 1.78]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219488_at	159	0.201258	0.0662151	-	-0.721799	0.530823	-0.241441	0.79 [0.37 - 1.67]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219488_at	159	0.201258	0.0468837	0.472573	-0.673189	0.404906	-0.272571	0.76 [0.40 - 1.45]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219488_at	54	0.87037	0.142892	-	-15.3803	0.370191	-0.764399	0.47 [0.09 - 2.48]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219488_at	117	0.700855	0.0263114	0.324183	-0.898135	0.37927	-0.351745	0.70 [0.32 - 1.54]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219488_at	117	0.692308	0.120936	-	-0.701884	0.673694	-0.194911	0.82 [0.33 - 2.04]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219488_at	117	0.888889	0.227053	-	0.600125	0.575277	0.254955	1.29 [0.53 - 3.15]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219488_at	117	0.700855	0.0263114	0.324183	-0.898135	0.37927	-0.351745	0.70 [0.32 - 1.54]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219488_at	236	0.110169	0.16202	-	-0.504991	0.908474	0.0394965	1.04 [0.53 - 2.04]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219488_at	249	0.289157	0.0206139	0.273718	-0.500582	0.461296	-0.191445	0.83 [0.50 - 1.37]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219488_at	125	0.536	0.0338362	0.383719	-0.636467	0.167865	-0.713337	0.49 [0.18 - 1.35]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219488_at	54	0.166667	0.104453	-	15.3372	0.972381	-0.0143084	0.99 [0.44 - 2.22]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219488_at	62	0.725806	0.11506	-	-0.905305	0.723664	-0.120492	0.89 [0.45 - 1.73]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219488_at	125	0.104	0.0623	-	15.2011	0.955174	0.037111	1.04 [0.28 - 3.79]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219488_at	198	0.626263	0.13623	-	0.317272	0.4592	0.0924963	1.10 [0.86 - 1.40]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219488_at	198	0.459596	0.0526581	-	0.512007	0.324976	0.152752	1.17 [0.86 - 1.58]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219488_at	198	0.459596	0.0508639	-	0.539651	0.258475	0.186078	1.20 [0.87 - 1.66]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219488_at	62	0.887097	0.165996	-	-15.2415	0.333735	-0.907774	0.40 [0.06 - 2.54]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219488_at	51	0.352941	0.221941	-	-1.06455	0.91841	-0.144145	0.87 [0.05 - 13.65]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219488_at	145	0.841379	0.136812	-	-0.871253	0.483696	-0.596922	0.55 [0.10 - 2.93]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219488_at	177	0.666667	0.0441677	0.455344	-0.631413	0.190307	-0.906973	0.40 [0.10 - 1.57]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219488_at	177	0.677966	0.00958029	0.156324	-0.720216	0.133572	-0.90132	0.41 [0.13 - 1.32]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219488_at	226	0.827434	0.0704809	-	0.57631	0.548911	0.112322	1.12 [0.77 - 1.62]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219488_at	55	0.836364	0.250062	-	-0.834385	0.771285	-0.27968	0.76 [0.11 - 4.98]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219488_at	55	0.854545	0.0439701	0.454066	-15.3349	0.35358	-1.05765	0.35 [0.04 - 3.24]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219488_at	49	0.816327	0.242236	-	-1.15701	0.722057	-0.434609	0.65 [0.06 - 7.10]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219488_at	63	0.349206	0.00298538	0.0627427	-0.972109	0.0445684	-14.4417	0.00 [0.00 - 0.70]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8392829_3p_x_at	28	0.5	0.176487	-	0.725304	0.835678	0.0816095	1.09 [0.50 - 2.35]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	219488_3p_at	28	0.892857	0.0753004	-	1.3593	0.974999	-0.107304	0.90 [0.00 - 737.72]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8392829_3p_at	28	0.107143	0.0391283	0.421692	-1.29458	0.0524865	-0.422363	0.66 [0.43 - 1.00]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219488_at	82	0.134146	0.0364571	0.402887	1.84663	0.0575238	1.06232	2.89 [0.97 - 8.66]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219488_at	79	0.873418	0.284917	-	0.385817	0.771438	-0.159843	0.85 [0.29 - 2.51]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219488_at	104	0.144231	0.0650147	-	-0.699015	0.712635	-0.293793	0.75 [0.16 - 3.56]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P57570	117	0.444444	0.323539	-	0.287474	0.99947	8.7957e-05	1.00 [0.77 - 1.30]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219488_at	204	0.102941	0.0147358	0.2152	-1.07271	0.832129	0.0650329	1.07 [0.58 - 1.95]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219488_at	204	0.171569	0.00488053	0.0928578	-0.833958	0.91685	-0.0242789	0.98 [0.62 - 1.54]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219488_at	178	0.348315	0.0220719	0.287148	0.507749	0.112225	0.415792	1.52 [0.91 - 2.53]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200011416	41	0.804878	0.00311056	0.0648546	1.28021	0.0590879	0.573087	1.77 [0.98 - 3.22]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219488_at	111	0.81982	0.0180816	0.249431	-0.984564	0.265304	-0.16928	0.84 [0.63 - 1.14]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219488_at	90	0.177778	0.0493887	0.487944	-0.709924	0.286379	-0.468036	0.63 [0.26 - 1.48]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219488_at	90	0.144444	0.00916471	0.151167	-1.03786	0.181123	-0.677123	0.51 [0.19 - 1.37]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219488_at	138	0.572464	0.0688572	-	-0.456359	0.221677	-0.308653	0.73 [0.45 - 1.20]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219488_at	129	0.899225	0.131394	-	0.537265	0.898666	-0.0273641	0.97 [0.64 - 1.48]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1743	56	0.732143	0.0246201	0.309747	0.861974	0.513214	0.109084	1.12 [0.80 - 1.55]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3257	56	0.678571	0.324826	-	0.358779	0.87179	0.039748	1.04 [0.64 - 1.69]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1743	56	0.732143	0.0614954	-	0.704825	0.777633	0.0443888	1.05 [0.77 - 1.42]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3257	56	0.678571	0.10959	-	0.592096	0.706175	0.100356	1.11 [0.66 - 1.86]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219488_at	278	0.895683	0.00468954	0.0899798	-1.21276	0.0372019	-0.494899	0.61 [0.38 - 0.97]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219488_at	133	0.556391	0.01265	0.192402	0.584324	0.206047	-0.440287	0.64 [0.33 - 1.27]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219488_at	185	0.264865	0.000115303	0.00396978	-0.69067	0.000557207	-0.824338	0.44 [0.27 - 0.70]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219488_at	185	0.264865	0.00018075	0.00588478	-0.714659	0.00239161	-0.785425	0.46 [0.27 - 0.76]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P57570	110	0.172727	0.145013	-	-0.543959	0.192761	-0.171417	0.84 [0.65 - 1.09]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P57570	110	0.827273	0.0429794	0.447612	-0.74045	0.112987	-0.157294	0.85 [0.70 - 1.04]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219488_at	80	0.725	0.0674697	-	-1.09313	0.334926	-0.233087	0.79 [0.49 - 1.27]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3083	281	0.149466	0.0015367	0.0364567	-0.565061	0.0245802	-0.222086	0.80 [0.66 - 0.97]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219488_at	38	0.210526	0.00740621	0.128481	-1.24458	0.109366	-0.668551	0.51 [0.23 - 1.16]
GENE	A4GALT	alpha 1,4-galactosyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219488_at	140	0.885714	0.0666729	-	0.671938	0.18099	0.754144	2.13 [0.70 - 6.42]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221131_at	30	0.366667	0.053833	-	-0.795704	0.469073	-0.670745	0.51 [0.08 - 3.14]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1680754	165	0.278788	0.177247	-	0.391831	0.749926	-0.13069	0.88 [0.39 - 1.96]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1680754	165	0.109091	0.121597	-	1.4444	0.626318	-0.368012	0.69 [0.16 - 3.04]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221131_at	163	0.472393	0.0802519	-	0.34963	0.912309	0.0946474	1.10 [0.20 - 5.92]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221131_at	79	0.670886	0.0125324	0.191079	0.727682	0.165977	1.39597	4.04 [0.56 - 29.11]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221131_at	58	0.724138	0.0515752	-	0.624418	0.162952	0.413	1.51 [0.85 - 2.70]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221131_at	34	0.470588	0.275805	-	-0.419814	0.751826	-0.0819251	0.92 [0.55 - 1.53]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221131_at	158	0.556962	0.113697	-	0.366465	0.329323	0.933031	2.54 [0.39 - 16.57]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221131_at	53	0.735849	0.367579	-	-0.38793	0.660312	-0.197735	0.82 [0.34 - 1.98]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221131_at	53	0.113208	0.203548	-	-0.610177	0.189424	-0.545855	0.58 [0.26 - 1.31]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221131_at	180	0.872222	0.0455995	0.464502	0.550655	0.635557	0.0679609	1.07 [0.81 - 1.42]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221131_at	559	0.515206	0.0332637	0.379432	0.426139	0.108805	0.20862	1.23 [0.95 - 1.59]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221131_at	77	0.727273	0.0920465	-	-0.514035	0.307465	-0.217032	0.80 [0.53 - 1.22]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221131_at	70	0.857143	0.178694	-	-0.540345	0.617259	-0.575036	0.56 [0.06 - 5.37]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221131_at	74	0.689189	0.0250895	0.313796	0.651823	0.186185	0.392947	1.48 [0.83 - 2.65]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221131_at	67	0.253731	0.0995079	-	15.446	0.843002	-0.520586	0.59 [0.00 - 102.64]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221131_at	115	0.391304	0.136851	-	-0.781401	0.816208	-0.216763	0.81 [0.13 - 5.01]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221131_at	204	0.568627	0.0592636	-	-0.268923	0.54102	-0.0561582	0.95 [0.79 - 1.13]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221131_at	87	0.241379	0.096329	-	0.871119	0.523928	0.634783	1.89 [0.27 - 13.29]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221131_at	87	0.241379	0.096329	-	0.871119	0.523928	0.634783	1.89 [0.27 - 13.29]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221131_at	77	0.688312	0.138325	-	0.906607	0.518824	1.1445	3.14 [0.10 - 101.64]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221131_at	77	0.688312	0.0378111	0.412508	1.10019	0.180492	1.96384	7.13 [0.40 - 126.21]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221131_at	136	0.580882	0.104176	-	0.722573	0.363532	0.427005	1.53 [0.61 - 3.85]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221131_at	200	0.685	0.0534783	-	0.566004	0.277799	0.30123	1.35 [0.78 - 2.33]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20551	60	0.883333	0.0185834	0.254347	1.04446	0.264795	0.24578	1.28 [0.83 - 1.97]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20551	60	0.166667	0.325272	-	-0.451725	0.945442	0.0134899	1.01 [0.69 - 1.49]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221131_at	286	0.667832	9.22349e-05	0.00326145	-0.919738	0.018613	-0.447183	0.64 [0.44 - 0.93]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221131_at	159	0.27673	0.0916055	-	-0.544659	0.0473148	-0.719077	0.49 [0.24 - 0.99]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221131_at	159	0.433962	0.130551	-	-0.474487	0.174399	-0.512072	0.60 [0.29 - 1.25]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221131_at	159	0.433962	0.120985	-	-0.571746	0.117885	-0.67909	0.51 [0.22 - 1.19]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221131_at	54	0.314815	0.0936296	-	1.60764	0.918968	0.203831	1.23 [0.02 - 62.23]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221131_at	117	0.529915	0.130463	-	0.596556	0.275751	0.978667	2.66 [0.46 - 15.47]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221131_at	117	0.837607	0.0528123	-	0.699746	0.243735	0.875935	2.40 [0.55 - 10.47]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221131_at	117	0.837607	0.0528123	-	0.699746	0.243735	0.875935	2.40 [0.55 - 10.47]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221131_at	117	0.837607	0.0462411	0.468551	0.811563	0.102851	1.37662	3.96 [0.76 - 20.71]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221131_at	236	0.665254	0.0703693	-	-0.568212	0.469537	-0.334933	0.72 [0.29 - 1.77]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221131_at	249	0.164659	0.0328892	0.376608	0.770557	0.943731	0.0270313	1.03 [0.48 - 2.18]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221131_at	62	0.209677	0.0175587	0.244252	15.4489	0.668296	-0.0725793	0.93 [0.67 - 1.30]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221131_at	125	0.736	0.114122	-	-0.777238	0.913558	0.0749007	1.08 [0.28 - 4.17]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221131_at	125	0.736	0.22601	-	-0.403738	0.785973	-0.145844	0.86 [0.30 - 2.48]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221131_at	54	0.277778	0.0339829	0.384812	15.5292	0.730915	-0.0704236	0.93 [0.62 - 1.39]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221131_at	198	0.60101	0.00243655	0.053221	-0.927145	0.434598	-0.138123	0.87 [0.62 - 1.23]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221131_at	198	0.60101	0.00689693	0.121618	-0.608753	0.19433	-0.173821	0.84 [0.65 - 1.09]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221131_at	198	0.60101	0.000562112	0.0156587	-1.00924	0.274135	-0.179414	0.84 [0.61 - 1.15]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221131_at	51	0.431373	0.0998376	-	-1.64759	0.767446	-0.698336	0.50 [0.00 - 50.92]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221131_at	62	0.16129	0.0950058	-	-0.982952	0.294032	-1.42035	0.24 [0.02 - 3.43]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221131_at	177	0.830508	0.096349	-	-0.762355	0.207397	-1.20364	0.30 [0.05 - 1.95]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221131_at	177	0.610169	0.118781	-	-0.39653	0.101291	-1.3561	0.26 [0.05 - 1.30]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221131_at	145	0.827586	0.111839	-	-0.925763	0.332819	-1.11764	0.33 [0.03 - 3.14]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221131_at	226	0.19469	0.0555219	-	-0.594423	0.505995	-0.0839839	0.92 [0.72 - 1.18]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221131_at	55	0.163636	0.221635	-	-0.621648	0.722704	0.723885	2.06 [0.04 - 112.42]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221131_at	55	0.163636	0.0731359	-	-0.954941	0.926373	-0.216936	0.80 [0.01 - 80.18]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221131_at	49	0.183673	0.0221253	0.287632	-1.25835	0.612969	-1.517	0.22 [0.00 - 78.33]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221131_at	63	0.539683	0.00186808	0.0428275	-1.11183	0.0493015	-31.0884	0.00 [0.00 - 0.91]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7705858_3p_at	28	0.714286	0.0430545	0.448105	-1.46337	0.168467	-3.10776	0.04 [0.00 - 3.73]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221131_at	82	0.512195	0.263273	-	-0.379788	0.738628	-0.146755	0.86 [0.36 - 2.04]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221131_at	79	0.493671	0.00754881	0.130377	0.693854	0.0923667	0.902335	2.47 [0.86 - 7.05]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221131_at	104	0.307692	0.027037	0.330247	-0.718567	0.468137	-0.265089	0.77 [0.37 - 1.57]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221131_at	204	0.431373	0.114852	-	-0.573415	0.476514	-0.180193	0.84 [0.51 - 1.37]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221131_at	204	0.897059	0.0834291	-	-1.17821	0.535939	-0.123873	0.88 [0.60 - 1.31]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221131_at	178	0.308989	0.0906305	-	-0.350299	0.472074	-0.226176	0.80 [0.43 - 1.48]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200017402	41	0.658537	0.0446602	0.458513	-0.980085	0.914289	-0.0124919	0.99 [0.79 - 1.24]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221131_at	111	0.756757	0.000845402	0.0221288	-1.26368	0.200624	-0.234143	0.79 [0.55 - 1.13]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221131_at	90	0.877778	0.0427277	0.445959	-1.80122	0.689442	-0.330256	0.72 [0.14 - 3.63]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221131_at	90	0.877778	0.0922856	-	-1.55325	0.518587	-0.609727	0.54 [0.09 - 3.46]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221131_at	138	0.333333	0.018809	0.25654	-0.563276	0.254789	-10.6268	0.00 [0.00 - 2128.51]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221131_at	129	0.689922	0.0595795	-	0.492681	0.497019	0.232249	1.26 [0.65 - 2.47]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2589	56	0.214286	0.0230841	0.296253	-0.826838	0.464776	-0.451039	0.64 [0.19 - 2.13]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2589	56	0.214286	0.0886147	-	-0.613655	0.933613	0.0469909	1.05 [0.35 - 3.17]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221131_at	278	0.899281	0.0261793	0.32307	0.579969	0.209686	0.687662	1.99 [0.68 - 5.82]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221131_at	133	0.736842	0.000912908	0.0236075	0.825365	0.00982237	4.35545	77.90 [2.86 - 2125.27]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221131_at	185	0.118919	0.0178141	0.246789	0.604962	0.668388	0.126671	1.14 [0.64 - 2.03]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221131_at	185	0.118919	0.0200301	0.268231	0.672105	0.401523	0.271632	1.31 [0.70 - 2.48]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P58046	110	0.363636	0.159494	-	-0.330808	0.859093	-0.0439908	0.96 [0.59 - 1.56]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P58046	110	0.318182	0.0602382	-	-0.60455	0.772527	-0.0997674	0.91 [0.46 - 1.78]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221131_at	80	0.4625	0.120373	-	0.711148	0.367252	0.269701	1.31 [0.73 - 2.35]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221131_at	38	0.894737	0.00223244	0.0495582	1.70076	0.185939	1.12293	3.07 [0.58 - 16.23]
GENE	A4GNT	alpha-1,4-N-acetylglucosaminyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221131_at	140	0.835714	0.00509734	0.0960889	-1.78144	0.0723926	-1.98535	0.14 [0.02 - 1.20]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218434_s_at	30	0.566667	0.00908172	0.150129	-1.21643	0.162448	-0.74909	0.47 [0.17 - 1.35]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1698554	165	0.89697	0.134326	-	-0.774276	0.546796	-0.192689	0.82 [0.44 - 1.54]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1698554	165	0.848485	0.0671171	-	0.731026	0.837496	0.0943475	1.10 [0.45 - 2.71]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218434_s_at	163	0.883436	0.0704741	-	0.501758	0.534649	0.123789	1.13 [0.77 - 1.67]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218434_s_at	79	0.594937	0.0865521	-	0.49677	0.548592	0.121311	1.13 [0.76 - 1.68]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218434_s_at	58	0.103448	0.19723	-	-0.563886	0.959648	0.0109666	1.01 [0.66 - 1.55]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218434_s_at	34	0.529412	0.0023227	0.0511868	-1.26963	0.0358823	-1.0713	0.34 [0.13 - 0.93]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218434_s_at	158	0.392405	0.063982	-	0.466094	0.803908	-0.0532087	0.95 [0.62 - 1.44]
GENE	AACS	acetoacetyl-CoA synthetase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218434_s_at	53	0.830189	0.0627703	-	-1.27784	0.305997	-0.351005	0.70 [0.36 - 1.38]
GENE	AACS	acetoacetyl-CoA synthetase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218434_s_at	53	0.830189	0.0236087	0.300904	-1.51125	0.29537	-0.325127	0.72 [0.39 - 1.33]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218434_s_at	180	0.805556	0.0356958	0.397395	-0.639621	0.328324	-0.18152	0.83 [0.58 - 1.20]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218434_s_at	559	0.706619	0.0092585	0.152338	0.531141	0.137619	0.388735	1.48 [0.88 - 2.46]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218434_s_at	77	0.857143	0.27374	-	-0.434873	0.756072	-0.124757	0.88 [0.40 - 1.94]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218434_s_at	70	0.771429	0.294253	-	-0.350923	0.842599	0.0750793	1.08 [0.51 - 2.26]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218434_s_at	74	0.648649	0.000907957	0.0234997	0.931253	0.00216617	1.11864	3.06 [1.50 - 6.26]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218434_s_at	67	0.865672	0.128781	-	1.20233	0.951651	-0.0507054	0.95 [0.18 - 4.90]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218434_s_at	115	0.643478	0.0725055	-	0.936856	0.845399	0.127199	1.14 [0.32 - 4.08]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218434_s_at	204	0.142157	0.0384764	0.417168	-0.421304	0.762666	-0.0520948	0.95 [0.68 - 1.33]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218434_s_at	87	0.471264	0.0119262	0.184188	-0.979189	0.148883	-0.529346	0.59 [0.29 - 1.21]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218434_s_at	87	0.471264	0.0119262	0.184188	-0.979189	0.148883	-0.529346	0.59 [0.29 - 1.21]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218434_s_at	77	0.116883	0.252682	-	15.1974	0.898068	-0.0786242	0.92 [0.28 - 3.08]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218434_s_at	77	0.285714	0.29259	-	-0.591813	0.802969	-0.136203	0.87 [0.30 - 2.54]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218434_s_at	136	0.470588	0.0829366	-	0.827237	0.817999	0.118473	1.13 [0.41 - 3.09]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218434_s_at	200	0.63	0.0912897	-	-0.560208	0.460469	-0.253858	0.78 [0.40 - 1.52]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5047	60	0.266667	0.0299934	0.35421	-0.829397	0.716956	-0.111669	0.89 [0.49 - 1.64]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5047	60	0.316667	0.00585683	0.107128	-1.017	0.505258	-0.184721	0.83 [0.48 - 1.43]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218434_s_at	286	0.36014	0.00111391	0.027895	0.719915	0.00327932	0.617169	1.85 [1.23 - 2.80]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218434_s_at	159	0.327044	0.104237	-	0.606067	0.188314	0.474117	1.61 [0.79 - 3.26]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218434_s_at	159	0.849057	0.0763573	-	0.659151	0.709921	0.137314	1.15 [0.56 - 2.37]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218434_s_at	159	0.861635	0.0600835	-	0.795424	0.323071	0.422655	1.53 [0.66 - 3.53]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218434_s_at	54	0.185185	0.137011	-	15.3812	0.569183	0.337018	1.40 [0.44 - 4.47]
GENE	AACS	acetoacetyl-CoA synthetase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218434_s_at	117	0.82906	0.156696	-	-1.00124	0.566022	-0.200617	0.82 [0.41 - 1.62]
GENE	AACS	acetoacetyl-CoA synthetase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218434_s_at	117	0.128205	0.220915	-	-0.506752	0.492719	-0.197347	0.82 [0.47 - 1.44]
GENE	AACS	acetoacetyl-CoA synthetase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218434_s_at	117	0.128205	0.220915	-	-0.506752	0.492719	-0.197347	0.82 [0.47 - 1.44]
GENE	AACS	acetoacetyl-CoA synthetase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218434_s_at	117	0.846154	0.138375	-	-1.04036	0.647271	-0.15448	0.86 [0.44 - 1.66]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218434_s_at	236	0.262712	0.0565179	-	0.682603	0.463365	0.256153	1.29 [0.65 - 2.56]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218434_s_at	249	0.429719	0.015702	0.225362	0.54096	0.259039	0.305683	1.36 [0.80 - 2.31]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218434_s_at	62	0.677419	0.406099	-	-0.429975	0.736163	-0.0850356	0.92 [0.56 - 1.51]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218434_s_at	125	0.352	0.0139541	0.206801	1.25173	0.0571732	0.54753	1.73 [0.98 - 3.04]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218434_s_at	125	0.352	0.00133438	0.032428	1.31662	0.0640206	0.419105	1.52 [0.98 - 2.37]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218434_s_at	54	0.166667	0.329691	-	-0.647477	0.563288	-0.17926	0.84 [0.46 - 1.54]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218434_s_at	198	0.242424	0.2007	-	0.443569	0.245275	0.223459	1.25 [0.86 - 1.82]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218434_s_at	198	0.525253	0.051294	-	0.411398	0.248731	0.177741	1.19 [0.88 - 1.62]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218434_s_at	198	0.242424	0.131825	-	0.501078	0.13971	0.260954	1.30 [0.92 - 1.84]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218434_s_at	51	0.588235	0.0490467	0.485874	-15.9752	0.272651	-0.980588	0.38 [0.07 - 2.16]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218434_s_at	62	0.129032	0.101053	-	-1.04779	0.666012	0.272831	1.31 [0.38 - 4.53]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218434_s_at	177	0.80791	0.0434728	0.450837	0.618732	0.419091	0.284125	1.33 [0.67 - 2.65]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218434_s_at	177	0.757062	0.0153736	0.221935	0.604892	0.162247	0.434358	1.54 [0.84 - 2.84]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218434_s_at	145	0.117241	0.0312925	0.364383	-0.840903	0.41951	-0.327082	0.72 [0.33 - 1.60]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218434_s_at	226	0.154867	0.000243714	0.00763211	-1.06584	0.0085624	-0.894967	0.41 [0.21 - 0.80]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218434_s_at	55	0.290909	0.0701556	-	1.08194	0.410253	0.3775	1.46 [0.59 - 3.58]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218434_s_at	55	0.472727	0.0116194	0.180655	1.32299	0.22607	0.593225	1.81 [0.69 - 4.73]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218434_s_at	49	0.285714	0.0171364	0.240025	15.6398	0.35284	0.543613	1.72 [0.55 - 5.42]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218434_s_at	63	0.238095	0.0022998	0.0507748	1.66548	0.0654499	0.568491	1.77 [0.96 - 3.23]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12965198_3p_a_at	28	0.25	0.298519	-	0.688912	0.792039	-0.0385268	0.96 [0.72 - 1.28]
GENE	AACS	acetoacetyl-CoA synthetase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218434_s_at	82	0.243902	0.00442143	0.0858872	-0.9683	0.20045	-0.367553	0.69 [0.39 - 1.22]
GENE	AACS	acetoacetyl-CoA synthetase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218434_s_at	79	0.189873	0.156332	-	-0.442902	0.385033	-0.213615	0.81 [0.50 - 1.31]
GENE	AACS	acetoacetyl-CoA synthetase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218434_s_at	104	0.471154	0.0219839	0.286348	0.781289	0.272438	0.34047	1.41 [0.77 - 2.58]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P204395	117	0.239316	0.182411	-	0.48873	0.614696	0.12238	1.13 [0.70 - 1.82]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218434_s_at	204	0.72549	0.0391334	0.421727	0.752681	0.195152	0.597941	1.82 [0.74 - 4.49]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218434_s_at	204	0.617647	0.0264346	0.325217	0.595758	0.172915	0.484116	1.62 [0.81 - 3.26]
GENE	AACS	acetoacetyl-CoA synthetase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218434_s_at	178	0.820225	0.251081	-	-0.320058	0.714255	0.0814812	1.08 [0.70 - 1.68]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218434_s_at	111	0.891892	0.205993	-	-0.644915	0.630636	-0.160888	0.85 [0.44 - 1.64]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218434_s_at	90	0.122222	0.0560312	-	1.71811	0.318576	0.260072	1.30 [0.78 - 2.16]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218434_s_at	90	0.122222	0.0351162	0.393173	15.2318	0.48817	0.206035	1.23 [0.69 - 2.20]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218434_s_at	138	0.202899	0.333929	-	0.305186	0.674634	0.061801	1.06 [0.80 - 1.42]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218434_s_at	129	0.899225	0.24121	-	0.438448	0.719074	0.124254	1.13 [0.58 - 2.23]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7674	56	0.803571	0.00400721	0.0794353	1.19137	0.0255803	0.783049	2.19 [1.10 - 4.35]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7674	56	0.392857	0.0479088	0.478922	0.721219	0.155637	0.46531	1.59 [0.84 - 3.03]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218434_s_at	278	0.100719	0.0844661	-	-0.463224	0.491191	-0.139131	0.87 [0.59 - 1.29]
GENE	AACS	acetoacetyl-CoA synthetase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218434_s_at	133	0.18797	0.0559981	-	-0.521181	0.782648	-0.0438455	0.96 [0.70 - 1.31]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218434_s_at	185	0.864865	0.197343	-	-0.301221	0.539366	-0.0996368	0.91 [0.66 - 1.24]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218434_s_at	185	0.864865	0.181587	-	-0.350614	0.869836	-0.0289372	0.97 [0.69 - 1.37]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P204395	110	0.472727	0.0215938	0.282786	0.734833	0.161457	0.405385	1.50 [0.85 - 2.65]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P204395	110	0.554545	0.196568	-	-0.301018	0.848114	-0.0436556	0.96 [0.61 - 1.50]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218434_s_at	80	0.85	0.052332	-	0.907164	0.951656	-0.0299537	0.97 [0.37 - 2.56]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218434_s_at	38	0.894737	0.0339251	0.384381	1.35788	0.203778	0.423723	1.53 [0.79 - 2.94]
GENE	AACS	acetoacetyl-CoA synthetase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218434_s_at	140	0.885714	0.0265728	0.326375	0.889754	0.232028	0.276467	1.32 [0.84 - 2.07]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205969_at	30	0.133333	0.012136	0.186587	-1.44609	0.185431	-0.499795	0.61 [0.29 - 1.27]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1805938	165	0.612121	0.00100616	0.0256169	0.775773	0.110533	0.20385	1.23 [0.95 - 1.57]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1805938	165	0.806061	7.72065e-05	0.00278738	1.31412	0.00284446	0.449274	1.57 [1.17 - 2.11]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205969_at	163	0.226994	0.0136078	0.203025	-0.542509	0.591217	-0.407519	0.67 [0.15 - 2.94]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205969_at	79	0.367089	0.207959	-	-0.370768	0.916588	-0.061735	0.94 [0.30 - 2.98]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205969_at	58	0.724138	0.167945	-	-0.432935	0.685441	-0.0604665	0.94 [0.70 - 1.26]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205969_at	34	0.5	0.0738069	-	-0.7202	0.809872	-0.0673689	0.93 [0.54 - 1.62]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205969_at	158	0.107595	0.0251646	0.314441	1.2375	0.463629	0.540029	1.72 [0.40 - 7.27]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205969_at	53	0.113208	0.0592675	-	-0.904188	0.773708	-0.0770462	0.93 [0.55 - 1.57]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205969_at	53	0.113208	0.0112848	0.176766	-1.11062	0.805212	-0.0635466	0.94 [0.57 - 1.56]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205969_at	180	0.588889	0.0222739	0.288979	0.477703	0.208814	0.158555	1.17 [0.92 - 1.50]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205969_at	559	0.763864	0.204499	-	-0.293605	0.824405	-0.0294349	0.97 [0.75 - 1.26]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205969_at	77	0.74026	0.0284224	0.341621	-0.683113	0.141762	-0.377031	0.69 [0.41 - 1.13]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205969_at	70	0.271429	0.0474796	0.476274	-0.564951	0.381475	-1.18651	0.31 [0.02 - 4.35]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36512_at	50	0.14	0.0145654	0.213384	-1.11177	0.163815	-1.28089	0.28 [0.05 - 1.69]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205969_at	74	0.135135	0.0449119	0.460125	-0.739698	0.756188	0.0851665	1.09 [0.64 - 1.86]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205969_at	67	0.58209	0.0105508	0.168097	1.81422	0.184204	1.94917	7.02 [0.40 - 124.73]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205969_at	115	0.165217	0.0841638	-	15.3107	0.405425	0.314132	1.37 [0.65 - 2.87]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36512_at	158	0.379747	0.0944749	-	0.568899	0.518133	0.115615	1.12 [0.79 - 1.59]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36512_at	76	0.105263	0.00410605	0.0809896	-1.57501	0.092026	-0.576465	0.56 [0.29 - 1.10]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205969_at	204	0.544118	0.0195481	0.263651	0.339476	0.0952759	0.11576	1.12 [0.98 - 1.29]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205969_at	87	0.275862	0.0236813	0.301545	1.29241	0.72934	0.265695	1.30 [0.29 - 5.88]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205969_at	87	0.275862	0.0236813	0.301545	1.29241	0.72934	0.265695	1.30 [0.29 - 5.88]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205969_at	77	0.324675	0.0216161	0.28299	15.7022	0.0157802	3.07168	21.58 [1.78 - 261.31]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205969_at	77	0.324675	0.00816361	0.138434	15.7153	0.0125409	2.80875	16.59 [1.83 - 150.48]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205969_at	136	0.102941	0.0590453	-	-0.969948	0.581497	-0.167519	0.85 [0.47 - 1.53]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205969_at	200	0.59	0.220395	-	0.360074	0.856106	0.0332557	1.03 [0.72 - 1.48]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11853	60	0.6	0.00878505	0.146392	0.975673	0.00137988	0.93339	2.54 [1.44 - 4.51]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11853	60	0.716667	0.000503729	0.0142604	1.26694	0.00194849	0.749069	2.12 [1.32 - 3.40]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12819	155	0.690323	0.0177217	0.245872	0.659378	0.387052	0.180967	1.20 [0.80 - 1.81]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205969_at	286	0.381119	0.0567511	-	-0.369388	0.313257	-0.127951	0.88 [0.69 - 1.13]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205969_at	159	0.333333	0.124967	-	0.689815	0.0689934	0.552882	1.74 [0.96 - 3.15]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205969_at	159	0.333333	0.118432	-	0.583109	0.175573	0.368943	1.45 [0.85 - 2.47]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205969_at	159	0.327044	0.06539	-	0.713398	0.0179323	0.628802	1.88 [1.11 - 3.16]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205969_at	54	0.111111	0.000559195	0.0155895	-2.12605	0.0702889	-5.79274	0.00 [0.00 - 1.62]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205969_at	117	0.615385	0.139584	-	0.462418	0.99883	-0.00122598	1.00 [0.19 - 5.14]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205969_at	117	0.615385	0.0490114	0.48566	0.734384	0.572456	0.479529	1.62 [0.31 - 8.54]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205969_at	117	0.623932	0.0545006	-	0.740923	0.736557	0.283324	1.33 [0.25 - 6.92]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205969_at	117	0.615385	0.139584	-	0.462418	0.99883	-0.00122598	1.00 [0.19 - 5.14]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205969_at	236	0.444915	0.00560968	0.103581	-0.745905	0.135873	-0.347568	0.71 [0.45 - 1.12]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205969_at	249	0.441767	0.00291689	0.0615782	-0.625894	0.0630795	-0.339309	0.71 [0.50 - 1.02]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205969_at	62	0.112903	0.162777	-	15.1902	0.659566	-0.197197	0.82 [0.34 - 1.97]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205969_at	125	0.88	0.255368	-	-0.812785	0.509025	-0.561543	0.57 [0.11 - 3.02]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205969_at	125	0.744	0.339961	-	0.295658	0.995058	0.00333562	1.00 [0.35 - 2.88]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205969_at	54	0.111111	0.297619	-	15.1665	0.794098	-0.140376	0.87 [0.30 - 2.49]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205969_at	198	0.772727	0.0431171	0.448514	-0.751183	0.305285	-0.113084	0.89 [0.72 - 1.11]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205969_at	198	0.772727	0.0483434	0.481589	-0.778776	0.3112	-0.119307	0.89 [0.70 - 1.12]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205969_at	198	0.782828	0.0537763	-	-0.554726	0.288317	-0.0937387	0.91 [0.77 - 1.08]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205969_at	51	0.843137	0.111391	-	1.34912	0.999298	-0.000790102	1.00 [0.17 - 5.81]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205969_at	62	0.645161	0.0852876	-	0.969627	0.542434	0.302317	1.35 [0.51 - 3.58]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205969_at	177	0.875706	0.236297	-	0.429379	0.780421	0.102249	1.11 [0.54 - 2.27]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205969_at	177	0.875706	0.153173	-	0.448078	0.369694	0.262953	1.30 [0.73 - 2.31]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205969_at	145	0.882759	0.00086468	0.0225533	1.22413	0.141443	0.610524	1.84 [0.82 - 4.16]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205969_at	226	0.893805	0.000683142	0.0184809	1.11139	0.112818	0.155408	1.17 [0.96 - 1.42]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205969_at	55	0.345455	0.0667346	-	-0.800698	0.24684	0.405148	1.50 [0.76 - 2.98]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205969_at	55	0.218182	0.225996	-	0.88818	0.0218307	0.55064	1.73 [1.08 - 2.78]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205969_at	49	0.714286	0.0170764	0.239422	-15.6423	0.187376	-2.23567	0.11 [0.00 - 2.97]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205969_at	63	0.253968	0.0771513	-	-0.621236	0.529522	2.48875	12.05 [0.01 - 28201.09]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557226_3p_at	28	0.178571	0.143103	-	-0.959833	0.31447	0.217242	1.24 [0.81 - 1.90]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205969_at	82	0.219512	0.0196441	0.264567	1.3135	0.618124	0.124433	1.13 [0.69 - 1.85]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205969_at	79	0.556962	0.0615767	-	-0.496274	0.334633	-0.251693	0.78 [0.47 - 1.30]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205969_at	104	0.634615	0.015086	0.218911	-0.981876	0.0508922	-0.815643	0.44 [0.20 - 1.00]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205969_at	204	0.509804	0.0239106	0.303561	-0.872354	0.132821	-0.174481	0.84 [0.67 - 1.05]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205969_at	204	0.107843	0.00199633	0.0452266	-1.00583	0.181834	-0.118681	0.89 [0.75 - 1.06]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205969_at	178	0.505618	0.00829554	0.140138	-0.525028	0.663195	-0.0995135	0.91 [0.58 - 1.42]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205969_at	111	0.63964	0.0721725	-	-0.524454	0.638719	-0.0409522	0.96 [0.81 - 1.14]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205969_at	90	0.666667	0.127847	-	0.499998	0.445291	0.194543	1.21 [0.74 - 2.00]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205969_at	90	0.477778	0.300843	-	-0.384769	0.870814	0.052239	1.05 [0.56 - 1.98]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1665	50	0.14	0.308709	-	1.00793	0.791415	-0.338269	0.71 [0.06 - 8.75]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205969_at	138	0.362319	0.204768	-	-0.311432	0.762843	-0.0190104	0.98 [0.87 - 1.11]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205969_at	129	0.589147	0.0444607	0.457232	-0.511622	0.232876	-0.108686	0.90 [0.75 - 1.07]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44432	56	0.178571	0.0506287	-	-0.828297	0.265651	-0.117251	0.89 [0.72 - 1.09]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44432	56	0.732143	0.0471472	0.474213	-0.786351	0.146116	-0.141779	0.87 [0.72 - 1.05]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205969_at	278	0.899281	0.0706379	-	-0.737971	0.483545	-0.0544075	0.95 [0.81 - 1.10]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205969_at	133	0.473684	0.0640801	-	0.446568	0.859169	-0.0128247	0.99 [0.86 - 1.14]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4966	81	0.123457	0.043453	0.450709	-1.09776	0.944164	-0.0133985	0.99 [0.68 - 1.44]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18470	81	0.888889	0.41026	-	-0.828913	0.779734	-0.0707953	0.93 [0.57 - 1.53]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205969_at	185	0.805405	0.00679869	0.120278	-0.569957	0.00626712	-0.284943	0.75 [0.61 - 0.92]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205969_at	185	0.8	0.00492687	0.0935515	-0.665631	0.00753948	-0.323659	0.72 [0.57 - 0.92]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P80570	110	0.109091	3.08369e-06	0.000153089	-1.56765	0.0619929	-0.155151	0.86 [0.73 - 1.01]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P80570	110	0.109091	2.61314e-05	0.00106197	-1.36671	0.696637	-0.0252924	0.98 [0.86 - 1.11]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205969_at	80	0.1375	0.0707222	-	15.2355	0.590818	0.0662477	1.07 [0.84 - 1.36]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_0050	281	0.69395	0.0315362	0.366269	-0.335711	0.861075	-0.0151241	0.98 [0.83 - 1.17]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:294130	59	0.59322	0.00608628	0.110383	1.34435	0.468196	0.85728	2.36 [0.23 - 23.89]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205969_at	38	0.263158	0.275893	-	0.670205	0.918839	0.0319067	1.03 [0.56 - 1.91]
GENE	AADAC	arylacetamide deacetylase (esterase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205969_at	140	0.242857	0.00138428	0.0334326	-0.914039	0.0290613	-1.99134	0.14 [0.02 - 0.82]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AADAT	aminoadipate aminotransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1726986	165	0.472727	0.128313	-	-0.365726	0.754843	-0.0586293	0.94 [0.65 - 1.36]
GENE	AADAT	aminoadipate aminotransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1726986	165	0.193939	0.0245835	0.30943	-0.834744	0.530215	-0.172285	0.84 [0.49 - 1.44]
GENE	AADAT	aminoadipate aminotransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P253484	117	0.102564	0.0159229	0.227651	2.0603	0.245554	0.149961	1.16 [0.90 - 1.50]
GENE	AADAT	aminoadipate aminotransferase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010038	41	0.390244	0.23404	-	-0.493233	0.978552	-0.00872719	0.99 [0.52 - 1.87]
GENE	AADAT	aminoadipate aminotransferase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	795	50	0.7	0.167693	-	0.673996	0.589084	0.205264	1.23 [0.58 - 2.59]
GENE	AADAT	aminoadipate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36066	56	0.125	0.166231	-	1.31377	0.620329	0.133328	1.14 [0.67 - 1.94]
GENE	AADAT	aminoadipate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36066	56	0.125	0.124096	-	1.43669	0.641947	0.118694	1.13 [0.68 - 1.86]
GENE	AADAT	aminoadipate aminotransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P253484	110	0.272727	0.000225807	0.00714289	-1.05607	0.027868	-0.371608	0.69 [0.50 - 0.96]
GENE	AADAT	aminoadipate aminotransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P253484	110	0.3	0.00137894	0.0333255	-0.743792	0.0379542	-0.276985	0.76 [0.58 - 0.98]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207225_at	30	0.433333	0.000746864	0.0199305	1.53876	0.119127	1.4428	4.23 [0.69 - 25.98]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1729835	165	0.454545	0.0162527	0.231049	-0.57826	0.280585	-1.09038	0.34 [0.05 - 2.44]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1729835	165	0.163636	0.111517	-	1.10537	0.988585	0.0207767	1.02 [0.06 - 17.58]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207225_at	163	0.331288	0.190449	-	-0.2688	0.586526	-0.285405	0.75 [0.27 - 2.10]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207225_at	79	0.64557	0.00619045	0.11185	-0.942996	0.082473	-1.36784	0.25 [0.05 - 1.19]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207225_at	58	0.655172	0.172048	-	-0.393909	0.895297	0.0243676	1.02 [0.71 - 1.47]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207225_at	34	0.235294	0.0520441	-	-0.815545	0.442626	-0.200807	0.82 [0.49 - 1.37]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207225_at	158	0.132911	0.0944265	-	0.696306	0.842687	-0.170472	0.84 [0.16 - 4.54]
GENE	AANAT	aralkylamine N-acetyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207225_at	53	0.45283	0.0347874	0.390761	0.744592	0.843527	0.0459595	1.05 [0.66 - 1.65]
GENE	AANAT	aralkylamine N-acetyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207225_at	53	0.45283	0.0256486	0.318576	0.844427	0.598766	0.129178	1.14 [0.70 - 1.84]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207225_at	180	0.316667	0.0121095	0.186285	0.598731	0.0809471	0.287975	1.33 [0.97 - 1.84]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207225_at	559	0.107335	0.00645055	0.115481	-0.731192	0.0368396	-0.30894	0.73 [0.55 - 0.98]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207225_at	77	0.558442	0.0414899	0.437747	0.512671	0.554269	0.125732	1.13 [0.75 - 1.72]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207225_at	70	0.114286	0.281488	-	0.461541	0.604544	0.460998	1.59 [0.28 - 9.08]
GENE	AANAT	aralkylamine N-acetyltransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36332_at	50	0.82	0.20951	-	-0.541335	0.376446	-2.04399	0.13 [0.00 - 12.01]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207225_at	74	0.391892	0.0642547	-	0.562988	0.645809	0.135533	1.15 [0.64 - 2.04]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207225_at	67	0.208955	0.346857	-	-0.653853	0.860598	-0.429096	0.65 [0.01 - 78.26]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207225_at	115	0.634783	0.0151337	0.219414	-2.10884	0.555929	-0.240893	0.79 [0.35 - 1.75]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36332_at	158	0.335443	0.354488	-	-0.281286	0.876244	-0.057156	0.94 [0.46 - 1.94]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36332_at	76	0.236842	0.0554977	-	-0.980219	0.329806	-1.07491	0.34 [0.04 - 2.97]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207225_at	204	0.348039	0.0926348	-	0.250663	0.303244	0.0871231	1.09 [0.92 - 1.29]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207225_at	87	0.528736	0.00237903	0.052196	1.20031	0.0596081	1.66393	5.28 [0.93 - 29.82]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207225_at	87	0.528736	0.00237903	0.052196	1.20031	0.0596081	1.66393	5.28 [0.93 - 29.82]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207225_at	77	0.350649	0.125363	-	-0.829688	0.524807	-0.994517	0.37 [0.02 - 7.93]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207225_at	77	0.350649	0.0992838	-	-1.02055	0.652242	-0.800402	0.45 [0.01 - 14.60]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207225_at	136	0.198529	0.302568	-	-0.501864	0.565766	-0.222749	0.80 [0.37 - 1.71]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207225_at	200	0.895	0.00397229	0.0788836	0.98987	0.424183	0.183009	1.20 [0.77 - 1.88]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6345	60	0.133333	0.0771259	-	1.61929	0.0966272	0.64942	1.91 [0.89 - 4.12]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6345	60	0.75	0.0130156	0.196489	0.955755	0.0482993	0.533271	1.70 [1.00 - 2.89]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3203	155	0.367742	0.00281168	0.0597769	1.00687	0.0119618	0.346415	1.41 [1.08 - 1.85]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207225_at	286	0.590909	0.000398227	0.0116605	-0.752579	0.0166927	-0.422766	0.66 [0.46 - 0.93]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207225_at	159	0.150943	0.0517486	-	1.31406	0.462096	0.227874	1.26 [0.68 - 2.31]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207225_at	159	0.389937	0.0954573	-	-0.610443	0.921695	-0.0364727	0.96 [0.47 - 2.00]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207225_at	159	0.389937	0.0164185	0.232746	-0.745719	0.796186	-0.0816157	0.92 [0.50 - 1.71]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207225_at	54	0.111111	0.484629	-	-0.565151	0.641725	-0.85664	0.42 [0.01 - 15.67]
GENE	AANAT	aralkylamine N-acetyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207225_at	117	0.811966	0.337661	-	-0.456217	0.584698	-0.639938	0.53 [0.05 - 5.23]
GENE	AANAT	aralkylamine N-acetyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207225_at	117	0.760684	0.209494	-	-0.666114	0.521489	-0.897025	0.41 [0.03 - 6.33]
GENE	AANAT	aralkylamine N-acetyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207225_at	117	0.760684	0.113108	-	-0.936141	0.531167	-0.872995	0.42 [0.03 - 6.42]
GENE	AANAT	aralkylamine N-acetyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207225_at	117	0.811966	0.337661	-	-0.456217	0.584698	-0.639938	0.53 [0.05 - 5.23]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207225_at	236	0.889831	0.0237249	0.301929	0.772565	0.0275468	0.780408	2.18 [1.09 - 4.37]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207225_at	249	0.75502	0.0316778	0.367361	0.486531	0.0130102	0.698242	2.01 [1.16 - 3.49]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207225_at	54	0.314815	0.039687	0.425538	15.5901	0.672484	-0.139343	0.87 [0.46 - 1.66]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207225_at	62	0.854839	0.137846	-	-1.42126	0.661087	-0.1186	0.89 [0.52 - 1.51]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207225_at	125	0.136	0.0930609	-	-0.718922	0.555034	-0.581389	0.56 [0.08 - 3.85]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207225_at	125	0.688	0.271191	-	-0.411522	0.748757	-0.24559	0.78 [0.17 - 3.52]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207225_at	198	0.186869	0.00188052	0.0430617	-0.718929	0.0160044	-0.352629	0.70 [0.53 - 0.94]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207225_at	198	0.570707	0.166595	-	-0.368073	0.313378	-0.170695	0.84 [0.60 - 1.17]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207225_at	198	0.570707	0.102365	-	-0.457806	0.290531	-0.189716	0.83 [0.58 - 1.18]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207225_at	51	0.607843	0.0459088	0.466458	1.92518	0.281365	2.90101	18.19 [0.09 - 3566.04]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207225_at	62	0.790323	0.0807082	-	-15.3683	0.38113	-1.63006	0.20 [0.01 - 7.52]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207225_at	177	0.762712	0.119226	-	-0.472903	0.375017	-0.932863	0.39 [0.05 - 3.09]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207225_at	145	0.758621	0.0694152	-	-0.850425	0.310302	-1.5497	0.21 [0.01 - 4.24]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207225_at	177	0.762712	0.121519	-	-0.558296	0.336603	-1.16434	0.31 [0.03 - 3.36]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207225_at	226	0.433628	0.0593708	-	-0.532409	0.752469	-0.0731166	0.93 [0.59 - 1.46]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207225_at	55	0.890909	0.00263586	0.056731	1.49319	0.151835	2.57891	13.18 [0.39 - 448.56]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207225_at	49	0.244898	0.250017	-	-0.66299	0.613925	-1.1323	0.32 [0.00 - 26.23]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207225_at	55	0.236364	0.233783	-	-0.551432	0.750849	-0.572072	0.56 [0.02 - 19.28]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	395440	34	0.264706	0.0723222	-	1.07842	0.233177	0.433966	1.54 [0.76 - 3.15]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207225_at	63	0.301587	0.00178063	0.0411713	-1.02239	0.0384761	-19.4068	0.00 [0.00 - 0.36]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501844_3p_at	28	0.25	0.0936952	-	-0.960981	0.557329	-5.05022	0.01 [0.00 - 135655.41]
GENE	AANAT	aralkylamine N-acetyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207225_at	82	0.865854	0.253508	-	0.505908	0.57533	0.216921	1.24 [0.58 - 2.65]
GENE	AANAT	aralkylamine N-acetyltransferase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36332_at	84	0.607143	0.0543236	-	-0.593579	0.116824	-1.02674	0.36 [0.10 - 1.29]
GENE	AANAT	aralkylamine N-acetyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207225_at	79	0.835443	0.0129069	0.195278	0.773263	0.768267	0.0923082	1.10 [0.59 - 2.03]
GENE	AANAT	aralkylamine N-acetyltransferase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U40391_rna1_at	86	0.244186	0.0153513	0.221701	1.63903	0.480532	0.639355	1.90 [0.32 - 11.20]
GENE	AANAT	aralkylamine N-acetyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207225_at	104	0.355769	0.106506	-	-0.519374	0.373531	-0.365007	0.69 [0.31 - 1.55]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P152527	117	0.42735	0.00188558	0.0431568	-0.885082	0.0180087	-1.2939	0.27 [0.09 - 0.80]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207225_at	204	0.544118	0.00497468	0.0942655	1.04352	0.0495826	0.408739	1.50 [1.00 - 2.26]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207225_at	204	0.426471	0.00352623	0.0717269	0.878499	0.0486088	0.327123	1.39 [1.00 - 1.92]
GENE	AANAT	aralkylamine N-acetyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207225_at	178	0.280899	0.0591305	-	-0.402473	0.755484	0.050781	1.05 [0.76 - 1.45]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300006147	41	0.146341	0.177393	-	-0.731018	0.706678	-0.137132	0.87 [0.43 - 1.78]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207225_at	111	0.207207	0.0504432	-	-0.579616	0.400272	-0.178062	0.84 [0.55 - 1.27]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207225_at	90	0.844444	0.0674685	-	0.687812	0.243723	0.788063	2.20 [0.58 - 8.27]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207225_at	90	0.888889	0.0782472	-	0.789962	0.140812	1.04456	2.84 [0.71 - 11.41]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207225_at	138	0.101449	0.0015306	0.0363369	-0.95166	0.0246061	-15.2651	0.00 [0.00 - 0.14]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207225_at	129	0.806202	0.0104955	0.167436	0.694378	0.225117	0.381898	1.47 [0.79 - 2.72]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10064	56	0.607143	0.229021	-	-0.452701	0.866595	-0.10071	0.90 [0.28 - 2.93]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10064	56	0.571429	0.112844	-	-0.638731	0.437358	-0.510844	0.60 [0.17 - 2.18]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207225_at	278	0.852518	0.109338	-	0.370877	0.546181	0.329654	1.39 [0.48 - 4.06]
GENE	AANAT	aralkylamine N-acetyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207225_at	133	0.834586	0.000927624	0.023927	0.905068	0.0438727	4.30364	73.97 [1.13 - 4861.88]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207225_at	185	0.745946	0.0575223	-	0.373467	0.968286	-0.0174127	0.98 [0.42 - 2.32]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207225_at	185	0.740541	0.0413558	0.436849	0.372956	0.45795	0.298056	1.35 [0.61 - 2.96]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152527	110	0.672727	0.0815018	-	-0.604563	0.361395	-0.451236	0.64 [0.24 - 1.68]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152527	110	0.345455	0.213942	-	0.310234	0.843149	-0.0702919	0.93 [0.46 - 1.87]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207225_at	80	0.125	0.000557815	0.0155567	-1.60785	0.487939	-0.192918	0.82 [0.48 - 1.42]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0265	281	0.153025	0.0441661	0.455334	0.424857	0.306548	0.133502	1.14 [0.88 - 1.48]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207225_at	38	0.552632	0.0103248	0.165388	-1.32864	0.141659	-0.45929	0.63 [0.34 - 1.17]
GENE	AANAT	aralkylamine N-acetyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207225_at	140	0.128571	0.0242728	0.306729	-0.814775	0.4105	-1.13533	0.32 [0.02 - 4.80]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214829_at	30	0.7	0.219275	-	-0.561102	0.411482	-0.432085	0.65 [0.23 - 1.82]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210852_s_at	30	0.5	0.08775	-	-0.688945	0.299522	-0.595769	0.55 [0.18 - 1.70]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1678323	165	0.521212	0.00157009	0.0371107	-0.785032	0.0385851	-0.380532	0.68 [0.48 - 0.98]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1678323	165	0.49697	0.00226433	0.0501352	-1.14068	0.0483869	-0.549262	0.58 [0.33 - 1.00]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210852_s_at	163	0.110429	0.0972826	-	0.571626	0.737406	-0.145915	0.86 [0.37 - 2.03]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214829_at	163	0.177914	0.101752	-	-0.40656	0.985409	-0.00712543	0.99 [0.46 - 2.13]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210852_s_at	79	0.898734	0.0130191	0.196528	0.990293	0.208685	0.389708	1.48 [0.80 - 2.71]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214829_at	79	0.443038	0.0436349	0.451892	0.613835	0.179733	0.361319	1.44 [0.85 - 2.43]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210852_s_at	58	0.189655	0.0495895	0.489156	-0.662346	0.892739	0.0237408	1.02 [0.73 - 1.45]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214829_at	58	0.155172	0.0569918	-	0.76796	0.203461	0.148027	1.16 [0.92 - 1.46]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210852_s_at	34	0.235294	0.0635503	-	-0.787995	0.473176	-0.191308	0.83 [0.49 - 1.39]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214829_at	34	0.294118	0.0366438	0.404224	-0.84434	0.536922	-0.0938033	0.91 [0.68 - 1.23]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210852_s_at	158	0.892405	0.00946213	0.154865	-1.41044	0.801505	-0.147886	0.86 [0.27 - 2.73]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214829_at	158	0.860759	0.00334768	0.0688004	-1.56417	0.0203988	-1.16412	0.31 [0.12 - 0.84]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214829_at	53	0.849057	0.0146908	0.214722	0.957745	0.473761	-0.098147	0.91 [0.69 - 1.19]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210852_s_at	53	0.679245	0.000796988	0.021055	1.2104	0.0190343	0.540173	1.72 [1.09 - 2.70]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214829_at	53	0.849057	0.0201349	0.26922	0.972401	0.918192	-0.0147801	0.99 [0.74 - 1.31]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210852_s_at	53	0.660377	0.00452546	0.0874828	0.975483	0.0645848	0.405018	1.50 [0.98 - 2.30]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214829_at	180	0.888889	0.124664	-	-0.596239	0.385994	-0.0503474	0.95 [0.85 - 1.07]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210852_s_at	180	0.894444	0.222032	-	0.39156	0.893905	0.0121085	1.01 [0.85 - 1.21]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210852_s_at	559	0.243292	0.205319	-	0.315506	0.799945	-0.039578	0.96 [0.71 - 1.31]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214829_at	559	0.323792	0.156372	-	0.336339	0.614134	0.0601435	1.06 [0.84 - 1.34]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210852_s_at	77	0.688312	0.00921555	0.151802	0.676566	0.351983	0.272886	1.31 [0.74 - 2.33]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214829_at	77	0.831169	0.000208734	0.00667099	1.14421	0.502457	0.192823	1.21 [0.69 - 2.13]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214829_at	70	0.271429	0.00751313	0.129904	0.886719	0.0274033	0.479907	1.62 [1.05 - 2.48]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210852_s_at	70	0.3	0.00787535	0.13468	0.845524	0.122037	0.384883	1.47 [0.90 - 2.39]
GENE	AASS	aminoadipate-semialdehyde synthase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35870_at	50	0.7	0.204809	-	0.444584	0.575392	0.249315	1.28 [0.54 - 3.07]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214829_at	74	0.27027	0.0179497	0.24813	-0.695193	0.164312	-0.410274	0.66 [0.37 - 1.18]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210852_s_at	74	0.689189	0.110904	-	0.47575	0.302741	0.361637	1.44 [0.72 - 2.86]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214829_at	67	0.253731	0.109986	-	15.4267	0.710203	0.220795	1.25 [0.39 - 4.00]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210852_s_at	67	0.656716	0.180265	-	-1.33316	0.40097	-0.510131	0.60 [0.18 - 1.97]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214829_at	115	0.826087	0.0747692	-	-15.3292	0.612374	-0.204674	0.81 [0.37 - 1.80]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210852_s_at	115	0.8	0.0518817	-	-15.3863	0.760291	-0.126394	0.88 [0.39 - 1.98]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35870_at	158	0.746835	0.0942538	-	-0.591701	0.263088	-0.216408	0.81 [0.55 - 1.18]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35870_at	76	0.618421	0.530062	-	-0.342519	0.90114	-0.0431363	0.96 [0.48 - 1.89]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214829_at	204	0.838235	0.0225289	0.29128	-0.455833	0.203983	-0.120556	0.89 [0.74 - 1.07]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210852_s_at	204	0.72549	0.0877345	-	-0.272631	0.501009	-0.0585313	0.94 [0.80 - 1.12]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210852_s_at	87	0.528736	0.00373659	0.0751286	-1.25371	0.0117719	-1.40236	0.25 [0.08 - 0.73]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214829_at	87	0.632184	0.0226283	0.292175	-1.07334	0.161814	-0.757074	0.47 [0.16 - 1.35]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214829_at	87	0.632184	0.0226283	0.292175	-1.07334	0.161814	-0.757074	0.47 [0.16 - 1.35]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210852_s_at	87	0.528736	0.00373659	0.0751286	-1.25371	0.0117719	-1.40236	0.25 [0.08 - 0.73]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214829_at	77	0.493506	0.00478729	0.0914566	-1.88171	0.0574738	-1.1501	0.32 [0.10 - 1.04]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210852_s_at	77	0.415584	0.0212191	0.279339	-1.29545	0.176065	-1.18515	0.31 [0.05 - 1.70]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214829_at	77	0.467532	0.0204589	0.272267	-1.64352	0.114333	-1.09934	0.33 [0.09 - 1.30]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210852_s_at	77	0.415584	0.179337	-	-0.843147	0.645298	-0.407778	0.67 [0.12 - 3.78]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214829_at	136	0.213235	0.0350847	0.392942	-0.973241	0.0769357	-0.321179	0.73 [0.51 - 1.04]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210852_s_at	136	0.625	0.0215938	0.282786	-1.28291	0.118552	-0.350712	0.70 [0.45 - 1.09]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214829_at	200	0.225	0.0001614	0.0053308	-1.07912	0.0275286	-0.287267	0.75 [0.58 - 0.97]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210852_s_at	200	0.155	0.000240381	0.00754149	-1.12244	0.00299455	-0.44258	0.64 [0.48 - 0.86]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3219	60	0.75	0.0531263	-	0.769281	0.779863	-0.0697113	0.93 [0.57 - 1.52]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	307	60	0.666667	0.257121	-	0.4407	0.742691	0.063261	1.07 [0.73 - 1.55]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	307	60	0.333333	0.140531	-	-0.567287	0.811353	-0.0864925	0.92 [0.45 - 1.87]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3219	60	0.116667	0.0105069	0.167572	-1.25218	0.528094	-0.249641	0.78 [0.36 - 1.69]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13021	155	0.16129	0.00680694	0.120391	-0.797443	0.173795	-0.403784	0.67 [0.37 - 1.19]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214829_at	286	0.363636	0.0023086	0.0509334	-0.581919	0.0489495	-0.156072	0.86 [0.73 - 1.00]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210852_s_at	286	0.821678	0.0324606	0.373356	-0.643585	0.0922551	-0.200604	0.82 [0.65 - 1.03]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210852_s_at	159	0.113208	0.0022728	0.0502882	-1.24925	0.163879	-0.315215	0.73 [0.47 - 1.14]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214829_at	159	0.471698	0.023731	0.301982	-0.724657	0.286461	-0.135489	0.87 [0.68 - 1.12]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210852_s_at	159	0.113208	0.00170301	0.0396867	-1.1321	0.0441581	-0.388005	0.68 [0.46 - 0.99]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214829_at	159	0.421384	0.0172318	0.240983	-0.883989	0.104579	-0.236555	0.79 [0.59 - 1.05]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214829_at	159	0.786164	0.0504628	-	-0.990414	0.172877	-0.173766	0.84 [0.65 - 1.08]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210852_s_at	159	0.113208	0.00437915	0.085236	-1.0381	0.245436	-0.220259	0.80 [0.55 - 1.16]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210852_s_at	54	0.444444	0.243364	-	-0.764622	0.644127	-0.666656	0.51 [0.03 - 8.69]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214829_at	54	0.574074	0.0512822	-	-1.81364	0.283678	-1.26828	0.28 [0.03 - 2.86]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210852_s_at	117	0.717949	0.283388	-	-0.405184	0.534146	0.340253	1.41 [0.48 - 4.11]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210852_s_at	117	0.512821	0.241152	-	0.450592	0.650083	0.288956	1.34 [0.38 - 4.65]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210852_s_at	117	0.162393	0.0618462	-	-0.800919	0.970988	-0.0264769	0.97 [0.23 - 4.06]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210852_s_at	117	0.717949	0.283388	-	-0.405184	0.534146	0.340253	1.41 [0.48 - 4.11]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214829_at	117	0.17094	0.0466247	0.470956	1.34092	0.765987	0.12342	1.13 [0.50 - 2.55]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214829_at	117	0.111111	0.0570986	-	15.1947	0.549959	0.273553	1.31 [0.54 - 3.22]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214829_at	117	0.444444	0.0229744	0.295274	-0.886625	0.705299	0.194192	1.21 [0.44 - 3.32]
GENE	AASS	aminoadipate-semialdehyde synthase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214829_at	117	0.17094	0.0466247	0.470956	1.34092	0.765987	0.12342	1.13 [0.50 - 2.55]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210852_s_at	236	0.381356	0.00051955	0.0146419	-0.912522	0.00837123	-0.421974	0.66 [0.48 - 0.90]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214829_at	236	0.105932	0.00437022	0.0850983	-0.927885	0.0331944	-0.318272	0.73 [0.54 - 0.97]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210852_s_at	249	0.26506	0.00217543	0.0485219	-0.667822	0.0197216	-0.316489	0.73 [0.56 - 0.95]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214829_at	249	0.35743	0.00072143	0.0193547	-0.704424	0.000347495	-0.440308	0.64 [0.51 - 0.82]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214829_at	54	0.796296	0.0896416	-	-1.64639	0.451688	-0.172517	0.84 [0.54 - 1.32]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210852_s_at	62	0.145161	0.0132624	0.199226	-1.34861	0.387342	-0.220402	0.80 [0.49 - 1.32]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210852_s_at	125	0.888	0.0794102	-	-15.1803	0.143344	-0.654157	0.52 [0.22 - 1.25]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214829_at	62	0.774194	0.103756	-	-1.04095	0.380936	-0.166856	0.85 [0.58 - 1.23]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210852_s_at	125	0.568	0.241805	-	-0.381282	0.52192	-0.2158	0.81 [0.42 - 1.56]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214829_at	125	0.768	0.147983	-	-0.860598	0.390484	-0.425979	0.65 [0.25 - 1.73]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210852_s_at	54	0.111111	0.00426877	0.0835281	-1.76343	0.446652	-0.234582	0.79 [0.43 - 1.45]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214829_at	125	0.616	0.152507	-	-0.482268	0.870181	-0.0616548	0.94 [0.45 - 1.97]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214829_at	198	0.878788	0.0743868	-	-0.68922	0.596333	-0.0310924	0.97 [0.86 - 1.09]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210852_s_at	198	0.277778	0.0465464	0.470466	-0.520559	0.160813	-0.120767	0.89 [0.75 - 1.05]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210852_s_at	198	0.277778	0.0968831	-	-0.454765	0.304103	-0.0936736	0.91 [0.76 - 1.09]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214829_at	198	0.358586	0.185122	-	-0.343604	0.60162	-0.0362604	0.96 [0.84 - 1.11]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214829_at	198	0.388889	0.0965976	-	-0.442554	0.440661	-0.0544949	0.95 [0.82 - 1.09]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210852_s_at	198	0.808081	0.380553	-	0.227438	0.847925	-0.0140731	0.99 [0.85 - 1.14]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210852_s_at	51	0.686275	0.189746	-	1.13534	0.849171	0.19816	1.22 [0.16 - 9.40]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210852_s_at	62	0.564516	0.286965	-	-0.641422	0.684549	-0.38672	0.68 [0.11 - 4.39]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214829_at	51	0.627451	0.00276567	0.0589842	16.958	0.383838	1.76965	5.87 [0.11 - 315.00]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214829_at	62	0.177419	0.10746	-	15.315	0.871567	0.294402	1.34 [0.04 - 47.64]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214829_at	145	0.137931	0.217414	-	0.728372	0.236992	0.506321	1.66 [0.72 - 3.84]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210852_s_at	177	0.141243	0.119236	-	-0.473049	0.567588	-0.284466	0.75 [0.28 - 2.00]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214829_at	177	0.887006	0.0375192	0.410449	0.71376	0.0612336	0.525176	1.69 [0.98 - 2.93]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210852_s_at	145	0.124138	0.0155701	0.223988	-0.947597	0.765218	-0.217585	0.80 [0.19 - 3.36]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210852_s_at	177	0.107345	0.0614447	-	-0.670481	0.467781	-0.426306	0.65 [0.21 - 2.06]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214829_at	177	0.887006	0.0572123	-	0.592781	0.113737	0.406176	1.50 [0.91 - 2.48]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210852_s_at	226	0.163717	0.0294386	0.349801	1.22206	0.11444	0.226919	1.25 [0.95 - 1.66]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214829_at	226	0.672566	0.000617928	0.0169723	0.935963	0.0602031	0.435818	1.55 [0.98 - 2.44]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210852_s_at	55	0.127273	0.0930693	-	15.235	0.943623	0.0774003	1.08 [0.13 - 9.23]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210852_s_at	55	0.127273	0.185503	-	1.27206	0.878752	0.149619	1.16 [0.17 - 7.94]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210852_s_at	49	0.632653	0.143918	-	-0.94204	0.728236	-0.566656	0.57 [0.02 - 13.87]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214829_at	55	0.836364	0.00120637	0.0298157	1.42461	0.0212781	0.780878	2.18 [1.12 - 4.24]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214829_at	55	0.563636	0.000548381	0.0153322	1.72114	0.0181521	0.826867	2.29 [1.15 - 4.54]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214829_at	49	0.571429	0.00167911	0.0392268	2.05874	0.0355292	0.866821	2.38 [1.06 - 5.34]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210852_s_at	63	0.619048	0.0716558	-	-0.664739	0.547015	0.109361	1.12 [0.78 - 1.59]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214829_at	63	0.206349	0.133911	-	0.710976	0.53475	-0.174139	0.84 [0.48 - 1.46]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7264723_3p_s_at	28	0.857143	0.0301724	0.355624	1.23416	0.844987	-0.0808694	0.92 [0.41 - 2.07]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.323091.0.S1_3p_at	28	0.178571	0.0520299	-	-1.14611	0.748349	-0.170141	0.84 [0.30 - 2.39]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214829_at	82	0.5	0.00106738	0.0269167	-1.14268	0.0419103	-0.486015	0.62 [0.39 - 0.98]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210852_s_at	82	0.621951	0.00187434	0.0429454	-1.24246	0.175479	-0.304504	0.74 [0.47 - 1.15]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214829_at	79	0.56962	0.147465	-	0.374674	0.522683	0.103507	1.11 [0.81 - 1.52]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210852_s_at	79	0.556962	0.198669	-	0.332908	0.532504	0.104544	1.11 [0.80 - 1.54]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214829_at	104	0.173077	0.00921449	0.151789	-0.880392	0.221578	-0.246338	0.78 [0.53 - 1.16]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210852_s_at	104	0.471154	0.0591896	-	-0.623815	0.385201	-0.197016	0.82 [0.53 - 1.28]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P8754	117	0.74359	0.0980593	-	0.49176	0.568428	0.0896413	1.09 [0.80 - 1.49]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214829_at	204	0.642157	0.0178859	0.2475	-1.10389	0.042317	-0.703318	0.49 [0.25 - 0.98]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214829_at	204	0.151961	6.13599e-09	4.67114e-07	-1.52101	4.12668e-07	-1.41737	0.24 [0.14 - 0.42]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210852_s_at	204	0.269608	0.0145279	0.212982	-0.874193	0.5033	-0.256839	0.77 [0.36 - 1.64]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210852_s_at	204	0.279412	0.00024347	0.0076255	-0.964892	0.0206996	-0.684927	0.50 [0.28 - 0.90]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210852_s_at	178	0.52809	0.0675204	-	-0.364996	0.352212	-0.11731	0.89 [0.69 - 1.14]
GENE	AASS	aminoadipate-semialdehyde synthase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214829_at	178	0.353933	0.0140057	0.20736	-0.485526	0.0590491	-0.237146	0.79 [0.62 - 1.01]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300018760	41	0.804878	0.197681	-	-0.779478	0.477312	-0.167498	0.85 [0.53 - 1.34]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214829_at	111	0.810811	0.141504	-	-0.552451	0.645968	-0.0673633	0.93 [0.70 - 1.25]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210852_s_at	111	0.882883	0.146051	-	-0.736193	0.488833	-0.138344	0.87 [0.59 - 1.29]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210852_s_at	90	0.6	0.143478	-	-0.505463	0.484622	-0.283314	0.75 [0.34 - 1.67]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210852_s_at	90	0.377778	0.0731755	-	-0.655346	0.334062	-0.468515	0.63 [0.24 - 1.62]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214829_at	90	0.622222	0.00145705	0.0348844	-1.25299	0.00494179	-1.69375	0.18 [0.06 - 0.60]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214829_at	90	0.611111	0.00296388	0.0623777	-1.35809	0.00907183	-1.8078	0.16 [0.04 - 0.64]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214829_at	138	0.297101	0.111952	-	-0.397112	0.539134	0.0852288	1.09 [0.83 - 1.43]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210852_s_at	138	0.115942	0.139243	-	0.674759	0.376786	0.11585	1.12 [0.87 - 1.45]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214829_at	129	0.271318	0.000367866	0.0108923	-0.882449	0.0249339	-0.324086	0.72 [0.54 - 0.96]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210852_s_at	129	0.395349	0.00368067	0.074229	-0.707744	0.0332417	-0.369352	0.69 [0.49 - 0.97]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	841	56	0.107143	0.045603	0.464524	-0.957435	0.313638	-0.168667	0.84 [0.61 - 1.17]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	841	56	0.107143	0.170281	-	-0.657608	0.418674	-0.125587	0.88 [0.65 - 1.20]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214829_at	278	0.143885	0.0889887	-	-0.405219	0.929693	-0.0151096	0.99 [0.70 - 1.38]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210852_s_at	278	0.241007	0.0153265	0.221441	-0.488407	0.72977	-0.055249	0.95 [0.69 - 1.29]
GENE	AASS	aminoadipate-semialdehyde synthase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210852_s_at	133	0.323308	0.00870893	0.145426	0.729298	0.103543	0.278971	1.32 [0.94 - 1.85]
GENE	AASS	aminoadipate-semialdehyde synthase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214829_at	133	0.105263	0.0788501	-	0.878164	0.672595	0.0866007	1.09 [0.73 - 1.63]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210852_s_at	185	0.135135	0.0561092	-	0.571651	0.390571	0.287475	1.33 [0.69 - 2.57]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214829_at	185	0.897297	0.000335423	0.0100599	0.898949	0.0358391	0.752619	2.12 [1.05 - 4.29]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210852_s_at	185	0.864865	0.198106	-	0.303507	0.867277	0.0531887	1.05 [0.57 - 1.97]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214829_at	185	0.897297	4.11878e-05	0.00159527	1.03195	0.00290937	1.1037	3.02 [1.46 - 6.24]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P8754	110	0.890909	0.0606837	-	-0.772575	0.283573	-0.0845694	0.92 [0.79 - 1.07]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P8754	110	0.890909	0.0587354	-	-1.07993	0.567393	-0.0567075	0.94 [0.78 - 1.15]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214829_at	80	0.7875	0.245973	-	-0.840467	0.613067	-0.0612025	0.94 [0.74 - 1.19]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210852_s_at	80	0.475	0.080805	-	0.791326	0.259173	0.174982	1.19 [0.88 - 1.61]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210852_s_at	38	0.842105	0.0213643	0.280678	1.29817	0.195006	0.713659	2.04 [0.69 - 6.01]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214829_at	38	0.5	0.117384	-	0.742854	0.124731	0.660366	1.94 [0.83 - 4.50]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210852_s_at	140	0.457143	0.203225	-	-0.369295	0.983851	0.00414305	1.00 [0.67 - 1.50]
GENE	AASS	aminoadipate-semialdehyde synthase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214829_at	140	0.192857	0.063202	-	-0.598369	0.962571	-0.0126167	0.99 [0.58 - 1.67]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206527_at	30	0.8	0.155448	-	0.681505	0.662648	0.211308	1.24 [0.48 - 3.19]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209459_s_at	30	0.233333	0.272356	-	-0.485995	0.982967	-0.00331993	1.00 [0.73 - 1.35]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209460_at	30	0.266667	0.261455	-	-0.476099	0.996011	-0.000807474	1.00 [0.73 - 1.37]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1670117	165	0.606061	0.00267435	0.0574017	-0.773625	0.0295246	-0.507345	0.60 [0.38 - 0.95]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1670117	165	0.50303	0.000196308	0.00632392	-1.46286	0.00538213	-0.988557	0.37 [0.19 - 0.75]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209459_s_at	163	0.141104	0.0682124	-	0.599254	0.916877	0.0157944	1.02 [0.76 - 1.37]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209460_at	163	0.128834	0.0420725	0.441629	0.69662	0.98335	0.00401811	1.00 [0.69 - 1.46]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206527_at	163	0.631902	0.0167739	0.236365	0.469334	0.499265	0.406763	1.50 [0.46 - 4.89]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206527_at	79	0.189873	0.0696967	-	-0.600329	0.21136	-1.04946	0.35 [0.07 - 1.82]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209460_at	79	0.822785	0.117325	-	-0.726253	0.343045	-0.22792	0.80 [0.50 - 1.28]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209459_s_at	79	0.797468	0.153359	-	-0.615779	0.412349	-0.152637	0.86 [0.60 - 1.24]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206527_at	58	0.327586	0.0983002	-	0.494852	0.329632	0.13258	1.14 [0.87 - 1.49]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209459_s_at	58	0.827586	0.016351	0.232056	-0.911705	0.0941963	-0.320667	0.73 [0.50 - 1.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209460_at	58	0.689655	0.129611	-	-0.455319	0.685138	0.0696241	1.07 [0.77 - 1.50]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206527_at	34	0.5	0.160661	-	0.553962	0.609556	0.107797	1.11 [0.74 - 1.68]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209459_s_at	34	0.882353	0.358926	-	0.498324	0.924947	-0.0180377	0.98 [0.67 - 1.43]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209460_at	34	0.617647	0.272434	-	-0.443654	0.844932	-0.0354107	0.97 [0.68 - 1.38]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209460_at	158	0.139241	1.46162e-05	0.000629686	-1.17219	0.139394	0.344299	1.41 [0.89 - 2.23]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206527_at	158	0.867089	0.0230887	0.296294	0.663065	0.170033	0.987915	2.69 [0.65 - 11.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209459_s_at	158	0.867089	0.00588575	0.10754	0.779633	0.187631	0.249763	1.28 [0.89 - 1.86]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209459_s_at	53	0.245283	0.0626167	-	0.963554	0.236668	0.326271	1.39 [0.81 - 2.38]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206527_at	53	0.113208	0.151888	-	-0.689508	0.528513	-0.179531	0.84 [0.48 - 1.46]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209460_at	53	0.113208	0.264608	-	0.796576	0.861807	0.0319279	1.03 [0.72 - 1.48]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209459_s_at	53	0.169811	0.0740964	-	1.03553	0.237636	0.304409	1.36 [0.82 - 2.25]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206527_at	53	0.113208	0.0414437	0.437438	-0.982937	0.364232	-0.279468	0.76 [0.41 - 1.38]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209460_at	53	0.113208	0.184223	-	0.934926	0.696298	0.067868	1.07 [0.76 - 1.50]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206527_at	180	0.144444	0.00632712	0.113763	-0.747898	0.0422203	-0.257756	0.77 [0.60 - 0.99]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209459_s_at	180	0.544444	0.0173838	0.242506	-0.508155	0.052614	-0.311744	0.73 [0.53 - 1.00]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209460_at	180	0.138889	0.00794793	0.135629	-0.704833	0.0480876	-0.257947	0.77 [0.60 - 1.00]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206527_at	559	0.756708	0.157674	-	-0.327084	0.712372	-0.0964347	0.91 [0.54 - 1.52]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209460_at	559	0.862254	0.0502704	-	0.505108	0.44021	0.0775043	1.08 [0.89 - 1.32]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209459_s_at	559	0.892665	0.112727	-	-0.61246	0.953039	-0.004761	1.00 [0.85 - 1.17]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206527_at	77	0.337662	0.0695308	-	-0.480979	0.34337	-0.175544	0.84 [0.58 - 1.21]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209459_s_at	77	0.727273	0.0281656	0.339533	-0.666248	0.0659484	-0.356703	0.70 [0.48 - 1.02]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209460_at	77	0.116883	0.0256429	0.318527	-0.837047	0.0424479	-0.367136	0.69 [0.49 - 0.99]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209460_at	70	0.214286	0.03312	0.37835	0.740802	0.15361	0.254311	1.29 [0.91 - 1.83]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209459_s_at	70	0.2	0.0176395	0.245056	0.85626	0.216989	0.224389	1.25 [0.88 - 1.79]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206527_at	70	0.357143	0.0309724	0.361895	0.611789	0.0997887	0.675666	1.97 [0.88 - 4.39]
GENE	ABAT	4-aminobutyrate aminotransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33446_at	50	0.24	0.0043263	0.0844197	-1.04764	0.00983112	-0.488103	0.61 [0.42 - 0.89]
GENE	ABAT	4-aminobutyrate aminotransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36364_at	50	0.36	0.00482267	0.0919892	-0.970401	0.135796	-0.414163	0.66 [0.38 - 1.14]
GENE	ABAT	4-aminobutyrate aminotransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33445_at	50	0.74	0.035922	0.399033	-0.876946	0.19899	-1.50506	0.22 [0.02 - 2.21]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206527_at	74	0.243243	0.00312136	0.0650358	-0.89929	0.0198712	-0.672824	0.51 [0.29 - 0.90]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209459_s_at	74	0.108108	0.0191938	0.260256	-1.00435	0.0537999	-0.456932	0.63 [0.40 - 1.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209460_at	74	0.837838	0.056177	-	-0.879564	0.131659	-0.363	0.70 [0.43 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206527_at	67	0.80597	0.0188568	0.257003	1.45594	0.0303059	3.66474	39.05 [1.42 - 1075.81]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209460_at	67	0.313433	0.03982	0.426449	15.6444	0.195834	0.90729	2.48 [0.63 - 9.80]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209459_s_at	67	0.238806	0.0660901	-	15.6128	0.26996	0.666627	1.95 [0.60 - 6.37]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209460_at	115	0.704348	0.0564297	-	-1.74862	0.148092	-0.326272	0.72 [0.46 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209459_s_at	115	0.426087	0.021709	0.283841	-1.2682	0.177328	-0.297937	0.74 [0.48 - 1.14]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206527_at	115	0.782609	0.172287	-	-1.3191	0.689895	-0.231439	0.79 [0.25 - 2.47]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33445_at	158	0.367089	0.0527765	-	0.650732	0.900434	0.022012	1.02 [0.72 - 1.44]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33446_at	158	0.772152	0.0115769	0.180163	-1.05436	0.0547972	-0.272546	0.76 [0.58 - 1.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36364_at	158	0.898734	0.291193	-	0.428323	0.814694	-0.0431885	0.96 [0.67 - 1.37]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33445_at	76	0.671053	0.0992552	-	-1.1832	0.323176	-0.405703	0.67 [0.30 - 1.49]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33446_at	76	0.894737	0.199424	-	0.807252	0.620678	0.135229	1.14 [0.67 - 1.96]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36364_at	76	0.342105	0.0378147	0.412533	1.45813	0.28356	0.306749	1.36 [0.78 - 2.38]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209460_at	204	0.5	3.03162e-07	1.80329e-05	-0.731051	2.34609e-05	-0.238717	0.79 [0.71 - 0.88]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209459_s_at	204	0.539216	2.18473e-06	0.000111646	-0.676124	0.000517218	-0.196898	0.82 [0.73 - 0.92]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206527_at	204	0.357843	5.67234e-06	0.000266997	-0.669895	8.46509e-05	-0.334573	0.72 [0.61 - 0.85]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206527_at	87	0.528736	0.0026818	0.0575312	-1.19256	0.0666111	-0.593445	0.55 [0.29 - 1.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209460_at	87	0.402299	0.000398026	0.0116555	-1.29138	0.0435098	-0.305107	0.74 [0.55 - 0.99]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209459_s_at	87	0.356322	0.000705827	0.0189996	-1.21982	0.0368891	-0.306166	0.74 [0.55 - 0.98]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209460_at	87	0.402299	0.000398026	0.0116555	-1.29138	0.0435098	-0.305107	0.74 [0.55 - 0.99]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206527_at	87	0.528736	0.0026818	0.0575312	-1.19256	0.0666111	-0.593445	0.55 [0.29 - 1.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209459_s_at	87	0.356322	0.000705827	0.0189996	-1.21982	0.0368891	-0.306166	0.74 [0.55 - 0.98]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209459_s_at	77	0.25974	0.0427669	0.446217	-1.20829	0.103822	-0.403196	0.67 [0.41 - 1.09]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209460_at	77	0.363636	0.0240946	0.305173	-1.21213	0.168869	-0.310359	0.73 [0.47 - 1.14]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206527_at	77	0.194805	0.0586006	-	-1.15603	0.264725	-0.836772	0.43 [0.10 - 1.88]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209459_s_at	77	0.519481	0.00881836	0.146813	-1.77352	0.0892623	-0.366894	0.69 [0.45 - 1.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206527_at	77	0.831169	0.0865353	-	-15.3297	0.265898	-0.709275	0.49 [0.14 - 1.72]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209460_at	77	0.532468	0.0621484	-	-1.36659	0.194745	-0.33695	0.71 [0.43 - 1.19]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209459_s_at	136	0.441176	0.151207	-	-0.644977	0.65881	-0.117339	0.89 [0.53 - 1.50]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209460_at	136	0.125	0.00135994	0.0329434	-1.47766	0.155942	-0.416734	0.66 [0.37 - 1.17]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206527_at	136	0.727941	0.113004	-	-1.1267	0.972125	0.00967813	1.01 [0.59 - 1.74]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206527_at	200	0.21	0.186988	-	0.536363	0.838967	0.053177	1.05 [0.63 - 1.76]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209459_s_at	200	0.125	0.00112755	0.0281801	-1.04852	0.0771692	-0.238901	0.79 [0.60 - 1.03]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209460_at	200	0.11	0.000593898	0.0164094	-1.131	0.0358742	-0.292831	0.75 [0.57 - 0.98]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8468	60	0.133333	0.0150379	0.218403	-1.0237	0.559031	-0.0925765	0.91 [0.67 - 1.24]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7756	60	0.783333	0.0342585	0.386858	-1.2253	0.153641	-0.38723	0.68 [0.40 - 1.16]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19702	60	0.383333	0.0257426	0.319375	-0.826733	0.161622	-0.246301	0.78 [0.55 - 1.10]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19702	60	0.316667	0.00170721	0.0397674	-1.13753	0.0279935	-0.35828	0.70 [0.51 - 0.96]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8468	60	0.85	0.0339279	0.384403	0.973757	0.956453	-0.0103819	0.99 [0.68 - 1.44]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7756	60	0.116667	0.0631032	-	-0.905911	0.393279	-0.323756	0.72 [0.34 - 1.52]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2582	155	0.148387	0.01459	0.213646	-0.752455	0.0147867	-0.406493	0.67 [0.48 - 0.92]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206527_at	286	0.286713	0.00128876	0.0315031	-0.635191	0.249681	-0.150926	0.86 [0.67 - 1.11]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209459_s_at	286	0.482517	0.120181	-	-0.300867	0.49992	-0.0534894	0.95 [0.81 - 1.11]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209460_at	286	0.465035	0.0333483	0.380068	-0.410214	0.220966	-0.0969721	0.91 [0.78 - 1.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209459_s_at	159	0.100629	0.017301	0.241677	-0.909711	0.0614312	-0.223646	0.80 [0.63 - 1.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206527_at	159	0.540881	0.080731	-	0.551752	0.663444	0.120664	1.13 [0.66 - 1.94]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206527_at	159	0.540881	0.131357	-	0.561676	0.904962	0.0397372	1.04 [0.54 - 2.00]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209459_s_at	159	0.36478	0.0148865	0.216801	-0.75399	0.0128077	-0.284068	0.75 [0.60 - 0.94]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209460_at	159	0.823899	0.0546796	-	-1.09785	0.33042	-0.153482	0.86 [0.63 - 1.17]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206527_at	159	0.540881	0.188279	-	0.415352	0.980345	0.00699378	1.01 [0.58 - 1.76]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209459_s_at	159	0.100629	0.00503311	0.0951355	-1.15311	0.00360758	-0.374477	0.69 [0.53 - 0.88]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209460_at	159	0.823899	0.0281613	0.339498	-1.92377	0.103443	-0.299494	0.74 [0.52 - 1.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209460_at	159	0.823899	0.021325	0.280316	-1.5202	0.161886	-0.219195	0.80 [0.59 - 1.09]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206527_at	54	0.462963	0.144834	-	-0.993362	0.554412	-0.439041	0.64 [0.15 - 2.76]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209459_s_at	54	0.87037	0.20875	-	0.990441	0.857345	0.0519372	1.05 [0.60 - 1.86]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209460_at	54	0.148148	0.142953	-	15.3756	0.608813	0.141528	1.15 [0.67 - 1.98]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209460_at	117	0.897436	0.00653649	0.116672	1.03789	0.0351885	0.203828	1.23 [1.01 - 1.48]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206527_at	117	0.760684	0.025969	0.321294	0.741036	0.395691	0.298985	1.35 [0.68 - 2.69]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209460_at	117	0.615385	0.0194583	0.262793	0.897142	0.319614	0.122757	1.13 [0.89 - 1.44]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206527_at	117	0.760684	0.00207845	0.0467453	1.11813	0.130544	0.601007	1.82 [0.84 - 3.98]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206527_at	117	0.760684	0.0470115	0.473369	0.80338	0.71622	0.159566	1.17 [0.50 - 2.77]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206527_at	117	0.760684	0.025969	0.321294	0.741036	0.395691	0.298985	1.35 [0.68 - 2.69]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209459_s_at	117	0.57265	0.00618784	0.111813	0.853781	0.0395154	0.182546	1.20 [1.01 - 1.43]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209459_s_at	117	0.700855	0.000646968	0.0176474	1.21769	0.00250644	0.330788	1.39 [1.12 - 1.73]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209460_at	117	0.615385	0.000354698	0.0105559	1.31389	0.00342076	0.341662	1.41 [1.12 - 1.77]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209459_s_at	117	0.495726	0.0317263	0.367734	0.864045	0.152453	0.160857	1.17 [0.94 - 1.46]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209459_s_at	117	0.57265	0.00618784	0.111813	0.853781	0.0395154	0.182546	1.20 [1.01 - 1.43]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209460_at	117	0.897436	0.00653649	0.116672	1.03789	0.0351885	0.203828	1.23 [1.01 - 1.48]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209459_s_at	236	0.101695	0.032843	0.376259	-0.763013	0.1256	-0.185988	0.83 [0.65 - 1.05]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209460_at	236	0.101695	0.0072351	0.126191	-0.912348	0.0217121	-0.298541	0.74 [0.57 - 0.96]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206527_at	236	0.114407	0.232608	-	0.60908	0.906785	0.0305642	1.03 [0.62 - 1.72]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209460_at	249	0.337349	0.0436211	0.451802	-0.434397	0.218816	-0.132579	0.88 [0.71 - 1.08]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206527_at	249	0.11245	0.0718292	-	0.743513	0.786981	0.0566727	1.06 [0.70 - 1.60]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209459_s_at	249	0.361446	0.0523887	-	-0.414766	0.137212	-0.15705	0.85 [0.69 - 1.05]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209459_s_at	125	0.696	0.0401247	0.42853	-0.686215	0.333498	-0.100042	0.90 [0.74 - 1.11]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209460_at	125	0.712	0.015505	0.223309	-0.850563	0.294466	-0.122802	0.88 [0.70 - 1.11]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209459_s_at	54	0.444444	0.0373298	0.409109	-1.22106	0.0888885	-0.28839	0.75 [0.54 - 1.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209460_at	125	0.224	0.0514529	-	1.32946	0.629787	0.0767796	1.08 [0.79 - 1.48]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209460_at	54	0.111111	0.00345351	0.0705395	-1.93489	0.0533032	-0.408973	0.66 [0.44 - 1.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206527_at	62	0.774194	0.278865	-	-0.631432	0.656004	-0.0817999	0.92 [0.64 - 1.32]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206527_at	125	0.272	0.150907	-	-0.550696	0.927632	0.042798	1.04 [0.41 - 2.63]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209459_s_at	62	0.612903	0.0204235	0.271936	-1.26883	0.073231	-0.249548	0.78 [0.59 - 1.02]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206527_at	125	0.28	0.0424915	0.444402	-0.583222	0.537267	-0.231872	0.79 [0.38 - 1.66]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209460_at	62	0.629032	0.02482	0.311476	-1.23643	0.0589447	-0.329342	0.72 [0.51 - 1.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209459_s_at	125	0.232	0.118538	-	0.921121	0.641144	0.0653895	1.07 [0.81 - 1.41]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206527_at	54	0.333333	0.300602	-	0.784662	0.705806	-0.0842784	0.92 [0.59 - 1.42]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209460_at	198	0.752525	0.0429828	0.447634	-0.685813	0.164314	-0.101519	0.90 [0.78 - 1.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209460_at	198	0.752525	0.00945752	0.154808	-1.00657	0.0646997	-0.13783	0.87 [0.75 - 1.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209459_s_at	198	0.888889	0.0385708	0.417826	-1.01451	0.558603	-0.0371971	0.96 [0.85 - 1.09]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206527_at	198	0.10101	0.22943	-	-0.435136	0.485088	-0.0698783	0.93 [0.77 - 1.13]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206527_at	198	0.10101	0.0936417	-	-0.602437	0.26301	-0.113907	0.89 [0.73 - 1.09]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209459_s_at	198	0.257576	0.12327	-	-0.42238	0.400627	-0.0652681	0.94 [0.80 - 1.09]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209460_at	198	0.893939	0.0164277	0.23284	-1.313	0.186049	-0.0819582	0.92 [0.82 - 1.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209459_s_at	198	0.257576	0.0630356	-	-0.527284	0.20494	-0.101678	0.90 [0.77 - 1.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206527_at	198	0.106061	0.108626	-	-0.478093	0.0986321	-0.134591	0.87 [0.75 - 1.03]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209459_s_at	62	0.693548	0.187583	-	-0.981519	0.850504	-0.0363359	0.96 [0.66 - 1.41]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209460_at	62	0.483871	0.125493	-	-0.907766	0.537717	-0.146022	0.86 [0.54 - 1.37]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209460_at	51	0.372549	0.0322406	0.371678	-2.02995	0.995874	0.00190081	1.00 [0.49 - 2.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206527_at	51	0.843137	0.00174642	0.0405186	2.31741	0.061538	3.0947	22.08 [0.86 - 566.24]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206527_at	62	0.177419	0.0790489	-	15.3712	0.20169	1.42411	4.15 [0.47 - 36.98]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209459_s_at	51	0.490196	0.130041	-	-1.53819	0.993903	0.00228827	1.00 [0.56 - 1.80]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209460_at	145	0.517241	0.0282303	0.34006	-0.757479	0.395164	-0.134029	0.87 [0.64 - 1.19]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206527_at	177	0.124294	0.0312624	0.36415	-0.722709	0.0315157	-1.14781	0.32 [0.11 - 0.90]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209459_s_at	177	0.751412	0.121751	-	-0.457638	0.583968	-0.0438337	0.96 [0.82 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206527_at	177	0.19209	0.03973	0.425833	-0.545896	0.0533981	-0.89811	0.41 [0.16 - 1.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209459_s_at	145	0.544828	0.0798518	-	-0.609995	0.363733	-0.10126	0.90 [0.73 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206527_at	145	0.8	0.0505942	-	-1.11896	0.211515	-0.844829	0.43 [0.11 - 1.62]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209460_at	177	0.740113	0.0530366	-	-0.693239	0.181401	-0.171491	0.84 [0.66 - 1.08]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209460_at	177	0.819209	0.0376754	0.411552	-0.763868	0.515749	-0.0713306	0.93 [0.75 - 1.15]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209459_s_at	177	0.706215	0.029881	0.35332	-0.743643	0.187429	-0.120988	0.89 [0.74 - 1.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209460_at	226	0.632743	0.0326363	0.374692	-0.676953	0.48466	-0.065076	0.94 [0.78 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209459_s_at	226	0.561947	0.039099	0.42149	-0.615667	0.474149	-0.0649581	0.94 [0.78 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206527_at	226	0.80531	0.0311818	0.363524	-0.980319	0.695015	0.0919749	1.10 [0.69 - 1.74]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209460_at	49	0.142857	0.124458	-	15.2929	0.540054	0.163338	1.18 [0.70 - 1.99]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206527_at	55	0.527273	0.0786708	-	-0.834444	0.4775	-0.724536	0.48 [0.07 - 3.58]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209459_s_at	55	0.654545	0.0238203	0.302768	1.03615	0.0791421	0.297289	1.35 [0.97 - 1.88]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209459_s_at	49	0.285714	0.0816114	-	1.63246	0.432085	0.159611	1.17 [0.79 - 1.75]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206527_at	55	0.2	0.0817849	-	1.61149	0.396722	0.928048	2.53 [0.30 - 21.64]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206527_at	49	0.204082	0.134056	-	1.44669	0.722751	0.450759	1.57 [0.13 - 18.93]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209460_at	55	0.145455	0.155368	-	1.35266	0.965042	0.00879315	1.01 [0.68 - 1.49]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209460_at	55	0.836364	0.00464359	0.0892829	1.42616	0.106742	0.35299	1.42 [0.93 - 2.19]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209459_s_at	55	0.272727	0.160225	-	0.853465	0.941589	0.0111121	1.01 [0.75 - 1.36]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	171774	34	0.794118	0.0195727	0.263886	-2.03463	0.83194	-0.13174	0.88 [0.26 - 2.96]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209459_s_at	63	0.619048	0.00829006	0.140068	-1.03019	0.233865	-0.180735	0.83 [0.62 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206527_at	63	0.253968	0.00767447	0.132039	-0.908371	0.0951405	-14.9463	0.00 [0.00 - 13.56]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209460_at	63	0.746032	0.0770854	-	-0.776347	0.325829	-0.156627	0.86 [0.63 - 1.17]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9963907_3p_s_at	28	0.392857	0.0484442	0.482205	-1.02621	0.352921	-0.443717	0.64 [0.25 - 1.64]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501846_3p_at	28	0.607143	0.348809	-	-0.51911	0.28785	1.14974	3.16 [0.38 - 26.31]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209459_s_at	82	0.243902	0.111337	-	0.754192	0.819019	-0.035063	0.97 [0.72 - 1.30]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209460_at	82	0.378049	0.175802	-	-0.455373	0.642603	-0.0792613	0.92 [0.66 - 1.29]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206527_at	82	0.109756	0.044114	0.454997	1.79044	0.535406	0.329988	1.39 [0.49 - 3.95]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209459_s_at	79	0.658228	0.00401546	0.0795653	-0.829219	0.00635491	-0.321583	0.73 [0.58 - 0.91]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209460_at	79	0.139241	0.000551836	0.0154145	-1.18239	0.00663513	-0.374839	0.69 [0.52 - 0.90]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206527_at	79	0.746835	0.0560292	-	-0.597232	0.255528	-0.572837	0.56 [0.21 - 1.51]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206527_at	104	0.115385	0.0145114	0.212805	-0.993016	0.149266	-0.950587	0.39 [0.11 - 1.41]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209459_s_at	104	0.471154	5.68895e-06	0.000267709	-1.54654	0.000184527	-0.508515	0.60 [0.46 - 0.79]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209460_at	104	0.269231	1.11359e-05	0.000492498	-1.35301	0.00021096	-0.607199	0.54 [0.40 - 0.75]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P152505	117	0.316239	0.00689194	0.12155	-0.764381	0.0944625	-0.233572	0.79 [0.60 - 1.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P330684	117	0.119658	0.160075	-	-0.537476	0.811915	-0.0363984	0.96 [0.71 - 1.30]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209460_at	204	0.127451	0.0115089	0.179375	-1.00293	0.202137	-0.324601	0.72 [0.44 - 1.19]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209460_at	204	0.181373	5.22568e-06	0.000247782	-1.2136	0.0264733	-0.423819	0.65 [0.45 - 0.95]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209459_s_at	204	0.348039	0.000874173	0.0227616	-1.17593	0.0680103	-0.54272	0.58 [0.32 - 1.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209459_s_at	204	0.284314	1.20391e-07	7.63444e-06	-1.34976	0.00146958	-0.717189	0.49 [0.31 - 0.76]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206527_at	204	0.504902	0.101991	-	0.610254	0.409156	0.318995	1.38 [0.64 - 2.93]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206527_at	204	0.872549	0.147084	-	-0.736784	0.54831	0.164001	1.18 [0.69 - 2.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209459_s_at	178	0.185393	1.73579e-05	0.000735252	-0.923992	0.000387823	-0.340872	0.71 [0.59 - 0.86]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209460_at	178	0.589888	2.02386e-05	0.000844211	-0.91401	3.68093e-05	-0.431198	0.65 [0.53 - 0.80]
GENE	ABAT	4-aminobutyrate aminotransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206527_at	178	0.325843	0.113113	-	0.341283	0.283121	0.410568	1.51 [0.71 - 3.19]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200017772	41	0.780488	0.00591655	0.107978	1.1842	0.605506	0.200617	1.22 [0.57 - 2.62]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209460_at	111	0.144144	0.000818894	0.0215423	-1.08482	0.228957	-0.140885	0.87 [0.69 - 1.09]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209459_s_at	111	0.864865	0.00869572	0.145259	-1.43297	0.147472	-0.201168	0.82 [0.62 - 1.07]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206527_at	111	0.738739	0.105514	-	0.450409	0.670115	0.136477	1.15 [0.61 - 2.15]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209459_s_at	90	0.755556	0.158964	-	0.477389	0.931746	-0.029813	0.97 [0.49 - 1.92]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209459_s_at	90	0.177778	0.230931	-	-0.514443	0.869506	-0.0674042	0.93 [0.42 - 2.09]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209460_at	90	0.377778	0.291021	-	-0.392103	0.846516	-0.0763287	0.93 [0.43 - 2.01]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209460_at	90	0.777778	0.222189	-	0.423271	0.924045	0.0310364	1.03 [0.54 - 1.95]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206527_at	90	0.555556	0.150441	-	-0.487101	0.762594	0.181952	1.20 [0.37 - 3.91]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206527_at	90	0.522222	0.148821	-	-0.557159	0.729043	0.235161	1.27 [0.33 - 4.79]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209460_at	138	0.115942	0.000253206	0.00788923	-1.08987	0.158372	-0.142053	0.87 [0.71 - 1.06]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209459_s_at	138	0.108696	0.00657631	0.117222	-0.873901	0.118893	-0.125499	0.88 [0.75 - 1.03]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206527_at	138	0.282609	0.033248	0.379314	-0.523483	0.71861	-0.258497	0.77 [0.19 - 3.15]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206527_at	129	0.108527	0.153837	-	-0.489336	0.440406	-0.285982	0.75 [0.36 - 1.55]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209459_s_at	129	0.496124	0.0954653	-	-0.413698	0.197033	-0.150518	0.86 [0.68 - 1.08]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209460_at	129	0.627907	0.0350515	0.392699	-0.566954	0.712407	-0.0572367	0.94 [0.70 - 1.28]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8999	56	0.232143	0.255422	-	0.469664	0.148555	0.480412	1.62 [0.84 - 3.10]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10646	56	0.767857	0.0231148	0.296526	0.895418	0.143813	0.345643	1.41 [0.89 - 2.25]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8999	56	0.232143	0.258596	-	0.484714	0.171241	0.484099	1.62 [0.81 - 3.25]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37375	56	0.178571	0.0691056	-	0.940359	0.393112	0.173166	1.19 [0.80 - 1.77]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10646	56	0.178571	0.0691056	-	0.940359	0.264008	0.238717	1.27 [0.84 - 1.93]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37375	56	0.767857	0.0381414	0.414827	0.810288	0.214642	0.276959	1.32 [0.85 - 2.04]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209459_s_at	278	0.514389	0.0663524	-	0.34907	0.164143	0.109659	1.12 [0.96 - 1.30]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206527_at	278	0.845324	0.0469824	0.473188	-0.560136	0.90575	-0.0274072	0.97 [0.62 - 1.53]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209460_at	278	0.26259	0.0344656	0.38839	0.487199	0.162135	0.139753	1.15 [0.95 - 1.40]
GENE	ABAT	4-aminobutyrate aminotransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209460_at	133	0.894737	0.132674	-	0.492073	0.861438	0.0164823	1.02 [0.84 - 1.22]
GENE	ABAT	4-aminobutyrate aminotransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206527_at	133	0.736842	0.0025352	0.0549661	0.738762	0.990798	0.00352336	1.00 [0.55 - 1.83]
GENE	ABAT	4-aminobutyrate aminotransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209459_s_at	133	0.518797	0.0841685	-	-0.41156	0.454401	-0.0695047	0.93 [0.78 - 1.12]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206527_at	185	0.854054	0.108815	-	-0.400528	0.591473	-0.121704	0.89 [0.57 - 1.38]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209459_s_at	185	0.113514	0.109742	-	0.500034	0.465702	0.07816	1.08 [0.88 - 1.33]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206527_at	185	0.854054	0.149615	-	-0.393773	0.625056	-0.121914	0.89 [0.54 - 1.44]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209460_at	185	0.108108	0.0736289	-	0.51442	0.997574	-0.000504254	1.00 [0.72 - 1.38]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209459_s_at	185	0.113514	0.137441	-	0.414612	0.84599	0.0196629	1.02 [0.84 - 1.24]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209460_at	185	0.108108	0.0322183	0.371508	0.725661	0.608672	0.0891628	1.09 [0.78 - 1.54]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152505	110	0.136364	0.467442	-	-0.285352	0.994314	0.000966964	1.00 [0.77 - 1.31]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P330684	110	0.109091	0.159295	-	-0.584236	0.847857	-0.0410315	0.96 [0.63 - 1.46]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152505	110	0.136364	0.049065	0.485985	-0.573822	0.882548	-0.015593	0.98 [0.80 - 1.21]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P330684	110	0.236364	0.060597	-	-0.483927	0.821065	-0.0377942	0.96 [0.69 - 1.34]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206527_at	80	0.675	0.000720915	0.019343	1.41723	0.0781747	0.606931	1.83 [0.93 - 3.60]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209459_s_at	80	0.325	0.0920188	-	0.876612	0.417439	0.176892	1.19 [0.78 - 1.83]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209460_at	80	0.8125	0.00584049	0.106894	1.36488	0.23954	0.19871	1.22 [0.88 - 1.70]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_5088	281	0.6121	1.49298e-06	7.87024e-05	-0.713595	6.25873e-06	-0.376685	0.69 [0.58 - 0.81]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:36699	59	0.355932	0.0934183	-	-0.799639	0.575025	-0.463077	0.63 [0.12 - 3.18]
GENE	ABAT	4-aminobutyrate aminotransferase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:418335	59	0.118644	0.0440122	0.454339	-1.03415	0.621579	-0.582263	0.56 [0.06 - 5.64]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209460_at	38	0.578947	0.0887084	-	-0.866046	0.373358	-0.21011	0.81 [0.51 - 1.29]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209459_s_at	38	0.578947	0.0887084	-	-0.866046	0.602843	-0.0900113	0.91 [0.65 - 1.28]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206527_at	38	0.105263	0.166296	-	15.203	0.772918	0.115599	1.12 [0.51 - 2.46]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209459_s_at	140	0.228571	1.99328e-05	0.00083273	-1.19679	0.380825	-0.328887	0.72 [0.34 - 1.50]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209460_at	140	0.135714	0.00505721	0.0954937	-0.940339	0.25748	-0.387876	0.68 [0.35 - 1.33]
GENE	ABAT	4-aminobutyrate aminotransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206527_at	140	0.871429	0.13357	-	-0.868006	0.733632	-0.282021	0.75 [0.15 - 3.83]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203504_s_at	30	0.333333	0.104773	-	-0.680973	0.877324	-0.0572335	0.94 [0.46 - 1.95]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203505_at	30	0.233333	0.144951	-	-0.66167	0.926654	-0.0434779	0.96 [0.38 - 2.42]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216066_at	30	0.133333	0.245409	-	0.839372	0.375771	0.568733	1.77 [0.50 - 6.22]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1766054	165	0.581818	0.00181058	0.0417405	-0.813484	0.0392044	-0.352063	0.70 [0.50 - 0.98]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1766054	165	0.10303	7.50266e-05	0.00271765	-1.4895	0.0111904	-0.61232	0.54 [0.34 - 0.87]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203504_s_at	163	0.631902	0.10518	-	-0.343364	0.469709	-0.0784102	0.92 [0.75 - 1.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203505_at	163	0.564417	0.0918201	-	-0.342564	0.561262	-0.0732	0.93 [0.73 - 1.19]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216066_at	163	0.300613	0.115307	-	-0.33019	0.609159	-0.190499	0.83 [0.40 - 1.72]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216066_at	79	0.632911	0.190027	-	-0.413882	0.814852	-0.0674324	0.93 [0.53 - 1.64]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203505_at	79	0.506329	0.0294716	0.350064	-0.639604	0.387745	-0.146145	0.86 [0.62 - 1.20]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1570279_at	79	0.582278	0.230806	-	-0.362389	0.618963	-0.266395	0.77 [0.27 - 2.19]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203504_s_at	79	0.291139	0.0147987	0.215869	-0.730155	0.236184	-0.168047	0.85 [0.64 - 1.12]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203505_at	58	0.103448	0.0876675	-	-0.737826	0.501991	-0.110014	0.90 [0.65 - 1.24]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216066_at	58	0.293103	0.207367	-	0.40497	0.67271	0.0635214	1.07 [0.79 - 1.43]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203504_s_at	58	0.172414	0.100082	-	0.605614	0.296196	0.226498	1.25 [0.82 - 1.92]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203505_at	34	0.823529	0.141345	-	0.708683	0.804097	0.0691911	1.07 [0.62 - 1.85]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216066_at	34	0.294118	0.0516305	-	-0.783747	0.156674	-0.333352	0.72 [0.45 - 1.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203504_s_at	34	0.882353	0.0663831	-	1.01974	0.945246	-0.0260972	0.97 [0.46 - 2.05]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203505_at	158	0.113924	0.00192303	0.0438596	-0.891789	0.0609783	-0.483615	0.62 [0.37 - 1.02]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216066_at	158	0.379747	0.0836479	-	0.426266	0.308578	0.906136	2.47 [0.43 - 14.16]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203504_s_at	158	0.120253	0.0108821	0.172034	-0.765901	0.052592	-0.488851	0.61 [0.37 - 1.01]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203504_s_at	53	0.245283	0.135675	-	0.718027	0.781041	0.116783	1.12 [0.49 - 2.56]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216066_at	53	0.132075	0.186252	-	-0.592076	0.431118	-0.166228	0.85 [0.56 - 1.28]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203505_at	53	0.377358	0.139332	-	-0.536806	0.794563	-0.0896477	0.91 [0.47 - 1.80]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203504_s_at	53	0.245283	0.24618	-	0.488621	0.851708	0.0744432	1.08 [0.49 - 2.35]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216066_at	53	0.698113	0.140363	-	-0.628417	0.383018	-0.191799	0.83 [0.54 - 1.27]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203505_at	53	0.377358	0.112484	-	-0.541291	0.647394	-0.149495	0.86 [0.45 - 1.63]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203504_s_at	180	0.888889	0.0801148	-	-0.684969	0.754135	-0.0609138	0.94 [0.64 - 1.38]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203505_at	180	0.122222	0.106451	-	-0.483165	0.807007	-0.0400759	0.96 [0.70 - 1.33]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216066_at	180	0.622222	0.0883282	-	0.359366	0.256045	0.111743	1.12 [0.92 - 1.36]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216066_at	559	0.561717	0.06846	-	0.362906	0.492753	0.10574	1.11 [0.82 - 1.50]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203505_at	559	0.461538	0.182215	-	-0.267063	0.913212	-0.0109634	0.99 [0.81 - 1.20]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1570279_at	559	0.109123	0.0283054	0.340671	-0.605694	0.543413	-0.079697	0.92 [0.71 - 1.19]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203504_s_at	559	0.595707	0.0745381	-	-0.377186	0.746858	-0.0535657	0.95 [0.68 - 1.31]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203505_at	77	0.194805	0.0237121	0.301816	0.866969	0.280221	0.230441	1.26 [0.83 - 1.91]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216066_at	77	0.74026	0.0345881	0.389294	0.574695	0.508909	0.124649	1.13 [0.78 - 1.64]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203504_s_at	77	0.545455	0.0963474	-	0.424224	0.243556	0.301762	1.35 [0.81 - 2.25]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203505_at	70	0.385714	0.0674706	-	-0.480461	0.916838	0.0275974	1.03 [0.61 - 1.73]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1570279_at	70	0.471429	0.21331	-	-0.326494	0.893215	-0.0934962	0.91 [0.23 - 3.57]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203504_s_at	70	0.428571	0.307157	-	-0.267924	0.834828	-0.0343559	0.97 [0.70 - 1.33]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216066_at	70	0.885714	0.0480189	0.479599	0.757124	0.363216	-0.907899	0.40 [0.06 - 2.86]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	31999_at	50	0.7	0.109085	-	-0.620574	0.197639	-1.56928	0.21 [0.02 - 2.27]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32000_g_at	50	0.74	0.114614	-	-0.638455	0.290654	-1.47052	0.23 [0.02 - 3.52]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	31998_at	50	0.64	0.0885977	-	-0.621606	0.315116	-0.808643	0.45 [0.09 - 2.16]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203504_s_at	74	0.837838	0.103995	-	0.577269	0.981534	-0.00621809	0.99 [0.59 - 1.68]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203505_at	74	0.810811	0.0915496	-	0.583854	0.517848	0.160601	1.17 [0.72 - 1.91]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216066_at	74	0.5	0.106284	-	0.467928	0.893721	-0.0287703	0.97 [0.64 - 1.48]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216066_at	67	0.358209	0.21411	-	1.24253	0.797956	-0.225313	0.80 [0.14 - 4.48]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203505_at	67	0.358209	0.039614	0.425037	15.6874	0.157773	0.914895	2.50 [0.70 - 8.88]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203504_s_at	67	0.716418	0.00558451	0.103217	1.74157	0.134229	0.908456	2.48 [0.76 - 8.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1570279_at	67	0.776119	0.260372	-	-1.14831	0.97227	-0.0380962	0.96 [0.11 - 8.25]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203505_at	115	0.13913	0.000387551	0.0113915	-1.71311	0.0551662	-1.2802	0.28 [0.08 - 1.03]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203504_s_at	115	0.33913	0.0456193	0.464628	-1.03764	0.181518	-0.894782	0.41 [0.11 - 1.52]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216066_at	115	0.66087	0.00155866	0.0368872	1.67255	0.0980242	1.32185	3.75 [0.78 - 17.95]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1570279_at	115	0.895652	0.0141457	0.208875	1.3515	0.120885	0.989143	2.69 [0.77 - 9.38]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	31998_at	158	0.85443	0.113831	-	0.535391	0.292034	0.201934	1.22 [0.84 - 1.78]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	31999_at	158	0.21519	0.152413	-	-0.480834	0.693753	-0.0879271	0.92 [0.59 - 1.42]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32000_g_at	158	0.708861	0.0653921	-	0.528359	0.475541	0.258437	1.29 [0.64 - 2.63]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	31998_at	76	0.421053	0.0587933	-	-0.963539	0.372587	-0.278601	0.76 [0.41 - 1.40]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	31999_at	76	0.157895	0.0750588	-	15.3099	0.628723	0.295171	1.34 [0.41 - 4.44]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32000_g_at	76	0.144737	0.0750577	-	-1.00275	0.931579	-0.0725241	0.93 [0.18 - 4.87]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203504_s_at	204	0.872549	0.17959	-	0.280791	0.460276	0.127755	1.14 [0.81 - 1.59]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1570279_at	204	0.107843	0.0126411	0.192302	0.555889	0.431226	0.0580956	1.06 [0.92 - 1.22]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216066_at	204	0.534314	0.00219246	0.0488321	-0.442514	0.0352857	-0.170507	0.84 [0.72 - 0.99]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203505_at	204	0.127451	0.0199017	0.267015	0.48481	0.0448076	0.340629	1.41 [1.01 - 1.96]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216066_at	87	0.896552	2.10554e-05	0.000874781	1.63993	0.0185474	2.65883	14.28 [1.56 - 130.60]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1570279_at	87	0.114943	0.00246219	0.0536761	-1.36383	0.60313	-0.600517	0.55 [0.06 - 5.28]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1570279_at	87	0.114943	0.00246219	0.0536761	-1.36383	0.60313	-0.600517	0.55 [0.06 - 5.28]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203504_s_at	87	0.436782	0.095086	-	-0.629301	0.61381	-0.109823	0.90 [0.58 - 1.37]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203505_at	87	0.827586	0.0867615	-	0.736348	0.776958	-0.104617	0.90 [0.44 - 1.86]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203504_s_at	87	0.436782	0.095086	-	-0.629301	0.61381	-0.109823	0.90 [0.58 - 1.37]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216066_at	87	0.896552	2.10554e-05	0.000874781	1.63993	0.0185474	2.65883	14.28 [1.56 - 130.60]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203505_at	87	0.827586	0.0867615	-	0.736348	0.776958	-0.104617	0.90 [0.44 - 1.86]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1570279_at	77	0.714286	0.0132666	0.199272	1.29238	0.0861088	3.11571	22.55 [0.64 - 791.44]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203504_s_at	77	0.103896	0.00336895	0.069151	-1.60059	0.321569	-0.40164	0.67 [0.30 - 1.48]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216066_at	77	0.350649	0.0120714	0.185849	15.8216	0.425978	1.3005	3.67 [0.15 - 90.23]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1570279_at	77	0.714286	0.0114388	0.17856	1.49443	0.0846267	3.55742	35.07 [0.62 - 1999.72]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203505_at	77	0.701299	0.158876	-	-1.37453	0.646316	-0.258055	0.77 [0.26 - 2.33]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216066_at	77	0.87013	0.00122477	0.0301944	1.65195	0.0275484	3.02951	20.69 [1.40 - 306.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203504_s_at	77	0.103896	0.0153032	0.221197	-1.52696	0.62989	-0.218729	0.80 [0.33 - 1.96]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203505_at	77	0.87013	0.160658	-	-15.2258	0.515083	-0.321794	0.72 [0.28 - 1.91]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216066_at	136	0.125	0.0535816	-	-0.962034	0.771397	-0.0787829	0.92 [0.54 - 1.57]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203504_s_at	136	0.595588	0.219702	-	-0.595828	0.903112	-0.0771789	0.93 [0.27 - 3.21]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203505_at	136	0.786765	0.0237895	0.302497	0.99279	0.261733	0.530172	1.70 [0.67 - 4.29]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216066_at	200	0.56	0.00355065	0.0721244	0.8642	0.0229685	0.457902	1.58 [1.07 - 2.35]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203504_s_at	200	0.53	0.00782538	0.134025	-0.818379	0.0463133	-0.820081	0.44 [0.20 - 0.99]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203505_at	200	0.86	0.236254	-	0.436849	0.820064	-0.0944659	0.91 [0.40 - 2.05]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12273	60	0.216667	0.110032	-	-0.645987	0.538475	-0.110294	0.90 [0.63 - 1.27]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12273	60	0.583333	0.0792086	-	0.649684	0.521723	0.207508	1.23 [0.65 - 2.32]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13525	155	0.83871	0.000618692	0.0169901	0.98742	0.00778159	0.28299	1.33 [1.08 - 1.63]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203504_s_at	286	0.181818	0.257311	-	0.305067	0.743875	0.0807432	1.08 [0.67 - 1.76]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203505_at	286	0.867133	0.0104438	0.166817	0.604898	0.0562791	0.431436	1.54 [0.99 - 2.40]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216066_at	286	0.118881	0.0221755	0.288088	-0.585169	0.925764	0.0124531	1.01 [0.78 - 1.32]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203504_s_at	159	0.660377	0.166447	-	0.439253	0.938029	0.0335875	1.03 [0.44 - 2.41]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203505_at	159	0.886792	0.1645	-	-1.31757	0.751773	-0.117219	0.89 [0.43 - 1.84]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216066_at	159	0.144654	0.00107946	0.0271714	-1.23652	0.141635	-0.353279	0.70 [0.44 - 1.13]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216066_at	159	0.144654	0.00681736	0.120533	-0.955027	0.218952	-0.254993	0.77 [0.52 - 1.16]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203505_at	159	0.113208	0.188249	-	-0.541158	0.712977	-0.115908	0.89 [0.48 - 1.65]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203504_s_at	159	0.63522	0.184977	-	0.41803	0.760628	0.130614	1.14 [0.49 - 2.64]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203504_s_at	159	0.63522	0.133575	-	0.550744	0.858123	0.0907449	1.09 [0.40 - 2.96]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203505_at	159	0.157233	0.0189713	0.258111	-0.809338	0.48474	-0.219706	0.80 [0.43 - 1.49]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216066_at	159	0.144654	0.00189689	0.0433695	-1.05361	0.428964	-0.165198	0.85 [0.56 - 1.28]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203505_at	54	0.888889	0.051491	-	1.49386	0.118041	1.16698	3.21 [0.74 - 13.88]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216066_at	54	0.833333	0.156589	-	-15.3658	0.388102	-1.63546	0.19 [0.00 - 7.99]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215869_at	54	0.851852	0.0744667	-	1.22669	0.757449	0.2311	1.26 [0.29 - 5.46]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203504_s_at	54	0.537037	0.0227913	0.293637	1.64038	0.0384259	1.19259	3.30 [1.07 - 10.19]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215876_at	54	0.685185	0.20061	-	-1.27067	0.44294	-1.06689	0.34 [0.02 - 5.25]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203505_at	117	0.846154	0.173463	-	-0.703307	0.8834	-0.0430825	0.96 [0.54 - 1.70]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203505_at	117	0.641026	0.0745937	-	-0.799868	0.616763	-0.170216	0.84 [0.43 - 1.64]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216066_at	117	0.538462	0.0182589	0.251174	-0.953338	0.632513	-0.619216	0.54 [0.04 - 6.81]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203505_at	117	0.649573	0.0511816	-	-0.935706	0.812959	-0.0860979	0.92 [0.45 - 1.87]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203505_at	117	0.846154	0.173463	-	-0.703307	0.8834	-0.0430825	0.96 [0.54 - 1.70]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216066_at	117	0.111111	0.100427	-	1.51531	0.633837	-0.525266	0.59 [0.07 - 5.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216066_at	117	0.111111	0.100427	-	1.51531	0.633837	-0.525266	0.59 [0.07 - 5.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203504_s_at	117	0.136752	0.349884	-	0.489873	0.918487	0.0235335	1.02 [0.65 - 1.61]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216066_at	117	0.880342	0.0894531	-	0.777728	0.337694	1.12981	3.10 [0.31 - 31.17]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203504_s_at	117	0.769231	0.361573	-	-0.445986	0.918953	-0.0271892	0.97 [0.58 - 1.64]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203504_s_at	117	0.136752	0.28534	-	0.769118	0.857685	-0.0505757	0.95 [0.55 - 1.65]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203504_s_at	117	0.136752	0.349884	-	0.489873	0.918487	0.0235335	1.02 [0.65 - 1.61]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203504_s_at	236	0.161017	0.0242941	0.306914	-0.683276	0.474137	-0.289391	0.75 [0.34 - 1.65]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203505_at	236	0.70339	0.188224	-	0.367747	0.894178	0.0452157	1.05 [0.54 - 2.04]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216066_at	236	0.868644	0.026997	0.329914	0.707415	0.869244	0.0366684	1.04 [0.67 - 1.61]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203505_at	249	0.819277	0.156186	-	0.366838	0.380045	0.233165	1.26 [0.75 - 2.13]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216066_at	249	0.662651	0.0292058	0.347939	-0.530202	0.60953	-0.0845027	0.92 [0.66 - 1.27]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203504_s_at	249	0.164659	0.0545923	-	-0.493775	0.986844	-0.00534331	0.99 [0.53 - 1.88]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203505_at	62	0.790323	0.0336189	0.382096	-1.50515	0.388679	-0.126024	0.88 [0.66 - 1.17]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203504_s_at	125	0.288	0.126789	-	0.536518	0.544471	0.147798	1.16 [0.72 - 1.87]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216066_at	62	0.112903	0.094077	-	-1.04246	0.668145	-0.0884686	0.92 [0.61 - 1.37]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203505_at	125	0.328	0.0553367	-	0.915245	0.572352	0.2615	1.30 [0.52 - 3.22]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203504_s_at	54	0.462963	0.0605367	-	-1.17433	0.315896	-0.305199	0.74 [0.41 - 1.34]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203505_at	125	0.328	0.0375688	0.410799	0.700886	0.278382	0.365028	1.44 [0.74 - 2.79]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216066_at	125	0.264	0.00860423	0.144095	-0.795022	0.158321	-1.43686	0.24 [0.03 - 1.75]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203505_at	54	0.87037	0.0807513	-	-15.3977	0.44825	-0.133425	0.88 [0.62 - 1.24]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216066_at	125	0.368	0.181257	-	-0.510408	0.816434	-0.302972	0.74 [0.06 - 9.54]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216066_at	54	0.833333	0.223661	-	-1.20955	0.727019	-0.0875375	0.92 [0.56 - 1.50]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203504_s_at	62	0.483871	0.0210577	0.277847	-1.15692	0.30275	-0.257961	0.77 [0.47 - 1.26]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203504_s_at	125	0.288	0.18318	-	0.646754	0.959145	0.0171602	1.02 [0.53 - 1.96]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203505_at	198	0.151515	0.0528921	-	-0.599032	0.501779	-0.123997	0.88 [0.62 - 1.27]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216066_at	198	0.29798	0.0859172	-	-0.372879	0.983314	-0.00183098	1.00 [0.84 - 1.19]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203505_at	198	0.151515	0.0960321	-	-0.537179	0.611493	-0.0980653	0.91 [0.62 - 1.32]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203504_s_at	198	0.681818	0.0188879	0.257304	0.498716	0.0909998	0.324109	1.38 [0.95 - 2.01]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216066_at	198	0.782828	0.130506	-	0.428818	0.937002	0.00827494	1.01 [0.82 - 1.24]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216066_at	198	0.782828	0.0909329	-	0.486842	0.476106	0.0773611	1.08 [0.87 - 1.34]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203505_at	198	0.444444	0.290949	-	0.227001	0.90541	0.0180313	1.02 [0.76 - 1.37]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203504_s_at	198	0.681818	0.0359576	0.39929	0.532349	0.300402	0.23908	1.27 [0.81 - 2.00]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203504_s_at	198	0.590909	0.0368144	0.405444	0.552764	0.345809	0.227496	1.26 [0.78 - 2.01]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203504_s_at	62	0.693548	0.117471	-	0.875827	0.872099	0.0974377	1.10 [0.34 - 3.61]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203505_at	51	0.392157	0.245437	-	-1.01871	0.861614	-0.15949	0.85 [0.14 - 5.12]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203505_at	62	0.822581	0.0710325	-	-15.3928	0.573723	-0.35048	0.70 [0.21 - 2.39]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216066_at	62	0.887097	0.0693994	-	1.15085	0.633265	0.897833	2.45 [0.06 - 98.10]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216066_at	51	0.176471	0.166244	-	-1.19269	0.6819	-1.21793	0.30 [0.00 - 100.10]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203504_s_at	51	0.843137	0.111391	-	1.34912	0.592216	0.414552	1.51 [0.33 - 6.90]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1570279_at	145	0.517241	0.0138567	0.205742	0.864605	0.523132	0.544787	1.72 [0.32 - 9.18]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203504_s_at	145	0.213793	0.00887296	0.147503	1.6951	0.0107797	0.74668	2.11 [1.19 - 3.75]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216066_at	177	0.225989	0.153618	-	-0.430623	0.57229	-0.504892	0.60 [0.10 - 3.48]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203505_at	177	0.836158	0.060011	-	0.579632	0.172481	0.372203	1.45 [0.85 - 2.48]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216066_at	177	0.898305	0.094745	-	-0.834858	0.486318	-0.537333	0.58 [0.13 - 2.65]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203505_at	177	0.836158	0.0813145	-	0.48259	0.363634	0.212963	1.24 [0.78 - 1.96]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203504_s_at	177	0.757062	0.0475516	0.476719	0.557777	0.287429	0.253594	1.29 [0.81 - 2.06]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216066_at	145	0.703448	0.259569	-	0.383147	0.877802	0.161669	1.18 [0.15 - 9.23]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203505_at	145	0.351724	0.0102265	0.164203	1.09391	0.0242375	0.76315	2.15 [1.10 - 4.17]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1570279_at	177	0.887006	0.0385697	0.417818	-1.02042	0.410943	-0.600826	0.55 [0.13 - 2.30]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1570279_at	177	0.186441	0.0801678	-	0.80098	0.790751	-0.214799	0.81 [0.17 - 3.94]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203504_s_at	177	0.757062	0.160251	-	0.35821	0.618034	0.103173	1.11 [0.74 - 1.66]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216066_at	226	0.685841	0.0269612	0.329616	0.620723	0.226533	0.166248	1.18 [0.90 - 1.55]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203505_at	226	0.469027	0.00272038	0.0582009	0.933702	0.0129316	0.506834	1.66 [1.11 - 2.48]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1570279_at	226	0.884956	0.0856951	-	0.59971	0.589668	0.0600011	1.06 [0.85 - 1.32]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203504_s_at	226	0.889381	0.00205694	0.0463489	0.98458	0.0204819	0.51656	1.68 [1.08 - 2.59]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1570279_at	55	0.872727	0.0142632	0.210141	1.22433	0.352099	1.27998	3.60 [0.24 - 53.31]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216066_at	55	0.709091	0.149428	-	0.647355	0.517012	0.902205	2.47 [0.16 - 37.76]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1570279_at	49	0.877551	0.0157871	0.226245	1.37987	0.136406	2.24562	9.45 [0.49 - 181.45]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203505_at	55	0.363636	0.00304403	0.0637348	1.91163	0.00980058	0.892077	2.44 [1.24 - 4.80]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216066_at	55	0.236364	0.110274	-	1.13516	0.787782	0.408986	1.51 [0.08 - 29.57]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216066_at	49	0.44898	0.199162	-	-0.769369	0.611392	-0.980249	0.38 [0.01 - 16.46]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1570279_at	55	0.872727	0.0172746	0.241413	1.17763	0.155248	1.80935	6.11 [0.50 - 74.04]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203505_at	55	0.363636	0.00119884	0.0296605	2.53516	0.0106001	0.92649	2.53 [1.24 - 5.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203504_s_at	55	0.545455	0.0294108	0.349579	0.983042	0.0500326	0.624652	1.87 [1.00 - 3.49]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203505_at	49	0.387755	0.0114166	0.178302	2.19148	0.100829	0.718172	2.05 [0.87 - 4.84]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203504_s_at	55	0.145455	0.0541525	-	15.2993	0.198558	0.41972	1.52 [0.80 - 2.89]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203504_s_at	49	0.204082	0.0469573	0.473032	15.4809	0.566013	0.236509	1.27 [0.56 - 2.84]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216066_at	63	0.238095	0.000677863	0.0183598	-1.14292	0.55264	-0.21529	0.81 [0.40 - 1.64]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203505_at	63	0.873016	0.0826628	-	-1.2009	0.621292	-0.093213	0.91 [0.63 - 1.32]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1570279_at	63	0.238095	0.0120871	0.186029	-0.877667	0.289165	-2.2611	0.10 [0.00 - 6.82]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203504_s_at	63	0.746032	0.198739	-	0.482447	0.68172	0.0545754	1.06 [0.81 - 1.37]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9755158_3p_at	28	0.107143	0.126995	-	15.2751	0.399849	0.120829	1.13 [0.85 - 1.50]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.211562.1.S1_3p_at	28	0.535714	0.131953	-	-0.893374	0.45702	-2.3173	0.10 [0.00 - 44.23]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5915657_3p_a_at	28	0.785714	0.088385	-	1.00482	0.951626	0.114165	1.12 [0.03 - 44.82]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.407188.1.S1_3p_at	28	0.142857	0.0685508	-	-1.19105	0.535544	-0.528169	0.59 [0.11 - 3.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216066_at	82	0.878049	0.0324125	0.372989	0.876608	0.962682	-0.0148129	0.99 [0.53 - 1.83]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203504_s_at	82	0.792683	0.0861916	-	-0.887635	0.138918	-0.482266	0.62 [0.33 - 1.17]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203505_at	82	0.329268	0.00450695	0.0871995	-0.950255	0.0180707	-1.11684	0.33 [0.13 - 0.83]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32000_g_at	84	0.642857	0.0414382	0.437401	-0.63484	0.0285342	-1.28512	0.28 [0.09 - 0.87]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203504_s_at	79	0.708861	0.167448	-	0.384603	0.655369	0.14458	1.16 [0.61 - 2.18]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203505_at	79	0.797468	0.198717	-	0.402697	0.724079	0.132133	1.14 [0.55 - 2.38]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216066_at	79	0.392405	0.0495159	0.488712	0.53501	0.459009	0.262477	1.30 [0.65 - 2.60]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216066_at	104	0.875	0.0822852	-	0.77733	0.68711	-0.120211	0.89 [0.49 - 1.59]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203504_s_at	104	0.201923	0.0913839	-	0.979599	0.510877	0.262839	1.30 [0.59 - 2.85]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203505_at	104	0.519231	0.0780663	-	-0.581119	0.984377	0.0103337	1.01 [0.36 - 2.84]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P216649	117	0.102564	0.0998855	-	1.12805	0.63246	0.0720816	1.07 [0.80 - 1.44]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P235429	117	0.102564	0.00564616	0.104107	15.2414	0.346307	0.159238	1.17 [0.84 - 1.63]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203505_at	204	0.151961	0.0145982	0.213733	-0.741717	0.196277	-0.443367	0.64 [0.33 - 1.26]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203504_s_at	204	0.79902	0.000140106	0.00471001	1.31031	0.0238645	1.13471	3.11 [1.16 - 8.32]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203504_s_at	204	0.79902	0.000198384	0.00638211	1.01866	0.0128096	0.92578	2.52 [1.22 - 5.23]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1570279_at	204	0.102941	0.150932	-	1.35541	0.405668	0.176587	1.19 [0.79 - 1.81]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1570279_at	204	0.754902	0.0809407	-	0.506213	0.159349	0.225952	1.25 [0.92 - 1.72]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216066_at	204	0.254902	0.109394	-	0.835692	0.685722	0.107758	1.11 [0.66 - 1.88]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216066_at	204	0.897059	0.0208513	0.275931	0.790605	0.886618	-0.0272823	0.97 [0.67 - 1.42]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203505_at	204	0.828431	0.0104678	0.167104	0.956649	0.964375	0.0202401	1.02 [0.42 - 2.48]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203504_s_at	178	0.797753	0.11421	-	0.38236	0.730772	0.0858092	1.09 [0.67 - 1.78]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203505_at	178	0.224719	0.120558	-	-0.342658	0.980078	-0.00743909	0.99 [0.55 - 1.78]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216066_at	178	0.797753	0.270712	-	0.269524	0.825551	-0.0461813	0.95 [0.63 - 1.44]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203504_s_at	111	0.873874	0.0129109	0.195323	-1.37179	0.33687	-0.221246	0.80 [0.51 - 1.26]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216066_at	111	0.801802	0.0950207	-	-0.627666	0.562648	-0.0918012	0.91 [0.67 - 1.24]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1570279_at	111	0.882883	0.0448086	0.459464	-1.13184	0.936348	0.0130603	1.01 [0.74 - 1.40]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203505_at	111	0.108108	0.209014	-	0.639643	0.846747	-0.0406842	0.96 [0.64 - 1.45]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203504_s_at	90	0.766667	0.00879754	0.14655	-1.30274	0.151722	-0.356649	0.70 [0.43 - 1.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203504_s_at	90	0.111111	0.0281947	0.33977	-0.96942	0.185726	-0.383783	0.68 [0.39 - 1.20]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203505_at	90	0.866667	0.0738667	-	-1.22408	0.112076	-0.518892	0.60 [0.31 - 1.13]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203505_at	90	0.133333	0.0351907	0.393717	-0.886775	0.079851	-0.678585	0.51 [0.24 - 1.08]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216066_at	90	0.888889	0.0610476	-	0.838715	0.0765166	1.61858	5.05 [0.84 - 30.25]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216066_at	90	0.866667	0.212478	-	0.5189	0.215801	1.09708	3.00 [0.53 - 17.02]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203504_s_at	138	0.644928	0.00309121	0.0645295	0.70678	0.108819	0.173262	1.19 [0.96 - 1.47]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216066_at	138	0.108696	0.00295908	0.0622962	-0.892593	0.299823	-1.14188	0.32 [0.04 - 2.76]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1570279_at	138	0.862319	0.0269196	0.329271	-0.994601	0.0297234	-6.72965	0.00 [0.00 - 0.52]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203505_at	138	0.710145	0.00942965	0.154463	0.631251	0.334527	0.158518	1.17 [0.85 - 1.62]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216066_at	129	0.875969	0.0453217	0.462738	0.653231	0.953647	0.0102771	1.01 [0.71 - 1.43]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203504_s_at	129	0.821705	0.038178	0.415083	-0.766634	0.24966	-0.413762	0.66 [0.33 - 1.34]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203505_at	129	0.565891	0.0517732	-	-0.50004	0.40754	-0.27323	0.76 [0.40 - 1.45]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40277	56	0.5	0.0856631	-	-0.595485	0.320578	-0.308122	0.73 [0.40 - 1.35]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33334	56	0.357143	0.0303196	0.356785	-0.748826	0.183632	-0.212844	0.81 [0.59 - 1.11]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40277	56	0.142857	0.0747815	-	-0.795877	0.385885	-0.281523	0.75 [0.40 - 1.43]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33334	56	0.357143	0.0123887	0.189455	-0.900881	0.236101	-0.202117	0.82 [0.58 - 1.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216066_at	278	0.870504	0.0449219	0.460189	0.516003	0.682758	0.167027	1.18 [0.53 - 2.63]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203505_at	278	0.597122	0.0350029	0.392343	0.396224	0.500113	0.107558	1.11 [0.81 - 1.52]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203504_s_at	278	0.71223	0.0464571	0.469907	0.396532	0.401727	0.105899	1.11 [0.87 - 1.42]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1570279_at	278	0.895683	0.00350476	0.071377	0.805229	0.738921	0.0984299	1.10 [0.62 - 1.97]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203505_at	133	0.105263	0.0944502	-	-0.569636	0.218215	-0.179235	0.84 [0.63 - 1.11]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216066_at	133	0.864662	0.00913787	0.150832	0.762632	0.195677	0.613969	1.85 [0.73 - 4.68]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203504_s_at	133	0.135338	0.224601	-	-0.372514	0.626598	-0.0436208	0.96 [0.80 - 1.14]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	465	81	0.839506	0.108275	-	0.933302	0.076395	1.57134	4.81 [0.85 - 27.37]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10651	81	0.493827	0.0774015	-	-0.997294	0.985124	-0.00748782	0.99 [0.45 - 2.18]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216066_at	185	0.324324	0.17882	-	-0.226623	0.583608	-0.155725	0.86 [0.49 - 1.49]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203505_at	185	0.8	0.202449	-	-0.267137	0.917475	0.0173164	1.02 [0.73 - 1.41]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216066_at	185	0.313514	0.0981517	-	-0.302018	0.842584	-0.0610596	0.94 [0.51 - 1.72]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203504_s_at	185	0.335135	0.0233001	0.298173	0.393024	0.391476	0.0900749	1.09 [0.89 - 1.34]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203505_at	185	0.886486	0.216731	-	0.328237	0.983882	0.00373233	1.00 [0.70 - 1.44]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203504_s_at	185	0.335135	0.036113	0.400412	0.397041	0.606708	0.0596476	1.06 [0.85 - 1.33]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P216649	110	0.436364	0.0275892	0.334813	0.514531	0.248386	0.223457	1.25 [0.86 - 1.83]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P235429	110	0.109091	0.166241	-	0.979369	0.295036	0.235371	1.27 [0.81 - 1.97]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P289265	110	0.881818	0.0427219	0.44592	0.690617	0.302765	0.121847	1.13 [0.90 - 1.42]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P216649	110	0.718182	0.312865	-	-0.351349	0.623582	0.129998	1.14 [0.68 - 1.91]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P289265	110	0.3	0.177828	-	0.463177	0.690482	0.0591396	1.06 [0.79 - 1.42]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P235429	110	0.881818	0.0978108	-	0.560258	0.121561	0.259254	1.30 [0.93 - 1.80]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203504_s_at	80	0.625	0.00994595	0.160803	-1.35163	0.568315	-0.215376	0.81 [0.38 - 1.69]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203505_at	80	0.5625	0.020133	0.269203	-1.13778	0.612268	-0.180999	0.83 [0.41 - 1.68]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216066_at	80	0.125	0.0382951	0.415903	15.3272	0.182592	0.23492	1.26 [0.90 - 1.79]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3380	281	0.231317	0.00835538	0.140909	0.454491	0.067331	0.233953	1.26 [0.98 - 1.62]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216066_at	38	0.421053	0.0227693	0.29344	-1.08533	0.335004	-0.188955	0.83 [0.56 - 1.22]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1570279_at	38	0.394737	0.0129607	0.195878	-1.16627	0.161628	-0.410704	0.66 [0.37 - 1.18]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203505_at	38	0.315789	0.144216	-	-0.665478	0.87275	-0.0643094	0.94 [0.43 - 2.06]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203504_s_at	38	0.815789	0.241602	-	0.657231	0.665099	0.167995	1.18 [0.55 - 2.53]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203504_s_at	140	0.4	0.0520157	-	-0.554776	0.355809	-0.153422	0.86 [0.62 - 1.19]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203505_at	140	0.328571	0.0320393	0.370138	-0.62044	0.310379	-0.215188	0.81 [0.53 - 1.22]
GENE	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216066_at	140	0.707143	0.000734579	0.0196528	0.941939	0.0211149	1.26911	3.56 [1.21 - 10.46]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211224_s_at	30	0.533333	0.0663335	-	0.752045	0.0933144	1.66195	5.27 [0.76 - 36.71]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208288_at	30	0.466667	0.0128775	0.19495	1.11846	0.301164	0.714449	2.04 [0.53 - 7.92]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1689082	165	0.393939	0.128254	-	-0.369378	0.799066	0.271442	1.31 [0.16 - 10.61]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1689082	165	0.50303	0.048022	0.479618	-0.721256	0.667222	-0.686956	0.50 [0.02 - 11.53]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208288_at	163	0.447853	0.0167582	0.236206	0.480344	0.103168	0.985971	2.68 [0.82 - 8.77]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211224_s_at	163	0.779141	0.137002	-	-0.362619	0.313709	-0.597049	0.55 [0.17 - 1.76]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211224_s_at	79	0.898734	0.158274	-	0.569941	0.608797	0.412023	1.51 [0.31 - 7.32]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208288_at	79	0.151899	0.00773984	0.132901	-0.921513	0.185021	-1.14934	0.32 [0.06 - 1.73]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208288_at	58	0.155172	0.0688168	-	0.726665	0.575697	0.0700061	1.07 [0.84 - 1.37]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211224_s_at	58	0.689655	0.000174963	0.00572005	1.14203	0.00637596	0.45917	1.58 [1.14 - 2.20]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208288_at	34	0.617647	0.0534931	-	0.781047	0.32076	0.23286	1.26 [0.80 - 2.00]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211224_s_at	34	0.176471	0.129726	-	0.820995	0.318098	0.320397	1.38 [0.73 - 2.58]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208288_at	158	0.348101	0.0486725	0.483599	0.511508	0.471745	0.461164	1.59 [0.45 - 5.57]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211224_s_at	158	0.778481	0.0659786	-	-0.572202	0.176981	-1.33549	0.26 [0.04 - 1.83]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211224_s_at	53	0.679245	0.0113646	0.177697	0.854059	0.164916	0.305218	1.36 [0.88 - 2.09]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208288_at	53	0.754717	0.0765009	-	-0.91954	0.19998	-0.296682	0.74 [0.47 - 1.17]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211224_s_at	53	0.528302	0.0237606	0.302243	0.824163	0.17901	0.317281	1.37 [0.86 - 2.18]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208288_at	53	0.811321	0.0827934	-	-0.896499	0.298725	-0.21855	0.80 [0.53 - 1.21]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211224_s_at	180	0.727778	0.158416	-	0.316665	0.869892	0.0233003	1.02 [0.77 - 1.35]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208288_at	180	0.544444	0.0991531	-	-0.353371	0.547059	-0.0540348	0.95 [0.79 - 1.13]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211224_s_at	559	0.665474	0.140171	-	-0.324104	0.474459	-0.13132	0.88 [0.61 - 1.26]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208288_at	559	0.855098	0.0294055	0.349536	-0.744872	0.364198	-0.114223	0.89 [0.70 - 1.14]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208288_at	77	0.12987	0.029609	0.351159	0.992806	0.940304	-0.0100588	0.99 [0.76 - 1.29]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211224_s_at	77	0.298701	0.0257428	0.319377	-0.59008	0.347594	-0.161943	0.85 [0.61 - 1.19]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211224_s_at	70	0.7	0.233309	-	0.340724	0.45236	0.895543	2.45 [0.24 - 25.31]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208288_at	70	0.228571	0.00116918	0.0290467	-0.972045	0.901979	-0.113549	0.89 [0.15 - 5.44]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	31398_at	50	0.14	0.00432008	0.0843235	-1.21513	0.130536	-1.12068	0.33 [0.08 - 1.39]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211224_s_at	74	0.689189	0.152073	-	0.432384	0.664186	0.0998346	1.10 [0.70 - 1.73]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208288_at	74	0.202703	0.0409085	0.433843	0.870275	0.62523	0.102199	1.11 [0.73 - 1.67]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211224_s_at	67	0.19403	0.190579	-	-0.898241	0.551732	-1.87223	0.15 [0.00 - 73.21]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208288_at	67	0.104478	0.187466	-	-1.01637	0.743137	-1.03569	0.35 [0.00 - 173.96]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211224_s_at	115	0.173913	0.251148	-	-0.672369	0.72977	-0.140497	0.87 [0.39 - 1.93]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208288_at	115	0.652174	0.0643058	-	0.963177	0.192123	0.554874	1.74 [0.76 - 4.01]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	31398_at	158	0.341772	0.117738	-	-0.464511	0.833829	-0.0359624	0.96 [0.69 - 1.35]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	31398_at	76	0.723684	0.0272362	0.331899	-1.97362	0.178448	-0.580003	0.56 [0.24 - 1.30]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208288_at	204	0.191176	0.0499226	0.491159	-0.350433	0.12731	-0.111913	0.89 [0.77 - 1.03]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211224_s_at	204	0.343137	0.0816646	-	-0.253618	0.502404	-0.0561203	0.95 [0.80 - 1.11]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208288_at	87	0.827586	0.274068	-	-0.656694	0.487326	-0.842061	0.43 [0.04 - 4.64]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211224_s_at	87	0.126437	0.0854052	-	1.58277	0.319972	0.821286	2.27 [0.45 - 11.47]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211224_s_at	87	0.126437	0.0854052	-	1.58277	0.319972	0.821286	2.27 [0.45 - 11.47]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208288_at	87	0.827586	0.274068	-	-0.656694	0.487326	-0.842061	0.43 [0.04 - 4.64]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208288_at	77	0.545455	0.0188797	0.257225	-2.07973	0.562888	-1.15737	0.31 [0.01 - 15.86]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208288_at	77	0.545455	0.0900431	-	-1.06511	0.691347	0.634195	1.89 [0.08 - 43.16]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211224_s_at	77	0.116883	0.0454813	0.463752	-1.29103	0.235801	-2.47176	0.08 [0.00 - 5.03]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211224_s_at	77	0.675325	0.0587546	-	1.00925	0.56323	0.916067	2.50 [0.11 - 55.82]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211224_s_at	136	0.125	0.205603	-	-0.656958	0.963	-0.0108327	0.99 [0.63 - 1.56]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208288_at	136	0.786765	0.13101	-	-1.08522	0.98841	0.00308908	1.00 [0.66 - 1.52]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211224_s_at	200	0.505	0.0351528	0.39344	-0.63596	0.14124	-0.266436	0.77 [0.54 - 1.09]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208288_at	200	0.18	0.0917713	-	0.85707	0.413631	0.131372	1.14 [0.83 - 1.56]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4361	60	0.516667	0.112474	-	-0.615802	0.46439	-0.586551	0.56 [0.12 - 2.68]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4361	60	0.533333	0.00121949	0.0300859	1.2724	0.0823292	1.48513	4.42 [0.83 - 23.58]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	8609	155	0.122581	1.39469e-06	7.39236e-05	-1.3768	0.00262332	-0.222531	0.80 [0.69 - 0.93]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211224_s_at	286	0.821678	0.0586509	-	-0.551772	0.620708	-0.0623083	0.94 [0.73 - 1.20]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208288_at	286	0.660839	0.0567271	-	-0.407683	0.647817	-0.0523813	0.95 [0.76 - 1.19]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208288_at	159	0.132075	0.0558105	-	-0.810004	0.451685	-0.169818	0.84 [0.54 - 1.31]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211224_s_at	159	0.591195	0.0970122	-	-0.565381	0.963656	0.01066	1.01 [0.64 - 1.60]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208288_at	159	0.893082	0.0666857	-	-1.66016	0.660575	-0.0839326	0.92 [0.63 - 1.34]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211224_s_at	159	0.591195	0.0497094	0.489878	-0.827839	0.468381	-0.19246	0.82 [0.49 - 1.39]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211224_s_at	159	0.899371	0.0700767	-	0.73783	0.880948	0.0353934	1.04 [0.65 - 1.65]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208288_at	159	0.654088	0.0676914	-	-0.678705	0.289596	-0.204036	0.82 [0.56 - 1.19]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208288_at	54	0.62963	0.145299	-	-1.42455	0.43639	-1.47003	0.23 [0.01 - 9.32]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211224_s_at	54	0.111111	0.368099	-	-0.720789	0.950986	0.108872	1.12 [0.03 - 35.89]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208288_at	117	0.760684	0.00134136	0.0325689	-1.98632	0.141819	-1.82429	0.16 [0.01 - 1.84]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208288_at	117	0.760684	0.00426679	0.0834975	-2.34016	0.234584	-1.76858	0.17 [0.01 - 3.15]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208288_at	117	0.760684	0.00631928	0.113654	-2.26702	0.187576	-2.02879	0.13 [0.01 - 2.69]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208288_at	117	0.760684	0.00134136	0.0325689	-1.98632	0.141819	-1.82429	0.16 [0.01 - 1.84]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211224_s_at	117	0.393162	0.0541287	-	-0.605234	0.0918527	-1.98896	0.14 [0.01 - 1.38]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211224_s_at	117	0.897436	0.134114	-	-1.40719	0.262101	-1.53003	0.22 [0.01 - 3.14]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211224_s_at	117	0.897436	0.0584683	-	-15.2076	0.225993	-1.80647	0.16 [0.01 - 3.06]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211224_s_at	117	0.393162	0.0541287	-	-0.605234	0.0918527	-1.98896	0.14 [0.01 - 1.38]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208288_at	236	0.669492	0.00475712	0.0910017	0.74385	0.067534	0.331655	1.39 [0.98 - 1.99]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211224_s_at	236	0.419492	0.0389529	0.420479	-0.551621	0.104316	-0.306201	0.74 [0.51 - 1.07]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208288_at	249	0.783133	0.00846965	0.142375	0.599359	0.512508	0.0923304	1.10 [0.83 - 1.45]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211224_s_at	249	0.160643	0.104967	-	-0.418707	0.405998	-0.130663	0.88 [0.64 - 1.19]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211224_s_at	54	0.407407	0.0306918	0.359705	1.94761	0.926577	-0.0455697	0.96 [0.36 - 2.52]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208288_at	62	0.758065	0.0723131	-	-1.14186	0.779187	-0.199808	0.82 [0.20 - 3.31]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208288_at	125	0.72	0.0571861	-	0.714738	0.622598	0.314744	1.37 [0.39 - 4.80]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211224_s_at	62	0.403226	0.0164591	0.233162	1.62397	0.842881	-0.0808189	0.92 [0.41 - 2.05]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208288_at	125	0.896	0.191606	-	-0.760528	0.697135	-0.194214	0.82 [0.31 - 2.19]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211224_s_at	125	0.808	0.0717088	-	0.717395	0.459804	0.508988	1.66 [0.43 - 6.41]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208288_at	54	0.240741	0.113941	-	15.393	0.950701	0.0530132	1.05 [0.20 - 5.66]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211224_s_at	125	0.8	0.0513109	-	0.593095	0.978194	0.014638	1.01 [0.36 - 2.90]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211224_s_at	198	0.883838	0.00511231	0.0963105	0.758215	0.674624	-0.035096	0.97 [0.82 - 1.14]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208288_at	198	0.20202	0.168414	-	0.492033	0.927764	-0.00894682	0.99 [0.82 - 1.20]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208288_at	198	0.59596	0.250874	-	-0.323119	0.68245	-0.0427418	0.96 [0.78 - 1.18]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211224_s_at	198	0.89899	0.00030962	0.00938867	1.07986	0.514541	0.0641231	1.07 [0.88 - 1.29]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211224_s_at	198	0.89899	0.000235008	0.00739498	1.13882	0.234441	0.122571	1.13 [0.92 - 1.38]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208288_at	198	0.429293	0.176171	-	-0.28512	0.72382	-0.029093	0.97 [0.83 - 1.14]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208288_at	51	0.54902	0.00926699	0.152443	16.5495	0.258372	2.43054	11.37 [0.17 - 769.25]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208288_at	62	0.629032	0.0995588	-	0.930892	0.90306	0.185944	1.20 [0.06 - 24.00]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211224_s_at	51	0.196078	0.252861	-	15.3758	0.708521	0.965981	2.63 [0.02 - 415.91]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211224_s_at	62	0.16129	0.129425	-	-0.898352	0.462195	-1.19564	0.30 [0.01 - 7.33]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208288_at	177	0.836158	0.0334886	0.381121	-0.879319	0.0850662	-1.20984	0.30 [0.08 - 1.18]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211224_s_at	177	0.237288	0.0217773	0.284465	-0.635713	0.0551603	-2.22757	0.11 [0.01 - 1.05]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208288_at	145	0.696552	0.133702	-	-0.621799	0.282543	-1.06182	0.35 [0.05 - 2.40]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208288_at	177	0.836158	0.0190833	0.259192	-1.30036	0.0838866	-1.43345	0.24 [0.05 - 1.21]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211224_s_at	177	0.59887	0.00418558	0.0822335	-0.747225	0.0587147	-1.90771	0.15 [0.02 - 1.07]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211224_s_at	145	0.151724	0.00557865	0.103133	-0.965752	0.0604173	-2.93243	0.05 [0.00 - 1.14]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208288_at	226	0.376106	0.0137871	0.204984	-0.688364	0.156761	-0.184603	0.83 [0.64 - 1.07]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211224_s_at	226	0.884956	0.163425	-	-0.968517	0.953293	-0.00813493	0.99 [0.76 - 1.30]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208288_at	55	0.363636	0.027956	0.337821	-0.959003	0.0933409	-1.95509	0.14 [0.01 - 1.39]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208288_at	49	0.346939	0.00803332	0.136742	-1.49253	0.0430273	-3.34648	0.04 [0.00 - 0.90]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211224_s_at	55	0.127273	0.210315	-	1.21056	0.665002	0.575631	1.78 [0.13 - 24.07]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211224_s_at	55	0.763636	0.0304433	0.357757	1.07109	0.578234	0.804098	2.23 [0.13 - 38.05]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211224_s_at	49	0.77551	0.176509	-	0.809505	0.799625	0.418633	1.52 [0.06 - 38.52]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208288_at	55	0.272727	0.000232562	0.00732809	-1.70357	0.00676376	-4.07249	0.02 [0.00 - 0.32]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208288_at	63	0.111111	0.000944363	0.0242894	-1.3802	0.128518	-15.0086	0.00 [0.00 - 77.09]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211224_s_at	63	0.111111	5.57617e-05	0.00208901	-1.64877	0.0681422	-19.4269	0.00 [0.00 - 4.25]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502456_3p_at	28	0.75	0.132812	-	-1.11021	0.650624	-1.28442	0.28 [0.00 - 71.82]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4704819_3p_a_at	28	0.357143	0.217816	-	-0.692907	0.29179	-3.79894	0.02 [0.00 - 26.16]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211224_s_at	82	0.853659	0.224078	-	-0.719421	0.805797	0.133126	1.14 [0.40 - 3.30]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208288_at	82	0.304878	0.0362397	0.401325	0.910157	0.30085	0.175508	1.19 [0.85 - 1.66]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211224_s_at	79	0.759494	0.0327987	0.375923	0.598146	0.105926	0.905561	2.47 [0.83 - 7.41]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208288_at	79	0.683544	0.0204445	0.272132	0.616916	0.449401	0.117944	1.13 [0.83 - 1.53]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211224_s_at	104	0.269231	0.0439491	0.453931	0.870498	0.907049	0.0708918	1.07 [0.33 - 3.53]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208288_at	104	0.288462	0.179464	-	-0.461207	0.771294	-0.0651331	0.94 [0.60 - 1.45]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211224_s_at	204	0.431373	0.0540681	-	0.775896	0.333954	0.198032	1.22 [0.82 - 1.82]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211224_s_at	204	0.210784	0.0520565	-	0.81827	0.765532	0.0449128	1.05 [0.78 - 1.41]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208288_at	204	0.588235	0.178211	-	-0.531055	0.619403	-0.110917	0.90 [0.58 - 1.39]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208288_at	204	0.176471	0.0010964	0.0275276	-0.910895	0.0755582	-0.319458	0.73 [0.51 - 1.03]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208288_at	178	0.601124	0.0321423	0.370927	-0.442819	0.113284	-0.149819	0.86 [0.72 - 1.04]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211224_s_at	178	0.162921	0.0684974	-	0.60025	0.0909306	0.510179	1.67 [0.92 - 3.01]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208288_at	111	0.72973	0.236662	-	-0.370175	0.91477	-0.016996	0.98 [0.72 - 1.34]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211224_s_at	111	0.252252	0.0553475	-	-0.540972	0.892199	0.0237046	1.02 [0.73 - 1.44]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208288_at	90	0.255556	0.145385	-	0.602431	0.213655	0.642965	1.90 [0.69 - 5.24]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208288_at	90	0.411111	0.225286	-	0.471106	0.14807	0.774637	2.17 [0.76 - 6.20]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211224_s_at	90	0.144444	0.257955	-	0.590677	0.915362	-0.0782775	0.92 [0.22 - 3.92]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211224_s_at	90	0.266667	0.151832	-	0.692115	0.708991	0.307979	1.36 [0.27 - 6.86]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211224_s_at	138	0.297101	0.000847774	0.0221812	-0.794347	0.161681	-7.21059	0.00 [0.00 - 17.96]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208288_at	138	0.898551	0.0785047	-	-0.885906	0.134923	-6.31724	0.00 [0.00 - 7.14]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211224_s_at	129	0.852713	0.00259922	0.0560904	0.843629	0.152037	0.268753	1.31 [0.91 - 1.89]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208288_at	129	0.682171	0.0177382	0.246036	0.594922	0.533557	0.103134	1.11 [0.80 - 1.53]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7868	56	0.303571	0.0511782	-	-0.716792	0.78982	0.214336	1.24 [0.26 - 5.99]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7868	56	0.303571	0.0471557	0.474266	-0.697435	0.986453	-0.0125985	0.99 [0.23 - 4.23]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211224_s_at	278	0.334532	0.0389055	0.420151	0.447464	0.316273	0.592204	1.81 [0.57 - 5.76]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208288_at	278	0.863309	0.00343882	0.0702989	0.706675	0.477798	0.386218	1.47 [0.51 - 4.27]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208288_at	133	0.796992	0.000851	0.0222523	0.867665	0.0668937	1.22825	3.42 [0.92 - 12.71]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211224_s_at	133	0.616541	0.00218971	0.0487821	0.717991	0.0272508	2.63453	13.94 [1.34 - 144.49]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16327	81	0.82716	0.0796268	-	1.0013	0.883172	0.15793	1.17 [0.14 - 9.63]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208288_at	185	0.313514	0.0677491	-	-0.337371	0.948066	-0.025739	0.97 [0.45 - 2.11]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211224_s_at	185	0.643243	0.0728584	-	0.310121	0.285686	0.357588	1.43 [0.74 - 2.76]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208288_at	185	0.313514	0.0473293	0.475343	-0.337251	0.747434	-0.119383	0.89 [0.43 - 1.84]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211224_s_at	185	0.643243	0.166695	-	0.261147	0.360769	0.336168	1.40 [0.68 - 2.88]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P39703	110	0.745455	0.239203	-	-0.324849	0.929945	-0.0132335	0.99 [0.73 - 1.33]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P39703	110	0.872727	0.0376692	0.411508	0.819333	0.432632	-0.160235	0.85 [0.57 - 1.27]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211224_s_at	80	0.65	0.0506923	-	-0.993671	0.819398	-0.0415157	0.96 [0.67 - 1.37]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208288_at	80	0.2375	0.00415681	0.0817842	-1.20022	0.265033	-0.194068	0.82 [0.59 - 1.16]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208288_at	38	0.131579	0.207899	-	1.22426	0.882814	0.0374634	1.04 [0.63 - 1.71]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211224_s_at	38	0.289474	0.00185375	0.0425573	-1.51161	0.0075764	-1.05918	0.35 [0.16 - 0.75]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208288_at	140	0.621429	0.0109217	0.172502	-0.855147	0.0520458	-2.68416	0.07 [0.00 - 1.02]
GENE	ABCB11	ATP-binding cassette, sub-family B (MDR/TAP), member 11	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211224_s_at	140	0.114286	0.186139	-	0.922876	0.75251	0.29282	1.34 [0.22 - 8.27]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207819_s_at	30	0.866667	0.170367	-	-0.831946	0.515419	-0.32942	0.72 [0.27 - 1.94]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1767349	165	0.266667	0.000815117	0.0214584	-0.805372	0.0377384	-1.18655	0.31 [0.10 - 0.94]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1767349	165	0.266667	0.0149108	0.217059	-0.84339	0.417375	-0.631328	0.53 [0.12 - 2.45]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207819_s_at	163	0.288344	0.00231492	0.051047	-0.620212	0.229566	-0.842704	0.43 [0.11 - 1.70]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1570505_at	79	0.177215	0.0635349	-	-0.635757	0.628742	-0.319124	0.73 [0.20 - 2.65]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207819_s_at	79	0.898734	0.0645114	-	0.750152	0.278885	0.570754	1.77 [0.63 - 4.97]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207819_s_at	58	0.551724	0.112164	-	-0.436614	0.899877	-0.0179735	0.98 [0.74 - 1.30]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207819_s_at	34	0.852941	0.0444382	0.457087	-1.19509	0.262729	-0.240313	0.79 [0.52 - 1.20]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207819_s_at	158	0.56962	0.0141486	0.208906	0.563806	0.225904	0.223201	1.25 [0.87 - 1.79]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207819_s_at	53	0.45283	0.00536659	0.10005	1.09959	0.0628909	0.305155	1.36 [0.98 - 1.87]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207819_s_at	53	0.301887	0.0624826	-	0.772926	0.224439	0.176864	1.19 [0.90 - 1.59]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207819_s_at	180	0.35	0.220581	-	0.271867	0.595322	0.0550822	1.06 [0.86 - 1.29]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1570505_at	559	0.872987	0.102774	-	-0.629167	0.728589	-0.050724	0.95 [0.71 - 1.27]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207819_s_at	559	0.651163	0.0101282	0.163015	-0.586616	0.824852	-0.0202572	0.98 [0.82 - 1.17]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207819_s_at	77	0.337662	0.0352115	0.393869	0.586912	0.194919	0.159883	1.17 [0.92 - 1.49]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1570505_at	70	0.842857	0.0452337	0.462179	-0.848862	0.075369	-0.821016	0.44 [0.18 - 1.09]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207819_s_at	70	0.428571	0.0429242	0.44725	-0.532009	0.103242	-0.390225	0.68 [0.42 - 1.08]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33978_at	50	0.66	0.128678	-	-0.56019	0.773672	-0.233525	0.79 [0.16 - 3.89]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207819_s_at	74	0.864865	0.080902	-	-0.999485	0.346731	-0.171335	0.84 [0.59 - 1.20]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207819_s_at	67	0.104478	0.0315567	0.366427	-1.4336	0.176388	-2.28581	0.10 [0.00 - 2.80]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1570505_at	67	0.895522	0.12168	-	1.22628	0.922817	0.279015	1.32 [0.00 - 373.72]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1570505_at	115	0.2	0.114684	-	-0.858578	0.887835	-0.0744884	0.93 [0.33 - 2.61]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207819_s_at	115	0.243478	0.00158215	0.0373464	-1.55525	0.075274	-1.18367	0.31 [0.08 - 1.13]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33978_at	158	0.772152	0.0334744	0.381014	0.655425	0.81973	-0.0457409	0.96 [0.64 - 1.42]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33978_at	76	0.842105	0.287931	-	0.612493	0.867529	0.0576183	1.06 [0.54 - 2.08]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207819_s_at	204	0.294118	0.0478968	0.478849	-0.30868	0.391006	-0.0762659	0.93 [0.78 - 1.10]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1570505_at	204	0.29902	0.0485421	0.482804	-0.296377	0.825521	0.0151764	1.02 [0.89 - 1.16]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1570505_at	87	0.758621	0.0246892	0.310345	-1.5039	0.196712	-0.957111	0.38 [0.09 - 1.64]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1570505_at	87	0.758621	0.0246892	0.310345	-1.5039	0.196712	-0.957111	0.38 [0.09 - 1.64]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207819_s_at	87	0.505747	0.0319426	0.369397	-0.830392	0.0588171	-0.954184	0.39 [0.14 - 1.04]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207819_s_at	87	0.505747	0.0319426	0.369397	-0.830392	0.0588171	-0.954184	0.39 [0.14 - 1.04]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1570505_at	77	0.792208	0.195916	-	-1.26259	0.367325	1.09291	2.98 [0.28 - 32.11]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207819_s_at	77	0.350649	0.00569585	0.104822	15.7704	0.163909	1.12215	3.07 [0.63 - 14.91]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1570505_at	77	0.181818	0.260026	-	-0.759771	0.261935	1.4904	4.44 [0.33 - 60.00]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207819_s_at	77	0.350649	0.0172038	0.240702	15.7475	0.191955	1.19266	3.30 [0.55 - 19.77]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207819_s_at	136	0.727941	0.0231999	0.297284	-1.9898	0.443283	-0.167904	0.85 [0.55 - 1.30]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207819_s_at	200	0.24	0.00104042	0.0263461	-0.965408	0.257033	-0.187143	0.83 [0.60 - 1.15]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20349	60	0.466667	0.0930521	-	-0.644245	0.986279	-0.00350744	1.00 [0.67 - 1.49]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20349	60	0.333333	0.00500253	0.0946805	1.40526	0.0560755	0.493288	1.64 [0.99 - 2.72]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16768	155	0.23871	2.09846e-06	0.000107595	-1.25452	0.000443922	-0.15034	0.86 [0.79 - 0.94]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207819_s_at	286	0.576923	0.0377499	0.412077	-0.419045	0.275538	-0.12262	0.88 [0.71 - 1.10]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207819_s_at	159	0.389937	0.0461769	0.468147	0.841385	0.635725	0.117961	1.13 [0.69 - 1.83]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207819_s_at	159	0.389937	0.0103158	0.165279	0.938056	0.463867	0.156337	1.17 [0.77 - 1.78]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207819_s_at	159	0.371069	0.157075	-	0.496042	0.818313	-0.0483032	0.95 [0.63 - 1.44]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207819_s_at	54	0.833333	0.219948	-	0.968985	0.118638	2.05124	7.78 [0.59 - 102.27]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207819_s_at	117	0.897436	0.0460208	0.467165	-1.77773	0.282183	-0.673771	0.51 [0.15 - 1.74]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207819_s_at	117	0.222222	0.0832829	-	1.01497	0.343988	-0.725475	0.48 [0.11 - 2.18]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207819_s_at	117	0.897436	0.15834	-	-1.33757	0.458257	-0.577469	0.56 [0.12 - 2.58]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207819_s_at	117	0.897436	0.0460208	0.467165	-1.77773	0.282183	-0.673771	0.51 [0.15 - 1.74]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207819_s_at	236	0.504237	0.225113	-	-0.328236	0.423263	-0.135876	0.87 [0.63 - 1.22]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207819_s_at	249	0.100402	0.222378	-	-0.390916	0.473853	-0.102034	0.90 [0.68 - 1.19]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207819_s_at	62	0.5	0.230859	-	0.631128	0.639558	-0.148416	0.86 [0.46 - 1.60]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207819_s_at	125	0.144	0.122269	-	-0.704558	0.846525	0.0735199	1.08 [0.51 - 2.27]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207819_s_at	125	0.36	0.12388	-	-0.476881	0.702107	-0.115177	0.89 [0.49 - 1.61]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207819_s_at	54	0.444444	0.128187	-	1.13075	0.823277	-0.0853942	0.92 [0.43 - 1.94]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207819_s_at	198	0.828283	0.0429794	0.447613	0.583996	0.381594	0.0856523	1.09 [0.90 - 1.32]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207819_s_at	198	0.878788	0.0550231	-	0.639349	0.545343	0.0609311	1.06 [0.87 - 1.29]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207819_s_at	198	0.535354	0.124811	-	0.321513	0.722197	0.0282189	1.03 [0.88 - 1.20]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207819_s_at	51	0.235294	0.207391	-	15.449	0.834278	-0.46014	0.63 [0.01 - 47.02]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207819_s_at	62	0.112903	0.00296676	0.0624267	-1.64541	0.0158656	-4.26416	0.01 [0.00 - 0.45]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1570505_at	177	0.299435	0.152663	-	-0.349988	0.792758	-0.245216	0.78 [0.13 - 4.88]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1570505_at	177	0.310734	0.084909	-	-0.473783	0.68967	-0.431049	0.65 [0.08 - 5.39]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207819_s_at	177	0.779661	0.109881	-	-0.501712	0.781105	-0.0874404	0.92 [0.49 - 1.70]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1570505_at	145	0.324138	0.12553	-	-0.512854	0.404816	-1.09176	0.34 [0.03 - 4.38]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207819_s_at	145	0.110345	0.104594	-	-0.670833	0.680662	-0.192787	0.82 [0.33 - 2.07]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207819_s_at	177	0.79096	0.144178	-	-0.554142	0.533695	-0.242041	0.79 [0.37 - 1.68]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1570505_at	226	0.252212	0.0780308	-	-0.536477	0.722963	-0.0460096	0.96 [0.74 - 1.23]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207819_s_at	226	0.792035	0.0524857	-	0.581292	0.291293	0.114632	1.12 [0.91 - 1.39]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207819_s_at	55	0.436364	0.0992542	-	-0.767549	0.838378	0.239208	1.27 [0.13 - 12.65]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207819_s_at	49	0.346939	0.0181962	0.250559	-1.30322	0.528473	-1.01332	0.36 [0.02 - 8.48]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1570505_at	55	0.781818	0.104181	-	0.787243	0.635614	1.2067	3.34 [0.02 - 491.82]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1570505_at	49	0.816327	0.0682144	-	1.08478	0.888432	-0.416404	0.66 [0.00 - 221.69]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1570505_at	55	0.309091	0.0240635	0.3049	-0.972113	0.709844	-0.877691	0.42 [0.00 - 42.35]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207819_s_at	55	0.4	0.00036323	0.0107741	-1.5916	0.0585	-2.22046	0.11 [0.01 - 1.08]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1570505_at	63	0.111111	0.000100529	0.00351862	-1.54277	0.0306213	0.507585	1.66 [1.05 - 2.63]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207819_s_at	63	0.47619	0.00215105	0.0480769	1.07932	0.0129684	0.321914	1.38 [1.07 - 1.78]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9961253_3p_s_at	28	0.428571	0.110514	-	-0.893139	0.51497	-0.396343	0.67 [0.20 - 2.22]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.434244.1.S1_3p_at	28	0.678571	0.00668519	0.118722	-2.46599	0.533677	-0.101465	0.90 [0.66 - 1.24]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9961253_3p_a_at	28	0.214286	0.0326968	0.375151	-1.20526	0.318226	-3.12852	0.04 [0.00 - 20.39]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207819_s_at	82	0.890244	0.0529356	-	0.801231	0.654982	0.202224	1.22 [0.50 - 2.97]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207819_s_at	79	0.240506	0.00638804	0.114612	0.913412	0.105437	0.399754	1.49 [0.92 - 2.42]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207819_s_at	104	0.596154	0.177799	-	-0.466938	0.628029	-0.223721	0.80 [0.32 - 1.98]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207819_s_at	204	0.769608	0.00113945	0.0284286	1.13022	0.0146288	0.689721	1.99 [1.15 - 3.47]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207819_s_at	204	0.696078	0.00180171	0.0415721	0.829989	0.00887939	0.556305	1.74 [1.15 - 2.65]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1570505_at	204	0.627451	0.0273962	0.333222	-0.96929	0.377174	-0.155092	0.86 [0.61 - 1.21]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1570505_at	204	0.647059	0.231482	-	-0.35484	0.959882	-0.00710894	0.99 [0.75 - 1.31]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207819_s_at	178	0.769663	0.0513443	-	0.424841	0.739378	0.0932644	1.10 [0.63 - 1.90]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207819_s_at	111	0.261261	0.0795731	-	-0.484595	0.886195	0.0220229	1.02 [0.76 - 1.38]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1570505_at	111	0.810811	0.179792	-	-0.50751	0.710685	-0.0576737	0.94 [0.70 - 1.28]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207819_s_at	90	0.155556	0.165564	-	0.720666	0.418795	0.451504	1.57 [0.53 - 4.69]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207819_s_at	90	0.244444	0.219434	-	0.59687	0.220255	0.74204	2.10 [0.64 - 6.88]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1570505_at	138	0.15942	0.00544077	0.101132	-0.748095	0.0438044	-9.99406	0.00 [0.00 - 0.76]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207819_s_at	138	0.202899	0.0272877	0.332325	-0.57931	0.904471	-0.0293336	0.97 [0.60 - 1.57]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207819_s_at	129	0.728682	0.0217655	0.284357	-0.742346	0.471363	-0.144772	0.87 [0.58 - 1.28]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15016	56	0.75	0.10844	-	0.57798	0.735628	-0.147144	0.86 [0.37 - 2.03]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15016	56	0.267857	0.0500275	-	-0.709711	0.412831	-0.36835	0.69 [0.29 - 1.67]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1570505_at	278	0.230216	0.0128121	0.194219	0.624778	0.297772	0.398914	1.49 [0.70 - 3.16]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207819_s_at	278	0.633094	0.081937	-	0.336201	0.930109	0.0219225	1.02 [0.63 - 1.67]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207819_s_at	133	0.864662	0.00741716	0.128627	0.785218	0.0769771	2.44531	11.53 [0.77 - 173.37]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7237	81	0.888889	0.07039	-	1.12351	0.227206	0.539223	1.71 [0.71 - 4.11]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13504	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1662	81	0.703704	0.118064	-	0.82728	0.342289	0.443333	1.56 [0.62 - 3.89]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207819_s_at	185	0.108108	0.0595237	-	-0.489058	0.774867	-0.0756446	0.93 [0.55 - 1.56]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207819_s_at	185	0.108108	0.0618159	-	-0.457493	0.58514	-0.132896	0.88 [0.54 - 1.41]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P123112	110	0.872727	0.0944204	-	-0.695753	0.298172	-0.152701	0.86 [0.64 - 1.14]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P123112	110	0.890909	0.15348	-	-0.990581	0.83177	-0.0410302	0.96 [0.66 - 1.40]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207819_s_at	80	0.3125	0.14169	-	0.887368	0.651726	0.0789077	1.08 [0.77 - 1.52]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_1885	281	0.88968	0.00221347	0.049214	-0.76025	0.16675	-0.228275	0.80 [0.58 - 1.10]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207819_s_at	38	0.894737	0.00099127	0.0252984	1.87491	0.0721958	0.485072	1.62 [0.96 - 2.76]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1570505_at	38	0.394737	0.197247	-	-0.605867	0.782449	-0.0771618	0.93 [0.54 - 1.60]
GENE	ABCB4	ATP-binding cassette, sub-family B (MDR/TAP), member 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207819_s_at	140	0.128571	0.103238	-	-0.596707	0.6913	-0.154979	0.86 [0.40 - 1.84]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202804_at	30	0.866667	0.00278812	0.0593713	1.64599	0.556458	0.335591	1.40 [0.46 - 4.28]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202805_s_at	30	0.866667	0.00278812	0.0593713	1.64599	0.0157839	0.955483	2.60 [1.20 - 5.65]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1802404	165	0.121212	0.0318612	0.368772	-0.653854	0.890616	-0.0381687	0.96 [0.56 - 1.66]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1802404	165	0.121212	0.0571414	-	-0.794568	0.946237	-0.0265746	0.97 [0.45 - 2.11]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202804_at	163	0.527607	0.00182133	0.0419442	0.614981	0.00764158	0.399951	1.49 [1.11 - 2.00]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202805_s_at	163	0.840491	0.00992545	0.160553	0.625594	0.0359564	0.432676	1.54 [1.03 - 2.31]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202804_at	79	0.810127	0.0328544	0.376345	0.703566	0.175402	0.280456	1.32 [0.88 - 1.99]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202805_s_at	79	0.582278	0.00872367	0.145613	0.755004	0.115713	0.380109	1.46 [0.91 - 2.35]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202805_s_at	58	0.896552	0.00656545	0.117072	1.23531	0.0775107	0.420094	1.52 [0.95 - 2.43]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202804_at	58	0.431034	0.107615	-	0.460975	0.517659	0.163613	1.18 [0.72 - 1.93]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202805_s_at	34	0.823529	0.133155	-	0.695237	0.455559	-0.244317	0.78 [0.41 - 1.49]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202804_at	34	0.882353	0.000177937	0.00580479	2.03846	0.0180302	0.913781	2.49 [1.17 - 5.32]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202804_at	158	0.120253	0.0208877	0.27627	-0.67386	0.191581	-0.459651	0.63 [0.32 - 1.26]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202805_s_at	158	0.373418	0.0577423	-	-0.440134	0.199761	-0.466773	0.63 [0.31 - 1.28]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202805_s_at	53	0.622642	0.209277	-	-0.496471	0.566841	-0.243347	0.78 [0.34 - 1.80]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202804_at	53	0.396226	0.181808	-	0.487369	0.680755	0.180306	1.20 [0.51 - 2.83]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202805_s_at	53	0.886792	0.17332	-	-0.957219	0.840359	-0.0848421	0.92 [0.40 - 2.10]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202804_at	53	0.396226	0.357814	-	0.355247	0.775195	0.134968	1.14 [0.45 - 2.89]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202804_at	180	0.722222	0.10824	-	0.365173	0.382678	0.290631	1.34 [0.70 - 2.57]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202805_s_at	180	0.15	0.0516365	-	-0.508092	0.532053	-0.120178	0.89 [0.61 - 1.29]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202804_at	559	0.296959	0.00614946	0.111273	0.673282	0.223662	0.324206	1.38 [0.82 - 2.33]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202805_s_at	559	0.100179	0.0459092	0.466461	0.979336	0.10138	0.365185	1.44 [0.93 - 2.23]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202805_s_at	77	0.61039	0.0351418	0.393359	0.531304	0.0400088	0.349333	1.42 [1.02 - 1.98]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202804_at	77	0.376623	0.00698983	0.122881	0.74657	0.0342278	0.433544	1.54 [1.03 - 2.30]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202804_at	70	0.5	0.221703	-	-0.321388	0.888896	-0.0301655	0.97 [0.64 - 1.48]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202805_s_at	70	0.142857	0.0755112	-	-0.615025	0.779871	-0.0962467	0.91 [0.46 - 1.78]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34384_at	50	0.52	0.0490904	0.486139	-0.686723	0.349298	-0.695074	0.50 [0.12 - 2.14]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34016_s_at	50	0.16	0.0495373	0.488841	-0.834059	0.831703	-0.178582	0.84 [0.16 - 4.34]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	1896_s_at	50	0.14	0.0406458	0.432068	-0.937039	0.13979	-1.72551	0.18 [0.02 - 1.76]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34017_s_at	50	0.74	0.0257338	0.319301	-0.931214	0.0918246	-1.81014	0.16 [0.02 - 1.34]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202804_at	74	0.797297	0.0594644	-	0.658169	0.583701	0.204281	1.23 [0.59 - 2.55]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202805_s_at	74	0.540541	0.0690788	-	0.52793	0.856648	-0.0476751	0.95 [0.57 - 1.60]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202804_at	67	0.328358	0.00427253	0.0835865	-1.96821	0.0689384	-1.37924	0.25 [0.06 - 1.11]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202805_s_at	67	0.238806	0.024121	0.305404	-1.40095	0.373799	-0.785383	0.46 [0.08 - 2.57]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202804_at	115	0.113043	0.166695	-	15.2047	0.674386	0.261518	1.30 [0.38 - 4.40]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202805_s_at	115	0.426087	0.254326	-	0.66457	0.584034	0.295552	1.34 [0.47 - 3.87]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	1896_s_at	158	0.696203	0.0309639	0.36183	0.61462	0.201046	0.448422	1.57 [0.79 - 3.11]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34017_s_at	158	0.132911	0.0818638	-	-0.632396	0.678532	-0.0960973	0.91 [0.58 - 1.43]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34384_at	158	0.278481	0.0303392	0.356939	0.784709	0.354008	0.255427	1.29 [0.75 - 2.22]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34016_s_at	158	0.696203	0.00662727	0.117925	0.763221	0.0925098	0.493754	1.64 [0.92 - 2.91]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34016_s_at	76	0.315789	0.178679	-	0.984631	0.703621	-0.238301	0.79 [0.23 - 2.69]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	1896_s_at	76	0.539474	0.190455	-	-0.712269	0.910424	-0.104532	0.90 [0.15 - 5.57]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34017_s_at	76	0.236842	0.121753	-	1.46929	0.469719	0.385505	1.47 [0.52 - 4.18]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34384_at	76	0.144737	0.0936722	-	15.2785	0.68463	0.223727	1.25 [0.42 - 3.68]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202805_s_at	204	0.818627	0.0368865	0.405958	0.381496	0.458527	0.0939826	1.10 [0.86 - 1.41]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202804_at	204	0.27451	8.05074e-05	0.00289247	0.616337	0.163254	0.188806	1.21 [0.93 - 1.57]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202805_s_at	87	0.896552	0.0659994	-	0.88142	0.360393	0.339546	1.40 [0.68 - 2.91]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202804_at	87	0.862069	0.000765132	0.0203418	1.33474	0.527048	-0.220188	0.80 [0.41 - 1.59]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202805_s_at	87	0.896552	0.0659994	-	0.88142	0.360393	0.339546	1.40 [0.68 - 2.91]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202804_at	87	0.862069	0.000765132	0.0203418	1.33474	0.527048	-0.220188	0.80 [0.41 - 1.59]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202805_s_at	77	0.831169	0.00214677	0.0479988	1.73496	0.0510873	1.08348	2.95 [0.99 - 8.78]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202804_at	77	0.896104	0.000711927	0.0191386	1.89759	0.00467026	1.69107	5.43 [1.68 - 17.51]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202805_s_at	77	0.766234	0.00223134	0.0495382	1.55868	0.0881477	0.849675	2.34 [0.88 - 6.21]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202804_at	77	0.844156	0.000373695	0.0110405	1.75972	0.0116463	1.30886	3.70 [1.34 - 10.23]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202804_at	136	0.897059	0.121537	-	0.842505	0.79679	0.142778	1.15 [0.39 - 3.42]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202805_s_at	136	0.397059	0.00683346	0.120753	-1.24467	0.0327333	-0.66017	0.52 [0.28 - 0.95]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202804_at	200	0.54	0.0030638	0.064068	0.90192	0.190587	0.548386	1.73 [0.76 - 3.93]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202805_s_at	200	0.43	0.061493	-	0.603876	0.623886	0.17437	1.19 [0.59 - 2.39]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22158	60	0.533333	0.309676	-	-0.390642	0.743561	0.0621856	1.06 [0.73 - 1.54]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22158	60	0.533333	0.025185	0.314616	0.864876	0.206236	0.248157	1.28 [0.87 - 1.88]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1899	155	0.122581	0.00744996	0.129064	-0.886967	0.791096	0.0568874	1.06 [0.69 - 1.61]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202804_at	286	0.458042	0.00348813	0.0711056	0.582257	0.0111306	0.663965	1.94 [1.16 - 3.24]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202805_s_at	286	0.814685	0.0717972	-	0.408973	0.914726	-0.0176578	0.98 [0.71 - 1.36]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202805_s_at	159	0.528302	0.0100203	0.161707	0.830743	0.030597	0.812555	2.25 [1.08 - 4.71]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202804_at	159	0.301887	0.0590861	-	-0.595195	0.977024	-0.0142457	0.99 [0.37 - 2.60]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202804_at	159	0.295597	0.130043	-	-0.563466	0.799854	-0.144394	0.87 [0.28 - 2.64]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202805_s_at	159	0.591195	0.00337008	0.0691696	0.916383	0.0872694	0.641633	1.90 [0.91 - 3.96]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202804_at	159	0.295597	0.112065	-	-0.507495	0.925544	-0.0453465	0.96 [0.37 - 2.47]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202805_s_at	159	0.528302	0.00870896	0.145427	1.01087	0.0389672	0.914381	2.50 [1.05 - 5.94]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202804_at	54	0.814815	0.00524715	0.0982999	1.79583	0.0514155	1.00345	2.73 [0.99 - 7.49]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202805_s_at	54	0.851852	0.00818509	0.138712	1.67338	0.0798375	0.904299	2.47 [0.90 - 6.79]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202805_s_at	117	0.145299	0.0235443	0.300336	-0.97549	0.599012	-0.165443	0.85 [0.46 - 1.57]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202805_s_at	117	0.435897	0.191795	-	0.430516	0.826049	0.0520326	1.05 [0.66 - 1.68]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202804_at	117	0.316239	0.0441849	0.455455	0.776873	0.482541	0.162577	1.18 [0.75 - 1.85]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202804_at	117	0.641026	0.299085	-	0.395013	0.878163	0.0413936	1.04 [0.61 - 1.77]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202804_at	117	0.65812	0.149996	-	0.558264	0.766264	-0.085233	0.92 [0.52 - 1.61]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202804_at	117	0.316239	0.0441849	0.455455	0.776873	0.482541	0.162577	1.18 [0.75 - 1.85]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202805_s_at	117	0.435897	0.191795	-	0.430516	0.826049	0.0520326	1.05 [0.66 - 1.68]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202805_s_at	117	0.145299	0.0245092	0.308785	-0.910429	0.747071	-0.0936802	0.91 [0.52 - 1.61]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202805_s_at	236	0.139831	0.023518	0.300103	-0.749265	0.810694	0.0824169	1.09 [0.55 - 2.13]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202804_at	236	0.101695	0.0291524	0.347511	1.90147	0.466507	0.295478	1.34 [0.61 - 2.98]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202805_s_at	249	0.413655	0.0607127	-	0.421957	0.311513	0.274295	1.32 [0.77 - 2.24]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202804_at	249	0.104418	0.0224181	0.290282	1.10993	0.175143	0.436165	1.55 [0.82 - 2.91]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202804_at	125	0.896	0.00125045	0.0307212	1.20788	0.00612991	0.968592	2.63 [1.32 - 5.27]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202805_s_at	62	0.129032	0.0631358	-	-1.0312	0.469653	-0.129671	0.88 [0.62 - 1.25]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202805_s_at	125	0.248	0.0119354	0.184294	1.51821	0.210482	0.568793	1.77 [0.73 - 4.30]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202804_at	54	0.481481	0.211211	-	-0.754485	0.582417	-0.1257	0.88 [0.56 - 1.38]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202805_s_at	125	0.248	0.00565831	0.104282	1.12012	0.0517231	0.682565	1.98 [0.99 - 3.94]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202805_s_at	54	0.111111	0.022523	0.291227	-1.45234	0.542275	-0.13267	0.88 [0.57 - 1.34]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202804_at	62	0.774194	0.144042	-	-0.914799	0.420714	-0.15351	0.86 [0.59 - 1.25]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202804_at	125	0.208	0.00678306	0.120064	2.28069	0.0256666	1.01087	2.75 [1.13 - 6.68]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202805_s_at	198	0.858586	0.015818	0.226565	0.747347	0.116397	0.275811	1.32 [0.93 - 1.86]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202804_at	198	0.848485	0.13918	-	0.400854	0.508368	0.101651	1.11 [0.82 - 1.50]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202805_s_at	198	0.111111	0.141481	-	0.575085	0.398091	0.105428	1.11 [0.87 - 1.42]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202804_at	198	0.80303	0.00079141	0.0209305	0.887998	0.0432001	0.378833	1.46 [1.01 - 2.11]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202804_at	198	0.80303	0.0008519	0.0222721	0.911502	0.0615506	0.365843	1.44 [0.98 - 2.12]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202805_s_at	198	0.858586	0.00697106	0.122626	0.801875	0.042086	0.351165	1.42 [1.01 - 1.99]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202804_at	62	0.596774	0.233613	-	-0.775381	0.513011	-0.317425	0.73 [0.28 - 1.88]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202805_s_at	51	0.333333	0.0964668	-	15.7313	0.331805	1.99046	7.32 [0.13 - 407.65]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202805_s_at	62	0.225806	0.207255	-	1.23739	0.669138	0.51975	1.68 [0.16 - 18.24]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202804_at	51	0.490196	0.130587	-	-1.53615	0.463632	-0.553605	0.57 [0.13 - 2.53]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202805_s_at	177	0.836158	0.391702	-	0.28838	0.962554	0.0149264	1.02 [0.54 - 1.89]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202804_at	145	0.848276	0.0380688	0.414318	-1.4035	0.235101	-0.571024	0.56 [0.22 - 1.45]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202804_at	177	0.864407	0.00966155	0.157324	-1.66808	0.279737	-0.417736	0.66 [0.31 - 1.40]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202805_s_at	177	0.38983	0.389242	-	0.21184	0.858159	-0.0492075	0.95 [0.55 - 1.63]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202804_at	177	0.870057	0.00507151	0.0957059	-1.50878	0.193281	-0.433912	0.65 [0.34 - 1.25]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202805_s_at	145	0.875862	0.125127	-	-1.06574	0.764282	-0.118094	0.89 [0.41 - 1.92]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202805_s_at	226	0.721239	0.0640637	-	-0.649191	0.592948	-0.130907	0.88 [0.54 - 1.42]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202804_at	226	0.539823	0.00844509	0.14206	-0.788518	0.100649	-0.5632	0.57 [0.29 - 1.12]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202805_s_at	55	0.490909	0.0657244	-	-0.839495	0.602986	-0.201518	0.82 [0.38 - 1.75]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202805_s_at	55	0.218182	0.174976	-	0.945631	0.90668	0.0493056	1.05 [0.46 - 2.40]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202804_at	55	0.727273	0.151459	-	0.646176	0.798414	0.146035	1.16 [0.38 - 3.55]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202805_s_at	49	0.510204	0.0144632	0.212289	-1.49843	0.22074	-0.605717	0.55 [0.21 - 1.44]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202804_at	55	0.181818	0.0814076	-	1.58052	0.104171	1.01402	2.76 [0.81 - 9.37]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202804_at	49	0.714286	0.34305	-	0.550665	0.656775	0.349374	1.42 [0.30 - 6.62]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202805_s_at	63	0.730159	5.03636e-05	0.00190824	1.32457	5.14163e-05	1.21067	3.36 [1.87 - 6.03]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202804_at	63	0.777778	5.79009e-05	0.00216004	1.33625	0.000203118	0.971856	2.64 [1.58 - 4.41]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9955961_3p_a_at	28	0.142857	0.331889	-	-0.627406	0.986611	0.00512023	1.01 [0.55 - 1.83]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89433.4.S3_3p_at	28	0.321429	0.0510903	-	1.27045	0.507395	0.131899	1.14 [0.77 - 1.69]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202804_at	82	0.109756	0.103501	-	-0.726806	0.629128	0.231449	1.26 [0.49 - 3.22]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202805_s_at	82	0.695122	0.0382546	0.41562	0.693002	0.329216	0.370427	1.45 [0.69 - 3.05]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	1896_s_at	84	0.214286	0.146221	-	0.556178	0.560298	0.217697	1.24 [0.60 - 2.59]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34384_at	84	0.77381	0.0100182	0.161681	0.789963	0.153669	0.358317	1.43 [0.87 - 2.34]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34016_s_at	84	0.166667	0.0322852	0.372019	0.927295	0.185289	0.356464	1.43 [0.84 - 2.42]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202804_at	79	0.860759	0.00154002	0.0365219	1.04278	0.0336513	0.781051	2.18 [1.06 - 4.49]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202805_s_at	79	0.873418	0.00688094	0.121401	0.928803	0.0787107	0.585524	1.80 [0.94 - 3.45]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X78338_at	86	0.895349	0.00128469	0.0314201	1.50196	0.0982432	1.04494	2.84 [0.82 - 9.81]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202804_at	104	0.884615	0.0385267	0.417518	0.896521	0.933851	-0.0502079	0.95 [0.29 - 3.11]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202805_s_at	104	0.509615	0.0500213	-	-0.663716	0.476221	-0.371334	0.69 [0.25 - 1.92]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P227831	117	0.538462	0.0559252	-	-0.567093	0.557583	-0.140949	0.87 [0.54 - 1.39]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202804_at	204	0.666667	0.00623236	0.112438	-0.925556	0.419695	-0.356208	0.70 [0.29 - 1.66]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202805_s_at	204	0.867647	0.0715781	-	0.759847	0.57559	0.304966	1.36 [0.47 - 3.95]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202805_s_at	204	0.651961	0.0568656	-	0.514224	0.445414	0.303722	1.35 [0.62 - 2.96]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202804_at	204	0.666667	0.0640439	-	-0.822799	0.962114	-0.0287594	0.97 [0.30 - 3.18]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202805_s_at	178	0.893258	0.0283116	0.340722	0.626485	0.664585	-0.118801	0.89 [0.52 - 1.52]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202804_at	178	0.870786	0.11791	-	0.424356	0.756987	0.0961268	1.10 [0.60 - 2.02]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202805_s_at	111	0.126126	0.0317678	0.368054	1.20093	0.357433	-0.131056	0.88 [0.66 - 1.16]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202804_at	111	0.873874	0.038092	0.414481	-1.032	0.312017	-0.175132	0.84 [0.60 - 1.18]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202804_at	90	0.411111	0.0261208	0.322577	-0.712433	0.180167	-0.275075	0.76 [0.51 - 1.14]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202804_at	90	0.433333	0.0111185	0.174819	-0.940027	0.0701489	-0.457024	0.63 [0.39 - 1.04]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202805_s_at	90	0.677778	0.0170004	0.238656	-0.962892	0.150754	-0.2673	0.77 [0.53 - 1.10]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202805_s_at	90	0.677778	0.0100898	0.16255	-1.2951	0.137944	-0.325028	0.72 [0.47 - 1.11]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202805_s_at	138	0.297101	0.0783299	-	-0.438828	0.286289	-0.0874688	0.92 [0.78 - 1.08]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202804_at	138	0.753623	0.107909	-	-0.491325	0.375978	-0.0760686	0.93 [0.78 - 1.10]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202804_at	129	0.131783	0.0760254	-	-0.581413	0.956249	-0.00949889	0.99 [0.71 - 1.39]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202805_s_at	129	0.100775	0.0280472	0.338567	-0.780937	0.697373	-0.0693484	0.93 [0.66 - 1.32]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29466	56	0.214286	0.0209419	0.276773	-0.853207	0.269271	-0.163233	0.85 [0.64 - 1.13]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1568	56	0.25	0.0420615	0.441556	-0.734367	0.421626	-0.11771	0.89 [0.67 - 1.18]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29466	56	0.214286	0.182969	-	-0.540724	0.67541	-0.06144	0.94 [0.71 - 1.25]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1568	56	0.25	0.197332	-	-0.506433	0.852786	-0.0272463	0.97 [0.73 - 1.30]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202805_s_at	278	0.226619	0.043944	0.453898	0.492381	0.102468	0.232677	1.26 [0.95 - 1.67]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202804_at	278	0.154676	0.00892995	0.148222	0.814789	0.0346272	0.345442	1.41 [1.03 - 1.95]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202805_s_at	133	0.842105	0.13924	-	0.472162	0.801779	-0.0461425	0.95 [0.67 - 1.37]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202804_at	133	0.120301	0.0927083	-	-0.506984	0.236141	-0.185783	0.83 [0.61 - 1.13]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11918	81	0.728395	0.124795	-	0.808007	0.472769	0.425281	1.53 [0.48 - 4.89]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202804_at	185	0.464865	0.00630513	0.113456	0.443878	0.203607	0.233611	1.26 [0.88 - 1.81]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202805_s_at	185	0.47027	0.145388	-	0.257938	0.712536	0.0823597	1.09 [0.70 - 1.68]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202804_at	185	0.464865	0.00392676	0.0781628	0.51241	0.174607	0.273891	1.32 [0.89 - 1.95]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202805_s_at	185	0.47027	0.118772	-	0.253748	0.774875	0.0588568	1.06 [0.71 - 1.59]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P227831	110	0.109091	0.0571109	-	-0.627815	0.806683	-0.0537834	0.95 [0.62 - 1.46]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P227831	110	0.163636	0.0553969	-	-0.636272	0.92459	-0.0240284	0.98 [0.59 - 1.61]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202804_at	80	0.8	0.0232202	0.297464	1.04828	0.302914	0.563008	1.76 [0.60 - 5.13]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202805_s_at	80	0.7625	0.0264061	0.324978	1.00277	0.228725	0.549842	1.73 [0.71 - 4.24]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5022	281	0.850534	0.172184	-	-0.285438	0.623353	-0.05348	0.95 [0.77 - 1.17]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202805_s_at	38	0.789474	0.000425962	0.012354	1.79943	0.0784031	0.765665	2.15 [0.92 - 5.04]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202804_at	38	0.894737	0.0107432	0.170389	1.57463	0.181719	0.501487	1.65 [0.79 - 3.45]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202805_s_at	140	0.721429	0.032329	0.372353	0.622313	0.0471272	0.907036	2.48 [1.01 - 6.07]
GENE	ABCC1	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202804_at	140	0.728571	0.0284004	0.341443	0.64402	0.274012	0.435604	1.55 [0.71 - 3.37]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209641_s_at	30	0.466667	0.0247369	0.310758	-0.901911	0.502443	-0.197632	0.82 [0.46 - 1.46]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214979_at	30	0.6	0.0939009	-	-0.707191	0.92342	-0.0948545	0.91 [0.13 - 6.29]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1677814	165	0.818182	0.00594254	0.108348	-1.12211	0.315775	-0.0846443	0.92 [0.78 - 1.08]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1677814	165	0.381818	8.45589e-05	0.0030207	-1.35962	0.0100433	-0.295944	0.74 [0.59 - 0.93]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209641_s_at	163	0.754601	0.22225	-	-0.292542	0.879799	-0.0915696	0.91 [0.28 - 2.99]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214979_at	163	0.398773	0.0514847	-	-0.385683	0.109332	-1.32283	0.27 [0.05 - 1.35]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	230682_x_at	163	0.460123	0.00243545	0.0532013	-0.59349	0.21782	-1.11666	0.33 [0.06 - 1.93]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	239217_x_at	163	0.251534	0.0191252	0.259595	-0.512723	0.105288	-1.03385	0.36 [0.10 - 1.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214979_at	79	0.607595	0.0870409	-	-0.532038	0.836078	-0.179254	0.84 [0.15 - 4.57]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209641_s_at	79	0.898734	0.109014	-	-1.10136	0.532893	-0.378627	0.68 [0.21 - 2.25]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	230682_x_at	79	0.886076	0.0559976	-	-1.29102	0.34077	-0.757729	0.47 [0.10 - 2.23]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	239217_x_at	79	0.126582	0.0118006	0.182745	-0.953604	0.113316	-1.20265	0.30 [0.07 - 1.33]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214979_at	58	0.482759	0.0131128	0.197569	0.709719	0.0617594	0.317044	1.37 [0.98 - 1.91]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209641_s_at	58	0.482759	0.0367494	0.404979	0.600379	0.0592292	0.371186	1.45 [0.99 - 2.13]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214979_at	34	0.382353	0.0739961	-	0.702835	0.222569	0.419295	1.52 [0.78 - 2.98]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209641_s_at	34	0.5	0.0316264	0.366965	-0.830504	0.17044	-0.416979	0.66 [0.36 - 1.20]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209641_s_at	158	0.202532	0.00161014	0.0378915	-0.797985	0.0608163	-1.12812	0.32 [0.10 - 1.05]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214979_at	158	0.303797	0.27397	-	-0.262732	0.969026	0.044298	1.05 [0.11 - 9.78]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214979_at	53	0.320755	0.0711523	-	0.762854	0.521577	0.220325	1.25 [0.64 - 2.45]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209641_s_at	53	0.603774	0.198308	-	-0.459269	0.74504	-0.0684769	0.93 [0.62 - 1.41]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214979_at	53	0.320755	0.0652221	-	0.730602	0.560059	0.185078	1.20 [0.65 - 2.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209641_s_at	53	0.603774	0.188907	-	-0.506229	0.588393	-0.122174	0.88 [0.57 - 1.38]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209641_s_at	180	0.105556	0.122603	-	0.642575	0.692732	0.0404384	1.04 [0.85 - 1.27]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214979_at	180	0.111111	0.0473979	0.475768	-0.556499	0.362857	-0.167967	0.85 [0.59 - 1.21]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	230682_x_at	180	0.25	0.0299906	0.354188	0.589722	0.263543	0.213298	1.24 [0.85 - 1.80]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	239217_x_at	180	0.111111	0.124332	-	-0.474425	0.314835	-0.126632	0.88 [0.69 - 1.13]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214979_at	559	0.525939	0.085036	-	-0.347525	0.278272	-0.121521	0.89 [0.71 - 1.10]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209641_s_at	559	0.100179	0.0366704	0.404415	-0.541341	0.639468	-0.0726615	0.93 [0.69 - 1.26]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	239217_x_at	559	0.137746	0.00743033	0.128802	-0.658703	0.390304	-0.111131	0.89 [0.69 - 1.15]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	230682_x_at	559	0.141324	0.222549	-	0.374479	0.826119	0.0252449	1.03 [0.82 - 1.28]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214979_at	77	0.38961	0.100465	-	0.432462	0.150053	0.359486	1.43 [0.88 - 2.34]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209641_s_at	77	0.350649	0.00341441	0.0698986	0.842243	0.0915229	0.142958	1.15 [0.98 - 1.36]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	239217_x_at	77	0.61039	0.0724762	-	0.458459	0.763975	0.0373476	1.04 [0.81 - 1.32]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	230682_x_at	77	0.532468	0.00247738	0.0539451	0.77249	0.0254773	0.277384	1.32 [1.03 - 1.68]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214979_at	70	0.885714	0.327352	-	-0.454111	0.860586	-0.162578	0.85 [0.14 - 5.22]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209641_s_at	70	0.571429	0.148149	-	-0.394301	0.728227	-0.0465418	0.95 [0.73 - 1.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	239217_x_at	70	0.814286	0.222811	-	-0.422248	0.785479	0.122038	1.13 [0.47 - 2.72]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	230682_x_at	70	0.857143	0.119643	-	-0.711381	0.921486	-0.0199594	0.98 [0.66 - 1.46]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38261_at	50	0.74	2.50134e-06	0.000126393	1.81489	6.18116e-05	0.5517	1.74 [1.33 - 2.27]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	1930_at	50	0.24	0.0124774	0.190458	1.27088	0.0113429	1.43654	4.21 [1.38 - 12.79]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209641_s_at	74	0.635135	0.000177988	0.00580625	1.09454	0.0100559	0.244028	1.28 [1.06 - 1.54]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214979_at	74	0.459459	0.00576091	0.105756	0.818846	0.059609	0.494021	1.64 [0.98 - 2.74]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	239217_x_at	74	0.662162	0.0113605	0.17765	0.764229	0.0776253	0.211182	1.24 [0.98 - 1.56]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	230682_x_at	74	0.472973	3.1434e-06	0.000155798	1.41396	0.00386365	0.393074	1.48 [1.13 - 1.93]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	239217_x_at	67	0.373134	0.0733859	-	1.69117	0.391518	1.72945	5.64 [0.11 - 294.53]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214979_at	67	0.61194	0.202221	-	0.833311	0.994353	0.0222558	1.02 [0.00 - 485.53]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	230682_x_at	67	0.895522	0.00165439	0.0387495	2.05071	0.109955	2.90943	18.35 [0.52 - 650.06]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209641_s_at	67	0.835821	0.131872	-	1.02411	0.27797	1.28788	3.63 [0.35 - 37.14]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214979_at	115	0.869565	0.0783228	-	1.00165	0.642948	0.448992	1.57 [0.23 - 10.46]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209641_s_at	115	0.365217	0.0628915	-	1.3205	0.206454	0.390679	1.48 [0.81 - 2.71]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	239217_x_at	115	0.417391	0.028161	0.339495	1.52597	0.0639923	1.24623	3.48 [0.93 - 13.00]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	230682_x_at	115	0.73913	0.127163	-	0.801783	0.576631	0.425276	1.53 [0.34 - 6.81]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	1930_at	158	0.588608	0.000914594	0.0236441	0.920656	0.0227598	0.445692	1.56 [1.06 - 2.29]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38261_at	158	0.841772	0.000684062	0.018502	1.03389	0.00205519	0.410325	1.51 [1.16 - 1.96]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38261_at	76	0.526316	0.0349772	0.392154	1.16656	0.433721	0.207781	1.23 [0.73 - 2.07]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	1930_at	76	0.776316	0.101544	-	-1.54289	0.552013	0.288354	1.33 [0.52 - 3.45]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209641_s_at	204	0.740196	0.0547498	-	-0.30321	0.557286	-0.0350966	0.97 [0.86 - 1.09]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	239217_x_at	204	0.72549	0.0264606	0.325435	-0.347571	0.332181	-0.0792117	0.92 [0.79 - 1.08]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214979_at	204	0.22549	0.0804723	-	-0.293577	0.401854	-0.0725567	0.93 [0.78 - 1.10]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	230682_x_at	204	0.20098	1.70724e-05	0.000724348	-0.75757	0.014374	-0.164184	0.85 [0.74 - 0.97]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209641_s_at	87	0.402299	0.143347	-	0.603955	0.295694	0.21185	1.24 [0.83 - 1.84]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214979_at	87	0.402299	0.0373242	0.40907	0.881493	0.945609	0.0511729	1.05 [0.24 - 4.58]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209641_s_at	87	0.402299	0.143347	-	0.603955	0.295694	0.21185	1.24 [0.83 - 1.84]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	239217_x_at	87	0.54023	0.0863072	-	-0.682494	0.903627	0.0516688	1.05 [0.46 - 2.43]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	239217_x_at	87	0.54023	0.0863072	-	-0.682494	0.903627	0.0516688	1.05 [0.46 - 2.43]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	230682_x_at	87	0.896552	0.0755018	-	0.852437	0.38245	0.187415	1.21 [0.79 - 1.84]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	230682_x_at	87	0.896552	0.0755018	-	0.852437	0.38245	0.187415	1.21 [0.79 - 1.84]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214979_at	87	0.402299	0.0373242	0.40907	0.881493	0.945609	0.0511729	1.05 [0.24 - 4.58]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209641_s_at	77	0.766234	0.135401	-	0.828824	0.878134	0.0973074	1.10 [0.32 - 3.82]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214979_at	77	0.493506	0.250027	-	0.774499	0.419096	1.42352	4.15 [0.13 - 131.19]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	239217_x_at	77	0.324675	0.142111	-	1.07633	0.592528	0.444642	1.56 [0.31 - 7.95]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	230682_x_at	77	0.896104	0.00209877	0.0471192	1.66131	0.02084	2.19595	8.99 [1.40 - 57.89]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209641_s_at	77	0.766234	0.0238694	0.303199	1.33178	0.499441	0.471877	1.60 [0.41 - 6.30]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	239217_x_at	77	0.363636	0.336286	-	-0.599366	0.81821	0.221925	1.25 [0.19 - 8.28]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214979_at	77	0.883117	0.0159536	0.227969	1.34552	0.0744707	2.74115	15.50 [0.76 - 315.20]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	230682_x_at	77	0.896104	0.000124409	0.00424388	2.09172	0.0220007	2.51505	12.37 [1.44 - 106.41]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209641_s_at	136	0.286765	0.00790958	0.135128	2.24015	0.539008	0.135483	1.15 [0.74 - 1.76]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214979_at	136	0.132353	0.000994274	0.0253627	-1.42454	0.0561941	-0.546511	0.58 [0.33 - 1.01]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209641_s_at	200	0.84	0.310167	-	-0.476432	0.543183	-0.112673	0.89 [0.62 - 1.28]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214979_at	200	0.32	0.0419994	0.441144	-0.621716	0.13172	-0.447294	0.64 [0.36 - 1.14]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14213	155	0.8	0.000216158	0.00687686	1.02015	0.000171287	0.315918	1.37 [1.16 - 1.62]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209641_s_at	286	0.737762	0.0453038	0.462625	-0.492172	0.14447	-0.165478	0.85 [0.68 - 1.06]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214979_at	286	0.77972	0.0270642	0.330473	-0.591677	0.736569	0.0713208	1.07 [0.71 - 1.63]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214979_at	159	0.811321	0.00917463	0.151291	0.853965	0.0906371	0.71029	2.03 [0.89 - 4.63]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209641_s_at	159	0.534591	0.0197769	0.265831	0.744933	0.317729	0.251517	1.29 [0.79 - 2.11]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209641_s_at	159	0.496855	0.00656906	0.117122	1.07908	0.0850639	0.470357	1.60 [0.94 - 2.73]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214979_at	159	0.408805	0.00517263	0.0972022	1.01531	0.471768	0.274932	1.32 [0.62 - 2.78]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209641_s_at	159	0.496855	0.00129212	0.0315713	1.08798	0.0361979	0.483382	1.62 [1.03 - 2.55]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214979_at	159	0.377358	0.0213214	0.280283	1.01221	0.248273	0.549126	1.73 [0.68 - 4.40]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230682_x_at	159	0.893082	0.000908583	0.0235134	1.19081	0.954341	0.0148044	1.01 [0.61 - 1.68]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230682_x_at	159	0.169811	0.00157174	0.0371429	-1.02483	0.152442	-0.345318	0.71 [0.44 - 1.14]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230682_x_at	159	0.893082	0.00176474	0.0408685	1.2755	0.968887	0.0118375	1.01 [0.56 - 1.83]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239217_x_at	159	0.798742	0.0148235	0.216132	0.803091	0.057752	0.330724	1.39 [0.99 - 1.96]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239217_x_at	159	0.591195	0.0200675	0.268584	0.724098	0.0346382	0.35913	1.43 [1.03 - 2.00]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239217_x_at	159	0.779874	0.0040387	0.0799315	1.03932	0.0158797	0.466342	1.59 [1.09 - 2.33]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209641_s_at	54	0.333333	0.114996	-	1.57041	0.189715	0.500089	1.65 [0.78 - 3.48]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214979_at	54	0.759259	0.299801	-	-1.05257	0.542338	-1.34215	0.26 [0.00 - 19.60]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214979_at	117	0.273504	0.0947181	-	0.87907	0.84586	-0.207869	0.81 [0.10 - 6.61]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214979_at	117	0.726496	0.0301815	0.355696	0.696212	0.805819	0.19097	1.21 [0.26 - 5.55]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209641_s_at	117	0.871795	0.00492031	0.0934535	0.995155	0.00155359	0.604467	1.83 [1.26 - 2.66]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209641_s_at	117	0.384615	0.046552	0.470501	0.8878	0.0135	0.553217	1.74 [1.12 - 2.70]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209641_s_at	117	0.675214	0.0124759	0.190442	0.944666	0.00215678	0.688405	1.99 [1.28 - 3.09]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209641_s_at	117	0.871795	0.00492031	0.0934535	0.995155	0.00155359	0.604467	1.83 [1.26 - 2.66]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214979_at	117	0.726496	0.0301815	0.355696	0.696212	0.805819	0.19097	1.21 [0.26 - 5.55]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214979_at	117	0.735043	0.107368	-	0.62701	0.902471	-0.124525	0.88 [0.12 - 6.47]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214979_at	236	0.516949	0.0195917	0.264068	0.637559	0.463567	0.289128	1.34 [0.62 - 2.89]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209641_s_at	236	0.355932	0.0748064	-	-0.478157	0.767549	0.0547694	1.06 [0.73 - 1.52]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	239217_x_at	236	0.699153	0.0291296	0.347328	0.587512	0.372996	0.12259	1.13 [0.86 - 1.48]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	230682_x_at	236	0.84322	0.15153	-	0.463661	0.579311	0.100922	1.11 [0.77 - 1.58]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214979_at	249	0.401606	0.0808821	-	0.387344	0.26536	0.356384	1.43 [0.76 - 2.67]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209641_s_at	249	0.373494	0.0881191	-	-0.361048	0.499779	0.096657	1.10 [0.83 - 1.46]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	239217_x_at	249	0.871486	0.00550041	0.101999	0.719619	0.28947	0.116466	1.12 [0.91 - 1.39]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	230682_x_at	249	0.787149	0.167654	-	0.332353	0.243951	0.170928	1.19 [0.89 - 1.58]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214979_at	62	0.870968	0.362983	-	0.574816	0.715184	-0.104481	0.90 [0.51 - 1.58]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209641_s_at	125	0.864	0.000310357	0.00940797	1.11846	0.0125048	0.83761	2.31 [1.20 - 4.46]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214979_at	125	0.64	0.0641634	-	-0.887125	0.73238	-0.373085	0.69 [0.08 - 5.84]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209641_s_at	54	0.12963	0.00420268	0.0825002	-1.80998	0.579775	-0.122005	0.89 [0.57 - 1.36]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214979_at	125	0.896	0.0703625	-	0.730288	0.900518	0.102214	1.11 [0.22 - 5.50]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214979_at	54	0.888889	0.406819	-	0.635632	0.790157	-0.0922693	0.91 [0.46 - 1.80]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209641_s_at	62	0.129032	0.00535095	0.0998219	-1.56277	0.433525	-0.142983	0.87 [0.61 - 1.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209641_s_at	125	0.864	0.0116564	0.181082	1.05686	0.0269928	0.872905	2.39 [1.10 - 5.19]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214979_at	198	0.616162	0.0183022	0.251599	-0.71345	0.324392	-0.146049	0.86 [0.65 - 1.16]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209641_s_at	198	0.69697	0.0405423	0.431368	-0.514213	0.503275	-0.047928	0.95 [0.83 - 1.10]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214979_at	198	0.585859	0.121529	-	-0.340772	0.98573	-0.00218069	1.00 [0.79 - 1.27]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209641_s_at	198	0.666667	0.0822568	-	-0.510009	0.727152	-0.0302595	0.97 [0.82 - 1.15]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209641_s_at	198	0.459596	0.0586636	-	-0.503412	0.612713	-0.0471251	0.95 [0.79 - 1.14]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214979_at	198	0.616162	0.0467242	0.471578	-0.561312	0.669193	-0.0633773	0.94 [0.70 - 1.26]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209641_s_at	62	0.177419	0.0664732	-	-1.07499	0.234216	-0.725334	0.48 [0.15 - 1.60]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214979_at	51	0.235294	0.202814	-	15.4569	0.724516	0.908639	2.48 [0.02 - 388.37]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214979_at	62	0.370968	0.149077	-	-0.821606	0.480541	-1.56109	0.21 [0.00 - 16.06]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209641_s_at	51	0.196078	0.00817176	0.138539	-2.04873	0.850119	-0.163329	0.85 [0.16 - 4.62]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209641_s_at	145	0.234483	0.037173	0.407997	1.05702	0.62045	0.17806	1.19 [0.59 - 2.42]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	239217_x_at	177	0.158192	0.0394055	0.423604	-0.567378	0.71144	-0.158717	0.85 [0.37 - 1.98]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	239217_x_at	177	0.158192	0.0783977	-	-0.55713	0.989568	-0.00637249	0.99 [0.38 - 2.58]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214979_at	177	0.367232	0.0046165	0.0888712	-0.750119	0.0587464	-2.06279	0.13 [0.01 - 1.08]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	230682_x_at	177	0.135593	0.00381716	0.0764187	1.81548	0.351084	0.370758	1.45 [0.66 - 3.16]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	230682_x_at	177	0.135593	0.00705498	0.123764	2.2291	0.129865	0.671401	1.96 [0.82 - 4.67]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209641_s_at	177	0.141243	0.0349349	0.391844	1.18404	0.522909	0.187284	1.21 [0.68 - 2.14]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214979_at	177	0.367232	0.00467698	0.0897896	-0.653817	0.0348635	-1.99293	0.14 [0.02 - 0.87]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	230682_x_at	145	0.131034	0.0490351	0.485804	1.76073	0.972495	-0.020238	0.98 [0.31 - 3.10]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	239217_x_at	145	0.110345	0.00039894	0.0116785	-1.24371	0.145132	-0.950466	0.39 [0.11 - 1.39]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214979_at	145	0.868966	0.024445	0.308228	-1.95721	0.220462	-1.57367	0.21 [0.02 - 2.57]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209641_s_at	177	0.141243	0.0688128	-	0.758993	0.863841	0.0432947	1.04 [0.64 - 1.71]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	239217_x_at	226	0.106195	0.0472284	0.474718	1.76596	0.259202	0.249448	1.28 [0.83 - 1.98]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	230682_x_at	226	0.150442	0.104029	-	-0.54836	0.897813	-0.020123	0.98 [0.72 - 1.33]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214979_at	226	0.464602	0.0731064	-	-0.509455	0.79648	0.0464226	1.05 [0.74 - 1.49]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209641_s_at	226	0.247788	0.0374157	0.409717	0.825403	0.0819372	0.219803	1.25 [0.97 - 1.60]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	239217_x_at	55	0.6	0.00352085	0.0716393	-1.64245	0.0775329	-1.25265	0.29 [0.07 - 1.15]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	230682_x_at	55	0.545455	0.0216658	0.283446	-1.12933	0.0566601	-1.17078	0.31 [0.09 - 1.03]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214979_at	55	0.127273	0.116209	-	-0.853583	0.435456	-1.17542	0.31 [0.02 - 5.92]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	239217_x_at	55	0.363636	0.0303104	0.356712	-1.01381	0.22819	-0.940118	0.39 [0.08 - 1.80]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214979_at	55	0.345455	0.108635	-	-0.765356	0.20641	-2.19309	0.11 [0.00 - 3.35]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209641_s_at	55	0.527273	0.0115077	0.179361	-1.22912	0.04083	-0.937865	0.39 [0.16 - 0.96]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	230682_x_at	55	0.545455	0.125377	-	-0.755184	0.356467	-0.694006	0.50 [0.11 - 2.18]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	239217_x_at	49	0.571429	0.0269709	0.329697	-1.55684	0.369377	-0.832053	0.44 [0.07 - 2.68]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214979_at	49	0.653061	0.116429	-	0.881633	0.596815	-1.00463	0.37 [0.01 - 15.15]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	230682_x_at	49	0.530612	0.143013	-	-0.942137	0.407481	-0.709297	0.49 [0.09 - 2.64]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209641_s_at	55	0.381818	0.00888691	0.147679	-1.21256	0.117817	-0.76823	0.46 [0.18 - 1.21]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209641_s_at	49	0.489796	0.0243595	0.307484	-1.39015	0.152293	-0.833803	0.43 [0.14 - 1.36]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	781139	34	0.852941	0.0594077	-	1.03632	0.0716991	0.598798	1.82 [0.95 - 3.49]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	239217_x_at	63	0.142857	0.000294694	0.00899642	-1.3671	0.0497255	-32.4788	0.00 [0.00 - 0.96]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	230682_x_at	63	0.238095	0.000134549	0.00454586	-1.28907	0.463309	-1.17737	0.31 [0.01 - 7.16]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214979_at	63	0.269841	0.00527309	0.098681	-0.938651	0.046811	-7.84503	0.00 [0.00 - 0.90]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209641_s_at	63	0.269841	4.9451e-05	0.00187745	-1.32206	0.685366	-1.00317	0.37 [0.00 - 46.99]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.298107.0.A1_3p_at	28	0.892857	0.0252915	0.315529	1.3775	0.810269	0.768706	2.16 [0.00 - 1146.43]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4102187_3p_a_at	28	0.642857	0.106351	-	-1.03201	0.209049	-8.79242	0.00 [0.00 - 137.86]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.90786.4.S1_3p_a_at	28	0.142857	0.0685508	-	-1.19105	0.509985	-2.19987	0.11 [0.00 - 77.04]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.90786.4.S1_3p_x_at	28	0.285714	0.0384487	0.416975	-1.11035	0.940573	0.031858	1.03 [0.45 - 2.39]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.187913.0.A1_3p_s_at	28	0.607143	0.03983	0.426517	-1.32371	0.829976	0.520216	1.68 [0.01 - 194.14]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209641_s_at	82	0.719512	0.0471833	0.474437	-0.928398	0.140883	-0.244804	0.78 [0.57 - 1.08]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214979_at	82	0.414634	0.00673615	0.119422	-0.909085	0.126938	-0.454333	0.63 [0.35 - 1.14]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	1930_at	84	0.27381	0.0164495	0.233064	-0.727968	0.405385	-0.157612	0.85 [0.59 - 1.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209641_s_at	79	0.531646	0.281175	-	-0.280748	0.865484	-0.0195755	0.98 [0.78 - 1.23]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214979_at	79	0.202532	0.0395111	0.424331	0.764175	0.700061	0.119283	1.13 [0.61 - 2.07]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209641_s_at	104	0.721154	0.060339	-	-0.768766	0.588436	-0.104376	0.90 [0.62 - 1.31]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214979_at	104	0.682692	0.0158545	0.226943	0.768165	0.130234	0.644832	1.91 [0.83 - 4.39]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P207507	117	0.102564	0.0751691	-	-0.713462	0.185527	-0.126762	0.88 [0.73 - 1.06]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	239217_x_at	204	0.77451	0.285964	-	-0.371877	0.984073	-0.00558281	0.99 [0.57 - 1.72]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214979_at	204	0.504902	0.00179658	0.0414747	-0.886254	0.157109	-0.459577	0.63 [0.33 - 1.19]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	230682_x_at	204	0.676471	0.00461882	0.0889064	-0.993748	0.0225672	-0.399417	0.67 [0.48 - 0.95]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209641_s_at	204	0.465686	0.0817014	-	-0.639026	0.761577	-0.0643696	0.94 [0.62 - 1.42]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209641_s_at	204	0.671569	0.119348	-	-0.491203	0.404637	-0.127497	0.88 [0.65 - 1.19]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	239217_x_at	204	0.147059	0.081916	-	1.59591	0.49607	0.269097	1.31 [0.60 - 2.84]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214979_at	204	0.583333	0.0127303	0.193304	-1.08403	0.0508044	-0.839635	0.43 [0.19 - 1.00]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	230682_x_at	204	0.431373	0.00112351	0.0280959	-1.22226	0.0527889	-0.465	0.63 [0.39 - 1.01]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214979_at	178	0.11236	0.00355682	0.0722247	-0.788455	0.058401	-0.393177	0.67 [0.45 - 1.01]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209641_s_at	178	0.117978	0.012476	0.190443	1.01115	0.523701	0.0689331	1.07 [0.87 - 1.32]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209641_s_at	111	0.837838	0.114972	-	0.493197	0.537368	0.0595148	1.06 [0.88 - 1.28]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	239217_x_at	111	0.882883	0.320475	-	0.359938	0.853634	0.0272169	1.03 [0.77 - 1.37]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	230682_x_at	111	0.468468	0.0543057	-	0.521273	0.741209	0.0415284	1.04 [0.81 - 1.33]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214979_at	111	0.162162	0.120575	-	-0.484718	0.560949	-0.098312	0.91 [0.65 - 1.26]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209641_s_at	90	0.644444	0.00820429	0.13896	0.83919	0.0229005	0.524999	1.69 [1.08 - 2.66]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209641_s_at	90	0.744444	0.00980252	0.159053	0.943853	0.0469137	0.516733	1.68 [1.01 - 2.79]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214979_at	90	0.177778	0.11437	-	0.813113	0.507735	0.459795	1.58 [0.41 - 6.17]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214979_at	90	0.4	0.125568	-	0.627469	0.430465	0.608901	1.84 [0.40 - 8.35]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3957	50	0.18	0.0416203	0.438618	-1.04078	0.109261	-0.669202	0.51 [0.23 - 1.16]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209641_s_at	138	0.695652	0.0896558	-	0.420054	0.414997	0.0578825	1.06 [0.92 - 1.22]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	239217_x_at	138	0.608696	0.0520587	-	0.465393	0.308543	0.127918	1.14 [0.89 - 1.45]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	230682_x_at	138	0.884058	0.147772	-	-0.626661	0.985321	0.00157771	1.00 [0.85 - 1.18]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214979_at	138	0.876812	0.131503	-	-0.63808	0.356845	-0.716087	0.49 [0.11 - 2.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209641_s_at	129	0.124031	0.0295201	0.350451	1.07054	0.282732	0.108804	1.11 [0.91 - 1.36]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214979_at	129	0.627907	0.0519702	-	0.481551	0.605501	0.156883	1.17 [0.65 - 2.12]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44347	56	0.482143	0.0198317	0.266352	-0.852017	0.906812	0.0151388	1.02 [0.79 - 1.31]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28578	56	0.5	0.0147461	0.21531	-0.851494	0.555062	-0.06784	0.93 [0.75 - 1.17]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42466	56	0.464286	0.0725702	-	-0.65725	0.809893	0.0306481	1.03 [0.80 - 1.32]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25810	56	0.642857	0.142873	-	-0.543564	0.716174	-0.0496138	0.95 [0.73 - 1.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28578	56	0.5	0.0333966	0.38043	-0.782974	0.82418	0.0281275	1.03 [0.80 - 1.32]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10784	56	0.375	0.0964789	-	-0.575143	0.570773	-0.0666998	0.94 [0.74 - 1.18]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44347	56	0.589286	0.00536102	0.0999691	-1.0198	0.484477	-0.0822238	0.92 [0.73 - 1.16]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25810	56	0.178571	0.216865	-	0.65351	0.653977	0.0672791	1.07 [0.80 - 1.44]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42466	56	0.589286	0.0220523	0.28697	-0.827654	0.540408	-0.070856	0.93 [0.74 - 1.17]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10784	56	0.178571	0.216865	-	0.65351	0.840367	0.0261324	1.03 [0.80 - 1.32]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	239217_x_at	278	0.399281	0.0309538	0.361751	-0.405257	0.675507	-0.12225	0.88 [0.50 - 1.57]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214979_at	278	0.723022	0.0959484	-	-0.373371	0.320156	-0.552845	0.58 [0.19 - 1.71]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	230682_x_at	278	0.298561	0.11935	-	-0.301291	0.363862	-0.161356	0.85 [0.60 - 1.21]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209641_s_at	278	0.672662	0.309274	-	0.205983	0.693572	-0.0534144	0.95 [0.73 - 1.24]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214979_at	133	0.383459	0.00472541	0.0905227	0.730496	0.00227371	2.75619	15.74 [2.68 - 92.41]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209641_s_at	133	0.360902	0.0107784	0.170805	0.663524	0.728297	-0.0528662	0.95 [0.70 - 1.28]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11399	81	0.111111	0.0124967	0.190677	-1.57134	0.214843	-1.01317	0.36 [0.07 - 1.80]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4953	81	0.148148	0.0751349	-	-0.999397	0.872521	0.0630717	1.07 [0.49 - 2.30]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214979_at	185	0.210811	0.148315	-	0.284013	0.48031	-0.234529	0.79 [0.41 - 1.52]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209641_s_at	185	0.243243	0.110615	-	0.299201	0.861075	0.0455551	1.05 [0.63 - 1.74]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214979_at	185	0.762162	0.106197	-	-0.376671	0.452291	-0.279024	0.76 [0.37 - 1.57]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209641_s_at	185	0.259459	0.181611	-	0.267643	0.694576	0.11158	1.12 [0.64 - 1.95]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P207507	110	0.6	0.0215913	0.282763	-0.566298	0.151351	-0.120473	0.89 [0.75 - 1.05]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P207507	110	0.6	0.182331	-	-0.424543	0.710327	-0.04134	0.96 [0.77 - 1.19]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209641_s_at	80	0.5375	0.00200354	0.0453606	1.38875	0.141467	0.27168	1.31 [0.91 - 1.88]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214979_at	80	0.825	0.068297	-	0.876692	0.525823	0.238039	1.27 [0.61 - 2.65]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5060	281	0.644128	0.0622965	-	0.266841	0.356985	0.0605461	1.06 [0.93 - 1.21]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:208097	59	0.864407	0.146178	-	-15.1904	0.987693	-0.0226821	0.98 [0.05 - 17.45]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	239217_x_at	38	0.394737	0.00922192	0.151882	-1.19431	0.0422465	-0.847802	0.43 [0.19 - 0.97]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	230682_x_at	38	0.105263	0.0446104	0.458194	-1.26833	0.0490934	-0.865656	0.42 [0.18 - 1.00]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214979_at	38	0.842105	0.021923	0.285794	-2.07324	0.16161	-0.708261	0.49 [0.18 - 1.33]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209641_s_at	38	0.394737	0.0470974	0.473904	-0.895344	0.130211	-0.544047	0.58 [0.29 - 1.17]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214979_at	140	0.7	0.11339	-	-0.524988	0.343349	-1.07495	0.34 [0.04 - 3.15]
GENE	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209641_s_at	140	0.107143	0.153333	-	-0.577942	0.548895	-0.328966	0.72 [0.25 - 2.11]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203196_at	30	0.8	0.0584903	-	-1.11703	0.172249	-0.302237	0.74 [0.48 - 1.14]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1788457	165	0.315152	0.000381467	0.0112377	-0.84392	0.00252381	-0.299829	0.74 [0.61 - 0.90]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1788457	165	0.533333	0.000383988	0.0113014	-1.47601	0.00372058	-0.439096	0.64 [0.48 - 0.87]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203196_at	163	0.595092	0.174645	-	-0.278689	0.95386	0.00739657	1.01 [0.78 - 1.29]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	243928_s_at	163	0.226994	0.0241515	0.30567	0.56707	0.083048	0.898911	2.46 [0.89 - 6.79]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203196_at	79	0.101266	0.0181709	0.25031	-0.941349	0.127914	-0.24378	0.78 [0.57 - 1.07]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555039_a_at	79	0.101266	9.71067e-06	0.000435066	-1.66376	0.137378	-0.518391	0.60 [0.30 - 1.18]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554918_a_at	79	0.544304	0.00371409	0.074767	-0.870542	0.0337454	-0.486193	0.61 [0.39 - 0.96]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	243928_s_at	79	0.772152	0.0232447	0.297682	-0.957353	0.311174	-0.408984	0.66 [0.30 - 1.47]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203196_at	58	0.137931	0.289991	-	0.427437	0.835357	0.0319151	1.03 [0.76 - 1.39]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203196_at	34	0.205882	0.0262132	0.323356	1.31573	0.565088	0.129339	1.14 [0.73 - 1.77]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203196_at	158	0.310127	0.00763964	0.13158	-0.617911	0.91194	-0.0334022	0.97 [0.54 - 1.75]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203196_at	53	0.566038	0.0276024	0.334921	-0.853493	0.794293	-0.046996	0.95 [0.67 - 1.36]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203196_at	53	0.792453	0.0158052	0.226433	-1.35958	0.400099	-0.12766	0.88 [0.65 - 1.18]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203196_at	180	0.227778	0.107165	-	-0.381911	0.743468	-0.0562955	0.95 [0.67 - 1.32]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	243928_s_at	180	0.844444	0.103043	-	0.426496	0.574797	0.0476634	1.05 [0.89 - 1.24]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203196_at	559	0.830054	0.0778666	-	-0.556485	0.991666	-0.000918042	1.00 [0.84 - 1.19]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555039_a_at	559	0.840787	0.0419311	0.44069	0.506991	0.380646	0.154352	1.17 [0.83 - 1.65]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554918_a_at	559	0.833631	0.0021756	0.0485251	0.678455	0.220385	0.127283	1.14 [0.93 - 1.39]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	243928_s_at	559	0.799642	0.0123434	0.188943	-0.689272	0.123146	-0.164918	0.85 [0.69 - 1.05]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203196_at	77	0.103896	0.143973	-	0.740065	0.618992	0.159088	1.17 [0.63 - 2.19]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	243928_s_at	77	0.155844	0.0631535	-	-0.61908	0.436842	-0.114228	0.89 [0.67 - 1.19]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203196_at	70	0.485714	0.202376	-	-0.338183	0.441254	-0.182311	0.83 [0.52 - 1.33]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555039_a_at	70	0.642857	0.317211	-	0.270475	0.904422	-0.118243	0.89 [0.13 - 6.12]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554918_a_at	70	0.771429	0.0428078	0.446486	-0.693691	0.546055	-0.799401	0.45 [0.03 - 6.03]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	243928_s_at	70	0.114286	0.014079	0.208153	-0.938116	0.525707	-0.661256	0.52 [0.07 - 3.98]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34955_at	50	0.14	0.0094094	0.154213	-1.16968	0.159227	-0.825329	0.44 [0.14 - 1.38]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	1931_at	50	0.26	0.00967355	0.157472	-0.980331	0.284291	-0.71505	0.49 [0.13 - 1.81]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203196_at	74	0.108108	0.000715354	0.0192166	-1.26132	0.00293092	-1.00737	0.37 [0.19 - 0.71]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	243928_s_at	74	0.554054	0.150004	-	0.414303	0.973412	0.00588515	1.01 [0.71 - 1.42]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203196_at	67	0.895522	0.126824	-	1.18047	0.46031	0.337664	1.40 [0.57 - 3.44]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	243928_s_at	67	0.179104	0.133498	-	15.3621	0.748629	-0.593841	0.55 [0.01 - 20.87]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555039_a_at	67	0.80597	0.0806861	-	1.22059	0.100232	0.732883	2.08 [0.87 - 4.99]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554918_a_at	67	0.865672	0.0251205	0.314063	1.5087	0.267502	0.443421	1.56 [0.71 - 3.41]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554918_a_at	115	0.608696	0.146721	-	0.768974	0.720727	-0.246697	0.78 [0.20 - 3.02]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203196_at	115	0.121739	0.0268976	0.329088	-1.23388	0.116702	-0.741399	0.48 [0.19 - 1.20]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	243928_s_at	115	0.356522	0.22526	-	-0.638956	0.848185	-0.136597	0.87 [0.22 - 3.53]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555039_a_at	115	0.478261	0.00124297	0.030568	2.57789	0.353777	0.486405	1.63 [0.58 - 4.55]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	1931_at	158	0.879747	0.287937	-	-0.549172	0.970918	-0.00600117	0.99 [0.72 - 1.37]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34955_at	158	0.835443	0.11067	-	0.525448	0.293304	0.175224	1.19 [0.86 - 1.65]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	1931_at	76	0.842105	0.115385	-	0.892861	0.962312	0.0125968	1.01 [0.60 - 1.71]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34955_at	76	0.105263	0.143454	-	15.2183	0.255981	0.419663	1.52 [0.74 - 3.14]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555039_a_at	204	0.892157	0.000932728	0.0240377	0.756096	0.633005	0.038681	1.04 [0.89 - 1.22]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554918_a_at	204	0.808824	0.000313712	0.00949569	0.647159	0.094112	0.12843	1.14 [0.98 - 1.32]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203196_at	204	0.794118	0.00021086	0.00673006	0.661718	0.00412274	0.234185	1.26 [1.08 - 1.48]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	243928_s_at	204	0.897059	0.00907122	0.149997	-0.597819	0.089844	-0.110978	0.89 [0.79 - 1.02]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555039_a_at	87	0.37931	0.238749	-	0.473004	0.544131	0.569268	1.77 [0.28 - 11.12]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554918_a_at	87	0.586207	0.0684504	-	-0.74672	0.599026	0.345451	1.41 [0.39 - 5.12]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554918_a_at	87	0.586207	0.0684504	-	-0.74672	0.599026	0.345451	1.41 [0.39 - 5.12]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203196_at	87	0.333333	0.00145276	0.0347992	-1.1752	0.0867576	-0.440665	0.64 [0.39 - 1.07]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	243928_s_at	87	0.126437	0.0599522	-	-0.799961	0.386111	-1.09302	0.34 [0.03 - 3.97]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	243928_s_at	87	0.126437	0.0599522	-	-0.799961	0.386111	-1.09302	0.34 [0.03 - 3.97]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555039_a_at	87	0.37931	0.238749	-	0.473004	0.544131	0.569268	1.77 [0.28 - 11.12]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203196_at	87	0.333333	0.00145276	0.0347992	-1.1752	0.0867576	-0.440665	0.64 [0.39 - 1.07]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555039_a_at	77	0.103896	0.259692	-	-0.864416	0.916515	0.197929	1.22 [0.03 - 49.34]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555039_a_at	77	0.688312	0.176754	-	0.73656	0.409868	1.30867	3.70 [0.16 - 83.18]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554918_a_at	77	0.779221	0.293603	-	0.621561	0.593752	0.63829	1.89 [0.18 - 19.76]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554918_a_at	77	0.298701	0.149957	-	-0.883893	0.915358	0.153018	1.17 [0.07 - 19.59]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203196_at	77	0.441558	0.0661943	-	-1.20007	0.841856	-0.108653	0.90 [0.31 - 2.61]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	243928_s_at	77	0.324675	0.054264	-	-1.02716	0.857664	-0.362381	0.70 [0.01 - 36.52]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	243928_s_at	77	0.181818	0.119972	-	15.3498	0.906096	0.269853	1.31 [0.01 - 115.99]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203196_at	77	0.207792	0.0704512	-	-0.993071	0.679487	-0.211336	0.81 [0.30 - 2.21]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203196_at	136	0.661765	0.0400946	0.428324	-1.21504	0.865496	-0.0418987	0.96 [0.59 - 1.56]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203196_at	200	0.255	0.0589762	-	-0.577023	0.915562	-0.0243429	0.98 [0.62 - 1.53]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15306	60	0.3	0.186061	-	0.642266	0.951453	-0.00768518	0.99 [0.77 - 1.27]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15306	60	0.216667	0.0463081	0.468972	-0.831272	0.775194	-0.0574311	0.94 [0.64 - 1.40]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21537	155	0.16129	0.00222804	0.0494784	-0.884217	0.216138	-0.239897	0.79 [0.54 - 1.15]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203196_at	286	0.503497	0.153189	-	0.275873	0.167265	0.19255	1.21 [0.92 - 1.59]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203196_at	159	0.899371	0.00359123	0.0727832	1.19336	0.944645	0.0265128	1.03 [0.49 - 2.17]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203196_at	159	0.899371	0.0120467	0.185567	0.956817	0.950319	0.0202553	1.02 [0.54 - 1.93]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203196_at	159	0.899371	0.00874175	0.145843	0.99723	0.9403	0.0245684	1.02 [0.54 - 1.95]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	243928_s_at	159	0.106918	0.121621	-	-0.633758	0.891798	-0.024457	0.98 [0.69 - 1.39]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	243928_s_at	159	0.377358	0.0689677	-	0.652394	0.526043	0.115701	1.12 [0.79 - 1.61]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	243928_s_at	159	0.622642	0.102134	-	-0.695341	0.940443	0.0158122	1.02 [0.67 - 1.54]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203196_at	54	0.111111	0.000275485	0.008487	-2.14353	0.0282534	-3.04553	0.05 [0.00 - 0.72]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	HC-AF071202_at	54	0.796296	0.115196	-	-15.4138	0.239719	-1.79219	0.17 [0.01 - 3.31]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203196_at	117	0.863248	0.0489017	0.484994	-1.75935	0.348129	-0.267085	0.77 [0.44 - 1.34]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203196_at	117	0.623932	0.022899	0.2946	-1.07065	0.141362	-0.550139	0.58 [0.28 - 1.20]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203196_at	117	0.863248	0.0391333	0.421727	-15.2448	0.136039	-0.567935	0.57 [0.27 - 1.20]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203196_at	117	0.863248	0.0489017	0.484994	-1.75935	0.348129	-0.267085	0.77 [0.44 - 1.34]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203196_at	236	0.279661	0.0149673	0.217657	-0.65905	0.499397	-0.185395	0.83 [0.49 - 1.42]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	243928_s_at	236	0.817797	0.0265676	0.326332	-1.09558	0.171958	-0.200709	0.82 [0.61 - 1.09]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203196_at	249	0.156627	0.00240071	0.0525829	-0.742185	0.375692	-0.195278	0.82 [0.53 - 1.27]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	243928_s_at	249	0.851406	0.107223	-	-0.559132	0.855832	-0.0211874	0.98 [0.78 - 1.23]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203196_at	62	0.741935	0.135751	-	-0.863084	0.956394	-0.0118673	0.99 [0.65 - 1.51]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203196_at	125	0.376	0.00842764	0.141837	-0.987822	0.522255	-0.272569	0.76 [0.33 - 1.75]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203196_at	125	0.632	0.10886	-	-0.517184	0.914172	-0.0279109	0.97 [0.59 - 1.62]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203196_at	54	0.888889	0.178827	-	-15.2337	0.489872	-0.193897	0.82 [0.48 - 1.43]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203196_at	198	0.116162	0.157666	-	0.716088	0.689882	0.0434349	1.04 [0.84 - 1.29]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203196_at	198	0.116162	0.102747	-	0.934799	0.599067	0.0601796	1.06 [0.85 - 1.33]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203196_at	198	0.116162	0.0583067	-	0.780726	0.87573	0.0133489	1.01 [0.86 - 1.20]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203196_at	51	0.411765	0.00483995	0.092249	-16.7707	0.0975854	-0.66868	0.51 [0.23 - 1.13]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203196_at	62	0.193548	0.0977506	-	-0.980743	0.5807	-0.146517	0.86 [0.51 - 1.45]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555039_a_at	145	0.786207	0.0410222	0.434609	-1.16629	0.286923	-0.323909	0.72 [0.40 - 1.31]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554918_a_at	145	0.848276	0.0165296	0.233881	-2.05739	0.403043	-0.176883	0.84 [0.55 - 1.27]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203196_at	177	0.824859	0.105916	-	-0.687572	0.863854	-0.0354437	0.97 [0.64 - 1.45]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	243928_s_at	177	0.435028	0.0786627	-	0.42783	0.835283	0.179817	1.20 [0.22 - 6.52]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	243928_s_at	177	0.435028	0.0509068	-	0.555439	0.900787	0.124278	1.13 [0.16 - 7.99]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	243928_s_at	145	0.131034	0.0576111	-	-0.749198	0.816103	-0.29477	0.74 [0.06 - 8.93]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555039_a_at	177	0.101695	0.0114479	0.178667	2.14454	0.950727	0.0149016	1.02 [0.63 - 1.63]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203196_at	177	0.581921	0.145473	-	0.341555	0.87741	0.0277473	1.03 [0.72 - 1.46]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203196_at	145	0.889655	0.0436065	0.451708	-1.79663	0.24818	-0.285207	0.75 [0.46 - 1.22]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555039_a_at	177	0.101695	0.00703113	0.123441	1.72641	0.972825	0.00709939	1.01 [0.67 - 1.52]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554918_a_at	177	0.146893	0.100041	-	0.646478	0.786648	0.0396043	1.04 [0.78 - 1.39]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554918_a_at	177	0.146893	0.241426	-	0.505324	0.798017	0.0433055	1.04 [0.75 - 1.45]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555039_a_at	226	0.818584	0.0934043	-	-0.772996	0.75335	-0.0614993	0.94 [0.64 - 1.38]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554918_a_at	226	0.858407	0.117737	-	-0.79639	0.84111	0.0323328	1.03 [0.75 - 1.42]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	243928_s_at	226	0.654867	0.0887102	-	-0.544844	0.494544	-0.0794768	0.92 [0.74 - 1.16]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203196_at	226	0.871681	0.0293337	0.348963	-1.44471	0.604705	-0.0856184	0.92 [0.66 - 1.27]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	243928_s_at	55	0.890909	0.00070535	0.0189888	1.61784	0.00274029	4.81246	123.03 [5.28 - 2867.96]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554918_a_at	55	0.563636	0.373999	-	-0.459894	0.692989	0.153249	1.17 [0.54 - 2.49]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554918_a_at	49	0.469388	0.377012	-	0.534963	0.821244	0.0977269	1.10 [0.47 - 2.57]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203196_at	55	0.145455	0.206673	-	1.21916	0.464994	0.258452	1.29 [0.65 - 2.59]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203196_at	55	0.8	0.0382801	0.415798	0.969005	0.298266	0.401684	1.49 [0.70 - 3.19]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	243928_s_at	55	0.2	0.0136497	0.203483	15.4869	0.107209	2.29552	9.93 [0.61 - 162.16]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555039_a_at	55	0.709091	0.0182548	0.251134	-1.59156	0.18563	-0.730801	0.48 [0.16 - 1.42]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554918_a_at	55	0.509091	0.2431	-	0.527013	0.739668	0.115442	1.12 [0.57 - 2.22]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203196_at	49	0.897959	0.0471282	0.474095	1.26218	0.317386	0.467976	1.60 [0.64 - 4.00]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	243928_s_at	49	0.897959	0.00553635	0.102521	1.68935	0.0248953	4.22027	68.05 [1.70 - 2719.03]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555039_a_at	55	0.690909	0.0413566	0.436854	-1.37726	0.184142	-0.822873	0.44 [0.13 - 1.48]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555039_a_at	49	0.428571	0.0258615	0.320384	-1.28339	0.18554	-0.912106	0.40 [0.10 - 1.55]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	289473	34	0.147059	0.0116971	0.181553	-1.33595	0.262468	-0.506863	0.60 [0.25 - 1.46]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	243928_s_at	63	0.111111	0.000658516	0.0179144	-1.37181	0.960869	-0.113207	0.89 [0.01 - 82.20]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203196_at	63	0.793651	0.00026262	0.00814275	1.28173	0.0011862	0.56418	1.76 [1.25 - 2.47]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555039_a_at	63	0.746032	0.000813052	0.0214126	-1.79198	0.0205862	-16.6683	0.00 [0.00 - 0.08]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554918_a_at	63	0.238095	0.000753519	0.0200805	-1.1472	0.128893	0.830335	2.29 [0.79 - 6.70]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.137263.0.A1_3p_s_at	28	0.892857	0.15124	-	1.08604	0.225107	0.420487	1.52 [0.77 - 3.00]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.139336.2.S1_3p_s_at	28	0.214286	0.027653	0.335337	-1.23725	0.819021	-0.809312	0.45 [0.00 - 456.45]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	1554918_3p_a_at	28	0.857143	0.024573	0.309339	-15.6257	0.101523	-8.27765	0.00 [0.00 - 5.10]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.139336.0.S2_3p_at	28	0.892857	0.12219	-	1.16158	0.416191	0.583277	1.79 [0.44 - 7.31]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.139336.3.S1_3p_s_at	28	0.678571	0.0403548	0.430095	-1.47818	0.126745	-3.77872	0.02 [0.00 - 2.92]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.137263.0.A1_3p_at	28	0.464286	0.266315	-	0.611649	0.153787	0.30303	1.35 [0.89 - 2.05]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.139336.2.S1_3p_at	28	0.25	0.10564	-	-0.929474	0.990427	0.00564434	1.01 [0.40 - 2.53]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203196_at	82	0.158537	0.0701514	-	-0.71544	0.888469	-0.0382369	0.96 [0.56 - 1.64]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203196_at	79	0.126582	0.00235392	0.0517468	-1.07073	0.00727914	-0.540902	0.58 [0.39 - 0.86]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203196_at	104	0.471154	0.00476837	0.0911714	-0.954724	0.0478688	-0.377187	0.69 [0.47 - 1.00]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P25559	117	0.25641	0.000246276	0.00770167	-1.03934	0.069593	-0.260118	0.77 [0.58 - 1.02]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P16913	117	0.222222	0.0172377	0.241043	-0.724644	0.105392	-0.188873	0.83 [0.66 - 1.04]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203196_at	204	0.671569	0.0501631	-	-0.63086	0.171885	-0.306233	0.74 [0.47 - 1.14]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	243928_s_at	204	0.117647	0.00300982	0.0631566	-0.937151	0.022936	-0.315311	0.73 [0.56 - 0.96]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555039_a_at	204	0.892157	0.0445536	0.457829	-15.2082	0.0666989	-0.512029	0.60 [0.35 - 1.04]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555039_a_at	204	0.47549	0.0716772	-	-0.491042	0.304951	-0.235887	0.79 [0.50 - 1.24]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554918_a_at	204	0.740196	0.00847493	0.142443	-1.71186	0.179625	-0.33074	0.72 [0.44 - 1.16]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554918_a_at	204	0.151961	0.0327452	0.375518	-0.68595	0.23306	-0.213727	0.81 [0.57 - 1.15]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203196_at	204	0.558824	0.013469	0.201502	-1.02345	0.0571766	-0.587129	0.56 [0.30 - 1.02]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	243928_s_at	204	0.112745	0.00845629	0.142204	-1.04397	0.0217389	-0.404076	0.67 [0.47 - 0.94]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203196_at	178	0.275281	0.00119041	0.0294863	-0.661345	0.0241161	-0.36417	0.69 [0.51 - 0.95]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	243928_s_at	111	0.675676	0.258095	-	-0.325155	0.621503	-0.0707095	0.93 [0.70 - 1.23]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555039_a_at	111	0.837838	0.0724607	-	-0.758865	0.696075	-0.10077	0.90 [0.55 - 1.50]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554918_a_at	111	0.126126	5.85231e-05	0.00218063	-1.25858	0.00458337	-0.496254	0.61 [0.43 - 0.86]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203196_at	111	0.144144	0.000310653	0.00941571	-1.14537	0.0216318	-0.449333	0.64 [0.43 - 0.94]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203196_at	90	0.788889	0.260628	-	0.412084	0.894126	-0.0424196	0.96 [0.51 - 1.79]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203196_at	90	0.522222	0.203696	-	0.475661	0.965245	0.0156139	1.02 [0.50 - 2.05]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	243928_s_at	138	0.152174	0.00867096	0.144944	-0.735995	0.164324	-2.96988	0.05 [0.00 - 3.37]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555039_a_at	138	0.826087	0.0826085	-	-0.643561	0.645661	-0.0799254	0.92 [0.66 - 1.30]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554918_a_at	138	0.884058	0.138829	-	-0.675829	0.826688	-0.0247707	0.98 [0.78 - 1.22]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203196_at	138	0.673913	0.00088598	0.0230202	-0.961271	0.0804561	-0.197403	0.82 [0.66 - 1.02]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203196_at	129	0.263566	8.2835e-07	4.57355e-05	-1.2106	0.0020735	-0.775115	0.46 [0.28 - 0.75]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29482	56	0.732143	0.127667	-	0.574073	0.379636	0.275948	1.32 [0.71 - 2.44]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34630	56	0.767857	0.063316	-	0.693176	0.856189	0.0373945	1.04 [0.69 - 1.56]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24161	56	0.892857	0.182216	-	0.596253	0.789579	0.0603576	1.06 [0.68 - 1.65]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29482	56	0.714286	0.212182	-	0.461454	0.558278	0.191396	1.21 [0.64 - 2.30]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16487	56	0.857143	0.0643958	-	0.740537	0.822213	0.0514447	1.05 [0.67 - 1.65]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24161	56	0.160714	0.0441949	0.455519	-0.91067	0.932165	0.0191742	1.02 [0.66 - 1.59]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34630	56	0.214286	0.0703747	-	-0.737074	0.967501	-0.00856262	0.99 [0.66 - 1.50]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16487	56	0.857143	0.225301	-	0.492678	0.967631	0.00912699	1.01 [0.65 - 1.57]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554918_a_at	278	0.841727	0.171466	-	-0.352394	0.640879	-0.0417714	0.96 [0.80 - 1.14]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203196_at	278	0.410072	0.0546371	-	-0.367954	0.870283	-0.0160859	0.98 [0.81 - 1.19]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	243928_s_at	278	0.161871	0.0797832	-	0.494622	0.405769	0.262851	1.30 [0.70 - 2.42]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555039_a_at	278	0.140288	0.0413029	0.436494	-0.541545	0.291555	-0.118412	0.89 [0.71 - 1.11]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203196_at	133	0.894737	0.0612353	-	-0.932682	0.122192	-0.162769	0.85 [0.69 - 1.04]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203196_at	185	0.605405	0.0261521	0.322841	-0.372426	0.347659	-0.0992094	0.91 [0.74 - 1.11]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203196_at	185	0.745946	0.0183584	0.25215	-0.50776	0.286784	-0.123235	0.88 [0.70 - 1.11]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P16913	110	0.109091	0.0684532	-	-0.613975	0.933995	0.00759842	1.01 [0.84 - 1.21]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P222291	110	0.172727	0.0987472	-	0.769697	0.749709	0.038834	1.04 [0.82 - 1.32]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P25559	110	0.172727	0.0504125	-	-0.551064	0.861447	-0.0155436	0.98 [0.83 - 1.17]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P16913	110	0.281818	0.116765	-	-0.505062	0.953404	0.00662897	1.01 [0.81 - 1.26]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P25559	110	0.4	0.0760754	-	-0.524021	0.742182	-0.0368972	0.96 [0.77 - 1.20]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P222291	110	0.154545	0.0459166	0.466507	0.774001	0.642659	0.0437107	1.04 [0.87 - 1.26]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203196_at	80	0.625	0.20422	-	-0.640933	0.667347	-0.0862298	0.92 [0.62 - 1.36]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_4092	281	0.822064	0.00971906	0.15803	-0.494297	0.624167	-0.0554393	0.95 [0.76 - 1.18]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	243928_s_at	38	0.105263	0.00314557	0.0654416	-1.79973	0.411641	-0.209518	0.81 [0.49 - 1.34]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555039_a_at	38	0.763158	0.000258761	0.008039	1.65389	0.160651	0.936401	2.55 [0.69 - 9.44]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554918_a_at	38	0.552632	0.0048451	0.0923262	1.28583	0.0149293	0.969357	2.64 [1.21 - 5.75]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203196_at	38	0.552632	0.0203098	0.270868	1.09582	0.113054	0.590149	1.80 [0.87 - 3.74]
GENE	ABCC4	ATP-binding cassette, sub-family C (CFTR/MRP), member 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203196_at	140	0.792857	0.000952679	0.024469	0.95039	0.00147636	0.802891	2.23 [1.36 - 3.66]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209380_s_at	30	0.633333	0.0665847	-	-0.812821	0.556664	-0.182293	0.83 [0.45 - 1.53]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1720535	165	0.436364	0.047844	0.478523	-0.475218	0.861398	-0.0213297	0.98 [0.77 - 1.24]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1720535	165	0.381818	0.00838831	0.141332	-0.908736	0.147981	-0.25578	0.77 [0.55 - 1.09]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209380_s_at	163	0.380368	0.0175608	0.244273	-0.468082	0.0372349	-0.505658	0.60 [0.37 - 0.97]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226363_at	163	0.852761	0.185586	-	-0.403935	0.809019	-0.0503663	0.95 [0.63 - 1.43]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209380_s_at	79	0.78481	0.00172766	0.0401597	-1.50207	0.258297	-0.302026	0.74 [0.44 - 1.25]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1558460_at	79	0.518987	0.00303874	0.0636455	-0.872751	0.0223058	-0.803374	0.45 [0.22 - 0.89]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226363_at	79	0.101266	0.0512633	-	-0.786764	0.600058	-0.115381	0.89 [0.58 - 1.37]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209380_s_at	58	0.62069	0.157244	-	-0.398979	0.722945	-0.10962	0.90 [0.49 - 1.64]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209380_s_at	34	0.441176	0.00756586	0.130603	-1.07591	0.310715	-0.451102	0.64 [0.27 - 1.52]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209380_s_at	158	0.810127	0.200461	-	-0.40104	0.505951	-0.39102	0.68 [0.21 - 2.14]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209380_s_at	53	0.811321	0.296487	-	-0.501144	0.914274	-0.0623231	0.94 [0.30 - 2.92]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209380_s_at	53	0.886792	0.351212	-	0.497705	0.842578	0.123386	1.13 [0.33 - 3.82]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209380_s_at	180	0.866667	0.00315385	0.0655803	0.800575	0.030053	0.832587	2.30 [1.08 - 4.88]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226363_at	180	0.544444	0.131732	-	0.314061	0.355206	0.292006	1.34 [0.72 - 2.49]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1558460_at	559	0.649374	0.135094	-	0.300737	0.942211	0.0148624	1.01 [0.68 - 1.52]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226363_at	559	0.858676	0.0013939	0.0336254	0.732836	0.0306721	0.508902	1.66 [1.05 - 2.64]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209380_s_at	559	0.550984	0.0209105	0.276481	0.466037	0.100606	0.498585	1.65 [0.91 - 2.99]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209380_s_at	77	0.805195	0.000362524	0.010756	-1.35154	0.038558	-0.636821	0.53 [0.29 - 0.97]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226363_at	77	0.220779	0.00581375	0.106512	-0.796168	0.987649	0.00743967	1.01 [0.39 - 2.58]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226363_at	70	0.685714	0.0590383	-	-0.564076	0.666919	-0.0895583	0.91 [0.61 - 1.37]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209380_s_at	70	0.614286	0.117032	-	-0.432587	0.374018	-0.306816	0.74 [0.37 - 1.45]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1558460_at	70	0.114286	0.00202284	0.0457184	-1.15716	0.11087	-1.34836	0.26 [0.05 - 1.36]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	1933_g_at	50	0.74	0.0672751	-	0.69814	0.192838	0.296533	1.35 [0.86 - 2.10]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	1932_at	50	0.2	0.00684321	0.120886	-1.09595	0.82916	-0.15152	0.86 [0.22 - 3.40]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41428_at	50	0.3	0.00943434	0.154521	-0.943359	0.554721	-0.413789	0.66 [0.17 - 2.61]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209380_s_at	74	0.27027	0.236855	-	-0.381711	0.635748	-0.368735	0.69 [0.15 - 3.18]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226363_at	74	0.864865	0.0151271	0.219344	-1.35186	0.103692	-0.81656	0.44 [0.17 - 1.18]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1558460_at	67	0.895522	7.44147e-05	0.00269804	2.63244	0.0789584	6.15177	469.55 [0.49 - 449207.05]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226363_at	67	0.895522	0.0132572	0.199168	1.86976	0.616421	0.529727	1.70 [0.21 - 13.50]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209380_s_at	67	0.179104	0.174879	-	-0.931585	0.843844	-0.321301	0.73 [0.03 - 17.74]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1558460_at	115	0.669565	0.137161	-	0.777	0.727855	0.181027	1.20 [0.43 - 3.32]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209380_s_at	115	0.53913	0.172248	-	-0.78406	0.918839	-0.0491992	0.95 [0.37 - 2.45]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226363_at	115	0.73913	0.295299	-	-0.777305	0.895479	-0.0583055	0.94 [0.40 - 2.25]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	1932_at	158	0.639241	0.0798909	-	0.493547	0.861653	0.0398536	1.04 [0.66 - 1.63]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41428_at	158	0.746835	0.00587674	0.107411	0.786044	0.188821	0.458463	1.58 [0.80 - 3.13]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	1933_g_at	158	0.835443	0.0545103	-	0.621155	0.610081	0.116526	1.12 [0.72 - 1.76]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	1933_g_at	76	0.894737	0.170435	-	0.860258	0.70835	0.173734	1.19 [0.48 - 2.96]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	1932_at	76	0.881579	0.00139574	0.0336622	1.59653	0.668925	0.198471	1.22 [0.49 - 3.03]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41428_at	76	0.855263	0.10774	-	0.910304	0.502543	0.497236	1.64 [0.38 - 7.03]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226363_at	204	0.343137	0.043422	0.450506	-0.298433	0.99684	0.000365583	1.00 [0.83 - 1.20]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209380_s_at	204	0.279412	0.0479063	0.478907	-0.309856	0.885869	-0.0192956	0.98 [0.75 - 1.28]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1558460_at	204	0.259804	0.0290268	0.346502	-0.350078	0.807955	-0.0312475	0.97 [0.75 - 1.25]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226363_at	87	0.781609	0.0176301	0.244963	0.889649	0.0549215	0.377448	1.46 [0.99 - 2.14]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226363_at	87	0.781609	0.0176301	0.244963	0.889649	0.0549215	0.377448	1.46 [0.99 - 2.14]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209380_s_at	87	0.781609	0.00174938	0.0405752	1.136	0.0264701	0.491719	1.64 [1.06 - 2.52]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1558460_at	87	0.735632	0.0196817	0.264926	0.865453	0.0823221	0.515258	1.67 [0.94 - 2.99]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1558460_at	87	0.735632	0.0196817	0.264926	0.865453	0.0823221	0.515258	1.67 [0.94 - 2.99]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209380_s_at	87	0.781609	0.00174938	0.0405752	1.136	0.0264701	0.491719	1.64 [1.06 - 2.52]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226363_at	77	0.532468	0.092165	-	0.973431	0.372694	0.253479	1.29 [0.74 - 2.25]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226363_at	77	0.532468	0.148591	-	0.959707	0.411099	0.269063	1.31 [0.69 - 2.49]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209380_s_at	77	0.493506	0.0446201	0.458256	1.24118	0.167183	0.418919	1.52 [0.84 - 2.75]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558460_at	77	0.467532	0.0689445	-	1.13554	0.793673	-0.147661	0.86 [0.29 - 2.61]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558460_at	77	0.103896	0.210227	-	-0.954518	0.528046	-0.435689	0.65 [0.17 - 2.50]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209380_s_at	77	0.493506	0.0567077	-	1.39181	0.179201	0.46821	1.60 [0.81 - 3.16]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209380_s_at	136	0.794118	5.5821e-06	0.000263127	1.80593	0.00539583	1.22514	3.40 [1.44 - 8.07]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209380_s_at	200	0.59	0.000163608	0.00539449	1.10978	0.00433772	1.04341	2.84 [1.39 - 5.81]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1901	60	0.833333	0.000537345	0.0150687	1.38478	0.496234	0.11884	1.13 [0.80 - 1.59]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1901	60	0.733333	0.00427248	0.0835858	1.05869	0.358251	0.184489	1.20 [0.81 - 1.78]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3096	155	0.812903	0.000381341	0.0112345	0.993484	0.000402687	0.210585	1.23 [1.10 - 1.39]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209380_s_at	286	0.783217	4.81021e-06	0.000229764	0.896046	4.32682e-06	0.829703	2.29 [1.61 - 3.27]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209380_s_at	159	0.874214	0.00318074	0.0660297	1.03274	0.100854	0.749701	2.12 [0.86 - 5.18]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209380_s_at	159	0.874214	0.00327663	0.0676255	1.16024	0.106001	0.824701	2.28 [0.84 - 6.20]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209380_s_at	159	0.874214	0.00343752	0.0702776	1.02646	0.0713816	0.787138	2.20 [0.93 - 5.17]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226363_at	159	0.63522	0.186047	-	0.417439	0.991302	-0.00452849	1.00 [0.44 - 2.25]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226363_at	159	0.691824	0.0706424	-	0.570359	0.834897	0.0861622	1.09 [0.48 - 2.45]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226363_at	159	0.698113	0.125343	-	0.570498	0.881975	-0.0727874	0.93 [0.36 - 2.43]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209380_s_at	54	0.888889	0.00301094	0.0631755	1.90061	0.0408318	0.822615	2.28 [1.03 - 5.01]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209380_s_at	117	0.25641	0.0125753	0.191562	-0.786898	0.435323	-0.142145	0.87 [0.61 - 1.24]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209380_s_at	117	0.897436	0.00569822	0.104856	1.14585	0.980517	0.00517062	1.01 [0.66 - 1.52]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209380_s_at	117	0.897436	0.00986762	0.159848	1.14315	0.54079	0.132929	1.14 [0.75 - 1.75]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209380_s_at	117	0.25641	0.0125753	0.191562	-0.786898	0.435323	-0.142145	0.87 [0.61 - 1.24]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209380_s_at	236	0.470339	0.00123521	0.030409	0.926867	0.0225487	0.784858	2.19 [1.12 - 4.30]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226363_at	236	0.457627	0.00103891	0.026314	0.957339	0.0271306	0.646258	1.91 [1.08 - 3.39]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209380_s_at	249	0.485944	0.0105181	0.167706	0.549335	0.100316	0.475569	1.61 [0.91 - 2.84]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226363_at	249	0.144578	0.00247446	0.0538934	1.42383	0.0433018	0.471946	1.60 [1.01 - 2.53]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209380_s_at	54	0.833333	0.0254365	0.316768	1.29622	0.372974	0.224796	1.25 [0.76 - 2.05]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209380_s_at	62	0.854839	0.166997	-	0.776287	0.811249	0.047641	1.05 [0.71 - 1.55]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209380_s_at	125	0.816	0.0109423	0.172744	0.968073	0.0594297	0.451892	1.57 [0.98 - 2.51]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209380_s_at	125	0.816	0.0213455	0.280505	0.721162	0.177298	0.263079	1.30 [0.89 - 1.91]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209380_s_at	198	0.808081	0.000170103	0.00558107	0.845754	0.00931258	0.420646	1.52 [1.11 - 2.09]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209380_s_at	198	0.808081	7.27138e-06	0.000334645	1.1274	0.0113041	0.493497	1.64 [1.12 - 2.40]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209380_s_at	198	0.808081	6.67153e-07	3.74482e-05	1.26769	0.00645889	0.564865	1.76 [1.17 - 2.64]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209380_s_at	51	0.470588	0.115339	-	-1.59001	0.838735	-0.176215	0.84 [0.15 - 4.58]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209380_s_at	62	0.725806	0.0254652	0.317014	-15.5712	0.307886	-0.606678	0.55 [0.17 - 1.75]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226363_at	145	0.489655	0.189966	-	-0.43861	0.526257	-0.278419	0.76 [0.32 - 1.79]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1558460_at	177	0.135593	0.0716143	-	-0.599748	0.638696	-0.339247	0.71 [0.17 - 2.94]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209380_s_at	177	0.864407	0.0154604	0.222842	0.678872	0.358759	0.339743	1.40 [0.68 - 2.90]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1558460_at	177	0.135593	0.062887	-	-0.546929	0.594732	-0.332565	0.72 [0.21 - 2.44]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209380_s_at	145	0.172414	0.0617073	-	1.27306	0.678689	0.22913	1.26 [0.43 - 3.72]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1558460_at	145	0.889655	0.023276	0.297959	-15.2271	0.395698	-0.778587	0.46 [0.08 - 2.77]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226363_at	177	0.830508	0.0221926	0.288243	0.6971	0.0562969	0.50725	1.66 [0.99 - 2.80]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209380_s_at	177	0.864407	0.046788	0.471976	0.64624	0.171933	0.563023	1.76 [0.78 - 3.94]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226363_at	177	0.830508	0.0130669	0.197059	0.664044	0.182633	0.329499	1.39 [0.86 - 2.26]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209380_s_at	226	0.853982	0.122166	-	-0.892021	0.861671	0.0702896	1.07 [0.49 - 2.37]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1558460_at	226	0.433628	0.0679106	-	-0.514151	0.585434	-0.137564	0.87 [0.53 - 1.43]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226363_at	226	0.530973	0.163272	-	0.397642	0.421824	0.27022	1.31 [0.68 - 2.53]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226363_at	55	0.436364	0.129638	-	-0.772583	0.837534	-0.11709	0.89 [0.29 - 2.72]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209380_s_at	55	0.690909	0.0138399	0.205559	1.15472	0.0642632	1.28724	3.62 [0.93 - 14.16]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209380_s_at	55	0.745455	0.000813684	0.0214266	1.39758	0.0180666	1.56512	4.78 [1.31 - 17.51]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1558460_at	55	0.836364	3.04562e-05	0.00121816	1.73474	0.00648992	3.0827	21.82 [2.37 - 200.83]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226363_at	49	0.77551	0.0880053	-	0.969673	0.988465	0.0103026	1.01 [0.25 - 4.08]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209380_s_at	49	0.795918	0.0316359	0.367038	1.21785	0.463834	0.677432	1.97 [0.32 - 12.06]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226363_at	55	0.763636	0.08977	-	0.757324	0.578522	0.282019	1.33 [0.49 - 3.59]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1558460_at	55	0.836364	0.000285843	0.00876236	1.62323	0.00383117	3.38688	29.57 [2.98 - 293.68]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1558460_at	49	0.857143	4.6043e-05	0.00176183	2.10562	0.0151146	3.27058	26.33 [1.88 - 368.34]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	292212	34	0.823529	0.196589	-	-0.928359	0.453992	-0.304418	0.74 [0.33 - 1.64]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1558460_at	63	0.777778	0.00246523	0.0537299	-1.91211	0.0263809	-0.664635	0.51 [0.29 - 0.92]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226363_at	63	0.857143	0.0245892	0.309479	-1.49869	0.0602207	-0.318114	0.73 [0.52 - 1.01]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209380_s_at	63	0.730159	0.0464178	0.46966	-0.932205	0.0667634	-0.386324	0.68 [0.45 - 1.03]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.348628.1.S1_3p_at	28	0.571429	0.123424	-	-0.924564	0.347138	-4.35479	0.01 [0.00 - 112.61]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5006890_3p_s_at	28	0.678571	0.311246	-	-0.595849	0.738548	-0.0379114	0.96 [0.77 - 1.20]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.34744.0.S1_3p_at	28	0.107143	0.0642932	-	15.4298	0.873125	-0.0209931	0.98 [0.76 - 1.27]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5006890_3p_a_at	28	0.571429	0.00395066	0.0785415	-1.74715	0.262631	-4.02931	0.02 [0.00 - 20.51]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209380_s_at	82	0.134146	0.0201815	0.26966	2.00544	0.0652561	0.857964	2.36 [0.95 - 5.87]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	1932_at	84	0.119048	0.144173	-	-0.564991	0.676092	-0.133847	0.87 [0.47 - 1.64]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	41428_at	84	0.785714	0.0680916	-	0.571004	0.762674	0.0959441	1.10 [0.59 - 2.05]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	1933_g_at	84	0.547619	0.0114094	0.178219	0.725085	0.3605	0.204222	1.23 [0.79 - 1.90]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209380_s_at	79	0.506329	0.0176067	0.24473	-0.620588	0.196539	-0.493129	0.61 [0.29 - 1.29]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209380_s_at	104	0.701923	0.00769393	0.132296	-1.13675	0.0379504	-0.933911	0.39 [0.16 - 0.95]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P212665	117	0.675214	0.0036806	0.0742279	0.829177	0.192264	0.223177	1.25 [0.89 - 1.75]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P258221	117	0.726496	0.107307	-	-0.585963	0.769058	-0.0553203	0.95 [0.65 - 1.37]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1558460_at	204	0.514706	0.260496	-	0.412404	0.473379	0.241705	1.27 [0.66 - 2.47]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1558460_at	204	0.117647	0.0935766	-	0.959412	0.345411	0.23003	1.26 [0.78 - 2.03]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226363_at	204	0.235294	0.280798	-	-0.428172	0.815281	-0.106849	0.90 [0.37 - 2.20]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209380_s_at	204	0.867647	0.292953	-	0.475561	0.72023	0.188676	1.21 [0.43 - 3.39]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226363_at	204	0.29902	0.152056	-	-0.401169	0.810627	-0.0811031	0.92 [0.47 - 1.79]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209380_s_at	204	0.436274	0.348675	-	-0.254509	0.95748	-0.0212988	0.98 [0.45 - 2.14]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209380_s_at	178	0.280899	0.0201676	0.269529	-0.481701	0.250357	-0.298798	0.74 [0.45 - 1.23]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300007492	41	0.268293	0.0283849	0.341317	1.27363	0.0516384	0.351205	1.42 [1.00 - 2.02]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1558460_at	111	0.378378	0.0686574	-	-0.479311	0.50193	-0.114923	0.89 [0.64 - 1.25]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209380_s_at	111	0.837838	0.0195506	0.263675	-1.04934	0.120017	-0.244511	0.78 [0.58 - 1.07]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226363_at	111	0.738739	0.0280553	0.338633	-0.725417	0.193667	-0.190048	0.83 [0.62 - 1.10]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209380_s_at	90	0.266667	0.0112343	0.176175	-0.823889	0.129988	-0.260838	0.77 [0.55 - 1.08]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209380_s_at	90	0.266667	0.00613228	0.111032	-0.986151	0.183813	-0.260233	0.77 [0.53 - 1.13]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1472	50	0.52	0.0960254	-	0.825567	0.24065	0.269484	1.31 [0.83 - 2.05]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1558460_at	138	0.73913	0.0971078	-	-0.492219	0.50457	-0.0777568	0.93 [0.74 - 1.16]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209380_s_at	138	0.876812	0.204822	-	-0.536437	0.574409	-0.0350333	0.97 [0.85 - 1.09]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226363_at	138	0.282609	0.183478	-	-0.343767	0.472514	-0.0447959	0.96 [0.85 - 1.08]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209380_s_at	129	0.209302	0.0129161	0.195381	-0.720308	0.182539	-0.232209	0.79 [0.56 - 1.12]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34118	56	0.214286	0.170169	-	-0.561124	0.937205	-0.00937223	0.99 [0.78 - 1.25]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36153	56	0.321429	0.183992	-	0.564133	0.905858	-0.0139519	0.99 [0.78 - 1.24]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34118	56	0.571429	0.16088	-	0.497392	0.71824	0.0437129	1.04 [0.82 - 1.32]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36153	56	0.142857	0.0753271	-	-0.80469	0.569292	-0.0660304	0.94 [0.75 - 1.18]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1558460_at	278	0.899281	0.107701	-	0.432454	0.4861	0.265909	1.30 [0.62 - 2.76]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226363_at	278	0.884892	0.000247774	0.00774228	0.940718	0.000687123	0.525274	1.69 [1.25 - 2.29]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209380_s_at	278	0.384892	0.000138715	0.00466901	0.786128	5.40139e-05	0.814941	2.26 [1.52 - 3.36]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209380_s_at	133	0.120301	0.00418113	0.0821641	-0.832806	0.420984	-0.109838	0.90 [0.69 - 1.17]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16179	81	0.111111	0.0229867	0.295385	-1.29034	0.760584	0.181423	1.20 [0.37 - 3.85]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16773	81	0.111111	0.0245681	0.309296	-1.24073	0.0140189	-1.51442	0.22 [0.07 - 0.74]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1072	81	0.728395	0.0218339	0.284982	1.16065	0.146528	0.520963	1.68 [0.83 - 3.40]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209380_s_at	185	0.816216	0.0624259	-	-0.459513	0.556295	-0.132654	0.88 [0.56 - 1.36]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209380_s_at	185	0.816216	0.159873	-	-0.301984	0.899702	0.0256224	1.03 [0.69 - 1.53]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258221	110	0.881818	0.146175	-	-0.849646	0.624043	-0.106657	0.90 [0.59 - 1.38]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P212665	110	0.681818	0.277765	-	-0.36308	0.529753	-0.146287	0.86 [0.55 - 1.36]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258221	110	0.2	0.0224172	0.290274	0.759171	0.31945	0.162372	1.18 [0.85 - 1.62]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P212665	110	0.245455	0.0959911	-	0.488334	0.393002	0.143202	1.15 [0.83 - 1.60]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209380_s_at	80	0.7375	0.197531	-	0.566878	0.525906	0.323787	1.38 [0.51 - 3.76]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1558460_at	38	0.710526	0.00917875	0.151343	1.23587	0.0248366	0.981227	2.67 [1.13 - 6.29]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209380_s_at	38	0.315789	0.00631203	0.113552	1.65561	0.0261547	1.1848	3.27 [1.15 - 9.29]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226363_at	38	0.421053	0.00390953	0.0778894	1.57653	0.014922	0.908195	2.48 [1.19 - 5.15]
GENE	ABCC5	ATP-binding cassette, sub-family C (CFTR/MRP), member 5	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209380_s_at	140	0.435714	0.0276909	0.335649	0.702739	0.0601652	0.746686	2.11 [0.97 - 4.60]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214504_at	30	0.766667	0.0339002	0.384196	0.965342	0.0467312	1.71252	5.54 [1.03 - 29.97]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216929_x_at	30	0.6	0.0673098	-	0.725672	0.211062	0.791696	2.21 [0.64 - 7.63]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216716_at	30	0.133333	0.000335179	0.0100536	-2.0356	0.113768	-2.11908	0.12 [0.01 - 1.66]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1656979	165	0.575758	0.000168445	0.00553353	-1.00609	0.00879669	-1.33526	0.26 [0.10 - 0.71]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1656979	165	0.224242	0.00763045	0.131458	-0.927742	0.023003	-1.85872	0.16 [0.03 - 0.77]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214504_at	163	0.595092	0.0237135	0.301828	-0.467472	0.406352	-0.46525	0.63 [0.21 - 1.88]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216716_at	163	0.717791	0.168276	-	0.29325	0.689213	-0.261089	0.77 [0.21 - 2.77]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216929_x_at	163	0.564417	0.134457	-	-0.300992	0.546121	-0.240882	0.79 [0.36 - 1.72]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216716_at	79	0.164557	0.00309838	0.06465	-0.958466	0.166005	-1.00317	0.37 [0.09 - 1.52]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214504_at	79	0.113924	0.111691	-	-0.646992	0.90951	0.0961248	1.10 [0.21 - 5.78]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216929_x_at	79	0.556962	0.181983	-	-0.399495	0.525532	-0.321747	0.72 [0.27 - 1.96]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216716_at	58	0.775862	0.11421	-	0.508161	0.687049	0.0695244	1.07 [0.76 - 1.50]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214504_at	58	0.275862	0.0357241	0.3976	0.655851	0.719829	0.0470753	1.05 [0.81 - 1.36]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216929_x_at	58	0.741379	0.0398993	0.426991	0.679747	0.247637	0.158396	1.17 [0.90 - 1.53]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216929_x_at	34	0.5	0.0720421	-	0.707476	0.275787	0.27354	1.31 [0.80 - 2.15]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216716_at	34	0.852941	0.183342	-	-0.946712	0.668689	-0.156418	0.86 [0.42 - 1.75]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214504_at	34	0.852941	0.118973	-	-0.933672	0.328965	-0.654429	0.52 [0.14 - 1.93]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216716_at	158	0.493671	0.0200642	0.268553	0.546419	0.155845	0.577552	1.78 [0.80 - 3.96]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216929_x_at	158	0.835443	0.0224974	0.290997	0.640394	0.0863426	0.811631	2.25 [0.89 - 5.69]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214504_at	158	0.411392	0.0701196	-	-0.417139	0.319255	-0.815162	0.44 [0.09 - 2.20]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214504_at	53	0.528302	0.279225	-	-0.40222	0.927558	-0.0411708	0.96 [0.40 - 2.33]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216929_x_at	53	0.735849	0.103324	-	-0.682095	0.623218	-0.118452	0.89 [0.55 - 1.42]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216929_x_at	53	0.377358	0.0563338	-	-0.694058	0.314649	-0.258944	0.77 [0.47 - 1.28]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216716_at	53	0.245283	0.0535855	-	-0.735955	0.523086	-0.224858	0.80 [0.40 - 1.59]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214504_at	53	0.320755	0.208006	-	-0.444852	0.773159	-0.118682	0.89 [0.40 - 1.99]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216716_at	53	0.245283	0.153613	-	-0.535503	0.832097	-0.0691363	0.93 [0.49 - 1.77]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216929_x_at	180	0.894444	0.00995431	0.160905	0.726657	0.941523	-0.00933762	0.99 [0.77 - 1.27]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214504_at	180	0.372222	0.00927158	0.152501	-0.539189	0.315031	-0.206327	0.81 [0.54 - 1.22]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216716_at	180	0.422222	0.00300949	0.063151	0.657069	0.118973	0.201363	1.22 [0.95 - 1.58]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216716_at	559	0.19678	0.0578769	-	0.557426	0.652232	0.0627034	1.06 [0.81 - 1.40]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214504_at	559	0.255814	0.00271064	0.058032	-0.638579	0.0193712	-0.424962	0.65 [0.46 - 0.93]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216929_x_at	559	0.101968	0.158134	-	0.706537	0.676838	0.0571836	1.06 [0.81 - 1.39]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216929_x_at	77	0.701299	0.119974	-	0.43346	0.780338	0.0622398	1.06 [0.69 - 1.65]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216716_at	77	0.753247	0.00561132	0.103605	0.760339	0.531066	0.133862	1.14 [0.75 - 1.74]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214504_at	77	0.649351	0.0235301	0.300211	0.575244	0.458525	0.242842	1.27 [0.67 - 2.42]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214504_at	70	0.3	0.16905	-	0.401562	0.549803	0.340631	1.41 [0.46 - 4.29]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216929_x_at	70	0.185714	0.00770427	0.132432	-0.847416	0.738079	-0.115859	0.89 [0.45 - 1.76]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216716_at	70	0.7	0.0948852	-	-0.490222	0.588805	-0.453206	0.64 [0.12 - 3.29]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34469_at	50	0.84	0.0934814	-	-0.815817	0.203836	-1.77223	0.17 [0.01 - 2.62]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214504_at	74	0.256757	0.126279	-	-0.484364	0.407724	-0.470783	0.62 [0.20 - 1.90]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216929_x_at	74	0.743243	0.0258041	0.319898	-0.815152	0.0560722	-0.624081	0.54 [0.28 - 1.02]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216716_at	74	0.175676	0.217507	-	-0.438311	0.38233	-0.208787	0.81 [0.51 - 1.30]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216716_at	67	0.447761	0.0170141	0.238793	2.14263	0.145317	3.45053	31.52 [0.30 - 3276.70]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214504_at	67	0.671642	1.21638e-05	0.000533433	17.2722	0.00607776	3.72951	41.66 [2.90 - 598.17]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216929_x_at	67	0.522388	0.0942633	-	1.14401	0.628856	0.655922	1.93 [0.13 - 27.54]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214504_at	115	0.434783	0.0243946	0.307789	-1.24898	0.623796	-0.298916	0.74 [0.22 - 2.45]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216929_x_at	115	0.86087	0.119022	-	-15.2566	0.800367	-0.13445	0.87 [0.31 - 2.48]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216716_at	115	0.895652	0.186254	-	-15.1878	0.914787	-0.0594573	0.94 [0.32 - 2.80]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34469_at	158	0.113924	0.0228659	0.294305	-0.821621	0.71906	-0.142945	0.87 [0.40 - 1.89]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34469_at	76	0.842105	0.0557965	-	-15.3655	0.737445	-0.23539	0.79 [0.20 - 3.13]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216929_x_at	204	0.127451	0.187137	-	-0.280729	0.950837	-0.00518439	0.99 [0.84 - 1.17]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216716_at	204	0.593137	0.0482892	0.481257	0.284438	0.218427	0.127278	1.14 [0.93 - 1.39]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214504_at	204	0.691176	8.84468e-05	0.00314299	-0.605204	0.00355333	-0.31686	0.73 [0.59 - 0.90]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214504_at	87	0.563218	0.0362041	0.401068	-0.88537	0.205588	-1.00246	0.37 [0.08 - 1.73]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216716_at	87	0.37931	0.015732	0.225673	1.06376	0.362189	0.855085	2.35 [0.37 - 14.80]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214504_at	87	0.563218	0.0362041	0.401068	-0.88537	0.205588	-1.00246	0.37 [0.08 - 1.73]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216929_x_at	87	0.850575	0.0448081	0.459461	-1.79448	0.55021	-0.360242	0.70 [0.21 - 2.27]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216716_at	87	0.37931	0.015732	0.225673	1.06376	0.362189	0.855085	2.35 [0.37 - 14.80]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216929_x_at	87	0.850575	0.0448081	0.459461	-1.79448	0.55021	-0.360242	0.70 [0.21 - 2.27]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216929_x_at	77	0.25974	0.300055	-	-0.657198	0.428241	-0.874938	0.42 [0.05 - 3.63]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216716_at	77	0.805195	0.000316416	0.00956629	1.99343	0.160158	1.77516	5.90 [0.50 - 70.27]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216929_x_at	77	0.480519	0.156985	-	0.827675	0.703569	0.357709	1.43 [0.23 - 9.03]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214504_at	77	0.103896	0.185431	-	-1.00679	0.535113	-0.859298	0.42 [0.03 - 6.40]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216716_at	77	0.805195	0.000379934	0.0111988	1.76128	0.101111	1.80268	6.07 [0.70 - 52.34]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214504_at	77	0.896104	0.110993	-	1.00657	0.847012	-0.225496	0.80 [0.08 - 7.89]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216929_x_at	136	0.433824	0.365081	-	-0.404796	0.773493	-0.0678947	0.93 [0.59 - 1.48]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214504_at	136	0.455882	0.234965	-	0.578391	0.950256	0.0189437	1.02 [0.56 - 1.85]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216716_at	136	0.25	0.217642	-	0.754831	0.918931	-0.0259742	0.97 [0.59 - 1.61]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216929_x_at	200	0.885	0.0507592	-	-1.31604	0.56308	0.134912	1.14 [0.72 - 1.81]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214504_at	200	0.875	0.0166705	0.235315	0.837826	0.0888591	0.453724	1.57 [0.93 - 2.65]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216716_at	200	0.705	0.147605	-	0.435379	0.583019	0.154333	1.17 [0.67 - 2.02]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14390	60	0.116667	0.0714789	-	-0.870618	0.254741	-1.15527	0.31 [0.04 - 2.30]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14390	60	0.783333	0.129043	-	0.640539	0.815537	0.306943	1.36 [0.10 - 17.92]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	8152	155	0.167742	0.0168047	0.236677	-0.766574	0.136152	-0.477669	0.62 [0.33 - 1.16]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214504_at	286	0.20979	6.37443e-05	0.0023524	-0.819353	0.147658	-0.377784	0.69 [0.41 - 1.14]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216929_x_at	286	0.101399	5.30645e-05	0.00199898	-0.969156	0.00111871	-0.381381	0.68 [0.54 - 0.86]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216716_at	286	0.104895	1.12799e-05	0.000498255	-1.05013	0.000406178	-0.529454	0.59 [0.44 - 0.79]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214504_at	159	0.849057	0.0333211	0.379864	0.758958	0.085219	0.835629	2.31 [0.89 - 5.97]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216716_at	159	0.301887	0.0788785	-	-0.645101	0.933343	-0.0252827	0.98 [0.54 - 1.76]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216929_x_at	159	0.811321	0.0872717	-	0.596541	0.995551	-0.00189479	1.00 [0.51 - 1.94]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216716_at	159	0.301887	0.293193	-	-0.341727	0.66165	0.116852	1.12 [0.67 - 1.90]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214504_at	159	0.641509	0.0030767	0.0642853	0.90953	0.121545	0.667595	1.95 [0.84 - 4.54]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214504_at	159	0.641509	0.0177662	0.246315	0.858798	0.197084	0.741341	2.10 [0.68 - 6.47]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216716_at	159	0.308176	0.0141437	0.208853	-0.758871	0.337692	-0.235065	0.79 [0.49 - 1.28]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216929_x_at	159	0.805031	0.0302845	0.356508	0.732154	0.948432	0.023057	1.02 [0.51 - 2.06]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216929_x_at	159	0.823899	0.0795356	-	0.714158	0.686969	0.178998	1.20 [0.50 - 2.86]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214504_at	54	0.12963	0.147462	-	15.3748	0.626786	-0.426774	0.65 [0.12 - 3.65]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216716_at	54	0.87037	0.130327	-	-15.3922	0.614595	-0.814863	0.44 [0.02 - 10.56]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216929_x_at	54	0.796296	0.159167	-	-15.3592	0.384973	-0.863383	0.42 [0.06 - 2.96]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216716_at	117	0.273504	0.141529	-	0.573706	0.944248	0.051786	1.05 [0.25 - 4.50]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216716_at	117	0.273504	0.148912	-	0.697611	0.712111	0.310735	1.36 [0.26 - 7.11]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216716_at	117	0.863248	0.0624585	-	0.855187	0.290688	0.904776	2.47 [0.46 - 13.24]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216716_at	117	0.273504	0.141529	-	0.573706	0.944248	0.051786	1.05 [0.25 - 4.50]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216929_x_at	117	0.700855	0.137963	-	0.474225	0.345626	0.350851	1.42 [0.69 - 2.94]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216929_x_at	117	0.700855	0.112007	-	0.597377	0.579764	0.248407	1.28 [0.53 - 3.09]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216929_x_at	117	0.700855	0.137963	-	0.474225	0.345626	0.350851	1.42 [0.69 - 2.94]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214504_at	117	0.692308	0.124854	-	-0.59837	0.861282	-0.0821119	0.92 [0.37 - 2.31]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216929_x_at	117	0.846154	0.0158301	0.22669	0.988448	0.0976369	0.755224	2.13 [0.87 - 5.20]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214504_at	117	0.598291	0.0958148	-	-0.712439	0.802541	-0.142437	0.87 [0.28 - 2.65]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214504_at	117	0.598291	0.046838	0.472289	-0.895794	0.579497	-0.350818	0.70 [0.20 - 2.44]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214504_at	117	0.692308	0.124854	-	-0.59837	0.861282	-0.0821119	0.92 [0.37 - 2.31]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214504_at	236	0.800847	0.0146501	0.214288	0.699674	0.122434	0.696324	2.01 [0.83 - 4.85]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216716_at	236	0.105932	0.120842	-	0.892887	0.803867	0.0618399	1.06 [0.65 - 1.73]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216929_x_at	236	0.885593	0.1716	-	-0.791497	0.917399	0.0305165	1.03 [0.58 - 1.84]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216716_at	249	0.453815	0.010985	0.173249	-0.537441	0.975207	0.00579423	1.01 [0.70 - 1.45]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216929_x_at	249	0.285141	0.0486356	0.483374	-0.43015	0.122327	-0.327476	0.72 [0.48 - 1.09]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214504_at	249	0.742972	0.0586252	-	0.429468	0.590615	0.195839	1.22 [0.60 - 2.48]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216929_x_at	54	0.111111	0.166929	-	15.2747	0.870393	-0.0636727	0.94 [0.44 - 2.02]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216716_at	62	0.483871	0.16533	-	0.724931	0.892999	-0.0649045	0.94 [0.36 - 2.41]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214504_at	125	0.824	0.0536052	-	-0.847281	0.976362	-0.0073236	0.99 [0.61 - 1.61]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216716_at	125	0.624	0.0603095	-	0.708802	0.431205	0.491482	1.63 [0.48 - 5.56]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214504_at	54	0.777778	0.129316	-	0.870914	0.884411	-0.0529267	0.95 [0.46 - 1.94]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216929_x_at	125	0.232	0.222019	-	0.531655	0.829821	0.0629266	1.06 [0.60 - 1.89]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216716_at	125	0.872	0.144549	-	-0.689999	0.805737	-0.116381	0.89 [0.35 - 2.25]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216716_at	54	0.796296	0.0977904	-	0.945278	0.958464	-0.0306582	0.97 [0.31 - 3.07]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216929_x_at	125	0.744	0.0125624	0.191417	0.930605	0.115561	0.618632	1.86 [0.86 - 4.01]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214504_at	62	0.790323	0.223023	-	0.608089	0.770887	-0.0873397	0.92 [0.51 - 1.65]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214504_at	125	0.56	0.180514	-	0.522054	0.454931	0.237916	1.27 [0.68 - 2.37]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216929_x_at	62	0.145161	0.244143	-	1.13943	0.921904	-0.0312034	0.97 [0.52 - 1.81]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216716_at	198	0.393939	0.00868838	0.145165	-0.656503	0.260668	-0.115997	0.89 [0.73 - 1.09]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216929_x_at	198	0.378788	0.00267475	0.0574087	0.702769	0.0169891	0.262582	1.30 [1.05 - 1.61]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216716_at	198	0.873737	0.0041002	0.080898	-2.33557	0.35247	-0.101736	0.90 [0.73 - 1.12]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214504_at	198	0.429293	0.29986	-	0.223698	0.818681	-0.030326	0.97 [0.75 - 1.26]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216929_x_at	198	0.318182	0.0400844	0.428255	0.652473	0.199169	0.166221	1.18 [0.92 - 1.52]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216929_x_at	198	0.318182	0.0307718	0.36033	0.740113	0.18741	0.181152	1.20 [0.92 - 1.57]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216716_at	198	0.393939	0.0114472	0.178658	-0.53119	0.172854	-0.117764	0.89 [0.75 - 1.05]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214504_at	198	0.787879	0.248476	-	-0.396441	0.985771	-0.00283523	1.00 [0.73 - 1.36]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214504_at	198	0.787879	0.192505	-	-0.492884	0.938758	0.0129751	1.01 [0.73 - 1.41]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214504_at	62	0.129032	0.0234044	0.299099	-1.29792	0.721777	-0.393041	0.68 [0.08 - 5.87]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216716_at	51	0.333333	0.0153925	0.222132	-2.22543	0.252114	-2.19609	0.11 [0.00 - 4.77]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216929_x_at	62	0.129032	0.135592	-	-0.958513	0.700411	-0.249799	0.78 [0.22 - 2.78]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216716_at	62	0.870968	0.118706	-	0.998666	0.7167	0.49069	1.63 [0.12 - 23.13]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216929_x_at	51	0.117647	0.0310139	0.362219	-1.74498	0.208446	-1.7459	0.17 [0.01 - 2.65]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214504_at	51	0.745098	0.064261	-	1.53451	0.291255	1.89829	6.67 [0.20 - 226.72]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216716_at	177	0.627119	0.117754	-	-0.46107	0.504384	-0.341631	0.71 [0.26 - 1.94]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216929_x_at	177	0.683616	0.0284783	0.342075	-0.598972	0.376617	-0.227658	0.80 [0.48 - 1.32]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214504_at	177	0.875706	0.0327289	0.375394	-1.2047	0.210657	-0.978773	0.38 [0.08 - 1.74]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216716_at	177	0.615819	0.151639	-	-0.355567	0.762382	-0.135044	0.87 [0.36 - 2.10]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216929_x_at	145	0.806897	0.0419444	0.440778	-1.16225	0.978782	-0.0104426	0.99 [0.46 - 2.14]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214504_at	177	0.129944	0.00418973	0.0822983	-0.84041	0.0720987	-1.25795	0.28 [0.07 - 1.12]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216716_at	145	0.131034	0.159274	-	0.984336	0.811261	-0.149377	0.86 [0.25 - 2.93]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214504_at	145	0.806897	0.00936611	0.153676	-1.68614	0.0630073	-1.86616	0.15 [0.02 - 1.11]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216929_x_at	177	0.711864	0.0544008	-	-0.639623	0.32305	-0.284343	0.75 [0.43 - 1.32]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216929_x_at	226	0.261062	0.00187014	0.0428663	-0.865945	0.536248	-0.085796	0.92 [0.70 - 1.20]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216716_at	226	0.889381	0.122362	-	-1.06593	0.572669	-0.0917827	0.91 [0.66 - 1.25]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214504_at	226	0.336283	0.00404131	0.0799727	-0.796256	0.0821973	-0.386007	0.68 [0.44 - 1.05]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216929_x_at	55	0.454545	0.0646844	-	0.948411	0.252917	0.869271	2.39 [0.54 - 10.59]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216716_at	55	0.236364	0.0214594	0.281552	-1.01068	0.348139	-0.992573	0.37 [0.05 - 2.95]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216929_x_at	49	0.632653	0.00186436	0.0427573	1.72978	0.0173971	2.61185	13.62 [1.58 - 117.26]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214504_at	55	0.872727	0.246441	-	0.639973	0.917325	0.1224	1.13 [0.11 - 11.40]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216716_at	55	0.218182	0.0137239	0.204294	-1.21385	0.181388	-1.47855	0.23 [0.03 - 1.99]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216716_at	49	0.204082	0.0468463	0.47234	-1.10983	0.833975	-0.279555	0.76 [0.06 - 10.32]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214504_at	55	0.181818	0.117765	-	-0.890527	0.135691	-2.18584	0.11 [0.01 - 1.98]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214504_at	49	0.877551	0.112915	-	1.02697	0.650102	0.612661	1.85 [0.13 - 26.05]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216929_x_at	55	0.509091	0.00150482	0.0358295	1.50908	0.0431333	1.52664	4.60 [1.05 - 20.21]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216929_x_at	63	0.365079	0.000286125	0.00876982	-1.19703	0.176591	-0.944896	0.39 [0.10 - 1.53]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216716_at	63	0.126984	0.00102482	0.0260147	-1.31792	0.236012	-6.39702	0.00 [0.00 - 65.60]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214504_at	63	0.190476	0.00060971	0.0167802	-1.21377	0.857865	0.370061	1.45 [0.03 - 83.10]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.113271.1.A1_3p_at	28	0.678571	0.0195428	0.263601	-1.65279	0.232444	-5.44294	0.00 [0.00 - 32.83]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.113271.0.S1_3p_a_at	28	0.607143	0.0372821	0.408771	-1.33729	0.388856	-3.50269	0.03 [0.00 - 86.88]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.113271.1.A1_3p_x_at	28	0.857143	0.0258342	0.320153	1.33265	0.533224	0.478857	1.61 [0.36 - 7.28]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.113271.0.S1_3p_x_at	28	0.214286	0.027653	0.335337	-1.23725	0.802561	0.508237	1.66 [0.03 - 89.32]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.113271.1.S1_3p_x_at	28	0.785714	0.301901	-	-0.776029	0.715464	0.147569	1.16 [0.52 - 2.56]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	216716_3p_at	28	0.5	0.0395319	0.424473	-1.20218	0.271698	-2.06101	0.13 [0.00 - 5.02]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216929_x_at	82	0.329268	0.225959	-	-0.424647	0.783545	0.107575	1.11 [0.52 - 2.40]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214504_at	82	0.390244	0.0571002	-	0.704928	0.250235	0.707019	2.03 [0.61 - 6.77]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216716_at	82	0.109756	0.167592	-	0.96768	0.45887	0.315244	1.37 [0.60 - 3.16]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34469_at	84	0.892857	0.032852	0.376326	-1.43865	0.144761	-0.863037	0.42 [0.13 - 1.35]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214504_at	79	0.873418	0.140197	-	0.531445	0.456525	0.382868	1.47 [0.54 - 4.02]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216929_x_at	79	0.493671	0.00206709	0.046536	-0.812471	0.121301	-0.495401	0.61 [0.33 - 1.14]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216716_at	79	0.151899	0.183119	-	-0.443253	0.406588	-0.34871	0.71 [0.31 - 1.61]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U15197_at	86	0.848837	0.0550285	-	-15.2499	0.0719557	-0.499703	0.61 [0.35 - 1.05]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216929_x_at	104	0.557692	0.0166456	0.235062	-0.839523	0.149177	-0.590032	0.55 [0.25 - 1.24]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214504_at	104	0.144231	0.00828045	0.139944	-1.00258	0.441302	-0.510723	0.60 [0.16 - 2.20]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216716_at	104	0.894231	0.0769126	-	0.734102	0.787643	0.145317	1.16 [0.40 - 3.33]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214504_at	204	0.803922	0.0737905	-	-1.22992	0.658312	-0.155804	0.86 [0.43 - 1.71]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214504_at	204	0.862745	0.249743	-	-0.534048	0.913074	-0.0283802	0.97 [0.58 - 1.62]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216929_x_at	204	0.156863	0.0172052	0.240716	-0.918055	0.167941	-0.372229	0.69 [0.41 - 1.17]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216929_x_at	204	0.691176	0.0415489	0.438141	-0.676114	0.301025	-0.220203	0.80 [0.53 - 1.22]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216716_at	204	0.784314	0.117122	-	0.598343	0.980728	-0.00791878	0.99 [0.52 - 1.89]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216716_at	204	0.784314	0.0167906	0.236534	0.677766	0.468517	0.195334	1.22 [0.72 - 2.06]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214504_at	178	0.219101	0.0109897	0.173304	-0.559286	0.0565363	-0.657371	0.52 [0.26 - 1.02]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216716_at	178	0.303371	0.0868394	-	0.386255	0.557705	0.139675	1.15 [0.72 - 1.83]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216929_x_at	178	0.11236	0.0615774	-	-0.517995	0.34616	-0.167533	0.85 [0.60 - 1.20]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216929_x_at	111	0.207207	0.00904223	0.149634	-0.750932	0.0365541	-0.263557	0.77 [0.60 - 0.98]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216716_at	111	0.198198	0.0474043	0.475808	0.780448	0.253544	0.231684	1.26 [0.85 - 1.88]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214504_at	111	0.783784	0.060643	-	-0.700218	0.473143	-0.171013	0.84 [0.53 - 1.34]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214504_at	90	0.622222	0.134708	-	-0.544599	0.813294	-0.143349	0.87 [0.26 - 2.85]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214504_at	90	0.133333	0.148893	-	-0.650796	0.692719	0.273359	1.31 [0.34 - 5.10]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216716_at	90	0.622222	0.22396	-	-0.432442	0.728997	0.209833	1.23 [0.38 - 4.04]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216716_at	90	0.5	0.180036	-	-0.508353	0.929735	0.0616307	1.06 [0.27 - 4.19]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216929_x_at	90	0.8	0.00479349	0.09155	1.06675	0.365889	0.504886	1.66 [0.55 - 4.95]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216929_x_at	90	0.8	0.00342699	0.070105	0.996856	0.514213	0.32753	1.39 [0.52 - 3.71]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214504_at	138	0.369565	0.0156804	0.225137	-0.575857	0.388605	0.485965	1.63 [0.54 - 4.91]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216929_x_at	138	0.318841	0.0718189	-	-0.43806	0.840384	-0.15955	0.85 [0.18 - 4.03]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216716_at	138	0.137681	0.0125464	0.191237	-0.718069	0.993518	-0.0102563	0.99 [0.08 - 11.76]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216929_x_at	129	0.899225	0.0436629	0.452074	0.71512	0.404124	0.202226	1.22 [0.76 - 1.97]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214504_at	129	0.697674	0.0261707	0.322998	-0.644821	0.308829	-0.393238	0.67 [0.32 - 1.44]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216716_at	129	0.271318	0.000689069	0.0186167	-0.86156	0.0720839	-0.478441	0.62 [0.37 - 1.04]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17097	56	0.303571	0.0208597	0.276009	0.948759	0.152813	1.65877	5.25 [0.54 - 51.05]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17097	56	0.339286	0.0104846	0.167305	1.10777	0.136555	1.70469	5.50 [0.58 - 51.88]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216929_x_at	278	0.848921	0.0494155	0.488106	-0.524099	0.151137	-0.278067	0.76 [0.52 - 1.11]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216716_at	278	0.244604	0.0528682	-	-0.408754	0.810049	0.0980252	1.10 [0.50 - 2.45]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214504_at	278	0.316547	0.0210868	0.278117	-0.447172	0.0810416	-0.643773	0.53 [0.25 - 1.08]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216716_at	133	0.556391	0.00364776	0.0736981	0.678592	0.31721	0.592263	1.81 [0.57 - 5.77]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216929_x_at	133	0.112782	0.136852	-	-0.485885	0.706349	-0.0539286	0.95 [0.72 - 1.25]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214504_at	133	0.548872	0.0191022	0.259374	0.553154	0.409679	0.910956	2.49 [0.29 - 21.68]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5609	81	0.148148	3.22937e-05	0.00128372	-1.99293	0.0026776	-1.03561	0.36 [0.18 - 0.70]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16711	81	0.17284	0.000688918	0.0186133	-1.60996	0.0712365	-0.815618	0.44 [0.18 - 1.07]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216716_at	185	0.740541	0.000737808	0.0197259	-0.639543	0.00929462	-0.845579	0.43 [0.23 - 0.81]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216929_x_at	185	0.248649	0.00412398	0.0812706	-0.555677	0.82805	-0.0552148	0.95 [0.57 - 1.56]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214504_at	185	0.27027	0.0480974	0.480081	-0.349355	0.95074	-0.0171043	0.98 [0.57 - 1.69]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216716_at	185	0.740541	0.0205818	0.273418	-0.46735	0.101523	-0.561109	0.57 [0.29 - 1.12]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214504_at	185	0.27027	0.0195958	0.264107	-0.439983	0.549202	-0.181056	0.83 [0.46 - 1.51]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216929_x_at	185	0.248649	0.0016583	0.0388251	-0.564681	0.463957	-0.173806	0.84 [0.53 - 1.34]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P112646	110	0.372727	0.185223	-	-0.313676	0.92282	-0.0271411	0.97 [0.56 - 1.69]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P112646	110	0.872727	0.225849	-	0.48077	0.915073	-0.0395904	0.96 [0.46 - 1.99]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214504_at	80	0.5125	0.236631	-	-0.521452	0.378414	-0.307012	0.74 [0.37 - 1.46]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216929_x_at	80	0.325	0.0749826	-	1.06243	0.701914	0.0872233	1.09 [0.70 - 1.71]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216716_at	80	0.1125	0.0126418	0.19231	-1.35976	0.497312	-0.20377	0.82 [0.45 - 1.47]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5055	281	0.843416	0.0171702	0.240365	-0.497518	0.0984523	-0.192146	0.83 [0.66 - 1.04]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216929_x_at	38	0.710526	0.0224125	0.290231	-1.27567	0.303582	-0.285833	0.75 [0.44 - 1.30]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216716_at	38	0.157895	0.10534	-	-0.843267	0.79954	-0.140923	0.87 [0.29 - 2.58]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214504_at	38	0.815789	0.18432	-	0.783914	0.393465	0.297704	1.35 [0.68 - 2.67]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214504_at	140	0.171429	0.0833867	-	-0.637092	0.893946	-0.0751545	0.93 [0.31 - 2.80]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216716_at	140	0.128571	0.011655	0.181067	-0.846073	0.206411	-1.29238	0.27 [0.04 - 2.04]
GENE	ABO	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216929_x_at	140	0.178571	0.0095749	0.156258	-0.802156	0.0529131	-1.16347	0.31 [0.10 - 1.01]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202025_x_at	30	0.5	0.0210599	0.277867	-0.923262	0.0646291	-1.11188	0.33 [0.10 - 1.07]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214274_s_at	30	0.6	0.00415569	0.0817667	-1.2163	0.0130352	-0.739763	0.48 [0.27 - 0.86]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1738921	165	0.381818	0.0941155	-	-0.403307	0.88424	-0.0216054	0.98 [0.73 - 1.31]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1738921	165	0.266667	0.000388163	0.011407	-1.18563	0.0452585	-0.347342	0.71 [0.50 - 0.99]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214274_s_at	163	0.239264	0.0593914	-	0.459329	0.257201	0.178587	1.20 [0.88 - 1.63]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202025_x_at	163	0.196319	0.119194	-	0.411531	0.596834	0.145083	1.16 [0.68 - 1.98]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214274_s_at	79	0.189873	0.00494059	0.0937567	1.36716	0.0522036	0.436733	1.55 [1.00 - 2.41]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202025_x_at	79	0.734177	0.0550622	-	0.592845	0.375691	0.270379	1.31 [0.72 - 2.38]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202025_x_at	58	0.896552	0.000401023	0.0117308	1.52293	0.158834	0.509497	1.66 [0.82 - 3.38]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214274_s_at	58	0.482759	0.0124133	0.189734	0.698059	0.0188663	0.682127	1.98 [1.12 - 3.50]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202025_x_at	34	0.823529	0.0655897	-	0.85151	0.365766	0.494256	1.64 [0.56 - 4.78]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214274_s_at	34	0.382353	0.113909	-	0.635031	0.37955	0.390625	1.48 [0.62 - 3.53]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202025_x_at	158	0.873418	0.0511998	-	0.590336	0.303078	0.566482	1.76 [0.60 - 5.18]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214274_s_at	158	0.550633	0.0279763	0.337987	0.505335	0.132539	0.526896	1.69 [0.85 - 3.37]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214274_s_at	53	0.886792	0.0359459	0.399205	-1.85581	0.0934367	-1.17932	0.31 [0.08 - 1.22]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202025_x_at	53	0.641509	0.0151888	0.219994	0.870363	0.570927	0.372564	1.45 [0.40 - 5.27]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214274_s_at	53	0.867925	0.0349423	0.391899	-1.87113	0.171787	-1.00737	0.37 [0.09 - 1.55]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202025_x_at	53	0.603774	0.0285611	0.342746	0.739476	0.746048	0.197792	1.22 [0.37 - 4.03]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202025_x_at	180	0.516667	0.12259	-	-0.324333	0.424439	-0.278863	0.76 [0.38 - 1.50]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214274_s_at	180	0.666667	0.157534	-	0.309047	0.385106	0.238799	1.27 [0.74 - 2.18]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214274_s_at	559	0.275492	0.00144415	0.0346282	-0.639488	0.021731	-0.855005	0.43 [0.20 - 0.88]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202025_x_at	559	0.631485	0.0343771	0.387735	-0.537194	0.184114	-0.360286	0.70 [0.41 - 1.19]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202025_x_at	77	0.181818	0.0149513	0.217487	-0.759878	0.222887	-0.567275	0.57 [0.23 - 1.41]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214274_s_at	77	0.818182	0.119868	-	0.487235	0.446037	-0.348351	0.71 [0.29 - 1.73]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202025_x_at	70	0.814286	0.107789	-	0.539981	0.338096	0.485936	1.63 [0.60 - 4.39]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214274_s_at	70	0.314286	0.364001	-	0.258014	0.658815	0.160463	1.17 [0.58 - 2.39]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36417_s_at	50	0.44	0.108065	-	0.580383	0.452297	0.261428	1.30 [0.66 - 2.57]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40415_at	50	0.26	0.0809053	-	0.830372	0.561935	0.42752	1.53 [0.36 - 6.50]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214274_s_at	74	0.851351	0.21311	-	0.459506	0.815115	0.133482	1.14 [0.37 - 3.50]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202025_x_at	74	0.121622	0.0740321	-	1.02318	0.236762	0.874703	2.40 [0.56 - 10.21]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214274_s_at	67	0.134328	0.0793164	-	-1.18245	0.322543	-0.967912	0.38 [0.06 - 2.59]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202025_x_at	67	0.104478	0.0875733	-	-1.18822	0.361193	-1.37764	0.25 [0.01 - 4.85]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202025_x_at	115	0.156522	0.0169708	0.238357	-1.24552	0.400797	-0.672861	0.51 [0.11 - 2.45]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214274_s_at	115	0.130435	0.0472505	0.474855	-1.11151	0.35156	-0.690395	0.50 [0.12 - 2.14]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36417_s_at	158	0.898734	0.129506	-	0.580071	0.752228	-0.138702	0.87 [0.37 - 2.06]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40415_at	158	0.702532	0.177851	-	0.40358	0.601898	0.185476	1.20 [0.60 - 2.42]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40415_at	76	0.828947	0.204296	-	-1.23597	0.666122	-0.216632	0.81 [0.30 - 2.15]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36417_s_at	76	0.894737	0.138984	-	-15.2248	0.706348	-0.181488	0.83 [0.32 - 2.14]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214274_s_at	204	0.54902	0.00228459	0.0505009	-0.435833	0.00705409	-0.429634	0.65 [0.48 - 0.89]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202025_x_at	204	0.191176	0.00469649	0.0900851	-0.504248	0.0675784	-0.347548	0.71 [0.49 - 1.03]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202025_x_at	87	0.494253	0.122239	-	-0.589673	0.420664	-0.426354	0.65 [0.23 - 1.84]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214274_s_at	87	0.333333	0.040435	0.430639	-0.762627	0.214247	-0.53396	0.59 [0.25 - 1.36]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202025_x_at	87	0.494253	0.122239	-	-0.589673	0.420664	-0.426354	0.65 [0.23 - 1.84]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214274_s_at	87	0.333333	0.040435	0.430639	-0.762627	0.214247	-0.53396	0.59 [0.25 - 1.36]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214274_s_at	77	0.74026	0.198978	-	-1.26786	0.575698	-0.312349	0.73 [0.25 - 2.18]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202025_x_at	77	0.688312	0.104735	-	-1.55139	0.512377	-0.461124	0.63 [0.16 - 2.51]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214274_s_at	77	0.896104	0.19539	-	-15.1945	0.778653	-0.13712	0.87 [0.34 - 2.27]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202025_x_at	77	0.506494	0.123414	-	-0.896178	0.761295	-0.185151	0.83 [0.25 - 2.74]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214274_s_at	136	0.176471	0.0342177	0.386555	-1.03319	0.509263	-0.28727	0.75 [0.32 - 1.76]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202025_x_at	136	0.404412	0.0680374	-	0.918298	0.837989	-0.136215	0.87 [0.24 - 3.22]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214274_s_at	200	0.11	0.000272356	0.00840352	-1.18932	0.106078	-0.615434	0.54 [0.26 - 1.14]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202025_x_at	200	0.215	0.00362353	0.0733065	-0.861821	0.0208231	-1.39564	0.25 [0.08 - 0.81]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15416	60	0.883333	0.120174	-	0.75183	0.656436	0.149349	1.16 [0.60 - 2.24]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11043	60	0.816667	0.0171707	0.240369	0.976856	0.539874	0.274704	1.32 [0.55 - 3.17]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6885	60	0.783333	0.0220124	0.286607	0.913683	0.575967	0.19101	1.21 [0.62 - 2.36]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15416	60	0.133333	0.114995	-	-0.785269	0.926421	-0.0343392	0.97 [0.47 - 2.00]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11043	60	0.116667	0.0408884	0.433707	-1.00454	0.891232	0.0798677	1.08 [0.34 - 3.40]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6885	60	0.166667	0.149825	-	-0.667232	0.932596	0.0278876	1.03 [0.54 - 1.96]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214274_s_at	286	0.409091	0.0170985	0.239644	-0.457794	0.106115	-0.45699	0.63 [0.36 - 1.10]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202025_x_at	286	0.458042	0.000131654	0.00445997	-0.736594	0.00580628	-0.83671	0.43 [0.24 - 0.78]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202025_x_at	159	0.786164	0.000417383	0.0121403	1.23783	0.0211746	1.482	4.40 [1.25 - 15.52]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214274_s_at	159	0.238994	0.0855847	-	-0.562295	0.777165	-0.115636	0.89 [0.40 - 1.98]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202025_x_at	159	0.786164	0.0102045	0.163938	0.828226	0.0932006	0.995099	2.70 [0.85 - 8.64]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214274_s_at	159	0.264151	0.0669631	-	-0.677765	0.762901	-0.143761	0.87 [0.34 - 2.20]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214274_s_at	159	0.213836	0.0911499	-	-0.562918	0.743296	-0.132903	0.88 [0.40 - 1.94]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202025_x_at	159	0.899371	0.00167072	0.0390649	1.13122	0.0176047	1.37066	3.94 [1.27 - 12.21]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214274_s_at	54	0.685185	0.0947896	-	-1.59887	0.886258	-0.074393	0.93 [0.33 - 2.57]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202025_x_at	54	0.222222	0.159506	-	15.3609	0.765678	0.1778	1.19 [0.37 - 3.85]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202025_x_at	117	0.119658	0.0196171	0.26431	2.00996	0.382015	0.274083	1.32 [0.71 - 2.43]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202025_x_at	117	0.145299	0.0467976	0.472036	1.7808	0.343181	0.345591	1.41 [0.69 - 2.89]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202025_x_at	117	0.111111	0.119833	-	1.45583	0.586153	0.214059	1.24 [0.57 - 2.68]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202025_x_at	117	0.119658	0.0196171	0.26431	2.00996	0.382015	0.274083	1.32 [0.71 - 2.43]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214274_s_at	117	0.273504	0.0633107	-	0.768714	0.142557	0.463971	1.59 [0.86 - 2.96]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214274_s_at	117	0.273504	0.0368497	0.405696	1.20311	0.100572	0.608928	1.84 [0.89 - 3.80]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214274_s_at	117	0.17094	0.0451289	0.461511	1.79385	0.190695	0.515082	1.67 [0.77 - 3.62]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214274_s_at	117	0.273504	0.0633107	-	0.768714	0.142557	0.463971	1.59 [0.86 - 2.96]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202025_x_at	236	0.305085	0.0504283	-	-0.530711	0.696188	-0.262295	0.77 [0.21 - 2.87]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214274_s_at	236	0.271186	0.0287699	0.344434	-0.598865	0.811557	-0.105131	0.90 [0.38 - 2.14]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202025_x_at	249	0.88755	0.0256455	0.31855	0.62231	0.450764	0.414696	1.51 [0.52 - 4.45]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214274_s_at	249	0.710843	0.0450404	0.460946	0.440077	0.184994	0.472273	1.60 [0.80 - 3.22]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214274_s_at	125	0.792	0.0770856	-	0.569385	0.396302	0.286437	1.33 [0.69 - 2.58]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214274_s_at	54	0.185185	0.00111945	0.0280108	-1.69743	0.147182	-0.490961	0.61 [0.32 - 1.19]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202025_x_at	62	0.274194	0.0919132	-	-0.800814	0.512494	-0.186723	0.83 [0.47 - 1.45]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202025_x_at	125	0.568	0.189182	-	-0.544298	0.838319	-0.147062	0.86 [0.21 - 3.55]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214274_s_at	62	0.177419	0.000797378	0.0210636	-1.46644	0.134456	-0.422323	0.66 [0.38 - 1.14]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202025_x_at	125	0.768	0.0385025	0.41735	0.679523	0.433622	0.433281	1.54 [0.52 - 4.56]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214274_s_at	125	0.112	0.152562	-	1.35246	0.64017	0.20401	1.23 [0.52 - 2.88]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202025_x_at	54	0.259259	0.0676147	-	-1.03747	0.596933	-0.182719	0.83 [0.42 - 1.64]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214274_s_at	198	0.494949	0.116667	-	-0.33271	0.277364	-0.212404	0.81 [0.55 - 1.19]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202025_x_at	198	0.368687	0.000662354	0.0180029	-0.843513	0.0307189	-0.833994	0.43 [0.20 - 0.93]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202025_x_at	198	0.368687	0.000236327	0.00743098	-0.957731	0.0125096	-1.02023	0.36 [0.16 - 0.80]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214274_s_at	198	0.818182	0.0623213	-	-0.781745	0.22968	-0.288448	0.75 [0.47 - 1.20]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214274_s_at	198	0.813131	0.102452	-	-0.692018	0.212255	-0.310226	0.73 [0.45 - 1.19]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202025_x_at	198	0.10101	0.000147986	0.00494118	-1.02412	0.0116182	-0.804373	0.45 [0.24 - 0.84]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214274_s_at	62	0.225806	0.00931767	0.153074	-1.39281	0.190196	-0.73809	0.48 [0.16 - 1.44]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202025_x_at	51	0.117647	0.021573	0.282595	-1.83538	0.172351	-1.77832	0.17 [0.01 - 2.17]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202025_x_at	62	0.129032	0.00498663	0.0944437	-1.56859	0.0418478	-1.65258	0.19 [0.04 - 0.94]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214274_s_at	51	0.254902	0.00214729	0.0480083	-2.62437	0.0844747	-1.69247	0.18 [0.03 - 1.26]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214274_s_at	177	0.819209	0.0612384	-	-0.937583	0.411923	-0.317484	0.73 [0.34 - 1.55]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202025_x_at	177	0.621469	0.0262033	0.323273	-0.692558	0.319857	-0.475687	0.62 [0.24 - 1.59]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214274_s_at	177	0.310734	0.026154	0.322856	0.620623	0.230266	0.384572	1.47 [0.78 - 2.75]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202025_x_at	177	0.180791	0.085175	-	0.635713	0.428921	0.327635	1.39 [0.62 - 3.12]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214274_s_at	145	0.6	0.0198362	0.266394	-0.905046	0.345529	-0.447625	0.64 [0.25 - 1.62]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202025_x_at	145	0.6	0.0103913	0.166187	-1.03361	0.171574	-0.790891	0.45 [0.15 - 1.41]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214274_s_at	226	0.853982	0.0393811	0.423436	-1.37674	0.273374	-0.364572	0.69 [0.36 - 1.33]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202025_x_at	226	0.513274	0.0154353	0.222581	-0.719609	0.961666	-0.0200037	0.98 [0.43 - 2.22]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214274_s_at	55	0.8	0.0159141	0.22756	1.08298	0.128995	0.793539	2.21 [0.79 - 6.16]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214274_s_at	55	0.8	0.00570024	0.104885	1.29945	0.0281476	1.18162	3.26 [1.13 - 9.36]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202025_x_at	55	0.872727	0.0105506	0.168094	1.25475	0.135618	1.10393	3.02 [0.71 - 12.86]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214274_s_at	49	0.816327	0.00172707	0.0401484	1.72546	0.106805	1.31216	3.71 [0.75 - 18.30]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202025_x_at	55	0.872727	0.00834039	0.140716	1.39313	0.0309208	1.5359	4.65 [1.15 - 18.74]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202025_x_at	49	0.897959	0.0231123	0.296504	1.43015	0.265448	1.1691	3.22 [0.41 - 25.20]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214274_s_at	63	0.396825	0.000270477	0.00835328	-1.21353	0.011079	-0.487918	0.61 [0.42 - 0.89]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202025_x_at	63	0.571429	0.00218686	0.0487302	-1.14627	0.041175	-0.506239	0.60 [0.37 - 0.98]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6598316_3p_s_at	28	0.321429	0.147035	-	-0.769243	0.93177	-0.0336899	0.97 [0.45 - 2.09]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.200188.5.A1_3p_s_at	28	0.857143	0.0889532	-	-15.3236	0.649886	-0.184892	0.83 [0.37 - 1.85]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214274_s_at	82	0.256098	0.0364185	0.40261	-0.715928	0.46733	-0.399029	0.67 [0.23 - 1.97]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202025_x_at	82	0.182927	0.019487	0.263068	-0.85142	0.462195	-0.476177	0.62 [0.17 - 2.21]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40415_at	84	0.357143	0.238141	-	0.367283	0.568023	-0.199042	0.82 [0.41 - 1.62]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36417_s_at	84	0.607143	0.0493039	0.487432	0.564378	0.566506	0.170299	1.19 [0.66 - 2.12]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214274_s_at	79	0.139241	0.117072	-	0.668109	0.575771	0.204762	1.23 [0.60 - 2.51]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202025_x_at	79	0.113924	0.14879	-	0.669907	0.729769	0.149631	1.16 [0.50 - 2.71]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X14813_at	86	0.790698	0.219565	-	-0.741939	0.399956	-0.439715	0.64 [0.23 - 1.79]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202025_x_at	104	0.326923	0.0258602	0.320373	-0.710237	0.222998	-0.803391	0.45 [0.12 - 1.63]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214274_s_at	104	0.317308	0.00191126	0.0436392	-0.970172	0.0612207	-1.04785	0.35 [0.12 - 1.05]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P379858	117	0.435897	0.0476977	0.477621	-0.562995	0.963466	-0.00809376	0.99 [0.70 - 1.40]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P69339	117	0.863248	0.00866014	0.144806	0.876819	0.775778	0.0971522	1.10 [0.56 - 2.15]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202025_x_at	204	0.514706	0.0440444	0.454548	0.761744	0.524369	0.391154	1.48 [0.44 - 4.93]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202025_x_at	204	0.509804	0.106055	-	0.44402	0.490079	0.315681	1.37 [0.56 - 3.36]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214274_s_at	204	0.254902	0.279035	-	0.524541	0.710848	-0.249253	0.78 [0.21 - 2.91]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214274_s_at	204	0.112745	0.0432082	0.44911	-0.694564	0.422467	-0.401989	0.67 [0.25 - 1.79]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202025_x_at	178	0.730337	0.236214	-	-0.284243	0.882253	-0.0601314	0.94 [0.42 - 2.09]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214274_s_at	178	0.101124	0.169408	-	0.478691	0.720848	0.117801	1.13 [0.59 - 2.15]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300021452	41	0.170732	0.100731	-	-0.810972	0.273061	-0.678258	0.51 [0.15 - 1.71]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300017800	41	0.170732	0.0011151	0.0279199	-1.44967	0.0714378	-0.473988	0.62 [0.37 - 1.04]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300018479	41	0.121951	0.201213	-	-0.69292	0.639144	-0.134396	0.87 [0.50 - 1.53]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214274_s_at	111	0.756757	0.0387195	0.41886	-0.703331	0.633844	-0.161031	0.85 [0.44 - 1.65]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202025_x_at	111	0.126126	0.111179	-	-0.550191	0.85544	-0.075496	0.93 [0.41 - 2.09]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214274_s_at	90	0.122222	0.0111053	0.174663	-0.989859	0.82026	-0.0705905	0.93 [0.51 - 1.71]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214274_s_at	90	0.122222	0.00143907	0.0345272	-1.26307	0.274652	-0.393309	0.67 [0.33 - 1.37]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202025_x_at	90	0.577778	0.154926	-	0.462061	0.847695	0.119638	1.13 [0.33 - 3.82]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202025_x_at	90	0.3	0.132203	-	-0.561496	0.990314	-0.00854979	0.99 [0.25 - 3.94]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202025_x_at	138	0.26087	0.014314	0.210689	-0.613593	0.73061	-0.0657797	0.94 [0.64 - 1.36]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214274_s_at	138	0.275362	0.0204206	0.271909	-0.573593	0.891333	-0.0245555	0.98 [0.69 - 1.39]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202025_x_at	129	0.325581	0.202859	-	0.353092	0.508926	0.337122	1.40 [0.52 - 3.81]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214274_s_at	129	0.186047	0.121312	-	-0.463795	0.712717	-0.142857	0.87 [0.41 - 1.85]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20850	56	0.892857	0.209997	-	-0.885992	0.840228	-0.0631794	0.94 [0.51 - 1.74]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43528	56	0.857143	0.151659	-	-0.854057	0.729483	-0.10403	0.90 [0.50 - 1.63]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12127	56	0.267857	0.0552166	-	0.83977	0.416913	0.250843	1.29 [0.70 - 2.35]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20850	56	0.892857	0.139705	-	-1.38934	0.733249	-0.116741	0.89 [0.45 - 1.74]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12127	56	0.589286	0.0532669	-	0.689737	0.39753	0.285432	1.33 [0.69 - 2.58]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43528	56	0.857143	0.288001	-	-0.565782	0.802979	-0.0690279	0.93 [0.54 - 1.61]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214274_s_at	278	0.514389	0.0611347	-	-0.355713	0.190684	-0.235861	0.79 [0.55 - 1.12]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202025_x_at	278	0.413669	0.0171783	0.240446	-0.446174	0.154601	-0.36916	0.69 [0.42 - 1.15]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202025_x_at	133	0.195489	0.0918737	-	-0.475765	0.703813	-0.12373	0.88 [0.47 - 1.67]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214274_s_at	133	0.451128	0.0197244	0.265331	-0.555114	0.255054	-0.182004	0.83 [0.61 - 1.14]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13758	81	0.296296	0.0198116	0.266161	-1.21511	0.238642	-0.605908	0.55 [0.20 - 1.49]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214274_s_at	185	0.708108	0.00930876	0.152963	-0.462496	0.217405	-0.140219	0.87 [0.70 - 1.09]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202025_x_at	185	0.827027	0.00640205	0.114807	-0.565122	0.0275739	-0.490998	0.61 [0.40 - 0.95]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214274_s_at	185	0.708108	0.00575868	0.105724	-0.545562	0.0683577	-0.22815	0.80 [0.62 - 1.02]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202025_x_at	185	0.767568	0.00687731	0.121351	-0.57056	0.0299069	-0.527892	0.59 [0.37 - 0.95]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P69339	110	0.190909	0.0294703	0.350054	-0.760293	0.245617	-0.377787	0.69 [0.36 - 1.30]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P379858	110	0.563636	0.00588117	0.107475	-0.878797	0.132622	-0.3267	0.72 [0.47 - 1.10]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P69339	110	0.145455	0.0290934	0.347037	-0.663717	0.376411	-0.215185	0.81 [0.50 - 1.30]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P379858	110	0.563636	0.0451709	0.461778	-0.468428	0.409473	-0.143694	0.87 [0.62 - 1.22]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202025_x_at	80	0.325	0.00528282	0.0988239	-1.35557	0.417776	-0.583443	0.56 [0.14 - 2.29]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214274_s_at	80	0.475	0.0106534	0.169321	-1.14079	0.289993	-0.444174	0.64 [0.28 - 1.46]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5504	281	0.338078	0.00366607	0.0739937	-0.417872	0.00648178	-0.473215	0.62 [0.44 - 0.88]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:772449	59	0.864407	0.0922727	-	-15.2556	0.448808	0.513756	1.67 [0.44 - 6.32]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214274_s_at	38	0.789474	0.00325856	0.0673256	1.47827	0.0381698	1.20343	3.33 [1.07 - 10.39]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202025_x_at	38	0.894737	3.30911e-05	0.00131203	2.31762	0.0264575	1.31833	3.74 [1.17 - 11.97]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202025_x_at	140	0.207143	9.44193e-05	0.00332947	-1.114	0.0102674	-1.30098	0.27 [0.10 - 0.74]
GENE	ACAA1	acetyl-CoA acyltransferase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214274_s_at	140	0.142857	1.63438e-07	1.01514e-05	-1.48383	0.00110546	-0.891685	0.41 [0.24 - 0.70]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212186_at	30	0.5	0.0566627	-	0.774518	0.222002	0.702975	2.02 [0.65 - 6.24]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214358_at	30	0.233333	0.277514	-	0.583192	0.648734	0.273772	1.31 [0.40 - 4.27]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1667641	165	0.127273	0.0226769	0.292611	1.01906	0.112435	0.447173	1.56 [0.90 - 2.72]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1667641	165	0.109091	0.0885294	-	1.56687	0.0307781	0.81175	2.25 [1.08 - 4.70]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212186_at	163	0.656442	0.0342468	0.386771	0.427448	0.154625	0.363629	1.44 [0.87 - 2.37]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214358_at	163	0.533742	0.0386585	0.418436	0.407896	0.52251	0.235392	1.27 [0.62 - 2.60]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212186_at	79	0.594937	0.289301	-	0.308388	0.397298	0.293228	1.34 [0.68 - 2.64]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214358_at	79	0.607595	0.022492	0.290948	0.660552	0.196509	0.626823	1.87 [0.72 - 4.85]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214358_at	58	0.568965	0.124136	-	-0.431475	0.647535	-0.0873656	0.92 [0.63 - 1.33]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212186_at	58	0.741379	0.0120476	0.185577	0.784531	0.377728	0.190216	1.21 [0.79 - 1.85]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214358_at	34	0.205882	0.00774353	0.13295	1.55204	0.102651	0.252918	1.29 [0.95 - 1.74]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212186_at	34	0.235294	0.352517	-	0.455987	0.679502	0.236728	1.27 [0.41 - 3.90]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214358_at	158	0.126582	0.0194875	0.263073	-0.679431	0.147578	-0.610981	0.54 [0.24 - 1.24]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212186_at	158	0.544304	0.165562	-	-0.323625	0.615407	0.206475	1.23 [0.55 - 2.75]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212186_at	53	0.886792	0.0979374	-	-1.53088	0.829148	-0.0472793	0.95 [0.62 - 1.47]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214358_at	53	0.679245	0.0534326	-	-0.859224	0.10706	-0.328376	0.72 [0.48 - 1.07]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212186_at	53	0.886792	0.13452	-	-1.04368	0.754874	-0.0649668	0.94 [0.62 - 1.41]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214358_at	53	0.679245	0.0341354	0.385945	-0.87661	0.0949674	-0.311471	0.73 [0.51 - 1.06]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212186_at	180	0.877778	0.0354095	0.395313	0.625046	0.952961	0.00621165	1.01 [0.82 - 1.24]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214358_at	180	0.483333	0.0324528	0.373296	0.45278	0.333962	0.0848998	1.09 [0.92 - 1.29]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212186_at	559	0.847943	0.033131	0.378434	0.519361	0.486769	0.117988	1.13 [0.81 - 1.57]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214358_at	559	0.236136	0.00456087	0.0880237	0.820517	0.0295512	0.276096	1.32 [1.03 - 1.69]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214358_at	77	0.883117	0.1012	-	0.616112	0.493511	0.147608	1.16 [0.76 - 1.77]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212186_at	77	0.636364	0.000694647	0.0187444	-0.942125	0.0690108	-0.296971	0.74 [0.54 - 1.02]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212186_at	70	0.728571	0.376116	-	0.258843	0.733755	0.125013	1.13 [0.55 - 2.33]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214358_at	70	0.142857	0.00475181	0.0909215	-0.978634	0.083354	-1.30541	0.27 [0.06 - 1.19]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38528_at	50	0.88	0.0335481	0.381567	-1.25278	0.0435818	-2.39053	0.09 [0.01 - 0.93]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212186_at	74	0.527027	0.0239567	0.303965	-0.659481	0.430381	-0.208794	0.81 [0.48 - 1.36]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214358_at	74	0.378378	0.0124073	0.189667	0.797666	0.124983	0.425823	1.53 [0.89 - 2.64]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214358_at	67	0.19403	0.231863	-	-0.825371	0.740105	-0.739677	0.48 [0.01 - 37.74]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212186_at	67	0.895522	0.0187764	0.256224	1.5176	0.131605	1.51927	4.57 [0.63 - 32.92]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214358_at	115	0.895652	0.147976	-	0.907163	0.585154	0.292749	1.34 [0.47 - 3.83]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212186_at	115	0.878261	0.200895	-	0.807285	0.872808	-0.0912384	0.91 [0.30 - 2.79]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38528_at	158	0.886076	0.000247573	0.00773683	1.20198	0.431132	0.334773	1.40 [0.61 - 3.22]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38528_at	76	0.184211	0.0567753	-	15.3511	0.416433	0.6942	2.00 [0.38 - 10.68]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214358_at	204	0.102941	0.101135	-	0.376702	0.293691	0.087863	1.09 [0.93 - 1.29]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212186_at	204	0.720588	0.0368975	0.406037	0.330827	0.37081	0.122889	1.13 [0.86 - 1.48]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212186_at	87	0.172414	0.0575416	-	-0.775474	0.405091	-0.280086	0.76 [0.39 - 1.46]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214358_at	87	0.298851	0.0925956	-	-0.632163	0.201604	-0.334412	0.72 [0.43 - 1.20]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214358_at	87	0.298851	0.0925956	-	-0.632163	0.201604	-0.334412	0.72 [0.43 - 1.20]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212186_at	87	0.172414	0.0575416	-	-0.775474	0.405091	-0.280086	0.76 [0.39 - 1.46]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212186_at	77	0.805195	0.008444	0.142047	1.35951	0.0133379	0.838283	2.31 [1.19 - 4.49]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212186_at	77	0.441558	0.0289337	0.345754	1.9689	0.0258359	0.871717	2.39 [1.11 - 5.15]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214358_at	77	0.545455	0.00268801	0.0576391	1.9734	0.220265	0.407877	1.50 [0.78 - 2.89]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214358_at	77	0.545455	0.0232642	0.297854	1.61381	0.550062	0.232044	1.26 [0.59 - 2.70]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212186_at	136	0.375	0.0642826	-	1.00048	0.425421	0.346752	1.41 [0.60 - 3.32]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214358_at	136	0.735294	0.0252252	0.314961	0.979922	0.354435	0.218744	1.24 [0.78 - 1.98]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212186_at	200	0.815	0.0610362	-	0.605438	0.711238	0.0940506	1.10 [0.67 - 1.81]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214358_at	200	0.855	0.0968535	-	0.586041	0.415794	0.133117	1.14 [0.83 - 1.57]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12328	60	0.866667	0.191378	-	-0.928244	0.634173	-0.11833	0.89 [0.55 - 1.45]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12328	60	0.666667	0.0079492	0.135646	-1.23998	0.372395	-0.221487	0.80 [0.49 - 1.30]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3359	155	0.129032	0.00068156	0.0184447	-1.00984	0.0339696	-0.417926	0.66 [0.45 - 0.97]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212186_at	286	0.475524	0.165186	-	0.271348	0.561246	0.0910101	1.10 [0.81 - 1.49]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214358_at	286	0.188811	0.000899069	0.0233061	-0.702661	0.440763	0.0776506	1.08 [0.89 - 1.32]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212186_at	159	0.805031	0.399796	-	-0.370766	0.862416	-0.0372761	0.96 [0.63 - 1.47]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214358_at	159	0.509434	0.00147676	0.0352751	1.28917	0.0085347	0.557136	1.75 [1.15 - 2.64]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214358_at	159	0.72327	0.000604123	0.0166494	1.04014	0.00400283	0.519128	1.68 [1.18 - 2.39]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212186_at	159	0.672956	0.158572	-	-0.52792	0.531913	-0.128481	0.88 [0.59 - 1.32]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212186_at	159	0.672956	0.172516	-	-0.615608	0.566614	-0.137823	0.87 [0.54 - 1.40]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214358_at	159	0.446541	0.0038974	0.0776969	1.01099	0.0451276	0.357122	1.43 [1.01 - 2.03]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212186_at	54	0.185185	0.100357	-	15.4384	0.651008	0.23375	1.26 [0.46 - 3.48]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214358_at	54	0.888889	0.147462	-	-15.3748	0.562919	-0.55691	0.57 [0.09 - 3.78]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214358_at	117	0.615385	0.138367	-	0.465773	0.578571	0.171056	1.19 [0.65 - 2.17]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214358_at	117	0.615385	0.154583	-	0.53202	0.626882	-0.22675	0.80 [0.32 - 1.99]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214358_at	117	0.410256	0.0272545	0.33205	0.989996	0.743699	-0.154515	0.86 [0.34 - 2.16]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214358_at	117	0.615385	0.138367	-	0.465773	0.578571	0.171056	1.19 [0.65 - 2.17]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212186_at	117	0.897436	0.0349278	0.391792	0.911384	0.268724	0.263243	1.30 [0.82 - 2.07]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212186_at	117	0.897436	0.150839	-	0.760311	0.623106	0.138519	1.15 [0.66 - 2.00]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212186_at	117	0.897436	0.0401374	0.428616	0.990106	0.249845	0.336124	1.40 [0.79 - 2.48]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212186_at	117	0.897436	0.0349278	0.391792	0.911384	0.268724	0.263243	1.30 [0.82 - 2.07]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212186_at	236	0.881356	0.00771341	0.132553	0.875245	0.575571	0.131858	1.14 [0.72 - 1.81]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214358_at	236	0.758475	0.0569736	-	0.541038	0.36597	0.141404	1.15 [0.85 - 1.57]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214358_at	249	0.863454	0.0501439	-	0.537829	0.326978	0.123405	1.13 [0.88 - 1.45]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212186_at	249	0.871486	0.0183552	0.252118	0.64601	0.549772	0.105735	1.11 [0.79 - 1.57]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214358_at	62	0.306452	0.0250248	0.31324	1.97288	0.852048	-0.0307923	0.97 [0.70 - 1.34]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212186_at	125	0.28	0.0281706	0.339574	-0.639226	0.072135	-0.486683	0.61 [0.36 - 1.04]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214358_at	125	0.672	0.00400127	0.0793415	-1.58822	0.022561	-1.42978	0.24 [0.07 - 0.82]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212186_at	54	0.888889	0.177175	-	-15.2411	0.996367	-0.00135188	1.00 [0.56 - 1.79]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214358_at	125	0.672	0.0112262	0.176081	-0.873102	0.0970775	-0.699754	0.50 [0.22 - 1.14]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214358_at	54	0.296296	0.115917	-	1.49917	0.879699	-0.0302468	0.97 [0.66 - 1.44]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212186_at	62	0.112903	0.193676	-	-0.814392	0.559311	-0.144014	0.87 [0.53 - 1.40]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212186_at	125	0.68	0.029575	0.350888	-1.1182	0.0909705	-0.617787	0.54 [0.26 - 1.10]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214358_at	198	0.828283	0.0912414	-	-0.666336	0.935503	0.00698471	1.01 [0.85 - 1.19]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214358_at	198	0.828283	0.0927139	-	-0.71191	0.963861	0.00414272	1.00 [0.84 - 1.20]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212186_at	198	0.242424	0.0336391	0.382247	0.609667	0.347577	0.122036	1.13 [0.88 - 1.46]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214358_at	198	0.146465	0.088793	-	0.591918	0.575752	0.0403845	1.04 [0.90 - 1.20]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212186_at	198	0.262626	0.0240787	0.305034	0.792703	0.328295	0.157956	1.17 [0.85 - 1.61]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212186_at	198	0.262626	0.0371406	0.407766	0.776337	0.501145	0.115347	1.12 [0.80 - 1.57]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212186_at	62	0.112903	0.204227	-	15.2028	0.82646	0.127663	1.14 [0.36 - 3.56]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214358_at	51	0.490196	0.0232641	0.297854	16.2337	0.0218688	0.801647	2.23 [1.12 - 4.42]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214358_at	62	0.403226	0.0131871	0.198393	2.15212	0.474261	0.24727	1.28 [0.65 - 2.52]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212186_at	51	0.666667	0.171747	-	1.17856	0.878258	0.136188	1.15 [0.20 - 6.55]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212186_at	145	0.593103	0.0865074	-	-0.613227	0.637651	-0.22757	0.80 [0.31 - 2.05]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214358_at	145	0.875862	0.0389027	0.420132	0.852688	0.261978	0.516144	1.68 [0.68 - 4.13]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214358_at	177	0.830508	0.240641	-	0.395568	0.722517	0.140783	1.15 [0.53 - 2.50]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212186_at	177	0.20339	0.0557071	-	0.641772	0.110629	0.53086	1.70 [0.89 - 3.26]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212186_at	177	0.514124	0.085029	-	0.46688	0.117769	0.602441	1.83 [0.86 - 3.89]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214358_at	177	0.824859	0.180333	-	0.387938	0.644817	0.160007	1.17 [0.59 - 2.32]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214358_at	226	0.893805	0.18049	-	0.542094	0.801708	0.0272209	1.03 [0.83 - 1.27]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212186_at	226	0.340708	0.220723	-	0.384844	0.845235	0.0291403	1.03 [0.77 - 1.38]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214358_at	49	0.204082	0.159744	-	-0.839885	0.729047	-0.340132	0.71 [0.10 - 4.88]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212186_at	55	0.636364	0.177504	-	-0.777364	0.967325	-0.0216851	0.98 [0.35 - 2.76]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212186_at	49	0.632653	0.0462437	0.468568	-1.42802	0.555146	-0.410759	0.66 [0.17 - 2.60]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212186_at	55	0.690909	0.0608433	-	-1.11657	0.301633	-0.543836	0.58 [0.21 - 1.63]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214358_at	55	0.127273	0.244245	-	1.13386	0.846634	-0.13836	0.87 [0.21 - 3.54]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214358_at	55	0.890909	0.233101	-	0.724281	0.914827	0.0819898	1.09 [0.24 - 4.88]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	295502	34	0.294118	0.334953	-	-0.433218	0.905855	-0.152811	0.86 [0.07 - 10.80]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212186_at	63	0.857143	0.0020161	0.0455936	1.20704	0.0051474	0.705502	2.02 [1.24 - 3.32]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214358_at	63	0.698413	0.178481	-	0.468035	0.937076	0.0267271	1.03 [0.53 - 1.99]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.7232.1.S1_3p_at	28	0.428571	0.157733	-	-0.754639	0.946079	-0.0587784	0.94 [0.17 - 5.18]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.7232.0.S2_3p_at	28	0.392857	0.175634	-	0.793634	0.614783	0.0816396	1.09 [0.79 - 1.49]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212186_at	82	0.853659	0.0803188	-	-1.19877	0.126372	-0.673359	0.51 [0.22 - 1.21]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214358_at	82	0.878049	0.232994	-	0.533055	0.997855	0.00114583	1.00 [0.43 - 2.31]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38528_at	84	0.535714	0.305856	-	-0.299347	0.831145	-0.101102	0.90 [0.36 - 2.29]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212186_at	79	0.177215	0.108293	-	-0.501911	0.398821	-0.243373	0.78 [0.45 - 1.38]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214358_at	79	0.708861	0.0506207	-	0.533665	0.400271	0.267144	1.31 [0.70 - 2.43]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212186_at	104	0.201923	0.100173	-	0.848334	0.881983	-0.0507055	0.95 [0.49 - 1.86]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214358_at	104	0.778846	0.106544	-	-0.760137	0.421678	-0.318424	0.73 [0.33 - 1.58]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P215318	117	0.153846	0.0575962	-	0.955793	0.124037	0.283764	1.33 [0.93 - 1.91]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P141434	117	0.333333	0.00449301	0.0869862	1.0064	0.0735319	0.317092	1.37 [0.97 - 1.94]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214358_at	204	0.686275	0.0170991	0.23965	-1.20691	0.0926675	-0.570496	0.57 [0.29 - 1.10]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214358_at	204	0.102941	0.00648289	0.11593	-0.925059	0.101525	-0.41622	0.66 [0.40 - 1.09]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212186_at	204	0.352941	0.179046	-	0.572305	0.868429	0.0800224	1.08 [0.42 - 2.79]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212186_at	204	0.352941	0.120224	-	0.478126	0.353861	0.338616	1.40 [0.69 - 2.87]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212186_at	178	0.837079	0.15105	-	0.357886	0.696276	0.105213	1.11 [0.66 - 1.88]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214358_at	178	0.780899	0.0310946	0.362847	0.481391	0.287382	0.201682	1.22 [0.84 - 1.77]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214358_at	111	0.837838	0.0194889	0.263086	-1.2932	0.830022	-0.0285873	0.97 [0.75 - 1.26]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212186_at	111	0.882883	0.0533592	-	-0.962601	0.46985	-0.146701	0.86 [0.58 - 1.29]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212186_at	90	0.877778	0.0122938	0.188381	0.961077	0.0399477	0.798352	2.22 [1.04 - 4.76]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212186_at	90	0.888889	0.00874291	0.145858	1.14244	0.133979	0.665933	1.95 [0.81 - 4.65]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214358_at	90	0.766667	0.0288208	0.344844	0.732066	0.583716	0.175491	1.19 [0.64 - 2.23]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214358_at	90	0.766667	0.054657	-	0.734947	0.610138	0.187454	1.21 [0.59 - 2.48]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1826	50	0.84	0.0341261	0.385876	1.09032	0.883314	0.0724934	1.08 [0.41 - 2.83]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214358_at	138	0.818841	0.180458	-	-0.457773	0.560671	-0.0771372	0.93 [0.71 - 1.20]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212186_at	138	0.804348	0.0307908	0.360479	0.579137	0.365239	0.140072	1.15 [0.85 - 1.56]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212186_at	129	0.891473	0.0254676	0.317034	0.724357	0.109575	0.23957	1.27 [0.95 - 1.70]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214358_at	129	0.875969	0.114993	-	-0.718852	0.793752	-0.0360072	0.96 [0.74 - 1.26]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31327	56	0.5	0.0282871	0.340522	0.785542	0.328718	0.210695	1.23 [0.81 - 1.88]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25726	56	0.553571	0.150268	-	0.509949	0.610001	0.120207	1.13 [0.71 - 1.79]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31754	56	0.160714	0.131538	-	0.783218	0.618284	-0.111926	0.89 [0.58 - 1.39]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31327	56	0.5	0.0552185	-	0.661476	0.452888	0.155855	1.17 [0.78 - 1.76]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31754	56	0.464286	0.072097	-	0.65843	0.79447	-0.0600944	0.94 [0.60 - 1.48]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25726	56	0.142857	0.16206	-	0.822317	0.735258	0.0756803	1.08 [0.70 - 1.67]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212186_at	278	0.618705	0.00573148	0.105334	0.526573	0.148073	0.361362	1.44 [0.88 - 2.34]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214358_at	278	0.133094	0.0409161	0.433894	-0.492153	0.33088	-0.288605	0.75 [0.42 - 1.34]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214358_at	133	0.511278	0.00455612	0.0879512	0.669909	0.525636	0.217791	1.24 [0.63 - 2.44]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212186_at	133	0.834586	0.227756	-	-0.42858	0.746902	-0.0502368	0.95 [0.70 - 1.29]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214358_at	185	0.189189	0.0304978	0.358185	0.446851	0.337542	0.233131	1.26 [0.78 - 2.03]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212186_at	185	0.697297	0.00183008	0.0421099	0.566304	0.027707	0.482966	1.62 [1.05 - 2.49]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212186_at	185	0.697297	0.00382716	0.0765784	0.490091	0.0319809	0.431975	1.54 [1.04 - 2.29]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214358_at	185	0.475676	0.0126267	0.192141	0.441919	0.2564	0.303107	1.35 [0.80 - 2.29]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P141434	110	0.809091	0.307564	-	0.353121	0.437016	0.173521	1.19 [0.77 - 1.84]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P215318	110	0.818182	0.0218657	0.285272	0.757239	0.463993	0.14464	1.16 [0.78 - 1.70]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P141434	110	0.172727	0.159713	-	-0.395783	0.526258	0.109363	1.12 [0.80 - 1.56]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P215318	110	0.854545	0.0105882	0.168544	0.769294	0.919036	0.0197112	1.02 [0.70 - 1.49]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212186_at	80	0.25	0.0598197	-	-0.813079	0.685872	-0.0701794	0.93 [0.66 - 1.31]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214358_at	80	0.8	0.000283349	0.0086962	1.46599	0.0526977	0.390467	1.48 [1.00 - 2.19]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214358_at	38	0.710526	0.0632886	-	0.836887	0.434323	0.360113	1.43 [0.58 - 3.54]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212186_at	38	0.315789	0.0453042	0.462627	1.11389	0.126554	0.653629	1.92 [0.83 - 4.45]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212186_at	140	0.885714	0.0225536	0.291502	-1.97139	0.0921011	-0.44092	0.64 [0.39 - 1.07]
GENE	ACACA	acetyl-CoA carboxylase alpha	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214358_at	140	0.285714	0.107033	-	-0.477378	0.956546	0.049389	1.05 [0.18 - 6.21]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214584_x_at	30	0.133333	0.0301855	0.355728	1.9348	0.199599	1.24071	3.46 [0.52 - 23.02]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	43427_at	30	0.533333	0.0114004	0.178113	-1.04509	0.349582	-0.444071	0.64 [0.25 - 1.63]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221928_at	30	0.333333	0.0895942	-	-0.721594	0.712552	-0.223906	0.80 [0.24 - 2.63]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	49452_at	30	0.633333	0.0405964	0.431733	-0.895176	0.382853	-0.324116	0.72 [0.35 - 1.50]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1763852	165	0.412121	0.00207818	0.0467403	-0.731005	0.0585815	-0.185252	0.83 [0.69 - 1.01]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1763852	165	0.412121	0.00248847	0.0541415	-1.05947	0.0826962	-0.253446	0.78 [0.58 - 1.03]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221928_at	163	0.717791	0.0473602	0.475535	-0.464678	0.456317	-0.417075	0.66 [0.22 - 1.97]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	49452_at	163	0.693252	0.00900927	0.14922	-0.592888	0.390898	-0.337661	0.71 [0.33 - 1.54]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	43427_at	163	0.730061	0.0173246	0.241914	-0.574428	0.263481	-0.479156	0.62 [0.27 - 1.43]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214584_x_at	163	0.656442	0.0960962	-	-0.362745	0.774874	-0.203043	0.82 [0.20 - 3.28]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	43427_at	79	0.822785	0.156887	-	-0.610654	0.552683	-0.158634	0.85 [0.51 - 1.44]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221928_at	79	0.822785	0.0578711	-	-0.871565	0.540915	-0.215259	0.81 [0.40 - 1.61]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552616_a_at	79	0.151899	0.0983284	-	-0.604468	0.318637	-0.827641	0.44 [0.09 - 2.22]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552615_at	79	0.835443	0.13172	-	-0.650508	0.5599	-0.325743	0.72 [0.24 - 2.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214584_x_at	79	0.78481	0.00407174	0.0804512	0.876502	0.314024	0.706003	2.03 [0.51 - 8.01]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	49452_at	79	0.898734	0.0701775	-	-1.23048	0.315858	-0.223577	0.80 [0.52 - 1.24]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	49452_at	58	0.275862	0.216878	-	-0.380407	0.936428	0.0134181	1.01 [0.73 - 1.41]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214584_x_at	58	0.551724	0.122493	-	0.431337	0.63079	0.107855	1.11 [0.72 - 1.73]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	43427_at	58	0.327586	0.0691295	-	0.558385	0.363936	0.198903	1.22 [0.79 - 1.87]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221928_at	58	0.62069	0.0261196	0.322567	0.635704	0.090919	0.262777	1.30 [0.96 - 1.76]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221928_at	34	0.852941	0.0980127	-	-0.986458	0.451345	-0.21174	0.81 [0.47 - 1.40]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	49452_at	34	0.558824	0.0561005	-	-0.795448	0.256548	-0.31654	0.73 [0.42 - 1.26]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214584_x_at	34	0.117647	0.345043	-	0.686952	0.314757	0.331342	1.39 [0.73 - 2.66]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	43427_at	34	0.823529	0.0145982	0.213733	-1.42893	0.401812	-0.160229	0.85 [0.59 - 1.24]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	43427_at	158	0.689873	0.0148943	0.216883	-0.661926	0.212422	-1.15332	0.32 [0.05 - 1.93]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214584_x_at	158	0.303797	0.11032	-	0.436076	0.704216	0.352853	1.42 [0.23 - 8.80]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221928_at	158	0.443038	0.103365	-	-0.373912	0.823426	-0.216364	0.81 [0.12 - 5.39]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	49452_at	158	0.411392	0.0065162	0.116391	-0.625384	0.0449878	-1.57048	0.21 [0.04 - 0.97]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221928_at	53	0.867925	0.126906	-	0.733931	0.281724	0.299508	1.35 [0.78 - 2.33]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214584_x_at	53	0.358491	0.0521872	-	0.768787	0.301166	0.216414	1.24 [0.82 - 1.87]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	49452_at	53	0.792453	0.245069	-	-0.616523	0.880933	0.0459974	1.05 [0.57 - 1.91]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221928_at	53	0.679245	0.142531	-	0.514384	0.302738	0.264691	1.30 [0.79 - 2.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	49452_at	53	0.226415	0.0606399	-	-0.698893	0.257895	-0.314002	0.73 [0.42 - 1.26]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214584_x_at	53	0.830189	0.123435	-	0.657715	0.493472	0.155108	1.17 [0.75 - 1.82]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	43427_at	53	0.150943	0.0141579	0.209007	-0.974735	0.248189	-0.330241	0.72 [0.41 - 1.26]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	43427_at	53	0.113208	0.0722504	-	-0.868016	0.580596	-0.177477	0.84 [0.45 - 1.57]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	43427_at	180	0.672222	0.0523884	-	-0.464375	0.315126	-0.230483	0.79 [0.51 - 1.25]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214584_x_at	180	0.872222	0.0605117	-	0.511465	0.786177	-0.030834	0.97 [0.78 - 1.21]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221928_at	180	0.872222	0.288906	-	0.307772	0.842139	-0.0275993	0.97 [0.74 - 1.28]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	49452_at	180	0.377778	0.117486	-	-0.327479	0.777543	0.0617259	1.06 [0.69 - 1.63]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	43427_at	559	0.896243	0.162607	-	-0.631012	0.470051	-0.0843927	0.92 [0.73 - 1.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221928_at	559	0.898032	0.0688586	-	-1.02275	0.418072	-0.0769143	0.93 [0.77 - 1.12]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552616_a_at	559	0.352415	0.017849	0.247135	-0.472372	0.1287	-0.170224	0.84 [0.68 - 1.05]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552615_at	559	0.109123	0.0964551	-	0.943418	0.731008	0.0809064	1.08 [0.68 - 1.72]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214584_x_at	559	0.305903	0.0275474	0.334468	-0.461359	0.375054	-0.119788	0.89 [0.68 - 1.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	49452_at	559	0.57424	0.0155732	0.224021	-0.528592	0.190288	-0.166899	0.85 [0.66 - 1.09]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221928_at	77	0.831169	0.106236	-	-0.642971	0.389125	-0.144341	0.87 [0.62 - 1.20]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	49452_at	77	0.857143	4.58723e-05	0.00175601	1.36772	0.164088	0.401623	1.49 [0.85 - 2.63]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214584_x_at	77	0.831169	0.0147804	0.215675	0.787387	0.700897	0.0727165	1.08 [0.74 - 1.56]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	43427_at	77	0.792208	0.0922136	-	0.516192	0.579052	0.169064	1.18 [0.65 - 2.15]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221928_at	70	0.314286	4.79389e-05	0.00182628	1.28929	0.018029	0.85406	2.35 [1.16 - 4.77]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552616_a_at	70	0.357143	0.186454	-	0.373732	0.448755	0.522551	1.69 [0.44 - 6.52]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552615_at	70	0.328571	0.113137	-	-0.431811	0.977709	0.0218734	1.02 [0.22 - 4.74]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214584_x_at	70	0.528571	0.0644896	-	0.500295	0.479801	0.82539	2.28 [0.23 - 22.53]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	49452_at	70	0.342857	0.000236086	0.00742441	1.11729	0.0137728	0.409469	1.51 [1.09 - 2.09]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	43427_at	70	0.3	8.19457e-05	0.00293809	1.29716	0.0179489	0.449689	1.57 [1.08 - 2.28]
GENE	ACACB	acetyl-CoA carboxylase beta	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	31530_at	50	0.74	0.0893439	-	-0.685733	0.165531	-1.75046	0.17 [0.01 - 2.06]
GENE	ACACB	acetyl-CoA carboxylase beta	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	31531_g_at	50	0.8	0.166257	-	-0.591818	0.210991	-1.4982	0.22 [0.02 - 2.34]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214584_x_at	74	0.864865	0.217221	-	0.478716	0.542949	0.103572	1.11 [0.79 - 1.55]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	43427_at	74	0.891892	0.00242808	0.0530703	1.13768	0.0311795	0.759961	2.14 [1.07 - 4.27]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221928_at	74	0.891892	0.00242808	0.0530703	1.13768	0.0593987	0.49146	1.63 [0.98 - 2.72]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	49452_at	74	0.810811	0.00443806	0.086143	0.965173	0.02673	0.733368	2.08 [1.09 - 3.98]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	43427_at	67	0.477612	0.344479	-	0.657643	0.809266	-0.246839	0.78 [0.11 - 5.80]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221928_at	67	0.791045	0.00266351	0.0572131	1.795	0.664372	0.371267	1.45 [0.27 - 7.76]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214584_x_at	67	0.298507	0.060923	-	15.5415	0.461558	1.00145	2.72 [0.19 - 39.15]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552615_at	67	0.253731	0.0749167	-	15.4944	0.396542	1.61306	5.02 [0.12 - 208.97]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	49452_at	67	0.134328	0.020803	0.275482	-1.54383	0.414037	-1.01845	0.36 [0.03 - 4.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552616_a_at	67	0.268657	0.0599505	-	15.5446	0.444051	1.38949	4.01 [0.11 - 140.86]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221928_at	115	0.747826	0.023576	0.300616	-15.5086	0.203338	-0.500596	0.61 [0.28 - 1.31]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214584_x_at	115	0.434783	0.091967	-	-0.911485	0.0600801	-0.552804	0.58 [0.32 - 1.02]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	49452_at	115	0.643478	0.0182877	0.251457	-2.06351	0.074437	-0.702631	0.50 [0.23 - 1.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	43427_at	115	0.104348	0.0123845	0.189408	-1.37389	0.031428	-0.913133	0.40 [0.17 - 0.92]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552616_a_at	115	0.443478	0.0300504	0.354661	-1.20863	0.194685	-0.721635	0.49 [0.16 - 1.45]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552615_at	115	0.286957	0.0603874	-	1.72336	0.960887	0.0608921	1.06 [0.09 - 12.12]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	31530_at	158	0.892405	0.0279175	0.337507	0.795968	0.378824	0.191088	1.21 [0.79 - 1.85]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	31531_g_at	158	0.335443	0.158176	-	-0.402119	0.51661	-0.189299	0.83 [0.47 - 1.47]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	31530_at	76	0.171053	0.0621741	-	-0.983849	0.656934	0.141572	1.15 [0.62 - 2.15]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	31531_g_at	76	0.5	0.245735	-	-0.60435	0.791673	0.116203	1.12 [0.47 - 2.66]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214584_x_at	204	0.156863	0.0867319	-	-0.324505	0.535085	-0.0476535	0.95 [0.82 - 1.11]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552615_at	204	0.215686	0.0123662	0.189201	-0.426314	0.469306	-0.134056	0.87 [0.61 - 1.26]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	49452_at	204	0.598039	0.0558203	-	-0.268606	0.227015	-0.108193	0.90 [0.75 - 1.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552616_a_at	204	0.215686	0.112844	-	-0.268449	0.71782	-0.0242514	0.98 [0.86 - 1.11]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	43427_at	204	0.107843	0.0102587	0.164592	-0.579905	0.110066	-0.159154	0.85 [0.70 - 1.04]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221928_at	204	0.156863	0.000798521	0.0210891	-0.653264	0.0557991	-0.172537	0.84 [0.71 - 1.00]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221928_at	87	0.632184	0.243857	-	0.442519	0.559758	0.159621	1.17 [0.69 - 2.01]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	43427_at	87	0.425287	0.264666	-	0.437315	0.855424	0.0420988	1.04 [0.66 - 1.64]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552616_a_at	87	0.885057	0.252826	-	-1.10728	0.481298	-0.610997	0.54 [0.10 - 2.97]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552616_a_at	87	0.885057	0.252826	-	-1.10728	0.481298	-0.610997	0.54 [0.10 - 2.97]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552615_at	87	0.482759	0.0669383	-	0.710143	0.771764	0.213812	1.24 [0.29 - 5.25]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552615_at	87	0.482759	0.0669383	-	0.710143	0.771764	0.213812	1.24 [0.29 - 5.25]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214584_x_at	87	0.206897	0.0828087	-	1.01741	0.71918	0.320872	1.38 [0.24 - 7.92]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221928_at	87	0.632184	0.243857	-	0.442519	0.559758	0.159621	1.17 [0.69 - 2.01]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	49452_at	87	0.666667	0.216973	-	0.474895	0.664088	0.0895348	1.09 [0.73 - 1.64]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214584_x_at	87	0.206897	0.0828087	-	1.01741	0.71918	0.320872	1.38 [0.24 - 7.92]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	43427_at	87	0.425287	0.264666	-	0.437315	0.855424	0.0420988	1.04 [0.66 - 1.64]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	49452_at	87	0.666667	0.216973	-	0.474895	0.664088	0.0895348	1.09 [0.73 - 1.64]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	49452_at	77	0.155844	0.167883	-	15.2802	0.859538	-0.0603149	0.94 [0.48 - 1.84]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552616_a_at	77	0.506494	0.114359	-	0.916783	0.9055	0.0991702	1.10 [0.21 - 5.68]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552615_at	77	0.103896	0.0728383	-	-1.12297	0.59124	-0.894674	0.41 [0.02 - 10.70]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214584_x_at	77	0.428571	0.0372653	0.408652	-1.18236	0.601863	-0.731375	0.48 [0.03 - 7.51]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	43427_at	77	0.194805	0.109474	-	15.3693	0.9015	-0.0464465	0.95 [0.46 - 1.99]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552615_at	77	0.103896	0.0142817	0.210341	-1.5396	0.153577	-2.95639	0.05 [0.00 - 3.02]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	49452_at	77	0.883117	0.173679	-	-15.2138	0.701991	-0.113786	0.89 [0.50 - 1.60]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552616_a_at	77	0.415584	0.150107	-	1.08418	0.820153	0.213278	1.24 [0.20 - 7.78]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221928_at	77	0.168831	0.145975	-	15.3092	0.688795	-0.204763	0.81 [0.30 - 2.22]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	43427_at	77	0.168831	0.0959253	-	15.3118	0.804241	-0.0812786	0.92 [0.48 - 1.75]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214584_x_at	77	0.376623	0.0223429	0.289603	-1.44733	0.747178	-0.503284	0.60 [0.03 - 12.89]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221928_at	77	0.857143	0.123509	-	-15.2696	0.624855	-0.218233	0.80 [0.34 - 1.93]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214584_x_at	136	0.705882	0.047681	0.477518	-1.36798	0.16205	-0.415596	0.66 [0.37 - 1.18]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221928_at	136	0.102941	0.0114371	0.178541	-1.24887	0.0288789	-0.522848	0.59 [0.37 - 0.95]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	49452_at	136	0.272059	0.032112	0.370695	-0.940322	0.143369	-0.466124	0.63 [0.34 - 1.17]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	43427_at	136	0.720588	0.0214242	0.281229	-1.58067	0.291332	-0.291799	0.75 [0.43 - 1.28]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214584_x_at	200	0.24	0.0731533	-	-0.54763	0.592983	-0.120699	0.89 [0.57 - 1.38]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221928_at	200	0.5	0.0112979	0.176919	-0.768099	0.251441	-0.23229	0.79 [0.53 - 1.18]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	49452_at	200	0.465	0.0316394	0.367065	-0.636078	0.311471	-0.254721	0.78 [0.47 - 1.27]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	43427_at	200	0.125	0.044947	0.46035	-0.73307	0.598711	-0.137515	0.87 [0.52 - 1.45]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9624	60	0.766667	0.145053	-	0.581485	0.358842	0.151819	1.16 [0.84 - 1.61]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8769	60	0.35	0.00936352	0.153643	-0.957167	0.231569	-0.562143	0.57 [0.23 - 1.43]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8769	60	0.3	0.0856176	-	0.793837	0.206177	0.762068	2.14 [0.66 - 6.98]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9624	60	0.8	0.0137243	0.204299	0.965908	0.339909	0.242799	1.27 [0.77 - 2.10]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14720	155	0.167742	8.29046e-05	0.00296844	-1.09818	0.0177688	-0.252379	0.78 [0.63 - 0.96]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214584_x_at	286	0.22028	0.00986111	0.159769	-0.546247	0.0337314	-0.318389	0.73 [0.54 - 0.98]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	43427_at	286	0.783217	0.0543218	-	-0.503627	0.41597	-0.1293	0.88 [0.64 - 1.20]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221928_at	286	0.545455	0.00221354	0.0492152	-0.613053	0.020128	-0.266362	0.77 [0.61 - 0.96]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	49452_at	286	0.444056	0.0605973	-	-0.361391	0.350929	-0.153532	0.86 [0.62 - 1.18]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221928_at	159	0.578616	0.00144316	0.0346084	-1.18929	0.0984373	-0.295716	0.74 [0.52 - 1.06]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214584_x_at	159	0.622642	0.00774234	0.132934	-1.00982	0.034655	-0.462425	0.63 [0.41 - 0.97]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	49452_at	159	0.597484	0.0128858	0.195043	-0.910306	0.121329	-0.443607	0.64 [0.37 - 1.12]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214584_x_at	159	0.622642	0.0332152	0.379067	-0.941198	0.0783654	-0.452355	0.64 [0.38 - 1.05]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221928_at	159	0.54717	0.000348253	0.0103905	-1.31747	0.0196306	-0.410527	0.66 [0.47 - 0.94]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	43427_at	159	0.628931	0.0139703	0.206976	-0.937373	0.0985882	-0.449814	0.64 [0.37 - 1.09]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	43427_at	159	0.421384	7.32159e-05	0.00265954	-1.55958	0.00938159	-0.792721	0.45 [0.25 - 0.82]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	49452_at	159	0.496855	0.00017535	0.00573108	-1.2826	0.00419921	-0.841926	0.43 [0.24 - 0.77]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214584_x_at	159	0.685535	0.0306363	0.359271	-0.871911	0.136511	-0.319452	0.73 [0.48 - 1.11]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221928_at	159	0.528302	0.000492644	0.0139919	-1.55363	0.0131993	-0.50664	0.60 [0.40 - 0.90]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	43427_at	159	0.528302	2.42195e-05	0.000991997	-1.58754	0.00741457	-0.705139	0.49 [0.29 - 0.83]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	49452_at	159	0.18239	0.000351354	0.0104702	-1.263	0.011641	-0.878552	0.42 [0.21 - 0.82]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214584_x_at	54	0.37037	0.00461918	0.0889119	-1.95515	0.087276	-4.00263	0.02 [0.00 - 1.80]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	43427_at	54	0.240741	1.77027e-06	9.20423e-05	-2.95499	0.00628311	-1.68372	0.19 [0.06 - 0.62]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221928_at	54	0.148148	0.000174365	0.00570297	-2.22326	0.0131383	-2.28074	0.10 [0.02 - 0.62]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	49452_at	54	0.148148	9.58877e-08	6.17359e-06	-3.14258	0.00541546	-1.45587	0.23 [0.08 - 0.65]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221928_at	117	0.350427	0.17464	-	0.621693	0.996078	-0.00111749	1.00 [0.64 - 1.56]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221928_at	117	0.316239	0.101289	-	0.637264	0.770864	-0.055671	0.95 [0.65 - 1.38]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	43427_at	117	0.111111	0.0145299	0.213004	15.2444	0.906487	-0.017606	0.98 [0.73 - 1.32]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	49452_at	117	0.324786	0.263796	-	0.421457	0.801426	-0.0370314	0.96 [0.72 - 1.29]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	49452_at	117	0.358974	0.198608	-	0.589994	0.851006	0.0326486	1.03 [0.73 - 1.45]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	43427_at	117	0.111111	0.0145299	0.213004	15.2444	0.906487	-0.017606	0.98 [0.73 - 1.32]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214584_x_at	117	0.153846	0.0491011	0.486204	-0.733013	0.928459	-0.073217	0.93 [0.19 - 4.60]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	43427_at	117	0.282051	0.158205	-	0.747771	0.933558	-0.0154589	0.98 [0.68 - 1.42]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214584_x_at	117	0.153846	0.00175034	0.0405935	-1.20172	0.160383	-1.62788	0.20 [0.02 - 1.91]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	43427_at	117	0.111111	0.0533444	-	15.2022	0.772936	0.0492753	1.05 [0.75 - 1.47]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214584_x_at	117	0.282051	0.000771086	0.0204755	-1.24489	0.0872764	-2.1391	0.12 [0.01 - 1.37]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214584_x_at	117	0.153846	0.0491011	0.486204	-0.733013	0.928459	-0.073217	0.93 [0.19 - 4.60]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221928_at	117	0.316239	0.101289	-	0.637264	0.770864	-0.055671	0.95 [0.65 - 1.38]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221928_at	117	0.350427	0.0701298	-	0.865896	0.727373	0.0728434	1.08 [0.71 - 1.62]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	49452_at	117	0.324786	0.263796	-	0.421457	0.801426	-0.0370314	0.96 [0.72 - 1.29]
GENE	ACACB	acetyl-CoA carboxylase beta	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	49452_at	117	0.57265	0.133064	-	0.565996	0.713743	0.0603005	1.06 [0.77 - 1.47]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221928_at	236	0.148305	0.000137942	0.00464621	-1.06295	0.00852513	-0.411243	0.66 [0.49 - 0.90]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	49452_at	236	0.449153	0.00734276	0.127634	-0.728631	0.0118654	-0.64257	0.53 [0.32 - 0.87]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	43427_at	236	0.716102	0.00595254	0.10849	-1.06276	0.0211112	-0.651013	0.52 [0.30 - 0.91]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214584_x_at	236	0.898305	0.0606406	-	0.672684	0.713861	0.0747758	1.08 [0.72 - 1.61]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	49452_at	249	0.771084	0.00680484	0.120362	-0.846745	0.0377018	-0.40697	0.67 [0.45 - 0.98]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	43427_at	249	0.26506	0.00181188	0.0417651	-0.674272	0.0340486	-0.469559	0.63 [0.41 - 0.97]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214584_x_at	249	0.899598	0.0164991	0.23357	0.685111	0.398962	0.132279	1.14 [0.84 - 1.55]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221928_at	249	0.156627	0.00283497	0.0601769	-0.73192	0.0167605	-0.320007	0.73 [0.56 - 0.94]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221928_at	125	0.264	0.289745	-	-0.426003	0.768101	-0.105167	0.90 [0.45 - 1.81]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214584_x_at	54	0.203704	0.173031	-	15.2999	0.753148	-0.124036	0.88 [0.41 - 1.91]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	49452_at	62	0.870968	0.0331703	0.378729	-15.408	0.519401	-0.134863	0.87 [0.58 - 1.32]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	43427_at	125	0.288	0.23185	-	-0.373172	0.861668	-0.0323915	0.97 [0.67 - 1.39]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	49452_at	125	0.112	0.179711	-	1.27791	0.991949	0.00224026	1.00 [0.65 - 1.55]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221928_at	125	0.192	0.149755	-	-0.474342	0.794694	-0.0691333	0.93 [0.55 - 1.57]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221928_at	54	0.833333	0.0487303	0.483951	-15.4932	0.381228	-0.261563	0.77 [0.43 - 1.38]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	43427_at	125	0.84	0.262794	-	0.48489	0.866345	0.0392068	1.04 [0.66 - 1.64]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	49452_at	125	0.104	0.200588	-	0.7461	0.896982	-0.0221828	0.98 [0.70 - 1.37]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214584_x_at	62	0.112903	0.188846	-	15.1778	0.748177	-0.104037	0.90 [0.48 - 1.70]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	49452_at	54	0.833333	0.0560486	-	-15.4633	0.290199	-0.27361	0.76 [0.46 - 1.26]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214584_x_at	125	0.64	0.232871	-	0.450667	0.654479	0.148227	1.16 [0.61 - 2.22]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	43427_at	62	0.887097	0.0529216	-	-15.3502	0.679628	-0.103801	0.90 [0.55 - 1.48]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	43427_at	54	0.851852	0.064828	-	-15.4499	0.399518	-0.26089	0.77 [0.42 - 1.41]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221928_at	62	0.854839	0.0220425	0.286881	-15.4551	0.570314	-0.1388	0.87 [0.54 - 1.41]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214584_x_at	125	0.104	0.38156	-	-0.417017	0.918648	-0.0268239	0.97 [0.58 - 1.63]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214584_x_at	198	0.106061	0.0759742	-	-0.533479	0.301535	-0.0884867	0.92 [0.77 - 1.08]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	49452_at	198	0.126263	0.0213688	0.280719	-0.734243	0.159851	-0.177732	0.84 [0.65 - 1.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	43427_at	198	0.358586	0.0104644	0.167063	-0.642884	0.0763275	-0.209052	0.81 [0.64 - 1.02]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	43427_at	198	0.358586	0.0139652	0.20692	-0.647458	0.117648	-0.193021	0.82 [0.65 - 1.05]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221928_at	198	0.277778	0.165797	-	-0.314349	0.712652	-0.0326224	0.97 [0.81 - 1.15]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214584_x_at	198	0.641414	0.153662	-	-0.397463	0.522906	-0.0666768	0.94 [0.76 - 1.15]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214584_x_at	198	0.641414	0.136871	-	-0.436783	0.38483	-0.0954648	0.91 [0.73 - 1.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	49452_at	198	0.126263	0.0494208	0.488138	-0.556063	0.41072	-0.0887776	0.92 [0.74 - 1.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221928_at	198	0.444444	0.0221366	0.287735	-0.576573	0.399104	-0.0874831	0.92 [0.75 - 1.12]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	43427_at	198	0.146465	0.105931	-	-0.435935	0.417077	-0.0834425	0.92 [0.75 - 1.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221928_at	198	0.444444	0.0182561	0.251147	-0.627629	0.425633	-0.085425	0.92 [0.74 - 1.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	49452_at	198	0.60101	0.0339717	0.384728	-0.579553	0.203659	-0.160202	0.85 [0.67 - 1.09]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221928_at	51	0.392157	0.0381896	0.415164	-1.98299	0.30145	-0.929758	0.39 [0.07 - 2.30]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	43427_at	62	0.322581	0.00950422	0.155386	-1.40653	0.0455415	-0.775318	0.46 [0.22 - 0.98]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	49452_at	51	0.647059	0.0785607	-	-15.8085	0.434292	-0.358664	0.70 [0.28 - 1.72]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221928_at	62	0.112903	2.0803e-05	0.000865351	-2.24677	0.048427	-1.19342	0.30 [0.09 - 0.99]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	43427_at	51	0.627451	0.0658622	-	-15.8724	0.377563	-0.519124	0.60 [0.19 - 1.89]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	49452_at	62	0.322581	0.0109955	0.173372	-1.38165	0.0605554	-0.558529	0.57 [0.32 - 1.03]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214584_x_at	51	0.490196	0.163583	-	1.43248	0.335147	1.89553	6.66 [0.14 - 314.29]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214584_x_at	62	0.887097	0.118706	-	0.998666	0.588718	0.756067	2.13 [0.14 - 33.01]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552616_a_at	145	0.131034	0.000353291	0.0105198	-1.22495	0.0279793	-2.14748	0.12 [0.02 - 0.79]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552615_at	145	0.710345	0.112325	-	-0.656682	0.695731	-0.350086	0.70 [0.12 - 4.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214584_x_at	145	0.110345	0.0162523	0.231044	-0.977954	0.981477	-0.0276969	0.97 [0.09 - 10.08]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	43427_at	177	0.881356	0.142778	-	0.508469	0.356992	0.296287	1.34 [0.72 - 2.53]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	49452_at	177	0.836158	0.227995	-	-0.409649	0.869	0.0446679	1.05 [0.61 - 1.78]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221928_at	177	0.768362	0.0725223	-	-0.645767	0.633099	0.25545	1.29 [0.45 - 3.69]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	43427_at	177	0.39548	0.225885	-	-0.286449	0.870566	0.0514562	1.05 [0.57 - 1.96]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	49452_at	145	0.393103	0.11845	-	-0.522296	0.504848	-0.30527	0.74 [0.30 - 1.81]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221928_at	177	0.79096	0.0179662	0.248293	-0.821856	0.884127	-0.0734531	0.93 [0.35 - 2.50]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	43427_at	145	0.627586	0.266802	-	-0.399961	0.590249	-0.296593	0.74 [0.25 - 2.19]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214584_x_at	177	0.559322	0.0313964	0.365188	0.580687	0.276794	0.947407	2.58 [0.47 - 14.22]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552615_at	177	0.694915	0.0830503	-	-0.560156	0.473684	-0.546462	0.58 [0.13 - 2.58]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552616_a_at	177	0.305085	0.0279384	0.337678	-0.518375	0.256863	-0.72269	0.49 [0.14 - 1.69]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552615_at	177	0.694915	0.0115672	0.18005	-0.735631	0.165894	-0.920878	0.40 [0.11 - 1.46]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221928_at	145	0.124138	0.265611	-	-0.495667	0.546214	-0.500116	0.61 [0.12 - 3.08]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	49452_at	177	0.118644	0.239295	-	0.602034	0.380081	0.24828	1.28 [0.74 - 2.23]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552616_a_at	177	0.706215	0.0987399	-	-0.551479	0.575841	-0.399315	0.67 [0.17 - 2.72]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214584_x_at	177	0.124294	0.0473127	0.47524	-0.619606	0.907187	-0.0935364	0.91 [0.19 - 4.39]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214584_x_at	226	0.628319	0.0413731	0.436965	0.570446	0.144307	0.16835	1.18 [0.94 - 1.48]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	49452_at	226	0.530973	0.0255619	0.317838	-0.664772	0.289074	-0.224575	0.80 [0.53 - 1.21]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	43427_at	226	0.283186	0.0270449	0.330313	-0.633357	0.200909	-0.196588	0.82 [0.61 - 1.11]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221928_at	226	0.668142	0.0484895	0.482482	-0.685139	0.403811	-0.0887762	0.92 [0.74 - 1.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552616_a_at	226	0.50885	0.120537	-	-0.444942	0.240152	-0.146267	0.86 [0.68 - 1.10]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552615_at	226	0.19469	0.0324597	0.373349	1.06467	0.674761	-0.135198	0.87 [0.46 - 1.64]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214584_x_at	49	0.265306	0.0484257	0.482093	-1.09676	0.610737	-1.16687	0.31 [0.00 - 27.83]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552615_at	55	0.127273	0.000104616	0.00364428	-1.97209	0.000811051	-4.97119	0.01 [0.00 - 0.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	49452_at	55	0.618182	0.000907915	0.0234988	1.64472	0.0053843	1.1626	3.20 [1.41 - 7.25]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552616_a_at	55	0.381818	0.00402581	0.0797284	-1.38855	0.041322	-3.03385	0.05 [0.00 - 0.89]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	43427_at	55	0.618182	0.0771793	-	0.775855	0.467531	0.415482	1.52 [0.49 - 4.65]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552615_at	49	0.102041	0.000186007	0.00603376	-2.06266	0.0024081	-5.28089	0.01 [0.00 - 0.15]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	49452_at	49	0.510204	0.0371356	0.407731	1.29819	0.0730902	0.845154	2.33 [0.92 - 5.87]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552616_a_at	49	0.102041	0.000739172	0.0197567	-2.71404	0.0512712	-4.10974	0.02 [0.00 - 1.02]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221928_at	55	0.272727	0.0207045	0.274564	-1.00783	0.85354	-0.161889	0.85 [0.15 - 4.74]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	43427_at	55	0.490909	0.00197447	0.0448202	1.7485	0.00489229	1.50347	4.50 [1.58 - 12.82]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	43427_at	49	0.428571	0.0180251	0.248875	1.64474	0.10057	1.01178	2.75 [0.82 - 9.20]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552616_a_at	55	0.109091	0.000166081	0.00546565	-1.76074	0.00620041	-3.80756	0.02 [0.00 - 0.34]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552615_at	55	0.236364	0.000262606	0.00814239	-1.50575	0.00156706	-4.11968	0.02 [0.00 - 0.21]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221928_at	55	0.745455	0.098619	-	0.795002	0.271096	0.933004	2.54 [0.48 - 13.39]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214584_x_at	55	0.254545	0.191075	-	-0.605644	0.563733	-0.990862	0.37 [0.01 - 10.73]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221928_at	49	0.285714	0.0514789	-	-1.08458	0.629863	0.475537	1.61 [0.23 - 11.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214584_x_at	55	0.254545	0.0525783	-	-0.893581	0.438819	-1.40362	0.25 [0.01 - 8.58]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	49452_at	55	0.472727	0.0679548	-	0.864471	0.394689	0.380581	1.46 [0.61 - 3.51]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	28229	34	0.647059	0.139205	-	0.643689	0.374171	1.209	3.35 [0.23 - 48.20]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	49452_at	63	0.47619	0.00120938	0.0298778	1.13095	0.161762	0.182054	1.20 [0.93 - 1.55]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	43427_at	63	0.539683	0.0015077	0.0358863	1.07149	0.165109	0.18875	1.21 [0.93 - 1.58]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221928_at	63	0.539683	0.000588956	0.0162931	1.15674	0.244007	0.181037	1.20 [0.88 - 1.63]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552616_a_at	63	0.761905	0.0788018	-	0.640091	0.120007	1.5125	4.54 [0.67 - 30.55]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552615_at	63	0.190476	0.0699548	-	0.935096	0.474296	0.284653	1.33 [0.61 - 2.90]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214584_x_at	63	0.174603	0.163227	-	-0.556126	0.890322	0.121409	1.13 [0.20 - 6.34]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.234898.0.A1_3p_at	28	0.5	0.0164683	0.233256	-1.39119	0.0930243	-4.34712	0.01 [0.00 - 2.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.234898.0.A1_3p_x_at	28	0.714286	0.0540683	-	-1.40877	0.174879	-6.91098	0.00 [0.00 - 21.61]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.183857.0.S2_3p_at	28	0.642857	0.116773	-	-1.00635	0.345768	-1.89076	0.15 [0.00 - 7.69]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.183857.1.S1_3p_s_at	28	0.25	0.0395524	0.424614	-1.17533	0.713981	-1.83637	0.16 [0.00 - 2933.40]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214584_x_at	82	0.207317	0.0143795	0.211393	-0.867133	0.147072	-0.269382	0.76 [0.53 - 1.10]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221928_at	82	0.402439	0.123266	-	-0.520884	0.708976	-0.171147	0.84 [0.34 - 2.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	49452_at	82	0.121951	0.194165	-	-0.579025	0.963116	-0.0242841	0.98 [0.35 - 2.73]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	43427_at	82	0.5	0.097718	-	-0.5616	0.370941	-0.418472	0.66 [0.26 - 1.65]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214584_x_at	79	0.113924	0.11673	-	-0.593717	0.704064	-0.0844092	0.92 [0.59 - 1.42]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	43427_at	79	0.582278	0.12594	-	-0.403196	0.929957	-0.0381817	0.96 [0.41 - 2.26]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221928_at	79	0.341772	0.0447949	0.459376	-0.539904	0.223277	-0.538644	0.58 [0.25 - 1.39]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	49452_at	79	0.113924	0.0151407	0.219488	-0.918894	0.552309	-0.26451	0.77 [0.32 - 1.84]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	43427_at	104	0.538462	0.00105739	0.0267056	-1.18096	0.00686745	-1.38256	0.25 [0.09 - 0.68]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214584_x_at	104	0.894231	0.0639912	-	-1.67514	0.372795	-0.194857	0.82 [0.54 - 1.26]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221928_at	104	0.576923	3.92532e-06	0.000190868	-2.05735	2.14655e-05	-2.09044	0.12 [0.05 - 0.32]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	49452_at	104	0.365385	0.0021582	0.0482077	-0.974231	0.00835501	-1.31492	0.27 [0.10 - 0.71]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P87791	117	0.897436	0.020447	0.272156	-1.99549	0.273099	-0.187597	0.83 [0.59 - 1.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221928_at	204	0.377451	5.7903e-08	3.85254e-06	-2.08557	0.000131347	-1.34189	0.26 [0.13 - 0.52]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221928_at	204	0.357843	1.73496e-11	1.75805e-09	-1.77863	2.81453e-07	-1.33221	0.26 [0.16 - 0.44]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214584_x_at	204	0.387255	0.00266304	0.0572049	-1.08564	0.092598	-0.338984	0.71 [0.48 - 1.06]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214584_x_at	204	0.397059	0.000675582	0.0183074	-0.910563	0.0140786	-0.36739	0.69 [0.52 - 0.93]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552615_at	204	0.102941	6.90613e-06	0.000319337	-1.61844	0.00842534	-2.30698	0.10 [0.02 - 0.55]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	49452_at	204	0.460784	1.4169e-07	8.88676e-06	-2.50177	0.000310658	-1.08237	0.34 [0.19 - 0.61]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552616_a_at	204	0.161765	0.000809707	0.0213382	-1.20091	0.0113823	-0.662198	0.52 [0.31 - 0.86]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552615_at	204	0.323529	2.0129e-05	0.000840099	-1.1102	0.000319683	-2.31011	0.10 [0.03 - 0.35]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	49452_at	204	0.323529	4.79908e-10	4.17772e-08	-1.59156	1.45124e-07	-1.16129	0.31 [0.20 - 0.48]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552616_a_at	204	0.411765	0.000207419	0.0066344	-0.996505	0.00255809	-0.598767	0.55 [0.37 - 0.81]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	43427_at	204	0.348039	4.58175e-08	3.09421e-06	-2.012	9.16732e-05	-1.2904	0.28 [0.14 - 0.53]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	43427_at	204	0.284314	5.09177e-10	4.41958e-08	-1.55905	8.92985e-08	-1.30377	0.27 [0.17 - 0.44]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221928_at	178	0.483146	0.00102349	0.0259863	-0.651485	0.0108097	-0.757414	0.47 [0.26 - 0.84]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	49452_at	178	0.550562	0.00329921	0.0679995	-0.603434	0.0168681	-0.756268	0.47 [0.25 - 0.87]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214584_x_at	178	0.825843	0.00472819	0.0905648	0.665819	0.0709334	0.273323	1.31 [0.98 - 1.77]
GENE	ACACB	acetyl-CoA carboxylase beta	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	43427_at	178	0.544944	0.00152582	0.0362429	-0.659655	0.00371964	-0.937052	0.39 [0.21 - 0.74]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214584_x_at	111	0.837838	0.111373	-	-0.671833	0.462131	-0.131461	0.88 [0.62 - 1.24]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	49452_at	111	0.756757	0.00565797	0.104277	-0.971306	0.00645293	-0.468427	0.63 [0.45 - 0.88]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	43427_at	111	0.684685	0.000299831	0.00913177	-1.19379	0.0179714	-0.409885	0.66 [0.47 - 0.93]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552615_at	111	0.324324	0.282865	-	0.321666	0.300122	0.323626	1.38 [0.75 - 2.55]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552616_a_at	111	0.171171	0.0703996	-	-0.563672	0.962247	0.00698005	1.01 [0.75 - 1.34]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221928_at	111	0.144144	0.000225467	0.00713353	-1.08833	0.00028783	-0.519001	0.60 [0.45 - 0.79]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221928_at	90	0.422222	0.0859898	-	0.585752	0.543918	0.324015	1.38 [0.49 - 3.94]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221928_at	90	0.455556	0.113568	-	0.612946	0.475183	0.429255	1.54 [0.47 - 4.99]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	49452_at	90	0.444444	0.137523	-	-0.480219	0.38743	-0.515909	0.60 [0.19 - 1.92]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	49452_at	90	0.777778	0.194803	-	0.516057	0.749021	-0.201988	0.82 [0.24 - 2.82]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	43427_at	90	0.266667	0.0236757	0.301495	-0.831113	0.881831	0.102459	1.11 [0.29 - 4.28]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	43427_at	90	0.288889	0.00740776	0.128502	-0.85016	0.829815	-0.139436	0.87 [0.24 - 3.10]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214584_x_at	90	0.133333	0.0535361	-	-0.752016	0.460009	-1.03528	0.36 [0.02 - 5.54]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214584_x_at	90	0.133333	0.0277751	0.33634	-0.924143	0.261199	-1.80824	0.16 [0.01 - 3.84]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	54	50	0.88	0.0886338	-	-15.255	0.515881	-0.32003	0.73 [0.28 - 1.91]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221928_at	138	0.463768	0.000810561	0.0213572	-0.806372	0.0788493	-0.585079	0.56 [0.29 - 1.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214584_x_at	138	0.282609	0.00290633	0.0613981	-0.713557	0.0736754	-3.86911	0.02 [0.00 - 1.45]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	49452_at	138	0.101449	0.00815469	0.138318	-0.852061	0.128297	-0.228191	0.80 [0.59 - 1.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	43427_at	138	0.101449	0.00970776	0.157892	-0.861988	0.128606	-0.271589	0.76 [0.54 - 1.08]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552616_a_at	138	0.15942	0.000229237	0.00723705	-0.965504	0.608608	-3.67258	0.03 [0.00 - 32364.40]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552615_at	138	0.782609	0.2119	-	-0.407887	0.862648	-0.0648441	0.94 [0.45 - 1.95]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	43427_at	129	0.364341	0.119812	-	-0.385579	0.376998	-0.180238	0.84 [0.56 - 1.25]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214584_x_at	129	0.596899	0.0152433	0.220568	-0.649671	0.0959034	-0.424999	0.65 [0.40 - 1.08]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221928_at	129	0.116279	0.0151208	0.219278	-0.792191	0.115391	-0.350945	0.70 [0.45 - 1.09]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	49452_at	129	0.100775	0.0614945	-	-0.632964	0.980679	0.00940501	1.01 [0.47 - 2.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11492	56	0.464286	0.0266251	0.326814	0.770686	0.252175	0.575684	1.78 [0.66 - 4.76]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11492	56	0.464286	0.219128	-	0.440801	0.973961	0.0172802	1.02 [0.36 - 2.87]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	49452_at	278	0.532374	0.00215116	0.048079	0.578511	0.0099914	0.331565	1.39 [1.08 - 1.79]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552616_a_at	278	0.330935	0.0363412	0.402054	0.441868	0.608455	0.182253	1.20 [0.60 - 2.41]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	43427_at	278	0.834532	0.0016147	0.0379802	0.65715	0.0030934	0.45372	1.57 [1.17 - 2.13]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221928_at	278	0.406475	0.016203	0.230538	0.481355	0.0489097	0.385728	1.47 [1.00 - 2.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214584_x_at	278	0.557554	0.0948077	-	0.314236	0.910707	0.0543266	1.06 [0.41 - 2.73]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552615_at	278	0.784173	0.0310213	0.362277	-0.497091	0.6439	-0.147724	0.86 [0.46 - 1.61]
GENE	ACACB	acetyl-CoA carboxylase beta	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	49452_at	133	0.428571	0.134435	-	-0.370634	0.416373	-0.099756	0.91 [0.71 - 1.15]
GENE	ACACB	acetyl-CoA carboxylase beta	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	43427_at	133	0.654135	0.135241	-	-0.382975	0.822167	-0.0272907	0.97 [0.77 - 1.23]
GENE	ACACB	acetyl-CoA carboxylase beta	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214584_x_at	133	0.541353	0.000260375	0.00808242	0.853614	0.0671512	1.30884	3.70 [0.91 - 15.03]
GENE	ACACB	acetyl-CoA carboxylase beta	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221928_at	133	0.421053	0.202317	-	0.314268	0.521181	0.143483	1.15 [0.74 - 1.79]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	43427_at	185	0.389189	0.102005	-	0.272292	0.888898	0.0201424	1.02 [0.77 - 1.35]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	49452_at	185	0.524324	0.018269	0.251274	0.415351	0.650386	0.0635874	1.07 [0.81 - 1.40]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221928_at	185	0.891892	0.125879	-	-0.427431	0.779105	0.0520301	1.05 [0.73 - 1.52]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	43427_at	185	0.389189	0.0846746	-	0.314654	0.812303	-0.0381984	0.96 [0.70 - 1.32]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214584_x_at	185	0.102703	0.191975	-	0.33227	0.465581	0.259266	1.30 [0.65 - 2.60]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221928_at	185	0.367568	0.0934048	-	0.311539	0.696178	0.0786705	1.08 [0.73 - 1.61]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	49452_at	185	0.410811	0.0146549	0.214339	0.404915	0.469789	0.0920837	1.10 [0.85 - 1.41]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214584_x_at	185	0.102703	0.207666	-	0.3596	0.2861	0.405148	1.50 [0.71 - 3.16]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87791	110	0.518182	0.0190222	0.258603	0.535429	0.147446	0.19774	1.22 [0.93 - 1.59]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87791	110	0.827273	0.012692	0.192874	0.870855	0.172121	0.237165	1.27 [0.90 - 1.78]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214584_x_at	80	0.7875	0.085643	-	-1.20664	0.556085	-0.1088	0.90 [0.62 - 1.29]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	43427_at	80	0.275	0.208831	-	-0.567447	0.282926	-0.296488	0.74 [0.43 - 1.28]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221928_at	80	0.3	0.0489799	0.485469	-0.859739	0.118916	-0.279475	0.76 [0.53 - 1.07]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	49452_at	80	0.825	0.118238	-	-1.46793	0.325576	-0.277535	0.76 [0.44 - 1.32]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214584_x_at	38	0.236842	0.070644	-	-0.911265	0.65247	-0.248547	0.78 [0.26 - 2.30]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	49452_at	38	0.710526	0.117256	-	0.819317	0.945299	0.0353776	1.04 [0.38 - 2.85]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	43427_at	38	0.710526	0.117256	-	0.819317	0.958048	0.0162965	1.02 [0.55 - 1.87]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552616_a_at	38	0.894737	0.077497	-	1.07138	0.909578	-0.0686613	0.93 [0.29 - 3.05]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552615_at	38	0.894737	0.0226574	0.292436	-15.6468	0.221767	-1.30238	0.27 [0.03 - 2.20]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221928_at	38	0.842105	0.0222637	0.288886	1.31438	0.421371	0.645174	1.91 [0.40 - 9.19]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221928_at	140	0.407143	1.69828e-06	8.85981e-05	-1.38281	0.000211785	-0.39761	0.67 [0.54 - 0.83]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	49452_at	140	0.414286	3.50245e-06	0.000171993	-1.34553	0.000121325	-0.305021	0.74 [0.63 - 0.86]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	43427_at	140	0.392857	1.45546e-06	7.68815e-05	-1.37155	0.000157986	-0.324021	0.72 [0.61 - 0.86]
GENE	ACACB	acetyl-CoA carboxylase beta	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214584_x_at	140	0.421429	3.51722e-06	0.000172656	-1.34813	0.000823991	-0.692442	0.50 [0.33 - 0.75]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219986_s_at	30	0.8	0.204336	-	-0.68529	0.685243	-0.32595	0.72 [0.15 - 3.49]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1687303	165	0.230303	0.113683	-	-0.441294	0.844618	0.0322183	1.03 [0.75 - 1.43]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1687303	165	0.230303	0.00709579	0.124315	-0.950967	0.653347	-0.110204	0.90 [0.55 - 1.45]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219986_s_at	163	0.104294	0.0740221	-	-0.524243	0.613552	-0.357582	0.70 [0.17 - 2.80]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	237481_at	163	0.226994	0.000638852	0.0174593	0.949022	0.316257	0.65828	1.93 [0.53 - 7.00]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	237482_s_at	163	0.159509	0.107297	-	-0.40724	0.698981	-0.206045	0.81 [0.29 - 2.31]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238655_at	163	0.797546	0.00809878	0.137593	0.603707	0.076823	1.32095	3.75 [0.87 - 16.19]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219986_s_at	79	0.481013	0.0242086	0.306169	-0.660219	0.350198	-0.564556	0.57 [0.17 - 1.86]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238655_at	79	0.886076	0.119103	-	0.601306	0.885181	0.12241	1.13 [0.21 - 5.95]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	237481_at	79	0.873418	0.102421	-	-0.93781	0.260042	-0.992475	0.37 [0.07 - 2.08]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	237482_s_at	79	0.177215	0.0708646	-	0.832585	0.409457	0.424265	1.53 [0.56 - 4.19]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219986_s_at	58	0.724138	0.15642	-	-0.43602	0.485354	-0.169815	0.84 [0.52 - 1.36]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219986_s_at	34	0.117647	0.217214	-	0.882257	0.729597	0.125249	1.13 [0.56 - 2.31]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219986_s_at	158	0.664557	0.0217724	0.28442	0.532183	0.194553	0.871539	2.39 [0.64 - 8.92]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219986_s_at	53	0.622642	0.0110927	0.174516	0.904754	0.279241	0.600701	1.82 [0.61 - 5.41]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219986_s_at	53	0.622642	0.119686	-	0.532755	0.979736	0.0133757	1.01 [0.36 - 2.84]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219986_s_at	180	0.105556	0.0112148	0.175947	-0.70388	0.166205	-0.425331	0.65 [0.36 - 1.19]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	237482_s_at	180	0.327778	0.0313578	0.364889	-0.463812	0.277496	-0.151861	0.86 [0.65 - 1.13]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238655_at	180	0.372222	0.0250803	0.313717	-0.471489	0.447044	-0.0954299	0.91 [0.71 - 1.16]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	237481_at	180	0.622222	0.01492	0.217156	0.516363	0.109104	0.161758	1.18 [0.96 - 1.43]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219986_s_at	559	0.54025	0.0262093	0.323323	-0.519661	0.382029	-0.105862	0.90 [0.71 - 1.14]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	237482_s_at	559	0.826476	0.00869531	0.145253	-1.14359	0.0539398	-0.293883	0.75 [0.55 - 1.00]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238655_at	559	0.368515	0.08281	-	0.393631	0.426805	0.150822	1.16 [0.80 - 1.69]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	237481_at	559	0.423971	0.062822	-	0.393172	0.952649	-0.00807702	0.99 [0.76 - 1.30]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219986_s_at	77	0.220779	0.00175066	0.0405997	-0.926274	0.240429	-0.309161	0.73 [0.44 - 1.23]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	237482_s_at	77	0.116883	8.71896e-05	0.00310352	-1.39473	0.569011	-0.0994832	0.91 [0.64 - 1.27]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238655_at	77	0.753247	0.0707794	-	0.509249	0.301964	0.205302	1.23 [0.83 - 1.81]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	237481_at	77	0.753247	0.073933	-	-0.559384	0.865276	-0.0243743	0.98 [0.74 - 1.29]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219986_s_at	70	0.114286	0.12381	-	-0.584548	0.798789	0.2015	1.22 [0.26 - 5.76]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238655_at	70	0.757143	0.0424009	0.443804	0.610377	0.361256	1.00663	2.74 [0.32 - 23.75]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	237481_at	70	0.485714	0.0415787	0.438341	0.535941	0.543321	0.717444	2.05 [0.20 - 20.72]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	237482_s_at	70	0.857143	0.00366521	0.0739798	1.02331	0.669188	0.280928	1.32 [0.37 - 4.80]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219986_s_at	74	0.689189	0.089095	-	0.50256	0.162889	0.627554	1.87 [0.78 - 4.52]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238655_at	74	0.135135	0.076197	-	0.901084	0.833878	0.0479523	1.05 [0.67 - 1.64]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	237481_at	74	0.162162	0.0206572	0.274122	-0.80527	0.157262	-0.216946	0.80 [0.60 - 1.09]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	237482_s_at	74	0.608108	0.0404092	0.430465	0.604194	0.895554	-0.028523	0.97 [0.63 - 1.49]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	237482_s_at	67	0.179104	0.0390348	0.421046	-1.29399	0.215378	-1.95421	0.14 [0.01 - 3.12]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219986_s_at	67	0.820895	0.062567	-	1.19096	0.325399	1.81192	6.12 [0.17 - 226.59]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238655_at	67	0.507463	0.331873	-	-0.674032	0.923038	-0.150559	0.86 [0.04 - 18.25]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	237481_at	67	0.432836	0.210502	-	0.971233	0.835686	-0.329128	0.72 [0.03 - 16.14]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219986_s_at	115	0.217391	0.168809	-	-0.746005	0.46782	-0.655293	0.52 [0.09 - 3.05]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	237482_s_at	115	0.373913	0.194281	-	0.823818	0.794752	0.16753	1.18 [0.33 - 4.18]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238655_at	115	0.269565	0.0286095	0.343138	-1.11145	0.185071	-0.598653	0.55 [0.23 - 1.33]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	237481_at	115	0.652174	0.0103863	0.166127	1.33149	0.0639714	1.18591	3.27 [0.93 - 11.48]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	237482_s_at	204	0.254902	0.0122252	0.187601	-0.411407	0.0783059	-0.164336	0.85 [0.71 - 1.02]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238655_at	204	0.151961	0.0766958	-	0.344939	0.269622	0.0966793	1.10 [0.93 - 1.31]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	237481_at	204	0.127451	0.000781891	0.0207177	-0.718077	0.0735445	-0.127197	0.88 [0.77 - 1.01]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219986_s_at	204	0.627451	0.0119173	0.184086	-0.367305	0.997463	0.00050966	1.00 [0.73 - 1.37]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	237482_s_at	87	0.229885	0.00669314	0.118831	-1.00988	0.115119	-1.14926	0.32 [0.08 - 1.32]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238655_at	87	0.264368	0.0311101	0.362967	1.23791	0.82277	0.154612	1.17 [0.30 - 4.52]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238655_at	87	0.264368	0.0311101	0.362967	1.23791	0.82277	0.154612	1.17 [0.30 - 4.52]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	237481_at	87	0.149425	0.147825	-	1.01922	0.588517	0.662054	1.94 [0.18 - 21.34]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	237481_at	87	0.149425	0.147825	-	1.01922	0.588517	0.662054	1.94 [0.18 - 21.34]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	237482_s_at	87	0.229885	0.00669314	0.118831	-1.00988	0.115119	-1.14926	0.32 [0.08 - 1.32]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219986_s_at	87	0.252874	0.00630383	0.113438	-1.00544	0.0146544	-1.79328	0.17 [0.04 - 0.70]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219986_s_at	87	0.252874	0.00630383	0.113438	-1.00544	0.0146544	-1.79328	0.17 [0.04 - 0.70]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	237482_s_at	77	0.662338	0.208304	-	0.77714	0.873977	-0.161246	0.85 [0.12 - 6.24]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238655_at	77	0.233766	0.0353819	0.395113	-1.2486	0.431476	-1.10325	0.33 [0.02 - 5.18]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	237481_at	77	0.831169	0.000911253	0.0235715	1.84003	0.0373527	1.90079	6.69 [1.12 - 40.06]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219986_s_at	77	0.272727	0.201761	-	1.26065	0.961489	-0.0554958	0.95 [0.10 - 9.00]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219986_s_at	77	0.272727	0.0933144	-	1.5781	0.877208	0.152202	1.16 [0.17 - 8.03]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	237482_s_at	77	0.662338	0.0913341	-	0.90916	0.586228	0.47321	1.61 [0.29 - 8.82]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238655_at	77	0.662338	0.0778669	-	0.946933	0.810366	0.27222	1.31 [0.14 - 12.13]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	237481_at	77	0.831169	0.0141493	0.208913	1.30827	0.117685	1.38874	4.01 [0.70 - 22.84]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219986_s_at	136	0.823529	0.00960419	0.156619	1.18376	0.696634	0.199893	1.22 [0.45 - 3.34]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219986_s_at	200	0.87	0.0927195	-	0.614856	0.97036	0.0126224	1.01 [0.52 - 1.97]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14062	60	0.15	0.18448	-	0.936546	0.390453	0.39735	1.49 [0.60 - 3.68]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14062	60	0.133333	2.70513e-10	2.4215e-08	-2.45154	0.00270794	-1.76069	0.17 [0.05 - 0.54]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219986_s_at	286	0.374126	0.115619	-	-0.30636	0.834655	-0.0565454	0.95 [0.56 - 1.61]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219986_s_at	159	0.735849	0.0198976	0.266977	0.844307	0.172961	0.968556	2.63 [0.65 - 10.61]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219986_s_at	159	0.735849	0.180467	-	0.44058	0.539769	0.359869	1.43 [0.45 - 4.53]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219986_s_at	159	0.735849	0.0439862	0.454171	0.64006	0.352582	0.549531	1.73 [0.54 - 5.52]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238655_at	159	0.628931	0.0503828	-	0.610218	0.229105	0.281364	1.32 [0.84 - 2.10]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237481_at	159	0.603774	0.231177	-	0.376964	0.992859	-0.00179132	1.00 [0.67 - 1.48]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238655_at	159	0.63522	0.101977	-	0.599119	0.522346	0.174307	1.19 [0.70 - 2.03]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237481_at	159	0.767296	0.148587	-	-0.629499	0.944535	-0.0139225	0.99 [0.67 - 1.46]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237481_at	159	0.767296	0.0830566	-	-1.01304	0.773544	-0.0676306	0.93 [0.59 - 1.48]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237482_s_at	159	0.710692	0.0320298	0.370065	0.673674	0.680195	0.0852363	1.09 [0.73 - 1.63]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237482_s_at	159	0.509434	0.113835	-	0.504716	0.914949	0.0220518	1.02 [0.68 - 1.53]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237482_s_at	159	0.257862	0.135635	-	-0.563676	0.788539	-0.0630492	0.94 [0.59 - 1.49]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238655_at	159	0.805031	0.0330625	0.377917	0.720413	0.357206	0.214499	1.24 [0.78 - 1.96]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219986_s_at	54	0.62963	0.247888	-	0.801355	0.92909	0.0996167	1.10 [0.12 - 9.91]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219986_s_at	117	0.871795	0.0437709	0.452776	0.753228	0.352898	0.375851	1.46 [0.66 - 3.22]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219986_s_at	117	0.871795	0.0120634	0.185758	1.01202	0.0414916	0.895369	2.45 [1.04 - 5.79]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219986_s_at	117	0.854701	0.010935	0.172658	1.04001	0.0343842	1.03076	2.80 [1.08 - 7.28]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219986_s_at	117	0.871795	0.0437709	0.452776	0.753228	0.352898	0.375851	1.46 [0.66 - 3.22]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219986_s_at	236	0.135593	0.0689623	-	-0.604817	0.605163	-0.290222	0.75 [0.25 - 2.25]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	237482_s_at	236	0.165254	0.10485	-	-0.50979	0.432111	-0.155776	0.86 [0.58 - 1.26]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238655_at	236	0.898305	0.00143932	0.0345321	1.03049	0.972627	0.00766497	1.01 [0.65 - 1.56]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	237481_at	236	0.338983	0.102722	-	-0.441472	0.346195	-0.173037	0.84 [0.59 - 1.21]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219986_s_at	249	0.321285	0.0586793	-	-0.40605	0.37333	-0.391496	0.68 [0.29 - 1.60]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	237482_s_at	249	0.369478	0.0763667	-	0.415341	0.703729	0.0636381	1.07 [0.77 - 1.48]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238655_at	249	0.899598	0.0164188	0.23275	0.707146	0.684968	0.0707894	1.07 [0.76 - 1.51]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	237481_at	249	0.738956	0.19515	-	-0.334165	0.580572	-0.0791576	0.92 [0.70 - 1.22]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219986_s_at	62	0.322581	0.0874551	-	-0.812066	0.639439	-0.097946	0.91 [0.60 - 1.37]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219986_s_at	125	0.4	0.030715	0.359887	1.0268	0.198252	0.920667	2.51 [0.62 - 10.21]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219986_s_at	125	0.776	0.202669	-	-0.469383	0.869069	-0.0911814	0.91 [0.31 - 2.70]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219986_s_at	54	0.148148	0.0744232	-	-1.25142	0.794128	-0.0658792	0.94 [0.57 - 1.54]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219986_s_at	198	0.80303	0.324882	-	-0.34302	0.825447	-0.0382015	0.96 [0.69 - 1.35]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219986_s_at	198	0.393939	0.230399	-	0.341814	0.687706	0.0791723	1.08 [0.74 - 1.59]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219986_s_at	198	0.80303	0.180208	-	-0.388096	0.870506	-0.0227755	0.98 [0.74 - 1.29]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219986_s_at	51	0.137255	0.0830895	-	-1.45188	0.214126	-1.58214	0.21 [0.02 - 2.49]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219986_s_at	62	0.516129	0.0150755	0.2188	-1.67929	0.0920219	-1.39256	0.25 [0.05 - 1.26]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219986_s_at	177	0.870057	0.18303	-	-0.617374	0.502772	-0.457083	0.63 [0.17 - 2.41]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219986_s_at	177	0.887006	0.0605237	-	-0.84721	0.65529	-0.262888	0.77 [0.24 - 2.44]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	237482_s_at	177	0.740113	0.0906718	-	-0.584794	0.966539	0.0259786	1.03 [0.30 - 3.45]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238655_at	177	0.152542	0.0998538	-	-0.500873	0.11802	-0.965166	0.38 [0.11 - 1.28]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	237481_at	177	0.79661	0.02318	0.297107	-0.790185	0.0677243	-1.51546	0.22 [0.04 - 1.12]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238655_at	177	0.372881	0.0102126	0.164036	-0.68664	0.0364515	-1.48665	0.23 [0.06 - 0.91]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	237481_at	177	0.853107	0.119697	-	-0.71628	0.122111	-1.47725	0.23 [0.04 - 1.49]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	237482_s_at	177	0.740113	0.115878	-	-0.45258	0.674109	-0.228968	0.80 [0.27 - 2.31]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219986_s_at	145	0.855172	0.131007	-	-0.883502	0.316602	-0.822308	0.44 [0.09 - 2.20]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238655_at	145	0.337931	0.0620383	-	-0.614791	0.302897	-0.94103	0.39 [0.07 - 2.34]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	237481_at	145	0.889655	0.0779193	-	-1.60912	0.368273	-0.988575	0.37 [0.04 - 3.21]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	237482_s_at	145	0.731034	0.00709984	0.12437	-1.33128	0.292794	-0.822264	0.44 [0.09 - 2.03]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219986_s_at	226	0.207965	0.05309	-	-0.591574	0.133935	-0.186268	0.83 [0.65 - 1.06]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238655_at	226	0.845133	0.0531147	-	-1.09684	0.941859	-0.0120192	0.99 [0.72 - 1.36]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	237481_at	226	0.477876	0.0428999	0.447091	-0.577148	0.282381	-0.145944	0.86 [0.66 - 1.13]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	237482_s_at	226	0.115044	0.0111745	0.175475	-0.842671	0.47326	-0.0884463	0.92 [0.72 - 1.17]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	237482_s_at	49	0.408163	0.0342221	0.386588	-1.22284	0.420169	-0.785482	0.46 [0.07 - 3.08]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238655_at	49	0.897959	0.0108994	0.172238	1.56899	0.647289	-0.762503	0.47 [0.02 - 12.23]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	237481_at	49	0.285714	0.05291	-	1.78358	0.680439	0.927593	2.53 [0.03 - 208.90]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219986_s_at	55	0.854545	0.227943	-	0.663739	0.868195	-0.224674	0.80 [0.06 - 11.35]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238655_at	55	0.309091	0.0158355	0.226747	-1.0343	0.300213	-1.31628	0.27 [0.02 - 3.24]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	237481_at	55	0.272727	0.146765	-	0.881681	0.77567	0.526449	1.69 [0.05 - 63.27]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	237482_s_at	55	0.545455	0.269931	-	-0.512002	0.917945	-0.0824783	0.92 [0.19 - 4.42]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219986_s_at	55	0.854545	0.171223	-	0.769686	0.924246	0.139609	1.15 [0.06 - 20.44]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219986_s_at	49	0.857143	0.15156	-	0.926526	0.79407	0.443966	1.56 [0.06 - 43.71]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	237482_s_at	55	0.818182	0.147825	-	0.833767	0.581565	0.533961	1.71 [0.26 - 11.39]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238655_at	55	0.309091	0.251076	-	-0.582181	0.880961	-0.203092	0.82 [0.06 - 11.65]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	237481_at	55	0.127273	0.0689369	-	15.2715	0.313424	1.89906	6.68 [0.17 - 268.12]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219986_s_at	63	0.619048	0.0166249	0.234851	0.793365	0.132739	0.516037	1.68 [0.85 - 3.28]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	237482_s_at	63	0.15873	0.00779428	0.133617	-0.999109	0.903574	-0.253663	0.78 [0.01 - 47.01]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238655_at	63	0.111111	4.38251e-05	0.00168602	-1.67208	0.531823	-1.7124	0.18 [0.00 - 38.70]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	237481_at	63	0.68254	0.00175785	0.0407369	1.03398	0.535587	0.170499	1.19 [0.69 - 2.03]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13376863_3p_s_at	28	0.821429	0.0964805	-	-1.56687	0.987676	-0.00331447	1.00 [0.65 - 1.52]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.279653.0.S1_3p_s_at	28	0.142857	0.0685508	-	-1.19105	0.707508	-0.452356	0.64 [0.06 - 6.76]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.198529.0.A1_3p_at	28	0.178571	0.0985542	-	-0.986004	0.131765	-7.0125	0.00 [0.00 - 8.22]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13376863_3p_a_at	28	0.357143	0.0103281	0.165428	-1.33652	0.998528	-0.00449423	1.00 [0.01 - 117.95]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.198529.0.A1_3p_s_at	28	0.321429	0.0691516	-	-1.03791	0.985486	0.0767915	1.08 [0.00 - 4231.39]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219986_s_at	82	0.670732	0.0180987	0.2496	-1.01646	0.472009	-0.44516	0.64 [0.19 - 2.16]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219986_s_at	79	0.898734	0.321742	-	-0.508249	0.634252	-0.257483	0.77 [0.27 - 2.23]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219986_s_at	104	0.798077	0.0135692	0.202602	-1.40075	0.0215416	-1.65886	0.19 [0.05 - 0.78]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P25348	117	0.299145	0.301301	-	0.342075	0.67582	-0.0874204	0.92 [0.61 - 1.38]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P227450	117	0.324786	1.56139e-05	0.000668331	-1.18216	0.00012439	-1.18787	0.30 [0.17 - 0.56]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219986_s_at	204	0.897059	0.0801551	-	0.629584	0.242307	0.733297	2.08 [0.61 - 7.12]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	237482_s_at	204	0.892157	0.227813	-	0.58301	0.925207	-0.0314584	0.97 [0.50 - 1.87]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238655_at	204	0.235294	0.092525	-	-0.627232	0.24463	-0.317659	0.73 [0.43 - 1.24]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	237481_at	204	0.534314	0.0201204	0.269084	-0.926748	0.122822	-0.389355	0.68 [0.41 - 1.11]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	237482_s_at	204	0.455882	0.059826	-	0.530352	0.281953	0.319187	1.38 [0.77 - 2.46]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238655_at	204	0.112745	0.140402	-	-0.532204	0.582734	-0.119495	0.89 [0.58 - 1.36]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	237481_at	204	0.823529	0.0104604	0.167015	-1.40338	0.308365	-0.213566	0.81 [0.54 - 1.22]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219986_s_at	204	0.215686	0.20176	-	0.673096	0.682213	0.335505	1.40 [0.28 - 6.97]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219986_s_at	178	0.882023	0.2745	-	0.324947	0.948165	0.0304083	1.03 [0.41 - 2.58]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	237482_s_at	111	0.783784	0.0532198	-	0.575371	0.724793	0.0721091	1.07 [0.72 - 1.61]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238655_at	111	0.324324	0.00105605	0.0266772	-0.855376	0.118829	-0.262551	0.77 [0.55 - 1.07]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	237481_at	111	0.396396	0.358528	-	0.25329	0.952321	0.00960233	1.01 [0.74 - 1.38]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219986_s_at	111	0.405405	0.0156298	0.224611	-0.630839	0.370816	-0.192468	0.82 [0.54 - 1.26]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219986_s_at	90	0.166667	0.142361	-	-0.553469	0.777409	-0.150094	0.86 [0.30 - 2.44]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219986_s_at	90	0.166667	0.0612697	-	-0.760544	0.671073	-0.256173	0.77 [0.24 - 2.52]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3087	50	0.88	0.393404	-	-0.855604	0.766039	-0.0873167	0.92 [0.52 - 1.63]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	237482_s_at	138	0.26087	0.252841	-	-0.294558	0.844177	0.119052	1.13 [0.34 - 3.69]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238655_at	138	0.362319	0.115575	-	-0.378768	0.760781	0.176798	1.19 [0.38 - 3.72]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	237481_at	138	0.811594	0.0250997	0.313884	-0.822101	0.0742529	-2.46839	0.08 [0.01 - 1.27]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219986_s_at	138	0.898551	0.00651067	0.116315	-1.74073	0.0594544	-0.590779	0.55 [0.30 - 1.02]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219986_s_at	129	0.108527	0.0243231	0.307167	-0.743202	0.416649	-0.34561	0.71 [0.31 - 1.63]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16338	56	0.178571	0.100926	-	0.853103	0.723109	0.178378	1.20 [0.45 - 3.21]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40585	56	0.339286	0.0464136	0.469634	0.7555	0.402541	0.323776	1.38 [0.65 - 2.95]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2250	56	0.107143	0.00255637	0.0553385	-1.4383	0.452028	-0.410184	0.66 [0.23 - 1.93]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36712	56	0.107143	0.0344409	0.388207	-1.1116	0.657497	-0.204619	0.81 [0.33 - 2.01]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40585	56	0.285714	0.0451533	0.461666	0.837477	0.340486	0.375171	1.46 [0.67 - 3.15]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16338	56	0.160714	0.0991261	-	0.859211	0.387101	0.443202	1.56 [0.57 - 4.25]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36712	56	0.410714	0.130394	-	0.609825	0.959216	-0.022403	0.98 [0.41 - 2.31]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2250	56	0.107143	0.0237627	0.302261	-1.07689	0.582242	-0.263682	0.77 [0.30 - 1.97]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219986_s_at	278	0.697842	0.161313	-	0.275001	0.869753	-0.0538789	0.95 [0.50 - 1.80]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	237482_s_at	278	0.165468	0.274065	-	0.295617	0.757563	0.0640941	1.07 [0.71 - 1.60]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238655_at	278	0.834532	0.0195165	0.263349	-0.657529	0.0764516	-0.535542	0.59 [0.32 - 1.06]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	237481_at	278	0.730216	0.0379811	0.413702	0.424237	0.233858	0.317729	1.37 [0.81 - 2.32]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219986_s_at	133	0.578947	0.00295493	0.0622257	0.690807	0.16743	0.294093	1.34 [0.88 - 2.04]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4784	81	0.765432	0.000129674	0.00440109	1.78119	0.0357291	1.13588	3.11 [1.08 - 8.99]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5147	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219986_s_at	185	0.648649	0.0123283	0.188772	-0.430042	0.33627	-0.19707	0.82 [0.55 - 1.23]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219986_s_at	185	0.648649	0.0302779	0.356456	-0.405527	0.520935	-0.142025	0.87 [0.56 - 1.34]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P227450	110	0.554545	0.118612	-	-0.479015	0.45276	-0.346054	0.71 [0.29 - 1.75]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P8284	110	0.890909	0.183337	-	-0.521444	0.804285	-0.0388282	0.96 [0.71 - 1.31]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P25348	110	0.890909	0.163691	-	0.47751	0.913546	0.0243422	1.02 [0.66 - 1.59]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P8284	110	0.890909	0.178828	-	-0.940084	0.686886	-0.082933	0.92 [0.61 - 1.38]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P227450	110	0.127273	0.100312	-	0.682722	0.992348	-0.00307934	1.00 [0.53 - 1.87]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P25348	110	0.136364	0.0796734	-	-0.617829	0.582085	-0.172877	0.84 [0.45 - 1.56]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219986_s_at	80	0.85	0.0446721	0.45859	1.0389	0.254979	0.486868	1.63 [0.70 - 3.76]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	237482_s_at	38	0.815789	0.00999922	0.161451	1.413	0.722451	0.275184	1.32 [0.29 - 6.01]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238655_at	38	0.105263	0.004745	0.0908187	-1.55025	0.0997951	-1.4329	0.24 [0.04 - 1.31]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	237481_at	38	0.157895	0.0764807	-	-1.03485	0.24507	-0.247099	0.78 [0.51 - 1.18]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219986_s_at	38	0.421053	0.0521681	-	0.990887	0.119137	0.682886	1.98 [0.84 - 4.67]
GENE	ACAD10	acyl-CoA dehydrogenase family, member 10	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219986_s_at	140	0.107143	0.0133745	0.200463	-0.89045	0.212834	-0.847254	0.43 [0.11 - 1.63]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1761058	165	0.890909	0.137338	-	-0.680332	0.825736	0.0330242	1.03 [0.77 - 1.39]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1761058	165	0.327273	0.145157	-	0.614151	0.758741	0.0725822	1.08 [0.68 - 1.71]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222578_s_at	163	0.269939	0.0442593	0.455935	0.468257	0.225239	0.288366	1.33 [0.84 - 2.13]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222579_at	163	0.411043	0.0464527	0.469879	0.407933	0.10031	0.294879	1.34 [0.94 - 1.91]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225573_at	163	0.883436	0.00313342	0.0652381	0.792671	0.0369844	0.543583	1.72 [1.03 - 2.87]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222578_s_at	79	0.860759	1.11137e-06	5.99762e-05	1.58655	0.0717548	0.701918	2.02 [0.94 - 4.33]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222579_at	79	0.898734	0.000778805	0.0206486	1.30852	0.287679	0.246304	1.28 [0.81 - 2.01]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225573_at	79	0.443038	0.14124	-	0.437409	0.431822	0.202232	1.22 [0.74 - 2.03]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222579_at	180	0.855556	0.128611	-	-0.503884	0.950143	-0.0208073	0.98 [0.51 - 1.88]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225573_at	180	0.116667	0.000168989	0.00554915	-0.988321	0.239458	-0.344412	0.71 [0.40 - 1.26]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222578_s_at	180	0.105556	0.00229597	0.0507059	-0.874822	0.00354975	-1.11841	0.33 [0.15 - 0.69]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222578_s_at	559	0.583184	0.00286532	0.0606972	0.591497	0.723198	0.113897	1.12 [0.60 - 2.10]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222579_at	559	0.724508	0.0988193	-	-0.396774	0.242137	-0.324193	0.72 [0.42 - 1.24]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225573_at	559	0.250447	0.0298334	0.352943	-0.441497	0.137799	-0.425321	0.65 [0.37 - 1.15]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222579_at	77	0.688312	0.206463	-	0.351102	0.761323	0.123445	1.13 [0.51 - 2.51]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225573_at	77	0.896104	0.266875	-	0.448855	0.746323	0.108139	1.11 [0.58 - 2.15]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222578_s_at	77	0.142857	0.281572	-	-0.355495	0.934925	-0.0392555	0.96 [0.37 - 2.47]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222578_s_at	70	0.457143	0.218088	-	0.332559	0.911039	0.034844	1.04 [0.56 - 1.91]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222579_at	70	0.457143	0.0232512	0.297739	0.615266	0.565196	0.215642	1.24 [0.59 - 2.59]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225573_at	70	0.3	0.0781246	-	0.526499	0.478991	0.204323	1.23 [0.70 - 2.16]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225573_at	74	0.716216	0.138494	-	0.452509	0.869829	0.0880959	1.09 [0.38 - 3.13]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222578_s_at	74	0.337838	0.110518	-	0.516101	0.219483	0.737782	2.09 [0.64 - 6.79]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222579_at	74	0.891892	0.094493	-	-0.962386	0.151083	-0.639861	0.53 [0.22 - 1.26]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225573_at	67	0.104478	0.195067	-	-1.01626	0.968778	-0.0437109	0.96 [0.11 - 8.54]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222578_s_at	67	0.865672	1.99401e-05	0.000833004	3.01987	0.0496019	4.94489	140.46 [1.01 - 19560.50]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222579_at	67	0.835821	0.00139952	0.0337379	1.8882	0.0271825	2.70786	15.00 [1.36 - 165.77]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225573_at	115	0.33913	0.0522041	-	-1.00398	0.868495	-0.100049	0.90 [0.28 - 2.96]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222578_s_at	115	0.826087	0.0506025	-	1.04327	0.451738	1.16612	3.21 [0.15 - 66.91]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222579_at	115	0.13913	0.0107454	0.170414	-1.321	0.701355	0.304285	1.36 [0.29 - 6.42]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225573_at	204	0.107843	0.00428842	0.0838331	-0.639557	0.733936	-0.052996	0.95 [0.70 - 1.29]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222578_s_at	204	0.323529	0.0616997	-	0.278299	0.436282	0.159879	1.17 [0.78 - 1.75]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222579_at	204	0.357843	0.0606232	-	-0.278652	0.862399	-0.0284779	0.97 [0.70 - 1.34]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225573_at	87	0.586207	0.056608	-	0.711889	0.62595	0.225087	1.25 [0.51 - 3.10]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222578_s_at	87	0.551724	0.0823813	-	0.655095	0.828882	0.0784443	1.08 [0.53 - 2.20]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222578_s_at	87	0.551724	0.0823813	-	0.655095	0.828882	0.0784443	1.08 [0.53 - 2.20]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222579_at	87	0.781609	0.179146	-	0.55804	0.438115	0.253583	1.29 [0.68 - 2.45]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222579_at	87	0.781609	0.179146	-	0.55804	0.438115	0.253583	1.29 [0.68 - 2.45]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225573_at	87	0.586207	0.056608	-	0.711889	0.62595	0.225087	1.25 [0.51 - 3.10]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225573_at	77	0.25974	0.000560073	0.0156103	-2.02539	0.0474174	-1.62198	0.20 [0.04 - 0.98]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222578_s_at	77	0.441558	0.0759628	-	-1.15946	0.480552	-0.489094	0.61 [0.16 - 2.39]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222579_at	77	0.12987	0.00365961	0.0738894	-1.6804	0.032688	-1.47991	0.23 [0.06 - 0.89]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222578_s_at	77	0.649351	0.0242611	0.306627	-1.99718	0.278927	-0.659825	0.52 [0.16 - 1.71]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222579_at	77	0.571429	0.00621685	0.11222	-2.30489	0.120691	-0.910395	0.40 [0.13 - 1.27]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225573_at	77	0.25974	0.0105229	0.167764	-1.32994	0.0706663	-1.2828	0.28 [0.07 - 1.11]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16889	60	0.133333	0.0565555	-	-0.862518	0.600065	-0.147482	0.86 [0.50 - 1.50]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16889	60	0.55	0.100929	-	-0.637587	0.464885	-0.223789	0.80 [0.44 - 1.46]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225573_at	159	0.880503	0.123798	-	-1.06562	0.851131	0.104047	1.11 [0.37 - 3.29]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222578_s_at	159	0.893082	0.0219646	0.286172	0.878495	0.0678626	1.05219	2.86 [0.93 - 8.86]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225573_at	159	0.861635	0.208974	-	-0.891036	0.889559	-0.0890658	0.91 [0.26 - 3.22]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222578_s_at	159	0.773585	0.000281811	0.00865536	1.10666	0.00130173	1.76666	5.85 [1.99 - 17.18]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222578_s_at	159	0.383648	0.00332526	0.0684304	1.4518	0.00400799	1.91204	6.77 [1.84 - 24.89]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222579_at	159	0.396226	0.0440552	0.454617	0.720045	0.330684	0.387899	1.47 [0.67 - 3.22]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222579_at	159	0.81761	0.00119146	0.0295081	1.03022	0.0787468	0.74034	2.10 [0.92 - 4.79]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222579_at	159	0.396226	0.0104602	0.167013	1.18815	0.154576	0.696902	2.01 [0.77 - 5.24]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225573_at	159	0.786164	0.138036	-	-0.695147	0.488522	-0.37614	0.69 [0.24 - 1.99]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222579_at	236	0.101695	0.114387	-	-0.598131	0.47045	-0.310917	0.73 [0.31 - 1.70]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225573_at	236	0.792373	0.0465926	0.470755	0.583221	0.792379	-0.104651	0.90 [0.41 - 1.96]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222578_s_at	236	0.868644	0.0448264	0.459578	-1.13333	0.263209	-0.567066	0.57 [0.21 - 1.53]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222579_at	249	0.795181	0.0540963	-	-0.610537	0.335921	-0.326656	0.72 [0.37 - 1.40]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225573_at	249	0.164659	0.0455865	0.46442	-0.502581	0.317258	-0.310097	0.73 [0.40 - 1.35]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222578_s_at	249	0.702811	0.0344781	0.388482	0.460322	0.475359	-0.292314	0.75 [0.33 - 1.67]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222578_s_at	177	0.898305	0.064422	-	0.597555	0.366304	0.341373	1.41 [0.67 - 2.95]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225573_at	177	0.717514	0.058576	-	0.517614	0.186569	0.499096	1.65 [0.79 - 3.45]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222578_s_at	177	0.135593	0.0856395	-	0.866499	0.354984	0.404835	1.50 [0.64 - 3.53]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222579_at	177	0.20339	0.0440112	0.454333	-0.527589	0.829677	0.0881537	1.09 [0.49 - 2.44]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222579_at	177	0.242938	0.0719765	-	-0.515098	0.830817	-0.100556	0.90 [0.36 - 2.27]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225573_at	177	0.717514	0.100797	-	0.396841	0.326308	0.334094	1.40 [0.72 - 2.72]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222578_s_at	145	0.365517	0.017946	0.248094	0.959941	0.187996	0.699884	2.01 [0.71 - 5.71]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222579_at	145	0.151724	0.289185	-	0.629053	0.828845	0.12832	1.14 [0.36 - 3.64]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225573_at	145	0.193103	0.094748	-	0.970609	0.22593	0.659646	1.93 [0.66 - 5.63]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222578_s_at	226	0.89823	0.0469072	0.47272	-1.7691	0.587936	-0.245895	0.78 [0.32 - 1.90]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222579_at	226	0.504425	0.0285138	0.342363	-0.634582	0.465435	-0.319072	0.73 [0.31 - 1.71]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225573_at	226	0.526549	0.0353865	0.395146	0.604585	0.0909375	0.472476	1.60 [0.93 - 2.77]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222578_s_at	55	0.4	0.0293249	0.348892	1.15891	0.245942	0.77411	2.17 [0.59 - 8.02]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222579_at	55	0.890909	0.00488307	0.0928959	1.35962	0.0971144	0.809712	2.25 [0.86 - 5.85]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225573_at	55	0.872727	0.149814	-	0.787023	0.24525	0.824968	2.28 [0.57 - 9.18]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225573_at	55	0.363636	0.187548	-	0.698461	0.195816	0.877273	2.40 [0.64 - 9.08]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222578_s_at	55	0.4	0.0598839	-	1.00855	0.578836	0.396244	1.49 [0.37 - 6.02]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222579_at	55	0.890909	0.003894	0.0776428	1.43953	0.147995	0.883898	2.42 [0.73 - 8.02]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225573_at	49	0.183673	0.347858	-	0.945836	0.816597	0.248886	1.28 [0.16 - 10.51]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222578_s_at	49	0.755102	0.016688	0.235493	1.29546	0.415765	0.720967	2.06 [0.36 - 11.67]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222579_at	49	0.857143	0.00827607	0.139887	1.42569	0.0559532	1.05668	2.88 [0.97 - 8.50]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	241874	34	0.411765	0.00409595	0.0808312	1.39715	0.108303	0.731871	2.08 [0.85 - 5.08]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222578_s_at	63	0.238095	0.0651882	-	0.864484	0.709233	0.0843537	1.09 [0.70 - 1.70]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222579_at	63	0.15873	0.300517	-	-0.436045	0.860403	-0.0258747	0.97 [0.73 - 1.30]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225573_at	63	0.793651	0.0441419	0.455177	-1.15515	0.188471	-0.231479	0.79 [0.56 - 1.12]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.170737.0.A3_3p_at	28	0.892857	8.79189e-05	0.00312643	3.31791	0.337563	0.731663	2.08 [0.47 - 9.27]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.23100.0.S1_3p_at	28	0.107143	0.0101351	0.163099	-1.5889	0.251915	0.324728	1.38 [0.79 - 2.41]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.170737.0.A1_3p_a_at	28	0.107143	0.0877346	-	-1.28653	0.571908	-0.931373	0.39 [0.02 - 9.96]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P212497	117	0.102564	0.0357664	0.397906	-0.793802	0.371391	-0.210985	0.81 [0.51 - 1.29]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225573_at	204	0.77451	0.0219404	0.285952	-1.52587	0.111213	-0.934217	0.39 [0.12 - 1.24]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222578_s_at	204	0.872549	0.0279246	0.337565	-15.2414	0.609692	-0.401724	0.67 [0.14 - 3.13]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222579_at	204	0.205882	0.0299171	0.353606	-0.802286	0.272889	-1.11535	0.33 [0.04 - 2.41]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225573_at	204	0.480392	0.00450663	0.0871947	-0.789541	0.0884082	-0.760907	0.47 [0.19 - 1.12]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222578_s_at	204	0.29902	0.00995076	0.160862	0.910101	0.12964	0.815028	2.26 [0.79 - 6.48]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222579_at	204	0.220588	0.288605	-	-0.321342	0.777415	0.198085	1.22 [0.31 - 4.81]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300022076	41	0.804878	0.0367681	0.405113	-1.43054	0.644006	-0.199389	0.82 [0.35 - 1.91]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225573_at	111	0.378378	0.123638	-	0.428136	0.559855	0.187301	1.21 [0.64 - 2.26]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222578_s_at	111	0.648649	0.254397	-	0.306745	0.493552	0.236392	1.27 [0.64 - 2.49]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222579_at	111	0.783784	0.0243875	0.307728	-0.884079	0.0833373	-0.457976	0.63 [0.38 - 1.06]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1043	50	0.38	0.047816	0.478351	1.18773	0.639099	1.06537	2.90 [0.03 - 249.15]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225573_at	138	0.376812	0.0927023	-	-0.40521	0.0843227	-0.374503	0.69 [0.45 - 1.05]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222578_s_at	138	0.673913	0.124972	-	-0.418985	0.928411	-0.0138233	0.99 [0.73 - 1.33]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222579_at	138	0.731884	0.0261447	0.322779	-0.683844	0.239345	-0.223408	0.80 [0.55 - 1.16]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20986	56	0.428571	0.137267	-	0.567612	0.384853	0.269455	1.31 [0.71 - 2.40]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10995	56	0.892857	0.0627895	-	-1.2782	0.786872	-0.103379	0.90 [0.43 - 1.91]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32882	56	0.232143	0.079688	-	-0.72031	0.465345	-0.28396	0.75 [0.35 - 1.61]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8628	56	0.178571	0.0218189	0.284845	-1.08186	0.856002	-0.0653157	0.94 [0.46 - 1.90]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20986	56	0.178571	0.350398	-	-0.421183	0.935985	0.0231469	1.02 [0.58 - 1.80]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8628	56	0.196429	0.0936628	-	-0.726022	0.594652	-0.17504	0.84 [0.44 - 1.60]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32882	56	0.232143	0.0120174	0.185232	-1.05899	0.700496	-0.1633	0.85 [0.37 - 1.95]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10995	56	0.892857	0.0350833	0.392932	-1.42231	0.418052	-0.293203	0.75 [0.37 - 1.52]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225573_at	278	0.294964	0.0527501	-	0.427512	0.113473	0.293038	1.34 [0.93 - 1.93]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222578_s_at	278	0.122302	0.0477143	0.477724	0.602909	0.154535	0.322912	1.38 [0.89 - 2.15]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222579_at	278	0.564748	0.073743	-	0.337529	0.112148	0.335614	1.40 [0.92 - 2.12]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11127	81	0.82716	0.0428742	0.446922	1.03119	0.786425	0.137873	1.15 [0.42 - 3.11]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P212497	110	0.790909	0.00805217	0.136987	0.701775	0.711689	0.0587829	1.06 [0.78 - 1.45]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P212497	110	0.8	0.00756401	0.130579	0.837713	0.209825	0.249507	1.28 [0.87 - 1.90]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225573_at	38	0.447368	0.00201734	0.0456165	1.61437	0.0125402	0.933728	2.54 [1.22 - 5.30]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222578_s_at	38	0.789474	0.000451752	0.0129922	1.69955	0.00425112	1.60471	4.98 [1.66 - 14.95]
GENE	ACAD11	acyl-CoA dehydrogenase family, member 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222579_at	38	0.842105	0.00200434	0.0453754	1.58927	0.0219355	0.879132	2.41 [1.14 - 5.11]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221669_s_at	30	0.7	0.0571384	-	-0.888629	0.0969927	-0.676693	0.51 [0.23 - 1.13]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1724699	165	0.169697	0.021214	0.279292	-0.653756	0.096698	-0.213037	0.81 [0.63 - 1.04]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1724699	165	0.739394	0.0029057	0.0613873	-1.89172	0.0237095	-0.428437	0.65 [0.45 - 0.94]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221669_s_at	163	0.177914	0.0182152	0.250745	-0.544152	0.446573	-0.222517	0.80 [0.45 - 1.42]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221669_s_at	79	0.455696	0.158301	-	-0.41092	0.82668	-0.068854	0.93 [0.50 - 1.73]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221669_s_at	58	0.672414	0.000492418	0.0139864	1.01248	0.208156	0.395087	1.48 [0.80 - 2.75]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221669_s_at	34	0.735294	0.0324899	0.373579	0.854498	0.73678	0.229812	1.26 [0.33 - 4.81]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221669_s_at	158	0.398734	0.0288039	0.344708	0.534608	0.173069	0.531654	1.70 [0.79 - 3.66]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221669_s_at	53	0.603774	0.000199786	0.00642137	1.31927	0.0162821	1.66102	5.26 [1.36 - 20.41]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221669_s_at	53	0.811321	0.000324927	0.00978787	1.32408	0.0457593	1.35299	3.87 [1.03 - 14.59]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221669_s_at	180	0.3	0.141371	-	-0.324412	0.654021	-0.182869	0.83 [0.37 - 1.85]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221669_s_at	559	0.397138	0.0833081	-	0.366526	0.832852	0.0549802	1.06 [0.63 - 1.76]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221669_s_at	77	0.662338	0.0589074	-	0.489044	0.575916	0.216431	1.24 [0.58 - 2.65]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221669_s_at	70	0.528571	0.033253	0.379351	0.569026	0.494111	0.173846	1.19 [0.72 - 1.96]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221669_s_at	74	0.824324	0.00493582	0.0936854	-1.37256	0.00792566	-1.3494	0.26 [0.10 - 0.70]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221669_s_at	67	0.104478	0.0856704	-	-1.19856	0.886863	-0.183181	0.83 [0.07 - 10.38]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221669_s_at	115	0.895652	0.0148275	0.216175	1.33542	0.0259461	1.58758	4.89 [1.21 - 19.78]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221669_s_at	204	0.789216	0.0962081	-	0.291162	0.776726	0.041541	1.04 [0.78 - 1.39]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221669_s_at	87	0.344828	0.00163211	0.0383182	-1.1444	0.00380241	-0.872126	0.42 [0.23 - 0.75]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221669_s_at	87	0.344828	0.00163211	0.0383182	-1.1444	0.00380241	-0.872126	0.42 [0.23 - 0.75]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221669_s_at	77	0.753247	0.0518863	-	-15.5277	0.256343	-0.578713	0.56 [0.21 - 1.52]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221669_s_at	77	0.753247	0.0251433	0.314258	-15.5394	0.231666	-0.533237	0.59 [0.24 - 1.41]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221669_s_at	136	0.367647	0.00724172	0.12628	-1.20645	0.0568927	-1.05374	0.35 [0.12 - 1.03]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221669_s_at	200	0.325	0.000119038	0.00408257	-1.09211	0.000973852	-1.27375	0.28 [0.13 - 0.60]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3190	60	0.816667	0.00526494	0.0985613	1.09405	0.225655	0.465587	1.59 [0.75 - 3.38]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3190	60	0.883333	0.141704	-	0.715377	0.256267	0.491971	1.64 [0.70 - 3.82]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	22366	155	0.690323	0.0010081	0.0256583	0.895071	0.0147674	0.57781	1.78 [1.12 - 2.84]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221669_s_at	286	0.384615	0.00403276	0.079838	-0.549369	0.0245192	-0.619126	0.54 [0.31 - 0.92]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221669_s_at	159	0.899371	3.44259e-05	0.00135924	1.56507	0.0169448	1.3333	3.79 [1.27 - 11.33]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221669_s_at	159	0.899371	0.000244352	0.00764944	1.3025	0.0159924	1.16245	3.20 [1.24 - 8.23]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221669_s_at	159	0.899371	0.00375364	0.0754021	1.09412	0.0687506	0.913971	2.49 [0.93 - 6.67]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221669_s_at	54	0.222222	0.0889316	-	15.4632	0.457447	0.287462	1.33 [0.62 - 2.85]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221669_s_at	117	0.598291	0.0195372	0.263547	0.727544	0.0634341	0.407388	1.50 [0.98 - 2.31]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221669_s_at	117	0.598291	0.0750015	-	0.663095	0.2422	0.298674	1.35 [0.82 - 2.22]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221669_s_at	117	0.153846	0.329448	-	-0.449372	0.995842	0.00131259	1.00 [0.61 - 1.64]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221669_s_at	117	0.598291	0.0195372	0.263547	0.727544	0.0634341	0.407388	1.50 [0.98 - 2.31]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221669_s_at	236	0.355932	0.00452839	0.0875275	-0.749099	0.0293028	-0.928795	0.40 [0.17 - 0.91]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221669_s_at	249	0.883534	0.0977297	-	-0.686193	0.166211	-0.453865	0.64 [0.33 - 1.21]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221669_s_at	62	0.274194	0.00360227	0.0729622	-1.34731	0.243008	-0.288601	0.75 [0.46 - 1.22]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221669_s_at	125	0.376	0.2044	-	0.583014	0.5717	0.146141	1.16 [0.70 - 1.92]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221669_s_at	125	0.864	0.154932	-	-0.62983	0.615385	-0.0991835	0.91 [0.62 - 1.33]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221669_s_at	54	0.240741	0.0135203	0.202066	-1.41459	0.250877	-0.345989	0.71 [0.39 - 1.28]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221669_s_at	198	0.868687	0.00905701	0.149819	0.778223	0.446764	0.15979	1.17 [0.78 - 1.77]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221669_s_at	198	0.868687	0.0815222	-	0.578406	0.869515	0.0365722	1.04 [0.67 - 1.60]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221669_s_at	198	0.858586	0.0512721	-	0.509543	0.238686	0.203378	1.23 [0.87 - 1.72]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221669_s_at	51	0.117647	0.0261842	0.323111	-1.78663	0.123162	-2.512	0.08 [0.00 - 1.98]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221669_s_at	62	0.322581	0.018479	0.253329	-1.29155	0.174333	-1.03458	0.36 [0.08 - 1.58]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221669_s_at	177	0.152542	0.016991	0.238561	1.32092	0.0826523	0.584525	1.79 [0.93 - 3.47]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221669_s_at	177	0.146893	0.00260903	0.0562622	1.59984	0.0570108	0.554852	1.74 [0.98 - 3.08]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221669_s_at	145	0.172414	0.0814854	-	1.00764	0.936824	-0.0326913	0.97 [0.43 - 2.17]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221669_s_at	226	0.106195	0.0104583	0.166991	-0.881295	0.31574	-0.351238	0.70 [0.35 - 1.40]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221669_s_at	55	0.363636	0.348525	-	-0.418758	0.535481	-0.276224	0.76 [0.32 - 1.82]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221669_s_at	55	0.545455	0.0764802	-	-0.8571	0.294484	-0.490649	0.61 [0.24 - 1.53]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221669_s_at	49	0.183673	0.0652279	-	-1.08165	0.109648	-0.944077	0.39 [0.12 - 1.24]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	210623	34	0.147059	0.014597	0.213721	15.4312	0.0396894	1.40566	4.08 [1.07 - 15.57]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	266343	34	0.529412	0.0810222	-	0.758808	0.125847	1.72842	5.63 [0.62 - 51.50]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221669_s_at	63	0.111111	0.0278088	0.336616	1.92551	0.285132	0.241625	1.27 [0.82 - 1.98]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12805020_3p_a_at	28	0.107143	0.191063	-	15.2012	0.98217	-0.0264152	0.97 [0.10 - 9.88]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221669_s_at	82	0.329268	0.00647333	0.115797	-0.892601	0.158177	-0.349853	0.70 [0.43 - 1.15]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221669_s_at	79	0.291139	0.0329539	0.377097	-0.582818	0.183869	-0.267255	0.77 [0.52 - 1.14]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221669_s_at	104	0.798077	0.0714295	-	-0.918799	0.194186	-0.355298	0.70 [0.41 - 1.20]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P47426	117	0.145299	0.214051	-	-0.456342	0.753171	-0.0436295	0.96 [0.73 - 1.26]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P4678	117	0.239316	0.090284	-	0.647958	0.903624	0.0186796	1.02 [0.75 - 1.38]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221669_s_at	204	0.254902	0.0156439	0.224757	-0.670626	0.363221	-0.239073	0.79 [0.47 - 1.32]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221669_s_at	204	0.117647	0.00337477	0.0692469	-1.1495	0.141815	-0.52521	0.59 [0.29 - 1.19]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221669_s_at	178	0.157303	0.0505995	-	-0.49392	0.872605	-0.0260583	0.97 [0.71 - 1.34]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221669_s_at	111	0.234234	0.024803	0.311328	0.831961	0.18145	0.255741	1.29 [0.89 - 1.88]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221669_s_at	90	0.455556	0.17756	-	0.450048	0.691128	0.0758555	1.08 [0.74 - 1.57]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221669_s_at	90	0.455556	0.137365	-	0.572987	0.771097	0.0643387	1.07 [0.69 - 1.65]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221669_s_at	138	0.115942	0.0658639	-	-0.597636	0.985526	-0.0015608	1.00 [0.84 - 1.18]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221669_s_at	129	0.496124	0.0991625	-	0.414934	0.611619	0.180837	1.20 [0.60 - 2.41]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35227	56	0.875	0.0624858	-	-1.27115	0.342716	-0.374435	0.69 [0.32 - 1.49]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35227	56	0.839286	0.0996148	-	-0.971074	0.681725	-0.170818	0.84 [0.37 - 1.91]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221669_s_at	278	0.140288	0.0369823	0.406641	0.633706	0.130056	0.24749	1.28 [0.93 - 1.76]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221669_s_at	133	0.894737	0.0219806	0.286318	-1.26214	0.118397	-0.158687	0.85 [0.70 - 1.04]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9482	81	0.111111	0.00795427	0.135712	-1.47217	0.0481473	-0.851147	0.43 [0.18 - 0.99]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221669_s_at	185	0.286486	0.129994	-	0.272884	0.349634	0.177431	1.19 [0.82 - 1.73]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221669_s_at	185	0.12973	0.0801436	-	0.492241	0.220338	0.249356	1.28 [0.86 - 1.91]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P47426	110	0.145455	0.0687264	-	-0.698814	0.90713	0.0308271	1.03 [0.61 - 1.73]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P4678	110	0.827273	0.260981	-	-0.351158	0.89511	-0.0242355	0.98 [0.68 - 1.40]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P47426	110	0.481818	0.0189817	0.258211	0.545822	0.624277	0.100344	1.11 [0.74 - 1.65]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P4678	110	0.109091	0.255211	-	0.679165	0.610567	0.12636	1.13 [0.70 - 1.85]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221669_s_at	80	0.7625	0.0878664	-	0.790031	0.232332	0.605545	1.83 [0.68 - 4.95]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221669_s_at	38	0.605263	0.02552	0.317481	1.08446	0.282716	0.490175	1.63 [0.67 - 3.99]
GENE	ACAD8	acyl-CoA dehydrogenase family, member 8	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221669_s_at	140	0.464286	0.000446872	0.0128719	-1.03419	0.00769696	-0.723988	0.48 [0.28 - 0.83]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1775579	165	0.181818	0.0504466	-	0.721031	0.134213	0.361446	1.44 [0.89 - 2.30]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1775579	165	0.193939	0.00318104	0.0660347	15.3901	0.0313565	0.84427	2.33 [1.08 - 5.02]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	224160_s_at	163	0.496933	0.158117	-	0.279597	0.642359	0.0868779	1.09 [0.76 - 1.57]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	239976_at	163	0.674847	0.0728204	-	-0.399892	0.384744	-0.914001	0.40 [0.05 - 3.15]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	224160_s_at	79	0.683544	0.0528862	-	0.584144	0.396466	0.22069	1.25 [0.75 - 2.08]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	239976_at	79	0.151899	0.0580398	-	-0.677597	0.333602	-0.944224	0.39 [0.06 - 2.64]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1557601_s_at	79	0.860759	0.072523	-	-0.906859	0.857835	-0.127207	0.88 [0.22 - 3.54]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	224160_s_at	180	0.433333	0.00488732	0.0929596	-0.583747	0.550556	-0.275174	0.76 [0.31 - 1.87]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	239976_at	180	0.111111	0.0418121	0.439898	-0.603052	0.11471	-0.299423	0.74 [0.51 - 1.08]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1557601_s_at	559	0.876565	0.194675	-	-0.412151	0.486866	-0.113793	0.89 [0.65 - 1.23]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	224160_s_at	559	0.649374	0.301968	-	0.214909	0.87919	-0.0626419	0.94 [0.42 - 2.11]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	239976_at	559	0.889088	0.000582144	0.0161327	0.838867	0.0648271	0.388395	1.47 [0.98 - 2.23]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	239976_at	77	0.87013	0.0382844	0.415828	0.706883	0.0869325	0.555381	1.74 [0.92 - 3.29]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	224160_s_at	77	0.727273	0.0760771	-	0.477434	0.708583	0.205162	1.23 [0.42 - 3.60]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1557601_s_at	70	0.128571	0.073977	-	-0.65343	0.474811	0.662311	1.94 [0.32 - 11.93]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	224160_s_at	70	0.857143	0.217622	-	0.432665	0.602489	0.244269	1.28 [0.51 - 3.20]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	239976_at	70	0.685714	0.000414295	0.0120632	0.969315	0.0115758	3.04944	21.10 [1.98 - 225.14]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	239976_at	74	0.891892	0.0304059	0.357463	0.872137	0.77394	-0.101045	0.90 [0.45 - 1.80]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	224160_s_at	74	0.594595	0.00489137	0.0930202	0.826612	0.0382043	1.62628	5.08 [1.09 - 23.67]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	239976_at	67	0.895522	0.0288204	0.344841	1.43649	0.0541551	4.67131	106.84 [0.92 - 12407.96]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1557601_s_at	67	0.343284	0.1419	-	-0.951921	0.4338	-2.13649	0.12 [0.00 - 24.87]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	224160_s_at	67	0.880597	0.268571	-	-15.2067	0.759645	-0.661415	0.52 [0.01 - 35.72]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1557601_s_at	115	0.573913	0.0976146	-	-1.03417	0.259417	-0.315776	0.73 [0.42 - 1.26]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	224160_s_at	115	0.869565	0.00325108	0.0672014	1.50069	0.146445	1.45259	4.27 [0.60 - 30.36]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	239976_at	115	0.2	0.0518817	-	15.3863	0.0861439	1.82867	6.23 [0.77 - 50.26]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	239976_at	204	0.833333	0.136092	-	-0.277773	0.808076	0.0213991	1.02 [0.86 - 1.21]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1557601_s_at	204	0.897059	0.058844	-	-0.430102	0.603904	-0.0460035	0.96 [0.80 - 1.14]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	224160_s_at	204	0.156863	0.0995091	-	0.316998	0.465962	0.195345	1.22 [0.72 - 2.06]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1557601_s_at	87	0.896552	0.150472	-	-1.3588	0.546082	-0.563066	0.57 [0.09 - 3.54]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1557601_s_at	87	0.896552	0.150472	-	-1.3588	0.546082	-0.563066	0.57 [0.09 - 3.54]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	224160_s_at	87	0.103448	0.149364	-	-0.699117	0.404598	-0.442697	0.64 [0.23 - 1.82]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	224160_s_at	87	0.103448	0.149364	-	-0.699117	0.404598	-0.442697	0.64 [0.23 - 1.82]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	239976_at	87	0.827586	0.0179869	0.248498	0.966119	0.441991	0.557782	1.75 [0.42 - 7.24]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	239976_at	87	0.827586	0.0179869	0.248498	0.966119	0.441991	0.557782	1.75 [0.42 - 7.24]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1557601_s_at	77	0.12987	0.0264844	0.325636	-1.25349	0.797696	-0.387916	0.68 [0.03 - 13.17]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	224160_s_at	77	0.883117	0.168236	-	-15.2187	0.951188	0.0487233	1.05 [0.22 - 5.00]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	239976_at	77	0.12987	0.0236935	0.301652	-1.27991	0.636694	-0.69144	0.50 [0.03 - 8.83]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	239976_at	77	0.12987	0.0456108	0.464574	-1.29953	0.711137	-0.619485	0.54 [0.02 - 14.28]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1557601_s_at	77	0.12987	0.0562697	-	-1.23933	0.820026	0.395033	1.48 [0.05 - 44.62]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	224160_s_at	77	0.181818	0.217166	-	-0.83163	0.510446	-0.589051	0.55 [0.10 - 3.21]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2746	60	0.2	0.0245778	0.30938	-0.88414	0.778466	0.114053	1.12 [0.51 - 2.48]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2746	60	0.85	0.390319	-	0.427068	0.946208	-0.0340722	0.97 [0.36 - 2.60]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224160_s_at	159	0.251572	0.00463705	0.0891835	1.5429	0.0083593	1.63216	5.11 [1.52 - 17.21]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224160_s_at	159	0.874214	0.000312426	0.00946207	1.20684	0.000110047	2.44478	11.53 [3.34 - 39.80]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224160_s_at	159	0.805031	0.000663083	0.0180197	1.20995	0.001483	2.31708	10.15 [2.43 - 42.36]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239976_at	159	0.867925	0.240657	-	-0.690699	0.805943	-0.077749	0.93 [0.50 - 1.72]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239976_at	159	0.861635	0.0883299	-	0.635114	0.460244	0.269591	1.31 [0.64 - 2.68]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239976_at	159	0.345912	0.173857	-	0.582344	0.810103	0.095933	1.10 [0.50 - 2.41]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	239976_at	236	0.822034	0.0172791	0.241458	0.707882	0.162401	0.679976	1.97 [0.76 - 5.12]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	224160_s_at	236	0.733051	0.0460708	0.46748	0.553978	0.265087	0.720387	2.06 [0.58 - 7.30]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	239976_at	249	0.863454	0.0300373	0.354557	0.577117	0.322627	0.365877	1.44 [0.70 - 2.98]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	224160_s_at	249	0.783133	0.0334079	0.380515	0.505614	0.213774	0.632061	1.88 [0.69 - 5.10]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	239976_at	177	0.80791	0.0419683	0.440937	-0.922824	0.188499	-1.20312	0.30 [0.05 - 1.80]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1557601_s_at	177	0.813559	0.0257802	0.319694	-1.00478	0.0560685	-1.53621	0.22 [0.04 - 1.04]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	224160_s_at	177	0.135593	0.0869802	-	0.715052	0.679604	0.175421	1.19 [0.52 - 2.74]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	224160_s_at	177	0.847458	0.0455605	0.464255	-1.0029	0.407164	-0.415669	0.66 [0.25 - 1.76]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	239976_at	177	0.265537	0.0181758	0.250358	-0.567495	0.082108	-1.39741	0.25 [0.05 - 1.19]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1557601_s_at	177	0.101695	0.00907967	0.150103	-0.779922	0.0453949	-1.38821	0.25 [0.06 - 0.97]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	224160_s_at	145	0.813793	0.0676508	-	-1.0535	0.276744	-0.680733	0.51 [0.15 - 1.73]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	239976_at	145	0.482759	0.0404166	0.430515	-0.697223	0.31095	-1.13338	0.32 [0.04 - 2.88]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1557601_s_at	145	0.337931	0.0718674	-	-0.592797	0.4271	-0.779187	0.46 [0.07 - 3.14]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1557601_s_at	226	0.59292	0.0764941	-	-0.52512	0.722384	-0.0802241	0.92 [0.59 - 1.44]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	224160_s_at	226	0.376106	0.0735451	-	-0.502608	0.467875	-0.402355	0.67 [0.23 - 1.98]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	239976_at	226	0.190265	0.0400027	0.427698	1.02672	0.471894	0.190394	1.21 [0.72 - 2.03]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	239976_at	55	0.472727	0.0215411	0.282303	-1.18362	0.157462	-2.78617	0.06 [0.00 - 2.94]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1557601_s_at	55	0.127273	0.0813885	-	-1.06459	0.395154	-1.43053	0.24 [0.01 - 6.47]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	224160_s_at	55	0.163636	0.032465	0.373389	15.3703	0.0679249	1.59235	4.92 [0.89 - 27.17]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	239976_at	49	0.102041	0.000609707	0.0167801	-1.85896	0.112647	-3.90366	0.02 [0.00 - 2.51]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1557601_s_at	49	0.326531	0.0142613	0.210121	-1.34393	0.136976	-2.81563	0.06 [0.00 - 2.45]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	224160_s_at	49	0.836735	0.0640407	-	1.0817	0.350642	1.01796	2.77 [0.33 - 23.47]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1557601_s_at	55	0.127273	0.0301457	0.355414	-1.07775	0.196317	-2.0122	0.13 [0.01 - 2.83]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	224160_s_at	55	0.818182	0.0574709	-	0.899142	0.400092	0.676449	1.97 [0.41 - 9.51]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	239976_at	55	0.454545	0.0332006	0.378957	-0.967182	0.138307	-2.81345	0.06 [0.00 - 2.48]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1557601_s_at	63	0.15873	0.00745384	0.129115	-1.00721	0.0869075	-19.843	0.00 [0.00 - 17.73]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	224160_s_at	63	0.52381	0.00387763	0.0773825	-1.02345	0.452371	-0.224418	0.80 [0.44 - 1.43]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	239976_at	63	0.333333	0.0042289	0.0829086	-0.942727	0.462899	-1.09437	0.33 [0.02 - 6.22]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.97377.2.A1_3p_s_at	28	0.214286	0.0350528	0.392708	-1.16467	0.597009	-0.187197	0.83 [0.41 - 1.66]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12804754_3p_a_at	28	0.428571	0.0812819	-	1.10266	0.970669	0.0313472	1.03 [0.19 - 5.49]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.156307.0.A1_3p_at	28	0.821429	0.0259283	0.32095	-15.5367	0.0724313	-1.96902	0.14 [0.02 - 1.20]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P132405	117	0.179487	0.0317232	0.367711	1.06985	0.0970269	0.683678	1.98 [0.88 - 4.44]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P191656	117	0.213675	0.245025	-	-0.37442	0.724812	0.105373	1.11 [0.62 - 2.00]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	239976_at	204	0.818627	0.062134	-	-1.27728	0.0286141	-0.729802	0.48 [0.25 - 0.93]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1557601_s_at	204	0.401961	0.0550309	-	-0.693392	0.0916016	-0.463708	0.63 [0.37 - 1.08]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	224160_s_at	204	0.529412	0.0087327	0.145728	1.0029	0.0239869	1.52687	4.60 [1.22 - 17.33]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	239976_at	204	0.112745	0.0506671	-	-0.672117	0.0404921	-0.573422	0.56 [0.33 - 0.98]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1557601_s_at	204	0.333333	0.0728874	-	-0.488982	0.291181	-0.207209	0.81 [0.55 - 1.19]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	224160_s_at	204	0.892157	0.000605326	0.0166776	1.07164	0.0159029	1.27335	3.57 [1.27 - 10.06]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300022077	41	0.560976	0.026297	0.324061	0.923524	0.162356	0.594818	1.81 [0.79 - 4.18]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300019965	41	0.829268	0.0384504	0.416987	0.956377	0.210972	0.506839	1.66 [0.75 - 3.67]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300022583	41	0.878049	0.0129029	0.195234	1.20819	0.137061	0.583687	1.79 [0.83 - 3.87]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300021406	41	0.804878	0.0650401	-	0.822643	0.236099	0.547257	1.73 [0.70 - 4.27]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	239976_at	111	0.468468	0.205084	-	-0.33251	0.8704	-0.0408723	0.96 [0.59 - 1.57]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1557601_s_at	111	0.441441	0.00214218	0.0479149	0.850821	0.357281	0.174757	1.19 [0.82 - 1.73]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	224160_s_at	111	0.783784	0.180817	-	-0.48019	0.865321	-0.0667698	0.94 [0.43 - 2.02]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1477	50	0.16	0.195771	-	1.25126	0.323669	0.422975	1.53 [0.66 - 3.54]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1557601_s_at	138	0.333333	0.00470988	0.0902879	-0.67152	0.270978	-2.91789	0.05 [0.00 - 9.75]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	224160_s_at	138	0.833333	0.0788547	-	-0.650946	0.510216	-0.124552	0.88 [0.61 - 1.28]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	239976_at	138	0.434783	0.0386999	0.418724	-0.495008	0.131681	-8.51912	0.00 [0.00 - 12.90]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35704	56	0.75	0.0603169	-	-0.751303	0.361772	-0.364459	0.69 [0.32 - 1.52]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9980	56	0.321429	0.169515	-	-0.482362	0.93013	0.0307881	1.03 [0.52 - 2.05]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35704	56	0.571429	0.088761	-	-0.631288	0.639765	-0.198911	0.82 [0.36 - 1.89]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9980	56	0.803571	0.123341	-	0.632672	0.664076	0.162221	1.18 [0.57 - 2.45]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	239976_at	278	0.669065	0.00148432	0.0354246	0.624514	0.00820831	0.796138	2.22 [1.23 - 4.00]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1557601_s_at	278	0.456835	0.00699996	0.123018	-0.50704	0.055619	-1.01287	0.36 [0.13 - 1.02]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	224160_s_at	278	0.392086	0.00564931	0.104152	0.568979	0.027744	0.412913	1.51 [1.05 - 2.18]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14356	81	0.481481	0.0489496	0.485285	1.10177	0.307368	0.499301	1.65 [0.63 - 4.30]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P191656	110	0.509091	0.00564626	0.104109	0.640117	0.145124	0.3772	1.46 [0.88 - 2.42]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P132405	110	0.845455	0.0310742	0.362688	0.604648	0.189983	0.32483	1.38 [0.85 - 2.25]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P191656	110	0.809091	0.02291	0.294699	0.743852	0.237729	0.410668	1.51 [0.76 - 2.98]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P132405	110	0.845455	0.00472575	0.0905278	0.930332	0.0821713	0.552527	1.74 [0.93 - 3.24]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1557601_s_at	38	0.657895	0.0387961	0.419392	-1.07555	0.667809	-0.121344	0.89 [0.51 - 1.54]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	224160_s_at	38	0.131579	0.0677048	-	1.74317	0.0694564	1.13892	3.12 [0.91 - 10.68]
GENE	ACAD9	acyl-CoA dehydrogenase family, member 9	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	239976_at	38	0.447368	0.0252776	0.315409	1.1984	0.533671	0.394708	1.48 [0.43 - 5.14]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202502_at	30	0.2	0.122277	-	-0.73921	0.228231	-0.524375	0.59 [0.25 - 1.39]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1778104	165	0.430303	0.053883	-	-0.461825	0.533641	-0.0767317	0.93 [0.73 - 1.18]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1778104	165	0.406061	0.0152173	0.220294	-0.848797	0.271304	-0.19575	0.82 [0.58 - 1.17]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202502_at	163	0.717791	0.112457	-	0.338178	0.692552	0.0436338	1.04 [0.84 - 1.30]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202502_at	79	0.886076	0.023919	0.303634	0.904215	0.188049	0.224388	1.25 [0.90 - 1.75]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202502_at	58	0.310345	0.11687	-	0.465742	0.522883	0.137445	1.15 [0.75 - 1.75]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202502_at	34	0.735294	0.000529647	0.0148844	1.44375	0.019648	0.645005	1.91 [1.11 - 3.28]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202502_at	158	0.126582	0.00883818	0.147064	-0.767655	0.185368	-0.22234	0.80 [0.58 - 1.11]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202502_at	53	0.150943	0.0741575	-	1.23069	0.932066	0.0307882	1.03 [0.51 - 2.09]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202502_at	53	0.886792	0.102129	-	-1.13205	0.814532	-0.0769378	0.93 [0.49 - 1.76]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202502_at	180	0.7	0.136849	-	-0.34926	0.528698	-0.149804	0.86 [0.54 - 1.37]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202502_at	559	0.202147	0.00125734	0.0308623	-0.698723	0.0428561	-0.457063	0.63 [0.41 - 0.99]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202502_at	77	0.896104	8.9376e-07	4.90588e-05	1.84143	0.0026997	1.19636	3.31 [1.51 - 7.23]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202502_at	70	0.328571	0.0522743	-	0.568477	0.277659	0.262496	1.30 [0.81 - 2.09]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37532_at	50	0.86	0.0171115	0.239775	1.00884	0.0735873	0.471674	1.60 [0.96 - 2.69]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202502_at	74	0.527027	0.223211	-	-0.359177	0.719919	-0.147296	0.86 [0.39 - 1.93]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202502_at	67	0.38806	0.0476555	0.477361	-1.30924	0.200626	-1.33097	0.26 [0.03 - 2.03]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202502_at	115	0.104348	0.169944	-	-0.870194	0.898144	-0.116125	0.89 [0.15 - 5.27]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37532_at	158	0.126582	0.0196205	0.264342	-0.760604	0.0670283	-0.454277	0.63 [0.39 - 1.03]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37532_at	76	0.828947	0.0694473	-	-15.3279	0.308107	-0.469849	0.63 [0.25 - 1.54]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202502_at	204	0.156863	0.175498	-	-0.266536	0.819064	-0.0335567	0.97 [0.73 - 1.29]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202502_at	87	0.287356	0.0163249	0.231789	-0.908919	0.191294	-0.533671	0.59 [0.26 - 1.31]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202502_at	87	0.287356	0.0163249	0.231789	-0.908919	0.191294	-0.533671	0.59 [0.26 - 1.31]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202502_at	77	0.480519	0.00028423	0.00871958	-16.5204	0.00389589	-1.04489	0.35 [0.17 - 0.72]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202502_at	77	0.337662	0.000157312	0.00521256	-2.09593	0.00189288	-1.04933	0.35 [0.18 - 0.68]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202502_at	136	0.470588	0.0841875	-	-0.784818	0.539636	-0.242454	0.78 [0.36 - 1.70]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202502_at	200	0.83	0.122342	-	0.530392	0.915458	-0.0368271	0.96 [0.49 - 1.90]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	965	60	0.633333	0.117851	-	-0.647165	0.392525	-0.178332	0.84 [0.56 - 1.26]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	965	60	0.233333	0.00982185	0.159289	-0.986189	0.467265	-0.198066	0.82 [0.48 - 1.40]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3280	155	0.496774	0.222342	-	-0.344971	0.930936	0.0225126	1.02 [0.61 - 1.70]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202502_at	286	0.15035	0.0383215	0.416087	0.675403	0.619541	0.10305	1.11 [0.74 - 1.67]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202502_at	159	0.534591	0.0087735	0.146245	-0.898773	0.207295	-0.448201	0.64 [0.32 - 1.28]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202502_at	159	0.238994	0.0198128	0.266172	-0.744654	0.12881	-0.529055	0.59 [0.30 - 1.17]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202502_at	159	0.534591	0.00967825	0.157529	-1.07216	0.110848	-0.641239	0.53 [0.24 - 1.16]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202502_at	54	0.722222	0.123031	-	-1.54786	0.176719	-0.517441	0.60 [0.28 - 1.26]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202502_at	117	0.880342	0.0226389	0.292269	0.887387	0.0970676	0.3802	1.46 [0.93 - 2.29]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202502_at	117	0.888889	0.0583431	-	0.906443	0.168535	0.375327	1.46 [0.85 - 2.48]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202502_at	117	0.470085	0.0387371	0.418982	-0.827332	0.858693	-0.0433283	0.96 [0.59 - 1.54]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202502_at	117	0.880342	0.0226389	0.292269	0.887387	0.0970676	0.3802	1.46 [0.93 - 2.29]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202502_at	236	0.110169	0.000605506	0.0166818	-1.11023	0.005477	-0.968492	0.38 [0.19 - 0.75]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202502_at	249	0.192771	5.56857e-05	0.00208648	-0.905468	0.000621694	-0.942001	0.39 [0.23 - 0.67]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202502_at	125	0.328	0.133586	-	0.552461	0.857337	0.0258237	1.03 [0.77 - 1.36]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202502_at	54	0.111111	0.0165206	0.233789	-1.50978	0.166965	-0.50736	0.60 [0.29 - 1.24]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202502_at	62	0.112903	0.0529454	-	-1.06766	0.17338	-0.41596	0.66 [0.36 - 1.20]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202502_at	125	0.104	0.0410979	0.435118	-0.980017	0.847767	0.0361845	1.04 [0.72 - 1.50]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202502_at	198	0.10101	0.026792	0.328208	-0.655911	0.138408	-0.230509	0.79 [0.59 - 1.08]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202502_at	198	0.328283	0.0944284	-	-0.432945	0.110492	-0.304001	0.74 [0.51 - 1.07]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202502_at	198	0.409091	0.162192	-	-0.371642	0.263785	-0.221142	0.80 [0.54 - 1.18]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202502_at	62	0.887097	0.156791	-	0.913116	0.888237	-0.0493775	0.95 [0.48 - 1.90]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202502_at	51	0.54902	0.212912	-	-1.30016	0.675681	-0.228416	0.80 [0.27 - 2.32]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202502_at	177	0.372881	0.0362925	0.401704	-0.562867	0.201444	-0.393443	0.67 [0.37 - 1.23]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202502_at	177	0.723164	0.0439172	0.453724	-0.608594	0.228449	-0.32317	0.72 [0.43 - 1.22]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202502_at	145	0.606897	0.00825214	0.139578	-1.06218	0.0902827	-0.600914	0.55 [0.27 - 1.10]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202502_at	226	0.588496	0.000232116	0.00731589	-1.26891	0.0104467	-0.787978	0.45 [0.25 - 0.83]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202502_at	55	0.527273	0.0567794	-	0.869088	0.184115	0.511446	1.67 [0.78 - 3.55]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202502_at	55	0.872727	0.0888774	-	0.958568	0.248358	0.506847	1.66 [0.70 - 3.93]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202502_at	49	0.857143	0.273131	-	0.7159	0.408677	0.395924	1.49 [0.58 - 3.80]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202502_at	63	0.634921	0.00851685	0.142979	-1.0322	0.142311	-0.194306	0.82 [0.64 - 1.07]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557230_3p_at	28	0.107143	5.49351e-05	0.00206148	-2.6203	0.112544	-0.396893	0.67 [0.41 - 1.10]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202502_at	82	0.109756	0.000574679	0.0159564	-1.37931	0.0423411	-0.83391	0.43 [0.19 - 0.97]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37532_at	84	0.440476	0.109678	-	0.479302	0.457474	0.233135	1.26 [0.68 - 2.34]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202502_at	79	0.379747	0.00391989	0.0780539	0.81665	0.261738	0.446411	1.56 [0.72 - 3.41]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M91432_at	86	0.174419	0.0183031	0.251608	-1.01905	0.443057	-0.340346	0.71 [0.30 - 1.70]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202502_at	104	0.451923	0.0110357	0.173845	0.880496	0.841331	0.0982053	1.10 [0.42 - 2.89]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P96761	117	0.897436	0.101359	-	0.658881	0.583848	0.138858	1.15 [0.70 - 1.89]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202502_at	204	0.102941	0.000155397	0.00515703	-1.39385	0.00163824	-2.16768	0.11 [0.03 - 0.44]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202502_at	204	0.279412	6.01053e-05	0.00223288	-1.04699	0.000126613	-1.99449	0.14 [0.05 - 0.38]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202502_at	178	0.191011	0.0884576	-	-0.395667	0.665868	-0.134012	0.87 [0.48 - 1.61]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202502_at	111	0.720721	0.0524688	-	-0.638552	0.840281	-0.061534	0.94 [0.52 - 1.71]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202502_at	90	0.611111	0.249197	-	0.372718	0.981464	0.00674353	1.01 [0.57 - 1.78]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202502_at	90	0.611111	0.123268	-	0.565795	0.738023	0.109691	1.12 [0.59 - 2.12]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2287	50	0.84	0.00304573	0.0637634	1.41652	0.0201473	1.167	3.21 [1.20 - 8.60]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202502_at	138	0.304348	0.126483	-	0.424925	0.278265	0.219749	1.25 [0.84 - 1.85]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202502_at	129	0.116279	0.00123809	0.030468	-1.02393	0.202871	-0.425238	0.65 [0.34 - 1.26]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38290	56	0.839286	0.0144364	0.212002	0.978475	0.183341	0.365631	1.44 [0.84 - 2.47]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41434	56	0.767857	0.000669648	0.0181709	1.26479	0.263209	0.393362	1.48 [0.74 - 2.95]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25814	56	0.678571	0.00319613	0.0662867	1.0537	0.352334	0.296697	1.35 [0.72 - 2.51]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38290	56	0.839286	0.0331828	0.378823	0.868022	0.185134	0.3771	1.46 [0.83 - 2.55]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25814	56	0.678571	0.00116065	0.0288698	1.20089	0.242076	0.390973	1.48 [0.77 - 2.85]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41434	56	0.767857	0.00189799	0.0433901	1.15271	0.336476	0.31842	1.37 [0.72 - 2.63]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202502_at	278	0.658273	0.0863983	-	-0.352458	0.426336	-0.173205	0.84 [0.55 - 1.29]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202502_at	133	0.142857	0.0110876	0.174455	-0.741761	0.0308565	-0.263065	0.77 [0.61 - 0.98]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1225	81	0.518519	0.0848192	-	0.919173	0.538365	0.372991	1.45 [0.44 - 4.76]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202502_at	185	0.405405	0.290072	-	0.191887	0.393676	0.104456	1.11 [0.87 - 1.41]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202502_at	185	0.362162	0.404926	-	0.142267	0.513942	0.0721049	1.07 [0.87 - 1.33]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P96761	110	0.718182	0.200601	-	-0.340388	0.634605	-0.0899916	0.91 [0.63 - 1.32]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P96761	110	0.363636	0.0367619	0.405069	0.711231	0.478927	0.165237	1.18 [0.75 - 1.86]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202502_at	80	0.8375	0.00376591	0.0755988	1.38852	0.203041	0.524902	1.69 [0.75 - 3.79]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1804	281	0.882562	0.20422	-	0.275739	0.57985	0.0939537	1.10 [0.79 - 1.53]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202502_at	38	0.236842	0.183841	-	0.75453	0.377255	0.535478	1.71 [0.52 - 5.61]
GENE	ACADM	acyl-CoA dehydrogenase, C-4 to C-12 straight chain	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202502_at	140	0.514286	0.0048601	0.0925514	-0.854227	0.0634572	-0.406226	0.67 [0.43 - 1.02]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202366_at	30	0.833333	0.0321911	0.3713	1.07199	0.216766	1.51866	4.57 [0.41 - 50.83]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1795104	165	0.230303	0.0975728	-	-0.436986	0.394296	-0.191226	0.83 [0.53 - 1.28]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1795104	165	0.272727	0.0509996	-	-0.689364	0.540568	-0.207477	0.81 [0.42 - 1.58]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202366_at	163	0.134969	0.156198	-	-0.384067	0.442917	-0.385324	0.68 [0.25 - 1.82]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202366_at	79	0.683544	0.0508338	-	-0.682294	0.168138	-0.8602	0.42 [0.12 - 1.44]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202366_at	58	0.810345	0.101441	-	-0.591757	0.393619	-0.209755	0.81 [0.50 - 1.31]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202366_at	34	0.852941	0.00364771	0.0736973	-2.46786	0.0159575	-1.62585	0.20 [0.05 - 0.74]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202366_at	158	0.56962	0.103875	-	0.373479	0.304182	0.679615	1.97 [0.54 - 7.21]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202366_at	53	0.113208	0.110064	-	1.10917	0.475347	0.28269	1.33 [0.61 - 2.88]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202366_at	53	0.132075	0.109627	-	1.11476	0.396558	0.369697	1.45 [0.62 - 3.40]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202366_at	180	0.811111	0.201765	-	0.327479	0.532301	-0.184812	0.83 [0.47 - 1.48]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202366_at	559	0.635063	0.0149695	0.21768	-0.548204	0.06547	-0.343324	0.71 [0.49 - 1.02]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202366_at	77	0.493506	0.152587	-	0.365874	0.706472	0.116457	1.12 [0.61 - 2.06]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202366_at	70	0.714286	0.233922	-	-0.357553	0.83707	-0.156504	0.86 [0.19 - 3.80]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39408_at	50	0.86	0.0451333	0.461539	0.835413	0.184789	1.07566	2.93 [0.60 - 14.37]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202366_at	74	0.635135	4.86607e-05	0.00185073	1.15476	0.0139379	0.880983	2.41 [1.20 - 4.87]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202366_at	67	0.507463	0.0538906	-	1.42554	0.413362	1.42697	4.17 [0.14 - 127.25]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202366_at	115	0.6	0.0363492	0.402112	-1.45985	0.139863	-0.907916	0.40 [0.12 - 1.35]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39408_at	158	0.873418	0.0498518	0.490734	-1.11287	0.789953	-0.0871975	0.92 [0.48 - 1.74]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39408_at	76	0.25	0.0937757	-	1.5692	0.936946	0.045317	1.05 [0.34 - 3.22]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202366_at	204	0.529412	0.0414579	0.437533	-0.282663	0.135041	-0.208036	0.81 [0.62 - 1.07]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202366_at	87	0.172414	0.00303559	0.0635922	-1.14318	0.0125704	-1.22021	0.30 [0.11 - 0.77]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202366_at	87	0.172414	0.00303559	0.0635922	-1.14318	0.0125704	-1.22021	0.30 [0.11 - 0.77]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202366_at	77	0.857143	0.135496	-	-15.2538	0.70984	-0.286012	0.75 [0.17 - 3.39]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202366_at	77	0.857143	0.195701	-	-15.2483	0.624471	-0.435083	0.65 [0.11 - 3.69]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202366_at	136	0.816176	0.0600481	-	0.909741	0.856623	-0.0816858	0.92 [0.38 - 2.24]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202366_at	200	0.175	0.0658718	-	0.92912	0.731443	-0.149314	0.86 [0.37 - 2.02]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9506	60	0.333333	0.028786	0.344563	-0.809078	0.137623	-0.285909	0.75 [0.52 - 1.10]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9506	60	0.133333	0.0330684	0.377961	-0.953861	0.701725	-0.0862654	0.92 [0.59 - 1.43]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16383	155	0.832258	0.000148513	0.00495659	1.05956	0.0121662	0.239883	1.27 [1.05 - 1.53]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202366_at	286	0.272727	0.27893	-	-0.228379	0.89111	-0.0312082	0.97 [0.62 - 1.52]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202366_at	159	0.314465	0.0792318	-	-0.554503	0.705157	-0.148084	0.86 [0.40 - 1.86]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202366_at	159	0.144654	0.215299	-	0.879528	0.9212	0.0465189	1.05 [0.42 - 2.63]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202366_at	159	0.144654	0.0717875	-	1.22777	0.532731	0.25463	1.29 [0.58 - 2.87]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202366_at	54	0.62963	0.0425745	0.44495	-1.87294	0.374846	-0.83441	0.43 [0.07 - 2.74]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202366_at	117	0.811966	0.0192262	0.260568	0.793161	0.450119	0.236155	1.27 [0.69 - 2.34]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202366_at	117	0.811966	0.00875823	0.146052	0.994273	0.209276	0.433386	1.54 [0.78 - 3.03]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202366_at	117	0.811966	0.000911149	0.0235692	1.26283	0.141509	0.531142	1.70 [0.84 - 3.45]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202366_at	117	0.811966	0.0192262	0.260568	0.793161	0.450119	0.236155	1.27 [0.69 - 2.34]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202366_at	236	0.36017	0.0182237	0.250829	-0.627981	0.0744662	-0.553208	0.58 [0.31 - 1.06]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202366_at	249	0.277108	0.0386853	0.418623	-0.457569	0.19995	-0.324999	0.72 [0.44 - 1.19]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202366_at	62	0.322581	0.151718	-	-0.677725	0.561815	-0.181221	0.83 [0.45 - 1.54]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202366_at	125	0.552	0.0904956	-	0.665869	0.767371	0.110624	1.12 [0.54 - 2.32]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202366_at	125	0.72	0.0776556	-	-0.593008	0.471247	-0.213895	0.81 [0.45 - 1.44]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202366_at	54	0.851852	0.0938922	-	-15.349	0.621201	-0.191137	0.83 [0.39 - 1.76]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202366_at	198	0.59596	0.0378159	0.412542	-0.565906	0.423976	-0.158646	0.85 [0.58 - 1.26]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202366_at	198	0.59596	0.0280639	0.338703	-0.639766	0.30199	-0.220819	0.80 [0.53 - 1.22]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202366_at	198	0.106061	0.131116	-	0.628335	0.602808	0.0909657	1.10 [0.78 - 1.54]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202366_at	51	0.588235	0.0514099	-	-15.9566	0.177472	-1.62557	0.20 [0.02 - 2.09]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202366_at	62	0.629032	0.0734839	-	-1.29679	0.26753	-0.775293	0.46 [0.12 - 1.81]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202366_at	177	0.694915	0.00785239	0.134379	-0.753974	0.137097	-0.619328	0.54 [0.24 - 1.22]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202366_at	145	0.662069	0.00015681	0.00519803	-1.95628	0.0272979	-1.43082	0.24 [0.07 - 0.85]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202366_at	177	0.694915	0.000178984	0.00583458	-1.48422	0.0246565	-1.15287	0.32 [0.12 - 0.86]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202366_at	226	0.460177	0.00467729	0.0897943	-0.813101	0.0230117	-0.4803	0.62 [0.41 - 0.94]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202366_at	55	0.690909	0.284173	-	-0.585643	0.958294	-0.0330036	0.97 [0.28 - 3.33]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202366_at	49	0.612245	0.033163	0.378674	1.23549	0.966505	0.0328645	1.03 [0.22 - 4.79]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202366_at	55	0.527273	0.0320226	0.370011	0.972989	0.913053	0.063558	1.07 [0.34 - 3.33]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202366_at	63	0.333333	0.000120512	0.00412694	1.80519	0.0253715	0.536696	1.71 [1.07 - 2.74]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557232_3p_at	28	0.75	0.00726342	0.126571	1.43048	0.0433907	1.29989	3.67 [1.04 - 12.95]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202366_at	82	0.573171	0.0163161	0.231699	-0.874281	0.216256	-0.872683	0.42 [0.10 - 1.67]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202366_at	79	0.177215	0.0992789	-	-0.518063	0.43748	-0.520361	0.59 [0.16 - 2.21]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202366_at	104	0.144231	0.000419395	0.0121905	-1.21171	0.0382897	-1.97187	0.14 [0.02 - 0.90]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P65022	117	0.290598	0.018273	0.251313	-0.680314	0.221007	-0.225654	0.80 [0.56 - 1.15]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202366_at	204	0.284314	0.00563314	0.103919	-0.974221	0.0461295	-1.33024	0.26 [0.07 - 0.98]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202366_at	204	0.264706	0.00144175	0.0345804	-0.851464	0.0135285	-1.20693	0.30 [0.11 - 0.78]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202366_at	178	0.140449	1.60895e-06	8.43059e-05	-1.16166	0.820993	0.116939	1.12 [0.41 - 3.10]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200020380	41	0.536585	0.170209	-	-0.580423	0.668764	-0.1627	0.85 [0.40 - 1.79]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202366_at	111	0.162162	0.0961501	-	-0.538734	0.446512	-0.229977	0.79 [0.44 - 1.44]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202366_at	90	0.577778	0.272442	-	-0.374014	0.762649	0.236024	1.27 [0.27 - 5.86]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202366_at	90	0.122222	0.239643	-	0.837391	0.675477	0.376435	1.46 [0.25 - 8.49]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4748	50	0.84	0.172304	-	-1.31167	0.878826	-0.0630597	0.94 [0.42 - 2.11]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202366_at	138	0.369565	0.0907492	-	-0.410648	0.18937	-0.377567	0.69 [0.39 - 1.20]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202366_at	129	0.217054	0.161421	-	0.477371	0.72294	0.16594	1.18 [0.47 - 2.95]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	150	56	0.75	0.042076	0.441652	0.730419	0.784519	0.113766	1.12 [0.50 - 2.53]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14414	56	0.696429	0.153388	-	0.507825	0.883485	0.057532	1.06 [0.49 - 2.29]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2857	56	0.875	0.030062	0.354753	1.15877	0.835187	0.086966	1.09 [0.48 - 2.48]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21427	56	0.142857	0.207463	-	-0.544369	0.837142	-0.0850397	0.92 [0.41 - 2.07]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11265	56	0.125	0.0893563	-	-0.714259	0.96235	0.0189235	1.02 [0.46 - 2.24]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	150	56	0.75	0.0643444	-	0.697571	0.91171	0.0501257	1.05 [0.43 - 2.55]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14414	56	0.107143	0.21916	-	-0.559212	0.880414	0.062372	1.06 [0.47 - 2.40]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31212	56	0.410714	0.0268234	0.328469	0.79647	0.33026	0.304721	1.36 [0.73 - 2.50]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3474	56	0.892857	0.0941926	-	0.886698	0.913	0.0422274	1.04 [0.49 - 2.23]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11265	56	0.892857	0.0169161	0.237805	1.25836	0.96163	0.0203658	1.02 [0.45 - 2.34]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2857	56	0.732143	0.10724	-	0.582761	0.674432	0.161388	1.18 [0.55 - 2.50]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21427	56	0.142857	0.0709872	-	-0.725682	0.784182	-0.107949	0.90 [0.41 - 1.94]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31212	56	0.410714	0.0124498	0.190146	0.956525	0.250819	0.380723	1.46 [0.76 - 2.80]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3474	56	0.892857	0.0169161	0.237805	1.25836	0.990222	0.00501343	1.01 [0.45 - 2.24]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202366_at	278	0.44964	0.0062378	0.112514	-0.512656	0.40873	-0.241523	0.79 [0.44 - 1.39]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202366_at	133	0.12782	0.0771742	-	0.737256	0.119989	0.525352	1.69 [0.87 - 3.28]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11061	81	0.283951	0.168865	-	1.00291	0.379178	0.334769	1.40 [0.66 - 2.95]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11497	81	0.876543	0.0291823	0.34775	1.21948	0.211319	0.69579	2.01 [0.67 - 5.97]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5155	81	0.333333	0.0478857	0.47878	-1.0056	0.481706	-0.38527	0.68 [0.23 - 1.99]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13639	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202366_at	185	0.691892	0.0977156	-	-0.3185	0.205512	-0.337626	0.71 [0.42 - 1.20]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202366_at	185	0.691892	0.0417221	0.439298	-0.360515	0.108317	-0.392336	0.68 [0.42 - 1.09]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P65022	110	0.445455	0.0394846	0.424148	-0.469964	0.329598	-0.188036	0.83 [0.57 - 1.21]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P65022	110	0.445455	0.192859	-	-0.385602	0.525173	-0.161396	0.85 [0.52 - 1.40]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202366_at	80	0.675	0.0708434	-	-0.972571	0.53055	-0.223827	0.80 [0.40 - 1.61]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1771	281	0.679715	0.0304704	0.35797	0.323326	0.366631	0.0851228	1.09 [0.91 - 1.31]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202366_at	38	0.684211	0.346369	-	0.477555	0.733514	0.25197	1.29 [0.30 - 5.49]
GENE	ACADS	acyl-CoA dehydrogenase, C-2 to C-3 short chain	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202366_at	140	0.135714	1.68405e-07	1.04385e-05	-1.4915	2.36688e-05	-1.82894	0.16 [0.07 - 0.37]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205355_at	30	0.133333	0.242762	-	0.843708	0.496983	0.350194	1.42 [0.52 - 3.90]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1740920	165	0.878788	0.139285	-	0.483108	0.695316	0.114751	1.12 [0.63 - 1.99]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1740920	165	0.89697	0.0687376	-	0.803519	0.386545	0.314059	1.37 [0.67 - 2.79]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205355_at	163	0.889571	0.0864073	-	-0.659282	0.66537	-0.161979	0.85 [0.41 - 1.77]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226030_at	163	0.883436	0.0697316	-	-0.656172	0.912208	0.0297972	1.03 [0.61 - 1.75]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205355_at	79	0.493671	0.055419	-	0.565041	0.42587	0.298164	1.35 [0.65 - 2.81]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226030_at	79	0.417722	0.048837	0.484601	0.620087	0.457158	0.20794	1.23 [0.71 - 2.13]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205355_at	58	0.775862	0.236925	-	0.380728	0.525205	-0.119955	0.89 [0.61 - 1.28]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205355_at	34	0.235294	0.231634	-	-0.507968	0.884833	0.0274645	1.03 [0.71 - 1.49]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205355_at	158	0.386076	0.139925	-	-0.344005	0.602252	-0.284809	0.75 [0.26 - 2.20]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205355_at	53	0.54717	0.00717631	0.125401	0.911701	0.182724	0.267126	1.31 [0.88 - 1.93]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205355_at	53	0.528302	0.0202805	0.270593	0.848482	0.331152	0.209255	1.23 [0.81 - 1.88]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205355_at	180	0.25	0.00629721	0.113345	-0.621373	0.00213745	-0.316543	0.73 [0.60 - 0.89]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226030_at	180	0.127778	0.00178039	0.0411667	-0.850159	0.190798	-0.428372	0.65 [0.34 - 1.24]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205355_at	559	0.202147	0.00740464	0.12846	-0.596346	0.175541	-0.290471	0.75 [0.49 - 1.14]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226030_at	559	0.19678	0.00217018	0.0484262	-0.701104	0.0566815	-0.491764	0.61 [0.37 - 1.01]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205355_at	77	0.545455	0.1668	-	0.355658	0.425357	0.130729	1.14 [0.83 - 1.57]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226030_at	77	0.220779	0.00608261	0.110331	-0.794406	0.00571989	-0.82857	0.44 [0.24 - 0.79]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205355_at	70	0.828571	0.174541	-	0.459974	0.730597	0.184132	1.20 [0.42 - 3.43]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226030_at	70	0.857143	0.237333	-	0.437971	0.7397	0.0982095	1.10 [0.62 - 1.97]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40673_at	50	0.52	0.0226978	0.292799	-0.80537	0.113524	-1.19804	0.30 [0.07 - 1.33]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205355_at	74	0.891892	0.0745825	-	0.77206	0.329303	0.237229	1.27 [0.79 - 2.04]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226030_at	74	0.675676	0.0193359	0.261621	-0.772727	0.0550157	-0.73184	0.48 [0.23 - 1.02]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205355_at	67	0.895522	0.00103499	0.0262307	2.04369	0.122963	1.57207	4.82 [0.65 - 35.51]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226030_at	67	0.895522	0.000506798	0.0143346	2.20469	0.56197	0.700237	2.01 [0.19 - 21.47]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205355_at	115	0.26087	0.039363	0.423312	-1.05137	0.11786	-0.463363	0.63 [0.35 - 1.12]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226030_at	115	0.2	0.00018776	0.0060833	-1.77577	0.0486558	-0.511648	0.60 [0.36 - 1.00]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40673_at	158	0.746835	0.0142593	0.2101	-0.923065	0.131626	-0.226618	0.80 [0.59 - 1.07]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40673_at	76	0.710526	0.0109589	0.172941	1.25754	0.51173	0.200604	1.22 [0.67 - 2.23]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226030_at	204	0.45098	7.90654e-08	5.15552e-06	-0.775137	2.66873e-06	-0.392249	0.68 [0.57 - 0.80]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205355_at	204	0.107843	1.87952e-05	0.000789849	-0.9762	1.90865e-05	-0.34064	0.71 [0.61 - 0.83]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226030_at	87	0.103448	0.190157	-	-0.694525	0.551493	-0.129024	0.88 [0.57 - 1.34]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205355_at	87	0.37931	0.0612472	-	0.837887	0.766868	-0.0676215	0.93 [0.60 - 1.46]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226030_at	87	0.103448	0.190157	-	-0.694525	0.551493	-0.129024	0.88 [0.57 - 1.34]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205355_at	87	0.37931	0.0612472	-	0.837887	0.766868	-0.0676215	0.93 [0.60 - 1.46]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226030_at	77	0.12987	0.0032705	0.0675238	-1.6944	0.012058	-0.755377	0.47 [0.26 - 0.85]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205355_at	77	0.103896	0.0232381	0.297623	-1.44123	0.0389538	-0.553796	0.57 [0.34 - 0.97]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205355_at	77	0.467532	0.0171959	0.240623	-1.44319	0.0346927	-0.503314	0.60 [0.38 - 0.96]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226030_at	77	0.155844	0.00513839	0.0966965	-1.46585	0.00617631	-0.718165	0.49 [0.29 - 0.82]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205355_at	136	0.448529	0.0194477	0.262692	1.22847	0.469535	0.231756	1.26 [0.67 - 2.36]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205355_at	200	0.265	0.00531997	0.0993684	-0.809658	0.166174	-0.22033	0.80 [0.59 - 1.10]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6470	60	0.833333	0.0391419	0.421787	-1.41988	0.823729	-0.0418795	0.96 [0.66 - 1.39]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6470	60	0.816667	0.0542521	-	-1.32402	0.531983	-0.125461	0.88 [0.60 - 1.31]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12070	155	0.174194	0.00162336	0.0381483	-0.960861	0.0357315	-0.350701	0.70 [0.51 - 0.98]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205355_at	286	0.125874	0.168429	-	0.475106	0.686326	0.0393363	1.04 [0.86 - 1.26]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205355_at	159	0.238994	0.00358446	0.0726734	-0.911452	0.0245736	-0.376975	0.69 [0.49 - 0.95]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205355_at	159	0.238994	0.000489299	0.0139106	-1.22064	0.0191506	-0.450204	0.64 [0.44 - 0.93]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205355_at	159	0.251572	0.00202641	0.0457845	-0.952554	0.138705	-0.259769	0.77 [0.55 - 1.09]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226030_at	159	0.358491	0.00206936	0.0465779	-0.945134	0.0865242	-0.313987	0.73 [0.51 - 1.05]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226030_at	159	0.36478	0.00125555	0.0308255	-0.993182	0.189926	-0.24873	0.78 [0.54 - 1.13]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226030_at	159	0.327044	3.45601e-05	0.00136398	-1.48114	0.0847083	-0.361871	0.70 [0.46 - 1.05]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205355_at	54	0.388889	0.0951681	-	-1.07469	0.869933	-0.0745994	0.93 [0.38 - 2.27]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205355_at	117	0.57265	0.0573724	-	0.595007	0.454658	0.124549	1.13 [0.82 - 1.57]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205355_at	117	0.709402	0.00344757	0.0704423	1.05742	0.0595598	0.358624	1.43 [0.99 - 2.08]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205355_at	117	0.57265	0.0393259	0.423056	0.80402	0.332793	0.207389	1.23 [0.81 - 1.87]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205355_at	117	0.57265	0.0573724	-	0.595007	0.454658	0.124549	1.13 [0.82 - 1.57]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205355_at	236	0.690678	0.0544699	-	-0.637975	0.393376	-0.114155	0.89 [0.69 - 1.16]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226030_at	236	0.309322	0.00419116	0.0823206	-0.758381	0.260114	-0.240304	0.79 [0.52 - 1.19]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205355_at	249	0.694779	0.0403259	0.429899	-0.514946	0.0616541	-0.205107	0.81 [0.66 - 1.01]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226030_at	249	0.100402	0.03332	0.379855	-0.651132	0.192981	-0.216703	0.81 [0.58 - 1.12]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205355_at	62	0.822581	0.0603684	-	0.91337	0.734168	0.0899869	1.09 [0.65 - 1.84]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205355_at	125	0.616	0.276639	-	-0.437854	0.694202	-0.0944999	0.91 [0.57 - 1.46]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205355_at	125	0.592	0.118722	-	-0.46311	0.384671	-0.162675	0.85 [0.59 - 1.23]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205355_at	54	0.814815	0.0205254	0.272891	1.27692	0.566886	0.186104	1.20 [0.64 - 2.28]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205355_at	198	0.121212	0.197142	-	0.656175	0.84215	-0.0185408	0.98 [0.82 - 1.18]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205355_at	198	0.121212	0.272021	-	0.562622	0.793167	-0.0250697	0.98 [0.81 - 1.18]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205355_at	198	0.89899	0.224787	-	-0.508247	0.726723	-0.027162	0.97 [0.84 - 1.13]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205355_at	51	0.372549	0.077361	-	15.8096	0.821068	0.19626	1.22 [0.22 - 6.67]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205355_at	62	0.322581	0.203979	-	-0.735365	0.340859	-0.733071	0.48 [0.11 - 2.17]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205355_at	177	0.745763	0.0031961	0.0662861	-1.29281	0.0537798	-0.472726	0.62 [0.39 - 1.01]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226030_at	177	0.717514	0.295318	-	-0.289821	0.65525	0.112696	1.12 [0.68 - 1.84]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226030_at	145	0.731034	0.00540705	0.100641	-1.52605	0.043218	-0.650086	0.52 [0.28 - 0.98]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205355_at	177	0.745763	0.0762773	-	-0.537182	0.598731	-0.105716	0.90 [0.61 - 1.33]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226030_at	177	0.830508	0.0415636	0.438239	-1.01551	0.434208	-0.223441	0.80 [0.46 - 1.40]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205355_at	145	0.517241	0.000372468	0.0110094	-1.38636	0.00628146	-0.836986	0.43 [0.24 - 0.79]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226030_at	226	0.300885	0.000321146	0.00968954	-0.993136	0.0420435	-0.530963	0.59 [0.35 - 0.98]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205355_at	226	0.256637	4.18747e-05	0.00161897	-1.10803	9.68086e-05	-0.676892	0.51 [0.36 - 0.71]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226030_at	55	0.181818	0.0590695	-	1.71975	0.490917	0.33891	1.40 [0.54 - 3.68]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226030_at	49	0.204082	0.0546218	-	15.4427	0.895121	0.0867247	1.09 [0.30 - 3.96]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205355_at	55	0.181818	0.0694379	-	1.66535	0.115198	0.515951	1.68 [0.88 - 3.18]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205355_at	55	0.890909	0.045325	0.462759	1.13509	0.194669	0.4857	1.63 [0.78 - 3.39]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205355_at	49	0.22449	0.0373082	0.408956	15.5169	0.261929	0.496682	1.64 [0.69 - 3.91]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226030_at	55	0.345455	0.0359835	0.399477	-0.968296	0.628972	0.259751	1.30 [0.45 - 3.72]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	241429	34	0.352941	0.0545104	-	0.968959	0.119817	1.03794	2.82 [0.76 - 10.44]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	243100	34	0.147059	0.228734	-	0.88054	0.779186	0.114379	1.12 [0.50 - 2.49]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205355_at	63	0.68254	0.0230534	0.295979	0.760923	0.785085	0.0738452	1.08 [0.63 - 1.83]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226030_at	63	0.761905	0.00549876	0.101975	0.965137	0.105635	0.260742	1.30 [0.95 - 1.78]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501858_3p_at	28	0.357143	0.0835396	-	-0.910317	0.620803	-0.452428	0.64 [0.11 - 3.82]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.11805.0.A1_3p_at	28	0.642857	0.0795965	-	-1.11045	0.482812	-0.850467	0.43 [0.04 - 4.59]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205355_at	82	0.329268	0.183268	-	0.510774	0.754992	0.046521	1.05 [0.78 - 1.40]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205355_at	79	0.873418	0.0396992	0.425621	0.715761	0.887736	0.0207615	1.02 [0.77 - 1.36]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U12778_at	86	0.302326	0.10896	-	-0.650507	0.509322	-0.233891	0.79 [0.40 - 1.59]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205355_at	104	0.259615	0.0501168	-	-0.645031	0.330463	-0.131214	0.88 [0.67 - 1.14]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P189516	117	0.179487	2.42611e-05	0.000993526	-1.21892	0.0348867	-0.356683	0.70 [0.50 - 0.98]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P31945	117	0.333333	0.0128396	0.194526	-0.701586	0.202702	-0.195158	0.82 [0.61 - 1.11]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P158570	117	0.837607	0.0989195	-	0.558923	0.743719	0.0499644	1.05 [0.78 - 1.42]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205355_at	204	0.186275	6.44825e-08	4.2607e-06	-1.39618	4.5685e-05	-0.923876	0.40 [0.25 - 0.62]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226030_at	204	0.544118	9.59043e-05	0.00337559	-1.8313	0.000513141	-0.959279	0.38 [0.22 - 0.66]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226030_at	204	0.411765	8.89275e-08	5.75403e-06	-1.46505	5.37565e-05	-0.838686	0.43 [0.29 - 0.65]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205355_at	204	0.637255	0.00122384	0.0301754	-1.7423	0.000576545	-1.05091	0.35 [0.19 - 0.64]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205355_at	178	0.578652	0.00230256	0.0508245	-0.628835	0.107542	-0.188684	0.83 [0.66 - 1.04]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006864	41	0.170732	0.0984235	-	1.1599	0.285699	0.369953	1.45 [0.73 - 2.86]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226030_at	111	0.162162	0.0196619	0.264737	-0.707742	0.17009	-0.235867	0.79 [0.56 - 1.11]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205355_at	111	0.108108	0.0321374	0.37089	-0.765879	0.652522	-0.110197	0.90 [0.55 - 1.45]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205355_at	90	0.744444	0.0223657	0.289809	0.75224	0.279643	1.17205	3.23 [0.39 - 27.03]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205355_at	90	0.722222	0.0245149	0.308835	0.82678	0.285331	1.32386	3.76 [0.33 - 42.63]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	5364	50	0.56	0.0385546	0.417713	-1.12143	0.280372	-0.474718	0.62 [0.26 - 1.47]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3416	50	0.68	0.0453065	0.462642	-1.39006	0.400146	-0.211683	0.81 [0.49 - 1.33]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226030_at	138	0.565217	0.0493662	0.487809	-0.488921	0.231681	-0.110477	0.90 [0.75 - 1.07]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205355_at	138	0.57971	0.00745429	0.129122	-0.690308	0.159891	-0.244913	0.78 [0.56 - 1.10]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205355_at	129	0.899225	0.0316448	0.367106	0.734247	0.72799	0.0536046	1.06 [0.78 - 1.43]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7342	56	0.196429	0.169156	-	0.66282	0.800259	0.0464244	1.05 [0.73 - 1.50]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35723	56	0.107143	0.0468166	0.472155	-1.0502	0.991197	-0.00221188	1.00 [0.67 - 1.48]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26958	56	0.178571	0.00156847	0.0370791	-1.22003	0.126396	-0.366697	0.69 [0.43 - 1.11]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5612	56	0.125	0.0413113	0.436551	-0.983573	0.940789	-0.0149866	0.99 [0.66 - 1.46]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29411	56	0.285714	0.281456	-	0.458336	0.889003	0.0269055	1.03 [0.70 - 1.50]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12956	56	0.285714	0.0505843	-	-0.69179	0.713251	-0.0748258	0.93 [0.62 - 1.38]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26958	56	0.214286	0.0417245	0.439314	-0.809005	0.247606	-0.298674	0.74 [0.45 - 1.23]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7342	56	0.410714	0.225053	-	-0.411999	0.954578	0.0102153	1.01 [0.71 - 1.44]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35723	56	0.107143	0.0134171	0.200931	-1.17142	0.580257	-0.110092	0.90 [0.61 - 1.32]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12956	56	0.285714	0.170795	-	-0.522348	0.913632	0.022275	1.02 [0.68 - 1.53]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5612	56	0.107143	0.0134171	0.200931	-1.17142	0.555194	-0.118197	0.89 [0.60 - 1.32]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29411	56	0.410714	0.126536	-	-0.517326	0.711832	-0.0708719	0.93 [0.64 - 1.36]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205355_at	278	0.100719	0.098333	-	-0.471667	0.634773	-0.107252	0.90 [0.58 - 1.40]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226030_at	278	0.169065	0.0607936	-	0.492989	0.531291	0.0844852	1.09 [0.84 - 1.42]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205355_at	133	0.556391	0.0350736	0.39286	0.494998	0.742498	0.0783757	1.08 [0.68 - 1.73]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3824	81	0.851852	0.0476905	0.477577	1.05274	0.600607	0.274927	1.32 [0.47 - 3.68]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18525	81	0.234568	0.200982	-	-0.699541	0.515556	-0.269781	0.76 [0.34 - 1.72]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205355_at	185	0.135135	0.245478	-	0.316282	0.629709	-0.193091	0.82 [0.38 - 1.81]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205355_at	185	0.135135	0.14617	-	0.455624	0.709982	-0.162691	0.85 [0.36 - 2.00]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P189516	110	0.736364	0.152331	-	-0.519673	0.519886	-0.120457	0.89 [0.61 - 1.28]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P158570	110	0.845455	0.033521	0.381363	0.592337	0.343548	0.138756	1.15 [0.86 - 1.53]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P31945	110	0.236364	0.276394	-	-0.289466	0.612324	0.0742079	1.08 [0.81 - 1.44]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P158570	110	0.254545	0.0108357	0.171485	-0.770955	0.568386	-0.100923	0.90 [0.64 - 1.28]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P189516	110	0.363636	0.0695283	-	0.45568	0.311587	0.148741	1.16 [0.87 - 1.55]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P31945	110	0.5	0.0120133	0.185186	-0.765112	0.481389	-0.134815	0.87 [0.60 - 1.27]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205355_at	80	0.825	0.0175158	0.243825	1.03469	0.656529	0.103737	1.11 [0.70 - 1.75]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_4290	281	0.113879	0.0345785	0.389223	-0.426797	0.0499769	-0.21633	0.81 [0.65 - 1.00]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:203736	59	0.118644	0.00027417	0.00845193	-1.84207	0.0214165	-2.78303	0.06 [0.01 - 0.66]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:297035	59	0.305085	0.0347541	0.390516	-1.03102	0.380601	-0.844192	0.43 [0.07 - 2.84]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226030_at	38	0.710526	0.00936404	0.15365	1.32932	0.16557	0.597245	1.82 [0.78 - 4.23]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205355_at	38	0.710526	0.0855073	-	0.916964	0.356132	0.413771	1.51 [0.63 - 3.64]
GENE	ACADSB	acyl-CoA dehydrogenase, short/branched chain	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205355_at	140	0.464286	6.77669e-05	0.00248351	-1.18468	0.000411301	-5.55677	0.00 [0.00 - 0.08]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205412_at	30	0.633333	0.00796527	0.135855	1.14361	0.32941	0.313688	1.37 [0.73 - 2.57]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1800008	165	0.278788	0.0466088	0.470857	0.576234	0.467871	0.0913526	1.10 [0.86 - 1.40]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1800008	165	0.278788	0.0268779	0.328923	1.12428	0.484604	0.129474	1.14 [0.79 - 1.64]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205412_at	163	0.417178	0.103988	-	-0.319374	0.571418	-0.0702858	0.93 [0.73 - 1.19]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205412_at	79	0.873418	0.00579087	0.106185	0.997168	0.324998	0.155901	1.17 [0.86 - 1.59]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554947_at	79	0.708861	0.21099	-	-0.428487	0.857085	-0.125813	0.88 [0.22 - 3.47]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1559239_s_at	79	0.607595	0.00449803	0.087063	0.811535	0.223239	0.748971	2.11 [0.63 - 7.06]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205412_at	58	0.103448	0.0970769	-	-0.718136	0.781398	-0.0789268	0.92 [0.53 - 1.61]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205412_at	34	0.588235	0.13991	-	0.564741	0.735012	0.134855	1.14 [0.52 - 2.50]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205412_at	158	0.531646	0.00714877	0.12503	-0.648478	0.132765	-0.27899	0.76 [0.53 - 1.09]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205412_at	53	0.339623	0.120966	-	-0.533607	0.250637	-0.606876	0.55 [0.19 - 1.53]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205412_at	53	0.339623	0.0470311	0.473491	-0.717857	0.192984	-0.745476	0.47 [0.15 - 1.46]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205412_at	180	0.105556	0.0314149	0.365331	1.05099	0.0947783	0.541469	1.72 [0.91 - 3.24]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205412_at	559	0.203936	0.100316	-	0.41803	0.752886	0.0671342	1.07 [0.70 - 1.62]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554947_at	559	0.695886	0.00133416	0.0324236	-0.770846	0.0409718	-0.256669	0.77 [0.60 - 0.99]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1559239_s_at	559	0.127013	0.00495012	0.093899	-0.704467	0.128864	-0.206361	0.81 [0.62 - 1.06]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205412_at	77	0.844156	0.0491581	0.486549	0.654479	0.530069	0.270394	1.31 [0.56 - 3.05]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205412_at	70	0.214286	0.0370754	0.407303	-0.626167	0.272671	-0.28627	0.75 [0.45 - 1.25]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554947_at	70	0.542857	0.160436	-	-0.372477	0.728995	-0.538593	0.58 [0.03 - 12.28]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1559239_s_at	70	0.485714	0.112666	-	0.417586	0.449486	0.65507	1.93 [0.35 - 10.51]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39678_at	50	0.48	0.00234782	0.0516375	-1.05184	0.0899038	-1.40712	0.24 [0.05 - 1.24]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205412_at	74	0.621622	0.00104779	0.0265023	-1.04415	0.00405351	-1.61888	0.20 [0.07 - 0.60]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1559239_s_at	67	0.895522	0.00852963	0.143143	1.71006	0.00888508	2.53822	12.66 [1.89 - 84.74]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554947_at	67	0.761194	0.244592	-	0.812911	0.961853	0.191637	1.21 [0.00 - 3117.63]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205412_at	67	0.865672	0.0117184	0.181798	1.62157	0.0751722	2.01838	7.53 [0.81 - 69.52]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205412_at	115	0.452174	0.137087	-	-0.807615	0.14379	-0.848377	0.43 [0.14 - 1.34]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1559239_s_at	115	0.782609	0.166838	-	-1.33387	0.636797	-0.192227	0.83 [0.37 - 1.83]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554947_at	115	0.104348	0.108561	-	-0.999511	0.787563	-0.18979	0.83 [0.21 - 3.29]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39678_at	158	0.78481	0.0732942	-	-0.720338	0.755587	0.0641032	1.07 [0.71 - 1.60]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39678_at	76	0.473684	0.0988279	-	-0.877445	0.702868	-0.139882	0.87 [0.42 - 1.78]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1559239_s_at	204	0.210784	0.00668294	0.118691	-0.470302	0.204303	-0.0890839	0.91 [0.80 - 1.05]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554947_at	204	0.661765	0.114869	-	-0.24085	0.870779	0.0117695	1.01 [0.88 - 1.17]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205412_at	204	0.22549	0.00635569	0.114162	0.464796	0.142967	0.224133	1.25 [0.93 - 1.69]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205412_at	87	0.103448	0.189573	-	-0.695933	0.432448	-0.245904	0.78 [0.42 - 1.44]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1559239_s_at	87	0.793103	0.0307996	0.360547	0.853802	0.592327	0.268791	1.31 [0.49 - 3.50]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554947_at	87	0.448276	0.132305	-	0.586743	0.870736	0.250157	1.28 [0.06 - 26.14]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554947_at	87	0.448276	0.132305	-	0.586743	0.870736	0.250157	1.28 [0.06 - 26.14]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1559239_s_at	87	0.793103	0.0307996	0.360547	0.853802	0.592327	0.268791	1.31 [0.49 - 3.50]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205412_at	87	0.103448	0.189573	-	-0.695933	0.432448	-0.245904	0.78 [0.42 - 1.44]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554947_at	77	0.454545	0.191323	-	-0.728932	0.453444	-1.62044	0.20 [0.00 - 13.68]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559239_s_at	77	0.103896	0.0973791	-	-1.04509	0.582702	-0.617844	0.54 [0.06 - 4.88]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205412_at	77	0.155844	0.0121349	0.186574	-1.48501	0.108678	-0.917327	0.40 [0.13 - 1.23]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559239_s_at	77	0.103896	0.0221726	0.288061	-1.45286	0.176552	-1.65271	0.19 [0.02 - 2.10]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554947_at	77	0.12987	0.0789765	-	-1.14938	0.216124	-3.1195	0.04 [0.00 - 6.19]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205412_at	77	0.155844	0.0636183	-	-1.06683	0.205394	-0.603842	0.55 [0.21 - 1.39]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205412_at	136	0.558824	0.151177	-	0.646093	0.625735	0.194065	1.21 [0.56 - 2.65]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205412_at	200	0.105	0.0648131	-	-0.705137	0.68707	-0.16094	0.85 [0.39 - 1.86]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16895	60	0.866667	0.0597111	-	0.842626	0.264364	0.27316	1.31 [0.81 - 2.12]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16895	60	0.133333	0.0318829	0.368939	-0.963794	0.652813	-0.18361	0.83 [0.37 - 1.85]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21273	155	0.748387	1.97255e-05	0.000824935	1.1291	0.0810163	0.246276	1.28 [0.97 - 1.69]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205412_at	286	0.202797	0.206693	-	-0.28346	0.662465	-0.101324	0.90 [0.57 - 1.42]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205412_at	159	0.220126	0.0330736	0.378	-0.693083	0.361345	-0.378975	0.68 [0.30 - 1.54]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205412_at	159	0.528302	0.146148	-	-0.560467	0.752035	-0.148795	0.86 [0.34 - 2.17]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205412_at	159	0.213836	0.0657707	-	-0.611779	0.780139	-0.111519	0.89 [0.41 - 1.96]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205412_at	54	0.611111	0.0404058	0.430441	-1.91775	0.395779	-0.231422	0.79 [0.47 - 1.35]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205412_at	117	0.162393	0.025176	0.314539	-0.778597	0.544181	-0.094293	0.91 [0.67 - 1.23]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205412_at	117	0.461538	0.120521	-	-0.592179	0.752919	-0.0585497	0.94 [0.66 - 1.36]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205412_at	117	0.461538	0.0233603	0.298707	-0.909099	0.145357	-0.260179	0.77 [0.54 - 1.09]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205412_at	117	0.162393	0.025176	0.314539	-0.778597	0.544181	-0.094293	0.91 [0.67 - 1.23]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205412_at	236	0.661017	0.0790827	-	-0.550818	0.32334	-0.359983	0.70 [0.34 - 1.43]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205412_at	249	0.554217	0.203408	-	0.268731	0.776279	0.0844505	1.09 [0.61 - 1.95]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205412_at	62	0.887097	0.410252	-	0.521085	0.849737	-0.0570406	0.94 [0.52 - 1.70]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205412_at	125	0.64	0.0231333	0.296691	0.846139	0.492224	0.195555	1.22 [0.70 - 2.12]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205412_at	125	0.592	0.0830407	-	0.49514	0.978712	0.00565742	1.01 [0.66 - 1.52]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205412_at	54	0.277778	0.114846	-	-0.91315	0.601569	-0.196779	0.82 [0.39 - 1.72]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205412_at	198	0.843434	0.00729465	0.12699	-1.4571	0.206324	-0.257736	0.77 [0.52 - 1.15]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205412_at	198	0.843434	0.0142706	0.210222	-1.35009	0.231382	-0.25325	0.78 [0.51 - 1.18]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205412_at	198	0.580808	0.0108076	0.171151	-0.562188	0.385151	-0.140682	0.87 [0.63 - 1.19]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205412_at	51	0.588235	0.0470445	0.473575	-15.9903	0.602461	-0.284895	0.75 [0.26 - 2.20]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205412_at	62	0.741935	0.0203713	0.271446	-15.6147	0.839413	-0.0755277	0.93 [0.45 - 1.93]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1559239_s_at	177	0.841808	0.0138314	0.205467	-1.35751	0.267879	-1.06803	0.34 [0.05 - 2.27]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554947_at	177	0.446328	0.118692	-	-0.366415	0.975698	-0.0454147	0.96 [0.05 - 17.75]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554947_at	177	0.40678	0.219718	-	-0.333158	0.774061	0.4899	1.63 [0.06 - 46.28]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1559239_s_at	177	0.841808	0.00967893	0.157538	-1.13845	0.259938	-0.928886	0.39 [0.08 - 1.99]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205412_at	177	0.60452	0.109898	-	0.43464	0.471397	0.197262	1.22 [0.71 - 2.08]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205412_at	145	0.827586	0.136247	-	-0.87199	0.856395	-0.0583832	0.94 [0.50 - 1.78]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554947_at	145	0.193103	0.0630437	-	-0.660661	0.722425	-0.754039	0.47 [0.01 - 30.16]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1559239_s_at	145	0.475862	0.0218552	0.285176	-0.777571	0.114856	-1.90893	0.15 [0.01 - 1.59]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205412_at	177	0.553672	0.0149642	0.217624	0.570344	0.183435	0.315378	1.37 [0.86 - 2.18]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554947_at	226	0.243363	0.0316473	0.367126	-0.626019	0.337647	-0.113471	0.89 [0.71 - 1.13]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1559239_s_at	226	0.880531	0.07332	-	-1.218	0.830765	-0.0290553	0.97 [0.74 - 1.27]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205412_at	226	0.70354	0.00645545	0.11555	-1.06038	0.206904	-0.332615	0.72 [0.43 - 1.20]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205412_at	55	0.218182	0.124737	-	1.0906	0.298115	0.362054	1.44 [0.73 - 2.84]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1559239_s_at	55	0.418182	0.014094	0.208316	-1.20083	0.370718	-1.56608	0.21 [0.01 - 6.44]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554947_at	55	0.818182	0.141378	-	-1.40737	0.765459	-0.584068	0.56 [0.01 - 25.88]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1559239_s_at	49	0.244898	0.0647919	-	-1.04936	0.946341	0.129005	1.14 [0.03 - 48.71]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554947_at	49	0.183673	0.125931	-	-0.908273	0.942027	-0.180026	0.84 [0.01 - 106.91]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205412_at	55	0.781818	0.122162	-	0.752908	0.816308	0.0872179	1.09 [0.52 - 2.28]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205412_at	49	0.77551	0.0701245	-	1.0296	0.398103	0.412759	1.51 [0.58 - 3.94]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554947_at	55	0.818182	0.316089	-	-0.731012	0.621637	0.999288	2.72 [0.05 - 143.72]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1559239_s_at	55	0.163636	0.0991384	-	-0.831691	0.851247	-0.272439	0.76 [0.04 - 13.13]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554947_at	63	0.174603	0.000709335	0.0190796	-1.21341	0.253975	-3.79111	0.02 [0.00 - 15.22]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1559239_s_at	63	0.206349	0.000179405	0.00584655	-1.28554	0.0127851	-9.8208	0.00 [0.00 - 0.12]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205412_at	63	0.238095	0.259451	-	0.474651	0.846258	0.0306149	1.03 [0.76 - 1.41]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.397519.1.S1_3p_s_at	28	0.142857	0.0685508	-	-1.19105	0.73634	-0.426985	0.65 [0.05 - 7.83]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557236_3p_s_at	28	0.714286	0.0311404	0.363202	1.13447	0.274499	0.862865	2.37 [0.50 - 11.14]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.37.2.S1_3p_at	28	0.571429	0.123424	-	-0.924564	0.424734	-0.933373	0.39 [0.04 - 3.89]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205412_at	82	0.170732	0.149306	-	-0.575288	0.373068	-0.363436	0.70 [0.31 - 1.55]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205412_at	79	0.101266	0.00349008	0.0711374	-1.08355	0.34852	-0.266297	0.77 [0.44 - 1.34]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D10511_at	86	0.209302	0.032406	0.37294	-0.90929	0.942432	0.029305	1.03 [0.46 - 2.28]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205412_at	104	0.817308	0.126122	-	-0.893564	0.687349	-0.140105	0.87 [0.44 - 1.72]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P203678	117	0.247863	0.0204963	0.272618	-0.684046	0.40684	-0.190934	0.83 [0.53 - 1.30]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P24515	117	0.179487	0.0025992	0.0560901	-0.922822	0.198091	-0.279544	0.76 [0.49 - 1.16]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205412_at	204	0.54902	0.00763061	0.13146	-0.776015	0.11986	-0.57093	0.56 [0.28 - 1.16]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1559239_s_at	204	0.362745	0.00187073	0.0428774	-1.10388	0.00896716	-0.539476	0.58 [0.39 - 0.87]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554947_at	204	0.436274	0.00105778	0.0267137	-1.22797	0.302305	-0.207118	0.81 [0.55 - 1.20]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1559239_s_at	204	0.436274	0.0017251	0.0401106	-0.849885	0.00766011	-0.417731	0.66 [0.48 - 0.90]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554947_at	204	0.436274	0.00414927	0.0816664	-0.775351	0.0541316	-0.28581	0.75 [0.56 - 1.01]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205412_at	204	0.504902	0.00255164	0.0552554	-1.22582	0.0511947	-0.982595	0.37 [0.14 - 1.01]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205412_at	178	0.292135	0.00153792	0.0364807	-0.644522	0.0193985	-0.587931	0.56 [0.34 - 0.91]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1559239_s_at	111	0.171171	0.0104487	0.166876	-0.777254	0.843687	-0.0335062	0.97 [0.69 - 1.35]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554947_at	111	0.108108	0.017098	0.239639	-0.887995	0.086115	-0.270122	0.76 [0.56 - 1.04]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205412_at	111	0.162162	0.0617483	-	-0.616386	0.587379	-0.139336	0.87 [0.53 - 1.44]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205412_at	90	0.844444	0.0453084	0.462654	0.748251	0.343886	0.286305	1.33 [0.74 - 2.41]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205412_at	90	0.855556	0.0235079	0.300014	0.949417	0.656508	0.154076	1.17 [0.59 - 2.30]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554947_at	138	0.246377	0.0241449	0.305613	-0.564057	0.328749	-2.63762	0.07 [0.00 - 14.24]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1559239_s_at	138	0.253623	0.00668945	0.118781	-0.664654	0.164701	-1.74839	0.17 [0.01 - 2.05]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205412_at	138	0.318841	0.0237586	0.302225	-0.550081	0.199081	-0.180105	0.84 [0.63 - 1.10]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205412_at	129	0.79845	0.00200817	0.0454465	0.822357	0.188534	0.423135	1.53 [0.81 - 2.87]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32401	56	0.196429	0.0070848	0.124167	-1.04081	0.139576	-0.491667	0.61 [0.32 - 1.17]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9708	56	0.178571	0.0302961	0.356599	-0.877234	0.245519	-0.385926	0.68 [0.35 - 1.30]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32401	56	0.196429	0.0179963	0.248591	-0.909661	0.11039	-0.520413	0.59 [0.31 - 1.13]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6421	56	0.857143	0.00571511	0.105099	1.10725	0.453431	0.225613	1.25 [0.69 - 2.26]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9708	56	0.178571	0.0626281	-	-0.750295	0.198343	-0.41903	0.66 [0.35 - 1.25]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6421	56	0.875	0.0209323	0.276684	0.974409	0.730527	0.104274	1.11 [0.61 - 2.01]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1559239_s_at	278	0.467626	0.0102496	0.164482	-0.484737	0.155072	-0.572894	0.56 [0.26 - 1.24]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554947_at	278	0.881295	0.0153297	0.221474	0.636102	0.595236	0.417591	1.52 [0.33 - 7.09]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205412_at	278	0.888489	0.132394	-	-0.544448	0.481272	-0.1117	0.89 [0.66 - 1.22]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205412_at	133	0.210526	0.0390474	0.421133	-0.547849	0.333135	-0.101353	0.90 [0.74 - 1.11]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12928	81	0.839506	0.0247	0.310439	1.16667	0.245807	0.567261	1.76 [0.68 - 4.60]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1394	81	0.592593	0.164689	-	-0.754149	0.750579	-0.133335	0.88 [0.38 - 1.99]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11939	81	0.17284	0.155133	-	-0.823716	0.491899	0.323354	1.38 [0.55 - 3.47]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205412_at	185	0.87027	0.163585	-	0.323508	0.488504	0.074209	1.08 [0.87 - 1.33]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205412_at	185	0.87027	0.204109	-	0.31771	0.577524	0.0646327	1.07 [0.85 - 1.34]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P203678	110	0.436364	0.0749077	-	0.421403	0.503738	0.0897186	1.09 [0.84 - 1.42]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P24515	110	0.245455	0.036781	0.405205	0.77881	0.234985	0.232123	1.26 [0.86 - 1.85]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P203678	110	0.372727	0.0613704	-	0.602557	0.436895	0.136831	1.15 [0.81 - 1.62]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P24515	110	0.245455	0.0271391	0.331094	0.634517	0.236031	0.18255	1.20 [0.89 - 1.62]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205412_at	80	0.725	0.161545	-	-0.848528	0.894242	-0.0493926	0.95 [0.46 - 1.97]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1382	281	0.565836	0.0184671	0.253213	0.331501	0.414899	0.141771	1.15 [0.82 - 1.62]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205412_at	38	0.815789	0.00835956	0.140962	1.41142	0.0429194	0.982617	2.67 [1.03 - 6.92]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1559239_s_at	38	0.105263	0.0791426	-	15.2839	0.823611	0.0470074	1.05 [0.69 - 1.58]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554947_at	38	0.631579	0.175489	-	-0.680426	0.789361	-0.0777932	0.93 [0.52 - 1.64]
GENE	ACAT1	acetyl-CoA acetyltransferase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205412_at	140	0.428571	3.94045e-05	0.0015335	-1.19923	3.67046e-05	-0.925677	0.40 [0.26 - 0.62]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209608_s_at	30	0.833333	0.187325	-	-0.807273	0.216242	-0.704901	0.49 [0.16 - 1.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	222011_s_at	30	0.133333	0.179857	-	-0.744709	0.912789	-0.0706099	0.93 [0.26 - 3.30]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	222010_at	30	0.333333	0.0339557	0.384609	-0.879854	0.167566	-0.925846	0.40 [0.11 - 1.48]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1708672	165	0.866667	0.00865817	0.144781	0.769123	0.101082	0.233829	1.26 [0.96 - 1.67]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1708672	165	0.872727	0.0102782	0.164827	1.00522	0.382305	0.182506	1.20 [0.80 - 1.81]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	222010_at	163	0.662577	0.000449325	0.0129324	0.694425	0.0872385	0.366966	1.44 [0.95 - 2.20]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	222011_s_at	163	0.546012	0.0772876	-	0.349013	0.527931	0.139532	1.15 [0.75 - 1.77]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209608_s_at	163	0.895706	0.00381981	0.076461	0.798244	0.434927	0.205743	1.23 [0.73 - 2.06]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222011_s_at	79	0.139241	0.187377	-	0.615752	0.598157	0.165574	1.18 [0.64 - 2.18]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222010_at	79	0.746835	0.0776563	-	0.557383	0.16358	0.459972	1.58 [0.83 - 3.03]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209608_s_at	79	0.683544	0.0617569	-	0.55341	0.277589	0.342163	1.41 [0.76 - 2.61]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209608_s_at	58	0.103448	0.0183533	0.252099	-1.04912	0.270889	-0.375975	0.69 [0.35 - 1.34]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222011_s_at	58	0.758621	0.0210547	0.277819	0.736018	0.174889	0.43259	1.54 [0.82 - 2.88]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222010_at	58	0.827586	0.0248294	0.311557	0.82464	0.18015	0.52069	1.68 [0.79 - 3.60]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209608_s_at	34	0.823529	0.298286	-	0.525334	0.76684	0.135071	1.14 [0.47 - 2.80]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222011_s_at	34	0.676471	0.112114	-	-0.664427	0.509375	-0.429883	0.65 [0.18 - 2.33]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222010_at	34	0.647059	0.327156	-	0.395213	0.564658	0.475105	1.61 [0.32 - 8.10]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	222011_s_at	158	0.367089	0.0183146	0.25172	-0.544525	0.179933	-0.333265	0.72 [0.44 - 1.17]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209608_s_at	158	0.234177	0.0610227	-	-0.481925	0.338345	-0.263377	0.77 [0.45 - 1.32]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	222010_at	158	0.310127	0.0735014	-	-0.426042	0.382688	-0.221693	0.80 [0.49 - 1.32]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	222010_at	53	0.584906	0.116026	-	-0.601574	0.425891	-0.5497	0.58 [0.15 - 2.23]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209608_s_at	53	0.226415	0.127515	-	-0.56779	0.510883	-0.287675	0.75 [0.32 - 1.77]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	222010_at	53	0.207547	0.0975082	-	-0.637187	0.842848	-0.130315	0.88 [0.24 - 3.18]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209608_s_at	53	0.226415	0.0285353	0.342537	-0.828162	0.359428	-0.430194	0.65 [0.26 - 1.63]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	222011_s_at	53	0.471698	0.325786	-	0.341338	0.852423	0.0885203	1.09 [0.43 - 2.78]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	222011_s_at	53	0.792453	0.129578	-	-0.794204	0.577538	-0.273119	0.76 [0.29 - 1.99]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209608_s_at	180	0.127778	0.000235829	0.0074174	-0.971002	0.0565862	-0.719838	0.49 [0.23 - 1.02]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	222010_at	180	0.833333	0.0290968	0.347065	0.546471	0.243291	0.473305	1.61 [0.72 - 3.56]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	222011_s_at	180	0.277778	0.0791676	-	-0.394747	0.772792	-0.11108	0.89 [0.42 - 1.90]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222011_s_at	559	0.740608	0.000350672	0.0104527	0.70619	0.00505471	1.02305	2.78 [1.36 - 5.69]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222010_at	559	0.783542	0.118255	-	0.359643	0.727986	0.110856	1.12 [0.60 - 2.09]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209608_s_at	559	0.794275	0.0339948	0.3849	0.463248	0.0489873	0.467833	1.60 [1.00 - 2.54]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209608_s_at	77	0.662338	0.0916329	-	0.446584	0.539667	0.172476	1.19 [0.68 - 2.06]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	222011_s_at	77	0.792208	0.118403	-	0.480256	0.701973	-0.136945	0.87 [0.43 - 1.76]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	222010_at	77	0.467532	0.0150096	0.218104	-0.615144	0.117067	-0.5861	0.56 [0.27 - 1.16]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222010_at	70	0.342857	0.302645	-	-0.282608	0.542175	-0.176929	0.84 [0.47 - 1.48]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209608_s_at	70	0.757143	0.0524188	-	0.569397	0.236998	0.256981	1.29 [0.84 - 1.98]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222011_s_at	70	0.657143	0.0455104	0.463937	-0.565937	0.493885	-0.150981	0.86 [0.56 - 1.33]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34790_at	50	0.78	0.0253638	0.316147	-1.27192	0.11902	-0.629094	0.53 [0.24 - 1.18]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209608_s_at	74	0.662162	0.0391231	0.421657	0.607532	0.686502	0.15022	1.16 [0.56 - 2.41]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	222011_s_at	74	0.324324	0.121697	-	-0.475	0.489887	-0.249466	0.78 [0.38 - 1.58]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	222010_at	74	0.5	0.00370961	0.0746949	-0.869136	0.396516	-0.36533	0.69 [0.30 - 1.61]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222011_s_at	67	0.880597	0.090243	-	1.32164	0.639592	0.444324	1.56 [0.24 - 10.02]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222010_at	67	0.358209	0.0112587	0.176461	15.9245	0.147178	1.38109	3.98 [0.61 - 25.75]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209608_s_at	67	0.447761	0.0603865	-	-1.39957	0.564818	-0.466047	0.63 [0.13 - 3.07]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222010_at	115	0.234783	0.233648	-	-0.652782	0.809325	-0.181537	0.83 [0.19 - 3.64]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209608_s_at	115	0.66087	0.0104343	0.166702	1.33022	0.120925	1.16502	3.21 [0.74 - 13.98]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222011_s_at	115	0.869565	0.0574323	-	1.07461	0.100149	1.24329	3.47 [0.79 - 15.26]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34790_at	158	0.253165	0.0555245	-	-0.561128	0.379611	-0.1668	0.85 [0.58 - 1.23]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34790_at	76	0.276316	0.190606	-	-0.677998	0.649726	-0.16508	0.85 [0.42 - 1.73]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209608_s_at	204	0.343137	0.0062275	0.11237	0.404245	0.134944	0.198665	1.22 [0.94 - 1.58]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222011_s_at	204	0.696078	0.0277154	0.33585	0.335701	0.0906358	0.292828	1.34 [0.95 - 1.88]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222010_at	204	0.867647	0.00699578	0.122962	0.560477	0.108051	0.295962	1.34 [0.94 - 1.93]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222010_at	87	0.494253	0.00807787	0.137321	1.05882	0.023939	0.672406	1.96 [1.09 - 3.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222011_s_at	87	0.678161	0.0244161	0.307976	0.83087	0.0298747	0.658586	1.93 [1.07 - 3.50]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209608_s_at	87	0.804598	0.00171413	0.0399003	1.18126	0.180601	0.345542	1.41 [0.85 - 2.34]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222010_at	87	0.494253	0.00807787	0.137321	1.05882	0.023939	0.672406	1.96 [1.09 - 3.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209608_s_at	87	0.804598	0.00171413	0.0399003	1.18126	0.180601	0.345542	1.41 [0.85 - 2.34]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222011_s_at	87	0.678161	0.0244161	0.307976	0.83087	0.0298747	0.658586	1.93 [1.07 - 3.50]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209608_s_at	77	0.766234	0.0328799	0.376537	1.12758	0.700344	0.200943	1.22 [0.44 - 3.40]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222011_s_at	77	0.753247	0.0443808	0.456718	1.19873	0.230239	0.654376	1.92 [0.66 - 5.60]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222010_at	77	0.831169	0.0472389	0.474783	1.2065	0.166445	0.720767	2.06 [0.74 - 5.71]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222011_s_at	77	0.753247	0.048382	0.481825	1.05004	0.524017	0.304461	1.36 [0.53 - 3.46]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209608_s_at	77	0.766234	0.0289633	0.345992	1.29086	0.6566	0.261552	1.30 [0.41 - 4.11]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222010_at	77	0.155844	0.0756505	-	-1.02388	0.433169	0.367289	1.44 [0.58 - 3.62]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	222010_at	136	0.360294	0.0149282	0.217243	1.43619	0.0563876	1.31295	3.72 [0.96 - 14.32]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	222011_s_at	136	0.272059	0.0386451	0.418343	1.42386	0.253918	0.574246	1.78 [0.66 - 4.76]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209608_s_at	136	0.647059	0.00939372	0.154018	1.14145	0.426948	0.474757	1.61 [0.50 - 5.19]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209608_s_at	200	0.88	0.0141435	0.208851	0.88787	0.254923	0.45819	1.58 [0.72 - 3.48]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	222010_at	200	0.26	0.040054	0.428048	0.821236	0.138673	0.697282	2.01 [0.80 - 5.05]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	222011_s_at	200	0.105	0.129174	-	-0.61985	0.756305	0.138781	1.15 [0.48 - 2.76]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6124	60	0.833333	0.030009	0.354333	0.923681	0.118509	0.457407	1.58 [0.89 - 2.81]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6124	60	0.566667	0.28351	-	0.40413	0.344867	0.332435	1.39 [0.70 - 2.78]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3269	155	0.206452	2.94627e-05	0.00118252	-1.13568	0.014171	-0.214484	0.81 [0.68 - 0.96]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209608_s_at	286	0.77972	0.189953	-	0.290958	0.985297	0.00448048	1.00 [0.62 - 1.62]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	222010_at	286	0.562937	0.0296996	0.35188	0.418087	0.189444	0.32535	1.38 [0.85 - 2.25]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	222011_s_at	286	0.566434	0.207634	-	0.243212	0.566932	0.139731	1.15 [0.71 - 1.86]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222010_at	159	0.641509	0.00711071	0.124517	0.828967	0.608	0.197153	1.22 [0.57 - 2.59]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209608_s_at	159	0.528302	0.000557848	0.0155575	1.13318	0.00690721	0.828492	2.29 [1.26 - 4.18]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209608_s_at	159	0.767296	0.00139519	0.0336513	1.13299	0.0155948	0.872602	2.39 [1.18 - 4.85]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222010_at	159	0.641509	0.0194573	0.262784	0.724065	0.320584	0.375001	1.45 [0.69 - 3.05]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222011_s_at	159	0.138365	0.00601123	0.109322	15.2795	0.0750191	0.50885	1.66 [0.95 - 2.91]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222011_s_at	159	0.704403	0.00808352	0.137395	0.94874	0.0355836	0.682584	1.98 [1.05 - 3.74]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209608_s_at	159	0.647799	0.00155891	0.0368922	0.969106	0.0653787	0.593479	1.81 [0.96 - 3.40]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222010_at	159	0.641509	0.000670098	0.0181813	1.22482	0.22235	0.536482	1.71 [0.72 - 4.05]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222011_s_at	159	0.704403	0.0699412	-	0.57777	0.158223	0.410784	1.51 [0.85 - 2.67]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209608_s_at	54	0.148148	0.182156	-	15.3415	0.995944	0.00276156	1.00 [0.35 - 2.91]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222011_s_at	117	0.692308	0.082734	-	0.560901	0.419443	0.175478	1.19 [0.78 - 1.82]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222011_s_at	117	0.34188	0.192656	-	-0.488304	0.630098	-0.133295	0.88 [0.51 - 1.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222011_s_at	117	0.692308	0.082734	-	0.560901	0.419443	0.175478	1.19 [0.78 - 1.82]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209608_s_at	117	0.726496	0.0620389	-	0.594669	0.715487	0.0920195	1.10 [0.67 - 1.80]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222011_s_at	117	0.820513	0.1935	-	-0.920598	0.465587	-0.212974	0.81 [0.46 - 1.43]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209608_s_at	117	0.102564	0.0384522	0.416999	-0.921186	0.176389	-0.439173	0.64 [0.34 - 1.22]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209608_s_at	117	0.102564	0.00910229	0.150387	-1.16767	0.128163	-0.521674	0.59 [0.30 - 1.16]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209608_s_at	117	0.726496	0.0620389	-	0.594669	0.715487	0.0920195	1.10 [0.67 - 1.80]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222010_at	117	0.863248	0.252907	-	0.44862	0.93709	0.021493	1.02 [0.60 - 1.74]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222010_at	117	0.470085	0.0453402	0.462856	-0.77029	0.114476	-0.520014	0.59 [0.31 - 1.13]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222010_at	117	0.333333	0.102495	-	-0.637347	0.120259	-0.544123	0.58 [0.29 - 1.15]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222010_at	117	0.863248	0.252907	-	0.44862	0.93709	0.021493	1.02 [0.60 - 1.74]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	222010_at	236	0.838983	0.000488909	0.0139012	1.01707	0.00864409	0.910282	2.49 [1.26 - 4.90]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	222011_s_at	236	0.847458	0.00130968	0.0319281	0.961559	0.0461275	0.655115	1.93 [1.01 - 3.67]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209608_s_at	236	0.690678	0.0202287	0.270105	0.627484	0.0579769	0.756473	2.13 [0.97 - 4.66]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	222011_s_at	249	0.722892	0.00455826	0.0879839	0.624724	0.047298	0.517879	1.68 [1.01 - 2.80]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209608_s_at	249	0.594378	0.000685496	0.0185349	0.709928	0.00811233	0.763482	2.15 [1.22 - 3.78]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	222010_at	249	0.204819	0.000417066	0.0121324	1.29741	0.0102735	0.72698	2.07 [1.19 - 3.60]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222010_at	125	0.192	0.0649142	-	0.93631	0.433257	0.217982	1.24 [0.72 - 2.15]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222010_at	54	0.796296	0.0166786	0.235397	1.32535	0.55207	0.242345	1.27 [0.57 - 2.83]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222011_s_at	125	0.456	0.0263066	0.324142	0.939096	0.0382099	0.661871	1.94 [1.04 - 3.62]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209608_s_at	62	0.387097	0.478807	-	-0.340436	0.896305	-0.0383337	0.96 [0.54 - 1.71]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209608_s_at	125	0.608	0.0460833	0.467558	0.745852	0.292881	0.391423	1.48 [0.71 - 3.07]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222011_s_at	62	0.870968	0.0222919	0.289142	1.25827	0.916124	0.0199433	1.02 [0.70 - 1.48]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222011_s_at	54	0.851852	0.165299	-	0.910815	0.957272	-0.012533	0.99 [0.62 - 1.56]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222010_at	62	0.822581	0.000403688	0.0117977	1.68	0.302494	0.337939	1.40 [0.74 - 2.67]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209608_s_at	125	0.544	0.116277	-	0.456947	0.432397	0.229483	1.26 [0.71 - 2.23]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222010_at	125	0.208	0.0248856	0.312041	1.95911	0.234531	0.408749	1.50 [0.77 - 2.95]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209608_s_at	54	0.166667	0.142758	-	-0.980737	0.795055	-0.0929013	0.91 [0.45 - 1.84]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222011_s_at	125	0.152	0.0380081	0.413893	1.38908	0.152106	0.365512	1.44 [0.87 - 2.38]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222011_s_at	198	0.348485	0.0614434	-	0.539259	0.124252	0.341553	1.41 [0.91 - 2.18]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222011_s_at	198	0.373737	0.0351356	0.393314	0.639916	0.0389992	0.475955	1.61 [1.02 - 2.53]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222010_at	198	0.813131	0.00850474	0.142824	-0.899494	0.310274	-0.213276	0.81 [0.54 - 1.22]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209608_s_at	198	0.494949	0.0438833	0.453505	0.527007	0.92039	0.0231679	1.02 [0.65 - 1.61]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209608_s_at	198	0.494949	0.0379172	0.413254	0.565067	0.863239	0.0421633	1.04 [0.65 - 1.69]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222010_at	198	0.19697	0.0605809	-	0.73771	0.60087	0.13117	1.14 [0.70 - 1.86]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222011_s_at	198	0.247475	0.153813	-	0.374384	0.5414	0.11228	1.12 [0.78 - 1.60]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222010_at	198	0.19697	0.0967471	-	0.659756	0.497663	0.178574	1.20 [0.71 - 2.00]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209608_s_at	198	0.893939	0.0644098	-	-0.827698	0.856016	-0.0341343	0.97 [0.67 - 1.40]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	222010_at	62	0.403226	0.185122	-	0.857999	0.499909	0.487425	1.63 [0.40 - 6.71]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	222011_s_at	51	0.431373	0.0440362	0.454494	16.0107	0.251603	0.888781	2.43 [0.53 - 11.11]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209608_s_at	51	0.843137	0.110446	-	1.3531	0.525225	0.621432	1.86 [0.27 - 12.66]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209608_s_at	62	0.870968	0.00313345	0.0652386	1.63247	0.182703	0.79577	2.22 [0.69 - 7.14]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	222010_at	51	0.627451	0.076944	-	-15.812	0.866984	-0.180406	0.83 [0.10 - 6.89]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	222011_s_at	62	0.725806	0.00487693	0.0928039	1.50833	0.0483907	1.00797	2.74 [1.01 - 7.45]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222011_s_at	177	0.757062	0.134372	-	0.443221	0.768185	0.0985887	1.10 [0.57 - 2.13]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209608_s_at	145	0.668966	0.151675	-	-0.567671	0.869666	-0.0562426	0.95 [0.48 - 1.85]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222010_at	177	0.875706	0.190943	-	-0.66735	0.641585	-0.175819	0.84 [0.40 - 1.76]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222011_s_at	177	0.757062	0.022948	0.295039	0.568248	0.0769771	0.472784	1.60 [0.95 - 2.71]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209608_s_at	177	0.327684	0.0320605	0.370301	0.686884	0.176751	0.37545	1.46 [0.84 - 2.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222010_at	177	0.423729	0.0943814	-	0.411505	0.523606	0.192176	1.21 [0.67 - 2.19]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222011_s_at	145	0.6	0.115215	-	-0.578816	0.398224	-0.347313	0.71 [0.32 - 1.58]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209608_s_at	177	0.19209	0.00500176	0.0946691	1.13519	0.0137863	0.601498	1.82 [1.13 - 2.95]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222010_at	145	0.475862	0.0504508	-	-0.65777	0.140932	-0.698226	0.50 [0.20 - 1.26]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209608_s_at	226	0.371681	0.00838078	0.141235	-0.73314	0.210994	-0.291982	0.75 [0.47 - 1.18]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222011_s_at	226	0.845133	0.0208273	0.275708	-1.51826	0.0512248	-0.619831	0.54 [0.29 - 1.00]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222010_at	226	0.10177	0.138264	-	-0.564863	0.232346	-0.391916	0.68 [0.36 - 1.29]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209608_s_at	49	0.836735	0.0443104	0.456264	1.19776	0.559101	0.39919	1.49 [0.39 - 5.69]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222011_s_at	55	0.618182	0.126428	-	0.672108	0.812672	0.112972	1.12 [0.44 - 2.85]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222011_s_at	55	0.618182	0.00376549	0.0755921	1.39753	0.0492486	1.05589	2.87 [1.00 - 8.23]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222010_at	55	0.145455	0.103789	-	-0.819971	0.484515	-0.356051	0.70 [0.26 - 1.90]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222011_s_at	49	0.591837	0.00798846	0.136158	1.49915	0.271296	0.717576	2.05 [0.57 - 7.36]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209608_s_at	55	0.818182	0.0352291	0.393998	0.994309	0.847237	0.0855619	1.09 [0.46 - 2.60]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222010_at	55	0.672727	0.0406493	0.432091	0.97532	0.697809	0.222621	1.25 [0.41 - 3.84]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222010_at	49	0.836735	0.160152	-	0.836482	0.853109	-0.124477	0.88 [0.24 - 3.30]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209608_s_at	55	0.818182	0.00128746	0.0314765	1.57132	0.0655521	0.969733	2.64 [0.94 - 7.40]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	36393	34	0.764706	0.294355	-	0.508506	0.754141	-0.160847	0.85 [0.31 - 2.33]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	292541	34	0.176471	0.0877183	-	-0.87578	0.331471	-0.555537	0.57 [0.19 - 1.76]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222011_s_at	63	0.68254	0.086134	-	-0.682895	0.821307	-0.0399336	0.96 [0.68 - 1.36]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222010_at	63	0.253968	0.118245	-	-0.555403	0.65875	-0.120013	0.89 [0.52 - 1.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209608_s_at	63	0.825397	0.00190189	0.0434633	1.15365	0.161989	0.428126	1.53 [0.84 - 2.80]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12653278_3p_s_at	28	0.107143	5.49351e-05	0.00206148	-2.6203	0.0661408	-0.399661	0.67 [0.44 - 1.03]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.278544.2.A1_3p_s_at	28	0.535714	0.223319	-	-0.675784	0.431091	-0.165308	0.85 [0.56 - 1.28]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	222010_at	82	0.792683	0.0708641	-	0.696347	0.910724	0.0672541	1.07 [0.33 - 3.47]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	222011_s_at	82	0.853659	0.00492731	0.0935581	1.10413	0.234818	0.641633	1.90 [0.66 - 5.47]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209608_s_at	82	0.658537	0.0057626	0.10578	0.912485	0.144214	0.742197	2.10 [0.78 - 5.69]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	222011_s_at	79	0.303797	0.0647507	-	0.540394	0.170269	0.575986	1.78 [0.78 - 4.05]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	222010_at	79	0.810127	0.0160278	0.228735	0.73208	0.0296961	1.08179	2.95 [1.11 - 7.82]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209608_s_at	79	0.392405	0.0644987	-	0.50356	0.419669	0.48294	1.62 [0.50 - 5.24]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209608_s_at	104	0.394231	0.0399811	0.42755	0.764501	0.303805	0.770728	2.16 [0.50 - 9.39]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	222010_at	104	0.134615	0.0846474	-	1.17529	0.137523	0.868749	2.38 [0.76 - 7.50]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	222011_s_at	104	0.384615	0.0749421	-	-0.580184	0.482147	-0.430092	0.65 [0.20 - 2.16]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P383835	117	0.777778	4.24348e-05	0.00163826	1.14142	0.000871492	0.627927	1.87 [1.29 - 2.71]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P31135	117	0.794872	1.58551e-05	0.000677632	1.21129	0.00346004	0.636146	1.89 [1.23 - 2.89]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222010_at	204	0.196078	0.0526835	-	1.32229	0.241318	0.958595	2.61 [0.52 - 12.96]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222010_at	204	0.514706	0.149935	-	0.393789	0.727037	0.212549	1.24 [0.37 - 4.08]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209608_s_at	204	0.833333	6.7141e-05	0.00246318	1.36263	0.00374919	1.38968	4.01 [1.57 - 10.27]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209608_s_at	204	0.818627	0.000706378	0.0190122	0.943798	0.0242118	0.889757	2.43 [1.12 - 5.28]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222011_s_at	204	0.245098	0.0191174	0.259521	1.55519	0.720633	0.301333	1.35 [0.26 - 7.05]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222011_s_at	204	0.392157	0.0448052	0.459442	-0.540047	0.183466	-0.830978	0.44 [0.13 - 1.48]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	222010_at	178	0.668539	0.0512719	-	0.39476	0.516341	0.18387	1.20 [0.69 - 2.09]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	222011_s_at	178	0.303371	0.0057065	0.104975	0.655116	0.0960183	0.404695	1.50 [0.93 - 2.41]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209608_s_at	178	0.837079	0.0630318	-	-0.567243	0.831775	0.0897862	1.09 [0.48 - 2.50]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200017303	41	0.780488	0.0200827	0.268728	0.98326	0.944875	-0.0148041	0.99 [0.65 - 1.50]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209608_s_at	111	0.135135	0.123339	-	-0.510894	0.545573	-0.133862	0.87 [0.57 - 1.35]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222011_s_at	111	0.774775	0.073818	-	0.532789	0.993671	-0.00238284	1.00 [0.55 - 1.80]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222010_at	111	0.414414	0.10777	-	0.434506	0.552103	0.213913	1.24 [0.61 - 2.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	222010_at	90	0.811111	0.0165734	0.234328	0.835809	0.133417	0.542817	1.72 [0.85 - 3.50]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	222010_at	90	0.811111	0.0127443	0.19346	0.965424	0.425472	0.353301	1.42 [0.60 - 3.39]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	222011_s_at	90	0.755556	0.0225255	0.29125	0.849533	0.122506	0.610945	1.84 [0.85 - 4.00]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	222011_s_at	90	0.722222	0.0325131	0.373755	0.697719	0.119824	0.546599	1.73 [0.87 - 3.44]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209608_s_at	90	0.866667	0.193773	-	0.537749	0.940669	-0.02572	0.97 [0.50 - 1.92]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209608_s_at	90	0.877778	0.0601755	-	0.838014	0.725485	0.133752	1.14 [0.54 - 2.41]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2126	50	0.62	0.0196104	0.264246	1.10258	0.287562	0.459688	1.58 [0.68 - 3.69]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222010_at	138	0.326087	0.024615	0.309703	0.611934	0.728956	0.0753778	1.08 [0.70 - 1.65]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209608_s_at	138	0.152174	0.0339696	0.384712	0.84525	0.228376	0.134318	1.14 [0.92 - 1.42]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222011_s_at	138	0.862319	0.00825454	0.139609	0.798878	0.151566	0.215982	1.24 [0.92 - 1.67]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209608_s_at	129	0.697674	0.0274251	0.33346	0.548881	0.35312	0.218691	1.24 [0.78 - 1.97]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	222010_at	129	0.44186	0.062187	-	0.478422	0.246847	0.351773	1.42 [0.78 - 2.58]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	222011_s_at	129	0.527132	0.163316	-	0.343072	0.672246	0.113578	1.12 [0.66 - 1.90]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12710	56	0.267857	0.0342565	0.386843	0.898225	0.23922	0.274741	1.32 [0.83 - 2.08]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24248	56	0.357143	0.0507274	-	0.786556	0.471834	0.158583	1.17 [0.76 - 1.81]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	692	56	0.303571	0.0302186	0.355988	0.870476	0.122263	0.362902	1.44 [0.91 - 2.28]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12710	56	0.267857	0.0246948	0.310394	1.06166	0.294599	0.259243	1.30 [0.80 - 2.10]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	692	56	0.303571	0.0320781	0.370435	0.946497	0.173678	0.338285	1.40 [0.86 - 2.28]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24248	56	0.464286	0.0724272	-	0.637948	0.351466	0.1956	1.22 [0.81 - 1.84]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222011_s_at	278	0.744604	0.0322272	0.371576	0.432537	0.51339	0.106575	1.11 [0.81 - 1.53]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222010_at	278	0.600719	0.0149263	0.217223	0.45911	0.563204	0.110031	1.12 [0.77 - 1.62]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209608_s_at	278	0.392086	0.0459326	0.466608	-0.377566	0.302888	-0.180103	0.84 [0.59 - 1.18]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	222011_s_at	133	0.203008	0.0136729	0.203738	-0.699427	0.331178	-0.14032	0.87 [0.65 - 1.15]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209608_s_at	133	0.120301	0.211076	-	-0.416314	0.437679	-0.147928	0.86 [0.59 - 1.25]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	222010_at	133	0.887218	0.0374257	0.409788	0.653177	0.911245	0.0165489	1.02 [0.76 - 1.36]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5042	81	0.864198	0.00742593	0.128744	1.36566	0.00732408	1.3923	4.02 [1.45 - 11.13]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222011_s_at	185	0.886486	0.00124114	0.0305305	0.794556	0.0308883	0.452163	1.57 [1.04 - 2.37]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222010_at	185	0.172973	0.17929	-	0.30361	0.474822	0.1133	1.12 [0.82 - 1.53]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222011_s_at	185	0.886486	0.00797606	0.135996	0.711782	0.0188506	0.523498	1.69 [1.09 - 2.61]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209608_s_at	185	0.805405	0.0211191	0.278415	0.473291	0.336072	0.241031	1.27 [0.78 - 2.08]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222010_at	185	0.389189	0.0212778	0.279881	0.438416	0.121971	0.262035	1.30 [0.93 - 1.81]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209608_s_at	185	0.805405	0.0686607	-	0.408355	0.375754	0.240198	1.27 [0.75 - 2.16]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P31135	110	0.7	0.0753096	-	-0.473297	0.554186	-0.090715	0.91 [0.68 - 1.23]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P383835	110	0.109091	0.148908	-	-0.635061	0.387736	0.157781	1.17 [0.82 - 1.68]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P31135	110	0.772727	0.228107	-	0.390153	0.566076	0.107999	1.11 [0.77 - 1.61]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P383835	110	0.836364	0.080707	-	-0.607679	0.543415	-0.0907377	0.91 [0.68 - 1.22]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209608_s_at	80	0.2375	0.0922187	-	-0.7489	0.691407	0.145542	1.16 [0.56 - 2.37]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	222011_s_at	80	0.3375	0.157058	-	-0.61795	0.437986	-0.271311	0.76 [0.38 - 1.51]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	222010_at	80	0.3625	0.178354	-	0.643686	0.984928	-0.00747929	0.99 [0.46 - 2.16]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209608_s_at	38	0.894737	0.000453706	0.0130403	2.05415	0.0219165	0.939848	2.56 [1.15 - 5.72]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222011_s_at	38	0.552632	0.00229143	0.0506242	1.4698	0.0279661	1.07209	2.92 [1.12 - 7.60]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222010_at	38	0.473684	0.0334981	0.381192	1.07675	0.127294	0.676974	1.97 [0.82 - 4.70]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	222010_at	140	0.742857	0.169933	-	0.419205	0.72724	0.136486	1.15 [0.53 - 2.47]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	222011_s_at	140	0.892857	0.0194169	0.262397	0.885681	0.845665	0.0826528	1.09 [0.47 - 2.50]
GENE	ACAT2	acetyl-CoA acetyltransferase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209608_s_at	140	0.842857	0.134722	-	0.526028	0.598368	0.205017	1.23 [0.57 - 2.63]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACHE	acetylcholinesterase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205377_s_at	30	0.633333	0.00567778	0.104562	1.16993	0.248555	1.24055	3.46 [0.42 - 28.44]
GENE	ACHE	acetylcholinesterase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205378_s_at	30	0.6	0.357403	-	0.375289	0.715145	0.474026	1.61 [0.13 - 20.49]
GENE	ACHE	acetylcholinesterase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210332_at	30	0.7	0.116111	-	0.676863	0.581527	0.400781	1.49 [0.36 - 6.21]
GENE	ACHE	acetylcholinesterase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1735471	165	0.133333	0.00781146	0.133842	1.44334	0.181114	1.24198	3.46 [0.56 - 21.38]
GENE	ACHE	acetylcholinesterase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1735471	165	0.181818	0.0136258	0.203222	2.10003	0.610238	0.714529	2.04 [0.13 - 31.88]
GENE	ACHE	acetylcholinesterase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205377_s_at	163	0.754601	0.0575293	-	-0.454099	0.0398617	-1.13727	0.32 [0.11 - 0.95]
GENE	ACHE	acetylcholinesterase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210332_at	163	0.276074	0.0761167	-	-0.37627	0.440819	-0.554588	0.57 [0.14 - 2.35]
GENE	ACHE	acetylcholinesterase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205378_s_at	163	0.858896	0.0362744	0.401574	-0.684799	0.0358492	-0.826521	0.44 [0.20 - 0.95]
GENE	ACHE	acetylcholinesterase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205378_s_at	79	0.202532	4.26911e-07	2.47726e-05	-1.50912	0.0198324	-1.01296	0.36 [0.15 - 0.85]
GENE	ACHE	acetylcholinesterase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205377_s_at	79	0.151899	0.000945102	0.0243054	-1.13136	0.0812312	-1.01344	0.36 [0.12 - 1.13]
GENE	ACHE	acetylcholinesterase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210332_at	79	0.708861	0.00310749	0.064803	-1.15072	0.237375	-1.10954	0.33 [0.05 - 2.08]
GENE	ACHE	acetylcholinesterase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205378_s_at	58	0.275862	0.247588	-	0.363713	0.948618	-0.00964813	0.99 [0.74 - 1.33]
GENE	ACHE	acetylcholinesterase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210332_at	58	0.172414	0.00763937	0.131576	-0.965818	0.598661	-0.106873	0.90 [0.60 - 1.34]
GENE	ACHE	acetylcholinesterase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205377_s_at	58	0.827586	0.199967	-	-0.496197	0.537622	-0.12267	0.88 [0.60 - 1.31]
GENE	ACHE	acetylcholinesterase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205378_s_at	34	0.470588	0.0730394	-	0.688162	0.672853	0.0725983	1.08 [0.77 - 1.51]
GENE	ACHE	acetylcholinesterase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210332_at	34	0.352941	0.0647417	-	-0.728788	0.437011	-0.19021	0.83 [0.51 - 1.34]
GENE	ACHE	acetylcholinesterase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205377_s_at	34	0.823529	0.00664603	0.118184	1.3587	0.17437	0.515006	1.67 [0.80 - 3.52]
GENE	ACHE	acetylcholinesterase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210332_at	158	0.746835	0.016163	0.230128	0.58686	0.186503	0.806965	2.24 [0.68 - 7.42]
GENE	ACHE	acetylcholinesterase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205377_s_at	158	0.734177	0.0169167	0.23781	-0.714558	0.115642	-0.969074	0.38 [0.11 - 1.27]
GENE	ACHE	acetylcholinesterase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205378_s_at	158	0.594937	0.100565	-	0.376919	0.975375	-0.0138318	0.99 [0.41 - 2.37]
GENE	ACHE	acetylcholinesterase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205378_s_at	53	0.150943	0.0218231	0.284883	-0.967381	0.927796	-0.0191993	0.98 [0.65 - 1.49]
GENE	ACHE	acetylcholinesterase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205377_s_at	53	0.679245	0.152645	-	-0.571887	0.646471	0.100914	1.11 [0.72 - 1.70]
GENE	ACHE	acetylcholinesterase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210332_at	53	0.396226	0.0176539	0.2452	0.948657	0.214542	0.379284	1.46 [0.80 - 2.66]
GENE	ACHE	acetylcholinesterase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210332_at	53	0.396226	0.0572839	-	0.702832	0.242323	0.327428	1.39 [0.80 - 2.40]
GENE	ACHE	acetylcholinesterase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205378_s_at	53	0.132075	0.0329829	0.377316	-0.941288	0.942485	0.0143187	1.01 [0.69 - 1.50]
GENE	ACHE	acetylcholinesterase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205377_s_at	53	0.679245	0.224054	-	-0.520841	0.816117	0.055387	1.06 [0.66 - 1.69]
GENE	ACHE	acetylcholinesterase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205377_s_at	180	0.755556	0.0518533	-	0.45522	0.348348	-0.133897	0.87 [0.66 - 1.16]
GENE	ACHE	acetylcholinesterase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210332_at	180	0.894444	0.0992982	-	-0.554821	0.729335	-0.0476884	0.95 [0.73 - 1.25]
GENE	ACHE	acetylcholinesterase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205378_s_at	180	0.85	0.000778021	0.020631	0.868686	0.983534	0.00395558	1.00 [0.69 - 1.46]
GENE	ACHE	acetylcholinesterase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205378_s_at	559	0.896243	0.00662392	0.117879	-1.71997	0.0367887	-0.370651	0.69 [0.49 - 0.98]
GENE	ACHE	acetylcholinesterase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205377_s_at	559	0.717352	0.0261503	0.322826	-0.584242	0.249585	-0.158113	0.85 [0.65 - 1.12]
GENE	ACHE	acetylcholinesterase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210332_at	559	0.506261	0.00272575	0.0582939	-0.659491	0.184499	-0.198182	0.82 [0.61 - 1.10]
GENE	ACHE	acetylcholinesterase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205378_s_at	77	0.194805	0.144353	-	-0.453786	0.561754	-0.0606996	0.94 [0.77 - 1.16]
GENE	ACHE	acetylcholinesterase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210332_at	77	0.181818	0.0118897	0.18377	0.980765	0.607942	0.0803034	1.08 [0.80 - 1.47]
GENE	ACHE	acetylcholinesterase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205377_s_at	77	0.220779	0.0107423	0.170377	-0.76196	0.133579	-0.20778	0.81 [0.62 - 1.07]
GENE	ACHE	acetylcholinesterase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205378_s_at	70	0.757143	0.108016	-	0.471421	0.627022	0.203182	1.23 [0.54 - 2.78]
GENE	ACHE	acetylcholinesterase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205377_s_at	70	0.828571	0.0429219	0.447235	0.654369	0.798571	0.174131	1.19 [0.31 - 4.53]
GENE	ACHE	acetylcholinesterase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210332_at	70	0.642857	0.00511763	0.0963893	0.74716	0.0891018	1.28676	3.62 [0.82 - 15.96]
GENE	ACHE	acetylcholinesterase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35386_at	50	0.5	0.0237518	0.302165	-0.77893	0.181887	-1.23724	0.29 [0.05 - 1.78]
GENE	ACHE	acetylcholinesterase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35387_r_at	50	0.88	0.0658711	-	-1.09164	0.165378	-3.22177	0.04 [0.00 - 3.78]
GENE	ACHE	acetylcholinesterase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40249_at	50	0.8	0.0187867	0.256323	0.906888	0.52142	0.130713	1.14 [0.76 - 1.70]
GENE	ACHE	acetylcholinesterase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205377_s_at	74	0.108108	0.0903693	-	-0.684082	0.776156	-0.0523668	0.95 [0.66 - 1.36]
GENE	ACHE	acetylcholinesterase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205378_s_at	74	0.391892	0.0874139	-	0.519962	0.356754	0.150245	1.16 [0.84 - 1.60]
GENE	ACHE	acetylcholinesterase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210332_at	74	0.121622	0.0289145	0.3456	1.23304	0.385547	0.129521	1.14 [0.85 - 1.53]
GENE	ACHE	acetylcholinesterase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205378_s_at	67	0.507463	0.0967808	-	1.25539	0.816547	0.17673	1.19 [0.27 - 5.31]
GENE	ACHE	acetylcholinesterase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205377_s_at	67	0.552239	0.240394	-	0.812929	0.999114	-0.0012703	1.00 [0.11 - 9.41]
GENE	ACHE	acetylcholinesterase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210332_at	67	0.61194	0.000733138	0.0196202	2.32321	0.00277125	5.78054	323.93 [7.34 - 14288.65]
GENE	ACHE	acetylcholinesterase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205378_s_at	115	0.478261	0.0169638	0.238286	-1.4323	0.133507	-0.521403	0.59 [0.30 - 1.17]
GENE	ACHE	acetylcholinesterase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205377_s_at	115	0.791304	0.0223326	0.28951	1.16239	0.91692	-0.0638054	0.94 [0.28 - 3.11]
GENE	ACHE	acetylcholinesterase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210332_at	115	0.382609	0.0388782	0.419961	-1.10008	0.447205	-0.615537	0.54 [0.11 - 2.64]
GENE	ACHE	acetylcholinesterase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35386_at	158	0.398734	0.168987	-	-0.39241	0.769733	-0.0576102	0.94 [0.64 - 1.39]
GENE	ACHE	acetylcholinesterase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35387_r_at	158	0.417722	0.00804033	0.136833	-0.762617	0.12992	-0.643427	0.53 [0.23 - 1.21]
GENE	ACHE	acetylcholinesterase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40249_at	158	0.892405	0.000360931	0.0107154	1.13256	0.0152927	0.533458	1.70 [1.11 - 2.62]
GENE	ACHE	acetylcholinesterase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40249_at	76	0.315789	0.0333483	0.380068	-1.05467	0.104281	-1.45554	0.23 [0.04 - 1.35]
GENE	ACHE	acetylcholinesterase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35386_at	76	0.828947	0.041051	0.434802	-15.4414	0.3992	-0.31541	0.73 [0.35 - 1.52]
GENE	ACHE	acetylcholinesterase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35387_r_at	76	0.171053	0.00125378	0.0307894	-1.57047	0.114224	-1.65319	0.19 [0.02 - 1.49]
GENE	ACHE	acetylcholinesterase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205377_s_at	204	0.872549	0.0192715	0.261003	-0.494502	0.0612175	-0.156635	0.86 [0.73 - 1.01]
GENE	ACHE	acetylcholinesterase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210332_at	204	0.843137	0.0642849	-	0.354909	0.53993	0.0534261	1.05 [0.89 - 1.25]
GENE	ACHE	acetylcholinesterase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205378_s_at	204	0.867647	0.120826	-	-0.32076	0.504746	-0.046991	0.95 [0.83 - 1.10]
GENE	ACHE	acetylcholinesterase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210332_at	87	0.321839	0.247363	-	0.50014	0.891624	0.0778385	1.08 [0.35 - 3.31]
GENE	ACHE	acetylcholinesterase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205377_s_at	87	0.54023	0.0267019	0.327456	0.834233	0.396857	0.652384	1.92 [0.42 - 8.68]
GENE	ACHE	acetylcholinesterase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205378_s_at	87	0.45977	0.258165	-	-0.426166	0.58958	-0.470505	0.62 [0.11 - 3.45]
GENE	ACHE	acetylcholinesterase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205377_s_at	87	0.54023	0.0267019	0.327456	0.834233	0.396857	0.652384	1.92 [0.42 - 8.68]
GENE	ACHE	acetylcholinesterase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210332_at	87	0.321839	0.247363	-	0.50014	0.891624	0.0778385	1.08 [0.35 - 3.31]
GENE	ACHE	acetylcholinesterase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205378_s_at	87	0.45977	0.258165	-	-0.426166	0.58958	-0.470505	0.62 [0.11 - 3.45]
GENE	ACHE	acetylcholinesterase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205377_s_at	77	0.766234	0.000151269	0.00503699	1.88179	0.0438712	1.64307	5.17 [1.05 - 25.56]
GENE	ACHE	acetylcholinesterase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210332_at	77	0.142857	0.00782534	0.134025	-1.55721	0.0457875	-3.22567	0.04 [0.00 - 0.94]
GENE	ACHE	acetylcholinesterase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205378_s_at	77	0.818182	0.00344628	0.0704212	1.65926	0.137667	0.697385	2.01 [0.80 - 5.04]
GENE	ACHE	acetylcholinesterase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210332_at	77	0.142857	0.0487036	0.483788	-1.126	0.350339	-1.29628	0.27 [0.02 - 4.15]
GENE	ACHE	acetylcholinesterase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205377_s_at	77	0.766234	7.40396e-05	0.002686	2.24357	0.0806897	1.63979	5.15 [0.82 - 32.45]
GENE	ACHE	acetylcholinesterase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205378_s_at	77	0.727273	0.000118379	0.00406271	1.98461	0.091388	0.691245	2.00 [0.89 - 4.45]
GENE	ACHE	acetylcholinesterase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205377_s_at	136	0.882353	0.105689	-	-15.2202	0.360004	-0.319212	0.73 [0.37 - 1.44]
GENE	ACHE	acetylcholinesterase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210332_at	136	0.132353	0.162835	-	1.34603	0.647264	0.133208	1.14 [0.65 - 2.02]
GENE	ACHE	acetylcholinesterase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205378_s_at	136	0.191176	0.191762	-	-0.629712	0.702403	-0.101038	0.90 [0.54 - 1.52]
GENE	ACHE	acetylcholinesterase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210332_at	200	0.865	0.0145855	0.213598	0.852655	0.100488	0.307596	1.36 [0.94 - 1.96]
GENE	ACHE	acetylcholinesterase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205377_s_at	200	0.26	0.0935401	-	-0.52555	0.649626	-0.129705	0.88 [0.50 - 1.54]
GENE	ACHE	acetylcholinesterase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205378_s_at	200	0.115	0.143207	-	-0.564301	0.704495	0.0685283	1.07 [0.75 - 1.53]
GENE	ACHE	acetylcholinesterase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12747	60	0.766667	0.185079	-	-0.702173	0.722324	-0.153117	0.86 [0.37 - 2.00]
GENE	ACHE	acetylcholinesterase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12747	60	0.233333	0.0427476	0.44609	1.17081	0.18325	0.585976	1.80 [0.76 - 4.26]
GENE	ACHE	acetylcholinesterase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17405	155	0.148387	4.06193e-05	0.00157561	-1.18172	0.137848	-0.247382	0.78 [0.56 - 1.08]
GENE	ACHE	acetylcholinesterase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205377_s_at	286	0.86014	0.0166504	0.235111	0.577788	0.216414	0.228359	1.26 [0.87 - 1.80]
GENE	ACHE	acetylcholinesterase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205378_s_at	286	0.475524	0.00273881	0.05852	-0.581172	0.0298558	-0.334096	0.72 [0.53 - 0.97]
GENE	ACHE	acetylcholinesterase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210332_at	286	0.769231	0.013544	0.202326	-0.657613	0.0387775	-0.251354	0.78 [0.61 - 0.99]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205378_s_at	159	0.509434	0.296236	-	0.332586	0.882758	-0.03255	0.97 [0.63 - 1.49]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205377_s_at	159	0.314465	0.0170563	0.239219	-0.741567	0.249602	-0.353399	0.70 [0.38 - 1.28]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205377_s_at	159	0.220126	0.102174	-	-0.645628	0.450844	-0.279346	0.76 [0.37 - 1.56]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210332_at	159	0.157233	0.0980768	-	0.956376	0.607035	0.110748	1.12 [0.73 - 1.70]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205378_s_at	159	0.100629	0.161767	-	-0.611262	0.65128	-0.101258	0.90 [0.58 - 1.40]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210332_at	159	0.157233	0.098512	-	0.95517	0.871447	0.0347231	1.04 [0.68 - 1.58]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205377_s_at	159	0.144654	0.00690813	0.121771	-0.952063	0.400145	-0.264383	0.77 [0.41 - 1.42]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205378_s_at	159	0.704403	0.267757	-	-0.502857	0.716989	-0.0943442	0.91 [0.55 - 1.52]
GENE	ACHE	acetylcholinesterase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210332_at	159	0.899371	0.221268	-	0.592994	0.562435	0.14518	1.16 [0.71 - 1.89]
GENE	ACHE	acetylcholinesterase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205377_s_at	54	0.12963	0.194809	-	15.334	0.936632	-0.124494	0.88 [0.04 - 19.00]
GENE	ACHE	acetylcholinesterase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205378_s_at	54	0.222222	0.328092	-	0.997266	0.628033	0.441754	1.56 [0.26 - 9.29]
GENE	ACHE	acetylcholinesterase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210332_at	54	0.388889	0.080522	-	1.66208	0.86733	-0.178923	0.84 [0.10 - 6.82]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205378_s_at	117	0.683761	0.0691433	-	0.703544	0.50912	0.43128	1.54 [0.43 - 5.54]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205378_s_at	117	0.863248	0.115824	-	-0.914442	0.9947	0.00395619	1.00 [0.31 - 3.23]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210332_at	117	0.777778	0.0761445	-	-1.03635	0.381016	-0.700493	0.50 [0.10 - 2.38]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205377_s_at	117	0.897436	0.0470515	0.473618	0.806797	0.0524697	1.49093	4.44 [0.98 - 20.04]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210332_at	117	0.777778	0.127053	-	-0.903678	0.697471	-0.281639	0.75 [0.18 - 3.12]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205377_s_at	117	0.880342	0.0115105	0.179394	1.05351	0.00877159	2.24185	9.41 [1.76 - 50.32]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210332_at	117	0.273504	0.169591	-	0.56475	0.816157	-0.127935	0.88 [0.30 - 2.59]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205377_s_at	117	0.897436	0.007821	0.133967	1.17941	0.0278545	1.96777	7.15 [1.24 - 41.32]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205377_s_at	117	0.897436	0.0470515	0.473618	0.806797	0.0524697	1.49093	4.44 [0.98 - 20.04]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210332_at	117	0.273504	0.169591	-	0.56475	0.816157	-0.127935	0.88 [0.30 - 2.59]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205378_s_at	117	0.863248	0.115824	-	-0.914442	0.9947	0.00395619	1.00 [0.31 - 3.23]
GENE	ACHE	acetylcholinesterase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205378_s_at	117	0.863248	0.176165	-	-0.956519	0.73744	0.227042	1.25 [0.33 - 4.73]
GENE	ACHE	acetylcholinesterase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210332_at	236	0.169492	0.0692493	-	0.827898	0.930448	0.0173865	1.02 [0.69 - 1.50]
GENE	ACHE	acetylcholinesterase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205378_s_at	236	0.877119	0.0856138	-	-0.979783	0.57172	-0.11203	0.89 [0.61 - 1.32]
GENE	ACHE	acetylcholinesterase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205377_s_at	236	0.84322	0.0951584	-	0.539862	0.649867	0.105148	1.11 [0.71 - 1.75]
GENE	ACHE	acetylcholinesterase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205378_s_at	249	0.746988	0.0167059	0.235675	0.531453	0.125518	0.220185	1.25 [0.94 - 1.65]
GENE	ACHE	acetylcholinesterase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210332_at	249	0.514056	0.197493	-	-0.274572	0.523602	-0.103853	0.90 [0.66 - 1.24]
GENE	ACHE	acetylcholinesterase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205377_s_at	249	0.84739	0.0438076	0.453014	0.527484	0.416542	0.151893	1.16 [0.81 - 1.68]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205378_s_at	62	0.758065	0.0521654	-	-1.37096	0.760544	-0.159293	0.85 [0.31 - 2.38]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205377_s_at	125	0.896	0.00847079	0.14239	-2.20616	0.104271	-1.59414	0.20 [0.03 - 1.39]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210332_at	62	0.854839	0.0174199	0.242867	1.14962	0.891489	-0.0402525	0.96 [0.54 - 1.71]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205378_s_at	125	0.152	0.0888914	-	1.56915	0.879901	0.0566875	1.06 [0.51 - 2.21]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205377_s_at	54	0.388889	0.0739856	-	1.67998	0.901201	-0.0383725	0.96 [0.53 - 1.76]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205378_s_at	125	0.152	0.129469	-	0.880068	0.820403	-0.068603	0.93 [0.52 - 1.69]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210332_at	125	0.104	0.0714425	-	-0.686907	0.566052	-0.432266	0.65 [0.15 - 2.84]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210332_at	125	0.824	0.127198	-	0.659535	0.764369	0.301931	1.35 [0.19 - 9.74]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205378_s_at	54	0.740741	0.0507943	-	-1.81168	0.994222	0.00456664	1.00 [0.29 - 3.46]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205377_s_at	62	0.419355	0.103089	-	1.00345	0.763018	-0.0769303	0.93 [0.56 - 1.53]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205377_s_at	125	0.888	0.0266516	0.327035	-15.2879	0.172549	-1.83771	0.16 [0.01 - 2.23]
GENE	ACHE	acetylcholinesterase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210332_at	54	0.851852	0.00803295	0.136737	1.44962	0.908983	-0.0413909	0.96 [0.47 - 1.95]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210332_at	198	0.161616	0.0603223	-	0.855471	0.650809	0.053217	1.05 [0.84 - 1.33]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205378_s_at	198	0.565657	0.00451769	0.087364	-0.835207	0.105698	-0.219085	0.80 [0.62 - 1.05]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205377_s_at	198	0.222222	0.0167021	0.235637	0.706359	0.345011	0.117387	1.12 [0.88 - 1.43]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205378_s_at	198	0.106061	0.00448221	0.0868206	-0.822561	0.30247	-0.105722	0.90 [0.74 - 1.10]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205377_s_at	198	0.267677	0.0422568	0.442851	0.689461	0.559645	0.0905457	1.09 [0.81 - 1.48]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205377_s_at	198	0.358586	0.0437031	0.452336	0.613744	0.94074	0.0125406	1.01 [0.73 - 1.41]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210332_at	198	0.161616	0.130709	-	0.599157	0.720321	0.0406994	1.04 [0.83 - 1.30]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205378_s_at	198	0.565657	0.0267293	0.327685	-0.595032	0.19539	-0.164108	0.85 [0.66 - 1.09]
GENE	ACHE	acetylcholinesterase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210332_at	198	0.121212	0.092851	-	0.617329	0.854528	0.0172374	1.02 [0.85 - 1.22]
GENE	ACHE	acetylcholinesterase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205377_s_at	62	0.258065	0.190621	-	-0.749126	0.786141	-0.389305	0.68 [0.04 - 11.28]
GENE	ACHE	acetylcholinesterase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210332_at	51	0.784314	0.223631	-	-15.421	0.786605	0.347538	1.42 [0.11 - 17.53]
GENE	ACHE	acetylcholinesterase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205378_s_at	51	0.54902	0.0985962	-	1.65275	0.30772	2.17431	8.80 [0.13 - 573.82]
GENE	ACHE	acetylcholinesterase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205378_s_at	62	0.66129	0.182343	-	0.752606	0.853107	0.241312	1.27 [0.10 - 16.38]
GENE	ACHE	acetylcholinesterase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210332_at	62	0.822581	0.0771876	-	-15.3755	0.705508	-0.312244	0.73 [0.14 - 3.70]
GENE	ACHE	acetylcholinesterase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205377_s_at	51	0.509804	0.128953	-	1.54349	0.61163	1.13798	3.12 [0.04 - 252.34]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205377_s_at	145	0.296552	0.0113597	0.17764	1.1563	0.0121888	1.47354	4.36 [1.38 - 13.81]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210332_at	177	0.107345	4.16696e-05	0.0016119	-1.27222	0.0910855	-1.34076	0.26 [0.06 - 1.24]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210332_at	177	0.107345	0.000380556	0.0112146	-1.05137	0.0871394	-1.16694	0.31 [0.08 - 1.19]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205378_s_at	177	0.141243	0.0951195	-	-0.579971	0.433962	0.424359	1.53 [0.53 - 4.43]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205377_s_at	177	0.830508	0.0666083	-	0.577417	0.169964	0.698291	2.01 [0.74 - 5.45]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205378_s_at	177	0.141243	0.136331	-	-0.46883	0.319401	0.474651	1.61 [0.63 - 4.09]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210332_at	145	0.82069	0.0836074	-	-1.00375	0.265657	-1.05583	0.35 [0.05 - 2.23]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205377_s_at	177	0.841808	0.0307243	0.35996	0.605888	0.223895	0.558984	1.75 [0.71 - 4.31]
GENE	ACHE	acetylcholinesterase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205378_s_at	145	0.551724	0.0732259	-	0.59453	0.108107	1.0858	2.96 [0.79 - 11.14]
GENE	ACHE	acetylcholinesterase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210332_at	226	0.756637	0.0532006	-	-0.769214	0.754185	0.0433388	1.04 [0.80 - 1.37]
GENE	ACHE	acetylcholinesterase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205378_s_at	226	0.199115	0.00823422	0.139347	1.44536	0.275661	0.137239	1.15 [0.90 - 1.47]
GENE	ACHE	acetylcholinesterase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205377_s_at	226	0.340708	0.00245937	0.053626	1.06598	0.0230986	0.286886	1.33 [1.04 - 1.71]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210332_at	55	0.327273	0.0361482	0.400666	-0.908953	0.159443	-1.62366	0.20 [0.02 - 1.89]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210332_at	55	0.636364	0.0418642	0.440244	-1.211	0.226688	-1.5135	0.22 [0.02 - 2.56]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205378_s_at	55	0.218182	0.106574	-	1.1409	0.890838	0.0958311	1.10 [0.28 - 4.32]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210332_at	49	0.632653	0.050231	-	-1.41203	0.313984	-1.57359	0.21 [0.01 - 4.43]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205377_s_at	55	0.472727	0.0467711	0.471871	-0.903543	0.667672	-0.372455	0.69 [0.13 - 3.77]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205378_s_at	55	0.709091	0.0652207	-	-1.25875	0.283513	-0.902441	0.41 [0.08 - 2.11]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205378_s_at	49	0.857143	0.0991247	-	-15.3381	0.306514	-0.95408	0.39 [0.06 - 2.40]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205377_s_at	55	0.472727	0.0344004	0.387908	-1.02217	0.348941	-0.905783	0.40 [0.06 - 2.69]
GENE	ACHE	acetylcholinesterase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205377_s_at	49	0.469388	0.000503343	0.0142511	-2.25318	0.0813553	-1.86642	0.15 [0.02 - 1.26]
GENE	ACHE	acetylcholinesterase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	293924	34	0.470588	0.0438599	0.453353	-0.900469	0.411378	-0.315452	0.73 [0.34 - 1.55]
GENE	ACHE	acetylcholinesterase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	180694	34	0.441176	0.00377421	0.0757318	1.33012	0.0279236	3.73221	41.77 [1.50 - 1164.17]
GENE	ACHE	acetylcholinesterase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210332_at	63	0.142857	0.0101374	0.163127	-1.0092	0.800844	0.403335	1.50 [0.07 - 34.37]
GENE	ACHE	acetylcholinesterase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205378_s_at	63	0.111111	0.00275487	0.0587977	-1.2262	0.316824	-6.93787	0.00 [0.00 - 770.23]
GENE	ACHE	acetylcholinesterase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205377_s_at	63	0.15873	0.00107422	0.0270609	-1.22186	0.0586313	-19.806	0.00 [0.00 - 2.06]
GENE	ACHE	acetylcholinesterase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7710111_3p_a_at	28	0.25	0.0183719	0.252282	-1.41629	0.61831	-1.20811	0.30 [0.00 - 34.62]
GENE	ACHE	acetylcholinesterase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.154495.0.S1_3p_a_at	28	0.25	0.0468457	0.472336	-1.13531	0.184589	-7.13517	0.00 [0.00 - 30.13]
GENE	ACHE	acetylcholinesterase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.154495.2.A1_3p_at	28	0.428571	0.00453476	0.0876249	-1.49981	0.0754971	-4.00157	0.02 [0.00 - 1.51]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205377_s_at	82	0.5	0.000775332	0.0205707	-1.19337	0.00664549	-0.883198	0.41 [0.22 - 0.78]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205378_s_at	82	0.109756	0.00241237	0.0527907	-1.2434	0.101162	-0.459387	0.63 [0.36 - 1.09]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205377_s_at	79	0.518987	1.77943e-05	0.000751878	-1.17086	0.00424109	-0.708416	0.49 [0.30 - 0.80]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205378_s_at	79	0.43038	5.35732e-05	0.002016	-1.07287	0.0195546	-0.574771	0.56 [0.35 - 0.91]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210332_at	79	0.607595	0.0222608	0.288861	-0.625447	0.679239	-0.0981752	0.91 [0.57 - 1.44]
GENE	ACHE	acetylcholinesterase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M55040_at	86	0.174419	0.0203692	0.271426	-0.979391	0.134946	-1.02114	0.36 [0.09 - 1.37]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205377_s_at	104	0.798077	0.133451	-	-0.707111	0.550822	-0.133383	0.88 [0.56 - 1.36]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210332_at	104	0.884615	0.00501395	0.0948505	1.08231	0.643865	-0.122542	0.88 [0.53 - 1.49]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205378_s_at	104	0.663462	0.0847327	-	-0.626118	0.275177	-0.238267	0.79 [0.51 - 1.21]
GENE	ACHE	acetylcholinesterase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P60845	117	0.102564	4.89703e-06	0.000233542	-1.49813	0.024126	-0.317306	0.73 [0.55 - 0.96]
GENE	ACHE	acetylcholinesterase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205378_s_at	204	0.803922	0.0661877	-	0.551529	0.263673	0.155266	1.17 [0.89 - 1.53]
GENE	ACHE	acetylcholinesterase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205377_s_at	204	0.102941	0.327615	-	-0.477102	0.725257	-0.111408	0.89 [0.48 - 1.67]
GENE	ACHE	acetylcholinesterase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205377_s_at	204	0.843137	0.112184	-	0.515411	0.697516	0.087335	1.09 [0.70 - 1.70]
GENE	ACHE	acetylcholinesterase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210332_at	204	0.102941	2.89197e-05	0.00116298	-1.52124	0.164471	-0.346327	0.71 [0.43 - 1.15]
GENE	ACHE	acetylcholinesterase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210332_at	204	0.833333	0.0237689	0.302316	-1.25858	0.260636	-0.207516	0.81 [0.57 - 1.17]
GENE	ACHE	acetylcholinesterase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205378_s_at	204	0.740196	0.0214457	0.281427	0.82418	0.133989	0.269946	1.31 [0.92 - 1.86]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205378_s_at	178	0.775281	0.0118874	0.183743	-0.645076	0.0872229	-0.270414	0.76 [0.56 - 1.04]
GENE	ACHE	acetylcholinesterase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205377_s_at	178	0.713483	0.0261252	0.322614	-0.507817	0.153815	-0.220019	0.80 [0.59 - 1.09]
GENE	ACHE	acetylcholinesterase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205377_s_at	111	0.216216	0.173965	-	0.488919	0.438372	0.0852125	1.09 [0.88 - 1.35]
GENE	ACHE	acetylcholinesterase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210332_at	111	0.387387	0.0620959	-	0.531935	0.244778	0.299094	1.35 [0.81 - 2.23]
GENE	ACHE	acetylcholinesterase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205378_s_at	111	0.603604	0.188189	-	0.343933	0.895093	-0.0131235	0.99 [0.81 - 1.20]
GENE	ACHE	acetylcholinesterase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205377_s_at	90	0.877778	0.0721015	-	0.741254	0.246664	0.576489	1.78 [0.67 - 4.72]
GENE	ACHE	acetylcholinesterase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205377_s_at	90	0.877778	0.0619865	-	0.836972	0.117691	0.801996	2.23 [0.82 - 6.09]
GENE	ACHE	acetylcholinesterase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210332_at	90	0.766667	0.0513618	-	-1.12927	0.985264	0.0100925	1.01 [0.35 - 2.95]
GENE	ACHE	acetylcholinesterase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205378_s_at	90	0.888889	0.000607072	0.0167185	1.3045	0.0279124	0.896295	2.45 [1.10 - 5.45]
GENE	ACHE	acetylcholinesterase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205378_s_at	90	0.888889	0.00784853	0.134329	1.16489	0.0600676	0.853022	2.35 [0.96 - 5.71]
GENE	ACHE	acetylcholinesterase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210332_at	90	0.766667	0.013573	0.202644	-1.37731	0.939494	-0.0367998	0.96 [0.37 - 2.49]
GENE	ACHE	acetylcholinesterase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205377_s_at	138	0.101449	0.0124914	0.190617	-0.805299	0.927385	-0.0183755	0.98 [0.66 - 1.46]
GENE	ACHE	acetylcholinesterase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210332_at	138	0.891304	0.0406022	0.431773	0.692923	0.350149	0.443038	1.56 [0.61 - 3.95]
GENE	ACHE	acetylcholinesterase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205378_s_at	138	0.137681	0.00420945	0.0826056	-0.801262	0.781954	-0.0470917	0.95 [0.68 - 1.33]
GENE	ACHE	acetylcholinesterase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210332_at	129	0.596899	0.0329979	0.37743	-0.553733	0.114432	-0.271527	0.76 [0.54 - 1.07]
GENE	ACHE	acetylcholinesterase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205377_s_at	129	0.891473	0.0725106	-	-0.897624	0.702302	-0.0737218	0.93 [0.64 - 1.36]
GENE	ACHE	acetylcholinesterase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205378_s_at	129	0.527132	0.0986995	-	0.409986	0.496472	0.125428	1.13 [0.79 - 1.63]
GENE	ACHE	acetylcholinesterase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35780	56	0.321429	0.0623293	-	-0.637838	0.804264	-0.117772	0.89 [0.35 - 2.26]
GENE	ACHE	acetylcholinesterase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	637	56	0.892857	0.12219	-	-0.915061	0.402089	-0.282686	0.75 [0.39 - 1.46]
GENE	ACHE	acetylcholinesterase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35780	56	0.178571	0.19655	-	-0.508314	0.576067	-0.287611	0.75 [0.27 - 2.06]
GENE	ACHE	acetylcholinesterase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	637	56	0.892857	0.056276	-	-1.31116	0.266657	-0.407734	0.67 [0.32 - 1.37]
GENE	ACHE	acetylcholinesterase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210332_at	278	0.683453	0.0314272	0.365426	-0.444152	0.626191	-0.185094	0.83 [0.39 - 1.75]
GENE	ACHE	acetylcholinesterase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205378_s_at	278	0.895683	0.0711846	-	-0.616326	0.433308	-0.314843	0.73 [0.33 - 1.60]
GENE	ACHE	acetylcholinesterase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205377_s_at	278	0.647482	0.103143	-	0.308885	0.874304	-0.0684663	0.93 [0.40 - 2.18]
GENE	ACHE	acetylcholinesterase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210332_at	133	0.849624	8.98895e-06	0.000405656	1.19453	4.64201e-05	1.03863	2.83 [1.71 - 4.66]
GENE	ACHE	acetylcholinesterase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205378_s_at	133	0.789474	0.00102809	0.0260842	0.839369	0.030819	1.4178	4.13 [1.14 - 14.95]
GENE	ACHE	acetylcholinesterase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205377_s_at	133	0.834586	0.00197758	0.044878	0.841713	0.278408	0.754203	2.13 [0.54 - 8.31]
GENE	ACHE	acetylcholinesterase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5865	81	0.111111	0.0629853	-	-1.36509	0.125504	-0.893123	0.41 [0.13 - 1.28]
GENE	ACHE	acetylcholinesterase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16596	81	0.358025	0.0434666	0.450797	1.24276	0.158794	0.702676	2.02 [0.76 - 5.37]
GENE	ACHE	acetylcholinesterase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205378_s_at	185	0.881081	0.141409	-	-0.387271	0.202526	-0.424644	0.65 [0.34 - 1.26]
GENE	ACHE	acetylcholinesterase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210332_at	185	0.264865	7.24693e-05	0.00263552	-0.749878	0.0950547	-0.408871	0.66 [0.41 - 1.07]
GENE	ACHE	acetylcholinesterase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205377_s_at	185	0.372973	0.00877799	0.146302	-0.431	0.125718	-0.543469	0.58 [0.29 - 1.16]
GENE	ACHE	acetylcholinesterase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205378_s_at	185	0.589189	0.325424	-	-0.175792	0.692584	-0.135388	0.87 [0.45 - 1.71]
GENE	ACHE	acetylcholinesterase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205377_s_at	185	0.351351	0.00110853	0.0277822	-0.574143	0.109026	-0.632128	0.53 [0.25 - 1.15]
GENE	ACHE	acetylcholinesterase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210332_at	185	0.264865	4.66739e-05	0.00178331	-0.72155	0.023434	-0.522449	0.59 [0.38 - 0.93]
GENE	ACHE	acetylcholinesterase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P60845	110	0.836364	0.0990004	-	0.474453	0.775851	0.0799796	1.08 [0.62 - 1.88]
GENE	ACHE	acetylcholinesterase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P60845	110	0.118182	0.0394724	0.424064	-0.803902	0.78253	-0.105682	0.90 [0.42 - 1.91]
GENE	ACHE	acetylcholinesterase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205377_s_at	80	0.6375	0.105495	-	0.701557	0.883178	0.032567	1.03 [0.67 - 1.60]
GENE	ACHE	acetylcholinesterase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205378_s_at	80	0.3	0.00621105	0.112139	1.81613	0.539017	0.0803229	1.08 [0.84 - 1.40]
GENE	ACHE	acetylcholinesterase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210332_at	80	0.8875	0.0960085	-	0.83283	0.158079	0.284127	1.33 [0.90 - 1.97]
GENE	ACHE	acetylcholinesterase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3510	281	0.160142	0.14631	-	-0.27006	0.875536	-0.0119008	0.99 [0.85 - 1.15]
GENE	ACHE	acetylcholinesterase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210332_at	38	0.157895	0.0032947	0.0679248	-1.55433	0.0813112	-0.585117	0.56 [0.29 - 1.08]
GENE	ACHE	acetylcholinesterase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205378_s_at	38	0.289474	0.0110549	0.174071	-1.34444	0.045015	-0.457221	0.63 [0.40 - 0.99]
GENE	ACHE	acetylcholinesterase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205377_s_at	38	0.736842	0.0109772	0.173156	-2.17264	0.0203546	-0.958245	0.38 [0.17 - 0.86]
GENE	ACHE	acetylcholinesterase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210332_at	140	0.814286	0.215012	-	-0.535349	0.49328	-0.549307	0.58 [0.12 - 2.78]
GENE	ACHE	acetylcholinesterase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205378_s_at	140	0.4	0.153327	-	-0.410583	0.565396	-0.43643	0.65 [0.15 - 2.86]
GENE	ACHE	acetylcholinesterase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205377_s_at	140	0.821429	0.211509	-	0.443532	0.406845	0.587047	1.80 [0.45 - 7.20]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACLY	ATP citrate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201127_s_at	30	0.166667	0.260561	-	-0.550921	0.912711	0.0846071	1.09 [0.24 - 4.94]
GENE	ACLY	ATP citrate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210337_s_at	30	0.566667	0.0139418	0.206667	0.982961	0.217091	0.559566	1.75 [0.72 - 4.26]
GENE	ACLY	ATP citrate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201128_s_at	30	0.733333	0.0772789	-	0.756135	0.959759	0.0248965	1.03 [0.39 - 2.70]
GENE	ACLY	ATP citrate lyase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1749014	165	0.89697	0.0236941	0.301657	0.729126	0.0696223	0.336432	1.40 [0.97 - 2.01]
GENE	ACLY	ATP citrate lyase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1749014	165	0.666667	0.0336409	0.382261	0.735743	0.1881	0.354296	1.43 [0.84 - 2.42]
GENE	ACLY	ATP citrate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201127_s_at	163	0.245399	0.0692789	-	-0.397137	0.769941	0.0850267	1.09 [0.62 - 1.92]
GENE	ACLY	ATP citrate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201128_s_at	163	0.791411	0.0501885	-	0.448188	0.776507	0.0461263	1.05 [0.76 - 1.44]
GENE	ACLY	ATP citrate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210337_s_at	163	0.865031	0.303979	-	0.286709	0.898187	0.0226579	1.02 [0.72 - 1.45]
GENE	ACLY	ATP citrate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210337_s_at	79	0.860759	0.00188284	0.0431053	1.11644	0.0702901	0.47072	1.60 [0.96 - 2.67]
GENE	ACLY	ATP citrate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201128_s_at	79	0.78481	0.0246048	0.309614	0.718805	0.136924	0.416322	1.52 [0.88 - 2.62]
GENE	ACLY	ATP citrate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201127_s_at	79	0.848101	0.00381956	0.076457	1.004	0.275584	0.354221	1.43 [0.75 - 2.69]
GENE	ACLY	ATP citrate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201128_s_at	58	0.344828	0.0376139	0.411118	0.630334	0.23042	0.356786	1.43 [0.80 - 2.56]
GENE	ACLY	ATP citrate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201127_s_at	58	0.586207	0.00985428	0.159685	0.724694	0.0583467	0.747002	2.11 [0.97 - 4.57]
GENE	ACLY	ATP citrate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210337_s_at	58	0.689655	0.0102768	0.16481	0.75786	0.0957013	0.389268	1.48 [0.93 - 2.33]
GENE	ACLY	ATP citrate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210337_s_at	34	0.323529	0.151767	-	0.607097	0.697154	0.0784821	1.08 [0.73 - 1.61]
GENE	ACLY	ATP citrate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201128_s_at	34	0.735294	0.028567	0.342794	0.881629	0.302656	0.547201	1.73 [0.61 - 4.89]
GENE	ACLY	ATP citrate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201127_s_at	34	0.411765	0.184684	-	0.524301	0.28032	0.577825	1.78 [0.62 - 5.09]
GENE	ACLY	ATP citrate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201128_s_at	158	0.879747	0.2022	-	-0.501166	0.789358	-0.0794266	0.92 [0.52 - 1.65]
GENE	ACLY	ATP citrate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210337_s_at	158	0.101266	0.107763	-	-0.544299	0.649788	-0.112303	0.89 [0.55 - 1.45]
GENE	ACLY	ATP citrate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201127_s_at	158	0.556962	0.117856	-	-0.369411	0.384264	-0.331901	0.72 [0.34 - 1.52]
GENE	ACLY	ATP citrate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201127_s_at	53	0.754717	0.192306	-	0.515486	0.51009	0.349215	1.42 [0.50 - 4.01]
GENE	ACLY	ATP citrate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210337_s_at	53	0.377358	0.135224	-	0.556743	0.946833	0.0377329	1.04 [0.34 - 3.15]
GENE	ACLY	ATP citrate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210337_s_at	53	0.886792	0.0878003	-	-1.57263	0.696482	-0.241683	0.79 [0.23 - 2.65]
GENE	ACLY	ATP citrate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201128_s_at	53	0.339623	0.023965	0.304038	-0.810634	0.110495	-1.0524	0.35 [0.10 - 1.27]
GENE	ACLY	ATP citrate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201127_s_at	53	0.415094	0.241676	-	0.418392	0.407762	0.401999	1.49 [0.58 - 3.87]
GENE	ACLY	ATP citrate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201128_s_at	53	0.339623	0.0845696	-	-0.596552	0.276116	-0.677279	0.51 [0.15 - 1.72]
GENE	ACLY	ATP citrate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210337_s_at	180	0.211111	0.0234308	0.299332	-0.543094	0.356246	-0.0809108	0.92 [0.78 - 1.10]
GENE	ACLY	ATP citrate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201127_s_at	180	0.816667	0.023462	0.299608	0.562089	0.612874	0.143106	1.15 [0.66 - 2.01]
GENE	ACLY	ATP citrate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201128_s_at	180	0.855556	0.112483	-	0.436172	0.805274	0.115317	1.12 [0.45 - 2.81]
GENE	ACLY	ATP citrate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210337_s_at	559	0.150268	0.00943431	0.154521	0.978674	0.0127052	0.50104	1.65 [1.11 - 2.45]
GENE	ACLY	ATP citrate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201128_s_at	559	0.73703	0.00951875	0.155565	0.53845	0.111757	0.557067	1.75 [0.88 - 3.47]
GENE	ACLY	ATP citrate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201127_s_at	559	0.103757	0.141169	-	0.510044	0.508969	0.22491	1.25 [0.64 - 2.44]
GENE	ACLY	ATP citrate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210337_s_at	77	0.753247	0.0547849	-	0.537037	0.576644	0.114891	1.12 [0.75 - 1.68]
GENE	ACLY	ATP citrate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201128_s_at	77	0.714286	0.119548	-	0.424835	0.559489	0.259207	1.30 [0.54 - 3.09]
GENE	ACLY	ATP citrate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201127_s_at	77	0.298701	0.0722318	-	0.529683	0.439075	0.260159	1.30 [0.67 - 2.51]
GENE	ACLY	ATP citrate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210337_s_at	70	0.671429	0.157244	-	0.392739	0.829938	0.0641504	1.07 [0.59 - 1.91]
GENE	ACLY	ATP citrate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201128_s_at	70	0.285714	0.239281	-	-0.333511	0.705009	-0.136361	0.87 [0.43 - 1.77]
GENE	ACLY	ATP citrate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201127_s_at	70	0.871429	0.153339	-	0.55663	0.925413	-0.0374287	0.96 [0.44 - 2.11]
GENE	ACLY	ATP citrate lyase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40881_at	50	0.78	0.228718	-	0.515865	0.780868	0.0739694	1.08 [0.64 - 1.81]
GENE	ACLY	ATP citrate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201127_s_at	74	0.202703	0.189813	-	-0.447652	0.720491	-0.159948	0.85 [0.35 - 2.05]
GENE	ACLY	ATP citrate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210337_s_at	74	0.121622	0.0343167	0.387289	-0.813393	0.112514	-0.389314	0.68 [0.42 - 1.10]
GENE	ACLY	ATP citrate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201128_s_at	74	0.162162	0.00604652	0.109821	-0.892068	0.592029	-0.278001	0.76 [0.27 - 2.09]
GENE	ACLY	ATP citrate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210337_s_at	67	0.268657	0.107418	-	-1.03615	0.37785	-0.916189	0.40 [0.05 - 3.07]
GENE	ACLY	ATP citrate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201128_s_at	67	0.238806	0.0403903	0.430336	-1.31364	0.424819	-0.99535	0.37 [0.03 - 4.26]
GENE	ACLY	ATP citrate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201127_s_at	67	0.477612	0.18546	-	-1.03157	0.928423	-0.110175	0.90 [0.08 - 9.91]
GENE	ACLY	ATP citrate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210337_s_at	115	0.895652	0.000237961	0.00747557	1.79498	0.0718705	0.827843	2.29 [0.93 - 5.64]
GENE	ACLY	ATP citrate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201128_s_at	115	0.895652	0.0888618	-	1.05469	0.414969	0.500219	1.65 [0.50 - 5.49]
GENE	ACLY	ATP citrate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201127_s_at	115	0.852174	0.0117012	0.1816	1.30638	0.278545	0.660047	1.93 [0.59 - 6.38]
GENE	ACLY	ATP citrate lyase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40881_at	158	0.151899	0.00799236	0.136209	-0.838437	0.21689	-0.548909	0.58 [0.24 - 1.38]
GENE	ACLY	ATP citrate lyase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40881_at	76	0.473684	0.131104	-	-0.78251	0.940781	0.0446188	1.05 [0.32 - 3.39]
GENE	ACLY	ATP citrate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201128_s_at	204	0.102941	0.00208018	0.0467771	0.707588	0.0321	0.447533	1.56 [1.04 - 2.36]
GENE	ACLY	ATP citrate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201127_s_at	204	0.102941	0.0090672	0.149947	0.627683	0.0491075	0.360821	1.43 [1.00 - 2.05]
GENE	ACLY	ATP citrate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210337_s_at	204	0.617647	0.0590866	-	0.278217	0.209665	0.178666	1.20 [0.90 - 1.58]
GENE	ACLY	ATP citrate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201128_s_at	87	0.126437	0.0278597	0.337033	-0.980435	0.042858	-0.798104	0.45 [0.21 - 0.97]
GENE	ACLY	ATP citrate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210337_s_at	87	0.252874	0.0351583	0.39348	-0.796366	0.107295	-0.492667	0.61 [0.34 - 1.11]
GENE	ACLY	ATP citrate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201127_s_at	87	0.241379	0.0115693	0.180075	-0.944602	0.0942252	-0.62512	0.54 [0.26 - 1.11]
GENE	ACLY	ATP citrate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201128_s_at	87	0.126437	0.0278597	0.337033	-0.980435	0.042858	-0.798104	0.45 [0.21 - 0.97]
GENE	ACLY	ATP citrate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201127_s_at	87	0.241379	0.0115693	0.180075	-0.944602	0.0942252	-0.62512	0.54 [0.26 - 1.11]
GENE	ACLY	ATP citrate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210337_s_at	87	0.252874	0.0351583	0.39348	-0.796366	0.107295	-0.492667	0.61 [0.34 - 1.11]
GENE	ACLY	ATP citrate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201128_s_at	77	0.168831	0.0838378	-	15.335	0.190013	0.812373	2.25 [0.67 - 7.59]
GENE	ACLY	ATP citrate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201127_s_at	77	0.207792	0.0507141	-	15.4183	0.221436	0.655074	1.93 [0.67 - 5.50]
GENE	ACLY	ATP citrate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210337_s_at	77	0.38961	0.049862	0.490795	1.81029	0.302539	0.426228	1.53 [0.68 - 3.44]
GENE	ACLY	ATP citrate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201128_s_at	77	0.168831	0.133668	-	15.3277	0.21657	0.877532	2.40 [0.60 - 9.67]
GENE	ACLY	ATP citrate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210337_s_at	77	0.311688	0.0520337	-	1.77869	0.358402	0.334206	1.40 [0.68 - 2.85]
GENE	ACLY	ATP citrate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201127_s_at	77	0.207792	0.0890446	-	15.4123	0.240776	0.718417	2.05 [0.62 - 6.81]
GENE	ACLY	ATP citrate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210337_s_at	136	0.419118	0.0151681	0.219776	-1.08923	0.127394	-0.307546	0.74 [0.50 - 1.09]
GENE	ACLY	ATP citrate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201127_s_at	136	0.720588	0.0686961	-	-1.27163	0.330847	-0.579669	0.56 [0.17 - 1.80]
GENE	ACLY	ATP citrate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201128_s_at	136	0.683824	0.0544675	-	-1.3385	0.807998	-0.125351	0.88 [0.32 - 2.42]
GENE	ACLY	ATP citrate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210337_s_at	200	0.18	0.0869425	-	-0.568483	0.510656	-0.19034	0.83 [0.47 - 1.46]
GENE	ACLY	ATP citrate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201127_s_at	200	0.635	0.0671427	-	0.53423	0.204445	0.578061	1.78 [0.73 - 4.35]
GENE	ACLY	ATP citrate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201128_s_at	200	0.59	0.010819	0.171287	0.74619	0.0445493	0.966556	2.63 [1.02 - 6.75]
GENE	ACLY	ATP citrate lyase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5470	60	0.266667	0.115175	-	-0.614664	0.514564	-0.206289	0.81 [0.44 - 1.51]
GENE	ACLY	ATP citrate lyase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5470	60	0.133333	0.188503	-	-0.601381	0.578033	-0.223639	0.80 [0.36 - 1.76]
GENE	ACLY	ATP citrate lyase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	19938	155	0.832258	0.000148513	0.00495659	1.05956	0.000399239	0.279454	1.32 [1.13 - 1.54]
GENE	ACLY	ATP citrate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201127_s_at	286	0.562937	0.072049	-	-0.358692	0.203958	-0.31465	0.73 [0.45 - 1.19]
GENE	ACLY	ATP citrate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210337_s_at	286	0.451049	0.0385373	0.417592	-0.398183	0.359155	-0.084197	0.92 [0.77 - 1.10]
GENE	ACLY	ATP citrate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201128_s_at	286	0.311189	0.0259967	0.321529	0.504004	0.0906943	0.517708	1.68 [0.92 - 3.06]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201127_s_at	159	0.415094	0.0856218	-	0.584959	0.152767	0.58611	1.80 [0.80 - 4.01]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201128_s_at	159	0.295597	0.0897366	-	0.812059	0.336441	0.524397	1.69 [0.58 - 4.92]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210337_s_at	159	0.125786	0.0904949	-	1.16202	0.344142	0.196642	1.22 [0.81 - 1.83]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201128_s_at	159	0.333333	0.039082	0.421372	0.794858	0.230317	0.556555	1.74 [0.70 - 4.33]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201127_s_at	159	0.836478	0.025142	0.314247	0.774321	0.091652	0.699064	2.01 [0.89 - 4.53]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201127_s_at	159	0.849057	0.0478719	0.478695	0.800563	0.0809328	0.843108	2.32 [0.90 - 5.99]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201128_s_at	159	0.333333	0.0786723	-	0.654424	0.34188	0.442872	1.56 [0.62 - 3.88]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210337_s_at	159	0.685535	0.0300805	0.354899	0.677178	0.254136	0.240841	1.27 [0.84 - 1.92]
GENE	ACLY	ATP citrate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210337_s_at	159	0.880503	0.0297433	0.352227	0.912248	0.230151	0.305846	1.36 [0.82 - 2.24]
GENE	ACLY	ATP citrate lyase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201127_s_at	54	0.537037	0.120579	-	1.19531	0.312989	0.504696	1.66 [0.62 - 4.42]
GENE	ACLY	ATP citrate lyase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201128_s_at	54	0.851852	0.124255	-	1.07272	0.387114	0.487527	1.63 [0.54 - 4.92]
GENE	ACLY	ATP citrate lyase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210337_s_at	54	0.592593	0.154971	-	0.997083	0.295466	0.399872	1.49 [0.71 - 3.16]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201128_s_at	117	0.871795	0.0290878	0.346993	0.84072	0.0840866	0.567731	1.76 [0.93 - 3.36]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201128_s_at	117	0.555556	0.0266347	0.326894	0.835255	0.0733257	0.72101	2.06 [0.93 - 4.53]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201128_s_at	117	0.547009	0.00101451	0.0257949	1.34827	0.05479	0.808644	2.24 [0.98 - 5.12]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201128_s_at	117	0.871795	0.0290878	0.346993	0.84072	0.0840866	0.567731	1.76 [0.93 - 3.36]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210337_s_at	117	0.153846	0.0506494	-	1.3224	0.152455	0.280679	1.32 [0.90 - 1.94]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210337_s_at	117	0.897436	0.0319994	0.369833	1.01481	0.115666	0.371785	1.45 [0.91 - 2.30]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210337_s_at	117	0.153846	0.0506494	-	1.3224	0.152455	0.280679	1.32 [0.90 - 1.94]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201127_s_at	117	0.880342	0.034495	0.388607	0.858707	0.165949	0.394403	1.48 [0.85 - 2.59]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210337_s_at	117	0.863248	0.117573	-	0.764251	0.322755	0.235466	1.27 [0.79 - 2.02]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201127_s_at	117	0.880342	0.00781563	0.133897	1.16081	0.102843	0.554614	1.74 [0.89 - 3.39]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201127_s_at	117	0.547009	0.000493967	0.014024	1.42412	0.106932	0.555793	1.74 [0.89 - 3.43]
GENE	ACLY	ATP citrate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201127_s_at	117	0.880342	0.034495	0.388607	0.858707	0.165949	0.394403	1.48 [0.85 - 2.59]
GENE	ACLY	ATP citrate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201127_s_at	236	0.110169	0.103235	-	-0.585561	0.826592	-0.0965971	0.91 [0.38 - 2.15]
GENE	ACLY	ATP citrate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201128_s_at	236	0.847458	0.0422296	0.442671	0.634523	0.822811	0.102818	1.11 [0.45 - 2.73]
GENE	ACLY	ATP citrate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210337_s_at	236	0.423729	0.11423	-	-0.423859	0.38448	-0.189653	0.83 [0.54 - 1.27]
GENE	ACLY	ATP citrate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201128_s_at	249	0.84739	9.41379e-05	0.00332072	0.916631	0.196101	0.47742	1.61 [0.78 - 3.32]
GENE	ACLY	ATP citrate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210337_s_at	249	0.369478	0.0405408	0.431357	-0.433894	0.66286	-0.0787048	0.92 [0.65 - 1.32]
GENE	ACLY	ATP citrate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201127_s_at	249	0.425703	0.186903	-	0.29069	0.41494	0.279171	1.32 [0.68 - 2.59]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210337_s_at	54	0.759259	0.00424067	0.0830917	1.51733	0.39787	0.518379	1.68 [0.50 - 5.59]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201128_s_at	62	0.112903	0.0405114	0.431158	-1.13535	0.689003	-0.113307	0.89 [0.51 - 1.56]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201127_s_at	125	0.144	0.332899	-	-0.378088	0.873743	-0.0524439	0.95 [0.50 - 1.81]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201128_s_at	125	0.216	0.0204568	0.272248	2.00796	0.274687	0.433251	1.54 [0.71 - 3.36]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201127_s_at	54	0.814815	0.16016	-	0.845538	0.553705	0.299176	1.35 [0.50 - 3.63]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210337_s_at	125	0.256	0.119847	-	-0.504683	0.664363	-0.105113	0.90 [0.56 - 1.45]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201128_s_at	125	0.216	0.0381235	0.414702	1.04041	0.51566	0.198865	1.22 [0.67 - 2.22]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201128_s_at	54	0.111111	0.0186485	0.254981	-1.51271	0.630968	-0.165775	0.85 [0.43 - 1.67]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210337_s_at	125	0.776	0.068585	-	0.715265	0.955146	0.0177357	1.02 [0.55 - 1.89]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201127_s_at	62	0.822581	0.0620576	-	0.917937	0.700573	0.151856	1.16 [0.54 - 2.52]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201127_s_at	125	0.728	0.153844	-	0.551007	0.959991	0.0217158	1.02 [0.44 - 2.39]
GENE	ACLY	ATP citrate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210337_s_at	62	0.758065	0.00342736	0.0701111	1.31501	0.378585	0.425431	1.53 [0.59 - 3.94]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201128_s_at	198	0.767677	1.06414e-05	0.000472662	1.09863	0.00127281	0.848293	2.34 [1.39 - 3.91]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210337_s_at	198	0.89899	0.000156641	0.00519312	0.984453	0.00778965	0.432209	1.54 [1.12 - 2.12]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201128_s_at	198	0.767677	6.81842e-05	0.00249705	1.04013	0.00689425	0.734343	2.08 [1.22 - 3.55]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201127_s_at	198	0.843434	0.047345	0.475441	0.508787	0.0848858	0.421028	1.52 [0.94 - 2.46]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210337_s_at	198	0.292929	0.00431534	0.0842501	0.989188	0.00665607	0.538162	1.71 [1.16 - 2.53]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210337_s_at	198	0.222222	0.0156624	0.224949	1.00437	0.0488629	0.392536	1.48 [1.00 - 2.19]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201128_s_at	198	0.893939	0.000105676	0.00367676	1.03421	0.00224921	0.675026	1.96 [1.27 - 3.03]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201127_s_at	198	0.893939	0.0196558	0.264679	0.760334	0.0841078	0.510411	1.67 [0.93 - 2.97]
GENE	ACLY	ATP citrate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201127_s_at	198	0.843434	0.0555367	-	0.583147	0.309432	0.311171	1.37 [0.75 - 2.49]
GENE	ACLY	ATP citrate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201127_s_at	62	0.387097	0.256572	-	0.739706	0.920672	0.0738201	1.08 [0.25 - 4.60]
GENE	ACLY	ATP citrate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201128_s_at	51	0.45098	0.0352938	0.39447	16.0898	0.413824	0.837712	2.31 [0.31 - 17.24]
GENE	ACLY	ATP citrate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210337_s_at	62	0.483871	0.0550085	-	1.20636	0.471877	0.621575	1.86 [0.34 - 10.12]
GENE	ACLY	ATP citrate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201128_s_at	62	0.806452	0.0233829	0.298908	1.24631	0.466888	0.494598	1.64 [0.43 - 6.22]
GENE	ACLY	ATP citrate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210337_s_at	51	0.705882	0.0819586	-	1.46112	0.729129	0.467641	1.60 [0.11 - 22.52]
GENE	ACLY	ATP citrate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201127_s_at	51	0.784314	0.242218	-	1.02349	0.549295	0.694961	2.00 [0.21 - 19.48]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201127_s_at	177	0.367232	0.114202	-	0.412329	0.220106	0.515859	1.68 [0.73 - 3.82]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201128_s_at	145	0.42069	0.140634	-	0.528693	0.679258	0.208261	1.23 [0.46 - 3.31]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201127_s_at	145	0.372414	0.264147	-	0.412925	0.666727	0.261505	1.30 [0.40 - 4.27]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210337_s_at	177	0.305085	0.0542534	-	0.638613	0.19546	0.390832	1.48 [0.82 - 2.67]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201128_s_at	177	0.694915	0.0223072	0.28928	0.613665	0.129715	0.609051	1.84 [0.84 - 4.04]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210337_s_at	177	0.305085	0.036206	0.401082	0.598438	0.237323	0.307056	1.36 [0.82 - 2.26]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201127_s_at	177	0.683616	0.0392643	0.422631	0.560068	0.191574	0.632252	1.88 [0.73 - 4.86]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201128_s_at	177	0.666667	0.0138954	0.206163	0.571736	0.0618183	0.654335	1.92 [0.97 - 3.82]
GENE	ACLY	ATP citrate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210337_s_at	145	0.296552	0.154332	-	0.590351	0.689927	0.145153	1.16 [0.57 - 2.36]
GENE	ACLY	ATP citrate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201127_s_at	226	0.132743	0.176889	-	-0.496894	0.480313	-0.261351	0.77 [0.37 - 1.59]
GENE	ACLY	ATP citrate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210337_s_at	226	0.681416	0.238279	-	-0.388693	0.82713	-0.0477407	0.95 [0.62 - 1.46]
GENE	ACLY	ATP citrate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201128_s_at	226	0.411504	0.0616292	-	-0.530875	0.992326	-0.00345322	1.00 [0.49 - 2.01]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201127_s_at	55	0.381818	0.144026	-	0.838646	0.858297	0.128304	1.14 [0.28 - 4.65]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201127_s_at	49	0.102041	0.0329039	0.376719	-1.62864	0.58038	-0.511888	0.60 [0.10 - 3.68]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210337_s_at	55	0.727273	0.156838	-	-0.86002	0.947421	-0.0274271	0.97 [0.43 - 2.20]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210337_s_at	55	0.709091	0.37464	-	0.436319	0.865479	-0.0761861	0.93 [0.38 - 2.24]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201128_s_at	55	0.763636	0.0170798	0.239455	1.04478	0.418245	0.460523	1.58 [0.52 - 4.83]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210337_s_at	49	0.693878	0.197898	-	-0.961128	0.327177	-0.508144	0.60 [0.22 - 1.66]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201127_s_at	55	0.381818	0.348994	-	0.453249	0.809727	-0.165538	0.85 [0.22 - 3.26]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201128_s_at	55	0.8	0.00790261	0.135037	1.25372	0.113133	0.989171	2.69 [0.79 - 9.14]
GENE	ACLY	ATP citrate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201128_s_at	49	0.816327	0.0276637	0.335425	1.2173	0.304734	0.84886	2.34 [0.46 - 11.82]
GENE	ACLY	ATP citrate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210337_s_at	63	0.365079	0.00505121	0.0954046	1.13052	0.0270498	0.42781	1.53 [1.05 - 2.24]
GENE	ACLY	ATP citrate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201128_s_at	63	0.126984	0.00816532	0.138456	15.303	0.0324279	0.687137	1.99 [1.06 - 3.73]
GENE	ACLY	ATP citrate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201127_s_at	63	0.603175	0.0110098	0.17354	0.849928	0.0949937	0.410743	1.51 [0.93 - 2.44]
GENE	ACLY	ATP citrate lyase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g603073_3p_s_at	28	0.642857	0.0153059	0.221224	-1.6982	0.0854112	-6.78378	0.00 [0.00 - 2.58]
GENE	ACLY	ATP citrate lyase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501864_3p_s_at	28	0.857143	0.0685508	-	1.19105	0.39651	0.109385	1.12 [0.87 - 1.44]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210337_s_at	82	0.585366	0.0263225	0.324276	0.738179	0.621219	0.144736	1.16 [0.65 - 2.05]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201127_s_at	82	0.780488	0.231578	-	0.444568	0.392283	0.537652	1.71 [0.50 - 5.87]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201128_s_at	82	0.158537	0.0421216	0.441955	-0.772886	0.581466	-0.295587	0.74 [0.26 - 2.13]
GENE	ACLY	ATP citrate lyase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40881_at	84	0.559524	0.00381969	0.0764592	0.827829	0.00928163	1.30839	3.70 [1.38 - 9.92]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201127_s_at	79	0.113924	0.00568239	0.104629	-0.97998	0.832402	-0.0956447	0.91 [0.37 - 2.20]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210337_s_at	79	0.265823	0.0044025	0.0855959	-0.788106	0.456446	-0.211125	0.81 [0.46 - 1.41]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201128_s_at	79	0.113924	0.00328176	0.0677105	-1.04	0.66032	-0.161594	0.85 [0.41 - 1.75]
GENE	ACLY	ATP citrate lyase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X64330_at	86	0.325581	0.307618	-	0.511771	0.553316	0.388904	1.48 [0.41 - 5.34]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210337_s_at	104	0.105769	0.146736	-	1.01298	0.382989	0.266708	1.31 [0.72 - 2.38]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201127_s_at	104	0.211538	0.0443453	0.456489	1.14254	0.122291	1.11322	3.04 [0.74 - 12.49]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201128_s_at	104	0.461538	0.112309	-	0.537984	0.446206	0.382823	1.47 [0.55 - 3.93]
GENE	ACLY	ATP citrate lyase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P66787	117	0.854701	0.000133609	0.00451803	1.1842	0.000188913	1.43757	4.21 [1.98 - 8.96]
GENE	ACLY	ATP citrate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210337_s_at	204	0.715686	0.000229564	0.007246	0.966929	0.000538366	1.2667	3.55 [1.73 - 7.27]
GENE	ACLY	ATP citrate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201128_s_at	204	0.892157	0.158622	-	-1.3343	0.43599	-0.525894	0.59 [0.16 - 2.22]
GENE	ACLY	ATP citrate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201128_s_at	204	0.519608	0.0204483	0.272168	0.642959	0.191732	0.607177	1.84 [0.74 - 4.57]
GENE	ACLY	ATP citrate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201127_s_at	204	0.196078	0.342249	-	0.505058	0.632456	-0.337254	0.71 [0.18 - 2.84]
GENE	ACLY	ATP citrate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201127_s_at	204	0.740196	0.00865719	0.144769	0.718134	0.0343041	1.02259	2.78 [1.08 - 7.17]
GENE	ACLY	ATP citrate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210337_s_at	204	0.220588	0.0271219	0.330951	1.47937	0.493463	0.35011	1.42 [0.52 - 3.87]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201127_s_at	178	0.848315	0.0897265	-	0.42861	0.185442	0.60612	1.83 [0.75 - 4.50]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201128_s_at	178	0.803371	0.0587879	-	0.42645	0.425743	0.309292	1.36 [0.64 - 2.92]
GENE	ACLY	ATP citrate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210337_s_at	178	0.55618	0.114231	-	-0.319741	0.965571	-0.010652	0.99 [0.61 - 1.60]
GENE	ACLY	ATP citrate lyase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300019279	41	0.121951	0.00673774	0.119443	-1.3373	0.346022	-0.34911	0.71 [0.34 - 1.46]
GENE	ACLY	ATP citrate lyase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200008204	41	0.292683	0.161336	-	0.696633	0.482777	0.197938	1.22 [0.70 - 2.12]
GENE	ACLY	ATP citrate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201128_s_at	111	0.738739	0.163606	-	-0.447984	0.929964	-0.0286557	0.97 [0.51 - 1.84]
GENE	ACLY	ATP citrate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201127_s_at	111	0.765766	0.155972	-	-0.472923	0.842442	0.0751838	1.08 [0.51 - 2.26]
GENE	ACLY	ATP citrate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210337_s_at	111	0.306306	0.00919184	0.151506	0.822768	0.234434	0.18171	1.20 [0.89 - 1.62]
GENE	ACLY	ATP citrate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201127_s_at	90	0.866667	0.00280919	0.0597341	1.09408	0.0497944	0.80135	2.23 [1.00 - 4.96]
GENE	ACLY	ATP citrate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201127_s_at	90	0.877778	0.00244437	0.0533598	1.24082	0.0908215	0.788842	2.20 [0.88 - 5.49]
GENE	ACLY	ATP citrate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201128_s_at	90	0.777778	0.0244937	0.308651	0.753231	0.0946721	0.450023	1.57 [0.93 - 2.66]
GENE	ACLY	ATP citrate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201128_s_at	90	0.833333	0.0264811	0.325607	0.894618	0.223496	0.369121	1.45 [0.80 - 2.62]
GENE	ACLY	ATP citrate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210337_s_at	90	0.733333	0.022678	0.292621	0.836105	0.0347834	0.693444	2.00 [1.05 - 3.81]
GENE	ACLY	ATP citrate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210337_s_at	90	0.722222	0.0293205	0.348857	0.709771	0.0458825	0.578497	1.78 [1.01 - 3.15]
GENE	ACLY	ATP citrate lyase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3675	50	0.74	0.195086	-	0.643297	0.933654	-0.0312077	0.97 [0.46 - 2.02]
GENE	ACLY	ATP citrate lyase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5460	50	0.42	0.0198061	0.266108	-1.1248	0.298057	-0.828755	0.44 [0.09 - 2.08]
GENE	ACLY	ATP citrate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201128_s_at	138	0.15942	0.00984231	0.159539	1.13752	0.080994	0.378252	1.46 [0.95 - 2.23]
GENE	ACLY	ATP citrate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201127_s_at	138	0.57971	0.0138527	0.205698	0.585095	0.0531978	0.401234	1.49 [0.99 - 2.24]
GENE	ACLY	ATP citrate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210337_s_at	138	0.57971	0.00154357	0.0365915	0.756684	0.0378515	0.25718	1.29 [1.01 - 1.65]
GENE	ACLY	ATP citrate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210337_s_at	129	0.162791	0.213245	-	-0.3638	0.985623	-0.00512233	0.99 [0.57 - 1.74]
GENE	ACLY	ATP citrate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201127_s_at	129	0.79845	0.133402	-	0.421747	0.379994	0.39893	1.49 [0.61 - 3.63]
GENE	ACLY	ATP citrate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201128_s_at	129	0.20155	0.141263	-	0.486407	0.752171	0.128967	1.14 [0.51 - 2.53]
GENE	ACLY	ATP citrate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41223	56	0.553571	0.0292967	0.348667	0.753323	0.366847	0.277635	1.32 [0.72 - 2.41]
GENE	ACLY	ATP citrate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20050	56	0.660714	0.10618	-	0.573235	0.517368	0.223771	1.25 [0.64 - 2.46]
GENE	ACLY	ATP citrate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41223	56	0.571429	0.0199962	0.26791	0.848952	0.288603	0.337714	1.40 [0.75 - 2.62]
GENE	ACLY	ATP citrate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3284	56	0.303571	0.152386	-	0.538777	0.684012	0.126186	1.13 [0.62 - 2.08]
GENE	ACLY	ATP citrate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20050	56	0.660714	0.0592845	-	0.691005	0.367477	0.318675	1.38 [0.69 - 2.75]
GENE	ACLY	ATP citrate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3284	56	0.321429	0.129341	-	0.601338	0.405629	0.269014	1.31 [0.69 - 2.47]
GENE	ACLY	ATP citrate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210337_s_at	278	0.143885	0.100478	-	-0.404582	0.0832055	-0.333804	0.72 [0.49 - 1.04]
GENE	ACLY	ATP citrate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201128_s_at	278	0.791367	0.175941	-	-0.332934	0.496165	-0.133547	0.87 [0.60 - 1.29]
GENE	ACLY	ATP citrate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201127_s_at	278	0.172662	0.00905316	0.149771	-0.566176	0.034043	-0.513328	0.60 [0.37 - 0.96]
GENE	ACLY	ATP citrate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201128_s_at	133	0.842105	0.00875008	0.145948	-1.15025	0.0248733	-0.37445	0.69 [0.50 - 0.95]
GENE	ACLY	ATP citrate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210337_s_at	133	0.308271	0.0484659	0.482338	-0.477036	0.385157	-0.0758827	0.93 [0.78 - 1.10]
GENE	ACLY	ATP citrate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201127_s_at	133	0.827068	0.0238929	0.303405	0.622369	0.386993	0.215474	1.24 [0.76 - 2.02]
GENE	ACLY	ATP citrate lyase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15143	81	0.246914	0.0319744	0.369641	-1.10514	0.0520929	-0.450264	0.64 [0.40 - 1.00]
GENE	ACLY	ATP citrate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201127_s_at	185	0.108108	0.242628	-	-0.313023	0.522002	-0.151699	0.86 [0.54 - 1.37]
GENE	ACLY	ATP citrate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210337_s_at	185	0.886486	0.179928	-	-0.357355	0.857887	-0.0260306	0.97 [0.73 - 1.30]
GENE	ACLY	ATP citrate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201128_s_at	185	0.643243	0.0102787	0.164833	0.419819	0.153964	0.207216	1.23 [0.93 - 1.64]
GENE	ACLY	ATP citrate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210337_s_at	185	0.886486	0.162973	-	-0.422472	0.758849	-0.0492177	0.95 [0.70 - 1.30]
GENE	ACLY	ATP citrate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201127_s_at	185	0.416216	0.142408	-	-0.243014	0.275344	-0.240998	0.79 [0.51 - 1.21]
GENE	ACLY	ATP citrate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201128_s_at	185	0.486486	0.0067984	0.120274	0.481699	0.100763	0.263091	1.30 [0.95 - 1.78]
GENE	ACLY	ATP citrate lyase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P66787	110	0.145455	0.0884939	-	-0.676919	0.860326	-0.0652594	0.94 [0.45 - 1.94]
GENE	ACLY	ATP citrate lyase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P66787	110	0.718182	0.108167	-	0.391198	0.61472	0.136181	1.15 [0.67 - 1.95]
GENE	ACLY	ATP citrate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201127_s_at	80	0.4625	0.0182706	0.25129	1.15155	0.144202	0.6669	1.95 [0.80 - 4.77]
GENE	ACLY	ATP citrate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210337_s_at	80	0.6375	0.0929474	-	0.736413	0.735375	0.0900994	1.09 [0.65 - 1.85]
GENE	ACLY	ATP citrate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201128_s_at	80	0.1625	0.0144594	0.212249	-1.17224	0.361151	-0.449772	0.64 [0.24 - 1.67]
GENE	ACLY	ATP citrate lyase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3461	281	0.359431	0.0065557	0.116938	-0.388334	0.107425	-0.246393	0.78 [0.58 - 1.06]
GENE	ACLY	ATP citrate lyase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:37690	59	0.576271	0.0431641	0.448822	-1.10906	0.250104	-0.585355	0.56 [0.21 - 1.51]
GENE	ACLY	ATP citrate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201127_s_at	38	0.447368	0.00487114	0.0927171	1.43097	0.0359127	1.00411	2.73 [1.07 - 6.97]
GENE	ACLY	ATP citrate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210337_s_at	38	0.710526	0.00506126	0.0955538	1.40089	0.0387772	0.937275	2.55 [1.05 - 6.21]
GENE	ACLY	ATP citrate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201128_s_at	38	0.842105	0.0174598	0.243265	1.19552	0.465857	0.469091	1.60 [0.45 - 5.64]
GENE	ACLY	ATP citrate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201127_s_at	140	0.85	0.00881057	0.146715	0.852692	0.152547	0.474873	1.61 [0.84 - 3.08]
GENE	ACLY	ATP citrate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201128_s_at	140	0.8	5.5494e-05	0.0020801	1.18355	0.000378241	0.960722	2.61 [1.54 - 4.44]
GENE	ACLY	ATP citrate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210337_s_at	140	0.714286	0.000239425	0.00751544	1.02016	0.0316757	0.55187	1.74 [1.05 - 2.87]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1727091	165	0.109091	0.0963005	-	0.833378	0.955506	-0.0416745	0.96 [0.22 - 4.15]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1727091	165	0.4	0.04082	0.433246	-0.713755	0.713455	-0.467844	0.63 [0.05 - 7.61]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	230602_at	163	0.104294	0.0508721	-	-0.559393	0.791375	-0.221452	0.80 [0.16 - 4.13]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	230602_at	79	0.202532	0.0583245	-	0.806244	0.49987	0.486987	1.63 [0.40 - 6.70]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	230602_at	180	0.122222	0.00299635	0.0629285	-0.806577	0.0194564	-0.300345	0.74 [0.58 - 0.95]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	230602_at	559	0.728086	0.0609492	-	-0.442983	0.39091	-0.115611	0.89 [0.68 - 1.16]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	230602_at	77	0.155844	0.107331	-	-0.517769	0.540873	-0.162099	0.85 [0.51 - 1.43]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	230602_at	70	0.857143	0.14483	-	0.533023	0.188432	0.362769	1.44 [0.84 - 2.47]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	230602_at	74	0.891892	7.32813e-05	0.00266164	1.5	0.295764	0.309283	1.36 [0.76 - 2.43]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	230602_at	67	0.597015	0.0783531	-	1.18222	0.592074	2.13345	8.44 [0.00 - 20688.37]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	230602_at	115	0.582609	0.0272766	0.332233	-1.53307	0.0878654	-0.925669	0.40 [0.14 - 1.15]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	230602_at	204	0.137255	0.180495	-	-0.26819	0.942456	-0.00397659	1.00 [0.89 - 1.11]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	230602_at	87	0.528736	0.0372501	0.408544	-0.821044	0.546081	-0.108884	0.90 [0.63 - 1.28]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	230602_at	87	0.528736	0.0372501	0.408544	-0.821044	0.546081	-0.108884	0.90 [0.63 - 1.28]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	230602_at	77	0.181818	0.291445	-	1.04947	0.78968	0.0586838	1.06 [0.69 - 1.63]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	230602_at	77	0.363636	0.0842895	-	-1.06408	0.741932	0.0816264	1.09 [0.67 - 1.76]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21868	60	0.65	0.178677	-	-0.581151	0.969367	0.00492675	1.00 [0.78 - 1.29]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21868	60	0.116667	0.00221675	0.0492736	-1.35323	0.250872	-0.210251	0.81 [0.57 - 1.16]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230602_at	159	0.113208	0.00405278	0.0801531	-1.13291	0.0391034	-0.528046	0.59 [0.36 - 0.97]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230602_at	159	0.389937	0.034099	0.385675	-0.659664	0.366719	-0.213268	0.81 [0.51 - 1.28]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230602_at	159	0.100629	6.0323e-05	0.00224005	-1.36517	0.0376794	-0.477019	0.62 [0.40 - 0.97]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	230602_at	236	0.851695	0.028636	0.343352	-1.22182	0.695226	-0.085786	0.92 [0.60 - 1.41]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	230602_at	249	0.453815	0.0786289	-	0.38039	0.791811	-0.0441043	0.96 [0.69 - 1.33]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	230602_at	145	0.144828	0.0233912	0.298981	-0.849773	0.194666	-1.63748	0.19 [0.02 - 2.31]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	230602_at	177	0.576271	0.384468	-	-0.210243	0.570126	-0.302683	0.74 [0.26 - 2.10]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	230602_at	177	0.689266	0.201586	-	0.357755	0.509672	-0.467657	0.63 [0.16 - 2.52]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	230602_at	226	0.137168	0.0238574	0.303094	1.48932	0.193463	0.191243	1.21 [0.91 - 1.62]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	230602_at	55	0.836364	0.0269659	0.329656	1.24169	0.0064491	2.15172	8.60 [1.83 - 40.44]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	230602_at	49	0.897959	0.0317733	0.368096	1.58569	0.158044	3.48609	32.66 [0.26 - 4130.90]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	230602_at	55	0.836364	0.00412252	0.0812477	1.3205	0.00439281	2.79409	16.35 [2.39 - 111.79]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	230602_at	63	0.111111	0.0161514	0.230008	-1.05097	0.677733	-1.32993	0.26 [0.00 - 140.15]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.13197.0.A1_3p_at	28	0.321429	0.0132032	0.19857	-1.39597	0.611951	0.437426	1.55 [0.29 - 8.39]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	230602_at	204	0.171569	0.0142876	0.210404	-0.91669	0.204359	-0.177616	0.84 [0.64 - 1.10]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	230602_at	204	0.897059	0.180203	-	-0.776664	0.679567	-0.042607	0.96 [0.78 - 1.17]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	230602_at	111	0.864865	0.243834	-	-0.498887	0.831506	-0.0282562	0.97 [0.75 - 1.26]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3584	50	0.88	0.053082	-	1.08503	0.820724	0.0688264	1.07 [0.59 - 1.94]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	230602_at	138	0.326087	0.0277544	0.336169	-0.52944	0.756079	-0.0487128	0.95 [0.70 - 1.30]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11241	56	0.821429	0.0382482	0.415574	0.872931	0.315241	0.5545	1.74 [0.59 - 5.14]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11241	56	0.714286	0.021926	0.285821	0.829346	0.105246	0.946702	2.58 [0.82 - 8.10]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	230602_at	278	0.543165	0.0945783	-	0.320216	0.76537	0.0636889	1.07 [0.70 - 1.62]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P376727	110	0.663636	0.00264136	0.056827	0.702906	0.391346	0.100993	1.11 [0.88 - 1.39]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P376727	110	0.663636	0.00885619	0.147291	0.777295	0.112522	0.251918	1.29 [0.94 - 1.76]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:67069	59	0.322034	0.00361617	0.0731872	-1.34276	0.0445977	-1.0121	0.36 [0.14 - 0.98]
GENE	ACMSD	aminocarboxymuconate semialdehyde decarboxylase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	230602_at	38	0.473684	0.0857982	-	-0.835887	0.256918	-0.260488	0.77 [0.49 - 1.21]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACO1	aconitase 1, soluble	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207071_s_at	30	0.8	0.0151767	0.219866	-1.41542	0.159485	-0.71446	0.49 [0.18 - 1.32]
GENE	ACO1	aconitase 1, soluble	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1750800	165	0.260606	0.0036379	0.0735387	-0.724427	0.198957	-0.169734	0.84 [0.65 - 1.09]
GENE	ACO1	aconitase 1, soluble	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1750800	165	0.260606	0.000206419	0.00660655	-1.2374	0.110113	-0.303879	0.74 [0.51 - 1.07]
GENE	ACO1	aconitase 1, soluble	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207071_s_at	163	0.282209	0.0735157	-	0.415348	0.340919	0.258866	1.30 [0.76 - 2.21]
GENE	ACO1	aconitase 1, soluble	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207071_s_at	79	0.544304	0.000961627	0.0246619	0.952555	0.0143162	0.677415	1.97 [1.14 - 3.39]
GENE	ACO1	aconitase 1, soluble	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207071_s_at	58	0.672414	0.0253012	0.315612	0.647341	0.221291	0.539217	1.71 [0.72 - 4.07]
GENE	ACO1	aconitase 1, soluble	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207071_s_at	34	0.676471	0.0509434	-	-0.854447	0.291885	-0.683766	0.50 [0.14 - 1.80]
GENE	ACO1	aconitase 1, soluble	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207071_s_at	158	0.5	0.0558295	-	-0.445472	0.339625	-0.29549	0.74 [0.41 - 1.36]
GENE	ACO1	aconitase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207071_s_at	53	0.509434	0.0955834	-	0.613075	0.158898	0.620717	1.86 [0.78 - 4.41]
GENE	ACO1	aconitase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207071_s_at	53	0.509434	0.0730161	-	0.617372	0.193882	0.560277	1.75 [0.75 - 4.08]
GENE	ACO1	aconitase 1, soluble	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207071_s_at	180	0.772222	0.00794905	0.135644	0.607267	0.107639	0.478695	1.61 [0.90 - 2.89]
GENE	ACO1	aconitase 1, soluble	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207071_s_at	559	0.334526	0.0441178	0.455022	-0.407551	0.536564	-0.211272	0.81 [0.41 - 1.58]
GENE	ACO1	aconitase 1, soluble	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207071_s_at	77	0.116883	0.0379333	0.413367	-0.777625	0.496653	-0.38851	0.68 [0.22 - 2.08]
GENE	ACO1	aconitase 1, soluble	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207071_s_at	70	0.157143	0.133558	-	-0.498086	0.64238	-0.212872	0.81 [0.33 - 1.98]
GENE	ACO1	aconitase 1, soluble	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40077_at	50	0.36	0.142807	-	-0.509744	0.48364	-0.249789	0.78 [0.39 - 1.57]
GENE	ACO1	aconitase 1, soluble	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207071_s_at	74	0.648649	0.000634763	0.0173643	-1.13955	0.00106057	-2.25086	0.11 [0.03 - 0.41]
GENE	ACO1	aconitase 1, soluble	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207071_s_at	67	0.38806	0.0736742	-	-1.19905	0.821008	-0.313929	0.73 [0.05 - 11.09]
GENE	ACO1	aconitase 1, soluble	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207071_s_at	115	0.834783	0.324218	-	-0.983578	0.766575	-0.226877	0.80 [0.18 - 3.56]
GENE	ACO1	aconitase 1, soluble	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40077_at	158	0.468354	0.0700837	-	-0.525907	0.905163	-0.0483378	0.95 [0.43 - 2.11]
GENE	ACO1	aconitase 1, soluble	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40077_at	76	0.421053	0.0375194	0.410451	-1.08743	0.82406	-0.121434	0.89 [0.30 - 2.58]
GENE	ACO1	aconitase 1, soluble	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207071_s_at	204	0.161765	0.046771	0.47187	0.375765	0.343052	0.174488	1.19 [0.83 - 1.71]
GENE	ACO1	aconitase 1, soluble	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207071_s_at	87	0.149425	0.00408152	0.0806048	-1.20173	0.199472	-0.385805	0.68 [0.38 - 1.23]
GENE	ACO1	aconitase 1, soluble	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207071_s_at	87	0.149425	0.00408152	0.0806048	-1.20173	0.199472	-0.385805	0.68 [0.38 - 1.23]
GENE	ACO1	aconitase 1, soluble	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207071_s_at	77	0.194805	0.0412487	0.436131	-1.24027	0.501609	-0.436795	0.65 [0.18 - 2.31]
GENE	ACO1	aconitase 1, soluble	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207071_s_at	77	0.194805	0.169917	-	-0.804594	0.991968	0.00571834	1.01 [0.33 - 3.06]
GENE	ACO1	aconitase 1, soluble	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207071_s_at	136	0.75	0.0161644	0.230142	1.03917	0.426867	-0.401354	0.67 [0.25 - 1.80]
GENE	ACO1	aconitase 1, soluble	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207071_s_at	200	0.105	0.148269	-	-0.588547	0.96936	0.0179719	1.02 [0.41 - 2.55]
GENE	ACO1	aconitase 1, soluble	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14565	60	0.7	0.0527544	-	0.732539	0.29995	0.230305	1.26 [0.81 - 1.95]
GENE	ACO1	aconitase 1, soluble	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3767	60	0.383333	0.0449293	0.460236	-0.747002	0.918086	-0.0233959	0.98 [0.63 - 1.53]
GENE	ACO1	aconitase 1, soluble	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14565	60	0.116667	0.00270219	0.0578855	-1.30924	0.977313	0.0107049	1.01 [0.48 - 2.11]
GENE	ACO1	aconitase 1, soluble	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3767	60	0.866667	0.0152057	0.220171	1.04214	0.892604	0.0396305	1.04 [0.59 - 1.85]
GENE	ACO1	aconitase 1, soluble	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	19146	155	0.135484	9.68101e-09	7.18094e-07	-1.54701	0.027429	-0.341728	0.71 [0.52 - 0.96]
GENE	ACO1	aconitase 1, soluble	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207071_s_at	286	0.660839	0.0132295	0.198862	-0.545261	0.186895	-0.415335	0.66 [0.36 - 1.22]
GENE	ACO1	aconitase 1, soluble	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207071_s_at	159	0.125786	0.0369766	0.4066	1.84155	0.809873	0.135884	1.15 [0.38 - 3.47]
GENE	ACO1	aconitase 1, soluble	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207071_s_at	159	0.125786	0.121952	-	1.07045	0.834458	0.118965	1.13 [0.37 - 3.44]
GENE	ACO1	aconitase 1, soluble	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207071_s_at	159	0.698113	0.0894699	-	-0.812564	0.872397	0.106654	1.11 [0.30 - 4.09]
GENE	ACO1	aconitase 1, soluble	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207071_s_at	54	0.296296	0.134031	-	-1.01622	0.286989	-0.414369	0.66 [0.31 - 1.42]
GENE	ACO1	aconitase 1, soluble	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207071_s_at	117	0.196581	0.0475441	0.476673	-0.673927	0.546267	-0.154568	0.86 [0.52 - 1.42]
GENE	ACO1	aconitase 1, soluble	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207071_s_at	117	0.145299	0.0548628	-	-0.818186	0.568831	-0.171935	0.84 [0.47 - 1.52]
GENE	ACO1	aconitase 1, soluble	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207071_s_at	117	0.145299	0.00257502	0.0556661	-1.22568	0.106827	-0.504409	0.60 [0.33 - 1.11]
GENE	ACO1	aconitase 1, soluble	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207071_s_at	117	0.196581	0.0475441	0.476673	-0.673927	0.546267	-0.154568	0.86 [0.52 - 1.42]
GENE	ACO1	aconitase 1, soluble	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207071_s_at	236	0.152542	0.0241098	0.305306	-0.685391	0.204063	-0.704026	0.49 [0.17 - 1.47]
GENE	ACO1	aconitase 1, soluble	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207071_s_at	249	0.140562	0.0352115	0.393869	-0.548299	0.336681	-0.42333	0.65 [0.28 - 1.55]
GENE	ACO1	aconitase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207071_s_at	125	0.784	0.0225583	0.291545	0.688133	0.897425	0.0481491	1.05 [0.50 - 2.18]
GENE	ACO1	aconitase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207071_s_at	54	0.111111	6.67978e-06	0.00030981	-2.66304	0.269279	-0.297105	0.74 [0.44 - 1.26]
GENE	ACO1	aconitase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207071_s_at	62	0.112903	0.00155878	0.0368896	-1.57518	0.291667	-0.230498	0.79 [0.52 - 1.22]
GENE	ACO1	aconitase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207071_s_at	125	0.824	0.0143322	0.210885	0.935731	0.776789	0.13569	1.15 [0.45 - 2.93]
GENE	ACO1	aconitase 1, soluble	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207071_s_at	198	0.742424	0.0375498	0.410666	0.455647	0.367108	0.17354	1.19 [0.82 - 1.73]
GENE	ACO1	aconitase 1, soluble	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207071_s_at	198	0.121212	0.0844532	-	-0.590643	0.765191	0.0714581	1.07 [0.67 - 1.72]
GENE	ACO1	aconitase 1, soluble	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207071_s_at	198	0.121212	0.0973094	-	-0.572414	0.998663	-0.000409947	1.00 [0.62 - 1.61]
GENE	ACO1	aconitase 1, soluble	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207071_s_at	62	0.5	0.00819348	0.13882	-1.79957	0.0547021	-1.83099	0.16 [0.02 - 1.04]
GENE	ACO1	aconitase 1, soluble	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207071_s_at	51	0.313726	0.120696	-	15.6487	0.948191	0.0895705	1.09 [0.07 - 16.30]
GENE	ACO1	aconitase 1, soluble	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207071_s_at	177	0.864407	0.102275	-	-0.754803	0.807997	-0.0955269	0.91 [0.42 - 1.96]
GENE	ACO1	aconitase 1, soluble	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207071_s_at	177	0.864407	0.0727201	-	-0.703114	0.530474	-0.213504	0.81 [0.41 - 1.57]
GENE	ACO1	aconitase 1, soluble	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207071_s_at	145	0.758621	0.0584985	-	-0.884547	0.462575	-0.354442	0.70 [0.27 - 1.81]
GENE	ACO1	aconitase 1, soluble	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207071_s_at	226	0.690265	0.00465294	0.0894248	-1.04501	0.0186068	-0.946888	0.39 [0.18 - 0.85]
GENE	ACO1	aconitase 1, soluble	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207071_s_at	55	0.872727	0.000186244	0.00604047	1.67227	0.00273166	1.70584	5.51 [1.80 - 16.80]
GENE	ACO1	aconitase 1, soluble	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207071_s_at	55	0.872727	0.00195587	0.0444736	1.77038	0.00747395	1.82558	6.21 [1.63 - 23.65]
GENE	ACO1	aconitase 1, soluble	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207071_s_at	49	0.44898	0.00503669	0.0951888	2.36064	0.00838989	1.91611	6.79 [1.63 - 28.24]
GENE	ACO1	aconitase 1, soluble	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	502355	34	0.558824	0.00719434	0.125643	-1.30745	0.0810569	-0.605302	0.55 [0.28 - 1.08]
GENE	ACO1	aconitase 1, soluble	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	126725	34	0.529412	0.0629923	-	-0.850342	0.468363	-0.281074	0.75 [0.35 - 1.61]
GENE	ACO1	aconitase 1, soluble	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207071_s_at	63	0.365079	0.00172959	0.0401966	1.25767	0.0277206	0.500818	1.65 [1.06 - 2.58]
GENE	ACO1	aconitase 1, soluble	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8659554_3p_a_at	28	0.107143	0.0642932	-	15.4298	0.130079	0.482897	1.62 [0.87 - 3.03]
GENE	ACO1	aconitase 1, soluble	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207071_s_at	82	0.109756	0.02124	0.279532	-1.01132	0.0468104	-0.763846	0.47 [0.22 - 0.99]
GENE	ACO1	aconitase 1, soluble	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40077_at	84	0.797619	0.149993	-	0.477286	0.589593	-0.172172	0.84 [0.45 - 1.57]
GENE	ACO1	aconitase 1, soluble	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207071_s_at	79	0.164557	0.00093206	0.0240232	-1.03943	0.0982759	-0.541077	0.58 [0.31 - 1.11]
GENE	ACO1	aconitase 1, soluble	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Z11559_at	86	0.697674	0.00853009	0.143148	1.03583	0.163637	0.62795	1.87 [0.77 - 4.53]
GENE	ACO1	aconitase 1, soluble	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207071_s_at	104	0.326923	0.0270706	0.330526	0.950504	0.4883	0.280991	1.32 [0.60 - 2.93]
GENE	ACO1	aconitase 1, soluble	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P9415	117	0.803419	0.0321059	0.370648	0.667376	0.923992	0.0212995	1.02 [0.66 - 1.58]
GENE	ACO1	aconitase 1, soluble	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P9416	117	0.119658	0.000672361	0.0182334	-1.11486	0.225405	-0.281268	0.75 [0.48 - 1.19]
GENE	ACO1	aconitase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207071_s_at	204	0.269608	0.00516378	0.0970715	1.79826	0.0701982	0.768319	2.16 [0.94 - 4.95]
GENE	ACO1	aconitase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207071_s_at	204	0.264706	0.000779691	0.0206684	1.44961	0.041118	0.659323	1.93 [1.03 - 3.64]
GENE	ACO1	aconitase 1, soluble	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207071_s_at	178	0.196629	0.116756	-	0.415701	0.58341	0.116538	1.12 [0.74 - 1.70]
GENE	ACO1	aconitase 1, soluble	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207071_s_at	111	0.126126	0.010507	0.167573	1.40357	0.178357	0.387295	1.47 [0.84 - 2.59]
GENE	ACO1	aconitase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207071_s_at	90	0.766667	0.265062	-	0.39625	0.855593	0.0560349	1.06 [0.58 - 1.93]
GENE	ACO1	aconitase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207071_s_at	90	0.766667	0.219276	-	0.488407	0.912682	0.0382818	1.04 [0.52 - 2.06]
GENE	ACO1	aconitase 1, soluble	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3599	50	0.88	0.0886338	-	-15.255	0.62912	-0.258782	0.77 [0.27 - 2.21]
GENE	ACO1	aconitase 1, soluble	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207071_s_at	138	0.731884	0.0235714	0.300575	0.567641	0.294255	0.147996	1.16 [0.88 - 1.53]
GENE	ACO1	aconitase 1, soluble	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207071_s_at	129	0.356589	0.15943	-	-0.350307	0.607485	-0.249575	0.78 [0.30 - 2.02]
GENE	ACO1	aconitase 1, soluble	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24336	56	0.232143	0.0967467	-	0.696864	0.612678	0.172172	1.19 [0.61 - 2.31]
GENE	ACO1	aconitase 1, soluble	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10558	56	0.125	0.0165747	0.23434	1.60944	0.490668	0.250163	1.28 [0.63 - 2.62]
GENE	ACO1	aconitase 1, soluble	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24336	56	0.696429	0.131715	-	0.586305	0.676531	0.153699	1.17 [0.57 - 2.40]
GENE	ACO1	aconitase 1, soluble	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10558	56	0.142857	0.0224055	0.290168	1.36139	0.445196	0.296442	1.35 [0.63 - 2.88]
GENE	ACO1	aconitase 1, soluble	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207071_s_at	278	0.604317	0.0376501	0.411374	-0.409831	0.500347	-0.111895	0.89 [0.65 - 1.24]
GENE	ACO1	aconitase 1, soluble	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207071_s_at	133	0.578947	0.00103682	0.0262696	-0.822082	0.0480084	-0.206753	0.81 [0.66 - 1.00]
GENE	ACO1	aconitase 1, soluble	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14803	81	0.82716	0.405261	-	0.481542	0.664935	0.177446	1.19 [0.53 - 2.67]
GENE	ACO1	aconitase 1, soluble	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207071_s_at	185	0.156757	0.00137611	0.0332687	0.974664	0.00388416	0.701642	2.02 [1.25 - 3.25]
GENE	ACO1	aconitase 1, soluble	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207071_s_at	185	0.535135	0.00372154	0.0748868	0.472921	0.0104608	0.568188	1.77 [1.14 - 2.73]
GENE	ACO1	aconitase 1, soluble	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P9416	110	0.763636	0.0343159	0.387283	0.53544	0.133303	0.277669	1.32 [0.92 - 1.90]
GENE	ACO1	aconitase 1, soluble	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P9415	110	0.845455	0.0407367	0.432682	0.598511	0.19683	0.215695	1.24 [0.89 - 1.72]
GENE	ACO1	aconitase 1, soluble	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P9416	110	0.845455	0.0101203	0.16292	0.83444	0.212644	0.295365	1.34 [0.84 - 2.14]
GENE	ACO1	aconitase 1, soluble	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P9415	110	0.881818	0.00183132	0.0421333	1.10509	0.199608	0.292277	1.34 [0.86 - 2.09]
GENE	ACO1	aconitase 1, soluble	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207071_s_at	80	0.65	0.0951358	-	-0.899473	0.527987	-0.310446	0.73 [0.28 - 1.92]
GENE	ACO1	aconitase 1, soluble	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3072	281	0.44484	0.0622887	-	-0.261857	0.63919	-0.0806968	0.92 [0.66 - 1.29]
GENE	ACO1	aconitase 1, soluble	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:310442	59	0.847458	0.0562768	-	1.06925	0.416164	0.811529	2.25 [0.32 - 15.92]
GENE	ACO1	aconitase 1, soluble	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207071_s_at	38	0.842105	0.176111	-	-1.30025	0.574255	0.304615	1.36 [0.47 - 3.92]
GENE	ACO1	aconitase 1, soluble	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207071_s_at	140	0.457143	0.000588154	0.0162743	-1.01148	0.0121629	-0.495484	0.61 [0.41 - 0.90]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200793_s_at	30	0.8	0.0534656	-	-1.13968	0.534953	-0.256991	0.77 [0.34 - 1.74]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209981_at	30	0.5	0.111681	-	0.649705	0.87014	0.148089	1.16 [0.20 - 6.85]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1654861	165	0.848485	0.00131395	0.0320146	-1.51596	0.396154	-0.142401	0.87 [0.62 - 1.21]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1654861	165	0.848485	0.00664957	0.118232	-15.3491	0.255921	-0.278133	0.76 [0.47 - 1.22]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209981_at	163	0.877301	0.0904713	-	-0.581624	0.639652	-0.279522	0.76 [0.23 - 2.44]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200793_s_at	163	0.889571	0.144943	-	0.417445	0.8328	0.0387427	1.04 [0.73 - 1.49]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	232857_at	163	0.858896	0.146167	-	0.375123	0.502497	0.61166	1.84 [0.31 - 11.02]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225309_at	163	0.220859	0.0455119	0.463947	0.515932	0.275752	0.23691	1.27 [0.83 - 1.94]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	232857_at	79	0.341772	0.116686	-	0.50676	0.563233	0.47368	1.61 [0.32 - 8.00]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225309_at	79	0.101266	0.0265843	0.326472	-0.885919	0.628786	-0.159387	0.85 [0.45 - 1.63]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209981_at	79	0.848101	0.126884	-	-0.709497	0.362566	-0.47506	0.62 [0.22 - 1.73]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200793_s_at	79	0.506329	0.0127453	0.193471	0.723975	0.398461	0.221656	1.25 [0.75 - 2.09]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200793_s_at	58	0.517241	0.00106239	0.0268111	-0.991983	0.0360052	-0.45366	0.64 [0.42 - 0.97]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209981_at	58	0.344828	0.0711265	-	0.528133	0.515496	0.109514	1.12 [0.80 - 1.55]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200793_s_at	34	0.852941	0.000762023	0.020272	1.81944	0.598033	0.198198	1.22 [0.58 - 2.55]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209981_at	34	0.5	0.00293729	0.0619256	-1.19096	0.0618091	-0.572368	0.56 [0.31 - 1.03]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200793_s_at	158	0.265823	0.0426925	0.445727	-0.493148	0.902438	-0.0329871	0.97 [0.57 - 1.64]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209981_at	158	0.708861	0.0486057	0.483192	0.477352	0.134479	1.53972	4.66 [0.62 - 35.03]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209981_at	53	0.54717	0.0838783	-	0.624629	0.461702	0.278845	1.32 [0.63 - 2.78]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200793_s_at	53	0.283019	0.0648688	-	-0.643791	0.114296	-0.769414	0.46 [0.18 - 1.20]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209981_at	53	0.54717	0.0700672	-	0.614724	0.424572	0.282731	1.33 [0.66 - 2.66]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200793_s_at	53	0.283019	0.0364134	0.402573	-0.766744	0.136065	-0.766757	0.46 [0.17 - 1.27]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200793_s_at	180	0.105556	0.00176575	0.0408878	-0.837785	0.134105	-0.348734	0.71 [0.45 - 1.11]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209981_at	180	0.577778	0.128575	-	-0.325807	0.966836	-0.00597884	0.99 [0.75 - 1.32]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225309_at	180	0.261111	0.0729565	-	-0.396174	0.86426	0.0615245	1.06 [0.53 - 2.15]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	232857_at	180	0.883333	0.0629674	-	0.574868	0.679272	0.0532095	1.05 [0.82 - 1.36]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	232857_at	559	0.686941	0.0877483	-	-0.388183	0.412982	-0.116757	0.89 [0.67 - 1.18]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225309_at	559	0.26297	0.143464	-	0.338031	0.94459	0.0193097	1.02 [0.59 - 1.76]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209981_at	559	0.679785	0.0108835	0.17205	0.505769	0.313473	0.153491	1.17 [0.87 - 1.57]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200793_s_at	559	0.80322	0.00865688	0.144765	0.618497	0.0984601	0.382577	1.47 [0.93 - 2.31]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200793_s_at	77	0.25974	0.000289404	0.00885665	-1.02837	0.0144894	-0.409152	0.66 [0.48 - 0.92]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209981_at	77	0.701299	9.29076e-06	0.000417983	-1.42441	0.000146052	-0.377741	0.69 [0.56 - 0.83]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225309_at	77	0.896104	0.0637409	-	0.704596	0.740845	0.125284	1.13 [0.54 - 2.38]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	232857_at	77	0.714286	0.465419	-	0.197893	0.835543	-0.0577009	0.94 [0.55 - 1.63]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	232857_at	70	0.728571	0.00580256	0.106352	0.785309	0.0701693	1.35895	3.89 [0.89 - 16.94]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225309_at	70	0.871429	0.0732348	-	0.681883	0.469809	0.245786	1.28 [0.66 - 2.49]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209981_at	70	0.628571	0.160169	-	0.377719	0.797964	0.157705	1.17 [0.35 - 3.92]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200793_s_at	70	0.457143	0.0517703	-	0.521365	0.197551	0.303836	1.36 [0.85 - 2.15]
GENE	ACO2	aconitase 2, mitochondrial	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	160044_g_at	50	0.12	0.00242974	0.0530999	-1.42749	0.00989463	-0.860117	0.42 [0.22 - 0.81]
GENE	ACO2	aconitase 2, mitochondrial	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41412_at	50	0.7	0.000393382	0.0115386	-1.58818	0.00320067	-0.597541	0.55 [0.37 - 0.82]
GENE	ACO2	aconitase 2, mitochondrial	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37189_at	50	0.48	0.0345676	0.389143	-0.748459	0.280637	-0.321384	0.73 [0.40 - 1.30]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200793_s_at	74	0.824324	0.139735	-	-0.597406	0.590085	-0.152248	0.86 [0.49 - 1.49]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209981_at	74	0.689189	0.000231876	0.00730933	-1.31916	0.00647692	-0.306327	0.74 [0.59 - 0.92]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225309_at	74	0.891892	0.024354	0.307436	0.914271	0.65394	0.211328	1.24 [0.49 - 3.11]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	232857_at	74	0.324324	0.00356337	0.0723311	1.00126	0.146119	0.481111	1.62 [0.85 - 3.10]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225309_at	67	0.253731	0.00117655	0.0291996	-1.96836	0.0363823	-3.17957	0.04 [0.00 - 0.82]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209981_at	67	0.358209	0.107495	-	1.54905	0.79793	-0.257417	0.77 [0.11 - 5.55]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	232857_at	67	0.104478	0.00594728	0.108415	-1.77927	0.241928	-4.1632	0.02 [0.00 - 16.61]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200793_s_at	67	0.686567	0.0410755	0.434967	1.28938	0.408424	0.895862	2.45 [0.29 - 20.49]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209981_at	115	0.513043	0.221853	-	0.671814	0.929736	-0.0537717	0.95 [0.29 - 3.13]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200793_s_at	115	0.843478	0.0274615	0.33376	1.16463	0.689015	0.309349	1.36 [0.30 - 6.20]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	232857_at	115	0.373913	0.104038	-	-0.853232	0.94428	0.048651	1.05 [0.27 - 4.11]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225309_at	115	0.495652	0.0895033	-	-0.966226	0.323493	-0.914279	0.40 [0.07 - 2.46]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	160044_g_at	158	0.360759	0.0664302	-	-0.522174	0.317377	-0.275217	0.76 [0.44 - 1.30]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41412_at	158	0.310127	0.0292039	0.347923	-0.63383	0.539851	-0.155754	0.86 [0.52 - 1.41]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37189_at	158	0.221519	0.0159783	0.228224	-0.738087	0.419659	-0.474909	0.62 [0.20 - 1.97]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37189_at	76	0.631579	0.0912624	-	-1.04879	0.434654	-0.947459	0.39 [0.04 - 4.18]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	160044_g_at	76	0.171053	0.0983421	-	-0.877157	0.594007	-0.434395	0.65 [0.13 - 3.20]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41412_at	76	0.75	0.0767537	-	-1.64236	0.339011	-0.653161	0.52 [0.14 - 1.99]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225309_at	204	0.235294	0.032822	0.376099	0.351987	0.41686	0.136813	1.15 [0.82 - 1.60]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209981_at	204	0.647059	0.0268207	0.328447	-0.322109	0.217283	-0.0955516	0.91 [0.78 - 1.06]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	232857_at	204	0.862745	0.0294617	0.349985	-0.43754	0.660914	-0.0304712	0.97 [0.85 - 1.11]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200793_s_at	204	0.181373	0.0229631	0.295174	0.414041	0.459621	0.101587	1.11 [0.85 - 1.45]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209981_at	87	0.114943	0.381595	-	-0.469613	0.529612	-0.378471	0.68 [0.21 - 2.23]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200793_s_at	87	0.356322	0.128394	-	0.653092	0.44695	0.342683	1.41 [0.58 - 3.41]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209981_at	87	0.114943	0.381595	-	-0.469613	0.529612	-0.378471	0.68 [0.21 - 2.23]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200793_s_at	87	0.356322	0.128394	-	0.653092	0.44695	0.342683	1.41 [0.58 - 3.41]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	232857_at	87	0.37931	0.202826	-	-0.479549	0.609107	-0.533586	0.59 [0.08 - 4.53]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	232857_at	87	0.37931	0.202826	-	-0.479549	0.609107	-0.533586	0.59 [0.08 - 4.53]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225309_at	87	0.758621	0.0158866	0.227276	0.906988	0.161599	0.56938	1.77 [0.80 - 3.92]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225309_at	87	0.758621	0.0158866	0.227276	0.906988	0.161599	0.56938	1.77 [0.80 - 3.92]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	232857_at	77	0.87013	0.0799071	-	1.14516	0.277613	1.1501	3.16 [0.40 - 25.19]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209981_at	77	0.142857	0.0768002	-	-1.0191	0.737435	-0.37822	0.69 [0.08 - 6.25]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225309_at	77	0.701299	0.0352292	0.393998	-15.6026	0.881792	-0.122541	0.88 [0.18 - 4.45]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200793_s_at	77	0.337662	0.00499373	0.0945495	15.7962	0.0233022	1.32577	3.77 [1.20 - 11.84]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209981_at	77	0.12987	0.0944005	-	-1.09861	0.585979	-0.713282	0.49 [0.04 - 6.38]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	232857_at	77	0.87013	0.0405408	0.431357	1.16447	0.128793	1.36554	3.92 [0.67 - 22.82]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225309_at	77	0.298701	0.049783	0.490321	1.79455	0.659888	0.320663	1.38 [0.33 - 5.75]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200793_s_at	77	0.337662	0.0150912	0.218965	15.7763	0.0964072	1.11286	3.04 [0.82 - 11.30]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209981_at	136	0.889706	0.0664674	-	0.930445	0.946043	-0.0199427	0.98 [0.55 - 1.75]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200793_s_at	136	0.286765	0.0477847	0.478158	-0.867028	0.0728746	-0.579202	0.56 [0.30 - 1.06]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200793_s_at	200	0.28	0.0955392	-	-0.503918	0.686753	-0.166664	0.85 [0.38 - 1.90]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209981_at	200	0.615	0.00522451	0.0979669	-0.962131	0.159794	-0.261086	0.77 [0.54 - 1.11]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13814	155	0.406452	0.0681272	-	-0.505666	0.24029	-0.386197	0.68 [0.36 - 1.29]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200793_s_at	286	0.804196	0.176024	-	-0.364824	0.483915	-0.152436	0.86 [0.56 - 1.32]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209981_at	286	0.111888	0.193834	-	-0.362456	0.909237	0.0170778	1.02 [0.76 - 1.36]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209981_at	159	0.823899	0.00557724	0.103112	-2.28066	0.0847146	-0.349157	0.71 [0.47 - 1.05]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200793_s_at	159	0.867925	0.00623101	0.112419	0.964083	0.014849	0.841241	2.32 [1.18 - 4.56]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200793_s_at	159	0.867925	0.0105021	0.167515	1.01941	0.011732	1.01305	2.75 [1.25 - 6.06]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209981_at	159	0.823899	0.0200096	0.268037	-1.53332	0.109362	-0.325969	0.72 [0.48 - 1.08]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200793_s_at	159	0.232704	0.00938565	0.153918	1.43407	0.0379512	0.728604	2.07 [1.04 - 4.12]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209981_at	159	0.823899	0.0253877	0.316352	-1.95136	0.329078	-0.225228	0.80 [0.51 - 1.25]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225309_at	159	0.578616	0.00714969	0.125042	1.00853	0.276827	0.551527	1.74 [0.64 - 4.69]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232857_at	159	0.72956	0.0775687	-	0.569317	0.263536	0.336113	1.40 [0.78 - 2.52]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232857_at	159	0.779874	0.161647	-	0.478712	0.534708	0.177254	1.19 [0.68 - 2.09]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232857_at	159	0.792453	0.0394314	0.423782	0.784968	0.16302	0.53541	1.71 [0.81 - 3.62]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225309_at	159	0.578616	0.0145653	0.213383	0.769983	0.350011	0.404435	1.50 [0.64 - 3.50]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225309_at	159	0.578616	0.00214943	0.0480474	0.965991	0.161741	0.602103	1.83 [0.79 - 4.24]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200793_s_at	54	0.759259	0.069848	-	1.21043	0.455344	0.279871	1.32 [0.63 - 2.76]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200793_s_at	117	0.128205	0.0891014	-	-0.664733	0.711245	-0.091103	0.91 [0.56 - 1.48]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200793_s_at	117	0.128205	0.0458878	0.466325	-0.846038	0.992369	0.00277241	1.00 [0.57 - 1.77]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200793_s_at	117	0.136752	0.00290838	0.061433	-1.20451	0.39447	-0.26047	0.77 [0.42 - 1.40]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200793_s_at	117	0.128205	0.0891014	-	-0.664733	0.711245	-0.091103	0.91 [0.56 - 1.48]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209981_at	117	0.393162	0.00156972	0.0371036	1.18812	0.21842	0.492729	1.64 [0.75 - 3.59]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209981_at	117	0.393162	0.00596982	0.108735	1.27099	0.175546	0.626587	1.87 [0.76 - 4.63]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209981_at	117	0.811966	0.0809232	-	0.733579	0.40505	0.432918	1.54 [0.56 - 4.27]
GENE	ACO2	aconitase 2, mitochondrial	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209981_at	117	0.393162	0.00156972	0.0371036	1.18812	0.21842	0.492729	1.64 [0.75 - 3.59]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209981_at	236	0.432203	0.0130919	0.197338	-0.662444	0.139721	-0.286035	0.75 [0.51 - 1.10]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200793_s_at	236	0.885593	0.0260131	0.321667	0.761138	0.421692	0.260389	1.30 [0.69 - 2.45]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225309_at	236	0.733051	0.00354513	0.0720346	0.783395	0.0555595	0.731347	2.08 [0.98 - 4.39]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	232857_at	236	0.127119	0.0425616	0.444865	-0.670927	0.561314	-0.124687	0.88 [0.58 - 1.34]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200793_s_at	249	0.751004	0.0683741	-	0.427426	0.493576	0.171632	1.19 [0.73 - 1.94]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209981_at	249	0.104418	0.0215739	0.282604	-0.680306	0.115274	-0.236147	0.79 [0.59 - 1.06]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225309_at	249	0.526104	0.00431299	0.0842137	0.604175	0.111608	0.481967	1.62 [0.89 - 2.93]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	232857_at	249	0.128514	0.00148473	0.0354328	-0.82012	0.0195892	-0.3755	0.69 [0.50 - 0.94]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209981_at	125	0.656	0.26196	-	-0.373157	0.990159	-0.0079545	0.99 [0.28 - 3.51]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209981_at	54	0.851852	0.0466902	0.471365	-15.5657	0.546624	-0.141513	0.87 [0.55 - 1.38]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200793_s_at	62	0.758065	0.113192	-	0.759082	0.608429	0.14587	1.16 [0.66 - 2.02]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200793_s_at	125	0.76	0.165924	-	0.540716	0.490891	0.283994	1.33 [0.59 - 2.98]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200793_s_at	125	0.552	0.137823	-	-0.437317	0.847294	-0.0622147	0.94 [0.50 - 1.77]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209981_at	62	0.870968	0.0230071	0.295566	-15.5074	0.541934	-0.118096	0.89 [0.61 - 1.30]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209981_at	125	0.888	0.217874	-	-1.1849	0.77239	0.242332	1.27 [0.25 - 6.58]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200793_s_at	54	0.314815	0.217906	-	-0.728482	0.94584	-0.0239514	0.98 [0.49 - 1.95]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209981_at	198	0.823232	0.135899	-	-0.458697	0.866874	0.0144066	1.01 [0.86 - 1.20]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200793_s_at	198	0.676768	0.188563	-	-0.373873	0.965724	-0.00997011	0.99 [0.63 - 1.56]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200793_s_at	198	0.10101	0.134074	-	0.86631	0.979572	0.00635081	1.01 [0.62 - 1.64]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209981_at	198	0.358586	0.0816404	-	0.491322	0.364904	0.0935892	1.10 [0.90 - 1.34]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209981_at	198	0.50505	0.111094	-	0.427495	0.458999	0.0814099	1.08 [0.87 - 1.35]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200793_s_at	198	0.89899	0.0109248	0.172538	0.729026	0.287418	0.208869	1.23 [0.84 - 1.81]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209981_at	62	0.483871	0.0476451	0.477297	-1.24028	0.32846	-1.17914	0.31 [0.03 - 3.27]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200793_s_at	51	0.117647	0.000137468	0.00463221	-2.6499	0.0200938	-1.55495	0.21 [0.06 - 0.78]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200793_s_at	62	0.225806	0.0727158	-	-1.00923	0.279355	-0.520678	0.59 [0.23 - 1.53]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209981_at	51	0.294118	0.130834	-	15.6193	0.639268	0.773915	2.17 [0.09 - 55.15]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209981_at	145	0.586207	0.0301678	0.355588	-0.786804	0.125777	-1.29805	0.27 [0.05 - 1.44]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200793_s_at	177	0.107345	0.095629	-	-0.540378	0.367285	-0.317899	0.73 [0.36 - 1.45]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200793_s_at	145	0.806897	0.0280352	0.338469	-1.46427	0.298238	-0.514668	0.60 [0.23 - 1.58]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	232857_at	177	0.163842	0.00576896	0.105872	-0.751361	0.30223	-0.647173	0.52 [0.15 - 1.79]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	232857_at	177	0.163842	0.00120799	0.0298491	-0.952091	0.156301	-1.02593	0.36 [0.09 - 1.48]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209981_at	177	0.79096	0.0188377	0.256818	-1.05403	0.251138	-0.79808	0.45 [0.12 - 1.76]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225309_at	177	0.180791	0.00690648	0.121748	-0.700341	0.686173	-0.157392	0.85 [0.40 - 1.83]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225309_at	177	0.180791	0.00323858	0.0669936	-0.842769	0.314668	-0.45331	0.64 [0.26 - 1.54]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	232857_at	145	0.227586	0.0284868	0.342144	-0.747387	0.373786	-0.788226	0.45 [0.08 - 2.58]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200793_s_at	177	0.107345	0.0240168	0.304492	-0.773107	0.0930689	-0.681242	0.51 [0.23 - 1.12]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209981_at	177	0.615819	0.00519085	0.0974711	-0.731853	0.0506468	-1.18744	0.31 [0.09 - 1.00]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225309_at	145	0.765517	0.19427	-	-0.6177	0.669553	-0.239433	0.79 [0.26 - 2.36]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200793_s_at	226	0.557522	0.0358783	0.398717	-0.639919	0.112976	-0.439058	0.64 [0.37 - 1.11]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	232857_at	226	0.256637	0.0457736	0.465604	-0.598212	0.521383	-0.0922583	0.91 [0.69 - 1.21]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225309_at	226	0.685841	0.0350032	0.392345	0.593273	0.841201	0.0483638	1.05 [0.65 - 1.68]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209981_at	226	0.831858	0.031233	0.363921	-1.20819	0.601432	-0.077227	0.93 [0.69 - 1.24]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200793_s_at	55	0.8	0.204635	-	-0.884761	0.971932	0.0170581	1.02 [0.39 - 2.63]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200793_s_at	49	0.836735	0.313981	-	-1.00928	0.819815	-0.135362	0.87 [0.27 - 2.80]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	232857_at	55	0.290909	0.0355332	0.396213	-0.916714	0.215289	-1.51817	0.22 [0.02 - 2.42]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225309_at	55	0.509091	0.209288	-	0.566247	0.846658	-0.116398	0.89 [0.27 - 2.90]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209981_at	55	0.4	0.000710694	0.0191105	-1.52156	0.0189605	-4.28787	0.01 [0.00 - 0.49]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	232857_at	55	0.254545	0.390727	-	0.505377	0.805301	-0.315468	0.73 [0.06 - 8.96]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209981_at	55	0.272727	0.0813536	-	-0.8239	0.264683	-2.02671	0.13 [0.00 - 4.64]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200793_s_at	55	0.872727	0.193613	-	0.712107	0.553878	0.282016	1.33 [0.52 - 3.37]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225309_at	55	0.145455	0.246816	-	1.09475	0.882569	0.0968354	1.10 [0.30 - 3.98]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	232857_at	49	0.122449	0.107105	-	-1.04875	0.531419	-0.985455	0.37 [0.02 - 8.17]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209981_at	49	0.367347	0.0096406	0.157067	-1.47344	0.0836487	-4.22277	0.01 [0.00 - 1.75]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225309_at	49	0.530612	0.100281	-	0.969236	0.74312	0.28269	1.33 [0.24 - 7.19]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	232857_at	63	0.142857	9.18746e-05	0.00325021	-1.46109	0.676224	0.395832	1.49 [0.23 - 9.52]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225309_at	63	0.793651	0.154693	-	0.527045	0.723576	0.0852955	1.09 [0.68 - 1.75]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209981_at	63	0.285714	3.73941e-05	0.00146347	-1.36008	0.331065	-0.693883	0.50 [0.12 - 2.02]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200793_s_at	63	0.111111	0.148132	-	1.0145	0.136736	0.410174	1.51 [0.88 - 2.59]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.106635.0.S2_3p_at	28	0.142857	0.0371904	0.40812	15.4771	0.123059	1.82315	6.19 [0.61 - 62.83]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501866_3p_at	28	0.571429	0.0508925	-	-1.20395	0.475651	-3.0573	0.05 [0.00 - 209.21]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.273234.0.A1_3p_at	28	0.892857	0.00516744	0.0971256	1.69994	0.0212296	4.549	94.54 [1.97 - 4532.46]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501866_3p_x_at	28	0.107143	0.0052911	0.0989453	-1.80725	0.954894	0.0504756	1.05 [0.18 - 6.05]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.300463.2.A1_3p_a_at	28	0.571429	0.0943672	-	0.91047	0.606698	0.174834	1.19 [0.61 - 2.32]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209981_at	82	0.109756	0.00264962	0.056971	-1.23591	0.0505247	-0.602375	0.55 [0.30 - 1.00]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200793_s_at	82	0.121951	0.154058	-	0.998137	0.702766	0.210932	1.23 [0.42 - 3.65]
GENE	ACO2	aconitase 2, mitochondrial	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37189_at	84	0.52381	0.00367202	0.0740896	-0.869872	0.129946	-0.518327	0.60 [0.30 - 1.16]
GENE	ACO2	aconitase 2, mitochondrial	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	160044_g_at	84	0.595238	0.153328	-	0.412045	0.845632	0.0795458	1.08 [0.49 - 2.41]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209981_at	79	0.506329	0.131227	-	-0.395187	0.627488	-0.147391	0.86 [0.48 - 1.57]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200793_s_at	79	0.873418	0.0234546	0.299542	0.819453	0.116136	0.567593	1.76 [0.87 - 3.58]
GENE	ACO2	aconitase 2, mitochondrial	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U80040_at	86	0.116279	0.0238739	0.303238	-1.1148	0.0755408	-1.50341	0.22 [0.04 - 1.17]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200793_s_at	104	0.355769	0.0220766	0.287191	-0.73001	0.49686	-0.381094	0.68 [0.23 - 2.05]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209981_at	104	0.865385	0.129329	-	-1.0486	0.385655	-0.309001	0.73 [0.37 - 1.48]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P103149	117	0.717949	0.0350195	0.392464	-0.79589	0.158097	-0.425837	0.65 [0.36 - 1.18]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P305481	117	0.350427	0.0736019	-	-0.508955	0.227247	-0.293969	0.75 [0.46 - 1.20]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	232857_at	204	0.882353	0.0395632	0.424688	0.86344	0.184159	0.503938	1.66 [0.79 - 3.48]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209981_at	204	0.828431	0.123415	-	-1.07586	0.152797	-0.33309	0.72 [0.45 - 1.13]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225309_at	204	0.598039	0.134994	-	0.541586	0.804066	0.136213	1.15 [0.39 - 3.36]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225309_at	204	0.637255	0.0781875	-	0.476467	0.640898	0.198472	1.22 [0.53 - 2.81]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209981_at	204	0.79902	0.00832456	0.140512	-1.28183	0.0174499	-0.425567	0.65 [0.46 - 0.93]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	232857_at	204	0.720588	0.0840338	-	-0.596736	0.642525	0.111155	1.12 [0.70 - 1.79]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200793_s_at	204	0.769608	0.00774251	0.132936	0.949605	0.0842669	0.865364	2.38 [0.89 - 6.35]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200793_s_at	204	0.142157	0.00102924	0.0261085	15.2946	0.0601639	0.695344	2.00 [0.97 - 4.14]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209981_at	178	0.342697	0.0491173	0.486302	0.42071	0.387956	0.182238	1.20 [0.79 - 1.81]
GENE	ACO2	aconitase 2, mitochondrial	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200793_s_at	178	0.297753	0.0505828	-	-0.400235	0.306535	-0.379849	0.68 [0.33 - 1.42]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300003824	41	0.682927	0.0362183	0.40117	0.859575	0.743948	0.102084	1.11 [0.60 - 2.04]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209981_at	111	0.810811	0.000440191	0.0127069	0.98844	0.0530965	0.311593	1.37 [1.00 - 1.87]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200793_s_at	111	0.81982	0.184425	-	-0.4999	0.35126	-0.231881	0.79 [0.49 - 1.29]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	232857_at	111	0.585586	0.0388187	0.419549	-0.565395	0.0571877	-0.387594	0.68 [0.46 - 1.01]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225309_at	111	0.207207	0.116643	-	0.589691	0.685987	0.0964037	1.10 [0.69 - 1.76]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209981_at	90	0.211111	0.182468	-	0.586276	0.353576	0.624752	1.87 [0.50 - 6.99]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209981_at	90	0.577778	0.253984	-	-0.454993	0.353203	0.693232	2.00 [0.46 - 8.64]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200793_s_at	90	0.522222	0.0913719	-	-0.554202	0.390149	-0.321584	0.72 [0.35 - 1.51]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200793_s_at	90	0.477778	0.0404362	0.430648	-0.766855	0.153118	-0.626757	0.53 [0.23 - 1.26]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2630	50	0.88	0.263887	-	0.688397	0.821468	0.156019	1.17 [0.30 - 4.53]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209981_at	138	0.449275	0.160979	-	0.345241	0.490844	0.377732	1.46 [0.50 - 4.27]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200793_s_at	138	0.847826	0.0459505	0.466721	0.592591	0.94242	0.012742	1.01 [0.72 - 1.43]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	232857_at	138	0.195652	0.0109156	0.172429	-0.655693	0.257105	-1.95026	0.14 [0.00 - 4.15]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225309_at	138	0.76087	0.269363	-	0.296669	0.891439	0.023038	1.02 [0.74 - 1.42]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200793_s_at	129	0.124031	0.0739221	-	-0.645356	0.837178	-0.0639942	0.94 [0.51 - 1.73]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209981_at	129	0.108527	0.0770289	-	0.882329	0.869628	0.0317296	1.03 [0.71 - 1.51]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23060	56	0.517857	0.130458	-	-0.540616	0.235513	-0.449877	0.64 [0.30 - 1.34]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15317	56	0.125	0.00329768	0.0679742	-1.33287	0.261443	-0.526278	0.59 [0.24 - 1.48]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23060	56	0.107143	0.0041742	0.0820559	-1.35785	0.142725	-0.547169	0.58 [0.28 - 1.20]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15317	56	0.125	0.000876346	0.0228093	-1.41138	0.112463	-0.730265	0.48 [0.20 - 1.19]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225309_at	278	0.874101	0.215592	-	0.311169	0.982979	0.00304223	1.00 [0.76 - 1.33]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209981_at	278	0.125899	0.0141342	0.208751	0.988322	0.141916	0.342379	1.41 [0.89 - 2.22]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	232857_at	278	0.273381	0.000372355	0.0110065	-0.701723	0.0404126	-1.07227	0.34 [0.12 - 0.95]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200793_s_at	278	0.284173	0.0115301	0.179621	-0.499689	0.0367065	-0.347691	0.71 [0.51 - 0.98]
GENE	ACO2	aconitase 2, mitochondrial	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200793_s_at	133	0.142857	0.0828376	-	-0.511375	0.664056	-0.0472191	0.95 [0.77 - 1.18]
GENE	ACO2	aconitase 2, mitochondrial	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209981_at	133	0.586466	0.00147385	0.0352175	0.741202	0.125125	0.290098	1.34 [0.92 - 1.94]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5850	81	0.481481	0.00695971	0.122472	1.80345	0.0277646	0.86631	2.38 [1.10 - 5.14]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200793_s_at	185	0.151351	0.0480132	0.479564	-0.45736	0.459863	-0.113094	0.89 [0.66 - 1.21]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209981_at	185	0.8	0.0454899	0.463807	0.401809	0.205309	0.188787	1.21 [0.90 - 1.62]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200793_s_at	185	0.151351	0.0710478	-	-0.398178	0.578437	-0.0781884	0.92 [0.70 - 1.22]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209981_at	185	0.832432	0.0115387	0.17972	0.560838	0.0769194	0.273081	1.31 [0.97 - 1.78]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P103149	110	0.736364	0.0711577	-	0.453143	0.2533	0.241397	1.27 [0.84 - 1.93]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P305481	110	0.754545	0.0507123	-	0.496934	0.302077	0.204672	1.23 [0.83 - 1.81]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P103149	110	0.127273	0.0810879	-	-0.649065	0.871083	0.0430866	1.04 [0.62 - 1.76]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P305481	110	0.163636	0.0286824	0.343727	-0.727981	0.714568	-0.089782	0.91 [0.56 - 1.48]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200793_s_at	80	0.6125	0.0217494	0.28421	0.994554	0.208432	0.425916	1.53 [0.79 - 2.97]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209981_at	80	0.1625	0.00803871	0.136812	-1.33512	0.632856	-0.0899906	0.91 [0.63 - 1.32]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1333	281	0.163701	0.11684	-	0.303868	0.199505	0.169988	1.19 [0.91 - 1.54]
GENE	ACO2	aconitase 2, mitochondrial	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:729195	59	0.322034	0.101236	-	-0.789876	0.291846	-1.25753	0.28 [0.03 - 2.95]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200793_s_at	38	0.842105	0.000908198	0.023505	1.74164	0.0482279	1.26243	3.53 [1.01 - 12.37]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	232857_at	38	0.789474	0.0477168	0.477739	1.06432	0.050485	0.860728	2.36 [1.00 - 5.60]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225309_at	38	0.605263	0.00544015	0.101123	1.27113	0.0341312	1.20322	3.33 [1.09 - 10.14]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209981_at	38	0.789474	0.101649	-	0.873633	0.392469	0.328472	1.39 [0.65 - 2.95]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209981_at	140	0.171429	0.162146	-	0.71538	0.645381	0.265726	1.30 [0.42 - 4.05]
GENE	ACO2	aconitase 2, mitochondrial	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200793_s_at	140	0.164286	1.56969e-06	8.24128e-05	-1.36254	0.00243708	-1.04671	0.35 [0.18 - 0.69]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1785474	165	0.133333	0.0743397	-	-0.544391	0.162795	-1.40063	0.25 [0.03 - 1.76]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1785474	165	0.6	0.0421857	0.44238	-0.808433	0.367092	-1.4585	0.23 [0.01 - 5.53]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238160_at	163	0.638037	0.0136924	0.20395	-0.531134	0.0244881	-1.61968	0.20 [0.05 - 0.81]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238160_at	79	0.101266	0.000774157	0.0205444	-1.26606	0.413453	-0.75312	0.47 [0.08 - 2.86]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238160_at	180	0.755556	0.0440581	0.454636	0.448954	0.695208	-0.0368968	0.96 [0.80 - 1.16]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238160_at	559	0.134168	0.0204491	0.272176	-0.652272	0.515399	-0.0696213	0.93 [0.76 - 1.15]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238160_at	77	0.597403	0.37271	-	0.231721	0.762351	0.0387958	1.04 [0.81 - 1.34]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238160_at	70	0.642857	0.000857097	0.0223865	0.884626	0.00140726	1.42036	4.14 [1.73 - 9.90]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238160_at	74	0.743243	0.0023146	0.0510411	0.908336	0.0713872	0.39245	1.48 [0.97 - 2.27]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238160_at	67	0.820895	0.088055	-	-15.4886	0.458544	-2.39392	0.09 [0.00 - 51.22]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238160_at	115	0.173913	0.0747692	-	15.3292	0.318463	0.407956	1.50 [0.67 - 3.35]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238160_at	204	0.897059	0.118995	-	0.360269	0.994022	0.000612414	1.00 [0.85 - 1.17]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238160_at	87	0.229885	0.117816	-	-0.647853	0.809632	0.322739	1.38 [0.10 - 19.08]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238160_at	87	0.229885	0.117816	-	-0.647853	0.809632	0.322739	1.38 [0.10 - 19.08]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238160_at	77	0.181818	0.12424	-	15.3429	0.873804	-0.362525	0.70 [0.01 - 61.02]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238160_at	77	0.181818	0.0751938	-	15.3524	0.623652	0.951192	2.59 [0.06 - 115.66]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238160_at	159	0.867925	0.252295	-	-0.816285	0.569463	0.126797	1.14 [0.73 - 1.76]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238160_at	159	0.138365	0.185274	-	0.776139	0.607136	0.0968768	1.10 [0.76 - 1.59]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238160_at	159	0.830189	0.155883	-	-0.731807	0.936226	-0.0148342	0.99 [0.69 - 1.42]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238160_at	236	0.440678	0.00634956	0.114076	0.805063	0.0227475	0.423827	1.53 [1.06 - 2.20]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238160_at	249	0.445783	0.000898911	0.0233026	0.749237	0.0061718	0.393374	1.48 [1.12 - 1.96]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238160_at	177	0.118644	0.0805477	-	-0.553366	0.350144	-1.33829	0.26 [0.02 - 4.35]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238160_at	177	0.118644	0.0682942	-	-0.637848	0.23876	-1.94454	0.14 [0.01 - 3.63]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238160_at	145	0.848276	0.0814458	-	-1.19582	0.632245	-0.958092	0.38 [0.01 - 19.41]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238160_at	226	0.110619	0.0155561	0.223842	-0.832474	0.262309	-0.137838	0.87 [0.68 - 1.11]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238160_at	55	0.236364	0.232324	-	-0.553336	0.691662	-0.909537	0.40 [0.00 - 36.07]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238160_at	55	0.8	0.338054	-	-0.720217	0.88858	0.336266	1.40 [0.01 - 154.56]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238160_at	49	0.102041	0.210956	-	-0.816125	0.541253	-1.69294	0.18 [0.00 - 42.03]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	191691	34	0.205882	0.000304525	0.00925511	-1.62995	0.158149	-1.14036	0.32 [0.07 - 1.56]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238160_at	63	0.15873	0.00257581	0.05568	-1.12766	0.428365	-0.984297	0.37 [0.03 - 4.27]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.108311.0.A1_3p_at	28	0.428571	0.0452059	0.462001	-1.10676	0.583804	-1.00612	0.37 [0.01 - 13.38]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238160_at	204	0.872549	0.0582277	-	0.799087	0.711614	0.100212	1.11 [0.65 - 1.88]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238160_at	204	0.852941	0.0751083	-	0.574951	0.202202	0.27778	1.32 [0.86 - 2.02]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238160_at	111	0.441441	0.0742651	-	-0.46493	0.24952	-0.16991	0.84 [0.63 - 1.13]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4296	50	0.58	0.157982	-	-0.733366	0.894692	-0.0456181	0.96 [0.49 - 1.88]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	2753	50	0.22	0.0813089	-	-0.862574	0.320923	-0.337615	0.71 [0.37 - 1.39]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238160_at	138	0.123188	0.008077	0.13731	-0.779447	0.504591	-0.393519	0.67 [0.21 - 2.14]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30476	56	0.696429	0.0282941	0.340579	0.804328	0.396589	0.830011	2.29 [0.34 - 15.63]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30476	56	0.696429	0.122426	-	0.55015	0.628034	0.461832	1.59 [0.25 - 10.28]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238160_at	278	0.143885	0.189041	-	-0.339349	0.677683	-0.3088	0.73 [0.17 - 3.15]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P44207	110	0.572727	0.201897	-	-0.401984	0.511653	-0.175902	0.84 [0.50 - 1.42]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P44207	110	0.2	0.0647248	-	-0.481069	0.457002	-0.145797	0.86 [0.59 - 1.27]
GENE	ACOT12	acyl-CoA thioesterase 12	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238160_at	38	0.842105	0.00775845	0.133146	1.27023	0.658723	0.227578	1.26 [0.46 - 3.45]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202982_s_at	30	0.366667	0.0395831	0.424825	0.900502	0.218619	0.419357	1.52 [0.78 - 2.97]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1716237	165	0.515152	0.187181	-	0.31821	0.584728	0.120213	1.13 [0.73 - 1.74]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1716237	165	0.848485	0.0254885	0.317212	0.851998	0.0746849	0.528632	1.70 [0.95 - 3.03]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202982_s_at	163	0.828221	0.00449798	0.0870622	0.663808	0.191956	0.304651	1.36 [0.86 - 2.14]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202982_s_at	79	0.835443	0.00984356	0.159554	0.87258	0.179187	0.382032	1.47 [0.84 - 2.56]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202982_s_at	58	0.413793	0.0159339	0.227766	0.690725	0.123124	0.510142	1.67 [0.87 - 3.19]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202982_s_at	34	0.176471	0.0659218	-	1.08289	0.41895	0.352642	1.42 [0.61 - 3.35]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202982_s_at	158	0.373418	0.076115	-	-0.416692	0.352005	-0.333786	0.72 [0.35 - 1.45]
GENE	ACOT2	acyl-CoA thioesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202982_s_at	53	0.245283	0.0159683	0.228121	1.36464	0.152075	0.781098	2.18 [0.75 - 6.36]
GENE	ACOT2	acyl-CoA thioesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202982_s_at	53	0.150943	0.0450654	0.461105	1.35711	0.247635	0.585461	1.80 [0.67 - 4.85]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202982_s_at	180	0.105556	0.0519769	-	-0.599221	0.944824	0.0209372	1.02 [0.56 - 1.85]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202982_s_at	559	0.872987	0.0349603	0.39203	0.53266	0.366837	0.112607	1.12 [0.88 - 1.43]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202982_s_at	77	0.818182	0.188419	-	0.41312	0.72699	0.0868902	1.09 [0.67 - 1.78]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202982_s_at	70	0.871429	0.000636627	0.0174076	1.24735	0.0684329	0.420677	1.52 [0.97 - 2.39]
GENE	ACOT2	acyl-CoA thioesterase 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36625_at	50	0.2	0.133102	-	0.67515	0.460195	0.229737	1.26 [0.68 - 2.32]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202982_s_at	74	0.189189	0.0229512	0.295067	1.03341	0.164447	0.490038	1.63 [0.82 - 3.26]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202982_s_at	67	0.149254	0.00133284	0.0323969	-1.87427	0.096732	-1.23399	0.29 [0.07 - 1.25]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202982_s_at	115	0.452174	0.326011	-	-0.522587	0.541152	-0.376469	0.69 [0.21 - 2.30]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36625_at	158	0.234177	0.0297204	0.352045	-0.653976	0.441484	-0.283951	0.75 [0.37 - 1.55]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36625_at	76	0.855263	0.169415	-	0.784752	0.446569	0.446676	1.56 [0.49 - 4.94]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202982_s_at	204	0.132353	9.37918e-06	0.000421587	-0.941827	0.000810803	-0.526958	0.59 [0.43 - 0.80]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202982_s_at	87	0.896552	0.0812469	-	0.836978	0.455824	-0.217757	0.80 [0.45 - 1.43]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202982_s_at	87	0.896552	0.0812469	-	0.836978	0.455824	-0.217757	0.80 [0.45 - 1.43]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202982_s_at	77	0.103896	0.198918	-	-0.978523	0.512039	-0.302766	0.74 [0.30 - 1.83]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202982_s_at	77	0.532468	0.0947862	-	0.967306	0.964889	0.0189408	1.02 [0.44 - 2.37]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202982_s_at	136	0.433824	0.0261341	0.322689	1.1751	0.851195	0.096118	1.10 [0.40 - 3.01]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202982_s_at	200	0.105	0.00804556	0.136901	-0.953852	0.393796	-0.338323	0.71 [0.33 - 1.55]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6579	60	0.866667	0.324694	-	-0.712601	0.904365	-0.0288603	0.97 [0.61 - 1.56]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6579	60	0.116667	0.075002	-	1.6299	0.392811	0.221538	1.25 [0.75 - 2.07]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202982_s_at	286	0.611888	0.138785	-	-0.300427	0.444896	-0.154186	0.86 [0.58 - 1.27]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202982_s_at	159	0.308176	0.127309	-	-0.487393	0.519602	-0.224667	0.80 [0.40 - 1.58]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202982_s_at	159	0.647799	0.196263	-	0.407839	0.933837	0.029316	1.03 [0.52 - 2.06]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202982_s_at	159	0.710692	0.290983	-	0.401458	0.945262	0.0290936	1.03 [0.45 - 2.36]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202982_s_at	54	0.277778	0.0438354	0.453194	15.6158	0.258343	0.588625	1.80 [0.65 - 5.00]
GENE	ACOT2	acyl-CoA thioesterase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202982_s_at	117	0.34188	0.106255	-	0.583823	0.887596	0.026782	1.03 [0.71 - 1.49]
GENE	ACOT2	acyl-CoA thioesterase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202982_s_at	117	0.188034	0.0616305	-	1.28287	0.399585	0.191855	1.21 [0.78 - 1.89]
GENE	ACOT2	acyl-CoA thioesterase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202982_s_at	117	0.179487	0.0302569	0.35629	1.90742	0.610807	0.120073	1.13 [0.71 - 1.79]
GENE	ACOT2	acyl-CoA thioesterase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202982_s_at	117	0.34188	0.106255	-	0.583823	0.887596	0.026782	1.03 [0.71 - 1.49]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202982_s_at	236	0.822034	0.0899976	-	-0.776403	0.394972	-0.26618	0.77 [0.41 - 1.42]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202982_s_at	249	0.192771	0.0909006	-	0.537555	0.513804	0.166842	1.18 [0.72 - 1.95]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202982_s_at	125	0.52	0.0439164	0.453719	-0.614737	0.205208	-0.326849	0.72 [0.43 - 1.20]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202982_s_at	54	0.259259	0.00711702	0.124602	-1.45534	0.276329	-0.334851	0.72 [0.39 - 1.31]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202982_s_at	62	0.290323	0.0114432	0.178612	-1.15841	0.482349	-0.179714	0.84 [0.51 - 1.38]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202982_s_at	125	0.68	0.0264865	0.325653	-1.06206	0.178418	-0.448557	0.64 [0.33 - 1.23]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202982_s_at	198	0.853535	0.00866834	0.144911	0.669768	0.126548	0.264137	1.30 [0.93 - 1.83]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202982_s_at	198	0.893939	0.00800005	0.136309	0.860489	0.33027	0.199618	1.22 [0.82 - 1.82]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202982_s_at	198	0.893939	0.00727854	0.126774	0.876395	0.424681	0.167895	1.18 [0.78 - 1.79]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202982_s_at	62	0.177419	0.0128961	0.195158	-1.35381	0.535581	-0.36914	0.69 [0.22 - 2.22]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202982_s_at	51	0.156863	0.133403	-	-1.2812	0.827879	-0.186603	0.83 [0.15 - 4.46]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202982_s_at	177	0.152542	0.00248195	0.0540261	1.60655	0.00106052	0.78829	2.20 [1.37 - 3.53]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202982_s_at	145	0.344828	0.0145716	0.21345	1.04556	0.0318206	0.849492	2.34 [1.08 - 5.08]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202982_s_at	177	0.418079	0.00474473	0.0908147	0.871687	0.00283919	0.815052	2.26 [1.32 - 3.86]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202982_s_at	226	0.106195	0.0662381	-	1.24461	0.273498	0.241525	1.27 [0.83 - 1.96]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202982_s_at	55	0.818182	0.0150671	0.218712	1.29428	0.250805	0.53201	1.70 [0.69 - 4.22]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202982_s_at	49	0.836735	0.0258125	0.319968	1.2866	0.637572	0.290455	1.34 [0.40 - 4.48]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202982_s_at	55	0.818182	0.0196666	0.264781	1.09304	0.40192	0.37352	1.45 [0.61 - 3.48]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202982_s_at	63	0.857143	0.108236	-	0.64685	0.111021	0.358336	1.43 [0.92 - 2.22]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13375613_3p_s_at	28	0.785714	0.1198	-	0.878001	0.242197	0.366263	1.44 [0.78 - 2.66]
GENE	ACOT2	acyl-CoA thioesterase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202982_s_at	82	0.548781	0.124004	-	0.520115	0.354713	0.336824	1.40 [0.69 - 2.86]
GENE	ACOT2	acyl-CoA thioesterase 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36625_at	84	0.25	0.148263	-	0.52883	0.317171	0.402281	1.50 [0.68 - 3.29]
GENE	ACOT2	acyl-CoA thioesterase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202982_s_at	79	0.139241	0.0560979	-	-0.659694	0.757986	-0.0935808	0.91 [0.50 - 1.65]
GENE	ACOT2	acyl-CoA thioesterase 2	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	L40401_at	86	0.860465	0.109413	-	0.795597	0.538332	-0.419174	0.66 [0.17 - 2.50]
GENE	ACOT2	acyl-CoA thioesterase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202982_s_at	104	0.884615	0.0485232	0.482688	-1.76223	0.242235	-0.431701	0.65 [0.31 - 1.34]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P301195	117	0.65812	0.147989	-	-0.477737	0.56535	-0.110401	0.90 [0.61 - 1.30]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P3111	117	0.735043	0.0204209	0.271911	-0.914711	0.329933	-0.218411	0.80 [0.52 - 1.25]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202982_s_at	204	0.764706	0.014048	0.207819	-1.61824	0.153377	-0.678903	0.51 [0.20 - 1.29]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202982_s_at	204	0.230392	0.0224086	0.290196	-0.648614	0.779025	-0.092243	0.91 [0.48 - 1.74]
GENE	ACOT2	acyl-CoA thioesterase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202982_s_at	178	0.848315	0.0523117	-	0.484239	0.451047	0.208285	1.23 [0.72 - 2.12]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200009894	41	0.609756	0.0122342	0.187704	-1.20404	0.0953801	-0.300015	0.74 [0.52 - 1.05]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202982_s_at	111	0.225225	0.0438075	0.453013	0.689584	0.564738	0.0953647	1.10 [0.80 - 1.52]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202982_s_at	90	0.677778	0.0121534	0.186784	0.798633	0.120677	0.507389	1.66 [0.88 - 3.15]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202982_s_at	90	0.655556	0.0274103	0.333338	0.799188	0.246566	0.437125	1.55 [0.74 - 3.24]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202982_s_at	138	0.166667	0.284086	-	0.380588	0.851457	0.0213152	1.02 [0.82 - 1.28]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202982_s_at	129	0.868217	0.101104	-	0.567621	0.415494	0.240169	1.27 [0.71 - 2.27]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38366	56	0.25	0.00190121	0.0434505	1.6996	0.0438141	0.62105	1.86 [1.02 - 3.40]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10757	56	0.821429	0.00490639	0.0932453	1.2139	0.0679317	0.564611	1.76 [0.96 - 3.22]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23690	56	0.732143	0.0600832	-	0.758667	0.354675	0.286013	1.33 [0.73 - 2.44]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10757	56	0.821429	0.0531674	-	0.884146	0.28739	0.323431	1.38 [0.76 - 2.51]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38366	56	0.25	0.00173877	0.0403723	1.543	0.017386	0.690666	2.00 [1.13 - 3.52]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23690	56	0.839286	0.0154445	0.222677	1.10071	0.0803172	0.549556	1.73 [0.94 - 3.21]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202982_s_at	278	0.255396	0.0647446	-	-0.37205	0.868108	-0.0256854	0.97 [0.72 - 1.32]
GENE	ACOT2	acyl-CoA thioesterase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202982_s_at	133	0.105263	0.00905068	0.14974	-0.815072	0.0706044	-0.391725	0.68 [0.44 - 1.03]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5965	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202982_s_at	185	0.140541	0.0389752	0.420634	0.577927	0.425912	0.144004	1.15 [0.81 - 1.65]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202982_s_at	185	0.497297	0.117094	-	0.255662	0.585519	0.0909952	1.10 [0.79 - 1.52]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P161036	110	0.745455	0.00738286	0.128169	0.860987	0.230023	0.250711	1.28 [0.85 - 1.93]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P3111	110	0.763636	0.0432907	0.449649	0.661964	0.281135	0.209333	1.23 [0.84 - 1.80]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P301195	110	0.445455	0.119751	-	0.361188	0.245762	0.169199	1.18 [0.89 - 1.58]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P161036	110	0.745455	0.000443507	0.0127889	0.900232	0.0354261	0.38295	1.47 [1.03 - 2.10]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P301195	110	0.872727	0.415176	-	0.337858	0.811144	0.039299	1.04 [0.75 - 1.44]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P3111	110	0.845455	0.0100365	0.161904	0.783925	0.0670711	0.314113	1.37 [0.98 - 1.92]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202982_s_at	80	0.15	0.104961	-	15.2168	0.711431	-0.132475	0.88 [0.43 - 1.77]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3503	281	0.854093	0.300257	-	-0.211657	0.986752	0.00182123	1.00 [0.81 - 1.24]
GENE	ACOT2	acyl-CoA thioesterase 2	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:322484	59	0.186441	0.0949548	-	1.56235	0.985534	-0.0153565	0.98 [0.19 - 5.18]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202982_s_at	38	0.315789	0.0112944	0.176878	1.5252	0.057081	0.849977	2.34 [0.97 - 5.62]
GENE	ACOT2	acyl-CoA thioesterase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202982_s_at	140	0.457143	0.000127949	0.00434969	-1.13634	0.00324344	-0.477561	0.62 [0.45 - 0.85]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204212_at	30	0.266667	0.0318369	0.368585	1.05539	0.0484863	1.19804	3.31 [1.01 - 10.89]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1679600	165	0.878788	0.21767	-	-0.522665	0.822488	-0.0395551	0.96 [0.68 - 1.36]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1679600	165	0.327273	0.146658	-	0.610917	0.385328	0.229097	1.26 [0.75 - 2.11]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204212_at	163	0.110429	0.00577083	0.105898	-0.756908	0.270961	-0.430359	0.65 [0.30 - 1.40]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	236514_at	163	0.822086	0.0957761	-	-0.475617	0.43277	-0.391224	0.68 [0.25 - 1.80]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	236514_at	79	0.113924	0.00889389	0.147767	-1.04746	0.368531	-0.398921	0.67 [0.28 - 1.60]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204212_at	79	0.113924	0.0214656	0.281609	1.51671	0.414333	0.253622	1.29 [0.70 - 2.37]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204212_at	58	0.810345	0.0107436	0.170392	0.878254	0.574652	0.204555	1.23 [0.60 - 2.51]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204212_at	34	0.117647	0.269342	-	0.79754	0.938638	0.0303232	1.03 [0.48 - 2.23]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204212_at	158	0.455696	0.0474677	0.4762	-0.456996	0.359354	-0.469198	0.63 [0.23 - 1.71]
GENE	ACOT8	acyl-CoA thioesterase 8	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204212_at	53	0.773585	0.27774	-	-0.527764	0.63075	-0.337824	0.71 [0.18 - 2.83]
GENE	ACOT8	acyl-CoA thioesterase 8	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204212_at	53	0.773585	0.19793	-	-0.574183	0.516643	-0.416381	0.66 [0.19 - 2.32]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204212_at	180	0.727778	0.0364906	0.403127	-0.545669	0.697712	-0.109689	0.90 [0.52 - 1.56]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	236514_at	180	0.894444	0.00202729	0.0458008	0.877242	0.250595	0.355516	1.43 [0.78 - 2.62]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	236514_at	559	0.100179	0.0308825	0.361195	-0.555556	0.626075	-0.113397	0.89 [0.57 - 1.41]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204212_at	559	0.470483	0.239959	-	0.238622	0.410557	0.240794	1.27 [0.72 - 2.26]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204212_at	77	0.831169	0.285831	-	-0.407579	0.593156	-0.21586	0.81 [0.37 - 1.78]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	236514_at	77	0.441558	0.272815	-	0.2834	0.895414	0.0615582	1.06 [0.42 - 2.66]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	236514_at	70	0.514286	0.0348626	0.391314	0.56002	0.269652	0.556485	1.74 [0.65 - 4.69]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204212_at	70	0.4	0.0650304	-	-0.501639	0.93498	-0.0378628	0.96 [0.39 - 2.39]
GENE	ACOT8	acyl-CoA thioesterase 8	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36841_at	50	0.36	0.00176399	0.0408543	-1.06471	0.0667709	-1.20324	0.30 [0.08 - 1.09]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204212_at	74	0.675676	0.0293385	0.349001	0.630428	0.132973	0.839234	2.31 [0.77 - 6.92]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	236514_at	74	0.135135	0.013747	0.204547	-0.865826	0.772624	-0.168269	0.85 [0.27 - 2.65]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	236514_at	67	0.850746	0.011246	0.176312	1.55368	0.0704419	1.16726	3.21 [0.91 - 11.38]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204212_at	67	0.373134	0.0130067	0.196391	15.8802	0.476573	1.21838	3.38 [0.12 - 96.85]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	236514_at	115	0.608696	0.00866192	0.144829	1.43199	0.131818	0.717566	2.05 [0.81 - 5.21]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204212_at	115	0.208696	0.134974	-	-0.811776	0.656528	-0.382436	0.68 [0.13 - 3.68]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36841_at	158	0.272152	0.15917	-	0.51407	0.716089	-0.108186	0.90 [0.50 - 1.61]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36841_at	76	0.75	0.0438323	0.453174	1.00396	0.633621	0.330953	1.39 [0.36 - 5.43]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204212_at	204	0.803922	0.0143983	0.211594	-0.426374	0.024312	-0.474667	0.62 [0.41 - 0.94]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	236514_at	204	0.887255	0.0187354	0.255825	0.518967	0.0312006	0.313499	1.37 [1.03 - 1.82]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	236514_at	87	0.816092	0.0592112	-	0.775902	0.0708218	0.377138	1.46 [0.97 - 2.20]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	236514_at	87	0.816092	0.0592112	-	0.775902	0.0708218	0.377138	1.46 [0.97 - 2.20]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204212_at	87	0.724138	0.0670552	-	0.686659	0.492609	0.317755	1.37 [0.55 - 3.41]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204212_at	87	0.724138	0.0670552	-	0.686659	0.492609	0.317755	1.37 [0.55 - 3.41]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204212_at	77	0.74026	0.0522237	-	-15.5226	0.431317	-0.675103	0.51 [0.09 - 2.74]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	236514_at	77	0.467532	0.2706	-	-0.618801	0.668511	-0.157309	0.85 [0.42 - 1.76]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	236514_at	77	0.831169	0.21544	-	0.833108	0.895236	0.0513348	1.05 [0.49 - 2.26]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204212_at	77	0.753247	0.127792	-	-1.45384	0.823622	-0.16412	0.85 [0.20 - 3.59]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204212_at	136	0.794118	0.00124836	0.0306784	1.34605	0.263912	0.822109	2.28 [0.54 - 9.63]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204212_at	200	0.775	4.18999e-05	0.00161984	1.16301	0.0179981	1.31568	3.73 [1.25 - 11.09]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	339	60	0.283333	0.0239873	0.304233	1.15941	0.177803	0.499963	1.65 [0.80 - 3.41]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12528	60	0.383333	0.0974812	-	0.71095	0.711835	0.116241	1.12 [0.61 - 2.08]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12528	60	0.283333	0.171754	-	-0.53385	0.677471	-0.191883	0.83 [0.33 - 2.04]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	339	60	0.166667	0.0115751	0.180142	2.14933	0.272953	0.33323	1.40 [0.77 - 2.53]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204212_at	286	0.884615	0.0450245	0.460845	-0.764445	0.30022	-0.255421	0.77 [0.48 - 1.26]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204212_at	159	0.220126	0.0154906	0.223159	1.3489	0.0357106	1.29187	3.64 [1.09 - 12.15]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204212_at	159	0.232704	0.0084915	0.142655	1.45003	0.0589599	1.15368	3.17 [0.96 - 10.50]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204212_at	159	0.232704	0.00708325	0.124146	2.24143	0.016219	1.73386	5.66 [1.38 - 23.28]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	236514_at	159	0.389937	0.0444576	0.457212	0.719257	0.0867317	0.952416	2.59 [0.87 - 7.71]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	236514_at	159	0.754717	0.00616465	0.111487	0.85898	0.102437	0.899971	2.46 [0.84 - 7.24]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	236514_at	159	0.427673	0.0623376	-	0.757394	0.144035	0.954022	2.60 [0.72 - 9.34]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204212_at	54	0.740741	0.00110716	0.0277535	2.02151	0.306197	0.840614	2.32 [0.46 - 11.60]
GENE	ACOT8	acyl-CoA thioesterase 8	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204212_at	117	0.854701	0.194667	-	-0.760185	0.486126	-0.237551	0.79 [0.40 - 1.54]
GENE	ACOT8	acyl-CoA thioesterase 8	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204212_at	117	0.777778	0.243899	-	-0.618902	0.950123	-0.0245784	0.98 [0.45 - 2.11]
GENE	ACOT8	acyl-CoA thioesterase 8	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204212_at	117	0.307692	0.0578785	-	-0.725239	0.862105	-0.0709383	0.93 [0.42 - 2.07]
GENE	ACOT8	acyl-CoA thioesterase 8	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204212_at	117	0.854701	0.194667	-	-0.760185	0.486126	-0.237551	0.79 [0.40 - 1.54]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204212_at	236	0.644068	1.91855e-05	0.00080459	1.11854	0.000178652	2.00697	7.44 [2.60 - 21.26]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	236514_at	236	0.805085	0.102255	-	0.501148	0.271706	0.440005	1.55 [0.71 - 3.40]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204212_at	249	0.534137	2.71529e-06	0.000136261	1.01272	0.000812714	1.35699	3.88 [1.76 - 8.60]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	236514_at	249	0.104418	0.00438145	0.0852715	-0.786318	0.826904	-0.0774944	0.93 [0.46 - 1.85]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204212_at	125	0.896	0.00312487	0.0650948	1.01368	0.0839198	0.812125	2.25 [0.90 - 5.66]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204212_at	54	0.12963	0.207801	-	15.2085	0.974594	0.0124494	1.01 [0.47 - 2.18]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204212_at	62	0.822581	0.264887	-	0.585707	0.893695	-0.0426414	0.96 [0.51 - 1.79]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204212_at	125	0.896	1.15687e-05	0.000509782	1.60733	0.0122799	1.48818	4.43 [1.38 - 14.20]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204212_at	198	0.808081	4.29602e-05	0.00165633	0.930782	0.00502342	0.804699	2.24 [1.27 - 3.92]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204212_at	198	0.813131	0.000805188	0.0212377	0.898936	0.0240377	0.760623	2.14 [1.11 - 4.14]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204212_at	198	0.813131	0.000252922	0.00788156	1.00899	0.0134091	0.892426	2.44 [1.20 - 4.95]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204212_at	62	0.258065	0.137654	-	1.42713	0.794561	0.104668	1.11 [0.51 - 2.44]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204212_at	51	0.529412	0.215941	-	-1.29226	0.62282	0.29499	1.34 [0.41 - 4.35]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204212_at	177	0.700565	0.0426203	0.445252	-0.595037	0.114223	-0.461995	0.63 [0.36 - 1.12]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	236514_at	145	0.737931	0.439826	-	-0.30785	0.740053	-0.0826511	0.92 [0.57 - 1.50]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	236514_at	177	0.107345	0.126505	-	-0.55191	0.436253	-0.16003	0.85 [0.57 - 1.27]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204212_at	145	0.468966	0.00183694	0.0422396	-1.10224	0.0327049	-0.965647	0.38 [0.16 - 0.92]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	236514_at	177	0.107345	0.174912	-	-0.441999	0.705873	-0.0658783	0.94 [0.66 - 1.32]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204212_at	177	0.59887	0.00253124	0.0548964	-0.950507	0.0191241	-0.8047	0.45 [0.23 - 0.88]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	236514_at	226	0.646018	0.0851936	-	-0.548246	0.562903	-0.104413	0.90 [0.63 - 1.28]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204212_at	226	0.132743	0.00302271	0.0633745	-0.924357	0.0521323	-0.554977	0.57 [0.33 - 1.01]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204212_at	55	0.636364	0.00332007	0.0683446	1.38265	0.257055	0.63863	1.89 [0.63 - 5.71]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204212_at	49	0.142857	0.128239	-	-0.980602	0.553362	-0.350139	0.70 [0.22 - 2.24]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	236514_at	55	0.145455	0.00143794	0.0345046	-1.69682	0.449635	-0.26716	0.77 [0.38 - 1.53]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	236514_at	55	0.254545	0.00118844	0.0294455	-1.35905	0.0715569	-0.676524	0.51 [0.24 - 1.06]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	236514_at	49	0.22449	0.0023172	0.0510879	-1.60678	0.0601329	-1.0034	0.37 [0.13 - 1.04]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204212_at	55	0.163636	0.00320341	0.0664081	-1.30044	0.42335	-0.375947	0.69 [0.27 - 1.72]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	347313	34	0.205882	0.0485687	0.482966	1.37013	0.235878	1.08816	2.97 [0.49 - 17.95]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204212_at	63	0.571429	0.0121835	0.187127	0.843406	0.187587	0.236539	1.27 [0.89 - 1.80]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	236514_at	63	0.111111	0.0914101	-	-0.745638	0.406978	0.146045	1.16 [0.82 - 1.63]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4885564_3p_at	28	0.642857	0.00422865	0.0829046	1.63474	0.708448	0.165639	1.18 [0.50 - 2.81]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.6511.0.A1_3p_at	28	0.714286	0.0499211	0.49115	-1.42805	0.212647	-4.05308	0.02 [0.00 - 10.19]
GENE	ACOT8	acyl-CoA thioesterase 8	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204212_at	82	0.756098	0.0177642	0.246295	0.835322	0.320994	0.711846	2.04 [0.50 - 8.31]
GENE	ACOT8	acyl-CoA thioesterase 8	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36841_at	84	0.619048	0.302227	-	-0.311545	0.676539	-0.19461	0.82 [0.33 - 2.05]
GENE	ACOT8	acyl-CoA thioesterase 8	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204212_at	79	0.873418	0.00563419	0.103935	-1.49961	0.34147	-0.391522	0.68 [0.30 - 1.51]
GENE	ACOT8	acyl-CoA thioesterase 8	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204212_at	104	0.442308	0.0360183	0.399729	-0.68653	0.481577	-0.548785	0.58 [0.13 - 2.66]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P143218	117	0.794872	0.00110096	0.0276235	0.949746	0.0482262	0.755191	2.13 [1.01 - 4.50]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	236514_at	204	0.117647	0.000886467	0.0230308	-1.04236	0.37997	-0.252343	0.78 [0.44 - 1.36]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204212_at	204	0.857843	0.0136868	0.203889	0.950623	0.105934	1.17196	3.23 [0.78 - 13.37]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204212_at	204	0.872549	4.75139e-05	0.00181185	1.1698	0.0231765	1.28806	3.63 [1.19 - 11.02]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	236514_at	204	0.892157	0.00976191	0.158556	1.0691	0.937814	0.0285366	1.03 [0.50 - 2.11]
GENE	ACOT8	acyl-CoA thioesterase 8	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204212_at	178	0.831461	0.0101133	0.162835	-0.806133	0.474199	-0.279183	0.76 [0.35 - 1.62]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204212_at	111	0.351351	0.0140551	0.207895	0.741753	0.283724	0.520641	1.68 [0.65 - 4.36]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	236514_at	111	0.576577	0.0264524	0.325367	0.576063	0.124725	0.500443	1.65 [0.87 - 3.12]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204212_at	90	0.377778	0.195041	-	0.449579	0.627427	0.25391	1.29 [0.46 - 3.59]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204212_at	90	0.833333	0.105607	-	0.689698	0.536339	0.365205	1.44 [0.45 - 4.58]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1884	50	0.66	0.0806329	-	-1.05679	0.888433	-0.0693583	0.93 [0.35 - 2.46]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3386	50	0.14	0.0620551	-	15.3027	0.546948	-0.141425	0.87 [0.55 - 1.38]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204212_at	138	0.572464	0.00121037	0.0298981	0.76911	0.0606139	0.497584	1.64 [0.98 - 2.77]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	236514_at	138	0.202899	0.00329431	0.0679183	-0.758054	0.216388	-0.202926	0.82 [0.59 - 1.13]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204212_at	129	0.868217	0.161959	-	0.45883	0.660044	0.203372	1.23 [0.50 - 3.03]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24575	56	0.107143	0.203966	-	-0.616536	0.870989	0.0674583	1.07 [0.47 - 2.41]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24575	56	0.107143	0.0555741	-	-0.942083	0.724736	-0.162694	0.85 [0.34 - 2.10]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204212_at	278	0.118705	0.0245798	0.309398	0.908764	0.13832	0.378529	1.46 [0.89 - 2.41]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	236514_at	278	0.874101	0.0125964	0.191799	0.596584	0.146929	0.213756	1.24 [0.93 - 1.65]
GENE	ACOT8	acyl-CoA thioesterase 8	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204212_at	133	0.699248	0.00138498	0.0334466	0.757427	0.00205715	0.567778	1.76 [1.23 - 2.53]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15197	81	0.160494	0.0738562	-	-1.00929	0.344453	-0.756359	0.47 [0.10 - 2.25]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18365	81	0.839506	0.00337698	0.0692832	1.52046	0.122054	1.67318	5.33 [0.64 - 44.44]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204212_at	185	0.313514	0.198248	-	-0.248108	0.785327	-0.0543692	0.95 [0.64 - 1.40]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204212_at	185	0.227027	0.157521	-	-0.285202	0.452953	-0.140161	0.87 [0.60 - 1.25]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P143218	110	0.318182	0.0131087	0.197524	0.659651	0.0107794	0.580499	1.79 [1.14 - 2.79]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P143218	110	0.881818	0.0169567	0.238215	0.840287	0.0199296	0.621238	1.86 [1.10 - 3.14]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204212_at	80	0.8375	0.15284	-	0.684369	0.520493	0.325111	1.38 [0.51 - 3.73]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_4102	281	0.373665	0.159702	-	-0.20423	0.679308	-0.0559127	0.95 [0.73 - 1.23]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204212_at	38	0.842105	1.71146e-07	1.05966e-05	2.63876	0.0587984	0.831237	2.30 [0.97 - 5.44]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	236514_at	38	0.894737	0.000391512	0.0114914	1.91525	0.00537081	1.36348	3.91 [1.50 - 10.21]
GENE	ACOT8	acyl-CoA thioesterase 8	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204212_at	140	0.885714	0.000267306	0.00826845	1.2379	0.00672418	1.39007	4.02 [1.47 - 10.97]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209601_at	30	0.7	0.120504	-	0.667948	0.902551	-0.0969506	0.91 [0.19 - 4.28]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209600_s_at	30	0.733333	0.209279	-	0.5746	0.95415	-0.0214686	0.98 [0.47 - 2.03]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213501_at	30	0.8	0.0401518	0.428714	1.02801	0.968002	0.0155939	1.02 [0.47 - 2.18]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207656_s_at	30	0.633333	0.0473858	0.475693	0.807268	0.366439	0.730615	2.08 [0.43 - 10.14]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1750158	165	0.848485	0.0118736	0.183584	0.723979	0.268139	0.17106	1.19 [0.88 - 1.61]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1750158	165	0.848485	0.161273	-	0.591634	0.968368	-0.00883433	0.99 [0.64 - 1.53]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213501_at	163	0.693252	0.162839	-	0.291367	0.659114	0.119682	1.13 [0.66 - 1.92]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209601_at	163	0.705521	0.00689217	0.121554	-0.63215	0.208983	-0.736838	0.48 [0.15 - 1.51]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209600_s_at	163	0.699386	0.0351612	0.393502	0.43185	0.344708	0.239969	1.27 [0.77 - 2.09]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207656_s_at	163	0.171779	0.0222705	0.288948	-0.535876	0.212109	-0.703532	0.49 [0.16 - 1.49]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	227962_at	163	0.122699	0.0254697	0.317052	0.763053	0.104451	0.389131	1.48 [0.92 - 2.36]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207656_s_at	79	0.481013	0.0969744	-	-0.487087	0.281633	-0.856536	0.42 [0.09 - 2.02]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	227962_at	79	0.860759	0.0766948	-	0.677663	0.559174	0.137695	1.15 [0.72 - 1.82]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213501_at	79	0.810127	0.0318147	0.368414	0.728355	0.227273	0.279903	1.32 [0.84 - 2.08]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209601_at	79	0.822785	0.0110264	0.173735	-1.25304	0.370842	-0.834779	0.43 [0.07 - 2.70]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209600_s_at	79	0.734177	0.012223	0.187577	0.758075	0.130659	0.403208	1.50 [0.89 - 2.52]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207656_s_at	58	0.810345	0.172724	-	-0.510201	0.605995	-0.0738197	0.93 [0.70 - 1.23]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209601_at	58	0.396552	0.234844	-	-0.333027	0.659452	-0.106156	0.90 [0.56 - 1.44]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209600_s_at	58	0.551724	0.00262711	0.0565782	0.853665	0.0417019	0.481374	1.62 [1.02 - 2.57]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213501_at	58	0.327586	0.00652364	0.116494	0.834089	0.13263	0.287707	1.33 [0.92 - 1.94]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207656_s_at	34	0.588235	0.121407	-	-0.607706	0.349522	-0.256776	0.77 [0.45 - 1.32]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209601_at	34	0.235294	0.0712369	-	-0.790479	0.506608	-0.315141	0.73 [0.29 - 1.85]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209600_s_at	34	0.323529	0.147728	-	0.628045	0.604946	0.150049	1.16 [0.66 - 2.05]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213501_at	34	0.235294	0.155377	-	-0.625597	0.352215	-0.241181	0.79 [0.47 - 1.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209600_s_at	158	0.246835	0.0133895	0.200628	-0.599966	0.180148	-0.584399	0.56 [0.24 - 1.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207656_s_at	158	0.746835	0.0678507	-	0.457839	0.271647	0.919485	2.51 [0.49 - 12.92]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213501_at	158	0.265823	0.00141454	0.034038	-0.75557	0.208021	-0.522555	0.59 [0.26 - 1.34]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209601_at	158	0.626582	0.000476175	0.013591	0.79546	0.0155968	2.02248	7.56 [1.47 - 38.93]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209600_s_at	53	0.226415	0.25451	-	-0.442514	0.651252	0.284363	1.33 [0.39 - 4.56]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207656_s_at	53	0.867925	0.0021251	0.0476022	1.26762	0.113272	0.361559	1.44 [0.92 - 2.25]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213501_at	53	0.509434	0.25488	-	0.391191	0.871806	-0.0850487	0.92 [0.33 - 2.58]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207656_s_at	53	0.867925	0.00899335	0.14902	1.15665	0.384656	0.207515	1.23 [0.77 - 1.96]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209601_at	53	0.528302	0.11646	-	0.536447	0.61858	0.118013	1.13 [0.71 - 1.79]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209601_at	53	0.603774	0.0448431	0.459685	0.722324	0.356673	0.232439	1.26 [0.77 - 2.07]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209600_s_at	53	0.226415	0.0724394	-	-0.704933	0.614368	0.323756	1.38 [0.39 - 4.87]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213501_at	53	0.509434	0.0992796	-	0.605851	0.842209	0.1084	1.11 [0.38 - 3.24]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209600_s_at	180	0.377778	0.147039	-	-0.307583	0.815624	-0.0775131	0.93 [0.48 - 1.78]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207656_s_at	180	0.838889	0.0440732	0.454733	-0.664545	0.284851	-0.111861	0.89 [0.73 - 1.10]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213501_at	180	0.544444	0.183336	-	-0.282607	0.426482	-0.184	0.83 [0.53 - 1.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209601_at	180	0.261111	0.316923	-	0.261584	0.708205	0.0501352	1.05 [0.81 - 1.37]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	227962_at	180	0.544444	0.0999506	-	0.345252	0.289844	0.399377	1.49 [0.71 - 3.12]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207656_s_at	559	0.522361	0.0022011	0.0489892	-0.625551	0.116782	-0.299576	0.74 [0.51 - 1.08]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	227962_at	559	0.22898	0.073249	-	-0.382075	0.317099	-0.281517	0.75 [0.43 - 1.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213501_at	559	0.370304	0.127127	-	-0.305585	0.928841	-0.0188474	0.98 [0.65 - 1.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209601_at	559	0.152057	0.0089716	0.148746	-0.632847	0.258618	-0.167234	0.85 [0.63 - 1.13]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209600_s_at	559	0.128801	0.0100624	0.162218	-0.611981	0.0973002	-0.463501	0.63 [0.36 - 1.09]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207656_s_at	77	0.506494	0.201995	-	-0.327399	0.837232	-0.040232	0.96 [0.65 - 1.41]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209601_at	77	0.766234	0.0481517	0.480415	0.574556	0.188513	0.2735	1.31 [0.87 - 1.98]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209600_s_at	77	0.87013	0.0595943	-	0.679835	0.125059	0.564832	1.76 [0.85 - 3.62]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213501_at	77	0.272727	0.0646816	-	0.560952	0.26153	0.473913	1.61 [0.70 - 3.67]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	227962_at	77	0.415584	0.0438766	0.453461	-0.5282	0.476383	-0.275895	0.76 [0.36 - 1.62]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	227962_at	70	0.614286	0.325702	-	-0.267158	0.766693	-0.0866496	0.92 [0.52 - 1.63]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213501_at	70	0.342857	0.330578	-	-0.26851	0.600717	-0.174529	0.84 [0.44 - 1.61]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209601_at	70	0.214286	0.192259	-	0.436823	0.740967	0.43232	1.54 [0.12 - 20.00]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209600_s_at	70	0.142857	0.0614699	-	-0.656166	0.161464	-0.652564	0.52 [0.21 - 1.30]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207656_s_at	70	0.485714	0.152846	-	0.376444	0.387189	0.629452	1.88 [0.45 - 7.82]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40459_at	50	0.4	0.00571783	0.105138	-0.942784	0.0929501	-1.47533	0.23 [0.04 - 1.28]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40460_s_at	50	0.64	0.0204946	0.272602	-0.866721	0.204311	-1.39057	0.25 [0.03 - 2.13]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209600_s_at	74	0.405405	0.00398983	0.0791608	-0.831415	0.0036988	-1.13883	0.32 [0.15 - 0.69]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213501_at	74	0.716216	2.19326e-05	0.000907464	-1.66443	0.00148366	-1.04094	0.35 [0.19 - 0.67]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207656_s_at	74	0.824324	0.0306249	0.359181	0.731027	0.0932303	0.421298	1.52 [0.93 - 2.49]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209601_at	74	0.648649	0.146796	-	-0.450522	0.919965	-0.0312329	0.97 [0.53 - 1.78]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	227962_at	74	0.648649	0.00138383	0.0334234	-1.05411	0.0291623	-1.0827	0.34 [0.13 - 0.90]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207656_s_at	67	0.343284	0.0685169	-	1.72158	0.727324	0.863919	2.37 [0.02 - 304.93]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	227962_at	67	0.522388	0.257667	-	0.783228	0.83792	0.200574	1.22 [0.18 - 8.35]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213501_at	67	0.776119	0.0578739	-	1.20255	0.863155	0.22967	1.26 [0.09 - 17.14]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209601_at	67	0.119403	0.237657	-	-0.921971	0.622566	-2.30112	0.10 [0.00 - 955.20]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209600_s_at	67	0.80597	0.0879909	-	1.18406	0.893703	0.190757	1.21 [0.07 - 19.86]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213501_at	115	0.843478	0.00127549	0.0312328	1.56951	0.0186516	1.09773	3.00 [1.20 - 7.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209601_at	115	0.486957	0.0149125	0.217076	-1.45113	0.449061	-0.311077	0.73 [0.33 - 1.64]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	227962_at	115	0.86087	0.0727024	-	1.01375	0.661282	0.314182	1.37 [0.34 - 5.58]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209600_s_at	115	0.686957	0.0189774	0.25817	1.19027	0.269117	0.561672	1.75 [0.65 - 4.75]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207656_s_at	115	0.504348	0.0891947	-	-0.970123	0.170125	-0.451868	0.64 [0.33 - 1.21]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40459_at	158	0.835443	0.124187	-	-0.782238	0.594229	-0.159932	0.85 [0.47 - 1.53]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40460_s_at	158	0.253165	0.0535241	-	0.703999	0.547889	0.131445	1.14 [0.74 - 1.75]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40459_at	76	0.815789	0.189709	-	-1.27148	0.801917	-0.0899306	0.91 [0.45 - 1.85]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40460_s_at	76	0.236842	0.028353	0.341058	15.4538	0.137236	0.848219	2.34 [0.76 - 7.15]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	227962_at	204	0.112745	0.000509758	0.014406	-0.764164	0.303942	-0.176658	0.84 [0.60 - 1.17]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213501_at	204	0.622549	0.0900437	-	-0.247007	0.478133	-0.108944	0.90 [0.66 - 1.21]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209601_at	204	0.671569	0.0356064	0.396746	-0.320147	0.265509	-0.0976098	0.91 [0.76 - 1.08]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209600_s_at	204	0.289216	0.000276455	0.00851285	-0.57717	0.251609	-0.200437	0.82 [0.58 - 1.15]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207656_s_at	204	0.558824	0.113335	-	-0.224736	0.818601	-0.0175604	0.98 [0.85 - 1.14]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209600_s_at	87	0.310345	0.0181744	0.250344	-0.865901	0.285337	-0.416743	0.66 [0.31 - 1.42]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213501_at	87	0.195402	0.0591004	-	-0.747166	0.309454	-0.355902	0.70 [0.35 - 1.39]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207656_s_at	87	0.609195	0.0203499	0.271245	0.855319	0.651034	0.362068	1.44 [0.30 - 6.90]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209601_at	87	0.678161	0.0234242	0.299274	0.836112	0.305681	1.55751	4.75 [0.24 - 93.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213501_at	87	0.195402	0.0591004	-	-0.747166	0.309454	-0.355902	0.70 [0.35 - 1.39]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209600_s_at	87	0.310345	0.0181744	0.250344	-0.865901	0.285337	-0.416743	0.66 [0.31 - 1.42]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209601_at	87	0.678161	0.0234242	0.299274	0.836112	0.305681	1.55751	4.75 [0.24 - 93.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207656_s_at	87	0.609195	0.0203499	0.271245	0.855319	0.651034	0.362068	1.44 [0.30 - 6.90]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	227962_at	87	0.896552	0.271969	-	0.5917	0.792288	-0.0983142	0.91 [0.44 - 1.88]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	227962_at	87	0.896552	0.271969	-	0.5917	0.792288	-0.0983142	0.91 [0.44 - 1.88]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	227962_at	77	0.792208	0.111782	-	0.986482	0.930855	-0.0621599	0.94 [0.23 - 3.83]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213501_at	77	0.38961	0.0146832	0.21464	-1.35977	0.735662	-0.138557	0.87 [0.39 - 1.95]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209600_s_at	77	0.181818	0.111459	-	15.3673	0.813596	0.133527	1.14 [0.38 - 3.47]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209601_at	77	0.896104	0.198029	-	-15.1923	0.933569	-0.15213	0.86 [0.02 - 30.72]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207656_s_at	77	0.363636	0.0759399	-	1.66997	0.832079	0.304035	1.36 [0.08 - 22.52]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209600_s_at	77	0.181818	0.0671342	-	15.3744	0.940263	0.0370082	1.04 [0.39 - 2.73]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213501_at	77	0.181818	0.117443	-	15.3547	0.972529	-0.0161696	0.98 [0.39 - 2.47]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207656_s_at	77	0.363636	0.0933929	-	1.21404	0.610889	0.627153	1.87 [0.17 - 20.97]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	227962_at	77	0.12987	0.146823	-	15.2412	0.915704	-0.0661254	0.94 [0.28 - 3.18]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209601_at	77	0.883117	0.231451	-	-15.2146	0.504156	-1.46272	0.23 [0.00 - 16.93]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209600_s_at	136	0.375	0.074924	-	1.07146	0.0978064	0.86946	2.39 [0.85 - 6.68]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207656_s_at	136	0.139706	0.0354127	0.395337	-0.991951	0.769769	-0.0897412	0.91 [0.50 - 1.67]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213501_at	136	0.139706	0.00464755	0.0893431	-1.32417	0.0169564	-0.799919	0.45 [0.23 - 0.87]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209601_at	136	0.897059	0.0373883	0.409523	1.12246	0.0596289	0.618009	1.86 [0.98 - 3.53]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209600_s_at	200	0.635	0.000339474	0.0101645	1.02783	0.0257635	0.68497	1.98 [1.09 - 3.62]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207656_s_at	200	0.305	0.00666422	0.118434	1.06687	0.0975776	0.31497	1.37 [0.94 - 1.99]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213501_at	200	0.895	0.0395766	0.42478	0.748496	0.488542	0.283791	1.33 [0.59 - 2.96]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209601_at	200	0.235	0.0112697	0.176589	1.2442	0.00784395	0.562058	1.75 [1.16 - 2.65]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15766	155	0.683871	8.74731e-06	0.000395756	1.17848	0.000352874	0.285615	1.33 [1.14 - 1.56]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209600_s_at	286	0.101399	0.207288	-	-0.358972	0.568892	-0.141991	0.87 [0.53 - 1.41]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213501_at	286	0.77972	0.163033	-	-0.351079	0.117443	-0.328754	0.72 [0.48 - 1.09]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207656_s_at	286	0.867133	0.0872556	-	0.428795	0.90495	0.0182335	1.02 [0.75 - 1.37]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209601_at	286	0.737762	0.0325775	0.374245	-0.523821	0.41568	-0.145387	0.86 [0.61 - 1.23]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207656_s_at	159	0.867925	0.0234154	0.299195	-15.2629	0.327368	-0.323951	0.72 [0.38 - 1.38]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209600_s_at	159	0.742138	0.143446	-	0.480234	0.440182	0.388927	1.48 [0.55 - 3.96]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207656_s_at	159	0.867925	0.030869	0.36109	-1.89169	0.739517	-0.09141	0.91 [0.53 - 1.56]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209601_at	159	0.264151	0.0165305	0.23389	-0.757053	0.365191	-0.294334	0.75 [0.39 - 1.41]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209601_at	159	0.352201	0.00950008	0.155335	-0.935617	0.124007	-0.607093	0.54 [0.25 - 1.18]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213501_at	159	0.899371	0.000468575	0.0134052	1.2481	0.0709974	0.994068	2.70 [0.92 - 7.95]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209600_s_at	159	0.767296	0.0334952	0.38117	0.792969	0.222834	0.677572	1.97 [0.66 - 5.85]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209601_at	159	0.352201	0.0498864	0.490941	-0.612177	0.71492	-0.113253	0.89 [0.49 - 1.64]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213501_at	159	0.899371	8.51966e-05	0.00304081	1.49626	0.0271533	1.35064	3.86 [1.16 - 12.79]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209600_s_at	159	0.767296	0.0965619	-	0.554023	0.376713	0.433801	1.54 [0.59 - 4.04]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207656_s_at	159	0.874214	0.0321887	0.371282	-1.88028	0.441155	-0.212708	0.81 [0.47 - 1.39]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213501_at	159	0.792453	3.79788e-05	0.00148389	1.23871	0.0189176	1.2416	3.46 [1.23 - 9.76]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227962_at	159	0.899371	0.000584041	0.0161774	1.22855	0.450434	0.39978	1.49 [0.53 - 4.21]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227962_at	159	0.779874	0.0431484	0.448719	0.670277	0.544557	0.316212	1.37 [0.49 - 3.82]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227962_at	159	0.899371	0.00990363	0.160287	1.12584	0.673134	0.263203	1.30 [0.38 - 4.42]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207656_s_at	54	0.851852	0.0744667	-	1.22669	0.344632	1.68322	5.38 [0.16 - 176.64]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213501_at	54	0.333333	0.0177854	0.246505	15.8123	0.061762	1.31498	3.72 [0.94 - 14.80]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209600_s_at	54	0.888889	0.00537168	0.100125	1.80516	0.055054	1.13115	3.10 [0.98 - 9.84]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209601_at	54	0.148148	0.272132	-	-0.768018	0.585622	-1.01872	0.36 [0.01 - 14.06]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209601_at	117	0.128205	0.159866	-	-0.552101	0.326889	-1.23104	0.29 [0.02 - 3.42]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209601_at	117	0.871795	0.348774	-	-0.67312	0.619299	-0.725976	0.48 [0.03 - 8.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209600_s_at	117	0.376068	0.0860629	-	-0.541165	0.235959	-0.304237	0.74 [0.45 - 1.22]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209600_s_at	117	0.34188	0.058095	-	-0.704092	0.166204	-0.418708	0.66 [0.36 - 1.19]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207656_s_at	117	0.102564	0.139489	-	1.02758	0.331782	0.453961	1.57 [0.63 - 3.94]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207656_s_at	117	0.555556	0.0990654	-	0.619701	0.221378	0.604191	1.83 [0.69 - 4.82]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213501_at	117	0.162393	0.00504423	0.0953009	-0.960247	0.182793	-0.488191	0.61 [0.30 - 1.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213501_at	117	0.153846	0.00141635	0.0340743	-1.21622	0.277443	-0.483874	0.62 [0.26 - 1.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209600_s_at	117	0.102564	0.0857304	-	-0.834172	0.285821	-0.344264	0.71 [0.38 - 1.33]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207656_s_at	117	0.196581	0.0637422	-	1.27738	0.0985298	0.995019	2.70 [0.83 - 8.81]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209600_s_at	117	0.376068	0.0860629	-	-0.541165	0.235959	-0.304237	0.74 [0.45 - 1.22]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207656_s_at	117	0.102564	0.139489	-	1.02758	0.331782	0.453961	1.57 [0.63 - 3.94]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209601_at	117	0.128205	0.159866	-	-0.552101	0.326889	-1.23104	0.29 [0.02 - 3.42]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209601_at	117	0.871795	0.263248	-	-0.799809	0.322283	-1.50858	0.22 [0.01 - 4.39]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213501_at	117	0.162393	0.00504423	0.0953009	-0.960247	0.182793	-0.488191	0.61 [0.30 - 1.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213501_at	117	0.179487	0.011193	0.175692	-1.04955	0.37789	-0.414914	0.66 [0.26 - 1.66]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209601_at	236	0.199153	0.0748064	-	-0.524937	0.364818	-0.23126	0.79 [0.48 - 1.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209600_s_at	236	0.457627	0.0672669	-	0.508326	0.272824	0.410495	1.51 [0.72 - 3.14]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207656_s_at	236	0.741525	0.00664407	0.118157	0.731688	0.16396	0.344527	1.41 [0.87 - 2.29]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213501_at	236	0.572034	0.143784	-	0.393254	0.832624	0.0902351	1.09 [0.47 - 2.53]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	227962_at	236	0.838983	0.0061519	0.111308	0.811202	0.834273	0.0943342	1.10 [0.45 - 2.66]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209600_s_at	249	0.883534	0.0190584	0.258952	0.654234	0.181958	0.401781	1.49 [0.83 - 2.70]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207656_s_at	249	0.831325	0.0605864	-	0.481266	0.543578	0.120546	1.13 [0.76 - 1.66]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213501_at	249	0.253012	0.135249	-	0.392481	0.330089	0.332215	1.39 [0.71 - 2.72]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209601_at	249	0.75502	0.0374796	0.410169	-0.580608	0.282658	-0.209649	0.81 [0.55 - 1.19]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	227962_at	249	0.823293	0.0005204	0.0146624	0.79899	0.209386	0.441113	1.55 [0.78 - 3.10]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209600_s_at	54	0.277778	0.171837	-	1.33413	0.829659	0.107892	1.11 [0.42 - 2.98]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207656_s_at	54	0.222222	0.12086	-	15.3173	0.942663	-0.0348122	0.97 [0.37 - 2.49]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209601_at	125	0.496	0.030188	0.355748	-0.850858	0.196572	-2.16716	0.11 [0.00 - 3.07]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213501_at	125	0.824	0.156786	-	0.471181	0.774551	0.0960331	1.10 [0.57 - 2.12]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207656_s_at	62	0.790323	0.168646	-	0.684351	0.845432	-0.0771713	0.93 [0.43 - 2.01]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213501_at	54	0.833333	0.250134	-	-1.14627	0.833365	-0.0719252	0.93 [0.48 - 1.82]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209601_at	62	0.467742	0.112457	-	0.878574	0.722671	-0.109185	0.90 [0.49 - 1.64]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209601_at	54	0.351852	0.098641	-	1.56885	0.699419	-0.144747	0.87 [0.41 - 1.80]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209600_s_at	62	0.564516	0.381596	-	0.42026	0.896794	-0.0527755	0.95 [0.43 - 2.11]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207656_s_at	125	0.336	0.0831518	-	-0.496781	0.585386	-0.675058	0.51 [0.05 - 5.76]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209600_s_at	125	0.584	0.0151968	0.220078	0.930281	0.0854777	0.471615	1.60 [0.94 - 2.74]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207656_s_at	125	0.272	0.0291437	0.347441	-0.812718	0.336607	-1.55752	0.21 [0.01 - 5.05]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213501_at	62	0.887097	0.298301	-	-1.02732	0.797336	-0.0718756	0.93 [0.54 - 1.61]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209601_at	125	0.224	0.0209378	0.276735	-0.71864	0.0722619	-2.33028	0.10 [0.01 - 1.23]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213501_at	125	0.144	0.117271	-	1.46354	0.459205	0.315241	1.37 [0.59 - 3.16]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209600_s_at	125	0.88	0.00301534	0.06325	0.987446	0.412014	0.171264	1.19 [0.79 - 1.79]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209600_s_at	198	0.419192	0.00668066	0.11866	-0.564894	0.105837	-0.289525	0.75 [0.53 - 1.06]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207656_s_at	198	0.409091	0.153623	-	0.310636	0.356727	0.0829866	1.09 [0.91 - 1.30]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213501_at	198	0.762626	0.0659231	-	-0.491893	0.700601	-0.0686866	0.93 [0.66 - 1.33]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209600_s_at	198	0.419192	0.00335527	0.0689256	-0.735902	0.0886034	-0.369001	0.69 [0.45 - 1.06]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207656_s_at	198	0.681818	0.129892	-	0.392678	0.274962	0.119475	1.13 [0.91 - 1.40]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209601_at	198	0.217172	0.0753007	-	0.499675	0.363417	0.0861664	1.09 [0.91 - 1.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209600_s_at	198	0.489899	0.00597589	0.108821	-0.741449	0.140986	-0.341044	0.71 [0.45 - 1.12]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207656_s_at	198	0.151515	0.182747	-	0.568673	0.513399	0.0757122	1.08 [0.86 - 1.35]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213501_at	198	0.762626	0.0621063	-	-0.617721	0.824354	-0.0481208	0.95 [0.62 - 1.46]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213501_at	198	0.762626	0.136782	-	-0.500716	0.896909	-0.0299227	0.97 [0.62 - 1.53]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209601_at	198	0.217172	0.02037	0.271434	0.901763	0.243648	0.132495	1.14 [0.91 - 1.43]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209601_at	198	0.217172	0.0413546	0.436841	0.804041	0.240445	0.139324	1.15 [0.91 - 1.45]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209601_at	51	0.686275	0.112761	-	-15.6741	0.729995	-0.795328	0.45 [0.00 - 41.32]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213501_at	62	0.33871	0.159826	-	1.04209	0.632741	-0.310922	0.73 [0.20 - 2.62]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207656_s_at	62	0.612903	0.171789	-	0.771937	0.934513	0.13432	1.14 [0.05 - 28.17]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209600_s_at	51	0.27451	0.0963954	-	-1.40082	0.876547	0.112545	1.12 [0.27 - 4.63]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207656_s_at	51	0.607843	0.03849	0.417263	1.97956	0.248288	2.60918	13.59 [0.16 - 1139.93]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209601_at	62	0.725806	0.0211533	0.278731	-15.6064	0.31689	-1.5448	0.21 [0.01 - 4.39]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213501_at	51	0.117647	0.0380387	0.414107	-1.68786	0.997781	-0.00237327	1.00 [0.19 - 5.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209600_s_at	62	0.193548	0.0710325	-	15.3928	0.905926	-0.0558807	0.95 [0.37 - 2.39]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213501_at	145	0.158621	0.0329143	0.376797	-0.77455	0.0789086	-0.566095	0.57 [0.30 - 1.07]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209600_s_at	177	0.186441	2.14991e-05	0.000891333	-1.14524	0.0087154	-0.880076	0.41 [0.21 - 0.80]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209601_at	177	0.59322	0.00694803	0.122313	-0.706075	0.0435194	-2.28467	0.10 [0.01 - 0.94]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207656_s_at	177	0.254237	0.00945155	0.154734	-0.719759	0.179198	-0.978886	0.38 [0.09 - 1.57]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209600_s_at	177	0.186441	0.000351462	0.0104729	-0.892842	0.103385	-0.485481	0.62 [0.34 - 1.10]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209601_at	145	0.255172	0.0638816	-	-0.623113	0.621999	-0.788026	0.45 [0.02 - 10.43]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207656_s_at	177	0.254237	0.0166154	0.234755	-0.593289	0.110458	-1.01503	0.36 [0.10 - 1.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	227962_at	177	0.220339	0.0129166	0.195387	-0.706455	0.0593781	-0.571554	0.56 [0.31 - 1.02]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209600_s_at	145	0.103448	0.00440996	0.0857108	-1.08805	0.0735282	-0.767238	0.46 [0.20 - 1.08]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213501_at	177	0.141243	9.27542e-05	0.00327764	-1.14295	0.0051497	-0.731494	0.48 [0.29 - 0.80]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	227962_at	177	0.847458	0.0372469	0.408521	-0.862482	0.139962	-0.387184	0.68 [0.41 - 1.14]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207656_s_at	145	0.310345	0.00126362	0.0309906	-1.03311	0.0724285	-1.75128	0.17 [0.03 - 1.17]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209601_at	177	0.59322	0.00631495	0.113593	-0.842457	0.0596751	-2.46307	0.09 [0.01 - 1.11]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213501_at	177	0.141243	0.000347357	0.0103675	-0.968609	0.0637129	-0.429812	0.65 [0.41 - 1.02]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	227962_at	145	0.365517	0.0132094	0.198639	-0.807902	0.12229	-0.55929	0.57 [0.28 - 1.16]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209601_at	226	0.163717	0.0455877	0.464427	-0.636084	0.919061	0.0152946	1.02 [0.76 - 1.36]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209600_s_at	226	0.451327	0.0193717	0.261964	-0.65951	0.519705	-0.169652	0.84 [0.50 - 1.41]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207656_s_at	226	0.59292	0.0825568	-	0.490541	0.472158	0.103211	1.11 [0.84 - 1.47]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	227962_at	226	0.265487	0.0807543	-	-0.509039	0.820693	-0.0635323	0.94 [0.54 - 1.63]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213501_at	226	0.141593	0.0165978	0.234576	-0.776822	0.0908558	-0.395944	0.67 [0.43 - 1.07]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209601_at	55	0.4	0.00672041	0.119206	1.76254	0.559217	1.02848	2.80 [0.09 - 88.25]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209600_s_at	55	0.836364	0.0356697	0.397205	0.988311	0.503044	0.303217	1.35 [0.56 - 3.29]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209601_at	49	0.387755	0.0562012	-	1.37189	0.600545	1.05889	2.88 [0.05 - 151.79]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207656_s_at	55	0.563636	0.124812	-	0.678514	0.445428	1.32304	3.75 [0.13 - 112.33]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209600_s_at	55	0.836364	0.00988682	0.160082	1.24311	0.179664	0.65324	1.92 [0.74 - 4.99]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	227962_at	55	0.363636	0.0246203	0.309749	-0.977215	0.271002	-0.439168	0.64 [0.29 - 1.41]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209600_s_at	49	0.857143	0.0333521	0.380097	1.23742	0.335157	0.5696	1.77 [0.56 - 5.63]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207656_s_at	55	0.618182	0.0746458	-	0.79168	0.384294	1.67525	5.34 [0.12 - 232.60]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213501_at	55	0.890909	0.00646006	0.115613	1.32198	0.169355	0.561589	1.75 [0.79 - 3.91]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207656_s_at	49	0.22449	0.146095	-	1.40171	0.528904	1.3232	3.76 [0.06 - 230.89]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	227962_at	55	0.890909	0.264153	-	0.599753	0.589085	-0.22623	0.80 [0.35 - 1.81]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213501_at	55	0.854545	0.00234582	0.0516016	1.45699	0.0776447	0.767002	2.15 [0.92 - 5.05]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209601_at	55	0.872727	0.204826	-	-1.22382	0.791224	-0.454236	0.63 [0.02 - 18.34]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	227962_at	49	0.367347	0.0847189	-	-0.973691	0.39053	-0.450098	0.64 [0.23 - 1.78]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213501_at	49	0.877551	0.00537653	0.100196	1.59784	0.231334	0.636171	1.89 [0.67 - 5.35]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	126887	34	0.852941	0.0979666	-	0.844193	0.451015	0.558873	1.75 [0.41 - 7.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209600_s_at	63	0.253968	0.0286113	0.343152	-0.768481	0.239734	-0.219956	0.80 [0.56 - 1.16]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207656_s_at	63	0.126984	0.0210526	0.2778	-0.954715	0.995826	-0.024299	0.98 [0.00 - 8776.06]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	227962_at	63	0.52381	0.105261	-	-0.556981	0.660782	-0.12204	0.89 [0.51 - 1.53]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213501_at	63	0.111111	0.0213196	0.280266	-1.01709	0.319682	-0.283079	0.75 [0.43 - 1.32]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209601_at	63	0.190476	9.91082e-05	0.00347477	-1.37092	0.0259906	-13.7772	0.00 [0.00 - 0.19]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.293649.0.A1_3p_at	28	0.785714	0.139885	-	-1.09365	0.314865	-2.9349	0.05 [0.00 - 16.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6031153_3p_a_at	28	0.75	0.0131448	0.197924	-2.2067	0.0797231	-6.17662	0.00 [0.00 - 2.08]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.167835.3.S1_3p_a_at	28	0.785714	0.0900868	-	-1.59536	0.214656	-1.07822	0.34 [0.06 - 1.87]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209600_s_at	82	0.109756	3.44148e-05	0.00135885	-1.68494	0.00559539	-1.22975	0.29 [0.12 - 0.70]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207656_s_at	82	0.682927	0.00226746	0.0501918	1.00107	0.0370481	0.777437	2.18 [1.05 - 4.52]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213501_at	82	0.207317	0.00417364	0.0820472	-1.02321	0.0470335	-0.844966	0.43 [0.19 - 0.99]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209601_at	82	0.865854	0.0702847	-	0.71869	0.428208	-0.261923	0.77 [0.40 - 1.47]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209600_s_at	79	0.772152	0.0828134	-	0.5194	0.210965	0.426492	1.53 [0.79 - 2.99]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213501_at	79	0.759494	0.00561487	0.103656	0.803641	0.394343	0.275628	1.32 [0.70 - 2.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207656_s_at	79	0.632911	0.223966	-	0.321718	0.815634	0.0642549	1.07 [0.62 - 1.83]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209601_at	79	0.721519	0.0583486	-	0.53437	0.899382	-0.0350713	0.97 [0.56 - 1.66]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	S69189_at	86	0.162791	0.181762	-	0.950454	0.879859	0.080421	1.08 [0.38 - 3.07]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209600_s_at	104	0.865385	0.0100782	0.16241	1.0099	0.408601	0.404541	1.50 [0.57 - 3.91]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207656_s_at	104	0.875	0.129405	-	0.62716	0.988651	0.00487434	1.00 [0.51 - 1.97]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213501_at	104	0.403846	0.00866423	0.144858	1.00686	0.443564	0.332494	1.39 [0.60 - 3.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209601_at	104	0.711538	0.104436	-	-0.66944	0.56785	-0.169031	0.84 [0.47 - 1.51]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P206945	117	0.854701	0.0195161	0.263346	0.781477	0.158723	0.41454	1.51 [0.85 - 2.69]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P77761	117	0.846154	5.34858e-06	0.000253085	1.38326	0.00340456	0.85577	2.35 [1.33 - 4.17]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	227962_at	204	0.573529	0.0320108	0.36992	-0.859822	0.817732	-0.125814	0.88 [0.30 - 2.57]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213501_at	204	0.803922	0.128777	-	0.598125	0.105366	0.837969	2.31 [0.84 - 6.37]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	227962_at	204	0.25	0.00152346	0.0361965	-0.861147	0.186056	-0.560137	0.57 [0.25 - 1.31]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213501_at	204	0.70098	0.00482972	0.0920952	0.754558	0.0186132	0.938061	2.56 [1.17 - 5.58]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209601_at	204	0.681373	0.139385	-	0.53831	0.566226	0.164427	1.18 [0.67 - 2.07]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209601_at	204	0.897059	0.0271569	0.331242	0.757081	0.499828	0.142738	1.15 [0.76 - 1.75]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209600_s_at	204	0.372549	0.0163664	0.232214	1.11721	0.00939459	1.35377	3.87 [1.39 - 10.75]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209600_s_at	204	0.676471	0.0103031	0.165127	0.687182	0.0054014	1.16318	3.20 [1.41 - 7.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207656_s_at	204	0.769608	0.340898	-	-0.463312	0.726752	-0.0729497	0.93 [0.62 - 1.40]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207656_s_at	204	0.843137	0.302509	-	0.346904	0.953936	-0.00902097	0.99 [0.73 - 1.35]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209601_at	178	0.140449	0.0538619	-	0.662431	0.129337	0.271129	1.31 [0.92 - 1.86]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209600_s_at	178	0.769663	0.0442017	0.455563	0.434832	0.264873	0.348327	1.42 [0.77 - 2.61]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213501_at	178	0.876405	0.172048	-	0.3701	0.822665	0.0550988	1.06 [0.65 - 1.71]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300020783	41	0.487805	0.0357364	0.397689	-0.892685	0.323799	-0.411955	0.66 [0.29 - 1.50]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213501_at	111	0.225225	0.224596	-	-0.347188	0.51375	0.140967	1.15 [0.75 - 1.76]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209601_at	111	0.621622	0.136724	-	-0.420327	0.354902	-0.191724	0.83 [0.55 - 1.24]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	227962_at	111	0.603604	0.184397	-	0.353623	0.642884	0.125281	1.13 [0.67 - 1.92]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209600_s_at	111	0.342342	0.301678	-	0.303625	0.876634	-0.0436636	0.96 [0.55 - 1.66]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207656_s_at	111	0.198198	0.264485	-	0.420866	0.914137	-0.0212655	0.98 [0.67 - 1.44]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213501_at	90	0.8	0.0456272	0.464678	0.701931	0.0917523	0.842186	2.32 [0.87 - 6.18]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213501_at	90	0.733333	0.075933	-	0.667285	0.219778	0.714925	2.04 [0.65 - 6.40]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209601_at	90	0.366667	0.105792	-	0.690707	0.551911	0.764751	2.15 [0.17 - 26.69]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209601_at	90	0.366667	0.155934	-	0.505717	0.624956	0.555825	1.74 [0.19 - 16.19]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209600_s_at	90	0.855556	0.000472642	0.0135047	1.18619	0.0089357	1.03655	2.82 [1.30 - 6.13]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209600_s_at	90	0.855556	0.00538701	0.100349	1.10478	0.112219	0.737342	2.09 [0.84 - 5.19]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207656_s_at	90	0.188889	0.174248	-	0.642448	0.829011	0.152877	1.17 [0.29 - 4.67]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207656_s_at	90	0.377778	0.203653	-	-0.468724	0.662889	0.338501	1.40 [0.31 - 6.43]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4073	50	0.68	0.311565	-	-0.567273	0.73803	0.138969	1.15 [0.51 - 2.59]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	854	50	0.12	0.0886338	-	15.255	0.945351	0.0297772	1.03 [0.44 - 2.41]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3310	50	0.18	0.0390423	0.421098	-1.05319	0.734727	0.144728	1.16 [0.50 - 2.67]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213501_at	138	0.123188	0.00546635	0.101505	1.50529	0.0177877	0.374766	1.45 [1.07 - 1.98]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209601_at	138	0.195652	0.0977518	-	-0.443449	0.215471	-5.25675	0.01 [0.00 - 21.36]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	227962_at	138	0.144928	0.0471897	0.474477	-0.621564	0.966553	0.0066191	1.01 [0.74 - 1.37]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209600_s_at	138	0.84058	0.0197805	0.265865	0.67201	0.109165	0.328145	1.39 [0.93 - 2.07]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207656_s_at	138	0.108696	0.0809199	-	-0.567879	0.275142	-2.70113	0.07 [0.00 - 8.59]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209600_s_at	129	0.302326	0.21391	-	-0.33024	0.980432	0.0114072	1.01 [0.41 - 2.52]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207656_s_at	129	0.217054	0.0549306	-	0.650451	0.56929	0.104579	1.11 [0.77 - 1.59]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213501_at	129	0.193798	0.150953	-	-0.419611	0.81695	0.118732	1.13 [0.41 - 3.08]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209601_at	129	0.488372	0.00132478	0.0322339	0.818266	0.137812	0.32656	1.39 [0.90 - 2.13]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13731	56	0.767857	0.195681	-	-0.580077	0.91464	-0.0287704	0.97 [0.57 - 1.64]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20941	56	0.125	0.116666	-	-0.753038	0.465444	-0.197115	0.82 [0.48 - 1.39]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16128	56	0.107143	0.0537196	-	1.33017	0.664688	0.12721	1.14 [0.64 - 2.02]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20941	56	0.125	0.0485359	0.482766	-0.941467	0.547157	-0.173993	0.84 [0.48 - 1.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13731	56	0.767857	0.0658646	-	-0.807178	0.475818	-0.176311	0.84 [0.52 - 1.36]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16128	56	0.107143	0.0321593	0.371057	1.90807	0.504261	0.209033	1.23 [0.67 - 2.28]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209600_s_at	278	0.489209	0.15308	-	-0.270232	0.482724	-0.128256	0.88 [0.61 - 1.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207656_s_at	278	0.507194	0.0478951	0.478838	-0.371507	0.663945	-0.200257	0.82 [0.33 - 2.02]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	227962_at	278	0.589928	0.218935	-	0.233309	0.508954	0.101903	1.11 [0.82 - 1.50]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213501_at	278	0.111511	0.0523781	-	-0.540121	0.69837	-0.0613966	0.94 [0.69 - 1.28]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209601_at	278	0.169065	0.236228	-	0.328399	0.9061	-0.087574	0.92 [0.21 - 3.93]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209600_s_at	133	0.172932	0.0156319	0.224632	-0.638792	0.0810352	-0.231769	0.79 [0.61 - 1.03]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207656_s_at	133	0.639098	0.00339125	0.069518	0.693372	0.02767	1.6109	5.01 [1.19 - 21.01]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213501_at	133	0.458647	0.00220432	0.0490477	-0.725438	0.0458607	-0.444882	0.64 [0.41 - 0.99]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209601_at	133	0.593985	0.00274928	0.058701	0.700419	0.024308	1.33041	3.78 [1.19 - 12.04]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6030	81	0.753086	0.339244	-	0.518524	0.490316	-0.26692	0.77 [0.36 - 1.63]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209601_at	185	0.124324	0.223786	-	0.333476	0.917014	0.0397468	1.04 [0.49 - 2.20]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207656_s_at	185	0.513514	0.0152449	0.220584	-0.398548	0.0515958	-0.569957	0.57 [0.32 - 1.00]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209600_s_at	185	0.627027	0.147727	-	-0.267424	0.798036	-0.0395637	0.96 [0.71 - 1.30]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213501_at	185	0.762162	0.0229948	0.295457	-0.438582	0.235815	-0.277865	0.76 [0.48 - 1.20]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207656_s_at	185	0.513514	0.000896219	0.0232439	-0.596718	0.0405566	-0.706572	0.49 [0.25 - 0.97]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209601_at	185	0.113514	0.152153	-	0.377951	0.793463	-0.0939499	0.91 [0.45 - 1.84]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213501_at	185	0.762162	0.0343281	0.387373	-0.449052	0.297461	-0.264568	0.77 [0.47 - 1.26]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209600_s_at	185	0.183784	0.118518	-	-0.318773	0.556329	-0.0846147	0.92 [0.69 - 1.22]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P77761	110	0.109091	0.0825335	-	0.777181	0.666362	0.0977545	1.10 [0.71 - 1.72]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P206945	110	0.154545	0.0716963	-	0.912045	0.43368	0.212709	1.24 [0.73 - 2.11]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P935889	110	0.263636	0.00223515	0.0496073	-0.74265	0.253103	-0.153093	0.86 [0.66 - 1.12]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P77761	110	0.118182	0.163146	-	0.970266	0.82149	0.0693755	1.07 [0.59 - 1.96]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P935889	110	0.109091	0.00207478	0.0466778	-1.17276	0.0890402	-0.312483	0.73 [0.51 - 1.05]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P206945	110	0.136364	0.0477946	0.478219	0.766072	0.980195	0.00488611	1.00 [0.68 - 1.48]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209601_at	80	0.4125	0.0188508	0.256945	-1.00222	0.132083	-0.49079	0.61 [0.32 - 1.16]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209600_s_at	80	0.2625	0.055178	-	-0.844383	0.387285	-0.326615	0.72 [0.34 - 1.51]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213501_at	80	0.3125	0.176931	-	-0.588769	0.502932	-0.333007	0.72 [0.27 - 1.90]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207656_s_at	80	0.4625	0.0125658	0.191455	-1.14645	0.590081	-0.10944	0.90 [0.60 - 1.33]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3136	281	0.238434	0.10709	-	-0.261745	0.962505	0.00902381	1.01 [0.69 - 1.47]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:126887	59	0.508475	0.0350675	0.392816	-1.0727	0.892608	-0.16525	0.85 [0.08 - 9.34]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209601_at	38	0.394737	0.0125785	0.191599	-1.15067	0.122965	-0.427204	0.65 [0.38 - 1.12]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	227962_at	38	0.657895	0.00735885	0.127849	1.44042	0.178645	0.704817	2.02 [0.72 - 5.65]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209600_s_at	38	0.315789	0.0332973	0.379685	1.20804	0.243145	0.442826	1.56 [0.74 - 3.28]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207656_s_at	38	0.473684	0.0549894	-	-0.895125	0.275921	-0.303745	0.74 [0.43 - 1.27]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213501_at	38	0.236842	0.00257835	0.0557246	2.59644	0.0591196	0.741315	2.10 [0.97 - 4.53]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209601_at	140	0.678571	0.00671613	0.119147	-0.966979	0.212017	-1.79419	0.17 [0.01 - 2.78]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209600_s_at	140	0.171429	0.000596354	0.0164671	-1.06467	0.0118167	-0.869265	0.42 [0.21 - 0.82]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207656_s_at	140	0.55	0.0435955	0.451636	0.581051	0.94471	0.0871812	1.09 [0.09 - 12.82]
GENE	ACOX1	acyl-CoA oxidase 1, palmitoyl	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213501_at	140	0.742857	0.00640845	0.114896	-1.13233	0.0355771	-0.808226	0.45 [0.21 - 0.95]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205364_at	30	0.733333	0.167152	-	0.591754	0.595262	0.216631	1.24 [0.56 - 2.76]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1685703	165	0.884848	0.0637135	-	-1.04805	0.252521	-0.141719	0.87 [0.68 - 1.11]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1685703	165	0.866667	0.206537	-	-0.892938	0.730015	-0.0547436	0.95 [0.69 - 1.29]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205364_at	163	0.895706	0.203161	-	0.377165	0.669455	0.156976	1.17 [0.57 - 2.41]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205364_at	79	0.113924	0.00741981	0.128662	-0.981433	0.396573	-0.322468	0.72 [0.34 - 1.53]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205364_at	58	0.137931	0.0208007	0.27546	0.935478	0.163774	0.165868	1.18 [0.93 - 1.49]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205364_at	34	0.617647	0.0819392	-	0.672387	0.467374	0.152519	1.16 [0.77 - 1.76]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205364_at	158	0.101266	0.0109394	0.172711	1.39047	0.457752	0.635196	1.89 [0.35 - 10.09]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205364_at	53	0.603774	0.0174065	0.242734	0.800938	0.166413	0.346208	1.41 [0.87 - 2.31]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205364_at	53	0.54717	0.149426	-	0.523951	0.486483	0.176127	1.19 [0.73 - 1.96]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205364_at	180	0.533333	0.0428753	0.446929	0.422376	0.678907	0.0839088	1.09 [0.73 - 1.62]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205364_at	559	0.842576	0.0265766	0.326407	-0.724896	0.158521	-0.170316	0.84 [0.67 - 1.07]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205364_at	77	0.714286	0.058936	-	0.522213	0.489147	0.139159	1.15 [0.77 - 1.70]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205364_at	70	0.3	0.215327	-	0.362699	0.801037	0.0567786	1.06 [0.68 - 1.65]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38348_at	50	0.42	0.0741366	-	-0.617024	0.968175	-0.0241797	0.98 [0.30 - 3.20]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205364_at	74	0.22973	0.0118771	0.183625	1.01349	0.332263	0.197227	1.22 [0.82 - 1.81]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205364_at	67	0.38806	0.0479407	0.479119	1.87857	0.404553	1.05346	2.87 [0.24 - 34.15]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205364_at	115	0.834783	0.324218	-	-0.983578	0.769376	-0.0852278	0.92 [0.52 - 1.62]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38348_at	158	0.860759	0.175366	-	-0.693562	0.486761	-0.0810952	0.92 [0.73 - 1.16]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38348_at	76	0.894737	0.0559512	-	1.06882	0.826949	0.0430004	1.04 [0.71 - 1.53]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205364_at	204	0.142157	0.000506996	0.0143394	-0.691213	0.00663911	-0.13251	0.88 [0.80 - 0.96]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205364_at	87	0.103448	0.0522084	-	-0.926617	0.680649	0.0507391	1.05 [0.83 - 1.34]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205364_at	87	0.103448	0.0522084	-	-0.926617	0.680649	0.0507391	1.05 [0.83 - 1.34]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205364_at	77	0.103896	0.0554244	-	-1.19498	0.759991	-0.0706868	0.93 [0.59 - 1.47]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205364_at	77	0.103896	0.0108727	0.171923	-1.59699	0.707216	-0.101054	0.90 [0.53 - 1.53]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205364_at	136	0.191176	0.00494129	0.0937672	-1.21101	0.0376047	-0.430074	0.65 [0.43 - 0.98]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205364_at	200	0.13	0.0177858	0.246509	-0.829434	0.621189	0.0737	1.08 [0.80 - 1.44]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11058	60	0.883333	0.0153956	0.222165	1.08028	0.496243	-0.0833853	0.92 [0.72 - 1.17]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11058	60	0.166667	0.00670017	0.118928	-1.13238	0.463009	-0.108875	0.90 [0.67 - 1.20]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13282	155	0.135484	4.90834e-05	0.00186503	-1.16891	2.5506e-05	-0.356873	0.70 [0.59 - 0.83]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205364_at	286	0.888112	0.081495	-	0.469287	0.439999	0.0720547	1.07 [0.90 - 1.29]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205364_at	159	0.289308	0.313315	-	-0.332899	0.822988	-0.032154	0.97 [0.73 - 1.28]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205364_at	159	0.220126	0.14118	-	-0.582407	0.667468	-0.0728341	0.93 [0.67 - 1.30]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205364_at	159	0.220126	0.0536104	-	-0.640644	0.842697	0.028751	1.03 [0.77 - 1.37]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205364_at	54	0.814815	0.0947429	-	1.15873	0.864847	0.0353877	1.04 [0.69 - 1.56]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205364_at	117	0.111111	0.0148721	0.216648	2.0841	0.392679	0.0794073	1.08 [0.90 - 1.30]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205364_at	117	0.410256	0.0202755	0.270546	1.02361	0.124303	0.163943	1.18 [0.96 - 1.45]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205364_at	117	0.188034	0.069173	-	1.25626	0.5527	0.0679543	1.07 [0.86 - 1.34]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205364_at	117	0.111111	0.0148721	0.216648	2.0841	0.392679	0.0794073	1.08 [0.90 - 1.30]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205364_at	236	0.851695	0.0797535	-	0.564512	0.48807	0.0966057	1.10 [0.84 - 1.45]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205364_at	249	0.100402	0.163038	-	0.63025	0.342731	0.103366	1.11 [0.90 - 1.37]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205364_at	62	0.145161	0.000353712	0.0105306	-1.74602	0.474897	-0.131951	0.88 [0.61 - 1.26]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205364_at	125	0.512	0.00837631	0.141178	1.05618	0.0338265	0.33875	1.40 [1.03 - 1.92]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205364_at	125	0.712	0.0998956	-	0.480645	0.11699	0.196352	1.22 [0.95 - 1.56]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205364_at	54	0.12963	0.00198775	0.0450673	-1.8476	0.450886	-0.1743	0.84 [0.53 - 1.32]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205364_at	198	0.191919	0.0929584	-	-0.495415	0.729578	-0.0267609	0.97 [0.84 - 1.13]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205364_at	198	0.191919	0.0815202	-	-0.532757	0.701637	-0.0306804	0.97 [0.83 - 1.13]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205364_at	198	0.727273	0.105543	-	-0.415843	0.700309	-0.0241359	0.98 [0.86 - 1.10]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205364_at	51	0.647059	0.0875099	-	-15.7671	0.42191	-0.757093	0.47 [0.07 - 2.98]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205364_at	62	0.16129	0.0403389	0.429987	-1.18745	0.740211	-0.171419	0.84 [0.31 - 2.32]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205364_at	145	0.344828	0.0173296	0.241964	-0.77392	0.248353	-0.347937	0.71 [0.39 - 1.27]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205364_at	177	0.644068	0.0415894	0.438412	-0.624583	0.680313	-0.0967826	0.91 [0.57 - 1.44]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205364_at	177	0.644068	0.0203343	0.271098	-0.61282	0.662111	-0.0887373	0.92 [0.61 - 1.36]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205364_at	226	0.460177	0.00544701	0.101223	-0.792155	0.00960342	-0.350347	0.70 [0.54 - 0.92]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205364_at	49	0.326531	0.133215	-	1.10705	0.576556	0.271603	1.31 [0.51 - 3.40]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205364_at	55	0.890909	0.0757724	-	0.961797	0.835149	0.0782199	1.08 [0.52 - 2.26]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205364_at	55	0.272727	0.0201511	0.269373	2.02113	0.0949962	0.645627	1.91 [0.89 - 4.07]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205364_at	63	0.15873	0.000401209	0.0117355	-1.31067	0.157053	-0.573368	0.56 [0.25 - 1.25]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501868_3p_at	28	0.785714	0.0416632	0.438905	-1.86914	0.124967	-7.31134	0.00 [0.00 - 7.61]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205364_at	82	0.207317	0.0154668	0.22291	-0.886653	0.308219	-0.688083	0.50 [0.13 - 1.89]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205364_at	79	0.21519	0.0343672	0.387662	-0.639296	0.142216	-0.410719	0.66 [0.38 - 1.15]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205364_at	104	0.894231	0.111933	-	-1.47257	0.390566	-0.4884	0.61 [0.20 - 1.87]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P10182	117	0.102564	0.00485627	0.0924939	-1.00186	0.302389	-0.12811	0.88 [0.69 - 1.12]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205364_at	204	0.102941	0.003548	0.0720813	-1.19061	0.409735	-0.284268	0.75 [0.38 - 1.48]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205364_at	204	0.338235	0.0575784	-	-0.517908	0.205095	-0.327725	0.72 [0.43 - 1.20]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205364_at	178	0.646067	0.141351	-	-0.314768	0.44697	-0.17311	0.84 [0.54 - 1.31]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205364_at	111	0.864865	0.114989	-	0.524762	0.532764	0.0916123	1.10 [0.82 - 1.46]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205364_at	90	0.866667	0.0262766	0.32389	0.858839	0.172875	0.601024	1.82 [0.77 - 4.33]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205364_at	90	0.311111	0.112558	-	0.713097	0.275393	0.556758	1.75 [0.64 - 4.75]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	33	50	0.34	0.0308899	0.361253	-1.0124	0.164765	-0.882041	0.41 [0.12 - 1.44]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205364_at	138	0.891304	0.168557	-	0.473698	0.447579	0.0650321	1.07 [0.90 - 1.26]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205364_at	129	0.782946	0.0916576	-	-0.572454	0.596829	-0.102581	0.90 [0.62 - 1.32]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13856	56	0.892857	0.189713	-	-0.927394	0.856888	-0.0308732	0.97 [0.69 - 1.36]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11134	56	0.75	0.0572053	-	-0.898707	0.757372	-0.0443316	0.96 [0.72 - 1.27]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16799	56	0.803571	0.0621694	-	-0.961673	0.993305	-0.00118155	1.00 [0.76 - 1.32]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13856	56	0.160714	0.242719	-	0.612546	0.945149	0.0113403	1.01 [0.73 - 1.40]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16799	56	0.803571	0.0448858	0.459959	-1.15339	0.704721	-0.0544918	0.95 [0.71 - 1.26]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11134	56	0.75	0.0624008	-	-0.819277	0.991283	0.00154208	1.00 [0.76 - 1.32]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205364_at	278	0.471223	0.176762	-	-0.25408	0.189131	-0.136339	0.87 [0.71 - 1.07]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205364_at	133	0.43609	0.098455	-	0.398129	0.551604	-0.0889255	0.91 [0.68 - 1.23]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18435	81	0.222222	0.0762379	-	1.65678	0.779992	0.114518	1.12 [0.50 - 2.50]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205364_at	185	0.551351	0.128657	-	-0.251273	0.610358	-0.106853	0.90 [0.60 - 1.36]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205364_at	185	0.167568	0.127574	-	-0.333256	0.584685	-0.12566	0.88 [0.56 - 1.38]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P10182	110	0.136364	0.171653	-	-0.42937	0.408697	-0.103228	0.90 [0.71 - 1.15]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P10182	110	0.690909	0.0286864	0.343759	-0.831056	0.15554	-0.224683	0.80 [0.59 - 1.09]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205364_at	80	0.1625	0.163149	-	0.894588	0.405275	0.187888	1.21 [0.78 - 1.88]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2893	281	0.896797	0.157404	-	-0.335832	0.617792	-0.0470707	0.95 [0.79 - 1.15]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:229881	59	0.152542	0.0469746	0.47314	-1.09929	0.745439	-0.35629	0.70 [0.08 - 6.02]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205364_at	38	0.184211	0.0361816	0.400906	1.91977	0.193819	0.339469	1.40 [0.84 - 2.34]
GENE	ACOX2	acyl-CoA oxidase 2, branched chain	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205364_at	140	0.335714	8.01448e-05	0.00288095	-1.09625	0.000428253	-0.762016	0.47 [0.31 - 0.71]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204241_at	30	0.566667	0.0737907	-	-0.72065	0.302377	-0.60706	0.54 [0.17 - 1.73]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204242_s_at	30	0.333333	0.212502	-	-0.518058	0.586733	-0.314521	0.73 [0.23 - 2.27]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1743396	165	0.363636	0.126835	-	0.404283	0.247806	0.187582	1.21 [0.88 - 1.66]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1743396	165	0.89697	0.0279884	0.338086	0.911241	0.118617	0.377613	1.46 [0.91 - 2.34]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204242_s_at	163	0.159509	0.0760165	-	-0.431183	0.799313	-0.113677	0.89 [0.37 - 2.14]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204241_at	163	0.171779	0.130699	-	-0.36803	0.808735	0.0796953	1.08 [0.57 - 2.06]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204241_at	79	0.253165	0.119206	-	0.569416	0.307547	0.341757	1.41 [0.73 - 2.71]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204242_s_at	79	0.683544	0.013508	0.201931	0.728616	0.0602999	0.988335	2.69 [0.96 - 7.53]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204241_at	58	0.896552	0.050599	-	0.860432	0.145393	0.329716	1.39 [0.89 - 2.17]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204242_s_at	58	0.62069	0.00281248	0.0597907	0.884113	0.16649	0.243882	1.28 [0.90 - 1.80]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204241_at	34	0.5	0.163275	-	-0.540482	0.922185	0.0252479	1.03 [0.62 - 1.70]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204242_s_at	34	0.264706	0.268782	-	-0.473829	0.829084	0.0394204	1.04 [0.73 - 1.49]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204241_at	158	0.164557	0.0286309	0.343311	0.799558	0.597694	0.249176	1.28 [0.51 - 3.24]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204242_s_at	158	0.120253	0.00192755	0.0439443	1.64218	0.310049	0.555982	1.74 [0.60 - 5.10]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204242_s_at	53	0.301887	0.0561741	-	-0.702233	0.877232	-0.0520131	0.95 [0.49 - 1.84]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204241_at	53	0.528302	0.0262161	0.32338	0.765285	0.231904	0.53005	1.70 [0.71 - 4.05]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204242_s_at	53	0.622642	0.123157	-	0.530302	0.857442	0.0567838	1.06 [0.57 - 1.97]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204241_at	53	0.584906	0.0121182	0.186383	0.901586	0.139976	0.716946	2.05 [0.79 - 5.31]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204241_at	180	0.622222	0.321115	-	-0.216164	0.603417	-0.144483	0.87 [0.50 - 1.49]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204242_s_at	180	0.394444	0.126558	-	-0.319428	0.702176	-0.0921086	0.91 [0.57 - 1.46]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204241_at	559	0.880143	0.129354	-	0.392954	0.857134	0.0243443	1.02 [0.79 - 1.34]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204242_s_at	559	0.162791	0.13711	-	0.439322	0.907649	0.0148042	1.01 [0.79 - 1.30]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204241_at	77	0.74026	0.0929291	-	0.468953	0.687658	0.170509	1.19 [0.52 - 2.72]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204242_s_at	77	0.324675	0.0299299	0.353707	0.629545	0.206873	0.206795	1.23 [0.89 - 1.70]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204241_at	70	0.114286	0.0115189	0.179491	-0.975318	0.16152	-0.56823	0.57 [0.26 - 1.26]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204242_s_at	70	0.871429	0.101277	-	0.620053	0.915007	0.0822499	1.09 [0.24 - 4.92]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41697_at	50	0.16	0.030167	0.355582	-0.920562	0.482695	-0.691575	0.50 [0.07 - 3.45]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204241_at	74	0.121622	0.0109689	0.173058	-0.921593	0.0905576	-1.006	0.37 [0.11 - 1.17]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204242_s_at	74	0.216216	0.0774404	-	-0.569384	0.444202	-0.140581	0.87 [0.61 - 1.25]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204241_at	67	0.119403	0.227828	-	-0.949364	0.960703	-0.0470765	0.95 [0.15 - 6.21]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204242_s_at	67	0.865672	0.0872011	-	1.15463	0.690933	0.569347	1.77 [0.11 - 29.26]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204242_s_at	115	0.469565	0.0546952	-	-1.08017	0.817711	-0.0944779	0.91 [0.41 - 2.03]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204241_at	115	0.530435	0.151927	-	-0.821116	0.609453	-0.212752	0.81 [0.36 - 1.83]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41697_at	158	0.651899	0.0704872	-	-0.577085	0.568421	-0.124784	0.88 [0.57 - 1.36]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41697_at	76	0.605263	0.0369727	0.406573	1.07449	0.750212	0.120984	1.13 [0.54 - 2.38]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204242_s_at	204	0.102941	0.06644	-	-0.428939	0.350365	-0.132638	0.88 [0.66 - 1.16]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204241_at	204	0.514706	0.184597	-	-0.185924	0.421535	-0.102189	0.90 [0.70 - 1.16]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204241_at	87	0.241379	0.00696035	0.122481	-1.00667	0.041226	-0.480487	0.62 [0.39 - 0.98]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204242_s_at	87	0.16092	0.000244088	0.00764228	-1.39024	0.00649221	-0.921377	0.40 [0.20 - 0.77]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204241_at	87	0.241379	0.00696035	0.122481	-1.00667	0.041226	-0.480487	0.62 [0.39 - 0.98]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204242_s_at	87	0.16092	0.000244088	0.00764228	-1.39024	0.00649221	-0.921377	0.40 [0.20 - 0.77]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204242_s_at	77	0.857143	0.176952	-	-15.2693	0.986307	-0.0091078	0.99 [0.35 - 2.80]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204241_at	77	0.467532	0.219369	-	0.72231	0.747203	0.105891	1.11 [0.58 - 2.12]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204241_at	77	0.883117	0.224787	-	-15.2211	0.899231	-0.0468286	0.95 [0.46 - 1.97]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204242_s_at	77	0.428571	0.1243	-	0.973086	0.585136	0.244777	1.28 [0.53 - 3.08]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204242_s_at	136	0.713235	0.0352982	0.394502	-1.4453	0.205937	-0.421764	0.66 [0.34 - 1.26]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204241_at	136	0.522059	0.134294	-	-0.717234	0.339266	-0.405853	0.67 [0.29 - 1.53]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204241_at	200	0.105	0.0116271	0.180744	-0.909213	0.139998	-0.450108	0.64 [0.35 - 1.16]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204242_s_at	200	0.225	0.0316017	0.366774	-0.665818	0.0505428	-0.464901	0.63 [0.39 - 1.00]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1804	60	0.883333	0.0394203	0.423706	0.918389	0.4245	0.198965	1.22 [0.75 - 1.99]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1804	60	0.266667	0.0739646	-	-0.679531	0.479784	-0.174361	0.84 [0.52 - 1.36]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1388	155	0.264516	2.33463e-05	0.000959833	-1.12673	0.000149603	-0.508695	0.60 [0.46 - 0.78]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204241_at	286	0.265734	0.0406526	0.432114	0.501945	0.648895	0.0881945	1.09 [0.75 - 1.60]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204242_s_at	286	0.486014	0.175733	-	-0.261856	0.780535	-0.0411163	0.96 [0.72 - 1.28]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204242_s_at	159	0.257862	0.0112236	0.17605	-0.798063	0.204336	-0.252111	0.78 [0.53 - 1.15]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204241_at	159	0.113208	0.104095	-	-0.665791	0.77752	-0.127201	0.88 [0.36 - 2.13]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204241_at	159	0.113208	0.048962	0.48536	-0.876774	0.423969	-0.419188	0.66 [0.24 - 1.84]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204242_s_at	159	0.301887	0.093941	-	-0.534708	0.279359	-0.219348	0.80 [0.54 - 1.19]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204241_at	159	0.113208	0.101885	-	-0.669723	0.502184	-0.301488	0.74 [0.31 - 1.78]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204242_s_at	159	0.257862	0.00527432	0.0986991	-1.00064	0.131913	-0.339814	0.71 [0.46 - 1.11]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	HC-Y11411_at	54	0.888889	0.286677	-	0.846218	0.523649	0.414483	1.51 [0.42 - 5.41]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204241_at	54	0.12963	0.226346	-	-0.952849	0.763733	-0.129009	0.88 [0.38 - 2.04]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204242_s_at	54	0.462963	0.0908854	-	-1.13852	0.940401	-0.046322	0.95 [0.28 - 3.22]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204241_at	117	0.111111	0.0361909	0.400973	1.84889	0.630816	0.0846743	1.09 [0.77 - 1.54]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204241_at	117	0.606838	0.115254	-	0.588498	0.571572	0.119202	1.13 [0.75 - 1.70]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204241_at	117	0.606838	0.150203	-	0.562757	0.672055	0.0929895	1.10 [0.71 - 1.69]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204241_at	117	0.111111	0.0361909	0.400973	1.84889	0.630816	0.0846743	1.09 [0.77 - 1.54]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204242_s_at	117	0.401709	0.179421	-	-0.421314	0.674614	-0.114413	0.89 [0.52 - 1.52]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204242_s_at	117	0.401709	0.0625336	-	-0.696908	0.843225	-0.0633888	0.94 [0.50 - 1.76]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204242_s_at	117	0.239316	0.0991165	-	-0.646689	0.980199	-0.00827181	0.99 [0.52 - 1.91]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204242_s_at	117	0.401709	0.179421	-	-0.421314	0.674614	-0.114413	0.89 [0.52 - 1.52]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204242_s_at	236	0.101695	0.0415408	0.438087	-0.727197	0.349342	-0.196505	0.82 [0.54 - 1.24]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204241_at	236	0.872881	0.0922068	-	0.582054	0.751385	0.115411	1.12 [0.55 - 2.29]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204241_at	249	0.236948	0.0606279	-	-0.429605	0.841892	0.058818	1.06 [0.60 - 1.89]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204242_s_at	249	0.108434	0.0336884	0.382616	-0.610756	0.188812	-0.219075	0.80 [0.58 - 1.11]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204242_s_at	125	0.824	0.0807572	-	-0.712399	0.630382	-0.104056	0.90 [0.59 - 1.38]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204242_s_at	54	0.888889	0.255231	-	0.866529	0.998347	-0.000743811	1.00 [0.49 - 2.02]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204241_at	62	0.258065	0.0152928	0.221088	-1.13142	0.467357	-0.142871	0.87 [0.59 - 1.27]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204241_at	125	0.176	0.255827	-	0.681418	0.976591	-0.00981492	0.99 [0.51 - 1.91]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204242_s_at	62	0.887097	0.135479	-	0.931469	0.879416	-0.0444143	0.96 [0.54 - 1.70]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204241_at	125	0.176	0.418591	-	0.329113	0.744708	-0.0801656	0.92 [0.57 - 1.50]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204242_s_at	125	0.112	0.181681	-	1.27443	0.696147	0.109594	1.12 [0.64 - 1.93]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204241_at	54	0.222222	0.0352153	0.393897	-1.2188	0.486961	-0.167505	0.85 [0.53 - 1.36]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204242_s_at	198	0.131313	0.272934	-	0.385399	0.666082	-0.0494984	0.95 [0.76 - 1.19]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204241_at	198	0.494949	0.00305049	0.0638437	-0.757019	0.0960827	-0.266328	0.77 [0.56 - 1.05]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204241_at	198	0.494949	0.00194168	0.0442085	-0.841341	0.0291025	-0.373666	0.69 [0.49 - 0.96]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204242_s_at	198	0.717172	0.0806865	-	-0.539473	0.247031	-0.146467	0.86 [0.67 - 1.11]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204242_s_at	198	0.373737	0.0219216	0.285781	-0.61107	0.106987	-0.208746	0.81 [0.63 - 1.05]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204241_at	198	0.818182	0.137227	-	-0.429579	0.613342	-0.0685823	0.93 [0.72 - 1.22]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204242_s_at	62	0.129032	0.113865	-	-1.01471	0.26775	-1.1624	0.31 [0.04 - 2.44]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204241_at	51	0.176471	0.00502942	0.0950808	-2.13803	0.351016	-0.840467	0.43 [0.07 - 2.52]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204241_at	62	0.209677	0.000475177	0.0135666	-1.80922	0.0898195	-0.957812	0.38 [0.13 - 1.16]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204242_s_at	51	0.137255	0.0502073	-	-1.61102	0.731119	0.505301	1.66 [0.09 - 29.59]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204241_at	177	0.779661	0.0225905	0.291835	-0.760648	0.211427	-0.418891	0.66 [0.34 - 1.27]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204241_at	177	0.779661	0.0130013	0.19633	-1.03242	0.210548	-0.481465	0.62 [0.29 - 1.31]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204242_s_at	177	0.367232	2.86508e-05	0.00115329	-0.951892	0.00168761	-1.75219	0.17 [0.06 - 0.52]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204241_at	145	0.310345	0.0354597	0.395679	-0.688341	0.0874918	-0.875721	0.42 [0.15 - 1.14]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204242_s_at	145	0.158621	0.0402915	0.429665	-0.772737	0.241745	-0.939163	0.39 [0.08 - 1.88]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204242_s_at	177	0.344633	0.00105239	0.0265997	-0.860608	0.00812524	-1.70466	0.18 [0.05 - 0.64]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204241_at	226	0.79646	0.012637	0.192256	-1.37496	0.0600765	-0.356236	0.70 [0.48 - 1.02]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204242_s_at	226	0.128319	0.0113231	0.177213	-0.840759	0.061871	-0.399837	0.67 [0.44 - 1.02]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204242_s_at	55	0.763636	0.319775	-	0.494975	0.643998	0.394372	1.48 [0.28 - 7.90]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204242_s_at	49	0.244898	0.073484	-	1.67555	0.792047	0.257776	1.29 [0.19 - 8.79]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204241_at	55	0.890909	0.0324261	0.373093	1.3068	0.259287	0.8363	2.31 [0.54 - 9.87]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204241_at	49	0.183673	0.0520229	-	15.4658	0.256455	0.796729	2.22 [0.56 - 8.78]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204241_at	55	0.181818	0.0691951	-	1.66603	0.208761	0.736258	2.09 [0.66 - 6.58]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204242_s_at	55	0.2	0.0413417	0.436754	1.82983	0.584172	0.436766	1.55 [0.32 - 7.40]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	431501	34	0.617647	0.04116	0.435535	0.879226	0.117064	0.787345	2.20 [0.82 - 5.88]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204242_s_at	63	0.666667	0.00909063	0.150241	0.876707	0.0772293	0.551666	1.74 [0.94 - 3.20]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204241_at	63	0.603175	0.011682	0.181378	0.836759	0.0596178	0.301108	1.35 [0.99 - 1.85]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501870_3p_a_at	28	0.428571	0.0131227	0.197679	-1.46065	0.647475	-0.888186	0.41 [0.01 - 18.52]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204242_s_at	82	0.731707	0.0012349	0.0304026	1.08223	0.00694617	2.55457	12.87 [2.01 - 82.22]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204241_at	82	0.402439	0.0165028	0.233607	0.903224	0.0740421	0.502376	1.65 [0.95 - 2.87]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204242_s_at	79	0.139241	0.00320332	0.0664065	-1.01131	0.0999444	-0.994966	0.37 [0.11 - 1.21]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204241_at	79	0.810127	0.372553	-	0.288639	0.839773	-0.0452172	0.96 [0.62 - 1.48]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204241_at	104	0.125	8.69308e-05	0.00309539	-1.43211	0.00412684	-1.05872	0.35 [0.17 - 0.72]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204242_s_at	104	0.115385	0.00299209	0.0628563	-1.20017	0.319394	-0.87376	0.42 [0.07 - 2.33]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P316381	117	0.153846	0.000343324	0.0102637	-1.08077	0.0751325	-0.369403	0.69 [0.46 - 1.04]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P354451	117	0.57265	0.0164447	0.233014	-0.743113	0.121584	-0.31329	0.73 [0.49 - 1.09]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204242_s_at	204	0.245098	0.364723	-	0.440729	0.790189	0.152338	1.16 [0.38 - 3.58]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204242_s_at	204	0.818627	0.0138233	0.205379	0.719374	0.892093	0.0568989	1.06 [0.47 - 2.41]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204241_at	204	0.813725	0.311155	-	-0.538232	0.749862	-0.160177	0.85 [0.32 - 2.28]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204241_at	204	0.166667	0.000267501	0.00827366	-1.02627	0.0174546	-0.914393	0.40 [0.19 - 0.85]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204242_s_at	178	0.831461	0.0098695	0.159871	-0.834964	0.232165	-0.549366	0.58 [0.23 - 1.42]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204241_at	178	0.623595	0.129135	-	0.301441	0.880272	0.0294897	1.03 [0.70 - 1.51]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204242_s_at	111	0.54955	0.00034709	0.0103606	0.944505	0.037721	0.509381	1.66 [1.03 - 2.69]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204241_at	111	0.702703	0.0331051	0.378238	0.584237	0.867107	0.0407373	1.04 [0.65 - 1.68]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204242_s_at	90	0.888889	0.0354437	0.395562	0.855674	0.228081	0.972874	2.65 [0.54 - 12.87]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204242_s_at	90	0.888889	0.0258928	0.320649	0.983354	0.0778269	1.54788	4.70 [0.84 - 26.27]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204241_at	90	0.588889	0.0223874	0.290005	0.730914	0.268747	0.632203	1.88 [0.61 - 5.77]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204241_at	90	0.611111	0.00905714	0.149821	0.950828	0.151594	0.929989	2.53 [0.71 - 9.04]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204241_at	138	0.811594	0.305607	-	0.292759	0.884414	0.0302403	1.03 [0.69 - 1.55]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204242_s_at	138	0.898551	0.168536	-	0.469582	0.803066	0.084751	1.09 [0.56 - 2.12]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204241_at	129	0.116279	0.0493266	0.487569	-0.641261	0.272908	-0.332167	0.72 [0.40 - 1.30]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204242_s_at	129	0.682171	0.0729091	-	-0.534391	0.606084	-0.0821701	0.92 [0.67 - 1.26]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36486	56	0.446429	0.194684	-	0.478754	0.231534	0.455321	1.58 [0.75 - 3.32]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	445	56	0.892857	0.0915302	-	0.896366	0.38364	0.305083	1.36 [0.68 - 2.70]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23315	56	0.892857	0.00236747	0.0519892	1.47888	0.133341	0.567966	1.76 [0.84 - 3.70]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	445	56	0.857143	0.0193427	0.261686	1.16899	0.2473	0.440581	1.55 [0.74 - 3.28]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36486	56	0.446429	0.159612	-	0.497433	0.312894	0.356567	1.43 [0.71 - 2.86]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23315	56	0.892857	0.0211284	0.278501	1.10686	0.257435	0.393945	1.48 [0.75 - 2.93]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204242_s_at	278	0.859712	0.0160826	0.2293	0.576551	0.12211	0.399248	1.49 [0.90 - 2.47]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204241_at	278	0.269784	0.0030862	0.0644452	0.715117	0.0446816	0.333551	1.40 [1.01 - 1.93]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204241_at	133	0.210526	0.0200081	0.268023	-0.621814	0.456743	-0.199747	0.82 [0.48 - 1.39]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204242_s_at	133	0.691729	0.00421584	0.0827052	0.706484	0.628955	0.180591	1.20 [0.58 - 2.49]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10466	81	0.135802	0.0109542	0.172885	-1.31112	0.793363	-0.11408	0.89 [0.38 - 2.09]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4193	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204241_at	185	0.167568	0.0242675	0.306683	0.593985	0.331515	0.212005	1.24 [0.81 - 1.90]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204241_at	185	0.140541	0.0998409	-	0.393665	0.738937	0.0668535	1.07 [0.72 - 1.58]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204242_s_at	185	0.297297	0.137725	-	-0.280691	0.220387	-0.485839	0.62 [0.28 - 1.34]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204242_s_at	185	0.291892	0.145475	-	-0.257201	0.262888	-0.401676	0.67 [0.33 - 1.35]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P316381	110	0.872727	0.0213652	0.280686	0.741852	0.569365	0.114945	1.12 [0.76 - 1.67]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P316381	110	0.190909	0.0447268	0.45894	-0.653433	0.823033	-0.0556974	0.95 [0.58 - 1.54]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204241_at	80	0.7375	0.0391031	0.421518	0.902026	0.351235	0.339597	1.40 [0.69 - 2.87]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204242_s_at	80	0.35	0.00650244	0.116201	1.57178	0.147069	0.338861	1.40 [0.89 - 2.22]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204242_s_at	38	0.710526	0.077115	-	0.931271	0.820575	0.123063	1.13 [0.39 - 3.28]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204241_at	38	0.789474	0.0648412	-	1.01046	0.406185	0.316796	1.37 [0.65 - 2.90]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204242_s_at	140	0.257143	2.34523e-05	0.000963743	-1.16417	0.0031031	-2.69691	0.07 [0.01 - 0.40]
GENE	ACOX3	acyl-CoA oxidase 3, pristanoyl	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204241_at	140	0.364286	0.0102211	0.164138	-0.733669	0.196501	-0.746314	0.47 [0.15 - 1.47]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201629_s_at	30	0.566667	0.173036	-	-0.564547	0.410486	-0.295583	0.74 [0.37 - 1.50]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215227_x_at	30	0.4	0.20448	-	-0.514377	0.58546	-0.224562	0.80 [0.36 - 1.79]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201630_s_at	30	0.433333	0.0511829	-	-0.807211	0.123808	-0.624786	0.54 [0.24 - 1.19]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1669633	165	0.29697	0.215133	-	0.336753	0.768691	0.0440179	1.05 [0.78 - 1.40]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1669633	165	0.369697	0.185407	-	0.516245	0.8043	0.0555422	1.06 [0.68 - 1.64]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201629_s_at	163	0.613497	0.137606	-	0.296575	0.782059	-0.0590962	0.94 [0.62 - 1.43]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201630_s_at	163	0.730061	0.00321456	0.0665938	0.615682	0.148809	0.346976	1.41 [0.88 - 2.27]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215227_x_at	163	0.282209	0.0744954	-	0.420156	0.758497	0.0714106	1.07 [0.68 - 1.69]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215227_x_at	79	0.177215	0.00520495	0.0976788	-0.916904	0.661866	-0.198006	0.82 [0.34 - 1.99]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201630_s_at	79	0.177215	0.094599	-	-0.572188	0.619852	-0.19465	0.82 [0.38 - 1.78]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554808_at	79	0.43038	0.20471	-	-0.370293	0.763802	-0.240093	0.79 [0.16 - 3.77]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201629_s_at	79	0.101266	0.000304605	0.00925722	-1.34557	0.13324	-0.404979	0.67 [0.39 - 1.13]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201630_s_at	58	0.12069	0.000519114	0.0146315	-1.3875	0.143919	-0.934044	0.39 [0.11 - 1.38]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201629_s_at	58	0.344828	0.00626933	0.112955	0.795369	0.0702425	0.208911	1.23 [0.98 - 1.55]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215227_x_at	58	0.189655	0.171357	-	0.480991	0.733873	0.104065	1.11 [0.61 - 2.02]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215227_x_at	34	0.176471	0.174228	-	-0.628858	0.169408	-0.504656	0.60 [0.29 - 1.24]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201630_s_at	34	0.294118	0.0812455	-	0.864608	0.755884	0.175065	1.19 [0.40 - 3.59]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201629_s_at	34	0.176471	0.00596944	0.10873	1.84417	0.470746	0.0918802	1.10 [0.85 - 1.41]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201630_s_at	158	0.721519	0.0349822	0.392191	-0.602224	0.154789	-0.39371	0.67 [0.39 - 1.16]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215227_x_at	158	0.227848	0.000754284	0.0200978	-0.820719	0.0109299	-0.767259	0.46 [0.26 - 0.84]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201629_s_at	158	0.21519	0.00699402	0.122938	-0.675755	0.0482633	-0.556546	0.57 [0.33 - 1.00]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201629_s_at	53	0.886792	0.0119479	0.184437	1.10854	0.445459	0.378678	1.46 [0.55 - 3.86]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215227_x_at	53	0.132075	0.201815	-	-0.57558	0.875887	-0.112711	0.89 [0.22 - 3.68]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215227_x_at	53	0.132075	0.0594367	-	-0.852663	0.926693	-0.0706822	0.93 [0.21 - 4.20]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201630_s_at	53	0.113208	0.244011	-	0.831906	0.644082	-0.397021	0.67 [0.12 - 3.62]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201629_s_at	53	0.754717	0.0223028	0.28924	0.822063	0.408089	0.388252	1.47 [0.59 - 3.70]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201630_s_at	53	0.698113	0.10416	-	-0.680441	0.27028	-0.901358	0.41 [0.08 - 2.02]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215227_x_at	180	0.766667	0.146161	-	0.33179	0.483442	0.212875	1.24 [0.68 - 2.24]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201629_s_at	180	0.522222	0.0857677	-	0.360182	0.37157	0.150787	1.16 [0.84 - 1.62]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201630_s_at	180	0.138889	0.00524274	0.098235	-0.757077	0.941763	0.0310621	1.03 [0.45 - 2.37]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215227_x_at	559	0.830054	0.0013608	0.0329609	0.700016	0.00283076	0.949118	2.58 [1.39 - 4.82]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201630_s_at	559	0.726297	0.0420429	0.441433	-0.489129	0.771777	-0.106293	0.90 [0.44 - 1.84]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554808_at	559	0.615385	0.00287826	0.0609187	0.589329	0.0397597	0.267057	1.31 [1.01 - 1.68]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201629_s_at	559	0.681574	0.0158846	0.227256	0.516768	0.146525	0.321825	1.38 [0.89 - 2.13]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215227_x_at	77	0.87013	0.0114891	0.179145	0.924305	0.265312	0.441714	1.56 [0.71 - 3.38]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201630_s_at	77	0.87013	0.00116191	0.0288958	1.10984	0.0177602	1.61611	5.03 [1.32 - 19.15]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201629_s_at	77	0.766234	4.95251e-05	0.00187995	1.20413	0.0220032	0.480673	1.62 [1.07 - 2.44]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215227_x_at	70	0.885714	0.0577949	-	0.728989	0.692943	-0.156104	0.86 [0.39 - 1.86]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201630_s_at	70	0.685714	0.100113	-	0.455164	0.923532	0.0362291	1.04 [0.49 - 2.17]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554808_at	70	0.271429	0.0646475	-	0.563384	0.284767	1.18497	3.27 [0.37 - 28.68]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201629_s_at	70	0.771429	0.113705	-	0.478987	0.742741	0.0885159	1.09 [0.64 - 1.85]
GENE	ACP1	acid phosphatase 1, soluble	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36611_at	50	0.8	0.0479277	0.479039	0.807853	0.500484	0.38715	1.47 [0.48 - 4.54]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201629_s_at	74	0.108108	0.0947535	-	-0.679403	0.709378	-0.0777899	0.93 [0.61 - 1.39]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215227_x_at	74	0.121622	0.0357349	0.397678	-0.79995	0.967144	0.0276951	1.03 [0.28 - 3.84]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201630_s_at	74	0.351351	0.125362	-	0.48749	0.193194	1.35119	3.86 [0.50 - 29.56]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554808_at	67	0.746269	0.0435972	0.451647	1.28036	0.265187	1.36362	3.91 [0.36 - 43.05]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215227_x_at	67	0.865672	9.11613e-07	4.99622e-05	2.72332	0.00169103	4.12335	61.77 [4.71 - 810.28]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201630_s_at	67	0.865672	3.74818e-07	2.19571e-05	2.8138	0.00161621	4.83291	125.58 [6.23 - 2533.15]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201629_s_at	67	0.865672	4.57113e-07	2.63924e-05	2.87235	0.00213308	3.56062	35.19 [3.63 - 341.41]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215227_x_at	115	0.147826	0.106174	-	15.2744	0.434717	0.585108	1.80 [0.41 - 7.79]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554808_at	115	0.721739	0.00987668	0.159959	1.30236	0.174441	0.813283	2.26 [0.70 - 7.29]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201630_s_at	115	0.347826	0.18955	-	-0.686373	0.552958	-0.610492	0.54 [0.07 - 4.08]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201629_s_at	115	0.86087	0.0783507	-	1.00145	0.665051	0.205088	1.23 [0.49 - 3.11]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36611_at	158	0.139241	0.0154057	0.222271	-0.811679	0.0667904	-0.864474	0.42 [0.17 - 1.06]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36611_at	76	0.894737	0.00725447	0.126451	1.45532	0.0166002	2.44099	11.48 [1.56 - 84.63]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215227_x_at	204	0.519608	0.00123554	0.0304157	0.456099	0.00985036	0.518667	1.68 [1.13 - 2.49]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201630_s_at	204	0.25	0.0600604	-	-0.304777	0.546393	-0.134671	0.87 [0.56 - 1.35]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201629_s_at	204	0.852941	0.0053351	0.0995899	0.55114	0.00472246	0.370627	1.45 [1.12 - 1.87]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554808_at	204	0.882353	0.0637577	-	0.405987	0.963192	-0.00329806	1.00 [0.87 - 1.15]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215227_x_at	87	0.816092	0.0402839	0.429613	0.835276	0.148974	0.621302	1.86 [0.80 - 4.33]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201630_s_at	87	0.666667	0.0124666	0.190337	0.916308	0.158726	0.831298	2.30 [0.72 - 7.30]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215227_x_at	87	0.816092	0.0402839	0.429613	0.835276	0.148974	0.621302	1.86 [0.80 - 4.33]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554808_at	87	0.597701	0.0806518	-	0.651282	0.797187	0.269079	1.31 [0.17 - 10.19]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554808_at	87	0.597701	0.0806518	-	0.651282	0.797187	0.269079	1.31 [0.17 - 10.19]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201629_s_at	87	0.436782	0.0105415	0.167986	1.06978	0.104251	0.440305	1.55 [0.91 - 2.64]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201630_s_at	87	0.666667	0.0124666	0.190337	0.916308	0.158726	0.831298	2.30 [0.72 - 7.30]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201629_s_at	87	0.436782	0.0105415	0.167986	1.06978	0.104251	0.440305	1.55 [0.91 - 2.64]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215227_x_at	77	0.480519	0.199187	-	0.753675	0.626461	0.342863	1.41 [0.35 - 5.60]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201629_s_at	77	0.623377	0.131993	-	0.938817	0.488544	0.448071	1.57 [0.44 - 5.56]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201630_s_at	77	0.415584	0.00197244	0.0447823	-1.79588	0.0801042	-1.17979	0.31 [0.08 - 1.15]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554808_at	77	0.285714	0.0755984	-	1.65449	0.989656	0.0275796	1.03 [0.02 - 66.48]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201629_s_at	77	0.623377	0.198904	-	0.700861	0.671653	0.231721	1.26 [0.43 - 3.68]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215227_x_at	77	0.779221	0.125621	-	0.954933	0.572969	0.456999	1.58 [0.32 - 7.74]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554808_at	77	0.467532	0.117985	-	-1.03258	0.667227	-1.03921	0.35 [0.00 - 40.37]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201630_s_at	77	0.415584	0.0051501	0.0968695	-1.91165	0.206666	-0.985447	0.37 [0.08 - 1.72]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215227_x_at	136	0.294118	0.112559	-	0.959464	0.846525	0.115005	1.12 [0.35 - 3.60]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201629_s_at	136	0.889706	0.174212	-	0.743414	0.68748	0.0905649	1.09 [0.70 - 1.70]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201630_s_at	136	0.602941	0.00944027	0.154595	-1.49316	0.52852	-0.493551	0.61 [0.13 - 2.83]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215227_x_at	200	0.77	0.00447256	0.0866726	0.8351	0.193162	0.654403	1.92 [0.72 - 5.16]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201629_s_at	200	0.22	0.0263596	0.324588	-0.675356	0.3741	-0.254244	0.78 [0.44 - 1.36]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201630_s_at	200	0.14	0.00790282	0.135039	-0.895376	0.0994183	-1.13073	0.32 [0.08 - 1.24]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18314	60	0.8	0.000427213	0.0123851	1.32248	0.407933	0.39143	1.48 [0.59 - 3.74]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4764	60	0.883333	0.160432	-	0.683847	0.459808	0.600038	1.82 [0.37 - 8.95]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1031	60	0.15	0.246302	-	-0.530254	0.548886	-0.533614	0.59 [0.10 - 3.36]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1031	60	0.616667	0.0107932	0.170981	-1.12083	0.294045	-1.19733	0.30 [0.03 - 2.83]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18314	60	0.45	0.106	-	-0.609866	0.164954	-0.621174	0.54 [0.22 - 1.29]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4764	60	0.483333	0.139554	-	-0.555624	0.720191	-0.369194	0.69 [0.09 - 5.21]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	20985	155	0.548387	0.00824698	0.139512	0.728107	0.100048	0.260755	1.30 [0.95 - 1.77]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201629_s_at	286	0.891608	0.117789	-	-0.60146	0.651421	0.0478912	1.05 [0.85 - 1.29]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215227_x_at	286	0.339161	0.140657	-	0.313357	0.67559	0.127999	1.14 [0.62 - 2.07]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201630_s_at	286	0.867133	0.0741906	-	0.447099	0.713742	0.191078	1.21 [0.44 - 3.36]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201629_s_at	159	0.874214	0.000179688	0.00585459	1.25108	0.139886	0.312782	1.37 [0.90 - 2.07]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201630_s_at	159	0.666667	0.134212	-	0.553401	0.9089	0.106991	1.11 [0.18 - 6.96]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215227_x_at	159	0.886792	0.000133052	0.00450149	1.30989	0.00135361	1.38259	3.99 [1.71 - 9.28]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201630_s_at	159	0.396226	0.243365	-	-0.367379	0.789507	-0.21108	0.81 [0.17 - 3.81]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201629_s_at	159	0.855346	1.09429e-05	0.000484768	1.38648	0.00432929	0.655611	1.93 [1.23 - 3.02]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201629_s_at	159	0.874214	4.2468e-07	2.46526e-05	1.72664	0.00855089	0.729135	2.07 [1.20 - 3.57]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201630_s_at	159	0.666667	0.102663	-	0.516494	0.875056	0.124886	1.13 [0.24 - 5.37]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215227_x_at	159	0.698113	3.80805e-06	0.000185654	1.62899	0.000204202	1.82565	6.21 [2.37 - 16.27]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215227_x_at	159	0.698113	0.00117064	0.0290771	0.990055	0.0155586	1.06851	2.91 [1.22 - 6.92]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201630_s_at	54	0.296296	0.0647457	-	15.5297	0.195542	0.855344	2.35 [0.64 - 8.59]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215227_x_at	54	0.703704	0.00416411	0.0818984	2.00151	0.0359131	1.94855	7.02 [1.14 - 43.34]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201629_s_at	54	0.314815	0.0194428	0.262645	15.9135	0.0576501	0.811505	2.25 [0.97 - 5.20]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201630_s_at	117	0.367521	0.126895	-	0.523832	0.424178	0.200562	1.22 [0.75 - 2.00]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201630_s_at	117	0.367521	0.271901	-	0.442266	0.706378	0.108273	1.11 [0.63 - 1.96]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201630_s_at	117	0.452991	0.129601	-	-0.602076	0.655743	-0.125991	0.88 [0.51 - 1.53]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201630_s_at	117	0.367521	0.126895	-	0.523832	0.424178	0.200562	1.22 [0.75 - 2.00]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215227_x_at	117	0.452991	0.0826003	-	-0.550016	0.570858	-0.164885	0.85 [0.48 - 1.50]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215227_x_at	117	0.452991	0.024406	0.307888	-0.862316	0.169008	-0.459705	0.63 [0.33 - 1.22]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215227_x_at	117	0.452991	0.0826003	-	-0.550016	0.570858	-0.164885	0.85 [0.48 - 1.50]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201629_s_at	117	0.897436	0.0489878	0.485517	-1.76684	0.65137	-0.0896822	0.91 [0.62 - 1.35]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215227_x_at	117	0.102564	0.00204998	0.0462204	-1.27569	0.188829	-0.462727	0.63 [0.32 - 1.26]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201629_s_at	117	0.376068	0.15058	-	-0.537172	0.282037	-0.260701	0.77 [0.48 - 1.24]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201629_s_at	117	0.196581	0.0293194	0.348849	-0.873482	0.320829	-0.254236	0.78 [0.47 - 1.28]
GENE	ACP1	acid phosphatase 1, soluble	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201629_s_at	117	0.897436	0.0489878	0.485517	-1.76684	0.65137	-0.0896822	0.91 [0.62 - 1.35]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201629_s_at	236	0.898305	5.81541e-07	3.29817e-05	1.46861	0.0378741	0.386226	1.47 [1.02 - 2.12]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201630_s_at	236	0.101695	0.0492263	0.486962	-0.703185	0.92833	-0.0628244	0.94 [0.24 - 3.69]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215227_x_at	236	0.868644	2.99156e-05	0.00119878	1.19994	0.00598328	1.00695	2.74 [1.33 - 5.61]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201630_s_at	249	0.104418	0.0289133	0.34559	-0.627038	0.68995	-0.222918	0.80 [0.27 - 2.39]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215227_x_at	249	0.86747	3.84325e-06	0.00018722	1.12841	0.00197261	0.972704	2.65 [1.43 - 4.90]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201629_s_at	249	0.899598	3.46196e-05	0.00136608	1.12524	0.0595552	0.267782	1.31 [0.99 - 1.73]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215227_x_at	54	0.351852	0.0463898	0.469485	1.82459	0.476373	0.303704	1.35 [0.59 - 3.13]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201630_s_at	62	0.854839	0.0286876	0.343769	1.1199	0.981398	0.00907249	1.01 [0.47 - 2.16]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201629_s_at	125	0.536	0.0687658	-	0.528086	0.608401	0.0964136	1.10 [0.76 - 1.59]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201630_s_at	125	0.88	0.180879	-	0.611376	0.572768	0.317996	1.37 [0.46 - 4.15]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215227_x_at	125	0.88	0.226443	-	0.433197	0.677831	0.113238	1.12 [0.66 - 1.91]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201629_s_at	54	0.666667	0.00702355	0.123338	1.57685	0.0671787	0.90245	2.47 [0.94 - 6.48]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201630_s_at	125	0.624	0.0398063	0.426355	0.582991	0.611976	0.221485	1.25 [0.53 - 2.94]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201630_s_at	54	0.851852	0.131021	-	0.985124	0.886771	-0.0669073	0.94 [0.37 - 2.35]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215227_x_at	125	0.896	0.284265	-	0.528161	0.998561	0.000627805	1.00 [0.51 - 1.98]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201629_s_at	62	0.774194	0.00351508	0.0715453	1.37729	0.103651	0.642428	1.90 [0.88 - 4.12]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201629_s_at	125	0.544	0.0386395	0.418304	0.797685	0.592509	0.130775	1.14 [0.71 - 1.84]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215227_x_at	62	0.354839	0.0963761	-	1.01255	0.500869	0.236234	1.27 [0.64 - 2.52]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201630_s_at	198	0.560606	0.0029901	0.0628225	-0.828974	0.0906632	-0.578766	0.56 [0.29 - 1.10]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215227_x_at	198	0.126263	0.0389728	0.420617	0.793921	0.625066	0.112341	1.12 [0.71 - 1.76]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201630_s_at	198	0.560606	0.00696762	0.12258	-0.781913	0.287929	-0.379798	0.68 [0.34 - 1.38]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201629_s_at	198	0.111111	0.0530519	-	0.798059	0.465668	0.0966405	1.10 [0.85 - 1.43]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215227_x_at	198	0.141414	0.0507704	-	0.884501	0.603051	0.14631	1.16 [0.67 - 2.01]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215227_x_at	198	0.171717	0.0115222	0.179529	1.23522	0.148636	0.426448	1.53 [0.86 - 2.73]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201630_s_at	198	0.580808	0.0152726	0.220875	-0.538095	0.0588901	-0.564776	0.57 [0.32 - 1.02]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201629_s_at	198	0.474747	0.101242	-	0.422587	0.632262	0.0769986	1.08 [0.79 - 1.48]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201629_s_at	198	0.237374	0.0254728	0.317078	0.835299	0.247041	0.203739	1.23 [0.87 - 1.73]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201629_s_at	62	0.241935	0.0260746	0.322187	15.5733	0.170873	0.557023	1.75 [0.79 - 3.87]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201630_s_at	51	0.137255	0.0747612	-	-1.48712	0.141496	-1.20404	0.30 [0.06 - 1.49]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215227_x_at	62	0.887097	0.0243246	0.30718	1.39776	0.0970086	1.02234	2.78 [0.83 - 9.30]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201630_s_at	62	0.403226	0.168704	-	0.888819	0.801539	0.13527	1.14 [0.40 - 3.29]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215227_x_at	51	0.372549	0.0717054	-	15.838	0.130736	1.61271	5.02 [0.62 - 40.62]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201629_s_at	51	0.313726	0.112761	-	15.6741	0.544475	0.408556	1.50 [0.40 - 5.64]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554808_at	177	0.101695	0.00833144	0.140601	-0.813576	0.0309226	-1.92059	0.15 [0.03 - 0.84]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554808_at	177	0.101695	0.00133832	0.0325076	-1.0396	0.183156	-1.33204	0.26 [0.04 - 1.88]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201629_s_at	177	0.59322	0.047123	0.474063	-0.491496	0.742154	-0.0734723	0.93 [0.60 - 1.44]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201630_s_at	145	0.758621	0.0287276	0.344092	-1.23726	0.113839	-0.92387	0.40 [0.13 - 1.25]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554808_at	145	0.834483	0.232121	-	-0.623964	0.62891	-0.580209	0.56 [0.05 - 5.89]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201629_s_at	145	0.751724	0.00291835	0.061603	-1.87894	0.259356	-0.333026	0.72 [0.40 - 1.28]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215227_x_at	177	0.881356	0.0270108	0.330029	-1.9224	0.972744	-0.0155479	0.98 [0.40 - 2.40]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201630_s_at	177	0.655367	0.0302837	0.356502	-0.697287	0.110662	-0.752367	0.47 [0.19 - 1.19]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215227_x_at	177	0.881356	0.113634	-	-0.793324	0.796642	0.102053	1.11 [0.51 - 2.41]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215227_x_at	145	0.758621	0.00875818	0.146051	-1.69854	0.313283	-0.536125	0.59 [0.21 - 1.66]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201629_s_at	177	0.581921	0.00753246	0.13016	-0.791664	0.276405	-0.27086	0.76 [0.47 - 1.24]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201630_s_at	177	0.779661	0.0442649	0.455971	-0.703656	0.178261	-0.548931	0.58 [0.26 - 1.28]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201630_s_at	226	0.672566	0.0438452	0.453258	-0.698244	0.422959	-0.36569	0.69 [0.28 - 1.70]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554808_at	226	0.234513	0.22697	-	0.462527	0.6523	0.0616934	1.06 [0.81 - 1.39]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201629_s_at	226	0.69469	0.00760833	0.131166	-0.989875	0.167308	-0.349915	0.70 [0.43 - 1.16]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215227_x_at	226	0.787611	0.0171792	0.240455	-1.17402	0.338636	-0.377953	0.69 [0.32 - 1.49]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201630_s_at	49	0.44898	0.0184554	0.253098	1.65301	0.0709208	1.27941	3.59 [0.90 - 14.41]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201629_s_at	55	0.509091	0.0051393	0.0967099	1.46656	0.00836577	1.55651	4.74 [1.49 - 15.08]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201629_s_at	49	0.469388	0.0235891	0.300731	1.5994	0.0645108	1.37699	3.96 [0.92 - 17.06]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554808_at	55	0.163636	0.0269659	0.329656	-1.24169	0.106265	-3.78485	0.02 [0.00 - 2.24]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215227_x_at	55	0.745455	0.000272138	0.00839769	1.5154	0.00264636	1.76367	5.83 [1.85 - 18.42]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554808_at	49	0.163265	3.75983e-06	0.000183505	-2.45098	0.165511	-3.9068	0.02 [0.00 - 5.03]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201630_s_at	55	0.418182	0.0113884	0.177974	1.3238	0.0677343	0.957679	2.61 [0.93 - 7.28]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215227_x_at	55	0.745455	8.44163e-05	0.0030162	1.76087	0.000241675	2.15686	8.64 [2.73 - 27.34]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215227_x_at	49	0.897959	2.23392e-06	0.000113949	2.78625	0.0011694	3.86266	47.59 [4.62 - 490.22]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554808_at	55	0.163636	0.000189691	0.00613779	-1.60076	0.0867969	-3.74037	0.02 [0.00 - 1.72]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201630_s_at	55	0.254545	0.0244881	0.308602	1.97016	0.0338272	1.18476	3.27 [1.09 - 9.77]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201629_s_at	55	0.490909	0.00635744	0.114186	1.32167	0.0595698	0.979896	2.66 [0.96 - 7.38]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554808_at	63	0.269841	0.00249639	0.0542814	-1.02723	0.18972	-7.65363	0.00 [0.00 - 44.05]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201629_s_at	63	0.84127	0.0365151	0.403303	0.827766	0.073898	0.479117	1.61 [0.95 - 2.73]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215227_x_at	63	0.603175	0.0299288	0.353699	0.720334	0.298449	0.349042	1.42 [0.73 - 2.74]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201630_s_at	63	0.380952	0.0803811	-	-0.585073	0.618454	-0.127842	0.88 [0.53 - 1.46]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.75393.0.S1_3p_a_at	28	0.428571	0.00886364	0.147385	1.80546	0.604497	0.0927109	1.10 [0.77 - 1.56]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.75393.3.S1_3p_at	28	0.321429	0.0691516	-	-1.03791	0.487372	-2.66752	0.07 [0.00 - 129.12]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4757713_3p_a_at	28	0.892857	0.0598975	-	1.22538	0.599059	0.155194	1.17 [0.65 - 2.08]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215227_x_at	82	0.195122	0.114111	-	0.819891	0.194345	0.540401	1.72 [0.76 - 3.88]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201629_s_at	82	0.560976	0.108706	-	0.543732	0.215008	0.300619	1.35 [0.84 - 2.17]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201630_s_at	82	0.878049	0.220543	-	-0.86499	0.804733	0.0972984	1.10 [0.51 - 2.38]
GENE	ACP1	acid phosphatase 1, soluble	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36611_at	84	0.702381	0.0223323	0.289507	0.666017	0.799237	0.135536	1.15 [0.40 - 3.25]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201629_s_at	79	0.886076	0.00290541	0.0613824	1.08352	0.552613	0.142079	1.15 [0.72 - 1.84]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215227_x_at	79	0.886076	0.00223914	0.0496796	1.10962	0.523297	0.312465	1.37 [0.52 - 3.57]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201630_s_at	79	0.886076	0.00115577	0.0287683	1.15804	0.842035	-0.115158	0.89 [0.29 - 2.77]
GENE	ACP1	acid phosphatase 1, soluble	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U25849_at	86	0.872093	0.0263885	0.324831	1.00829	0.417685	0.355397	1.43 [0.60 - 3.37]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215227_x_at	104	0.884615	0.00456947	0.0881548	1.08066	0.0214198	1.03421	2.81 [1.17 - 6.79]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201629_s_at	104	0.807692	0.00339691	0.0696111	0.992139	0.046102	0.445868	1.56 [1.01 - 2.42]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201630_s_at	104	0.817308	0.0106018	0.168706	0.893742	0.0743877	0.946352	2.58 [0.91 - 7.29]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P56798	117	0.74359	0.00141228	0.033993	0.908476	0.000581732	1.18252	3.26 [1.66 - 6.40]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215227_x_at	204	0.661765	1.74268e-05	0.00073788	1.5163	0.00110677	1.17963	3.25 [1.60 - 6.61]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215227_x_at	204	0.598039	2.37989e-07	1.44012e-05	1.40072	8.02383e-06	1.18747	3.28 [1.95 - 5.52]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201630_s_at	204	0.166667	0.287832	-	-0.456153	0.829159	-0.170775	0.84 [0.18 - 3.98]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201630_s_at	204	0.245098	0.140255	-	0.532431	0.898163	0.0750499	1.08 [0.34 - 3.40]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201629_s_at	204	0.769608	0.00205602	0.0463318	1.0844	0.0115306	1.04624	2.85 [1.26 - 6.41]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201629_s_at	204	0.769608	0.000161584	0.00533611	1.01459	0.0013552	1.01017	2.75 [1.48 - 5.09]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554808_at	204	0.323529	0.038433	0.416865	-0.739065	0.563068	-0.165548	0.85 [0.48 - 1.49]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554808_at	204	0.70098	0.0180914	0.249528	-0.838707	0.432057	-0.168251	0.85 [0.56 - 1.29]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201629_s_at	178	0.129213	0.105404	-	-0.441546	0.816481	0.040216	1.04 [0.74 - 1.46]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201630_s_at	178	0.410112	0.209675	-	0.257856	0.353567	0.312425	1.37 [0.71 - 2.64]
GENE	ACP1	acid phosphatase 1, soluble	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215227_x_at	178	0.758427	0.0383219	0.41609	0.438626	0.344751	0.279854	1.32 [0.74 - 2.36]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215227_x_at	111	0.198198	0.0289266	0.345697	0.911553	0.131164	0.398794	1.49 [0.89 - 2.50]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554808_at	111	0.18018	0.0535262	-	0.809574	0.444829	0.0952342	1.10 [0.86 - 1.40]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201630_s_at	111	0.54955	0.239658	-	0.307757	0.670256	0.184294	1.20 [0.51 - 2.81]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201629_s_at	111	0.171171	0.0221172	0.287559	1.02549	0.178107	0.209841	1.23 [0.91 - 1.67]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201629_s_at	90	0.855556	0.0367447	0.404946	0.781252	0.93246	0.0242504	1.02 [0.58 - 1.80]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201629_s_at	90	0.855556	0.0767549	-	0.752605	0.68946	0.130751	1.14 [0.60 - 2.16]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201630_s_at	90	0.444444	0.0826861	-	0.597032	0.636075	0.134601	1.14 [0.66 - 2.00]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201630_s_at	90	0.611111	0.0226303	0.292192	0.828948	0.260903	0.360307	1.43 [0.77 - 2.69]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215227_x_at	90	0.7	0.0762803	-	0.657654	0.445434	0.250459	1.28 [0.68 - 2.44]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215227_x_at	90	0.7	0.0759117	-	0.581809	0.62273	0.139783	1.15 [0.66 - 2.01]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215227_x_at	138	0.710145	0.00397847	0.0789814	0.702317	0.0838898	0.241061	1.27 [0.97 - 1.67]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554808_at	138	0.876812	0.0247031	0.310465	-1.10207	0.12647	-5.72152	0.00 [0.00 - 5.04]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201630_s_at	138	0.333333	0.0653455	-	0.500589	0.540996	0.106183	1.11 [0.79 - 1.56]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201629_s_at	138	0.23913	0.0309603	0.361801	0.696119	0.107572	0.1734	1.19 [0.96 - 1.47]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215227_x_at	129	0.829457	0.150612	-	-0.513434	0.94668	0.0208837	1.02 [0.55 - 1.88]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201629_s_at	129	0.170543	0.378041	-	-0.272106	0.841683	0.0367721	1.04 [0.72 - 1.49]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201630_s_at	129	0.565891	0.0691017	-	0.460284	0.496043	0.40155	1.49 [0.47 - 4.75]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19898	56	0.214286	0.00800917	0.136428	-1.08226	0.849487	-0.0811755	0.92 [0.40 - 2.13]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19898	56	0.214286	0.0448365	0.459643	-0.807863	0.94711	-0.0264209	0.97 [0.45 - 2.13]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201629_s_at	278	0.741007	0.0203827	0.271552	-0.547141	0.550059	-0.0794707	0.92 [0.71 - 1.20]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554808_at	278	0.651079	0.0131613	0.198107	-0.515783	0.203804	-0.558508	0.57 [0.24 - 1.35]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215227_x_at	278	0.100719	0.00408585	0.0806728	-0.746836	0.141075	-0.28327	0.75 [0.52 - 1.10]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201630_s_at	278	0.571942	0.0141527	0.208951	-0.48585	0.183234	-0.263609	0.77 [0.52 - 1.13]
GENE	ACP1	acid phosphatase 1, soluble	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201630_s_at	133	0.819549	0.0224779	0.290821	0.65423	0.340667	0.156132	1.17 [0.85 - 1.61]
GENE	ACP1	acid phosphatase 1, soluble	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215227_x_at	133	0.781955	0.206704	-	0.354919	0.971773	-0.00640805	0.99 [0.70 - 1.42]
GENE	ACP1	acid phosphatase 1, soluble	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201629_s_at	133	0.887218	0.069563	-	0.658995	0.509547	0.077957	1.08 [0.86 - 1.36]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5157	81	0.876543	0.020942	0.276774	1.28204	0.0329428	1.41574	4.12 [1.12 - 15.13]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7399	81	0.703704	0.206176	-	0.647854	0.786717	-0.151362	0.86 [0.29 - 2.57]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201629_s_at	185	0.356757	0.00477177	0.0912227	-0.501235	0.277438	-0.117658	0.89 [0.72 - 1.10]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215227_x_at	185	0.178378	0.0242127	0.306204	-0.474434	0.468233	-0.0810967	0.92 [0.74 - 1.15]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201630_s_at	185	0.67027	0.085621	-	-0.30417	0.479611	-0.0743853	0.93 [0.76 - 1.14]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215227_x_at	185	0.178378	0.00324256	0.0670599	-0.63649	0.233709	-0.144131	0.87 [0.68 - 1.10]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201629_s_at	185	0.4	0.0126119	0.191974	-0.409163	0.450735	-0.0753866	0.93 [0.76 - 1.13]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201630_s_at	185	0.67027	0.228157	-	-0.229423	0.65958	-0.0504618	0.95 [0.76 - 1.19]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P922919	110	0.245455	0.00156754	0.0370609	0.977142	0.163143	0.196047	1.22 [0.92 - 1.60]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P56798	110	0.272727	0.127261	-	0.528397	0.670093	0.104338	1.11 [0.69 - 1.79]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P922919	110	0.363636	0.00593503	0.108241	0.925309	0.0542433	0.313511	1.37 [0.99 - 1.88]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P56798	110	0.2	0.108252	-	-0.424123	0.455847	-0.138964	0.87 [0.60 - 1.25]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201629_s_at	80	0.125	0.0409161	0.433893	15.3179	0.0946163	0.292726	1.34 [0.95 - 1.89]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215227_x_at	80	0.8875	0.0105216	0.167748	1.45101	0.0704768	0.646856	1.91 [0.95 - 3.85]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201630_s_at	80	0.2375	0.0881724	-	-0.754241	0.691778	0.21762	1.24 [0.42 - 3.65]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_4234	281	0.879004	0.141408	-	0.306266	0.820538	0.0289859	1.03 [0.80 - 1.32]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201630_s_at	38	0.815789	0.0206506	0.274061	1.27911	0.0467086	1.62411	5.07 [1.02 - 25.14]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201629_s_at	38	0.263158	0.000925369	0.0238781	2.76506	0.00329307	1.33644	3.81 [1.56 - 9.28]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215227_x_at	38	0.868421	1.04556e-05	0.000465187	2.30169	0.00251344	2.40615	11.09 [2.33 - 52.82]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554808_at	38	0.184211	0.0242416	0.306457	2.0287	0.0722615	0.627182	1.87 [0.94 - 3.71]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201629_s_at	140	0.864286	0.0127612	0.19365	0.834631	0.685479	0.13714	1.15 [0.59 - 2.23]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201630_s_at	140	0.507143	0.00305306	0.063887	-0.899033	0.0856839	-0.628805	0.53 [0.26 - 1.09]
GENE	ACP1	acid phosphatase 1, soluble	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215227_x_at	140	0.842857	0.0131927	0.198455	0.80553	0.0728221	0.744151	2.10 [0.93 - 4.75]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202767_at	30	0.266667	0.202528	-	-0.555664	0.874897	-0.0823557	0.92 [0.33 - 2.57]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1804815	165	0.606061	0.000239185	0.00750891	-0.995823	0.510975	-0.148122	0.86 [0.55 - 1.34]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1804815	165	0.884848	0.0062724	0.112998	1.06632	0.234052	0.418097	1.52 [0.76 - 3.02]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202767_at	163	0.521472	0.106478	-	0.318077	0.528881	0.168605	1.18 [0.70 - 2.00]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202767_at	79	0.481013	0.056775	-	0.561248	0.833226	0.0625382	1.06 [0.59 - 1.91]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202767_at	58	0.482759	0.0564872	-	0.519056	0.568638	0.231191	1.26 [0.57 - 2.79]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202767_at	34	0.852941	0.0913229	-	-1.00488	0.40393	-0.326728	0.72 [0.33 - 1.55]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202767_at	158	0.246835	0.0264759	0.325564	-0.557871	0.195191	-0.335212	0.72 [0.43 - 1.19]
GENE	ACP2	acid phosphatase 2, lysosomal	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202767_at	53	0.830189	0.237447	-	-0.625772	0.566563	-0.226136	0.80 [0.37 - 1.73]
GENE	ACP2	acid phosphatase 2, lysosomal	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202767_at	53	0.716981	0.240576	-	-0.470833	0.602383	-0.195355	0.82 [0.39 - 1.72]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202767_at	180	0.677778	0.00099102	0.0252931	0.687948	0.0481203	0.599805	1.82 [1.00 - 3.30]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202767_at	559	0.302326	0.00633621	0.11389	-0.543518	0.0556459	-0.516256	0.60 [0.35 - 1.01]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202767_at	77	0.649351	0.0115996	0.180426	-0.699758	0.363216	-0.338557	0.71 [0.34 - 1.48]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202767_at	70	0.557143	0.15989	-	-0.377702	0.700983	-0.146294	0.86 [0.41 - 1.82]
GENE	ACP2	acid phosphatase 2, lysosomal	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36651_at	50	0.62	0.0433174	0.449824	0.70375	0.106366	0.81302	2.25 [0.84 - 6.05]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202767_at	74	0.783784	0.377493	-	0.294177	0.762163	0.159878	1.17 [0.42 - 3.30]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202767_at	67	0.208955	0.110519	-	15.4133	0.869068	0.210748	1.23 [0.10 - 15.13]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202767_at	115	0.286957	0.066347	-	-0.948441	0.16945	-1.00261	0.37 [0.09 - 1.53]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36651_at	158	0.575949	0.0769897	-	0.496134	0.780065	0.120598	1.13 [0.48 - 2.63]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36651_at	76	0.118421	0.1234	-	15.239	0.806897	-0.165856	0.85 [0.22 - 3.20]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202767_at	204	0.171569	0.0965336	-	-0.304876	0.910359	0.0203049	1.02 [0.72 - 1.45]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202767_at	87	0.16092	0.0132741	0.199355	-1.05074	0.284275	-0.375235	0.69 [0.35 - 1.37]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202767_at	87	0.16092	0.0132741	0.199355	-1.05074	0.284275	-0.375235	0.69 [0.35 - 1.37]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202767_at	77	0.74026	0.246199	-	0.733282	0.885445	-0.0999187	0.90 [0.23 - 3.52]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202767_at	77	0.558442	0.157897	-	0.785129	0.91703	-0.063978	0.94 [0.28 - 3.13]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202767_at	136	0.397059	0.0362632	0.401494	-0.952541	0.185244	-0.942145	0.39 [0.10 - 1.57]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202767_at	200	0.38	0.0661401	-	0.595995	0.751439	0.160927	1.17 [0.43 - 3.18]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9911	60	0.883333	0.228436	-	0.586167	0.980363	0.00643716	1.01 [0.60 - 1.68]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9911	60	0.416667	0.0755523	-	0.725885	0.334311	0.290301	1.34 [0.74 - 2.41]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1979	155	0.8	0.0565641	-	0.578173	0.395135	0.185158	1.20 [0.79 - 1.84]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202767_at	286	0.188811	0.0130599	0.196982	-0.539968	0.449787	-0.284112	0.75 [0.36 - 1.57]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202767_at	159	0.163522	0.010688	0.169733	-0.878002	0.280521	-0.755229	0.47 [0.12 - 1.85]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202767_at	159	0.899371	0.0123834	0.189396	0.954121	0.433962	0.523449	1.69 [0.45 - 6.26]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202767_at	159	0.144654	0.0116948	0.181526	-1.00652	0.708556	-0.303365	0.74 [0.15 - 3.62]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202767_at	54	0.166667	0.0861275	-	15.5428	0.782572	0.139393	1.15 [0.43 - 3.09]
GENE	ACP2	acid phosphatase 2, lysosomal	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202767_at	117	0.74359	0.219187	-	0.414984	0.743912	0.0957081	1.10 [0.62 - 1.95]
GENE	ACP2	acid phosphatase 2, lysosomal	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202767_at	117	0.264957	0.0400987	0.428352	-0.775983	0.519494	-0.224867	0.80 [0.40 - 1.58]
GENE	ACP2	acid phosphatase 2, lysosomal	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202767_at	117	0.264957	0.235079	-	-0.486497	0.598656	-0.191583	0.83 [0.40 - 1.69]
GENE	ACP2	acid phosphatase 2, lysosomal	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202767_at	117	0.74359	0.219187	-	0.414984	0.743912	0.0957081	1.10 [0.62 - 1.95]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202767_at	236	0.648305	0.014896	0.216901	0.647005	0.0889062	0.830354	2.29 [0.88 - 5.97]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202767_at	249	0.654619	0.00240662	0.0526883	0.639293	0.0806614	0.691307	2.00 [0.92 - 4.34]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202767_at	125	0.112	0.0467544	0.471766	1.77221	0.655029	0.125387	1.13 [0.65 - 1.96]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202767_at	54	0.166667	0.183061	-	-0.868285	0.67355	-0.174829	0.84 [0.37 - 1.89]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202767_at	62	0.612903	0.115635	-	-0.788946	0.441421	-0.253898	0.78 [0.41 - 1.48]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202767_at	125	0.112	0.160206	-	1.33185	0.824057	0.0800872	1.08 [0.53 - 2.19]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202767_at	198	0.121212	0.138849	-	0.542963	0.655843	0.0941832	1.10 [0.73 - 1.66]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202767_at	198	0.106061	0.163279	-	0.70935	0.828037	0.0550289	1.06 [0.64 - 1.74]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202767_at	198	0.106061	0.144747	-	0.841356	0.748955	-0.0858979	0.92 [0.54 - 1.55]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202767_at	62	0.145161	0.156763	-	15.2533	0.805818	0.253143	1.29 [0.17 - 9.69]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202767_at	51	0.254902	0.0640135	-	-1.5363	0.520428	-1.09339	0.34 [0.01 - 9.40]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202767_at	177	0.175141	0.259494	-	-0.380551	0.886698	0.074868	1.08 [0.38 - 3.02]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202767_at	177	0.180791	0.0995821	-	-0.465056	0.898242	-0.058674	0.94 [0.38 - 2.32]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202767_at	145	0.682759	0.00647367	0.115802	0.883379	0.0163922	1.40826	4.09 [1.29 - 12.91]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202767_at	226	0.761062	0.128821	-	-0.580718	0.691266	0.130529	1.14 [0.60 - 2.17]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202767_at	55	0.709091	0.142197	-	0.659328	0.909987	0.0890673	1.09 [0.23 - 5.12]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202767_at	55	0.2	0.0566374	-	-0.976487	0.249369	-0.966407	0.38 [0.07 - 1.97]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202767_at	49	0.367347	0.0470588	0.473664	-1.15457	0.141614	-1.24922	0.29 [0.05 - 1.52]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202767_at	63	0.222222	0.0382621	0.415671	1.05712	0.0735435	0.374034	1.45 [0.96 - 2.19]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557009_3p_at	28	0.892857	0.0878875	-	1.12586	0.371795	0.351063	1.42 [0.66 - 3.07]
GENE	ACP2	acid phosphatase 2, lysosomal	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202767_at	82	0.146341	0.108205	-	-0.677261	0.494966	-0.389168	0.68 [0.22 - 2.07]
GENE	ACP2	acid phosphatase 2, lysosomal	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36651_at	84	0.511905	0.0409298	0.433986	0.589216	0.413471	0.275734	1.32 [0.68 - 2.55]
GENE	ACP2	acid phosphatase 2, lysosomal	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202767_at	79	0.303797	0.193552	-	-0.352081	0.760501	-0.121054	0.89 [0.41 - 1.93]
GENE	ACP2	acid phosphatase 2, lysosomal	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X15525_rna1_at	86	0.848837	0.129129	-	-1.08465	0.693098	-0.225134	0.80 [0.26 - 2.44]
GENE	ACP2	acid phosphatase 2, lysosomal	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202767_at	104	0.817308	0.127376	-	-0.785213	0.43605	-0.351318	0.70 [0.29 - 1.70]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P138782	117	0.82906	0.0318018	0.368315	0.700424	0.970955	0.00676776	1.01 [0.70 - 1.45]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P138776	117	0.205128	0.00337353	0.0692264	-0.868589	0.379713	-0.217456	0.80 [0.50 - 1.31]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202767_at	204	0.382353	0.000102159	0.00356881	2.30292	0.000723529	1.95881	7.09 [2.28 - 22.08]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202767_at	204	0.377451	3.79433e-07	2.22077e-05	2.02471	8.42617e-06	1.86897	6.48 [2.85 - 14.75]
GENE	ACP2	acid phosphatase 2, lysosomal	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202767_at	178	0.101124	0.291685	-	0.36684	0.890609	0.0448716	1.05 [0.55 - 1.98]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202767_at	111	0.684685	0.0291433	0.347438	0.581391	0.150263	0.497088	1.64 [0.84 - 3.24]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202767_at	90	0.111111	0.122963	-	-0.676401	0.858177	0.0724397	1.08 [0.49 - 2.38]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202767_at	90	0.111111	0.120672	-	-0.748444	0.987947	-0.00693411	0.99 [0.40 - 2.44]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202767_at	138	0.898551	0.00294314	0.0620252	0.918422	0.0967413	0.345451	1.41 [0.94 - 2.12]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202767_at	129	0.44186	0.110298	-	-0.392217	0.972114	-0.0168131	0.98 [0.38 - 2.52]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19642	56	0.589286	0.292185	-	-0.380532	0.84768	-0.0713094	0.93 [0.45 - 1.93]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19642	56	0.660714	0.122685	-	-0.62792	0.362552	-0.366955	0.69 [0.31 - 1.53]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202767_at	278	0.104317	0.09602	-	0.686049	0.564157	0.0972198	1.10 [0.79 - 1.53]
GENE	ACP2	acid phosphatase 2, lysosomal	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202767_at	133	0.120301	0.00141558	0.0340589	-1.00668	0.0228356	-0.397969	0.67 [0.48 - 0.95]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4872	81	0.209877	0.0936122	-	-0.86118	0.760399	-0.153828	0.86 [0.32 - 2.30]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8919	81	0.703704	0.126121	-	-1.11372	0.344917	-0.530469	0.59 [0.20 - 1.77]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202767_at	185	0.108108	0.0274375	0.333562	-0.537493	0.322569	-0.197176	0.82 [0.56 - 1.21]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202767_at	185	0.172973	0.0159341	0.227767	-0.518172	0.242531	-0.257836	0.77 [0.50 - 1.19]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P138782	110	0.536364	0.109929	-	0.364494	0.511612	0.116027	1.12 [0.79 - 1.59]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P138776	110	0.518182	0.0243698	0.307574	0.517768	0.180885	0.311189	1.37 [0.87 - 2.15]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P138782	110	0.363636	0.388376	-	0.278785	0.807155	-0.0538563	0.95 [0.61 - 1.46]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P138776	110	0.590909	0.0748555	-	0.530506	0.698014	0.114525	1.12 [0.63 - 2.00]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202767_at	80	0.85	0.295146	-	-0.762332	0.844906	-0.137706	0.87 [0.22 - 3.46]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_2966	281	0.790036	0.00401978	0.0796335	-0.535662	0.30018	-0.0977689	0.91 [0.75 - 1.09]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202767_at	38	0.289474	0.311786	-	0.53451	0.678397	0.20907	1.23 [0.46 - 3.31]
GENE	ACP2	acid phosphatase 2, lysosomal	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202767_at	140	0.107143	0.320742	-	-0.405547	0.903327	-0.0467732	0.95 [0.45 - 2.03]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201963_at	30	0.133333	0.00259321	0.0559851	-1.63717	0.520193	-0.176139	0.84 [0.49 - 1.43]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207275_s_at	30	0.133333	0.00153217	0.0363677	-1.68147	0.80755	-0.0728564	0.93 [0.52 - 1.67]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1684585	165	0.854545	0.000654616	0.0178243	0.909163	0.0494574	0.242049	1.27 [1.00 - 1.62]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1684585	165	0.290909	0.131572	-	0.670905	0.565957	0.10468	1.11 [0.78 - 1.59]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201963_at	163	0.116564	0.0144564	0.212217	0.925662	0.863605	0.0161887	1.02 [0.84 - 1.22]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207275_s_at	163	0.625767	0.0400448	0.427985	-0.438977	0.359845	-0.0926571	0.91 [0.75 - 1.11]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201963_at	79	0.139241	0.0133521	0.200216	1.61241	0.0558987	0.309163	1.36 [0.99 - 1.87]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207275_s_at	79	0.101266	0.013914	0.206365	2.08927	0.191628	0.181663	1.20 [0.91 - 1.58]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207275_s_at	58	0.844828	0.0147625	0.215484	0.904386	0.0800858	0.428833	1.54 [0.95 - 2.48]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201963_at	58	0.103448	0.112761	-	0.685111	0.223831	0.196237	1.22 [0.89 - 1.67]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207275_s_at	34	0.117647	0.0597197	-	-1.00833	0.471265	-0.181621	0.83 [0.51 - 1.37]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201963_at	34	0.205882	0.110072	-	0.860374	0.636273	-0.130331	0.88 [0.51 - 1.51]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207275_s_at	158	0.43038	0.213932	-	-0.286285	0.982028	0.0047049	1.00 [0.67 - 1.51]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201963_at	158	0.202532	0.298533	-	-0.286792	0.978228	-0.00408021	1.00 [0.74 - 1.34]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201963_at	53	0.867925	0.0628641	-	0.829837	0.647145	0.128275	1.14 [0.66 - 1.97]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207275_s_at	53	0.849057	0.0550754	-	0.812009	0.554052	0.181536	1.20 [0.66 - 2.19]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201963_at	53	0.867925	0.0194275	0.262499	0.982022	0.485373	0.186378	1.20 [0.71 - 2.03]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207275_s_at	53	0.849057	0.0132961	0.199597	0.996335	0.332132	0.284711	1.33 [0.75 - 2.36]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201963_at	180	0.522222	0.162801	-	0.29153	0.449864	0.164678	1.18 [0.77 - 1.81]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207275_s_at	180	0.788889	0.149084	-	0.347985	0.728188	0.0747561	1.08 [0.71 - 1.64]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207275_s_at	559	0.255814	0.071581	-	-0.381163	0.955539	-0.00855295	0.99 [0.73 - 1.34]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201963_at	559	0.72093	0.236261	-	-0.280606	0.734421	0.0359912	1.04 [0.84 - 1.28]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207275_s_at	77	0.753247	0.161344	-	-0.428078	0.954263	-0.0115659	0.99 [0.67 - 1.47]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201963_at	77	0.350649	0.0729738	-	0.493619	0.691863	0.0767401	1.08 [0.74 - 1.58]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201963_at	70	0.7	0.110665	-	-0.479272	0.466065	-0.113122	0.89 [0.66 - 1.21]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207275_s_at	70	0.457143	0.20847	-	-0.327351	0.791745	-0.0443989	0.96 [0.69 - 1.33]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40082_at	50	0.5	0.0119797	0.184801	0.920021	0.0016532	0.961957	2.62 [1.44 - 4.76]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201963_at	74	0.324324	0.00201106	0.0455001	1.03269	0.00593668	0.697123	2.01 [1.22 - 3.30]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207275_s_at	74	0.594595	0.0127482	0.193504	0.713839	0.0336356	0.530658	1.70 [1.04 - 2.77]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207275_s_at	67	0.776119	0.0527174	-	1.24342	0.370727	0.63528	1.89 [0.47 - 7.59]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201963_at	67	0.358209	0.133105	-	1.46859	0.431897	0.548113	1.73 [0.44 - 6.79]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207275_s_at	115	0.617391	0.031286	0.364333	1.13671	0.15549	0.562165	1.75 [0.81 - 3.81]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201963_at	115	0.817391	0.00760108	0.13107	1.33545	0.308	0.442897	1.56 [0.66 - 3.65]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40082_at	158	0.879747	0.0818494	-	0.661573	0.228515	0.219235	1.25 [0.87 - 1.78]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40082_at	76	0.407895	0.0266435	0.326968	-1.15198	0.176462	-0.542463	0.58 [0.26 - 1.28]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201963_at	204	0.651961	0.00345997	0.0706453	0.434421	0.0635149	0.219937	1.25 [0.99 - 1.57]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207275_s_at	204	0.539216	0.00834096	0.140723	0.382282	0.22412	0.134058	1.14 [0.92 - 1.42]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207275_s_at	87	0.678161	0.181506	-	0.515825	0.901594	-0.0266173	0.97 [0.64 - 1.48]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207275_s_at	87	0.678161	0.181506	-	0.515825	0.901594	-0.0266173	0.97 [0.64 - 1.48]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201963_at	87	0.563218	0.0410467	0.434773	0.76723	0.934271	-0.0168972	0.98 [0.66 - 1.47]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201963_at	87	0.563218	0.0410467	0.434773	0.76723	0.934271	-0.0168972	0.98 [0.66 - 1.47]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207275_s_at	77	0.207792	0.00381833	0.0764374	-1.65001	0.201129	-0.542948	0.58 [0.25 - 1.34]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201963_at	77	0.103896	0.00325974	0.0673452	-1.60021	0.231975	-0.411292	0.66 [0.34 - 1.30]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201963_at	77	0.103896	0.000148645	0.00496044	-2.07725	0.172455	-0.551997	0.58 [0.26 - 1.27]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207275_s_at	77	0.207792	0.00501084	0.0948042	-1.4417	0.217509	-0.441739	0.64 [0.32 - 1.30]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201963_at	136	0.227941	0.203206	-	-0.629182	0.685294	-0.124082	0.88 [0.48 - 1.61]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207275_s_at	136	0.691176	0.144969	-	-0.804755	0.561145	-0.177877	0.84 [0.46 - 1.53]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201963_at	200	0.17	0.0508583	-	1.10829	0.593615	0.139335	1.15 [0.69 - 1.92]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207275_s_at	200	0.18	0.176483	-	0.630677	0.861844	-0.038587	0.96 [0.62 - 1.49]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13529	60	0.233333	0.424468	-	-0.351225	0.768877	0.153432	1.17 [0.42 - 3.24]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7992	60	0.883333	0.0116765	0.181316	1.14115	0.181832	0.148164	1.16 [0.93 - 1.44]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13529	60	0.45	0.325173	-	0.378867	0.432655	0.377407	1.46 [0.57 - 3.74]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7992	60	0.816667	0.00189281	0.0432929	1.24395	0.282807	0.211624	1.24 [0.84 - 1.82]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201963_at	286	0.13986	0.070054	-	0.592147	0.163538	0.215172	1.24 [0.92 - 1.68]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207275_s_at	286	0.636364	0.140064	-	-0.307606	0.978119	0.00392401	1.00 [0.76 - 1.33]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201963_at	159	0.238994	0.0576026	-	-0.619906	0.60828	-0.12271	0.88 [0.55 - 1.41]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207275_s_at	159	0.830189	0.0634716	-	0.753323	0.576382	0.168295	1.18 [0.66 - 2.14]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207275_s_at	159	0.823899	0.107999	-	0.578977	0.655783	0.11515	1.12 [0.68 - 1.86]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201963_at	159	0.238994	0.0613122	-	-0.611317	0.352585	-0.222846	0.80 [0.50 - 1.28]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201963_at	159	0.238994	0.0437167	0.452424	-0.75446	0.730224	-0.0969729	0.91 [0.52 - 1.57]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207275_s_at	159	0.477987	0.183265	-	-0.422524	0.917274	-0.027808	0.97 [0.58 - 1.64]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207275_s_at	54	0.611111	0.00158428	0.0373878	2.60082	0.0633202	0.87378	2.40 [0.95 - 6.03]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201963_at	54	0.611111	0.00774661	0.13299	1.89221	0.127899	0.645538	1.91 [0.83 - 4.38]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207275_s_at	117	0.153846	0.149899	-	-0.538225	0.677873	-0.065147	0.94 [0.69 - 1.27]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207275_s_at	117	0.196581	0.100259	-	-0.652934	0.685647	-0.0757279	0.93 [0.64 - 1.34]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207275_s_at	117	0.196581	0.220582	-	-0.542192	0.873747	-0.0306791	0.97 [0.66 - 1.42]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207275_s_at	117	0.153846	0.149899	-	-0.538225	0.677873	-0.065147	0.94 [0.69 - 1.27]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201963_at	117	0.213675	0.0451384	0.461571	-0.665087	0.941526	-0.0105596	0.99 [0.75 - 1.31]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201963_at	117	0.213675	0.043349	0.45003	-0.777207	0.725736	-0.0586977	0.94 [0.68 - 1.31]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201963_at	117	0.42735	0.411327	-	0.331427	0.746774	0.0582573	1.06 [0.74 - 1.51]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201963_at	117	0.213675	0.0451384	0.461571	-0.665087	0.941526	-0.0105596	0.99 [0.75 - 1.31]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201963_at	236	0.665254	0.123117	-	0.418338	0.488533	0.165315	1.18 [0.74 - 1.88]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207275_s_at	236	0.309322	0.301421	-	0.318889	0.976245	0.0066759	1.01 [0.65 - 1.56]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207275_s_at	249	0.425703	0.152375	-	0.312896	0.788535	0.0472097	1.05 [0.74 - 1.48]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201963_at	249	0.871486	0.0522645	-	0.543629	0.461899	0.138523	1.15 [0.79 - 1.66]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207275_s_at	62	0.354839	0.0931971	-	-0.804847	0.460298	-0.185906	0.83 [0.51 - 1.36]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201963_at	125	0.76	0.0647894	-	0.544518	0.282702	0.171944	1.19 [0.87 - 1.63]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207275_s_at	125	0.824	0.159263	-	0.584908	0.680231	0.0762387	1.08 [0.75 - 1.55]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201963_at	54	0.537037	0.125038	-	-0.959016	0.448552	-0.179942	0.84 [0.52 - 1.33]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207275_s_at	125	0.76	0.103695	-	0.481708	0.709026	0.0524975	1.05 [0.80 - 1.39]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207275_s_at	54	0.388889	0.117793	-	-0.934193	0.822535	-0.0700486	0.93 [0.51 - 1.72]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201963_at	62	0.564516	0.0436523	0.452006	-1.06825	0.215785	-0.236735	0.79 [0.54 - 1.15]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201963_at	125	0.696	0.0713894	-	0.672152	0.353437	0.199545	1.22 [0.80 - 1.86]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207275_s_at	198	0.878788	0.00570637	0.104974	0.842962	0.0503327	0.23364	1.26 [1.00 - 1.60]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207275_s_at	198	0.878788	0.00420363	0.082515	0.905654	0.0220755	0.283236	1.33 [1.04 - 1.69]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201963_at	198	0.883838	0.00495973	0.0940426	0.759856	0.173595	0.160563	1.17 [0.93 - 1.48]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207275_s_at	198	0.29798	0.0186973	0.255456	0.591745	0.0988126	0.166288	1.18 [0.97 - 1.44]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201963_at	198	0.888889	0.00114324	0.0285075	0.982059	0.116487	0.220055	1.25 [0.95 - 1.64]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201963_at	198	0.888889	0.000940541	0.0242068	1.03536	0.0350752	0.299285	1.35 [1.02 - 1.78]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201963_at	62	0.241935	0.026259	0.323741	15.5707	0.232915	0.342238	1.41 [0.80 - 2.47]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207275_s_at	51	0.313726	0.128193	-	15.6255	0.568126	0.661446	1.94 [0.20 - 18.78]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207275_s_at	62	0.193548	0.0315548	0.366412	-1.1894	0.697207	0.287563	1.33 [0.31 - 5.68]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201963_at	51	0.882353	0.0369309	0.406274	1.69653	0.202108	0.618472	1.86 [0.72 - 4.80]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207275_s_at	177	0.299435	0.00753306	0.130168	0.98403	0.0466018	0.444702	1.56 [1.01 - 2.42]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201963_at	177	0.259887	0.000887298	0.023049	1.17781	0.0113455	0.460383	1.58 [1.11 - 2.26]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201963_at	177	0.259887	0.00436207	0.0849724	1.16751	0.0190333	0.497515	1.64 [1.09 - 2.49]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207275_s_at	177	0.214689	0.0139367	0.206612	0.892517	0.0466581	0.384377	1.47 [1.01 - 2.14]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201963_at	145	0.882759	0.00504406	0.0952983	1.07437	0.002551	0.81296	2.25 [1.33 - 3.82]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207275_s_at	145	0.344828	0.000623471	0.0171016	1.63021	0.00243481	0.803755	2.23 [1.33 - 3.76]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201963_at	226	0.535398	0.000630395	0.0172628	0.996116	0.0512228	0.357834	1.43 [1.00 - 2.05]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207275_s_at	226	0.60177	0.00585507	0.107102	0.772137	0.0749208	0.303853	1.36 [0.97 - 1.89]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201963_at	49	0.122449	0.205287	-	15.209	0.441489	0.216068	1.24 [0.72 - 2.15]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201963_at	55	0.218182	0.0366939	0.404583	1.86374	0.178312	0.302602	1.35 [0.87 - 2.10]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207275_s_at	55	0.327273	0.139132	-	0.805524	0.575972	0.133795	1.14 [0.72 - 1.83]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207275_s_at	55	0.436364	0.0981465	-	0.827126	0.656451	0.115817	1.12 [0.67 - 1.87]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207275_s_at	49	0.510204	0.246122	-	-0.696811	0.77162	-0.090355	0.91 [0.50 - 1.68]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201963_at	55	0.4	0.015667	0.224998	1.40125	0.164139	0.339769	1.40 [0.87 - 2.27]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	82734	34	0.852941	0.0853398	-	-1.59429	0.266852	-0.645753	0.52 [0.17 - 1.64]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201963_at	63	0.698413	0.115644	-	0.545357	0.652774	0.0653324	1.07 [0.80 - 1.42]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207275_s_at	63	0.396825	0.0121349	0.186574	0.940032	0.111721	0.164569	1.18 [0.96 - 1.44]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12669906_3p_at	28	0.214286	0.129296	-	1.45289	0.499028	0.116801	1.12 [0.80 - 1.58]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4503650_3p_s_at	28	0.357143	0.0504415	-	-1.03563	0.970722	0.261268	1.30 [0.00 - 1488840.82]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201963_at	82	0.158537	0.0500427	-	-0.772939	0.196239	-0.317702	0.73 [0.45 - 1.18]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207275_s_at	82	0.109756	0.190709	-	-0.626541	0.672585	-0.12497	0.88 [0.49 - 1.58]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40082_at	84	0.130952	0.101647	-	-0.634452	0.918761	-0.0225926	0.98 [0.63 - 1.51]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201963_at	79	0.151899	0.13252	-	0.599957	0.938521	0.0166409	1.02 [0.67 - 1.55]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207275_s_at	79	0.670886	0.169653	-	-0.382747	0.949115	-0.0129947	0.99 [0.66 - 1.47]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	L09229_s_at	86	0.883721	0.176485	-	-1.29076	0.236519	-0.459661	0.63 [0.30 - 1.35]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D10040_at	86	0.732558	0.0549087	-	0.776781	0.942144	0.023894	1.02 [0.54 - 1.95]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201963_at	104	0.721154	0.0248138	0.311422	-0.970081	0.503811	-0.180077	0.84 [0.49 - 1.42]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207275_s_at	104	0.865385	0.0570453	-	-1.29315	0.318517	-0.303513	0.74 [0.41 - 1.34]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P110212	117	0.880342	0.225012	-	-0.624073	0.605763	-0.09921	0.91 [0.62 - 1.32]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207275_s_at	204	0.436274	0.00568306	0.104638	1.19187	0.274832	0.396873	1.49 [0.73 - 3.03]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207275_s_at	204	0.436274	0.0205547	0.273165	0.677532	0.214508	0.332302	1.39 [0.82 - 2.36]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201963_at	204	0.308824	0.0425038	0.444483	1.04333	0.348942	0.422018	1.53 [0.63 - 3.69]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201963_at	204	0.308824	0.0986113	-	0.551352	0.619129	0.164958	1.18 [0.62 - 2.26]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201963_at	178	0.258427	0.340542	-	0.224046	0.790133	0.0483744	1.05 [0.73 - 1.50]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207275_s_at	178	0.168539	0.170894	-	0.382978	0.765444	0.0543942	1.06 [0.74 - 1.51]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201963_at	111	0.684685	0.124564	-	-0.457015	0.585333	-0.120463	0.89 [0.58 - 1.37]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207275_s_at	111	0.162162	0.184986	-	-0.445337	0.853219	0.0295143	1.03 [0.75 - 1.41]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201963_at	90	0.355556	0.141665	-	-0.481694	0.697169	-0.0717421	0.93 [0.65 - 1.34]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201963_at	90	0.355556	0.0240148	0.304474	-0.819322	0.245153	-0.238006	0.79 [0.53 - 1.18]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207275_s_at	90	0.111111	0.0971317	-	-0.726231	0.689999	-0.133832	0.87 [0.45 - 1.69]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207275_s_at	90	0.111111	0.0960015	-	-0.801265	0.394664	-0.338045	0.71 [0.33 - 1.55]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1966	50	0.4	0.295923	-	0.550712	0.911041	-0.0735006	0.93 [0.26 - 3.37]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207275_s_at	138	0.326087	0.0715522	-	0.490713	0.253474	0.122506	1.13 [0.92 - 1.39]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201963_at	138	0.442029	0.063382	-	0.462125	0.541761	0.0842846	1.09 [0.83 - 1.43]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201963_at	129	0.782946	0.0492748	0.487256	0.542518	0.63868	0.137717	1.15 [0.65 - 2.04]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207275_s_at	129	0.527132	0.0860924	-	0.423645	0.326011	0.257401	1.29 [0.77 - 2.16]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33118	56	0.357143	0.0844013	-	-0.626036	0.686773	-0.0941923	0.91 [0.58 - 1.44]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33118	56	0.357143	0.0166743	0.235353	-0.832006	0.37763	-0.191338	0.83 [0.54 - 1.26]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207275_s_at	278	0.571942	0.00154152	0.0365514	0.592191	0.150697	0.146967	1.16 [0.95 - 1.42]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201963_at	278	0.640288	0.00741486	0.128596	0.507222	0.127763	0.148072	1.16 [0.96 - 1.40]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207275_s_at	133	0.706767	0.00280479	0.0596584	-0.917022	0.117414	-0.137059	0.87 [0.73 - 1.04]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201963_at	133	0.56391	0.00548253	0.10174	-0.687383	0.037393	-0.164434	0.85 [0.73 - 0.99]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14052	81	0.703704	0.0216059	0.282897	1.22887	0.918495	-0.0857126	0.92 [0.18 - 4.74]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207275_s_at	185	0.281081	0.000845314	0.0221269	0.613423	0.0264956	0.280094	1.32 [1.03 - 1.69]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201963_at	185	0.610811	0.000274234	0.00845363	0.595622	0.00643935	0.235974	1.27 [1.07 - 1.50]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207275_s_at	185	0.281081	0.00246114	0.0536574	0.609381	0.0831019	0.241406	1.27 [0.97 - 1.67]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201963_at	185	0.610811	0.0011779	0.0292274	0.579194	0.0345774	0.199308	1.22 [1.01 - 1.47]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P110212	110	0.190909	0.0706679	-	0.561838	0.505667	0.104729	1.11 [0.82 - 1.51]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P110212	110	0.763636	0.319089	-	0.352361	0.641048	0.100006	1.11 [0.73 - 1.68]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201963_at	80	0.1375	0.26425	-	-0.620777	0.200195	-0.296402	0.74 [0.47 - 1.17]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207275_s_at	80	0.8875	0.054712	-	-15.2963	0.258801	-0.315112	0.73 [0.42 - 1.26]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1787	281	0.153025	0.259091	-	-0.210216	0.806222	0.0332177	1.03 [0.79 - 1.35]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201963_at	38	0.236842	0.00514008	0.0967214	2.39776	0.226403	0.443322	1.56 [0.76 - 3.20]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207275_s_at	38	0.210526	0.02623	0.323497	1.56818	0.219746	0.379738	1.46 [0.80 - 2.68]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201963_at	140	0.5	4.99631e-06	0.000237853	-1.44469	0.000144222	-0.410444	0.66 [0.54 - 0.82]
GENE	ACSL1	acyl-CoA synthetase long-chain family member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207275_s_at	140	0.45	9.67247e-06	0.000433515	-1.31312	8.05067e-05	-0.475286	0.62 [0.49 - 0.79]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201661_s_at	30	0.6	0.00164264	0.0385222	-1.36191	0.10054	-0.737654	0.48 [0.20 - 1.15]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201662_s_at	30	0.366667	0.00871616	0.145518	-1.06794	0.045677	-0.82681	0.44 [0.19 - 0.98]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1666096	165	0.733333	0.291476	-	0.275622	0.646415	0.119805	1.13 [0.68 - 1.88]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1666096	165	0.284848	0.130367	-	-0.53889	0.318282	-0.394806	0.67 [0.31 - 1.46]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201662_s_at	163	0.447853	0.0213123	0.280199	0.464936	0.263537	0.185734	1.20 [0.87 - 1.67]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201661_s_at	163	0.895706	0.194295	-	0.397229	0.713302	0.0687461	1.07 [0.74 - 1.55]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201661_s_at	79	0.101266	0.0743339	-	1.21506	0.222638	0.292937	1.34 [0.84 - 2.15]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201662_s_at	79	0.759494	0.00850226	0.142793	0.807776	0.0267506	0.482545	1.62 [1.06 - 2.48]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201661_s_at	58	0.224138	0.0958762	-	0.561858	0.562208	0.168647	1.18 [0.67 - 2.09]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201662_s_at	58	0.465517	0.231011	-	-0.329114	0.569709	0.0884596	1.09 [0.81 - 1.48]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201661_s_at	34	0.558824	0.0158436	0.226831	0.984998	0.430518	0.151326	1.16 [0.80 - 1.69]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201662_s_at	34	0.176471	0.0120662	0.18579	1.72344	0.0780414	0.601325	1.82 [0.93 - 3.56]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201661_s_at	158	0.126582	0.0533121	-	0.801368	0.214857	0.27816	1.32 [0.85 - 2.05]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201662_s_at	158	0.85443	0.161604	-	0.414861	0.761049	0.087066	1.09 [0.62 - 1.91]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201662_s_at	53	0.132075	0.0190524	0.258894	-1.0445	0.601485	-0.296635	0.74 [0.24 - 2.26]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201661_s_at	53	0.566038	0.00463024	0.08908	-1.03494	0.606185	-0.196666	0.82 [0.39 - 1.74]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201662_s_at	53	0.113208	0.048652	0.483474	-0.938371	0.493404	-0.371523	0.69 [0.24 - 2.00]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201661_s_at	53	0.566038	0.00600933	0.109295	-1.09144	0.539958	-0.252441	0.78 [0.35 - 1.74]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201661_s_at	180	0.872222	0.107173	-	0.455983	0.515191	0.123564	1.13 [0.78 - 1.64]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201662_s_at	180	0.105556	0.0395254	0.424428	-0.636499	0.332934	-0.33353	0.72 [0.36 - 1.41]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201661_s_at	559	0.466905	0.00499283	0.0945361	-0.561387	0.274157	-0.280402	0.76 [0.46 - 1.25]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201662_s_at	559	0.286225	0.254927	-	0.266048	0.846189	-0.0577622	0.94 [0.53 - 1.69]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201661_s_at	77	0.103896	0.0129688	0.195969	-0.947904	0.440202	-0.205868	0.81 [0.48 - 1.37]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201662_s_at	77	0.467532	0.124575	-	-0.388331	0.579772	-0.125263	0.88 [0.57 - 1.37]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201661_s_at	70	0.871429	0.000293031	0.00895252	1.3103	0.0701152	0.342748	1.41 [0.97 - 2.04]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201662_s_at	70	0.857143	0.0224584	0.290645	0.794206	0.66277	0.0713006	1.07 [0.78 - 1.48]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33880_at	50	0.84	0.0220301	0.286768	0.911975	0.557741	0.19268	1.21 [0.64 - 2.31]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201661_s_at	74	0.351351	0.0363325	0.401992	0.706458	0.233502	0.405575	1.50 [0.77 - 2.92]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201662_s_at	74	0.189189	0.0013618	0.032981	1.71061	0.107548	0.555481	1.74 [0.89 - 3.43]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201661_s_at	67	0.626866	0.0154579	0.222817	1.73362	0.311892	0.873467	2.40 [0.44 - 13.02]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201662_s_at	67	0.268657	0.238857	-	1.18044	0.622047	0.489061	1.63 [0.23 - 11.40]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201661_s_at	115	0.86087	0.119022	-	-15.2566	0.603557	-0.296572	0.74 [0.24 - 2.28]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201662_s_at	115	0.721739	0.0437267	0.452489	1.0308	0.960012	-0.0313698	0.97 [0.28 - 3.30]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33880_at	158	0.21519	0.107929	-	-0.519229	0.425244	-0.259322	0.77 [0.41 - 1.46]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33880_at	76	0.118421	0.141266	-	15.2186	0.515952	0.41101	1.51 [0.44 - 5.21]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201662_s_at	204	0.460784	0.337969	-	0.133039	0.651505	0.05856	1.06 [0.82 - 1.37]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201661_s_at	204	0.348039	0.0748474	-	-0.263948	0.491259	-0.0791722	0.92 [0.74 - 1.16]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201662_s_at	87	0.103448	0.0646161	-	-0.885299	0.175099	-0.409797	0.66 [0.37 - 1.20]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201661_s_at	87	0.103448	0.0929531	-	-0.809295	0.49845	-0.219191	0.80 [0.43 - 1.52]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201661_s_at	87	0.103448	0.0929531	-	-0.809295	0.49845	-0.219191	0.80 [0.43 - 1.52]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201662_s_at	87	0.103448	0.0646161	-	-0.885299	0.175099	-0.409797	0.66 [0.37 - 1.20]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201662_s_at	77	0.103896	0.0298659	0.3532	-1.38627	0.854623	-0.0820754	0.92 [0.38 - 2.22]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201661_s_at	77	0.116883	0.0101492	0.163269	-1.42388	0.176126	-0.576782	0.56 [0.24 - 1.30]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201661_s_at	77	0.103896	0.02453	0.308966	-1.42948	0.342371	-0.448428	0.64 [0.25 - 1.61]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201662_s_at	77	0.103896	0.0847814	-	-1.08324	0.641555	-0.188677	0.83 [0.37 - 1.83]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201662_s_at	136	0.882353	0.101768	-	-15.2045	0.4342	-0.444715	0.64 [0.21 - 1.95]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201661_s_at	136	0.808824	0.0319397	0.369375	0.969454	0.774191	0.167519	1.18 [0.38 - 3.71]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201661_s_at	200	0.105	0.000538888	0.0151056	-1.17915	0.0850883	-0.575163	0.56 [0.29 - 1.08]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201662_s_at	200	0.64	0.0601457	-	-0.63993	0.119088	-0.623752	0.54 [0.24 - 1.17]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1679	60	0.566667	0.0388883	0.420031	0.774043	0.220172	0.240665	1.27 [0.87 - 1.87]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1679	60	0.133333	0.0320555	0.370262	-0.979738	0.936141	-0.0159984	0.98 [0.67 - 1.46]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201661_s_at	286	0.472028	0.0880449	-	0.334101	0.169061	0.288714	1.33 [0.88 - 2.01]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201662_s_at	286	0.84965	0.26981	-	-0.326015	0.768153	0.0679975	1.07 [0.68 - 1.68]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201662_s_at	159	0.786164	0.0190228	0.258609	0.759531	0.200285	0.38293	1.47 [0.82 - 2.64]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201661_s_at	159	0.358491	0.0968529	-	0.597253	0.643648	0.142561	1.15 [0.63 - 2.11]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201661_s_at	159	0.113208	0.0653569	-	-0.822584	0.651584	0.164339	1.18 [0.58 - 2.41]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201662_s_at	159	0.773585	0.0110226	0.173692	0.809353	0.197281	0.384829	1.47 [0.82 - 2.64]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201661_s_at	159	0.157233	0.159154	-	-0.527668	0.980802	0.00749873	1.01 [0.55 - 1.86]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201662_s_at	159	0.786164	0.00461722	0.0888821	1.02344	0.139147	0.509192	1.66 [0.85 - 3.27]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201661_s_at	54	0.796296	0.0407262	0.432612	1.34559	0.119084	0.691845	2.00 [0.84 - 4.77]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201662_s_at	54	0.888889	0.023434	0.29936	1.51378	0.0851456	0.86781	2.38 [0.89 - 6.40]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201660_at	54	0.574074	0.0324567	0.373326	1.559	0.0788853	0.944702	2.57 [0.90 - 7.38]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201661_s_at	117	0.897436	0.222224	-	-0.859273	0.954678	0.0100795	1.01 [0.71 - 1.43]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201661_s_at	117	0.128205	0.0922283	-	1.55374	0.761189	0.0668515	1.07 [0.69 - 1.65]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201661_s_at	117	0.512821	0.111891	-	-0.639867	0.969698	0.0087821	1.01 [0.64 - 1.59]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201661_s_at	117	0.897436	0.222224	-	-0.859273	0.954678	0.0100795	1.01 [0.71 - 1.43]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201662_s_at	117	0.82906	0.249467	-	-0.552163	0.648409	-0.101392	0.90 [0.58 - 1.40]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201662_s_at	117	0.452991	0.0719976	-	-0.68319	0.246821	-0.312544	0.73 [0.43 - 1.24]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201662_s_at	117	0.444444	0.0453482	0.462907	-0.788096	0.220304	-0.347567	0.71 [0.41 - 1.23]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201662_s_at	117	0.82906	0.249467	-	-0.552163	0.648409	-0.101392	0.90 [0.58 - 1.40]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201662_s_at	236	0.516949	0.0906318	-	0.459693	0.298455	0.339911	1.40 [0.74 - 2.67]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201661_s_at	236	0.855932	0.0371211	0.407628	0.668671	0.587906	0.18801	1.21 [0.61 - 2.38]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201661_s_at	249	0.84739	0.0365115	0.403277	0.546808	0.566922	0.155431	1.17 [0.69 - 1.99]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201662_s_at	249	0.64257	0.00349374	0.0711972	0.613724	0.100538	0.409036	1.51 [0.92 - 2.45]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201662_s_at	125	0.264	0.174394	-	-0.425353	0.434947	0.202692	1.22 [0.74 - 2.04]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201662_s_at	54	0.111111	0.0564423	-	-1.239	0.923934	-0.0493334	0.95 [0.35 - 2.62]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201661_s_at	62	0.129032	0.00647181	0.115776	-1.32243	0.820268	-0.0796111	0.92 [0.46 - 1.84]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201661_s_at	125	0.48	0.0902286	-	0.68206	0.238042	0.266067	1.30 [0.84 - 2.03]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201662_s_at	62	0.112903	0.0432202	0.449189	-1.10885	0.685925	-0.169916	0.84 [0.37 - 1.92]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201661_s_at	125	0.656	0.293436	-	-0.334457	0.727018	0.0605984	1.06 [0.76 - 1.49]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201662_s_at	125	0.184	0.142352	-	1.03203	0.709028	0.126019	1.13 [0.59 - 2.20]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201661_s_at	54	0.240741	0.0201559	0.269419	-1.33876	0.950301	-0.027544	0.97 [0.41 - 2.31]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201662_s_at	198	0.621212	0.0567691	-	-0.426822	0.846116	-0.0278499	0.97 [0.73 - 1.29]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201661_s_at	198	0.116162	0.0785296	-	0.999639	0.796641	0.0419445	1.04 [0.76 - 1.43]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201661_s_at	198	0.116162	0.0485417	0.482801	1.32226	0.507267	0.11432	1.12 [0.80 - 1.57]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201662_s_at	198	0.515152	0.0303455	0.356988	-0.558764	0.950537	0.0111145	1.01 [0.71 - 1.44]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201662_s_at	198	0.126263	0.0354306	0.395467	1.39818	0.479936	0.133544	1.14 [0.79 - 1.66]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201661_s_at	198	0.449495	0.11893	-	0.340645	0.799909	0.0338297	1.03 [0.80 - 1.34]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201662_s_at	62	0.435484	0.0718276	-	1.30106	0.105056	1.07448	2.93 [0.80 - 10.74]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201661_s_at	51	0.803922	0.229911	-	1.04791	0.911815	0.044914	1.05 [0.47 - 2.32]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201661_s_at	62	0.758065	0.0713264	-	1.01454	0.276595	0.280194	1.32 [0.80 - 2.19]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201662_s_at	51	0.686275	0.181641	-	1.15441	0.269832	1.12953	3.09 [0.42 - 23.01]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201662_s_at	177	0.429379	0.206812	-	0.354168	0.801704	0.0831967	1.09 [0.57 - 2.08]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201661_s_at	177	0.779661	0.00809535	0.137549	0.666322	0.0414932	0.517683	1.68 [1.02 - 2.76]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201661_s_at	177	0.779661	0.04039	0.430334	0.603019	0.167602	0.401595	1.49 [0.84 - 2.64]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201662_s_at	177	0.638418	0.0060767	0.110248	0.637915	0.195258	0.361796	1.44 [0.83 - 2.48]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201661_s_at	145	0.117241	0.0912425	-	1.55339	0.445508	0.268386	1.31 [0.66 - 2.61]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201662_s_at	145	0.124138	0.20189	-	0.898602	0.708341	0.148787	1.16 [0.53 - 2.53]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201661_s_at	226	0.146018	0.0275077	0.334141	1.4587	0.4655	0.255209	1.29 [0.65 - 2.56]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201662_s_at	226	0.411504	0.0253269	0.315832	-0.627136	0.376932	-0.285143	0.75 [0.40 - 1.42]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201662_s_at	55	0.254545	0.0571658	-	-0.845438	0.960905	-0.0254602	0.97 [0.35 - 2.70]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201662_s_at	55	0.4	0.0248002	0.311304	1.32432	0.266339	0.712302	2.04 [0.58 - 7.16]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201662_s_at	49	0.816327	0.0437648	0.452736	1.17385	0.264466	0.980975	2.67 [0.48 - 14.94]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201661_s_at	55	0.545455	0.00115877	0.0288307	1.70461	0.0232233	0.829338	2.29 [1.12 - 4.69]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201661_s_at	49	0.530612	0.000444208	0.0128062	2.26621	0.0224237	1.11232	3.04 [1.17 - 7.90]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201661_s_at	55	0.363636	0.017601	0.244673	1.37887	0.216001	0.397744	1.49 [0.79 - 2.80]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201661_s_at	63	0.507937	0.106278	-	0.546205	0.997557	-0.000492909	1.00 [0.73 - 1.37]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201662_s_at	63	0.539683	0.0613532	-	0.630606	0.421478	0.114618	1.12 [0.85 - 1.48]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12669907_3p_a_at	28	0.142857	0.091528	-	-1.06788	0.991102	0.00314256	1.00 [0.58 - 1.74]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4165017_3p_a_at	28	0.857143	0.118144	-	1.0051	0.18758	0.569195	1.77 [0.76 - 4.12]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201662_s_at	82	0.292683	0.063233	-	-0.645655	0.210653	-0.359721	0.70 [0.40 - 1.23]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201661_s_at	82	0.195122	0.000793724	0.0209821	-1.2242	0.0170759	-0.816049	0.44 [0.23 - 0.86]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201662_s_at	79	0.379747	0.0335796	0.381802	0.579956	0.336977	0.381208	1.46 [0.67 - 3.19]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201661_s_at	79	0.632911	0.246335	-	0.312738	0.469277	0.238961	1.27 [0.66 - 2.43]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201661_s_at	104	0.259615	0.0567213	-	-0.627567	0.593418	-0.19016	0.83 [0.41 - 1.66]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201662_s_at	104	0.326923	0.0685829	-	0.688389	0.324776	0.343334	1.41 [0.71 - 2.79]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P37319	117	0.307692	0.00280151	0.0596019	1.10454	0.00724153	0.613426	1.85 [1.18 - 2.89]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P248606	117	0.102564	0.030281	0.35648	-0.816856	0.441541	-0.217498	0.80 [0.46 - 1.40]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201661_s_at	204	0.441176	6.25611e-07	3.52871e-05	-1.40033	4.19696e-05	-1.9753	0.14 [0.05 - 0.36]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201662_s_at	204	0.52451	0.00941591	0.154293	0.99451	0.0380751	1.04951	2.86 [1.06 - 7.70]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201662_s_at	204	0.343137	0.101179	-	0.503825	0.214615	0.498655	1.65 [0.75 - 3.62]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201661_s_at	204	0.269608	0.000391411	0.0114889	-1.22169	0.00962802	-1.70717	0.18 [0.05 - 0.66]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201662_s_at	178	0.898876	0.119285	-	-0.56775	0.541094	-0.150144	0.86 [0.53 - 1.39]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201661_s_at	178	0.264045	0.00675239	0.119644	-0.569046	0.119286	-0.306093	0.74 [0.50 - 1.08]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200016619	41	0.390244	0.0498216	0.490552	0.903865	0.355632	0.384844	1.47 [0.65 - 3.32]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201662_s_at	111	0.261261	0.0141849	0.209298	0.832447	0.125339	0.407155	1.50 [0.89 - 2.53]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201661_s_at	111	0.432432	0.066432	-	-0.478748	0.638167	-0.158375	0.85 [0.44 - 1.65]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201662_s_at	90	0.744444	0.0388835	0.419998	0.682408	0.652205	0.105253	1.11 [0.70 - 1.76]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201662_s_at	90	0.566667	0.0691092	-	0.673527	0.814552	0.0630086	1.07 [0.63 - 1.80]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201661_s_at	90	0.166667	0.145818	-	-0.572173	0.885673	0.0337284	1.03 [0.65 - 1.64]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201661_s_at	90	0.166667	0.075627	-	-0.754886	0.867282	0.0452212	1.05 [0.62 - 1.78]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3868	50	0.86	0.00559957	0.103435	1.39694	0.0643834	1.00571	2.73 [0.94 - 7.94]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4494	50	0.64	0.0135675	0.202584	1.15386	0.793854	0.151916	1.16 [0.37 - 3.64]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201662_s_at	138	0.594203	0.048738	0.483998	0.471321	0.428129	0.131802	1.14 [0.82 - 1.58]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201661_s_at	138	0.76087	0.0856983	-	0.449332	0.650007	0.0695753	1.07 [0.79 - 1.45]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201661_s_at	129	0.844961	0.00483794	0.0922186	0.856598	0.717919	0.148781	1.16 [0.52 - 2.60]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201662_s_at	129	0.829457	0.0337293	0.382922	0.635382	0.201655	0.473479	1.61 [0.78 - 3.32]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42231	56	0.375	0.0195798	0.263954	0.880111	0.352135	0.247834	1.28 [0.76 - 2.16]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22654	56	0.732143	0.137766	-	0.533492	0.837197	0.0387416	1.04 [0.72 - 1.50]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42231	56	0.553571	0.0149784	0.217774	0.853806	0.28809	0.301019	1.35 [0.78 - 2.35]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22654	56	0.714286	0.101915	-	0.599888	0.482399	0.133439	1.14 [0.79 - 1.66]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201662_s_at	278	0.5	0.0100135	0.161625	-0.486683	0.723834	-0.0597962	0.94 [0.68 - 1.31]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201661_s_at	278	0.852518	0.0645347	-	-0.578081	0.343811	-0.129251	0.88 [0.67 - 1.15]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201661_s_at	133	0.451128	0.00165437	0.0387492	-0.735724	0.0398844	-0.247455	0.78 [0.62 - 0.99]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201662_s_at	133	0.308271	0.000406426	0.0118663	-0.829899	0.000853681	-0.470842	0.62 [0.47 - 0.82]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201661_s_at	185	0.124324	0.0718697	-	0.486535	0.168479	0.207557	1.23 [0.92 - 1.65]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201662_s_at	185	0.897297	0.155471	-	0.38862	0.592912	0.0784262	1.08 [0.81 - 1.44]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201661_s_at	185	0.183784	0.0131221	0.197672	0.669825	0.059383	0.307809	1.36 [0.99 - 1.87]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201662_s_at	185	0.897297	0.141966	-	0.378101	0.47834	0.0960497	1.10 [0.84 - 1.44]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P37319	110	0.163636	0.0550541	-	0.666539	0.726371	0.0618715	1.06 [0.75 - 1.50]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P248606	110	0.663636	0.307766	-	0.246085	0.947217	-0.012057	0.99 [0.69 - 1.41]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P37319	110	0.272727	0.165706	-	0.493547	0.259768	0.292484	1.34 [0.81 - 2.23]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P248606	110	0.136364	0.114691	-	0.740485	0.336554	0.223946	1.25 [0.79 - 1.98]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201661_s_at	80	0.875	0.157111	-	-1.35192	0.845831	-0.0846311	0.92 [0.39 - 2.16]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201662_s_at	80	0.375	0.0106657	0.169467	1.46372	0.104896	0.474703	1.61 [0.91 - 2.85]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3920	281	0.69395	0.00805873	0.137073	-0.422494	0.0252719	-0.273501	0.76 [0.60 - 0.97]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201662_s_at	38	0.447368	0.000162027	0.00534889	2.1424	0.00308497	1.2046	3.34 [1.50 - 7.41]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201661_s_at	38	0.394737	0.00201368	0.0455486	1.79	0.0535103	0.809272	2.25 [0.99 - 5.11]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201662_s_at	140	0.892857	8.71764e-06	0.000394538	1.43194	0.0294127	0.603464	1.83 [1.06 - 3.15]
GENE	ACSL3	acyl-CoA synthetase long-chain family member 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201661_s_at	140	0.892857	0.00164643	0.0385955	1.12256	0.215374	0.265964	1.30 [0.86 - 1.99]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202422_s_at	30	0.166667	0.28594	-	-0.537484	0.605781	-0.22677	0.80 [0.34 - 1.89]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1683598	165	0.672727	0.0557535	-	0.475573	0.881786	0.0192407	1.02 [0.79 - 1.31]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1691714	165	0.133333	0.099723	-	0.748056	0.512175	0.636056	1.89 [0.28 - 12.65]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1683598	165	0.624242	0.157122	-	0.496881	0.881581	-0.0277924	0.97 [0.67 - 1.40]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1691714	165	0.448485	0.0717091	-	-0.637388	0.960355	-0.0711689	0.93 [0.06 - 15.41]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202422_s_at	163	0.619632	0.204548	-	0.254414	0.731101	0.0463822	1.05 [0.80 - 1.36]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202422_s_at	79	0.78481	0.0235712	0.300573	0.724911	0.366471	0.206959	1.23 [0.78 - 1.93]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202422_s_at	58	0.810345	0.0311377	0.363181	-0.788136	0.648142	-0.0680947	0.93 [0.70 - 1.25]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202422_s_at	34	0.205882	0.0466456	0.471087	1.03856	0.121435	0.682903	1.98 [0.83 - 4.70]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202422_s_at	158	0.443038	0.11234	-	-0.3647	0.693261	-0.0811275	0.92 [0.62 - 1.38]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202422_s_at	53	0.301887	0.199574	-	-0.458543	0.663828	-0.175355	0.84 [0.38 - 1.85]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202422_s_at	53	0.396226	0.0881654	-	-0.618397	0.253883	-0.488667	0.61 [0.26 - 1.42]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202422_s_at	180	0.855556	0.0267528	0.327881	0.575081	0.372762	0.193388	1.21 [0.79 - 1.86]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202422_s_at	559	0.858676	0.0054658	0.101497	0.624658	0.0853851	0.354948	1.43 [0.95 - 2.14]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202422_s_at	77	0.155844	0.124165	-	0.610054	0.443012	0.196067	1.22 [0.74 - 2.01]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202422_s_at	70	0.842857	0.00945421	0.154767	-1.06886	0.0457155	-0.454577	0.63 [0.41 - 0.99]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38099_r_at	50	0.16	0.00232141	0.0511636	-1.3439	0.247159	-0.924799	0.40 [0.08 - 1.90]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202422_s_at	74	0.851351	0.00796031	0.135791	-1.70809	0.38083	-0.277369	0.76 [0.41 - 1.41]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202422_s_at	67	0.671642	0.192712	-	0.849436	0.747376	0.213546	1.24 [0.34 - 4.54]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202422_s_at	115	0.165217	0.027396	0.33322	-1.17068	0.743592	0.186401	1.20 [0.39 - 3.68]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38099_r_at	158	0.424051	0.19988	-	0.382382	0.486946	0.137611	1.15 [0.78 - 1.69]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38099_r_at	76	0.671053	0.120601	-	-1.1205	0.85885	-0.0477784	0.95 [0.56 - 1.61]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202422_s_at	204	0.740196	0.00108873	0.0273665	0.519393	0.624161	0.0646797	1.07 [0.82 - 1.38]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202422_s_at	87	0.862069	0.132353	-	0.646251	0.885485	-0.0392127	0.96 [0.56 - 1.64]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202422_s_at	87	0.862069	0.132353	-	0.646251	0.885485	-0.0392127	0.96 [0.56 - 1.64]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202422_s_at	77	0.428571	0.068757	-	-1.18692	0.381841	-0.455334	0.63 [0.23 - 1.76]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202422_s_at	77	0.168831	0.121393	-	-0.90201	0.459753	-0.334402	0.72 [0.29 - 1.74]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202422_s_at	136	0.713235	0.101297	-	-0.991812	0.200361	-0.436888	0.65 [0.33 - 1.26]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202422_s_at	200	0.15	0.163951	-	0.81035	0.489161	0.204616	1.23 [0.69 - 2.19]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10669	60	0.25	0.0267362	0.327742	1.26843	0.828588	0.082182	1.09 [0.52 - 2.28]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10669	60	0.5	0.145485	-	-0.551949	0.645286	-0.164255	0.85 [0.42 - 1.71]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202422_s_at	286	0.195804	0.00701627	0.123239	0.80429	0.0432055	0.364452	1.44 [1.01 - 2.05]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202422_s_at	159	0.132075	0.000121873	0.00416784	-1.25091	0.0586646	-0.559251	0.57 [0.32 - 1.02]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202422_s_at	159	0.132075	1.33939e-06	7.12222e-05	-1.66595	0.0158694	-0.843594	0.43 [0.22 - 0.85]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202422_s_at	159	0.132075	5.54305e-05	0.00207799	-1.30502	0.0205638	-0.688941	0.50 [0.28 - 0.90]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202422_s_at	54	0.759259	0.177979	-	-1.38736	0.973843	-0.0235687	0.98 [0.24 - 4.00]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202422_s_at	117	0.42735	0.217354	-	-0.389622	0.940578	-0.0197768	0.98 [0.58 - 1.65]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202422_s_at	117	0.42735	0.127124	-	-0.570168	0.429817	-0.257661	0.77 [0.41 - 1.47]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202422_s_at	117	0.42735	0.0568842	-	-0.74345	0.870603	-0.0514702	0.95 [0.51 - 1.76]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202422_s_at	117	0.42735	0.217354	-	-0.389622	0.940578	-0.0197768	0.98 [0.58 - 1.65]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202422_s_at	236	0.355932	0.102136	-	-0.440515	0.527365	-0.183905	0.83 [0.47 - 1.47]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202422_s_at	249	0.248996	0.255319	-	-0.267071	0.501214	-0.152995	0.86 [0.55 - 1.34]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202422_s_at	62	0.709677	0.197357	-	-0.703216	0.43818	-0.261391	0.77 [0.40 - 1.49]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202422_s_at	125	0.896	0.167428	-	-1.31076	0.429393	-0.398132	0.67 [0.25 - 1.80]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202422_s_at	125	0.136	0.0773563	-	-0.686909	0.689756	-0.143868	0.87 [0.43 - 1.76]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202422_s_at	54	0.62963	0.29941	-	-0.654815	0.549268	-0.24104	0.79 [0.36 - 1.73]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202422_s_at	198	0.742424	0.240554	-	-0.375375	0.633764	0.0700476	1.07 [0.80 - 1.43]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202422_s_at	198	0.353535	0.2643	-	0.329027	0.539754	0.097669	1.10 [0.81 - 1.51]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202422_s_at	198	0.242424	0.0332	0.378953	0.610841	0.221361	0.152774	1.17 [0.91 - 1.49]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202422_s_at	51	0.411765	0.0605644	-	15.8971	0.749888	0.250652	1.28 [0.28 - 6.00]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202422_s_at	62	0.370968	0.0251506	0.314321	1.99266	0.324513	0.484204	1.62 [0.62 - 4.25]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202422_s_at	177	0.423729	0.0023713	0.0520578	0.91283	0.00877945	0.674324	1.96 [1.19 - 3.25]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202422_s_at	177	0.813559	7.13697e-05	0.00260009	0.967342	0.000896433	0.746792	2.11 [1.36 - 3.28]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202422_s_at	145	0.151724	0.0170129	0.238782	2.04604	0.0573673	0.624385	1.87 [0.98 - 3.55]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202422_s_at	226	0.884956	0.00233001	0.0513181	1.0026	0.0550898	0.537697	1.71 [0.99 - 2.97]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202422_s_at	55	0.254545	0.0704286	-	1.26355	0.311099	0.251915	1.29 [0.79 - 2.09]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202422_s_at	55	0.418182	0.0344347	0.388162	1.12297	0.102322	0.444998	1.56 [0.91 - 2.66]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202422_s_at	49	0.163265	0.100055	-	15.3285	0.483885	0.226277	1.25 [0.67 - 2.36]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202422_s_at	63	0.603175	0.0618499	-	-0.691142	0.61485	-0.100546	0.90 [0.61 - 1.34]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12669908_3p_a_at	28	0.357143	0.111227	-	0.929799	0.132288	0.381364	1.46 [0.89 - 2.41]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202422_s_at	82	0.317073	0.00740558	0.128472	-0.906167	0.152443	-0.331146	0.72 [0.46 - 1.13]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202422_s_at	79	0.405063	0.0718223	-	0.483583	0.221943	0.267028	1.31 [0.85 - 2.00]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202422_s_at	104	0.75	0.202313	-	-0.529764	0.943132	-0.0224641	0.98 [0.53 - 1.81]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P217564	117	0.777778	0.178637	-	-0.514792	0.746979	-0.0708302	0.93 [0.61 - 1.43]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202422_s_at	204	0.122549	0.000787682	0.0208472	-1.02495	0.00178453	-0.924832	0.40 [0.22 - 0.71]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202422_s_at	204	0.382353	0.0228185	0.29388	-0.816352	0.120018	-0.621452	0.54 [0.25 - 1.18]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202422_s_at	178	0.157303	0.0341146	0.385791	-0.524584	0.594623	-0.100592	0.90 [0.62 - 1.31]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006841	41	0.853659	0.111442	-	0.78622	0.468229	0.299914	1.35 [0.60 - 3.04]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202422_s_at	111	0.108108	0.0624699	-	-0.66712	0.837764	-0.0365082	0.96 [0.68 - 1.37]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202422_s_at	90	0.522222	0.0699803	-	-0.602707	0.606395	-0.240468	0.79 [0.31 - 1.96]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202422_s_at	90	0.5	0.0989682	-	-0.622788	0.797948	-0.133756	0.87 [0.31 - 2.44]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202422_s_at	138	0.485507	0.0434151	0.450461	0.491428	0.570098	0.0697944	1.07 [0.84 - 1.36]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202422_s_at	129	0.837209	0.134256	-	0.478775	0.947825	-0.0171801	0.98 [0.59 - 1.64]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27248	56	0.732143	0.1424	-	0.540463	0.452332	0.18691	1.21 [0.74 - 1.96]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27248	56	0.232143	0.140288	-	0.675922	0.326908	0.257453	1.29 [0.77 - 2.16]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202422_s_at	278	0.830935	0.130171	-	-0.40663	0.558714	-0.0769069	0.93 [0.72 - 1.20]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202422_s_at	133	0.157895	0.05158	-	-0.568331	0.210326	-0.218983	0.80 [0.57 - 1.13]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12520	81	0.382716	0.0771105	-	1.10044	0.753371	0.190408	1.21 [0.37 - 3.97]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202422_s_at	185	0.762162	0.00308343	0.0643986	0.538755	0.167224	0.189692	1.21 [0.92 - 1.58]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202422_s_at	185	0.762162	0.000231867	0.00730909	0.697484	0.0823896	0.256742	1.29 [0.97 - 1.73]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217564	110	0.509091	0.0615108	-	-0.427499	0.829438	0.0404027	1.04 [0.72 - 1.50]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217564	110	0.836364	0.0706777	-	0.620335	0.38763	0.197193	1.22 [0.78 - 1.91]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202422_s_at	80	0.2125	0.209286	-	0.902794	0.959159	-0.0129251	0.99 [0.60 - 1.62]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202422_s_at	38	0.5	0.281011	-	0.512442	0.348239	0.447016	1.56 [0.61 - 3.98]
GENE	ACSL4	acyl-CoA synthetase long-chain family member 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202422_s_at	140	0.885714	0.215228	-	0.475784	0.80122	0.0645649	1.07 [0.65 - 1.76]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218322_s_at	30	0.7	0.0525673	-	-0.944576	0.18593	-0.29434	0.75 [0.48 - 1.15]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1807914	165	0.460606	0.263528	-	-0.270302	0.885589	0.0158413	1.02 [0.82 - 1.26]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1807914	165	0.442424	0.00571199	0.105054	-0.989847	0.0806915	-0.232013	0.79 [0.61 - 1.03]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218322_s_at	163	0.680982	0.0342162	0.386544	0.433188	0.226891	0.209787	1.23 [0.88 - 1.73]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222592_s_at	163	0.723926	0.0223113	0.289317	0.473372	0.209304	0.217284	1.24 [0.89 - 1.74]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218322_s_at	79	0.835443	0.0348961	0.391559	0.736346	0.179596	0.27767	1.32 [0.88 - 1.98]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222592_s_at	79	0.392405	0.0707564	-	0.551585	0.180482	0.273456	1.31 [0.88 - 1.96]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218322_s_at	58	0.793103	0.00398373	0.0790646	0.999441	0.0760055	0.675889	1.97 [0.93 - 4.15]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218322_s_at	34	0.294118	0.243229	-	-0.473056	0.770109	0.124835	1.13 [0.49 - 2.62]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218322_s_at	158	0.746835	0.0135196	0.202058	0.597497	0.274448	0.353461	1.42 [0.76 - 2.68]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218322_s_at	53	0.245283	0.117723	-	-0.60455	0.400377	-0.493555	0.61 [0.19 - 1.93]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218322_s_at	53	0.830189	0.0699221	-	-1.04953	0.589373	-0.295664	0.74 [0.25 - 2.18]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218322_s_at	180	0.761111	0.226974	-	0.294041	0.786289	0.099728	1.10 [0.54 - 2.27]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222592_s_at	180	0.683333	0.052624	-	0.412374	0.904595	-0.031598	0.97 [0.58 - 1.62]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218322_s_at	559	0.858676	0.0363635	0.402215	0.500117	0.392369	0.324897	1.38 [0.66 - 2.91]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222592_s_at	559	0.116279	0.17374	-	-0.352864	0.724949	0.0754051	1.08 [0.71 - 1.64]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218322_s_at	77	0.519481	0.0892128	-	0.436379	0.409698	0.298505	1.35 [0.66 - 2.74]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222592_s_at	77	0.324675	0.0380142	0.413935	-0.541058	0.307569	-0.155322	0.86 [0.64 - 1.15]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222592_s_at	70	0.228571	0.016603	0.234629	-0.708878	0.163266	-0.607063	0.54 [0.23 - 1.28]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218322_s_at	70	0.257143	0.132849	-	-0.443565	0.402685	-0.339083	0.71 [0.32 - 1.58]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218322_s_at	74	0.27027	0.0090945	0.150289	0.937827	0.0312601	0.997814	2.71 [1.09 - 6.73]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222592_s_at	74	0.243243	0.00474679	0.0908458	1.12429	0.228385	0.195207	1.22 [0.88 - 1.67]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222592_s_at	67	0.835821	0.167732	-	-15.3108	0.516811	-0.407474	0.67 [0.19 - 2.28]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218322_s_at	67	0.850746	0.176546	-	-15.302	0.520598	-0.343211	0.71 [0.25 - 2.02]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222592_s_at	115	0.104348	0.012958	0.195848	-1.36629	0.0304492	-1.00993	0.36 [0.15 - 0.91]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218322_s_at	115	0.330435	0.00632332	0.11371	-1.40972	0.0306563	-1.38281	0.25 [0.07 - 0.88]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222592_s_at	204	0.803922	0.230251	-	0.213639	0.808677	0.0229343	1.02 [0.85 - 1.23]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218322_s_at	204	0.740196	0.143058	-	-0.231811	0.375575	-0.112738	0.89 [0.70 - 1.15]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218322_s_at	87	0.471264	0.000366546	0.0108586	-1.38701	0.0121441	-0.492933	0.61 [0.42 - 0.90]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222592_s_at	87	0.229885	0.0241552	0.305702	-0.867347	0.0712435	-0.380785	0.68 [0.45 - 1.03]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222592_s_at	87	0.229885	0.0241552	0.305702	-0.867347	0.0712435	-0.380785	0.68 [0.45 - 1.03]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218322_s_at	87	0.471264	0.000366546	0.0108586	-1.38701	0.0121441	-0.492933	0.61 [0.42 - 0.90]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218322_s_at	77	0.116883	0.0565067	-	-1.23698	0.252389	-0.460848	0.63 [0.29 - 1.39]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222592_s_at	77	0.74026	0.0962853	-	-1.56835	0.502712	-0.253293	0.78 [0.37 - 1.63]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222592_s_at	77	0.220779	0.137467	-	-0.926021	0.413802	-0.360452	0.70 [0.29 - 1.66]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218322_s_at	77	0.805195	0.0542649	-	-15.4124	0.247494	-0.402341	0.67 [0.34 - 1.32]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218322_s_at	136	0.529412	0.261102	-	0.506891	0.973258	0.0147416	1.01 [0.43 - 2.40]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218322_s_at	200	0.38	0.0087719	0.146225	-0.763048	0.185583	-0.467151	0.63 [0.31 - 1.25]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6818	60	0.583333	0.157248	-	-0.566122	0.478444	-0.0694647	0.93 [0.77 - 1.13]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6818	60	0.433333	0.125948	-	-0.576074	0.586808	-0.0922465	0.91 [0.65 - 1.27]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218322_s_at	286	0.611888	9.64189e-05	0.00339155	-0.854253	0.0124547	-0.569012	0.57 [0.36 - 0.88]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218322_s_at	159	0.257862	2.94274e-05	0.00118125	-1.43644	0.00112994	-1.66288	0.19 [0.07 - 0.52]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218322_s_at	159	0.100629	4.30413e-05	0.00165912	-1.385	0.00148931	-1.38806	0.25 [0.11 - 0.59]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218322_s_at	159	0.503145	0.00137891	0.0333248	-1.0807	0.00167593	-1.37884	0.25 [0.11 - 0.60]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222592_s_at	159	0.301887	0.000362644	0.0107591	-1.07686	0.0201427	-0.381358	0.68 [0.50 - 0.94]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222592_s_at	159	0.301887	0.0071292	0.124766	-0.829327	0.072429	-0.303467	0.74 [0.53 - 1.03]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222592_s_at	159	0.301887	0.00293035	0.0618075	-1.05621	0.0483713	-0.38018	0.68 [0.47 - 1.00]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218322_s_at	54	0.388889	0.00196071	0.0445637	-2.56669	0.00523654	-2.81069	0.06 [0.01 - 0.43]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218322_s_at	117	0.598291	0.0399323	0.427216	-0.713712	0.374475	-0.180865	0.83 [0.56 - 1.24]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218322_s_at	117	0.495726	0.0225989	0.29191	-0.893731	0.279878	-0.269939	0.76 [0.47 - 1.25]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218322_s_at	117	0.495726	0.124919	-	-0.610229	0.500545	-0.16631	0.85 [0.52 - 1.37]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218322_s_at	117	0.598291	0.0399323	0.427216	-0.713712	0.374475	-0.180865	0.83 [0.56 - 1.24]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218322_s_at	236	0.576271	0.0289215	0.345656	-0.637406	0.0448823	-0.616832	0.54 [0.30 - 0.99]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222592_s_at	236	0.110169	0.0211048	0.278282	-0.785654	0.0687074	-0.243316	0.78 [0.60 - 1.02]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218322_s_at	249	0.11245	0.0780464	-	-0.51028	0.139731	-0.358886	0.70 [0.43 - 1.12]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222592_s_at	249	0.305221	0.079073	-	-0.383564	0.126236	-0.162871	0.85 [0.69 - 1.05]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218322_s_at	62	0.258065	0.00393305	0.0782625	-1.34309	0.1351	-0.424265	0.65 [0.38 - 1.14]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218322_s_at	125	0.408	0.0906416	-	-0.637438	0.418133	-0.281045	0.75 [0.38 - 1.49]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218322_s_at	125	0.336	0.0945179	-	-0.51912	0.404713	-0.220884	0.80 [0.48 - 1.35]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218322_s_at	54	0.148148	0.00109856	0.0275732	-1.75812	0.22339	-0.414656	0.66 [0.34 - 1.29]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218322_s_at	198	0.747475	0.00786146	0.134498	-0.969388	0.123877	-0.297494	0.74 [0.51 - 1.08]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218322_s_at	198	0.747475	0.0275748	0.334694	-0.819125	0.146275	-0.292574	0.75 [0.50 - 1.11]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218322_s_at	198	0.737374	0.0113187	0.177161	-0.685753	0.131732	-0.2366	0.79 [0.58 - 1.07]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218322_s_at	51	0.529412	0.0269076	0.329171	-16.1843	0.080336	-1.18666	0.31 [0.08 - 1.15]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218322_s_at	62	0.16129	0.0272225	0.331785	-1.26906	0.0109904	-0.742635	0.48 [0.27 - 0.84]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222592_s_at	177	0.271186	0.0122593	0.187989	-0.678994	0.0406495	-0.394548	0.67 [0.46 - 0.98]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218322_s_at	177	0.576271	0.00417473	0.0820642	-0.862976	0.0805288	-0.349381	0.71 [0.48 - 1.04]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222592_s_at	177	0.271186	0.00383151	0.0766478	-0.680885	0.0703848	-0.319276	0.73 [0.51 - 1.03]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218322_s_at	177	0.587571	0.00853531	0.143215	-0.669832	0.078213	-0.313835	0.73 [0.52 - 1.04]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222592_s_at	145	0.496552	0.00196315	0.0446094	-1.09771	0.0124618	-0.634732	0.53 [0.32 - 0.87]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218322_s_at	145	0.544828	0.0105926	0.168595	-0.918585	0.0967343	-0.431123	0.65 [0.39 - 1.08]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222592_s_at	226	0.482301	0.00198346	0.0449874	-0.909399	0.00316681	-0.56744	0.57 [0.39 - 0.83]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218322_s_at	226	0.699115	0.00127942	0.0313129	-1.40207	0.0694566	-0.372428	0.69 [0.46 - 1.03]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218322_s_at	55	0.2	0.0207846	0.275311	-1.03984	0.440996	-0.225728	0.80 [0.45 - 1.42]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222592_s_at	55	0.4	0.016563	0.234222	1.39152	0.109111	0.646631	1.91 [0.87 - 4.21]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218322_s_at	55	0.781818	0.0841484	-	0.881771	0.576688	0.19171	1.21 [0.62 - 2.37]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222592_s_at	49	0.387755	0.0558441	-	1.37651	0.361912	0.479273	1.61 [0.58 - 4.52]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218322_s_at	49	0.857143	0.277542	-	0.710397	0.92656	0.0416162	1.04 [0.43 - 2.53]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222592_s_at	55	0.181818	0.064258	-	-0.875921	0.896454	0.039029	1.04 [0.58 - 1.87]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222592_s_at	63	0.301587	0.0305631	0.358697	-0.739354	0.253478	-0.255901	0.77 [0.50 - 1.20]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218322_s_at	63	0.746032	0.0274214	0.333429	-1.02692	0.136077	-0.25126	0.78 [0.56 - 1.08]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12669912_3p_a_at	28	0.535714	0.0161795	0.230297	-1.37907	0.309381	-0.966964	0.38 [0.06 - 2.45]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.11638.0.S1_3p_a_at	28	0.25	0.0238416	0.302955	-1.17426	0.835146	0.110695	1.12 [0.39 - 3.17]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218322_s_at	82	0.109756	0.14234	-	-0.706474	0.430728	-0.21435	0.81 [0.47 - 1.38]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218322_s_at	79	0.101266	0.0974815	-	-0.626286	0.193544	-0.201085	0.82 [0.60 - 1.11]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218322_s_at	104	0.25	0.0189119	0.257537	-0.773997	0.142578	-0.307723	0.74 [0.49 - 1.11]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P201360	117	0.111111	0.0270605	0.330442	-0.834355	0.301796	-0.160928	0.85 [0.63 - 1.16]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222592_s_at	204	0.102941	0.157152	-	-0.68085	0.239736	-0.355655	0.70 [0.39 - 1.27]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218322_s_at	204	0.181373	0.0572051	-	-0.743764	0.0903729	-0.433055	0.65 [0.39 - 1.07]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222592_s_at	204	0.205882	0.15755	-	-0.436724	0.561177	-0.129734	0.88 [0.57 - 1.36]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218322_s_at	204	0.401961	0.00375304	0.0753925	-0.776098	0.0363124	-0.398943	0.67 [0.46 - 0.97]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218322_s_at	178	0.803371	0.00581917	0.10659	-0.854087	0.586913	-0.0660091	0.94 [0.74 - 1.19]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200002021	41	0.121951	0.00819166	0.138797	-1.37167	0.24588	-0.239539	0.79 [0.53 - 1.18]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222592_s_at	111	0.882883	0.116222	-	0.562765	0.848985	0.0204719	1.02 [0.83 - 1.26]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218322_s_at	111	0.216216	0.229414	-	-0.36802	0.731579	0.0537669	1.06 [0.78 - 1.43]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218322_s_at	90	0.888889	0.097287	-	0.722789	0.750793	0.0532591	1.05 [0.76 - 1.47]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218322_s_at	90	0.888889	0.0806813	-	0.835248	0.771507	0.0559858	1.06 [0.72 - 1.54]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222592_s_at	138	0.26087	0.168871	-	-0.360601	0.920536	-0.0058574	0.99 [0.89 - 1.12]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218322_s_at	138	0.108696	0.00794162	0.135547	-0.824944	0.68837	-0.0211184	0.98 [0.88 - 1.09]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218322_s_at	129	0.139535	0.185935	-	-0.408717	0.840964	-0.0512889	0.95 [0.58 - 1.57]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3552	56	0.160714	0.317309	-	-0.405996	0.883352	-0.0195623	0.98 [0.76 - 1.27]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11852	56	0.767857	0.255504	-	-0.505557	0.829093	-0.0334085	0.97 [0.71 - 1.31]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3552	56	0.107143	0.157905	-	-0.687075	0.754416	-0.0445813	0.96 [0.72 - 1.26]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11852	56	0.75	0.178547	-	-0.646003	0.843165	-0.0339527	0.97 [0.69 - 1.35]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222592_s_at	278	0.118705	0.0284449	0.341804	-0.561282	0.0288422	-0.197739	0.82 [0.69 - 0.98]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218322_s_at	278	0.701439	0.0387002	0.418726	-0.491233	0.0376079	-0.173252	0.84 [0.71 - 0.99]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218322_s_at	133	0.894737	0.0497135	0.489902	-0.882096	0.234096	-0.10142	0.90 [0.76 - 1.07]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2203	81	0.320988	0.0384459	0.416955	-1.0276	0.142109	-0.251848	0.78 [0.56 - 1.09]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218322_s_at	185	0.513514	0.0261719	0.323008	0.365479	0.322013	0.149549	1.16 [0.86 - 1.56]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218322_s_at	185	0.513514	0.0239566	0.303964	0.401279	0.281715	0.175704	1.19 [0.87 - 1.64]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P201360	110	0.881818	0.00869217	0.145214	0.83284	0.250076	-0.11149	0.89 [0.74 - 1.08]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P201360	110	0.881818	0.0080251	0.136635	0.893639	0.828245	0.0269347	1.03 [0.81 - 1.31]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218322_s_at	80	0.4	0.046274	0.468758	-0.857473	0.518835	-0.161066	0.85 [0.52 - 1.39]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218322_s_at	38	0.578947	0.00247757	0.0539484	-1.70517	0.110697	-0.533989	0.59 [0.30 - 1.13]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222592_s_at	38	0.473684	0.00835997	0.140968	-1.28954	0.467246	-0.160438	0.85 [0.55 - 1.31]
GENE	ACSL5	acyl-CoA synthetase long-chain family member 5	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218322_s_at	140	0.107143	6.18633e-06	0.000288926	-1.41921	0.00451542	-0.730944	0.48 [0.29 - 0.80]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215432_at	30	0.566667	0.0530882	-	0.78212	0.400058	0.759555	2.14 [0.36 - 12.54]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1709539	165	0.618182	3.12426e-05	0.00124627	-1.16285	0.00244102	-1.892	0.15 [0.04 - 0.51]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1709539	165	0.606061	8.80728e-06	0.000398215	-2.52868	0.00410245	-2.78863	0.06 [0.01 - 0.41]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215432_at	163	0.153374	0.108366	-	-0.424422	0.788884	-0.18363	0.83 [0.22 - 3.19]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215432_at	79	0.835443	0.014222	0.209698	0.827302	0.715755	0.352475	1.42 [0.21 - 9.48]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215432_at	58	0.655172	0.0782093	-	0.515606	0.462586	0.102275	1.11 [0.84 - 1.46]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215432_at	34	0.352941	0.0898666	-	0.742572	0.213867	0.339389	1.40 [0.82 - 2.40]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215432_at	158	0.35443	0.000585103	0.0162024	0.93805	0.0955599	1.3987	4.05 [0.78 - 20.98]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215432_at	53	0.188679	0.126019	-	-0.630777	0.715167	0.0975478	1.10 [0.65 - 1.86]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215432_at	53	0.188679	0.0202908	0.270689	-0.889648	0.842742	-0.0505161	0.95 [0.58 - 1.57]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215432_at	180	0.461111	0.0446618	0.458524	0.427358	0.866169	0.0187067	1.02 [0.82 - 1.27]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215432_at	559	0.701252	0.0864104	-	-0.434552	0.292417	-0.157646	0.85 [0.64 - 1.15]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215432_at	77	0.116883	0.122543	-	-0.590884	0.439061	-0.184881	0.83 [0.52 - 1.33]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215432_at	70	0.2	0.145588	-	-0.462848	0.542096	0.637218	1.89 [0.24 - 14.67]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34050_at	50	0.44	0.0729547	-	-0.618204	0.122395	-1.20021	0.30 [0.07 - 1.38]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215432_at	74	0.621622	0.00438809	0.0853739	0.814308	0.0561309	0.506073	1.66 [0.99 - 2.79]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215432_at	67	0.701493	0.134688	-	0.975919	0.920034	0.338182	1.40 [0.00 - 1033.51]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215432_at	115	0.426087	0.024784	0.311164	1.55209	0.506192	0.331469	1.39 [0.52 - 3.70]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34050_at	158	0.632911	0.0797712	-	-0.528511	0.373178	-0.110165	0.90 [0.70 - 1.14]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34050_at	76	0.328947	0.0689429	-	1.29357	0.422619	0.14228	1.15 [0.81 - 1.63]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215432_at	204	0.171569	0.0507708	-	0.355314	0.676081	-0.0238285	0.98 [0.87 - 1.09]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215432_at	87	0.114943	0.0240881	0.305116	15.2816	0.454129	-0.240744	0.79 [0.42 - 1.48]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215432_at	87	0.114943	0.0240881	0.305116	15.2816	0.454129	-0.240744	0.79 [0.42 - 1.48]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215432_at	77	0.103896	0.000159282	0.00526961	-2.06903	0.84628	-0.112655	0.89 [0.29 - 2.79]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215432_at	77	0.103896	0.00307971	0.064336	-1.60845	0.937946	-0.0359497	0.96 [0.39 - 2.38]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215432_at	136	0.294118	0.0317497	0.367915	-0.928332	0.540031	-0.144819	0.87 [0.54 - 1.37]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215432_at	200	0.86	0.139809	-	-0.855312	0.800308	-0.0354455	0.97 [0.73 - 1.27]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12669	60	0.5	0.0294904	0.350214	-0.839474	0.980226	0.00314986	1.00 [0.78 - 1.29]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12669	60	0.166667	0.264585	-	-0.514355	0.998096	0.000363614	1.00 [0.74 - 1.35]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215432_at	286	0.391608	0.000309405	0.00938303	-0.686008	0.220403	-0.130524	0.88 [0.71 - 1.08]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215432_at	159	0.119497	0.0110264	0.173736	-0.930897	0.608835	0.0852287	1.09 [0.79 - 1.51]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215432_at	159	0.805031	0.090213	-	-0.865943	0.42973	-0.163332	0.85 [0.57 - 1.27]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215432_at	159	0.427673	0.190512	-	0.51961	0.943847	0.015166	1.02 [0.67 - 1.55]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215432_at	54	0.777778	0.102635	-	-15.4386	0.597499	-0.70122	0.50 [0.04 - 6.70]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215432_at	117	0.264957	0.0964739	-	0.877775	0.549731	0.302419	1.35 [0.50 - 3.64]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215432_at	117	0.247863	0.0614136	-	0.807681	0.856304	0.082275	1.09 [0.45 - 2.65]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215432_at	117	0.264957	0.0340475	0.385292	1.21858	0.468152	0.345717	1.41 [0.56 - 3.60]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215432_at	117	0.247863	0.0614136	-	0.807681	0.856304	0.082275	1.09 [0.45 - 2.65]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215432_at	236	0.254237	0.0271884	0.331502	-0.610201	0.469466	0.157021	1.17 [0.76 - 1.79]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215432_at	249	0.26506	0.0484617	0.482312	-0.444601	0.923776	0.0177658	1.02 [0.71 - 1.46]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215432_at	54	0.444444	0.145875	-	-0.8387	0.550298	-0.189339	0.83 [0.44 - 1.54]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215432_at	125	0.328	0.181913	-	-0.503365	0.967071	-0.014366	0.99 [0.50 - 1.95]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215432_at	125	0.416	0.316613	-	0.307221	0.612898	0.123965	1.13 [0.70 - 1.83]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215432_at	62	0.129032	0.130339	-	15.1993	0.549441	-0.156235	0.86 [0.51 - 1.43]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215432_at	198	0.863636	0.0506369	-	0.629783	0.421891	0.0609105	1.06 [0.92 - 1.23]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215432_at	198	0.747475	0.00217876	0.0485826	0.666719	0.158385	0.0833267	1.09 [0.97 - 1.22]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215432_at	198	0.863636	0.0135058	0.201906	0.740174	0.262902	0.0792782	1.08 [0.94 - 1.24]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215432_at	62	0.306452	0.124316	-	-0.861139	0.28372	-1.28513	0.28 [0.03 - 2.90]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215432_at	51	0.470588	0.0327742	0.375737	16.1137	0.516952	1.48442	4.41 [0.05 - 393.07]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215432_at	177	0.80226	0.00859964	0.144036	-0.952573	0.0600232	-1.32787	0.27 [0.07 - 1.06]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215432_at	145	0.586207	0.0312937	0.364392	-0.783079	0.146038	-1.52174	0.22 [0.03 - 1.70]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215432_at	177	0.242938	0.00415782	0.0818	-0.801915	0.105655	-1.31112	0.27 [0.06 - 1.32]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215432_at	226	0.884956	0.0646708	-	0.642387	0.186034	0.235554	1.27 [0.89 - 1.79]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215432_at	55	0.454545	0.0499436	0.491285	-0.974443	0.416291	-1.1885	0.30 [0.02 - 5.35]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215432_at	49	0.55102	0.109729	-	-1.02311	0.818102	0.418232	1.52 [0.04 - 53.65]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215432_at	55	0.236364	0.128625	-	-0.699647	0.805793	-0.343745	0.71 [0.05 - 10.99]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215432_at	63	0.126984	0.0432298	0.449251	-0.840218	0.199909	-3.54584	0.03 [0.00 - 6.53]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.98732.0.S1_3p_at	28	0.321429	0.0691516	-	-1.03791	0.591254	-0.907596	0.40 [0.01 - 11.08]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215432_at	204	0.112745	0.0267034	0.327468	-0.924467	0.411149	-0.16419	0.85 [0.57 - 1.26]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215432_at	204	0.691176	0.322126	-	0.281433	0.828079	-0.0318275	0.97 [0.73 - 1.29]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215432_at	111	0.792793	0.0156132	0.224438	0.715682	0.403406	0.141228	1.15 [0.83 - 1.60]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215432_at	90	0.666667	0.153551	-	0.528732	0.532775	0.411658	1.51 [0.41 - 5.50]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215432_at	90	0.866667	0.315906	-	-0.595921	0.839718	0.125115	1.13 [0.34 - 3.81]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215432_at	138	0.101449	0.022124	0.287621	-0.714499	0.310297	-2.33541	0.10 [0.00 - 8.81]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215432_at	129	0.705426	0.000582225	0.0161346	0.854828	0.138837	0.360587	1.43 [0.89 - 2.31]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21310	56	0.232143	0.0153095	0.221262	-0.915082	0.678998	-0.183732	0.83 [0.35 - 1.99]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21310	56	0.232143	0.0183932	0.25249	-0.930639	0.667968	-0.201447	0.82 [0.33 - 2.05]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215432_at	278	0.892086	0.0157398	0.225754	-0.906306	0.0744706	-0.955246	0.38 [0.13 - 1.10]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215432_at	133	0.857143	0.00189454	0.0433253	0.923661	0.00754352	1.53188	4.63 [1.50 - 14.23]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215432_at	185	0.102703	0.251949	-	0.346849	0.950201	-0.0206823	0.98 [0.51 - 1.87]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215432_at	185	0.124324	0.10106	-	0.431869	0.776874	0.0842487	1.09 [0.61 - 1.95]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106933	110	0.772727	0.0372185	0.408319	-0.645971	0.129398	-0.229026	0.80 [0.59 - 1.07]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106933	110	0.636364	0.181387	-	-0.427974	0.448702	-0.147255	0.86 [0.59 - 1.26]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215432_at	80	0.75	0.160099	-	-0.850594	0.588375	-0.114457	0.89 [0.59 - 1.35]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215432_at	38	0.157895	0.0420596	0.441543	-1.05322	0.0557836	-0.432884	0.65 [0.42 - 1.01]
GENE	ACSM1	acyl-CoA synthetase medium-chain family member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215432_at	140	0.892857	0.0591837	-	-1.27632	0.135595	-1.73599	0.18 [0.02 - 1.72]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1752269	165	0.127273	0.00714273	0.124949	-0.791846	0.948591	0.0100095	1.01 [0.75 - 1.37]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1752269	165	0.109091	0.00137233	0.0331926	-1.23453	0.522752	-0.140883	0.87 [0.56 - 1.34]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234483_at	163	0.349693	0.23255	-	-0.240735	0.638488	0.410381	1.51 [0.27 - 8.35]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	235724_at	163	0.239264	0.25764	-	0.276514	0.890668	0.112289	1.12 [0.23 - 5.55]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234484_s_at	163	0.742331	0.0956709	-	-0.392363	0.147835	-1.07758	0.34 [0.08 - 1.46]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	224882_at	163	0.754601	0.0708934	-	0.391073	0.959125	-0.0126341	0.99 [0.61 - 1.60]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234801_s_at	163	0.325153	0.28363	-	0.229893	0.859256	-0.143275	0.87 [0.18 - 4.22]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	235724_at	79	0.43038	0.0079987	0.136291	-0.761301	0.196389	-1.21392	0.30 [0.05 - 1.87]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234801_s_at	79	0.822785	0.196045	-	0.457521	0.255874	0.84523	2.33 [0.54 - 10.01]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234484_s_at	79	0.873418	0.0717182	-	-1.03079	0.230939	-1.05805	0.35 [0.06 - 1.96]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	224882_at	79	0.898734	0.148152	-	-0.837634	0.855809	-0.0549212	0.95 [0.52 - 1.71]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234483_at	79	0.772152	0.0733668	-	0.570181	0.72252	0.362022	1.44 [0.19 - 10.59]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	235724_at	180	0.866667	0.022914	0.294735	0.662513	0.042419	0.264507	1.30 [1.01 - 1.68]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234484_s_at	180	0.111111	0.119125	-	-0.449597	0.782745	-0.0590437	0.94 [0.62 - 1.43]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	224882_at	180	0.438889	0.123377	-	-0.322017	0.284377	-0.338144	0.71 [0.38 - 1.32]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234801_s_at	180	0.133333	0.045787	0.465689	-0.545855	0.157356	-0.156639	0.86 [0.69 - 1.06]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234483_at	180	0.111111	0.0102592	0.164597	-0.789252	0.593668	-0.0552314	0.95 [0.77 - 1.16]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	235724_at	559	0.488372	0.0512351	-	-0.393994	0.867907	-0.0256661	0.97 [0.72 - 1.32]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234484_s_at	559	0.171735	0.150601	-	-0.365414	0.57205	-0.12894	0.88 [0.56 - 1.37]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234801_s_at	559	0.207513	0.00981471	0.159202	-0.544779	0.328096	-0.154659	0.86 [0.63 - 1.17]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	224882_at	559	0.119857	0.243296	-	0.386717	0.576263	0.154282	1.17 [0.68 - 2.00]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234483_at	559	0.660107	0.00564548	0.104097	-0.656702	0.00826943	-0.326062	0.72 [0.57 - 0.92]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234484_s_at	77	0.584416	0.368148	-	0.235	0.958529	-0.0167421	0.98 [0.52 - 1.85]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	224882_at	77	0.103896	0.0204467	0.272153	-0.922801	0.153952	-0.464899	0.63 [0.33 - 1.19]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234801_s_at	77	0.545455	0.000473815	0.0135334	-0.931906	0.0101414	-0.408345	0.66 [0.49 - 0.91]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234483_at	77	0.246753	0.0808355	-	0.574133	0.40887	0.130985	1.14 [0.84 - 1.56]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	235724_at	77	0.194805	0.234879	-	-0.373921	0.702921	-0.0784363	0.92 [0.62 - 1.38]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	224882_at	70	0.371429	0.0527495	-	0.537968	0.331626	0.231773	1.26 [0.79 - 2.01]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234483_at	70	0.442857	0.068798	-	0.480808	0.0976321	1.74791	5.74 [0.73 - 45.43]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	235724_at	70	0.814286	0.0188365	0.256807	0.76742	0.44334	0.630686	1.88 [0.37 - 9.42]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234484_s_at	70	0.871429	0.0431975	0.449041	0.779147	0.315851	0.897118	2.45 [0.42 - 14.16]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234801_s_at	70	0.371429	0.0196261	0.264395	0.649888	0.387532	0.321782	1.38 [0.66 - 2.86]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	224882_at	74	0.878378	0.138287	-	0.603573	0.745144	0.144489	1.16 [0.48 - 2.76]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234801_s_at	74	0.851351	0.0538234	-	-0.972485	0.217147	-0.250804	0.78 [0.52 - 1.16]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234483_at	74	0.135135	0.00606817	0.110127	-0.998578	0.684761	-0.0744055	0.93 [0.65 - 1.33]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	235724_at	74	0.432432	0.0619512	-	-0.547004	0.786469	-0.0663878	0.94 [0.58 - 1.51]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234484_s_at	74	0.864865	2.69342e-09	2.1454e-07	2.04164	0.135061	0.672314	1.96 [0.81 - 4.73]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234801_s_at	67	0.850746	0.0072647	0.126588	1.62279	0.294158	1.11213	3.04 [0.38 - 24.29]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	235724_at	67	0.880597	0.14532	-	1.13599	0.599517	1.26334	3.54 [0.03 - 395.02]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234484_s_at	67	0.268657	0.0742302	-	15.4989	0.669896	1.01421	2.76 [0.03 - 292.17]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234483_at	67	0.19403	0.100653	-	15.4324	0.473759	2.54752	12.78 [0.01 - 13595.79]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	224882_at	67	0.895522	0.0458592	0.466145	1.50572	0.565677	0.725486	2.07 [0.17 - 24.55]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	224882_at	115	0.669565	0.049169	0.486616	1.02231	0.204726	0.642533	1.90 [0.70 - 5.13]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234483_at	115	0.652174	0.181833	-	0.698174	0.395359	-0.582713	0.56 [0.15 - 2.14]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234801_s_at	115	0.686957	0.100342	-	0.854498	0.597905	0.371339	1.45 [0.36 - 5.76]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	235724_at	115	0.226087	0.0353524	0.394897	15.446	0.0958993	1.73999	5.70 [0.73 - 44.18]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234484_s_at	115	0.895652	0.186254	-	-15.1878	0.933623	0.0287118	1.03 [0.52 - 2.02]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234483_at	204	0.245098	0.0253339	0.315891	-0.366731	0.427543	-0.0570046	0.94 [0.82 - 1.09]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	224882_at	204	0.867647	0.0289087	0.345553	-0.443475	0.414871	-0.0996438	0.91 [0.71 - 1.15]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234801_s_at	204	0.191176	0.0271538	0.331216	-0.398638	0.057428	-0.126907	0.88 [0.77 - 1.00]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	235724_at	204	0.455882	0.368567	-	0.128424	0.833466	0.0166848	1.02 [0.87 - 1.19]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234484_s_at	204	0.22549	0.036178	0.40088	-0.35505	0.434552	-0.0981494	0.91 [0.71 - 1.16]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234484_s_at	87	0.137931	0.0170927	0.239585	15.3024	0.0436668	1.82976	6.23 [1.05 - 36.88]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	224882_at	87	0.885057	0.000786183	0.0208137	1.37685	0.0568752	0.538375	1.71 [0.98 - 2.98]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	224882_at	87	0.885057	0.000786183	0.0208137	1.37685	0.0568752	0.538375	1.71 [0.98 - 2.98]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234483_at	87	0.816092	0.00430814	0.0841386	1.07601	0.127254	1.8266	6.21 [0.59 - 64.99]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234483_at	87	0.816092	0.00430814	0.0841386	1.07601	0.127254	1.8266	6.21 [0.59 - 64.99]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	235724_at	87	0.862069	0.0780225	-	-1.61527	0.523487	-0.447527	0.64 [0.16 - 2.53]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	235724_at	87	0.862069	0.0780225	-	-1.61527	0.523487	-0.447527	0.64 [0.16 - 2.53]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234484_s_at	87	0.137931	0.0170927	0.239585	15.3024	0.0436668	1.82976	6.23 [1.05 - 36.88]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234801_s_at	87	0.827586	0.0123874	0.189441	0.981927	0.0423738	0.675188	1.96 [1.02 - 3.77]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234801_s_at	87	0.827586	0.0123874	0.189441	0.981927	0.0423738	0.675188	1.96 [1.02 - 3.77]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	224882_at	77	0.428571	0.0365196	0.403335	-1.18649	0.266465	-0.389618	0.68 [0.34 - 1.35]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234483_at	77	0.883117	0.137004	-	0.947549	0.955835	-0.0795292	0.92 [0.06 - 15.41]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234483_at	77	0.103896	0.218639	-	-0.938625	0.537353	-1.09739	0.33 [0.01 - 10.91]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	224882_at	77	0.207792	0.107804	-	-0.996678	0.531858	-0.252994	0.78 [0.35 - 1.72]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	235724_at	77	0.87013	0.0130986	0.197412	1.38426	0.446358	-1.19424	0.30 [0.01 - 6.55]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234484_s_at	77	0.87013	0.00234555	0.0515969	1.5725	0.0928273	2.80508	16.53 [0.63 - 435.45]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234801_s_at	77	0.883117	0.183871	-	-15.2042	0.652439	-0.294246	0.75 [0.21 - 2.68]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234801_s_at	77	0.883117	0.248254	-	-15.2004	0.899691	-0.0920622	0.91 [0.22 - 3.82]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	235724_at	77	0.155844	0.00150291	0.0357918	-1.76944	0.0960838	-2.75921	0.06 [0.00 - 1.63]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234484_s_at	77	0.87013	0.077259	-	1.15497	0.465974	1.37252	3.95 [0.10 - 157.98]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6108	60	0.166667	0.0344909	0.388577	-0.906231	0.304811	-0.154042	0.86 [0.64 - 1.15]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6108	60	0.216667	0.335606	-	0.51339	0.63611	-0.0975218	0.91 [0.61 - 1.36]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224882_at	159	0.100629	0.00287006	0.0607783	-1.21801	0.139038	-0.838727	0.43 [0.14 - 1.31]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234801_s_at	159	0.113208	0.0232255	0.297511	-0.872483	0.0665257	-0.614499	0.54 [0.28 - 1.04]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234483_at	159	0.855346	0.0045173	0.0873579	0.967708	0.592191	0.113386	1.12 [0.74 - 1.70]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234801_s_at	159	0.113208	0.00472545	0.0905233	-1.16097	0.0379118	-0.864145	0.42 [0.19 - 0.95]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234483_at	159	0.301887	0.00313396	0.0652471	-0.904884	0.0821511	-0.333687	0.72 [0.49 - 1.04]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235724_at	159	0.63522	0.102126	-	0.512026	0.799553	0.0723852	1.08 [0.61 - 1.88]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235724_at	159	0.704403	0.0372383	0.40846	0.654432	0.998043	0.000712092	1.00 [0.57 - 1.77]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234483_at	159	0.855346	0.0606291	-	0.793413	0.731855	-0.0806611	0.92 [0.58 - 1.46]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235724_at	159	0.704403	0.0594336	-	0.6903	0.91503	0.035896	1.04 [0.54 - 2.00]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234484_s_at	159	0.698113	0.0420216	0.441291	0.641212	0.422363	0.302136	1.35 [0.65 - 2.83]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234484_s_at	159	0.125786	0.0620577	-	-0.722863	0.721225	0.136673	1.15 [0.54 - 2.43]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224882_at	159	0.100629	0.00994265	0.160763	-0.979998	0.205576	-0.615602	0.54 [0.21 - 1.40]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234484_s_at	159	0.641509	0.0915231	-	0.618339	0.660733	0.195998	1.22 [0.51 - 2.92]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224882_at	159	0.100629	0.00831577	0.140399	-1.00381	0.156108	-0.684867	0.50 [0.20 - 1.30]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234801_s_at	159	0.113208	0.00320524	0.0664385	-1.06628	0.0593761	-0.645449	0.52 [0.27 - 1.03]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234484_s_at	236	0.79661	0.203308	-	0.393672	0.894615	-0.0521723	0.95 [0.44 - 2.05]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	224882_at	236	0.860169	3.79836e-05	0.00148405	1.16132	0.00379346	1.12018	3.07 [1.44 - 6.54]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234801_s_at	236	0.898305	0.215875	-	-0.719883	0.972227	0.00719131	1.01 [0.67 - 1.51]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234483_at	236	0.894068	0.0012324	0.0303513	1.01501	0.0793867	0.380592	1.46 [0.96 - 2.24]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	235724_at	236	0.351695	0.0419244	0.440645	0.633983	0.42154	0.207797	1.23 [0.74 - 2.04]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234484_s_at	249	0.799197	0.179323	-	0.332978	0.985399	0.00563419	1.01 [0.55 - 1.84]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	224882_at	249	0.871486	0.000969481	0.0248309	0.84774	0.095286	0.545926	1.73 [0.91 - 3.28]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234801_s_at	249	0.899598	0.105929	-	-0.727461	0.787234	-0.0445072	0.96 [0.69 - 1.32]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234483_at	249	0.895582	0.0679773	-	0.543615	0.907867	-0.0179442	0.98 [0.72 - 1.33]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	235724_at	249	0.361446	0.108355	-	0.368711	0.714236	0.0790214	1.08 [0.71 - 1.65]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234483_at	177	0.124294	0.00122718	0.030244	-1.0172	0.0599136	-2.14015	0.12 [0.01 - 1.09]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234484_s_at	177	0.129944	0.021764	0.284343	-0.691177	0.151405	-0.994547	0.37 [0.10 - 1.44]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	224882_at	177	0.661017	0.162157	-	-0.365018	0.596665	-0.158451	0.85 [0.47 - 1.53]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	224882_at	177	0.638418	0.0639009	-	-0.566563	0.505703	-0.229084	0.80 [0.41 - 1.56]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234483_at	177	0.480226	0.000148605	0.00495928	-0.909668	0.0234824	-2.23386	0.11 [0.02 - 0.74]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234484_s_at	145	0.131034	0.0151951	0.220061	-0.908984	0.124913	-1.49574	0.22 [0.03 - 1.51]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	224882_at	145	0.158621	0.10501	-	-0.642508	0.580928	-0.245544	0.78 [0.33 - 1.87]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234483_at	145	0.606897	0.0781607	-	-0.644096	0.874126	-0.211088	0.81 [0.06 - 11.03]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234801_s_at	177	0.59322	0.00787801	0.134715	-0.803929	0.155863	-0.873266	0.42 [0.13 - 1.39]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	235724_at	177	0.581921	0.0277488	0.336124	-0.563587	0.0791538	-1.33069	0.26 [0.06 - 1.17]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	235724_at	177	0.259887	0.0314823	0.365852	-0.59028	0.170047	-1.18426	0.31 [0.06 - 1.66]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234484_s_at	177	0.129944	0.000818353	0.0215303	-1.02384	0.0919991	-1.33554	0.26 [0.06 - 1.24]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234801_s_at	177	0.627119	0.00563564	0.103956	-0.737578	0.120106	-0.829096	0.44 [0.15 - 1.24]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	235724_at	145	0.606897	0.019966	0.267625	-0.945731	0.14471	-1.60685	0.20 [0.02 - 1.74]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234801_s_at	145	0.241379	0.00858522	0.143852	-0.886327	0.0477141	-1.53988	0.21 [0.05 - 0.98]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	224882_at	226	0.221239	0.0447293	0.458956	-0.601241	0.3384	-0.25759	0.77 [0.46 - 1.31]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234483_at	226	0.10177	0.0232279	0.297533	-0.819688	0.620201	-0.0606877	0.94 [0.74 - 1.20]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	235724_at	226	0.787611	0.00289066	0.0611306	-1.59937	0.112647	-0.261046	0.77 [0.56 - 1.06]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234484_s_at	226	0.168142	0.31251	-	0.436741	0.766614	0.0986488	1.10 [0.58 - 2.12]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234801_s_at	226	0.393805	0.00313612	0.0652833	-0.826319	0.128687	-0.238134	0.79 [0.58 - 1.07]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	235724_at	55	0.545455	0.000781956	0.0207191	-1.84087	0.0125785	-3.65272	0.03 [0.00 - 0.46]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234801_s_at	55	0.327273	0.0245527	0.309163	-0.97449	0.052612	-1.70173	0.18 [0.03 - 1.02]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234483_at	55	0.109091	0.110191	-	15.2092	0.634701	0.858655	2.36 [0.07 - 81.52]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	224882_at	55	0.818182	0.0701662	-	0.911144	0.744841	0.134212	1.14 [0.51 - 2.57]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234483_at	49	0.77551	0.0907941	-	0.958113	0.230691	2.4903	12.06 [0.21 - 708.12]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	224882_at	49	0.408163	0.053538	-	-1.12411	0.590879	-0.300538	0.74 [0.25 - 2.21]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234801_s_at	55	0.672727	0.030499	0.358194	-1.45132	0.0606666	-1.79318	0.17 [0.03 - 1.08]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	235724_at	55	0.545455	0.0176394	0.245055	-1.26487	0.335538	-1.38117	0.25 [0.02 - 4.18]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234484_s_at	55	0.781818	0.20331	-	-0.927326	0.650887	-0.739715	0.48 [0.02 - 11.75]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234484_s_at	55	0.127273	0.0378465	0.412757	-1.02948	0.314776	-1.41432	0.24 [0.02 - 3.83]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	224882_at	55	0.4	0.133744	-	-0.662805	0.602051	-0.229655	0.79 [0.34 - 1.88]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234483_at	55	0.763636	0.0259817	0.321402	0.980282	0.142255	2.33415	10.32 [0.46 - 233.17]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234801_s_at	49	0.142857	0.0658037	-	-1.07952	0.0681916	-2.27929	0.10 [0.01 - 1.19]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	235724_at	49	0.367347	0.000587405	0.0162566	-1.9718	0.104489	-3.19787	0.04 [0.00 - 1.94]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234484_s_at	49	0.612245	0.291597	-	-0.689773	0.958089	-0.109847	0.90 [0.01 - 53.90]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	235724_at	63	0.888889	0.0173734	0.242402	0.983663	0.0246348	1.93233	6.91 [1.28 - 37.26]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234484_s_at	63	0.206349	0.000147285	0.00492071	-1.31078	0.793798	0.152923	1.17 [0.37 - 3.67]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234801_s_at	63	0.873016	0.0234499	0.299501	0.931471	0.0294213	0.426621	1.53 [1.04 - 2.25]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	224882_at	63	0.111111	0.00940093	0.154108	15.2977	0.368587	0.161295	1.18 [0.83 - 1.67]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234483_at	63	0.190476	0.0141903	0.209356	-0.894684	0.114188	-15.7057	0.00 [0.00 - 43.89]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.236001.0.A1_3p_at	28	0.357143	0.217816	-	-0.692907	0.696164	0.341684	1.41 [0.25 - 7.82]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.7218.0.A1_3p_at	28	0.214286	0.0458454	0.466058	-1.2349	0.199851	-5.40054	0.00 [0.00 - 17.40]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.287639.0.A1_3p_at	28	0.857143	0.0807369	-	1.09906	0.20552	5.54347	255.56 [0.05 - 1363954.01]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.287639.0.S1_3p_a_at	28	0.285714	0.0191692	0.260019	-1.31879	0.230169	0.723212	2.06 [0.63 - 6.72]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P120594	117	0.111111	8.35721e-05	0.00298954	-1.3085	0.00594912	-0.444977	0.64 [0.47 - 0.88]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P185689	117	0.487179	0.114851	-	-0.456258	0.285551	-0.144363	0.87 [0.66 - 1.13]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234801_s_at	204	0.5	0.000389276	0.011435	-1.4821	0.0117563	-0.501172	0.61 [0.41 - 0.89]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	235724_at	204	0.715686	0.211813	-	0.469965	0.602829	0.152703	1.16 [0.66 - 2.07]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234484_s_at	204	0.887255	0.0416502	0.438818	-15.209	0.984472	-0.00826241	0.99 [0.43 - 2.28]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234801_s_at	204	0.5	0.000353046	0.0105135	-1.02181	0.00303769	-0.456972	0.63 [0.47 - 0.86]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	235724_at	204	0.544118	0.0784761	-	-0.49706	0.620812	-0.097718	0.91 [0.62 - 1.34]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234484_s_at	204	0.661765	0.0423805	0.443669	0.549338	0.0868207	0.510642	1.67 [0.93 - 2.99]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234483_at	204	0.686275	0.00744885	0.129049	-1.48809	0.343474	-0.187249	0.83 [0.56 - 1.22]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	224882_at	204	0.240196	0.0634996	-	-0.690574	0.768456	-0.108011	0.90 [0.44 - 1.84]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234483_at	204	0.313726	0.0059791	0.108867	-0.734483	0.311477	-0.15063	0.86 [0.64 - 1.15]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	224882_at	204	0.401961	0.0641022	-	-0.498973	0.390005	-0.231085	0.79 [0.47 - 1.34]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234801_s_at	111	0.882883	0.0246487	0.309995	-1.25134	0.375722	-0.134548	0.87 [0.65 - 1.18]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	235724_at	111	0.117117	0.00867747	0.145027	-0.926258	0.590523	-0.100315	0.90 [0.63 - 1.30]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234484_s_at	111	0.837838	0.0269056	0.329154	0.669895	0.599221	0.171919	1.19 [0.63 - 2.25]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234483_at	111	0.207207	0.0592342	-	0.70791	0.22431	0.183078	1.20 [0.89 - 1.61]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	224882_at	111	0.387387	0.00050506	0.0142926	-0.89836	0.00637408	-0.86716	0.42 [0.23 - 0.78]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	224882_at	138	0.152174	0.000564263	0.0157097	-0.977749	0.0380659	-0.284802	0.75 [0.57 - 0.98]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234483_at	138	0.108696	0.000475945	0.0135854	-1.01466	0.0348226	-11.0503	0.00 [0.00 - 0.45]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	235724_at	138	0.202899	0.00645118	0.11549	-0.703355	0.966355	0.0476408	1.05 [0.11 - 9.60]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234484_s_at	138	0.23913	0.0115633	0.180006	-0.641146	0.668086	-1.2007	0.30 [0.00 - 72.81]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234801_s_at	138	0.231884	0.0174869	0.243537	-0.599564	0.058394	1.53944	4.66 [0.95 - 22.96]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5263	56	0.589286	0.273898	-	0.389179	0.592938	0.122891	1.13 [0.72 - 1.77]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27276	56	0.892857	0.281914	-	-0.640635	0.667269	-0.0888072	0.92 [0.61 - 1.37]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8455	56	0.875	0.262994	-	-0.665212	0.489151	-0.143259	0.87 [0.58 - 1.30]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27276	56	0.196429	0.169225	-	-0.557902	0.503841	-0.150725	0.86 [0.55 - 1.34]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5263	56	0.589286	0.18274	-	0.458226	0.359801	0.205335	1.23 [0.79 - 1.91]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8455	56	0.196429	0.0868205	-	-0.692983	0.357313	-0.208429	0.81 [0.52 - 1.27]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234483_at	278	0.406475	0.0167312	0.235932	0.485686	0.18929	0.731808	2.08 [0.70 - 6.20]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	224882_at	278	0.848921	0.114087	-	0.396832	0.703976	0.0701991	1.07 [0.75 - 1.54]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234801_s_at	278	0.21223	0.124794	-	0.370333	0.851261	0.0402384	1.04 [0.68 - 1.59]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	235724_at	278	0.5	0.078281	-	0.339657	0.81623	-0.0857276	0.92 [0.45 - 1.89]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234484_s_at	278	0.496403	0.181535	-	0.258265	0.816794	0.104139	1.11 [0.46 - 2.68]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P120594	110	0.709091	0.274389	-	-0.29007	0.306365	-0.135827	0.87 [0.67 - 1.13]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P185689	110	0.7	0.173446	-	-0.356714	0.421765	-0.13091	0.88 [0.64 - 1.21]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P120594	110	0.490909	0.0805404	-	0.519599	0.720298	0.0585833	1.06 [0.77 - 1.46]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P940831	110	0.8	0.10073	-	-0.547081	0.626386	-0.0415394	0.96 [0.81 - 1.13]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P185689	110	0.136364	0.124051	-	-0.576077	0.833942	-0.0413314	0.96 [0.65 - 1.41]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P940831	110	0.327273	0.19038	-	0.415644	0.844288	0.0228268	1.02 [0.81 - 1.28]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	235724_at	38	0.631579	0.0312573	0.364111	-1.16495	0.282039	-0.455602	0.63 [0.28 - 1.45]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234484_s_at	38	0.763158	0.103712	-	-0.998414	0.614077	-0.174119	0.84 [0.43 - 1.65]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234801_s_at	38	0.894737	0.00170278	0.0396823	2.00497	0.170039	0.945722	2.57 [0.67 - 9.94]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	224882_at	38	0.368421	0.124268	-	0.796181	0.937849	0.0260988	1.03 [0.53 - 1.98]
GENE	ACSS1	acyl-CoA synthetase short-chain family member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234483_at	38	0.421053	0.0227693	0.29344	-1.08533	0.284758	-0.274629	0.76 [0.46 - 1.26]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216548_x_at	30	0.866667	0.0101053	0.162738	1.40801	0.0388932	1.40885	4.09 [1.07 - 15.58]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1714197	165	0.793939	0.00818125	0.138662	0.681802	0.012354	0.545098	1.72 [1.13 - 2.64]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1714197	165	0.884848	0.00614234	0.111173	1.06985	0.0473221	0.633684	1.88 [1.01 - 3.53]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216548_x_at	163	0.159509	0.0578882	-	-0.469587	0.481037	-0.25043	0.78 [0.39 - 1.56]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226469_s_at	163	0.208589	0.0588325	-	0.508205	0.64646	-0.386649	0.68 [0.13 - 3.54]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226470_at	163	0.374233	0.0385544	0.417712	0.431651	0.25723	0.692569	2.00 [0.60 - 6.62]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234312_s_at	163	0.595092	0.00604234	0.109762	0.540348	0.0349343	0.496108	1.64 [1.04 - 2.60]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234312_s_at	79	0.443038	0.00440632	0.0856547	0.868939	0.00714676	0.815046	2.26 [1.25 - 4.09]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226470_at	79	0.126582	0.080245	-	1.00273	0.840191	-0.0772596	0.93 [0.44 - 1.96]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226469_s_at	79	0.291139	0.0266341	0.326888	-0.662458	0.120236	-1.13712	0.32 [0.08 - 1.35]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216548_x_at	79	0.278481	0.114993	-	-0.481254	0.825952	0.0637169	1.07 [0.60 - 1.88]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216548_x_at	58	0.12069	0.0564371	-	0.874874	0.514589	-0.0992199	0.91 [0.67 - 1.22]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216548_x_at	34	0.588235	0.0381661	0.415	0.817309	0.314757	0.3868	1.47 [0.69 - 3.13]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216548_x_at	158	0.481013	0.0268308	0.328531	-0.51803	0.0760923	-0.948911	0.39 [0.14 - 1.10]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216548_x_at	53	0.45283	0.120567	-	0.583995	0.556007	0.179026	1.20 [0.66 - 2.17]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216548_x_at	53	0.622642	0.0823694	-	0.592921	0.455383	0.213008	1.24 [0.71 - 2.16]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216548_x_at	180	0.183333	0.253803	-	-0.294082	0.821709	-0.0254098	0.97 [0.78 - 1.22]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226470_at	180	0.527778	0.0910719	-	0.352277	0.857782	0.0214303	1.02 [0.81 - 1.29]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234312_s_at	180	0.872222	0.0592286	-	0.542615	0.426686	0.262823	1.30 [0.68 - 2.49]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226469_s_at	180	0.883333	0.000777936	0.0206291	0.879224	0.587537	0.0701912	1.07 [0.83 - 1.38]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234312_s_at	559	0.214669	0.00641322	0.114963	0.790162	0.155929	0.281673	1.33 [0.90 - 1.96]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226469_s_at	559	0.316637	0.0228604	0.294255	-0.453079	0.212522	-0.161904	0.85 [0.66 - 1.10]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226470_at	559	0.715564	0.0254053	0.316502	-0.616969	0.095921	-0.178673	0.84 [0.68 - 1.03]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216548_x_at	559	0.73703	0.0103251	0.165392	0.525593	0.11745	0.239416	1.27 [0.94 - 1.71]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216548_x_at	77	0.766234	0.0212774	0.279877	0.673909	0.160902	0.228114	1.26 [0.91 - 1.73]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226470_at	77	0.272727	0.103899	-	-0.453755	0.72162	-0.0718699	0.93 [0.63 - 1.38]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234312_s_at	77	0.207792	0.0230404	0.295864	-0.673795	0.974462	-0.0189684	0.98 [0.31 - 3.13]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226469_s_at	77	0.207792	0.18681	-	-0.398962	0.622944	-0.0808569	0.92 [0.67 - 1.27]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216548_x_at	70	0.2	0.193798	-	-0.425822	0.855136	-0.0947245	0.91 [0.33 - 2.51]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234312_s_at	70	0.228571	0.0406118	0.431838	-0.603678	0.510363	-0.279609	0.76 [0.33 - 1.74]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226469_s_at	70	0.142857	0.0452439	0.462244	-0.711617	0.946009	0.0637357	1.07 [0.17 - 6.74]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226470_at	70	0.542857	0.124998	-	0.404814	0.436345	-0.350355	0.70 [0.29 - 1.70]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216548_x_at	74	0.5	0.0111671	0.175389	0.737855	0.0775246	0.397068	1.49 [0.96 - 2.31]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234312_s_at	74	0.608108	5.02612e-05	0.00190479	1.17279	0.00606707	1.69409	5.44 [1.62 - 18.25]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226469_s_at	74	0.891892	0.0898149	-	0.685665	0.745841	-0.078154	0.92 [0.58 - 1.48]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226470_at	74	0.378378	0.00624966	0.11268	-0.780464	0.0988321	-1.02514	0.36 [0.11 - 1.21]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226470_at	67	0.149254	0.00094006	0.0241964	-2.00718	0.310389	-1.69561	0.18 [0.01 - 4.86]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234312_s_at	67	0.850746	0.0112168	0.17597	1.55557	0.155698	2.49949	12.18 [0.39 - 383.85]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226469_s_at	67	0.567164	0.217083	-	-0.955796	0.532946	-0.99391	0.37 [0.02 - 8.42]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216548_x_at	67	0.820895	0.137945	-	-15.3553	0.503091	-0.958138	0.38 [0.02 - 6.34]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226470_at	115	0.669565	0.0298206	0.352841	-1.93442	0.149047	-0.819655	0.44 [0.14 - 1.34]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234312_s_at	115	0.113043	0.213185	-	-0.793251	0.946264	-0.0648125	0.94 [0.14 - 6.17]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226469_s_at	115	0.443478	0.299341	-	-0.551516	0.963641	-0.0319412	0.97 [0.25 - 3.82]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216548_x_at	115	0.504348	0.0214272	0.281257	1.3817	0.179253	0.786328	2.20 [0.70 - 6.92]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216548_x_at	204	0.421569	0.000179553	0.00585076	0.525461	0.0028233	0.345025	1.41 [1.13 - 1.77]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226470_at	204	0.210784	0.000222451	0.00705055	-0.63293	0.0268837	-0.215595	0.81 [0.67 - 0.98]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234312_s_at	204	0.151961	0.00303406	0.0635664	-0.577207	0.160018	-0.286872	0.75 [0.50 - 1.12]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226469_s_at	204	0.29902	0.00292183	0.0616623	-0.463698	0.0124836	-0.263208	0.77 [0.63 - 0.94]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216548_x_at	87	0.344828	0.141493	-	0.631716	0.397491	0.252038	1.29 [0.72 - 2.31]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226469_s_at	87	0.885057	0.0582004	-	0.857732	0.464189	0.416505	1.52 [0.50 - 4.63]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216548_x_at	87	0.344828	0.141493	-	0.631716	0.397491	0.252038	1.29 [0.72 - 2.31]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234312_s_at	87	0.114943	3.20097e-08	2.21072e-06	-2.02136	0.554937	-0.320791	0.73 [0.25 - 2.10]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234312_s_at	87	0.114943	3.20097e-08	2.21072e-06	-2.02136	0.554937	-0.320791	0.73 [0.25 - 2.10]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226469_s_at	87	0.885057	0.0582004	-	0.857732	0.464189	0.416505	1.52 [0.50 - 4.63]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226470_at	87	0.149425	0.00167011	0.0390531	-1.24224	0.712092	-0.112495	0.89 [0.49 - 1.62]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226470_at	87	0.149425	0.00167011	0.0390531	-1.24224	0.712092	-0.112495	0.89 [0.49 - 1.62]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216548_x_at	77	0.272727	0.0378373	0.412692	15.5914	0.138382	0.891512	2.44 [0.75 - 7.93]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216548_x_at	77	0.272727	0.0171413	0.240075	15.5989	0.0787753	0.932326	2.54 [0.90 - 7.18]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234312_s_at	77	0.883117	0.176284	-	-15.2112	0.670814	-0.302468	0.74 [0.18 - 2.98]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226469_s_at	77	0.662338	0.0170164	0.238816	1.27742	0.16806	0.490002	1.63 [0.81 - 3.28]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226470_at	77	0.623377	0.0136527	0.203516	1.37438	0.153886	0.492026	1.64 [0.83 - 3.22]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226470_at	77	0.857143	0.010388	0.166147	1.5119	0.187561	0.510551	1.67 [0.78 - 3.56]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234312_s_at	77	0.168831	0.18595	-	-0.885135	0.659456	-0.37099	0.69 [0.13 - 3.59]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226469_s_at	77	0.662338	0.0472756	0.475011	1.2091	0.2051	0.505647	1.66 [0.76 - 3.62]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216548_x_at	136	0.132353	0.18466	-	-0.683155	0.955404	0.0134321	1.01 [0.63 - 1.62]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216548_x_at	200	0.855	0.000160918	0.00531689	1.15148	0.0383128	0.418084	1.52 [1.02 - 2.26]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19174	60	0.433333	0.218615	-	0.493039	0.456649	0.205692	1.23 [0.71 - 2.11]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19174	60	0.833333	0.170325	-	0.588553	0.204048	0.397206	1.49 [0.81 - 2.75]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216548_x_at	286	0.297203	0.0573416	-	0.431253	0.697764	0.0602165	1.06 [0.78 - 1.44]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216548_x_at	159	0.566038	0.0561561	-	0.705752	0.40707	0.194852	1.22 [0.77 - 1.93]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216548_x_at	159	0.301887	0.0463028	0.468939	0.807405	0.368785	0.178968	1.20 [0.81 - 1.77]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216548_x_at	159	0.566038	0.318687	-	0.314491	0.929969	0.0167907	1.02 [0.70 - 1.48]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234312_s_at	159	0.899371	0.00520137	0.097626	1.05849	0.275295	0.678472	1.97 [0.58 - 6.67]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226469_s_at	159	0.194969	0.133432	-	-0.525878	0.462243	-0.191601	0.83 [0.50 - 1.38]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234312_s_at	159	0.899371	0.000754373	0.0200998	1.35806	0.116275	1.12807	3.09 [0.76 - 12.63]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226469_s_at	159	0.389937	0.117266	-	-0.49081	0.561653	-0.151563	0.86 [0.52 - 1.43]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226469_s_at	159	0.163522	0.0651267	-	-0.749114	0.240706	-0.356114	0.70 [0.39 - 1.27]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226470_at	159	0.578616	0.0100651	0.162252	0.810297	0.496848	-0.155552	0.86 [0.55 - 1.34]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226470_at	159	0.54717	0.0878478	-	0.539409	0.537776	-0.139855	0.87 [0.56 - 1.36]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226470_at	159	0.578616	0.0414375	0.437396	0.752865	0.824868	-0.0618017	0.94 [0.54 - 1.63]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234312_s_at	159	0.899371	0.00307423	0.0642438	1.11383	0.188822	0.818979	2.27 [0.67 - 7.69]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216548_x_at	117	0.264957	0.0286788	0.343698	-0.704688	0.398508	-0.251443	0.78 [0.43 - 1.39]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216548_x_at	117	0.264957	0.000400366	0.0117143	-1.25847	0.0338692	-0.765818	0.46 [0.23 - 0.94]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216548_x_at	117	0.136752	0.0106518	0.169301	-1.07361	0.309231	-0.37603	0.69 [0.33 - 1.42]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216548_x_at	117	0.264957	0.0286788	0.343698	-0.704688	0.398508	-0.251443	0.78 [0.43 - 1.39]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216548_x_at	236	0.788136	8.85314e-06	0.000400095	1.17076	0.0522689	0.40991	1.51 [1.00 - 2.28]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226470_at	236	0.5	0.00882971	0.146957	-0.72677	0.208915	-0.337438	0.71 [0.42 - 1.21]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234312_s_at	236	0.258475	0.311872	-	0.338806	0.977651	-0.0196564	0.98 [0.25 - 3.88]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226469_s_at	236	0.241525	0.0610365	-	-0.532891	0.594692	-0.147221	0.86 [0.50 - 1.48]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216548_x_at	249	0.815261	1.40805e-05	0.000608817	0.995534	0.028662	0.372229	1.45 [1.04 - 2.03]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226470_at	249	0.594378	0.00543772	0.101088	-0.643924	0.253768	-0.255591	0.77 [0.50 - 1.20]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234312_s_at	249	0.891566	0.0777106	-	0.525077	0.594714	0.295706	1.34 [0.45 - 4.00]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226469_s_at	249	0.269076	0.0570976	-	-0.426461	0.557904	-0.130091	0.88 [0.57 - 1.36]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216548_x_at	62	0.870968	0.108	-	0.898084	0.958669	-0.00806833	0.99 [0.73 - 1.35]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216548_x_at	125	0.888	0.0520524	-	-15.2032	0.640117	-0.270702	0.76 [0.25 - 2.37]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216548_x_at	125	0.36	0.060454	-	0.58461	0.6585	0.185618	1.20 [0.53 - 2.74]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216548_x_at	54	0.277778	0.0504577	-	15.4884	0.85447	0.0349045	1.04 [0.71 - 1.50]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216548_x_at	198	0.10101	0.0195962	0.264111	2.00277	0.674925	0.0351393	1.04 [0.88 - 1.22]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216548_x_at	198	0.10101	0.037411	0.409684	1.834	0.470813	0.0646682	1.07 [0.89 - 1.27]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216548_x_at	198	0.848485	0.147387	-	-0.483568	0.94626	0.00462237	1.00 [0.88 - 1.15]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216548_x_at	51	0.882353	4.81847e-05	0.00183461	2.7788	0.0173297	5.19782	180.88 [2.50 - 13082.47]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216548_x_at	62	0.887097	0.00107845	0.0271502	1.78163	0.106983	1.71581	5.56 [0.69 - 44.80]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216548_x_at	177	0.305085	0.0151293	0.219368	0.827776	0.874025	-0.0599193	0.94 [0.45 - 1.98]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226469_s_at	177	0.728814	0.0307622	0.360255	-0.650686	0.265737	-0.426335	0.65 [0.31 - 1.38]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226469_s_at	145	0.103448	0.0996125	-	1.52082	0.746125	-0.172608	0.84 [0.30 - 2.39]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216548_x_at	177	0.293785	0.1442	-	0.39495	0.938425	0.0253649	1.03 [0.54 - 1.95]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226470_at	177	0.79096	0.0800882	-	0.526726	0.938893	0.0189249	1.02 [0.63 - 1.65]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234312_s_at	177	0.881356	0.104617	-	-0.684197	0.645271	-0.119304	0.89 [0.53 - 1.47]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234312_s_at	177	0.881356	0.111342	-	-0.813057	0.845381	-0.0588288	0.94 [0.52 - 1.70]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226469_s_at	177	0.824859	0.0485816	0.483045	-0.896093	0.168126	-0.62151	0.54 [0.22 - 1.30]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226470_at	177	0.740113	0.0650435	-	0.464037	0.718311	0.0771357	1.08 [0.71 - 1.64]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216548_x_at	145	0.689655	0.0583883	-	-0.778488	0.377401	-0.423856	0.65 [0.26 - 1.68]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234312_s_at	145	0.496552	0.00957029	0.156201	-0.888471	0.242787	-0.425123	0.65 [0.32 - 1.33]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226470_at	145	0.227586	0.0350251	0.392506	-0.736938	0.912363	-0.0343722	0.97 [0.52 - 1.78]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216548_x_at	226	0.464602	0.187598	-	-0.373989	0.591299	-0.143486	0.87 [0.51 - 1.46]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234312_s_at	226	0.557522	0.0271498	0.331183	-0.660465	0.0302937	-0.493667	0.61 [0.39 - 0.95]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226469_s_at	226	0.641593	0.0615646	-	-0.628687	0.813075	0.035528	1.04 [0.77 - 1.39]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226470_at	226	0.769912	0.190506	-	0.402388	0.577579	0.0766326	1.08 [0.82 - 1.41]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216548_x_at	55	0.345455	0.00824677	0.139509	-1.13147	0.637438	-0.35565	0.70 [0.16 - 3.08]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234312_s_at	55	0.181818	0.00851082	0.142902	-1.17054	0.549938	-0.267818	0.77 [0.32 - 1.84]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226470_at	55	0.363636	0.0268482	0.328676	-0.964598	0.129386	-0.932672	0.39 [0.12 - 1.31]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216548_x_at	55	0.145455	0.0513909	-	15.3074	0.588681	0.443098	1.56 [0.31 - 7.76]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216548_x_at	49	0.142857	0.248111	-	15.1958	0.918475	0.103723	1.11 [0.15 - 8.08]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226470_at	55	0.127273	0.074641	-	-0.99962	0.933677	0.0470833	1.05 [0.35 - 3.18]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234312_s_at	55	0.890909	0.2816	-	0.660376	0.468896	0.346819	1.41 [0.55 - 3.62]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226469_s_at	55	0.654545	0.0132289	0.198856	-1.63095	0.0341922	-1.86915	0.15 [0.03 - 0.87]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226469_s_at	55	0.4	0.0027108	0.0580348	-1.33378	0.0101465	-2.14367	0.12 [0.02 - 0.60]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226470_at	49	0.122449	0.0504096	-	-1.25571	0.212509	-1.11788	0.33 [0.06 - 1.90]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234312_s_at	49	0.77551	0.260402	-	-1.11786	0.996064	-0.00288695	1.00 [0.32 - 3.14]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226469_s_at	49	0.142857	0.00886816	0.147442	-1.50469	0.0284024	-2.404	0.09 [0.01 - 0.78]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	239883	34	0.205882	0.200867	-	-0.652903	0.670898	-0.130362	0.88 [0.48 - 1.60]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216548_x_at	63	0.412698	0.0321582	0.371049	-0.713017	0.846811	-0.16318	0.85 [0.16 - 4.45]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234312_s_at	63	0.269841	0.0864865	-	0.754098	0.993364	-0.00276917	1.00 [0.52 - 1.92]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226469_s_at	63	0.730159	0.0789592	-	0.60717	0.793154	-0.134427	0.87 [0.32 - 2.39]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226470_at	63	0.238095	0.00466038	0.0895378	-0.98761	0.357009	-0.545939	0.58 [0.18 - 1.85]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.14779.1.A1_3p_a_at	28	0.892857	0.126995	-	-15.2751	0.421304	-1.7003	0.18 [0.00 - 11.52]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.272268.0.S1_3p_at	28	0.142857	0.0685508	-	-1.19105	0.789931	-0.435324	0.65 [0.03 - 15.92]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.100997.0.A2_3p_at	28	0.178571	0.0416912	0.439092	-1.25205	0.252098	-2.76799	0.06 [0.00 - 7.16]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216548_x_at	82	0.170732	0.150667	-	-0.54829	0.920466	-0.0263903	0.97 [0.58 - 1.64]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216548_x_at	79	0.898734	0.071189	-	-1.03661	0.283169	-0.190466	0.83 [0.58 - 1.17]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216548_x_at	104	0.653846	0.184671	-	0.437837	0.61414	0.125895	1.13 [0.70 - 1.85]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P156295	117	0.74359	0.115558	-	0.475516	0.134526	0.238325	1.27 [0.93 - 1.73]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226470_at	204	0.230392	0.000297871	0.00908017	-1.24649	0.221662	-0.342575	0.71 [0.41 - 1.23]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234312_s_at	204	0.372549	0.00578807	0.106145	-0.988043	0.502396	-0.260171	0.77 [0.36 - 1.65]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226469_s_at	204	0.740196	0.0894649	-	-0.883618	0.226013	-0.415166	0.66 [0.34 - 1.29]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226470_at	204	0.235294	0.0416001	0.438483	-0.589214	0.488485	-0.157589	0.85 [0.55 - 1.33]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234312_s_at	204	0.348039	0.00203126	0.0458742	-0.817675	0.235293	-0.343308	0.71 [0.40 - 1.25]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226469_s_at	204	0.892157	0.0171319	0.23998	-2.0363	0.0777384	-0.442845	0.64 [0.39 - 1.05]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216548_x_at	204	0.784314	0.000634678	0.0173623	1.18943	0.0553861	0.528766	1.70 [0.99 - 2.91]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216548_x_at	204	0.779412	0.00102011	0.0259143	0.897328	0.122352	0.32231	1.38 [0.92 - 2.08]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216548_x_at	178	0.320225	0.195472	-	0.283332	0.915654	-0.0171979	0.98 [0.72 - 1.35]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226470_at	111	0.117117	0.131106	-	0.764571	0.526339	0.164105	1.18 [0.71 - 1.96]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234312_s_at	111	0.126126	0.00954199	0.155852	-0.884239	0.117115	-0.748357	0.47 [0.19 - 1.21]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226469_s_at	111	0.855856	0.000651955	0.0177628	1.03511	0.00560705	0.653806	1.92 [1.21 - 3.05]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216548_x_at	111	0.108108	0.00671349	0.119111	2.23786	0.033581	0.458283	1.58 [1.04 - 2.41]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216548_x_at	90	0.888889	0.00360479	0.073003	1.11469	0.00358195	1.01434	2.76 [1.39 - 5.46]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216548_x_at	90	0.888889	0.00339394	0.0695624	1.20572	0.000761922	1.22267	3.40 [1.67 - 6.92]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1843	50	0.7	0.0532244	-	0.904688	0.522507	0.444406	1.56 [0.40 - 6.09]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234312_s_at	138	0.123188	0.0853331	-	0.860499	0.994715	0.00100975	1.00 [0.74 - 1.35]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226469_s_at	138	0.536232	0.052279	-	-0.473333	0.379443	-0.345608	0.71 [0.33 - 1.53]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226470_at	138	0.231884	0.338681	-	-0.267073	0.729703	-0.0512432	0.95 [0.71 - 1.27]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216548_x_at	138	0.369565	0.0425847	0.445017	0.539795	0.873418	0.0188417	1.02 [0.81 - 1.28]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216548_x_at	129	0.891473	0.0716249	-	-1.02092	0.805013	-0.0469429	0.95 [0.66 - 1.39]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42567	56	0.696429	0.0140416	0.207749	0.897564	0.0509283	0.414652	1.51 [1.00 - 2.30]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42785	56	0.357143	0.0520421	-	0.720466	0.152713	0.461462	1.59 [0.84 - 2.99]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42567	56	0.607143	0.0292241	0.348086	0.753507	0.101174	0.322957	1.38 [0.94 - 2.03]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42785	56	0.875	0.0476389	0.477259	0.895509	0.0878332	0.598721	1.82 [0.92 - 3.62]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216548_x_at	278	0.733813	0.194022	-	-0.287262	0.58165	-0.102463	0.90 [0.63 - 1.30]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226470_at	278	0.892086	0.0190972	0.259326	0.616264	0.0739447	0.283247	1.33 [0.97 - 1.81]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234312_s_at	278	0.158273	0.0537137	-	0.546076	0.989066	-0.00267472	1.00 [0.68 - 1.46]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226469_s_at	278	0.71223	0.0262735	0.323863	0.432185	0.159813	0.354152	1.42 [0.87 - 2.33]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216548_x_at	133	0.654135	0.00298748	0.0627781	-0.825472	0.0400257	-0.558042	0.57 [0.34 - 0.97]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	648	81	0.111111	0.0120476	0.185578	-1.29051	0.275908	-0.536138	0.59 [0.22 - 1.53]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216548_x_at	185	0.135135	0.0566467	-	-0.436123	0.720967	-0.0942536	0.91 [0.54 - 1.53]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216548_x_at	185	0.108108	0.253221	-	-0.279528	0.691376	-0.0955347	0.91 [0.57 - 1.46]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P156295	110	0.890909	0.0778004	-	0.602124	0.589698	0.0692614	1.07 [0.83 - 1.38]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P210900	110	0.790909	0.00193767	0.0441336	0.777298	0.128226	0.358451	1.43 [0.90 - 2.27]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P156295	110	0.827273	0.146763	-	0.518041	0.399752	0.135545	1.15 [0.84 - 1.57]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P210900	110	0.881818	0.0565034	-	0.678168	0.269732	0.301726	1.35 [0.79 - 2.31]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216548_x_at	80	0.4	0.0978244	-	-0.714088	0.830333	-0.0379931	0.96 [0.68 - 1.36]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234312_s_at	38	0.736842	0.00285157	0.0604616	1.46675	0.108647	0.845501	2.33 [0.83 - 6.54]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226469_s_at	38	0.894737	0.0134042	0.20079	1.5268	0.133883	0.720314	2.06 [0.80 - 5.27]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226470_at	38	0.710526	0.00679395	0.120213	1.35897	0.0655318	0.84252	2.32 [0.95 - 5.69]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216548_x_at	38	0.5	0.000707231	0.0190316	1.77729	0.00273539	1.93702	6.94 [1.95 - 24.64]
GENE	ACSS2	acyl-CoA synthetase short-chain family member 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216548_x_at	140	0.75	0.00118128	0.0292975	0.918874	0.00088659	1.64115	5.16 [1.96 - 13.58]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACY1	aminoacylase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202740_at	30	0.866667	0.115834	-	-1.10978	0.458009	-0.192144	0.83 [0.50 - 1.37]
GENE	ACY1	aminoacylase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1683883	165	0.218182	0.0486809	0.48365	-0.527211	0.640214	0.0705523	1.07 [0.80 - 1.44]
GENE	ACY1	aminoacylase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1683883	165	0.218182	0.00241738	0.05288	-1.04681	0.493845	-0.142251	0.87 [0.58 - 1.30]
GENE	ACY1	aminoacylase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202740_at	163	0.116564	0.0430519	0.448088	-0.545566	0.994064	0.00164489	1.00 [0.65 - 1.54]
GENE	ACY1	aminoacylase 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238849_at	163	0.374233	0.0960108	-	0.349782	0.570852	-0.424694	0.65 [0.15 - 2.84]
GENE	ACY1	aminoacylase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238849_at	79	0.392405	0.137778	-	-0.434455	0.79537	0.23518	1.27 [0.21 - 7.48]
GENE	ACY1	aminoacylase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202740_at	79	0.56962	0.0555741	-	0.55761	0.43739	0.190059	1.21 [0.75 - 1.95]
GENE	ACY1	aminoacylase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202740_at	58	0.810345	0.00673042	0.119343	0.944609	0.0385089	0.990556	2.69 [1.05 - 6.88]
GENE	ACY1	aminoacylase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202740_at	34	0.411765	0.0241913	0.306017	-0.886506	0.0318158	-1.16653	0.31 [0.11 - 0.90]
GENE	ACY1	aminoacylase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202740_at	158	0.278481	0.0015838	0.0373784	0.992426	0.0101971	0.62722	1.87 [1.16 - 3.02]
GENE	ACY1	aminoacylase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202740_at	53	0.716981	0.0017669	0.0409097	1.11375	0.117964	0.595726	1.81 [0.86 - 3.83]
GENE	ACY1	aminoacylase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202740_at	53	0.716981	0.0197234	0.265322	0.806718	0.244063	0.403643	1.50 [0.76 - 2.95]
GENE	ACY1	aminoacylase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202740_at	180	0.716667	0.117679	-	0.353008	0.691707	0.0892348	1.09 [0.70 - 1.70]
GENE	ACY1	aminoacylase 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238849_at	180	0.844444	0.0977208	-	0.425262	0.661977	0.0774132	1.08 [0.76 - 1.53]
GENE	ACY1	aminoacylase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238849_at	559	0.261181	0.00118004	0.0292719	-0.643653	0.128301	-0.26683	0.77 [0.54 - 1.08]
GENE	ACY1	aminoacylase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202740_at	559	0.629696	0.155886	-	0.285888	0.709212	0.099727	1.10 [0.65 - 1.87]
GENE	ACY1	aminoacylase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202740_at	77	0.805195	0.0106054	0.168748	0.783791	0.537958	0.187872	1.21 [0.66 - 2.19]
GENE	ACY1	aminoacylase 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238849_at	77	0.181818	0.0788065	-	0.626676	0.915587	0.0249185	1.03 [0.65 - 1.63]
GENE	ACY1	aminoacylase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238849_at	70	0.642857	0.154355	-	0.38452	0.310864	0.706257	2.03 [0.52 - 7.94]
GENE	ACY1	aminoacylase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202740_at	70	0.871429	0.0238916	0.303394	-1.11581	0.278349	-0.478721	0.62 [0.26 - 1.47]
GENE	ACY1	aminoacylase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37713_at	50	0.82	0.0100154	0.161648	1.17505	0.486086	-0.401989	0.67 [0.22 - 2.07]
GENE	ACY1	aminoacylase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202740_at	74	0.324324	0.0914249	-	0.542288	0.632824	0.204075	1.23 [0.53 - 2.83]
GENE	ACY1	aminoacylase 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238849_at	74	0.824324	0.0676407	-	-0.787272	0.492226	-0.184017	0.83 [0.49 - 1.41]
GENE	ACY1	aminoacylase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238849_at	67	0.641791	0.00327288	0.0675632	1.90241	0.3617	1.96355	7.12 [0.10 - 484.37]
GENE	ACY1	aminoacylase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202740_at	67	0.626866	0.0457746	0.46561	1.32081	0.714321	0.328994	1.39 [0.24 - 8.09]
GENE	ACY1	aminoacylase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238849_at	115	0.104348	0.1376	-	-0.92942	0.254721	-0.610486	0.54 [0.19 - 1.55]
GENE	ACY1	aminoacylase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202740_at	115	0.208696	0.122799	-	-0.832479	0.499798	-0.47729	0.62 [0.16 - 2.48]
GENE	ACY1	aminoacylase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37713_at	158	0.405063	0.0728735	-	-0.502644	0.403248	-0.299086	0.74 [0.37 - 1.50]
GENE	ACY1	aminoacylase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37713_at	76	0.513158	0.0860665	-	0.967488	0.887756	0.0745927	1.08 [0.38 - 3.04]
GENE	ACY1	aminoacylase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202740_at	204	0.27451	0.00548447	0.101768	-0.446497	0.0739638	-0.279739	0.76 [0.56 - 1.03]
GENE	ACY1	aminoacylase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238849_at	204	0.843137	0.0048557	0.0924854	0.549199	0.852404	0.0199365	1.02 [0.83 - 1.26]
GENE	ACY1	aminoacylase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202740_at	87	0.183908	0.0127588	0.193623	-1.01285	0.0535526	-0.66257	0.52 [0.26 - 1.01]
GENE	ACY1	aminoacylase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238849_at	87	0.816092	0.0600061	-	-1.29005	0.558162	-0.477635	0.62 [0.13 - 3.07]
GENE	ACY1	aminoacylase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238849_at	87	0.816092	0.0600061	-	-1.29005	0.558162	-0.477635	0.62 [0.13 - 3.07]
GENE	ACY1	aminoacylase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202740_at	87	0.183908	0.0127588	0.193623	-1.01285	0.0535526	-0.66257	0.52 [0.26 - 1.01]
GENE	ACY1	aminoacylase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202740_at	77	0.792208	0.0157135	0.225481	1.40929	0.444999	0.399904	1.49 [0.53 - 4.16]
GENE	ACY1	aminoacylase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238849_at	77	0.831169	0.00128431	0.0314125	1.61279	0.0336504	2.67677	14.54 [1.23 - 171.84]
GENE	ACY1	aminoacylase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202740_at	77	0.727273	0.0151559	0.219648	1.26646	0.292925	0.477073	1.61 [0.66 - 3.92]
GENE	ACY1	aminoacylase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238849_at	77	0.87013	0.0678359	-	1.18978	0.566116	0.88298	2.42 [0.12 - 49.36]
GENE	ACY1	aminoacylase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202740_at	136	0.102941	0.0679292	-	-0.984296	0.459582	-0.438046	0.65 [0.20 - 2.06]
GENE	ACY1	aminoacylase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202740_at	200	0.275	0.241656	-	0.416126	0.474472	-0.248932	0.78 [0.39 - 1.54]
GENE	ACY1	aminoacylase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3016	60	0.616667	0.202987	-	0.477826	0.604249	0.151563	1.16 [0.66 - 2.06]
GENE	ACY1	aminoacylase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3016	60	0.65	0.122956	-	-0.66354	0.852778	-0.0557454	0.95 [0.52 - 1.70]
GENE	ACY1	aminoacylase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1740	155	0.245161	0.0695965	-	-0.536122	0.69192	0.0516979	1.05 [0.82 - 1.36]
GENE	ACY1	aminoacylase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202740_at	286	0.244755	0.0147955	0.215835	-0.500939	0.0100772	-0.615496	0.54 [0.34 - 0.86]
GENE	ACY1	aminoacylase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202740_at	159	0.880503	2.17177e-05	0.000899473	1.36703	0.0229359	0.705199	2.02 [1.10 - 3.72]
GENE	ACY1	aminoacylase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202740_at	159	0.830189	0.00305611	0.0639384	0.984635	0.0260396	0.70989	2.03 [1.09 - 3.80]
GENE	ACY1	aminoacylase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202740_at	159	0.880503	0.000145488	0.00486809	1.41505	0.0242412	0.811776	2.25 [1.11 - 4.56]
GENE	ACY1	aminoacylase 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238849_at	159	0.352201	0.00240373	0.0526368	1.65565	0.550297	0.190746	1.21 [0.65 - 2.26]
GENE	ACY1	aminoacylase 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238849_at	159	0.352201	0.0208807	0.276204	0.884467	0.50841	0.181019	1.20 [0.70 - 2.05]
GENE	ACY1	aminoacylase 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238849_at	159	0.352201	0.0554073	-	0.710725	0.672883	-0.127487	0.88 [0.49 - 1.59]
GENE	ACY1	aminoacylase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202740_at	54	0.5	0.206117	-	0.870941	0.948129	0.0359071	1.04 [0.35 - 3.06]
GENE	ACY1	aminoacylase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202740_at	117	0.880342	0.0347117	0.390205	-1.8611	0.816303	0.0569917	1.06 [0.65 - 1.71]
GENE	ACY1	aminoacylase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202740_at	117	0.880342	0.0369235	0.406222	-15.2337	0.53941	0.184275	1.20 [0.67 - 2.17]
GENE	ACY1	aminoacylase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202740_at	117	0.863248	0.0330548	0.377859	-15.2596	0.938311	-0.0235928	0.98 [0.54 - 1.78]
GENE	ACY1	aminoacylase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202740_at	117	0.880342	0.0347117	0.390205	-1.8611	0.816303	0.0569917	1.06 [0.65 - 1.71]
GENE	ACY1	aminoacylase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202740_at	236	0.131356	0.0269901	0.329857	1.46033	0.0900997	0.6508	1.92 [0.90 - 4.07]
GENE	ACY1	aminoacylase 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238849_at	236	0.84322	4.40114e-05	0.00169241	1.13928	0.201551	0.445415	1.56 [0.79 - 3.09]
GENE	ACY1	aminoacylase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202740_at	249	0.710843	0.000678788	0.018381	0.720755	0.0167137	0.7139	2.04 [1.14 - 3.66]
GENE	ACY1	aminoacylase 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238849_at	249	0.714859	0.00212497	0.0475997	0.66218	0.131174	0.476492	1.61 [0.87 - 2.99]
GENE	ACY1	aminoacylase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202740_at	125	0.144	0.118844	-	0.903625	0.488217	0.184352	1.20 [0.71 - 2.03]
GENE	ACY1	aminoacylase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202740_at	54	0.888889	0.0217529	0.284242	1.3246	0.761342	0.13184	1.14 [0.49 - 2.67]
GENE	ACY1	aminoacylase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202740_at	62	0.129032	0.0021676	0.0483792	-1.41588	0.813917	-0.0831565	0.92 [0.46 - 1.84]
GENE	ACY1	aminoacylase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202740_at	125	0.336	0.08192	-	0.841376	0.291681	0.359562	1.43 [0.73 - 2.80]
GENE	ACY1	aminoacylase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202740_at	198	0.378788	0.124956	-	0.344424	0.583696	0.096547	1.10 [0.78 - 1.56]
GENE	ACY1	aminoacylase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202740_at	198	0.10101	0.0384012	0.416644	-0.707953	0.52078	-0.135323	0.87 [0.58 - 1.32]
GENE	ACY1	aminoacylase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202740_at	198	0.10101	0.0311789	0.363502	-0.767872	0.37186	-0.198342	0.82 [0.53 - 1.27]
GENE	ACY1	aminoacylase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202740_at	62	0.870968	0.0961741	-	1.063	0.749161	-0.149758	0.86 [0.34 - 2.16]
GENE	ACY1	aminoacylase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202740_at	51	0.490196	0.015879	0.227198	-16.3669	0.0566279	-1.16716	0.31 [0.09 - 1.03]
GENE	ACY1	aminoacylase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238849_at	177	0.350282	0.00113176	0.028268	-0.758098	0.00132318	-2.20912	0.11 [0.03 - 0.42]
GENE	ACY1	aminoacylase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202740_at	177	0.819209	0.0174726	0.243394	-1.17325	0.0872756	-0.442587	0.64 [0.39 - 1.07]
GENE	ACY1	aminoacylase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238849_at	145	0.806897	0.0139876	0.207164	-1.61053	0.0531402	-1.83413	0.16 [0.02 - 1.03]
GENE	ACY1	aminoacylase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202740_at	177	0.474576	0.0181068	0.24968	-0.556587	0.123682	-0.349662	0.70 [0.45 - 1.10]
GENE	ACY1	aminoacylase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238849_at	177	0.299435	0.000254777	0.00793162	-0.960595	0.000582226	-2.82255	0.06 [0.01 - 0.30]
GENE	ACY1	aminoacylase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202740_at	145	0.462069	0.0138278	0.205428	-0.832713	0.107518	-0.541201	0.58 [0.30 - 1.13]
GENE	ACY1	aminoacylase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238849_at	226	0.743363	0.0133591	0.200293	-1.0329	0.191503	-0.21201	0.81 [0.59 - 1.11]
GENE	ACY1	aminoacylase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202740_at	226	0.20354	0.0102976	0.165061	-0.765551	0.0631484	-0.420458	0.66 [0.42 - 1.02]
GENE	ACY1	aminoacylase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202740_at	55	0.672727	0.199135	-	-0.703505	0.898532	-0.0439786	0.96 [0.49 - 1.88]
GENE	ACY1	aminoacylase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202740_at	55	0.381818	0.0417792	0.439679	1.2155	0.196171	0.493161	1.64 [0.78 - 3.46]
GENE	ACY1	aminoacylase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202740_at	49	0.22449	0.22824	-	1.18772	0.688457	0.206821	1.23 [0.45 - 3.38]
GENE	ACY1	aminoacylase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238849_at	55	0.109091	0.000886052	0.0230217	-1.75907	0.0101832	-3.96464	0.02 [0.00 - 0.39]
GENE	ACY1	aminoacylase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238849_at	55	0.109091	1.86247e-05	0.000783396	-1.9275	0.00435524	-3.83587	0.02 [0.00 - 0.30]
GENE	ACY1	aminoacylase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238849_at	49	0.102041	0.000844684	0.022113	-1.89336	0.0364292	-3.44083	0.03 [0.00 - 0.80]
GENE	ACY1	aminoacylase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	120522	34	0.852941	0.0618509	-	-1.71858	0.831532	-0.123638	0.88 [0.28 - 2.76]
GENE	ACY1	aminoacylase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202740_at	63	0.238095	0.349821	-	-0.34926	0.923627	-0.0172119	0.98 [0.69 - 1.40]
GENE	ACY1	aminoacylase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238849_at	63	0.206349	5.60714e-05	0.00209932	-1.37062	0.761229	1.39558	4.04 [0.00 - 32772.68]
GENE	ACY1	aminoacylase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501900_3p_at	28	0.642857	0.00455572	0.0879451	-2.37021	0.0609778	-2.15055	0.12 [0.01 - 1.10]
GENE	ACY1	aminoacylase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.236025.0.A1_3p_at	28	0.25	0.0468457	0.472336	-1.13531	0.101127	-13.6278	0.00 [0.00 - 14.37]
GENE	ACY1	aminoacylase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202740_at	82	0.292683	0.10518	-	-0.552485	0.970918	0.0226174	1.02 [0.30 - 3.45]
GENE	ACY1	aminoacylase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37713_at	84	0.142857	0.144136	-	0.683743	0.469537	0.160018	1.17 [0.76 - 1.81]
GENE	ACY1	aminoacylase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202740_at	79	0.822785	0.174703	-	0.438597	0.923988	0.0288618	1.03 [0.57 - 1.86]
GENE	ACY1	aminoacylase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	L07548_at	86	0.5	0.0458711	0.46622	0.869613	0.255583	0.689994	1.99 [0.61 - 6.55]
GENE	ACY1	aminoacylase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202740_at	104	0.884615	0.119743	-	0.679302	0.750147	0.1745	1.19 [0.41 - 3.49]
GENE	ACY1	aminoacylase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P57868	117	0.393162	0.205406	-	0.384338	0.914452	-0.0321331	0.97 [0.54 - 1.74]
GENE	ACY1	aminoacylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238849_at	204	0.872549	0.0167292	0.235911	0.95206	0.383437	0.227399	1.26 [0.75 - 2.09]
GENE	ACY1	aminoacylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238849_at	204	0.642157	0.0637174	-	0.500936	0.406633	0.16903	1.18 [0.79 - 1.77]
GENE	ACY1	aminoacylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202740_at	204	0.436274	0.00652934	0.116573	1.17454	0.154209	0.635269	1.89 [0.79 - 4.52]
GENE	ACY1	aminoacylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202740_at	204	0.411765	0.0164382	0.232948	0.714011	0.0217512	0.776996	2.17 [1.12 - 4.22]
GENE	ACY1	aminoacylase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202740_at	178	0.882023	0.0881934	-	-0.591714	0.832756	0.0683022	1.07 [0.57 - 2.02]
GENE	ACY1	aminoacylase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200019660	41	0.268293	0.156562	-	0.764365	0.390104	0.306838	1.36 [0.68 - 2.74]
GENE	ACY1	aminoacylase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238849_at	111	0.288288	0.00737246	0.128031	0.938886	0.770923	0.0607035	1.06 [0.71 - 1.60]
GENE	ACY1	aminoacylase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202740_at	111	0.441441	0.0274361	0.333551	0.60596	0.20478	0.319966	1.38 [0.84 - 2.26]
GENE	ACY1	aminoacylase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202740_at	90	0.822222	0.000272555	0.00840883	1.20354	0.000942794	1.39223	4.02 [1.76 - 9.18]
GENE	ACY1	aminoacylase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202740_at	90	0.822222	0.0021348	0.0477797	1.1699	0.0051401	1.3864	4.00 [1.51 - 10.56]
GENE	ACY1	aminoacylase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238849_at	138	0.297101	0.00321948	0.0666758	-0.704961	0.595924	-2.70765	0.07 [0.00 - 1480.96]
GENE	ACY1	aminoacylase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202740_at	138	0.413043	0.0558761	-	0.485264	0.235762	0.1885	1.21 [0.88 - 1.65]
GENE	ACY1	aminoacylase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202740_at	129	0.868217	0.223081	-	-0.557421	0.832319	0.0746683	1.08 [0.54 - 2.15]
GENE	ACY1	aminoacylase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32700	56	0.107143	0.00134631	0.0326688	-1.56866	0.315856	-0.319036	0.73 [0.39 - 1.36]
GENE	ACY1	aminoacylase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32700	56	0.107143	0.0143897	0.211502	-1.19566	0.774418	-0.0871741	0.92 [0.50 - 1.66]
GENE	ACY1	aminoacylase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202740_at	278	0.392086	0.00649654	0.116119	-0.513747	0.210973	-0.197908	0.82 [0.60 - 1.12]
GENE	ACY1	aminoacylase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238849_at	278	0.115108	0.164734	-	0.506509	0.855401	-0.0759235	0.93 [0.41 - 2.10]
GENE	ACY1	aminoacylase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202740_at	133	0.789474	0.00218573	0.0487095	0.786351	0.0497947	0.276331	1.32 [1.00 - 1.74]
GENE	ACY1	aminoacylase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8626	81	0.790123	0.0284333	0.34171	1.12672	0.505965	0.175256	1.19 [0.71 - 2.00]
GENE	ACY1	aminoacylase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202740_at	185	0.637838	0.00130155	0.031763	-0.609462	0.0143986	-0.357347	0.70 [0.53 - 0.93]
GENE	ACY1	aminoacylase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202740_at	185	0.648649	0.000768923	0.020427	-0.584931	0.0146968	-0.327324	0.72 [0.55 - 0.94]
GENE	ACY1	aminoacylase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P57868	110	0.827273	0.0187454	0.255923	0.666625	0.278559	0.188992	1.21 [0.86 - 1.70]
GENE	ACY1	aminoacylase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P57868	110	0.827273	0.0423168	0.443248	0.738897	0.81458	0.0548741	1.06 [0.67 - 1.67]
GENE	ACY1	aminoacylase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202740_at	80	0.875	0.317819	-	0.558644	0.929223	0.0234371	1.02 [0.61 - 1.72]
GENE	ACY1	aminoacylase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3091	281	0.192171	0.00889958	0.147839	-0.445602	0.291083	-0.106717	0.90 [0.74 - 1.10]
GENE	ACY1	aminoacylase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:270248	59	0.20339	0.00189161	0.0432703	-1.45082	0.0992935	-1.4122	0.24 [0.05 - 1.31]
GENE	ACY1	aminoacylase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:741988	59	0.101695	0.0275584	0.334559	-1.37515	0.755658	-0.253285	0.78 [0.16 - 3.83]
GENE	ACY1	aminoacylase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:51293	59	0.220339	0.0311502	0.363279	-1.02399	0.382392	-0.602291	0.55 [0.14 - 2.12]
GENE	ACY1	aminoacylase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:199315	59	0.677966	0.0751707	-	-1.2544	0.540925	-0.538194	0.58 [0.10 - 3.28]
GENE	ACY1	aminoacylase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:713675	59	0.169492	0.0490278	0.48576	-0.964315	0.193898	-1.37212	0.25 [0.03 - 2.01]
GENE	ACY1	aminoacylase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202740_at	38	0.894737	0.00838643	0.141308	1.4314	0.0864644	0.704067	2.02 [0.90 - 4.52]
GENE	ACY1	aminoacylase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238849_at	38	0.868421	0.0773209	-	0.975142	0.869675	0.0666711	1.07 [0.48 - 2.37]
GENE	ACY1	aminoacylase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202740_at	140	0.264286	6.5771e-09	4.9874e-07	-1.54137	9.72034e-06	-1.33994	0.26 [0.14 - 0.47]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1670193	165	0.642424	0.0138195	0.205337	-0.675514	0.588214	-0.305924	0.74 [0.24 - 2.23]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1670193	165	0.266667	0.117808	-	0.744654	0.624717	0.373909	1.45 [0.32 - 6.50]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	230481_at	163	0.331288	0.0378141	0.412529	0.457334	0.250903	0.289248	1.34 [0.82 - 2.19]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	230481_at	79	0.303797	0.0907373	-	-0.504548	0.498506	-0.217283	0.80 [0.43 - 1.51]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554974_at	79	0.240506	0.0291245	0.347287	0.825128	0.821637	0.0871252	1.09 [0.51 - 2.33]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	230481_at	180	0.133333	0.082775	-	-0.453422	0.930372	-0.00894219	0.99 [0.81 - 1.21]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	230481_at	559	0.119857	0.0246987	0.310428	-0.555211	0.148247	-0.116589	0.89 [0.76 - 1.04]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554974_at	559	0.753131	0.0238927	0.303404	-0.607118	0.265271	-0.10306	0.90 [0.75 - 1.08]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	230481_at	77	0.805195	0.218429	-	-0.42272	0.778318	0.0971867	1.10 [0.56 - 2.17]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	230481_at	70	0.314286	0.0701159	-	-0.505681	0.85946	0.097222	1.10 [0.38 - 3.23]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554974_at	70	0.228571	0.00758828	0.1309	-0.783929	0.797068	-0.196132	0.82 [0.18 - 3.66]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	230481_at	74	0.891892	0.0790333	-	0.709003	0.413914	0.31614	1.37 [0.64 - 2.93]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554974_at	67	0.432836	0.0235432	0.300326	2.06946	0.897378	0.24845	1.28 [0.03 - 55.93]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	230481_at	67	0.701493	0.0696559	-	-15.5206	0.581339	-1.11257	0.33 [0.01 - 17.15]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	230481_at	115	0.443478	0.231435	-	0.696219	0.37885	0.955747	2.60 [0.31 - 21.85]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554974_at	115	0.626087	0.181506	-	-0.846728	0.790209	-0.0767612	0.93 [0.53 - 1.63]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554974_at	204	0.343137	0.0306749	0.359573	0.324996	0.0849901	0.122375	1.13 [0.98 - 1.30]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	230481_at	204	0.205882	0.0209706	0.277039	-0.40358	0.669288	-0.0343982	0.97 [0.83 - 1.13]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	230481_at	87	0.804598	0.0877033	-	-1.00564	0.377125	-0.643523	0.53 [0.13 - 2.19]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	230481_at	87	0.804598	0.0877033	-	-1.00564	0.377125	-0.643523	0.53 [0.13 - 2.19]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554974_at	87	0.195402	0.0404545	0.430772	1.39065	0.950683	0.0447729	1.05 [0.25 - 4.32]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554974_at	87	0.195402	0.0404545	0.430772	1.39065	0.950683	0.0447729	1.05 [0.25 - 4.32]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	230481_at	77	0.896104	0.00406552	0.0803533	1.56667	0.0114239	1.61915	5.05 [1.44 - 17.70]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554974_at	77	0.857143	0.00351418	0.0715306	1.51792	0.314848	1.47764	4.38 [0.25 - 78.19]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	230481_at	77	0.896104	0.0125708	0.191512	1.56418	0.029556	1.61121	5.01 [1.17 - 21.38]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554974_at	77	0.103896	0.0267395	0.32777	-1.41075	0.810113	-0.407078	0.67 [0.02 - 18.42]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7077	60	0.416667	0.0691284	-	0.77726	0.167967	0.847911	2.33 [0.70 - 7.79]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7077	60	0.4	0.108102	-	-0.597365	0.215006	0.51281	1.67 [0.74 - 3.76]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230481_at	159	0.144654	0.0844593	-	1.58519	0.985257	0.00588757	1.01 [0.54 - 1.88]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230481_at	159	0.666667	0.0879066	-	-0.635642	0.849548	-0.0531172	0.95 [0.55 - 1.64]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230481_at	159	0.226415	0.0357958	0.398119	1.05682	0.898763	-0.0353127	0.97 [0.56 - 1.66]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	230481_at	236	0.898305	4.76042e-05	0.00181492	1.2531	0.00774352	1.37964	3.97 [1.44 - 10.97]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	230481_at	249	0.899598	0.00118651	0.0294056	0.916941	0.181243	0.532891	1.70 [0.78 - 3.72]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	230481_at	145	0.524138	0.00262951	0.0566201	-1.0713	0.0386751	-1.3382	0.26 [0.07 - 0.93]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554974_at	145	0.848276	0.0187776	0.256235	-2.02186	0.0127959	-2.60867	0.07 [0.01 - 0.57]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	230481_at	177	0.536723	0.0167948	0.236577	-0.577341	0.130431	-0.664882	0.51 [0.22 - 1.22]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	230481_at	177	0.497175	0.000995376	0.0253863	-0.928362	0.111975	-0.803365	0.45 [0.17 - 1.21]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554974_at	177	0.870057	0.0226221	0.292119	-1.11566	0.0376732	-1.35421	0.26 [0.07 - 0.93]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554974_at	177	0.870057	0.0212133	0.279286	-1.51334	0.0810885	-1.30662	0.27 [0.06 - 1.18]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	230481_at	226	0.362832	9.29551e-05	0.0032839	-1.08051	0.115339	-0.183721	0.83 [0.66 - 1.05]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554974_at	226	0.420354	0.0339418	0.384506	-0.596742	0.186993	-0.149402	0.86 [0.69 - 1.08]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	230481_at	55	0.218182	0.0280238	0.338376	-1.05081	0.652638	0.307244	1.36 [0.36 - 5.18]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554974_at	55	0.890909	0.0324261	0.373093	1.3068	0.190003	1.18542	3.27 [0.56 - 19.26]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	230481_at	49	0.22449	0.0205667	0.273276	-1.26264	0.130369	-1.74233	0.18 [0.02 - 1.67]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554974_at	49	0.22449	0.0581045	-	-1.06393	0.351926	-1.50116	0.22 [0.01 - 5.26]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	230481_at	55	0.272727	0.00319505	0.0662686	-1.24273	0.482414	-0.545367	0.58 [0.13 - 2.65]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554974_at	55	0.327273	0.0119498	0.184459	-1.08086	0.68314	-0.463844	0.63 [0.07 - 5.83]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	230481_at	63	0.222222	0.000328474	0.00987994	-1.21965	0.218057	-7.10217	0.00 [0.00 - 66.65]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554974_at	63	0.333333	0.000733477	0.0196278	-1.10143	0.449471	-4.06707	0.02 [0.00 - 647.45]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.126265.0.A1_3p_at	28	0.214286	0.195204	-	-0.780011	0.501578	-2.69385	0.07 [0.00 - 174.71]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.126265.2.S1_3p_at	28	0.285714	0.0473916	0.475729	-1.11911	0.186404	-8.85963	0.00 [0.00 - 72.44]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P47102	117	0.239316	0.129105	-	0.578644	0.492705	0.0849388	1.09 [0.85 - 1.39]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	230481_at	204	0.892157	0.000752273	0.0200525	1.30546	0.00860962	1.05077	2.86 [1.31 - 6.26]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554974_at	204	0.877451	0.0195388	0.263562	0.9723	0.465064	0.192434	1.21 [0.72 - 2.03]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	230481_at	204	0.887255	0.00103747	0.0262834	1.03045	0.00444693	0.795889	2.22 [1.28 - 3.84]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554974_at	204	0.877451	0.0034854	0.071061	0.926967	0.2038	0.24781	1.28 [0.87 - 1.88]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	230481_at	111	0.189189	0.132797	-	-0.460742	0.912832	0.0147867	1.01 [0.78 - 1.32]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554974_at	111	0.891892	0.170014	-	-0.69941	0.322121	-0.179245	0.84 [0.59 - 1.19]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	230481_at	138	0.811594	0.0491403	0.486442	0.544154	0.857405	0.0577118	1.06 [0.56 - 1.99]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554974_at	138	0.195652	0.103491	-	-0.437615	0.908301	-0.0653962	0.94 [0.31 - 2.85]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29085	56	0.232143	0.00398838	0.079138	-1.06118	0.0863407	-1.292	0.27 [0.06 - 1.20]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29085	56	0.232143	0.00184228	0.0423406	-1.15948	0.0667188	-1.38116	0.25 [0.06 - 1.10]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	230481_at	278	0.140288	2.61518e-05	0.00106271	-1.03147	0.255866	-0.307603	0.74 [0.43 - 1.25]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554974_at	278	0.798561	0.00486611	0.0926416	-0.731768	0.0600733	-0.884963	0.41 [0.16 - 1.04]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P47102	110	0.281818	0.00340912	0.0698118	-0.707392	0.0108771	-0.506707	0.60 [0.41 - 0.89]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P47102	110	0.390909	0.0142465	0.209962	-0.72078	0.127004	-0.413583	0.66 [0.39 - 1.12]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	230481_at	38	0.342105	0.123278	-	-0.812319	0.122279	-0.885005	0.41 [0.13 - 1.27]
GENE	ACY3	aspartoacylase (aminocyclase) 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554974_at	38	0.631579	0.00979029	0.158903	-1.41513	0.136876	-0.412617	0.66 [0.38 - 1.14]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205260_s_at	30	0.6	0.254619	-	0.474994	0.842223	0.0549288	1.06 [0.62 - 1.81]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1694233	165	0.115152	0.0622258	-	0.858455	0.293348	0.191702	1.21 [0.85 - 1.73]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1694233	165	0.854545	0.144072	-	0.614697	0.231321	0.327337	1.39 [0.81 - 2.37]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205260_s_at	163	0.865031	0.00622515	0.112337	0.705009	0.150145	0.207487	1.23 [0.93 - 1.63]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205260_s_at	79	0.898734	0.00526057	0.0984971	1.1707	0.282243	0.200217	1.22 [0.85 - 1.76]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205260_s_at	58	0.862069	0.0259837	0.321419	0.845567	0.156834	0.270814	1.31 [0.90 - 1.91]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205260_s_at	34	0.205882	0.130044	-	-0.685767	0.53756	-0.109065	0.90 [0.63 - 1.27]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205260_s_at	158	0.85443	0.0296655	0.351609	-0.896515	0.191743	-0.248607	0.78 [0.54 - 1.13]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205260_s_at	53	0.264151	0.00688547	0.121462	-0.98225	0.0935295	-0.764095	0.47 [0.19 - 1.14]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205260_s_at	53	0.867925	0.0205844	0.273443	-2.00642	0.167161	-0.56908	0.57 [0.25 - 1.27]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205260_s_at	180	0.666667	0.0304469	0.357785	-0.516089	0.222875	-0.280703	0.76 [0.48 - 1.19]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205260_s_at	559	0.867621	0.00141504	0.0340481	0.823195	0.0594722	0.37958	1.46 [0.98 - 2.17]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205260_s_at	77	0.883117	0.0183293	0.251865	0.883599	0.0983483	0.387889	1.47 [0.93 - 2.33]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205260_s_at	70	0.357143	0.00481678	0.0919007	0.834044	0.0188662	0.587205	1.80 [1.10 - 2.94]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33334_at	50	0.46	0.026027	0.321785	0.804074	0.0210067	0.67349	1.96 [1.11 - 3.47]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205260_s_at	74	0.77027	0.00287339	0.0608354	0.907308	0.371195	0.325159	1.38 [0.68 - 2.82]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205260_s_at	67	0.626866	0.0936594	-	-1.60305	0.214673	-0.912267	0.40 [0.10 - 1.70]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205260_s_at	115	0.773913	0.175549	-	0.739055	0.748048	0.236927	1.27 [0.30 - 5.38]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33334_at	158	0.670886	0.00934559	0.153421	-0.89958	0.0565006	-0.638382	0.53 [0.27 - 1.02]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33334_at	76	0.407895	0.0347207	0.39027	-1.10041	0.17033	-1.03285	0.36 [0.08 - 1.56]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205260_s_at	204	0.833333	0.0528235	-	0.363027	0.336513	0.130681	1.14 [0.87 - 1.49]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205260_s_at	87	0.701149	0.0295112	0.35038	0.804082	0.136796	0.592987	1.81 [0.83 - 3.95]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205260_s_at	87	0.701149	0.0295112	0.35038	0.804082	0.136796	0.592987	1.81 [0.83 - 3.95]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205260_s_at	77	0.662338	0.0360988	0.400309	-1.88853	0.354669	-0.417508	0.66 [0.27 - 1.59]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205260_s_at	77	0.428571	0.068155	-	-1.1883	0.322007	-0.512745	0.60 [0.22 - 1.65]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205260_s_at	136	0.102941	0.169337	-	-0.858343	0.725878	0.166224	1.18 [0.47 - 2.99]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205260_s_at	200	0.795	0.00104877	0.0265231	1.0019	0.397065	0.310988	1.36 [0.66 - 2.80]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8300	60	0.15	0.103958	-	-0.739335	0.899305	-0.0377831	0.96 [0.54 - 1.73]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8300	60	0.6	0.0107919	0.170966	-1.0714	0.169325	-0.387141	0.68 [0.39 - 1.18]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15192	155	0.845161	4.84979e-05	0.00184521	1.13485	0.0125471	0.321374	1.38 [1.07 - 1.77]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205260_s_at	286	0.660839	0.0726668	-	0.351329	0.581305	0.126865	1.14 [0.72 - 1.78]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205260_s_at	159	0.440252	0.0165808	0.234402	0.82507	0.197774	0.522064	1.69 [0.76 - 3.73]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205260_s_at	159	0.698113	0.454287	-	-0.271906	0.729155	0.14299	1.15 [0.51 - 2.59]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205260_s_at	159	0.477987	0.0881657	-	0.654554	0.30636	0.488203	1.63 [0.64 - 4.15]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205260_s_at	54	0.537037	0.0561602	-	1.42445	0.032113	0.859421	2.36 [1.08 - 5.18]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205260_s_at	117	0.418803	0.107001	-	0.55202	0.535732	0.193745	1.21 [0.66 - 2.24]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205260_s_at	117	0.435897	0.0873318	-	0.701284	0.330651	0.339906	1.40 [0.71 - 2.79]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205260_s_at	117	0.461538	0.0259216	0.320893	0.949538	0.120489	0.525657	1.69 [0.87 - 3.28]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205260_s_at	117	0.418803	0.107001	-	0.55202	0.535732	0.193745	1.21 [0.66 - 2.24]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205260_s_at	236	0.300847	0.00428161	0.0837275	-0.756494	0.129265	-0.480164	0.62 [0.33 - 1.15]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205260_s_at	249	0.698795	0.336724	-	0.216655	0.815449	0.0646365	1.07 [0.62 - 1.84]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205260_s_at	125	0.288	0.0900277	-	0.620543	0.436478	0.17705	1.19 [0.76 - 1.86]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205260_s_at	54	0.111111	0.0158891	0.227302	-1.52368	0.475986	-0.217225	0.80 [0.44 - 1.46]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205260_s_at	62	0.112903	0.138053	-	-0.930079	0.735816	-0.0834929	0.92 [0.57 - 1.49]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205260_s_at	125	0.312	0.0913725	-	0.812565	0.364839	0.266852	1.31 [0.73 - 2.33]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205260_s_at	198	0.232323	0.0182107	0.250701	-0.533045	0.333191	-0.118601	0.89 [0.70 - 1.13]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205260_s_at	198	0.222222	0.000405938	0.0118541	-0.897546	0.0561211	-0.267996	0.76 [0.58 - 1.01]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205260_s_at	198	0.222222	0.00357086	0.0724527	-0.785027	0.0938213	-0.246146	0.78 [0.59 - 1.04]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205260_s_at	62	0.387097	0.368265	-	-0.513877	0.87809	0.0797534	1.08 [0.39 - 3.00]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205260_s_at	51	0.215686	0.316832	-	-0.885276	0.535417	-0.479025	0.62 [0.14 - 2.82]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205260_s_at	145	0.510345	0.0177895	0.246546	0.821699	0.155372	0.481376	1.62 [0.83 - 3.14]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205260_s_at	177	0.711864	1.86931e-05	0.000785984	1.12335	0.00394427	0.795944	2.22 [1.29 - 3.81]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205260_s_at	177	0.677966	7.96534e-06	0.000363521	1.01788	0.0058868	0.662982	1.94 [1.21 - 3.11]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205260_s_at	226	0.809735	0.00681342	0.120479	0.838279	0.119075	0.395519	1.49 [0.90 - 2.44]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205260_s_at	55	0.181818	0.396004	-	-0.435217	0.812597	-0.0820101	0.92 [0.47 - 1.81]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205260_s_at	55	0.472727	0.24139	-	0.540158	0.837737	0.079866	1.08 [0.50 - 2.33]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205260_s_at	49	0.693878	0.203571	-	0.7312	0.407384	0.455596	1.58 [0.54 - 4.63]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	415388	34	0.323529	0.0843756	-	-0.753217	0.677635	-0.174824	0.84 [0.37 - 1.91]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205260_s_at	63	0.619048	0.0853976	-	-0.637569	0.321485	-0.231604	0.79 [0.50 - 1.25]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557244_3p_a_at	28	0.464286	0.00417993	0.0821454	-1.72844	0.160854	-1.48313	0.23 [0.03 - 1.80]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557244_3p_x_at	28	0.428571	0.00313533	0.06527	-1.59439	0.0179786	-1.5141	0.22 [0.06 - 0.77]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205260_s_at	82	0.426829	0.0300094	0.354337	0.785816	0.129369	0.420533	1.52 [0.88 - 2.62]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33334_at	84	0.690476	0.000815119	0.0214585	0.966419	0.037943	0.852305	2.35 [1.05 - 5.24]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205260_s_at	79	0.177215	0.206453	-	-0.396041	0.802869	-0.0752698	0.93 [0.51 - 1.67]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X84194_at	86	0.360465	0.072481	-	0.950122	0.750865	0.112885	1.12 [0.56 - 2.25]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205260_s_at	104	0.394231	0.112337	-	0.550028	0.739802	0.109863	1.12 [0.58 - 2.13]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P163143	117	0.897436	0.104946	-	0.651667	0.556267	0.153406	1.17 [0.70 - 1.94]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205260_s_at	204	0.52451	0.000148761	0.00496383	-1.6623	0.0297359	-0.82367	0.44 [0.21 - 0.92]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205260_s_at	204	0.539216	0.000276523	0.00851467	-1.0784	0.0158721	-0.674495	0.51 [0.29 - 0.88]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205260_s_at	178	0.421348	0.123261	-	-0.304341	0.950366	-0.0127528	0.99 [0.66 - 1.48]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200002740	41	0.634146	0.0230868	0.296277	0.925813	0.262823	0.522737	1.69 [0.68 - 4.21]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205260_s_at	111	0.153153	0.0348477	0.391204	-0.675711	0.138764	-0.34844	0.71 [0.44 - 1.12]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205260_s_at	90	0.111111	0.0205059	0.272707	-0.937542	0.607382	-0.131761	0.88 [0.53 - 1.45]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205260_s_at	90	0.111111	0.0728183	-	-0.857672	0.983044	0.00588277	1.01 [0.58 - 1.73]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4080	50	0.78	0.119085	-	0.78155	0.282452	0.456699	1.58 [0.69 - 3.63]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205260_s_at	138	0.391304	0.0257003	0.319016	0.576617	0.202015	0.16785	1.18 [0.91 - 1.53]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205260_s_at	129	0.124031	0.00711568	0.124584	-0.895565	0.883241	0.0377531	1.04 [0.63 - 1.72]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2160	56	0.107143	0.194852	-	-0.627204	0.949034	0.0223047	1.02 [0.52 - 2.03]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2160	56	0.642857	0.128067	-	0.516046	0.861839	0.0578882	1.06 [0.55 - 2.03]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205260_s_at	278	0.140288	0.0490106	0.485655	-0.476436	0.671782	-0.0691185	0.93 [0.68 - 1.28]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205260_s_at	133	0.736842	0.0317145	0.367644	-0.618453	0.240992	-0.220693	0.80 [0.55 - 1.16]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9064	81	0.111111	0.0304999	0.358201	-1.2064	0.0713776	-0.733935	0.48 [0.22 - 1.07]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205260_s_at	185	0.832432	0.0453295	0.462788	-0.438413	0.123359	-0.220413	0.80 [0.61 - 1.06]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205260_s_at	185	0.832432	0.0396387	0.425207	-0.506559	0.218414	-0.18997	0.83 [0.61 - 1.12]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P163143	110	0.690909	0.0187702	0.256163	-0.611543	0.250437	-0.217295	0.80 [0.56 - 1.17]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P163143	110	0.754545	0.0810449	-	-0.667112	0.765851	-0.0693059	0.93 [0.59 - 1.47]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205260_s_at	80	0.1125	0.0843079	-	15.2408	0.959219	-0.0147984	0.99 [0.56 - 1.74]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5591	281	0.793594	0.0347894	0.390776	0.344634	0.153095	0.127361	1.14 [0.95 - 1.35]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:299436	59	0.169492	0.0413932	0.4371	15.3865	0.191767	1.67228	5.32 [0.43 - 65.58]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205260_s_at	38	0.131579	0.0106967	0.169835	15.695	0.0317963	0.972942	2.65 [1.09 - 6.43]
GENE	ACYP1	acylphosphatase 1, erythrocyte (common) type	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205260_s_at	140	0.578571	1.46018e-05	0.000629126	1.25116	0.000768648	0.600717	1.82 [1.28 - 2.59]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206833_s_at	30	0.833333	0.120922	-	-0.933716	0.477256	-0.259103	0.77 [0.38 - 1.58]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1697550	165	0.272727	0.00321712	0.0666365	-0.721492	0.0104365	-1.53325	0.22 [0.07 - 0.70]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1697550	165	0.630303	0.00147197	0.0351803	-1.54605	0.00374456	-2.78871	0.06 [0.01 - 0.41]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206833_s_at	163	0.674847	0.000341405	0.0102143	0.719653	0.0154072	0.485553	1.63 [1.10 - 2.41]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206833_s_at	79	0.848101	0.056033	-	0.697143	0.115264	0.531086	1.70 [0.88 - 3.29]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206833_s_at	58	0.810345	0.0110475	0.173984	0.878187	0.167026	0.418678	1.52 [0.84 - 2.75]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206833_s_at	34	0.264706	0.00685327	0.121023	1.31621	0.043733	0.898312	2.46 [1.03 - 5.88]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206833_s_at	158	0.867089	0.0181819	0.250418	-1.0492	0.17277	-0.278778	0.76 [0.51 - 1.13]
GENE	ACYP2	acylphosphatase 2, muscle type	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206833_s_at	53	0.867925	0.0333191	0.379849	-1.43282	0.156043	-0.458688	0.63 [0.34 - 1.19]
GENE	ACYP2	acylphosphatase 2, muscle type	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206833_s_at	53	0.849057	0.0432161	0.449162	-1.37553	0.15851	-0.490394	0.61 [0.31 - 1.21]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206833_s_at	180	0.894444	0.0625072	-	0.581546	0.467945	-0.214084	0.81 [0.45 - 1.44]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206833_s_at	559	0.103757	0.0393883	0.423485	-0.587038	0.6358	-0.131923	0.88 [0.51 - 1.51]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206833_s_at	77	0.142857	0.0178266	0.246913	-0.782602	0.624547	-0.169689	0.84 [0.43 - 1.67]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206833_s_at	70	0.885714	0.0356546	0.397096	0.80662	0.0540549	0.589895	1.80 [0.99 - 3.29]
GENE	ACYP2	acylphosphatase 2, muscle type	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36221_at	50	0.54	0.0240406	0.304701	-0.805486	0.392404	-0.319559	0.73 [0.35 - 1.51]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206833_s_at	74	0.837838	0.126504	-	0.542345	0.674123	-0.155494	0.86 [0.41 - 1.77]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206833_s_at	67	0.776119	0.104334	-	-15.4199	0.291417	-1.07061	0.34 [0.05 - 2.51]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206833_s_at	115	0.286957	0.0579757	-	1.73998	0.72136	0.244821	1.28 [0.33 - 4.91]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36221_at	158	0.107595	0.256027	-	-0.442235	0.963805	-0.0096011	0.99 [0.65 - 1.50]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36221_at	76	0.25	0.107703	-	-0.828833	0.306	-0.324103	0.72 [0.39 - 1.35]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206833_s_at	204	0.313726	0.0170512	0.239168	0.36597	0.669282	0.0718608	1.07 [0.77 - 1.49]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206833_s_at	87	0.218391	0.000340413	0.0101887	-1.32088	0.0432784	-0.62085	0.54 [0.29 - 0.98]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206833_s_at	87	0.218391	0.000340413	0.0101887	-1.32088	0.0432784	-0.62085	0.54 [0.29 - 0.98]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206833_s_at	77	0.519481	0.00750224	0.129759	-2.28939	0.326238	-0.398999	0.67 [0.30 - 1.49]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206833_s_at	77	0.558442	0.00371746	0.0748213	-2.40181	0.23443	-0.421317	0.66 [0.33 - 1.31]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206833_s_at	136	0.102941	0.0502359	-	-1.06102	0.23105	-0.726584	0.48 [0.15 - 1.59]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206833_s_at	200	0.465	0.0904618	-	-0.498375	0.286781	-0.463798	0.63 [0.27 - 1.48]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10349	60	0.233333	0.0648832	-	-0.713546	0.205963	-0.266889	0.77 [0.51 - 1.16]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10349	60	0.15	0.00206617	0.0465191	-1.22896	0.0286266	-0.519152	0.60 [0.37 - 0.95]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2328	155	0.754839	0.0508026	-	0.557855	0.303396	0.305365	1.36 [0.76 - 2.43]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206833_s_at	286	0.108392	1.01274e-05	0.000451946	-1.03881	0.000752285	-1.00177	0.37 [0.21 - 0.66]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206833_s_at	159	0.157233	0.101462	-	0.947023	0.390543	0.477675	1.61 [0.54 - 4.80]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206833_s_at	159	0.679245	0.289999	-	-0.455407	0.606915	0.332286	1.39 [0.39 - 4.94]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206833_s_at	159	0.150943	0.116389	-	0.911087	0.426062	0.436454	1.55 [0.53 - 4.53]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206833_s_at	54	0.240741	0.112511	-	15.4189	0.536444	0.324676	1.38 [0.49 - 3.87]
GENE	ACYP2	acylphosphatase 2, muscle type	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206833_s_at	117	0.589744	0.0950829	-	-0.569419	0.43954	-0.177727	0.84 [0.53 - 1.31]
GENE	ACYP2	acylphosphatase 2, muscle type	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206833_s_at	117	0.547009	0.257437	-	-0.44375	0.931875	-0.0228479	0.98 [0.58 - 1.65]
GENE	ACYP2	acylphosphatase 2, muscle type	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206833_s_at	117	0.222222	0.114214	-	-0.641086	0.246327	-0.342012	0.71 [0.40 - 1.27]
GENE	ACYP2	acylphosphatase 2, muscle type	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206833_s_at	117	0.589744	0.0950829	-	-0.569419	0.43954	-0.177727	0.84 [0.53 - 1.31]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206833_s_at	236	0.194915	0.0609079	-	-0.560514	0.426832	-0.39621	0.67 [0.25 - 1.79]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206833_s_at	249	0.128514	0.00809941	0.137601	-0.702815	0.481688	-0.275246	0.76 [0.35 - 1.63]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206833_s_at	62	0.112903	0.0131291	0.19775	-1.25825	0.4596	-0.228846	0.80 [0.43 - 1.46]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206833_s_at	125	0.376	0.0986416	-	-0.61616	0.670873	-0.178868	0.84 [0.37 - 1.91]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206833_s_at	125	0.384	0.0711108	-	-0.514171	0.203415	-0.402877	0.67 [0.36 - 1.24]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206833_s_at	54	0.12963	0.000177058	0.00577977	-2.0251	0.212118	-0.500427	0.61 [0.28 - 1.33]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206833_s_at	198	0.141414	0.0400347	0.427916	-0.635136	0.792097	-0.0645704	0.94 [0.58 - 1.52]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206833_s_at	198	0.141414	0.0345363	0.388912	-0.660638	0.5952	-0.134533	0.87 [0.53 - 1.44]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206833_s_at	198	0.176768	0.114985	-	-0.400901	0.66804	-0.084592	0.92 [0.62 - 1.35]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206833_s_at	51	0.235294	0.231246	-	15.4106	0.700898	-0.510864	0.60 [0.04 - 8.13]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206833_s_at	62	0.887097	0.0715713	-	1.14081	0.402779	0.621865	1.86 [0.43 - 7.99]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206833_s_at	177	0.129944	0.021053	0.277803	1.51402	0.445667	0.219349	1.25 [0.71 - 2.19]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206833_s_at	177	0.118644	0.0469675	0.473096	0.982558	0.56589	0.142388	1.15 [0.71 - 1.87]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206833_s_at	145	0.165517	0.0407761	0.432949	1.37936	0.992507	0.00330771	1.00 [0.50 - 2.00]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206833_s_at	226	0.384956	0.122487	-	-0.433762	0.552741	-0.196933	0.82 [0.43 - 1.57]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206833_s_at	55	0.327273	0.038819	0.419551	1.22067	0.0967613	0.59146	1.81 [0.90 - 3.63]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206833_s_at	55	0.872727	0.00834039	0.140716	1.39313	0.081377	0.723425	2.06 [0.91 - 4.65]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206833_s_at	49	0.346939	0.0148695	0.216621	2.1324	0.0395767	0.863796	2.37 [1.04 - 5.40]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206833_s_at	63	0.507937	0.31343	-	-0.343463	0.976186	0.00635149	1.01 [0.66 - 1.53]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557246_3p_at	28	0.25	0.0541134	-	-1.10326	0.467031	-1.24929	0.29 [0.01 - 8.31]
GENE	ACYP2	acylphosphatase 2, muscle type	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206833_s_at	82	0.890244	0.0586516	-	-1.70488	0.707543	-0.219573	0.80 [0.25 - 2.53]
GENE	ACYP2	acylphosphatase 2, muscle type	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206833_s_at	79	0.227848	0.0669531	-	0.618222	0.453736	0.260048	1.30 [0.66 - 2.56]
GENE	ACYP2	acylphosphatase 2, muscle type	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206833_s_at	104	0.875	0.0129113	0.195328	-15.2508	0.555729	-0.282558	0.75 [0.29 - 1.93]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P159424	117	0.709402	0.013564	0.202546	0.7045	0.618321	0.131092	1.14 [0.68 - 1.91]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P1587	117	0.846154	0.142867	-	-0.679065	0.639941	-0.107496	0.90 [0.57 - 1.41]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P256988	117	0.863248	0.0164878	0.233455	0.800887	0.608957	0.120827	1.13 [0.71 - 1.79]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P336848	117	0.74359	0.0164884	0.233461	0.697647	0.690318	0.0999057	1.11 [0.68 - 1.81]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206833_s_at	204	0.676471	0.11307	-	-0.708602	0.768005	0.201969	1.22 [0.32 - 4.68]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206833_s_at	204	0.691176	0.044168	0.455346	-0.667827	0.783256	-0.135671	0.87 [0.33 - 2.30]
GENE	ACYP2	acylphosphatase 2, muscle type	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206833_s_at	178	0.106742	0.171797	-	0.498757	0.888495	0.0436289	1.04 [0.57 - 1.92]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206833_s_at	111	0.81982	0.225625	-	-0.456761	0.478749	-0.280802	0.76 [0.35 - 1.64]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206833_s_at	90	0.111111	0.00928375	0.152652	-1.04725	0.466234	-0.380911	0.68 [0.25 - 1.90]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206833_s_at	90	0.111111	0.00500592	0.0947311	-1.21942	0.394604	-0.51049	0.60 [0.19 - 1.94]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206833_s_at	138	0.101449	0.0932426	-	0.847991	0.866492	0.0261641	1.03 [0.76 - 1.39]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206833_s_at	129	0.186047	0.11458	-	-0.476841	0.304911	-0.473032	0.62 [0.25 - 1.54]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37937	56	0.410714	0.0625237	-	-0.634566	0.250549	-0.307217	0.74 [0.44 - 1.24]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20749	56	0.125	0.017831	0.246956	-1.12639	0.107625	-0.351398	0.70 [0.46 - 1.08]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37937	56	0.785714	0.0929588	-	-0.871559	0.331061	-0.275748	0.76 [0.44 - 1.32]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20749	56	0.125	0.0592627	-	-1.00426	0.187487	-0.310228	0.73 [0.46 - 1.16]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206833_s_at	278	0.316547	0.0492566	0.487146	-0.386517	0.973067	0.00483151	1.00 [0.76 - 1.33]
GENE	ACYP2	acylphosphatase 2, muscle type	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206833_s_at	133	0.308271	0.135196	-	0.394647	0.857373	0.0269051	1.03 [0.77 - 1.38]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206833_s_at	185	0.827027	0.0614751	-	-0.409212	0.380623	-0.132341	0.88 [0.65 - 1.18]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206833_s_at	185	0.778378	0.0927558	-	-0.365543	0.506914	-0.108244	0.90 [0.65 - 1.24]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P256988	110	0.681818	0.0822436	-	0.528018	0.202405	0.271077	1.31 [0.86 - 1.99]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P159424	110	0.254545	0.0155381	0.223654	-0.605545	0.726039	-0.0974351	0.91 [0.53 - 1.56]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P336848	110	0.227273	0.048505	0.482577	-0.505161	0.722516	-0.0663339	0.94 [0.65 - 1.35]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P159424	110	0.890909	0.0642114	-	0.816243	0.305835	0.34675	1.41 [0.73 - 2.75]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P256988	110	0.136364	0.034989	0.392241	-0.635805	0.712601	-0.0610025	0.94 [0.68 - 1.30]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P336848	110	0.890909	0.0543927	-	0.852819	0.321417	0.229086	1.26 [0.80 - 1.98]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206833_s_at	80	0.3875	0.24741	-	-0.503382	0.614555	0.235568	1.27 [0.51 - 3.17]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3608	281	0.419929	0.0738114	-	-0.249985	0.763537	-0.0208758	0.98 [0.85 - 1.12]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206833_s_at	38	0.236842	0.317284	-	0.561481	0.890522	0.0628606	1.06 [0.44 - 2.61]
GENE	ACYP2	acylphosphatase 2, muscle type	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206833_s_at	140	0.121429	0.000233783	0.00736149	-1.17183	0.000680855	-0.944777	0.39 [0.23 - 0.67]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADA	adenosine deaminase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204639_at	30	0.866667	0.10326	-	0.885617	0.112963	0.601974	1.83 [0.87 - 3.84]
GENE	ADA	adenosine deaminase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221472_at	30	0.366667	0.0225398	0.291378	-1.0302	0.123846	-1.098	0.33 [0.08 - 1.35]
GENE	ADA	adenosine deaminase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216705_s_at	30	0.133333	0.0634653	-	1.28969	0.146857	0.605123	1.83 [0.81 - 4.15]
GENE	ADA	adenosine deaminase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1803686	165	0.484848	0.000757583	0.0201721	0.824542	0.0134474	0.251731	1.29 [1.05 - 1.57]
GENE	ADA	adenosine deaminase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1803686	165	0.521212	3.57049e-05	0.00140428	1.60166	0.000291637	0.472815	1.60 [1.24 - 2.07]
GENE	ADA	adenosine deaminase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216705_s_at	163	0.736196	0.0362739	0.40157	0.440216	0.0937755	0.184918	1.20 [0.97 - 1.49]
GENE	ADA	adenosine deaminase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221472_at	163	0.883436	0.161603	-	0.400712	0.893598	-0.0316664	0.97 [0.61 - 1.54]
GENE	ADA	adenosine deaminase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204639_at	163	0.515337	0.00323846	0.0669916	0.580368	0.0328134	0.233004	1.26 [1.02 - 1.56]
GENE	ADA	adenosine deaminase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216705_s_at	79	0.291139	0.00201697	0.0456097	1.19761	0.188234	0.16095	1.17 [0.92 - 1.49]
GENE	ADA	adenosine deaminase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204639_at	79	0.278481	0.0130611	0.196995	0.933046	0.19845	0.161432	1.18 [0.92 - 1.50]
GENE	ADA	adenosine deaminase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221472_at	79	0.797468	0.0730845	-	0.591966	0.833061	0.0681636	1.07 [0.57 - 2.02]
GENE	ADA	adenosine deaminase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204639_at	58	0.413793	0.38076	-	-0.241722	0.955048	0.0142963	1.01 [0.62 - 1.67]
GENE	ADA	adenosine deaminase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221472_at	58	0.224138	0.00735134	0.127748	-0.886265	0.0529911	-0.651639	0.52 [0.27 - 1.01]
GENE	ADA	adenosine deaminase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216705_s_at	58	0.103448	0.00485553	0.0924828	-1.23554	0.430188	-0.19516	0.82 [0.51 - 1.34]
GENE	ADA	adenosine deaminase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216705_s_at	34	0.852941	0.0742409	-	0.905369	0.320542	0.407365	1.50 [0.67 - 3.36]
GENE	ADA	adenosine deaminase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204639_at	34	0.882353	0.0944291	-	0.914513	0.788513	-0.0912892	0.91 [0.47 - 1.78]
GENE	ADA	adenosine deaminase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221472_at	34	0.882353	0.0715764	-	0.978554	0.850525	0.0993274	1.10 [0.39 - 3.10]
GENE	ADA	adenosine deaminase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221472_at	158	0.101266	0.00454738	0.0878176	2.30898	0.117639	0.76087	2.14 [0.83 - 5.55]
GENE	ADA	adenosine deaminase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204639_at	158	0.170886	0.000170492	0.00559223	-0.983087	0.0485292	-0.288971	0.75 [0.56 - 1.00]
GENE	ADA	adenosine deaminase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216705_s_at	158	0.170886	0.011404	0.178156	-0.700657	0.055489	-0.287867	0.75 [0.56 - 1.01]
GENE	ADA	adenosine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216705_s_at	53	0.377358	0.0466262	0.470966	0.805228	0.344633	0.261159	1.30 [0.76 - 2.23]
GENE	ADA	adenosine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204639_at	53	0.641509	0.0458746	0.466242	0.679965	0.377736	0.247404	1.28 [0.74 - 2.22]
GENE	ADA	adenosine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216705_s_at	53	0.622642	0.155854	-	0.486733	0.551907	0.151921	1.16 [0.71 - 1.92]
GENE	ADA	adenosine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204639_at	53	0.641509	0.0218306	0.284951	0.821878	0.317603	0.307981	1.36 [0.74 - 2.49]
GENE	ADA	adenosine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221472_at	53	0.566038	0.029995	0.354223	-0.779716	0.0956675	-1.32978	0.26 [0.06 - 1.26]
GENE	ADA	adenosine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221472_at	53	0.641509	0.109809	-	-0.650015	0.349506	-0.813256	0.44 [0.08 - 2.44]
GENE	ADA	adenosine deaminase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221472_at	180	0.872222	0.132923	-	-0.522198	0.983157	0.00897389	1.01 [0.44 - 2.32]
GENE	ADA	adenosine deaminase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204639_at	180	0.772222	0.0151661	0.219755	0.552593	0.300761	0.127099	1.14 [0.89 - 1.44]
GENE	ADA	adenosine deaminase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216705_s_at	180	0.805556	0.0838546	-	0.421908	0.506528	0.0782734	1.08 [0.86 - 1.36]
GENE	ADA	adenosine deaminase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216705_s_at	559	0.216458	0.0503291	-	0.516083	0.0460631	0.19528	1.22 [1.00 - 1.47]
GENE	ADA	adenosine deaminase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204639_at	559	0.808587	0.0254612	0.31698	0.499182	0.108435	0.289405	1.34 [0.94 - 1.90]
GENE	ADA	adenosine deaminase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221472_at	559	0.749553	0.127402	-	-0.38632	0.581979	-0.172406	0.84 [0.46 - 1.55]
GENE	ADA	adenosine deaminase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216705_s_at	77	0.896104	0.0965446	-	0.623546	0.53722	0.123679	1.13 [0.76 - 1.68]
GENE	ADA	adenosine deaminase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204639_at	77	0.597403	0.0248302	0.311564	-0.596344	0.411893	-0.157513	0.85 [0.59 - 1.24]
GENE	ADA	adenosine deaminase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221472_at	77	0.12987	0.0077368	0.132861	-0.912979	0.16072	-0.562995	0.57 [0.26 - 1.25]
GENE	ADA	adenosine deaminase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204639_at	70	0.114286	0.0256699	0.318758	-0.84308	0.125266	-0.411665	0.66 [0.39 - 1.12]
GENE	ADA	adenosine deaminase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221472_at	70	0.742857	0.181503	-	0.395066	0.904279	-0.0504463	0.95 [0.42 - 2.16]
GENE	ADA	adenosine deaminase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216705_s_at	70	0.371429	0.0288815	0.345334	-0.593996	0.36647	-0.372695	0.69 [0.31 - 1.55]
GENE	ADA	adenosine deaminase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41654_at	50	0.28	0.065063	-	-0.682089	0.228496	-0.639435	0.53 [0.19 - 1.49]
GENE	ADA	adenosine deaminase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	907_at	50	0.34	0.0423374	0.443384	-0.724146	0.0517579	-1.21196	0.30 [0.09 - 1.01]
GENE	ADA	adenosine deaminase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204639_at	74	0.189189	0.120357	-	0.629739	0.929985	-0.035071	0.97 [0.44 - 2.11]
GENE	ADA	adenosine deaminase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221472_at	74	0.77027	0.131802	-	0.466061	0.199322	0.636741	1.89 [0.71 - 5.00]
GENE	ADA	adenosine deaminase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216705_s_at	74	0.648649	0.0368495	0.405694	0.613351	0.388677	0.255513	1.29 [0.72 - 2.31]
GENE	ADA	adenosine deaminase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216705_s_at	67	0.731343	0.259409	-	-1.14124	0.693144	-0.421205	0.66 [0.08 - 5.32]
GENE	ADA	adenosine deaminase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204639_at	67	0.656716	0.0158183	0.226568	-15.9048	0.902228	-0.101904	0.90 [0.18 - 4.59]
GENE	ADA	adenosine deaminase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221472_at	67	0.671642	0.184326	-	0.873627	0.740089	0.5466	1.73 [0.07 - 43.65]
GENE	ADA	adenosine deaminase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204639_at	115	0.826087	0.0747692	-	-15.3292	0.429726	-0.524172	0.59 [0.16 - 2.17]
GENE	ADA	adenosine deaminase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221472_at	115	0.26087	0.115684	-	-0.821923	0.754266	-0.237458	0.79 [0.18 - 3.49]
GENE	ADA	adenosine deaminase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216705_s_at	115	0.617391	0.113307	-	0.829338	0.733908	0.204812	1.23 [0.38 - 4.00]
GENE	ADA	adenosine deaminase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41654_at	158	0.873418	1.1028e-05	0.000488178	1.33397	0.0574731	0.719616	2.05 [0.98 - 4.31]
GENE	ADA	adenosine deaminase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	907_at	158	0.329114	0.00153658	0.0364544	1.16326	0.0108843	0.748361	2.11 [1.19 - 3.76]
GENE	ADA	adenosine deaminase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41654_at	76	0.328947	0.00527289	0.098678	-1.38218	0.00454721	-1.80213	0.16 [0.05 - 0.57]
GENE	ADA	adenosine deaminase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	907_at	76	0.789474	0.046637	0.471033	-15.3895	0.929965	0.053732	1.06 [0.32 - 3.50]
GENE	ADA	adenosine deaminase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221472_at	204	0.20098	1.26576e-05	0.000552969	-0.770575	0.00927589	-0.533874	0.59 [0.39 - 0.88]
GENE	ADA	adenosine deaminase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216705_s_at	204	0.696078	0.00500697	0.0947467	0.429188	0.00517459	0.288502	1.33 [1.09 - 1.63]
GENE	ADA	adenosine deaminase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204639_at	204	0.382353	0.00535217	0.0998397	0.404221	0.0537592	0.2277	1.26 [1.00 - 1.58]
GENE	ADA	adenosine deaminase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204639_at	87	0.83908	0.0480468	0.479771	-1.77277	0.789832	-0.0730827	0.93 [0.54 - 1.59]
GENE	ADA	adenosine deaminase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216705_s_at	87	0.551724	0.14514	-	0.549698	0.899334	0.0452552	1.05 [0.52 - 2.11]
GENE	ADA	adenosine deaminase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204639_at	87	0.83908	0.0480468	0.479771	-1.77277	0.789832	-0.0730827	0.93 [0.54 - 1.59]
GENE	ADA	adenosine deaminase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221472_at	87	0.781609	0.0957944	-	0.6651	0.399233	0.484883	1.62 [0.53 - 5.01]
GENE	ADA	adenosine deaminase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216705_s_at	87	0.551724	0.14514	-	0.549698	0.899334	0.0452552	1.05 [0.52 - 2.11]
GENE	ADA	adenosine deaminase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221472_at	87	0.781609	0.0957944	-	0.6651	0.399233	0.484883	1.62 [0.53 - 5.01]
GENE	ADA	adenosine deaminase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221472_at	77	0.103896	0.0159644	0.22808	-1.51651	0.525366	0.498075	1.65 [0.35 - 7.65]
GENE	ADA	adenosine deaminase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216705_s_at	77	0.87013	0.00602858	0.109568	1.60082	0.000684682	1.22655	3.41 [1.68 - 6.92]
GENE	ADA	adenosine deaminase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221472_at	77	0.402597	0.0520107	-	-1.0602	0.880981	0.112133	1.12 [0.26 - 4.86]
GENE	ADA	adenosine deaminase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204639_at	77	0.883117	0.00219609	0.0488981	1.75235	0.000795566	1.25548	3.51 [1.69 - 7.31]
GENE	ADA	adenosine deaminase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216705_s_at	77	0.857143	0.00453604	0.0876444	1.48177	0.00169653	0.998075	2.71 [1.45 - 5.06]
GENE	ADA	adenosine deaminase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204639_at	77	0.883117	0.000362829	0.0107638	1.79379	0.00112622	1.06206	2.89 [1.53 - 5.48]
GENE	ADA	adenosine deaminase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204639_at	136	0.713235	0.0283593	0.341109	0.9622	0.572898	0.224145	1.25 [0.57 - 2.73]
GENE	ADA	adenosine deaminase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216705_s_at	136	0.220588	0.000922073	0.0238066	-1.37971	0.00602705	-0.812754	0.44 [0.25 - 0.79]
GENE	ADA	adenosine deaminase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221472_at	136	0.639706	0.0452004	0.461966	-1.18444	0.70638	-0.294962	0.74 [0.16 - 3.45]
GENE	ADA	adenosine deaminase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204639_at	200	0.89	0.000369078	0.0109231	1.13701	0.0280069	1.01899	2.77 [1.12 - 6.88]
GENE	ADA	adenosine deaminase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216705_s_at	200	0.88	0.0114725	0.178952	0.878685	0.149054	0.447031	1.56 [0.85 - 2.87]
GENE	ADA	adenosine deaminase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221472_at	200	0.55	0.0184884	0.25342	-0.754459	0.0211094	-1.04197	0.35 [0.15 - 0.86]
GENE	ADA	adenosine deaminase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1325	60	0.866667	0.0521346	-	0.867893	0.113781	0.282591	1.33 [0.93 - 1.88]
GENE	ADA	adenosine deaminase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1325	60	0.8	0.010091	0.162565	1.0051	0.147559	0.346626	1.41 [0.88 - 2.26]
GENE	ADA	adenosine deaminase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11938	155	0.670968	0.0503178	-	0.545219	0.587591	0.108746	1.11 [0.75 - 1.65]
GENE	ADA	adenosine deaminase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204639_at	286	0.29021	0.282146	-	0.237863	0.495491	0.156014	1.17 [0.75 - 1.83]
GENE	ADA	adenosine deaminase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221472_at	286	0.895105	0.0395024	0.424271	0.552718	0.574897	0.156961	1.17 [0.68 - 2.02]
GENE	ADA	adenosine deaminase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216705_s_at	286	0.444056	0.12639	-	0.301175	0.687287	-0.0640472	0.94 [0.69 - 1.28]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216705_s_at	159	0.138365	0.0130224	0.196565	-0.879501	0.564821	-0.251658	0.78 [0.33 - 1.83]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204639_at	159	0.308176	0.0476876	0.477559	0.802286	0.672641	0.151229	1.16 [0.58 - 2.35]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204639_at	159	0.308176	0.127438	-	0.732975	0.553681	0.265017	1.30 [0.54 - 3.13]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216705_s_at	159	0.691824	0.0495179	0.488724	0.618866	0.263566	0.488128	1.63 [0.69 - 3.83]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221472_at	159	0.132075	0.000966169	0.0247596	-1.11229	0.164392	-0.614442	0.54 [0.23 - 1.29]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221472_at	159	0.132075	5.26132e-05	0.00198386	-1.45179	0.0294136	-1.11504	0.33 [0.12 - 0.89]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204639_at	159	0.798742	0.0548512	-	-0.973543	0.770864	-0.0962697	0.91 [0.48 - 1.74]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216705_s_at	159	0.666667	0.0750222	-	0.650328	0.559253	0.301878	1.35 [0.49 - 3.73]
GENE	ADA	adenosine deaminase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221472_at	159	0.132075	2.97142e-05	0.00119155	-1.31649	0.0100665	-1.11966	0.33 [0.14 - 0.77]
GENE	ADA	adenosine deaminase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204639_at	54	0.148148	0.202294	-	-1.00234	0.64879	-0.342525	0.71 [0.16 - 3.10]
GENE	ADA	adenosine deaminase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216705_s_at	54	0.148148	0.20191	-	15.3007	0.94015	-0.0814334	0.92 [0.11 - 7.72]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216705_s_at	117	0.196581	0.271427	-	-0.488624	0.743973	-0.171267	0.84 [0.30 - 2.36]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216705_s_at	117	0.854701	0.136472	-	-0.86777	0.743213	-0.134386	0.87 [0.39 - 1.95]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221472_at	117	0.760684	0.207816	-	-0.518488	0.768637	-0.0872482	0.92 [0.51 - 1.64]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221472_at	117	0.760684	0.207816	-	-0.518488	0.768637	-0.0872482	0.92 [0.51 - 1.64]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204639_at	117	0.623932	0.152214	-	0.451314	0.644141	-0.127486	0.88 [0.51 - 1.51]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221472_at	117	0.752137	0.0847935	-	-1.01556	0.85097	0.065953	1.07 [0.54 - 2.13]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204639_at	117	0.358974	0.069027	-	-0.674549	0.320254	-0.331016	0.72 [0.37 - 1.38]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221472_at	117	0.393162	0.110019	-	0.684756	0.439237	0.24274	1.27 [0.69 - 2.36]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204639_at	117	0.316239	0.0971071	-	-0.654181	0.937567	-0.0261612	0.97 [0.51 - 1.87]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204639_at	117	0.623932	0.152214	-	0.451314	0.644141	-0.127486	0.88 [0.51 - 1.51]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216705_s_at	117	0.854701	0.136472	-	-0.86777	0.743213	-0.134386	0.87 [0.39 - 1.95]
GENE	ADA	adenosine deaminase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216705_s_at	117	0.854701	0.180288	-	-0.947629	0.530959	-0.314404	0.73 [0.27 - 1.95]
GENE	ADA	adenosine deaminase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216705_s_at	236	0.894068	0.0405211	0.431223	0.703909	0.61219	-0.159459	0.85 [0.46 - 1.58]
GENE	ADA	adenosine deaminase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221472_at	236	0.385593	0.36333	-	-0.246655	0.592396	0.221306	1.25 [0.55 - 2.81]
GENE	ADA	adenosine deaminase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204639_at	236	0.34322	0.00321936	0.0666738	0.990085	0.145974	0.720994	2.06 [0.78 - 5.44]
GENE	ADA	adenosine deaminase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221472_at	249	0.333333	0.0900937	-	0.407251	0.0797858	0.568398	1.77 [0.93 - 3.33]
GENE	ADA	adenosine deaminase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204639_at	249	0.417671	0.0258774	0.320519	0.495562	0.411335	0.304663	1.36 [0.66 - 2.81]
GENE	ADA	adenosine deaminase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216705_s_at	249	0.895582	0.250311	-	0.357435	0.857278	-0.0413045	0.96 [0.61 - 1.51]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216705_s_at	125	0.784	0.223644	-	-0.646435	0.472109	-0.417609	0.66 [0.21 - 2.06]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204639_at	54	0.796296	0.191142	-	-1.28161	0.636291	-0.117688	0.89 [0.55 - 1.45]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221472_at	125	0.36	0.280875	-	0.330343	0.513993	0.297197	1.35 [0.55 - 3.29]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216705_s_at	125	0.784	0.154071	-	-0.545347	0.483535	-0.298457	0.74 [0.32 - 1.71]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216705_s_at	54	0.648148	0.154483	-	-0.956819	0.653923	-0.13066	0.88 [0.50 - 1.55]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221472_at	125	0.36	0.0483054	0.481357	0.887794	0.0821582	1.03736	2.82 [0.88 - 9.09]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204639_at	62	0.709677	0.066202	-	-1.05361	0.679373	-0.0846948	0.92 [0.61 - 1.37]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204639_at	125	0.296	0.207918	-	-0.499517	0.999332	0.000391319	1.00 [0.40 - 2.50]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221472_at	62	0.112903	0.000787631	0.020846	-1.63851	0.34116	-0.35397	0.70 [0.34 - 1.45]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221472_at	54	0.666667	0.0615131	-	-1.38489	0.524665	-0.285836	0.75 [0.31 - 1.81]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216705_s_at	62	0.693548	0.0918988	-	-0.959531	0.597045	-0.127599	0.88 [0.55 - 1.41]
GENE	ADA	adenosine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204639_at	125	0.592	0.19216	-	0.375389	0.836365	-0.0734052	0.93 [0.46 - 1.86]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204639_at	198	0.611111	0.224579	-	-0.270402	0.82086	-0.0256309	0.97 [0.78 - 1.22]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221472_at	198	0.616162	0.00227304	0.0502924	-0.878445	0.305439	-0.21042	0.81 [0.54 - 1.21]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221472_at	198	0.616162	0.00040501	0.0118309	-1.13024	0.208144	-0.274568	0.76 [0.50 - 1.17]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216705_s_at	198	0.10101	0.0416357	0.438721	0.907739	0.33091	0.110105	1.12 [0.89 - 1.39]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204639_at	198	0.878788	0.0436976	0.4523	0.661634	0.806897	0.0340435	1.03 [0.79 - 1.36]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204639_at	198	0.878788	0.0131273	0.19773	0.814223	0.402256	0.133448	1.14 [0.84 - 1.56]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216705_s_at	198	0.191919	0.0685662	-	0.716987	0.117715	0.228034	1.26 [0.94 - 1.67]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221472_at	198	0.616162	0.0128224	0.194335	-0.560682	0.622588	-0.083966	0.92 [0.66 - 1.28]
GENE	ADA	adenosine deaminase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216705_s_at	198	0.191919	0.0515349	-	0.819059	0.108629	0.246385	1.28 [0.95 - 1.73]
GENE	ADA	adenosine deaminase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216705_s_at	51	0.72549	0.160146	-	-15.5436	0.352031	-1.96102	0.14 [0.00 - 8.75]
GENE	ADA	adenosine deaminase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221472_at	62	0.241935	0.0555131	-	-1.0728	0.467712	-0.403074	0.67 [0.23 - 1.98]
GENE	ADA	adenosine deaminase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216705_s_at	62	0.241935	0.0278594	0.33703	15.5587	0.434999	0.773097	2.17 [0.31 - 15.09]
GENE	ADA	adenosine deaminase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221472_at	51	0.352941	0.0914168	-	15.7492	0.446444	0.715123	2.04 [0.32 - 12.89]
GENE	ADA	adenosine deaminase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204639_at	51	0.431373	0.00885593	0.147288	-16.5632	0.140593	-1.02791	0.36 [0.09 - 1.40]
GENE	ADA	adenosine deaminase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204639_at	62	0.112903	0.169817	-	15.2364	0.616882	0.199528	1.22 [0.56 - 2.67]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216705_s_at	177	0.644068	0.0099767	0.161177	-0.798534	0.0221978	-0.817061	0.44 [0.22 - 0.89]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221472_at	177	0.706215	0.181816	-	0.330226	0.48201	0.233894	1.26 [0.66 - 2.43]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204639_at	177	0.858757	0.0291144	0.347206	-1.22037	0.113282	-0.399616	0.67 [0.41 - 1.10]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216705_s_at	177	0.474576	0.00058009	0.0160842	-0.808579	0.0112255	-0.780497	0.46 [0.25 - 0.84]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221472_at	145	0.124138	0.0627695	-	1.68281	0.763374	0.140078	1.15 [0.46 - 2.86]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204639_at	177	0.519774	0.0246629	0.310117	-0.532188	0.067969	-0.397655	0.67 [0.44 - 1.03]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216705_s_at	145	0.227586	0.0754409	-	0.914188	0.872184	-0.0610429	0.94 [0.45 - 1.98]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204639_at	145	0.896552	0.0758384	-	-1.61829	0.673114	-0.125598	0.88 [0.49 - 1.58]
GENE	ADA	adenosine deaminase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221472_at	177	0.101695	0.0705188	-	1.22551	0.551281	0.228624	1.26 [0.59 - 2.67]
GENE	ADA	adenosine deaminase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221472_at	226	0.154867	0.0310955	0.362854	1.20955	0.436124	0.224504	1.25 [0.71 - 2.20]
GENE	ADA	adenosine deaminase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216705_s_at	226	0.367257	0.146167	-	0.464698	0.578003	0.0619906	1.06 [0.86 - 1.32]
GENE	ADA	adenosine deaminase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204639_at	226	0.327434	0.183384	-	0.4385	0.843796	-0.0411587	0.96 [0.64 - 1.45]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221472_at	55	0.654545	0.116784	-	0.716566	0.757139	0.200041	1.22 [0.34 - 4.34]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216705_s_at	55	0.872727	1.09757e-05	0.000486082	1.96673	0.00612068	1.37791	3.97 [1.48 - 10.62]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221472_at	49	0.755102	0.132947	-	-1.44535	0.385937	-0.694474	0.50 [0.10 - 2.40]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204639_at	55	0.890909	6.11547e-05	0.00226744	1.88961	0.00658885	1.49964	4.48 [1.52 - 13.22]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216705_s_at	55	0.563636	0.0211221	0.278443	1.11382	0.315084	0.536758	1.71 [0.60 - 4.87]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216705_s_at	49	0.897959	0.000359149	0.0106698	2.14621	0.251531	0.841202	2.32 [0.55 - 9.77]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204639_at	55	0.290909	0.0393416	0.423164	1.4164	0.0888024	0.929372	2.53 [0.87 - 7.39]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204639_at	49	0.897959	0.117191	-	1.15673	0.106185	1.27425	3.58 [0.76 - 16.78]
GENE	ADA	adenosine deaminase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221472_at	55	0.272727	0.0159363	0.22779	-1.0503	0.143317	-0.895916	0.41 [0.12 - 1.36]
GENE	ADA	adenosine deaminase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	505881	34	0.852941	0.0200311	0.26824	1.15393	0.302236	0.554565	1.74 [0.61 - 4.99]
GENE	ADA	adenosine deaminase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	824678	34	0.764706	0.234074	-	0.571914	0.826269	0.0774283	1.08 [0.54 - 2.16]
GENE	ADA	adenosine deaminase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221472_at	63	0.603175	0.00128717	0.0314707	1.0574	0.00138675	1.23598	3.44 [1.61 - 7.34]
GENE	ADA	adenosine deaminase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216705_s_at	63	0.428571	0.0686893	-	-0.611256	0.64625	0.127448	1.14 [0.66 - 1.96]
GENE	ADA	adenosine deaminase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204639_at	63	0.174603	0.026191	0.323169	1.481	0.669357	0.0992025	1.10 [0.70 - 1.74]
GENE	ADA	adenosine deaminase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.272168.0.S3_3p_at	28	0.892857	0.12219	-	1.16158	0.93858	0.0143559	1.01 [0.70 - 1.46]
GENE	ADA	adenosine deaminase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.1217.1.S1_3p_a_at	28	0.714286	0.0499211	0.49115	-1.42805	0.261296	-4.67638	0.01 [0.00 - 32.56]
GENE	ADA	adenosine deaminase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204639_at	82	0.841463	0.15365	-	0.592558	0.33482	0.341733	1.41 [0.70 - 2.82]
GENE	ADA	adenosine deaminase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216705_s_at	82	0.853659	0.018574	0.254256	0.972448	0.322086	0.434374	1.54 [0.65 - 3.65]
GENE	ADA	adenosine deaminase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221472_at	82	0.207317	0.0403442	0.430023	-0.757447	0.299176	-0.446333	0.64 [0.28 - 1.49]
GENE	ADA	adenosine deaminase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204639_at	79	0.848101	0.000555477	0.0155011	1.12749	0.055991	0.480898	1.62 [0.99 - 2.65]
GENE	ADA	adenosine deaminase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221472_at	79	0.772152	0.0128581	0.194733	-0.87795	0.0518581	-0.824221	0.44 [0.19 - 1.01]
GENE	ADA	adenosine deaminase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216705_s_at	79	0.886076	4.10877e-08	2.79389e-06	2.00335	0.0076508	0.780972	2.18 [1.23 - 3.88]
GENE	ADA	adenosine deaminase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M13792_at	86	0.883721	0.137468	-	-1.40405	0.646943	-0.266524	0.77 [0.24 - 2.40]
GENE	ADA	adenosine deaminase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221472_at	104	0.25	0.031766	0.36804	-0.704227	0.221421	-0.749148	0.47 [0.14 - 1.57]
GENE	ADA	adenosine deaminase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204639_at	104	0.211538	0.0668576	-	0.932471	0.436655	0.25456	1.29 [0.68 - 2.45]
GENE	ADA	adenosine deaminase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216705_s_at	104	0.615385	0.216562	-	-0.431468	0.918974	-0.0486327	0.95 [0.37 - 2.43]
GENE	ADA	adenosine deaminase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P210482	117	0.487179	0.26537	-	0.320693	0.652155	0.0760288	1.08 [0.78 - 1.50]
GENE	ADA	adenosine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204639_at	204	0.676471	0.0220737	0.287164	0.813655	0.239618	0.3466	1.41 [0.79 - 2.52]
GENE	ADA	adenosine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204639_at	204	0.676471	0.00052134	0.014685	0.915762	0.00682088	0.600085	1.82 [1.18 - 2.81]
GENE	ADA	adenosine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221472_at	204	0.828431	0.0927934	-	-1.16394	0.821055	-0.184795	0.83 [0.17 - 4.12]
GENE	ADA	adenosine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221472_at	204	0.495098	0.0646102	-	-0.51059	0.915475	-0.064726	0.94 [0.28 - 3.10]
GENE	ADA	adenosine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216705_s_at	204	0.338235	0.00581237	0.106493	1.37276	0.0348008	0.583948	1.79 [1.04 - 3.08]
GENE	ADA	adenosine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216705_s_at	204	0.632353	6.09867e-05	0.00226191	1.05872	0.00036539	0.753746	2.12 [1.40 - 3.22]
GENE	ADA	adenosine deaminase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216705_s_at	178	0.522472	0.266918	-	0.219461	0.743418	0.0870078	1.09 [0.65 - 1.84]
GENE	ADA	adenosine deaminase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204639_at	178	0.780899	0.00836117	0.140983	0.571862	0.526815	0.133118	1.14 [0.76 - 1.73]
GENE	ADA	adenosine deaminase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221472_at	178	0.876405	0.0227012	0.292829	-0.817527	0.323968	-0.388717	0.68 [0.31 - 1.47]
GENE	ADA	adenosine deaminase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221472_at	111	0.666667	0.0260723	0.322168	-0.657275	0.798079	-0.0906767	0.91 [0.46 - 1.83]
GENE	ADA	adenosine deaminase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216705_s_at	111	0.738739	0.0182418	0.251007	-0.875086	0.350744	-0.11078	0.90 [0.71 - 1.13]
GENE	ADA	adenosine deaminase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204639_at	111	0.207207	0.0518383	-	-0.548678	0.118821	-0.257743	0.77 [0.56 - 1.07]
GENE	ADA	adenosine deaminase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216705_s_at	90	0.633333	0.0157991	0.22637	-0.928394	0.0806573	-0.525086	0.59 [0.33 - 1.07]
GENE	ADA	adenosine deaminase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216705_s_at	90	0.866667	0.064415	-	-1.68025	0.167882	-0.478429	0.62 [0.31 - 1.22]
GENE	ADA	adenosine deaminase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221472_at	90	0.788889	0.0989878	-	-0.970789	0.383675	-0.502856	0.60 [0.20 - 1.87]
GENE	ADA	adenosine deaminase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221472_at	90	0.788889	0.102748	-	-0.768561	0.338374	-0.478417	0.62 [0.23 - 1.65]
GENE	ADA	adenosine deaminase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204639_at	90	0.611111	0.100314	-	-0.581808	0.221883	-0.307136	0.74 [0.45 - 1.20]
GENE	ADA	adenosine deaminase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204639_at	90	0.433333	0.117912	-	-0.57748	0.269533	-0.323408	0.72 [0.41 - 1.28]
GENE	ADA	adenosine deaminase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204639_at	138	0.130435	0.0343878	0.387815	0.951814	0.837836	0.0158369	1.02 [0.87 - 1.18]
GENE	ADA	adenosine deaminase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221472_at	138	0.782609	0.0626936	-	0.490295	0.704201	0.0829221	1.09 [0.71 - 1.67]
GENE	ADA	adenosine deaminase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216705_s_at	138	0.130435	0.0128796	0.194973	1.21348	0.497339	0.0617297	1.06 [0.89 - 1.27]
GENE	ADA	adenosine deaminase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221472_at	129	0.348837	0.0778159	-	-0.437758	0.976624	-0.0120213	0.99 [0.44 - 2.21]
GENE	ADA	adenosine deaminase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204639_at	129	0.767442	0.127418	-	-0.48345	0.446674	-0.293641	0.75 [0.35 - 1.59]
GENE	ADA	adenosine deaminase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216705_s_at	129	0.713178	0.287488	-	-0.294992	0.728032	-0.0815717	0.92 [0.58 - 1.46]
GENE	ADA	adenosine deaminase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21478	56	0.107143	0.21417	-	-0.597867	0.858099	-0.0434244	0.96 [0.59 - 1.54]
GENE	ADA	adenosine deaminase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21478	56	0.107143	0.0931986	-	-0.811205	0.506216	-0.17082	0.84 [0.51 - 1.39]
GENE	ADA	adenosine deaminase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221472_at	278	0.219424	0.000469669	0.013432	0.993787	0.000729093	0.79241	2.21 [1.39 - 3.50]
GENE	ADA	adenosine deaminase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216705_s_at	278	0.230216	0.000702761	0.0189297	0.995461	0.0051393	0.495687	1.64 [1.16 - 2.32]
GENE	ADA	adenosine deaminase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204639_at	278	0.115108	0.000862979	0.0225159	1.40467	0.00300549	0.425009	1.53 [1.16 - 2.03]
GENE	ADA	adenosine deaminase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221472_at	133	0.894737	0.107077	-	0.543128	0.866892	-0.0434079	0.96 [0.58 - 1.59]
GENE	ADA	adenosine deaminase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204639_at	133	0.639098	0.0588623	-	-0.493167	0.790007	-0.0563497	0.95 [0.62 - 1.43]
GENE	ADA	adenosine deaminase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216705_s_at	133	0.894737	0.0351258	0.393242	0.717206	0.387937	0.213598	1.24 [0.76 - 2.01]
GENE	ADA	adenosine deaminase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12684	81	0.111111	0.215435	-	1.23429	0.206528	0.557479	1.75 [0.74 - 4.15]
GENE	ADA	adenosine deaminase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13435	81	0.888889	7.74602e-06	0.000354424	2.0541	0.00184879	1.31823	3.74 [1.63 - 8.57]
GENE	ADA	adenosine deaminase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216705_s_at	185	0.648649	0.00235021	0.0516804	-0.534816	0.168373	-0.347622	0.71 [0.43 - 1.16]
GENE	ADA	adenosine deaminase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221472_at	185	0.886486	0.0160742	0.229213	0.595787	0.105848	0.368544	1.45 [0.92 - 2.26]
GENE	ADA	adenosine deaminase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204639_at	185	0.405405	0.048818	0.484485	-0.322135	0.72892	-0.081007	0.92 [0.58 - 1.46]
GENE	ADA	adenosine deaminase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216705_s_at	185	0.637838	0.0088144	0.146763	-0.495668	0.261585	-0.305564	0.74 [0.43 - 1.26]
GENE	ADA	adenosine deaminase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204639_at	185	0.454054	0.0459508	0.466723	-0.352043	0.699264	-0.098423	0.91 [0.55 - 1.49]
GENE	ADA	adenosine deaminase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221472_at	185	0.162162	0.0111704	0.175427	0.605247	0.140566	0.309934	1.36 [0.90 - 2.06]
GENE	ADA	adenosine deaminase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P210482	110	0.272727	0.0124683	0.190356	0.694416	0.172448	0.238582	1.27 [0.90 - 1.79]
GENE	ADA	adenosine deaminase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P210482	110	0.854545	0.0142214	0.209692	0.831169	0.0581347	0.4338	1.54 [0.99 - 2.42]
GENE	ADA	adenosine deaminase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204639_at	80	0.1125	0.0126106	0.191959	-1.21623	0.125625	-0.543951	0.58 [0.29 - 1.16]
GENE	ADA	adenosine deaminase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221472_at	80	0.6875	0.0321145	0.370714	-1.27217	0.375196	-0.471795	0.62 [0.22 - 1.77]
GENE	ADA	adenosine deaminase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216705_s_at	80	0.1125	0.195698	-	1.24786	0.285231	0.291485	1.34 [0.78 - 2.28]
GENE	ADA	adenosine deaminase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_5573	281	0.149466	0.0992559	-	-0.309664	0.935303	-0.0124815	0.99 [0.73 - 1.33]
GENE	ADA	adenosine deaminase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221472_at	38	0.710526	0.079334	-	-1.2346	0.670552	-0.269639	0.76 [0.22 - 2.65]
GENE	ADA	adenosine deaminase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216705_s_at	38	0.263158	0.135302	-	0.831369	0.380724	0.225961	1.25 [0.76 - 2.08]
GENE	ADA	adenosine deaminase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204639_at	38	0.236842	0.135579	-	0.846652	0.549345	0.23835	1.27 [0.58 - 2.77]
GENE	ADA	adenosine deaminase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216705_s_at	140	0.814286	0.0299321	0.353725	0.678897	0.37495	0.251149	1.29 [0.74 - 2.24]
GENE	ADA	adenosine deaminase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221472_at	140	0.764286	0.0192846	0.261129	-0.927478	0.422046	-0.243051	0.78 [0.43 - 1.42]
GENE	ADA	adenosine deaminase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204639_at	140	0.807143	0.0819207	-	0.560718	0.177945	0.343967	1.41 [0.86 - 2.33]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213245_at	30	0.7	0.0531149	-	0.856599	0.316104	0.324228	1.38 [0.73 - 2.61]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215348_at	30	0.466667	0.0420327	0.441365	0.829653	0.530677	0.545649	1.73 [0.31 - 9.50]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215340_at	30	0.133333	0.0139976	0.207272	-1.39431	0.999076	0.000978382	1.00 [0.19 - 5.24]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1742073	165	0.460606	0.0298756	0.353277	-0.527162	0.260082	-0.409505	0.66 [0.33 - 1.35]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1742073	165	0.460606	0.112014	-	-0.565221	0.525403	-0.340037	0.71 [0.25 - 2.03]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215340_at	163	0.171779	0.181854	-	0.381853	0.725746	0.23592	1.27 [0.34 - 4.73]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215348_at	163	0.269939	0.0364937	0.403149	-0.4559	0.372365	-0.569232	0.57 [0.16 - 1.98]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213245_at	163	0.834356	0.248399	-	0.305226	0.942285	-0.0486303	0.95 [0.26 - 3.55]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	232062_at	163	0.858896	0.0423863	0.443708	-0.637753	0.223211	-1.0945	0.33 [0.06 - 1.95]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215340_at	79	0.898734	0.31467	-	0.441567	0.459968	0.647418	1.91 [0.34 - 10.64]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213245_at	79	0.56962	0.0689276	-	0.526889	0.192477	0.693989	2.00 [0.70 - 5.68]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	232062_at	79	0.202532	0.220178	-	-0.437613	0.906868	-0.0894813	0.91 [0.20 - 4.09]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215348_at	79	0.632911	0.000738018	0.0197306	-1.1487	0.0169754	-1.72089	0.18 [0.04 - 0.73]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213245_at	58	0.517241	0.0431218	0.448545	-0.583546	0.572934	-0.0821547	0.92 [0.69 - 1.23]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215348_at	58	0.327586	0.123546	-	0.464973	0.611611	0.0885582	1.09 [0.78 - 1.54]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215340_at	58	0.827586	0.184075	-	-0.506914	0.739565	-0.0469314	0.95 [0.72 - 1.26]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213245_at	34	0.676471	0.342201	-	-0.396012	0.832158	-0.0513734	0.95 [0.59 - 1.53]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215348_at	34	0.117647	0.257844	-	0.815671	0.33684	0.302311	1.35 [0.73 - 2.51]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215340_at	34	0.323529	0.115124	-	-0.661926	0.479645	-0.184839	0.83 [0.50 - 1.39]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215348_at	158	0.607595	0.00406239	0.0803042	0.653331	0.267629	0.772683	2.17 [0.55 - 8.49]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213245_at	158	0.803797	0.196818	-	0.353408	0.435659	-0.295874	0.74 [0.35 - 1.57]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215340_at	158	0.664557	0.00103791	0.0262928	0.748629	0.637609	0.522162	1.69 [0.19 - 14.80]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215340_at	53	0.226415	0.00312314	0.0650658	-1.09301	0.959902	0.0124855	1.01 [0.62 - 1.65]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213245_at	53	0.509434	0.030009	0.354333	0.754488	0.167334	0.360979	1.43 [0.86 - 2.39]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215340_at	53	0.207547	0.00168472	0.0393349	-1.16238	0.705477	-0.0882221	0.92 [0.58 - 1.45]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213245_at	53	0.169811	0.166529	-	0.82025	0.40378	0.218961	1.24 [0.74 - 2.08]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215348_at	53	0.754717	0.0360518	0.39997	0.741232	0.552156	0.166142	1.18 [0.68 - 2.04]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215348_at	53	0.754717	0.0177297	0.245952	0.88088	0.424165	0.237124	1.27 [0.71 - 2.27]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213245_at	180	0.638889	0.172013	-	0.290238	0.611654	0.0774991	1.08 [0.80 - 1.46]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215340_at	180	0.555556	0.0234256	0.299286	0.473128	0.0935166	0.20455	1.23 [0.97 - 1.56]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215348_at	180	0.433333	0.0102886	0.164953	-0.536858	0.102261	-0.144197	0.87 [0.73 - 1.03]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	232062_at	180	0.266667	0.0282078	0.339877	-0.482937	0.916474	-0.0194443	0.98 [0.68 - 1.41]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215340_at	559	0.631485	0.00978816	0.158877	-0.55807	0.24849	-0.1306	0.88 [0.70 - 1.10]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213245_at	559	0.134168	0.0630093	-	0.713637	0.278912	0.126157	1.13 [0.90 - 1.43]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	232062_at	559	0.828265	0.0359779	0.399437	0.456438	0.247049	0.154233	1.17 [0.90 - 1.51]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215348_at	559	0.348837	0.0881024	-	-0.343103	0.554754	-0.0904885	0.91 [0.68 - 1.23]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213245_at	77	0.74026	0.0811975	-	-0.559002	0.162277	-0.233911	0.79 [0.57 - 1.10]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215348_at	77	0.142857	0.0018264	0.0420403	-1.0484	0.022484	-0.422906	0.66 [0.46 - 0.94]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215340_at	77	0.597403	0.00621773	0.112233	0.692277	0.379359	0.179514	1.20 [0.80 - 1.79]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	232062_at	77	0.506494	0.0236838	0.301566	-0.580686	0.0518692	-0.466092	0.63 [0.39 - 1.00]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215340_at	70	0.742857	0.0280006	0.338187	0.63344	0.0900414	1.09499	2.99 [0.84 - 10.60]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213245_at	70	0.142857	0.106714	-	-0.569144	0.422898	-0.0877586	0.92 [0.74 - 1.14]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	232062_at	70	0.157143	0.112606	-	-0.539195	0.640553	-0.333353	0.72 [0.18 - 2.90]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215348_at	70	0.357143	0.217566	-	0.350144	0.932675	0.068553	1.07 [0.22 - 5.25]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35580_at	50	0.88	0.115828	-	-0.840159	0.328855	-1.55799	0.21 [0.01 - 4.80]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213245_at	74	0.486486	0.0208763	0.276164	0.677795	0.218977	0.211664	1.24 [0.88 - 1.73]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215348_at	74	0.162162	0.000546442	0.015286	2.11672	0.0618676	0.389918	1.48 [0.98 - 2.22]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215340_at	74	0.824324	0.0462028	0.468311	0.676139	0.454805	0.173979	1.19 [0.75 - 1.88]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	232062_at	74	0.324324	0.0964263	-	0.549843	0.702317	0.0777252	1.08 [0.73 - 1.61]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215348_at	67	0.41791	0.161684	-	1.07286	0.546771	1.55354	4.73 [0.03 - 739.89]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	232062_at	67	0.179104	0.180314	-	15.3039	0.156046	2.44784	11.56 [0.39 - 340.40]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215340_at	67	0.134328	0.297409	-	15.2007	0.978239	0.0536891	1.06 [0.02 - 49.98]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213245_at	67	0.298507	0.000530597	0.0149072	-2.28602	0.0264936	-3.14314	0.04 [0.00 - 0.69]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215340_at	115	0.226087	0.0469677	0.473096	-1.0269	0.298544	-0.805475	0.45 [0.10 - 2.04]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	232062_at	115	0.556522	0.0308035	0.360578	1.20389	0.210689	1.12798	3.09 [0.53 - 18.07]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213245_at	115	0.791304	0.0457541	0.465481	-15.4059	0.358139	-0.30811	0.73 [0.38 - 1.42]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215348_at	115	0.869565	0.00568133	0.104614	1.42278	0.86856	0.214668	1.24 [0.10 - 15.76]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35580_at	158	0.860759	0.03294	0.376992	0.716498	0.467115	0.254963	1.29 [0.65 - 2.57]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35580_at	76	0.763158	0.0802929	-	-1.62879	0.528948	-0.332458	0.72 [0.25 - 2.02]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213245_at	204	0.29902	0.00618788	0.111814	-0.420759	0.060718	-0.0994339	0.91 [0.82 - 1.00]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215348_at	204	0.769608	0.0689594	-	-0.302759	0.601317	-0.0364942	0.96 [0.84 - 1.11]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	232062_at	204	0.651961	0.000515424	0.0145426	-0.517252	0.00254811	-0.195768	0.82 [0.72 - 0.93]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215340_at	204	0.205882	0.0400245	0.427846	0.36336	0.142329	0.109676	1.12 [0.96 - 1.29]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215348_at	87	0.758621	0.137841	-	-0.782238	0.579508	-0.355704	0.70 [0.20 - 2.47]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213245_at	87	0.149425	0.135636	-	-0.675554	0.896904	-0.0121436	0.99 [0.82 - 1.19]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215340_at	87	0.551724	0.0395157	0.424362	-0.815934	0.275328	-0.931828	0.39 [0.07 - 2.10]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	232062_at	87	0.517241	0.192402	-	-0.508902	0.91816	-0.0681165	0.93 [0.25 - 3.43]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	232062_at	87	0.517241	0.192402	-	-0.508902	0.91816	-0.0681165	0.93 [0.25 - 3.43]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213245_at	87	0.149425	0.135636	-	-0.675554	0.896904	-0.0121436	0.99 [0.82 - 1.19]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215348_at	87	0.758621	0.137841	-	-0.782238	0.579508	-0.355704	0.70 [0.20 - 2.47]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215340_at	87	0.551724	0.0395157	0.424362	-0.815934	0.275328	-0.931828	0.39 [0.07 - 2.10]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213245_at	77	0.12987	0.192287	-	-0.835454	0.699267	-0.0628808	0.94 [0.68 - 1.29]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215348_at	77	0.623377	0.238882	-	-0.900446	0.91431	-0.147736	0.86 [0.06 - 12.72]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	232062_at	77	0.636364	0.0468962	0.472651	1.07992	0.91346	0.0650716	1.07 [0.33 - 3.45]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215340_at	77	0.636364	0.250554	-	-0.880375	0.591386	-0.719448	0.49 [0.04 - 6.73]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215348_at	77	0.181818	0.211787	-	-0.734403	0.792778	-0.31987	0.73 [0.07 - 7.90]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	232062_at	77	0.103896	0.218639	-	-0.938625	0.658152	-0.406244	0.67 [0.11 - 4.03]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213245_at	77	0.12987	0.0778207	-	-1.15332	0.672538	-0.0795666	0.92 [0.64 - 1.34]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215340_at	77	0.25974	0.30406	-	-0.578341	0.858207	-0.208146	0.81 [0.08 - 7.97]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215340_at	136	0.102941	0.0863627	-	15.2404	0.512415	0.168806	1.18 [0.71 - 1.96]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215348_at	136	0.279412	0.178432	-	0.819957	0.724486	0.0899937	1.09 [0.66 - 1.80]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213245_at	136	0.661765	0.0453227	0.462745	-1.18637	0.606359	-0.128734	0.88 [0.54 - 1.43]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213245_at	200	0.18	0.013485	0.201678	-0.774797	0.462757	-0.124943	0.88 [0.63 - 1.23]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215340_at	200	0.3	0.0220432	0.286887	-0.678026	0.17087	-0.276267	0.76 [0.51 - 1.13]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215348_at	200	0.84	0.00868016	0.145061	0.836477	0.342079	0.173844	1.19 [0.83 - 1.70]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18857	60	0.783333	0.107853	-	0.668976	0.444949	0.144657	1.16 [0.80 - 1.68]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20576	60	0.116667	0.181021	-	-0.649739	0.620299	-0.162233	0.85 [0.45 - 1.62]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20576	60	0.183333	0.0975012	-	1.15124	0.797094	-0.122222	0.88 [0.35 - 2.25]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18857	60	0.116667	7.61891e-07	4.23365e-05	-1.99033	0.315311	-0.208121	0.81 [0.54 - 1.22]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	22379	155	0.587097	0.291398	-	-0.305211	0.972573	-0.00868413	0.99 [0.60 - 1.63]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213245_at	286	0.863636	0.198588	-	-0.405266	0.971771	0.00334578	1.00 [0.83 - 1.21]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215340_at	286	0.248252	0.10314	-	-0.342579	0.895469	-0.0176681	0.98 [0.75 - 1.28]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215348_at	286	0.293706	0.0218692	0.285304	-0.458364	0.250288	-0.164844	0.85 [0.64 - 1.12]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215340_at	159	0.176101	0.133653	-	0.771538	0.987287	-0.0034248	1.00 [0.65 - 1.52]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213245_at	159	0.144654	0.0225409	0.291389	-0.811341	0.393498	-0.185121	0.83 [0.54 - 1.27]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213245_at	159	0.132075	0.00566288	0.104348	-1.09482	0.152972	-0.367978	0.69 [0.42 - 1.15]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215340_at	159	0.874214	0.0836115	-	0.671116	0.789034	0.0593082	1.06 [0.69 - 1.64]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215348_at	159	0.150943	0.0958315	-	-0.620775	0.954207	0.0149354	1.02 [0.61 - 1.69]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215348_at	159	0.572327	0.034852	0.391236	0.787648	0.249519	0.387724	1.47 [0.76 - 2.85]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213245_at	159	0.36478	0.0257606	0.319528	-0.691717	0.0546219	-0.419765	0.66 [0.43 - 1.01]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215340_at	159	0.496855	0.298193	-	-0.389809	0.745712	-0.0812131	0.92 [0.56 - 1.51]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215348_at	159	0.528302	0.0861902	-	0.547302	0.286609	0.289092	1.34 [0.78 - 2.27]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232062_at	159	0.27044	0.227757	-	0.584623	0.966849	-0.0122595	0.99 [0.55 - 1.76]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232062_at	159	0.647799	0.0283635	0.341143	-0.841739	0.2085	-0.328926	0.72 [0.43 - 1.20]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232062_at	159	0.383648	0.108084	-	0.561951	0.983128	0.00530262	1.01 [0.61 - 1.64]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213245_at	54	0.203704	0.0701911	-	15.513	0.740018	0.0617244	1.06 [0.74 - 1.53]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215340_at	54	0.388889	0.150706	-	1.09973	0.512282	-0.40027	0.67 [0.20 - 2.22]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215348_at	54	0.87037	0.331721	-	0.790697	0.982111	-0.0312865	0.97 [0.06 - 14.93]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215348_at	117	0.162393	0.0833135	-	0.997524	0.803324	0.146331	1.16 [0.37 - 3.66]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215348_at	117	0.521368	0.115387	-	0.600121	0.699207	0.263397	1.30 [0.34 - 4.95]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215348_at	117	0.162393	0.0833135	-	0.997524	0.803324	0.146331	1.16 [0.37 - 3.66]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213245_at	117	0.820513	0.0798274	-	0.612396	0.283074	0.0891159	1.09 [0.93 - 1.29]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215348_at	117	0.196581	0.0832469	-	1.20215	0.854628	-0.140402	0.87 [0.19 - 3.90]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213245_at	117	0.82906	0.0185655	0.254173	0.920545	0.0846417	0.158734	1.17 [0.98 - 1.40]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213245_at	117	0.205128	0.0644358	-	1.2704	0.318806	0.100954	1.11 [0.91 - 1.35]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213245_at	117	0.820513	0.0798274	-	0.612396	0.283074	0.0891159	1.09 [0.93 - 1.29]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215340_at	117	0.25641	0.0759216	-	0.723991	0.854232	0.0758542	1.08 [0.48 - 2.42]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215340_at	117	0.264957	0.14651	-	0.702476	0.981952	0.0113035	1.01 [0.38 - 2.69]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215340_at	117	0.521368	0.07608	-	-0.730468	0.713914	-0.207184	0.81 [0.27 - 2.46]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215340_at	117	0.25641	0.0759216	-	0.723991	0.854232	0.0758542	1.08 [0.48 - 2.42]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215340_at	236	0.830508	0.181586	-	-0.570133	0.805934	-0.0522632	0.95 [0.63 - 1.44]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215348_at	236	0.148305	0.0298206	0.352841	-0.676343	0.133631	-0.355266	0.70 [0.44 - 1.12]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213245_at	236	0.588983	0.0141019	0.208401	-0.727981	0.0378287	-0.396657	0.67 [0.46 - 0.98]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	232062_at	236	0.271186	0.0389005	0.420116	0.737023	0.255074	0.28359	1.33 [0.81 - 2.16]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215348_at	249	0.289157	0.0246026	0.309595	-0.489461	0.0995206	-0.3165	0.73 [0.50 - 1.06]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213245_at	249	0.582329	0.0473568	0.475514	-0.439281	0.216878	-0.17278	0.84 [0.64 - 1.11]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215340_at	249	0.86747	0.0694594	-	-0.699688	0.807821	0.0402577	1.04 [0.75 - 1.44]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	232062_at	249	0.807229	0.0554393	-	0.460872	0.353862	0.186488	1.21 [0.81 - 1.79]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215340_at	125	0.232	0.0198441	0.266469	-0.681576	0.899169	-0.0356794	0.96 [0.56 - 1.68]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215340_at	54	0.351852	0.092728	-	1.59194	0.734871	-0.0695301	0.93 [0.62 - 1.39]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215348_at	125	0.896	0.312713	-	-0.741735	0.67959	0.240801	1.27 [0.41 - 3.99]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213245_at	62	0.709677	0.0693809	-	-1.01131	0.308128	-0.154653	0.86 [0.64 - 1.15]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213245_at	125	0.872	0.285284	-	-0.764507	0.751972	-0.056938	0.94 [0.66 - 1.34]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215348_at	62	0.870968	0.472305	-	-0.533468	0.805368	-0.081194	0.92 [0.48 - 1.76]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215348_at	54	0.444444	0.337793	-	0.635362	0.85517	-0.0729671	0.93 [0.42 - 2.04]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215340_at	62	0.193548	0.0366004	0.403913	15.3561	0.685578	-0.0683989	0.93 [0.67 - 1.30]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213245_at	125	0.152	0.0352737	0.394323	-0.707293	0.678547	-0.0563493	0.95 [0.72 - 1.23]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215340_at	125	0.176	0.0013776	0.0332986	-1.17844	0.403621	-0.304589	0.74 [0.36 - 1.51]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213245_at	54	0.648148	0.0406867	0.432344	-1.47862	0.199034	-0.25093	0.78 [0.53 - 1.14]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215348_at	125	0.896	0.281607	-	-0.516675	0.773396	-0.129037	0.88 [0.37 - 2.12]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215348_at	198	0.409091	0.00294912	0.0621269	0.841195	0.0150567	0.264371	1.30 [1.05 - 1.61]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215348_at	198	0.409091	0.00180908	0.0417119	0.953565	0.00834779	0.307079	1.36 [1.08 - 1.71]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215340_at	198	0.777778	0.0981287	-	0.393653	0.296388	0.0896585	1.09 [0.92 - 1.29]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213245_at	198	0.262626	0.0284271	0.34166	-0.584454	0.326409	-0.0878916	0.92 [0.77 - 1.09]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213245_at	198	0.262626	0.00813442	0.138055	-0.7311	0.192225	-0.121365	0.89 [0.74 - 1.06]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215340_at	198	0.893939	0.210006	-	0.472966	0.36917	0.0932513	1.10 [0.90 - 1.35]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215348_at	198	0.50505	0.0173981	0.242649	0.503138	0.176596	0.119158	1.13 [0.95 - 1.34]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215340_at	198	0.651515	0.0876934	-	0.457869	0.163063	0.149656	1.16 [0.94 - 1.43]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213245_at	198	0.868687	0.135617	-	0.409671	0.532416	0.0461541	1.05 [0.91 - 1.21]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215340_at	62	0.725806	0.439285	-	-0.590632	0.846348	-0.314913	0.73 [0.03 - 17.64]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215348_at	51	0.176471	0.277317	-	15.3433	0.887536	-0.20445	0.82 [0.05 - 13.86]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213245_at	51	0.686275	0.112761	-	-15.6741	0.385071	-1.48813	0.23 [0.01 - 6.49]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213245_at	62	0.322581	0.0535094	-	1.77516	0.683486	0.342072	1.41 [0.27 - 7.29]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215340_at	51	0.235294	0.386685	-	-0.771411	0.799282	-0.627721	0.53 [0.00 - 67.41]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215348_at	62	0.177419	0.207518	-	-0.754133	0.900792	-0.118299	0.89 [0.14 - 5.71]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213245_at	145	0.613793	0.268264	-	0.368352	0.801592	0.151788	1.16 [0.36 - 3.80]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215348_at	177	0.101695	0.00425647	0.0833373	-1.0116	0.014487	-1.55835	0.21 [0.06 - 0.73]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	232062_at	177	0.305085	0.0017441	0.0404744	-0.728909	0.00942214	-2.16805	0.11 [0.02 - 0.59]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	232062_at	177	0.288136	0.00224091	0.0497116	-0.812664	0.0339869	-2.02107	0.13 [0.02 - 0.86]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215340_at	177	0.163842	0.0119587	0.18456	-0.762928	0.0177693	-1.81779	0.16 [0.04 - 0.73]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215348_at	177	0.661017	0.00280784	0.0597108	-0.823717	0.00560154	-1.53943	0.21 [0.07 - 0.64]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	232062_at	145	0.517241	0.00129777	0.0316861	-1.17267	0.0197088	-2.91286	0.05 [0.00 - 0.63]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215348_at	145	0.662069	0.00654928	0.116849	-1.15469	0.195446	-1.01094	0.36 [0.08 - 1.68]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213245_at	177	0.350282	0.0616135	-	-0.509744	0.798573	0.113294	1.12 [0.47 - 2.67]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215340_at	177	0.762712	0.00466906	0.0896695	-1.01741	0.00370963	-1.93336	0.14 [0.04 - 0.53]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213245_at	177	0.548023	0.0855863	-	-0.4127	0.892739	0.0533944	1.05 [0.49 - 2.29]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215340_at	145	0.558621	0.033234	0.379209	-0.773326	0.337808	-0.863741	0.42 [0.07 - 2.47]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	232062_at	226	0.792035	0.00759074	0.130933	0.779452	0.0319099	0.350723	1.42 [1.03 - 1.96]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215348_at	226	0.292035	0.0266679	0.327172	-0.625416	0.529764	-0.0802654	0.92 [0.72 - 1.19]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215340_at	226	0.185841	0.0346528	0.38977	1.05461	0.532509	0.0721554	1.07 [0.86 - 1.35]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213245_at	226	0.283186	0.234464	-	0.418077	0.975166	0.00690926	1.01 [0.65 - 1.56]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215348_at	55	0.8	0.0507431	-	-1.76721	0.0943067	-2.09952	0.12 [0.01 - 1.43]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215340_at	55	0.363636	0.00511141	0.0962972	-1.21202	0.0518353	-3.09378	0.05 [0.00 - 1.02]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215348_at	55	0.890909	0.089457	-	-15.2428	0.319837	-1.28626	0.28 [0.02 - 3.48]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	232062_at	55	0.581818	0.0358451	0.398477	-1.14368	0.100653	-3.20289	0.04 [0.00 - 1.86]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215348_at	49	0.857143	0.124694	-	-15.2907	0.432486	-1.19372	0.30 [0.02 - 5.97]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	232062_at	49	0.102041	0.043322	0.449854	-1.28786	0.096599	-4.16856	0.02 [0.00 - 2.11]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213245_at	55	0.563636	0.00273896	0.0585226	1.35963	0.376498	0.455912	1.58 [0.57 - 4.33]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215340_at	55	0.181818	0.139273	-	-0.790096	0.362683	-1.54552	0.21 [0.01 - 5.94]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215340_at	49	0.285714	0.138529	-	-0.832462	0.395734	-1.82453	0.16 [0.00 - 10.87]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213245_at	55	0.563636	0.222666	-	0.593396	0.89925	0.0836515	1.09 [0.30 - 3.97]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	232062_at	55	0.109091	0.00303046	0.0635055	-1.44436	0.0175451	-4.76184	0.01 [0.00 - 0.44]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213245_at	49	0.571429	0.00470398	0.0901986	1.89714	0.273872	0.640337	1.90 [0.60 - 5.97]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	232062_at	63	0.412698	0.00011489	0.00395728	-1.27177	0.891657	-0.42742	0.65 [0.00 - 305.84]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215348_at	63	0.15873	1.16861e-05	0.000514457	-1.61712	0.152289	-3.57647	0.03 [0.00 - 3.75]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215340_at	63	0.15873	0.000227102	0.00717846	-1.36273	0.172802	-12.42	0.00 [0.00 - 229.68]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213245_at	63	0.492063	1.91034e-05	0.000801493	1.52767	0.000342746	0.276894	1.32 [1.13 - 1.53]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.301663.0.A1_3p_at	28	0.285714	0.148073	-	-0.839381	0.238741	-2.81441	0.06 [0.00 - 6.47]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.259768.0.S1_3p_x_at	28	0.678571	0.0195428	0.263601	-1.65279	0.0318913	-30.5041	0.00 [0.00 - 0.07]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.259768.0.A1_3p_at	28	0.107143	0.0528595	-	-1.29102	0.574798	-2.66298	0.07 [0.00 - 765.76]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.282846.0.S1_3p_at	28	0.321429	0.0691516	-	-1.03791	0.252665	-2.18895	0.11 [0.00 - 4.77]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.259768.0.S1_3p_at	28	0.142857	0.0685508	-	-1.19105	0.545264	-5.25822	0.01 [0.00 - 130649.78]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215340_at	82	0.5	0.208627	-	0.431698	0.950048	0.0314655	1.03 [0.39 - 2.76]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215348_at	82	0.878049	0.00594431	0.108373	1.12672	0.140628	0.612609	1.85 [0.82 - 4.17]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213245_at	82	0.890244	0.0373672	0.409374	0.924163	0.0293746	1.35813	3.89 [1.15 - 13.20]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215348_at	79	0.848101	0.134636	-	0.496559	0.662167	0.201659	1.22 [0.50 - 3.02]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215340_at	79	0.316456	0.189739	-	0.374173	0.952522	-0.0387854	0.96 [0.27 - 3.45]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213245_at	79	0.632911	0.023594	0.300775	-0.661186	0.468688	-0.40485	0.67 [0.22 - 1.99]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213245_at	104	0.307692	0.105532	-	-0.532629	0.98822	-0.0105279	0.99 [0.24 - 4.00]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215340_at	104	0.336538	0.100262	-	0.641979	0.230719	0.97473	2.65 [0.54 - 13.05]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215348_at	104	0.875	0.0191638	0.259968	0.914896	0.147731	0.943801	2.57 [0.72 - 9.22]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P577694	117	0.675214	0.00556021	0.102866	0.775926	0.12587	0.201306	1.22 [0.95 - 1.58]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215340_at	204	0.529412	0.158533	-	-0.391536	0.265277	-0.164622	0.85 [0.63 - 1.13]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213245_at	204	0.318627	0.000199528	0.00641416	-1.29577	0.0107417	-1.02052	0.36 [0.16 - 0.79]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213245_at	204	0.436274	0.00576876	0.105869	-0.747538	0.139043	-0.418217	0.66 [0.38 - 1.15]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215348_at	204	0.897059	0.0120624	0.185747	1.03681	0.717627	0.0902885	1.09 [0.67 - 1.79]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	232062_at	204	0.220588	0.0306096	0.359061	-0.79866	0.23182	-0.368985	0.69 [0.38 - 1.27]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215348_at	204	0.897059	0.0471515	0.47424	0.710091	0.725495	0.0658745	1.07 [0.74 - 1.54]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	232062_at	204	0.220588	0.0345844	0.389267	-0.610027	0.452843	-0.175943	0.84 [0.53 - 1.33]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215340_at	204	0.656863	0.0685084	-	-0.809941	0.352131	-0.183468	0.83 [0.57 - 1.23]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215340_at	178	0.106742	0.0167401	0.236022	-0.628454	0.413066	-0.358	0.70 [0.30 - 1.65]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215348_at	178	0.337079	0.00854316	0.143315	-0.526717	0.154618	-0.351149	0.70 [0.43 - 1.14]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213245_at	178	0.376404	0.114022	-	0.327828	0.430518	0.351624	1.42 [0.59 - 3.41]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	232062_at	111	0.792793	0.02741	0.333335	0.639581	0.319467	0.207387	1.23 [0.82 - 1.85]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213245_at	111	0.198198	0.0428944	0.447054	-0.605575	0.266587	-0.233241	0.79 [0.52 - 1.20]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215348_at	111	0.54955	0.148377	-	-0.385389	0.629269	-0.0891234	0.91 [0.64 - 1.31]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215340_at	111	0.72973	0.214167	-	0.349831	0.770376	0.0486783	1.05 [0.76 - 1.46]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215340_at	90	0.311111	0.00393049	0.0782219	-0.905159	0.526809	-0.470664	0.62 [0.15 - 2.68]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215340_at	90	0.111111	0.0057442	0.105516	-1.14423	0.951662	-0.0480886	0.95 [0.20 - 4.51]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215348_at	90	0.277778	0.295559	-	0.476398	0.36075	0.47978	1.62 [0.58 - 4.52]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215348_at	90	0.888889	0.21306	-	-0.876779	0.810934	0.117717	1.12 [0.43 - 2.95]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213245_at	90	0.122222	0.105363	-	1.11809	0.320148	0.25985	1.30 [0.78 - 2.16]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213245_at	90	0.3	0.0330243	0.377628	1.09312	0.122047	0.401798	1.49 [0.90 - 2.49]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4862	50	0.44	0.166303	-	0.727403	0.612599	0.230171	1.26 [0.52 - 3.07]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	232062_at	138	0.224638	0.0134194	0.200957	-0.630192	0.23828	-8.44754	0.00 [0.00 - 268.36]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213245_at	138	0.789855	0.00111992	0.0280208	0.828819	0.0430244	0.349178	1.42 [1.01 - 1.99]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215348_at	138	0.297101	0.0963887	-	-0.407945	0.132741	-3.21132	0.04 [0.00 - 2.65]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215340_at	138	0.217391	0.00819215	0.138803	-0.674623	0.103981	-10.2542	0.00 [0.00 - 8.23]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213245_at	129	0.751938	0.0812246	-	-0.550344	0.813927	-0.0458656	0.96 [0.65 - 1.40]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215340_at	129	0.100775	0.149124	-	0.729773	0.399758	0.167543	1.18 [0.80 - 1.75]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215348_at	129	0.821705	0.0318598	0.368761	0.63493	0.591158	0.108118	1.11 [0.75 - 1.65]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34813	56	0.732143	0.233245	-	0.43618	0.677821	0.375431	1.46 [0.25 - 8.56]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32275	56	0.107143	0.0806291	-	1.2187	0.781885	0.145849	1.16 [0.41 - 3.25]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34813	56	0.625	0.0875284	-	0.606481	0.763314	0.2842	1.33 [0.21 - 8.45]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32275	56	0.625	0.0364807	0.403056	-0.917981	0.873022	-0.0889417	0.91 [0.31 - 2.72]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215348_at	278	0.31295	0.0301592	0.35552	-0.432766	0.325772	-0.353723	0.70 [0.35 - 1.42]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	232062_at	278	0.161871	0.00670536	0.118999	-0.602369	0.04456	-0.812676	0.44 [0.20 - 0.98]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215340_at	278	0.100719	9.31718e-05	0.00329065	-1.00407	0.0400788	-0.76661	0.46 [0.22 - 0.97]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213245_at	278	0.107914	0.0509167	-	0.862295	0.502353	-0.0861806	0.92 [0.71 - 1.18]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215348_at	133	0.827068	0.000232829	0.00733541	0.947337	8.59043e-05	2.90684	18.30 [4.29 - 78.07]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213245_at	133	0.473684	0.0977248	-	0.394819	0.575249	-0.0835391	0.92 [0.69 - 1.23]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215340_at	133	0.609023	0.000829123	0.021769	0.779194	0.00765506	3.82844	45.99 [2.76 - 766.69]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7843	81	0.111111	0.0604848	-	-1.06197	0.138697	-0.713455	0.49 [0.19 - 1.26]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215340_at	185	0.124324	0.019192	0.260239	0.568567	0.623972	0.10253	1.11 [0.74 - 1.67]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215348_at	185	0.259459	0.00837573	0.14117	-0.499766	0.0628807	-0.541315	0.58 [0.33 - 1.03]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213245_at	185	0.427027	0.00525758	0.0984531	0.462073	0.00278102	0.619721	1.86 [1.24 - 2.79]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215340_at	185	0.124324	0.0373348	0.409145	0.56029	0.65974	0.102569	1.11 [0.70 - 1.75]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213245_at	185	0.772973	0.00514415	0.0967816	0.556574	0.00151471	0.679071	1.97 [1.30 - 3.00]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215348_at	185	0.578378	0.0068878	0.121494	-0.452061	0.0338659	-0.5637	0.57 [0.34 - 0.96]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P21002	110	0.190909	0.329461	-	-0.271435	0.894233	0.0345654	1.04 [0.62 - 1.72]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P577694	110	0.409091	0.0188111	0.25656	0.561674	0.10408	0.210636	1.23 [0.96 - 1.59]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P21002	110	0.118182	0.395219	-	0.372224	0.754321	0.0969301	1.10 [0.60 - 2.02]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P577694	110	0.818182	0.226323	-	0.475046	0.468708	0.119087	1.13 [0.82 - 1.55]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213245_at	80	0.6375	0.0642171	-	0.796457	0.891191	0.0392165	1.04 [0.59 - 1.82]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215348_at	80	0.6625	0.00485053	0.0924079	1.20735	0.219253	0.351527	1.42 [0.81 - 2.49]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215340_at	80	0.275	0.0497925	0.490377	-0.848217	0.44652	-0.14141	0.87 [0.60 - 1.25]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5052	281	0.597865	0.0227575	0.293334	0.32271	0.535321	0.0485944	1.05 [0.90 - 1.22]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215348_at	38	0.710526	0.102572	-	-0.908574	0.464121	-0.371898	0.69 [0.25 - 1.87]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215340_at	38	0.157895	0.0475924	0.476971	-1.12083	0.211041	-0.525773	0.59 [0.26 - 1.35]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	232062_at	38	0.131579	0.105262	-	15.2266	0.476512	0.953924	2.60 [0.19 - 35.88]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213245_at	38	0.789474	0.00336339	0.0690595	1.37042	0.0760794	0.335632	1.40 [0.97 - 2.03]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215340_at	140	0.157143	0.0261393	0.322733	1.4721	0.270546	0.647338	1.91 [0.60 - 6.04]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215348_at	140	0.714286	0.00418463	0.0822187	-1.11924	0.175713	-1.0842	0.34 [0.07 - 1.62]
GENE	ADCY1	adenylate cyclase 1 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213245_at	140	0.678571	0.0119201	0.184118	0.718401	0.211428	0.190456	1.21 [0.90 - 1.63]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217305_s_at	30	0.333333	0.0350099	0.392394	-0.901927	0.997096	0.00307371	1.00 [0.19 - 5.25]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214547_at	30	0.4	0.111261	-	0.678963	0.622601	0.278741	1.32 [0.44 - 4.01]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217305_s_at	163	0.214724	0.0208119	0.275565	-0.513783	0.293773	-0.799302	0.45 [0.10 - 2.00]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214547_at	163	0.840491	0.18533	-	0.337755	0.999117	0.000602082	1.00 [0.34 - 2.91]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217305_s_at	79	0.379747	0.131262	-	-0.439213	0.377418	-0.770462	0.46 [0.08 - 2.56]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214547_at	79	0.164557	0.207084	-	-0.466462	0.463899	-0.617512	0.54 [0.10 - 2.81]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214547_at	58	0.275862	0.0417595	0.439547	0.647634	0.256482	0.141084	1.15 [0.90 - 1.47]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217305_s_at	58	0.12069	0.100047	-	-0.662872	0.756525	-0.0533211	0.95 [0.68 - 1.33]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214547_at	34	0.382353	0.115122	-	0.62198	0.48833	0.138713	1.15 [0.78 - 1.70]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217305_s_at	34	0.558824	0.182204	-	0.524612	0.852908	0.0390153	1.04 [0.69 - 1.57]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217305_s_at	158	0.56962	0.0449721	0.46051	0.460739	0.235879	1.07972	2.94 [0.49 - 17.55]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214547_at	158	0.556962	0.043438	0.450611	0.464312	0.366207	0.572144	1.77 [0.51 - 6.13]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217305_s_at	53	0.132075	0.11555	-	1.09393	0.98807	0.00422487	1.00 [0.58 - 1.75]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214547_at	53	0.490566	0.0665648	-	0.627568	0.50468	0.135862	1.15 [0.77 - 1.71]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214547_at	53	0.603774	0.0198453	0.266481	0.832718	0.332642	0.21202	1.24 [0.80 - 1.90]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217305_s_at	53	0.132075	0.19983	-	0.907929	0.87666	-0.0455652	0.96 [0.54 - 1.70]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217305_s_at	180	0.594444	0.0239776	0.304149	0.469011	0.07518	0.229682	1.26 [0.98 - 1.62]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214547_at	180	0.455556	0.00932138	0.15312	0.559522	0.287095	0.0881887	1.09 [0.93 - 1.28]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217305_s_at	559	0.892665	0.0826457	-	-0.667968	0.515856	-0.114716	0.89 [0.63 - 1.26]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214547_at	559	0.110912	0.018964	0.25804	0.953815	0.582696	0.0653784	1.07 [0.85 - 1.35]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214547_at	77	0.116883	0.343335	-	0.406244	0.925883	0.0121412	1.01 [0.78 - 1.31]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217305_s_at	77	0.896104	0.243721	-	-0.545036	0.932032	-0.0203457	0.98 [0.61 - 1.56]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214547_at	70	0.285714	0.00799065	0.136186	0.81355	0.329262	1.18353	3.27 [0.30 - 35.21]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217305_s_at	70	0.814286	0.282531	-	-0.3734	0.84409	0.247899	1.28 [0.11 - 15.16]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	31924_at	50	0.12	0.0125093	0.190818	-1.11866	0.173625	-1.37807	0.25 [0.03 - 1.83]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217305_s_at	74	0.648649	0.0709413	-	-0.581658	0.365525	-0.197987	0.82 [0.53 - 1.26]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214547_at	74	0.648649	0.0464341	0.469763	0.584737	0.667321	0.0735343	1.08 [0.77 - 1.51]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217305_s_at	67	0.895522	0.186229	-	1.03613	0.0552667	3.71903	41.22 [0.92 - 1848.11]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214547_at	67	0.880597	0.278746	-	0.843827	0.609909	1.63502	5.13 [0.01 - 2741.10]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214547_at	115	0.217391	0.152414	-	-0.774712	0.762436	-0.206613	0.81 [0.21 - 3.11]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217305_s_at	115	0.234783	0.0309658	0.361844	15.4665	0.188755	1.44296	4.23 [0.49 - 36.41]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	31924_at	158	0.272152	0.133614	-	-0.447272	0.714415	-0.0782377	0.92 [0.61 - 1.41]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	31924_at	76	0.763158	0.176971	-	0.699908	0.473541	0.250656	1.28 [0.65 - 2.55]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217305_s_at	204	0.789216	0.199999	-	-0.218434	0.737164	-0.0241484	0.98 [0.85 - 1.12]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214547_at	204	0.245098	0.000360203	0.0106968	0.597843	0.0151994	0.164686	1.18 [1.03 - 1.35]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214547_at	87	0.45977	0.0750518	-	0.708114	0.530778	0.760439	2.14 [0.20 - 23.06]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217305_s_at	87	0.448276	0.0165158	0.23374	-0.914698	0.197087	-1.45581	0.23 [0.03 - 2.13]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214547_at	87	0.45977	0.0750518	-	0.708114	0.530778	0.760439	2.14 [0.20 - 23.06]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217305_s_at	87	0.448276	0.0165158	0.23374	-0.914698	0.197087	-1.45581	0.23 [0.03 - 2.13]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214547_at	77	0.363636	0.0662694	-	1.71741	0.516708	1.18957	3.29 [0.09 - 119.74]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217305_s_at	77	0.103896	0.0272317	0.331862	-1.40743	0.157285	-2.47654	0.08 [0.00 - 2.60]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214547_at	77	0.363636	0.0207261	0.274765	2.03745	0.0536048	2.45808	11.68 [0.96 - 141.79]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217305_s_at	77	0.103896	0.109756	-	-1.01035	0.463027	-1.12121	0.33 [0.02 - 6.51]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217305_s_at	136	0.654412	0.154001	-	0.643195	0.819258	-0.0545614	0.95 [0.59 - 1.51]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214547_at	136	0.889706	0.0261986	0.323233	1.09712	0.361658	0.225376	1.25 [0.77 - 2.03]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217305_s_at	200	0.11	0.0445667	0.457913	-0.769511	0.275845	-0.237232	0.79 [0.51 - 1.21]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214547_at	200	0.84	0.0970178	-	0.5922	0.678452	0.0638594	1.07 [0.79 - 1.44]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3680	60	0.3	0.177613	-	0.615897	0.626828	-0.279282	0.76 [0.25 - 2.33]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3680	60	0.883333	0.271972	-	-0.784475	0.920567	-0.0667233	0.94 [0.25 - 3.47]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217305_s_at	286	0.272727	0.0853882	-	-0.354265	0.59453	-0.0662823	0.94 [0.73 - 1.19]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214547_at	286	0.118881	0.00692905	0.122056	-0.670601	0.146407	-0.142922	0.87 [0.71 - 1.05]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217305_s_at	159	0.427673	0.0267416	0.327787	0.765975	0.411652	0.290804	1.34 [0.67 - 2.68]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214547_at	159	0.100629	0.0227523	0.293287	15.196	0.376962	0.152593	1.16 [0.83 - 1.63]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217305_s_at	159	0.427673	0.0631401	-	0.754601	0.518156	0.259339	1.30 [0.59 - 2.85]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217305_s_at	159	0.427673	0.119832	-	0.519611	0.744265	0.110428	1.12 [0.58 - 2.17]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214547_at	159	0.54717	0.00526145	0.09851	0.895813	0.0543788	0.330027	1.39 [0.99 - 1.95]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214547_at	159	0.572327	0.0506948	-	0.721844	0.359246	0.184184	1.20 [0.81 - 1.78]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214547_at	54	0.203704	0.0595701	-	15.555	0.847874	-0.40848	0.66 [0.01 - 43.17]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217305_s_at	54	0.518519	0.235154	-	0.823142	0.650968	-0.68406	0.50 [0.03 - 9.77]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217305_s_at	117	0.102564	0.170515	-	0.960278	0.369514	-0.743368	0.48 [0.09 - 2.41]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217305_s_at	117	0.102564	0.204548	-	1.21592	0.640273	-0.444834	0.64 [0.10 - 4.14]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214547_at	117	0.196581	0.0701393	-	0.922649	0.955573	-0.0462872	0.95 [0.19 - 4.87]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214547_at	117	0.307692	0.0107618	0.170609	1.43294	0.747056	0.288148	1.33 [0.23 - 7.68]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217305_s_at	117	0.794872	0.295477	-	0.46217	0.77684	-0.266132	0.77 [0.12 - 4.83]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214547_at	117	0.307692	0.0394605	0.423982	1.07052	0.665259	0.393256	1.48 [0.25 - 8.80]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217305_s_at	117	0.102564	0.170515	-	0.960278	0.369514	-0.743368	0.48 [0.09 - 2.41]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214547_at	117	0.196581	0.0701393	-	0.922649	0.955573	-0.0462872	0.95 [0.19 - 4.87]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217305_s_at	236	0.631356	0.138099	-	-0.444674	0.687645	-0.103831	0.90 [0.54 - 1.50]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214547_at	236	0.177966	0.0774735	-	0.806987	0.414745	0.129734	1.14 [0.83 - 1.56]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217305_s_at	249	0.666667	0.14325	-	-0.348497	0.765796	-0.0563326	0.95 [0.65 - 1.37]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214547_at	249	0.449799	0.102874	-	0.354041	0.616328	0.0623091	1.06 [0.83 - 1.36]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214547_at	62	0.806452	0.138876	-	-1.07435	0.670013	-0.19995	0.82 [0.33 - 2.05]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217305_s_at	62	0.758065	0.119346	-	-0.975998	0.6402	-0.160014	0.85 [0.44 - 1.67]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214547_at	125	0.152	0.140499	-	-0.548411	0.753349	-0.173355	0.84 [0.29 - 2.48]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217305_s_at	125	0.88	0.0186523	0.255018	0.989041	0.47739	0.527058	1.69 [0.40 - 7.25]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214547_at	125	0.856	0.0239906	0.304262	0.918271	0.618663	0.352795	1.42 [0.35 - 5.71]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217305_s_at	125	0.424	0.207325	-	-0.387778	0.728193	-0.200494	0.82 [0.26 - 2.54]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217305_s_at	54	0.888889	0.125044	-	-15.3283	0.743202	-0.134944	0.87 [0.39 - 1.96]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214547_at	54	0.777778	0.114793	-	-1.52389	0.679908	-0.23679	0.79 [0.26 - 2.43]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217305_s_at	198	0.717172	5.74313e-06	0.000270028	1.09817	0.0170749	0.27255	1.31 [1.05 - 1.64]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214547_at	198	0.292929	0.086635	-	-0.449687	0.670843	-0.0400383	0.96 [0.80 - 1.16]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217305_s_at	198	0.717172	1.34532e-05	0.000584275	1.1082	0.0146338	0.300886	1.35 [1.06 - 1.72]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214547_at	198	0.787879	0.184591	-	0.398086	0.937065	-0.00779993	0.99 [0.82 - 1.20]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217305_s_at	198	0.712121	0.000150145	0.00500424	0.788528	0.0646143	0.162642	1.18 [0.99 - 1.40]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214547_at	198	0.151515	0.355591	-	0.285833	0.963704	0.00351894	1.00 [0.86 - 1.17]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214547_at	62	0.887097	1.16625e-05	0.000513517	2.15238	0.190516	1.91159	6.76 [0.39 - 118.36]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217305_s_at	51	0.588235	0.0680662	-	1.7914	0.824319	0.626674	1.87 [0.01 - 473.26]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214547_at	51	0.764706	0.0435035	0.451037	1.65057	0.292741	2.37342	10.73 [0.13 - 893.23]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217305_s_at	62	0.435484	0.250142	-	-0.662483	0.837275	-0.390592	0.68 [0.02 - 28.13]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214547_at	177	0.875706	0.0563554	-	-1.08096	0.642438	-0.624747	0.54 [0.04 - 7.48]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217305_s_at	177	0.870057	0.00706926	0.123957	-2.229	0.0250354	-3.28034	0.04 [0.00 - 0.66]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214547_at	177	0.875706	0.0571703	-	-0.855536	0.472252	-0.838502	0.43 [0.04 - 4.25]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217305_s_at	177	0.870057	0.00113671	0.0283714	-2.53848	0.000443764	-4.58651	0.01 [0.00 - 0.13]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214547_at	145	0.875862	0.0258841	0.320575	-1.94354	0.972227	-0.0574218	0.94 [0.04 - 23.93]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217305_s_at	145	0.17931	0.0190145	0.258528	-0.8521	0.11163	-2.75603	0.06 [0.00 - 1.90]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214547_at	226	0.393805	0.244884	-	0.351302	0.50747	0.0755407	1.08 [0.86 - 1.35]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217305_s_at	226	0.823009	0.0170395	0.23905	-1.32389	0.248525	-0.238105	0.79 [0.53 - 1.18]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214547_at	55	0.818182	0.250886	-	0.585648	0.722047	0.559486	1.75 [0.08 - 38.18]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217305_s_at	55	0.345455	0.223109	-	-0.541421	0.986763	-0.0314498	0.97 [0.02 - 39.80]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214547_at	55	0.763636	0.130751	-	0.819576	0.500973	1.089	2.97 [0.12 - 70.86]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214547_at	49	0.44898	0.0490598	0.485954	1.24048	0.597093	1.11202	3.04 [0.05 - 187.81]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217305_s_at	55	0.418182	0.165877	-	0.698839	0.492222	1.22733	3.41 [0.10 - 113.30]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217305_s_at	49	0.489796	0.47591	-	-0.415198	0.823998	-0.51768	0.60 [0.01 - 57.08]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214547_at	63	0.412698	0.0436312	0.451868	-0.672519	0.646477	0.688499	1.99 [0.11 - 37.74]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217305_s_at	63	0.126984	1.00093e-05	0.000447169	-1.72222	0.522254	-2.78423	0.06 [0.00 - 312.36]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.163045.1.S1_3p_a_at	28	0.25	0.10564	-	-0.929474	0.664274	-1.53638	0.22 [0.00 - 221.80]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217305_s_at	82	0.817073	0.0234217	0.299251	0.833466	0.148723	0.439492	1.55 [0.85 - 2.82]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214547_at	82	0.329268	0.0426689	0.445572	0.833955	0.406274	0.145178	1.16 [0.82 - 1.63]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214547_at	79	0.848101	0.106461	-	-0.647658	0.604243	-0.164593	0.85 [0.46 - 1.58]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217305_s_at	79	0.696203	0.206829	-	-0.367421	0.758567	-0.0870448	0.92 [0.53 - 1.60]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217305_s_at	104	0.115385	0.0130189	0.196526	-1.02118	0.183211	-0.356399	0.70 [0.41 - 1.18]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214547_at	104	0.288462	0.0475054	0.476433	-0.656889	0.971712	0.00986989	1.01 [0.59 - 1.74]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214547_at	204	0.563725	0.0571031	-	-0.767474	0.571813	-0.101045	0.90 [0.64 - 1.28]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214547_at	204	0.563725	0.294006	-	-0.294725	0.944063	-0.00952147	0.99 [0.76 - 1.29]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217305_s_at	204	0.843137	0.0142581	0.210086	-15.2965	0.876747	-0.0381844	0.96 [0.59 - 1.56]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217305_s_at	204	0.843137	0.00610606	0.110662	-1.74605	0.0948923	-0.276527	0.76 [0.55 - 1.05]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217305_s_at	178	0.230337	0.0695241	-	0.468324	0.413362	0.139072	1.15 [0.82 - 1.60]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214547_at	111	0.369369	0.0162809	0.231338	-0.631061	0.197082	-0.179849	0.84 [0.64 - 1.10]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217305_s_at	111	0.585586	0.0103661	0.165884	-0.71029	0.561556	-0.106179	0.90 [0.63 - 1.29]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217305_s_at	90	0.122222	0.0539037	-	-0.750486	0.368697	-0.534619	0.59 [0.18 - 1.88]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217305_s_at	90	0.122222	0.29314	-	-0.511845	0.688055	-0.26681	0.77 [0.21 - 2.82]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214547_at	90	0.411111	0.049697	0.489803	-0.630539	0.326236	-0.820386	0.44 [0.09 - 2.26]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214547_at	90	0.155556	0.00932201	0.153128	-1.03891	0.353623	-0.883824	0.41 [0.06 - 2.67]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214547_at	138	0.492754	0.0728787	-	-0.434366	0.66297	0.0756134	1.08 [0.77 - 1.52]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217305_s_at	138	0.456522	0.0919253	-	-0.404358	0.768264	0.0375553	1.04 [0.81 - 1.33]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217305_s_at	129	0.813953	0.0413721	0.436959	0.577897	0.781401	0.0493219	1.05 [0.74 - 1.49]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214547_at	129	0.589147	0.0123645	0.189182	0.608199	0.275962	0.129285	1.14 [0.90 - 1.44]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217305_s_at	278	0.143885	0.0545949	-	-0.494625	0.75478	0.210846	1.23 [0.33 - 4.64]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214547_at	278	0.895683	0.0996263	-	0.444516	0.919646	-0.064938	0.94 [0.27 - 3.31]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217305_s_at	133	0.526316	0.000981524	0.0250895	0.775561	0.0422905	1.0337	2.81 [1.04 - 7.63]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214547_at	133	0.75188	0.000457593	0.0131359	0.851183	0.0104083	1.1155	3.05 [1.30 - 7.16]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217305_s_at	185	0.448649	0.134319	-	0.247019	0.728856	0.104458	1.11 [0.61 - 2.00]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214547_at	185	0.194595	0.031957	0.369507	0.518641	0.638276	0.128146	1.14 [0.67 - 1.94]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217305_s_at	185	0.437838	0.0838833	-	0.310674	0.484119	0.230151	1.26 [0.66 - 2.40]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214547_at	185	0.172973	0.0568344	-	0.422919	0.685523	-0.107647	0.90 [0.53 - 1.51]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P126313	110	0.818182	0.0723375	-	-0.600424	0.376086	-0.129781	0.88 [0.66 - 1.17]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P126313	110	0.227273	0.156259	-	0.571037	0.893139	0.0260818	1.03 [0.70 - 1.50]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217305_s_at	80	0.8375	0.000576495	0.0159993	1.44952	0.0276411	0.592624	1.81 [1.07 - 3.06]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214547_at	80	0.4625	0.138398	-	0.688431	0.980278	0.00447661	1.00 [0.70 - 1.43]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214547_at	38	0.684211	0.0653713	-	-0.969041	0.19662	-0.284467	0.75 [0.49 - 1.16]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217305_s_at	38	0.684211	0.0505004	-	-1.07491	0.463639	-0.643112	0.53 [0.09 - 2.94]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217305_s_at	140	0.121429	0.00499785	0.0946108	-1.00149	0.137425	-2.31302	0.10 [0.00 - 2.09]
GENE	ADCY10	adenylate cyclase 10 (soluble)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214547_at	140	0.721429	0.216775	-	-0.454768	0.336987	-1.50375	0.22 [0.01 - 4.79]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213217_at	30	0.266667	0.249357	-	-0.516346	0.843622	0.116123	1.12 [0.35 - 3.56]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217687_at	30	0.4	0.0661369	-	-0.746136	0.567298	-0.314927	0.73 [0.25 - 2.15]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213219_at	30	0.166667	0.0206867	0.274398	-1.25355	0.567498	0.400494	1.49 [0.38 - 5.89]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217688_at	30	0.533333	0.055594	-	0.780744	0.512018	0.427877	1.53 [0.43 - 5.51]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1810691	165	0.393939	0.0358934	0.398826	0.544527	0.922744	-0.0150908	0.99 [0.73 - 1.34]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1810691	165	0.393939	0.0525042	-	0.772586	0.592342	-0.220215	0.80 [0.36 - 1.80]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213219_at	163	0.834356	0.0412993	0.43647	0.505431	0.498255	0.474963	1.61 [0.41 - 6.36]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217688_at	163	0.288344	0.150034	-	0.329281	0.588139	0.314929	1.37 [0.44 - 4.28]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217687_at	163	0.288344	0.0430069	0.447792	0.469175	0.828347	0.109549	1.12 [0.41 - 3.00]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213217_at	163	0.601227	1.76721e-05	0.000747228	0.832491	0.000507543	0.545743	1.73 [1.27 - 2.35]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217687_at	79	0.21519	0.106026	-	-0.535132	0.443453	-0.538023	0.58 [0.15 - 2.31]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213219_at	79	0.367089	0.103331	-	0.515857	0.502918	0.627874	1.87 [0.30 - 11.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213217_at	79	0.78481	0.0160984	0.229463	0.755659	0.0603638	0.460004	1.58 [0.98 - 2.56]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217688_at	79	0.392405	0.13244	-	0.461917	0.881878	-0.122317	0.88 [0.18 - 4.44]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213217_at	58	0.465517	0.308993	-	0.283509	0.95181	0.00668002	1.01 [0.81 - 1.25]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217687_at	58	0.224138	0.232872	-	0.393766	0.526397	0.129752	1.14 [0.76 - 1.70]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213219_at	58	0.137931	0.153996	-	-0.541114	0.673541	-0.0585637	0.94 [0.72 - 1.24]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217688_at	58	0.775862	0.00337183	0.0691984	0.963533	0.0640286	0.332348	1.39 [0.98 - 1.98]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217688_at	34	0.117647	0.218518	-	-0.682227	0.569396	-0.19853	0.82 [0.41 - 1.62]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213217_at	34	0.705882	0.00199517	0.0452051	1.21469	0.208916	0.225868	1.25 [0.88 - 1.78]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217687_at	34	0.794118	0.283803	-	0.475991	0.820842	0.0875151	1.09 [0.51 - 2.33]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213219_at	34	0.411765	0.263854	-	0.457438	0.91646	-0.0226376	0.98 [0.64 - 1.49]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217687_at	158	0.14557	0.0681644	-	-0.523009	0.800233	-0.233347	0.79 [0.13 - 4.83]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213217_at	158	0.78481	0.0651392	-	0.47875	0.976239	0.0283787	1.03 [0.16 - 6.66]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213219_at	158	0.170886	0.0439079	0.453664	0.739197	0.221851	0.893298	2.44 [0.58 - 10.24]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217688_at	158	0.443038	0.0365424	0.403499	0.501831	0.196393	0.995229	2.71 [0.60 - 12.25]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213219_at	53	0.773585	0.0187331	0.255803	0.917727	0.414876	0.181034	1.20 [0.78 - 1.85]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213217_at	53	0.54717	0.0414382	0.437401	0.692944	0.284554	0.277962	1.32 [0.79 - 2.20]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217688_at	53	0.603774	0.0288265	0.344891	0.784131	0.313702	0.255679	1.29 [0.79 - 2.12]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213219_at	53	0.679245	0.134254	-	0.526208	0.73473	0.0687968	1.07 [0.72 - 1.59]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217688_at	53	0.471698	0.0387699	0.41921	0.728677	0.325884	0.23445	1.26 [0.79 - 2.02]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213217_at	53	0.54717	0.00473067	0.0906022	1.02113	0.089248	0.444553	1.56 [0.93 - 2.60]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217687_at	53	0.113208	0.212918	-	-0.597551	0.985974	0.00545973	1.01 [0.55 - 1.85]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217687_at	53	0.113208	0.0874931	-	-0.82156	0.813284	-0.0795833	0.92 [0.48 - 1.79]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213217_at	180	0.716667	0.109524	-	0.352646	0.545922	0.0736238	1.08 [0.85 - 1.37]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213219_at	180	0.361111	0.083973	-	-0.362785	0.326153	-0.0809527	0.92 [0.78 - 1.08]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217688_at	180	0.461111	0.127977	-	-0.318817	0.949377	-0.00681163	0.99 [0.80 - 1.23]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217687_at	180	0.222222	0.073998	-	-0.422697	0.168155	-0.373516	0.69 [0.40 - 1.17]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217687_at	559	0.626118	0.0322658	0.371871	0.43095	0.398411	0.170818	1.19 [0.80 - 1.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213219_at	559	0.187835	0.0547416	-	-0.44035	0.182187	-0.170921	0.84 [0.66 - 1.08]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213217_at	559	0.128801	0.0271123	0.330872	-0.597335	0.244484	-0.121738	0.89 [0.72 - 1.09]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217688_at	559	0.127013	0.0704194	-	-0.478139	0.353407	-0.138862	0.87 [0.65 - 1.17]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217688_at	77	0.506494	0.00214538	0.0479733	0.789668	0.00837179	0.424263	1.53 [1.12 - 2.10]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213217_at	77	0.766234	0.00428813	0.0838285	-0.914314	0.122573	-0.150911	0.86 [0.71 - 1.04]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217687_at	77	0.441558	0.0308535	0.360968	-0.551604	0.190671	-0.269776	0.76 [0.51 - 1.14]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213219_at	77	0.883117	0.00467819	0.089808	-1.53824	0.00664909	-0.365436	0.69 [0.53 - 0.90]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213219_at	70	0.3	0.137364	-	-0.416257	0.780977	0.109088	1.12 [0.52 - 2.41]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213217_at	70	0.885714	0.0683343	-	0.691086	0.839833	0.0268125	1.03 [0.79 - 1.33]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217688_at	70	0.328571	0.170173	-	-0.375275	0.665525	-0.296881	0.74 [0.19 - 2.86]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217687_at	70	0.857143	0.0474219	0.475917	-0.837837	0.372046	-0.800625	0.45 [0.08 - 2.60]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34686_at	50	0.14	0.00217505	0.0485151	-1.3192	0.382182	-0.838644	0.43 [0.07 - 2.84]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213217_at	74	0.175676	8.08063e-05	0.00290196	-1.34844	0.00317232	-0.597641	0.55 [0.37 - 0.82]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217687_at	74	0.243243	0.000108836	0.00377332	-1.18142	0.00402399	-0.791217	0.45 [0.26 - 0.78]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213219_at	74	0.202703	0.266055	-	-0.384601	0.634401	-0.0805333	0.92 [0.66 - 1.29]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217688_at	74	0.175676	0.00225734	0.0500089	-1.00294	0.651417	-0.114382	0.89 [0.54 - 1.46]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217687_at	67	0.671642	0.223814	-	-0.973613	0.950469	0.0334196	1.03 [0.36 - 2.97]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213219_at	67	0.820895	0.0755046	-	-15.5414	0.336685	-1.92723	0.15 [0.00 - 7.42]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213217_at	67	0.895522	0.240883	-	0.909663	0.92457	-0.0396359	0.96 [0.42 - 2.18]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217688_at	67	0.41791	0.0929427	-	-1.13557	0.296955	-2.70601	0.07 [0.00 - 10.80]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213219_at	115	0.269565	0.0828589	-	1.6178	0.548199	0.190646	1.21 [0.65 - 2.25]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213217_at	115	0.730435	0.00069809	0.0188231	1.68874	0.00452487	0.785224	2.19 [1.28 - 3.77]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217688_at	115	0.826087	0.059112	-	1.00533	0.141602	0.793206	2.21 [0.77 - 6.37]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217687_at	115	0.791304	0.000280013	0.00860758	1.73216	0.00433479	2.19767	9.00 [1.99 - 40.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34686_at	158	0.879747	0.0487013	0.483774	-1.12266	0.519708	-0.171393	0.84 [0.50 - 1.42]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34686_at	76	0.868421	0.364247	-	-0.909133	0.758831	-0.160486	0.85 [0.31 - 2.37]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213217_at	204	0.132353	0.00110875	0.0277869	0.662548	0.0382799	0.114209	1.12 [1.01 - 1.25]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217688_at	204	0.122549	0.0839741	-	-0.369699	0.9589	-0.00447289	1.00 [0.84 - 1.18]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217687_at	204	0.431373	0.115924	-	-0.226039	0.464957	-0.0637104	0.94 [0.79 - 1.11]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213219_at	204	0.289216	0.0802446	-	0.269257	0.628247	0.0311034	1.03 [0.91 - 1.17]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217687_at	87	0.712644	0.159242	-	-0.682157	0.565031	-0.50323	0.60 [0.11 - 3.36]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213217_at	87	0.62069	0.0468023	0.472065	-0.844644	0.344957	-0.185804	0.83 [0.56 - 1.22]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213219_at	87	0.45977	0.094204	-	-0.63059	0.424335	-1.04317	0.35 [0.03 - 4.55]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217688_at	87	0.37931	0.0701734	-	-0.675784	0.115279	-1.31607	0.27 [0.05 - 1.38]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213217_at	87	0.62069	0.0468023	0.472065	-0.844644	0.344957	-0.185804	0.83 [0.56 - 1.22]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217687_at	87	0.712644	0.159242	-	-0.682157	0.565031	-0.50323	0.60 [0.11 - 3.36]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217688_at	87	0.37931	0.0701734	-	-0.675784	0.115279	-1.31607	0.27 [0.05 - 1.38]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213219_at	87	0.45977	0.094204	-	-0.63059	0.424335	-1.04317	0.35 [0.03 - 4.55]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217688_at	77	0.662338	0.0408386	0.433371	1.24198	0.246339	2.07275	7.95 [0.24 - 264.31]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213217_at	77	0.779221	0.0461129	0.467745	-15.4345	0.420286	-0.281854	0.75 [0.38 - 1.50]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217687_at	77	0.207792	0.0910285	-	15.4074	0.977314	0.0336371	1.03 [0.10 - 10.51]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217688_at	77	0.857143	0.00540469	0.100607	1.4585	0.0241538	3.48252	32.54 [1.58 - 671.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213219_at	77	0.25974	0.0116981	0.181564	-1.48698	0.0631425	-4.39338	0.01 [0.00 - 1.27]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217687_at	77	0.207792	0.0518918	-	15.4144	0.511172	0.636492	1.89 [0.28 - 12.62]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213217_at	77	0.779221	0.0839077	-	-15.4244	0.435772	-0.31529	0.73 [0.33 - 1.61]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213219_at	77	0.779221	0.0397821	0.42619	-15.4606	0.122203	-2.91731	0.05 [0.00 - 2.19]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213219_at	136	0.735294	0.0996235	-	0.737722	0.933181	-0.0185546	0.98 [0.64 - 1.51]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217688_at	136	0.823529	0.0379242	0.413303	0.958877	0.450106	0.223676	1.25 [0.70 - 2.23]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217687_at	136	0.727941	0.0221341	0.287712	0.993558	0.376697	0.257249	1.29 [0.73 - 2.29]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213217_at	136	0.808824	0.0741192	-	0.815885	0.113609	0.324005	1.38 [0.93 - 2.07]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213217_at	200	0.17	0.158812	-	0.721279	0.611664	0.0782227	1.08 [0.80 - 1.46]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213219_at	200	0.86	0.0571536	-	0.647558	0.444654	0.132456	1.14 [0.81 - 1.60]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217688_at	200	0.11	0.136807	-	1.02964	0.792773	0.0518092	1.05 [0.72 - 1.55]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217687_at	200	0.42	0.309897	-	-0.301374	0.591458	-0.173456	0.84 [0.45 - 1.58]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10350	60	0.716667	0.12548	-	-0.738785	0.604669	-0.044092	0.96 [0.81 - 1.13]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10350	60	0.716667	0.12548	-	-0.738785	0.735266	-0.0410882	0.96 [0.76 - 1.22]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18714	155	0.896774	0.0144568	0.212221	0.926	0.434027	0.133266	1.14 [0.82 - 1.60]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213217_at	286	0.846154	0.0277541	0.336167	-0.715063	0.87441	-0.0123993	0.99 [0.85 - 1.15]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213219_at	286	0.13986	0.0979925	-	-0.416898	0.916668	0.0105879	1.01 [0.83 - 1.23]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217688_at	286	0.832168	0.113275	-	-0.465145	0.418809	-0.126036	0.88 [0.65 - 1.20]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217687_at	286	0.276224	3.60115e-06	0.000176417	-0.886287	9.80564e-05	-0.773258	0.46 [0.31 - 0.68]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213219_at	159	0.899371	0.0450309	0.460885	0.812412	0.726074	0.0635121	1.07 [0.75 - 1.52]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213217_at	159	0.805031	0.0749096	-	-0.907499	0.304898	-0.146132	0.86 [0.65 - 1.14]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217688_at	159	0.654088	0.0389603	0.42053	0.64328	0.4381	0.19642	1.22 [0.74 - 2.00]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213217_at	159	0.786164	0.130142	-	-0.893005	0.910596	-0.0189588	0.98 [0.70 - 1.37]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213219_at	159	0.899371	0.271113	-	0.482629	0.640766	0.0845039	1.09 [0.76 - 1.55]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217687_at	159	0.886792	0.00227761	0.050375	1.0656	0.450282	0.372204	1.45 [0.55 - 3.81]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217687_at	159	0.886792	0.00213621	0.0478057	1.20499	0.427288	0.467165	1.60 [0.50 - 5.06]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217688_at	159	0.81761	0.0668466	-	0.638369	0.65144	0.118163	1.13 [0.67 - 1.88]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213217_at	159	0.666667	0.0797589	-	0.549989	0.671195	0.0616447	1.06 [0.80 - 1.41]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213219_at	159	0.157233	0.158886	-	-0.60294	0.863573	-0.035694	0.96 [0.64 - 1.45]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217687_at	159	0.886792	0.00146988	0.0351388	1.10601	0.342168	0.47533	1.61 [0.60 - 4.29]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217688_at	159	0.81761	0.0106732	0.169556	0.962025	0.45188	0.223211	1.25 [0.70 - 2.24]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213217_at	54	0.222222	0.01679	0.236528	-1.57861	0.158794	-1.11282	0.33 [0.07 - 1.54]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217688_at	54	0.185185	0.264813	-	-0.794552	0.419395	-1.38774	0.25 [0.01 - 7.25]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213219_at	54	0.5	0.118756	-	-1.18931	0.330183	-1.81668	0.16 [0.00 - 6.30]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217687_at	54	0.722222	0.280076	-	-1.09202	0.615974	-0.683802	0.50 [0.03 - 7.30]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217687_at	117	0.461538	0.146193	-	0.471473	0.742713	0.233247	1.26 [0.31 - 5.08]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217687_at	117	0.435897	0.117987	-	0.622633	0.590386	0.436216	1.55 [0.32 - 7.57]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217688_at	117	0.102564	0.14218	-	-0.643365	0.792082	-0.216926	0.80 [0.16 - 4.04]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217688_at	117	0.102564	0.0493864	0.487931	-0.954719	0.898547	0.123602	1.13 [0.17 - 7.57]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217687_at	117	0.461538	0.146193	-	0.471473	0.742713	0.233247	1.26 [0.31 - 5.08]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213217_at	117	0.162393	0.0298261	0.352884	-0.784649	0.863903	0.0266015	1.03 [0.76 - 1.39]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217687_at	117	0.623932	0.266479	-	0.435892	0.912741	0.0981083	1.10 [0.19 - 6.38]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213217_at	117	0.692308	0.0124656	0.190326	0.913032	0.366577	0.160403	1.17 [0.83 - 1.66]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213217_at	117	0.692308	0.109001	-	0.630521	0.857934	0.0346278	1.04 [0.71 - 1.51]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213217_at	117	0.162393	0.0298261	0.352884	-0.784649	0.863903	0.0266015	1.03 [0.76 - 1.39]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213219_at	117	0.854701	0.0122937	0.18838	-2.11887	0.0942025	-1.67127	0.19 [0.03 - 1.33]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213219_at	117	0.854701	0.0161121	0.229603	-15.3044	0.121138	-1.92121	0.15 [0.01 - 1.66]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217688_at	117	0.102564	0.108984	-	-0.773813	0.919616	0.0944617	1.10 [0.18 - 6.88]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217688_at	117	0.102564	0.14218	-	-0.643365	0.792082	-0.216926	0.80 [0.16 - 4.04]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213219_at	117	0.65812	0.0539251	-	-0.923408	0.234932	-1.43302	0.24 [0.02 - 2.54]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213219_at	117	0.854701	0.0122937	0.18838	-2.11887	0.0942025	-1.67127	0.19 [0.03 - 1.33]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213219_at	236	0.877119	0.0286577	0.343528	-1.44656	0.545851	-0.10732	0.90 [0.63 - 1.27]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217688_at	236	0.567797	0.26402	-	0.299922	0.930235	0.0242569	1.02 [0.60 - 1.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217687_at	236	0.173729	0.111993	-	0.674808	0.437042	0.434522	1.54 [0.52 - 4.62]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213217_at	236	0.275424	0.0631998	-	-0.515171	0.54994	-0.0617231	0.94 [0.77 - 1.15]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217687_at	249	0.686747	0.123652	-	-0.382529	0.844016	-0.0836889	0.92 [0.40 - 2.12]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213217_at	249	0.666667	0.0150367	0.21839	-0.598548	0.13971	-0.120173	0.89 [0.76 - 1.04]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213219_at	249	0.481928	0.00326469	0.0674274	-0.629099	0.268937	-0.150112	0.86 [0.66 - 1.12]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217688_at	249	0.686747	0.174005	-	-0.332437	0.544673	-0.135006	0.87 [0.56 - 1.35]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217688_at	125	0.384	0.0134769	0.201589	-0.914179	0.698007	-0.557413	0.57 [0.03 - 9.57]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213219_at	125	0.16	0.0149062	0.21701	-0.830028	0.293829	-0.795204	0.45 [0.10 - 1.99]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213219_at	54	0.87037	0.0848639	-	-15.4153	0.705991	-0.109518	0.90 [0.51 - 1.58]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217687_at	125	0.104	0.264323	-	-0.600167	0.926775	0.0376047	1.04 [0.47 - 2.32]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217688_at	125	0.384	0.00174481	0.0404878	-0.894765	0.290701	-1.16258	0.31 [0.04 - 2.70]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213217_at	62	0.177419	0.0397286	0.425823	-1.07578	0.654777	-0.0753292	0.93 [0.67 - 1.29]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217688_at	54	0.888889	0.133385	-	-15.2981	0.557245	-0.264093	0.77 [0.32 - 1.85]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213217_at	125	0.752	0.00688961	0.121519	0.996567	0.0321634	0.580041	1.79 [1.05 - 3.04]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217687_at	62	0.129032	0.083661	-	15.2519	0.812262	-0.0522201	0.95 [0.62 - 1.46]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217687_at	54	0.333333	0.116351	-	1.50491	0.864685	-0.0455927	0.96 [0.57 - 1.61]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213219_at	62	0.887097	0.046282	0.468808	-15.3788	0.638647	-0.11252	0.89 [0.56 - 1.43]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213217_at	125	0.856	0.0101859	0.163713	0.835364	0.0970742	0.369626	1.45 [0.94 - 2.24]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213219_at	125	0.896	0.0412961	0.436449	-15.2267	0.56592	-0.553817	0.57 [0.09 - 3.81]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213217_at	54	0.888889	0.318797	-	0.671917	0.88981	-0.0284454	0.97 [0.65 - 1.45]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217688_at	62	0.580645	0.279915	-	-0.529753	0.564753	-0.211711	0.81 [0.39 - 1.66]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217687_at	125	0.248	0.0574952	-	-0.628084	0.847378	-0.0614129	0.94 [0.50 - 1.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217687_at	198	0.141414	0.00283921	0.0602497	1.86968	0.0351971	0.45779	1.58 [1.03 - 2.42]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217687_at	198	0.141414	0.00298209	0.0626868	2.38799	0.0387945	0.47008	1.60 [1.02 - 2.50]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213219_at	198	0.747475	0.158189	-	0.328109	0.62308	0.0365308	1.04 [0.90 - 1.20]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213217_at	198	0.666667	0.17597	-	-0.390498	0.970715	-0.00294154	1.00 [0.85 - 1.17]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213217_at	198	0.540404	0.221673	-	0.32661	0.958267	0.00436831	1.00 [0.85 - 1.18]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217688_at	198	0.863636	0.136244	-	0.411142	0.599768	0.056685	1.06 [0.86 - 1.31]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213219_at	198	0.707071	0.116426	-	0.418529	0.43915	0.070137	1.07 [0.90 - 1.28]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217687_at	198	0.444444	0.213819	-	-0.260509	0.68594	0.0668858	1.07 [0.77 - 1.48]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213219_at	198	0.707071	0.0665465	-	0.504339	0.635414	0.0450241	1.05 [0.87 - 1.26]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217688_at	198	0.681818	0.233997	-	0.312067	0.440731	0.0972255	1.10 [0.86 - 1.41]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213217_at	198	0.808081	0.0145268	0.212971	-0.80016	0.220421	-0.079711	0.92 [0.81 - 1.05]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217688_at	198	0.868687	0.249075	-	0.402289	0.513274	0.08774	1.09 [0.84 - 1.42]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217688_at	51	0.313726	0.00984601	0.159584	-2.32921	0.353154	-2.2403	0.11 [0.00 - 12.05]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213219_at	62	0.241935	0.24848	-	-0.694125	0.564381	-0.875748	0.42 [0.02 - 8.19]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217687_at	51	0.784314	0.254203	-	1.00032	0.989512	0.027826	1.03 [0.02 - 65.15]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217688_at	62	0.258065	0.0315241	0.366175	-1.17443	0.968319	0.0585239	1.06 [0.06 - 19.04]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213217_at	51	0.745098	0.16745	-	-15.5298	0.819409	-0.284554	0.75 [0.07 - 8.66]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213217_at	62	0.725806	0.0211533	0.278731	-15.6064	0.415416	-0.781227	0.46 [0.07 - 3.00]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213219_at	51	0.196078	0.214907	-	-1.08004	0.746661	-0.770015	0.46 [0.00 - 49.50]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217687_at	62	0.758065	0.051321	-	1.09308	0.433372	1.07407	2.93 [0.20 - 43.00]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213217_at	145	0.358621	0.119325	-	0.590782	0.638575	0.32176	1.38 [0.36 - 5.28]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217688_at	177	0.80226	0.266438	-	-0.349567	0.699731	-0.179719	0.84 [0.34 - 2.08]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217687_at	177	0.830508	0.163109	-	0.473129	0.920646	0.0754638	1.08 [0.24 - 4.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217688_at	145	0.282759	0.0910658	-	-0.571959	0.797052	-0.179913	0.84 [0.21 - 3.29]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213219_at	177	0.225989	0.0953583	-	0.629162	0.709082	0.296121	1.34 [0.28 - 6.37]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217687_at	177	0.502825	0.162579	-	-0.33297	0.922167	-0.0646485	0.94 [0.26 - 3.43]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213217_at	177	0.463277	0.00105008	0.0265507	0.958275	0.0288061	1.19315	3.30 [1.13 - 9.61]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213219_at	177	0.225989	0.174472	-	0.413422	0.848032	0.131496	1.14 [0.30 - 4.38]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217687_at	145	0.565517	0.0705293	-	0.598068	0.82248	0.203501	1.23 [0.21 - 7.25]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213219_at	145	0.268966	0.0764883	-	0.773843	0.380659	0.860472	2.36 [0.35 - 16.19]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213217_at	177	0.463277	0.00900581	0.149176	0.6355	0.108561	0.769425	2.16 [0.84 - 5.52]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217688_at	177	0.180791	0.134725	-	-0.487631	0.395932	-0.450225	0.64 [0.23 - 1.80]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217688_at	226	0.663717	0.000569572	0.0158356	-1.38677	0.0100921	-0.452863	0.64 [0.45 - 0.90]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217687_at	226	0.19469	0.123506	-	0.659606	0.276607	0.285162	1.33 [0.80 - 2.22]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213219_at	226	0.185841	0.0354746	0.395787	1.04903	0.165813	0.190935	1.21 [0.92 - 1.59]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213217_at	226	0.867257	0.00956686	0.156159	0.815092	0.0921823	0.237441	1.27 [0.96 - 1.67]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217688_at	55	0.836364	0.266728	-	0.621435	0.774549	-0.413285	0.66 [0.04 - 11.19]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217687_at	55	0.890909	0.121695	-	0.847225	0.414747	1.47797	4.38 [0.13 - 152.91]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217688_at	49	0.816327	0.0220426	0.286882	1.33071	0.272841	1.93778	6.94 [0.22 - 221.72]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213219_at	55	0.327273	0.0207074	0.274591	-0.999839	0.18292	-1.67853	0.19 [0.02 - 2.21]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217687_at	55	0.636364	0.136536	-	-0.809498	0.616583	-1.00281	0.37 [0.01 - 18.59]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217687_at	49	0.122449	0.200815	-	15.208	0.812035	-0.639071	0.53 [0.00 - 102.34]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213217_at	55	0.854545	0.128378	-	-1.43526	0.861447	-0.149045	0.86 [0.16 - 4.59]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213219_at	55	0.490909	0.0041406	0.0815308	-1.51438	0.0545982	-2.75035	0.06 [0.00 - 1.06]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213219_at	49	0.428571	0.137906	-	-0.880565	0.52519	-1.03353	0.36 [0.01 - 8.63]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213217_at	55	0.2	0.0289497	0.345882	-1.06843	0.0976727	-1.57637	0.21 [0.03 - 1.34]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217688_at	55	0.454545	0.069644	-	0.860422	0.928237	0.115371	1.12 [0.09 - 13.82]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213217_at	49	0.836735	0.0946174	-	-15.3423	0.600622	-0.647107	0.52 [0.05 - 5.90]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	38139	34	0.352941	0.018167	0.250272	1.24543	0.0534224	2.16393	8.71 [0.97 - 78.24]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217688_at	63	0.142857	0.000195898	0.00631243	-1.39665	0.278237	-6.53171	0.00 [0.00 - 195.44]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217687_at	63	0.301587	0.000121754	0.00416426	-1.24413	0.983	-0.0344919	0.97 [0.04 - 23.06]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213219_at	63	0.571429	0.00162096	0.0381018	-1.15918	0.12208	-9.7455	0.00 [0.00 - 13.58]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213217_at	63	0.730159	1.74032e-05	0.000736981	1.41298	0.000846384	0.302505	1.35 [1.13 - 1.62]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.311561.0.S1_3p_at	28	0.107143	0.12219	-	-1.16158	0.409114	-1.76584	0.17 [0.00 - 11.33]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.2352.0.S2_3p_at	28	0.571429	0.15131	-	-0.837111	0.300671	-2.54089	0.08 [0.00 - 9.69]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.311561.0.A1_3p_at	28	0.321429	0.278597	-	0.693712	0.671795	-0.207646	0.81 [0.31 - 2.12]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.2352.0.S1_3p_at	28	0.821429	0.342791	-	-0.951476	0.848359	0.229447	1.26 [0.12 - 13.21]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213219_at	82	0.256098	0.043199	0.44905	-0.721316	0.494199	-0.294145	0.75 [0.32 - 1.73]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217688_at	82	0.621951	0.128514	-	0.509738	0.652731	0.141603	1.15 [0.62 - 2.13]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217687_at	82	0.121951	0.0167781	0.236407	15.2452	0.164693	0.897972	2.45 [0.69 - 8.71]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213217_at	82	0.804878	0.00198146	0.0449502	1.13589	0.42568	0.412292	1.51 [0.55 - 4.16]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217687_at	79	0.632911	0.0338776	0.384027	-0.592812	0.143985	-1.09718	0.33 [0.08 - 1.45]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213219_at	79	0.898734	0.105004	-	-0.928492	0.603807	-0.205075	0.81 [0.38 - 1.77]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217688_at	79	0.278481	0.0349817	0.392187	0.657461	0.891698	-0.0534278	0.95 [0.44 - 2.05]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213217_at	79	0.43038	0.143462	-	-0.388591	0.952193	-0.0277346	0.97 [0.39 - 2.41]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	L21993_at	86	0.488372	0.257136	-	0.470585	0.828382	0.149378	1.16 [0.30 - 4.48]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213217_at	104	0.365385	0.130069	-	0.555197	0.404354	0.692531	2.00 [0.39 - 10.18]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213219_at	104	0.134615	0.0434962	0.45099	-0.798293	0.296519	-0.620322	0.54 [0.17 - 1.72]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217688_at	104	0.375	0.284997	-	-0.35109	0.972497	-0.0142855	0.99 [0.44 - 2.22]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217687_at	104	0.403846	0.0211903	0.279073	0.859173	0.111438	1.42192	4.15 [0.72 - 23.87]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P33539	117	0.478632	0.0202624	0.270422	-0.668799	0.543865	-0.0803492	0.92 [0.71 - 1.20]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213219_at	204	0.186275	0.0146591	0.214383	-0.914635	0.0533934	-0.346834	0.71 [0.50 - 1.01]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213219_at	204	0.676471	0.0745468	-	-0.575947	0.328987	-0.131986	0.88 [0.67 - 1.14]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213217_at	204	0.107843	0.0137781	0.204886	-1.02269	0.0665336	-0.447239	0.64 [0.40 - 1.03]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213217_at	204	0.107843	0.0359362	0.399135	-0.749943	0.122709	-0.302602	0.74 [0.50 - 1.09]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217688_at	204	0.514706	0.0237459	0.302113	-0.873739	0.160751	-0.33362	0.72 [0.45 - 1.14]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217688_at	204	0.514706	0.0342965	0.387139	-0.588291	0.372597	-0.159583	0.85 [0.60 - 1.21]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217687_at	204	0.279412	0.0389244	0.420281	-0.744175	0.280982	-0.387649	0.68 [0.34 - 1.37]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217687_at	204	0.279412	0.00974041	0.158292	-0.702428	0.201313	-0.370611	0.69 [0.39 - 1.22]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213219_at	178	0.106742	0.0382084	0.415296	-0.576699	0.104171	-0.518035	0.60 [0.32 - 1.11]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217688_at	178	0.185393	0.0223146	0.289347	0.667362	0.386761	0.183881	1.20 [0.79 - 1.82]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217687_at	178	0.117978	0.126133	-	0.528793	0.712089	0.18038	1.20 [0.46 - 3.12]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213217_at	178	0.859551	0.0932976	-	-0.579012	0.253954	-0.397883	0.67 [0.34 - 1.33]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213217_at	111	0.108108	0.000448135	0.0129031	-1.18434	0.812513	0.0324432	1.03 [0.79 - 1.35]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217688_at	111	0.207207	0.0879971	-	-0.519434	0.877016	-0.0294681	0.97 [0.67 - 1.41]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217687_at	111	0.828829	0.424606	-	-0.289147	0.660509	-0.104146	0.90 [0.57 - 1.43]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213219_at	111	0.891892	0.101222	-	-0.827373	0.971341	0.00453621	1.00 [0.78 - 1.29]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213219_at	90	0.844444	0.155054	-	-0.831495	0.858603	0.150883	1.16 [0.22 - 6.12]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213219_at	90	0.122222	0.0950699	-	1.54196	0.528652	0.590658	1.81 [0.29 - 11.34]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217688_at	90	0.555556	0.0376098	0.411089	-0.728182	0.921131	-0.0756703	0.93 [0.21 - 4.15]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217688_at	90	0.433333	0.0396449	0.425249	-0.768799	0.815526	0.192568	1.21 [0.24 - 6.11]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217687_at	90	0.555556	0.149541	-	0.532297	0.276691	0.813136	2.25 [0.52 - 9.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217687_at	90	0.888889	0.210421	-	0.551738	0.777906	0.179151	1.20 [0.34 - 4.15]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213217_at	90	0.4	0.0758421	-	-0.568738	0.387687	-0.478026	0.62 [0.21 - 1.83]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213217_at	90	0.322222	0.0517488	-	-0.71267	0.707215	-0.236166	0.79 [0.23 - 2.71]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213217_at	138	0.710145	0.0592051	-	0.462609	0.497151	0.0857832	1.09 [0.85 - 1.40]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217688_at	138	0.297101	0.0176887	0.245545	-0.574966	0.684129	0.391573	1.48 [0.22 - 9.76]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217687_at	138	0.65942	0.135453	-	-0.400256	0.63856	0.291686	1.34 [0.40 - 4.52]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213219_at	138	0.391304	0.0628776	-	-0.445409	0.069593	-6.55862	0.00 [0.00 - 1.69]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213217_at	129	0.116279	0.00074525	0.019894	-1.1547	0.0660543	-0.204386	0.82 [0.66 - 1.01]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213219_at	129	0.124031	0.0895835	-	0.849897	0.359567	0.132113	1.14 [0.86 - 1.51]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217688_at	129	0.821705	0.124485	-	-0.543866	0.839614	-0.0414676	0.96 [0.64 - 1.43]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217687_at	129	0.116279	0.0320325	0.370086	-0.730927	0.686916	-0.155458	0.86 [0.40 - 1.82]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10926	56	0.142857	0.120707	-	0.971409	0.187515	0.604229	1.83 [0.75 - 4.49]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19637	56	0.142857	0.0527032	-	-0.887969	0.827938	-0.0323467	0.97 [0.72 - 1.30]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10926	56	0.732143	0.0713703	-	0.711314	0.0918598	0.785647	2.19 [0.88 - 5.47]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19637	56	0.892857	0.0828067	-	0.767678	0.497509	0.0935596	1.10 [0.84 - 1.44]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217688_at	278	0.773381	0.0265269	0.325991	-0.525661	0.582629	-0.229558	0.79 [0.35 - 1.80]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217687_at	278	0.784173	0.234592	-	-0.293707	0.814333	-0.102186	0.90 [0.38 - 2.12]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213219_at	278	0.215827	0.0719651	-	-0.385146	0.816596	-0.144773	0.87 [0.25 - 2.94]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213217_at	278	0.183453	0.174912	-	0.362501	0.77426	-0.0418534	0.96 [0.72 - 1.28]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217687_at	133	0.631579	0.00732114	0.127345	0.630154	0.647428	0.154193	1.17 [0.60 - 2.26]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213217_at	133	0.360902	0.0929894	-	0.434713	0.861358	0.0171221	1.02 [0.84 - 1.23]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213219_at	133	0.578947	0.00232717	0.0512671	0.710796	0.0731415	1.57312	4.82 [0.86 - 26.94]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217688_at	133	0.744361	0.000736132	0.0196879	0.831289	0.00546377	1.59794	4.94 [1.60 - 15.26]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1582	81	0.432099	0.123486	-	-0.801936	0.59402	-0.119299	0.89 [0.57 - 1.38]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12090	81	0.296296	0.0863213	-	-0.862098	0.385681	-0.219769	0.80 [0.49 - 1.32]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217687_at	185	0.102703	0.0189765	0.258161	0.603931	0.343354	0.209362	1.23 [0.80 - 1.90]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217688_at	185	0.724324	0.0220466	0.286918	-0.491173	0.24331	-0.364288	0.69 [0.38 - 1.28]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213219_at	185	0.102703	0.0210533	0.277806	0.610737	0.710831	0.0771171	1.08 [0.72 - 1.62]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217687_at	185	0.102703	0.0135237	0.202104	0.740263	0.434455	0.191493	1.21 [0.75 - 1.96]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213217_at	185	0.291892	0.00910923	0.150473	0.471884	0.0323284	0.418045	1.52 [1.04 - 2.23]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213219_at	185	0.118919	0.0421833	0.442364	0.561111	0.344407	0.205885	1.23 [0.80 - 1.88]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217688_at	185	0.724324	0.0700408	-	-0.344164	0.268471	-0.308138	0.73 [0.43 - 1.27]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213217_at	185	0.291892	0.00374549	0.0752714	0.586487	0.0149797	0.509064	1.66 [1.10 - 2.51]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P33539	110	0.236364	0.0789673	-	-0.445233	0.708303	-0.0405544	0.96 [0.78 - 1.19]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P405973	110	0.890909	0.0623882	-	-0.774592	0.839246	-0.0267681	0.97 [0.75 - 1.26]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P33539	110	0.2	0.0238894	0.303375	-0.71199	0.565968	-0.0805815	0.92 [0.70 - 1.21]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P405973	110	0.218182	0.0460371	0.467267	-0.651861	0.217774	-0.225986	0.80 [0.56 - 1.14]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213217_at	80	0.425	0.102436	-	0.772445	0.799793	0.0414816	1.04 [0.76 - 1.44]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217687_at	80	0.8875	0.000796966	0.0210545	1.46561	0.769733	-0.0798683	0.92 [0.54 - 1.58]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213219_at	80	0.4625	0.00883451	0.147017	-1.14833	0.501834	-0.140885	0.87 [0.58 - 1.31]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217688_at	80	0.15	0.0450281	0.460868	15.2933	0.511402	0.137791	1.15 [0.76 - 1.73]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3934	281	0.202847	0.0491782	0.486671	0.36583	0.184287	0.103852	1.11 [0.95 - 1.29]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217688_at	38	0.447368	0.0572869	-	-0.9132	0.365768	-0.195692	0.82 [0.54 - 1.26]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217687_at	38	0.105263	0.0899016	-	15.27	0.744494	0.104684	1.11 [0.59 - 2.08]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213219_at	38	0.605263	0.0412519	0.436153	-1.10504	0.417015	-0.272927	0.76 [0.39 - 1.47]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213217_at	38	0.684211	0.0252783	0.315416	0.998196	0.176314	0.202382	1.22 [0.91 - 1.64]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213219_at	140	0.121429	0.000118979	0.0040808	-1.30306	0.0293896	-3.32506	0.04 [0.00 - 0.72]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217688_at	140	0.292857	0.0315238	0.366173	-0.625712	0.0812261	-2.12923	0.12 [0.01 - 1.30]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217687_at	140	0.421429	0.0317904	0.368228	0.684572	0.865035	0.093943	1.10 [0.37 - 3.25]
GENE	ADCY2	adenylate cyclase 2 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213217_at	140	0.107143	0.0394634	0.424003	-0.824965	0.557935	-0.151244	0.86 [0.52 - 1.43]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY3	adenylate cyclase 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209320_at	30	0.833333	0.0657457	-	-1.09157	0.10806	-1.26317	0.28 [0.06 - 1.32]
GENE	ADCY3	adenylate cyclase 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209321_s_at	30	0.266667	0.00637682	0.114456	-1.25034	0.190724	-0.863858	0.42 [0.12 - 1.54]
GENE	ADCY3	adenylate cyclase 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1676893	165	0.563636	0.00198624	0.0450391	0.741153	0.0315305	0.462732	1.59 [1.04 - 2.42]
GENE	ADCY3	adenylate cyclase 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1676893	165	0.254545	0.00498088	0.094358	1.80556	0.029299	0.72195	2.06 [1.08 - 3.94]
GENE	ADCY3	adenylate cyclase 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209320_at	163	0.398773	0.00491264	0.0933387	0.586122	0.0340175	0.747209	2.11 [1.06 - 4.21]
GENE	ADCY3	adenylate cyclase 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209321_s_at	163	0.582822	0.110631	-	0.316282	0.625341	0.109554	1.12 [0.72 - 1.73]
GENE	ADCY3	adenylate cyclase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209320_at	79	0.291139	0.104359	-	0.554331	0.574249	0.181413	1.20 [0.64 - 2.26]
GENE	ADCY3	adenylate cyclase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209321_s_at	79	0.531646	0.044321	0.456333	0.586119	0.530508	0.111875	1.12 [0.79 - 1.59]
GENE	ADCY3	adenylate cyclase 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209321_s_at	58	0.327586	0.345251	-	0.282093	0.899666	0.0316136	1.03 [0.63 - 1.69]
GENE	ADCY3	adenylate cyclase 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209320_at	58	0.672414	0.0134679	0.20149	0.779466	0.17305	0.356646	1.43 [0.86 - 2.39]
GENE	ADCY3	adenylate cyclase 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209321_s_at	34	0.705882	0.0652079	-	0.717965	0.652715	0.197255	1.22 [0.52 - 2.88]
GENE	ADCY3	adenylate cyclase 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209320_at	34	0.617647	0.10919	-	-0.641218	0.370189	-0.409487	0.66 [0.27 - 1.63]
GENE	ADCY3	adenylate cyclase 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209321_s_at	158	0.234177	0.0160512	0.228976	0.742389	0.950574	0.0153689	1.02 [0.62 - 1.65]
GENE	ADCY3	adenylate cyclase 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209320_at	158	0.265823	0.0183689	0.252252	0.706451	0.288277	0.408872	1.51 [0.71 - 3.20]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209320_at	53	0.830189	0.0267461	0.327824	0.903906	0.546901	0.286116	1.33 [0.52 - 3.38]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209321_s_at	53	0.132075	0.0229036	0.294642	1.98252	0.140282	0.688779	1.99 [0.80 - 4.97]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209320_at	53	0.830189	0.0379153	0.413241	0.797619	0.473161	0.310622	1.36 [0.58 - 3.19]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209321_s_at	53	0.132075	0.00999123	0.161354	2.17271	0.142449	0.624596	1.87 [0.81 - 4.30]
GENE	ADCY3	adenylate cyclase 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209320_at	180	0.861111	0.00157815	0.0372682	0.846464	0.0397165	0.512911	1.67 [1.02 - 2.72]
GENE	ADCY3	adenylate cyclase 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209321_s_at	180	0.877778	0.0110022	0.173451	0.693559	0.0751284	0.315861	1.37 [0.97 - 1.94]
GENE	ADCY3	adenylate cyclase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209320_at	559	0.871199	0.0526682	-	0.576651	0.809728	0.0657406	1.07 [0.63 - 1.82]
GENE	ADCY3	adenylate cyclase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209321_s_at	559	0.592129	0.00899511	0.149042	0.519633	0.0398514	0.426466	1.53 [1.02 - 2.30]
GENE	ADCY3	adenylate cyclase 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209321_s_at	77	0.818182	0.0598371	-	0.585223	0.584103	0.157174	1.17 [0.67 - 2.05]
GENE	ADCY3	adenylate cyclase 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209320_at	77	0.376623	0.100136	-	0.448079	0.345454	0.339616	1.40 [0.69 - 2.84]
GENE	ADCY3	adenylate cyclase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209320_at	70	0.685714	0.0936367	-	-0.492603	0.215161	-1.04244	0.35 [0.07 - 1.83]
GENE	ADCY3	adenylate cyclase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209321_s_at	70	0.828571	0.0114706	0.17893	0.833774	0.875812	0.10599	1.11 [0.29 - 4.20]
GENE	ADCY3	adenylate cyclase 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33134_at	50	0.56	0.051715	-	0.678461	0.112447	0.458212	1.58 [0.90 - 2.78]
GENE	ADCY3	adenylate cyclase 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209320_at	74	0.662162	0.000152959	0.0050862	1.05783	0.000984769	1.6925	5.43 [1.99 - 14.87]
GENE	ADCY3	adenylate cyclase 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209321_s_at	74	0.891892	0.0067355	0.119413	1.09797	0.241329	0.685761	1.99 [0.63 - 6.25]
GENE	ADCY3	adenylate cyclase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209321_s_at	67	0.895522	0.26687	-	-15.2104	0.741973	-0.210364	0.81 [0.23 - 2.83]
GENE	ADCY3	adenylate cyclase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209320_at	67	0.731343	0.165949	-	0.900171	0.806998	0.248326	1.28 [0.17 - 9.40]
GENE	ADCY3	adenylate cyclase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209321_s_at	115	0.104348	0.00735121	0.127747	-1.45354	0.637802	0.436969	1.55 [0.25 - 9.55]
GENE	ADCY3	adenylate cyclase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209320_at	115	0.13913	0.0620135	-	-1.05173	0.994412	0.00627266	1.01 [0.17 - 5.82]
GENE	ADCY3	adenylate cyclase 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33134_at	158	0.405063	0.0606319	-	0.597619	0.271059	0.558802	1.75 [0.65 - 4.73]
GENE	ADCY3	adenylate cyclase 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33134_at	76	0.526316	0.0209847	0.27717	-1.37998	0.0978944	-1.21159	0.30 [0.07 - 1.25]
GENE	ADCY3	adenylate cyclase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209321_s_at	204	0.308824	0.0456524	0.464837	-0.303628	0.276844	-0.171705	0.84 [0.62 - 1.15]
GENE	ADCY3	adenylate cyclase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209320_at	204	0.573529	0.031578	0.366591	-0.31046	0.173812	-0.280767	0.76 [0.50 - 1.13]
GENE	ADCY3	adenylate cyclase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209320_at	87	0.563218	0.134645	-	0.560395	0.701534	0.23919	1.27 [0.37 - 4.32]
GENE	ADCY3	adenylate cyclase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209321_s_at	87	0.758621	0.0403225	0.429876	-1.1852	0.106234	-0.520968	0.59 [0.32 - 1.12]
GENE	ADCY3	adenylate cyclase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209320_at	87	0.563218	0.134645	-	0.560395	0.701534	0.23919	1.27 [0.37 - 4.32]
GENE	ADCY3	adenylate cyclase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209321_s_at	87	0.758621	0.0403225	0.429876	-1.1852	0.106234	-0.520968	0.59 [0.32 - 1.12]
GENE	ADCY3	adenylate cyclase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209321_s_at	77	0.597403	0.286506	-	0.584673	0.469414	0.383515	1.47 [0.52 - 4.15]
GENE	ADCY3	adenylate cyclase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209321_s_at	77	0.857143	0.180815	-	0.893792	0.621758	0.296015	1.34 [0.41 - 4.36]
GENE	ADCY3	adenylate cyclase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209320_at	77	0.714286	0.0251106	0.313978	1.17729	0.288559	0.938753	2.56 [0.45 - 14.48]
GENE	ADCY3	adenylate cyclase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209320_at	77	0.714286	0.10163	-	0.994193	0.724316	0.354726	1.43 [0.20 - 10.24]
GENE	ADCY3	adenylate cyclase 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209320_at	136	0.213235	0.0723783	-	-0.832212	0.571214	-0.412921	0.66 [0.16 - 2.76]
GENE	ADCY3	adenylate cyclase 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209321_s_at	136	0.176471	0.00487961	0.092844	-1.21415	0.00199144	-1.2051	0.30 [0.14 - 0.64]
GENE	ADCY3	adenylate cyclase 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209320_at	200	0.89	0.0363998	0.402475	0.760374	0.437355	0.364643	1.44 [0.57 - 3.61]
GENE	ADCY3	adenylate cyclase 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209321_s_at	200	0.335	0.00687674	0.121343	-0.777838	0.257242	-0.446973	0.64 [0.30 - 1.39]
GENE	ADCY3	adenylate cyclase 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10885	60	0.116667	0.103257	-	-0.802875	0.137235	-0.265877	0.77 [0.54 - 1.09]
GENE	ADCY3	adenylate cyclase 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10885	60	0.116667	0.055281	-	-0.939835	0.302051	-0.321484	0.73 [0.39 - 1.34]
GENE	ADCY3	adenylate cyclase 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16974	155	0.83871	4.5337e-05	0.00173774	1.12933	0.00115353	0.35001	1.42 [1.15 - 1.75]
GENE	ADCY3	adenylate cyclase 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209320_at	286	0.664336	0.00440312	0.0856054	-0.640073	0.0412497	-0.723991	0.48 [0.24 - 0.97]
GENE	ADCY3	adenylate cyclase 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209321_s_at	286	0.898601	0.120382	-	0.443218	0.414442	-0.179337	0.84 [0.54 - 1.29]
GENE	ADCY3	adenylate cyclase 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209320_at	159	0.836478	0.19276	-	-0.673905	0.642161	-0.298353	0.74 [0.21 - 2.61]
GENE	ADCY3	adenylate cyclase 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209321_s_at	159	0.603774	0.0326187	0.374558	-0.944141	0.178976	-0.734124	0.48 [0.16 - 1.40]
GENE	ADCY3	adenylate cyclase 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209321_s_at	159	0.257862	0.0637835	-	-0.59684	0.32822	-0.456989	0.63 [0.25 - 1.58]
GENE	ADCY3	adenylate cyclase 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209320_at	159	0.283019	0.288613	-	-0.350202	0.659978	-0.286359	0.75 [0.21 - 2.69]
GENE	ADCY3	adenylate cyclase 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209320_at	159	0.169811	0.13223	-	1.05381	0.668752	0.330041	1.39 [0.31 - 6.31]
GENE	ADCY3	adenylate cyclase 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209321_s_at	159	0.603774	0.0192062	0.260375	-0.860154	0.198342	-0.604733	0.55 [0.22 - 1.37]
GENE	ADCY3	adenylate cyclase 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209321_s_at	54	0.166667	0.150787	-	15.3663	0.467357	0.461556	1.59 [0.46 - 5.51]
GENE	ADCY3	adenylate cyclase 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209320_at	54	0.444444	0.0887346	-	1.63421	0.553956	0.67389	1.96 [0.21 - 18.28]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209321_s_at	117	0.692308	0.00316095	0.065699	-1.23267	0.170538	-0.350039	0.70 [0.43 - 1.16]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209321_s_at	117	0.692308	0.0047509	0.0909078	-1.56274	0.0789795	-0.547899	0.58 [0.31 - 1.07]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209321_s_at	117	0.623932	0.00424629	0.083179	-1.43292	0.0298764	-0.715338	0.49 [0.26 - 0.93]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209321_s_at	117	0.692308	0.00316095	0.065699	-1.23267	0.170538	-0.350039	0.70 [0.43 - 1.16]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209320_at	117	0.57265	0.0677544	-	-0.608478	0.208882	-0.712283	0.49 [0.16 - 1.49]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209320_at	117	0.803419	0.0867801	-	-1.00466	0.283636	-0.73113	0.48 [0.13 - 1.83]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209320_at	117	0.128205	0.108842	-	1.49338	0.88089	-0.103882	0.90 [0.23 - 3.51]
GENE	ADCY3	adenylate cyclase 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209320_at	117	0.57265	0.0677544	-	-0.608478	0.208882	-0.712283	0.49 [0.16 - 1.49]
GENE	ADCY3	adenylate cyclase 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209320_at	236	0.101695	0.000527574	0.0148347	-1.15771	0.00692312	-1.69876	0.18 [0.05 - 0.63]
GENE	ADCY3	adenylate cyclase 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209321_s_at	236	0.122881	0.0120484	0.185586	-0.855195	0.0366327	-0.80817	0.45 [0.21 - 0.95]
GENE	ADCY3	adenylate cyclase 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209321_s_at	249	0.108434	0.0348226	0.39102	-0.647659	0.165937	-0.417078	0.66 [0.37 - 1.19]
GENE	ADCY3	adenylate cyclase 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209320_at	249	0.277108	0.00188998	0.0432396	-0.672642	0.00558951	-1.37557	0.25 [0.10 - 0.67]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209321_s_at	62	0.548387	0.323909	-	-0.483151	0.644377	-0.113337	0.89 [0.55 - 1.44]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209320_at	125	0.104	0.0476477	0.477313	-0.72186	0.368479	-0.566751	0.57 [0.16 - 1.95]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209321_s_at	125	0.248	0.0529126	-	-0.735621	0.434769	-0.36759	0.69 [0.28 - 1.74]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209320_at	54	0.851852	0.217262	-	-1.2327	0.6438	-0.129018	0.88 [0.51 - 1.52]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209321_s_at	125	0.248	0.0686134	-	-0.538475	0.643398	-0.167522	0.85 [0.42 - 1.72]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209321_s_at	54	0.166667	0.116338	-	-0.9344	0.533142	-0.189074	0.83 [0.46 - 1.50]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209320_at	62	0.887097	0.181092	-	-1.29675	0.625225	-0.112419	0.89 [0.57 - 1.40]
GENE	ADCY3	adenylate cyclase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209320_at	125	0.104	0.020646	0.274018	-1.02201	0.362856	-0.750633	0.47 [0.09 - 2.38]
GENE	ADCY3	adenylate cyclase 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209321_s_at	198	0.106061	0.0832409	-	0.986358	0.876561	0.0380139	1.04 [0.64 - 1.68]
GENE	ADCY3	adenylate cyclase 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209321_s_at	198	0.106061	0.0984185	-	0.945763	0.951699	0.0154802	1.02 [0.62 - 1.68]
GENE	ADCY3	adenylate cyclase 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209320_at	198	0.424242	0.0465657	0.470587	0.443683	0.722576	-0.093956	0.91 [0.54 - 1.53]
GENE	ADCY3	adenylate cyclase 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209321_s_at	198	0.848485	0.034639	0.389669	-0.740982	0.985722	0.0037159	1.00 [0.67 - 1.51]
GENE	ADCY3	adenylate cyclase 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209320_at	198	0.883838	0.0237808	0.30242	-1.28837	0.989562	-0.00403921	1.00 [0.54 - 1.82]
GENE	ADCY3	adenylate cyclase 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209320_at	198	0.858586	0.0645658	-	-0.929631	0.874377	0.049579	1.05 [0.57 - 1.94]
GENE	ADCY3	adenylate cyclase 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209320_at	62	0.725806	0.101391	-	-1.55102	0.412166	-0.604598	0.55 [0.13 - 2.32]
GENE	ADCY3	adenylate cyclase 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209321_s_at	51	0.705882	0.106626	-	1.36684	0.404854	1.6426	5.17 [0.11 - 246.56]
GENE	ADCY3	adenylate cyclase 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209321_s_at	62	0.387097	0.0494157	0.488107	1.40719	0.198137	1.60126	4.96 [0.43 - 56.83]
GENE	ADCY3	adenylate cyclase 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209320_at	51	0.235294	0.191154	-	15.4806	0.97996	-0.0270851	0.97 [0.12 - 8.06]
GENE	ADCY3	adenylate cyclase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209321_s_at	145	0.731034	0.0534077	-	-0.899955	0.0825867	-0.686447	0.50 [0.23 - 1.09]
GENE	ADCY3	adenylate cyclase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209321_s_at	177	0.740113	0.0161112	0.229594	-0.940396	0.172581	-0.440644	0.64 [0.34 - 1.21]
GENE	ADCY3	adenylate cyclase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209320_at	177	0.677966	0.00295734	0.0622666	-0.882665	0.157938	-0.666846	0.51 [0.20 - 1.30]
GENE	ADCY3	adenylate cyclase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209320_at	177	0.672316	0.00414954	0.0816705	-1.00524	0.313953	-0.546247	0.58 [0.20 - 1.68]
GENE	ADCY3	adenylate cyclase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209321_s_at	177	0.581921	0.0165339	0.233925	-0.610364	0.139333	-0.411121	0.66 [0.38 - 1.14]
GENE	ADCY3	adenylate cyclase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209320_at	145	0.648276	0.00271174	0.0580511	-1.34415	0.073401	-1.24537	0.29 [0.07 - 1.13]
GENE	ADCY3	adenylate cyclase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209320_at	226	0.278761	0.0140034	0.207335	-0.691753	0.250809	-0.396831	0.67 [0.34 - 1.32]
GENE	ADCY3	adenylate cyclase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209321_s_at	226	0.486726	0.0236783	0.301518	-0.650141	0.112019	-0.469812	0.63 [0.35 - 1.12]
GENE	ADCY3	adenylate cyclase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209320_at	55	0.363636	0.129126	-	0.823438	0.642809	0.368047	1.44 [0.31 - 6.84]
GENE	ADCY3	adenylate cyclase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209320_at	49	0.183673	0.0874566	-	-1.00865	0.248014	-1.05559	0.35 [0.06 - 2.09]
GENE	ADCY3	adenylate cyclase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209320_at	55	0.490909	0.171281	-	-0.615279	0.402658	-0.633878	0.53 [0.12 - 2.34]
GENE	ADCY3	adenylate cyclase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209321_s_at	55	0.890909	0.0920502	-	0.915199	0.745434	-0.135144	0.87 [0.39 - 1.98]
GENE	ADCY3	adenylate cyclase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209321_s_at	55	0.890909	0.153933	-	0.886324	0.735676	0.157317	1.17 [0.47 - 2.92]
GENE	ADCY3	adenylate cyclase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209321_s_at	49	0.653061	0.103366	-	-1.19222	0.198449	-0.599338	0.55 [0.22 - 1.37]
GENE	ADCY3	adenylate cyclase 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	29697	34	0.558824	0.0304058	0.357462	0.946025	0.404139	0.3886	1.47 [0.59 - 3.68]
GENE	ADCY3	adenylate cyclase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209320_at	63	0.68254	0.001994	0.0451834	1.01762	0.00826403	0.757212	2.13 [1.22 - 3.74]
GENE	ADCY3	adenylate cyclase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209321_s_at	63	0.603175	0.000252979	0.00788308	1.20502	0.0549372	0.446532	1.56 [0.99 - 2.47]
GENE	ADCY3	adenylate cyclase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4104225_3p_at	28	0.392857	0.039374	0.423387	1.20752	0.447973	0.555447	1.74 [0.42 - 7.32]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209320_at	82	0.670732	0.193721	-	0.443171	0.458082	0.316636	1.37 [0.59 - 3.17]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209321_s_at	82	0.695122	0.079179	-	0.59522	0.206445	0.995307	2.71 [0.58 - 12.67]
GENE	ADCY3	adenylate cyclase 3	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33134_at	84	0.404762	6.61341e-06	0.00030701	1.4862	0.00758244	0.939168	2.56 [1.28 - 5.10]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209320_at	79	0.620253	0.253116	-	-0.309708	0.614584	-0.180091	0.84 [0.41 - 1.68]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209321_s_at	79	0.607595	0.197037	-	0.336543	0.982154	-0.0099112	0.99 [0.42 - 2.36]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209320_at	104	0.884615	0.0334651	0.380945	0.870966	0.171242	0.894845	2.45 [0.68 - 8.82]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209321_s_at	104	0.567308	0.0133585	0.200286	0.81288	0.0939911	1.42169	4.14 [0.78 - 21.88]
GENE	ADCY3	adenylate cyclase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P67864	117	0.410256	0.0126772	0.192708	0.770652	0.167193	0.422681	1.53 [0.84 - 2.78]
GENE	ADCY3	adenylate cyclase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209321_s_at	204	0.740196	0.247813	-	-0.55896	0.956557	-0.0303686	0.97 [0.33 - 2.89]
GENE	ADCY3	adenylate cyclase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209321_s_at	204	0.740196	0.0351862	0.393684	-0.786663	0.443435	-0.313377	0.73 [0.33 - 1.63]
GENE	ADCY3	adenylate cyclase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209320_at	204	0.191176	0.182131	-	0.791292	0.622535	0.278913	1.32 [0.44 - 4.01]
GENE	ADCY3	adenylate cyclase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209320_at	204	0.598039	0.184488	-	-0.38649	0.92834	-0.0372791	0.96 [0.43 - 2.17]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209320_at	178	0.157303	0.0944056	-	0.528264	0.345012	0.356623	1.43 [0.68 - 2.99]
GENE	ADCY3	adenylate cyclase 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209321_s_at	178	0.898876	0.00881693	0.146795	0.740434	0.107852	0.845378	2.33 [0.83 - 6.53]
GENE	ADCY3	adenylate cyclase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209321_s_at	111	0.828829	0.00964259	0.157091	-1.15301	0.171037	-0.357529	0.70 [0.42 - 1.17]
GENE	ADCY3	adenylate cyclase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209320_at	111	0.54955	0.0664408	-	-0.503631	0.373925	-0.349822	0.70 [0.33 - 1.52]
GENE	ADCY3	adenylate cyclase 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209320_at	90	0.155556	0.121158	-	-0.583453	0.52198	-0.328035	0.72 [0.26 - 1.97]
GENE	ADCY3	adenylate cyclase 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209320_at	90	0.644444	0.136768	-	-0.635947	0.651916	-0.263838	0.77 [0.24 - 2.42]
GENE	ADCY3	adenylate cyclase 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209321_s_at	90	0.555556	0.171308	-	-0.456677	0.651541	-0.202478	0.82 [0.34 - 1.97]
GENE	ADCY3	adenylate cyclase 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209321_s_at	90	0.844444	0.122325	-	0.659765	0.97337	-0.0168571	0.98 [0.37 - 2.65]
GENE	ADCY3	adenylate cyclase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209320_at	138	0.485507	0.119232	-	-0.376054	0.446221	-0.138264	0.87 [0.61 - 1.24]
GENE	ADCY3	adenylate cyclase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209321_s_at	138	0.811594	0.262086	-	-0.382276	0.957656	-0.00636426	0.99 [0.79 - 1.26]
GENE	ADCY3	adenylate cyclase 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209320_at	129	0.131783	0.0253232	0.3158	-0.733213	0.0917705	-0.776198	0.46 [0.19 - 1.13]
GENE	ADCY3	adenylate cyclase 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209321_s_at	129	0.899225	0.0822333	-	-0.868696	0.477198	-0.251436	0.78 [0.39 - 1.56]
GENE	ADCY3	adenylate cyclase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40699	56	0.553571	0.106755	-	0.573278	0.749504	-0.139387	0.87 [0.37 - 2.05]
GENE	ADCY3	adenylate cyclase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40699	56	0.107143	0.238213	-	-0.714796	0.697012	-0.156274	0.86 [0.39 - 1.88]
GENE	ADCY3	adenylate cyclase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209321_s_at	278	0.507194	0.0236783	0.301518	0.435668	0.398835	0.112986	1.12 [0.86 - 1.46]
GENE	ADCY3	adenylate cyclase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209320_at	278	0.107914	0.220994	-	0.446725	0.454534	0.208432	1.23 [0.71 - 2.13]
GENE	ADCY3	adenylate cyclase 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209321_s_at	133	0.894737	0.0160067	0.228518	-1.56175	0.154454	-0.168239	0.85 [0.67 - 1.07]
GENE	ADCY3	adenylate cyclase 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209320_at	133	0.218045	0.0115313	0.179635	0.87882	0.641512	0.0951774	1.10 [0.74 - 1.64]
GENE	ADCY3	adenylate cyclase 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5829	81	0.876543	0.114099	-	0.9915	0.644434	0.19265	1.21 [0.53 - 2.75]
GENE	ADCY3	adenylate cyclase 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14347	81	0.111111	0.0546775	-	-1.09724	0.378715	0.450611	1.57 [0.58 - 4.28]
GENE	ADCY3	adenylate cyclase 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209321_s_at	185	0.394595	0.0610414	-	-0.305505	0.958249	-0.0129875	0.99 [0.61 - 1.61]
GENE	ADCY3	adenylate cyclase 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209320_at	185	0.183784	0.0641667	-	-0.399813	0.367124	-0.219626	0.80 [0.50 - 1.29]
GENE	ADCY3	adenylate cyclase 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209320_at	185	0.151351	0.0547982	-	-0.407846	0.136927	-0.332218	0.72 [0.46 - 1.11]
GENE	ADCY3	adenylate cyclase 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209321_s_at	185	0.394595	0.0896724	-	-0.299941	0.951774	-0.0161947	0.98 [0.58 - 1.66]
GENE	ADCY3	adenylate cyclase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P67864	110	0.336364	0.0147451	0.2153	0.851132	0.139225	0.319349	1.38 [0.90 - 2.10]
GENE	ADCY3	adenylate cyclase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P67864	110	0.254545	0.0201679	0.269532	0.677171	0.0610138	0.311536	1.37 [0.99 - 1.89]
GENE	ADCY3	adenylate cyclase 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209320_at	80	0.3375	0.110392	-	0.864325	0.6023	0.237585	1.27 [0.52 - 3.10]
GENE	ADCY3	adenylate cyclase 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209321_s_at	80	0.4875	0.360613	-	0.401327	0.843215	0.0695758	1.07 [0.54 - 2.14]
GENE	ADCY3	adenylate cyclase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209320_at	38	0.105263	0.0226574	0.292436	15.6468	0.188468	0.688406	1.99 [0.71 - 5.55]
GENE	ADCY3	adenylate cyclase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209321_s_at	38	0.342105	0.0125077	0.1908	1.46346	0.209957	0.566943	1.76 [0.73 - 4.28]
GENE	ADCY3	adenylate cyclase 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209320_at	140	0.135714	0.0108807	0.172017	-0.849966	0.286361	-0.518027	0.60 [0.23 - 1.54]
GENE	ADCY3	adenylate cyclase 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209321_s_at	140	0.171429	0.0775274	-	0.892609	0.928646	-0.0245856	0.98 [0.57 - 1.67]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY4	adenylate cyclase 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1677893	165	0.612121	0.00180511	0.0416365	0.749009	0.0905514	0.219131	1.24 [0.97 - 1.60]
GENE	ADCY4	adenylate cyclase 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1677893	165	0.612121	0.00607691	0.110251	0.956836	0.194656	0.235665	1.27 [0.89 - 1.81]
GENE	ADCY4	adenylate cyclase 4	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	230800_at	163	0.840491	0.0567684	-	-0.559652	0.198873	-0.6546	0.52 [0.19 - 1.41]
GENE	ADCY4	adenylate cyclase 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	230800_at	79	0.126582	0.0204835	0.272498	1.5247	0.628188	0.214346	1.24 [0.52 - 2.95]
GENE	ADCY4	adenylate cyclase 4	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	230800_at	180	0.244444	0.195729	-	-0.304046	0.436674	-0.0782904	0.92 [0.76 - 1.13]
GENE	ADCY4	adenylate cyclase 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	230800_at	559	0.146691	0.149261	-	0.559572	0.804777	0.0445049	1.05 [0.73 - 1.49]
GENE	ADCY4	adenylate cyclase 4	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	230800_at	77	0.441558	0.00483348	0.0921517	-0.711773	0.0820422	-0.364543	0.69 [0.46 - 1.05]
GENE	ADCY4	adenylate cyclase 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	230800_at	70	0.228571	0.0889402	-	-0.503983	0.596598	-0.347994	0.71 [0.19 - 2.56]
GENE	ADCY4	adenylate cyclase 4	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	230800_at	74	0.864865	0.0783239	-	0.690757	0.424112	0.215483	1.24 [0.73 - 2.10]
GENE	ADCY4	adenylate cyclase 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	230800_at	67	0.328358	0.129883	-	-0.977546	0.924093	-0.117971	0.89 [0.08 - 10.06]
GENE	ADCY4	adenylate cyclase 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	230800_at	115	0.252174	0.0191238	0.259582	-1.17791	0.199116	-0.773005	0.46 [0.14 - 1.50]
GENE	ADCY4	adenylate cyclase 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	230800_at	204	0.132353	0.000542009	0.0151802	-0.710751	0.0215986	-0.226957	0.80 [0.66 - 0.97]
GENE	ADCY4	adenylate cyclase 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	230800_at	87	0.873563	0.0291726	0.347673	-15.2566	0.0760986	-0.885318	0.41 [0.16 - 1.10]
GENE	ADCY4	adenylate cyclase 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	230800_at	87	0.873563	0.0291726	0.347673	-15.2566	0.0760986	-0.885318	0.41 [0.16 - 1.10]
GENE	ADCY4	adenylate cyclase 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	230800_at	77	0.558442	0.0192881	0.261163	-2.07588	0.285072	-0.869286	0.42 [0.09 - 2.06]
GENE	ADCY4	adenylate cyclase 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	230800_at	77	0.116883	0.203058	-	15.1938	0.990545	-0.00688735	0.99 [0.32 - 3.10]
GENE	ADCY4	adenylate cyclase 4	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230800_at	159	0.157233	0.00577008	0.105887	-1.06059	0.0526364	-0.49435	0.61 [0.37 - 1.01]
GENE	ADCY4	adenylate cyclase 4	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230800_at	159	0.119497	0.000189551	0.00613385	-1.24343	0.0215686	-0.499372	0.61 [0.40 - 0.93]
GENE	ADCY4	adenylate cyclase 4	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230800_at	159	0.157233	0.0559909	-	-0.685176	0.155228	-0.297321	0.74 [0.49 - 1.12]
GENE	ADCY4	adenylate cyclase 4	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	230800_at	236	0.144068	0.00124825	0.0306763	-0.964476	0.0173098	-0.390185	0.68 [0.49 - 0.93]
GENE	ADCY4	adenylate cyclase 4	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	230800_at	249	0.405622	0.0171524	0.240186	-0.501355	0.0576102	-0.246588	0.78 [0.61 - 1.01]
GENE	ADCY4	adenylate cyclase 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	230800_at	177	0.107345	0.0933975	-	-0.564953	0.508878	-0.473224	0.62 [0.15 - 2.54]
GENE	ADCY4	adenylate cyclase 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	230800_at	177	0.107345	0.0872556	-	-0.645418	0.749614	-0.259901	0.77 [0.16 - 3.80]
GENE	ADCY4	adenylate cyclase 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	230800_at	145	0.889655	0.103556	-	-1.50501	0.573866	-0.582117	0.56 [0.07 - 4.25]
GENE	ADCY4	adenylate cyclase 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	230800_at	226	0.80531	0.00430494	0.084089	0.828734	0.0562869	0.345805	1.41 [0.99 - 2.02]
GENE	ADCY4	adenylate cyclase 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	230800_at	55	0.181818	0.0113332	0.177331	-1.13955	0.0712517	-2.36443	0.09 [0.01 - 1.23]
GENE	ADCY4	adenylate cyclase 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	230800_at	55	0.727273	0.0165075	0.233655	-2.06776	0.0541874	-2.73066	0.07 [0.00 - 1.05]
GENE	ADCY4	adenylate cyclase 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	230800_at	49	0.77551	0.0457042	0.465165	-15.471	0.161503	-2.27398	0.10 [0.00 - 2.48]
GENE	ADCY4	adenylate cyclase 4	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	488368	34	0.323529	0.188057	-	0.669873	0.656424	0.280313	1.32 [0.38 - 4.55]
GENE	ADCY4	adenylate cyclase 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	230800_at	63	0.333333	8.99934e-06	0.000406081	-1.41966	0.138466	-3.8453	0.02 [0.00 - 3.46]
GENE	ADCY4	adenylate cyclase 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.58043.0.S1_3p_at	28	0.785714	0.124557	-	0.910615	0.22722	0.431093	1.54 [0.76 - 3.10]
GENE	ADCY4	adenylate cyclase 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P381261	117	0.495726	0.0132189	0.198744	-0.719532	0.121933	-0.381439	0.68 [0.42 - 1.11]
GENE	ADCY4	adenylate cyclase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	230800_at	204	0.411765	0.0200095	0.268036	-0.857271	0.163715	-0.617403	0.54 [0.23 - 1.29]
GENE	ADCY4	adenylate cyclase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	230800_at	204	0.397059	0.001249	0.0306916	-0.86675	0.0158554	-0.80973	0.44 [0.23 - 0.86]
GENE	ADCY4	adenylate cyclase 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	230800_at	111	0.855856	0.189483	-	-0.559956	0.93405	0.0131371	1.01 [0.74 - 1.38]
GENE	ADCY4	adenylate cyclase 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	230800_at	138	0.485507	0.116584	-	-0.380024	0.961275	-0.00956581	0.99 [0.67 - 1.46]
GENE	ADCY4	adenylate cyclase 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4137	56	0.857143	0.102539	-	-0.964968	0.226179	-0.205961	0.81 [0.58 - 1.14]
GENE	ADCY4	adenylate cyclase 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17444	56	0.392857	0.235934	-	-0.406075	0.767484	-0.0477003	0.95 [0.69 - 1.31]
GENE	ADCY4	adenylate cyclase 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4137	56	0.785714	0.369697	-	-0.40297	0.687726	-0.065613	0.94 [0.68 - 1.29]
GENE	ADCY4	adenylate cyclase 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17444	56	0.75	0.150467	-	-0.690315	0.245845	-0.194701	0.82 [0.59 - 1.14]
GENE	ADCY4	adenylate cyclase 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	230800_at	278	0.593525	0.180753	-	0.255133	0.508402	-0.153224	0.86 [0.54 - 1.35]
GENE	ADCY4	adenylate cyclase 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9478	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ADCY4	adenylate cyclase 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P381261	110	0.745455	0.0705713	-	0.446037	0.415747	0.0907118	1.09 [0.88 - 1.36]
GENE	ADCY4	adenylate cyclase 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P381261	110	0.263636	0.0726717	-	-0.552274	0.743736	-0.0479496	0.95 [0.72 - 1.27]
GENE	ADCY4	adenylate cyclase 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	230800_at	38	0.789474	0.00790319	0.135044	-15.526	0.360249	-0.41796	0.66 [0.27 - 1.61]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY5	adenylate cyclase 5	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1708588	165	0.375758	0.0940543	-	-0.409899	0.56612	0.197521	1.22 [0.62 - 2.39]
GENE	ADCY5	adenylate cyclase 5	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1708588	165	0.824242	0.107608	-	0.622698	0.671899	0.200737	1.22 [0.48 - 3.09]
GENE	ADCY5	adenylate cyclase 5	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	242891_at	163	0.711656	0.00138116	0.03337	-0.777886	0.147657	-1.33207	0.26 [0.04 - 1.60]
GENE	ADCY5	adenylate cyclase 5	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	228182_at	163	0.134969	0.134241	-	0.4739	0.274554	0.796905	2.22 [0.53 - 9.27]
GENE	ADCY5	adenylate cyclase 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	242891_at	79	0.126582	0.227118	-	0.620058	0.853836	-0.169058	0.84 [0.14 - 5.10]
GENE	ADCY5	adenylate cyclase 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	228182_at	79	0.594937	0.124035	-	0.443951	0.886957	0.0888914	1.09 [0.32 - 3.72]
GENE	ADCY5	adenylate cyclase 5	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	228182_at	180	0.811111	0.0149325	0.217288	0.580492	0.505561	0.124554	1.13 [0.78 - 1.63]
GENE	ADCY5	adenylate cyclase 5	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	242891_at	180	0.388889	0.260733	-	-0.239632	0.618293	-0.0686777	0.93 [0.71 - 1.22]
GENE	ADCY5	adenylate cyclase 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	242891_at	559	0.100179	0.0874121	-	-0.521766	0.48028	-0.0821263	0.92 [0.73 - 1.16]
GENE	ADCY5	adenylate cyclase 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	228182_at	559	0.669052	0.0974302	-	-0.353319	0.342183	-0.120099	0.89 [0.69 - 1.14]
GENE	ADCY5	adenylate cyclase 5	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	228182_at	77	0.714286	0.0148963	0.216905	-0.751524	0.0283481	-0.334844	0.72 [0.53 - 0.97]
GENE	ADCY5	adenylate cyclase 5	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	242891_at	77	0.545455	0.0337976	0.383431	0.538826	0.754925	0.0693308	1.07 [0.69 - 1.66]
GENE	ADCY5	adenylate cyclase 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	242891_at	70	0.628571	6.9352e-05	0.0025349	1.08115	0.0308915	1.99932	7.38 [1.20 - 45.37]
GENE	ADCY5	adenylate cyclase 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	228182_at	70	0.328571	0.00420995	0.0826135	-0.785317	0.286871	-0.657559	0.52 [0.15 - 1.74]
GENE	ADCY5	adenylate cyclase 5	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	228182_at	74	0.108108	0.119292	-	-0.635435	0.848373	-0.0278325	0.97 [0.73 - 1.29]
GENE	ADCY5	adenylate cyclase 5	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	242891_at	74	0.851351	0.00103142	0.026155	1.12855	0.0551725	0.438475	1.55 [0.99 - 2.43]
GENE	ADCY5	adenylate cyclase 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	228182_at	67	0.895522	0.00229839	0.0507496	1.89551	0.058927	0.941062	2.56 [0.97 - 6.80]
GENE	ADCY5	adenylate cyclase 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	242891_at	67	0.701493	0.100126	-	-1.60565	0.966054	0.107475	1.11 [0.01 - 157.15]
GENE	ADCY5	adenylate cyclase 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	228182_at	115	0.426087	0.0763239	-	-0.949995	0.298289	-1.06942	0.34 [0.05 - 2.57]
GENE	ADCY5	adenylate cyclase 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	242891_at	115	0.156522	0.0945956	-	15.2924	0.754624	0.190582	1.21 [0.37 - 4.00]
GENE	ADCY5	adenylate cyclase 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	228182_at	204	0.264706	0.0499413	0.491271	-0.311414	0.202257	-0.0828651	0.92 [0.81 - 1.05]
GENE	ADCY5	adenylate cyclase 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	242891_at	204	0.279412	0.352106	-	-0.145248	0.857452	-0.0155589	0.98 [0.83 - 1.17]
GENE	ADCY5	adenylate cyclase 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	242891_at	87	0.678161	0.0812174	-	-0.786356	0.248819	-1.09485	0.33 [0.05 - 2.15]
GENE	ADCY5	adenylate cyclase 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	242891_at	87	0.678161	0.0812174	-	-0.786356	0.248819	-1.09485	0.33 [0.05 - 2.15]
GENE	ADCY5	adenylate cyclase 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	228182_at	87	0.287356	0.0102323	0.164273	1.44401	0.0749813	0.537037	1.71 [0.95 - 3.09]
GENE	ADCY5	adenylate cyclase 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	228182_at	87	0.287356	0.0102323	0.164273	1.44401	0.0749813	0.537037	1.71 [0.95 - 3.09]
GENE	ADCY5	adenylate cyclase 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	228182_at	77	0.324675	0.00478771	0.091463	-1.72707	0.0307237	-2.33589	0.10 [0.01 - 0.80]
GENE	ADCY5	adenylate cyclase 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	242891_at	77	0.155844	0.196147	-	-0.86538	0.929071	0.165014	1.18 [0.03 - 44.63]
GENE	ADCY5	adenylate cyclase 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	242891_at	77	0.805195	0.028518	0.342397	1.18781	0.143741	2.14117	8.51 [0.48 - 150.16]
GENE	ADCY5	adenylate cyclase 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	228182_at	77	0.324675	0.0650033	-	-0.986955	0.415742	-0.485998	0.62 [0.19 - 1.98]
GENE	ADCY5	adenylate cyclase 5	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5138	60	0.883333	0.199551	-	0.622206	0.779368	0.031816	1.03 [0.83 - 1.29]
GENE	ADCY5	adenylate cyclase 5	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5138	60	0.816667	0.0317805	0.368151	0.875633	0.715484	0.050354	1.05 [0.80 - 1.38]
GENE	ADCY5	adenylate cyclase 5	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228182_at	159	0.805031	0.0802888	-	-1.20716	0.326299	-0.259814	0.77 [0.46 - 1.30]
GENE	ADCY5	adenylate cyclase 5	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242891_at	159	0.836478	0.0747058	-	-1.02486	0.367456	0.252398	1.29 [0.74 - 2.23]
GENE	ADCY5	adenylate cyclase 5	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242891_at	159	0.54717	0.0445052	0.457518	0.637709	0.419722	0.22572	1.25 [0.72 - 2.17]
GENE	ADCY5	adenylate cyclase 5	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242891_at	159	0.811321	0.073606	-	-1.23207	0.764913	0.0940429	1.10 [0.59 - 2.03]
GENE	ADCY5	adenylate cyclase 5	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228182_at	159	0.113208	0.184927	-	-0.545056	0.640055	-0.0997268	0.91 [0.60 - 1.37]
GENE	ADCY5	adenylate cyclase 5	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228182_at	159	0.805031	0.0773158	-	-0.900635	0.378683	-0.190207	0.83 [0.54 - 1.26]
GENE	ADCY5	adenylate cyclase 5	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	228182_at	236	0.491525	0.00462658	0.0890244	0.793845	0.180439	0.193331	1.21 [0.91 - 1.61]
GENE	ADCY5	adenylate cyclase 5	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	242891_at	236	0.84322	0.120568	-	-0.713375	0.957949	-0.0146702	0.99 [0.57 - 1.70]
GENE	ADCY5	adenylate cyclase 5	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	228182_at	249	0.514056	0.03943	0.423773	0.437106	0.858034	0.0227293	1.02 [0.80 - 1.31]
GENE	ADCY5	adenylate cyclase 5	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	242891_at	249	0.751004	0.0190247	0.258626	-0.652538	0.55165	-0.121372	0.89 [0.59 - 1.32]
GENE	ADCY5	adenylate cyclase 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	228182_at	177	0.491525	0.282339	-	-0.29001	0.486548	0.388825	1.48 [0.49 - 4.41]
GENE	ADCY5	adenylate cyclase 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	242891_at	177	0.322034	0.0456172	0.464614	-0.479606	0.113215	-1.06789	0.34 [0.09 - 1.29]
GENE	ADCY5	adenylate cyclase 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	242891_at	177	0.322034	0.0250451	0.313415	-0.608742	0.220187	-0.95346	0.39 [0.08 - 1.77]
GENE	ADCY5	adenylate cyclase 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	228182_at	177	0.514124	0.156297	-	-0.334298	0.644105	0.239537	1.27 [0.46 - 3.51]
GENE	ADCY5	adenylate cyclase 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	242891_at	145	0.77931	0.183951	-	-0.632109	0.839575	-0.199138	0.82 [0.12 - 5.63]
GENE	ADCY5	adenylate cyclase 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	228182_at	145	0.234483	0.0292077	0.347954	-0.740283	0.518718	-0.611728	0.54 [0.08 - 3.48]
GENE	ADCY5	adenylate cyclase 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	242891_at	226	0.39823	0.0600333	-	0.598867	0.623747	0.0661941	1.07 [0.82 - 1.39]
GENE	ADCY5	adenylate cyclase 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	228182_at	226	0.464602	0.0119934	0.184958	0.779026	0.0663509	0.212382	1.24 [0.99 - 1.55]
GENE	ADCY5	adenylate cyclase 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	228182_at	49	0.877551	0.250105	-	0.868388	0.699314	0.734679	2.08 [0.05 - 86.73]
GENE	ADCY5	adenylate cyclase 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	242891_at	49	0.102041	0.102598	-	-1.2188	0.820701	-0.503235	0.60 [0.01 - 46.93]
GENE	ADCY5	adenylate cyclase 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	242891_at	55	0.709091	0.107092	-	0.721703	0.750112	0.518533	1.68 [0.07 - 40.84]
GENE	ADCY5	adenylate cyclase 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	228182_at	55	0.8	0.0687577	-	0.863645	0.165526	2.13305	8.44 [0.41 - 172.07]
GENE	ADCY5	adenylate cyclase 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	228182_at	55	0.545455	0.0415979	0.438469	1.00858	0.371654	1.36064	3.90 [0.20 - 77.15]
GENE	ADCY5	adenylate cyclase 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	242891_at	55	0.6	0.104705	-	0.748172	0.854642	0.318667	1.38 [0.05 - 41.60]
GENE	ADCY5	adenylate cyclase 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	242891_at	63	0.142857	0.000336257	0.0100814	-1.35814	0.0071479	-32.7733	0.00 [0.00 - 0.00]
GENE	ADCY5	adenylate cyclase 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	228182_at	63	0.174603	4.71402e-06	0.000225572	-1.61864	0.921997	0.122143	1.13 [0.10 - 13.03]
GENE	ADCY5	adenylate cyclase 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.9572.0.A1_3p_at	28	0.607143	0.360537	-	0.494091	0.490988	-8.84927	0.00 [0.00 - 12407230.93]
GENE	ADCY5	adenylate cyclase 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.235224.0.A1_3p_at	28	0.178571	0.0757846	-	-1.05061	0.248449	-12.2212	0.00 [0.00 - 5081.88]
GENE	ADCY5	adenylate cyclase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	228182_at	204	0.401961	0.0374885	0.410232	-0.749672	0.19086	-0.281567	0.75 [0.49 - 1.15]
GENE	ADCY5	adenylate cyclase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	242891_at	204	0.107843	0.0148352	0.216257	-1.01044	0.151454	-0.492937	0.61 [0.31 - 1.20]
GENE	ADCY5	adenylate cyclase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	228182_at	204	0.132353	0.0107385	0.170332	-0.814174	0.066994	-0.300412	0.74 [0.54 - 1.02]
GENE	ADCY5	adenylate cyclase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	242891_at	204	0.107843	0.000981553	0.0250902	-1.03494	0.0603832	-0.48523	0.62 [0.37 - 1.02]
GENE	ADCY5	adenylate cyclase 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	228182_at	111	0.432432	0.329266	-	-0.256792	0.643459	-0.0779807	0.92 [0.66 - 1.29]
GENE	ADCY5	adenylate cyclase 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	242891_at	111	0.189189	0.111523	-	0.63214	0.824719	0.0301397	1.03 [0.79 - 1.35]
GENE	ADCY5	adenylate cyclase 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	242891_at	138	0.275362	0.00204609	0.0461485	-0.741608	0.119991	-10.3725	0.00 [0.00 - 14.93]
GENE	ADCY5	adenylate cyclase 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	228182_at	138	0.173913	0.000675719	0.0183106	-0.89918	0.494363	-0.311221	0.73 [0.30 - 1.79]
GENE	ADCY5	adenylate cyclase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11381	56	0.892857	0.048693	0.483724	-1.78921	0.0857831	-0.618258	0.54 [0.27 - 1.09]
GENE	ADCY5	adenylate cyclase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5707	56	0.75	0.0691331	-	-0.865573	0.17529	-0.469933	0.63 [0.32 - 1.23]
GENE	ADCY5	adenylate cyclase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11381	56	0.892857	0.160846	-	-1.00399	0.274977	-0.346568	0.71 [0.38 - 1.32]
GENE	ADCY5	adenylate cyclase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5707	56	0.125	0.215814	-	-0.555498	0.369484	-0.272635	0.76 [0.42 - 1.38]
GENE	ADCY5	adenylate cyclase 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	228182_at	278	0.809353	0.00197834	0.0448921	-1.02726	0.030254	-0.4053	0.67 [0.46 - 0.96]
GENE	ADCY5	adenylate cyclase 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	242891_at	278	0.755396	0.0266987	0.327429	-0.541324	0.222012	-0.66208	0.52 [0.18 - 1.49]
GENE	ADCY5	adenylate cyclase 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P919249	110	0.163636	0.290133	-	0.459802	0.522185	0.104805	1.11 [0.81 - 1.53]
GENE	ADCY5	adenylate cyclase 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P136623	110	0.263636	0.0513832	-	-0.499624	0.479702	-0.081787	0.92 [0.73 - 1.16]
GENE	ADCY5	adenylate cyclase 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P919249	110	0.290909	0.0991395	-	0.452383	0.187282	0.194702	1.21 [0.91 - 1.62]
GENE	ADCY5	adenylate cyclase 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P136623	110	0.245455	0.00861228	0.144197	-0.838739	0.229086	-0.172091	0.84 [0.64 - 1.11]
GENE	ADCY5	adenylate cyclase 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	228182_at	38	0.710526	0.249112	-	0.547815	0.803545	-0.104039	0.90 [0.40 - 2.05]
GENE	ADCY5	adenylate cyclase 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	242891_at	38	0.263158	0.0518183	-	-0.932924	0.656291	-0.162929	0.85 [0.41 - 1.74]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY6	adenylate cyclase 6	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209195_s_at	30	0.3	0.104273	-	0.759139	0.573535	0.365683	1.44 [0.40 - 5.15]
GENE	ADCY6	adenylate cyclase 6	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1685156	165	0.690909	0.0155794	0.224085	-0.711709	0.107848	-0.203874	0.82 [0.64 - 1.05]
GENE	ADCY6	adenylate cyclase 6	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1685156	165	0.121212	0.00251127	0.0545443	-1.16984	0.0101394	-0.438	0.65 [0.46 - 0.90]
GENE	ADCY6	adenylate cyclase 6	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209195_s_at	163	0.165644	0.0828158	-	-0.422889	0.909892	0.0675679	1.07 [0.33 - 3.45]
GENE	ADCY6	adenylate cyclase 6	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209195_s_at	79	0.113924	0.0215895	0.282746	1.98151	0.146343	0.632161	1.88 [0.80 - 4.42]
GENE	ADCY6	adenylate cyclase 6	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209195_s_at	58	0.362069	0.0578048	-	0.556057	0.214163	0.226084	1.25 [0.88 - 1.79]
GENE	ADCY6	adenylate cyclase 6	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209195_s_at	34	0.794118	0.083162	-	-1.03704	0.378191	-0.202251	0.82 [0.52 - 1.28]
GENE	ADCY6	adenylate cyclase 6	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209195_s_at	158	0.85443	0.00670487	0.118992	-1.18486	0.0116519	-2.26241	0.10 [0.02 - 0.60]
GENE	ADCY6	adenylate cyclase 6	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209195_s_at	53	0.849057	0.292471	-	-0.630576	0.947721	-0.0187012	0.98 [0.56 - 1.72]
GENE	ADCY6	adenylate cyclase 6	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209195_s_at	53	0.433962	0.382688	-	-0.299361	0.942904	0.0189655	1.02 [0.61 - 1.71]
GENE	ADCY6	adenylate cyclase 6	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209195_s_at	180	0.527778	0.0314095	0.365289	-0.456091	0.0373169	-0.403901	0.67 [0.46 - 0.98]
GENE	ADCY6	adenylate cyclase 6	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209195_s_at	559	0.323792	0.0447124	0.458848	-0.411632	0.841051	0.0343961	1.03 [0.74 - 1.45]
GENE	ADCY6	adenylate cyclase 6	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209195_s_at	77	0.896104	0.154393	-	0.567535	0.515075	0.276733	1.32 [0.57 - 3.03]
GENE	ADCY6	adenylate cyclase 6	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209195_s_at	70	0.128571	0.0144157	0.211781	-0.91905	0.178382	-0.941967	0.39 [0.10 - 1.54]
GENE	ADCY6	adenylate cyclase 6	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39383_at	50	0.44	0.0394638	0.424005	0.732606	0.028358	0.373419	1.45 [1.04 - 2.03]
GENE	ADCY6	adenylate cyclase 6	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209195_s_at	74	0.175676	0.255201	-	-0.402747	0.462322	-0.466879	0.63 [0.18 - 2.18]
GENE	ADCY6	adenylate cyclase 6	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209195_s_at	67	0.477612	0.194163	-	-0.889494	0.961344	-0.065423	0.94 [0.07 - 13.20]
GENE	ADCY6	adenylate cyclase 6	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209195_s_at	115	0.26087	0.0857446	-	1.6055	0.505668	0.379036	1.46 [0.48 - 4.46]
GENE	ADCY6	adenylate cyclase 6	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39383_at	158	0.107595	0.0626795	-	-0.676188	0.173006	-0.495578	0.61 [0.30 - 1.24]
GENE	ADCY6	adenylate cyclase 6	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39383_at	76	0.184211	0.329629	-	-0.563095	0.91334	-0.101305	0.90 [0.15 - 5.60]
GENE	ADCY6	adenylate cyclase 6	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209195_s_at	204	0.514706	0.00320705	0.0664688	-0.408711	0.11717	-0.236932	0.79 [0.59 - 1.06]
GENE	ADCY6	adenylate cyclase 6	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209195_s_at	87	0.275862	0.00701802	0.123263	-0.996636	0.46007	-0.336641	0.71 [0.29 - 1.74]
GENE	ADCY6	adenylate cyclase 6	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209195_s_at	87	0.275862	0.00701802	0.123263	-0.996636	0.46007	-0.336641	0.71 [0.29 - 1.74]
GENE	ADCY6	adenylate cyclase 6	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209195_s_at	77	0.12987	0.0715102	-	-1.1759	0.269705	-0.80832	0.45 [0.11 - 1.87]
GENE	ADCY6	adenylate cyclase 6	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209195_s_at	77	0.753247	0.135046	-	-1.43062	0.569807	-0.358427	0.70 [0.20 - 2.41]
GENE	ADCY6	adenylate cyclase 6	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209195_s_at	136	0.279412	0.0803856	-	-0.768685	0.279786	-0.526121	0.59 [0.23 - 1.53]
GENE	ADCY6	adenylate cyclase 6	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209195_s_at	200	0.465	0.0290602	0.346771	-0.648126	0.340381	-0.439668	0.64 [0.26 - 1.59]
GENE	ADCY6	adenylate cyclase 6	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4095	60	0.616667	0.0216553	0.283349	0.84927	0.211995	0.553931	1.74 [0.73 - 4.15]
GENE	ADCY6	adenylate cyclase 6	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4095	60	0.883333	0.00592482	0.108096	1.22497	0.596862	0.232667	1.26 [0.53 - 2.99]
GENE	ADCY6	adenylate cyclase 6	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21946	155	0.896774	0.00135157	0.032775	1.01356	0.0102218	0.441883	1.56 [1.11 - 2.18]
GENE	ADCY6	adenylate cyclase 6	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209195_s_at	286	0.891608	0.0362978	0.401742	-0.853619	0.12243	-0.288709	0.75 [0.52 - 1.08]
GENE	ADCY6	adenylate cyclase 6	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209195_s_at	159	0.735849	0.140181	-	0.48463	0.198845	0.654243	1.92 [0.71 - 5.22]
GENE	ADCY6	adenylate cyclase 6	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209195_s_at	159	0.855346	0.196718	-	0.504876	0.442145	0.36252	1.44 [0.57 - 3.62]
GENE	ADCY6	adenylate cyclase 6	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209195_s_at	159	0.867925	0.137239	-	0.669037	0.16322	0.867103	2.38 [0.70 - 8.05]
GENE	ADCY6	adenylate cyclase 6	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216743_at	54	0.425926	0.0333441	0.380037	-1.55513	0.253255	-1.21753	0.30 [0.04 - 2.39]
GENE	ADCY6	adenylate cyclase 6	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209195_s_at	54	0.759259	0.112171	-	-1.5388	0.831553	0.134548	1.14 [0.33 - 3.95]
GENE	ADCY6	adenylate cyclase 6	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209195_s_at	117	0.504274	0.0790745	-	0.562368	0.18673	0.351838	1.42 [0.84 - 2.40]
GENE	ADCY6	adenylate cyclase 6	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209195_s_at	117	0.811966	0.0121064	0.186249	0.95322	0.174976	0.435014	1.54 [0.82 - 2.90]
GENE	ADCY6	adenylate cyclase 6	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209195_s_at	117	0.897436	0.00531186	0.0992496	1.24411	0.232712	0.404408	1.50 [0.77 - 2.91]
GENE	ADCY6	adenylate cyclase 6	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209195_s_at	117	0.504274	0.0790745	-	0.562368	0.18673	0.351838	1.42 [0.84 - 2.40]
GENE	ADCY6	adenylate cyclase 6	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209195_s_at	236	0.741525	0.00446249	0.0865181	-1.16381	0.0783137	-0.867086	0.42 [0.16 - 1.10]
GENE	ADCY6	adenylate cyclase 6	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209195_s_at	249	0.751004	0.012658	0.192492	-0.710933	0.460731	-0.276377	0.76 [0.36 - 1.58]
GENE	ADCY6	adenylate cyclase 6	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209195_s_at	125	0.184	0.0693463	-	-0.60271	0.91042	0.0470212	1.05 [0.46 - 2.38]
GENE	ADCY6	adenylate cyclase 6	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209195_s_at	54	0.111111	0.224369	-	-0.946642	0.7622	-0.0560904	0.95 [0.66 - 1.36]
GENE	ADCY6	adenylate cyclase 6	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209195_s_at	62	0.403226	0.113006	-	0.969608	0.789442	-0.0405761	0.96 [0.71 - 1.29]
GENE	ADCY6	adenylate cyclase 6	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209195_s_at	125	0.48	0.0424135	0.443888	0.826308	0.300046	0.57811	1.78 [0.60 - 5.32]
GENE	ADCY6	adenylate cyclase 6	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209195_s_at	198	0.691919	0.00900059	0.149111	0.559605	0.0743936	0.352794	1.42 [0.97 - 2.10]
GENE	ADCY6	adenylate cyclase 6	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209195_s_at	198	0.611111	0.027882	0.337216	0.552568	0.293914	0.253588	1.29 [0.80 - 2.07]
GENE	ADCY6	adenylate cyclase 6	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209195_s_at	198	0.661616	0.11914	-	0.420227	0.4444	0.193056	1.21 [0.74 - 1.99]
GENE	ADCY6	adenylate cyclase 6	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209195_s_at	62	0.564516	0.0337222	0.382868	-1.50241	0.140901	-1.64131	0.19 [0.02 - 1.72]
GENE	ADCY6	adenylate cyclase 6	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209195_s_at	51	0.843137	0.14446	-	1.24966	0.729657	0.479218	1.61 [0.11 - 24.46]
GENE	ADCY6	adenylate cyclase 6	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209195_s_at	177	0.779661	0.246166	-	0.358515	0.438586	0.302819	1.35 [0.63 - 2.91]
GENE	ADCY6	adenylate cyclase 6	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209195_s_at	177	0.180791	0.129659	-	0.511157	0.632607	0.165035	1.18 [0.60 - 2.32]
GENE	ADCY6	adenylate cyclase 6	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209195_s_at	145	0.882759	0.0833334	-	-1.58742	0.572784	-0.296923	0.74 [0.26 - 2.09]
GENE	ADCY6	adenylate cyclase 6	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209195_s_at	226	0.172566	0.050862	-	-0.622833	0.0942399	-0.573083	0.56 [0.29 - 1.10]
GENE	ADCY6	adenylate cyclase 6	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209195_s_at	55	0.363636	0.0225369	0.291353	-0.988786	0.0835598	-1.20571	0.30 [0.08 - 1.17]
GENE	ADCY6	adenylate cyclase 6	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209195_s_at	55	0.363636	0.0914541	-	-0.806836	0.214286	-1.08451	0.34 [0.06 - 1.87]
GENE	ADCY6	adenylate cyclase 6	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209195_s_at	49	0.326531	0.0322713	0.371912	-1.18743	0.0522441	-1.62205	0.20 [0.04 - 1.02]
GENE	ADCY6	adenylate cyclase 6	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209195_s_at	63	0.52381	0.0213357	0.280415	-0.791453	0.116124	-0.403254	0.67 [0.40 - 1.10]
GENE	ADCY6	adenylate cyclase 6	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9049782_3p_a_at	28	0.25	0.18121	-	-0.828742	0.921778	0.0922655	1.10 [0.17 - 6.92]
GENE	ADCY6	adenylate cyclase 6	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209195_s_at	82	0.365854	0.011493	0.179191	1.02909	0.215383	0.550725	1.73 [0.73 - 4.15]
GENE	ADCY6	adenylate cyclase 6	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	39383_at	84	0.833333	0.0265046	0.325805	-1.10372	0.466286	-0.525179	0.59 [0.14 - 2.43]
GENE	ADCY6	adenylate cyclase 6	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209195_s_at	79	0.329114	0.0699014	-	-0.494246	0.55532	-0.247443	0.78 [0.34 - 1.78]
GENE	ADCY6	adenylate cyclase 6	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209195_s_at	104	0.567308	0.0486576	0.483508	-0.677279	0.802998	-0.121263	0.89 [0.34 - 2.30]
GENE	ADCY6	adenylate cyclase 6	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P501547	117	0.444444	0.0117079	0.181677	-0.718654	0.279142	-0.178282	0.84 [0.61 - 1.16]
GENE	ADCY6	adenylate cyclase 6	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209195_s_at	204	0.22549	0.042628	0.445302	-0.751167	0.303269	-0.807377	0.45 [0.10 - 2.07]
GENE	ADCY6	adenylate cyclase 6	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209195_s_at	204	0.176471	0.0071258	0.12472	-0.797896	0.138131	-0.912107	0.40 [0.12 - 1.34]
GENE	ADCY6	adenylate cyclase 6	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209195_s_at	178	0.786517	0.087478	-	0.381788	0.782969	0.0799339	1.08 [0.61 - 1.91]
GENE	ADCY6	adenylate cyclase 6	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200002119	41	0.756098	0.326089	-	0.442017	0.77995	0.0911823	1.10 [0.58 - 2.08]
GENE	ADCY6	adenylate cyclase 6	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209195_s_at	111	0.117117	0.052348	-	-0.728516	0.894938	-0.0355666	0.97 [0.57 - 1.64]
GENE	ADCY6	adenylate cyclase 6	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209195_s_at	90	0.344444	0.161592	-	0.512549	0.64918	0.346149	1.41 [0.32 - 6.28]
GENE	ADCY6	adenylate cyclase 6	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209195_s_at	90	0.266667	0.173637	-	0.657935	0.406015	0.718124	2.05 [0.38 - 11.16]
GENE	ADCY6	adenylate cyclase 6	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	2971	50	0.62	0.361688	-	0.446709	0.877991	-0.0549685	0.95 [0.47 - 1.91]
GENE	ADCY6	adenylate cyclase 6	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209195_s_at	138	0.695652	0.0117737	0.182435	0.610375	0.167958	0.292728	1.34 [0.88 - 2.03]
GENE	ADCY6	adenylate cyclase 6	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209195_s_at	129	0.751938	0.0843661	-	-0.563565	0.708329	-0.12846	0.88 [0.45 - 1.72]
GENE	ADCY6	adenylate cyclase 6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34797	56	0.821429	0.156052	-	-0.746464	0.411545	-0.629005	0.53 [0.12 - 2.39]
GENE	ADCY6	adenylate cyclase 6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28074	56	0.875	0.0231519	0.296856	0.958683	0.449613	0.240724	1.27 [0.68 - 2.37]
GENE	ADCY6	adenylate cyclase 6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34797	56	0.767857	0.10455	-	-0.843798	0.370643	-0.700984	0.50 [0.11 - 2.30]
GENE	ADCY6	adenylate cyclase 6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28074	56	0.107143	0.0914278	-	-0.919372	0.837031	0.065371	1.07 [0.57 - 1.99]
GENE	ADCY6	adenylate cyclase 6	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209195_s_at	278	0.151079	0.064956	-	0.578744	0.922753	0.0208497	1.02 [0.67 - 1.56]
GENE	ADCY6	adenylate cyclase 6	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209195_s_at	133	0.729323	0.0961375	-	-0.536595	0.111171	-0.389088	0.68 [0.42 - 1.09]
GENE	ADCY6	adenylate cyclase 6	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11842	81	0.320988	0.0756871	-	1.10989	0.731552	0.172078	1.19 [0.44 - 3.17]
GENE	ADCY6	adenylate cyclase 6	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209195_s_at	185	0.659459	0.0296927	0.351825	0.394362	0.103251	0.470763	1.60 [0.91 - 2.82]
GENE	ADCY6	adenylate cyclase 6	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209195_s_at	185	0.291892	0.0198691	0.266706	0.421197	0.08383	0.458677	1.58 [0.94 - 2.66]
GENE	ADCY6	adenylate cyclase 6	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P501547	110	0.363636	0.272231	-	0.345764	0.986584	-0.00398321	1.00 [0.63 - 1.58]
GENE	ADCY6	adenylate cyclase 6	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P501547	110	0.890909	0.185108	-	-0.560356	0.657608	-0.0807702	0.92 [0.65 - 1.32]
GENE	ADCY6	adenylate cyclase 6	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209195_s_at	80	0.25	0.106669	-	-0.805925	0.966575	0.0243103	1.02 [0.33 - 3.19]
GENE	ADCY6	adenylate cyclase 6	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209195_s_at	38	0.631579	0.0263668	0.324648	1.05354	0.0752905	0.922003	2.51 [0.91 - 6.94]
GENE	ADCY6	adenylate cyclase 6	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209195_s_at	140	0.385714	1.97244e-05	0.000824895	-1.2172	0.00787721	-1.08194	0.34 [0.15 - 0.75]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY7	adenylate cyclase 7	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203741_s_at	30	0.633333	0.0962548	-	-0.718259	0.584238	-0.148166	0.86 [0.51 - 1.47]
GENE	ADCY7	adenylate cyclase 7	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1655935	165	0.824242	0.00206852	0.0465624	0.830491	0.00547089	0.869835	2.39 [1.29 - 4.41]
GENE	ADCY7	adenylate cyclase 7	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1655935	165	0.581818	0.000476364	0.0135956	1.25436	0.000589136	1.37662	3.96 [1.81 - 8.69]
GENE	ADCY7	adenylate cyclase 7	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203741_s_at	163	0.349693	0.258723	-	-0.227641	0.737464	-0.0395063	0.96 [0.76 - 1.21]
GENE	ADCY7	adenylate cyclase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554827_a_at	79	0.265823	0.0561586	-	0.695875	0.909806	0.0376911	1.04 [0.54 - 1.99]
GENE	ADCY7	adenylate cyclase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203741_s_at	79	0.113924	0.151875	-	0.832034	0.537759	0.107608	1.11 [0.79 - 1.57]
GENE	ADCY7	adenylate cyclase 7	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203741_s_at	58	0.827586	0.257892	-	-0.434372	0.943059	0.0128228	1.01 [0.71 - 1.44]
GENE	ADCY7	adenylate cyclase 7	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203741_s_at	34	0.117647	0.175708	-	-0.730726	0.896789	-0.0398091	0.96 [0.53 - 1.75]
GENE	ADCY7	adenylate cyclase 7	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203741_s_at	158	0.101266	0.287101	-	0.4874	0.730225	0.087241	1.09 [0.66 - 1.79]
GENE	ADCY7	adenylate cyclase 7	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203741_s_at	53	0.849057	0.0618788	-	-1.28	0.355849	-0.316137	0.73 [0.37 - 1.43]
GENE	ADCY7	adenylate cyclase 7	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203741_s_at	53	0.811321	0.0633405	-	-0.953945	0.261368	-0.37515	0.69 [0.36 - 1.32]
GENE	ADCY7	adenylate cyclase 7	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203741_s_at	180	0.122222	0.0230742	0.296165	-0.618338	0.0596257	-0.485804	0.62 [0.37 - 1.02]
GENE	ADCY7	adenylate cyclase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203741_s_at	559	0.382826	0.053009	-	0.419603	0.586732	0.132187	1.14 [0.71 - 1.84]
GENE	ADCY7	adenylate cyclase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554827_a_at	559	0.29517	0.0921355	-	-0.351875	0.861355	-0.0235436	0.98 [0.75 - 1.27]
GENE	ADCY7	adenylate cyclase 7	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203741_s_at	77	0.272727	0.114207	-	-0.454218	0.99865	-0.000530076	1.00 [0.54 - 1.85]
GENE	ADCY7	adenylate cyclase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554827_a_at	70	0.385714	0.0292929	0.348636	-0.594035	0.217436	-1.17241	0.31 [0.05 - 2.00]
GENE	ADCY7	adenylate cyclase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203741_s_at	70	0.171429	0.00823831	0.1394	-0.846438	0.0896151	-0.305711	0.74 [0.52 - 1.05]
GENE	ADCY7	adenylate cyclase 7	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40585_at	50	0.88	0.0609075	-	-1.29594	0.192757	-0.794647	0.45 [0.14 - 1.49]
GENE	ADCY7	adenylate cyclase 7	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203741_s_at	74	0.121622	0.132104	-	-0.580498	0.597008	-0.203513	0.82 [0.38 - 1.73]
GENE	ADCY7	adenylate cyclase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554827_a_at	67	0.38806	0.0651024	-	1.73528	0.268988	1.96824	7.16 [0.22 - 234.67]
GENE	ADCY7	adenylate cyclase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203741_s_at	67	0.19403	0.127556	-	-1.00542	0.72848	-0.229933	0.79 [0.22 - 2.91]
GENE	ADCY7	adenylate cyclase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203741_s_at	115	0.113043	0.0288597	0.345158	-1.22031	0.330409	-0.503137	0.60 [0.22 - 1.67]
GENE	ADCY7	adenylate cyclase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554827_a_at	115	0.817391	0.0663142	-	-15.3479	0.787262	0.0952061	1.10 [0.55 - 2.20]
GENE	ADCY7	adenylate cyclase 7	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40585_at	158	0.208861	0.0625581	-	-0.583742	0.887196	0.0422037	1.04 [0.58 - 1.87]
GENE	ADCY7	adenylate cyclase 7	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40585_at	76	0.776316	0.106205	-	-1.52412	0.902735	-0.0407917	0.96 [0.50 - 1.85]
GENE	ADCY7	adenylate cyclase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554827_a_at	204	0.397059	0.0849934	-	-0.244016	0.613676	-0.0457254	0.96 [0.80 - 1.14]
GENE	ADCY7	adenylate cyclase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203741_s_at	204	0.568627	0.0337114	0.382787	0.300786	0.030319	0.271994	1.31 [1.03 - 1.68]
GENE	ADCY7	adenylate cyclase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554827_a_at	87	0.229885	0.0817806	-	1.01917	0.821868	-0.204248	0.82 [0.14 - 4.83]
GENE	ADCY7	adenylate cyclase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554827_a_at	87	0.229885	0.0817806	-	1.01917	0.821868	-0.204248	0.82 [0.14 - 4.83]
GENE	ADCY7	adenylate cyclase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203741_s_at	87	0.712644	0.0214794	0.281737	-1.31018	0.385709	-0.175201	0.84 [0.56 - 1.25]
GENE	ADCY7	adenylate cyclase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203741_s_at	87	0.712644	0.0214794	0.281737	-1.31018	0.385709	-0.175201	0.84 [0.56 - 1.25]
GENE	ADCY7	adenylate cyclase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554827_a_at	77	0.311688	0.137658	-	1.43786	0.881915	0.270895	1.31 [0.04 - 46.77]
GENE	ADCY7	adenylate cyclase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203741_s_at	77	0.896104	0.0198192	0.266232	1.47352	0.475373	0.364654	1.44 [0.53 - 3.92]
GENE	ADCY7	adenylate cyclase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203741_s_at	77	0.896104	0.0792053	-	1.10098	0.514915	0.290018	1.34 [0.56 - 3.20]
GENE	ADCY7	adenylate cyclase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554827_a_at	77	0.311688	0.0540395	-	1.7666	0.50187	1.06959	2.91 [0.13 - 66.11]
GENE	ADCY7	adenylate cyclase 7	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203741_s_at	136	0.889706	0.0143082	0.210626	1.20546	0.618646	0.182564	1.20 [0.58 - 2.46]
GENE	ADCY7	adenylate cyclase 7	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203741_s_at	200	0.85	0.238424	-	-0.552071	0.612051	-0.174329	0.84 [0.43 - 1.65]
GENE	ADCY7	adenylate cyclase 7	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18176	60	0.116667	0.236472	-	1.14218	0.659485	0.0987243	1.10 [0.71 - 1.71]
GENE	ADCY7	adenylate cyclase 7	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18176	60	0.2	0.0532663	-	1.31872	0.359583	0.281883	1.33 [0.73 - 2.42]
GENE	ADCY7	adenylate cyclase 7	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21595	155	0.116129	4.38564e-05	0.0016871	-1.22406	0.103647	-0.38208	0.68 [0.43 - 1.08]
GENE	ADCY7	adenylate cyclase 7	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203741_s_at	286	0.125874	0.051487	-	0.700883	0.310343	0.178887	1.20 [0.85 - 1.69]
GENE	ADCY7	adenylate cyclase 7	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203741_s_at	159	0.899371	0.258824	-	-0.797883	0.851192	-0.0730188	0.93 [0.43 - 1.99]
GENE	ADCY7	adenylate cyclase 7	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203741_s_at	159	0.427673	0.206737	-	-0.39717	0.702651	0.147124	1.16 [0.54 - 2.47]
GENE	ADCY7	adenylate cyclase 7	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203741_s_at	159	0.849057	0.20184	-	-0.904226	0.974241	0.0147476	1.01 [0.41 - 2.48]
GENE	ADCY7	adenylate cyclase 7	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203741_s_at	54	0.222222	0.20191	-	15.3007	0.668646	0.253349	1.29 [0.40 - 4.11]
GENE	ADCY7	adenylate cyclase 7	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203741_s_at	117	0.641026	0.217613	-	-0.433591	0.934442	0.0169206	1.02 [0.68 - 1.52]
GENE	ADCY7	adenylate cyclase 7	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203741_s_at	117	0.641026	0.105309	-	-0.729378	0.849255	-0.0468295	0.95 [0.59 - 1.55]
GENE	ADCY7	adenylate cyclase 7	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203741_s_at	117	0.641026	0.125129	-	-0.702505	0.794411	0.0664474	1.07 [0.65 - 1.76]
GENE	ADCY7	adenylate cyclase 7	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203741_s_at	117	0.641026	0.217613	-	-0.433591	0.934442	0.0169206	1.02 [0.68 - 1.52]
GENE	ADCY7	adenylate cyclase 7	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203741_s_at	236	0.173729	0.000176965	0.00577711	-1.04864	0.0766547	-0.482561	0.62 [0.36 - 1.05]
GENE	ADCY7	adenylate cyclase 7	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203741_s_at	249	0.144578	0.0011587	0.0288292	-0.821834	0.264966	-0.25083	0.78 [0.50 - 1.21]
GENE	ADCY7	adenylate cyclase 7	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203741_s_at	125	0.832	0.0126317	0.192196	-1.62207	0.826805	-0.0461656	0.95 [0.63 - 1.44]
GENE	ADCY7	adenylate cyclase 7	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203741_s_at	54	0.12963	0.0157874	0.226248	-1.37716	0.525978	-0.119316	0.89 [0.61 - 1.28]
GENE	ADCY7	adenylate cyclase 7	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203741_s_at	62	0.112903	0.05025	-	-1.06363	0.325167	-0.158919	0.85 [0.62 - 1.17]
GENE	ADCY7	adenylate cyclase 7	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203741_s_at	125	0.832	0.0110172	0.173628	-15.3447	0.181943	-0.387795	0.68 [0.38 - 1.20]
GENE	ADCY7	adenylate cyclase 7	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203741_s_at	198	0.878788	0.0160292	0.228749	-1.0594	0.613134	0.0620178	1.06 [0.84 - 1.35]
GENE	ADCY7	adenylate cyclase 7	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203741_s_at	198	0.252525	0.00943636	0.154547	0.947925	0.284489	0.167464	1.18 [0.87 - 1.61]
GENE	ADCY7	adenylate cyclase 7	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203741_s_at	198	0.252525	0.0128311	0.194432	0.967736	0.304558	0.16922	1.18 [0.86 - 1.64]
GENE	ADCY7	adenylate cyclase 7	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203741_s_at	62	0.854839	0.118462	-	-15.2987	0.337579	-0.557489	0.57 [0.18 - 1.79]
GENE	ADCY7	adenylate cyclase 7	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203741_s_at	51	0.176471	0.164255	-	-1.19941	0.521179	-0.569468	0.57 [0.10 - 3.22]
GENE	ADCY7	adenylate cyclase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203741_s_at	177	0.271186	0.000153232	0.00509413	1.7406	0.00372656	0.606883	1.83 [1.22 - 2.76]
GENE	ADCY7	adenylate cyclase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554827_a_at	177	0.824859	0.0579611	-	-0.737336	0.519899	-0.450889	0.64 [0.16 - 2.52]
GENE	ADCY7	adenylate cyclase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554827_a_at	177	0.813559	0.0760271	-	-0.810851	0.744916	-0.262824	0.77 [0.16 - 3.75]
GENE	ADCY7	adenylate cyclase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203741_s_at	177	0.271186	0.000469651	0.0134316	1.17826	0.0161653	0.426243	1.53 [1.08 - 2.17]
GENE	ADCY7	adenylate cyclase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554827_a_at	145	0.627586	0.0064577	0.115581	-1.15483	0.286408	-1.02972	0.36 [0.05 - 2.37]
GENE	ADCY7	adenylate cyclase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203741_s_at	145	0.262069	0.000964504	0.0247238	2.03415	0.0025164	0.789457	2.20 [1.32 - 3.68]
GENE	ADCY7	adenylate cyclase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554827_a_at	226	0.858407	0.0817223	-	-0.881704	0.391305	-0.16666	0.85 [0.58 - 1.24]
GENE	ADCY7	adenylate cyclase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203741_s_at	226	0.486726	0.0042578	0.0833578	0.856964	0.00579051	0.664805	1.94 [1.21 - 3.12]
GENE	ADCY7	adenylate cyclase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554827_a_at	49	0.204082	0.0438893	0.453543	-1.12239	0.246154	-2.00638	0.13 [0.00 - 3.99]
GENE	ADCY7	adenylate cyclase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554827_a_at	55	0.218182	0.0448578	0.45978	-0.909887	0.317994	-1.43634	0.24 [0.01 - 3.99]
GENE	ADCY7	adenylate cyclase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203741_s_at	55	0.472727	0.0209158	0.276531	1.13339	0.0650926	0.504107	1.66 [0.97 - 2.83]
GENE	ADCY7	adenylate cyclase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203741_s_at	55	0.472727	0.0918544	-	0.892827	0.322763	0.297106	1.35 [0.75 - 2.43]
GENE	ADCY7	adenylate cyclase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203741_s_at	49	0.489796	0.0866298	-	1.08805	0.342714	0.34449	1.41 [0.69 - 2.88]
GENE	ADCY7	adenylate cyclase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554827_a_at	55	0.109091	0.0508789	-	-1.1112	0.315763	-1.54991	0.21 [0.01 - 4.39]
GENE	ADCY7	adenylate cyclase 7	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	242806	34	0.882353	0.00127343	0.0311908	1.67414	0.0392716	2.70177	14.91 [1.14 - 194.56]
GENE	ADCY7	adenylate cyclase 7	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	512133	34	0.352941	0.240198	-	0.562593	0.390241	0.36787	1.44 [0.62 - 3.34]
GENE	ADCY7	adenylate cyclase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203741_s_at	63	0.31746	0.0329203	0.376843	0.875587	0.61259	0.0854209	1.09 [0.78 - 1.52]
GENE	ADCY7	adenylate cyclase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554827_a_at	63	0.174603	5.51564e-06	0.000260274	-1.60625	0.00193389	-58.3509	0.00 [0.00 - 0.00]
GENE	ADCY7	adenylate cyclase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557254_3p_at	28	0.607143	0.152749	-	0.757916	0.497614	0.160737	1.17 [0.74 - 1.87]
GENE	ADCY7	adenylate cyclase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.172199.2.S1_3p_s_at	28	0.321429	0.00380449	0.0762162	-1.6242	0.0698172	-18.9016	0.00 [0.00 - 4.63]
GENE	ADCY7	adenylate cyclase 7	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203741_s_at	82	0.560976	0.00101941	0.0258994	1.11883	0.121063	0.615589	1.85 [0.85 - 4.03]
GENE	ADCY7	adenylate cyclase 7	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40585_at	84	0.238095	0.0305409	0.358523	0.860731	0.70625	0.0956737	1.10 [0.67 - 1.81]
GENE	ADCY7	adenylate cyclase 7	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203741_s_at	79	0.101266	0.142637	-	0.74323	0.968857	0.0100548	1.01 [0.61 - 1.67]
GENE	ADCY7	adenylate cyclase 7	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D25538_at	86	0.22093	0.00726926	0.12665	-1.09934	0.0251842	-0.670532	0.51 [0.28 - 0.92]
GENE	ADCY7	adenylate cyclase 7	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203741_s_at	104	0.605769	0.0456913	0.465083	-0.719618	0.253934	-0.374357	0.69 [0.36 - 1.31]
GENE	ADCY7	adenylate cyclase 7	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P106945	117	0.675214	0.0016488	0.0386414	-1.21172	0.0118389	-0.517981	0.60 [0.40 - 0.89]
GENE	ADCY7	adenylate cyclase 7	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P416177	117	0.649573	0.00622376	0.112317	-0.936517	0.0263829	-0.385504	0.68 [0.48 - 0.96]
GENE	ADCY7	adenylate cyclase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203741_s_at	204	0.137255	0.0061413	0.111159	-1.08314	0.219106	-0.506687	0.60 [0.27 - 1.35]
GENE	ADCY7	adenylate cyclase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554827_a_at	204	0.151961	0.0455744	0.464343	1.78783	0.865398	-0.0354963	0.97 [0.64 - 1.45]
GENE	ADCY7	adenylate cyclase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554827_a_at	204	0.294118	0.0879367	-	-0.472648	0.843181	-0.0309868	0.97 [0.71 - 1.32]
GENE	ADCY7	adenylate cyclase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203741_s_at	204	0.79902	0.141767	-	-0.586887	0.806473	-0.0813807	0.92 [0.48 - 1.77]
GENE	ADCY7	adenylate cyclase 7	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203741_s_at	178	0.179775	0.0169575	0.238223	-0.542605	0.216196	-0.248111	0.78 [0.53 - 1.16]
GENE	ADCY7	adenylate cyclase 7	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300019294	41	0.146341	0.112193	-	-0.789794	0.055633	-0.68135	0.51 [0.25 - 1.02]
GENE	ADCY7	adenylate cyclase 7	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200008033	41	0.146341	0.0243239	0.307174	-1.06456	0.142722	-0.240318	0.79 [0.57 - 1.08]
GENE	ADCY7	adenylate cyclase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554827_a_at	111	0.765766	0.00389439	0.077649	0.790505	0.0200135	0.638442	1.89 [1.11 - 3.24]
GENE	ADCY7	adenylate cyclase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203741_s_at	111	0.162162	0.032049	0.370212	-0.686843	0.308637	-0.276614	0.76 [0.45 - 1.29]
GENE	ADCY7	adenylate cyclase 7	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203741_s_at	90	0.611111	0.214597	-	0.401348	0.872974	-0.0486224	0.95 [0.52 - 1.73]
GENE	ADCY7	adenylate cyclase 7	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203741_s_at	90	0.611111	0.372846	-	0.331638	0.748227	-0.1125	0.89 [0.45 - 1.78]
GENE	ADCY7	adenylate cyclase 7	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1309	50	0.38	0.180654	-	0.743215	0.418215	0.39819	1.49 [0.57 - 3.91]
GENE	ADCY7	adenylate cyclase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203741_s_at	138	0.173913	0.19513	-	0.461869	0.50239	0.0844856	1.09 [0.85 - 1.39]
GENE	ADCY7	adenylate cyclase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554827_a_at	138	0.173913	0.00208912	0.0469418	-0.812896	0.0479389	-24.7615	0.00 [0.00 - 0.80]
GENE	ADCY7	adenylate cyclase 7	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203741_s_at	129	0.496124	0.0910237	-	-0.419491	0.486782	-0.183632	0.83 [0.50 - 1.40]
GENE	ADCY7	adenylate cyclase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	876	56	0.196429	0.173776	-	0.647807	0.8504	0.0349392	1.04 [0.72 - 1.49]
GENE	ADCY7	adenylate cyclase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6364	56	0.875	0.0230264	0.295739	1.22017	0.617676	-0.162054	0.85 [0.45 - 1.61]
GENE	ADCY7	adenylate cyclase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	876	56	0.892857	0.180215	-	-0.948057	0.827995	0.0437299	1.04 [0.70 - 1.55]
GENE	ADCY7	adenylate cyclase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8410	56	0.357143	0.198904	-	0.466335	0.735865	0.0699498	1.07 [0.71 - 1.61]
GENE	ADCY7	adenylate cyclase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6364	56	0.660714	0.0803049	-	-0.702024	0.684522	-0.120574	0.89 [0.50 - 1.59]
GENE	ADCY7	adenylate cyclase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8410	56	0.875	0.116315	-	0.859937	0.728578	0.0785138	1.08 [0.69 - 1.69]
GENE	ADCY7	adenylate cyclase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554827_a_at	278	0.446043	0.00324528	0.067105	-0.55049	0.0819897	-0.776334	0.46 [0.19 - 1.10]
GENE	ADCY7	adenylate cyclase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203741_s_at	278	0.392086	0.00318767	0.0661454	0.599427	0.0747071	0.200037	1.22 [0.98 - 1.52]
GENE	ADCY7	adenylate cyclase 7	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203741_s_at	133	0.218045	9.98451e-05	0.00349752	-0.964952	0.00129265	-0.360149	0.70 [0.56 - 0.87]
GENE	ADCY7	adenylate cyclase 7	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15207	81	0.691358	0.0793598	-	-1.25756	0.318617	-0.532177	0.59 [0.21 - 1.67]
GENE	ADCY7	adenylate cyclase 7	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10561	81	0.296296	0.0837036	-	1.2351	0.151509	0.600863	1.82 [0.80 - 4.15]
GENE	ADCY7	adenylate cyclase 7	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203741_s_at	185	0.324324	0.0784291	-	0.312556	0.20401	0.26173	1.30 [0.87 - 1.95]
GENE	ADCY7	adenylate cyclase 7	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203741_s_at	185	0.827027	0.047365	0.475564	0.426542	0.139439	0.327338	1.39 [0.90 - 2.14]
GENE	ADCY7	adenylate cyclase 7	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P416177	110	0.181818	0.0435515	0.45135	1.0159	0.119841	0.289745	1.34 [0.93 - 1.92]
GENE	ADCY7	adenylate cyclase 7	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106945	110	0.427273	0.00725667	0.126481	0.631116	0.0764148	0.528955	1.70 [0.95 - 3.05]
GENE	ADCY7	adenylate cyclase 7	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P416177	110	0.527273	0.110293	-	0.365672	0.675942	0.0602984	1.06 [0.80 - 1.41]
GENE	ADCY7	adenylate cyclase 7	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106945	110	0.427273	0.00107989	0.0271804	1.02603	0.0320546	0.76428	2.15 [1.07 - 4.32]
GENE	ADCY7	adenylate cyclase 7	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203741_s_at	80	0.2875	0.0265895	0.326515	1.50924	0.429043	0.210101	1.23 [0.73 - 2.08]
GENE	ADCY7	adenylate cyclase 7	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_5879	281	0.298932	0.195197	-	-0.19337	0.662026	-0.0394103	0.96 [0.81 - 1.15]
GENE	ADCY7	adenylate cyclase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554827_a_at	38	0.131579	0.018089	0.249504	-1.33096	0.31477	-0.695482	0.50 [0.13 - 1.94]
GENE	ADCY7	adenylate cyclase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203741_s_at	38	0.789474	0.0115961	0.180386	-15.4987	0.622617	-0.106538	0.90 [0.59 - 1.37]
GENE	ADCY7	adenylate cyclase 7	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203741_s_at	140	0.392857	0.0539576	-	-0.551368	0.40642	-0.14527	0.86 [0.61 - 1.22]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206811_at	30	0.5	0.172089	-	-0.551753	0.434378	-0.625078	0.54 [0.11 - 2.57]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1672938	165	0.715151	0.0903583	-	-0.502207	0.272366	-1.13001	0.32 [0.04 - 2.43]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1672938	165	0.115152	0.313502	-	0.720619	0.637341	-0.667584	0.51 [0.03 - 8.23]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206811_at	163	0.582822	0.347955	-	0.184861	0.967782	0.02736	1.03 [0.27 - 3.88]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206811_at	79	0.101266	0.0770444	-	-0.71366	0.418949	-0.627343	0.53 [0.12 - 2.44]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206811_at	58	0.224138	0.00415271	0.0817202	0.954979	0.13035	0.187108	1.21 [0.95 - 1.54]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206811_at	34	0.117647	0.0305325	0.358457	-1.17769	0.277627	-0.269004	0.76 [0.47 - 1.24]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206811_at	158	0.670886	0.00566485	0.104376	0.634372	0.107085	1.08844	2.97 [0.79 - 11.16]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206811_at	53	0.188679	0.278726	-	-0.456531	0.70803	-0.0867805	0.92 [0.58 - 1.44]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206811_at	53	0.377358	0.410485	-	0.327335	0.920971	-0.0249283	0.98 [0.60 - 1.60]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206811_at	180	0.416667	0.0153579	0.22177	0.535415	0.373359	0.0961038	1.10 [0.89 - 1.36]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206811_at	559	0.855098	0.258587	-	-0.374627	0.891577	-0.0182136	0.98 [0.76 - 1.28]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206811_at	77	0.324675	0.0209605	0.276946	-0.608167	0.0416275	-0.291346	0.75 [0.56 - 0.99]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206811_at	70	0.285714	0.00832529	0.140521	0.822386	0.0101083	0.431022	1.54 [1.11 - 2.14]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36246_at	50	0.42	0.0722669	-	-0.632576	0.548591	-0.163276	0.85 [0.50 - 1.45]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206811_at	74	0.364865	0.0203259	0.271019	-0.687157	0.185433	-0.247727	0.78 [0.54 - 1.13]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206811_at	67	0.462687	0.0096044	0.156621	2.32335	0.0180417	5.5755	263.88 [2.60 - 26813.76]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206811_at	115	0.791304	0.176323	-	-1.30837	0.654093	-0.186637	0.83 [0.37 - 1.88]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36246_at	158	0.835443	0.0519845	-	0.628723	0.151052	0.259369	1.30 [0.91 - 1.85]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36246_at	76	0.434211	0.0142367	0.209856	1.66481	0.308483	0.347543	1.42 [0.73 - 2.76]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206811_at	204	0.416667	0.279379	-	0.156683	0.830473	0.0162538	1.02 [0.88 - 1.18]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206811_at	87	0.885057	0.0275097	0.334158	-15.2635	0.478151	-0.411131	0.66 [0.21 - 2.06]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206811_at	87	0.885057	0.0275097	0.334158	-15.2635	0.478151	-0.411131	0.66 [0.21 - 2.06]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206811_at	77	0.142857	0.0604406	-	-1.07663	0.697502	-0.301806	0.74 [0.16 - 3.39]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206811_at	77	0.142857	0.00917455	0.15129	-1.53145	0.412722	-1.00202	0.37 [0.03 - 4.04]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206811_at	136	0.169118	0.194739	-	0.950309	0.652282	0.101491	1.11 [0.71 - 1.72]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206811_at	200	0.895	2.33045e-05	0.00095829	1.3644	0.527344	0.10679	1.11 [0.80 - 1.55]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21717	60	0.733333	0.154434	-	-0.687597	0.877504	-0.0397494	0.96 [0.58 - 1.59]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21717	60	0.183333	0.000195268	0.00629472	-1.50835	0.501276	-0.178885	0.84 [0.50 - 1.41]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7407	155	0.16129	0.000403277	0.0117874	-1.00159	0.00226614	-0.265643	0.77 [0.65 - 0.91]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206811_at	286	0.213287	8.19157e-05	0.00293714	-0.792625	0.00699216	-0.327711	0.72 [0.57 - 0.91]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206811_at	159	0.383648	0.00257894	0.0557349	1.18427	0.056456	0.372973	1.45 [0.99 - 2.13]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206811_at	159	0.383648	0.0115419	0.179758	1.17363	0.0478261	0.468828	1.60 [1.00 - 2.54]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206811_at	159	0.383648	0.0497366	0.490041	0.702265	0.148317	0.275634	1.32 [0.91 - 1.91]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206811_at	54	0.351852	0.0607363	-	1.76891	0.848416	-0.231975	0.79 [0.07 - 8.56]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206811_at	117	0.606838	0.0993821	-	0.516626	0.889815	-0.0630167	0.94 [0.38 - 2.29]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206811_at	117	0.461538	0.11885	-	0.621145	0.920698	0.0498261	1.05 [0.39 - 2.80]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206811_at	117	0.410256	0.0913862	-	0.730604	0.589435	0.246433	1.28 [0.52 - 3.13]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206811_at	117	0.606838	0.0993821	-	0.516626	0.889815	-0.0630167	0.94 [0.38 - 2.29]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206811_at	236	0.495763	0.202596	-	0.344673	0.904521	-0.0242874	0.98 [0.66 - 1.45]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206811_at	249	0.285141	0.192749	-	-0.288144	0.821789	-0.0347468	0.97 [0.71 - 1.31]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206811_at	62	0.870968	0.0157441	0.225798	-15.572	0.537058	-0.181438	0.83 [0.47 - 1.48]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206811_at	125	0.112	0.0880131	-	-0.767142	0.294948	-1.14158	0.32 [0.04 - 2.70]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206811_at	125	0.12	0.0525781	-	-0.678568	0.3804	-0.594253	0.55 [0.15 - 2.08]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206811_at	54	0.851852	0.0350815	0.392918	-15.6309	0.648414	-0.160775	0.85 [0.43 - 1.70]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206811_at	198	0.717172	0.076463	-	-0.562949	0.918021	0.00930207	1.01 [0.85 - 1.20]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206811_at	198	0.717172	0.166612	-	-0.447468	0.957626	0.00498042	1.00 [0.84 - 1.21]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206811_at	198	0.555556	0.10922	-	-0.346936	0.663241	-0.0316255	0.97 [0.84 - 1.12]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206811_at	51	0.784314	0.217208	-	-15.4333	0.55343	-0.735193	0.48 [0.04 - 5.45]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206811_at	62	0.870968	0.129698	-	-15.2892	0.575977	-0.442937	0.64 [0.14 - 3.03]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206811_at	145	0.675862	0.0849709	-	-0.678503	0.214873	-1.04879	0.35 [0.07 - 1.84]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206811_at	177	0.101695	0.0122561	0.187953	-0.893159	0.0364737	-1.37049	0.25 [0.07 - 0.92]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206811_at	177	0.627119	0.0422953	0.443106	-0.519685	0.0440355	-1.15307	0.32 [0.10 - 0.97]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206811_at	226	0.207965	0.0698982	-	-0.554693	0.307164	-0.118417	0.89 [0.71 - 1.12]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206811_at	55	0.236364	0.00764591	0.131662	-1.16124	0.0275252	-2.70503	0.07 [0.01 - 0.74]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206811_at	55	0.618182	0.0748673	-	-0.956198	0.213542	-1.51843	0.22 [0.02 - 2.40]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206811_at	49	0.204082	0.0671086	-	-1.08169	0.218399	-2.00823	0.13 [0.01 - 3.29]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206811_at	63	0.52381	0.00637515	0.114433	-0.944561	0.632676	-1.19366	0.30 [0.00 - 40.50]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557256_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.0834913	-3.92229	0.02 [0.00 - 1.68]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206811_at	82	0.804878	0.0109319	0.172622	0.928201	0.174549	0.878371	2.41 [0.68 - 8.55]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206811_at	79	0.848101	0.291237	-	-0.399344	0.82413	-0.107759	0.90 [0.35 - 2.32]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206811_at	104	0.528846	0.0148713	0.21664	-0.833364	0.763389	0.183665	1.20 [0.36 - 3.97]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206811_at	204	0.779412	0.00649145	0.116049	0.977206	0.51664	0.117561	1.12 [0.79 - 1.60]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206811_at	204	0.622549	0.0106215	0.16894	0.683332	0.46579	0.0986562	1.10 [0.85 - 1.44]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206811_at	178	0.55618	0.115084	-	0.310028	0.654157	0.166685	1.18 [0.57 - 2.45]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206811_at	111	0.666667	0.145794	-	-0.433445	0.48759	-0.091899	0.91 [0.70 - 1.18]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206811_at	90	0.111111	0.00764683	0.131675	15.3029	0.593574	0.195707	1.22 [0.59 - 2.50]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206811_at	90	0.111111	0.0252781	0.315414	15.2734	0.601844	0.220442	1.25 [0.54 - 2.85]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206811_at	138	0.891304	0.0982141	-	0.561341	0.124709	0.160311	1.17 [0.96 - 1.44]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206811_at	129	0.472868	0.00527684	0.0987361	-0.687681	0.0482875	-0.335255	0.72 [0.51 - 1.00]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7714	56	0.482143	0.0418034	0.43984	0.742858	0.637452	0.059618	1.06 [0.83 - 1.36]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36018	56	0.107143	0.185454	-	0.933353	0.947401	-0.00540383	0.99 [0.85 - 1.17]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7714	56	0.464286	0.0148801	0.216734	0.851837	0.583903	0.0652363	1.07 [0.85 - 1.35]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36018	56	0.625	0.181909	-	0.470212	0.898825	0.0106577	1.01 [0.86 - 1.19]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206811_at	278	0.68705	0.195176	-	-0.273114	0.954305	0.00460507	1.00 [0.86 - 1.18]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206811_at	133	0.503759	3.09211e-05	0.00123479	0.991297	0.986586	0.00331397	1.00 [0.68 - 1.48]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7182	81	0.444444	0.0973087	-	-0.860494	0.268081	-0.253368	0.78 [0.50 - 1.22]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206811_at	185	0.410811	0.0553726	-	-0.310891	0.512623	-0.131939	0.88 [0.59 - 1.30]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206811_at	185	0.410811	0.0541843	-	-0.339262	0.645886	-0.100703	0.90 [0.59 - 1.39]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P169993	110	0.109091	0.0305452	0.358557	0.964954	0.67873	-0.0270807	0.97 [0.86 - 1.11]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P169993	110	0.136364	0.0597615	-	1.07949	0.446563	-0.0652025	0.94 [0.79 - 1.11]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206811_at	80	0.85	0.0372272	0.408381	-1.88015	0.20894	-0.206185	0.81 [0.59 - 1.12]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1256	281	0.263345	0.145255	-	0.233027	0.814934	0.0214797	1.02 [0.85 - 1.22]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206811_at	38	0.5	0.00108465	0.0272808	-1.58732	0.747293	-0.114894	0.89 [0.44 - 1.79]
GENE	ADCY8	adenylate cyclase 8 (brain)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206811_at	140	0.221429	0.000777121	0.0206108	-0.973766	0.059728	-1.72194	0.18 [0.03 - 1.07]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADCY9	adenylate cyclase 9	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204497_at	30	0.766667	0.148073	-	-0.77187	0.506063	-0.200001	0.82 [0.45 - 1.48]
GENE	ADCY9	adenylate cyclase 9	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215400_x_at	30	0.666667	0.0899274	-	0.70284	0.468044	0.707286	2.03 [0.30 - 13.70]
GENE	ADCY9	adenylate cyclase 9	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204498_s_at	30	0.266667	0.0492816	0.487297	-0.918172	0.844521	-0.16219	0.85 [0.17 - 4.30]
GENE	ADCY9	adenylate cyclase 9	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1654287	165	0.824242	0.163077	-	-0.501665	0.604061	-0.0958503	0.91 [0.63 - 1.31]
GENE	ADCY9	adenylate cyclase 9	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1654287	165	0.660606	0.316103	-	0.359354	0.566244	0.154158	1.17 [0.69 - 1.98]
GENE	ADCY9	adenylate cyclase 9	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204497_at	163	0.257669	0.204934	-	0.303755	0.863904	0.0246146	1.02 [0.77 - 1.36]
GENE	ADCY9	adenylate cyclase 9	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204498_s_at	163	0.153374	0.0157093	0.225437	-0.624538	0.653588	-0.283062	0.75 [0.22 - 2.59]
GENE	ADCY9	adenylate cyclase 9	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215400_x_at	163	0.116564	0.00347885	0.0709541	-0.804497	0.102742	-0.968663	0.38 [0.12 - 1.22]
GENE	ADCY9	adenylate cyclase 9	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204498_s_at	79	0.886076	0.00611544	0.110794	1.03039	0.455819	-0.57332	0.56 [0.12 - 2.54]
GENE	ADCY9	adenylate cyclase 9	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204497_at	79	0.379747	0.0986399	-	0.533083	0.669033	0.0774267	1.08 [0.76 - 1.54]
GENE	ADCY9	adenylate cyclase 9	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215400_x_at	79	0.291139	0.0722582	-	-0.539085	0.187253	-1.12059	0.33 [0.06 - 1.72]
GENE	ADCY9	adenylate cyclase 9	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204498_s_at	58	0.551724	0.0616166	-	-0.513421	0.472445	-0.184387	0.83 [0.50 - 1.38]
GENE	ADCY9	adenylate cyclase 9	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204497_at	58	0.689655	0.0319017	0.369083	0.626889	0.467434	0.0705712	1.07 [0.89 - 1.30]
GENE	ADCY9	adenylate cyclase 9	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215400_x_at	58	0.103448	0.0153074	0.22124	1.20134	0.0558604	0.322475	1.38 [0.99 - 1.92]
GENE	ADCY9	adenylate cyclase 9	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215400_x_at	34	0.647059	0.0880588	-	-0.711115	0.194702	-0.339293	0.71 [0.43 - 1.19]
GENE	ADCY9	adenylate cyclase 9	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204498_s_at	34	0.647059	0.0824637	-	-0.763261	0.219436	-0.574385	0.56 [0.23 - 1.41]
GENE	ADCY9	adenylate cyclase 9	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204497_at	34	0.588235	0.272248	-	-0.432419	0.465897	-0.111402	0.89 [0.66 - 1.21]
GENE	ADCY9	adenylate cyclase 9	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204498_s_at	158	0.740506	0.147569	-	-0.414893	0.636397	-0.415363	0.66 [0.12 - 3.69]
GENE	ADCY9	adenylate cyclase 9	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215400_x_at	158	0.601266	0.00353809	0.0719201	0.664303	0.266645	0.751693	2.12 [0.56 - 7.99]
GENE	ADCY9	adenylate cyclase 9	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204497_at	158	0.379747	0.00792482	0.135327	-0.605664	0.120724	-0.745243	0.47 [0.19 - 1.22]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204497_at	53	0.226415	0.00875172	0.145969	-0.990488	0.276259	-0.202268	0.82 [0.57 - 1.18]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215400_x_at	53	0.622642	0.0140936	0.208312	0.825797	0.269938	0.322454	1.38 [0.78 - 2.45]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215400_x_at	53	0.584906	0.0206321	0.273888	0.832858	0.255626	0.358364	1.43 [0.77 - 2.65]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204498_s_at	53	0.867925	0.0365832	0.403791	-1.8532	0.350201	-0.411308	0.66 [0.28 - 1.57]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204497_at	53	0.226415	0.0390289	0.421005	-0.765205	0.604998	-0.093768	0.91 [0.64 - 1.30]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204498_s_at	53	0.867925	0.193208	-	-0.770068	0.485656	-0.291649	0.75 [0.33 - 1.70]
GENE	ADCY9	adenylate cyclase 9	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215400_x_at	180	0.644444	0.0291672	0.34763	0.45992	0.187079	0.152362	1.16 [0.93 - 1.46]
GENE	ADCY9	adenylate cyclase 9	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204497_at	180	0.2	0.0937504	-	-0.404355	0.299053	-0.128502	0.88 [0.69 - 1.12]
GENE	ADCY9	adenylate cyclase 9	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204498_s_at	180	0.727778	0.0385959	0.418001	0.449708	0.791615	0.0651604	1.07 [0.66 - 1.73]
GENE	ADCY9	adenylate cyclase 9	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204498_s_at	559	0.842576	0.0852935	-	0.457994	0.437306	0.123053	1.13 [0.83 - 1.54]
GENE	ADCY9	adenylate cyclase 9	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204497_at	559	0.175313	0.0825308	-	-0.404473	0.444469	-0.0579504	0.94 [0.81 - 1.09]
GENE	ADCY9	adenylate cyclase 9	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215400_x_at	559	0.128801	0.0620923	-	-0.492862	0.474372	-0.0949211	0.91 [0.70 - 1.18]
GENE	ADCY9	adenylate cyclase 9	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215400_x_at	77	0.636364	0.16764	-	-0.371322	0.639198	-0.0875459	0.92 [0.64 - 1.32]
GENE	ADCY9	adenylate cyclase 9	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204498_s_at	77	0.103896	0.155575	-	0.72098	0.970961	0.0117769	1.01 [0.54 - 1.91]
GENE	ADCY9	adenylate cyclase 9	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204497_at	77	0.116883	0.0963044	-	-0.63832	0.467469	-0.21115	0.81 [0.46 - 1.43]
GENE	ADCY9	adenylate cyclase 9	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204498_s_at	70	0.857143	0.0151353	0.21943	-1.01464	0.082884	-1.51096	0.22 [0.04 - 1.22]
GENE	ADCY9	adenylate cyclase 9	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204497_at	70	0.671429	0.0296422	0.351423	-0.635475	0.0874525	-0.490442	0.61 [0.35 - 1.07]
GENE	ADCY9	adenylate cyclase 9	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215400_x_at	70	0.142857	0.00333322	0.0685618	-1.03546	0.897925	-0.136848	0.87 [0.11 - 7.06]
GENE	ADCY9	adenylate cyclase 9	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33800_at	50	0.84	0.000657	0.0178794	1.44244	0.00176356	1.29352	3.65 [1.62 - 8.20]
GENE	ADCY9	adenylate cyclase 9	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204497_at	74	0.135135	0.0132279	0.198844	-0.902185	0.386878	-0.400574	0.67 [0.27 - 1.66]
GENE	ADCY9	adenylate cyclase 9	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215400_x_at	74	0.486486	0.0142349	0.209837	-0.710126	0.105778	-0.332839	0.72 [0.48 - 1.07]
GENE	ADCY9	adenylate cyclase 9	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204498_s_at	74	0.891892	0.180029	-	-0.781411	0.435088	-0.280126	0.76 [0.37 - 1.53]
GENE	ADCY9	adenylate cyclase 9	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204498_s_at	67	0.895522	0.00306779	0.0641353	1.9124	0.0797198	2.93089	18.74 [0.71 - 497.28]
GENE	ADCY9	adenylate cyclase 9	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204497_at	67	0.895522	0.0217817	0.284505	1.48572	0.164501	1.56382	4.78 [0.53 - 43.33]
GENE	ADCY9	adenylate cyclase 9	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215400_x_at	67	0.656716	0.19206	-	-1.29409	0.397767	-2.06989	0.13 [0.00 - 15.30]
GENE	ADCY9	adenylate cyclase 9	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204498_s_at	115	0.26087	0.034055	0.385348	-1.07895	0.165223	-1.12891	0.32 [0.07 - 1.59]
GENE	ADCY9	adenylate cyclase 9	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204497_at	115	0.46087	0.046152	0.467991	-1.11743	0.914157	-0.0349097	0.97 [0.51 - 1.82]
GENE	ADCY9	adenylate cyclase 9	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215400_x_at	115	0.565217	0.0206715	0.274256	-1.59195	0.0712719	-0.642275	0.53 [0.26 - 1.06]
GENE	ADCY9	adenylate cyclase 9	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33800_at	158	0.341772	0.361292	-	-0.263567	0.995882	-0.00113068	1.00 [0.65 - 1.53]
GENE	ADCY9	adenylate cyclase 9	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33800_at	76	0.736842	0.0460647	0.467441	0.995244	0.831448	0.0801381	1.08 [0.52 - 2.27]
GENE	ADCY9	adenylate cyclase 9	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204497_at	204	0.514706	0.000446365	0.0128594	-0.491165	0.0354683	-0.257544	0.77 [0.61 - 0.98]
GENE	ADCY9	adenylate cyclase 9	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215400_x_at	204	0.382353	0.0175806	0.24447	-0.341842	0.0872786	-0.167561	0.85 [0.70 - 1.02]
GENE	ADCY9	adenylate cyclase 9	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204498_s_at	204	0.29902	0.0382745	0.415758	-0.319834	0.0654279	-0.188163	0.83 [0.68 - 1.01]
GENE	ADCY9	adenylate cyclase 9	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215400_x_at	87	0.103448	0.100334	-	-0.792755	0.826135	-0.168323	0.85 [0.19 - 3.79]
GENE	ADCY9	adenylate cyclase 9	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204497_at	87	0.103448	0.00971139	0.157936	-1.13077	0.0472213	-0.44379	0.64 [0.41 - 0.99]
GENE	ADCY9	adenylate cyclase 9	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204498_s_at	87	0.16092	0.00502378	0.0949969	-1.13035	0.125627	-0.784778	0.46 [0.17 - 1.25]
GENE	ADCY9	adenylate cyclase 9	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204497_at	87	0.103448	0.00971139	0.157936	-1.13077	0.0472213	-0.44379	0.64 [0.41 - 0.99]
GENE	ADCY9	adenylate cyclase 9	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215400_x_at	87	0.103448	0.100334	-	-0.792755	0.826135	-0.168323	0.85 [0.19 - 3.79]
GENE	ADCY9	adenylate cyclase 9	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204498_s_at	87	0.16092	0.00502378	0.0949969	-1.13035	0.125627	-0.784778	0.46 [0.17 - 1.25]
GENE	ADCY9	adenylate cyclase 9	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204497_at	77	0.181818	0.0116871	0.181438	-1.34281	0.073299	-0.703941	0.49 [0.23 - 1.07]
GENE	ADCY9	adenylate cyclase 9	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215400_x_at	77	0.272727	0.0392176	0.422309	15.584	0.184709	2.20854	9.10 [0.35 - 237.95]
GENE	ADCY9	adenylate cyclase 9	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204498_s_at	77	0.168831	0.198108	-	-0.861533	0.975401	0.0197611	1.02 [0.29 - 3.58]
GENE	ADCY9	adenylate cyclase 9	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215400_x_at	77	0.272727	0.0172644	0.241311	15.5992	0.136788	2.1483	8.57 [0.51 - 145.23]
GENE	ADCY9	adenylate cyclase 9	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204497_at	77	0.181818	0.000867768	0.0226211	-1.84729	0.0613924	-0.84852	0.43 [0.18 - 1.04]
GENE	ADCY9	adenylate cyclase 9	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204498_s_at	77	0.818182	0.276095	-	-1.08046	0.879643	-0.0863263	0.92 [0.30 - 2.80]
GENE	ADCY9	adenylate cyclase 9	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215400_x_at	136	0.566176	0.190166	-	-0.63064	0.997426	-0.000976001	1.00 [0.55 - 1.81]
GENE	ADCY9	adenylate cyclase 9	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204497_at	136	0.110294	0.110113	-	15.1953	0.872576	0.0645362	1.07 [0.48 - 2.35]
GENE	ADCY9	adenylate cyclase 9	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204498_s_at	136	0.102941	0.169707	-	-0.751519	0.870423	-0.0705816	0.93 [0.40 - 2.18]
GENE	ADCY9	adenylate cyclase 9	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215400_x_at	200	0.26	0.212223	-	-0.390619	0.970518	0.00895725	1.01 [0.63 - 1.62]
GENE	ADCY9	adenylate cyclase 9	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204497_at	200	0.235	0.245115	-	-0.380208	0.610138	-0.136045	0.87 [0.52 - 1.47]
GENE	ADCY9	adenylate cyclase 9	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204498_s_at	200	0.37	0.216179	-	-0.37021	0.840392	-0.0677713	0.93 [0.48 - 1.81]
GENE	ADCY9	adenylate cyclase 9	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19948	60	0.866667	0.0266536	0.327052	0.9909	0.245281	0.384431	1.47 [0.77 - 2.81]
GENE	ADCY9	adenylate cyclase 9	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7809	60	0.883333	0.180138	-	0.652864	0.211291	0.973025	2.65 [0.58 - 12.17]
GENE	ADCY9	adenylate cyclase 9	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7809	60	0.583333	0.150099	-	-0.574629	0.801753	-0.243787	0.78 [0.12 - 5.26]
GENE	ADCY9	adenylate cyclase 9	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19948	60	0.883333	0.0914016	-	-1.55633	0.322331	-0.515414	0.60 [0.22 - 1.66]
GENE	ADCY9	adenylate cyclase 9	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5626	155	0.23871	7.71077e-06	0.000352959	-1.18503	0.000572434	-0.477084	0.62 [0.47 - 0.81]
GENE	ADCY9	adenylate cyclase 9	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204497_at	286	0.853147	0.00546371	0.101466	0.633995	0.342635	0.15552	1.17 [0.85 - 1.61]
GENE	ADCY9	adenylate cyclase 9	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215400_x_at	286	0.877622	0.216645	-	-0.408324	0.825039	-0.0342727	0.97 [0.71 - 1.31]
GENE	ADCY9	adenylate cyclase 9	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204498_s_at	286	0.160839	0.000226501	0.00716195	-0.802543	0.00223808	-0.722993	0.49 [0.31 - 0.77]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204497_at	159	0.308176	0.0564019	-	-0.60169	0.0165351	-0.55075	0.58 [0.37 - 0.90]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204498_s_at	159	0.163522	0.00151096	0.0359504	-1.17291	0.039458	-0.912141	0.40 [0.17 - 0.96]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215400_x_at	159	0.446541	0.0825971	-	-0.548454	0.581301	-0.122209	0.88 [0.57 - 1.37]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204498_s_at	159	0.144654	0.0030786	0.0643172	-1.00681	0.0703489	-0.709547	0.49 [0.23 - 1.06]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204497_at	159	0.308176	0.00736835	0.127976	-0.826391	0.00335719	-0.628473	0.53 [0.35 - 0.81]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204497_at	159	0.308176	0.00636375	0.114274	-0.975716	0.000522799	-0.806438	0.45 [0.28 - 0.70]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204498_s_at	159	0.36478	0.0115034	0.179312	-0.780909	0.223437	-0.494822	0.61 [0.27 - 1.35]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215400_x_at	159	0.396226	0.171776	-	-0.502623	0.411747	-0.212927	0.81 [0.49 - 1.34]
GENE	ADCY9	adenylate cyclase 9	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215400_x_at	159	0.232704	0.160623	-	-0.469434	0.361204	-0.201957	0.82 [0.53 - 1.26]
GENE	ADCY9	adenylate cyclase 9	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204498_s_at	54	0.703704	0.309046	-	-0.815503	0.928319	0.0704149	1.07 [0.23 - 4.98]
GENE	ADCY9	adenylate cyclase 9	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215400_x_at	54	0.666667	0.167377	-	0.917948	0.728021	0.254937	1.29 [0.31 - 5.43]
GENE	ADCY9	adenylate cyclase 9	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204497_at	54	0.203704	0.117892	-	15.4334	0.376386	0.408258	1.50 [0.61 - 3.72]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204498_s_at	117	0.82906	0.0209381	0.276738	0.805287	0.321477	0.424857	1.53 [0.66 - 3.54]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204498_s_at	117	0.82906	0.0164038	0.232597	0.937988	0.0744319	0.835452	2.31 [0.92 - 5.77]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204498_s_at	117	0.760684	0.00967329	0.157469	1.01558	0.0468974	1.02478	2.79 [1.01 - 7.66]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204498_s_at	117	0.82906	0.0209381	0.276738	0.805287	0.321477	0.424857	1.53 [0.66 - 3.54]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215400_x_at	117	0.897436	0.000368686	0.0109131	1.28009	0.0623266	0.866416	2.38 [0.96 - 5.91]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215400_x_at	117	0.897436	4.17021e-06	0.000201709	1.67719	0.002578	1.30129	3.67 [1.58 - 8.56]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215400_x_at	117	0.897436	0.000368686	0.0109131	1.28009	0.0623266	0.866416	2.38 [0.96 - 5.91]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204497_at	117	0.837607	0.00613927	0.11113	0.945023	0.0450202	0.314819	1.37 [1.01 - 1.86]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215400_x_at	117	0.897436	2.39475e-06	0.000121448	1.80804	0.000565477	1.96058	7.10 [2.33 - 21.65]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204497_at	117	0.837607	0.000755453	0.0201241	1.2473	0.0062528	0.51449	1.67 [1.16 - 2.42]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204497_at	117	0.846154	0.00276207	0.058922	1.21304	0.0162052	0.489371	1.63 [1.09 - 2.43]
GENE	ADCY9	adenylate cyclase 9	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204497_at	117	0.837607	0.00613927	0.11113	0.945023	0.0450202	0.314819	1.37 [1.01 - 1.86]
GENE	ADCY9	adenylate cyclase 9	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204497_at	236	0.169492	0.0306541	0.35941	-0.674954	0.847857	-0.0435008	0.96 [0.61 - 1.49]
GENE	ADCY9	adenylate cyclase 9	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204498_s_at	236	0.322034	0.0414808	0.437686	-0.547366	0.188403	-0.607149	0.54 [0.22 - 1.35]
GENE	ADCY9	adenylate cyclase 9	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215400_x_at	236	0.711864	0.437742	-	-0.240699	0.857779	-0.0363501	0.96 [0.65 - 1.44]
GENE	ADCY9	adenylate cyclase 9	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204498_s_at	249	0.301205	0.0101127	0.162827	-0.555251	0.064021	-0.693821	0.50 [0.24 - 1.04]
GENE	ADCY9	adenylate cyclase 9	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215400_x_at	249	0.421687	0.0721345	-	-0.381525	0.24763	-0.184482	0.83 [0.61 - 1.14]
GENE	ADCY9	adenylate cyclase 9	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204497_at	249	0.200803	0.0076183	0.131298	-0.639541	0.576152	-0.0973672	0.91 [0.64 - 1.28]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215400_x_at	54	0.148148	0.240148	-	15.26	0.735984	-0.0975969	0.91 [0.51 - 1.60]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204498_s_at	62	0.354839	0.0535405	-	1.34897	0.975545	0.00623113	1.01 [0.68 - 1.50]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204497_at	125	0.504	0.0701506	-	-0.531656	0.737953	-0.0689294	0.93 [0.62 - 1.40]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204498_s_at	125	0.104	0.0762348	-	-0.932372	0.881485	-0.105235	0.90 [0.23 - 3.59]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215400_x_at	125	0.856	0.0609023	-	-0.954204	0.514426	-0.688253	0.50 [0.06 - 3.98]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204497_at	54	0.888889	0.251185	-	0.758307	0.662694	0.104348	1.11 [0.69 - 1.77]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204498_s_at	125	0.184	0.000912097	0.0235898	-1.04855	0.0821508	-1.01223	0.36 [0.12 - 1.14]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204498_s_at	54	0.333333	0.0229071	0.294673	15.5967	0.879033	0.0380073	1.04 [0.64 - 1.69]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215400_x_at	125	0.392	0.320547	-	-0.378037	0.970813	0.0500439	1.05 [0.07 - 15.35]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204497_at	62	0.129032	0.129376	-	15.2058	0.767485	0.0568225	1.06 [0.73 - 1.54]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204497_at	125	0.864	0.0414365	0.43739	0.832397	0.277526	0.294814	1.34 [0.79 - 2.29]
GENE	ADCY9	adenylate cyclase 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215400_x_at	62	0.790323	0.335185	-	-0.606511	0.638918	-0.111878	0.89 [0.56 - 1.43]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204498_s_at	198	0.106061	0.00878463	0.146386	2.18678	0.200972	0.192963	1.21 [0.90 - 1.63]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215400_x_at	198	0.611111	0.367459	-	-0.194178	0.856563	0.0194281	1.02 [0.83 - 1.26]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204498_s_at	198	0.106061	0.0232715	0.297919	1.96044	0.392324	0.132788	1.14 [0.84 - 1.55]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204497_at	198	0.106061	0.00397884	0.0789873	1.55173	0.377712	0.106567	1.11 [0.88 - 1.41]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215400_x_at	198	0.20202	0.088301	-	0.673212	0.691745	0.0524619	1.05 [0.81 - 1.37]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215400_x_at	198	0.20202	0.143315	-	0.583639	0.683158	0.0572041	1.06 [0.80 - 1.39]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204498_s_at	198	0.10101	0.0515034	-	0.875091	0.297504	0.125756	1.13 [0.90 - 1.44]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204497_at	198	0.106061	0.00531984	0.0993665	2.34186	0.651029	0.0663448	1.07 [0.80 - 1.42]
GENE	ADCY9	adenylate cyclase 9	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204497_at	198	0.116162	0.0142876	0.210404	2.07825	0.958179	-0.0080252	0.99 [0.73 - 1.34]
GENE	ADCY9	adenylate cyclase 9	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204497_at	62	0.790323	0.200063	-	-1.25499	0.692745	-0.163155	0.85 [0.38 - 1.91]
GENE	ADCY9	adenylate cyclase 9	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204498_s_at	51	0.117647	0.0369309	0.406274	-1.69653	0.618118	0.993782	2.70 [0.05 - 134.42]
GENE	ADCY9	adenylate cyclase 9	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215400_x_at	62	0.758065	0.0681334	-	1.02506	0.465284	0.732428	2.08 [0.29 - 14.86]
GENE	ADCY9	adenylate cyclase 9	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204498_s_at	62	0.145161	0.0290995	0.347086	-1.25508	0.0986383	-2.21468	0.11 [0.01 - 1.51]
GENE	ADCY9	adenylate cyclase 9	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215400_x_at	51	0.862745	0.0747612	-	1.48712	0.455483	1.10163	3.01 [0.17 - 54.32]
GENE	ADCY9	adenylate cyclase 9	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204497_at	51	0.392157	0.0514623	-	-1.88849	0.354079	-0.601251	0.55 [0.15 - 1.96]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204497_at	145	0.124138	0.115456	-	-0.655074	0.569497	-0.241669	0.79 [0.34 - 1.81]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215400_x_at	177	0.112994	0.00629749	0.113349	-0.896563	0.12865	-1.21055	0.30 [0.06 - 1.42]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215400_x_at	177	0.265537	0.0061176	0.110825	-0.666405	0.070159	-1.25198	0.29 [0.07 - 1.11]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204498_s_at	177	0.666667	0.000935813	0.0241045	-1.19638	0.0109763	-1.77297	0.17 [0.04 - 0.67]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204497_at	177	0.525424	0.062289	-	0.511082	0.173458	0.478731	1.61 [0.81 - 3.22]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204498_s_at	177	0.734463	0.00841197	0.141636	-0.838655	0.124056	-0.958986	0.38 [0.11 - 1.30]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215400_x_at	145	0.475862	0.0416047	0.438515	0.706474	0.748956	-0.269934	0.76 [0.15 - 3.99]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204497_at	177	0.163842	0.115356	-	0.582835	0.334999	0.290677	1.34 [0.74 - 2.41]
GENE	ADCY9	adenylate cyclase 9	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204498_s_at	145	0.627586	0.0666594	-	-0.698453	0.329066	-0.889894	0.41 [0.07 - 2.45]
GENE	ADCY9	adenylate cyclase 9	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215400_x_at	226	0.809735	0.000166538	0.00547878	1.053	0.0783456	0.26137	1.30 [0.97 - 1.74]
GENE	ADCY9	adenylate cyclase 9	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204498_s_at	226	0.845133	0.175128	-	-0.695335	0.50152	-0.0972411	0.91 [0.68 - 1.20]
GENE	ADCY9	adenylate cyclase 9	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204497_at	226	0.402655	0.0825304	-	0.541981	0.746666	0.0715393	1.07 [0.70 - 1.66]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215400_x_at	55	0.345455	0.00560733	0.103547	-1.18525	0.0618169	-2.64488	0.07 [0.00 - 1.14]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215400_x_at	55	0.636364	0.0470916	0.473867	-1.18507	0.19742	-1.93425	0.14 [0.01 - 2.74]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204498_s_at	55	0.781818	0.0438086	0.45302	0.916015	0.734124	-0.434998	0.65 [0.05 - 7.97]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215400_x_at	49	0.326531	0.00582276	0.106641	-1.49359	0.20043	-2.19954	0.11 [0.00 - 3.21]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204497_at	55	0.145455	0.0395408	0.424534	15.3125	0.22514	0.629247	1.88 [0.68 - 5.19]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204498_s_at	55	0.218182	0.015031	0.218331	-1.19957	0.0809205	-2.48185	0.08 [0.01 - 1.36]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204498_s_at	49	0.122449	0.00491685	0.0934017	-1.57681	0.154965	-2.52234	0.08 [0.00 - 2.60]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204497_at	55	0.145455	0.239049	-	1.11111	0.657727	0.256211	1.29 [0.42 - 4.01]
GENE	ADCY9	adenylate cyclase 9	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204497_at	49	0.163265	0.149983	-	15.2603	0.547939	0.463214	1.59 [0.35 - 7.20]
GENE	ADCY9	adenylate cyclase 9	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215400_x_at	63	0.555556	0.000558448	0.0155717	-1.26934	0.288187	-1.27083	0.28 [0.03 - 2.93]
GENE	ADCY9	adenylate cyclase 9	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204498_s_at	63	0.873016	0.0212442	0.279571	0.947375	0.238017	0.41411	1.51 [0.76 - 3.01]
GENE	ADCY9	adenylate cyclase 9	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204497_at	63	0.333333	0.0387396	0.419	0.810982	0.455288	0.193149	1.21 [0.73 - 2.01]
GENE	ADCY9	adenylate cyclase 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306624.0.S1_3p_x_at	28	0.107143	0.129336	-	-0.975496	0.707148	-0.528349	0.59 [0.04 - 9.28]
GENE	ADCY9	adenylate cyclase 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.20196.0.S2_3p_at	28	0.142857	0.0169852	0.238502	-1.33482	0.342459	-0.347099	0.71 [0.35 - 1.45]
GENE	ADCY9	adenylate cyclase 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306624.0.S1_3p_at	28	0.571429	0.046959	0.473042	-1.25596	0.0904929	-5.71156	0.00 [0.00 - 2.46]
GENE	ADCY9	adenylate cyclase 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557258_3p_a_at	28	0.642857	0.176697	-	-0.861106	0.66711	0.828211	2.29 [0.05 - 99.71]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215400_x_at	82	0.195122	0.040608	0.431812	1.16415	0.385648	0.389643	1.48 [0.61 - 3.56]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204497_at	82	0.341463	0.000907976	0.0235002	-1.07746	0.021225	-0.430624	0.65 [0.45 - 0.94]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204498_s_at	82	0.573171	0.206369	-	-0.443784	0.382708	-0.395585	0.67 [0.28 - 1.64]
GENE	ADCY9	adenylate cyclase 9	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33800_at	84	0.238095	0.00324335	0.0670729	-0.873144	0.102617	-0.493426	0.61 [0.34 - 1.10]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204497_at	79	0.253165	0.00360692	0.0730375	-0.828991	0.0814778	-0.271618	0.76 [0.56 - 1.03]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215400_x_at	79	0.886076	0.0202652	0.270449	-1.05949	0.47826	-0.22617	0.80 [0.43 - 1.49]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204498_s_at	79	0.594937	0.0378377	0.412695	-0.555352	0.159461	-0.543589	0.58 [0.27 - 1.24]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215400_x_at	104	0.461538	0.320797	-	-0.319364	0.51379	-0.307146	0.74 [0.29 - 1.85]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204497_at	104	0.423077	7.92336e-05	0.00285199	-1.27211	0.0256809	-0.377856	0.69 [0.49 - 0.96]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204498_s_at	104	0.173077	0.0649904	-	-0.735511	0.841848	0.121309	1.13 [0.34 - 3.72]
GENE	ADCY9	adenylate cyclase 9	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P49443	117	0.299145	0.00183531	0.0422088	-0.874758	0.0398407	-0.30972	0.73 [0.55 - 0.99]
GENE	ADCY9	adenylate cyclase 9	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P935103	117	0.623932	0.017656	0.24522	-0.770317	0.0815541	-0.273864	0.76 [0.56 - 1.03]
GENE	ADCY9	adenylate cyclase 9	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204498_s_at	204	0.318627	0.000168212	0.00552686	-0.986933	0.00042244	-0.800463	0.45 [0.29 - 0.70]
GENE	ADCY9	adenylate cyclase 9	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204497_at	204	0.372549	8.61555e-07	4.74252e-05	-1.85393	5.80789e-05	-1.46839	0.23 [0.11 - 0.47]
GENE	ADCY9	adenylate cyclase 9	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204497_at	204	0.323529	2.60542e-09	2.07901e-07	-1.53258	1.81637e-06	-1.26505	0.28 [0.17 - 0.47]
GENE	ADCY9	adenylate cyclase 9	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215400_x_at	204	0.338235	0.00168693	0.0393774	-1.11377	0.00239678	-0.789748	0.45 [0.27 - 0.76]
GENE	ADCY9	adenylate cyclase 9	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215400_x_at	204	0.607843	0.00174041	0.0404037	-1.0146	0.00684684	-0.601126	0.55 [0.35 - 0.85]
GENE	ADCY9	adenylate cyclase 9	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204498_s_at	204	0.102941	0.00042784	0.0124007	-1.35275	0.00279314	-0.889847	0.41 [0.23 - 0.74]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204497_at	178	0.101124	3.11026e-05	0.00124127	-1.09108	0.000242135	-0.524332	0.59 [0.45 - 0.78]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204498_s_at	178	0.792135	0.00189849	0.0433996	-0.869142	0.0182519	-0.634887	0.53 [0.31 - 0.90]
GENE	ADCY9	adenylate cyclase 9	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215400_x_at	178	0.893258	0.00360404	0.0729908	-1.37578	0.430094	0.180796	1.20 [0.76 - 1.88]
GENE	ADCY9	adenylate cyclase 9	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200002888	41	0.414634	0.0645365	-	-0.756577	0.216547	-0.291663	0.75 [0.47 - 1.19]
GENE	ADCY9	adenylate cyclase 9	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204497_at	111	0.279279	0.00572761	0.105278	-0.743874	0.00936779	-0.496584	0.61 [0.42 - 0.89]
GENE	ADCY9	adenylate cyclase 9	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215400_x_at	111	0.468468	0.13064	-	-0.396696	0.889462	-0.0253995	0.97 [0.68 - 1.39]
GENE	ADCY9	adenylate cyclase 9	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204498_s_at	111	0.117117	0.339247	-	-0.365079	0.897464	-0.0236195	0.98 [0.68 - 1.40]
GENE	ADCY9	adenylate cyclase 9	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204497_at	90	0.166667	0.0163502	0.232048	-0.862061	0.938349	-0.0173382	0.98 [0.63 - 1.53]
GENE	ADCY9	adenylate cyclase 9	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204497_at	90	0.166667	0.0257662	0.319576	-0.899688	0.845665	-0.0501418	0.95 [0.57 - 1.58]
GENE	ADCY9	adenylate cyclase 9	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204498_s_at	90	0.733333	0.207278	-	-0.522194	0.733525	-0.175499	0.84 [0.31 - 2.30]
GENE	ADCY9	adenylate cyclase 9	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204498_s_at	90	0.888889	0.270727	-	0.536218	0.925632	0.0533138	1.05 [0.34 - 3.23]
GENE	ADCY9	adenylate cyclase 9	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215400_x_at	90	0.255556	0.0139866	0.207153	-0.897543	0.717273	-0.243419	0.78 [0.21 - 2.93]
GENE	ADCY9	adenylate cyclase 9	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215400_x_at	90	0.255556	0.0370077	0.406822	-0.688861	0.700839	-0.226953	0.80 [0.25 - 2.54]
GENE	ADCY9	adenylate cyclase 9	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4006	50	0.16	0.21188	-	-0.691678	0.883841	-0.0513321	0.95 [0.48 - 1.89]
GENE	ADCY9	adenylate cyclase 9	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204497_at	138	0.195652	0.0138805	0.206001	0.949468	0.819042	0.0255639	1.03 [0.82 - 1.28]
GENE	ADCY9	adenylate cyclase 9	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215400_x_at	138	0.275362	0.00118781	0.0294325	-0.778813	0.0627809	-4.11849	0.02 [0.00 - 1.25]
GENE	ADCY9	adenylate cyclase 9	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204498_s_at	138	0.869565	0.0752335	-	-0.74826	0.137086	-0.29288	0.75 [0.51 - 1.10]
GENE	ADCY9	adenylate cyclase 9	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215400_x_at	129	0.899225	0.0513624	-	0.722971	0.250612	0.264062	1.30 [0.83 - 2.04]
GENE	ADCY9	adenylate cyclase 9	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204497_at	129	0.744186	0.0105876	0.168536	-0.803309	0.0844688	-0.240089	0.79 [0.60 - 1.03]
GENE	ADCY9	adenylate cyclase 9	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204498_s_at	129	0.899225	0.0185148	0.253678	0.831832	0.603706	0.250513	1.28 [0.50 - 3.31]
GENE	ADCY9	adenylate cyclase 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23824	56	0.785714	0.0332736	0.379507	0.841685	0.314588	0.313582	1.37 [0.74 - 2.52]
GENE	ADCY9	adenylate cyclase 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30882	56	0.642857	0.0407851	0.43301	0.736951	0.199436	0.478121	1.61 [0.78 - 3.35]
GENE	ADCY9	adenylate cyclase 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10410	56	0.25	0.0737335	-	0.756522	0.286257	0.345405	1.41 [0.75 - 2.67]
GENE	ADCY9	adenylate cyclase 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23824	56	0.857143	0.0445284	0.457667	0.902413	0.67489	0.11506	1.12 [0.66 - 1.92]
GENE	ADCY9	adenylate cyclase 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10410	56	0.446429	0.1587	-	0.519984	0.288703	0.378419	1.46 [0.73 - 2.94]
GENE	ADCY9	adenylate cyclase 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30882	56	0.5	0.0890002	-	0.59249	0.190082	0.444677	1.56 [0.80 - 3.03]
GENE	ADCY9	adenylate cyclase 9	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215400_x_at	278	0.453237	0.441277	-	-0.144981	0.921732	-0.0401224	0.96 [0.43 - 2.14]
GENE	ADCY9	adenylate cyclase 9	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204498_s_at	278	0.431655	0.00441423	0.0857764	-0.540829	0.0219323	-0.724042	0.48 [0.26 - 0.90]
GENE	ADCY9	adenylate cyclase 9	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204497_at	278	0.377698	0.139349	-	0.290653	0.294377	0.126072	1.13 [0.90 - 1.44]
GENE	ADCY9	adenylate cyclase 9	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204498_s_at	133	0.556391	0.00267221	0.0573644	0.706718	0.243156	0.184659	1.20 [0.88 - 1.64]
GENE	ADCY9	adenylate cyclase 9	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215400_x_at	133	0.729323	0.00120504	0.0297884	0.769926	0.0296972	1.15251	3.17 [1.12 - 8.95]
GENE	ADCY9	adenylate cyclase 9	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204497_at	133	0.233083	0.000212586	0.00677795	-0.956259	0.0423262	-0.236098	0.79 [0.63 - 0.99]
GENE	ADCY9	adenylate cyclase 9	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17336	81	0.802469	0.105545	-	-15.283	0.640593	-0.31221	0.73 [0.20 - 2.71]
GENE	ADCY9	adenylate cyclase 9	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204498_s_at	185	0.113514	0.00379556	0.0760735	0.77434	0.0544431	0.385702	1.47 [0.99 - 2.18]
GENE	ADCY9	adenylate cyclase 9	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215400_x_at	185	0.4	0.0201829	0.269673	-0.412111	0.125691	-0.441329	0.64 [0.37 - 1.13]
GENE	ADCY9	adenylate cyclase 9	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204497_at	185	0.145946	0.00208891	0.0469377	0.758946	0.00823254	0.390814	1.48 [1.11 - 1.98]
GENE	ADCY9	adenylate cyclase 9	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204498_s_at	185	0.691892	0.00487404	0.0927606	0.528218	0.0380784	0.451046	1.57 [1.03 - 2.40]
GENE	ADCY9	adenylate cyclase 9	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204497_at	185	0.610811	0.00247156	0.053842	0.550586	0.00467298	0.449196	1.57 [1.15 - 2.14]
GENE	ADCY9	adenylate cyclase 9	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215400_x_at	185	0.410811	0.00665234	0.11827	-0.44486	0.0503558	-0.522618	0.59 [0.35 - 1.00]
GENE	ADCY9	adenylate cyclase 9	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P935103	110	0.854545	0.0796773	-	0.488029	0.993669	0.00104345	1.00 [0.77 - 1.30]
GENE	ADCY9	adenylate cyclase 9	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P49443	110	0.3	0.0329962	0.377416	-0.648255	0.434635	-0.147972	0.86 [0.60 - 1.25]
GENE	ADCY9	adenylate cyclase 9	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P935103	110	0.418182	0.51611	-	-0.199995	0.940337	0.0127776	1.01 [0.72 - 1.42]
GENE	ADCY9	adenylate cyclase 9	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P49443	110	0.3	0.116741	-	-0.390235	0.30183	-0.140368	0.87 [0.67 - 1.13]
GENE	ADCY9	adenylate cyclase 9	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204497_at	80	0.775	0.169355	-	-0.984444	0.928195	0.0147692	1.01 [0.74 - 1.40]
GENE	ADCY9	adenylate cyclase 9	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215400_x_at	80	0.15	0.273213	-	-0.554242	0.851208	-0.0398913	0.96 [0.63 - 1.46]
GENE	ADCY9	adenylate cyclase 9	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204498_s_at	80	0.8375	0.0300393	0.354573	1.03826	0.153709	0.503066	1.65 [0.83 - 3.30]
GENE	ADCY9	adenylate cyclase 9	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215400_x_at	38	0.421053	0.00254227	0.0550907	-1.45387	0.0803388	-1.09384	0.33 [0.10 - 1.14]
GENE	ADCY9	adenylate cyclase 9	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204498_s_at	38	0.473684	0.0350836	0.392934	-0.975425	0.564886	-0.170554	0.84 [0.47 - 1.51]
GENE	ADCY9	adenylate cyclase 9	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204497_at	38	0.342105	0.123129	-	0.813631	0.787047	0.101582	1.11 [0.53 - 2.31]
GENE	ADCY9	adenylate cyclase 9	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204497_at	140	0.878571	6.32054e-05	0.00233475	1.23756	0.0531658	0.415964	1.52 [0.99 - 2.31]
GENE	ADCY9	adenylate cyclase 9	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204498_s_at	140	0.857143	0.0150404	0.21843	0.790579	0.604975	0.280263	1.32 [0.46 - 3.83]
GENE	ADCY9	adenylate cyclase 9	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215400_x_at	140	0.764286	0.126637	-	0.496997	0.839147	0.173287	1.19 [0.22 - 6.34]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207820_at	30	0.233333	0.00525092	0.0983554	-1.38186	0.522621	-0.420298	0.66 [0.18 - 2.38]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1764309	165	0.806061	0.0856846	-	0.477873	0.702285	-0.0254989	0.97 [0.86 - 1.11]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1764309	165	0.539394	0.213087	-	-0.45173	0.468713	-0.072679	0.93 [0.76 - 1.13]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207820_at	163	0.282209	0.094187	-	-0.35962	0.469313	-0.439914	0.64 [0.20 - 2.12]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207820_at	79	0.772152	0.0237646	0.302278	-0.954782	0.341324	-0.602663	0.55 [0.16 - 1.89]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207820_at	58	0.586207	0.0264364	0.325232	0.643293	0.307733	0.225256	1.25 [0.81 - 1.93]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207820_at	34	0.117647	0.0370422	0.407067	1.85645	0.286473	0.33281	1.39 [0.76 - 2.57]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207820_at	158	0.417722	0.0056058	0.103525	0.691427	0.0139527	1.54579	4.69 [1.37 - 16.09]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207820_at	53	0.54717	0.00502237	0.0949758	0.950465	0.356437	0.28598	1.33 [0.72 - 2.44]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207820_at	53	0.54717	0.0348014	0.390864	0.76421	0.546847	0.196269	1.22 [0.64 - 2.30]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207820_at	180	0.861111	0.0190871	0.259229	0.633995	0.542641	0.0761306	1.08 [0.84 - 1.38]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207820_at	559	0.137746	0.0586894	-	-0.528541	0.530511	-0.133509	0.88 [0.58 - 1.33]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207820_at	77	0.246753	0.0537802	-	-0.553025	0.226486	-0.3605	0.70 [0.39 - 1.25]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207820_at	70	0.171429	0.16787	-	0.523519	0.719532	0.189222	1.21 [0.43 - 3.39]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34637_f_at	50	0.74	0.123512	-	-0.623532	0.260007	-0.973262	0.38 [0.07 - 2.06]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34638_r_at	50	0.62	0.110462	-	-0.582446	0.301123	-0.663826	0.51 [0.15 - 1.81]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207820_at	74	0.810811	0.16619	-	0.459636	0.843673	0.0595675	1.06 [0.59 - 1.92]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207820_at	67	0.104478	0.240719	-	-0.920339	0.927401	0.181707	1.20 [0.02 - 59.77]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207820_at	115	0.321739	0.0378579	0.412837	1.87046	0.157066	1.01512	2.76 [0.68 - 11.26]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34637_f_at	158	0.512658	0.0421839	0.442368	0.586717	0.298066	0.13993	1.15 [0.88 - 1.50]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34638_r_at	158	0.601266	0.188489	-	-0.392179	0.988586	-0.00264555	1.00 [0.69 - 1.43]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34637_f_at	76	0.223684	0.00395333	0.0785838	-1.4002	0.312575	-0.265024	0.77 [0.46 - 1.28]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34638_r_at	76	0.513158	0.116296	-	0.838177	0.470254	0.314335	1.37 [0.58 - 3.21]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207820_at	204	0.828431	0.0168261	0.236894	-0.436447	0.296938	-0.093732	0.91 [0.76 - 1.09]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207820_at	87	0.83908	0.167608	-	-0.97542	0.424585	-0.680829	0.51 [0.10 - 2.69]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207820_at	87	0.83908	0.167608	-	-0.97542	0.424585	-0.680829	0.51 [0.10 - 2.69]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207820_at	77	0.376623	0.046802	0.472064	-1.081	0.749133	-0.378225	0.69 [0.07 - 6.96]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207820_at	77	0.441558	0.0718055	-	-1.1743	0.215871	-1.61761	0.20 [0.02 - 2.57]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207820_at	136	0.264706	0.0120083	0.185129	-1.0773	0.304968	-0.265092	0.77 [0.46 - 1.27]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207820_at	200	0.87	0.0132971	0.199609	0.833671	0.0895054	0.481395	1.62 [0.93 - 2.82]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207820_at	286	0.234266	0.0503281	-	-0.411524	0.526007	-0.092942	0.91 [0.68 - 1.21]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207820_at	159	0.113208	0.00592688	0.108125	-1.00172	0.0443747	-0.602292	0.55 [0.30 - 0.98]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207820_at	159	0.314465	0.037803	0.412451	-0.754883	0.113466	-0.564784	0.57 [0.28 - 1.14]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207820_at	159	0.113208	0.0337694	0.383221	-0.81874	0.141561	-0.464482	0.63 [0.34 - 1.17]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207820_at	54	0.148148	0.116721	-	15.4182	0.905868	-0.117531	0.89 [0.13 - 6.24]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207820_at	117	0.735043	0.0516844	-	-0.838284	0.30472	-0.637621	0.53 [0.16 - 1.79]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207820_at	117	0.726496	0.178646	-	-0.652555	0.627803	-0.347956	0.71 [0.17 - 2.88]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207820_at	117	0.666667	0.173896	-	-0.623491	0.82162	-0.167651	0.85 [0.20 - 3.63]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207820_at	117	0.735043	0.0516844	-	-0.838284	0.30472	-0.637621	0.53 [0.16 - 1.79]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207820_at	236	0.165254	0.00919979	0.151606	-0.769917	0.149558	-0.426215	0.65 [0.37 - 1.17]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207820_at	249	0.493976	0.0829741	-	-0.368831	0.456623	-0.184896	0.83 [0.51 - 1.35]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207820_at	54	0.759259	0.0566021	-	-1.77963	0.531871	-0.194506	0.82 [0.45 - 1.51]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207820_at	62	0.790323	0.016484	0.233416	-2.10201	0.448095	-0.196233	0.82 [0.49 - 1.36]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207820_at	125	0.776	0.0890571	-	-0.997624	0.178104	-1.41727	0.24 [0.03 - 1.91]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207820_at	125	0.152	0.00644799	0.115446	-0.949952	0.142721	-1.19486	0.30 [0.06 - 1.50]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207820_at	198	0.5	0.0900385	-	-0.357474	0.938069	-0.00691816	0.99 [0.83 - 1.18]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207820_at	198	0.434343	0.11765	-	-0.395547	0.840044	-0.021703	0.98 [0.79 - 1.21]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207820_at	198	0.434343	0.0896796	-	-0.45048	0.780866	-0.0313463	0.97 [0.78 - 1.21]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207820_at	51	0.176471	0.299815	-	15.3138	0.994758	0.0092779	1.01 [0.06 - 16.08]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207820_at	62	0.112903	0.0276179	0.335049	-1.36656	0.508996	-0.614352	0.54 [0.09 - 3.35]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207820_at	145	0.537931	0.0475386	0.476639	-0.687525	0.232826	-0.717302	0.49 [0.15 - 1.59]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207820_at	177	0.497175	0.000185323	0.00601441	-1.06092	0.00798739	-1.34557	0.26 [0.10 - 0.70]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207820_at	177	0.497175	0.0028043	0.0596498	-0.710213	0.0417961	-0.867088	0.42 [0.18 - 0.97]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207820_at	226	0.473451	0.0831098	-	-0.49192	0.281898	-0.221686	0.80 [0.54 - 1.20]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207820_at	49	0.816327	0.00634288	0.113983	1.49635	0.975331	0.0413652	1.04 [0.08 - 14.34]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207820_at	55	0.363636	0.0698424	-	0.975182	0.401295	0.627311	1.87 [0.43 - 8.10]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207820_at	55	0.181818	0.0116161	0.180617	-1.21265	0.318779	-1.05054	0.35 [0.04 - 2.76]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207820_at	63	0.47619	0.00239918	0.0525557	-1.04275	0.36766	-2.75835	0.06 [0.00 - 25.61]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11496886_3p_at	28	0.142857	0.00980347	0.159064	-1.54081	0.285771	-1.87031	0.15 [0.00 - 4.78]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207820_at	82	0.243902	0.0458432	0.466044	-0.732101	0.671072	-0.1355	0.87 [0.47 - 1.63]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207820_at	79	0.341772	0.104378	-	-0.439647	0.53716	-0.196459	0.82 [0.44 - 1.53]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207820_at	104	0.451923	0.232101	-	-0.384959	0.438257	-0.28884	0.75 [0.36 - 1.56]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P58359	117	0.555556	0.0022993	0.050766	-0.951582	0.399907	-0.0837091	0.92 [0.76 - 1.12]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207820_at	204	0.47549	2.81728e-05	0.00113604	-1.80115	0.00236898	-0.787183	0.46 [0.27 - 0.76]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207820_at	204	0.333333	9.65676e-09	7.164e-07	-1.48243	5.11802e-06	-0.877865	0.42 [0.29 - 0.61]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207820_at	178	0.101124	0.00921716	0.151822	-0.715148	0.582219	-0.139454	0.87 [0.53 - 1.43]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207820_at	111	0.513514	0.0304215	0.357586	-0.576036	0.215537	-0.315761	0.73 [0.44 - 1.20]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207820_at	90	0.388889	0.0808758	-	0.616584	0.450281	0.421963	1.52 [0.51 - 4.56]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207820_at	90	0.522222	0.114288	-	0.588796	0.422935	0.497164	1.64 [0.49 - 5.55]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207820_at	138	0.195652	0.00140849	0.0339173	-0.816861	0.2158	-0.33775	0.71 [0.42 - 1.22]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207820_at	129	0.868217	0.0126558	0.192468	0.819085	0.70995	0.107604	1.11 [0.63 - 1.96]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37190	56	0.142857	0.000101633	0.00355261	-1.54172	0.933173	-0.0100411	0.99 [0.78 - 1.25]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37190	56	0.142857	0.00293022	0.0618053	-1.18103	0.841695	0.0219232	1.02 [0.82 - 1.27]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207820_at	278	0.733813	0.0618451	-	0.372192	0.750742	0.129279	1.14 [0.51 - 2.53]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207820_at	133	0.842105	0.00175852	0.0407499	0.854086	0.0411004	0.946687	2.58 [1.04 - 6.39]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2668	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207820_at	185	0.216216	0.0177572	0.246225	0.476284	0.192132	0.365938	1.44 [0.83 - 2.50]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207820_at	185	0.562162	0.0205252	0.272888	0.414583	0.291886	0.322826	1.38 [0.76 - 2.52]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P58359	110	0.418182	0.0717933	-	-0.529449	0.776217	-0.027439	0.97 [0.81 - 1.18]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P291658	110	0.472727	0.111505	-	0.471774	0.475479	0.0733234	1.08 [0.88 - 1.32]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P58359	110	0.436364	0.131751	-	-0.346081	0.561438	0.0406705	1.04 [0.91 - 1.19]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P291658	110	0.763636	0.0300893	0.354968	0.556868	0.102084	0.125114	1.13 [0.98 - 1.32]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207820_at	80	0.1125	0.0135466	0.202355	-1.22353	0.5634	-0.127805	0.88 [0.57 - 1.36]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3103	281	0.896797	0.0409658	0.434228	-0.511042	0.202921	-0.163937	0.85 [0.66 - 1.09]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207820_at	38	0.5	0.00373962	0.0751772	-1.38672	0.344983	-0.268385	0.76 [0.44 - 1.33]
GENE	ADH1A	alcohol dehydrogenase 1A (class I), alpha polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207820_at	140	0.514286	0.000184436	0.00598929	-1.21046	0.00850594	-2.16206	0.12 [0.02 - 0.58]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209612_s_at	30	0.266667	0.0580712	-	-0.816491	0.640146	-0.0810052	0.92 [0.66 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209614_at	30	0.666667	0.149184	-	-0.628091	0.599519	-0.322142	0.72 [0.22 - 2.41]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209613_s_at	30	0.133333	0.0130197	0.196535	-1.37651	0.651035	-0.0721655	0.93 [0.68 - 1.27]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1811598	165	0.387879	0.0252429	0.315113	0.588776	0.871095	-0.0425116	0.96 [0.57 - 1.60]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1811598	165	0.545455	0.105464	-	-0.609145	0.427709	-0.384422	0.68 [0.26 - 1.76]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209613_s_at	163	0.453988	0.313172	-	-0.198935	0.7666	0.143992	1.15 [0.45 - 2.99]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209614_at	163	0.803681	0.169882	-	0.328814	0.937493	-0.0431912	0.96 [0.33 - 2.82]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209612_s_at	163	0.466258	0.030422	0.357589	0.431709	0.499126	0.346109	1.41 [0.52 - 3.86]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	243544_at	163	0.791411	0.00923667	0.152066	0.585523	0.165101	1.03246	2.81 [0.65 - 12.06]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209613_s_at	79	0.341772	0.0905346	-	0.546871	0.756558	0.151881	1.16 [0.45 - 3.04]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209612_s_at	79	0.113924	0.155809	-	0.820901	0.726811	-0.195548	0.82 [0.27 - 2.46]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	243544_at	79	0.392405	0.0944652	-	0.518886	0.289797	1.12719	3.09 [0.38 - 24.88]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209614_at	79	0.822785	0.0537622	-	-0.88511	0.56195	-0.427947	0.65 [0.15 - 2.77]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209612_s_at	58	0.896552	0.0558721	-	0.836658	0.535844	0.096338	1.10 [0.81 - 1.49]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209614_at	58	0.37931	0.0935589	-	0.485838	0.176202	0.227206	1.26 [0.90 - 1.74]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209613_s_at	58	0.327586	0.0038754	0.077347	0.87502	0.0128145	0.352193	1.42 [1.08 - 1.88]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209612_s_at	34	0.558824	0.0197148	0.26524	-0.89161	0.0392775	-0.478415	0.62 [0.39 - 0.98]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209614_at	34	0.176471	0.297079	-	-0.482476	0.812696	-0.0704132	0.93 [0.52 - 1.67]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209613_s_at	34	0.529412	0.272343	-	0.420586	0.668988	0.0905046	1.09 [0.72 - 1.66]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209614_at	158	0.753165	0.0369925	0.406713	0.520797	0.144886	1.05314	2.87 [0.70 - 11.81]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209612_s_at	158	0.183544	0.0279795	0.338013	0.800789	0.324718	0.208628	1.23 [0.81 - 1.87]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209613_s_at	158	0.835443	0.119247	-	0.445889	0.648447	0.0926845	1.10 [0.74 - 1.63]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209613_s_at	53	0.886792	0.0326231	0.374592	0.952617	0.740887	0.0469748	1.05 [0.79 - 1.38]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209612_s_at	53	0.886792	0.0143265	0.210823	1.08025	0.998029	0.00041868	1.00 [0.72 - 1.39]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209613_s_at	53	0.886792	0.0177841	0.246492	1.04964	0.955308	0.00737733	1.01 [0.78 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209612_s_at	53	0.867925	0.0164193	0.232755	1.01315	0.973083	0.00624873	1.01 [0.70 - 1.45]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209614_at	53	0.188679	0.054322	-	-0.763115	0.760479	-0.0667509	0.94 [0.61 - 1.44]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209614_at	53	0.188679	0.0487863	0.484292	-0.79504	0.761478	-0.0711068	0.93 [0.59 - 1.47]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209612_s_at	180	0.7	0.0339202	0.384345	0.455459	0.326539	0.102724	1.11 [0.90 - 1.36]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209613_s_at	180	0.677778	0.0781994	-	0.379892	0.57846	0.0440576	1.05 [0.89 - 1.22]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209614_at	180	0.244444	0.0308113	0.360639	0.572894	0.128193	0.13838	1.15 [0.96 - 1.37]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	243544_at	180	0.211111	0.155526	-	0.386771	0.51948	0.0671526	1.07 [0.87 - 1.31]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209613_s_at	559	0.894454	0.22392	-	-0.422183	0.752117	0.0300232	1.03 [0.86 - 1.24]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209612_s_at	559	0.379249	0.000648649	0.0176863	0.793813	0.093728	0.254895	1.29 [0.96 - 1.74]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	243544_at	559	0.499106	0.117085	-	-0.313817	0.51545	-0.0745956	0.93 [0.74 - 1.16]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209614_at	559	0.168157	0.000892192	0.0231559	-0.775228	0.0364885	-0.326939	0.72 [0.53 - 0.98]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209612_s_at	77	0.194805	0.0305643	0.358706	0.77151	0.170404	0.22273	1.25 [0.91 - 1.72]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209614_at	77	0.584416	0.188888	-	-0.344113	0.772347	-0.0556294	0.95 [0.65 - 1.38]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209613_s_at	77	0.493506	0.00190898	0.0435964	-0.803548	0.0487982	-0.217345	0.80 [0.65 - 1.00]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	243544_at	77	0.87013	0.0218465	0.285096	-1.02968	0.0582179	-0.333079	0.72 [0.51 - 1.01]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209612_s_at	70	0.328571	0.00258603	0.0558593	-0.814235	0.466447	-0.774765	0.46 [0.06 - 3.71]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	243544_at	70	0.185714	0.0979938	-	-0.532775	0.389336	-0.760632	0.47 [0.08 - 2.64]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209614_at	70	0.485714	0.00594241	0.108346	-0.726533	0.262748	-0.983076	0.37 [0.07 - 2.09]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209613_s_at	70	0.471429	0.0733387	-	-0.475613	0.55136	-0.762891	0.47 [0.04 - 5.74]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35730_at	50	0.5	0.012474	0.19042	-0.863142	0.245689	-0.834669	0.43 [0.11 - 1.78]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209612_s_at	74	0.891892	0.018865	0.257083	0.937634	0.787715	-0.0542017	0.95 [0.64 - 1.41]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209614_at	74	0.797297	0.146205	-	-0.58644	0.494311	-0.183455	0.83 [0.49 - 1.41]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209613_s_at	74	0.554054	0.00911097	0.150495	-0.786454	0.0126354	-0.404015	0.67 [0.49 - 0.92]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	243544_at	74	0.256757	0.288101	-	0.379086	0.900511	0.0245773	1.02 [0.70 - 1.51]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209613_s_at	67	0.641791	0.00494277	0.0937892	1.93882	0.0757253	0.385397	1.47 [0.96 - 2.25]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209612_s_at	67	0.656716	0.00331616	0.06828	2.00459	0.0848181	0.416855	1.52 [0.94 - 2.44]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209614_at	67	0.447761	0.00614049	0.111147	16.0378	0.0631227	2.19312	8.96 [0.89 - 90.58]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	243544_at	67	0.253731	0.119135	-	15.4144	0.599075	-2.18041	0.11 [0.00 - 383.15]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	243544_at	115	0.852174	0.106174	-	-15.2744	0.967179	-0.0221647	0.98 [0.34 - 2.81]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209612_s_at	115	0.382609	0.0318922	0.36901	-1.13561	0.2558	-0.364112	0.69 [0.37 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209614_at	115	0.495652	0.0787942	-	-0.997693	0.326029	-0.387183	0.68 [0.31 - 1.47]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209613_s_at	115	0.417391	0.015093	0.218984	-1.33628	0.258774	-0.264819	0.77 [0.48 - 1.22]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35730_at	158	0.132911	0.118172	-	0.902303	0.666025	0.059918	1.06 [0.81 - 1.39]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35730_at	76	0.328947	0.043046	0.448049	-1.00912	0.249496	-0.227708	0.80 [0.54 - 1.17]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209614_at	204	0.102941	0.114897	-	-0.363917	0.659424	-0.0254684	0.97 [0.87 - 1.09]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	243544_at	204	0.897059	0.121706	-	-0.362411	0.857334	0.0113669	1.01 [0.89 - 1.14]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209613_s_at	204	0.186275	0.0186243	0.254745	-0.426428	0.334069	-0.0351828	0.97 [0.90 - 1.04]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209612_s_at	204	0.25	0.0411747	0.435634	-0.336462	0.257861	-0.0421869	0.96 [0.89 - 1.03]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209612_s_at	87	0.126437	0.0148105	0.215995	-1.02328	0.16749	-0.118032	0.89 [0.75 - 1.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209613_s_at	87	0.241379	0.0306867	0.359665	-0.814753	0.13401	-0.117798	0.89 [0.76 - 1.04]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	243544_at	87	0.896552	0.0364845	0.403083	0.997617	0.0977058	2.28745	9.85 [0.66 - 147.63]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	243544_at	87	0.896552	0.0364845	0.403083	0.997617	0.0977058	2.28745	9.85 [0.66 - 147.63]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209612_s_at	87	0.126437	0.0148105	0.215995	-1.02328	0.16749	-0.118032	0.89 [0.75 - 1.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209614_at	87	0.402299	0.0354619	0.395695	-0.780373	0.447181	-0.25687	0.77 [0.40 - 1.50]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209613_s_at	87	0.241379	0.0306867	0.359665	-0.814753	0.13401	-0.117798	0.89 [0.76 - 1.04]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209614_at	87	0.402299	0.0354619	0.395695	-0.780373	0.447181	-0.25687	0.77 [0.40 - 1.50]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209614_at	77	0.727273	0.187817	-	-1.29622	0.587304	-0.461145	0.63 [0.12 - 3.33]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	243544_at	77	0.376623	0.0818002	-	1.25416	0.490693	1.27215	3.57 [0.10 - 132.95]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209613_s_at	77	0.766234	0.0612095	-	-15.4931	0.5779	-0.0858544	0.92 [0.68 - 1.24]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209614_at	77	0.896104	0.188779	-	-15.2016	0.549316	-0.443715	0.64 [0.15 - 2.74]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	243544_at	77	0.272727	0.0499671	0.491426	15.5316	0.615305	1.05418	2.87 [0.05 - 175.19]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209612_s_at	77	0.818182	0.113366	-	-15.3632	0.569671	-0.107998	0.90 [0.62 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209613_s_at	77	0.493506	0.104802	-	-0.942125	0.838669	-0.0275071	0.97 [0.75 - 1.27]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209612_s_at	77	0.818182	0.300244	-	-1.03227	0.853873	-0.0301611	0.97 [0.70 - 1.34]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209613_s_at	136	0.316176	0.00909431	0.150287	-1.18403	0.0776553	-0.196783	0.82 [0.66 - 1.02]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209614_at	136	0.102941	0.000213039	0.00679051	-1.65847	0.00202061	-0.661559	0.52 [0.34 - 0.79]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209612_s_at	136	0.588235	0.00148591	0.035456	-1.87359	0.0310747	-0.307205	0.74 [0.56 - 0.97]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209612_s_at	200	0.14	0.0626247	-	1.06129	0.89458	-0.016513	0.98 [0.77 - 1.26]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209613_s_at	200	0.755	0.0398	0.426312	-0.872553	0.824296	-0.0239437	0.98 [0.79 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209614_at	200	0.84	0.142248	-	-0.750946	0.889739	0.0195462	1.02 [0.77 - 1.34]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8884	60	0.433333	0.0588598	-	0.754064	0.248779	1.13566	3.11 [0.45 - 21.45]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8884	60	0.7	0.164516	-	0.531642	0.774572	0.0838315	1.09 [0.61 - 1.93]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15441	155	0.16129	2.45588e-05	0.00100446	-1.17263	0.0154888	-0.508253	0.60 [0.40 - 0.91]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209612_s_at	286	0.587413	0.0101322	0.163064	-0.528301	0.0298004	-0.179201	0.84 [0.71 - 0.98]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209613_s_at	286	0.58042	0.0502453	-	-0.395471	0.196334	-0.0817309	0.92 [0.81 - 1.04]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209614_at	286	0.118881	0.000613424	0.0168671	-0.833927	0.367863	-0.0925118	0.91 [0.75 - 1.11]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209613_s_at	159	0.641509	0.0306505	0.359382	-0.830708	0.0798334	-0.188112	0.83 [0.67 - 1.02]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209612_s_at	159	0.584906	0.00261114	0.0562989	-1.12973	0.094284	-0.200615	0.82 [0.65 - 1.03]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209612_s_at	159	0.584906	0.0018926	0.0432889	-1.52233	0.110151	-0.229011	0.80 [0.60 - 1.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209613_s_at	159	0.628931	0.00147748	0.0352893	-1.31244	0.0231214	-0.235697	0.79 [0.64 - 0.97]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209614_at	159	0.792453	0.0785186	-	-0.897085	0.765312	-0.0493287	0.95 [0.69 - 1.32]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209614_at	159	0.792453	0.0554694	-	-1.30841	0.424752	-0.156565	0.86 [0.58 - 1.26]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209612_s_at	159	0.584906	0.058718	-	-0.65776	0.274258	-0.137651	0.87 [0.68 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209613_s_at	159	0.628931	0.00231615	0.051069	-1.66071	0.015058	-0.302856	0.74 [0.58 - 0.94]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209614_at	159	0.805031	0.0129147	0.195365	-1.62084	0.15619	-0.23865	0.79 [0.57 - 1.10]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	243544_at	159	0.779874	0.0348202	0.391002	-1.06238	0.217434	-0.232131	0.79 [0.55 - 1.15]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	243544_at	159	0.132075	0.0977333	-	1.13895	0.748903	-0.0573369	0.94 [0.66 - 1.34]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	243544_at	159	0.779874	0.0285508	0.342663	-1.46966	0.24574	-0.258443	0.77 [0.50 - 1.19]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209614_at	54	0.833333	0.0730155	-	-15.8138	0.144357	-1.86171	0.16 [0.01 - 1.89]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209612_s_at	54	0.12963	0.0159838	0.228281	-1.59443	0.567683	-0.115733	0.89 [0.60 - 1.32]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209613_s_at	54	0.12963	0.0531804	-	-1.31993	0.295464	-0.243263	0.78 [0.50 - 1.24]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209614_at	117	0.803419	0.0263655	0.324637	-1.2512	0.537771	-0.249993	0.78 [0.35 - 1.72]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209614_at	117	0.538462	0.00909057	0.15024	1.04344	0.885535	-0.0539112	0.95 [0.45 - 1.97]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209614_at	117	0.803419	0.0263655	0.324637	-1.2512	0.537771	-0.249993	0.78 [0.35 - 1.72]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209612_s_at	117	0.897436	0.0428703	0.446896	-1.80062	0.450041	-0.0774664	0.93 [0.76 - 1.13]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209614_at	117	0.435897	0.0226513	0.292381	1.02009	0.689601	-0.181678	0.83 [0.34 - 2.03]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209612_s_at	117	0.376068	0.0307219	0.35994	1.02169	0.872194	0.0176413	1.02 [0.82 - 1.26]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209612_s_at	117	0.897436	0.177664	-	-1.28543	0.682414	-0.0501146	0.95 [0.75 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209612_s_at	117	0.897436	0.0428703	0.446896	-1.80062	0.450041	-0.0774664	0.93 [0.76 - 1.13]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209613_s_at	117	0.888889	0.0553894	-	-1.72052	0.588716	-0.0493842	0.95 [0.80 - 1.14]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209613_s_at	117	0.205128	0.0300983	0.355039	1.90718	0.643239	0.0459887	1.05 [0.86 - 1.27]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209613_s_at	117	0.205128	0.0358738	0.398684	1.85969	0.950485	-0.00668878	0.99 [0.80 - 1.23]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209613_s_at	117	0.888889	0.0553894	-	-1.72052	0.588716	-0.0493842	0.95 [0.80 - 1.14]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209613_s_at	236	0.118644	0.000516381	0.0145657	-1.08447	0.00109084	-0.320816	0.73 [0.60 - 0.88]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209614_at	236	0.855932	0.0381957	0.415207	-1.16429	0.821998	-0.0341444	0.97 [0.72 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209612_s_at	236	0.381356	0.000548446	0.0153337	-0.909188	0.00236434	-0.383316	0.68 [0.53 - 0.87]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	243544_at	236	0.347458	0.0204512	0.272195	-0.616354	0.918737	0.0202674	1.02 [0.69 - 1.51]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209614_at	249	0.863454	0.168604	-	-0.479625	0.957108	0.00625995	1.01 [0.80 - 1.26]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209612_s_at	249	0.37751	0.00478733	0.0914573	-0.591749	0.025165	-0.225404	0.80 [0.66 - 0.97]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209613_s_at	249	0.120482	0.00804701	0.13692	-0.736681	0.0292324	-0.174574	0.84 [0.72 - 0.98]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	243544_at	249	0.341365	0.00550585	0.102078	-0.584719	0.542177	-0.0964327	0.91 [0.67 - 1.24]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209613_s_at	125	0.792	0.220943	-	0.387706	0.781468	0.0234827	1.02 [0.87 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209613_s_at	54	0.148148	0.00216434	0.0483197	-1.67411	0.0212469	-0.575041	0.56 [0.34 - 0.92]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209614_at	125	0.104	0.0400434	0.427975	15.2404	0.651939	0.17931	1.20 [0.55 - 2.61]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209612_s_at	62	0.403226	0.000272785	0.00841495	-1.74504	0.00648005	-0.477108	0.62 [0.44 - 0.87]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209612_s_at	125	0.368	0.0697643	-	-0.67486	0.609033	-0.0665666	0.94 [0.72 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209614_at	62	0.258065	0.0142071	0.209538	-1.20538	0.271333	-0.325384	0.72 [0.40 - 1.29]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209614_at	54	0.240741	0.00468097	0.08985	-1.76221	0.278495	-0.392277	0.68 [0.33 - 1.37]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209613_s_at	62	0.290323	0.0033229	0.0683913	-1.36959	0.0260636	-0.39864	0.67 [0.47 - 0.95]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209612_s_at	125	0.368	0.0509254	-	-0.556745	0.952662	-0.00574079	0.99 [0.82 - 1.20]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209613_s_at	125	0.6	0.241327	-	-0.469247	0.85067	-0.0213959	0.98 [0.78 - 1.22]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209612_s_at	54	0.314815	0.000221229	0.00701688	-2.15149	0.0071804	-0.637972	0.53 [0.33 - 0.84]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209614_at	125	0.104	0.0943607	-	0.965642	0.632143	0.146165	1.16 [0.64 - 2.11]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209614_at	198	0.676768	0.0292619	0.348388	-0.669875	0.529439	-0.0527478	0.95 [0.80 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209614_at	198	0.676768	0.0646967	-	-0.594498	0.847886	-0.0171942	0.98 [0.82 - 1.17]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209613_s_at	198	0.181818	0.068142	-	0.582411	0.550018	0.0274693	1.03 [0.94 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209612_s_at	198	0.717172	0.0313445	0.364786	-0.701856	0.903871	-0.0071701	0.99 [0.88 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209612_s_at	198	0.717172	0.0771684	-	-0.607767	0.968492	-0.0025313	1.00 [0.88 - 1.13]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209613_s_at	198	0.691919	0.0973528	-	-0.498841	0.871277	0.00893658	1.01 [0.91 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209614_at	198	0.116162	0.204294	-	0.494909	0.738817	0.023278	1.02 [0.89 - 1.17]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209613_s_at	198	0.20202	0.0732265	-	0.755999	0.761976	0.0180083	1.02 [0.91 - 1.14]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209612_s_at	198	0.136364	0.0575864	-	0.696557	0.560517	0.0287216	1.03 [0.93 - 1.13]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209613_s_at	62	0.564516	0.0375421	0.410611	-1.4754	0.314843	-1.29971	0.27 [0.02 - 3.44]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209614_at	51	0.45098	0.113184	-	-1.59679	0.399736	-1.78155	0.17 [0.00 - 10.64]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209612_s_at	51	0.372549	0.0800171	-	15.7972	0.584326	-0.42306	0.66 [0.14 - 2.98]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209612_s_at	62	0.548387	0.101742	-	-1.04367	0.340906	-0.651277	0.52 [0.14 - 1.99]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209613_s_at	51	0.196078	0.199945	-	-1.11486	0.515035	-1.33718	0.26 [0.00 - 14.71]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209614_at	62	0.709677	0.0148407	0.216316	-15.6643	0.0682969	-2.62488	0.07 [0.00 - 1.22]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	243544_at	177	0.875706	0.00280263	0.0596211	-1.86285	0.0819599	-1.15512	0.32 [0.09 - 1.16]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	243544_at	177	0.875706	0.0178132	0.246781	-1.5488	0.313553	-0.765268	0.47 [0.11 - 2.06]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209614_at	177	0.898305	0.0289115	0.345575	0.707509	0.519605	0.242917	1.27 [0.61 - 2.67]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209613_s_at	177	0.548023	0.0334471	0.380809	0.571798	0.247812	0.0907417	1.09 [0.94 - 1.28]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	243544_at	145	0.22069	0.17326	-	0.646546	0.461282	0.642418	1.90 [0.34 - 10.50]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209614_at	145	0.2	0.123288	-	0.796961	0.548693	0.37413	1.45 [0.43 - 4.94]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209612_s_at	177	0.508475	0.0352059	0.393828	0.580625	0.274521	0.110844	1.12 [0.92 - 1.36]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209613_s_at	177	0.548023	0.0729965	-	0.417985	0.466148	0.0505936	1.05 [0.92 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209612_s_at	177	0.508475	0.117671	-	0.369645	0.418494	0.0728687	1.08 [0.90 - 1.28]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209613_s_at	145	0.875862	0.07161	-	0.744858	0.672705	0.04357	1.04 [0.85 - 1.28]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209612_s_at	145	0.848276	0.0686785	-	0.718092	0.727878	0.0480438	1.05 [0.80 - 1.38]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209614_at	177	0.898305	0.0318334	0.368558	0.770611	0.312464	0.407114	1.50 [0.68 - 3.31]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	243544_at	226	0.672566	0.237922	-	-0.378254	0.828278	-0.0285793	0.97 [0.75 - 1.26]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209614_at	226	0.889381	0.0499102	0.491084	0.708533	0.508283	0.0740616	1.08 [0.86 - 1.34]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209613_s_at	226	0.893805	0.052292	-	0.700907	0.413392	0.052371	1.05 [0.93 - 1.19]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209612_s_at	226	0.867257	0.0338893	0.384115	0.710715	0.557158	0.0478612	1.05 [0.89 - 1.23]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209614_at	55	0.709091	0.000496491	0.0140852	1.62054	0.000723706	1.3274	3.77 [1.75 - 8.14]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209613_s_at	55	0.454545	0.000445838	0.0128464	1.9107	0.00931412	0.245253	1.28 [1.06 - 1.54]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	243544_at	55	0.254545	0.00101276	0.0257577	-1.49847	0.0794765	-2.17753	0.11 [0.01 - 1.29]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209614_at	49	0.734694	0.000203015	0.00651163	1.97019	0.00495348	1.14803	3.15 [1.42 - 7.02]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	243544_at	49	0.897959	0.19961	-	-15.2084	0.682678	-0.502289	0.61 [0.05 - 6.73]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209612_s_at	55	0.636364	0.000334326	0.0100315	1.5422	0.00961677	0.348199	1.42 [1.09 - 1.84]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209613_s_at	55	0.781818	0.00647749	0.115855	1.35393	0.0123903	0.262816	1.30 [1.06 - 1.60]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209613_s_at	49	0.795918	0.000638789	0.0174578	1.7728	0.00911131	0.304137	1.36 [1.08 - 1.70]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209612_s_at	55	0.654545	0.00359897	0.0729088	1.41935	0.0233467	0.344649	1.41 [1.05 - 1.90]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	243544_at	55	0.781818	0.352081	-	-0.575431	0.766057	-0.289115	0.75 [0.11 - 5.03]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209612_s_at	49	0.693878	0.000994429	0.0253661	1.78719	0.0153812	0.404764	1.50 [1.08 - 2.08]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209614_at	55	0.690909	0.000130526	0.00442645	1.59481	0.00360803	1.04772	2.85 [1.41 - 5.77]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	727553	34	0.323529	0.113633	-	0.798267	0.881957	0.0374113	1.04 [0.63 - 1.70]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	307231	34	0.852941	0.0593395	-	-1.73189	0.989376	-0.00199346	1.00 [0.74 - 1.34]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209614_at	63	0.587302	0.000567694	0.0157911	-1.30453	0.221384	-3.19117	0.04 [0.00 - 6.85]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209613_s_at	63	0.126984	0.00864006	0.144551	-1.07407	0.0974836	-7.67934	0.00 [0.00 - 4.07]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209612_s_at	63	0.15873	0.00116274	0.028913	-1.20036	0.00848354	-19.0182	0.00 [0.00 - 0.01]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	243544_at	63	0.190476	0.00109782	0.0275576	-1.1487	0.74298	0.806831	2.24 [0.02 - 278.51]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.282347.0.A1_3p_at	28	0.571429	0.0292312	0.348142	-1.27573	0.420706	-0.756907	0.47 [0.07 - 2.96]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178099_3p_a_at	28	0.75	0.0608934	-	-1.3795	0.339868	-0.770403	0.46 [0.10 - 2.25]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5002378_3p_at	28	0.892857	0.0252915	0.315529	1.3775	0.0706134	0.701151	2.02 [0.94 - 4.31]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178097_3p_a_at	28	0.714286	0.0499211	0.49115	-1.42805	0.329643	-5.13796	0.01 [0.00 - 179.90]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209613_s_at	82	0.256098	0.00846627	0.142332	-0.897113	0.234228	-0.207176	0.81 [0.58 - 1.14]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209614_at	82	0.329268	0.0450577	0.461057	-0.684644	0.483842	-0.268124	0.76 [0.36 - 1.62]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209612_s_at	82	0.353659	0.0829744	-	0.688862	0.935945	0.0215443	1.02 [0.60 - 1.73]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209614_at	79	0.303797	0.180308	-	-0.371051	0.629437	-0.160557	0.85 [0.44 - 1.63]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209613_s_at	79	0.64557	0.0971821	-	0.429664	0.943918	-0.00904782	0.99 [0.77 - 1.28]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209612_s_at	79	0.78481	0.310905	-	0.302519	0.867704	-0.0348081	0.97 [0.64 - 1.45]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X03350_at	86	0.348837	0.00628964	0.11324	-1.07195	0.160816	-0.274751	0.76 [0.52 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209612_s_at	104	0.615385	0.0206047	0.273632	-0.941119	0.0786272	-0.428134	0.65 [0.40 - 1.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209613_s_at	104	0.134615	0.0154392	0.222622	-0.94197	0.0564832	-0.306287	0.74 [0.54 - 1.01]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209614_at	104	0.288462	0.00526763	0.0986008	-0.886825	0.072008	-0.567897	0.57 [0.31 - 1.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209612_s_at	204	0.642157	0.000467296	0.0133739	-2.1335	0.0156673	-0.191273	0.83 [0.71 - 0.96]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209612_s_at	204	0.303922	4.05134e-07	2.35991e-05	-1.30362	8.2598e-06	-0.253752	0.78 [0.69 - 0.87]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209614_at	204	0.362745	3.47017e-05	0.00136897	-1.50819	0.003801	-0.291288	0.75 [0.61 - 0.91]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	243544_at	204	0.691176	0.225371	-	-0.547101	0.555708	-0.116404	0.89 [0.60 - 1.31]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209614_at	204	0.289216	2.2955e-08	1.61797e-06	-1.42035	1.12633e-05	-0.32497	0.72 [0.62 - 0.84]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	243544_at	204	0.171569	0.111807	-	-0.501158	0.220405	-0.185269	0.83 [0.62 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209613_s_at	204	0.52451	5.55373e-05	0.00208154	-1.87842	0.00573591	-0.213924	0.81 [0.69 - 0.94]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209613_s_at	204	0.328431	1.1694e-07	7.43009e-06	-1.37336	9.48856e-07	-0.272543	0.76 [0.68 - 0.85]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209613_s_at	178	0.292135	0.0307898	0.360471	-0.441442	0.208104	-0.106432	0.90 [0.76 - 1.06]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209614_at	178	0.168539	0.0117841	0.182556	-0.581481	0.143009	-0.338742	0.71 [0.45 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209612_s_at	178	0.623595	0.071839	-	-0.390589	0.261418	-0.157892	0.85 [0.65 - 1.12]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209614_at	111	0.108108	0.00662513	0.117896	-0.95862	0.186041	-0.192966	0.82 [0.62 - 1.10]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209613_s_at	111	0.45045	0.0234186	0.299224	-0.592974	0.133364	-0.118967	0.89 [0.76 - 1.04]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	243544_at	111	0.711712	0.0595575	-	0.510219	0.31589	0.132304	1.14 [0.88 - 1.48]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209612_s_at	111	0.495495	0.0441658	0.455332	-0.529949	0.0683628	-0.205467	0.81 [0.65 - 1.02]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209613_s_at	90	0.111111	0.0269089	0.329182	-0.903942	0.607901	-0.0579097	0.94 [0.76 - 1.18]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209613_s_at	90	0.111111	0.0272442	0.331965	-0.978052	0.367614	-0.126188	0.88 [0.67 - 1.16]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209614_at	90	0.844444	0.138604	-	-1.03861	0.229283	-0.805362	0.45 [0.12 - 1.66]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209614_at	90	0.144444	0.0522748	-	-0.724907	0.1994	-0.754104	0.47 [0.15 - 1.49]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209612_s_at	90	0.144444	0.255607	-	-0.472243	0.745096	-0.037338	0.96 [0.77 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209612_s_at	90	0.188889	0.132996	-	-0.615199	0.398336	-0.119737	0.89 [0.67 - 1.17]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	243544_at	138	0.442029	0.0452854	0.462507	-0.481454	0.0601752	-5.20729	0.01 [0.00 - 1.25]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209612_s_at	138	0.826087	0.0295624	0.350788	-0.844351	0.330005	-0.0462992	0.95 [0.87 - 1.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209614_at	138	0.166667	0.0337999	0.383448	-0.600322	0.126923	-0.201024	0.82 [0.63 - 1.06]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209613_s_at	138	0.768116	0.0166743	0.235354	-0.799559	0.464353	-0.0326265	0.97 [0.89 - 1.06]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209612_s_at	129	0.852713	0.103793	-	0.544457	0.855753	0.0216445	1.02 [0.81 - 1.29]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209613_s_at	129	0.217054	0.123865	-	0.523679	0.665795	0.0463589	1.05 [0.85 - 1.29]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209614_at	129	0.465116	0.127221	-	-0.374392	0.620308	-0.0895213	0.91 [0.64 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23772	56	0.785714	0.0433148	0.449807	0.748727	0.489303	0.111965	1.12 [0.81 - 1.54]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41126	56	0.107143	0.00209213	0.046997	-1.3427	0.768969	-0.0268234	0.97 [0.81 - 1.16]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6271	56	0.732143	0.0160562	0.229028	0.870214	0.590968	0.081654	1.09 [0.81 - 1.46]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23772	56	0.785714	0.089112	-	0.663027	0.904009	0.0203351	1.02 [0.73 - 1.42]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6271	56	0.732143	0.0513546	-	0.737009	0.977021	-0.00474118	1.00 [0.72 - 1.37]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41126	56	0.107143	0.0210005	0.277316	-1.01833	0.951244	0.00520706	1.01 [0.85 - 1.19]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209614_at	278	0.622302	6.31905e-06	0.000294559	0.839298	0.00144832	0.346136	1.41 [1.14 - 1.75]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	243544_at	278	0.100719	0.0114718	0.178945	1.05366	0.0914863	1.32847	3.78 [0.81 - 17.66]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209613_s_at	278	0.625899	3.16312e-05	0.00126013	0.768782	0.00103473	0.118353	1.13 [1.05 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209612_s_at	278	0.600719	5.34459e-05	0.00201174	0.750357	0.00204827	0.114005	1.12 [1.04 - 1.21]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209614_at	133	0.593985	0.00103369	0.0262033	0.76425	0.112501	0.498977	1.65 [0.89 - 3.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209612_s_at	133	0.255639	0.0128566	0.194717	0.770572	0.398269	-0.0629954	0.94 [0.81 - 1.09]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209613_s_at	133	0.300752	0.0226696	0.292546	0.616866	0.457271	-0.06005	0.94 [0.80 - 1.10]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	239	81	0.17284	0.20404	-	-0.683824	0.596355	-0.0985053	0.91 [0.63 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16493	81	0.691358	0.1959	-	-0.815649	0.421236	-0.182023	0.83 [0.53 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209613_s_at	185	0.848649	0.00113295	0.0282929	0.731238	0.0142204	0.137605	1.15 [1.03 - 1.28]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209614_at	185	0.308108	0.0275142	0.334194	0.432135	0.187084	0.264331	1.30 [0.88 - 1.93]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209612_s_at	185	0.145946	0.00108005	0.0271837	0.793931	0.00932747	0.153855	1.17 [1.04 - 1.31]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209613_s_at	185	0.848649	0.00335018	0.0688417	0.706115	0.0135118	0.146006	1.16 [1.03 - 1.30]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209612_s_at	185	0.156757	0.000352325	0.010495	1.0127	0.00911747	0.162897	1.18 [1.04 - 1.33]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209614_at	185	0.897297	0.0778912	-	0.45658	0.235637	0.224186	1.25 [0.86 - 1.81]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209612_s_at	80	0.35	0.0670168	-	0.986706	0.826793	0.020688	1.02 [0.85 - 1.23]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209614_at	80	0.275	0.0714186	-	1.08254	0.7301	0.0483012	1.05 [0.80 - 1.38]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209613_s_at	80	0.875	0.260589	-	-1.09797	0.841696	-0.0143218	0.99 [0.86 - 1.13]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_4261	281	0.188612	0.0627131	-	0.344347	0.685207	0.0308196	1.03 [0.89 - 1.20]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:307231	59	0.728814	0.40047	-	-0.525666	0.69226	-0.383641	0.68 [0.10 - 4.55]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:61574	59	0.372881	0.266778	-	-0.532906	0.807495	-0.149546	0.86 [0.26 - 2.87]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209614_at	38	0.868421	0.048849	0.484673	-15.3275	0.53245	-0.210359	0.81 [0.42 - 1.57]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209613_s_at	38	0.131579	0.0142029	0.209492	-1.25427	0.0175922	-0.385491	0.68 [0.49 - 0.93]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	243544_at	38	0.631579	0.0588018	-	-0.947883	0.831179	-0.059069	0.94 [0.55 - 1.62]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209612_s_at	38	0.815789	0.0120611	0.185732	-15.483	0.0821777	-0.419319	0.66 [0.41 - 1.05]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209613_s_at	140	0.528571	1.88559e-05	0.000792144	-1.45431	0.000204789	-0.238562	0.79 [0.69 - 0.89]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209614_at	140	0.6	1.75664e-05	0.0007432	-1.67403	0.00141905	-0.505952	0.60 [0.44 - 0.82]
GENE	ADH1B	alcohol dehydrogenase 1B (class I), beta polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209612_s_at	140	0.514286	3.97897e-05	0.00154687	-1.35729	0.000464346	-0.22287	0.80 [0.71 - 0.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206262_at	30	0.366667	0.337839	-	0.418324	0.628927	0.217332	1.24 [0.51 - 3.00]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1740717	165	0.878788	0.0713414	-	0.566412	0.843483	-0.0150734	0.99 [0.85 - 1.14]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1740717	165	0.721212	0.22317	-	-0.545847	0.494853	-0.0819139	0.92 [0.73 - 1.17]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206262_at	163	0.638037	0.0290733	0.346876	-0.46594	0.544422	-0.318226	0.73 [0.26 - 2.04]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206262_at	79	0.227848	6.46877e-05	0.00238324	-1.17528	0.0128337	-2.44477	0.09 [0.01 - 0.60]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206262_at	58	0.810345	0.294715	-	-0.368843	0.740863	-0.0408298	0.96 [0.75 - 1.22]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206262_at	34	0.205882	0.270261	-	-0.510852	0.962073	0.0107435	1.01 [0.65 - 1.57]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206262_at	158	0.683544	0.0207795	0.275263	0.539492	0.699883	0.152968	1.17 [0.54 - 2.54]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206262_at	53	0.792453	0.0652501	-	0.712671	0.920451	0.0191468	1.02 [0.70 - 1.48]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206262_at	53	0.792453	0.00583466	0.106811	1.07796	0.266481	0.226536	1.25 [0.84 - 1.87]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206262_at	180	0.322222	0.054444	-	0.459604	0.358363	0.0795035	1.08 [0.91 - 1.28]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206262_at	559	0.209302	0.00757401	0.130711	-0.581016	0.0496358	-0.239361	0.79 [0.62 - 1.00]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206262_at	77	0.480519	0.238582	-	0.299293	0.831401	0.0321091	1.03 [0.77 - 1.39]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206262_at	70	0.114286	0.007245	0.126324	-1.01331	0.0876987	-1.74871	0.17 [0.02 - 1.29]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36247_f_at	50	0.38	0.0153025	0.221189	-0.833579	0.301386	-0.662415	0.52 [0.15 - 1.81]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206262_at	74	0.878378	0.00704434	0.12362	1.04206	0.299246	0.197967	1.22 [0.84 - 1.77]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206262_at	67	0.895522	0.000460675	0.0132116	2.22668	0.0945825	1.89149	6.63 [0.72 - 60.90]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206262_at	115	0.878261	0.282575	-	0.682788	0.616659	0.247725	1.28 [0.49 - 3.38]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36247_f_at	158	0.120253	0.0472855	0.475072	-0.721741	0.852497	-0.0345632	0.97 [0.67 - 1.39]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36247_f_at	76	0.605263	0.0320901	0.370527	-1.48948	0.330823	-0.310901	0.73 [0.39 - 1.37]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206262_at	204	0.877451	0.374395	-	0.198039	0.968884	0.00226519	1.00 [0.89 - 1.12]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206262_at	87	0.356322	0.0148475	0.216388	-0.901812	0.137816	-0.73092	0.48 [0.18 - 1.26]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206262_at	87	0.356322	0.0148475	0.216388	-0.901812	0.137816	-0.73092	0.48 [0.18 - 1.26]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206262_at	77	0.623377	0.0134951	0.201789	-2.14098	0.254404	-0.959264	0.38 [0.07 - 1.99]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206262_at	77	0.38961	0.0233164	0.298318	-1.44066	0.238646	-1.21526	0.30 [0.04 - 2.24]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206262_at	136	0.257353	0.00108207	0.0272264	-1.41225	0.00783343	-0.59324	0.55 [0.36 - 0.86]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206262_at	200	0.325	0.124991	-	-0.461846	0.757827	-0.0451769	0.96 [0.72 - 1.27]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21361	60	0.65	0.0271189	0.330927	0.819849	0.0253498	0.217895	1.24 [1.03 - 1.51]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21361	60	0.733333	0.0354164	0.395364	0.794123	0.350304	0.111643	1.12 [0.88 - 1.41]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206262_at	286	0.615385	0.00419538	0.0823864	-0.607532	0.210888	-0.117721	0.89 [0.74 - 1.07]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206262_at	159	0.201258	0.0733524	-	-0.608534	0.346724	-0.152636	0.86 [0.62 - 1.18]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206262_at	159	0.220126	0.121936	-	-0.595578	0.556708	-0.111737	0.89 [0.62 - 1.30]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206262_at	159	0.874214	0.182867	-	0.548024	0.939265	-0.0123881	0.99 [0.72 - 1.36]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206262_at	54	0.833333	0.334528	-	-15.1789	0.708562	-0.741483	0.48 [0.01 - 23.26]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206262_at	117	0.222222	0.0182428	0.251016	1.17687	0.665776	0.258336	1.29 [0.40 - 4.18]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206262_at	117	0.222222	0.0648333	-	1.07723	0.386977	0.527048	1.69 [0.51 - 5.59]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206262_at	117	0.871795	0.119428	-	-1.45076	0.363709	-0.917071	0.40 [0.06 - 2.89]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206262_at	117	0.222222	0.0182428	0.251016	1.17687	0.665776	0.258336	1.29 [0.40 - 4.18]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206262_at	236	0.838983	0.116011	-	-0.720853	0.568865	-0.0894162	0.91 [0.67 - 1.24]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206262_at	249	0.835341	0.0238608	0.303123	-0.814546	0.336866	-0.118689	0.89 [0.70 - 1.13]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206262_at	62	0.354839	0.116377	-	-0.76268	0.775953	-0.115373	0.89 [0.40 - 1.97]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206262_at	125	0.456	0.04207	0.441612	-0.774836	0.775867	-0.247838	0.78 [0.14 - 4.30]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206262_at	125	0.456	0.359598	-	-0.264009	0.969915	-0.0234263	0.98 [0.29 - 3.30]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206262_at	54	0.685185	0.102015	-	-1.22557	0.398008	-0.427027	0.65 [0.24 - 1.76]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206262_at	198	0.116162	0.0520638	-	-0.638279	0.988182	-0.00111435	1.00 [0.86 - 1.16]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206262_at	198	0.116162	0.122155	-	-0.534221	0.633178	0.0375396	1.04 [0.89 - 1.21]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206262_at	198	0.136364	0.193518	-	-0.366757	0.809873	0.0151502	1.02 [0.90 - 1.15]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206262_at	51	0.568627	0.0361786	0.400885	-16.0864	0.256878	-1.11285	0.33 [0.05 - 2.25]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206262_at	62	0.629032	0.0134231	0.200998	-2.14981	0.162122	-0.349871	0.70 [0.43 - 1.15]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206262_at	145	0.544828	0.0115451	0.179794	-0.909303	0.0821483	-0.251366	0.78 [0.59 - 1.03]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206262_at	177	0.418079	0.0023177	0.051097	-0.818631	0.0312277	-0.255101	0.77 [0.61 - 0.98]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206262_at	177	0.418079	0.0111443	0.175122	-0.592148	0.224206	-0.119255	0.89 [0.73 - 1.08]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206262_at	226	0.623894	0.0178691	0.247334	-0.76615	0.0765209	-0.102965	0.90 [0.81 - 1.01]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206262_at	55	0.581818	0.042924	0.447249	0.897189	0.331959	0.148282	1.16 [0.86 - 1.56]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206262_at	55	0.254545	0.240705	-	-0.563767	0.60843	-0.0873811	0.92 [0.66 - 1.28]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206262_at	49	0.632653	0.145017	-	0.831018	0.375167	0.186234	1.20 [0.80 - 1.82]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206262_at	63	0.111111	0.0110012	0.173439	-1.10214	0.397096	-2.87323	0.06 [0.00 - 43.68]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11496888_3p_at	28	0.892857	0.0902675	-	1.06919	0.836387	-0.317367	0.73 [0.04 - 14.80]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206262_at	82	0.134146	0.022189	0.28821	-0.948764	0.512263	-0.0757042	0.93 [0.74 - 1.16]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206262_at	79	0.898734	0.117309	-	0.627811	0.55223	0.0594677	1.06 [0.87 - 1.29]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206262_at	104	0.711538	0.0116164	0.180621	-1.25588	0.137882	-0.183659	0.83 [0.65 - 1.06]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P81158	117	0.461538	0.0174964	0.243631	-0.678682	0.306455	-0.0895375	0.91 [0.77 - 1.09]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206262_at	204	0.284314	2.30257e-06	0.000117156	-1.61367	0.000464104	-0.459171	0.63 [0.49 - 0.82]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206262_at	204	0.27451	2.5136e-06	0.00012696	-1.21084	0.00058867	-0.336939	0.71 [0.59 - 0.87]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206262_at	178	0.522472	0.0144637	0.212295	-0.488685	0.219578	-0.0860193	0.92 [0.80 - 1.05]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206262_at	111	0.324324	0.032183	0.371238	-0.563904	0.0650985	-0.207514	0.81 [0.65 - 1.01]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206262_at	90	0.233333	0.102579	-	-0.562606	0.495999	-0.184982	0.83 [0.49 - 1.42]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206262_at	90	0.755556	0.325344	-	-0.479451	0.335285	-0.338601	0.71 [0.36 - 1.42]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206262_at	138	0.268116	0.0131238	0.197691	-0.62413	0.502221	-0.0367038	0.96 [0.87 - 1.07]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206262_at	129	0.379845	0.115829	-	-0.391579	0.431162	-0.0751558	0.93 [0.77 - 1.12]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40925	56	0.107143	0.00209213	0.046997	-1.3427	0.940715	-0.00843583	0.99 [0.79 - 1.24]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40925	56	0.107143	0.0210005	0.277316	-1.01833	0.622599	0.0521101	1.05 [0.86 - 1.30]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206262_at	278	0.521583	0.00969927	0.157788	0.493992	0.690212	0.0491541	1.05 [0.82 - 1.34]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206262_at	133	0.706767	0.0060659	0.110095	0.684189	0.0437025	0.44434	1.56 [1.01 - 2.40]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16647	81	0.432099	0.0722526	-	-0.919657	0.375836	-0.17832	0.84 [0.56 - 1.24]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206262_at	185	0.281081	0.00435118	0.0848044	0.522892	0.225817	0.394962	1.48 [0.78 - 2.81]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206262_at	185	0.291892	0.00227727	0.0503689	0.618012	0.289778	0.375705	1.46 [0.73 - 2.92]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P81158	110	0.427273	0.131018	-	-0.346755	0.674003	0.0351676	1.04 [0.88 - 1.22]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P81158	110	0.363636	0.12324	-	-0.451454	0.951742	-0.00669336	0.99 [0.80 - 1.23]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206262_at	80	0.7	0.117176	-	-0.944266	0.585843	-0.0909344	0.91 [0.66 - 1.27]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:61574	59	0.372881	0.266778	-	-0.532906	0.807495	-0.149546	0.86 [0.26 - 2.87]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206262_at	38	0.763158	0.0119798	0.184802	1.26634	0.0779116	0.757759	2.13 [0.92 - 4.95]
GENE	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206262_at	140	0.178571	0.000116414	0.00400338	-1.1097	0.0260262	-0.332121	0.72 [0.54 - 0.96]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1797912	165	0.266667	0.00798577	0.136123	0.916452	0.000629839	0.898143	2.46 [1.47 - 4.11]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1797912	165	0.242424	0.108977	-	0.832775	0.64458	-0.586227	0.56 [0.05 - 6.72]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	223781_x_at	163	0.453988	0.0125041	0.190759	0.503847	0.492401	0.213766	1.24 [0.67 - 2.28]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231703_s_at	163	0.858896	0.0665632	-	-0.557861	0.268945	-0.840218	0.43 [0.10 - 1.91]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231675_s_at	163	0.159509	0.095049	-	0.508015	0.404015	0.760121	2.14 [0.36 - 12.75]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231678_s_at	163	0.325153	0.0119397	0.184343	-0.508211	0.136492	-1.28099	0.28 [0.05 - 1.50]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231678_s_at	79	0.265823	0.0576	-	-0.580909	0.42157	-0.846384	0.43 [0.05 - 3.38]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	223781_x_at	79	0.151899	0.0617765	-	0.942752	0.227512	0.447003	1.56 [0.76 - 3.23]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231675_s_at	79	0.78481	0.17337	-	-0.524574	0.573386	-0.552199	0.58 [0.08 - 3.94]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231703_s_at	79	0.835443	0.307035	-	-0.416259	0.742365	-0.323098	0.72 [0.11 - 4.97]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231703_s_at	180	0.35	0.00111742	0.0279685	0.791959	0.0164509	0.224589	1.25 [1.04 - 1.50]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231675_s_at	180	0.283333	0.0900995	-	0.433297	0.579542	0.06035	1.06 [0.86 - 1.32]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231678_s_at	180	0.883333	0.0977595	-	0.497876	0.962632	0.00390916	1.00 [0.85 - 1.18]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	223781_x_at	180	0.838889	0.0727101	-	0.469793	0.890432	-0.0390652	0.96 [0.55 - 1.68]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231678_s_at	559	0.169946	0.100979	-	-0.415749	0.400022	-0.0919597	0.91 [0.74 - 1.13]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	223781_x_at	559	0.898032	0.00133324	0.032405	0.769769	0.0500384	0.289378	1.34 [1.00 - 1.78]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231675_s_at	559	0.593918	0.0818026	-	-0.35951	0.36347	-0.117355	0.89 [0.69 - 1.15]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231703_s_at	559	0.116279	0.00494286	0.0937906	-0.733412	0.0100573	-0.303875	0.74 [0.59 - 0.93]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231675_s_at	77	0.207792	0.135966	-	0.492663	0.572464	0.0908582	1.10 [0.80 - 1.50]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231678_s_at	77	0.727273	0.0337212	0.382861	-0.638531	0.490072	0.103602	1.11 [0.83 - 1.49]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	223781_x_at	77	0.792208	0.00498534	0.0944244	-0.989687	0.0710337	-0.598494	0.55 [0.29 - 1.05]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231703_s_at	77	0.636364	0.0137057	0.204096	-0.673473	0.225685	-0.172987	0.84 [0.64 - 1.11]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231678_s_at	70	0.685714	0.378395	-	-0.256343	0.937703	-0.107223	0.90 [0.06 - 13.22]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	223781_x_at	70	0.728571	0.0239069	0.303528	0.636737	0.866504	-0.141191	0.87 [0.17 - 4.50]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231675_s_at	70	0.785714	0.000415169	0.0120851	1.06142	0.00868978	4.17858	65.27 [2.88 - 1479.92]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231703_s_at	70	0.257143	0.192557	-	0.410029	0.9879	0.0217186	1.02 [0.06 - 16.92]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231678_s_at	74	0.878378	0.00677493	0.119953	1.02435	0.840202	-0.0330338	0.97 [0.70 - 1.33]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	223781_x_at	74	0.216216	0.00951144	0.155475	-0.832805	0.619559	-0.201925	0.82 [0.37 - 1.81]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231703_s_at	74	0.581081	0.0703472	-	-0.549992	0.397231	-0.174616	0.84 [0.56 - 1.26]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231675_s_at	74	0.148649	0.026572	0.326369	1.10596	0.0746858	0.38589	1.47 [0.96 - 2.25]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231703_s_at	67	0.149254	0.161108	-	15.3311	0.631225	1.85422	6.39 [0.00 - 12401.38]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231678_s_at	67	0.820895	0.182192	-	-15.313	0.449867	-3.36194	0.03 [0.00 - 212.38]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231675_s_at	67	0.671642	0.0401956	0.429013	-15.6482	0.616031	-1.85184	0.16 [0.00 - 218.31]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	223781_x_at	67	0.104478	0.214037	-	-0.961178	0.259815	-1.82589	0.16 [0.01 - 3.86]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231678_s_at	115	0.4	0.0414432	0.437435	1.43301	0.954258	0.0340483	1.03 [0.32 - 3.31]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231703_s_at	115	0.104348	0.00667497	0.118582	-1.4747	0.648735	-0.239663	0.79 [0.28 - 2.21]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	223781_x_at	115	0.243478	0.289075	-	-0.586775	0.941868	0.0526665	1.05 [0.26 - 4.34]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231675_s_at	115	0.782609	0.157126	-	-1.36115	0.956804	-0.0222441	0.98 [0.44 - 2.19]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231675_s_at	204	0.377451	0.000300765	0.00915632	-0.524506	0.0169439	-0.214321	0.81 [0.68 - 0.96]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	223781_x_at	204	0.284314	0.0950701	-	-0.257936	0.688655	-0.0550999	0.95 [0.72 - 1.24]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231703_s_at	204	0.235294	0.0273059	0.332475	-0.36535	0.262979	-0.0907549	0.91 [0.78 - 1.07]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231678_s_at	204	0.401961	0.0657878	-	0.269584	0.325294	0.0570589	1.06 [0.94 - 1.19]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231678_s_at	87	0.126437	0.0139452	0.206703	-1.09816	0.272145	-1.32777	0.27 [0.02 - 2.84]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	223781_x_at	87	0.83908	0.0800555	-	-1.60496	0.545644	-0.504769	0.60 [0.12 - 3.10]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	223781_x_at	87	0.83908	0.0800555	-	-1.60496	0.545644	-0.504769	0.60 [0.12 - 3.10]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231675_s_at	87	0.873563	0.00187728	0.0430008	1.29912	0.00588326	2.58913	13.32 [2.11 - 84.07]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231675_s_at	87	0.873563	0.00187728	0.0430008	1.29912	0.00588326	2.58913	13.32 [2.11 - 84.07]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231678_s_at	87	0.126437	0.0139452	0.206703	-1.09816	0.272145	-1.32777	0.27 [0.02 - 2.84]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231703_s_at	87	0.45977	0.137386	-	0.592696	0.214741	1.78033	5.93 [0.36 - 98.79]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231703_s_at	87	0.45977	0.137386	-	0.592696	0.214741	1.78033	5.93 [0.36 - 98.79]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231678_s_at	77	0.896104	0.0968042	-	1.04551	0.856669	0.377274	1.46 [0.02 - 87.48]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	223781_x_at	77	0.428571	0.0221543	0.287895	1.58955	0.289602	1.20143	3.32 [0.36 - 30.72]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231675_s_at	77	0.727273	0.00184529	0.0423974	1.60358	0.0482897	4.16002	64.07 [1.03 - 3979.21]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	223781_x_at	77	0.428571	0.0193174	0.261444	2.07659	0.254613	1.43334	4.19 [0.36 - 49.37]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231675_s_at	77	0.727273	0.0696572	-	1.09442	0.642003	1.12144	3.07 [0.03 - 347.02]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231703_s_at	77	0.298701	0.061322	-	1.72598	0.879311	0.252708	1.29 [0.05 - 33.61]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231678_s_at	77	0.896104	0.0236341	0.301128	1.43614	0.916203	-0.260812	0.77 [0.01 - 99.24]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231703_s_at	77	0.298701	0.0329368	0.376968	15.6167	0.657091	-1.00239	0.37 [0.00 - 30.67]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6148	60	0.25	0.0360561	0.400002	-0.847615	0.710629	-0.200646	0.82 [0.28 - 2.36]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6148	60	0.35	0.00295332	0.0621983	-1.09546	0.0879884	-0.962616	0.38 [0.13 - 1.15]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13826	155	0.174194	0.00654195	0.116748	-0.789534	0.169111	-0.277657	0.76 [0.51 - 1.13]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231678_s_at	159	0.100629	0.154161	-	-0.621894	0.657763	-0.0814928	0.92 [0.64 - 1.32]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223781_x_at	159	0.559748	0.039827	0.426497	-0.696005	0.27619	-0.44639	0.64 [0.29 - 1.43]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231678_s_at	159	0.610063	0.0564293	-	0.698458	0.337482	0.228451	1.26 [0.79 - 2.00]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223781_x_at	159	0.264151	0.185946	-	-0.435613	0.771759	-0.120032	0.89 [0.39 - 2.00]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231703_s_at	159	0.106918	0.0122862	0.188294	-0.954593	0.363273	-0.202667	0.82 [0.53 - 1.26]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223781_x_at	159	0.559748	0.103611	-	-0.642928	0.384313	-0.418741	0.66 [0.26 - 1.69]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231703_s_at	159	0.106918	0.000182566	0.0059363	-1.28087	0.33915	-0.212188	0.81 [0.52 - 1.25]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231675_s_at	159	0.553459	0.115442	-	0.495625	0.554	0.128641	1.14 [0.74 - 1.74]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231703_s_at	159	0.106918	0.0230068	0.295564	-1.0011	0.626165	-0.127167	0.88 [0.53 - 1.47]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231675_s_at	159	0.553459	0.0592396	-	0.595259	0.338812	0.207236	1.23 [0.80 - 1.88]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231675_s_at	159	0.553459	0.0800519	-	0.649106	0.31577	0.256447	1.29 [0.78 - 2.13]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231678_s_at	159	0.610063	0.111335	-	0.498656	0.513915	0.126771	1.14 [0.78 - 1.66]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231675_s_at	236	0.79661	0.0860686	-	0.503367	0.389681	0.164029	1.18 [0.81 - 1.71]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231678_s_at	236	0.898305	0.000125665	0.00428149	1.18612	0.706511	0.0618869	1.06 [0.77 - 1.47]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	223781_x_at	236	0.894068	0.00911081	0.150493	0.885735	0.81068	0.0905329	1.09 [0.52 - 2.30]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231703_s_at	236	0.771186	0.0405689	0.431547	0.591394	0.38348	0.176181	1.19 [0.80 - 1.77]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231675_s_at	249	0.799197	0.0948606	-	0.403586	0.636841	0.0729059	1.08 [0.79 - 1.46]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231678_s_at	249	0.899598	0.000499219	0.0141513	0.956493	0.335829	0.128606	1.14 [0.88 - 1.48]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	223781_x_at	249	0.891566	0.0450839	0.461224	0.5945	0.966323	-0.0127939	0.99 [0.55 - 1.79]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231703_s_at	249	0.297189	0.0650559	-	0.464167	0.528499	0.0995564	1.10 [0.81 - 1.51]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231678_s_at	145	0.103448	0.0248638	0.311854	-0.979697	0.753109	0.136439	1.15 [0.49 - 2.68]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	223781_x_at	145	0.710345	0.077502	-	0.592796	0.46768	0.632371	1.88 [0.34 - 10.37]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231675_s_at	145	0.324138	0.0699395	-	-0.605567	0.845051	-0.315389	0.73 [0.03 - 17.25]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231678_s_at	177	0.186441	0.00377222	0.0756999	-0.845875	0.124583	-0.786951	0.46 [0.17 - 1.24]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231703_s_at	177	0.288136	0.00850105	0.142777	-0.617497	0.098774	-1.68992	0.18 [0.02 - 1.37]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231703_s_at	177	0.19774	0.0438234	0.453116	-0.594114	0.15994	-1.66	0.19 [0.02 - 1.93]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231703_s_at	145	0.813793	0.177571	-	-0.70186	0.355726	-1.28687	0.28 [0.02 - 4.24]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231678_s_at	177	0.186441	0.0783932	-	-0.49761	0.988691	-0.00377105	1.00 [0.59 - 1.68]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	223781_x_at	177	0.186441	0.136686	-	-0.422871	0.745724	0.187599	1.21 [0.39 - 3.75]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	223781_x_at	177	0.887006	0.160153	-	-0.721673	0.945884	-0.0446733	0.96 [0.26 - 3.47]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231675_s_at	177	0.282486	0.0214211	0.281201	-0.554209	0.150726	-1.62221	0.20 [0.02 - 1.80]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231675_s_at	177	0.282486	0.0654015	-	-0.514604	0.196574	-1.67879	0.19 [0.01 - 2.39]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231703_s_at	226	0.176991	0.0397865	0.426219	-0.657885	0.520375	-0.0857954	0.92 [0.71 - 1.19]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231678_s_at	226	0.610619	0.0208537	0.275954	-0.749245	0.413421	-0.0783003	0.92 [0.77 - 1.12]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	223781_x_at	226	0.880531	0.0188403	0.256843	0.785039	0.104553	0.315153	1.37 [0.94 - 2.01]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231675_s_at	226	0.300885	0.088275	-	0.618087	0.665609	-0.0521411	0.95 [0.75 - 1.20]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	223781_x_at	55	0.6	0.0504584	-	-1.07259	0.258751	-1.10225	0.33 [0.05 - 2.25]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231675_s_at	55	0.636364	0.0167505	0.236128	1.17644	0.229733	1.91636	6.80 [0.30 - 155.04]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	223781_x_at	49	0.387755	0.404633	-	0.549473	0.784844	-0.300641	0.74 [0.09 - 6.41]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231675_s_at	49	0.673469	0.0149346	0.217311	1.34609	0.0691006	3.4803	32.47 [0.76 - 1384.28]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231678_s_at	55	0.472727	0.00281056	0.0597575	1.69573	0.248952	0.687403	1.99 [0.62 - 6.40]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231703_s_at	55	0.290909	0.00382254	0.0765046	-1.31995	0.0216532	-5.58804	0.00 [0.00 - 0.44]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231678_s_at	55	0.890909	0.0530781	-	1.04465	0.403223	0.523115	1.69 [0.49 - 5.75]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	223781_x_at	55	0.6	0.064166	-	-0.925316	0.221311	-1.12104	0.33 [0.05 - 1.96]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231675_s_at	55	0.636364	0.012044	0.185537	1.08794	0.124231	2.43202	11.38 [0.51 - 252.86]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231703_s_at	49	0.673469	0.0495116	0.488686	-1.80498	0.159515	-3.87973	0.02 [0.00 - 4.60]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231678_s_at	49	0.326531	0.0464612	0.469933	1.82187	0.836996	0.184257	1.20 [0.21 - 6.96]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231703_s_at	55	0.709091	0.0205323	0.272955	-1.56567	0.106118	-3.11415	0.04 [0.00 - 1.94]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	208542	34	0.147059	0.106982	-	1.50861	0.865074	0.0334098	1.03 [0.70 - 1.52]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	429323	34	0.117647	0.266114	-	1.08844	0.475827	0.207193	1.23 [0.70 - 2.17]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231703_s_at	63	0.111111	6.39978e-05	0.00236069	-1.62824	0.949573	0.214753	1.24 [0.00 - 963.19]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231678_s_at	63	0.111111	6.39978e-05	0.00236069	-1.62824	0.159007	-4.30939	0.01 [0.00 - 5.41]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	223781_x_at	63	0.428571	0.0128034	0.194122	-0.840347	0.24354	-0.284192	0.75 [0.47 - 1.21]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231675_s_at	63	0.238095	0.0201739	0.269589	-0.810678	0.180148	-4.87962	0.01 [0.00 - 9.55]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	223781_3p_x_at	28	0.428571	0.022666	0.292513	-1.28756	0.640603	-0.560303	0.57 [0.05 - 6.00]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.1219.1.A1_3p_a_at	28	0.321429	0.0691516	-	-1.03791	0.294991	1.08895	2.97 [0.39 - 22.81]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.1219.2.A1_3p_a_at	28	0.607143	0.03983	0.426517	-1.32371	0.222464	-4.00843	0.02 [0.00 - 11.37]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	231678_3p_s_at	28	0.5	0.265456	-	-0.632912	0.643623	-0.649989	0.52 [0.03 - 8.20]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.1219.1.S1_3p_at	28	0.678571	0.141204	-	-0.951561	0.553277	-0.20651	0.81 [0.41 - 1.61]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178120_3p_at	28	0.357143	0.105429	-	-0.842341	0.774021	-0.167218	0.85 [0.27 - 2.65]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.1219.1.S1_3p_x_at	28	0.678571	0.141204	-	-0.951561	0.584921	-0.775742	0.46 [0.03 - 7.45]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	223781_x_at	204	0.102941	0.00424384	0.0831409	-1.16878	0.00530727	-1.52723	0.22 [0.07 - 0.64]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231675_s_at	204	0.284314	0.0427533	0.446127	-0.727011	0.206499	-0.258078	0.77 [0.52 - 1.15]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231675_s_at	204	0.303922	0.070449	-	-0.496089	0.139931	-0.229285	0.80 [0.59 - 1.08]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	223781_x_at	204	0.122549	0.000332701	0.00998945	-1.0899	0.000229724	-1.54015	0.21 [0.09 - 0.49]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231678_s_at	204	0.22549	0.0247567	0.310928	1.4995	0.237902	0.204239	1.23 [0.87 - 1.72]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231703_s_at	204	0.333333	0.00419886	0.0824407	1.57498	0.0110194	0.567656	1.76 [1.14 - 2.73]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231703_s_at	204	0.205882	0.0126824	0.192766	1.11295	0.0796636	0.316097	1.37 [0.96 - 1.95]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231678_s_at	204	0.27451	0.0775285	-	0.609574	0.536053	0.0762239	1.08 [0.85 - 1.37]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231678_s_at	111	0.126126	3.10031e-05	0.00123772	-1.29162	0.515606	-0.0851392	0.92 [0.71 - 1.19]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231703_s_at	111	0.846847	0.138217	-	0.492396	0.840607	0.032971	1.03 [0.75 - 1.43]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	223781_x_at	111	0.882883	0.0822031	-	-0.875604	0.787475	-0.0525344	0.95 [0.65 - 1.39]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231675_s_at	111	0.702703	0.137315	-	0.406638	0.306151	0.172107	1.19 [0.85 - 1.65]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1469	50	0.14	0.0620551	-	15.3027	0.657941	-0.145642	0.86 [0.45 - 1.65]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231703_s_at	138	0.181159	0.00175983	0.0407747	-0.800806	0.00850256	-9.92323	0.00 [0.00 - 0.08]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231678_s_at	138	0.101449	0.00565813	0.10428	-0.860841	0.0581034	-3.48898	0.03 [0.00 - 1.13]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	223781_x_at	138	0.297101	0.0138184	0.205325	-0.598603	0.107272	-0.292577	0.75 [0.52 - 1.07]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231675_s_at	138	0.123188	0.00991348	0.160408	-0.758773	0.019345	-5.72229	0.00 [0.00 - 0.40]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21365	56	0.696429	0.122668	-	0.528548	0.350225	0.13976	1.15 [0.86 - 1.54]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21365	56	0.160714	0.0980127	-	-0.66641	0.465035	0.118383	1.13 [0.82 - 1.55]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231703_s_at	278	0.302158	0.0082461	0.1395	-0.510592	0.0512848	-1.47163	0.23 [0.05 - 1.01]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231678_s_at	278	0.561151	0.0278457	0.336919	0.414504	0.98718	-0.00310887	1.00 [0.68 - 1.46]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231675_s_at	278	0.107914	0.0339469	0.384544	1.03321	0.063106	0.9359	2.55 [0.95 - 6.84]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	223781_x_at	278	0.410072	0.0160099	0.22855	-0.452974	0.557036	-0.273171	0.76 [0.31 - 1.89]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15641	81	0.17284	0.000450606	0.012964	-1.65841	0.448584	-0.357277	0.70 [0.28 - 1.76]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P30098	110	0.127273	0.111179	-	-0.499094	0.81495	-0.0305958	0.97 [0.75 - 1.25]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P30098	110	0.572727	0.0272621	0.332113	-0.711693	0.450796	-0.118544	0.89 [0.65 - 1.21]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:82205	59	0.440678	0.00834301	0.140749	1.53225	0.0405062	1.19387	3.30 [1.05 - 10.34]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	223781_x_at	38	0.815789	0.28642	-	0.611236	0.561517	0.176504	1.19 [0.66 - 2.16]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231675_s_at	38	0.263158	0.0283088	0.340698	-1.10157	0.167046	-0.308353	0.73 [0.47 - 1.14]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231678_s_at	38	0.710526	0.0353189	0.394653	1.08226	0.0966334	0.445171	1.56 [0.92 - 2.64]
GENE	ADH4	alcohol dehydrogenase 4 (class II), pi polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231703_s_at	38	0.184211	0.18052	-	-0.811526	0.767926	-0.111647	0.89 [0.43 - 1.88]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208847_s_at	30	0.8	0.3412	-	0.446591	0.92906	0.0358043	1.04 [0.47 - 2.28]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208848_at	30	0.4	0.0809075	-	-0.716917	0.853604	-0.0514452	0.95 [0.55 - 1.64]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1738604	165	0.10303	0.111908	-	-0.539276	0.366771	-0.223115	0.80 [0.49 - 1.30]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1738604	165	0.630303	0.100154	-	-0.659847	0.498113	-0.245285	0.78 [0.38 - 1.59]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208848_at	163	0.699386	0.0474163	0.475882	0.412833	0.0855247	0.299232	1.35 [0.96 - 1.90]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208847_s_at	163	0.858896	0.0326586	0.374861	0.566087	0.212151	0.2323	1.26 [0.88 - 1.82]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208848_at	79	0.797468	0.0102179	0.1641	0.820206	0.0348887	0.588369	1.80 [1.04 - 3.11]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208847_s_at	79	0.848101	0.00652285	0.116483	0.94941	0.0409388	0.806839	2.24 [1.03 - 4.86]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208847_s_at	58	0.275862	0.405893	-	0.255797	0.793548	0.0706649	1.07 [0.63 - 1.82]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208848_at	58	0.137931	0.21117	-	-0.485667	0.924063	0.0267021	1.03 [0.59 - 1.78]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208847_s_at	34	0.764706	6.29393e-07	3.54843e-05	2.31536	0.0160988	1.49254	4.45 [1.32 - 15.00]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208848_at	34	0.558824	0.00866449	0.144862	1.0166	0.0109835	1.22752	3.41 [1.33 - 8.79]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208847_s_at	158	0.563291	0.00164966	0.038658	-0.778204	0.0048132	-0.850407	0.43 [0.24 - 0.77]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208848_at	158	0.158228	0.0540772	-	-0.553833	0.211911	-0.353643	0.70 [0.40 - 1.22]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208848_at	53	0.339623	0.312097	-	-0.351623	0.883911	0.0800296	1.08 [0.37 - 3.17]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208847_s_at	53	0.867925	0.138079	-	-1.03886	0.772048	-0.207196	0.81 [0.20 - 3.30]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208848_at	53	0.490566	0.263483	-	0.410293	0.722431	0.20987	1.23 [0.39 - 3.93]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208847_s_at	53	0.641509	0.0576417	-	-0.724047	0.452044	-0.514025	0.60 [0.16 - 2.28]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208847_s_at	180	0.822222	0.062726	-	0.459176	0.60072	0.246381	1.28 [0.51 - 3.22]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208848_at	180	0.116667	0.0676173	-	-0.546114	0.10879	-0.490194	0.61 [0.34 - 1.12]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208848_at	559	0.347048	0.0534864	-	-0.392968	0.508125	-0.196442	0.82 [0.46 - 1.47]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208847_s_at	559	0.83542	0.0350262	0.392513	0.504183	0.490062	0.256621	1.29 [0.62 - 2.68]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208847_s_at	77	0.519481	0.029324	0.348885	0.562931	0.197661	0.549869	1.73 [0.75 - 4.00]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208848_at	77	0.246753	0.0247438	0.310817	-0.623607	0.443015	-0.249104	0.78 [0.41 - 1.47]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208847_s_at	70	0.714286	0.0834353	-	0.489913	0.701088	0.144162	1.16 [0.55 - 2.41]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208848_at	70	0.257143	0.257097	-	0.349478	0.877188	0.0348763	1.04 [0.67 - 1.61]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37707_i_at	50	0.66	0.0724988	-	-0.750511	0.376837	-0.320243	0.73 [0.36 - 1.48]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37708_r_at	50	0.4	0.0534947	-	-0.672988	0.201862	-0.975347	0.38 [0.08 - 1.69]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208848_at	74	0.797297	0.0210058	0.277365	-0.942402	0.144827	-0.77527	0.46 [0.16 - 1.31]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208847_s_at	74	0.297297	0.00479444	0.0915644	1.00543	0.12814	0.982147	2.67 [0.75 - 9.46]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208848_at	67	0.597015	0.0455538	0.464212	1.32527	0.387619	1.10204	3.01 [0.25 - 36.68]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208847_s_at	67	0.41791	0.215048	-	0.959053	0.863018	0.28799	1.33 [0.05 - 35.15]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208847_s_at	115	0.808696	0.0917931	-	0.909168	0.686261	0.429502	1.54 [0.19 - 12.35]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208848_at	115	0.869565	0.0695434	-	1.02977	0.188068	1.13609	3.11 [0.57 - 16.91]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37707_i_at	158	0.259494	0.122712	-	0.563651	0.486638	0.234222	1.26 [0.65 - 2.45]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37708_r_at	158	0.677215	0.0767897	-	-0.57969	0.352095	-0.327299	0.72 [0.36 - 1.44]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37708_r_at	76	0.776316	0.293614	-	-0.779396	0.778174	-0.176369	0.84 [0.25 - 2.86]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37707_i_at	76	0.881579	0.122761	-	-15.2392	0.787215	0.201562	1.22 [0.28 - 5.29]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208848_at	204	0.897059	0.0906612	-	0.389772	0.321276	0.199901	1.22 [0.82 - 1.81]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208847_s_at	204	0.867647	0.00346814	0.0707789	0.605724	0.0185449	0.492991	1.64 [1.09 - 2.47]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208847_s_at	87	0.793103	0.00860498	0.144104	0.978562	0.441629	0.40239	1.50 [0.54 - 4.17]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208848_at	87	0.804598	0.0188785	0.257213	0.921949	0.313822	0.403325	1.50 [0.68 - 3.28]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208847_s_at	87	0.793103	0.00860498	0.144104	0.978562	0.441629	0.40239	1.50 [0.54 - 4.17]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208848_at	87	0.804598	0.0188785	0.257213	0.921949	0.313822	0.403325	1.50 [0.68 - 3.28]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208848_at	77	0.506494	0.0379469	0.413462	-1.4995	0.256691	-0.695774	0.50 [0.15 - 1.66]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208847_s_at	77	0.337662	0.107356	-	1.54062	0.464786	0.70026	2.01 [0.31 - 13.17]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208848_at	77	0.220779	0.00140071	0.0337617	-1.60348	0.0403315	-1.08254	0.34 [0.12 - 0.95]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208847_s_at	77	0.519481	0.146608	-	-0.848107	0.637667	-0.352911	0.70 [0.16 - 3.05]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208848_at	136	0.198529	0.168187	-	-0.6689	0.933907	-0.0465996	0.95 [0.32 - 2.87]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208847_s_at	136	0.808824	0.341701	-	-0.597174	0.884647	-0.114036	0.89 [0.19 - 4.16]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208848_at	200	0.33	0.0277424	0.336072	-0.64174	0.568654	-0.239542	0.79 [0.35 - 1.79]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208847_s_at	200	0.815	4.93267e-07	2.83203e-05	1.39781	4.14519e-05	2.44146	11.49 [3.58 - 36.92]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7531	60	0.866667	2.10484e-05	0.00087452	1.72357	0.047551	0.778281	2.18 [1.01 - 4.70]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7531	60	0.433333	0.0422762	0.44298	0.830731	0.177703	0.467534	1.60 [0.81 - 3.15]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7014	155	0.2	0.00566594	0.104392	-0.799091	0.301955	-0.325063	0.72 [0.39 - 1.34]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208848_at	286	0.122378	0.0294926	0.350232	-0.558475	0.961495	-0.0122951	0.99 [0.60 - 1.63]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208847_s_at	286	0.136364	0.200641	-	-0.331285	0.615687	-0.1668	0.85 [0.44 - 1.62]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208847_s_at	159	0.761006	0.0942945	-	0.642712	0.198014	0.887267	2.43 [0.63 - 9.38]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208848_at	159	0.672956	0.103803	-	-0.606815	0.423574	-0.463664	0.63 [0.20 - 1.96]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208847_s_at	159	0.761006	0.00547824	0.101677	0.869138	0.0841084	1.00575	2.73 [0.87 - 8.56]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208848_at	159	0.672956	0.0433533	0.450058	-0.956511	0.173753	-0.918845	0.40 [0.11 - 1.50]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208848_at	159	0.672956	0.182918	-	-0.481795	0.376558	-0.510111	0.60 [0.19 - 1.86]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208847_s_at	159	0.830189	0.100536	-	0.590959	0.175414	0.805821	2.24 [0.70 - 7.18]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208847_s_at	54	0.888889	0.00460453	0.0886891	2.00394	0.140851	1.42083	4.14 [0.62 - 27.44]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208848_at	54	0.259259	0.0749844	-	15.4982	0.364154	0.406313	1.50 [0.62 - 3.61]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208847_s_at	117	0.880342	0.0607603	-	-1.28059	0.588133	-0.211589	0.81 [0.38 - 1.74]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208847_s_at	117	0.880342	0.0287303	0.344114	-15.2545	0.613994	-0.233286	0.79 [0.32 - 1.96]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208847_s_at	117	0.239316	0.0745663	-	1.04694	0.967341	0.0192555	1.02 [0.41 - 2.56]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208847_s_at	117	0.880342	0.0607603	-	-1.28059	0.588133	-0.211589	0.81 [0.38 - 1.74]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208848_at	117	0.641026	0.13819	-	0.468958	0.75138	0.0667171	1.07 [0.71 - 1.62]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208848_at	117	0.111111	0.0975761	-	1.5333	0.772101	0.0734006	1.08 [0.65 - 1.77]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208848_at	117	0.82906	0.0460453	0.467319	-1.78689	0.550309	-0.159218	0.85 [0.51 - 1.44]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208848_at	117	0.641026	0.13819	-	0.468958	0.75138	0.0667171	1.07 [0.71 - 1.62]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208847_s_at	236	0.872881	0.243139	-	0.422804	0.87465	0.0782936	1.08 [0.41 - 2.86]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208848_at	236	0.122881	0.0592203	-	-0.626108	0.259506	-0.524456	0.59 [0.24 - 1.47]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208847_s_at	249	0.875502	0.00782963	0.134081	0.723164	0.36783	0.366352	1.44 [0.65 - 3.20]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208848_at	249	0.144578	0.00801294	0.136477	-0.660826	0.18184	-0.493972	0.61 [0.30 - 1.26]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208848_at	125	0.184	0.0439895	0.454192	-0.694439	0.246865	-0.304597	0.74 [0.44 - 1.23]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208848_at	54	0.888889	0.115693	-	-15.3518	0.364037	-0.294787	0.74 [0.39 - 1.41]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208847_s_at	62	0.145161	0.169326	-	-0.767174	0.588674	-0.29393	0.75 [0.26 - 2.16]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208847_s_at	125	0.832	0.0612776	-	-1.69605	0.103011	-1.0612	0.35 [0.10 - 1.24]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208848_at	62	0.290323	0.364255	-	-0.46428	0.560426	-0.153869	0.86 [0.51 - 1.44]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208847_s_at	125	0.176	0.0944876	-	-0.549885	0.301048	-0.510103	0.60 [0.23 - 1.58]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208848_at	125	0.168	0.0643982	-	-0.796492	0.471152	-0.245941	0.78 [0.40 - 1.53]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208847_s_at	54	0.87037	0.117226	-	-15.3342	0.661021	-0.296494	0.74 [0.20 - 2.80]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208848_at	198	0.358586	0.113261	-	0.359677	0.43463	0.125807	1.13 [0.83 - 1.55]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208847_s_at	198	0.752525	0.0125641	0.191436	-0.96542	0.0710988	-0.466031	0.63 [0.38 - 1.04]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208847_s_at	198	0.752525	0.0181691	0.250293	-0.981436	0.0634959	-0.507963	0.60 [0.35 - 1.03]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208848_at	198	0.565657	0.142963	-	-0.386892	0.609662	-0.10101	0.90 [0.61 - 1.33]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208848_at	198	0.565657	0.239504	-	-0.323996	0.857675	-0.0381607	0.96 [0.63 - 1.46]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208847_s_at	198	0.752525	0.0712323	-	-0.492748	0.373719	-0.187481	0.83 [0.55 - 1.25]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208848_at	62	0.177419	0.306871	-	1.02253	0.902254	-0.0385923	0.96 [0.52 - 1.78]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208847_s_at	51	0.627451	0.0658622	-	-15.8724	0.556561	-0.432192	0.65 [0.15 - 2.74]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208847_s_at	62	0.419355	0.0639101	-	-1.08252	0.579486	-0.289719	0.75 [0.27 - 2.09]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208848_at	51	0.647059	0.0785607	-	-15.8085	0.480659	-0.349584	0.70 [0.27 - 1.86]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208848_at	177	0.751412	0.0289564	0.345936	-0.858544	0.71039	-0.10942	0.90 [0.50 - 1.60]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208847_s_at	177	0.576271	0.000129161	0.00438581	-1.18597	0.0300175	-0.873328	0.42 [0.19 - 0.92]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208848_at	177	0.180791	0.150774	-	0.486197	0.840993	0.0524976	1.05 [0.63 - 1.76]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208847_s_at	177	0.576271	0.00190806	0.0435791	-0.776784	0.220491	-0.442181	0.64 [0.32 - 1.30]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208848_at	145	0.744828	0.0554637	-	-0.976252	0.554478	-0.214781	0.81 [0.40 - 1.64]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208847_s_at	145	0.689655	0.00629038	0.11325	-1.34526	0.0997492	-0.817008	0.44 [0.17 - 1.17]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208848_at	226	0.132743	0.130341	-	0.873181	0.501391	0.203304	1.23 [0.68 - 2.22]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208847_s_at	226	0.128319	0.0234306	0.29933	-0.756745	0.323797	-0.363376	0.70 [0.34 - 1.43]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208848_at	55	0.890909	0.0719144	-	0.97689	0.359584	0.467001	1.60 [0.59 - 4.33]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208848_at	55	0.709091	0.1718	-	0.688935	0.587053	0.298998	1.35 [0.46 - 3.97]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208847_s_at	55	0.654545	0.0849752	-	0.757334	0.233937	0.850308	2.34 [0.58 - 9.49]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208848_at	49	0.102041	0.295623	-	-0.794632	0.835854	0.12392	1.13 [0.35 - 3.66]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208847_s_at	55	0.654545	0.00869582	0.14526	1.17355	0.113946	1.32506	3.76 [0.73 - 19.45]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208847_s_at	49	0.673469	0.036877	0.40589	1.16702	0.0520964	2.21456	9.16 [0.98 - 85.56]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	813711	34	0.735294	0.00274681	0.0586584	1.3519	0.0301149	1.30431	3.69 [1.13 - 11.98]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	344237	34	0.794118	0.08244	-	0.835278	0.518193	0.350018	1.42 [0.49 - 4.10]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208848_at	63	0.571429	0.000489045	0.0139045	-1.27612	0.496385	-0.104522	0.90 [0.67 - 1.22]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208847_s_at	63	0.873016	0.274891	-	0.489938	0.982894	0.00758824	1.01 [0.50 - 2.02]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178133_3p_at	28	0.178571	0.0906028	-	-0.973112	0.588304	-0.686654	0.50 [0.04 - 6.05]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178131_3p_a_at	28	0.857143	0.21775	-	-1.2087	0.924367	0.0393649	1.04 [0.46 - 2.34]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208848_at	82	0.646341	0.0264977	0.325747	-0.868081	0.775733	-0.0988067	0.91 [0.46 - 1.79]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208847_s_at	82	0.463415	0.203215	-	-0.429743	0.727836	-0.194513	0.82 [0.28 - 2.46]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37708_r_at	84	0.464286	0.00368118	0.0742373	-0.841308	0.116641	-0.701442	0.50 [0.21 - 1.19]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37707_i_at	84	0.869048	0.0490033	0.485611	-1.11639	0.21031	-0.278416	0.76 [0.49 - 1.17]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208848_at	79	0.227848	0.12044	-	-0.461505	0.242874	-0.417961	0.66 [0.33 - 1.33]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208847_s_at	79	0.126582	0.0046047	0.0886917	-0.971008	0.258708	-0.463341	0.63 [0.28 - 1.41]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M81118_at	86	0.209302	0.000783402	0.0207515	-1.48094	0.25831	-0.511685	0.60 [0.25 - 1.46]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208847_s_at	104	0.605769	0.0851366	-	-0.650419	0.93392	-0.0451856	0.96 [0.33 - 2.78]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208848_at	104	0.230769	0.274699	-	0.450977	0.917953	0.0406242	1.04 [0.48 - 2.26]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P260346	117	0.897436	0.0220815	0.287235	0.862447	0.607433	0.181305	1.20 [0.60 - 2.39]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P198399	117	0.863248	0.00912524	0.150674	0.899855	0.907366	0.0292947	1.03 [0.63 - 1.69]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P18692	117	0.880342	0.00237396	0.0521054	1.03598	0.672409	0.126269	1.13 [0.63 - 2.04]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208847_s_at	204	0.75	0.210612	-	0.481716	0.676321	0.340901	1.41 [0.28 - 6.97]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208847_s_at	204	0.558824	0.0604355	-	0.509329	0.540677	0.366617	1.44 [0.45 - 4.67]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208848_at	204	0.107843	0.017586	0.244524	-0.985504	0.0493033	-0.996041	0.37 [0.14 - 1.00]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208848_at	204	0.308824	0.0018307	0.0421217	-0.827766	0.0218184	-0.879394	0.42 [0.20 - 0.88]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208847_s_at	178	0.191011	0.133897	-	0.405795	0.626765	0.205009	1.23 [0.54 - 2.80]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208848_at	178	0.859551	0.257134	-	-0.34623	0.823191	0.0676655	1.07 [0.59 - 1.94]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208848_at	111	0.189189	0.114671	-	-0.481164	0.369722	-0.255268	0.77 [0.44 - 1.35]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208847_s_at	111	0.387387	0.210518	-	0.341512	0.463039	0.216845	1.24 [0.70 - 2.22]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208848_at	90	0.322222	0.113318	-	0.620437	0.725067	-0.0908871	0.91 [0.55 - 1.52]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208848_at	90	0.333333	0.133353	-	0.675429	0.768697	-0.0864421	0.92 [0.52 - 1.63]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208847_s_at	90	0.155556	0.0840779	-	-0.678532	0.421156	-0.239758	0.79 [0.44 - 1.41]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208847_s_at	90	0.155556	0.0138488	0.205656	-0.986816	0.194775	-0.440727	0.64 [0.33 - 1.25]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2276	50	0.8	0.308361	-	-0.740496	0.624652	0.229856	1.26 [0.50 - 3.16]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208847_s_at	138	0.398551	0.110806	-	-0.384495	0.364347	-0.184291	0.83 [0.56 - 1.24]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208848_at	138	0.485507	0.26427	-	0.275052	0.721138	0.0446255	1.05 [0.82 - 1.34]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208847_s_at	129	0.813953	0.244738	-	-0.385782	0.542161	-0.210364	0.81 [0.41 - 1.59]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208848_at	129	0.178295	0.00998698	0.161302	-0.715826	0.141998	-0.524618	0.59 [0.29 - 1.19]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20740	56	0.803571	0.193096	-	0.519808	0.390491	0.26256	1.30 [0.71 - 2.37]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13010	56	0.303571	0.105641	-	-0.594891	0.804238	0.0737294	1.08 [0.60 - 1.93]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20554	56	0.839286	0.0655959	-	0.789198	0.250928	0.354946	1.43 [0.78 - 2.61]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8369	56	0.892857	0.0757371	-	0.863407	0.593528	0.153472	1.17 [0.66 - 2.05]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13010	56	0.714286	0.154936	-	0.544013	0.542836	0.179446	1.20 [0.67 - 2.13]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20740	56	0.803571	0.138725	-	0.576828	0.482286	0.216741	1.24 [0.68 - 2.27]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8369	56	0.625	0.0627062	-	0.67038	0.431139	0.222779	1.25 [0.72 - 2.18]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20554	56	0.839286	0.138114	-	0.628326	0.413324	0.234898	1.26 [0.72 - 2.22]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208848_at	278	0.194245	0.102034	-	0.404016	0.246117	0.188922	1.21 [0.88 - 1.66]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208847_s_at	278	0.852518	0.21552	-	0.316412	0.985721	-0.00425736	1.00 [0.62 - 1.59]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208847_s_at	133	0.353383	0.289453	-	-0.252258	0.703095	-0.0851705	0.92 [0.59 - 1.42]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208848_at	133	0.56391	0.154084	-	0.33712	0.621073	-0.0497122	0.95 [0.78 - 1.16]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13803	81	0.123457	0.0834356	-	-0.975055	0.274087	-0.473789	0.62 [0.27 - 1.46]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4936	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208848_at	185	0.508108	0.0127591	0.193626	0.403101	0.106963	0.149753	1.16 [0.97 - 1.39]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208847_s_at	185	0.535135	0.0517947	-	-0.318463	0.390031	-0.0992315	0.91 [0.72 - 1.14]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208848_at	185	0.508108	0.00709715	0.124333	0.473386	0.0283394	0.219802	1.25 [1.02 - 1.52]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208847_s_at	185	0.178378	0.157596	-	0.349619	0.970695	-0.00466786	1.00 [0.78 - 1.28]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P260346	110	0.136364	0.00277311	0.0591126	-1.11477	0.205861	-0.296258	0.74 [0.47 - 1.18]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P198399	110	0.227273	0.260812	-	-0.366836	0.45688	-0.173238	0.84 [0.53 - 1.33]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P18692	110	0.163636	0.00536037	0.0999596	-0.778479	0.124474	-0.265037	0.77 [0.55 - 1.08]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P260346	110	0.836364	0.0310668	0.362631	-0.785996	0.206849	-0.214826	0.81 [0.58 - 1.13]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P18692	110	0.2	0.0250337	0.313317	-0.699935	0.193428	-0.285106	0.75 [0.49 - 1.16]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P198399	110	0.409091	0.226534	-	-0.28212	0.963279	0.00816135	1.01 [0.71 - 1.43]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208847_s_at	80	0.125	0.150778	-	1.3685	0.721939	0.181622	1.20 [0.44 - 3.26]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208848_at	80	0.55	0.104066	-	-0.821493	0.645646	-0.206117	0.81 [0.34 - 1.96]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_1407	281	0.227758	0.00896213	0.148627	-0.406999	0.0163049	-0.3017	0.74 [0.58 - 0.95]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208848_at	38	0.210526	0.0251764	0.314543	1.5672	0.329433	0.532619	1.70 [0.58 - 4.97]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208847_s_at	38	0.473684	0.00391115	0.0779152	1.50138	0.0845449	1.23569	3.44 [0.85 - 14.01]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208847_s_at	140	0.714286	0.00640774	0.114887	-1.06573	0.100266	-0.499809	0.61 [0.33 - 1.10]
GENE	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208848_at	140	0.578571	0.00858178	0.143808	-0.833167	0.0591771	-0.338364	0.71 [0.50 - 1.01]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214261_s_at	30	0.3	0.380631	-	-0.375292	0.902339	-0.0741108	0.93 [0.28 - 3.03]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207544_s_at	30	0.266667	0.00185037	0.0424933	-1.52921	0.424547	-0.679815	0.51 [0.10 - 2.69]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1691175	165	0.745455	0.0470718	0.473744	0.497278	0.585259	0.206646	1.23 [0.59 - 2.58]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1691175	165	0.121212	0.105391	-	1.50075	0.988454	0.0095636	1.01 [0.28 - 3.69]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214261_s_at	163	0.595092	0.105049	-	-0.332583	0.315705	-0.652021	0.52 [0.15 - 1.86]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207544_s_at	163	0.895706	0.086349	-	-0.660397	0.684356	-0.256401	0.77 [0.22 - 2.66]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207544_s_at	79	0.113924	0.0472079	0.47459	-0.797028	0.65515	-0.444189	0.64 [0.09 - 4.50]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214261_s_at	79	0.759494	0.0196497	0.26462	0.706648	0.551567	0.45228	1.57 [0.35 - 6.97]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214261_s_at	58	0.448276	0.178729	-	0.371653	0.416113	0.164899	1.18 [0.79 - 1.75]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207544_s_at	58	0.275862	0.0095817	0.156342	0.810938	0.0817709	0.222967	1.25 [0.97 - 1.61]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207544_s_at	34	0.558824	0.129129	-	-0.58889	0.812931	-0.0667834	0.94 [0.54 - 1.63]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214261_s_at	34	0.735294	0.0842889	-	-0.783961	0.459663	-0.212552	0.81 [0.46 - 1.42]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214261_s_at	158	0.291139	0.0158915	0.227327	0.683714	0.257667	0.728339	2.07 [0.59 - 7.31]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207544_s_at	158	0.898734	0.0908682	-	-0.843327	0.514218	-0.641425	0.53 [0.08 - 3.62]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207544_s_at	53	0.113208	0.0709978	-	1.64626	0.207873	0.280493	1.32 [0.86 - 2.05]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214261_s_at	53	0.283019	0.144227	-	-0.54765	0.807012	-0.0523576	0.95 [0.62 - 1.44]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214261_s_at	53	0.264151	0.163143	-	-0.508739	0.451971	-0.150458	0.86 [0.58 - 1.27]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207544_s_at	53	0.113208	0.119664	-	1.08212	0.201231	0.258441	1.29 [0.87 - 1.92]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214261_s_at	180	0.238889	0.140201	-	-0.3503	0.591324	-0.054866	0.95 [0.77 - 1.16]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207544_s_at	180	0.166667	0.10124	-	0.522659	0.372256	0.0767536	1.08 [0.91 - 1.28]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207544_s_at	559	0.266547	0.0876005	-	-0.36806	0.265532	-0.145495	0.86 [0.67 - 1.12]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214261_s_at	559	0.812165	0.224378	-	0.271613	0.57827	0.0735481	1.08 [0.83 - 1.39]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207544_s_at	77	0.896104	0.00176302	0.0408356	1.14717	0.00534348	0.496667	1.64 [1.16 - 2.33]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214261_s_at	77	0.649351	0.0722397	-	-0.501554	0.317216	-0.232409	0.79 [0.50 - 1.25]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207544_s_at	70	0.242857	0.177303	-	-0.404258	0.60859	-0.828311	0.44 [0.02 - 10.40]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214261_s_at	70	0.742857	0.242392	-	-0.362616	0.634386	-0.646995	0.52 [0.04 - 7.53]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207544_s_at	74	0.891892	0.271216	-	-0.645542	0.812314	-0.0423846	0.96 [0.68 - 1.36]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214261_s_at	74	0.783784	0.174438	-	0.450782	0.630459	-0.095087	0.91 [0.62 - 1.34]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214261_s_at	67	0.671642	0.27365	-	0.721983	0.549335	1.34043	3.82 [0.05 - 307.43]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207544_s_at	67	0.313433	0.24085	-	1.17761	0.977343	0.0997528	1.10 [0.00 - 1079.37]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214261_s_at	115	0.869565	0.00932963	0.153223	1.34802	0.0853913	1.03019	2.80 [0.87 - 9.06]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207544_s_at	115	0.33913	0.110512	-	1.1549	0.992589	-0.00347912	1.00 [0.48 - 2.08]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214261_s_at	204	0.441176	0.00447177	0.0866605	-0.411247	0.0576135	-0.16703	0.85 [0.71 - 1.01]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207544_s_at	204	0.102941	0.0679668	-	-0.419784	0.926781	-0.00688734	0.99 [0.86 - 1.15]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207544_s_at	87	0.494253	0.0251013	0.313898	0.878746	0.700697	0.543471	1.72 [0.11 - 27.51]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214261_s_at	87	0.321839	0.0377135	0.41182	1.07065	0.605074	0.53646	1.71 [0.22 - 13.06]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207544_s_at	87	0.494253	0.0251013	0.313898	0.878746	0.700697	0.543471	1.72 [0.11 - 27.51]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214261_s_at	87	0.321839	0.0377135	0.41182	1.07065	0.605074	0.53646	1.71 [0.22 - 13.06]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214261_s_at	77	0.844156	0.00624518	0.112617	1.44235	0.600136	0.73177	2.08 [0.13 - 32.07]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214261_s_at	77	0.376623	0.122045	-	-0.960834	0.710212	-0.631138	0.53 [0.02 - 14.85]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207544_s_at	77	0.584416	0.285487	-	0.586179	0.989423	0.0282432	1.03 [0.02 - 66.96]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207544_s_at	77	0.350649	0.282122	-	-0.668308	0.444459	-1.94229	0.14 [0.00 - 20.82]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214261_s_at	136	0.683824	0.00293145	0.0618262	1.28819	0.115079	0.37625	1.46 [0.91 - 2.33]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207544_s_at	136	0.830882	0.00194516	0.0442735	1.32443	0.277928	0.300023	1.35 [0.79 - 2.32]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214261_s_at	200	0.54	0.129464	-	0.447715	0.435667	0.170715	1.19 [0.77 - 1.82]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207544_s_at	200	0.88	0.0414814	0.43769	0.713179	0.77475	0.053096	1.05 [0.73 - 1.52]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5567	60	0.183333	0.0890671	-	1.18042	0.813773	0.0779991	1.08 [0.56 - 2.07]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5567	60	0.55	0.105289	-	-0.64565	0.523361	-0.297953	0.74 [0.30 - 1.85]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16391	155	0.103226	0.0927808	-	-0.592847	0.863384	0.0384696	1.04 [0.67 - 1.61]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207544_s_at	286	0.118881	0.00670191	0.118952	-0.661494	0.204411	-0.151097	0.86 [0.68 - 1.09]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214261_s_at	286	0.276224	0.0901575	-	0.402045	0.427522	0.118728	1.13 [0.84 - 1.51]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214261_s_at	159	0.654088	0.0035846	0.0726757	-1.60001	0.495567	0.20969	1.23 [0.67 - 2.25]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214261_s_at	159	0.283019	0.00442954	0.086012	1.38671	0.137492	0.427784	1.53 [0.87 - 2.70]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207544_s_at	159	0.654088	0.214479	-	0.394634	0.6417	0.0963395	1.10 [0.73 - 1.65]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207544_s_at	159	0.698113	0.142097	-	0.546886	0.654591	0.108723	1.11 [0.69 - 1.80]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214261_s_at	159	0.660377	0.00333812	0.0686428	-1.22305	0.837348	0.0509456	1.05 [0.65 - 1.71]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207544_s_at	159	0.72327	0.0639365	-	0.58943	0.485993	0.147294	1.16 [0.77 - 1.75]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207544_s_at	54	0.111111	0.00137948	0.0333362	-2.04035	0.122264	-6.63406	0.00 [0.00 - 5.93]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214261_s_at	54	0.796296	0.103023	-	-15.4378	0.270222	-1.29516	0.27 [0.03 - 2.74]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214261_s_at	117	0.888889	0.232048	-	-0.843008	0.695537	-0.307185	0.74 [0.16 - 3.43]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214261_s_at	117	0.555556	0.242662	-	0.439251	0.917095	-0.0909678	0.91 [0.16 - 5.06]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207544_s_at	117	0.282051	0.0312621	0.364148	-0.685635	0.540228	-0.877623	0.42 [0.03 - 6.90]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207544_s_at	117	0.282051	0.0286113	0.343153	-0.816272	0.604527	-0.881485	0.41 [0.01 - 11.64]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214261_s_at	117	0.418803	0.0511544	-	0.840917	0.894107	0.114648	1.12 [0.21 - 6.07]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207544_s_at	117	0.897436	0.12271	-	0.838052	0.914931	0.180861	1.20 [0.04 - 33.09]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214261_s_at	117	0.888889	0.232048	-	-0.843008	0.695537	-0.307185	0.74 [0.16 - 3.43]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207544_s_at	117	0.282051	0.0312621	0.364148	-0.685635	0.540228	-0.877623	0.42 [0.03 - 6.90]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214261_s_at	236	0.101695	0.159966	-	0.812133	0.578475	0.122715	1.13 [0.73 - 1.74]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207544_s_at	236	0.745763	0.187454	-	-0.457518	0.879375	-0.0259972	0.97 [0.70 - 1.36]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214261_s_at	249	0.100402	0.0310848	0.362771	1.05231	0.886885	0.0235672	1.02 [0.74 - 1.42]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207544_s_at	249	0.506024	0.0996304	-	-0.352605	0.721473	-0.0484077	0.95 [0.73 - 1.24]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214261_s_at	62	0.822581	0.0106125	0.168833	-15.5833	0.60225	-0.0959361	0.91 [0.63 - 1.30]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207544_s_at	125	0.112	0.0714958	-	-0.733839	0.454765	-0.436882	0.65 [0.21 - 2.03]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214261_s_at	125	0.184	0.0894395	-	-0.676143	0.373616	-0.415693	0.66 [0.26 - 1.65]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207544_s_at	125	0.744	0.125851	-	-0.752821	0.997836	-0.00202752	1.00 [0.23 - 4.32]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214261_s_at	125	0.896	0.200024	-	-0.898606	0.742551	-0.118864	0.89 [0.44 - 1.80]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214261_s_at	54	0.796296	0.026135	0.322696	-15.6438	0.628319	-0.108562	0.90 [0.58 - 1.39]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207544_s_at	54	0.259259	0.300461	-	-0.657566	0.746417	-0.16579	0.85 [0.31 - 2.31]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207544_s_at	62	0.693548	0.245272	-	-0.624118	0.699222	-0.162613	0.85 [0.37 - 1.94]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214261_s_at	198	0.606061	0.0607159	-	0.475703	0.37091	0.10101	1.11 [0.89 - 1.38]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207544_s_at	198	0.70202	0.0759444	-	-0.54833	0.217878	-0.11143	0.89 [0.75 - 1.07]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214261_s_at	198	0.106061	0.118678	-	-0.590531	0.790626	0.0311991	1.03 [0.82 - 1.30]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207544_s_at	198	0.70202	0.0386827	0.418604	-0.707349	0.087138	-0.164683	0.85 [0.70 - 1.02]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214261_s_at	198	0.111111	0.232878	-	-0.368298	0.861296	0.0160329	1.02 [0.85 - 1.22]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207544_s_at	198	0.171717	0.10442	-	-0.410611	0.454569	-0.0550342	0.95 [0.82 - 1.09]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207544_s_at	62	0.532258	0.0152178	0.2203	-1.67877	0.144714	-2.07023	0.13 [0.01 - 2.04]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214261_s_at	51	0.294118	0.00666486	0.118443	-2.41182	0.0986061	-1.33927	0.26 [0.05 - 1.28]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207544_s_at	51	0.607843	0.0621829	-	-15.8886	0.260007	-2.57565	0.08 [0.00 - 6.73]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214261_s_at	62	0.451613	0.0197568	0.26564	-1.43123	0.0461879	-0.860324	0.42 [0.18 - 0.99]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214261_s_at	145	0.503448	0.00519143	0.0974796	-0.974038	0.00915728	-0.903926	0.40 [0.21 - 0.80]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214261_s_at	177	0.536723	0.00113625	0.0283618	-0.953515	0.00700065	-0.730436	0.48 [0.28 - 0.82]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207544_s_at	177	0.186441	0.00753027	0.130131	-0.702693	0.293305	-0.177652	0.84 [0.60 - 1.17]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207544_s_at	177	0.163842	0.00263205	0.0566645	-0.886364	0.0282015	-0.526933	0.59 [0.37 - 0.95]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214261_s_at	177	0.536723	0.00799945	0.136301	-0.646326	0.140244	-0.285863	0.75 [0.51 - 1.10]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207544_s_at	145	0.558621	0.00156395	0.0369907	-1.19874	0.0180243	-0.788248	0.45 [0.24 - 0.87]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207544_s_at	226	0.469027	0.000343258	0.010262	-1.03972	0.000214319	-0.278649	0.76 [0.65 - 0.88]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214261_s_at	226	0.128319	3.50216e-07	2.06169e-05	-1.4252	0.000206139	-0.400869	0.67 [0.54 - 0.83]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207544_s_at	55	0.472727	0.161686	-	-0.636037	0.755954	0.114014	1.12 [0.55 - 2.30]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207544_s_at	49	0.183673	0.0542593	-	15.4468	0.91644	0.0442777	1.05 [0.46 - 2.39]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207544_s_at	55	0.345455	0.0527665	-	-0.842783	0.92706	0.0316843	1.03 [0.52 - 2.03]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214261_s_at	55	0.2	0.000647583	0.0176616	-1.45102	0.476769	-0.396273	0.67 [0.23 - 2.00]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214261_s_at	55	0.236364	0.0257947	0.319818	-1.10107	0.950887	0.0329847	1.03 [0.36 - 2.95]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214261_s_at	49	0.183673	0.0107935	0.170984	-1.38852	0.797448	-0.170743	0.84 [0.23 - 3.11]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207544_s_at	63	0.126984	8.39406e-05	0.00300118	-1.55351	0.0996798	-15.8199	0.00 [0.00 - 20.35]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214261_s_at	63	0.253968	0.0171915	0.240579	-0.828995	0.475506	-2.65933	0.07 [0.00 - 104.10]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11024646_3p_x_at	28	0.321429	0.0691516	-	-1.03791	0.829896	-0.165598	0.85 [0.19 - 3.84]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.76800.1.S1_3p_s_at	28	0.75	0.182087	-	-0.985893	0.588665	-0.85489	0.43 [0.02 - 9.43]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11024646_3p_a_at	28	0.892857	0.0386714	0.418526	1.2858	0.983971	-0.0166644	0.98 [0.19 - 5.00]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214261_s_at	82	0.414634	0.056389	-	-0.640935	0.780343	-0.106317	0.90 [0.43 - 1.90]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207544_s_at	82	0.512195	0.0200705	0.268613	0.797385	0.156627	0.442928	1.56 [0.84 - 2.87]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207544_s_at	79	0.873418	0.139994	-	0.529922	0.554766	0.118759	1.13 [0.76 - 1.67]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214261_s_at	79	0.189873	0.0146853	0.214663	-0.760128	0.695985	0.118912	1.13 [0.62 - 2.04]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214261_s_at	104	0.557692	0.0256062	0.318216	-0.779979	0.0969869	-0.561596	0.57 [0.29 - 1.11]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207544_s_at	104	0.355769	0.0615292	-	-0.61343	0.110806	-0.491142	0.61 [0.33 - 1.12]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214261_s_at	204	0.431373	0.0973092	-	-0.601855	0.452806	-0.121859	0.89 [0.64 - 1.22]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214261_s_at	204	0.45098	0.0881746	-	-0.461526	0.719434	-0.0428845	0.96 [0.76 - 1.21]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207544_s_at	204	0.647059	0.00625956	0.112819	0.973854	0.428028	0.155374	1.17 [0.80 - 1.72]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207544_s_at	204	0.892157	0.174223	-	0.515837	0.925368	0.0133851	1.01 [0.77 - 1.34]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214261_s_at	178	0.741573	0.0904647	-	0.369595	0.904805	-0.0303353	0.97 [0.59 - 1.59]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214261_s_at	111	0.531532	0.0265257	0.325982	0.584114	0.40609	0.123434	1.13 [0.85 - 1.51]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207544_s_at	111	0.675676	0.15106	-	-0.438067	0.449274	-0.0994753	0.91 [0.70 - 1.17]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214261_s_at	90	0.111111	0.161181	-	0.979658	0.222984	0.867549	2.38 [0.59 - 9.61]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214261_s_at	90	0.511111	0.201482	-	0.478422	0.0634604	1.40315	4.07 [0.92 - 17.90]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207544_s_at	90	0.844444	0.0345463	0.388985	0.793601	0.264705	1.07627	2.93 [0.44 - 19.45]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207544_s_at	90	0.822222	0.00379315	0.0760349	1.08644	0.113308	1.68995	5.42 [0.67 - 43.89]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	727	50	0.34	0.106983	-	0.989194	0.813731	0.0930633	1.10 [0.51 - 2.38]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207544_s_at	138	0.130435	0.0074786	0.129445	-0.788111	0.408306	-0.641709	0.53 [0.12 - 2.41]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214261_s_at	138	0.115942	0.00122869	0.030275	-0.936857	0.85409	0.0369198	1.04 [0.70 - 1.54]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214261_s_at	129	0.139535	0.00241512	0.0528397	-0.926661	0.13916	-0.319643	0.73 [0.48 - 1.11]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207544_s_at	129	0.651163	0.00169171	0.0394694	0.775238	0.154025	0.341235	1.41 [0.88 - 2.25]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19588	56	0.75	0.227668	-	0.458096	0.784786	0.0631937	1.07 [0.68 - 1.68]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19588	56	0.75	0.05754	-	0.674144	0.588004	0.11522	1.12 [0.74 - 1.70]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214261_s_at	278	0.899281	0.0197276	0.265362	-0.945179	0.208499	-0.508814	0.60 [0.27 - 1.33]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207544_s_at	278	0.215827	0.0653093	-	-0.400958	0.761341	-0.172511	0.84 [0.28 - 2.56]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214261_s_at	133	0.593985	0.00488141	0.092871	0.662409	0.527278	0.53736	1.71 [0.32 - 9.06]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207544_s_at	133	0.601504	0.000705597	0.0189944	0.78831	0.0162851	2.52755	12.52 [1.59 - 98.46]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214261_s_at	185	0.102703	0.0216336	0.28315	0.611421	0.851044	0.040836	1.04 [0.68 - 1.60]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207544_s_at	185	0.140541	4.67116e-06	0.000223701	-1.0035	0.513322	-0.321249	0.73 [0.28 - 1.90]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207544_s_at	185	0.167568	2.0376e-05	0.000849362	-0.86806	0.326095	-0.451658	0.64 [0.26 - 1.57]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214261_s_at	185	0.102703	0.0263279	0.324321	0.672286	0.73158	0.0826454	1.09 [0.68 - 1.74]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P25550	110	0.727273	0.0471257	0.47408	0.613981	0.711081	-0.0730081	0.93 [0.63 - 1.37]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P41498	110	0.109091	0.0774676	-	-0.571354	0.559632	-0.0973014	0.91 [0.65 - 1.26]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P29149	110	0.336364	0.0635172	-	-0.435881	0.208467	-0.130198	0.88 [0.72 - 1.08]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P41498	110	0.118182	0.021514	0.282054	-0.845108	0.494923	-0.143874	0.87 [0.57 - 1.31]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P25550	110	0.727273	0.0460094	0.467093	0.497084	0.376656	-0.121473	0.89 [0.68 - 1.16]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P29149	110	0.118182	0.0270404	0.330275	-0.856898	0.11398	-0.200774	0.82 [0.64 - 1.05]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214261_s_at	80	0.7875	0.0639319	-	0.825159	0.880908	-0.0306834	0.97 [0.65 - 1.45]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207544_s_at	80	0.75	0.0814895	-	0.785627	0.465051	0.122028	1.13 [0.81 - 1.57]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_6012	281	0.209964	0.00972563	0.158111	0.486849	0.826809	0.0275528	1.03 [0.80 - 1.32]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:292133	59	0.491525	0.0558885	-	0.986675	0.594656	0.317041	1.37 [0.43 - 4.41]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207544_s_at	38	0.105263	0.0188078	0.256528	-1.46605	0.207645	-0.750141	0.47 [0.15 - 1.52]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214261_s_at	38	0.5	0.0269907	0.329862	-1.08008	0.1631	-0.420377	0.66 [0.36 - 1.19]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214261_s_at	140	0.142857	0.00227351	0.050301	-0.989311	0.064189	-1.83246	0.16 [0.02 - 1.11]
GENE	ADH6	alcohol dehydrogenase 6 (class V)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207544_s_at	140	0.835714	0.0811752	-	-0.806592	0.637984	-0.855824	0.42 [0.01 - 15.02]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210505_at	30	0.3	0.351059	-	0.431771	0.74021	0.20038	1.22 [0.37 - 3.99]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210505_at	163	0.349693	0.226308	-	0.256817	0.144527	0.921331	2.51 [0.73 - 8.66]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210505_at	79	0.835443	0.176675	-	0.481181	0.877693	0.116559	1.12 [0.25 - 4.96]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210505_at	58	0.844828	0.00321489	0.0665993	1.17786	0.831184	0.0400768	1.04 [0.72 - 1.50]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210505_at	34	0.676471	0.050101	-	-0.837741	0.542973	-0.151215	0.86 [0.53 - 1.40]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210505_at	158	0.310127	0.0266256	0.326817	0.603192	0.390833	0.690251	1.99 [0.41 - 9.65]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210505_at	53	0.584906	0.345423	-	0.325357	0.519982	-0.150549	0.86 [0.54 - 1.36]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210505_at	53	0.54717	0.191844	-	0.474775	0.755285	0.0812136	1.08 [0.65 - 1.81]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210505_at	180	0.144444	0.0113502	0.177529	0.959871	0.0914934	0.416378	1.52 [0.93 - 2.46]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210505_at	559	0.110912	0.129727	-	0.757293	0.989791	0.00201754	1.00 [0.74 - 1.36]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210505_at	77	0.467532	0.152663	-	0.364512	0.133148	0.538363	1.71 [0.85 - 3.46]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210505_at	70	0.785714	0.126254	-	-0.509149	0.567301	-0.529917	0.59 [0.10 - 3.62]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33529_at	50	0.14	0.0238795	0.303288	-1.0264	0.17868	-1.18641	0.31 [0.05 - 1.72]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210505_at	74	0.567568	0.0783103	-	0.505755	0.466727	0.270214	1.31 [0.63 - 2.71]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210505_at	67	0.104478	0.0778368	-	-1.35207	0.961726	0.124134	1.13 [0.01 - 180.23]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210505_at	115	0.156522	0.0945956	-	15.2924	0.524272	0.536323	1.71 [0.33 - 8.91]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33529_at	158	0.240506	0.0252441	0.315123	-0.686104	0.573411	-0.111978	0.89 [0.61 - 1.32]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33529_at	76	0.697368	0.305347	-	-0.651939	0.890839	-0.0418065	0.96 [0.53 - 1.74]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210505_at	204	0.22549	0.125219	-	0.251687	0.705235	0.0287715	1.03 [0.89 - 1.19]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210505_at	87	0.195402	0.410342	-	0.441274	0.981594	-0.0286677	0.97 [0.09 - 11.10]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210505_at	87	0.195402	0.410342	-	0.441274	0.981594	-0.0286677	0.97 [0.09 - 11.10]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210505_at	77	0.74026	0.0895316	-	-1.59447	0.131015	-2.5761	0.08 [0.00 - 2.15]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210505_at	77	0.298701	0.0204808	0.272472	-1.38906	0.0508882	-4.11527	0.02 [0.00 - 1.02]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210505_at	136	0.779412	0.0909914	-	0.78041	0.743217	0.0893908	1.09 [0.64 - 1.87]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210505_at	200	0.16	0.0306902	0.359692	1.43737	0.291285	0.340387	1.41 [0.75 - 2.64]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21850	60	0.666667	0.0438372	0.453206	-0.903523	0.528059	0.339691	1.40 [0.49 - 4.03]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21850	60	0.45	0.0112063	0.175848	-0.957799	0.41718	-1.40694	0.24 [0.01 - 7.33]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18441	155	0.696774	0.100398	-	-0.534648	0.640323	-0.139111	0.87 [0.49 - 1.56]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210505_at	286	0.667832	0.0190463	0.258835	-0.516035	0.0463332	-0.317141	0.73 [0.53 - 0.99]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210505_at	159	0.220126	0.144297	-	-0.498497	0.554789	-0.174589	0.84 [0.47 - 1.50]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210505_at	159	0.220126	0.0237815	0.302427	-0.840713	0.322609	-0.302673	0.74 [0.41 - 1.35]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210505_at	159	0.792453	0.0440164	0.454366	0.667518	0.637378	-0.141196	0.87 [0.48 - 1.56]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210505_at	54	0.425926	0.0274431	0.333608	-1.61866	0.344677	-1.50778	0.22 [0.01 - 5.05]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210505_at	117	0.128205	0.196444	-	-0.532715	0.957845	-0.0373602	0.96 [0.24 - 3.85]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210505_at	117	0.333333	0.282709	-	0.465136	0.981841	0.0185504	1.02 [0.21 - 5.03]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210505_at	117	0.333333	0.183882	-	0.606305	0.96952	-0.0329343	0.97 [0.18 - 5.24]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210505_at	117	0.128205	0.196444	-	-0.532715	0.957845	-0.0373602	0.96 [0.24 - 3.85]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210505_at	236	0.652542	0.00603668	0.109682	0.731268	0.392205	0.305012	1.36 [0.67 - 2.73]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210505_at	249	0.879518	0.0485313	0.482738	-0.811083	0.671583	0.099668	1.10 [0.70 - 1.75]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210505_at	62	0.241935	0.171463	-	0.990703	0.760382	-0.0952651	0.91 [0.49 - 1.68]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210505_at	125	0.272	0.146635	-	-0.592258	0.601246	0.274374	1.32 [0.47 - 3.68]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210505_at	125	0.272	0.0323816	0.372754	-0.680258	0.807769	-0.100608	0.90 [0.40 - 2.03]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210505_at	54	0.222222	0.2208	-	1.20983	0.794512	-0.0989432	0.91 [0.43 - 1.91]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210505_at	198	0.80303	0.0113581	0.177621	0.686412	0.0201408	0.32471	1.38 [1.05 - 1.82]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210505_at	198	0.80303	0.00384737	0.0769006	0.795663	0.0430088	0.297116	1.35 [1.01 - 1.79]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210505_at	198	0.111111	0.046128	0.46784	0.889095	0.0725129	0.188135	1.21 [0.98 - 1.48]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210505_at	51	0.45098	0.220066	-	1.2822	0.586615	1.28922	3.63 [0.03 - 378.55]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210505_at	62	0.887097	0.153501	-	0.92054	0.437801	1.18067	3.26 [0.17 - 64.27]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210505_at	177	0.446328	0.259379	-	0.271451	0.951703	-0.0485944	0.95 [0.20 - 4.59]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210505_at	145	0.117241	0.178831	-	0.944638	0.504624	0.725286	2.07 [0.25 - 17.39]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210505_at	177	0.892655	0.186125	-	-0.766939	0.651708	-0.417928	0.66 [0.11 - 4.04]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210505_at	226	0.274336	0.0782959	-	0.63972	0.656917	0.117064	1.12 [0.67 - 1.88]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210505_at	55	0.2	0.158607	-	-0.711244	0.518019	-0.77977	0.46 [0.04 - 4.88]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210505_at	49	0.102041	0.141562	-	15.2846	0.842763	-0.237154	0.79 [0.08 - 8.22]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210505_at	55	0.472727	0.154409	-	-0.639545	0.561204	0.344991	1.41 [0.44 - 4.52]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210505_at	63	0.15873	0.00192764	0.0439459	-1.16592	0.321429	-1.85667	0.16 [0.00 - 6.13]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g499097_3p_at	28	0.107143	0.0389708	0.420603	-1.57294	0.536392	-0.441077	0.64 [0.16 - 2.60]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210505_at	82	0.256098	0.103255	-	-0.574756	0.573665	-0.333827	0.72 [0.22 - 2.29]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210505_at	79	0.898734	0.185725	-	-0.673564	0.802847	-0.142102	0.87 [0.28 - 2.65]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210505_at	104	0.144231	0.0182686	0.25127	1.56215	0.322371	0.615576	1.85 [0.55 - 6.26]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210505_at	204	0.583333	0.00200775	0.0454387	-1.39863	0.0793915	-0.396522	0.67 [0.43 - 1.05]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210505_at	204	0.102941	0.00587004	0.107316	-0.934532	0.0255711	-0.410177	0.66 [0.46 - 0.95]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210505_at	178	0.101124	0.130897	-	0.583937	0.986508	0.00391195	1.00 [0.64 - 1.58]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210505_at	111	0.855856	0.0460945	0.467629	-0.907297	0.0634342	-0.191612	0.83 [0.67 - 1.01]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210505_at	90	0.5	0.00588428	0.107519	-0.911902	0.16444	-0.314005	0.73 [0.47 - 1.14]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210505_at	90	0.5	0.0441539	0.455255	-0.753859	0.422777	-0.1904	0.83 [0.52 - 1.32]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210505_at	138	0.34058	0.0356369	0.396967	-0.509576	0.309136	-0.0441429	0.96 [0.88 - 1.04]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210505_at	129	0.124031	0.0643014	-	0.920927	0.66025	0.0505554	1.05 [0.84 - 1.32]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15341	56	0.196429	0.0131171	0.197617	-0.961757	0.192156	-0.076901	0.93 [0.82 - 1.04]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15341	56	0.107143	0.00154969	0.0367116	-1.53048	0.489764	-0.0425854	0.96 [0.85 - 1.08]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210505_at	278	0.73741	0.215921	-	-0.267913	0.930361	-0.0602183	0.94 [0.24 - 3.63]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210505_at	133	0.56391	0.000556955	0.0155363	0.803065	0.0213666	0.855462	2.35 [1.14 - 4.87]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17825	81	0.617284	0.0233201	0.298351	1.13684	0.317322	0.562396	1.75 [0.58 - 5.28]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210505_at	185	0.313514	0.156833	-	0.276164	0.985132	0.00750321	1.01 [0.46 - 2.22]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210505_at	185	0.335135	0.269294	-	0.191055	0.875327	-0.0588477	0.94 [0.45 - 1.97]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P92562	110	0.745455	0.00571355	0.105077	0.692034	0.269198	0.224373	1.25 [0.84 - 1.86]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P92562	110	0.709091	0.0346638	0.389852	0.63886	0.63941	0.123687	1.13 [0.67 - 1.90]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210505_at	80	0.7125	0.13779	-	0.658833	0.459541	0.251887	1.29 [0.66 - 2.51]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_6117	281	0.103203	0.237929	-	-0.263113	0.864548	0.0269191	1.03 [0.75 - 1.40]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210505_at	38	0.815789	0.223679	-	0.598214	0.621694	0.394819	1.48 [0.31 - 7.12]
GENE	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210505_at	140	0.457143	0.140665	-	-0.424465	0.373615	-1.44237	0.24 [0.01 - 5.67]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1702858	165	0.218182	0.00278564	0.0593286	-0.766226	0.166443	-0.157611	0.85 [0.68 - 1.07]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1702858	165	0.218182	6.13614e-05	0.00227424	-1.33212	0.00480219	-0.472604	0.62 [0.45 - 0.87]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	227113_at	163	0.815951	0.0168443	0.237078	0.571977	0.220094	0.501949	1.65 [0.74 - 3.68]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	227113_at	79	0.43038	0.0683295	-	0.555862	0.184641	0.495652	1.64 [0.79 - 3.41]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	227113_at	180	0.338889	0.113358	-	-0.341649	0.882769	-0.0513686	0.95 [0.48 - 1.88]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	227113_at	559	0.474061	0.109554	-	-0.320995	0.668593	-0.087028	0.92 [0.62 - 1.37]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	227113_at	77	0.337662	0.00161565	0.0379986	-0.850611	0.0023751	-1.20561	0.30 [0.14 - 0.65]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	227113_at	70	0.257143	0.000753774	0.0200863	1.18612	0.00407102	1.15537	3.18 [1.44 - 6.98]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	227113_at	74	0.837838	0.00597807	0.108852	-1.34508	0.0465533	-0.963829	0.38 [0.15 - 0.99]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	227113_at	67	0.686567	0.16769	-	-1.35792	0.981391	-0.0257758	0.97 [0.11 - 8.50]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	227113_at	115	0.669565	0.0298206	0.352841	-1.93442	0.075462	-1.03414	0.36 [0.11 - 1.11]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	227113_at	204	0.215686	0.0266372	0.326915	-0.380672	0.160479	-0.183058	0.83 [0.64 - 1.08]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	227113_at	87	0.712644	0.0404609	0.430815	-1.0576	0.0831507	-0.749301	0.47 [0.20 - 1.10]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	227113_at	87	0.712644	0.0404609	0.430815	-1.0576	0.0831507	-0.749301	0.47 [0.20 - 1.10]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	227113_at	77	0.272727	0.00889863	0.147827	-1.53599	0.103048	-1.54412	0.21 [0.03 - 1.37]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	227113_at	77	0.272727	0.0828631	-	-0.931621	0.320959	-0.803768	0.45 [0.09 - 2.19]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9549	60	0.633333	0.183416	-	-0.578624	0.309068	-0.132025	0.88 [0.68 - 1.13]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9549	60	0.133333	0.0102151	0.164066	-1.13455	0.151606	-0.354761	0.70 [0.43 - 1.14]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227113_at	159	0.867925	0.1075	-	0.626145	0.497004	0.434522	1.54 [0.44 - 5.41]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227113_at	159	0.666667	0.016009	0.228541	-0.964452	0.179081	-0.874326	0.42 [0.12 - 1.49]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227113_at	159	0.666667	0.121324	-	-0.696385	0.900391	0.0954724	1.10 [0.25 - 4.91]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	227113_at	236	0.110169	2.77922e-05	0.00112228	-1.22809	0.000729422	-1.97077	0.14 [0.04 - 0.44]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	227113_at	249	0.100402	1.78226e-05	0.000752953	-1.10932	0.0105739	-1.18984	0.30 [0.12 - 0.76]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	227113_at	177	0.310734	0.0326235	0.374595	-0.503549	0.577729	-0.418946	0.66 [0.15 - 2.87]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	227113_at	177	0.310734	0.0978102	-	-0.452649	0.956731	-0.0458775	0.96 [0.18 - 5.01]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	227113_at	145	0.131034	0.088264	-	-0.674778	0.314559	-1.13726	0.32 [0.03 - 2.94]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	227113_at	226	0.668142	0.205168	-	-0.417609	0.793718	-0.07371	0.93 [0.53 - 1.61]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	227113_at	49	0.285714	0.0255931	0.318104	-1.22926	0.116801	-3.44607	0.03 [0.00 - 2.36]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	227113_at	55	0.181818	0.103793	-	-0.776056	0.454213	-1.11254	0.33 [0.02 - 6.06]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	227113_at	55	0.272727	0.00279316	0.0594582	-1.32672	0.0955138	-2.78619	0.06 [0.00 - 1.63]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	227113_at	63	0.873016	0.000577103	0.0160136	1.37023	0.0136883	0.472202	1.60 [1.10 - 2.33]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.184261.0.A1_3p_at	28	0.178571	0.0538124	-	-1.13257	0.253915	-3.47477	0.03 [0.00 - 12.12]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P157569	117	0.598291	0.000416151	0.0121096	-1.1837	0.0272788	-0.329034	0.72 [0.54 - 0.96]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	227113_at	204	0.421569	7.76445e-05	0.00280136	-1.49413	0.000395052	-1.12539	0.32 [0.17 - 0.60]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	227113_at	204	0.490196	3.10303e-08	2.1472e-06	-1.67646	3.51279e-07	-1.20277	0.30 [0.19 - 0.48]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200021169	41	0.585366	0.0166289	0.234892	0.981821	0.032398	0.54057	1.72 [1.05 - 2.82]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	227113_at	111	0.297297	0.00366455	0.0739692	-0.766676	0.00141039	-1.20834	0.30 [0.14 - 0.63]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1482	50	0.52	0.20547	-	-0.622431	0.822439	-0.0755536	0.93 [0.48 - 1.79]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	227113_at	138	0.673913	0.0186387	0.254885	-0.659612	0.0479349	-0.461729	0.63 [0.40 - 1.00]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16591	56	0.875	0.0127666	0.19371	-2.14266	0.101338	-0.50764	0.60 [0.33 - 1.10]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16591	56	0.875	0.0147467	0.215317	-1.68311	0.0911773	-0.489374	0.61 [0.35 - 1.08]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	227113_at	278	0.169065	0.130585	-	0.419204	0.987685	-0.00256904	1.00 [0.72 - 1.38]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P157569	110	0.627273	0.0300352	0.35454	0.637132	0.478111	0.153524	1.17 [0.76 - 1.78]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P157569	110	0.109091	0.199911	-	0.538116	0.406253	0.150363	1.16 [0.82 - 1.66]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:299274	59	0.627119	0.139847	-	0.709309	0.748608	-0.398839	0.67 [0.06 - 7.69]
GENE	ADHFE1	alcohol dehydrogenase, iron containing, 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	227113_at	38	0.789474	0.062534	-	0.965889	0.43032	0.344631	1.41 [0.60 - 3.32]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADK	adenosine kinase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204120_s_at	30	0.8	0.199244	-	0.601836	0.89452	0.113834	1.12 [0.21 - 6.03]
GENE	ADK	adenosine kinase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204119_s_at	30	0.666667	0.0872249	-	0.699807	0.161194	0.460937	1.59 [0.83 - 3.02]
GENE	ADK	adenosine kinase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1693362	165	0.89697	0.177343	-	0.479027	0.367968	0.301812	1.35 [0.70 - 2.61]
GENE	ADK	adenosine kinase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1693362	165	0.266667	0.199406	-	-0.465295	0.768789	0.146584	1.16 [0.44 - 3.08]
GENE	ADK	adenosine kinase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204119_s_at	163	0.570552	0.086759	-	0.339387	0.275003	0.167813	1.18 [0.88 - 1.60]
GENE	ADK	adenosine kinase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204120_s_at	163	0.546012	0.0336922	0.382644	0.418365	0.0650383	0.31058	1.36 [0.98 - 1.90]
GENE	ADK	adenosine kinase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204119_s_at	79	0.898734	4.26591e-05	0.00164598	1.50761	0.256938	0.306743	1.36 [0.80 - 2.31]
GENE	ADK	adenosine kinase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204120_s_at	79	0.898734	2.22818e-05	0.000920436	1.55386	0.0163778	0.619102	1.86 [1.12 - 3.08]
GENE	ADK	adenosine kinase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204120_s_at	58	0.224138	0.186029	-	-0.421677	0.412227	-0.225549	0.80 [0.47 - 1.37]
GENE	ADK	adenosine kinase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204119_s_at	58	0.87931	0.016579	0.234384	0.981607	0.315187	0.294994	1.34 [0.76 - 2.39]
GENE	ADK	adenosine kinase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204119_s_at	34	0.558824	0.00181729	0.0418676	1.2356	0.218112	0.779644	2.18 [0.63 - 7.54]
GENE	ADK	adenosine kinase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204120_s_at	34	0.823529	0.0270192	0.330099	1.03853	0.124026	0.666548	1.95 [0.83 - 4.55]
GENE	ADK	adenosine kinase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204120_s_at	158	0.5	0.104408	-	-0.377036	0.417248	-0.192354	0.83 [0.52 - 1.31]
GENE	ADK	adenosine kinase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204119_s_at	158	0.411392	0.0328338	0.376189	-0.488394	0.502197	-0.155391	0.86 [0.54 - 1.35]
GENE	ADK	adenosine kinase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204119_s_at	53	0.396226	0.0204858	0.272519	0.927781	0.103061	0.653839	1.92 [0.88 - 4.22]
GENE	ADK	adenosine kinase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204120_s_at	53	0.716981	0.089831	-	0.633562	0.158767	0.423663	1.53 [0.85 - 2.75]
GENE	ADK	adenosine kinase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204119_s_at	53	0.433962	0.0459175	0.466513	0.705484	0.123197	0.582378	1.79 [0.85 - 3.75]
GENE	ADK	adenosine kinase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204120_s_at	53	0.584906	0.113784	-	0.539223	0.543477	0.164714	1.18 [0.69 - 2.01]
GENE	ADK	adenosine kinase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204120_s_at	180	0.705556	0.171498	-	0.305377	0.887293	-0.0249442	0.98 [0.69 - 1.38]
GENE	ADK	adenosine kinase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204119_s_at	180	0.355556	0.0565052	-	-0.402935	0.0454043	-0.493682	0.61 [0.38 - 0.99]
GENE	ADK	adenosine kinase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204120_s_at	559	0.865832	0.0184033	0.252589	0.563092	0.315093	0.246452	1.28 [0.79 - 2.07]
GENE	ADK	adenosine kinase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204119_s_at	559	0.871199	0.00271035	0.058027	0.786552	0.234866	0.201632	1.22 [0.88 - 1.71]
GENE	ADK	adenosine kinase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204119_s_at	77	0.363636	0.00699687	0.122977	-0.700514	0.286795	-0.359934	0.70 [0.36 - 1.35]
GENE	ADK	adenosine kinase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204120_s_at	77	0.467532	0.119746	-	0.401835	0.496342	0.220693	1.25 [0.66 - 2.36]
GENE	ADK	adenosine kinase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204120_s_at	70	0.785714	0.0477573	0.477989	-0.684161	0.496507	-0.194376	0.82 [0.47 - 1.44]
GENE	ADK	adenosine kinase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204119_s_at	70	0.4	0.171028	-	0.374657	0.693825	-0.120572	0.89 [0.49 - 1.62]
GENE	ADK	adenosine kinase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	168_at	50	0.34	0.00264696	0.0569246	-1.04117	0.258664	-0.819122	0.44 [0.11 - 1.83]
GENE	ADK	adenosine kinase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38301_at	50	0.12	0.00200049	0.045304	-1.41239	0.219103	-1.03063	0.36 [0.07 - 1.85]
GENE	ADK	adenosine kinase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204119_s_at	74	0.594595	9.39699e-05	0.00331549	-1.27668	0.00237797	-1.46599	0.23 [0.09 - 0.59]
GENE	ADK	adenosine kinase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204120_s_at	74	0.22973	2.67583e-05	0.00108479	-1.23557	0.000581599	-1.17434	0.31 [0.16 - 0.60]
GENE	ADK	adenosine kinase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204120_s_at	67	0.80597	0.121132	-	-15.3933	0.553908	-0.489217	0.61 [0.12 - 3.10]
GENE	ADK	adenosine kinase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204119_s_at	67	0.835821	0.203908	-	-15.2724	0.907415	-0.0879439	0.92 [0.21 - 4.03]
GENE	ADK	adenosine kinase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204120_s_at	115	0.443478	0.197427	-	0.744913	0.749756	-0.214963	0.81 [0.22 - 3.02]
GENE	ADK	adenosine kinase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204119_s_at	115	0.713043	0.0114597	0.178804	1.27609	0.7227	0.276262	1.32 [0.29 - 6.06]
GENE	ADK	adenosine kinase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	168_at	158	0.873418	0.0174012	0.24268	0.79594	0.192296	0.339823	1.40 [0.84 - 2.34]
GENE	ADK	adenosine kinase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38301_at	158	0.721519	0.027392	0.333187	0.630686	0.341547	0.204232	1.23 [0.81 - 1.87]
GENE	ADK	adenosine kinase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38301_at	76	0.118421	0.0679289	-	-1.02148	0.342014	-0.429393	0.65 [0.27 - 1.58]
GENE	ADK	adenosine kinase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	168_at	76	0.789474	0.181895	-	-1.29094	0.912717	0.0714161	1.07 [0.30 - 3.85]
GENE	ADK	adenosine kinase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204120_s_at	204	0.720588	0.0484282	0.482108	0.307227	0.524407	0.0816782	1.09 [0.84 - 1.40]
GENE	ADK	adenosine kinase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204119_s_at	204	0.872549	0.000652584	0.0177773	0.71741	0.0199532	0.388071	1.47 [1.06 - 2.04]
GENE	ADK	adenosine kinase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204119_s_at	87	0.563218	0.252814	-	-0.44757	0.821394	-0.0856859	0.92 [0.44 - 1.93]
GENE	ADK	adenosine kinase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204120_s_at	87	0.114943	0.00380937	0.0762942	-1.26919	0.859567	0.0545102	1.06 [0.58 - 1.93]
GENE	ADK	adenosine kinase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204120_s_at	87	0.114943	0.00380937	0.0762942	-1.26919	0.859567	0.0545102	1.06 [0.58 - 1.93]
GENE	ADK	adenosine kinase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204119_s_at	87	0.563218	0.252814	-	-0.44757	0.821394	-0.0856859	0.92 [0.44 - 1.93]
GENE	ADK	adenosine kinase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204120_s_at	77	0.376623	0.22273	-	0.782698	0.987645	0.00823236	1.01 [0.36 - 2.86]
GENE	ADK	adenosine kinase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204119_s_at	77	0.441558	0.0391091	0.421559	-1.17337	0.230062	-0.633941	0.53 [0.19 - 1.49]
GENE	ADK	adenosine kinase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204120_s_at	77	0.688312	0.1696	-	0.843762	0.590958	0.315922	1.37 [0.43 - 4.34]
GENE	ADK	adenosine kinase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204119_s_at	77	0.792208	0.0876651	-	-15.4157	0.46105	-0.457064	0.63 [0.19 - 2.13]
GENE	ADK	adenosine kinase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204119_s_at	136	0.110294	0.195963	-	-0.716372	0.997746	0.0014261	1.00 [0.37 - 2.69]
GENE	ADK	adenosine kinase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204120_s_at	136	0.897059	0.00142944	0.0343353	1.53828	0.110143	0.756816	2.13 [0.84 - 5.39]
GENE	ADK	adenosine kinase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204119_s_at	200	0.895	0.00250001	0.0543453	1.08425	0.412814	0.394888	1.48 [0.58 - 3.82]
GENE	ADK	adenosine kinase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204120_s_at	200	0.53	0.0616975	-	0.553222	0.234108	0.482577	1.62 [0.73 - 3.59]
GENE	ADK	adenosine kinase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11723	60	0.85	0.00756088	0.130537	1.16191	0.212694	0.44158	1.56 [0.78 - 3.11]
GENE	ADK	adenosine kinase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11723	60	0.15	0.00206617	0.0465191	-1.22896	0.455427	0.230807	1.26 [0.69 - 2.31]
GENE	ADK	adenosine kinase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17297	155	0.825806	0.000936176	0.0241123	0.942903	0.0538164	0.184788	1.20 [1.00 - 1.45]
GENE	ADK	adenosine kinase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204119_s_at	286	0.108392	0.0074298	0.128795	-0.679601	0.434362	-0.240497	0.79 [0.43 - 1.44]
GENE	ADK	adenosine kinase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204120_s_at	286	0.171329	0.0425039	0.444484	0.634291	0.138447	0.330714	1.39 [0.90 - 2.16]
GENE	ADK	adenosine kinase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204119_s_at	159	0.616352	0.121267	-	0.486324	0.549369	-0.274021	0.76 [0.31 - 1.86]
GENE	ADK	adenosine kinase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204120_s_at	159	0.100629	0.00315673	0.0656284	-1.20998	0.185887	-0.584772	0.56 [0.23 - 1.33]
GENE	ADK	adenosine kinase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204120_s_at	159	0.100629	0.0114115	0.178244	-0.964695	0.53673	-0.222717	0.80 [0.39 - 1.62]
GENE	ADK	adenosine kinase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204119_s_at	159	0.842767	0.0320465	0.370193	0.765931	0.95911	-0.022491	0.98 [0.41 - 2.31]
GENE	ADK	adenosine kinase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204119_s_at	159	0.792453	0.0341097	0.385754	0.806324	0.765532	-0.156676	0.85 [0.31 - 2.39]
GENE	ADK	adenosine kinase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204120_s_at	159	0.100629	0.01135	0.177526	-0.965598	0.138032	-0.557443	0.57 [0.27 - 1.20]
GENE	ADK	adenosine kinase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204120_s_at	54	0.796296	0.0133618	0.200322	1.55545	0.139272	0.622271	1.86 [0.82 - 4.25]
GENE	ADK	adenosine kinase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204119_s_at	54	0.722222	0.169773	-	0.8959	0.215446	0.481525	1.62 [0.76 - 3.47]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204119_s_at	117	0.444444	0.000341018	0.0102043	-1.52192	0.0247128	-0.652773	0.52 [0.29 - 0.92]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204119_s_at	117	0.42735	0.010654	0.169327	-0.820046	0.133587	-0.358161	0.70 [0.44 - 1.12]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204120_s_at	117	0.230769	0.0248525	0.311756	-0.733338	0.409785	-0.276397	0.76 [0.39 - 1.46]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204120_s_at	117	0.299145	0.0282537	0.340251	-0.810021	0.780772	-0.108742	0.90 [0.42 - 1.93]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204120_s_at	117	0.299145	0.0226169	0.292072	-0.876044	0.540878	-0.247451	0.78 [0.35 - 1.73]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204120_s_at	117	0.230769	0.0248525	0.311756	-0.733338	0.409785	-0.276397	0.76 [0.39 - 1.46]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204119_s_at	117	0.42735	0.010654	0.169327	-0.820046	0.133587	-0.358161	0.70 [0.44 - 1.12]
GENE	ADK	adenosine kinase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204119_s_at	117	0.42735	0.00641497	0.114987	-1.05522	0.132869	-0.421717	0.66 [0.38 - 1.14]
GENE	ADK	adenosine kinase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204119_s_at	236	0.775424	0.00282286	0.059969	0.809293	0.146963	0.512119	1.67 [0.84 - 3.33]
GENE	ADK	adenosine kinase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204120_s_at	236	0.711864	0.04373	0.45251	0.553922	0.416624	0.263803	1.30 [0.69 - 2.46]
GENE	ADK	adenosine kinase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204120_s_at	249	0.718876	0.00300491	0.0630734	0.642217	0.192378	0.333359	1.40 [0.85 - 2.30]
GENE	ADK	adenosine kinase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204119_s_at	249	0.803213	0.0053406	0.0996705	0.648766	0.114355	0.450871	1.57 [0.90 - 2.75]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204119_s_at	125	0.88	0.0890085	-	-1.56919	0.295581	-0.351765	0.70 [0.36 - 1.36]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204120_s_at	62	0.33871	0.395597	-	-0.403272	0.688982	-0.124613	0.88 [0.48 - 1.63]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204119_s_at	125	0.136	0.0941568	-	-0.650232	0.922131	-0.0253839	0.97 [0.59 - 1.62]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204120_s_at	125	0.16	0.258664	-	0.808226	0.928167	0.0337973	1.03 [0.50 - 2.16]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204119_s_at	54	0.851852	0.319129	-	-1.00214	0.942797	0.034946	1.04 [0.40 - 2.69]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204120_s_at	125	0.104	0.201982	-	-0.558291	0.720038	0.103747	1.11 [0.63 - 1.96]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204120_s_at	54	0.722222	0.292074	-	-0.733255	0.638328	-0.177705	0.84 [0.40 - 1.76]
GENE	ADK	adenosine kinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204119_s_at	62	0.870968	0.164053	-	-1.33625	0.840653	-0.0807888	0.92 [0.42 - 2.03]
GENE	ADK	adenosine kinase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204120_s_at	198	0.181818	0.00575621	0.105689	-0.777171	0.0932505	-0.285414	0.75 [0.54 - 1.05]
GENE	ADK	adenosine kinase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204120_s_at	198	0.181818	0.00364734	0.0736913	-0.845522	0.0582203	-0.338222	0.71 [0.50 - 1.01]
GENE	ADK	adenosine kinase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204119_s_at	198	0.525253	0.00372702	0.0749748	-0.628946	0.0522024	-0.374436	0.69 [0.47 - 1.00]
GENE	ADK	adenosine kinase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204120_s_at	198	0.565657	0.00605086	0.109883	-0.598041	0.121001	-0.220027	0.80 [0.61 - 1.06]
GENE	ADK	adenosine kinase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204119_s_at	198	0.525253	0.000391157	0.0114825	-0.959026	0.0368048	-0.468192	0.63 [0.40 - 0.97]
GENE	ADK	adenosine kinase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204119_s_at	198	0.520202	0.000425374	0.0123394	-1.00329	0.0657552	-0.428088	0.65 [0.41 - 1.03]
GENE	ADK	adenosine kinase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204119_s_at	51	0.882353	0.010189	0.163751	2.01724	0.0707062	1.74888	5.75 [0.86 - 38.30]
GENE	ADK	adenosine kinase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204119_s_at	62	0.854839	0.00861718	0.14426	1.4838	0.201389	0.773216	2.17 [0.66 - 7.10]
GENE	ADK	adenosine kinase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204120_s_at	51	0.745098	0.0596804	-	1.55746	0.390877	0.707378	2.03 [0.40 - 10.21]
GENE	ADK	adenosine kinase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204120_s_at	62	0.354839	0.00833992	0.14071	15.7625	0.47843	0.432595	1.54 [0.47 - 5.10]
GENE	ADK	adenosine kinase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204120_s_at	145	0.468966	0.00174774	0.0405438	-1.11076	0.120896	-0.368009	0.69 [0.43 - 1.10]
GENE	ADK	adenosine kinase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204120_s_at	177	0.146893	0.295921	-	0.422928	0.901486	0.0245254	1.02 [0.70 - 1.51]
GENE	ADK	adenosine kinase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204119_s_at	177	0.468927	0.0294717	0.350065	0.524405	0.267146	0.268113	1.31 [0.81 - 2.10]
GENE	ADK	adenosine kinase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204119_s_at	177	0.847458	0.046083	0.467556	-1.1245	0.987648	-0.00459295	1.00 [0.56 - 1.78]
GENE	ADK	adenosine kinase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204120_s_at	177	0.79096	0.0590356	-	0.492033	0.177238	0.226254	1.25 [0.90 - 1.74]
GENE	ADK	adenosine kinase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204119_s_at	145	0.448276	0.0117654	0.18234	-0.852176	0.123599	-0.573476	0.56 [0.27 - 1.17]
GENE	ADK	adenosine kinase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204119_s_at	226	0.539823	0.0262143	0.323365	-0.654217	0.0643837	-0.575162	0.56 [0.31 - 1.03]
GENE	ADK	adenosine kinase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204120_s_at	226	0.50885	0.00231264	0.051006	-0.909861	0.0267866	-0.558082	0.57 [0.35 - 0.94]
GENE	ADK	adenosine kinase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204119_s_at	55	0.8	0.0115215	0.179521	1.20158	0.0333789	0.906139	2.47 [1.07 - 5.70]
GENE	ADK	adenosine kinase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204119_s_at	49	0.816327	0.010638	0.169137	1.37733	0.051734	1.26332	3.54 [0.99 - 12.63]
GENE	ADK	adenosine kinase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204119_s_at	55	0.8	0.00467216	0.0897164	1.22922	0.0252777	0.960758	2.61 [1.13 - 6.06]
GENE	ADK	adenosine kinase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204120_s_at	55	0.581818	0.00802367	0.136616	1.183	0.0202829	0.693635	2.00 [1.11 - 3.59]
GENE	ADK	adenosine kinase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204120_s_at	55	0.581818	0.0115957	0.180381	1.24302	0.0177416	0.72061	2.06 [1.13 - 3.73]
GENE	ADK	adenosine kinase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204120_s_at	49	0.755102	0.00383721	0.0767387	1.55891	0.0252213	0.886535	2.43 [1.12 - 5.27]
GENE	ADK	adenosine kinase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	128243	34	0.794118	0.173843	-	0.694256	0.476327	0.336195	1.40 [0.55 - 3.53]
GENE	ADK	adenosine kinase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204120_s_at	63	0.746032	0.0475601	0.476772	-0.927182	0.161635	-0.817614	0.44 [0.14 - 1.39]
GENE	ADK	adenosine kinase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204119_s_at	63	0.539683	0.0146186	0.213952	0.817319	0.205579	0.206658	1.23 [0.89 - 1.69]
GENE	ADK	adenosine kinase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g1906010_3p_a_at	28	0.428571	0.102666	-	0.972441	0.804498	-0.0732334	0.93 [0.52 - 1.66]
GENE	ADK	adenosine kinase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204119_s_at	82	0.170732	0.0974137	-	-0.659102	0.545319	-0.23425	0.79 [0.37 - 1.69]
GENE	ADK	adenosine kinase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204120_s_at	82	0.231707	0.0042839	0.0837629	-0.968521	0.105243	-0.392434	0.68 [0.42 - 1.09]
GENE	ADK	adenosine kinase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	168_at	84	0.809524	0.00419557	0.0823894	-1.55432	0.0956158	-0.33078	0.72 [0.49 - 1.06]
GENE	ADK	adenosine kinase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204119_s_at	79	0.101266	0.130058	-	0.774522	0.893392	0.0422241	1.04 [0.56 - 1.93]
GENE	ADK	adenosine kinase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204120_s_at	79	0.620253	0.0673662	-	-0.494546	0.303283	-0.267373	0.77 [0.46 - 1.27]
GENE	ADK	adenosine kinase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U50196_at	86	0.244186	0.0185632	0.254151	-0.949568	0.895858	-0.0684255	0.93 [0.34 - 2.60]
GENE	ADK	adenosine kinase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U33936_s_at	86	0.872093	0.185678	-	0.711193	0.702209	0.175051	1.19 [0.49 - 2.92]
GENE	ADK	adenosine kinase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204120_s_at	104	0.875	0.13264	-	0.620636	0.1562	0.421518	1.52 [0.85 - 2.73]
GENE	ADK	adenosine kinase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204119_s_at	104	0.884615	0.0126181	0.192044	0.974745	0.050902	0.890176	2.44 [1.00 - 5.95]
GENE	ADK	adenosine kinase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P112596	117	0.717949	0.0491297	0.486377	0.576976	0.160351	0.271749	1.31 [0.90 - 1.92]
GENE	ADK	adenosine kinase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204120_s_at	204	0.754902	0.00360869	0.0730661	-2.36789	0.0473613	-0.698418	0.50 [0.25 - 0.99]
GENE	ADK	adenosine kinase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204120_s_at	204	0.598039	0.000149141	0.00497494	-1.24889	0.000594245	-0.899621	0.41 [0.24 - 0.68]
GENE	ADK	adenosine kinase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204119_s_at	204	0.563725	0.00143269	0.0344001	1.19826	0.112161	0.664668	1.94 [0.86 - 4.41]
GENE	ADK	adenosine kinase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204119_s_at	204	0.583333	0.00019628	0.00632312	1.0079	0.0261297	0.692137	2.00 [1.09 - 3.68]
GENE	ADK	adenosine kinase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204119_s_at	178	0.780899	0.10387	-	0.367894	0.209854	0.37866	1.46 [0.81 - 2.64]
GENE	ADK	adenosine kinase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204120_s_at	178	0.898876	0.00177666	0.0410957	0.923131	0.365777	0.138756	1.15 [0.85 - 1.55]
GENE	ADK	adenosine kinase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010643	41	0.341463	0.346497	-	0.424299	0.566286	0.208632	1.23 [0.60 - 2.51]
GENE	ADK	adenosine kinase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204120_s_at	111	0.117117	0.0907727	-	0.852105	0.489606	-0.197242	0.82 [0.47 - 1.44]
GENE	ADK	adenosine kinase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204119_s_at	111	0.864865	0.175791	-	-0.623898	0.445599	-0.207185	0.81 [0.48 - 1.38]
GENE	ADK	adenosine kinase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204119_s_at	90	0.411111	0.0753629	-	0.6264	0.778763	0.0786972	1.08 [0.62 - 1.87]
GENE	ADK	adenosine kinase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204119_s_at	90	0.411111	0.17738	-	0.535458	0.728456	0.111356	1.12 [0.60 - 2.10]
GENE	ADK	adenosine kinase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204120_s_at	90	0.888889	0.0163726	0.232277	0.97177	0.0487277	1.86697	6.47 [1.01 - 41.41]
GENE	ADK	adenosine kinase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204120_s_at	90	0.888889	0.00110569	0.0277227	1.32747	0.0144261	2.61433	13.66 [1.68 - 110.92]
GENE	ADK	adenosine kinase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2282	50	0.8	0.0201299	0.269174	1.12135	0.400145	0.900152	2.46 [0.30 - 20.03]
GENE	ADK	adenosine kinase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204120_s_at	138	0.449275	0.196156	-	0.314915	0.710986	-0.0529824	0.95 [0.72 - 1.26]
GENE	ADK	adenosine kinase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204119_s_at	138	0.876812	0.143431	-	-0.668078	0.804798	-0.0278602	0.97 [0.78 - 1.21]
GENE	ADK	adenosine kinase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204120_s_at	129	0.170543	0.0357764	0.397979	0.871635	0.120489	0.447723	1.56 [0.89 - 2.75]
GENE	ADK	adenosine kinase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204119_s_at	129	0.899225	0.099736	-	0.586962	0.578583	0.161077	1.17 [0.67 - 2.07]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33308	56	0.392857	0.273187	-	0.407644	0.692995	0.128825	1.14 [0.60 - 2.16]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15048	56	0.5	0.305536	-	-0.365087	0.799071	0.0880958	1.09 [0.55 - 2.15]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30190	56	0.839286	0.119004	-	-0.749565	0.977986	-0.00923996	0.99 [0.51 - 1.91]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33308	56	0.857143	0.184379	-	0.598271	0.461061	0.257347	1.29 [0.65 - 2.56]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18196	56	0.535714	0.268941	-	-0.37784	0.960623	0.017318	1.02 [0.51 - 2.02]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30190	56	0.107143	0.220751	-	0.738608	0.74012	0.117134	1.12 [0.56 - 2.25]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15048	56	0.196429	0.287222	-	-0.416897	0.938776	-0.0251964	0.98 [0.51 - 1.85]
GENE	ADK	adenosine kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18196	56	0.107143	0.31816	-	0.60763	0.662174	0.161932	1.18 [0.57 - 2.43]
GENE	ADK	adenosine kinase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204120_s_at	278	0.107914	0.0425854	0.445022	0.772961	0.824783	-0.0429762	0.96 [0.65 - 1.40]
GENE	ADK	adenosine kinase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204119_s_at	278	0.338129	0.137055	-	0.309777	0.885363	0.0188729	1.02 [0.79 - 1.32]
GENE	ADK	adenosine kinase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204120_s_at	133	0.210526	0.167136	-	-0.381276	0.988071	-0.00402743	1.00 [0.59 - 1.69]
GENE	ADK	adenosine kinase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204119_s_at	133	0.142857	0.0568043	-	-0.573271	0.0894907	-0.201482	0.82 [0.65 - 1.03]
GENE	ADK	adenosine kinase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13828	81	0.888889	0.0884435	-	1.07421	0.149708	0.676229	1.97 [0.78 - 4.93]
GENE	ADK	adenosine kinase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1967	81	0.888889	0.0936287	-	1.05853	0.119819	0.71344	2.04 [0.83 - 5.01]
GENE	ADK	adenosine kinase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204119_s_at	185	0.172973	0.029977	0.35408	0.525598	0.975103	-0.00406157	1.00 [0.77 - 1.29]
GENE	ADK	adenosine kinase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204120_s_at	185	0.578378	0.0404109	0.430476	0.333872	0.0722957	0.631575	1.88 [0.94 - 3.74]
GENE	ADK	adenosine kinase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204119_s_at	185	0.308108	0.028658	0.34353	0.394866	0.991168	0.00130453	1.00 [0.79 - 1.26]
GENE	ADK	adenosine kinase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204120_s_at	185	0.578378	0.0159208	0.22763	0.42232	0.10385	0.61673	1.85 [0.88 - 3.90]
GENE	ADK	adenosine kinase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P112596	110	0.645455	0.00482997	0.0920989	0.8172	0.00847572	0.533018	1.70 [1.15 - 2.53]
GENE	ADK	adenosine kinase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P112596	110	0.636364	0.00134296	0.0326013	0.741115	0.00603686	0.46097	1.59 [1.14 - 2.20]
GENE	ADK	adenosine kinase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204120_s_at	80	0.15	0.0796618	-	-0.888557	0.577233	0.187426	1.21 [0.62 - 2.33]
GENE	ADK	adenosine kinase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204119_s_at	80	0.15	0.0341354	0.385945	15.3329	0.0920489	0.585602	1.80 [0.91 - 3.55]
GENE	ADK	adenosine kinase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_1826	281	0.740214	0.00151977	0.036124	0.481362	0.132787	0.30318	1.35 [0.91 - 2.01]
GENE	ADK	adenosine kinase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204119_s_at	38	0.289474	0.102763	-	-0.741358	0.658828	-0.168058	0.85 [0.40 - 1.78]
GENE	ADK	adenosine kinase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204120_s_at	38	0.552632	0.22515	-	-0.594074	0.575909	-0.160182	0.85 [0.49 - 1.49]
GENE	ADK	adenosine kinase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204119_s_at	140	0.735714	0.0139326	0.206567	-1.03002	0.0225496	-0.701526	0.50 [0.27 - 0.91]
GENE	ADK	adenosine kinase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204120_s_at	140	0.571429	0.0084047	0.141542	-0.835398	0.026503	-1.90647	0.15 [0.03 - 0.80]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADSL	adenylosuccinate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210250_x_at	30	0.733333	0.150812	-	0.624892	0.926246	0.0602859	1.06 [0.30 - 3.81]
GENE	ADSL	adenylosuccinate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215292_s_at	30	0.533333	0.186186	-	0.542411	0.634364	0.39424	1.48 [0.29 - 7.53]
GENE	ADSL	adenylosuccinate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202144_s_at	30	0.133333	0.335683	-	-0.522648	0.753765	-0.185936	0.83 [0.26 - 2.65]
GENE	ADSL	adenylosuccinate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215291_at	30	0.166667	0.30527	-	0.616658	0.694586	-0.375505	0.69 [0.11 - 4.48]
GENE	ADSL	adenylosuccinate lyase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1790757	165	0.866667	4.34396e-05	0.0016728	1.18774	0.174579	0.368809	1.45 [0.85 - 2.46]
GENE	ADSL	adenylosuccinate lyase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1790757	165	0.866667	2.12945e-05	0.000883704	1.49958	0.306675	0.440975	1.55 [0.67 - 3.62]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202144_s_at	163	0.858896	0.07835	-	0.465995	0.203798	0.190054	1.21 [0.90 - 1.62]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215291_at	163	0.588957	0.1092	-	0.31429	0.546359	0.368566	1.45 [0.44 - 4.79]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210250_x_at	163	0.889571	0.0386529	0.418397	0.590975	0.383874	0.15954	1.17 [0.82 - 1.68]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215292_s_at	163	0.809816	0.00629318	0.113289	0.620168	0.557047	0.380638	1.46 [0.41 - 5.21]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202144_s_at	79	0.556962	0.0328714	0.376473	0.616662	0.187927	0.329689	1.39 [0.85 - 2.27]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215292_s_at	79	0.582278	0.0572229	-	0.552224	0.255757	0.925626	2.52 [0.51 - 12.45]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215291_at	79	0.329114	0.0429991	0.447741	0.651688	0.492279	0.416357	1.52 [0.46 - 4.98]
GENE	ADSL	adenylosuccinate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210250_x_at	79	0.607595	0.0144805	0.212475	0.706387	0.0827721	0.468102	1.60 [0.94 - 2.71]
GENE	ADSL	adenylosuccinate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215291_at	58	0.827586	0.0190215	0.258596	0.849634	0.0738584	0.333533	1.40 [0.97 - 2.01]
GENE	ADSL	adenylosuccinate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210250_x_at	58	0.206897	0.00405439	0.0801784	-0.998478	0.0472289	-0.818709	0.44 [0.20 - 0.99]
GENE	ADSL	adenylosuccinate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215292_s_at	58	0.155172	0.0245296	0.308962	0.895638	0.833029	0.0317125	1.03 [0.77 - 1.39]
GENE	ADSL	adenylosuccinate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202144_s_at	58	0.137931	0.0483903	0.481876	-0.766905	0.696934	-0.140084	0.87 [0.43 - 1.76]
GENE	ADSL	adenylosuccinate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202144_s_at	34	0.441176	0.00401207	0.0795119	1.16545	0.123627	0.926824	2.53 [0.78 - 8.22]
GENE	ADSL	adenylosuccinate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215291_at	34	0.147059	0.112546	-	-0.80104	0.651367	-0.0964955	0.91 [0.60 - 1.38]
GENE	ADSL	adenylosuccinate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210250_x_at	34	0.264706	0.31116	-	-0.425688	0.932784	0.0626159	1.06 [0.25 - 4.56]
GENE	ADSL	adenylosuccinate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215292_s_at	34	0.147059	0.124482	-	0.945083	0.276064	0.475825	1.61 [0.68 - 3.79]
GENE	ADSL	adenylosuccinate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210250_x_at	158	0.240506	0.0145322	0.213029	-0.594003	0.184005	-0.365995	0.69 [0.40 - 1.19]
GENE	ADSL	adenylosuccinate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215292_s_at	158	0.816456	0.181378	-	0.373443	0.815838	0.2062	1.23 [0.22 - 6.97]
GENE	ADSL	adenylosuccinate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215291_at	158	0.71519	0.146633	-	0.350996	0.688553	0.277109	1.32 [0.34 - 5.11]
GENE	ADSL	adenylosuccinate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202144_s_at	158	0.462025	0.0063186	0.113644	-0.633689	0.121648	-0.394183	0.67 [0.41 - 1.11]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215292_s_at	53	0.132075	0.18923	-	-0.589616	0.563203	-0.219369	0.80 [0.38 - 1.69]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202144_s_at	53	0.188679	0.00580695	0.106415	-1.06564	0.0887835	-0.965107	0.38 [0.13 - 1.16]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215291_at	53	0.584906	0.159993	-	-0.538275	0.430161	-0.175541	0.84 [0.54 - 1.30]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210250_x_at	53	0.150943	0.0229786	0.295312	-0.956228	0.146133	-0.993689	0.37 [0.10 - 1.41]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202144_s_at	53	0.188679	0.0120116	0.185166	-0.961004	0.0980207	-0.90352	0.41 [0.14 - 1.18]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215292_s_at	53	0.584906	0.166788	-	0.500676	0.920699	-0.0386678	0.96 [0.45 - 2.06]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215291_at	53	0.584906	0.0883327	-	-0.616413	0.197949	-0.272954	0.76 [0.50 - 1.15]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210250_x_at	53	0.245283	0.00651889	0.116429	-0.959544	0.24003	-0.781746	0.46 [0.12 - 1.69]
GENE	ADSL	adenylosuccinate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210250_x_at	180	0.266667	0.0253719	0.316216	0.576709	0.195557	0.480935	1.62 [0.78 - 3.35]
GENE	ADSL	adenylosuccinate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215292_s_at	180	0.416667	0.016094	0.229417	0.532213	0.0517938	0.6518	1.92 [0.99 - 3.70]
GENE	ADSL	adenylosuccinate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202144_s_at	180	0.744444	0.162991	-	0.317715	0.608311	0.169552	1.18 [0.62 - 2.27]
GENE	ADSL	adenylosuccinate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215291_at	180	0.511111	0.0236627	0.30138	0.474968	0.155599	0.141501	1.15 [0.95 - 1.40]
GENE	ADSL	adenylosuccinate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210250_x_at	559	0.708408	0.000126588	0.00430906	0.768272	0.00684582	0.440524	1.55 [1.13 - 2.14]
GENE	ADSL	adenylosuccinate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202144_s_at	559	0.812165	2.12547e-07	1.29639e-05	1.09452	2.82213e-05	1.1259	3.08 [1.82 - 5.22]
GENE	ADSL	adenylosuccinate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215292_s_at	559	0.67263	0.0101946	0.163819	-0.587295	0.0341163	-0.430224	0.65 [0.44 - 0.97]
GENE	ADSL	adenylosuccinate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215291_at	559	0.105546	0.00045821	0.0131511	-0.815634	0.0305316	-0.300271	0.74 [0.56 - 0.97]
GENE	ADSL	adenylosuccinate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202144_s_at	77	0.753247	0.137376	-	-0.47539	0.438287	-0.360844	0.70 [0.28 - 1.74]
GENE	ADSL	adenylosuccinate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215291_at	77	0.246753	0.0125577	0.191364	-0.717417	0.135872	-0.34812	0.71 [0.45 - 1.12]
GENE	ADSL	adenylosuccinate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210250_x_at	77	0.116883	0.00670595	0.119007	-0.97576	0.457699	0.292456	1.34 [0.62 - 2.90]
GENE	ADSL	adenylosuccinate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215292_s_at	77	0.883117	0.106845	-	-0.739533	0.129867	-0.443431	0.64 [0.36 - 1.14]
GENE	ADSL	adenylosuccinate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202144_s_at	70	0.885714	0.100231	-	-0.754598	0.95541	0.0162961	1.02 [0.57 - 1.80]
GENE	ADSL	adenylosuccinate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215292_s_at	70	0.885714	0.0424092	0.443859	0.762754	0.304578	0.602625	1.83 [0.58 - 5.77]
GENE	ADSL	adenylosuccinate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215291_at	70	0.128571	0.0913404	-	-0.61319	0.573564	0.264858	1.30 [0.52 - 3.28]
GENE	ADSL	adenylosuccinate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210250_x_at	70	0.271429	0.0832375	-	0.543671	0.760573	-0.0801986	0.92 [0.55 - 1.55]
GENE	ADSL	adenylosuccinate lyase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33366_at	50	0.32	0.120624	-	-0.573649	0.54495	-0.720078	0.49 [0.05 - 5.01]
GENE	ADSL	adenylosuccinate lyase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36639_at	50	0.78	0.263986	-	-0.539252	0.949147	-0.0629071	0.94 [0.14 - 6.49]
GENE	ADSL	adenylosuccinate lyase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35563_at	50	0.54	0.0223702	0.289849	-0.801019	0.180633	-0.997796	0.37 [0.09 - 1.59]
GENE	ADSL	adenylosuccinate lyase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35629_at	50	0.88	0.000204445	0.00655154	1.63314	0.347831	0.303944	1.36 [0.72 - 2.56]
GENE	ADSL	adenylosuccinate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215292_s_at	74	0.108108	2.53493e-05	0.00103342	-1.5947	0.267452	-0.40783	0.67 [0.32 - 1.37]
GENE	ADSL	adenylosuccinate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202144_s_at	74	0.864865	0.2758	-	0.423823	0.960328	-0.034546	0.97 [0.25 - 3.77]
GENE	ADSL	adenylosuccinate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215291_at	74	0.216216	0.128593	-	0.587788	0.448619	0.182129	1.20 [0.75 - 1.92]
GENE	ADSL	adenylosuccinate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210250_x_at	74	0.121622	0.0672662	-	-0.70096	0.542324	-0.323878	0.72 [0.26 - 2.05]
GENE	ADSL	adenylosuccinate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210250_x_at	67	0.776119	0.113669	-	-15.3986	0.237842	-1.368	0.25 [0.03 - 2.47]
GENE	ADSL	adenylosuccinate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202144_s_at	67	0.522388	0.0722986	-	-1.36001	0.179233	-1.69145	0.18 [0.02 - 2.17]
GENE	ADSL	adenylosuccinate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215292_s_at	67	0.19403	0.19437	-	15.2867	0.868808	0.288659	1.33 [0.04 - 41.02]
GENE	ADSL	adenylosuccinate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215291_at	67	0.522388	0.103281	-	-1.23406	0.872796	-0.308142	0.73 [0.02 - 31.95]
GENE	ADSL	adenylosuccinate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202144_s_at	115	0.130435	0.0692236	-	-1.03724	0.57632	-0.430774	0.65 [0.14 - 2.95]
GENE	ADSL	adenylosuccinate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215292_s_at	115	0.878261	0.0343495	0.387532	1.18481	0.250677	0.673915	1.96 [0.62 - 6.20]
GENE	ADSL	adenylosuccinate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215291_at	115	0.8	0.0123673	0.189214	1.26132	0.257108	0.868846	2.38 [0.53 - 10.71]
GENE	ADSL	adenylosuccinate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210250_x_at	115	0.130435	0.0692236	-	-1.03724	0.812717	0.169369	1.18 [0.29 - 4.81]
GENE	ADSL	adenylosuccinate lyase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35629_at	158	0.892405	0.0513363	-	0.706759	0.0638739	0.814685	2.26 [0.95 - 5.35]
GENE	ADSL	adenylosuccinate lyase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33366_at	158	0.708861	0.194897	-	-0.428347	0.583975	-0.287529	0.75 [0.27 - 2.10]
GENE	ADSL	adenylosuccinate lyase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36639_at	158	0.683544	0.0952103	-	0.481493	0.911678	0.052066	1.05 [0.42 - 2.64]
GENE	ADSL	adenylosuccinate lyase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35563_at	158	0.575949	0.0406637	0.432189	-0.613479	0.700874	-0.0789067	0.92 [0.62 - 1.38]
GENE	ADSL	adenylosuccinate lyase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35563_at	76	0.118421	0.0598642	-	-1.05276	0.214084	-0.577191	0.56 [0.23 - 1.40]
GENE	ADSL	adenylosuccinate lyase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35629_at	76	0.684211	0.0319911	0.369769	-1.91497	0.172849	-1.09922	0.33 [0.07 - 1.62]
GENE	ADSL	adenylosuccinate lyase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33366_at	76	0.394737	0.121067	-	-0.796272	0.568691	-0.560277	0.57 [0.08 - 3.92]
GENE	ADSL	adenylosuccinate lyase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36639_at	76	0.618421	0.0826741	-	-1.07799	0.256896	-1.00131	0.37 [0.07 - 2.07]
GENE	ADSL	adenylosuccinate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215292_s_at	204	0.102941	0.00329338	0.067903	-0.683267	0.560118	-0.0518775	0.95 [0.80 - 1.13]
GENE	ADSL	adenylosuccinate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215291_at	204	0.696078	0.027696	0.33569	0.33777	0.152707	0.0991087	1.10 [0.96 - 1.26]
GENE	ADSL	adenylosuccinate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210250_x_at	204	0.455882	0.0366684	0.4044	0.288432	0.0812401	0.30578	1.36 [0.96 - 1.91]
GENE	ADSL	adenylosuccinate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202144_s_at	204	0.573529	0.000485643	0.0138217	0.4927	0.03365	0.337482	1.40 [1.03 - 1.91]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210250_x_at	87	0.724138	0.0223862	0.289994	0.847684	0.0994073	0.652919	1.92 [0.88 - 4.18]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215292_s_at	87	0.103448	0.128823	-	1.42433	0.812646	-0.153199	0.86 [0.24 - 3.05]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202144_s_at	87	0.747126	0.00823609	0.139371	0.971937	0.118053	0.700985	2.02 [0.84 - 4.86]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215291_at	87	0.885057	0.0279017	0.337377	-15.2642	0.249962	-0.955001	0.38 [0.08 - 1.96]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215292_s_at	87	0.103448	0.128823	-	1.42433	0.812646	-0.153199	0.86 [0.24 - 3.05]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210250_x_at	87	0.724138	0.0223862	0.289994	0.847684	0.0994073	0.652919	1.92 [0.88 - 4.18]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215291_at	87	0.885057	0.0279017	0.337377	-15.2642	0.249962	-0.955001	0.38 [0.08 - 1.96]
GENE	ADSL	adenylosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202144_s_at	87	0.747126	0.00823609	0.139371	0.971937	0.118053	0.700985	2.02 [0.84 - 4.86]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215291_at	77	0.831169	0.209275	-	0.841888	0.878807	0.19287	1.21 [0.10 - 14.47]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215292_s_at	77	0.883117	0.00623744	0.112509	1.50637	0.70591	0.526088	1.69 [0.11 - 26.01]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210250_x_at	77	0.285714	0.0385368	0.417589	15.5853	0.183905	0.949427	2.58 [0.64 - 10.48]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215291_at	77	0.831169	0.147909	-	0.84464	0.704715	0.41244	1.51 [0.18 - 12.75]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202144_s_at	77	0.727273	0.00977087	0.158665	1.51903	0.0832298	1.69521	5.45 [0.80 - 37.09]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210250_x_at	77	0.272727	0.0204536	0.272218	15.5674	0.333827	0.575305	1.78 [0.55 - 5.71]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215292_s_at	77	0.103896	0.0159628	0.228064	-1.51704	0.315323	-1.74642	0.17 [0.01 - 5.27]
GENE	ADSL	adenylosuccinate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202144_s_at	77	0.415584	0.0327397	0.375476	1.49826	0.200646	1.03461	2.81 [0.58 - 13.72]
GENE	ADSL	adenylosuccinate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202144_s_at	136	0.301471	0.0540174	-	1.33658	0.218223	1.2077	3.35 [0.49 - 22.88]
GENE	ADSL	adenylosuccinate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215291_at	136	0.882353	0.0393793	0.423424	1.02197	0.434155	0.202968	1.23 [0.74 - 2.04]
GENE	ADSL	adenylosuccinate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210250_x_at	136	0.897059	0.0100245	0.161759	1.25862	0.580929	0.414532	1.51 [0.35 - 6.60]
GENE	ADSL	adenylosuccinate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215292_s_at	136	0.727941	0.201117	-	0.577574	0.365853	0.371105	1.45 [0.65 - 3.24]
GENE	ADSL	adenylosuccinate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215292_s_at	200	0.515	0.307883	-	0.302588	0.585012	0.188389	1.21 [0.61 - 2.37]
GENE	ADSL	adenylosuccinate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215291_at	200	0.675	0.00426881	0.0835288	0.826717	0.0166419	0.472278	1.60 [1.09 - 2.36]
GENE	ADSL	adenylosuccinate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202144_s_at	200	0.595	0.00121445	0.0299823	0.943018	0.00171747	1.51382	4.54 [1.76 - 11.71]
GENE	ADSL	adenylosuccinate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210250_x_at	200	0.27	0.0997276	-	0.66401	0.977854	0.0138822	1.01 [0.38 - 2.70]
GENE	ADSL	adenylosuccinate lyase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9897	60	0.566667	0.179982	-	0.503703	0.501542	0.230661	1.26 [0.64 - 2.47]
GENE	ADSL	adenylosuccinate lyase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9897	60	0.2	0.0202272	0.270091	-0.924132	0.633314	-0.180253	0.84 [0.40 - 1.75]
GENE	ADSL	adenylosuccinate lyase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5902	155	0.322581	3.54561e-06	0.000173929	-1.22973	7.83322e-05	-0.41798	0.66 [0.54 - 0.81]
GENE	ADSL	adenylosuccinate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215292_s_at	286	0.807692	0.0104625	0.167041	-0.765332	0.344044	-0.262836	0.77 [0.45 - 1.33]
GENE	ADSL	adenylosuccinate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202144_s_at	286	0.293706	0.0547	-	0.435659	0.323238	0.312755	1.37 [0.74 - 2.54]
GENE	ADSL	adenylosuccinate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215291_at	286	0.884615	0.0486482	0.483451	-0.752505	0.64555	-0.0627919	0.94 [0.72 - 1.23]
GENE	ADSL	adenylosuccinate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210250_x_at	286	0.300699	0.035393	0.395193	-0.418177	0.345702	-0.330546	0.72 [0.36 - 1.43]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215292_s_at	159	0.446541	0.207069	-	0.415232	0.997616	0.00160172	1.00 [0.35 - 2.86]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202144_s_at	159	0.106918	0.176977	-	0.944155	0.777529	0.146776	1.16 [0.42 - 3.21]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210250_x_at	159	0.572327	0.00707794	0.124074	1.00948	0.0718704	0.932794	2.54 [0.92 - 7.02]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215291_at	159	0.72956	0.0626787	-	0.599636	0.180865	0.31739	1.37 [0.86 - 2.19]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215292_s_at	159	0.163522	0.236582	-	-0.508176	0.945768	0.0433195	1.04 [0.30 - 3.64]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210250_x_at	159	0.572327	0.0333456	0.380047	0.66855	0.202964	0.593395	1.81 [0.73 - 4.51]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202144_s_at	159	0.534591	0.0491609	0.486567	0.625196	0.162466	0.649858	1.92 [0.77 - 4.77]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215292_s_at	159	0.899371	0.0221195	0.28758	0.876483	0.133446	0.7478	2.11 [0.80 - 5.61]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202144_s_at	159	0.106918	0.154848	-	1.34437	0.347989	0.524372	1.69 [0.57 - 5.05]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215291_at	159	0.201258	0.00807581	0.137295	1.70746	0.230526	0.270486	1.31 [0.84 - 2.04]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210250_x_at	159	0.534591	0.0212201	0.279348	0.736801	0.0618913	0.844714	2.33 [0.96 - 5.65]
GENE	ADSL	adenylosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215291_at	159	0.72956	0.0118916	0.183792	0.909124	0.140708	0.378996	1.46 [0.88 - 2.42]
GENE	ADSL	adenylosuccinate lyase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202144_s_at	54	0.148148	0.0634565	-	-1.27229	0.948318	-0.0422701	0.96 [0.27 - 3.44]
GENE	ADSL	adenylosuccinate lyase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210250_x_at	54	0.888889	0.0647307	-	1.40353	0.66908	0.24491	1.28 [0.42 - 3.93]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202144_s_at	117	0.675214	0.0463285	0.4691	-1.03804	0.173606	-0.548269	0.58 [0.26 - 1.27]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202144_s_at	117	0.897436	0.0326927	0.375119	-1.87808	0.13315	-0.474056	0.62 [0.34 - 1.16]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210250_x_at	117	0.273504	0.0325795	0.37426	-0.691329	0.186783	-0.325265	0.72 [0.45 - 1.17]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210250_x_at	117	0.273504	0.0226668	0.29252	-0.845201	0.120327	-0.448226	0.64 [0.36 - 1.12]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215291_at	117	0.777778	0.10938	-	0.535453	0.892578	0.119315	1.13 [0.20 - 6.37]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215292_s_at	117	0.213675	0.049456	0.488351	-0.658192	0.667384	-0.198176	0.82 [0.33 - 2.03]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215292_s_at	117	0.273504	0.0329593	0.377138	-0.794136	0.339518	-0.56541	0.57 [0.18 - 1.81]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210250_x_at	117	0.666667	0.0332881	0.379616	-1.10266	0.14635	-0.435596	0.65 [0.36 - 1.16]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210250_x_at	117	0.273504	0.0325795	0.37426	-0.691329	0.186783	-0.325265	0.72 [0.45 - 1.17]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215292_s_at	117	0.213675	0.049456	0.488351	-0.658192	0.667384	-0.198176	0.82 [0.33 - 2.03]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215292_s_at	117	0.205128	0.00515704	0.096972	-1.07742	0.319338	-0.611479	0.54 [0.16 - 1.81]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202144_s_at	117	0.675214	0.0411425	0.435417	-1.05378	0.119793	-0.590843	0.55 [0.26 - 1.17]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202144_s_at	117	0.897436	0.0326927	0.375119	-1.87808	0.13315	-0.474056	0.62 [0.34 - 1.16]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215291_at	117	0.401709	0.0181672	0.250274	1.11597	0.612015	0.545721	1.73 [0.21 - 14.22]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215291_at	117	0.777778	0.10938	-	0.535453	0.892578	0.119315	1.13 [0.20 - 6.37]
GENE	ADSL	adenylosuccinate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215291_at	117	0.777778	0.0267773	0.328085	0.832636	0.476373	0.71742	2.05 [0.28 - 14.76]
GENE	ADSL	adenylosuccinate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202144_s_at	236	0.881356	0.00946076	0.154849	0.851183	0.0694932	1.00551	2.73 [0.92 - 8.09]
GENE	ADSL	adenylosuccinate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215291_at	236	0.538136	0.0060425	0.109765	0.74818	0.0483357	0.412366	1.51 [1.00 - 2.27]
GENE	ADSL	adenylosuccinate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210250_x_at	236	0.894068	5.2316e-05	0.00197389	1.25092	0.0108113	1.27438	3.58 [1.34 - 9.53]
GENE	ADSL	adenylosuccinate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215292_s_at	236	0.741525	0.0702094	-	0.507537	0.478599	0.35228	1.42 [0.54 - 3.77]
GENE	ADSL	adenylosuccinate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210250_x_at	249	0.674699	0.00601269	0.109343	0.581257	0.0581788	0.700536	2.01 [0.98 - 4.16]
GENE	ADSL	adenylosuccinate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215292_s_at	249	0.859438	0.0185317	0.253843	-0.958308	0.348372	-0.409407	0.66 [0.28 - 1.56]
GENE	ADSL	adenylosuccinate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215291_at	249	0.538153	0.0634473	-	0.392118	0.221492	0.210713	1.23 [0.88 - 1.73]
GENE	ADSL	adenylosuccinate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202144_s_at	249	0.899598	0.0164831	0.233407	0.708115	0.0263461	0.9639	2.62 [1.12 - 6.14]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202144_s_at	125	0.856	0.0356305	0.396921	-1.87791	0.612699	0.169399	1.18 [0.61 - 2.28]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215291_at	62	0.370968	0.174312	-	0.844371	0.708433	-0.0951303	0.91 [0.55 - 1.50]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202144_s_at	125	0.856	0.0702381	-	-0.843686	0.568544	0.148207	1.16 [0.70 - 1.93]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210250_x_at	62	0.306452	0.127289	-	0.940104	0.341508	0.379221	1.46 [0.67 - 3.19]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202144_s_at	54	0.444444	0.0977071	-	1.05867	0.766348	0.160193	1.17 [0.41 - 3.38]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210250_x_at	125	0.864	0.0496122	0.489292	-1.77322	0.836875	0.0764099	1.08 [0.52 - 2.23]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215292_s_at	62	0.435484	0.142552	-	0.814326	0.705364	-0.0572001	0.94 [0.70 - 1.27]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215291_at	125	0.656	0.165917	-	-0.450849	0.955472	-0.0485208	0.95 [0.17 - 5.23]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215292_s_at	125	0.792	0.132131	-	0.624707	0.950138	0.0614804	1.06 [0.15 - 7.30]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215291_at	54	0.333333	0.105241	-	1.54686	0.725535	-0.108833	0.90 [0.49 - 1.65]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210250_x_at	125	0.144	0.123556	-	0.892456	0.764229	0.0859247	1.09 [0.62 - 1.91]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215291_at	125	0.56	0.0283812	0.341287	0.846753	0.437409	0.868717	2.38 [0.27 - 21.35]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210250_x_at	54	0.685185	0.178368	-	-1.01288	0.914703	-0.0530365	0.95 [0.36 - 2.50]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215292_s_at	125	0.856	0.313859	-	-0.521883	0.721061	-0.276072	0.76 [0.17 - 3.45]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202144_s_at	62	0.435484	0.0271612	0.331278	1.18686	0.198819	0.567995	1.76 [0.74 - 4.20]
GENE	ADSL	adenylosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215292_s_at	54	0.444444	0.0902724	-	1.24141	0.771492	-0.0533298	0.95 [0.66 - 1.36]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215291_at	198	0.611111	0.0120638	0.185763	-0.758647	0.227789	-0.124195	0.88 [0.72 - 1.08]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210250_x_at	198	0.868687	0.102751	-	-0.821292	0.804407	-0.0745256	0.93 [0.51 - 1.67]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215291_at	198	0.575758	0.00976964	0.15865	-0.577593	0.152077	-0.116977	0.89 [0.76 - 1.04]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210250_x_at	198	0.30303	0.0547914	-	0.604888	0.964061	-0.013972	0.99 [0.54 - 1.81]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215292_s_at	198	0.318182	0.0631892	-	0.546918	0.817496	-0.0485194	0.95 [0.63 - 1.44]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202144_s_at	198	0.747475	0.248827	-	0.275918	0.829308	0.0583811	1.06 [0.62 - 1.80]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215292_s_at	198	0.318182	0.0381074	0.414589	0.663748	0.939219	-0.016871	0.98 [0.64 - 1.52]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215291_at	198	0.611111	0.0136853	0.203873	-0.702771	0.191669	-0.129283	0.88 [0.72 - 1.07]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210250_x_at	198	0.29798	0.138409	-	0.349641	0.677766	0.101728	1.11 [0.69 - 1.79]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202144_s_at	198	0.858586	0.10432	-	-0.818141	0.674725	-0.136333	0.87 [0.46 - 1.65]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202144_s_at	198	0.858586	0.0961265	-	-0.952263	0.899003	-0.0441804	0.96 [0.48 - 1.89]
GENE	ADSL	adenylosuccinate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215292_s_at	198	0.338384	0.121474	-	0.358921	0.839294	-0.037259	0.96 [0.67 - 1.38]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202144_s_at	51	0.607843	0.064839	-	-15.8731	0.6139	-0.362736	0.70 [0.17 - 2.85]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202144_s_at	62	0.451613	0.102147	-	-0.963655	0.790363	-0.133917	0.87 [0.33 - 2.35]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210250_x_at	51	0.568627	0.0440362	0.454494	-16.0107	0.743242	-0.21427	0.81 [0.22 - 2.91]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215291_at	62	0.693548	0.195436	-	-0.966054	0.725969	-0.440018	0.64 [0.05 - 7.54]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215292_s_at	51	0.784314	0.270118	-	0.968807	0.935728	-0.146974	0.86 [0.02 - 30.73]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210250_x_at	62	0.209677	0.190136	-	1.28052	0.942185	-0.0314617	0.97 [0.41 - 2.27]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215291_at	51	0.509804	0.168585	-	-1.41867	0.990966	-0.0224576	0.98 [0.02 - 47.70]
GENE	ADSL	adenylosuccinate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215292_s_at	62	0.112903	0.0754362	-	-1.12762	0.897834	0.153257	1.17 [0.11 - 12.09]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215292_s_at	145	0.834483	0.0855073	-	-1.18223	0.502828	-0.375282	0.69 [0.23 - 2.06]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210250_x_at	177	0.107345	0.230712	-	0.619896	0.980522	-0.0104752	0.99 [0.43 - 2.29]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215291_at	177	0.146893	0.107195	-	-0.508744	0.283819	-0.501995	0.61 [0.24 - 1.52]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202144_s_at	177	0.327684	0.217076	-	-0.340167	0.453928	-0.304945	0.74 [0.33 - 1.64]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210250_x_at	177	0.892655	0.136548	-	0.466706	0.273395	0.408399	1.50 [0.72 - 3.12]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215291_at	145	0.862069	0.042355	0.443501	0.769896	0.65372	-0.307179	0.74 [0.19 - 2.81]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210250_x_at	145	0.703448	0.0114545	0.178743	-1.15464	0.443401	-0.415323	0.66 [0.23 - 1.91]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202144_s_at	177	0.779661	0.177356	-	0.353876	0.662304	0.153293	1.17 [0.59 - 2.32]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215292_s_at	177	0.875706	0.0423234	0.443291	-1.35802	0.17582	-0.619941	0.54 [0.22 - 1.32]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202144_s_at	145	0.641379	0.0117905	0.18263	-1.01869	0.100194	-0.833959	0.43 [0.16 - 1.17]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215291_at	177	0.146893	0.0104196	0.166527	-0.82497	0.118654	-0.835943	0.43 [0.15 - 1.24]
GENE	ADSL	adenylosuccinate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215292_s_at	177	0.745763	0.0146184	0.21395	-0.810197	0.145903	-0.578095	0.56 [0.26 - 1.22]
GENE	ADSL	adenylosuccinate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215292_s_at	226	0.606195	0.00660899	0.117673	-0.898522	0.0938661	-0.407182	0.67 [0.41 - 1.07]
GENE	ADSL	adenylosuccinate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215291_at	226	0.884956	0.00384505	0.0768638	0.952725	0.0190336	0.333813	1.40 [1.06 - 1.85]
GENE	ADSL	adenylosuccinate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210250_x_at	226	0.185841	0.0735305	-	0.82075	0.825972	-0.0883287	0.92 [0.42 - 2.01]
GENE	ADSL	adenylosuccinate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202144_s_at	226	0.513274	0.00809945	0.137602	-0.78329	0.0627016	-0.746499	0.47 [0.22 - 1.04]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215292_s_at	49	0.673469	0.0408884	0.433707	-1.85859	0.215872	-2.02075	0.13 [0.01 - 3.25]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215291_at	55	0.218182	0.238734	-	0.825482	0.830328	-0.274261	0.76 [0.06 - 9.34]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210250_x_at	55	0.872727	0.0929811	-	0.911759	0.739786	-0.180557	0.83 [0.29 - 2.42]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215291_at	49	0.673469	0.1658	-	0.780819	0.935613	-0.126411	0.88 [0.04 - 18.93]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202144_s_at	55	0.109091	0.00576008	0.105744	-1.33717	0.561907	-0.300629	0.74 [0.27 - 2.04]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210250_x_at	55	0.781818	0.0223634	0.289788	1.08594	0.403936	0.498083	1.65 [0.51 - 5.30]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210250_x_at	49	0.77551	0.0718417	-	1.01703	0.913974	0.0873334	1.09 [0.22 - 5.32]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202144_s_at	55	0.854545	0.040435	0.430639	1.0265	0.495923	0.390596	1.48 [0.48 - 4.55]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215292_s_at	55	0.636364	0.0439711	0.454073	-1.07547	0.17821	-1.65538	0.19 [0.02 - 2.13]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202144_s_at	49	0.857143	0.0105352	0.16791	1.47686	0.620221	0.411624	1.51 [0.30 - 7.69]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215292_s_at	55	0.818182	0.0205047	0.272697	-15.4342	0.0510156	-2.78498	0.06 [0.00 - 1.01]
GENE	ADSL	adenylosuccinate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215291_at	55	0.636364	0.0407148	0.432534	0.891872	0.851958	-0.221683	0.80 [0.08 - 8.22]
GENE	ADSL	adenylosuccinate lyase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	813280	34	0.411765	0.148756	-	-0.627711	0.382847	-0.40995	0.66 [0.26 - 1.67]
GENE	ADSL	adenylosuccinate lyase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	27665	34	0.235294	0.0343752	0.387721	-0.974031	0.481391	-0.308863	0.73 [0.31 - 1.73]
GENE	ADSL	adenylosuccinate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215291_at	63	0.142857	0.16489	-	-0.581137	0.533403	1.64334	5.17 [0.03 - 911.31]
GENE	ADSL	adenylosuccinate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210250_x_at	63	0.428571	0.000139885	0.0047035	1.45595	0.0375848	0.509474	1.66 [1.03 - 2.69]
GENE	ADSL	adenylosuccinate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202144_s_at	63	0.365079	0.000133408	0.00451204	1.60446	0.0509434	0.569516	1.77 [1.00 - 3.13]
GENE	ADSL	adenylosuccinate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215292_s_at	63	0.380952	0.00736816	0.127973	-0.887505	0.6938	0.443379	1.56 [0.17 - 14.16]
GENE	ADSL	adenylosuccinate lyase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.134751.0.A1_3p_at	28	0.892857	0.0234652	0.299636	1.74557	0.939955	0.0394712	1.04 [0.37 - 2.91]
GENE	ADSL	adenylosuccinate lyase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	215291_3p_at	28	0.5	0.150824	-	-0.788431	0.614404	-0.355974	0.70 [0.18 - 2.80]
GENE	ADSL	adenylosuccinate lyase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.134751.0.A1_3p_s_at	28	0.285714	0.0191692	0.260019	-1.31879	0.170177	-6.55108	0.00 [0.00 - 16.61]
GENE	ADSL	adenylosuccinate lyase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g3211983_3p_a_at	28	0.714286	0.0258275	0.320096	1.23693	0.198205	0.302286	1.35 [0.85 - 2.14]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215291_at	82	0.597561	0.0400686	0.428147	0.686385	0.820038	0.0893334	1.09 [0.51 - 2.36]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202144_s_at	82	0.890244	0.0176694	0.245353	1.02345	0.173451	0.869128	2.38 [0.68 - 8.34]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210250_x_at	82	0.451219	0.0947996	-	0.581824	0.509319	0.3462	1.41 [0.51 - 3.95]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215292_s_at	82	0.378049	0.206228	-	0.459805	0.700795	0.16305	1.18 [0.51 - 2.70]
GENE	ADSL	adenylosuccinate lyase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	35629_at	84	0.75	0.0602876	-	0.587238	0.903125	-0.0385662	0.96 [0.52 - 1.79]
GENE	ADSL	adenylosuccinate lyase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33366_at	84	0.392857	0.116539	-	-0.455364	0.482845	0.243044	1.28 [0.65 - 2.51]
GENE	ADSL	adenylosuccinate lyase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36639_at	84	0.892857	8.29926e-05	0.00297122	1.45043	0.00243108	1.87846	6.54 [1.94 - 22.04]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202144_s_at	79	0.164557	0.278324	-	0.392704	0.408812	0.367981	1.44 [0.60 - 3.46]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215291_at	79	0.848101	0.0965277	-	0.576708	0.439262	0.308141	1.36 [0.62 - 2.97]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210250_x_at	79	0.113924	0.056333	-	0.874514	0.17323	0.493055	1.64 [0.81 - 3.33]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215292_s_at	79	0.620253	0.00606764	0.11012	0.715427	0.400017	0.216431	1.24 [0.75 - 2.06]
GENE	ADSL	adenylosuccinate lyase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X65867_at	86	0.895349	0.30557	-	0.556871	0.356035	0.643296	1.90 [0.49 - 7.46]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210250_x_at	104	0.817308	0.0209447	0.276799	-1.30133	0.969326	-0.0177771	0.98 [0.40 - 2.43]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215292_s_at	104	0.134615	0.0410775	0.43498	1.81173	0.190688	0.543226	1.72 [0.76 - 3.88]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215291_at	104	0.721154	0.116089	-	0.524466	0.940533	-0.0306209	0.97 [0.43 - 2.17]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202144_s_at	104	0.884615	0.101565	-	-1.13356	0.657082	-0.250806	0.78 [0.26 - 2.35]
GENE	ADSL	adenylosuccinate lyase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P155103	117	0.709402	0.000209916	0.00670384	1.04177	0.00474039	0.901332	2.46 [1.32 - 4.60]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202144_s_at	204	0.862745	3.04567e-05	0.00121818	1.17959	0.00094892	1.57014	4.81 [1.89 - 12.20]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215292_s_at	204	0.563725	0.000987029	0.0252076	1.23529	0.00423339	0.737905	2.09 [1.26 - 3.47]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215292_s_at	204	0.52451	0.000245289	0.00767488	1.03105	0.00344689	0.555149	1.74 [1.20 - 2.53]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215291_at	204	0.52451	0.0489131	0.485063	0.746808	0.273911	0.373917	1.45 [0.74 - 2.84]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215291_at	204	0.897059	0.243586	-	0.443141	0.447121	0.180084	1.20 [0.75 - 1.90]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210250_x_at	204	0.465686	0.00207414	0.0466659	1.31116	0.190937	0.724621	2.06 [0.70 - 6.11]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210250_x_at	204	0.377451	3.11457e-06	0.000154491	1.7795	0.000146582	1.49227	4.45 [2.06 - 9.61]
GENE	ADSL	adenylosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202144_s_at	204	0.323529	0.00576384	0.105798	1.52863	0.214387	0.831584	2.30 [0.62 - 8.54]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202144_s_at	178	0.185393	0.156859	-	0.393924	0.729046	0.128165	1.14 [0.55 - 2.35]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215291_at	178	0.522472	0.0911303	-	-0.339343	0.532036	-0.141078	0.87 [0.56 - 1.35]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210250_x_at	178	0.219101	0.0878063	-	-0.400117	0.399707	-0.281742	0.75 [0.39 - 1.45]
GENE	ADSL	adenylosuccinate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215292_s_at	178	0.674157	0.0220306	0.286773	0.464303	0.281295	0.316846	1.37 [0.77 - 2.44]
GENE	ADSL	adenylosuccinate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215292_s_at	111	0.378378	0.0164786	0.233361	0.69247	0.799941	0.0612762	1.06 [0.66 - 1.71]
GENE	ADSL	adenylosuccinate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215291_at	111	0.594595	0.0416179	0.438603	-0.557145	0.402491	-0.145925	0.86 [0.61 - 1.22]
GENE	ADSL	adenylosuccinate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210250_x_at	111	0.252252	0.301144	-	-0.292411	0.899052	-0.0328627	0.97 [0.58 - 1.61]
GENE	ADSL	adenylosuccinate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202144_s_at	111	0.81982	0.236729	-	-0.471945	0.49422	0.283503	1.33 [0.59 - 2.99]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215291_at	90	0.744444	0.116719	-	-0.68523	0.51279	-0.482189	0.62 [0.15 - 2.62]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215291_at	90	0.744444	0.0972781	-	-0.86644	0.434473	-0.662386	0.52 [0.10 - 2.71]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202144_s_at	90	0.477778	0.0493353	0.487622	-0.640651	0.974408	-0.0102256	0.99 [0.53 - 1.85]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202144_s_at	90	0.477778	0.0417826	0.439701	-0.765044	0.647034	-0.164847	0.85 [0.42 - 1.72]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210250_x_at	90	0.444444	0.0943982	-	-0.540482	0.64539	0.163243	1.18 [0.59 - 2.36]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210250_x_at	90	0.5	0.0807566	-	-0.659998	0.922869	0.0392441	1.04 [0.47 - 2.30]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215292_s_at	90	0.244444	0.147796	-	-0.559388	0.683797	0.330316	1.39 [0.28 - 6.82]
GENE	ADSL	adenylosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215292_s_at	90	0.5	0.175073	-	-0.446945	0.650391	0.326177	1.39 [0.34 - 5.68]
GENE	ADSL	adenylosuccinate lyase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2280	50	0.64	0.215691	-	0.600499	0.446216	0.385032	1.47 [0.55 - 3.96]
GENE	ADSL	adenylosuccinate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215292_s_at	138	0.210145	0.00694485	0.12227	-0.698266	0.011741	-2.41828	0.09 [0.01 - 0.58]
GENE	ADSL	adenylosuccinate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215291_at	138	0.898551	0.131451	-	-0.759263	0.791677	-0.217849	0.80 [0.16 - 4.05]
GENE	ADSL	adenylosuccinate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210250_x_at	138	0.898551	0.0343481	0.387521	0.712641	0.482905	0.120171	1.13 [0.81 - 1.58]
GENE	ADSL	adenylosuccinate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202144_s_at	138	0.804348	0.10463	-	0.451149	0.661223	0.0823789	1.09 [0.75 - 1.57]
GENE	ADSL	adenylosuccinate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210250_x_at	129	0.434109	0.00330838	0.0681512	0.76931	0.142641	0.648521	1.91 [0.80 - 4.55]
GENE	ADSL	adenylosuccinate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215292_s_at	129	0.108527	0.025636	0.318469	1.11046	0.332496	0.426072	1.53 [0.65 - 3.62]
GENE	ADSL	adenylosuccinate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215291_at	129	0.186047	0.0461326	0.467868	0.737901	0.484544	0.135767	1.15 [0.78 - 1.68]
GENE	ADSL	adenylosuccinate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202144_s_at	129	0.790698	0.201689	-	0.353043	0.696666	0.168247	1.18 [0.51 - 2.76]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22071	56	0.642857	0.199832	-	0.455192	0.7634	0.0992849	1.10 [0.58 - 2.11]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45125	56	0.678571	0.147802	-	0.505222	0.541754	0.19965	1.22 [0.64 - 2.32]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17574	56	0.625	0.0198942	0.266944	0.832818	0.558623	0.165891	1.18 [0.68 - 2.06]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23751	56	0.303571	0.153664	-	0.631251	0.49561	0.28794	1.33 [0.58 - 3.05]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45125	56	0.678571	0.330657	-	0.349881	0.972896	0.0114546	1.01 [0.52 - 1.96]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22071	56	0.642857	0.091354	-	0.583905	0.315306	0.324365	1.38 [0.73 - 2.61]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23751	56	0.5	0.275883	-	0.390235	0.98017	-0.0114434	0.99 [0.40 - 2.44]
GENE	ADSL	adenylosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17574	56	0.446429	0.0171124	0.239784	0.855924	0.485767	0.186159	1.20 [0.71 - 2.03]
GENE	ADSL	adenylosuccinate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215291_at	278	0.532374	0.00354722	0.0720685	0.55139	0.110088	0.575811	1.78 [0.88 - 3.60]
GENE	ADSL	adenylosuccinate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210250_x_at	278	0.356115	0.132531	-	-0.286057	0.460886	-0.174032	0.84 [0.53 - 1.33]
GENE	ADSL	adenylosuccinate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202144_s_at	278	0.438849	0.0861253	-	-0.321805	0.273668	-0.253594	0.78 [0.49 - 1.22]
GENE	ADSL	adenylosuccinate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215292_s_at	278	0.848921	0.0137016	0.204051	-0.739985	0.283493	-0.373688	0.69 [0.35 - 1.36]
GENE	ADSL	adenylosuccinate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210250_x_at	133	0.639098	0.00789788	0.134975	-0.700528	0.0976658	-0.248305	0.78 [0.58 - 1.05]
GENE	ADSL	adenylosuccinate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215292_s_at	133	0.541353	0.00723288	0.126161	0.633607	0.577565	0.225576	1.25 [0.57 - 2.77]
GENE	ADSL	adenylosuccinate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215291_at	133	0.661654	0.00102625	0.026045	0.769822	0.045418	1.01272	2.75 [1.02 - 7.42]
GENE	ADSL	adenylosuccinate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202144_s_at	133	0.263158	0.0241713	0.305843	-0.589634	0.136265	-0.237863	0.79 [0.58 - 1.08]
GENE	ADSL	adenylosuccinate lyase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	722	81	0.296296	0.00970514	0.15786	15.6309	0.170684	0.880471	2.41 [0.68 - 8.50]
GENE	ADSL	adenylosuccinate lyase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16714	81	0.62963	0.0174694	0.243361	1.22498	0.313653	0.582092	1.79 [0.58 - 5.55]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210250_x_at	185	0.659459	0.0873022	-	-0.2929	0.658083	-0.0597363	0.94 [0.72 - 1.23]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215291_at	185	0.551351	0.021707	0.283822	-0.411811	0.155102	-0.463002	0.63 [0.33 - 1.19]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202144_s_at	185	0.675676	0.0360094	0.399664	-0.365901	0.678001	-0.0505959	0.95 [0.75 - 1.21]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210250_x_at	185	0.697297	0.261718	-	-0.214441	0.781727	0.0407444	1.04 [0.78 - 1.39]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215292_s_at	185	0.302703	0.200056	-	-0.219129	0.773321	0.0522652	1.05 [0.74 - 1.50]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202144_s_at	185	0.778378	0.174046	-	-0.281195	0.962031	0.00641364	1.01 [0.77 - 1.31]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215291_at	185	0.345946	0.0159524	0.227957	-0.407896	0.111239	-0.472139	0.62 [0.35 - 1.12]
GENE	ADSL	adenylosuccinate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215292_s_at	185	0.691892	0.194712	-	0.244393	0.544082	0.119906	1.13 [0.77 - 1.66]
GENE	ADSL	adenylosuccinate lyase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P155103	110	0.790909	0.139192	-	0.407471	0.403782	0.14402	1.15 [0.82 - 1.62]
GENE	ADSL	adenylosuccinate lyase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P155103	110	0.890909	0.00669645	0.118877	1.08896	0.535772	0.135736	1.15 [0.75 - 1.76]
GENE	ADSL	adenylosuccinate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210250_x_at	80	0.3375	0.0617458	-	1.11017	0.76162	0.156061	1.17 [0.43 - 3.20]
GENE	ADSL	adenylosuccinate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215292_s_at	80	0.5875	0.0424156	0.443901	0.892001	0.935324	0.032166	1.03 [0.47 - 2.25]
GENE	ADSL	adenylosuccinate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202144_s_at	80	0.15	0.0917827	-	15.2318	0.442252	0.468761	1.60 [0.48 - 5.28]
GENE	ADSL	adenylosuccinate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215291_at	80	0.3875	0.00191759	0.0437577	1.97443	0.0867008	0.340355	1.41 [0.95 - 2.07]
GENE	ADSL	adenylosuccinate lyase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5735	281	0.601424	0.258235	-	-0.161017	0.331662	0.105506	1.11 [0.90 - 1.38]
GENE	ADSL	adenylosuccinate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215292_s_at	38	0.236842	0.226194	-	0.879875	0.757209	0.133672	1.14 [0.49 - 2.67]
GENE	ADSL	adenylosuccinate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215291_at	38	0.894737	0.0271649	0.331308	1.3346	0.539506	0.350729	1.42 [0.46 - 4.35]
GENE	ADSL	adenylosuccinate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210250_x_at	38	0.815789	0.0147579	0.215436	1.19623	0.107721	0.673145	1.96 [0.86 - 4.45]
GENE	ADSL	adenylosuccinate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202144_s_at	38	0.842105	0.0553216	-	1.00468	0.138388	0.660994	1.94 [0.81 - 4.64]
GENE	ADSL	adenylosuccinate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202144_s_at	140	0.171429	0.0260081	0.321625	-0.733132	0.482274	-0.242544	0.78 [0.40 - 1.54]
GENE	ADSL	adenylosuccinate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210250_x_at	140	0.171429	0.104017	-	-0.536359	0.317497	-0.350826	0.70 [0.35 - 1.40]
GENE	ADSL	adenylosuccinate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215292_s_at	140	0.314286	0.0280679	0.338736	0.829333	0.381273	0.558129	1.75 [0.50 - 6.10]
GENE	ADSL	adenylosuccinate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215291_at	140	0.471429	0.00017366	0.00568282	1.18683	0.00575835	2.2211	9.22 [1.91 - 44.60]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADSS	adenylosuccinate synthase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221761_at	30	0.133333	0.310185	-	-0.551907	0.857384	-0.0764991	0.93 [0.40 - 2.13]
GENE	ADSS	adenylosuccinate synthase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1778796	165	0.672727	0.22792	-	0.298208	0.66345	0.0829195	1.09 [0.75 - 1.58]
GENE	ADSS	adenylosuccinate synthase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1778796	165	0.509091	0.155979	-	-0.512993	0.583548	-0.157302	0.85 [0.49 - 1.50]
GENE	ADSS	adenylosuccinate synthase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221761_at	163	0.570552	0.136956	-	0.293836	0.773488	0.0425937	1.04 [0.78 - 1.39]
GENE	ADSS	adenylosuccinate synthase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	227310_at	163	0.521472	0.134177	-	0.29433	0.967438	-0.0298541	0.97 [0.23 - 4.07]
GENE	ADSS	adenylosuccinate synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	227310_at	79	0.139241	0.0232764	0.297963	1.49691	0.074169	1.29933	3.67 [0.88 - 15.27]
GENE	ADSS	adenylosuccinate synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221761_at	79	0.860759	0.000728204	0.0195084	1.15222	0.251032	0.308657	1.36 [0.80 - 2.31]
GENE	ADSS	adenylosuccinate synthase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221761_at	58	0.775862	0.000127334	0.00433133	1.31729	0.00385709	1.08202	2.95 [1.42 - 6.15]
GENE	ADSS	adenylosuccinate synthase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221761_at	34	0.764706	0.00115596	0.0287723	1.36804	0.0533819	1.24544	3.47 [0.98 - 12.29]
GENE	ADSS	adenylosuccinate synthase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221761_at	158	0.474684	0.0894757	-	-0.394016	0.233061	-0.301945	0.74 [0.45 - 1.21]
GENE	ADSS	adenylosuccinate synthase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221761_at	53	0.754717	0.10809	-	-0.770683	0.759588	-0.214224	0.81 [0.20 - 3.18]
GENE	ADSS	adenylosuccinate synthase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221761_at	53	0.754717	0.0775371	-	-0.777483	0.617528	-0.323127	0.72 [0.20 - 2.57]
GENE	ADSS	adenylosuccinate synthase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221761_at	180	0.166667	0.100046	-	-0.44199	0.628743	-0.166228	0.85 [0.43 - 1.66]
GENE	ADSS	adenylosuccinate synthase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	227310_at	180	0.772222	0.0247609	0.310965	0.50935	0.27859	0.090847	1.10 [0.93 - 1.29]
GENE	ADSS	adenylosuccinate synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	227310_at	559	0.184258	0.0865984	-	-0.388473	0.502272	-0.0743834	0.93 [0.75 - 1.15]
GENE	ADSS	adenylosuccinate synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221761_at	559	0.899821	0.00278175	0.0592616	0.761811	0.00296106	0.796066	2.22 [1.31 - 3.75]
GENE	ADSS	adenylosuccinate synthase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221761_at	77	0.844156	2.32519e-05	0.000956346	1.38094	0.0025153	0.730425	2.08 [1.29 - 3.33]
GENE	ADSS	adenylosuccinate synthase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	227310_at	77	0.506494	0.0621711	-	-0.476093	0.195498	-0.183382	0.83 [0.63 - 1.10]
GENE	ADSS	adenylosuccinate synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	227310_at	70	0.185714	0.0895893	-	-0.552768	0.359476	-1.04744	0.35 [0.04 - 3.30]
GENE	ADSS	adenylosuccinate synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221761_at	70	0.314286	0.219037	-	-0.345656	0.838876	-0.0521594	0.95 [0.57 - 1.57]
GENE	ADSS	adenylosuccinate synthase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33167_r_at	50	0.52	0.014225	0.20973	-0.849274	0.261917	-0.58678	0.56 [0.20 - 1.55]
GENE	ADSS	adenylosuccinate synthase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221761_at	74	0.108108	0.00108776	0.0273461	-1.23461	0.800936	-0.112567	0.89 [0.37 - 2.14]
GENE	ADSS	adenylosuccinate synthase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	227310_at	74	0.405405	0.124115	-	0.461113	0.704548	0.0666978	1.07 [0.76 - 1.51]
GENE	ADSS	adenylosuccinate synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221761_at	67	0.880597	0.000852345	0.0222819	2.09678	0.652137	0.601088	1.82 [0.13 - 24.89]
GENE	ADSS	adenylosuccinate synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	227310_at	67	0.402985	0.0479673	0.479282	1.64799	0.683968	0.901282	2.46 [0.03 - 188.86]
GENE	ADSS	adenylosuccinate synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221761_at	115	0.608696	0.0485111	0.482614	1.05202	0.425158	0.775479	2.17 [0.32 - 14.60]
GENE	ADSS	adenylosuccinate synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	227310_at	115	0.286957	0.013202	0.198557	15.5969	0.063773	1.59581	4.93 [0.91 - 26.66]
GENE	ADSS	adenylosuccinate synthase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33167_r_at	158	0.740506	0.0749363	-	-0.624838	0.792569	-0.0661661	0.94 [0.57 - 1.53]
GENE	ADSS	adenylosuccinate synthase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33167_r_at	76	0.894737	0.00182841	0.0420782	1.65474	0.0863536	0.934298	2.55 [0.88 - 7.40]
GENE	ADSS	adenylosuccinate synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221761_at	204	0.387255	0.0688227	-	0.260205	0.412437	0.137616	1.15 [0.83 - 1.59]
GENE	ADSS	adenylosuccinate synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	227310_at	204	0.107843	0.101762	-	-0.374675	0.948912	-0.00469566	1.00 [0.86 - 1.15]
GENE	ADSS	adenylosuccinate synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221761_at	87	0.275862	0.0967777	-	-0.632479	0.194245	-0.553499	0.57 [0.25 - 1.33]
GENE	ADSS	adenylosuccinate synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221761_at	87	0.275862	0.0967777	-	-0.632479	0.194245	-0.553499	0.57 [0.25 - 1.33]
GENE	ADSS	adenylosuccinate synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	227310_at	87	0.885057	0.33315	-	-0.696565	0.862361	0.183887	1.20 [0.15 - 9.61]
GENE	ADSS	adenylosuccinate synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	227310_at	87	0.885057	0.33315	-	-0.696565	0.862361	0.183887	1.20 [0.15 - 9.61]
GENE	ADSS	adenylosuccinate synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	227310_at	77	0.207792	0.0131346	0.197811	-1.44263	0.101916	-3.20869	0.04 [0.00 - 1.89]
GENE	ADSS	adenylosuccinate synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221761_at	77	0.38961	0.0108737	0.171935	-1.41199	0.411058	-0.401347	0.67 [0.26 - 1.74]
GENE	ADSS	adenylosuccinate synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221761_at	77	0.324675	0.042856	0.446802	-1.22896	0.647421	-0.259459	0.77 [0.25 - 2.35]
GENE	ADSS	adenylosuccinate synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	227310_at	77	0.207792	0.013358	0.20028	-1.28826	0.0581588	-3.24035	0.04 [0.00 - 1.12]
GENE	ADSS	adenylosuccinate synthase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221761_at	136	0.323529	0.0166867	0.23548	-1.06141	0.0729932	-0.946612	0.39 [0.14 - 1.09]
GENE	ADSS	adenylosuccinate synthase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221761_at	200	0.655	0.147646	-	-0.482209	0.306064	-0.530032	0.59 [0.21 - 1.62]
GENE	ADSS	adenylosuccinate synthase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20798	60	0.116667	0.139233	-	1.39131	0.568453	0.170439	1.19 [0.66 - 2.13]
GENE	ADSS	adenylosuccinate synthase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20798	60	0.883333	0.00547926	0.101692	1.25763	0.777864	0.0876565	1.09 [0.59 - 2.01]
GENE	ADSS	adenylosuccinate synthase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21723	155	0.832258	0.0238279	0.302834	-1.49025	0.4242	-0.120288	0.89 [0.66 - 1.19]
GENE	ADSS	adenylosuccinate synthase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221761_at	286	0.314685	0.134031	-	-0.298672	0.938304	-0.0218448	0.98 [0.56 - 1.70]
GENE	ADSS	adenylosuccinate synthase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221761_at	159	0.232704	0.157325	-	0.616544	0.177011	0.566492	1.76 [0.77 - 4.01]
GENE	ADSS	adenylosuccinate synthase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221761_at	159	0.886792	0.0532493	-	0.747046	0.0463847	0.838822	2.31 [1.01 - 5.28]
GENE	ADSS	adenylosuccinate synthase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221761_at	159	0.861635	0.0252245	0.314955	0.899696	0.0399597	0.982839	2.67 [1.05 - 6.83]
GENE	ADSS	adenylosuccinate synthase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227310_at	159	0.893082	0.000877327	0.0228307	1.29148	0.896094	-0.0282831	0.97 [0.64 - 1.49]
GENE	ADSS	adenylosuccinate synthase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227310_at	159	0.893082	0.0228542	0.2942	0.872234	0.45455	0.137646	1.15 [0.80 - 1.65]
GENE	ADSS	adenylosuccinate synthase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227310_at	159	0.893082	0.000832732	0.0218489	1.1583	0.637325	-0.0873319	0.92 [0.64 - 1.32]
GENE	ADSS	adenylosuccinate synthase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221761_at	54	0.740741	0.00728312	0.126835	1.69678	0.0327086	1.35818	3.89 [1.12 - 13.53]
GENE	ADSS	adenylosuccinate synthase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221761_at	117	0.119658	0.117643	-	1.08268	0.759717	0.0737667	1.08 [0.67 - 1.73]
GENE	ADSS	adenylosuccinate synthase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221761_at	117	0.623932	0.059919	-	0.698944	0.73908	0.0956978	1.10 [0.63 - 1.93]
GENE	ADSS	adenylosuccinate synthase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221761_at	117	0.555556	0.0814385	-	0.677692	0.735108	0.100543	1.11 [0.62 - 1.98]
GENE	ADSS	adenylosuccinate synthase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221761_at	117	0.119658	0.117643	-	1.08268	0.759717	0.0737667	1.08 [0.67 - 1.73]
GENE	ADSS	adenylosuccinate synthase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221761_at	236	0.851695	0.00956891	0.156184	0.783477	0.925758	0.0382339	1.04 [0.46 - 2.32]
GENE	ADSS	adenylosuccinate synthase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	227310_at	236	0.101695	0.248648	-	-0.436141	0.891637	-0.021418	0.98 [0.72 - 1.33]
GENE	ADSS	adenylosuccinate synthase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221761_at	249	0.100402	0.0118142	0.182902	-0.719786	0.715641	-0.12233	0.88 [0.46 - 1.71]
GENE	ADSS	adenylosuccinate synthase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	227310_at	249	0.100402	0.0150872	0.218923	-0.716246	0.711772	-0.0464634	0.95 [0.75 - 1.22]
GENE	ADSS	adenylosuccinate synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221761_at	125	0.664	0.00310961	0.0648386	0.841849	0.0600241	0.596543	1.82 [0.98 - 3.38]
GENE	ADSS	adenylosuccinate synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221761_at	54	0.796296	0.0202171	0.269995	-15.7175	0.253701	-0.24832	0.78 [0.51 - 1.19]
GENE	ADSS	adenylosuccinate synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221761_at	62	0.274194	0.0371467	0.40781	-0.974466	0.194592	-0.235157	0.79 [0.55 - 1.13]
GENE	ADSS	adenylosuccinate synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221761_at	125	0.768	0.0152206	0.220328	0.919897	0.176939	0.565859	1.76 [0.77 - 4.00]
GENE	ADSS	adenylosuccinate synthase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221761_at	198	0.111111	0.112211	-	-0.460414	0.166933	-0.311494	0.73 [0.47 - 1.14]
GENE	ADSS	adenylosuccinate synthase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221761_at	198	0.272727	0.0204906	0.272564	-0.614259	0.0530487	-0.526164	0.59 [0.35 - 1.01]
GENE	ADSS	adenylosuccinate synthase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221761_at	198	0.287879	0.0740799	-	-0.495315	0.162287	-0.397866	0.67 [0.38 - 1.17]
GENE	ADSS	adenylosuccinate synthase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221761_at	62	0.822581	0.0967968	-	-15.3352	0.917493	0.0419866	1.04 [0.47 - 2.31]
GENE	ADSS	adenylosuccinate synthase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221761_at	51	0.411765	0.05376	-	15.94	0.824483	0.134521	1.14 [0.35 - 3.76]
GENE	ADSS	adenylosuccinate synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221761_at	145	0.662069	0.0546796	-	0.630878	0.280308	0.489503	1.63 [0.67 - 3.97]
GENE	ADSS	adenylosuccinate synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	227310_at	177	0.322034	0.0430248	0.44791	-0.47544	0.106249	-1.31097	0.27 [0.05 - 1.32]
GENE	ADSS	adenylosuccinate synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221761_at	177	0.384181	0.0409543	0.434151	-0.550236	0.447531	-0.286667	0.75 [0.36 - 1.57]
GENE	ADSS	adenylosuccinate synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221761_at	177	0.40678	0.250027	-	-0.272277	0.664241	-0.141603	0.87 [0.46 - 1.65]
GENE	ADSS	adenylosuccinate synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	227310_at	145	0.268966	0.0334187	0.380597	-0.707046	0.171113	-1.56394	0.21 [0.02 - 1.97]
GENE	ADSS	adenylosuccinate synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	227310_at	177	0.299435	0.00839298	0.141392	-0.700994	0.0647761	-1.75526	0.17 [0.03 - 1.11]
GENE	ADSS	adenylosuccinate synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	227310_at	226	0.181416	0.00645439	0.115535	-0.805558	0.160197	-0.144669	0.87 [0.71 - 1.06]
GENE	ADSS	adenylosuccinate synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221761_at	226	0.738938	0.05639	-	0.549254	0.391531	0.30849	1.36 [0.67 - 2.76]
GENE	ADSS	adenylosuccinate synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	227310_at	55	0.345455	0.243669	-	-0.518384	0.909549	-0.132085	0.88 [0.09 - 8.56]
GENE	ADSS	adenylosuccinate synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	227310_at	49	0.489796	0.0781089	-	-1.11622	0.813369	-0.345871	0.71 [0.04 - 12.50]
GENE	ADSS	adenylosuccinate synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221761_at	55	0.545455	0.0216105	0.282939	1.03454	0.155828	0.911754	2.49 [0.71 - 8.77]
GENE	ADSS	adenylosuccinate synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	227310_at	55	0.490909	0.350828	-	-0.434716	0.805679	0.313233	1.37 [0.11 - 16.59]
GENE	ADSS	adenylosuccinate synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221761_at	55	0.818182	0.110055	-	0.846804	0.448489	0.566605	1.76 [0.41 - 7.63]
GENE	ADSS	adenylosuccinate synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221761_at	49	0.693878	0.0172073	0.240737	1.30862	0.0924839	1.76738	5.86 [0.75 - 45.89]
GENE	ADSS	adenylosuccinate synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	227310_at	63	0.507937	0.00276328	0.0589429	-1.04976	0.135722	-6.96275	0.00 [0.00 - 8.89]
GENE	ADSS	adenylosuccinate synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221761_at	63	0.714286	0.0171524	0.240186	-1.03485	0.482824	-0.0931998	0.91 [0.70 - 1.18]
GENE	ADSS	adenylosuccinate synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.90011.0.S2_3p_at	28	0.892857	0.219776	-	-15.1822	0.971428	0.00884864	1.01 [0.62 - 1.64]
GENE	ADSS	adenylosuccinate synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.90011.1.A1_3p_at	28	0.678571	0.0176142	0.244804	-1.67241	0.0747858	-4.46657	0.01 [0.00 - 1.56]
GENE	ADSS	adenylosuccinate synthase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221761_at	82	0.341463	0.0289485	0.345873	-0.725203	0.499169	-0.28548	0.75 [0.33 - 1.72]
GENE	ADSS	adenylosuccinate synthase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33167_r_at	84	0.821429	0.21868	-	-0.533205	0.508281	-0.151994	0.86 [0.55 - 1.35]
GENE	ADSS	adenylosuccinate synthase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221761_at	79	0.493671	0.0485303	0.482732	0.512368	0.254809	0.589445	1.80 [0.65 - 4.97]
GENE	ADSS	adenylosuccinate synthase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X66503_at	86	0.895349	0.0439101	0.453678	0.97708	0.700358	0.194748	1.22 [0.45 - 3.28]
GENE	ADSS	adenylosuccinate synthase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221761_at	104	0.423077	0.00609632	0.110525	1.04674	0.0809313	1.13339	3.11 [0.87 - 11.09]
GENE	ADSS	adenylosuccinate synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P201432	117	0.794872	0.000921841	0.0238016	0.974249	0.0596324	0.498248	1.65 [0.98 - 2.76]
GENE	ADSS	adenylosuccinate synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P859	117	0.760684	0.000172848	0.00565964	1.06002	0.0122356	0.500895	1.65 [1.12 - 2.44]
GENE	ADSS	adenylosuccinate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221761_at	204	0.210784	0.104412	-	-0.64029	0.540239	-0.439854	0.64 [0.16 - 2.63]
GENE	ADSS	adenylosuccinate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221761_at	204	0.191176	0.0845164	-	-0.531205	0.707672	0.204386	1.23 [0.42 - 3.57]
GENE	ADSS	adenylosuccinate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	227310_at	204	0.122549	0.0413761	0.436985	15.2097	0.118891	0.270845	1.31 [0.93 - 1.84]
GENE	ADSS	adenylosuccinate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	227310_at	204	0.764706	0.0138833	0.206031	0.688079	0.0906245	0.211102	1.24 [0.97 - 1.58]
GENE	ADSS	adenylosuccinate synthase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221761_at	178	0.477528	0.114078	-	-0.312934	0.42035	-0.272433	0.76 [0.39 - 1.48]
GENE	ADSS	adenylosuccinate synthase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010408	41	0.317073	0.198023	-	0.603779	0.703434	0.152174	1.16 [0.53 - 2.55]
GENE	ADSS	adenylosuccinate synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221761_at	111	0.135135	0.175675	-	0.576375	0.566695	-0.217717	0.80 [0.38 - 1.69]
GENE	ADSS	adenylosuccinate synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	227310_at	111	0.531532	0.0170034	0.238685	0.624152	0.358481	0.115267	1.12 [0.88 - 1.44]
GENE	ADSS	adenylosuccinate synthase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221761_at	90	0.855556	0.114588	-	0.619722	0.473611	-0.169299	0.84 [0.53 - 1.34]
GENE	ADSS	adenylosuccinate synthase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221761_at	90	0.855556	0.0584091	-	0.802733	0.680429	-0.110781	0.90 [0.53 - 1.52]
GENE	ADSS	adenylosuccinate synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221761_at	138	0.413043	0.0171498	0.24016	0.60825	0.10365	0.339473	1.40 [0.93 - 2.11]
GENE	ADSS	adenylosuccinate synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	227310_at	138	0.84058	0.053527	-	-0.755372	0.115053	-4.23544	0.01 [0.00 - 2.81]
GENE	ADSS	adenylosuccinate synthase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221761_at	129	0.333333	0.0166627	0.235236	0.676797	0.11886	0.699945	2.01 [0.84 - 4.85]
GENE	ADSS	adenylosuccinate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20943	56	0.875	0.148776	-	0.604016	0.809967	-0.0736329	0.93 [0.51 - 1.69]
GENE	ADSS	adenylosuccinate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40301	56	0.25	0.0479261	0.479029	1.14526	0.428972	0.202386	1.22 [0.74 - 2.02]
GENE	ADSS	adenylosuccinate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20943	56	0.875	0.0372973	0.408879	0.871284	0.56986	0.193115	1.21 [0.62 - 2.36]
GENE	ADSS	adenylosuccinate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40301	56	0.25	0.112007	-	0.755827	0.980034	-0.00578431	0.99 [0.63 - 1.56]
GENE	ADSS	adenylosuccinate synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	227310_at	278	0.521583	0.109478	-	-0.304779	0.500204	-0.421721	0.66 [0.19 - 2.24]
GENE	ADSS	adenylosuccinate synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221761_at	278	0.895683	0.135887	-	-0.539793	0.687299	-0.0772988	0.93 [0.64 - 1.35]
GENE	ADSS	adenylosuccinate synthase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221761_at	133	0.684211	0.053531	-	0.46666	0.901002	0.0169429	1.02 [0.78 - 1.33]
GENE	ADSS	adenylosuccinate synthase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7962	81	0.111111	0.238285	-	-0.752653	0.732254	-0.170994	0.84 [0.32 - 2.24]
GENE	ADSS	adenylosuccinate synthase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221761_at	185	0.27027	0.333005	-	-0.182362	0.721653	-0.0437369	0.96 [0.75 - 1.22]
GENE	ADSS	adenylosuccinate synthase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221761_at	185	0.27027	0.215023	-	-0.249224	0.783909	-0.0366341	0.96 [0.74 - 1.25]
GENE	ADSS	adenylosuccinate synthase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P859	110	0.118182	0.0144426	0.212069	-0.995025	0.505896	-0.186568	0.83 [0.48 - 1.44]
GENE	ADSS	adenylosuccinate synthase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P201432	110	0.209091	0.0267055	0.327486	-0.595443	0.752617	-0.080109	0.92 [0.56 - 1.52]
GENE	ADSS	adenylosuccinate synthase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P859	110	0.3	0.0221376	0.287744	-0.548069	0.58577	-0.11547	0.89 [0.59 - 1.35]
GENE	ADSS	adenylosuccinate synthase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P201432	110	0.145455	0.0114103	0.17823	-0.927992	0.949035	-0.0213505	0.98 [0.51 - 1.88]
GENE	ADSS	adenylosuccinate synthase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221761_at	80	0.2	0.294929	-	0.643783	0.526557	0.310255	1.36 [0.52 - 3.56]
GENE	ADSS	adenylosuccinate synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	227310_at	38	0.894737	0.00291161	0.0614881	1.66331	0.253861	0.451826	1.57 [0.72 - 3.41]
GENE	ADSS	adenylosuccinate synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221761_at	38	0.236842	0.0820322	-	1.22905	0.350228	0.508018	1.66 [0.57 - 4.83]
GENE	ADSS	adenylosuccinate synthase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221761_at	140	0.692857	0.266313	-	0.33383	0.988465	0.00487265	1.00 [0.52 - 1.95]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1749804	165	0.557576	0.00919233	0.151513	-0.653486	0.0735974	-0.329053	0.72 [0.50 - 1.03]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1749804	165	0.333333	0.0135403	0.202286	-0.850192	0.0973241	-0.459777	0.63 [0.37 - 1.09]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238259_at	163	0.257669	0.0113851	0.177936	-0.541952	0.0435849	-1.71795	0.18 [0.03 - 0.95]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226325_at	163	0.785276	0.153053	-	-0.362166	0.784178	-0.110603	0.90 [0.41 - 1.98]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238259_at	79	0.670886	0.0338187	0.383588	-0.718398	0.122783	-1.29107	0.27 [0.05 - 1.42]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226325_at	79	0.696203	0.0551981	-	0.576545	0.234374	0.336407	1.40 [0.80 - 2.44]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226325_at	180	0.261111	0.0174147	0.242816	-0.53264	0.596703	-0.0584109	0.94 [0.76 - 1.17]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238259_at	180	0.894444	0.0523254	-	-0.798799	0.604163	-0.153223	0.86 [0.48 - 1.53]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238259_at	559	0.545617	0.0154526	0.222762	-0.510342	0.61014	-0.0869125	0.92 [0.66 - 1.28]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226325_at	559	0.876565	0.0452787	0.462465	-0.820613	0.196754	-0.127043	0.88 [0.73 - 1.07]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226325_at	77	0.727273	0.398464	-	0.236961	0.905682	-0.0153242	0.98 [0.76 - 1.27]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238259_at	77	0.103896	0.00549805	0.101965	1.37282	0.0334016	0.756412	2.13 [1.06 - 4.28]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238259_at	70	0.614286	0.096066	-	0.44202	0.561478	0.559864	1.75 [0.26 - 11.58]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226325_at	70	0.8	0.0521667	-	0.637363	0.258725	0.202757	1.22 [0.86 - 1.74]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226325_at	74	0.418919	0.00272148	0.05822	0.907512	0.0532239	0.376733	1.46 [0.99 - 2.14]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238259_at	74	0.783784	0.00011829	0.00406001	1.18989	0.0211537	1.23391	3.43 [1.20 - 9.81]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226325_at	67	0.238806	0.0137807	0.204914	-1.51561	0.0435304	-1.52569	0.22 [0.05 - 0.96]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238259_at	67	0.119403	0.00124202	0.0305486	-2.21881	0.542122	-1.46318	0.23 [0.00 - 25.56]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238259_at	115	0.756522	0.311529	-	0.557245	0.782042	-0.234218	0.79 [0.15 - 4.16]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226325_at	115	0.330435	0.00765418	0.131772	-1.37766	0.0674683	-0.600394	0.55 [0.29 - 1.04]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226325_at	204	0.637255	0.0706905	-	0.265802	0.895698	0.0119254	1.01 [0.85 - 1.21]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238259_at	204	0.156863	0.352503	-	-0.183502	0.764581	-0.048746	0.95 [0.69 - 1.31]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238259_at	87	0.528736	0.0395833	0.424826	0.791736	0.561018	0.395707	1.49 [0.39 - 5.64]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238259_at	87	0.528736	0.0395833	0.424826	0.791736	0.561018	0.395707	1.49 [0.39 - 5.64]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226325_at	87	0.517241	0.0864675	-	0.664423	0.296607	0.239656	1.27 [0.81 - 1.99]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226325_at	87	0.517241	0.0864675	-	0.664423	0.296607	0.239656	1.27 [0.81 - 1.99]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238259_at	77	0.324675	0.247432	-	-0.633333	0.895194	0.224259	1.25 [0.04 - 35.19]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226325_at	77	0.454545	0.0899621	-	1.06596	0.35397	0.36278	1.44 [0.67 - 3.10]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226325_at	77	0.454545	0.0191081	0.259431	2.0773	0.297421	0.470976	1.60 [0.66 - 3.88]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238259_at	77	0.896104	0.185944	-	1.00486	0.816666	0.456049	1.58 [0.03 - 74.56]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226325_at	159	0.698113	0.00827853	0.139919	0.946684	0.684636	0.096162	1.10 [0.69 - 1.75]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238259_at	159	0.867925	0.292604	-	0.43511	0.643194	-0.211207	0.81 [0.33 - 1.98]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238259_at	159	0.515723	0.0582976	-	0.609428	0.471778	0.322284	1.38 [0.57 - 3.32]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238259_at	159	0.584906	0.112876	-	0.583696	0.904573	-0.0642575	0.94 [0.33 - 2.68]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226325_at	159	0.213836	0.12768	-	-0.519822	0.595239	-0.0959607	0.91 [0.64 - 1.29]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226325_at	159	0.698113	0.0165213	0.233797	0.745872	0.576929	0.113565	1.12 [0.75 - 1.67]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226325_at	236	0.716102	0.161846	-	0.390438	0.490216	-0.11294	0.89 [0.65 - 1.23]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238259_at	236	0.788136	0.000421071	0.0122323	0.944344	0.113945	0.861828	2.37 [0.81 - 6.89]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226325_at	249	0.232932	0.275386	-	0.292688	0.703315	0.0503291	1.05 [0.81 - 1.36]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238259_at	249	0.7751	0.0803963	-	0.411421	0.800784	0.0941458	1.10 [0.53 - 2.28]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238259_at	145	0.648276	0.016787	0.236498	-0.972124	0.0480366	-1.64755	0.19 [0.04 - 0.99]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226325_at	145	0.241379	0.0107907	0.170951	1.41652	0.26184	0.342687	1.41 [0.77 - 2.56]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226325_at	177	0.237288	0.00687938	0.121379	1.19652	0.304427	0.277841	1.32 [0.78 - 2.24]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238259_at	177	0.152542	0.00215304	0.0481134	-0.831611	0.0163203	-1.38833	0.25 [0.08 - 0.77]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238259_at	177	0.152542	0.00049022	0.013933	-1.02078	0.011039	-1.69858	0.18 [0.05 - 0.68]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226325_at	177	0.237288	0.0259941	0.321507	0.741973	0.414586	0.198209	1.22 [0.76 - 1.96]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238259_at	226	0.69469	0.0131554	0.198041	-0.893785	0.996211	0.0013352	1.00 [0.58 - 1.74]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226325_at	226	0.570796	0.00656079	0.117008	0.766032	0.172186	0.112883	1.12 [0.95 - 1.32]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226325_at	55	0.872727	0.0813885	-	0.979402	0.106385	0.683818	1.98 [0.86 - 4.54]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238259_at	55	0.109091	0.0948625	-	15.2316	0.18122	1.81659	6.15 [0.43 - 88.20]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226325_at	49	0.510204	0.126777	-	0.90549	0.834587	0.143438	1.15 [0.30 - 4.44]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238259_at	49	0.510204	0.0209362	0.27672	1.61111	0.0849843	3.11939	22.63 [0.65 - 787.57]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238259_at	55	0.509091	0.0676	-	0.836913	0.211456	1.62745	5.09 [0.40 - 65.38]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226325_at	55	0.509091	0.013543	0.202315	1.14462	0.0708075	0.800526	2.23 [0.93 - 5.31]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238259_at	63	0.126984	6.01946e-07	3.40509e-05	-1.88385	0.00124426	-13.243	0.00 [0.00 - 0.01]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226325_at	63	0.555556	0.00883592	0.147035	0.884094	0.0235341	0.471199	1.60 [1.07 - 2.41]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.194570.0.A1_3p_at	28	0.285714	0.247663	-	-0.618775	0.371661	-6.7513	0.00 [0.00 - 3167.55]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.108300.3.A1_3p_at	28	0.178571	0.024852	0.311752	-1.25726	0.121326	-3.68244	0.03 [0.00 - 2.65]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P76823	117	0.888889	0.061827	-	-1.26358	0.146331	-0.213576	0.81 [0.61 - 1.08]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226325_at	204	0.622549	0.0690877	-	0.653708	0.473107	0.220398	1.25 [0.68 - 2.28]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238259_at	204	0.446078	0.161886	-	0.535532	0.804183	0.158989	1.17 [0.33 - 4.12]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226325_at	204	0.102941	0.169304	-	-0.52088	0.971752	-0.00838138	0.99 [0.62 - 1.58]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238259_at	204	0.431373	0.057414	-	0.550095	0.497605	0.318251	1.37 [0.55 - 3.45]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226325_at	111	0.765766	0.0195926	0.264076	0.678754	0.604614	0.0580825	1.06 [0.85 - 1.32]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238259_at	111	0.702703	0.049441	0.48826	-0.611388	0.254365	-0.350652	0.70 [0.39 - 1.29]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5565	50	0.4	0.0917338	-	-0.803436	0.571349	-0.175463	0.84 [0.46 - 1.54]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238259_at	138	0.318841	0.0969146	-	-0.404911	0.667053	0.468814	1.60 [0.19 - 13.53]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226325_at	138	0.166667	0.0122775	0.188195	1.10664	0.0181107	0.21174	1.24 [1.04 - 1.47]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38377	56	0.875	0.420304	-	-0.429098	0.882843	0.0312683	1.03 [0.68 - 1.56]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44139	56	0.303571	0.255002	-	0.512923	0.467326	0.152782	1.17 [0.77 - 1.76]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38377	56	0.875	0.341159	-	-0.573334	0.746501	0.0699154	1.07 [0.70 - 1.64]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44139	56	0.857143	0.233582	-	0.502311	0.585347	0.110586	1.12 [0.75 - 1.66]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226325_at	278	0.71223	0.0573647	-	-0.427701	0.71541	0.0400005	1.04 [0.84 - 1.29]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238259_at	278	0.47482	0.0312163	0.363792	-0.408367	0.475418	-0.312485	0.73 [0.31 - 1.73]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P76823	110	0.136364	0.113075	-	0.622533	0.663514	-0.0604896	0.94 [0.72 - 1.24]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P76823	110	0.190909	0.178692	-	0.578717	0.961513	0.0088761	1.01 [0.70 - 1.45]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238259_at	38	0.473684	0.00568563	0.104675	1.36607	0.0295638	1.25416	3.50 [1.13 - 10.85]
GENE	ADSSL1	adenylosuccinate synthase like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226325_at	38	0.184211	0.0363591	0.402183	1.87339	0.267072	0.346578	1.41 [0.77 - 2.61]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGA	aspartylglucosaminidase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204332_s_at	30	0.733333	0.0182738	0.25132	-1.25107	0.622761	-0.253573	0.78 [0.28 - 2.13]
GENE	AGA	aspartylglucosaminidase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216064_s_at	30	0.4	0.0662278	-	-0.736879	0.59549	-0.240774	0.79 [0.32 - 1.91]
GENE	AGA	aspartylglucosaminidase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204333_s_at	30	0.7	0.0815974	-	-0.853627	0.61704	-0.258578	0.77 [0.28 - 2.13]
GENE	AGA	aspartylglucosaminidase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1802631	165	0.515152	0.0105989	0.168671	-0.621232	0.0606965	-0.296474	0.74 [0.55 - 1.01]
GENE	AGA	aspartylglucosaminidase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1802631	165	0.569697	0.000351071	0.0104629	-1.57718	0.00301846	-0.63571	0.53 [0.35 - 0.81]
GENE	AGA	aspartylglucosaminidase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204333_s_at	163	0.834356	0.144825	-	0.371833	0.857648	0.0269414	1.03 [0.77 - 1.38]
GENE	AGA	aspartylglucosaminidase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216064_s_at	163	0.773006	0.22761	-	-0.299464	0.58523	-0.0966183	0.91 [0.64 - 1.28]
GENE	AGA	aspartylglucosaminidase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204332_s_at	163	0.723926	0.111705	-	-0.368843	0.704139	-0.0602845	0.94 [0.69 - 1.29]
GENE	AGA	aspartylglucosaminidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216064_s_at	79	0.582278	0.197869	-	0.374533	0.792426	0.0631152	1.07 [0.67 - 1.70]
GENE	AGA	aspartylglucosaminidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204333_s_at	79	0.139241	0.0137585	0.204672	1.60385	0.0596963	0.465795	1.59 [0.98 - 2.59]
GENE	AGA	aspartylglucosaminidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204332_s_at	79	0.493671	0.0819314	-	0.509518	0.580401	0.136222	1.15 [0.71 - 1.86]
GENE	AGA	aspartylglucosaminidase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216064_s_at	58	0.155172	0.0220366	0.286827	0.869342	0.193396	0.434871	1.54 [0.80 - 2.97]
GENE	AGA	aspartylglucosaminidase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204332_s_at	58	0.413793	0.0772029	-	0.492546	0.324785	0.388489	1.47 [0.68 - 3.20]
GENE	AGA	aspartylglucosaminidase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204333_s_at	58	0.224138	0.0136282	0.203249	0.80943	0.0808308	0.381963	1.47 [0.95 - 2.25]
GENE	AGA	aspartylglucosaminidase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204332_s_at	34	0.617647	0.00646799	0.115723	1.13552	0.125309	0.620044	1.86 [0.84 - 4.11]
GENE	AGA	aspartylglucosaminidase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216064_s_at	34	0.676471	0.115672	-	-0.680964	0.42383	-0.553031	0.58 [0.15 - 2.23]
GENE	AGA	aspartylglucosaminidase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204333_s_at	34	0.176471	0.209789	-	-0.586135	0.553584	0.199033	1.22 [0.63 - 2.36]
GENE	AGA	aspartylglucosaminidase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204332_s_at	158	0.696203	0.0573131	-	-0.51102	0.242067	-0.426935	0.65 [0.32 - 1.33]
GENE	AGA	aspartylglucosaminidase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204333_s_at	158	0.379747	0.0415615	0.438226	-0.469427	0.351155	-0.327231	0.72 [0.36 - 1.43]
GENE	AGA	aspartylglucosaminidase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216064_s_at	158	0.5	0.0550265	-	-0.443952	0.209168	-0.485663	0.62 [0.29 - 1.31]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204333_s_at	53	0.188679	0.410707	-	0.396128	0.984597	0.00795939	1.01 [0.45 - 2.26]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204332_s_at	53	0.377358	0.00564207	0.104048	-0.98241	0.165989	-0.84272	0.43 [0.13 - 1.42]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216064_s_at	53	0.283019	0.00489847	0.0931266	-0.974177	0.142633	-1.00917	0.36 [0.09 - 1.40]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216064_s_at	53	0.283019	0.00137905	0.0333276	-1.14625	0.219243	-0.904363	0.40 [0.10 - 1.71]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204333_s_at	53	0.867925	0.162477	-	0.677077	0.909444	-0.0510701	0.95 [0.39 - 2.29]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204332_s_at	53	0.45283	0.003066	0.0641052	-1.00236	0.088305	-0.97598	0.38 [0.12 - 1.16]
GENE	AGA	aspartylglucosaminidase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204332_s_at	180	0.283333	0.0257348	0.319309	-0.482092	0.0736518	-0.634832	0.53 [0.26 - 1.06]
GENE	AGA	aspartylglucosaminidase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204333_s_at	180	0.155556	0.125987	-	-0.40979	0.290115	-0.321825	0.72 [0.40 - 1.32]
GENE	AGA	aspartylglucosaminidase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216064_s_at	180	0.144444	0.0724547	-	-0.490938	0.196002	-0.284128	0.75 [0.49 - 1.16]
GENE	AGA	aspartylglucosaminidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216064_s_at	559	0.345259	0.125796	-	0.33109	0.550647	0.0846886	1.09 [0.82 - 1.44]
GENE	AGA	aspartylglucosaminidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204333_s_at	559	0.805009	0.51212	-	0.153439	0.948666	0.00999082	1.01 [0.75 - 1.37]
GENE	AGA	aspartylglucosaminidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204332_s_at	559	0.808587	0.228821	-	0.277166	0.608528	0.0803017	1.08 [0.80 - 1.47]
GENE	AGA	aspartylglucosaminidase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204332_s_at	77	0.285714	0.00082459	0.0216686	1.04103	0.0385914	0.631323	1.88 [1.03 - 3.42]
GENE	AGA	aspartylglucosaminidase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216064_s_at	77	0.766234	0.0211615	0.278807	0.645063	0.295377	0.281311	1.32 [0.78 - 2.24]
GENE	AGA	aspartylglucosaminidase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204333_s_at	77	0.272727	0.00798451	0.136106	0.824447	0.00820327	0.654397	1.92 [1.18 - 3.13]
GENE	AGA	aspartylglucosaminidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216064_s_at	70	0.442857	0.169613	-	0.372249	0.368467	0.190799	1.21 [0.80 - 1.83]
GENE	AGA	aspartylglucosaminidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204333_s_at	70	0.171429	0.0702217	-	0.720962	0.195208	0.204619	1.23 [0.90 - 1.67]
GENE	AGA	aspartylglucosaminidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204332_s_at	70	0.328571	0.176125	-	-0.371482	0.626824	0.106398	1.11 [0.72 - 1.71]
GENE	AGA	aspartylglucosaminidase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216064_s_at	74	0.77027	9.06701e-05	0.0032126	1.2095	0.0711543	0.633932	1.89 [0.95 - 3.75]
GENE	AGA	aspartylglucosaminidase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204333_s_at	74	0.121622	0.215416	-	-0.476821	0.933797	-0.0329733	0.97 [0.44 - 2.11]
GENE	AGA	aspartylglucosaminidase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204332_s_at	74	0.891892	0.000689693	0.0186311	1.28131	0.0211322	1.14423	3.14 [1.19 - 8.31]
GENE	AGA	aspartylglucosaminidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216064_s_at	67	0.223881	0.124962	-	-0.990505	0.711887	-0.297468	0.74 [0.15 - 3.60]
GENE	AGA	aspartylglucosaminidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204333_s_at	67	0.149254	0.212788	-	15.2603	0.503458	0.63754	1.89 [0.29 - 12.25]
GENE	AGA	aspartylglucosaminidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204332_s_at	67	0.865672	0.260914	-	-15.2137	0.839226	-0.199267	0.82 [0.12 - 5.62]
GENE	AGA	aspartylglucosaminidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216064_s_at	115	0.895652	0.00965573	0.157253	1.4079	0.51413	0.410589	1.51 [0.44 - 5.18]
GENE	AGA	aspartylglucosaminidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204333_s_at	115	0.208696	0.00520268	0.0976454	-1.38577	0.362007	-0.558283	0.57 [0.17 - 1.90]
GENE	AGA	aspartylglucosaminidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204332_s_at	115	0.243478	0.0923734	-	-0.883572	0.470361	-0.585327	0.56 [0.11 - 2.73]
GENE	AGA	aspartylglucosaminidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216064_s_at	204	0.598039	0.0756869	-	0.25381	0.51447	0.0889717	1.09 [0.84 - 1.43]
GENE	AGA	aspartylglucosaminidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204333_s_at	204	0.740196	0.150332	-	0.232454	0.273494	0.148228	1.16 [0.89 - 1.51]
GENE	AGA	aspartylglucosaminidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204332_s_at	204	0.784314	0.151451	-	0.243639	0.312372	0.147973	1.16 [0.87 - 1.55]
GENE	AGA	aspartylglucosaminidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204332_s_at	87	0.137931	0.00122615	0.0302229	-1.27978	0.0220047	-0.854944	0.43 [0.20 - 0.88]
GENE	AGA	aspartylglucosaminidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216064_s_at	87	0.195402	0.00597814	0.108853	-1.07563	0.0432887	-0.572392	0.56 [0.32 - 0.98]
GENE	AGA	aspartylglucosaminidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204333_s_at	87	0.172414	0.00211041	0.0473329	-1.15167	0.0751128	-0.615949	0.54 [0.27 - 1.06]
GENE	AGA	aspartylglucosaminidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216064_s_at	87	0.195402	0.00597814	0.108853	-1.07563	0.0432887	-0.572392	0.56 [0.32 - 0.98]
GENE	AGA	aspartylglucosaminidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204332_s_at	87	0.137931	0.00122615	0.0302229	-1.27978	0.0220047	-0.854944	0.43 [0.20 - 0.88]
GENE	AGA	aspartylglucosaminidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204333_s_at	87	0.172414	0.00211041	0.0473329	-1.15167	0.0751128	-0.615949	0.54 [0.27 - 1.06]
GENE	AGA	aspartylglucosaminidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216064_s_at	77	0.168831	0.0216499	0.2833	-1.2327	0.304635	-0.344171	0.71 [0.37 - 1.37]
GENE	AGA	aspartylglucosaminidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204332_s_at	77	0.168831	0.0269828	0.329797	-1.33158	0.331638	-0.542149	0.58 [0.19 - 1.74]
GENE	AGA	aspartylglucosaminidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204333_s_at	77	0.220779	0.00158163	0.0373361	-1.59038	0.099419	-0.654941	0.52 [0.24 - 1.13]
GENE	AGA	aspartylglucosaminidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204332_s_at	77	0.168831	0.00218082	0.0486201	-1.54981	0.134688	-0.722754	0.49 [0.19 - 1.25]
GENE	AGA	aspartylglucosaminidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216064_s_at	77	0.103896	0.0257332	0.319295	-1.42171	0.501523	-0.256798	0.77 [0.37 - 1.64]
GENE	AGA	aspartylglucosaminidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204333_s_at	77	0.220779	0.0115828	0.180231	-1.46671	0.277216	-0.475842	0.62 [0.26 - 1.47]
GENE	AGA	aspartylglucosaminidase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204333_s_at	136	0.845588	0.227846	-	-1.17182	0.923416	0.0444205	1.05 [0.42 - 2.59]
GENE	AGA	aspartylglucosaminidase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216064_s_at	136	0.5	0.0131757	0.198267	-1.20778	0.00570576	-0.852818	0.43 [0.23 - 0.78]
GENE	AGA	aspartylglucosaminidase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204332_s_at	136	0.110294	0.00086338	0.0225247	-1.49236	0.016856	-1.35019	0.26 [0.09 - 0.78]
GENE	AGA	aspartylglucosaminidase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204333_s_at	200	0.105	0.0160669	0.229138	-0.871005	0.113252	-0.58935	0.55 [0.27 - 1.15]
GENE	AGA	aspartylglucosaminidase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216064_s_at	200	0.265	0.00112019	0.0280264	-0.937789	0.0161668	-0.895439	0.41 [0.20 - 0.85]
GENE	AGA	aspartylglucosaminidase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204332_s_at	200	0.255	0.00252643	0.0548117	-0.878069	0.0534413	-0.827394	0.44 [0.19 - 1.01]
GENE	AGA	aspartylglucosaminidase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11743	60	0.716667	0.243162	-	-0.535512	0.609539	-0.149065	0.86 [0.49 - 1.53]
GENE	AGA	aspartylglucosaminidase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11743	60	0.783333	0.224216	-	0.498334	0.676198	0.128972	1.14 [0.62 - 2.08]
GENE	AGA	aspartylglucosaminidase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	10693	155	0.767742	1.0783e-05	0.00047835	1.16687	0.00245126	0.322205	1.38 [1.12 - 1.70]
GENE	AGA	aspartylglucosaminidase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204333_s_at	286	0.562937	0.050883	-	-0.38863	0.357136	-0.17738	0.84 [0.57 - 1.22]
GENE	AGA	aspartylglucosaminidase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216064_s_at	286	0.227273	5.37605e-06	0.000254268	-0.900758	0.0112968	-0.538115	0.58 [0.39 - 0.89]
GENE	AGA	aspartylglucosaminidase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204332_s_at	286	0.258741	0.00241991	0.052925	-0.609873	0.0542283	-0.605273	0.55 [0.29 - 1.01]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204332_s_at	159	0.880503	0.0341583	0.386115	0.891733	0.402554	0.516365	1.68 [0.50 - 5.61]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204333_s_at	159	0.169811	0.039387	0.423476	-0.715639	0.595388	-0.188413	0.83 [0.41 - 1.66]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216064_s_at	159	0.100629	0.0639534	-	-0.753303	0.810315	0.091778	1.10 [0.52 - 2.32]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216064_s_at	159	0.798742	0.105143	-	0.64035	0.611914	0.230367	1.26 [0.52 - 3.07]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204332_s_at	159	0.874214	0.0120623	0.185746	0.889566	0.288695	0.557298	1.75 [0.62 - 4.89]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204333_s_at	159	0.169811	0.0216778	0.283556	-0.892169	0.345852	-0.380009	0.68 [0.31 - 1.51]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216064_s_at	159	0.786164	0.120241	-	0.529999	0.510838	0.251588	1.29 [0.61 - 2.72]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204333_s_at	159	0.18239	0.0739654	-	-0.622905	0.787659	-0.0963388	0.91 [0.45 - 1.83]
GENE	AGA	aspartylglucosaminidase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204332_s_at	159	0.880503	0.0461647	0.46807	0.769938	0.911577	0.0579155	1.06 [0.38 - 2.95]
GENE	AGA	aspartylglucosaminidase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204333_s_at	54	0.444444	0.176908	-	-0.928865	0.966711	-0.0198688	0.98 [0.39 - 2.49]
GENE	AGA	aspartylglucosaminidase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216064_s_at	54	0.777778	0.0818881	-	1.11854	0.592443	0.202181	1.22 [0.58 - 2.57]
GENE	AGA	aspartylglucosaminidase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204332_s_at	54	0.759259	0.0818881	-	1.11854	0.551257	0.285298	1.33 [0.52 - 3.40]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216064_s_at	117	0.273504	0.181819	-	0.502353	0.530888	0.139136	1.15 [0.74 - 1.78]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204332_s_at	117	0.820513	0.10593	-	0.608438	0.702897	0.0886795	1.09 [0.69 - 1.72]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216064_s_at	117	0.42735	0.104063	-	0.67489	0.877802	0.0426469	1.04 [0.61 - 1.80]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204332_s_at	117	0.444444	0.0996049	-	0.656053	0.443515	0.215553	1.24 [0.71 - 2.15]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204332_s_at	117	0.461538	0.0200926	0.268822	0.98628	0.325473	0.290657	1.34 [0.75 - 2.39]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204332_s_at	117	0.820513	0.10593	-	0.608438	0.702897	0.0886795	1.09 [0.69 - 1.72]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204333_s_at	117	0.74359	0.302929	-	0.356154	0.716037	0.0792203	1.08 [0.71 - 1.66]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204333_s_at	117	0.675214	0.118455	-	0.589987	0.260467	0.294546	1.34 [0.80 - 2.24]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204333_s_at	117	0.675214	0.0683099	-	0.700173	0.290026	0.286196	1.33 [0.78 - 2.26]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204333_s_at	117	0.74359	0.302929	-	0.356154	0.716037	0.0792203	1.08 [0.71 - 1.66]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216064_s_at	117	0.273504	0.181819	-	0.502353	0.530888	0.139136	1.15 [0.74 - 1.78]
GENE	AGA	aspartylglucosaminidase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216064_s_at	117	0.273504	0.0937532	-	0.806492	0.477006	0.185755	1.20 [0.72 - 2.01]
GENE	AGA	aspartylglucosaminidase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216064_s_at	236	0.114407	0.0126981	0.192942	-0.822666	0.19654	-0.450604	0.64 [0.32 - 1.26]
GENE	AGA	aspartylglucosaminidase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204332_s_at	236	0.101695	0.0396672	0.425402	-0.736736	0.696621	-0.182787	0.83 [0.33 - 2.09]
GENE	AGA	aspartylglucosaminidase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204333_s_at	236	0.135593	0.00194768	0.0443207	-0.927767	0.183441	-0.453633	0.64 [0.33 - 1.24]
GENE	AGA	aspartylglucosaminidase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216064_s_at	249	0.116466	0.019135	0.25969	-0.653227	0.900538	-0.0351789	0.97 [0.56 - 1.68]
GENE	AGA	aspartylglucosaminidase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204332_s_at	249	0.297189	0.125404	-	0.381119	0.896017	0.0491239	1.05 [0.50 - 2.19]
GENE	AGA	aspartylglucosaminidase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204333_s_at	249	0.614458	0.0206489	0.274045	0.487419	0.611464	0.136558	1.15 [0.68 - 1.94]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204333_s_at	125	0.408	0.0851896	-	0.573741	0.752798	0.0632385	1.07 [0.72 - 1.58]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204333_s_at	54	0.166667	0.0740995	-	-1.10131	0.425859	-0.190316	0.83 [0.52 - 1.32]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216064_s_at	125	0.792	0.104552	-	-0.961433	0.705421	-0.121892	0.89 [0.47 - 1.67]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204332_s_at	62	0.112903	0.0638076	-	-1.02865	0.0384684	-0.843453	0.43 [0.19 - 0.96]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216064_s_at	125	0.104	0.0147193	0.215025	-0.981958	0.527662	-0.156138	0.86 [0.53 - 1.39]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204332_s_at	125	0.368	0.0264968	0.325739	1.14247	0.658386	0.0995546	1.10 [0.71 - 1.72]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216064_s_at	62	0.83871	0.192279	-	-1.25912	0.198514	-0.383784	0.68 [0.38 - 1.22]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216064_s_at	54	0.5	0.0873076	-	-1.017	0.21032	-0.438301	0.65 [0.32 - 1.28]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204333_s_at	62	0.129032	0.0508647	-	-1.01035	0.500222	-0.130501	0.88 [0.60 - 1.28]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204332_s_at	125	0.104	0.0119259	0.184185	-1.0095	0.888054	-0.024775	0.98 [0.69 - 1.38]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204333_s_at	125	0.408	0.0510527	-	0.874535	0.74478	0.0849579	1.09 [0.65 - 1.82]
GENE	AGA	aspartylglucosaminidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204332_s_at	54	0.185185	0.0566509	-	-1.17496	0.115492	-0.770134	0.46 [0.18 - 1.21]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216064_s_at	198	0.111111	0.0430006	0.447751	-0.695828	0.897893	-0.0228188	0.98 [0.69 - 1.39]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204333_s_at	198	0.368687	0.251142	-	0.25547	0.801841	-0.0404605	0.96 [0.70 - 1.32]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204332_s_at	198	0.146465	0.0502867	-	-0.60496	0.992643	-0.00220417	1.00 [0.62 - 1.59]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204332_s_at	198	0.146465	0.0382108	0.415313	-0.646186	0.964451	-0.0110218	0.99 [0.61 - 1.61]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204333_s_at	198	0.131313	0.185594	-	0.610032	0.444091	0.146666	1.16 [0.80 - 1.69]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216064_s_at	198	0.782828	0.199148	-	-0.35281	0.739291	-0.0461766	0.95 [0.73 - 1.25]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204333_s_at	198	0.282828	0.108837	-	0.53484	0.385812	0.171615	1.19 [0.81 - 1.75]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204332_s_at	198	0.146465	0.196267	-	-0.355535	0.725997	-0.0683871	0.93 [0.64 - 1.37]
GENE	AGA	aspartylglucosaminidase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216064_s_at	198	0.111111	0.057662	-	-0.647645	0.949005	-0.0111377	0.99 [0.70 - 1.39]
GENE	AGA	aspartylglucosaminidase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204333_s_at	62	0.112903	0.00178	0.0411593	-1.71399	0.0886591	-0.878967	0.42 [0.15 - 1.14]
GENE	AGA	aspartylglucosaminidase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216064_s_at	51	0.196078	0.0110895	0.174479	-1.9843	0.279705	-1.22778	0.29 [0.03 - 2.71]
GENE	AGA	aspartylglucosaminidase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204332_s_at	51	0.156863	0.081139	-	-1.46166	0.303653	-1.05062	0.35 [0.05 - 2.59]
GENE	AGA	aspartylglucosaminidase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204332_s_at	62	0.193548	0.00167868	0.0392184	-1.63137	0.0226133	-1.66074	0.19 [0.05 - 0.79]
GENE	AGA	aspartylglucosaminidase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204333_s_at	51	0.686275	0.164547	-	1.19633	0.859195	-0.128931	0.88 [0.21 - 3.65]
GENE	AGA	aspartylglucosaminidase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216064_s_at	62	0.209677	0.0529777	-	-1.08144	0.138656	-1.11487	0.33 [0.07 - 1.43]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204332_s_at	177	0.107345	0.02521	0.314831	-0.766266	0.187149	-0.42422	0.65 [0.35 - 1.23]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204333_s_at	177	0.898305	0.113048	-	-0.794663	0.569441	-0.111907	0.89 [0.61 - 1.31]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216064_s_at	145	0.103448	0.10166	-	-0.718993	0.530277	-0.200049	0.82 [0.44 - 1.53]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204332_s_at	177	0.892655	0.0148538	0.216454	-1.33764	0.130822	-0.421161	0.66 [0.38 - 1.13]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204333_s_at	145	0.896552	0.211652	-	-0.880795	0.731829	-0.0914747	0.91 [0.54 - 1.54]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204332_s_at	145	0.103448	0.0294239	0.349684	-0.891054	0.581652	-0.215691	0.81 [0.37 - 1.74]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216064_s_at	177	0.870057	0.0128053	0.194143	-1.6143	0.0927824	-0.442455	0.64 [0.38 - 1.08]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204333_s_at	177	0.751412	0.0640379	-	-0.664844	0.58977	-0.122243	0.88 [0.57 - 1.38]
GENE	AGA	aspartylglucosaminidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216064_s_at	177	0.870057	0.0121059	0.186243	-1.21606	0.0476428	-0.451371	0.64 [0.41 - 1.00]
GENE	AGA	aspartylglucosaminidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204333_s_at	226	0.367257	0.00712555	0.124717	-0.745896	0.0777744	-0.463406	0.63 [0.38 - 1.05]
GENE	AGA	aspartylglucosaminidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204332_s_at	226	0.185841	0.00107336	0.0270429	-0.942289	0.0174092	-0.816624	0.44 [0.23 - 0.87]
GENE	AGA	aspartylglucosaminidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216064_s_at	226	0.862832	0.0183945	0.252503	-1.54506	0.120533	-0.364705	0.69 [0.44 - 1.10]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204332_s_at	55	0.872727	0.00962486	0.156873	1.26848	0.0281093	0.984082	2.68 [1.11 - 6.44]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204333_s_at	55	0.890909	0.219574	-	0.837545	0.356061	0.377504	1.46 [0.65 - 3.25]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204333_s_at	49	0.897959	0.095513	-	1.07121	0.282481	0.470757	1.60 [0.68 - 3.78]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204332_s_at	55	0.890909	0.0324261	0.373093	1.3068	0.140011	0.756139	2.13 [0.78 - 5.81]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204332_s_at	49	0.897959	0.095513	-	1.07121	0.142586	0.826682	2.29 [0.76 - 6.90]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216064_s_at	55	0.781818	0.00727404	0.126714	1.16651	0.0870087	0.649067	1.91 [0.91 - 4.02]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216064_s_at	55	0.890909	0.0324261	0.373093	1.3068	0.492172	0.266487	1.31 [0.61 - 2.79]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204333_s_at	55	0.509091	0.115653	-	0.724713	0.192461	0.458495	1.58 [0.79 - 3.15]
GENE	AGA	aspartylglucosaminidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216064_s_at	49	0.897959	0.095513	-	1.07121	0.404658	0.384472	1.47 [0.59 - 3.63]
GENE	AGA	aspartylglucosaminidase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	281476	34	0.117647	0.080677	-	-1.05794	0.358789	-0.642735	0.53 [0.13 - 2.08]
GENE	AGA	aspartylglucosaminidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204332_s_at	63	0.47619	0.0412532	0.436161	-0.69267	0.456425	-0.114799	0.89 [0.66 - 1.21]
GENE	AGA	aspartylglucosaminidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216064_s_at	63	0.539683	0.128637	-	-0.526221	0.507905	-0.0844238	0.92 [0.72 - 1.18]
GENE	AGA	aspartylglucosaminidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204333_s_at	63	0.507937	0.00678016	0.120024	-0.934894	0.209647	-0.15358	0.86 [0.67 - 1.09]
GENE	AGA	aspartylglucosaminidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.207776.1.S1_3p_a_at	28	0.535714	0.131953	-	-0.893374	0.916543	-0.0771613	0.93 [0.22 - 3.92]
GENE	AGA	aspartylglucosaminidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557272_3p_a_at	28	0.535714	0.243537	-	0.631545	0.724578	0.0879677	1.09 [0.67 - 1.78]
GENE	AGA	aspartylglucosaminidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.207776.0.S1_3p_a_at	28	0.785714	0.478442	-	-0.536891	0.995876	0.00204763	1.00 [0.46 - 2.18]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204333_s_at	82	0.146341	0.000464451	0.0133042	-1.39309	0.101868	-0.572732	0.56 [0.28 - 1.12]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216064_s_at	82	0.146341	0.0542298	-	-0.80447	0.0801759	-0.563943	0.57 [0.30 - 1.07]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204332_s_at	82	0.768293	0.0186324	0.254824	-1.18206	0.0943997	-0.631585	0.53 [0.25 - 1.11]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204333_s_at	79	0.898734	0.209788	-	-0.64058	0.252817	-0.297252	0.74 [0.45 - 1.24]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204332_s_at	79	0.151899	0.0284617	0.34194	-0.722109	0.188254	-0.400787	0.67 [0.37 - 1.22]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216064_s_at	79	0.139241	0.0570902	-	-0.65781	0.329575	-0.224752	0.80 [0.51 - 1.25]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204332_s_at	104	0.451923	0.279829	-	-0.350521	0.52648	-0.259154	0.77 [0.35 - 1.72]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204333_s_at	104	0.778846	0.257447	-	-0.496224	0.592881	-0.174549	0.84 [0.44 - 1.59]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216064_s_at	104	0.682692	0.136606	-	-0.585941	0.670857	-0.120696	0.89 [0.51 - 1.55]
GENE	AGA	aspartylglucosaminidase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P7099	117	0.324786	0.199229	-	-0.371246	0.716645	-0.0951877	0.91 [0.54 - 1.52]
GENE	AGA	aspartylglucosaminidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216064_s_at	204	0.509804	0.0262885	0.32399	0.836779	0.07988	0.642986	1.90 [0.93 - 3.91]
GENE	AGA	aspartylglucosaminidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216064_s_at	204	0.259804	0.00414633	0.0816204	1.17335	0.0496893	0.528638	1.70 [1.00 - 2.88]
GENE	AGA	aspartylglucosaminidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204333_s_at	204	0.872549	0.0227166	0.292967	0.95027	0.438105	0.360056	1.43 [0.58 - 3.56]
GENE	AGA	aspartylglucosaminidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204333_s_at	204	0.897059	0.300689	-	-0.605654	0.779814	-0.100325	0.90 [0.45 - 1.83]
GENE	AGA	aspartylglucosaminidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204332_s_at	204	0.431373	0.0145417	0.21313	1.01191	0.070265	0.802594	2.23 [0.94 - 5.32]
GENE	AGA	aspartylglucosaminidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204332_s_at	204	0.426471	0.00373875	0.0751632	0.873108	0.112136	0.522528	1.69 [0.89 - 3.21]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216064_s_at	178	0.876405	0.088885	-	-0.58687	0.381178	-0.180491	0.83 [0.56 - 1.25]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204332_s_at	178	0.101124	0.0821065	-	-0.513215	0.843846	-0.0484476	0.95 [0.59 - 1.54]
GENE	AGA	aspartylglucosaminidase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204333_s_at	178	0.157303	0.0385268	0.41752	-0.51272	0.438695	-0.162962	0.85 [0.56 - 1.28]
GENE	AGA	aspartylglucosaminidase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300002630	41	0.243902	0.14495	-	0.784308	0.898894	0.0363713	1.04 [0.59 - 1.82]
GENE	AGA	aspartylglucosaminidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216064_s_at	111	0.135135	0.10411	-	-0.557199	0.699912	-0.0775901	0.93 [0.62 - 1.37]
GENE	AGA	aspartylglucosaminidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204333_s_at	111	0.126126	0.050057	-	-0.67462	0.260096	-0.273947	0.76 [0.47 - 1.22]
GENE	AGA	aspartylglucosaminidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204332_s_at	111	0.315315	0.056588	-	0.578527	0.558051	0.213404	1.24 [0.61 - 2.53]
GENE	AGA	aspartylglucosaminidase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204333_s_at	90	0.111111	0.170102	-	-0.602281	0.918009	-0.0403008	0.96 [0.45 - 2.07]
GENE	AGA	aspartylglucosaminidase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204333_s_at	90	0.111111	0.0388034	0.419442	-0.916744	0.689671	-0.183537	0.83 [0.34 - 2.05]
GENE	AGA	aspartylglucosaminidase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216064_s_at	90	0.755556	0.0161383	0.229873	-1.10677	0.611853	-0.173347	0.84 [0.43 - 1.64]
GENE	AGA	aspartylglucosaminidase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216064_s_at	90	0.788889	0.0562063	-	-1.11115	0.546914	-0.237694	0.79 [0.36 - 1.71]
GENE	AGA	aspartylglucosaminidase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204332_s_at	90	0.644444	0.26916	-	-0.385885	0.523483	-0.217526	0.80 [0.41 - 1.57]
GENE	AGA	aspartylglucosaminidase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204332_s_at	90	0.644444	0.206908	-	-0.520197	0.44923	-0.291665	0.75 [0.35 - 1.59]
GENE	AGA	aspartylglucosaminidase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	711	50	0.76	0.030418	0.357558	1.03043	0.282294	0.741515	2.10 [0.54 - 8.11]
GENE	AGA	aspartylglucosaminidase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3503	50	0.18	0.029198	0.347877	15.4036	0.24702	0.675559	1.97 [0.63 - 6.17]
GENE	AGA	aspartylglucosaminidase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	711	50	0.62	0.0367023	0.404642	0.987311	0.983216	-0.00984244	0.99 [0.40 - 2.48]
GENE	AGA	aspartylglucosaminidase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	2500	50	0.76	0.191056	-	-0.944771	0.708748	0.164593	1.18 [0.50 - 2.80]
GENE	AGA	aspartylglucosaminidase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3503	50	0.2	0.0189408	0.257816	-1.13498	0.581347	-0.221749	0.80 [0.36 - 1.76]
GENE	AGA	aspartylglucosaminidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216064_s_at	138	0.485507	0.0793231	-	0.428582	0.699956	0.0380947	1.04 [0.86 - 1.26]
GENE	AGA	aspartylglucosaminidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204333_s_at	138	0.898551	0.203476	-	-0.583616	0.819921	-0.0293053	0.97 [0.75 - 1.25]
GENE	AGA	aspartylglucosaminidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204332_s_at	138	0.695652	0.0349447	0.391916	-0.594107	0.59489	-0.0640332	0.94 [0.74 - 1.19]
GENE	AGA	aspartylglucosaminidase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204332_s_at	129	0.55814	0.117722	-	-0.397825	0.657173	-0.159815	0.85 [0.42 - 1.73]
GENE	AGA	aspartylglucosaminidase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204333_s_at	129	0.395349	0.0444297	0.457032	-0.494467	0.582108	-0.142144	0.87 [0.52 - 1.44]
GENE	AGA	aspartylglucosaminidase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216064_s_at	129	0.395349	0.0340549	0.385347	-0.519957	0.512092	-0.181699	0.83 [0.48 - 1.44]
GENE	AGA	aspartylglucosaminidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11598	56	0.660714	0.0289769	0.346102	-0.906037	0.514319	-0.165035	0.85 [0.52 - 1.39]
GENE	AGA	aspartylglucosaminidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11598	56	0.660714	0.0167743	0.236369	-0.941574	0.206741	-0.29934	0.74 [0.47 - 1.18]
GENE	AGA	aspartylglucosaminidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204332_s_at	278	0.769784	0.00348261	0.0710155	-0.714125	0.0923755	-0.26772	0.77 [0.56 - 1.05]
GENE	AGA	aspartylglucosaminidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216064_s_at	278	0.748201	0.00422419	0.0828353	-0.673212	0.0457492	-0.272619	0.76 [0.58 - 0.99]
GENE	AGA	aspartylglucosaminidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204333_s_at	278	0.679856	0.0147804	0.215674	-0.527496	0.314103	-0.135822	0.87 [0.67 - 1.14]
GENE	AGA	aspartylglucosaminidase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216064_s_at	133	0.721804	0.0862521	-	-0.496811	0.56326	-0.116573	0.89 [0.60 - 1.32]
GENE	AGA	aspartylglucosaminidase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204332_s_at	133	0.443609	0.0234945	0.299896	-0.5351	0.0190112	-0.260244	0.77 [0.62 - 0.96]
GENE	AGA	aspartylglucosaminidase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204333_s_at	133	0.481203	0.0267021	0.327457	-0.527532	0.197933	-0.177854	0.84 [0.64 - 1.10]
GENE	AGA	aspartylglucosaminidase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17682	81	0.654321	0.183053	-	0.680187	0.757225	0.171744	1.19 [0.40 - 3.53]
GENE	AGA	aspartylglucosaminidase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204333_s_at	185	0.475676	0.113541	-	0.283437	0.256649	0.246073	1.28 [0.84 - 1.96]
GENE	AGA	aspartylglucosaminidase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204332_s_at	185	0.572973	0.054613	-	0.338018	0.491607	0.125429	1.13 [0.79 - 1.62]
GENE	AGA	aspartylglucosaminidase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216064_s_at	185	0.767568	0.258421	-	0.211631	0.940989	0.0143462	1.01 [0.69 - 1.48]
GENE	AGA	aspartylglucosaminidase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204333_s_at	185	0.167568	0.0733874	-	0.410888	0.379415	0.178591	1.20 [0.80 - 1.78]
GENE	AGA	aspartylglucosaminidase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216064_s_at	185	0.583784	0.123006	-	-0.281809	0.521189	-0.141621	0.87 [0.56 - 1.34]
GENE	AGA	aspartylglucosaminidase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204332_s_at	185	0.572973	0.03917	0.42198	0.333793	0.392545	0.142171	1.15 [0.83 - 1.60]
GENE	AGA	aspartylglucosaminidase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P7099	110	0.854545	0.0643656	-	0.572757	0.939729	-0.0164351	0.98 [0.64 - 1.51]
GENE	AGA	aspartylglucosaminidase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P7099	110	0.872727	0.198428	-	0.572939	0.9521	0.0175353	1.02 [0.57 - 1.80]
GENE	AGA	aspartylglucosaminidase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204332_s_at	80	0.5875	0.00340741	0.0697837	-1.64891	0.0192985	-0.886397	0.41 [0.20 - 0.87]
GENE	AGA	aspartylglucosaminidase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204333_s_at	80	0.8625	0.047074	0.473758	-15.2813	0.209445	-0.353727	0.70 [0.40 - 1.22]
GENE	AGA	aspartylglucosaminidase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216064_s_at	80	0.2125	0.146179	-	-0.663011	0.720594	-0.105795	0.90 [0.50 - 1.61]
GENE	AGA	aspartylglucosaminidase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3931	281	0.206406	0.0206952	0.274477	0.421464	0.847807	0.0169087	1.02 [0.86 - 1.21]
GENE	AGA	aspartylglucosaminidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204333_s_at	38	0.368421	0.0145131	0.212824	1.37806	0.105281	0.617821	1.85 [0.88 - 3.92]
GENE	AGA	aspartylglucosaminidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204332_s_at	38	0.526316	0.024175	0.305875	1.15993	0.0923055	0.875764	2.40 [0.87 - 6.66]
GENE	AGA	aspartylglucosaminidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216064_s_at	38	0.236842	0.0178086	0.246735	1.65749	0.0558271	0.753294	2.12 [0.98 - 4.60]
GENE	AGA	aspartylglucosaminidase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216064_s_at	140	0.442857	0.143651	-	-0.421002	0.513727	-0.16099	0.85 [0.53 - 1.38]
GENE	AGA	aspartylglucosaminidase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204332_s_at	140	0.107143	0.17045	-	-0.554673	0.813208	0.0669606	1.07 [0.61 - 1.86]
GENE	AGA	aspartylglucosaminidase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204333_s_at	140	0.55	0.264865	-	0.322548	0.659985	0.147038	1.16 [0.60 - 2.23]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203566_s_at	30	0.166667	0.0551798	-	-0.960445	0.891543	-0.0403715	0.96 [0.54 - 1.72]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1750235	165	0.236364	0.00212028	0.0475137	-0.773949	0.0131598	-1.09883	0.33 [0.14 - 0.79]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1750235	165	0.224242	0.00011853	0.00406725	-1.28087	0.00806689	-1.78049	0.17 [0.05 - 0.63]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203566_s_at	163	0.852761	0.00643208	0.115225	0.673522	0.274228	0.152256	1.16 [0.89 - 1.53]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203566_s_at	79	0.455696	0.0100484	0.162049	0.787354	0.249677	0.226101	1.25 [0.85 - 1.84]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203566_s_at	58	0.137931	0.0471393	0.474164	0.818665	0.826515	0.0659892	1.07 [0.59 - 1.93]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203566_s_at	34	0.558824	0.0901404	-	0.68135	0.49705	0.325081	1.38 [0.54 - 3.54]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203566_s_at	158	0.525316	0.0296971	0.35186	-0.513627	0.0584099	-0.388182	0.68 [0.45 - 1.01]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203566_s_at	53	0.716981	0.0383724	0.416442	-0.977934	0.0618097	-0.705913	0.49 [0.24 - 1.04]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203566_s_at	53	0.339623	0.0243645	0.307528	-0.763866	0.0443525	-0.721475	0.49 [0.24 - 0.98]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203566_s_at	180	0.516667	0.0758527	-	-0.370789	0.298727	-0.305861	0.74 [0.41 - 1.31]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203566_s_at	559	0.354204	0.000361123	0.0107202	-0.703106	0.000171504	-0.932765	0.39 [0.24 - 0.64]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203566_s_at	77	0.792208	0.000473053	0.0135148	1.04375	0.508439	0.216436	1.24 [0.65 - 2.36]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203566_s_at	70	0.814286	0.000855648	0.0223546	1.03739	0.0247293	0.485259	1.62 [1.06 - 2.48]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38252_s_at	50	0.14	0.0978367	-	1.15275	0.84959	-0.0613975	0.94 [0.50 - 1.77]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38253_at	50	0.3	0.0265452	0.326145	0.938157	0.376372	0.18625	1.20 [0.80 - 1.82]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203566_s_at	74	0.837838	0.176194	-	0.498912	0.329473	0.467545	1.60 [0.62 - 4.08]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203566_s_at	67	0.208955	0.0150482	0.218512	-1.51778	0.053449	-1.24915	0.29 [0.08 - 1.02]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203566_s_at	115	0.869565	0.133281	-	-15.2391	0.19449	-0.707232	0.49 [0.17 - 1.44]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38252_s_at	158	0.272152	0.14484	-	-0.434895	0.547063	-0.109634	0.90 [0.63 - 1.28]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38253_at	158	0.272152	0.229262	-	-0.371237	0.589772	-0.104313	0.90 [0.62 - 1.32]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38252_s_at	76	0.263158	0.0340013	0.384948	-1.05499	0.701561	-0.13372	0.87 [0.44 - 1.73]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38253_at	76	0.486842	0.0598034	-	-1.05888	0.49721	-0.288732	0.75 [0.33 - 1.72]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203566_s_at	204	0.20098	0.0229932	0.295442	0.398166	0.419439	0.0694991	1.07 [0.91 - 1.27]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203566_s_at	87	0.873563	6.03756e-06	0.000282598	1.76077	0.152934	0.277976	1.32 [0.90 - 1.93]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203566_s_at	87	0.873563	6.03756e-06	0.000282598	1.76077	0.152934	0.277976	1.32 [0.90 - 1.93]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203566_s_at	77	0.805195	0.00946415	0.15489	1.49781	0.0909606	0.450783	1.57 [0.93 - 2.65]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203566_s_at	77	0.805195	0.0722265	-	0.984997	0.497548	0.163877	1.18 [0.73 - 1.89]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203566_s_at	136	0.867647	0.00899324	0.149018	1.21905	0.649473	0.135115	1.14 [0.64 - 2.05]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203566_s_at	200	0.65	0.202563	-	-0.415491	0.795192	-0.0680769	0.93 [0.56 - 1.56]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18186	60	0.433333	0.123542	-	-0.57996	0.610943	0.060257	1.06 [0.84 - 1.34]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18186	60	0.483333	0.242452	-	-0.439523	0.587564	0.0875738	1.09 [0.80 - 1.50]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16511	155	0.858065	9.45368e-06	0.00042462	1.23618	0.00083629	0.311201	1.37 [1.14 - 1.64]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203566_s_at	286	0.804196	0.0689547	-	0.397093	0.293083	0.136875	1.15 [0.89 - 1.48]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203566_s_at	159	0.522013	0.0564044	-	0.60682	0.624583	0.10715	1.11 [0.72 - 1.71]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203566_s_at	159	0.798742	0.0463979	0.469535	0.674994	0.42236	0.167697	1.18 [0.79 - 1.78]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203566_s_at	159	0.798742	0.0294088	0.349563	0.82749	0.494776	0.171765	1.19 [0.73 - 1.94]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203566_s_at	54	0.259259	0.0934614	-	-1.12683	0.706694	-0.0901558	0.91 [0.57 - 1.46]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203566_s_at	117	0.888889	0.0493916	0.487962	-15.2233	0.890644	0.0218677	1.02 [0.75 - 1.40]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203566_s_at	117	0.119658	0.120041	-	1.07764	0.880484	-0.0192939	0.98 [0.76 - 1.26]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203566_s_at	117	0.119658	0.120041	-	1.07764	0.880484	-0.0192939	0.98 [0.76 - 1.26]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203566_s_at	117	0.888889	0.0503642	-	-15.2058	0.738634	-0.0512821	0.95 [0.70 - 1.28]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203566_s_at	236	0.877119	0.0177425	0.24608	0.780376	0.19271	0.282239	1.33 [0.87 - 2.03]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203566_s_at	249	0.192771	0.0276027	0.334923	-0.520343	0.722789	0.0617405	1.06 [0.76 - 1.50]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203566_s_at	125	0.104	0.0554554	-	15.199	0.0927818	0.309592	1.36 [0.95 - 1.96]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203566_s_at	125	0.616	0.0247723	0.311064	0.633517	0.0561126	0.270094	1.31 [0.99 - 1.73]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203566_s_at	54	0.888889	0.177175	-	-15.2411	0.705323	-0.100997	0.90 [0.54 - 1.53]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203566_s_at	62	0.112903	0.0926293	-	-0.945412	0.407063	-0.190946	0.83 [0.53 - 1.30]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203566_s_at	198	0.89899	0.00101559	0.025818	0.904549	0.275527	0.106086	1.11 [0.92 - 1.35]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203566_s_at	198	0.89899	0.00146205	0.0349836	0.988762	0.344928	0.108986	1.12 [0.89 - 1.40]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203566_s_at	198	0.89899	0.00218175	0.048637	0.993222	0.241354	0.139852	1.15 [0.91 - 1.45]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203566_s_at	51	0.784314	0.217208	-	-15.4333	0.499429	-0.342163	0.71 [0.26 - 1.92]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203566_s_at	62	0.887097	0.169817	-	-15.2364	0.510499	-0.210352	0.81 [0.43 - 1.52]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203566_s_at	177	0.610169	0.0198108	0.266153	0.54302	0.0891652	0.46891	1.60 [0.93 - 2.74]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203566_s_at	145	0.275862	0.155728	-	-0.489285	0.905983	-0.0442278	0.96 [0.46 - 1.99]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203566_s_at	177	0.621469	0.0348278	0.391058	0.567437	0.131914	0.477694	1.61 [0.87 - 3.00]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203566_s_at	226	0.548673	0.050668	-	-0.585867	0.15922	-0.444682	0.64 [0.35 - 1.19]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203566_s_at	55	0.2	0.157736	-	1.05146	0.507202	0.269165	1.31 [0.59 - 2.90]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203566_s_at	49	0.22449	0.0240521	0.304801	15.5996	0.0703897	0.814232	2.26 [0.93 - 5.45]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203566_s_at	55	0.2	0.00943734	0.154559	15.4859	0.160265	0.502054	1.65 [0.82 - 3.33]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	853687	34	0.235294	0.0965919	-	1.03171	0.526791	0.197642	1.22 [0.66 - 2.25]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	784756	34	0.264706	0.36837	-	0.469473	0.75996	0.123018	1.13 [0.51 - 2.49]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203566_s_at	63	0.111111	0.0133258	0.199926	-1.03394	0.184949	-0.18756	0.83 [0.63 - 1.09]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557282_3p_a_at	28	0.214286	0.0377254	0.411905	-1.10859	0.613951	-0.127339	0.88 [0.54 - 1.44]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203566_s_at	82	0.390244	0.00338062	0.0693433	-0.967052	0.0844446	-0.621948	0.54 [0.26 - 1.09]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38253_at	84	0.321429	0.040138	0.42862	-0.599939	0.339283	-0.288411	0.75 [0.41 - 1.35]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203566_s_at	79	0.493671	0.171163	-	0.356106	0.997516	-0.00122494	1.00 [0.46 - 2.16]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U84011_s_at	86	0.244186	0.09727	-	1.16209	0.556867	0.362352	1.44 [0.43 - 4.81]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203566_s_at	104	0.634615	0.0666102	-	0.596884	0.649572	0.219472	1.25 [0.48 - 3.21]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P200298	117	0.683761	0.093385	-	0.484629	0.363341	0.194345	1.21 [0.80 - 1.85]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203566_s_at	204	0.681373	0.00164623	0.0385916	-1.97092	0.0220008	-1.28716	0.28 [0.09 - 0.83]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203566_s_at	204	0.382353	7.21704e-07	4.02694e-05	-1.31908	9.84565e-05	-1.57554	0.21 [0.09 - 0.46]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203566_s_at	178	0.837079	0.108028	-	-0.489342	0.304543	-0.278002	0.76 [0.45 - 1.29]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203566_s_at	111	0.117117	0.263388	-	-0.403863	0.875967	-0.0532408	0.95 [0.49 - 1.85]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203566_s_at	90	0.111111	0.0112817	0.17673	-1.02377	0.905089	0.0290127	1.03 [0.64 - 1.66]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203566_s_at	90	0.111111	0.058739	-	-0.90445	0.713405	-0.111123	0.89 [0.49 - 1.62]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4053	50	0.68	0.117263	-	0.754314	0.588667	0.198515	1.22 [0.59 - 2.50]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203566_s_at	138	0.847826	0.265294	-	-0.395762	0.792514	-0.0440168	0.96 [0.69 - 1.33]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203566_s_at	129	0.844961	0.00164942	0.0386534	-1.94079	0.06335	-0.668187	0.51 [0.25 - 1.04]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30884	56	0.321429	0.0359531	0.399258	0.892667	0.373843	0.243551	1.28 [0.75 - 2.18]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6223	56	0.160714	0.0630059	-	1.08497	0.769235	0.0776987	1.08 [0.64 - 1.82]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23897	56	0.428571	0.270193	-	0.402784	0.639827	0.13561	1.15 [0.65 - 2.02]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6223	56	0.160714	0.153384	-	0.84525	0.72323	0.102489	1.11 [0.63 - 1.95]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30884	56	0.25	0.0474218	0.475916	0.89274	0.709373	0.0990767	1.10 [0.66 - 1.86]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23897	56	0.107143	0.171783	-	1.2984	0.777008	0.0757264	1.08 [0.64 - 1.82]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203566_s_at	278	0.507194	0.231856	-	-0.232324	0.562327	-0.090606	0.91 [0.67 - 1.24]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203566_s_at	133	0.428571	0.000157959	0.00523131	-0.885935	0.00165602	-0.353388	0.70 [0.56 - 0.88]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15344	81	0.888889	0.00033017	0.0099239	1.79643	0.0147832	1.1193	3.06 [1.25 - 7.53]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203566_s_at	185	0.713513	0.00560618	0.10353	0.508533	0.715299	0.0533704	1.05 [0.79 - 1.41]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203566_s_at	185	0.713513	0.0290386	0.346598	0.380898	0.72327	0.0481116	1.05 [0.80 - 1.37]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P200298	110	0.863636	0.295199	-	-0.369505	0.812613	-0.0489091	0.95 [0.64 - 1.43]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P200298	110	0.418182	0.106296	-	0.525067	0.413757	0.217388	1.24 [0.74 - 2.09]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203566_s_at	80	0.7625	0.194866	-	-0.799172	0.644121	-0.190867	0.83 [0.37 - 1.86]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_4993	281	0.185053	0.0172902	0.241569	0.455958	0.491521	0.0527409	1.05 [0.91 - 1.23]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203566_s_at	38	0.868421	0.0691228	-	-15.2768	0.95052	-0.0308698	0.97 [0.37 - 2.57]
GENE	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203566_s_at	140	0.464286	0.00915147	0.151002	-0.761189	0.013109	-0.587773	0.56 [0.35 - 0.88]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219792_at	30	0.7	0.175007	-	0.572046	0.584031	0.286563	1.33 [0.48 - 3.72]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1707169	165	0.175758	0.00236801	0.0519989	-0.822324	0.0560842	-0.417433	0.66 [0.43 - 1.01]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1707169	165	0.109091	0.00197651	0.0448582	-1.19448	0.71376	-0.112853	0.89 [0.49 - 1.63]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219792_at	163	0.546012	0.150332	-	-0.287862	0.452982	-0.506843	0.60 [0.16 - 2.26]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222930_s_at	163	0.546012	0.21649	-	0.244224	0.989239	0.00943346	1.01 [0.26 - 3.98]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219792_at	79	0.455696	0.0173961	0.242629	0.711758	0.101086	1.3809	3.98 [0.76 - 20.73]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222930_s_at	79	0.607595	0.0187414	0.255884	-0.768183	0.230781	-0.699655	0.50 [0.16 - 1.56]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219792_at	58	0.896552	0.071018	-	0.795138	0.136533	0.376876	1.46 [0.89 - 2.39]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219792_at	34	0.264706	0.146518	-	-0.636869	0.886685	-0.0474227	0.95 [0.50 - 1.83]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219792_at	158	0.272152	0.0683101	-	0.534256	0.250612	0.911005	2.49 [0.53 - 11.77]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219792_at	53	0.339623	0.090285	-	0.717768	0.969365	-0.00996806	0.99 [0.60 - 1.65]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219792_at	53	0.320755	0.152562	-	0.571459	0.923834	-0.0226324	0.98 [0.61 - 1.55]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219792_at	180	0.444444	0.00197005	0.0447378	0.673136	0.178163	0.292742	1.34 [0.88 - 2.05]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222930_s_at	180	0.355556	0.0709424	-	0.404678	0.243349	0.262136	1.30 [0.84 - 2.02]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219792_at	559	0.313059	0.035041	0.392622	0.572419	0.219499	0.220058	1.25 [0.88 - 1.77]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222930_s_at	559	0.443649	0.00891082	0.147981	0.543852	0.16199	0.145327	1.16 [0.94 - 1.42]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219792_at	77	0.454545	0.0450752	0.461168	0.514048	0.145324	0.451176	1.57 [0.86 - 2.88]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222930_s_at	77	0.168831	0.0441259	0.455074	0.788245	0.432444	0.18565	1.20 [0.76 - 1.91]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222930_s_at	70	0.885714	0.243447	-	-0.541464	0.942805	-0.0454354	0.96 [0.28 - 3.31]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219792_at	70	0.214286	0.0415447	0.438113	-0.641803	0.374777	-0.86835	0.42 [0.06 - 2.86]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219792_at	74	0.486486	0.0169061	0.237704	0.697122	0.407377	0.406615	1.50 [0.57 - 3.93]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222930_s_at	74	0.256757	0.0791283	-	0.670651	0.236545	0.367701	1.44 [0.79 - 2.66]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222930_s_at	67	0.41791	0.016593	0.234526	-1.71194	0.381753	-2.09587	0.12 [0.00 - 13.47]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219792_at	67	0.104478	0.112144	-	-1.2055	0.462421	-2.04749	0.13 [0.00 - 30.37]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222930_s_at	115	0.895652	0.0166849	0.235461	1.3237	0.244577	0.837365	2.31 [0.56 - 9.47]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219792_at	115	0.66087	0.0116866	0.181432	1.31219	0.518148	0.658993	1.93 [0.26 - 14.26]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222930_s_at	204	0.137255	0.0916106	-	0.334747	0.161983	0.137277	1.15 [0.95 - 1.39]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219792_at	204	0.818627	0.00184879	0.0424636	-0.570276	0.231171	-0.129607	0.88 [0.71 - 1.09]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219792_at	87	0.137931	0.118693	-	1.45768	0.3937	0.75099	2.12 [0.38 - 11.90]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222930_s_at	87	0.137931	0.115758	-	-0.711689	0.2631	-0.724755	0.48 [0.14 - 1.72]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222930_s_at	87	0.137931	0.115758	-	-0.711689	0.2631	-0.724755	0.48 [0.14 - 1.72]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219792_at	87	0.137931	0.118693	-	1.45768	0.3937	0.75099	2.12 [0.38 - 11.90]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219792_at	77	0.87013	0.0835668	-	1.13293	0.579129	0.810594	2.25 [0.13 - 39.45]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222930_s_at	77	0.402597	0.111234	-	-0.880139	0.836057	0.194868	1.22 [0.19 - 7.69]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222930_s_at	77	0.402597	0.0531697	-	-1.2514	0.927203	0.098343	1.10 [0.13 - 9.10]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219792_at	77	0.662338	0.019405	0.262283	1.25175	0.231471	1.52061	4.58 [0.38 - 55.22]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219792_at	136	0.713235	0.0112584	0.176458	1.0868	0.612442	0.146742	1.16 [0.66 - 2.04]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219792_at	200	0.455	0.0117733	0.182431	0.804827	0.169836	0.486687	1.63 [0.81 - 3.26]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219792_at	286	0.493007	0.0700539	-	0.352629	0.7093	0.0790463	1.08 [0.71 - 1.64]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219792_at	159	0.641509	0.069749	-	-0.809264	0.832963	-0.120777	0.89 [0.29 - 2.72]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219792_at	159	0.855346	0.229116	-	0.471206	0.522351	0.330873	1.39 [0.51 - 3.84]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219792_at	159	0.383648	0.13135	-	-0.474166	0.295835	-0.487692	0.61 [0.25 - 1.53]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222930_s_at	159	0.465409	0.234232	-	-0.375948	0.986561	-0.00424846	1.00 [0.61 - 1.63]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222930_s_at	159	0.798742	0.053439	-	0.655174	0.240453	0.317338	1.37 [0.81 - 2.33]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222930_s_at	159	0.106918	0.19246	-	1.24455	0.443511	0.23826	1.27 [0.69 - 2.33]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219792_at	54	0.648148	0.0202841	0.270626	-15.7843	0.333865	-1.14119	0.32 [0.03 - 3.23]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219792_at	117	0.794872	0.208237	-	0.460884	0.810219	-0.164067	0.85 [0.22 - 3.24]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219792_at	117	0.794872	0.193577	-	0.538825	0.827469	0.158891	1.17 [0.28 - 4.89]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219792_at	117	0.393162	0.169253	-	-0.534601	0.924773	0.0733266	1.08 [0.23 - 4.93]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219792_at	117	0.794872	0.208237	-	0.460884	0.810219	-0.164067	0.85 [0.22 - 3.24]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219792_at	236	0.224576	0.109747	-	-0.462794	0.632902	-0.205761	0.81 [0.35 - 1.89]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222930_s_at	236	0.470339	0.160375	-	0.384459	0.842095	0.0538647	1.06 [0.62 - 1.79]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219792_at	249	0.228916	0.0232154	0.297421	-0.512507	0.315893	-0.336563	0.71 [0.37 - 1.38]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222930_s_at	249	0.180723	0.0292836	0.348562	0.715789	0.502757	0.13404	1.14 [0.77 - 1.69]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219792_at	62	0.725806	0.277197	-	-0.619115	0.57534	-0.158002	0.85 [0.49 - 1.48]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219792_at	125	0.232	0.0337767	0.383275	-0.802028	0.255974	-0.862959	0.42 [0.10 - 1.87]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219792_at	125	0.496	0.111322	-	-0.497865	0.334409	-0.572096	0.56 [0.18 - 1.80]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219792_at	54	0.37037	0.162022	-	1.04054	0.679218	-0.14115	0.87 [0.44 - 1.70]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219792_at	198	0.823232	0.0824285	-	0.500343	0.793441	0.0392537	1.04 [0.78 - 1.40]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219792_at	198	0.858586	0.114314	-	0.509491	0.896577	-0.0193362	0.98 [0.73 - 1.31]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219792_at	198	0.530303	0.0485592	0.482908	-0.419652	0.0627516	-0.208495	0.81 [0.65 - 1.01]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219792_at	51	0.176471	0.166244	-	-1.19269	0.602385	-0.941154	0.39 [0.01 - 13.46]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219792_at	62	0.822581	0.399332	-	-0.854371	0.954244	-0.0658312	0.94 [0.10 - 8.87]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222930_s_at	177	0.440678	0.000339679	0.0101698	-0.978089	0.00154369	-0.719343	0.49 [0.31 - 0.76]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219792_at	177	0.847458	0.0407907	0.433048	-1.15159	0.792885	-0.20033	0.82 [0.18 - 3.65]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222930_s_at	177	0.457627	0.000421498	0.0122429	-0.832873	0.00327515	-0.581278	0.56 [0.38 - 0.82]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219792_at	177	0.836158	0.28002	-	-0.38325	0.590297	-0.356147	0.70 [0.19 - 2.56]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222930_s_at	145	0.427586	3.9424e-05	0.00153418	-1.41543	0.000881045	-0.94153	0.39 [0.22 - 0.68]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219792_at	145	0.710345	0.0290771	0.346906	-1.00899	0.674752	-0.379481	0.68 [0.12 - 4.03]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222930_s_at	226	0.318584	2.03055e-07	1.24245e-05	-1.40494	1.71193e-05	-0.732309	0.48 [0.34 - 0.67]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219792_at	226	0.252212	0.0671487	-	0.731872	0.635054	0.128084	1.14 [0.67 - 1.93]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219792_at	55	0.2	0.0255062	0.317364	-1.01327	0.460568	-0.704036	0.49 [0.08 - 3.21]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222930_s_at	55	0.890909	0.0508789	-	1.1112	0.45334	0.354066	1.42 [0.56 - 3.59]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219792_at	55	0.6	0.0246382	0.309904	-1.3258	0.247489	-1.16062	0.31 [0.04 - 2.24]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222930_s_at	49	0.183673	0.015413	0.222348	-1.41287	0.404703	-0.544319	0.58 [0.16 - 2.09]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219792_at	49	0.183673	0.00943052	0.154474	-1.41217	0.471699	-0.826533	0.44 [0.05 - 4.16]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222930_s_at	55	0.872727	0.00780927	0.133814	1.3007	0.689603	0.184918	1.20 [0.49 - 2.98]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222930_s_at	63	0.111111	0.000303012	0.00921538	-1.43857	0.44799	-1.15675	0.31 [0.02 - 6.24]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219792_at	63	0.15873	0.00105926	0.0267452	-1.22605	0.3536	-0.785064	0.46 [0.09 - 2.40]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13376094_3p_at	28	0.75	0.0131448	0.197924	-2.2067	0.0814862	-2.6639	0.07 [0.00 - 1.40]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13477244_3p_a_at	28	0.607143	0.19986	-	-0.753611	0.358171	-2.82855	0.06 [0.00 - 24.66]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219792_at	82	0.768293	0.06395	-	0.666591	0.299574	0.74648	2.11 [0.51 - 8.64]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219792_at	79	0.835443	0.0554118	-	-0.771673	0.385857	-0.460638	0.63 [0.22 - 1.79]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219792_at	104	0.875	0.0388739	0.419931	0.807313	0.189086	1.05174	2.86 [0.60 - 13.75]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P936171	117	0.111111	0.0752876	-	-0.676405	0.955664	-0.00831162	0.99 [0.74 - 1.33]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P103720	117	0.230769	0.00841103	0.141624	1.17685	0.0554003	0.198394	1.22 [1.00 - 1.49]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222930_s_at	204	0.867647	0.000732431	0.0196042	1.26752	0.450402	0.277807	1.32 [0.64 - 2.72]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219792_at	204	0.887255	0.0345475	0.388994	-15.2261	0.259996	-0.527306	0.59 [0.24 - 1.48]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222930_s_at	204	0.862745	1.04568e-06	5.67015e-05	1.36443	2.37414e-05	1.10189	3.01 [1.81 - 5.02]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219792_at	204	0.892157	0.0433976	0.450347	-1.35127	0.351155	-0.325495	0.72 [0.36 - 1.43]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219792_at	178	0.61236	0.263236	-	0.226711	0.455956	0.296729	1.35 [0.62 - 2.94]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300002853	41	0.853659	0.00732424	0.127386	1.29852	0.17426	0.352843	1.42 [0.86 - 2.37]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222930_s_at	111	0.846847	0.00109948	0.0275925	1.02685	0.263421	0.223456	1.25 [0.85 - 1.85]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219792_at	111	0.495495	0.0782883	-	-0.462698	0.740109	0.0993322	1.10 [0.61 - 1.99]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219792_at	90	0.522222	0.160901	-	-0.461842	0.82138	-0.155504	0.86 [0.22 - 3.30]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219792_at	90	0.277778	0.13724	-	0.7155	0.953306	-0.0460947	0.95 [0.20 - 4.47]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222930_s_at	138	0.898551	0.0157367	0.225722	-1.56892	0.035698	-1.14864	0.32 [0.11 - 0.93]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219792_at	138	0.115942	0.011781	0.182519	-0.762919	0.822103	-0.133877	0.87 [0.27 - 2.81]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219792_at	129	0.364341	0.00590847	0.107863	0.772947	0.0987793	0.644858	1.91 [0.89 - 4.10]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10434	56	0.892857	0.00698097	0.122761	1.17806	0.17803	0.260226	1.30 [0.89 - 1.89]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35044	56	0.25	0.0800279	-	0.830173	0.399164	0.168822	1.18 [0.80 - 1.75]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10434	56	0.892857	0.0102496	0.164482	1.22647	0.347943	0.186005	1.20 [0.82 - 1.78]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35044	56	0.803571	0.0958126	-	0.696982	0.374867	0.190396	1.21 [0.79 - 1.84]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222930_s_at	278	0.888489	0.231276	-	-0.413906	0.490782	-0.150539	0.86 [0.56 - 1.32]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219792_at	278	0.780576	0.0149432	0.217402	-0.652991	0.076439	-0.728711	0.48 [0.22 - 1.08]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219792_at	133	0.548872	0.00134545	0.0326516	0.75051	0.00891428	2.10833	8.23 [1.70 - 39.98]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219792_at	185	0.708108	0.0706017	-	0.322789	0.639269	0.108662	1.11 [0.71 - 1.76]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219792_at	185	0.708108	0.0454363	0.463467	0.382743	0.386685	0.217378	1.24 [0.76 - 2.03]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P103720	110	0.527273	0.0967472	-	0.385965	0.391813	0.111375	1.12 [0.87 - 1.44]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P936171	110	0.363636	0.108368	-	0.56584	0.346168	0.220559	1.25 [0.79 - 1.97]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P103720	110	0.363636	0.0112998	0.176941	0.953543	0.0746078	0.295108	1.34 [0.97 - 1.86]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P936171	110	0.109091	0.0351469	0.393396	-0.674474	0.828966	0.0410924	1.04 [0.72 - 1.51]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219792_at	80	0.3125	0.108039	-	0.816561	0.298367	0.271513	1.31 [0.79 - 2.19]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219792_at	38	0.710526	0.00698544	0.122821	1.17225	0.138792	1.12887	3.09 [0.69 - 13.78]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222930_s_at	38	0.894737	0.000284631	0.00873022	2.01467	0.106683	0.373717	1.45 [0.92 - 2.29]
GENE	AGMAT	agmatine ureohydrolase (agmatinase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219792_at	140	0.828571	0.0185965	0.254474	0.732403	0.418709	0.792913	2.21 [0.32 - 15.10]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215535_s_at	30	0.7	0.0964336	-	0.724446	0.361686	0.836286	2.31 [0.38 - 13.92]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	32836_at	30	0.666667	0.0193477	0.261733	0.989741	0.141684	1.3976	4.05 [0.63 - 26.09]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1779109	165	0.218182	0.0138304	0.205455	-0.638553	0.266982	-0.48659	0.61 [0.26 - 1.45]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1779109	165	0.290909	0.119811	-	-0.555875	0.700742	-0.251422	0.78 [0.22 - 2.80]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215535_s_at	163	0.883436	0.131435	-	-0.521041	0.640057	-0.110117	0.90 [0.56 - 1.42]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	32836_at	163	0.392638	0.10569	-	-0.32034	0.972882	-0.0082282	0.99 [0.62 - 1.59]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215535_s_at	79	0.139241	0.111433	-	0.810606	0.4271	0.235262	1.27 [0.71 - 2.26]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	32836_at	79	0.78481	0.014156	0.208986	0.786618	0.0358926	0.716154	2.05 [1.05 - 4.00]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	32836_at	58	0.896552	0.223184	-	-0.574948	0.273027	-0.492094	0.61 [0.25 - 1.47]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215535_s_at	58	0.896552	0.0660273	-	-0.87085	0.468959	-0.217774	0.80 [0.45 - 1.45]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	32836_at	34	0.823529	0.0556252	-	-1.1712	0.507089	-0.400299	0.67 [0.21 - 2.19]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215535_s_at	34	0.735294	0.0555702	-	-0.956472	0.729321	0.0898459	1.09 [0.66 - 1.82]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	32836_at	158	0.772152	0.0516384	-	-0.62381	0.663739	-0.1824	0.83 [0.37 - 1.90]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215535_s_at	158	0.348101	0.188966	-	-0.316854	0.806987	0.101511	1.11 [0.49 - 2.50]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215535_s_at	53	0.867925	0.0467314	0.471623	-1.78231	0.317457	-0.601196	0.55 [0.17 - 1.78]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	32836_at	53	0.264151	0.0692923	-	-0.683428	0.245372	-0.847847	0.43 [0.10 - 1.79]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215535_s_at	53	0.886792	0.0429897	0.44768	-1.80487	0.347732	-0.528737	0.59 [0.20 - 1.78]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	32836_at	53	0.566038	0.106835	-	-0.576279	0.30124	-0.685226	0.50 [0.14 - 1.85]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215535_s_at	180	0.222222	0.0298205	0.35284	-0.51422	0.204863	-0.324605	0.72 [0.44 - 1.19]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	32836_at	180	0.166667	0.111227	-	-0.408318	0.766784	-0.105608	0.90 [0.45 - 1.81]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215535_s_at	559	0.815742	0.036888	0.405969	0.484802	0.425918	0.250237	1.28 [0.69 - 2.38]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	32836_at	559	0.286225	0.0102	0.163884	0.68787	0.0878084	0.538476	1.71 [0.92 - 3.18]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	32836_at	77	0.246753	0.0229263	0.294845	-0.65684	0.252504	-0.454656	0.63 [0.29 - 1.38]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215535_s_at	77	0.376623	0.0130435	0.1968	-0.646007	0.198641	-0.462022	0.63 [0.31 - 1.27]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	32836_at	70	0.585714	0.189365	-	-0.358717	0.672407	0.238581	1.27 [0.42 - 3.84]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215535_s_at	70	0.485714	0.175173	-	-0.360831	0.583367	0.257905	1.29 [0.51 - 3.25]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32836_at	50	0.42	0.0304244	0.357608	0.783204	0.327213	0.219184	1.25 [0.80 - 1.93]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215535_s_at	74	0.135135	0.066906	-	-0.671496	0.769426	-0.215604	0.81 [0.19 - 3.41]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	32836_at	74	0.378378	0.00543185	0.101002	-0.809698	0.0199835	-1.73603	0.18 [0.04 - 0.76]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	32836_at	67	0.283582	0.0147861	0.215735	-1.51993	0.82648	0.478091	1.61 [0.02 - 115.89]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215535_s_at	67	0.895522	0.0113719	0.177782	1.61538	0.20153	2.12899	8.41 [0.32 - 220.56]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	32836_at	115	0.895652	0.152125	-	0.905435	0.296118	1.43475	4.20 [0.28 - 61.95]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215535_s_at	115	0.4	0.0410232	0.434615	1.43554	0.360623	0.93939	2.56 [0.34 - 19.17]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32836_at	158	0.759494	0.0679065	-	-0.737688	0.102584	-0.976759	0.38 [0.12 - 1.22]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32836_at	76	0.25	0.0216221	0.283046	-1.1305	0.236969	-1.3519	0.26 [0.03 - 2.43]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215535_s_at	204	0.882353	0.0235006	0.29995	-0.486829	0.138079	-0.285037	0.75 [0.52 - 1.10]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	32836_at	204	0.892157	0.00704877	0.12368	-0.598665	0.0114727	-0.557617	0.57 [0.37 - 0.88]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	32836_at	87	0.252874	0.178239	-	0.712584	0.684432	0.244632	1.28 [0.39 - 4.16]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215535_s_at	87	0.275862	0.339647	-	0.468396	0.742629	0.166941	1.18 [0.44 - 3.20]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215535_s_at	87	0.275862	0.339647	-	0.468396	0.742629	0.166941	1.18 [0.44 - 3.20]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	32836_at	87	0.252874	0.178239	-	0.712584	0.684432	0.244632	1.28 [0.39 - 4.16]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	32836_at	77	0.194805	0.0785444	-	-1.08291	0.633352	-0.463412	0.63 [0.09 - 4.22]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215535_s_at	77	0.74026	0.13247	-	-1.4387	0.566823	-0.409594	0.66 [0.16 - 2.70]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215535_s_at	77	0.246753	0.240329	-	-0.741163	0.719884	-0.293407	0.75 [0.15 - 3.71]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	32836_at	77	0.272727	0.0183148	0.251722	-1.23321	0.411959	-0.706726	0.49 [0.09 - 2.67]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215535_s_at	136	0.860294	0.149796	-	0.811788	0.833538	0.112375	1.12 [0.39 - 3.19]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	32836_at	136	0.897059	0.158061	-	0.883463	0.968813	-0.0188684	0.98 [0.38 - 2.53]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215535_s_at	200	0.885	0.0287836	0.344544	0.795545	0.0853449	1.00854	2.74 [0.87 - 8.65]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	32836_at	200	0.895	0.00181028	0.0417346	1.07508	0.126166	1.14242	3.13 [0.72 - 13.55]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4579	60	0.216667	0.0142848	0.210374	1.62133	0.170978	0.510286	1.67 [0.80 - 3.46]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4579	60	0.666667	0.00163522	0.0383784	1.15106	0.047373	0.896767	2.45 [1.01 - 5.95]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14302	155	0.696774	0.00772769	0.132741	0.728979	0.289837	0.163808	1.18 [0.87 - 1.60]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215535_s_at	286	0.202797	0.0102593	0.164599	-0.547546	0.131843	-0.449858	0.64 [0.36 - 1.14]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	32836_at	286	0.307692	0.05145	-	-0.387068	0.172571	-0.493793	0.61 [0.30 - 1.24]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215535_s_at	159	0.886792	0.0482802	0.481202	0.762985	0.759159	0.167421	1.18 [0.41 - 3.45]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	32836_at	159	0.899371	0.00674435	0.119534	1.11737	0.0938989	1.43584	4.20 [0.78 - 22.55]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	32836_at	159	0.654088	0.0484906	0.482489	0.615444	0.354877	0.695377	2.00 [0.46 - 8.75]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215535_s_at	159	0.886792	0.00829315	0.140107	0.964747	0.562582	0.313939	1.37 [0.47 - 3.96]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215535_s_at	159	0.886792	0.0027696	0.0590521	1.17595	0.233996	0.738427	2.09 [0.62 - 7.06]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	32836_at	159	0.886792	0.0558182	-	0.73988	0.313135	0.757421	2.13 [0.49 - 9.29]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215535_s_at	54	0.111111	0.230106	-	-0.94593	0.832635	-0.126857	0.88 [0.27 - 2.86]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	32836_at	54	0.777778	0.00530454	0.0991424	1.7936	0.312164	0.98939	2.69 [0.39 - 18.32]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32836_at	117	0.777778	0.153876	-	0.488202	0.877654	0.0668909	1.07 [0.46 - 2.51]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32836_at	117	0.162393	0.111765	-	-0.682212	0.942323	0.0381494	1.04 [0.37 - 2.92]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32836_at	117	0.162393	0.093773	-	-0.731115	0.866929	-0.0973967	0.91 [0.29 - 2.83]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32836_at	117	0.777778	0.153876	-	0.488202	0.877654	0.0668909	1.07 [0.46 - 2.51]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215535_s_at	117	0.179487	0.102489	-	-0.588472	0.650173	-0.146522	0.86 [0.46 - 1.63]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215535_s_at	117	0.17094	0.0527241	-	-0.790916	0.682819	-0.157644	0.85 [0.40 - 1.82]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215535_s_at	117	0.17094	0.0922298	-	-0.738519	0.644606	-0.193107	0.82 [0.36 - 1.87]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215535_s_at	117	0.179487	0.102489	-	-0.588472	0.650173	-0.146522	0.86 [0.46 - 1.63]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215535_s_at	236	0.788136	0.000326492	0.00982851	0.96177	0.0580684	1.12589	3.08 [0.96 - 9.88]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	32836_at	236	0.677966	0.0100971	0.162638	0.682558	0.0594336	1.4209	4.14 [0.95 - 18.14]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	32836_at	249	0.385542	0.0016366	0.0384052	0.756239	0.0331682	1.22722	3.41 [1.10 - 10.55]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215535_s_at	249	0.807229	0.0015293	0.0363114	0.734272	0.00297071	1.35276	3.87 [1.58 - 9.44]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32836_at	62	0.887097	0.196608	-	0.729911	0.910503	-0.0199496	0.98 [0.69 - 1.39]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215535_s_at	125	0.288	0.258304	-	0.400433	0.790753	0.119112	1.13 [0.47 - 2.72]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32836_at	125	0.888	0.153668	-	0.647928	0.203306	0.833167	2.30 [0.64 - 8.30]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215535_s_at	54	0.185185	0.188774	-	15.2864	0.966133	0.0108089	1.01 [0.61 - 1.66]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32836_at	125	0.44	0.346276	-	0.284525	0.840527	0.102795	1.11 [0.41 - 3.02]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32836_at	54	0.259259	0.0854945	-	15.4008	0.954058	-0.0124968	0.99 [0.65 - 1.51]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215535_s_at	62	0.887097	0.196608	-	0.729911	0.973325	-0.006936	0.99 [0.66 - 1.49]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215535_s_at	125	0.616	0.159643	-	0.53118	0.289614	0.60983	1.84 [0.60 - 5.69]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	32836_at	198	0.156566	0.00748571	0.129539	1.45502	0.28982	0.342217	1.41 [0.75 - 2.65]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	32836_at	198	0.176768	0.017929	0.247926	1.16458	0.517281	0.220665	1.25 [0.64 - 2.43]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215535_s_at	198	0.722222	0.0373909	0.409542	-0.532397	0.933799	-0.0157494	0.98 [0.68 - 1.43]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	32836_at	198	0.116162	0.029877	0.353288	0.96799	0.954748	0.0147081	1.01 [0.61 - 1.69]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215535_s_at	198	0.717172	0.156155	-	-0.440419	0.932635	-0.0201794	0.98 [0.61 - 1.56]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215535_s_at	198	0.717172	0.158664	-	-0.455602	0.713649	-0.0927137	0.91 [0.56 - 1.50]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215535_s_at	62	0.193548	0.0974464	-	-0.978736	0.643704	-0.487082	0.61 [0.08 - 4.84]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	32836_at	51	0.647059	0.448583	-	-0.823827	0.85586	-0.423664	0.65 [0.01 - 63.29]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	32836_at	62	0.854839	0.196855	-	0.838286	0.955453	-0.0820334	0.92 [0.05 - 16.38]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215535_s_at	51	0.568627	0.282158	-	-1.13994	0.405866	-1.38807	0.25 [0.01 - 6.59]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	32836_at	177	0.875706	0.000849437	0.0222178	1.00634	0.00397598	1.4239	4.15 [1.58 - 10.95]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215535_s_at	177	0.112994	0.0308756	0.361141	1.2004	0.0394189	0.889063	2.43 [1.04 - 5.67]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215535_s_at	177	0.841808	0.0101607	0.163409	0.778916	0.0192152	1.1838	3.27 [1.21 - 8.80]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	32836_at	177	0.158192	0.00759173	0.130946	1.17102	0.013655	1.05808	2.88 [1.24 - 6.68]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215535_s_at	145	0.537931	0.00696741	0.122577	0.926349	0.0133266	1.55623	4.74 [1.38 - 16.26]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	32836_at	145	0.455172	0.00117143	0.0290933	1.22769	0.0216425	1.46739	4.34 [1.24 - 15.18]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215535_s_at	226	0.548673	0.0255891	0.31807	0.631665	0.178762	0.574981	1.78 [0.77 - 4.11]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	32836_at	226	0.676991	0.00183617	0.0422251	0.863174	0.0422861	0.897728	2.45 [1.03 - 5.84]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215535_s_at	55	0.109091	0.117668	-	-0.854508	0.618337	-0.413139	0.66 [0.13 - 3.36]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	32836_at	55	0.854545	0.234781	-	0.654305	0.68	0.336367	1.40 [0.28 - 6.92]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	32836_at	55	0.854545	0.100981	-	0.932055	0.51225	0.626733	1.87 [0.29 - 12.20]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	32836_at	49	0.612245	0.211877	-	-0.811148	0.341504	-0.869804	0.42 [0.07 - 2.52]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215535_s_at	55	0.163636	0.0716263	-	-0.960166	0.721812	-0.352239	0.70 [0.10 - 4.89]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215535_s_at	49	0.795918	0.0683308	-	-15.4074	0.176442	-1.25719	0.28 [0.05 - 1.76]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215535_s_at	63	0.793651	0.17629	-	-0.600031	0.952979	-0.0110501	0.99 [0.68 - 1.43]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	32836_at	63	0.349206	0.0924151	-	-0.575754	0.839004	0.0372989	1.04 [0.72 - 1.49]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	215535_3p_s_at	28	0.178571	0.127884	-	-1.01767	0.270056	-1.22524	0.29 [0.03 - 2.59]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.240534.2.S1_3p_s_at	28	0.107143	3.31259e-08	2.28297e-06	-3.87837	0.920601	-0.0765488	0.93 [0.21 - 4.17]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215535_s_at	82	0.890244	0.0208418	0.275843	0.967948	0.124456	0.919866	2.51 [0.78 - 8.11]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	32836_at	82	0.743902	0.0556575	-	0.68864	0.159986	1.36085	3.90 [0.58 - 26.03]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32836_at	84	0.178571	0.127803	-	-0.538523	0.80401	-0.168749	0.84 [0.22 - 3.20]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215535_s_at	79	0.316456	0.0261454	0.322784	-0.600102	0.493427	-0.324134	0.72 [0.29 - 1.83]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	32836_at	79	0.21519	0.0988844	-	-0.491687	0.206605	-0.965971	0.38 [0.09 - 1.70]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U56417_at	86	0.162791	0.0012913	0.0315548	-1.32966	0.0105666	-1.95418	0.14 [0.03 - 0.63]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215535_s_at	104	0.201923	0.0340117	0.385026	-0.727349	0.188845	-0.801126	0.45 [0.14 - 1.48]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	32836_at	104	0.230769	0.0185125	0.253655	-0.791903	0.176944	-1.24714	0.29 [0.05 - 1.76]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P258093	117	0.897436	0.0984195	-	0.66353	0.244835	0.404174	1.50 [0.76 - 2.96]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	32836_at	204	0.362745	0.0670287	-	0.561519	0.498123	0.458395	1.58 [0.42 - 5.96]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215535_s_at	204	0.480392	0.0725193	-	0.682418	0.3099	0.745265	2.11 [0.50 - 8.88]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215535_s_at	204	0.235294	0.080662	-	0.657458	0.443691	0.421632	1.52 [0.52 - 4.48]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	32836_at	204	0.215686	0.169868	-	0.722133	0.546471	0.538109	1.71 [0.30 - 9.85]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215535_s_at	178	0.168539	0.103468	-	-0.396045	0.583887	-0.184083	0.83 [0.43 - 1.61]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	32836_at	178	0.561798	0.145328	-	0.290255	0.955766	-0.0272716	0.97 [0.37 - 2.55]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300021275	41	0.439024	0.0727689	-	0.80026	0.51261	0.236371	1.27 [0.62 - 2.57]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215535_s_at	111	0.297297	0.0416457	0.438788	0.649983	0.174796	0.681245	1.98 [0.74 - 5.29]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	32836_at	111	0.882883	0.00278254	0.0592751	0.939143	0.246825	0.602004	1.83 [0.66 - 5.06]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215535_s_at	90	0.8	0.00111137	0.0278418	1.06919	0.149157	0.744625	2.11 [0.77 - 5.79]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215535_s_at	90	0.855556	0.000706772	0.0190212	1.28147	0.204769	0.754587	2.13 [0.66 - 6.83]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	32836_at	90	0.7	0.00951975	0.155578	0.826622	0.699379	0.23826	1.27 [0.38 - 4.25]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	32836_at	90	0.888889	0.0193251	0.261517	1.02905	0.723829	0.250684	1.28 [0.32 - 5.16]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2002	50	0.26	0.305815	-	0.640624	0.907332	0.0567599	1.06 [0.41 - 2.75]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215535_s_at	138	0.23913	0.00957344	0.15624	0.898169	0.495343	0.0908203	1.10 [0.84 - 1.42]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	32836_at	138	0.115942	0.00658782	0.117381	1.72831	0.265732	0.151918	1.16 [0.89 - 1.52]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215535_s_at	129	0.860465	0.0279042	0.337398	0.700071	0.763327	0.121958	1.13 [0.51 - 2.50]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	32836_at	129	0.790698	0.0800057	-	0.493897	0.663904	0.236713	1.27 [0.44 - 3.69]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11451	56	0.446429	0.186337	-	0.451056	0.650015	0.186741	1.21 [0.54 - 2.70]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11451	56	0.160714	0.115484	-	-0.6579	0.786866	-0.117617	0.89 [0.38 - 2.09]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	32836_at	278	0.622302	0.113225	-	0.299874	0.320528	0.240412	1.27 [0.79 - 2.04]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215535_s_at	278	0.629496	0.0715126	-	0.341537	0.259629	0.246374	1.28 [0.83 - 1.96]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	32836_at	133	0.669173	0.0241144	0.305346	0.540804	0.179085	0.188481	1.21 [0.92 - 1.59]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215535_s_at	133	0.676692	0.00098578	0.0251808	0.787772	0.0242095	0.401638	1.49 [1.05 - 2.12]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7018	81	0.17284	0.102998	-	-0.878124	0.459341	-0.434556	0.65 [0.20 - 2.05]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	32836_at	185	0.32973	0.210741	-	-0.215986	0.691849	-0.0894998	0.91 [0.59 - 1.42]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215535_s_at	185	0.524324	0.146113	-	-0.258217	0.444217	-0.168111	0.85 [0.55 - 1.30]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215535_s_at	185	0.427027	0.171655	-	-0.224351	0.476141	-0.143483	0.87 [0.58 - 1.29]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	32836_at	185	0.32973	0.239389	-	-0.218981	0.677854	-0.102751	0.90 [0.56 - 1.47]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258093	110	0.890909	0.0875536	-	0.555586	0.627224	0.101284	1.11 [0.74 - 1.67]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258093	110	0.890909	0.15247	-	0.576281	0.975181	0.00840362	1.01 [0.59 - 1.71]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215535_s_at	80	0.1375	0.110689	-	1.49857	0.150926	0.652988	1.92 [0.79 - 4.68]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	32836_at	80	0.5625	0.225676	-	-0.556481	0.933487	0.052835	1.05 [0.30 - 3.65]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	32836_at	38	0.289474	0.108301	-	0.973757	0.297929	0.383487	1.47 [0.71 - 3.02]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215535_s_at	38	0.289474	0.0541065	-	1.15529	0.157003	0.532315	1.70 [0.81 - 3.56]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215535_s_at	140	0.421429	0.0118199	0.182968	0.75648	0.060375	0.776941	2.17 [0.97 - 4.89]
GENE	AGPAT1	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	32836_at	140	0.335714	0.00134507	0.0326439	1.10113	0.00107243	1.40876	4.09 [1.76 - 9.52]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210678_s_at	30	0.533333	0.298028	-	0.420586	0.674742	0.215712	1.24 [0.45 - 3.40]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	32837_at	30	0.433333	0.1704	-	0.554378	0.536958	0.33864	1.40 [0.48 - 4.11]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1732176	165	0.793939	0.0026008	0.0561181	-1.14233	0.21813	-0.184831	0.83 [0.62 - 1.12]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1732176	165	0.581818	0.0239186	0.303631	-0.892787	0.131148	-0.342316	0.71 [0.46 - 1.11]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210678_s_at	163	0.392638	0.141787	-	0.303256	0.356589	0.360188	1.43 [0.67 - 3.08]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	32837_at	163	0.220859	0.0955948	-	0.429381	0.0605326	0.804706	2.24 [0.96 - 5.18]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210678_s_at	79	0.101266	0.0781682	-	-0.712696	0.816459	-0.156831	0.85 [0.23 - 3.21]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	32837_at	79	0.405063	0.0468205	0.47218	0.616673	0.283307	0.533064	1.70 [0.64 - 4.51]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	32837_at	58	0.396552	0.00892796	0.148197	0.756844	0.0986161	0.504666	1.66 [0.91 - 3.01]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210678_s_at	58	0.5	0.0018559	0.0425978	0.894971	0.162334	0.217987	1.24 [0.92 - 1.69]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	32837_at	34	0.117647	0.00197556	0.0448404	-1.66185	0.119502	-0.695058	0.50 [0.21 - 1.20]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210678_s_at	34	0.852941	0.0332184	0.379091	-1.48466	0.194953	-0.292751	0.75 [0.48 - 1.16]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	32837_at	158	0.120253	0.0810401	-	-0.543662	0.5895	-0.405558	0.67 [0.15 - 2.91]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210678_s_at	158	0.626582	0.00601533	0.10938	0.626548	0.112861	0.655334	1.93 [0.86 - 4.33]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210678_s_at	53	0.113208	0.00708576	0.12418	-1.26621	0.920309	-0.0276659	0.97 [0.57 - 1.67]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	32837_at	53	0.226415	0.00672503	0.119269	1.75627	0.0460543	1.6669	5.30 [1.03 - 27.24]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210678_s_at	53	0.113208	0.0200176	0.268112	-1.09794	0.885433	-0.0366071	0.96 [0.59 - 1.59]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	32837_at	53	0.226415	0.0282513	0.340231	1.11574	0.201707	0.941294	2.56 [0.60 - 10.87]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210678_s_at	180	0.294444	0.13125	-	-0.330359	0.745913	-0.0306494	0.97 [0.81 - 1.17]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	32837_at	180	0.894444	0.0456104	0.464571	0.557896	0.231876	0.465867	1.59 [0.74 - 3.42]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210678_s_at	559	0.100179	0.0301947	0.3558	-0.599334	0.522121	-0.0836131	0.92 [0.71 - 1.19]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	32837_at	559	0.100179	0.0830968	-	-0.512362	0.374834	-0.227057	0.80 [0.48 - 1.32]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	32837_at	77	0.896104	1.97725e-05	0.000826704	1.57132	0.0227278	0.904561	2.47 [1.13 - 5.38]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210678_s_at	77	0.363636	0.338383	-	0.254799	0.871403	0.029969	1.03 [0.72 - 1.48]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210678_s_at	70	0.142857	0.0240049	0.304387	-0.80662	0.685661	0.234204	1.26 [0.41 - 3.93]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	32837_at	70	0.5	0.258603	-	0.295632	0.935741	0.0584931	1.06 [0.26 - 4.40]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32837_at	50	0.48	0.357943	-	0.329824	0.396984	0.530608	1.70 [0.50 - 5.80]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210678_s_at	74	0.891892	0.000415656	0.0120972	1.32949	0.123482	0.309775	1.36 [0.92 - 2.02]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	32837_at	74	0.878378	0.0599025	-	0.770474	0.416552	0.506772	1.66 [0.49 - 5.64]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210678_s_at	67	0.895522	1.14971e-05	0.000506925	2.85297	0.0497798	3.47459	32.28 [1.00 - 1038.89]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	32837_at	67	0.731343	2.14568e-06	0.000109814	2.85596	0.0052133	6.86804	961.06 [7.76 - 118985.72]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210678_s_at	115	0.66087	0.0990838	-	-1.18956	0.878879	0.0885608	1.09 [0.35 - 3.41]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	32837_at	115	0.730435	0.0769627	-	-1.64417	0.982049	-0.0149632	0.99 [0.27 - 3.63]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32837_at	158	0.879747	0.000467941	0.0133897	1.10848	0.0845009	0.828174	2.29 [0.89 - 5.87]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32837_at	76	0.776316	0.00266437	0.057228	1.45006	0.227989	0.888184	2.43 [0.57 - 10.30]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	32837_at	204	0.705882	0.0822152	-	0.277348	0.803446	0.0378146	1.04 [0.77 - 1.40]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210678_s_at	204	0.52451	0.114613	-	0.224997	0.385598	0.122157	1.13 [0.86 - 1.49]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	32837_at	87	0.781609	0.0324042	0.372926	0.844569	0.240528	0.662161	1.94 [0.64 - 5.86]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210678_s_at	87	0.16092	0.190457	-	0.92747	0.66571	0.207802	1.23 [0.48 - 3.16]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210678_s_at	87	0.16092	0.190457	-	0.92747	0.66571	0.207802	1.23 [0.48 - 3.16]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	32837_at	87	0.781609	0.0324042	0.372926	0.844569	0.240528	0.662161	1.94 [0.64 - 5.86]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	32837_at	77	0.415584	0.00962909	0.156925	-1.79609	0.647399	-0.354511	0.70 [0.15 - 3.20]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210678_s_at	77	0.155844	0.107542	-	-0.93334	0.954609	-0.0395101	0.96 [0.25 - 3.75]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210678_s_at	77	0.155844	0.245053	-	-0.782323	0.977094	0.0225845	1.02 [0.22 - 4.78]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	32837_at	77	0.220779	0.115692	-	-0.869881	0.84484	-0.129282	0.88 [0.24 - 3.21]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210678_s_at	136	0.419118	0.101723	-	0.89881	0.334643	0.287943	1.33 [0.74 - 2.39]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	32837_at	136	0.139706	5.60809e-06	0.000264242	-1.90417	0.162299	-1.18573	0.31 [0.06 - 1.61]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210678_s_at	200	0.79	0.00674532	0.119547	0.837632	0.0556023	0.637377	1.89 [0.98 - 3.63]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	32837_at	200	0.85	0.104591	-	0.574243	0.758841	0.134786	1.14 [0.48 - 2.71]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4822	60	0.766667	0.0891367	-	0.664946	0.999011	-0.000387979	1.00 [0.54 - 1.85]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4822	60	0.6	0.0227846	0.293577	-0.970686	0.646662	-0.303302	0.74 [0.20 - 2.70]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	8826	155	0.122581	0.109072	-	-0.546154	0.975563	0.00556627	1.01 [0.70 - 1.44]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210678_s_at	286	0.104895	0.059477	-	-0.522061	0.439299	-0.0931917	0.91 [0.72 - 1.15]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	32837_at	286	0.856643	0.121761	-	-0.488255	0.242437	-0.322008	0.72 [0.42 - 1.24]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210678_s_at	159	0.616352	0.0118716	0.183562	0.780247	0.210456	0.291328	1.34 [0.85 - 2.11]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	32837_at	159	0.761006	0.0123124	0.188592	0.912355	0.0559255	1.12929	3.09 [0.97 - 9.85]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	32837_at	159	0.748428	0.00294379	0.0620363	0.919362	0.047329	1.00456	2.73 [1.01 - 7.37]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210678_s_at	159	0.641509	0.029565	0.350809	0.675411	0.293772	0.23863	1.27 [0.81 - 1.98]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210678_s_at	159	0.716981	0.00692825	0.122045	0.966149	0.173899	0.386438	1.47 [0.84 - 2.57]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	32837_at	159	0.842767	0.0126474	0.192373	0.857597	0.163603	0.720218	2.05 [0.75 - 5.66]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	32837_at	54	0.148148	0.327858	-	-0.781634	0.908105	0.0847591	1.09 [0.26 - 4.59]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210678_s_at	54	0.796296	0.316077	-	0.71695	0.760865	0.240378	1.27 [0.27 - 5.98]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32837_at	117	0.17094	0.0125206	0.190946	1.6445	0.754007	0.0729163	1.08 [0.68 - 1.70]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32837_at	117	0.17094	0.0101144	0.162848	15.3437	0.68002	0.115763	1.12 [0.65 - 1.95]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32837_at	117	0.598291	0.0874509	-	0.66149	0.879366	0.0455305	1.05 [0.58 - 1.88]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	32837_at	117	0.17094	0.0125206	0.190946	1.6445	0.754007	0.0729163	1.08 [0.68 - 1.70]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210678_s_at	117	0.239316	0.191696	-	0.570222	0.790588	-0.072158	0.93 [0.55 - 1.58]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210678_s_at	117	0.239316	0.246784	-	0.615095	0.960854	0.0159597	1.02 [0.54 - 1.92]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210678_s_at	117	0.854701	0.210817	-	0.580799	0.885782	0.0485253	1.05 [0.54 - 2.04]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210678_s_at	117	0.239316	0.191696	-	0.570222	0.790588	-0.072158	0.93 [0.55 - 1.58]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210678_s_at	236	0.38983	0.168797	-	0.399177	0.461926	0.122145	1.13 [0.82 - 1.56]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	32837_at	236	0.580508	0.0202912	0.270693	0.619232	0.202214	0.552807	1.74 [0.74 - 4.07]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	32837_at	249	0.51004	0.0813242	-	0.370957	0.261823	0.406231	1.50 [0.74 - 3.05]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210678_s_at	249	0.385542	0.286219	-	0.238211	0.831295	0.026701	1.03 [0.80 - 1.31]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32837_at	62	0.225806	0.0372749	0.40872	-1.03	0.369116	-0.239768	0.79 [0.47 - 1.33]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210678_s_at	125	0.4	0.181222	-	0.412205	0.9491	-0.018662	0.98 [0.55 - 1.74]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32837_at	125	0.784	0.129228	-	0.604853	0.961851	0.0202863	1.02 [0.44 - 2.34]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210678_s_at	54	0.555556	0.0944516	-	1.0702	0.755354	0.22642	1.25 [0.30 - 5.21]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32837_at	125	0.16	0.255221	-	0.530715	0.757969	-0.105735	0.90 [0.46 - 1.76]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	32837_at	54	0.796296	0.114014	-	-1.52657	0.602232	-0.165754	0.85 [0.45 - 1.58]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210678_s_at	62	0.790323	0.0447709	0.459223	-1.42228	0.514208	-0.389288	0.68 [0.21 - 2.18]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210678_s_at	125	0.808	0.135851	-	0.614226	0.72794	0.122752	1.13 [0.57 - 2.26]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	32837_at	198	0.343434	0.152714	-	0.404552	0.48237	0.171112	1.19 [0.74 - 1.91]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	32837_at	198	0.343434	0.251554	-	0.337805	0.800216	0.0649898	1.07 [0.65 - 1.77]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210678_s_at	198	0.878788	0.172137	-	0.395505	0.497323	0.100508	1.11 [0.83 - 1.48]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	32837_at	198	0.545455	0.189353	-	-0.282791	0.993374	-0.00167773	1.00 [0.67 - 1.48]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210678_s_at	198	0.818182	0.0471084	0.473972	0.572071	0.142862	0.280653	1.32 [0.91 - 1.93]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210678_s_at	198	0.818182	0.0892376	-	0.519804	0.331415	0.193679	1.21 [0.82 - 1.79]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210678_s_at	62	0.16129	0.054285	-	-1.12144	0.798455	0.18482	1.20 [0.29 - 4.97]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	32837_at	51	0.294118	0.0954196	-	-1.40532	0.553074	-0.724749	0.48 [0.04 - 5.31]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	32837_at	62	0.645161	0.192422	-	0.737392	0.551442	0.414734	1.51 [0.39 - 5.93]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210678_s_at	51	0.156863	0.000991678	0.0253072	-2.41123	0.374168	-1.07472	0.34 [0.03 - 3.65]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	32837_at	177	0.570621	0.181217	-	0.361997	0.862376	-0.0629551	0.94 [0.46 - 1.91]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210678_s_at	177	0.259887	0.199171	-	0.370596	0.829543	-0.0714454	0.93 [0.49 - 1.78]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210678_s_at	177	0.107345	0.111118	-	-0.606107	0.774781	-0.109208	0.90 [0.42 - 1.89]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	32837_at	177	0.819209	0.248559	-	-0.408644	0.813593	-0.0745999	0.93 [0.50 - 1.73]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210678_s_at	145	0.103448	0.119385	-	-0.68731	0.4503	-0.37691	0.69 [0.26 - 1.83]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	32837_at	145	0.103448	0.0179196	0.247833	-0.919034	0.765394	-0.142959	0.87 [0.34 - 2.22]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210678_s_at	226	0.10177	0.330318	-	0.572995	0.60112	0.133962	1.14 [0.69 - 1.89]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	32837_at	226	0.89823	0.082551	-	0.699574	0.874156	-0.0492525	0.95 [0.52 - 1.75]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	32837_at	55	0.454545	0.0294252	0.349694	-0.982916	0.0922871	-0.611585	0.54 [0.27 - 1.11]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	32837_at	55	0.454545	0.154205	-	-0.694777	0.429611	-0.41538	0.66 [0.24 - 1.85]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	32837_at	49	0.408163	0.0998273	-	-0.932901	0.133572	-0.649001	0.52 [0.22 - 1.22]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210678_s_at	55	0.4	0.113691	-	0.871834	0.967404	-0.0230585	0.98 [0.32 - 2.95]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210678_s_at	49	0.795918	0.0497793	0.490298	-15.4645	0.391345	-0.54062	0.58 [0.17 - 2.00]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210678_s_at	55	0.127273	0.0581604	-	-0.945825	0.229973	-0.57166	0.56 [0.22 - 1.44]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210678_s_at	63	0.539683	0.183052	-	-0.456291	0.612203	-0.10571	0.90 [0.60 - 1.35]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	32837_at	63	0.444444	0.106657	-	-0.541984	0.683864	-0.0546207	0.95 [0.73 - 1.23]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g2155239_3p_s_at	28	0.25	0.0472353	0.47476	1.81075	0.42842	0.501054	1.65 [0.48 - 5.70]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	210678_3p_s_at	28	0.535714	0.178118	-	-0.735944	0.724676	-0.368408	0.69 [0.09 - 5.37]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g2155239_3p_a_at	28	0.821429	0.00504232	0.0952725	1.59614	0.127479	0.568655	1.77 [0.85 - 3.67]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210678_s_at	82	0.219512	0.00927818	0.152583	-0.922932	0.535462	-0.187875	0.83 [0.46 - 1.50]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	32837_at	82	0.207317	0.00181933	0.0419063	-1.06738	0.316243	-0.375373	0.69 [0.33 - 1.43]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32837_at	84	0.119048	0.034424	0.388083	-0.807287	0.245191	-0.441787	0.64 [0.31 - 1.35]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210678_s_at	79	0.822785	0.0188677	0.257109	-0.97397	0.0604632	-0.461131	0.63 [0.39 - 1.02]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	32837_at	79	0.177215	0.00297372	0.0625448	-0.913697	0.0724647	-0.5094	0.60 [0.34 - 1.05]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U56418_at	86	0.348837	0.045218	0.462078	-0.798775	0.531864	-0.261156	0.77 [0.34 - 1.75]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210678_s_at	104	0.288462	0.045807	0.465815	0.93282	0.400511	0.264817	1.30 [0.70 - 2.42]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	32837_at	104	0.259615	0.116454	-	0.742822	0.496546	0.250523	1.28 [0.62 - 2.65]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P26103	117	0.162393	0.0956104	-	-0.563445	0.21762	-0.198082	0.82 [0.60 - 1.12]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210678_s_at	204	0.142157	0.00595556	0.108533	2.26229	0.0205604	0.731365	2.08 [1.12 - 3.86]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	32837_at	204	0.779412	0.0335947	0.381915	0.785916	0.263191	0.494333	1.64 [0.69 - 3.90]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	32837_at	204	0.897059	0.000151709	0.00504981	1.17719	0.0280816	0.728364	2.07 [1.08 - 3.97]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210678_s_at	204	0.161765	0.046559	0.470545	1.78016	0.100218	0.689657	1.99 [0.88 - 4.54]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210678_s_at	178	0.876405	0.030969	0.361869	-0.775878	0.499762	-0.127539	0.88 [0.61 - 1.27]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	32837_at	178	0.870786	0.0133681	0.200392	-0.883375	0.286561	-0.242991	0.78 [0.50 - 1.23]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300010729	41	0.390244	0.00169401	0.0395136	-1.2583	0.0632937	-0.257577	0.77 [0.59 - 1.01]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	32837_at	111	0.288288	0.0846094	-	-0.480352	0.918713	0.0303367	1.03 [0.58 - 1.85]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210678_s_at	111	0.387387	0.0415626	0.438233	0.580201	0.707579	0.087441	1.09 [0.69 - 1.72]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210678_s_at	90	0.722222	0.0501977	-	0.65423	0.414371	0.263694	1.30 [0.69 - 2.45]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210678_s_at	90	0.722222	0.0364964	0.403168	0.772794	0.155248	0.474364	1.61 [0.84 - 3.09]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	32837_at	90	0.888889	0.0958601	-	0.730836	0.201716	0.453089	1.57 [0.78 - 3.15]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	32837_at	90	0.888889	0.113318	-	0.76288	0.0956898	0.612944	1.85 [0.90 - 3.80]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	32837_at	138	0.5	0.0026892	0.0576599	0.738476	0.0495469	0.260865	1.30 [1.00 - 1.68]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210678_s_at	138	0.311594	0.00844633	0.142076	0.770206	0.0149778	0.41275	1.51 [1.08 - 2.11]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210678_s_at	129	0.883721	0.10144	-	-0.937096	0.872418	-0.0309694	0.97 [0.66 - 1.41]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	32837_at	129	0.899225	0.0719185	-	-1.21546	0.679874	-0.159429	0.85 [0.40 - 1.82]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21322	56	0.178571	0.0267221	0.327624	1.12624	0.291835	0.259278	1.30 [0.80 - 2.10]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1480	56	0.446429	0.012976	0.196049	0.880013	0.193787	0.317216	1.37 [0.85 - 2.22]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21322	56	0.178571	0.0141037	0.20842	1.38659	0.162144	0.37077	1.45 [0.86 - 2.44]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1480	56	0.446429	0.0086102	0.144171	0.97364	0.0907404	0.459282	1.58 [0.93 - 2.70]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	32837_at	278	0.794964	0.0039502	0.0785343	-0.804343	0.0116859	-0.440129	0.64 [0.46 - 0.91]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210678_s_at	278	0.784173	0.00157387	0.0371846	-0.851948	0.0136952	-0.401932	0.67 [0.49 - 0.92]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	32837_at	133	0.684211	0.0458299	0.46596	-0.533095	0.470867	-0.0761218	0.93 [0.75 - 1.14]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210678_s_at	133	0.75188	0.0370769	0.407314	-0.63723	0.441015	-0.175609	0.84 [0.54 - 1.31]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17932	81	0.530864	0.125728	-	0.830663	0.265848	0.369762	1.45 [0.75 - 2.78]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2713	81	0.888889	0.00154642	0.0366473	1.77504	0.0251536	1.15018	3.16 [1.15 - 8.65]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210678_s_at	185	0.891892	0.068548	-	-0.482849	0.165622	-0.19878	0.82 [0.62 - 1.09]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	32837_at	185	0.891892	0.187874	-	-0.377276	0.36137	-0.162539	0.85 [0.60 - 1.21]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210678_s_at	185	0.475676	0.106756	-	-0.286524	0.252737	-0.178609	0.84 [0.62 - 1.14]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	32837_at	185	0.843243	0.104021	-	-0.364433	0.277009	-0.177055	0.84 [0.61 - 1.15]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P26103	110	0.554545	0.0880601	-	-0.518487	0.458974	-0.0803781	0.92 [0.75 - 1.14]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P26103	110	0.754545	0.261591	-	0.295637	0.74089	-0.0333	0.97 [0.79 - 1.18]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210678_s_at	80	0.1375	0.0266701	0.32719	-1.03908	0.386783	-0.151929	0.86 [0.61 - 1.21]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	32837_at	80	0.8625	0.0128142	0.194243	1.22876	0.584228	0.244037	1.28 [0.53 - 3.06]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3057	281	0.480427	0.0854608	-	0.241619	0.750595	-0.029403	0.97 [0.81 - 1.16]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	32837_at	38	0.710526	0.0775844	-	0.838922	0.216884	0.571803	1.77 [0.71 - 4.39]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210678_s_at	38	0.368421	0.0243763	0.30763	1.21209	0.0649756	0.924729	2.52 [0.94 - 6.73]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210678_s_at	140	0.585714	1.50724e-05	0.000647392	-1.59828	0.000178809	-0.771386	0.46 [0.31 - 0.69]
GENE	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	32837_at	140	0.257143	9.68455e-07	5.28291e-05	-1.32599	4.1891e-05	-0.871826	0.42 [0.28 - 0.63]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219723_x_at	30	0.333333	0.111709	-	0.71067	0.735004	0.24012	1.27 [0.32 - 5.11]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1661373	165	0.10303	0.222185	-	0.619599	0.819255	-0.0910463	0.91 [0.42 - 1.99]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1678548	165	0.157576	0.0602906	-	0.734556	0.625735	-0.123274	0.88 [0.54 - 1.45]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1661373	165	0.806061	0.0379066	0.413179	0.773079	0.409517	0.44758	1.56 [0.54 - 4.53]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1678548	165	0.157576	0.0830002	-	1.19424	0.899991	0.0474084	1.05 [0.50 - 2.20]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219723_x_at	163	0.134969	0.0439713	0.454074	-0.519806	0.180134	-0.723568	0.49 [0.17 - 1.40]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	224282_s_at	163	0.760736	0.0625752	-	-0.461577	0.883387	0.0698984	1.07 [0.42 - 2.73]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	223183_at	163	0.202454	0.197019	-	-0.300222	0.71741	-0.0771829	0.93 [0.61 - 1.41]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225440_at	163	0.840491	0.0710463	-	-0.548627	0.548327	-0.0829195	0.92 [0.70 - 1.21]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	223184_s_at	163	0.858896	0.149835	-	-0.455628	0.359056	-0.201577	0.82 [0.53 - 1.26]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	223182_s_at	163	0.822086	0.0354602	0.395683	-0.615876	0.128439	-0.38308	0.68 [0.42 - 1.12]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	223182_s_at	79	0.64557	0.0404522	0.430756	-0.677718	0.219825	-0.324314	0.72 [0.43 - 1.21]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	224282_s_at	79	0.151899	0.145025	-	-0.535132	0.444549	-0.450501	0.64 [0.20 - 2.02]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	223183_at	79	0.101266	0.000769328	0.0204361	-1.28838	0.187419	-0.324388	0.72 [0.45 - 1.17]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	223184_s_at	79	0.101266	0.0201026	0.268916	-0.935557	0.125345	-0.390383	0.68 [0.41 - 1.11]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225440_at	79	0.113924	0.0151631	0.219724	-0.933206	0.0705231	-0.297886	0.74 [0.54 - 1.03]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219723_x_at	79	0.329114	0.0030043	0.0630632	-0.850663	0.204696	-0.548793	0.58 [0.25 - 1.35]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219723_x_at	58	0.534483	0.166183	-	0.38376	0.69449	-0.0767931	0.93 [0.63 - 1.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219723_x_at	34	0.235294	0.143265	-	0.709747	0.613586	0.208578	1.23 [0.55 - 2.77]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219723_x_at	158	0.240506	0.0376471	0.411352	-0.525922	0.87378	0.0802016	1.08 [0.40 - 2.91]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219723_x_at	53	0.113208	0.00479786	0.0916158	-1.26841	0.588116	-0.342479	0.71 [0.21 - 2.45]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219723_x_at	53	0.113208	6.02105e-05	0.00223635	-1.83978	0.48158	-0.499424	0.61 [0.15 - 2.44]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219723_x_at	180	0.105556	0.00545407	0.101326	-0.792801	0.46925	-0.128833	0.88 [0.62 - 1.25]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	223183_at	180	0.894444	0.390379	-	0.288025	0.797806	0.0783246	1.08 [0.59 - 1.97]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225440_at	180	0.155556	0.242584	-	-0.315204	0.518306	-0.152103	0.86 [0.54 - 1.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	223184_s_at	180	0.883333	0.00106892	0.0269492	0.936218	0.780717	0.101582	1.11 [0.54 - 2.26]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	223182_s_at	180	0.805556	0.0295106	0.350375	0.522348	0.52972	0.122832	1.13 [0.77 - 1.66]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	224282_s_at	180	0.538889	0.106253	-	-0.347719	0.244649	-0.193687	0.82 [0.59 - 1.14]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	223182_s_at	559	0.155635	0.0739921	-	0.51173	0.934882	0.00826975	1.01 [0.83 - 1.23]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	224282_s_at	559	0.604651	0.0625871	-	0.372244	0.377036	0.110274	1.12 [0.87 - 1.43]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	223183_at	559	0.520572	0.0692769	-	-0.366925	0.534887	-0.169395	0.84 [0.49 - 1.44]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	223184_s_at	559	0.416816	0.0530752	-	-0.385401	0.558154	-0.146222	0.86 [0.53 - 1.41]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225440_at	559	0.899821	0.142845	-	0.510218	0.974991	0.00380749	1.00 [0.79 - 1.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219723_x_at	559	0.255814	0.110761	-	0.383933	0.29572	0.123017	1.13 [0.90 - 1.42]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219723_x_at	77	0.246753	0.0562386	-	-0.546654	0.223369	-0.274815	0.76 [0.49 - 1.18]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	223183_at	77	0.337662	0.00853233	0.143177	-0.714017	0.0445897	-0.680877	0.51 [0.26 - 0.98]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225440_at	77	0.701299	0.0948215	-	0.454362	0.888598	-0.0267144	0.97 [0.67 - 1.41]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	223184_s_at	77	0.74026	0.0191408	0.259746	-0.772882	0.218018	-0.418531	0.66 [0.34 - 1.28]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	223182_s_at	77	0.61039	0.021836	0.285001	-0.634618	0.188007	-0.212517	0.81 [0.59 - 1.11]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	224282_s_at	77	0.103896	0.0165204	0.233788	-0.90343	0.0872327	-0.336057	0.71 [0.49 - 1.05]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	223182_s_at	70	0.128571	0.138156	-	0.680848	0.857921	0.0326053	1.03 [0.72 - 1.48]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	224282_s_at	70	0.471429	0.0324273	0.373102	-0.577761	0.415196	-0.611456	0.54 [0.12 - 2.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	223183_at	70	0.471429	0.145729	-	-0.385447	0.629403	-0.144131	0.87 [0.48 - 1.55]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	223184_s_at	70	0.214286	0.299737	-	0.360637	0.674627	0.143595	1.15 [0.59 - 2.26]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225440_at	70	0.557143	0.0327577	0.375613	0.556822	0.367617	0.307753	1.36 [0.70 - 2.66]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219723_x_at	70	0.3	0.0837946	-	-0.486155	0.744582	-0.284995	0.75 [0.14 - 4.18]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38303_at	50	0.78	0.313814	-	0.372237	0.684344	0.256681	1.29 [0.38 - 4.46]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219723_x_at	74	0.797297	0.0838197	-	0.573739	0.302213	-0.338751	0.71 [0.37 - 1.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	223184_s_at	74	0.608108	0.0985382	-	0.475077	0.266663	0.582886	1.79 [0.64 - 5.01]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	223182_s_at	74	0.567568	0.0218957	0.285545	0.657531	0.0430854	0.709142	2.03 [1.02 - 4.04]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	224282_s_at	74	0.135135	0.107732	-	-0.592917	0.433039	-0.130373	0.88 [0.63 - 1.22]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	223183_at	74	0.878378	0.0166496	0.235103	0.873049	0.709158	0.154801	1.17 [0.52 - 2.63]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225440_at	74	0.824324	0.00879897	0.146568	0.880132	0.740103	0.135178	1.14 [0.52 - 2.54]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	223184_s_at	67	0.731343	0.000328306	0.00987559	2.15449	0.0462134	1.99976	7.39 [1.03 - 52.77]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	223182_s_at	67	0.626866	0.183902	-	0.869483	0.654069	0.416666	1.52 [0.25 - 9.38]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	223183_at	67	0.731343	0.0121539	0.18679	1.53669	0.221328	1.30697	3.69 [0.45 - 30.01]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219723_x_at	67	0.820895	0.136804	-	-15.3744	0.864733	0.276176	1.32 [0.05 - 31.62]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225440_at	67	0.776119	0.00156305	0.0369732	1.86909	0.0428342	2.19816	9.01 [1.07 - 75.60]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	224282_s_at	67	0.492537	0.0389925	0.420754	1.5213	0.223295	1.66024	5.26 [0.36 - 76.12]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	223184_s_at	115	0.852174	0.108075	-	0.914168	0.529929	0.517507	1.68 [0.33 - 8.43]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	223182_s_at	115	0.834783	0.031649	0.367139	1.13237	0.706567	0.215348	1.24 [0.40 - 3.81]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	223183_at	115	0.695652	0.00250508	0.0544349	1.53423	0.0650138	1.64487	5.18 [0.90 - 29.73]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	224282_s_at	115	0.843478	0.00297308	0.0625339	1.46991	0.20318	0.717992	2.05 [0.68 - 6.20]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225440_at	115	0.878261	0.032184	0.371246	1.19784	0.76024	0.233805	1.26 [0.28 - 5.67]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219723_x_at	115	0.878261	0.0345883	0.389296	1.18309	0.370367	0.715696	2.05 [0.43 - 9.79]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38303_at	158	0.689873	0.120562	-	0.443756	0.501932	-0.160251	0.85 [0.53 - 1.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38303_at	76	0.644737	0.201024	-	-0.805295	0.259111	-0.45597	0.63 [0.29 - 1.40]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	223184_s_at	204	0.147059	0.00254771	0.0551863	-0.599554	0.0640801	-0.438576	0.64 [0.41 - 1.03]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	223182_s_at	204	0.308824	0.0013605	0.0329548	-0.49247	0.1015	-0.280117	0.76 [0.54 - 1.06]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	223183_at	204	0.421569	0.026931	0.329366	-0.311768	0.198594	-0.225071	0.80 [0.57 - 1.13]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219723_x_at	204	0.857843	0.0270619	0.330453	-0.445139	0.0332383	-0.332398	0.72 [0.53 - 0.97]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225440_at	204	0.107843	0.00281297	0.0597991	-0.684659	0.0802618	-0.255613	0.77 [0.58 - 1.03]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	224282_s_at	204	0.568627	0.0118328	0.183116	-0.359488	0.137061	-0.0919601	0.91 [0.81 - 1.03]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	223184_s_at	87	0.114943	0.160987	-	-0.679442	0.619455	-0.2476	0.78 [0.29 - 2.07]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	223182_s_at	87	0.827586	0.158627	-	0.646142	0.733901	0.121357	1.13 [0.56 - 2.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	223182_s_at	87	0.827586	0.158627	-	0.646142	0.733901	0.121357	1.13 [0.56 - 2.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	224282_s_at	87	0.574713	0.0636635	-	0.6953	0.831715	-0.118246	0.89 [0.30 - 2.64]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	223183_at	87	0.16092	0.00380476	0.0762206	-1.11459	0.30153	-0.418345	0.66 [0.30 - 1.46]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	223183_at	87	0.16092	0.00380476	0.0762206	-1.11459	0.30153	-0.418345	0.66 [0.30 - 1.46]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	223184_s_at	87	0.114943	0.160987	-	-0.679442	0.619455	-0.2476	0.78 [0.29 - 2.07]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	224282_s_at	87	0.574713	0.0636635	-	0.6953	0.831715	-0.118246	0.89 [0.30 - 2.64]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225440_at	87	0.321839	0.185062	-	-0.501245	0.48672	-0.354488	0.70 [0.26 - 1.90]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225440_at	87	0.321839	0.185062	-	-0.501245	0.48672	-0.354488	0.70 [0.26 - 1.90]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219723_x_at	87	0.149425	0.159216	-	0.99351	0.974135	0.0232756	1.02 [0.25 - 4.18]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219723_x_at	87	0.149425	0.159216	-	0.99351	0.974135	0.0232756	1.02 [0.25 - 4.18]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219723_x_at	77	0.311688	0.191051	-	-0.805177	0.722337	-0.371157	0.69 [0.09 - 5.34]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	223182_s_at	77	0.116883	0.171334	-	15.2161	0.561475	0.32008	1.38 [0.47 - 4.06]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	224282_s_at	77	0.792208	0.045793	0.465727	1.09792	0.531273	0.542848	1.72 [0.31 - 9.42]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	223183_at	77	0.25974	0.0430603	0.448142	-1.07792	0.144398	-0.762676	0.47 [0.17 - 1.30]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	223184_s_at	77	0.168831	0.0561275	-	-1.10347	0.489725	-0.386221	0.68 [0.23 - 2.03]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225440_at	77	0.324675	0.0695689	-	-0.97276	0.980099	0.0159866	1.02 [0.29 - 3.57]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	223184_s_at	77	0.662338	0.0892155	-	-1.61237	0.574547	-0.356021	0.70 [0.20 - 2.43]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	223182_s_at	77	0.311688	0.14232	-	1.42349	0.688128	0.250263	1.28 [0.38 - 4.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	223183_at	77	0.675325	0.0227367	0.293147	-15.6913	0.156426	-0.823303	0.44 [0.14 - 1.37]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219723_x_at	77	0.116883	0.159392	-	15.2297	0.948091	0.0577206	1.06 [0.19 - 6.02]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	224282_s_at	77	0.896104	0.223163	-	0.931349	0.63598	0.470651	1.60 [0.23 - 11.24]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225440_at	77	0.324675	0.0473836	0.47568	-1.2087	0.869155	-0.119456	0.89 [0.21 - 3.68]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219723_x_at	136	0.132353	0.00172113	0.0400345	-1.38263	0.194468	-0.435896	0.65 [0.33 - 1.25]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219723_x_at	200	0.865	0.0254166	0.316599	0.784867	0.724101	0.172285	1.19 [0.46 - 3.09]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21452	60	0.25	0.0724055	-	-0.726804	0.855494	0.0696714	1.07 [0.51 - 2.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12270	60	0.85	0.0347405	0.390416	0.899198	0.511822	0.192339	1.21 [0.68 - 2.15]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12270	60	0.866667	0.0834519	-	0.781583	0.466387	0.261509	1.30 [0.64 - 2.63]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21452	60	0.516667	0.00185586	0.042597	1.2256	0.0129331	1.45771	4.30 [1.36 - 13.56]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3984	155	0.258065	3.43915e-08	2.36468e-06	-1.4281	2.13174e-05	-0.333645	0.72 [0.61 - 0.84]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219723_x_at	286	0.188811	0.0147198	0.21503	0.730284	0.584719	0.12223	1.13 [0.73 - 1.75]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219723_x_at	159	0.333333	0.256098	-	0.411648	0.891463	0.0748731	1.08 [0.37 - 3.16]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219723_x_at	159	0.886792	0.223475	-	0.590445	0.895419	0.0867839	1.09 [0.30 - 3.98]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219723_x_at	159	0.886792	0.131364	-	0.618712	0.737634	-0.184611	0.83 [0.28 - 2.45]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223182_s_at	159	0.408805	0.090147	-	-0.530804	0.671697	0.128341	1.14 [0.63 - 2.06]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223184_s_at	159	0.106918	0.0612819	-	-0.834057	0.400744	-0.442787	0.64 [0.23 - 1.80]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223182_s_at	159	0.880503	0.0236321	0.30111	0.867395	0.642401	-0.12386	0.88 [0.52 - 1.49]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224282_s_at	159	0.27673	0.171567	-	0.534583	0.997173	-0.000731201	1.00 [0.67 - 1.50]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223182_s_at	159	0.402516	0.034438	0.388186	-0.778522	0.894182	-0.0429721	0.96 [0.51 - 1.80]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224282_s_at	159	0.899371	0.0210983	0.278223	0.885305	0.519877	0.134675	1.14 [0.76 - 1.72]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223183_at	159	0.899371	0.0141024	0.208406	0.936945	0.259642	0.546964	1.73 [0.67 - 4.47]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224282_s_at	159	0.465409	0.189861	-	-0.489606	0.572874	-0.136241	0.87 [0.54 - 1.40]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223183_at	159	0.899371	0.0060952	0.110509	1.03885	0.114039	0.785473	2.19 [0.83 - 5.81]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225440_at	159	0.647799	0.0265135	0.32588	0.688616	0.198706	0.324412	1.38 [0.84 - 2.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223183_at	159	0.880503	0.00341014	0.0698285	1.15373	0.26183	0.642715	1.90 [0.62 - 5.84]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225440_at	159	0.647799	0.0452902	0.462538	0.62405	0.432766	0.191311	1.21 [0.75 - 1.95]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223184_s_at	159	0.886792	0.0568274	-	0.736721	0.484779	-0.321679	0.72 [0.29 - 1.79]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225440_at	159	0.496855	0.0275455	0.334453	0.859081	0.322741	0.290487	1.34 [0.75 - 2.38]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223184_s_at	159	0.880503	0.0060648	0.11008	0.998069	0.540024	-0.288287	0.75 [0.30 - 1.88]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219723_x_at	54	0.666667	0.0859538	-	-15.5312	0.30713	-1.03241	0.36 [0.05 - 2.58]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219723_x_at	117	0.735043	0.13035	-	-0.5904	0.440977	-0.347153	0.71 [0.29 - 1.71]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219723_x_at	117	0.735043	0.00788642	0.134825	-1.72816	0.186281	-0.761742	0.47 [0.15 - 1.44]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219723_x_at	117	0.854701	0.0623026	-	-1.69235	0.21818	-0.7634	0.47 [0.14 - 1.57]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219723_x_at	117	0.735043	0.13035	-	-0.5904	0.440977	-0.347153	0.71 [0.29 - 1.71]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219723_x_at	236	0.584746	0.00349993	0.0712982	0.777422	0.0937723	0.790632	2.20 [0.87 - 5.56]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225440_at	236	0.809322	0.0230528	0.295974	0.663969	0.608697	0.124787	1.13 [0.70 - 1.83]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	223184_s_at	236	0.20339	0.0296972	0.351861	-0.615416	0.311365	-0.44631	0.64 [0.27 - 1.52]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	223182_s_at	236	0.173729	0.0167942	0.236571	-0.697684	0.269041	-0.305954	0.74 [0.43 - 1.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	224282_s_at	236	0.822034	0.00270313	0.0579017	0.850739	0.160239	0.296917	1.35 [0.89 - 2.04]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	223183_at	236	0.635593	0.0286567	0.343519	0.583818	0.643064	0.198914	1.22 [0.53 - 2.83]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219723_x_at	249	0.594378	0.0239434	0.303849	0.475799	0.334391	0.339714	1.40 [0.70 - 2.80]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	223183_at	249	0.895582	0.00146599	0.0350618	0.878083	0.201395	0.452214	1.57 [0.79 - 3.15]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225440_at	249	0.799197	0.0182989	0.251566	0.558605	0.787587	0.0549085	1.06 [0.71 - 1.58]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	223184_s_at	249	0.895582	0.195992	-	0.415123	0.627518	0.179498	1.20 [0.58 - 2.47]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	223182_s_at	249	0.694779	0.0166333	0.234937	0.51744	0.969649	-0.0104304	0.99 [0.58 - 1.69]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	224282_s_at	249	0.7751	0.000294565	0.00899302	0.786031	0.501931	0.115625	1.12 [0.80 - 1.57]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219723_x_at	62	0.403226	0.0421	0.441812	1.41506	0.769021	-0.0507128	0.95 [0.68 - 1.33]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219723_x_at	125	0.68	0.233166	-	0.456094	0.943485	0.0629649	1.06 [0.19 - 6.07]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219723_x_at	125	0.536	0.0242883	0.306864	-0.694827	0.170747	-0.939063	0.39 [0.10 - 1.50]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219723_x_at	54	0.351852	0.0953688	-	1.58202	0.753607	-0.0661803	0.94 [0.62 - 1.41]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219723_x_at	198	0.535354	0.0374171	0.409727	0.537663	0.438921	0.167305	1.18 [0.77 - 1.81]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219723_x_at	198	0.631313	0.0325626	0.374132	0.566654	0.544635	0.131287	1.14 [0.75 - 1.74]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219723_x_at	198	0.530303	0.00652448	0.116506	0.572417	0.710121	0.0652869	1.07 [0.76 - 1.51]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219723_x_at	51	0.568627	0.0708511	-	1.77796	0.485943	1.57223	4.82 [0.06 - 401.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219723_x_at	62	0.887097	2.74975e-05	0.00111161	2.24158	0.047376	2.67375	14.49 [1.03 - 203.69]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	224282_s_at	177	0.112994	0.000831316	0.0218176	-1.0959	0.0201294	-1.0398	0.35 [0.15 - 0.85]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225440_at	177	0.237288	0.00994693	0.160815	-0.635081	0.0284576	-0.855367	0.43 [0.20 - 0.91]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225440_at	177	0.118644	0.000528717	0.0148621	-1.06203	0.00500503	-1.26373	0.28 [0.12 - 0.68]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	224282_s_at	145	0.641379	0.00292023	0.0616351	-1.33446	0.135048	-0.98118	0.37 [0.10 - 1.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	223183_at	145	0.855172	0.145949	-	-1.01459	0.645904	-0.26255	0.77 [0.25 - 2.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219723_x_at	177	0.757062	0.0224593	0.290653	-0.759683	0.132263	-0.688846	0.50 [0.20 - 1.23]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	223184_s_at	145	0.889655	0.0280316	0.338439	-15.2022	0.0923984	-0.940093	0.39 [0.13 - 1.17]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	223182_s_at	145	0.324138	0.0181664	0.250266	-0.770675	0.0302536	-0.960924	0.38 [0.16 - 0.91]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225440_at	145	0.103448	2.83836e-05	0.00114365	-1.49214	0.0043351	-1.69221	0.18 [0.06 - 0.59]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219723_x_at	145	0.510345	0.0145763	0.2135	-0.840758	0.0980995	-1.18895	0.30 [0.07 - 1.25]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	223182_s_at	177	0.864407	0.0569192	-	0.595429	0.277605	0.31508	1.37 [0.78 - 2.42]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	223184_s_at	177	0.146893	0.190007	-	0.610562	0.933979	0.0378001	1.04 [0.42 - 2.54]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	224282_s_at	177	0.112994	0.00335575	0.0689335	-0.91155	0.0590546	-0.762668	0.47 [0.21 - 1.03]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	223182_s_at	177	0.864407	0.0431081	0.448455	0.697659	0.319009	0.331722	1.39 [0.73 - 2.68]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	223183_at	177	0.135593	0.113861	-	0.666251	0.214175	0.481219	1.62 [0.76 - 3.46]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	223183_at	177	0.299435	0.0751711	-	0.59269	0.266516	0.492416	1.64 [0.69 - 3.90]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	223184_s_at	177	0.276836	0.249263	-	-0.286752	0.845687	0.0770245	1.08 [0.50 - 2.35]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219723_x_at	177	0.717514	0.00746307	0.129238	-1.03737	0.0465385	-1.00983	0.36 [0.13 - 0.98]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	223182_s_at	226	0.292035	0.00127079	0.0311369	-0.885065	0.0861943	-0.2099	0.81 [0.64 - 1.03]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	224282_s_at	226	0.10177	0.0011459	0.0285628	-1.06255	0.0440503	-0.188047	0.83 [0.69 - 1.00]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	223183_at	226	0.889381	0.177433	-	0.515513	0.968007	-0.0112772	0.99 [0.57 - 1.72]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	223184_s_at	226	0.685841	0.0312375	0.363957	-0.810123	0.176457	-0.506362	0.60 [0.29 - 1.26]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225440_at	226	0.172566	0.0010897	0.0273869	-0.943397	0.00980163	-0.556234	0.57 [0.38 - 0.87]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219723_x_at	226	0.402655	0.000127344	0.00433165	-1.07822	0.00695196	-0.5093	0.60 [0.42 - 0.87]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	223184_s_at	55	0.872727	0.0866591	-	-15.2404	0.934358	-0.0600914	0.94 [0.23 - 3.93]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	223182_s_at	55	0.636364	0.258515	-	0.537391	0.641212	0.276212	1.32 [0.41 - 4.21]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	223183_at	55	0.872727	0.0686899	-	1.10638	0.968538	0.0263114	1.03 [0.28 - 3.80]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219723_x_at	55	0.454545	0.130418	-	-0.733726	0.182242	-1.79487	0.17 [0.01 - 2.32]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	224282_s_at	55	0.545455	0.00388037	0.077426	-1.64731	0.0711664	-2.04634	0.13 [0.01 - 1.19]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225440_at	55	0.545455	0.129949	-	0.720272	0.447169	0.680729	1.98 [0.34 - 11.43]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	223184_s_at	49	0.489796	0.133387	-	0.892228	0.715653	0.317668	1.37 [0.25 - 7.59]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	223182_s_at	49	0.77551	0.239439	-	-1.16447	0.77354	0.201387	1.22 [0.31 - 4.82]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	223183_at	49	0.877551	0.0113071	0.177027	1.58788	0.625493	0.405255	1.50 [0.29 - 7.63]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219723_x_at	49	0.428571	0.020887	0.276263	-1.33567	0.0623191	-2.64705	0.07 [0.00 - 1.15]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	224282_s_at	49	0.428571	0.003694	0.0744437	-1.72757	0.093474	-2.35552	0.09 [0.01 - 1.49]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225440_at	49	0.755102	0.104523	-	-1.54179	0.859287	-0.177435	0.84 [0.12 - 5.96]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	223182_s_at	55	0.781818	0.159819	-	-1.00619	0.696744	0.211494	1.24 [0.43 - 3.58]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	224282_s_at	55	0.454545	0.00205375	0.04629	-1.39569	0.0450064	-2.04219	0.13 [0.02 - 0.96]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	223183_at	55	0.872727	0.0195225	0.263406	1.14933	0.319206	0.616061	1.85 [0.55 - 6.22]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	223184_s_at	55	0.454545	0.0250301	0.313286	1.10298	0.583547	0.365907	1.44 [0.39 - 5.33]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225440_at	55	0.872727	0.0754947	-	0.959432	0.970491	0.0304729	1.03 [0.21 - 5.18]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219723_x_at	55	0.454545	0.0202498	0.270303	-1.04577	0.0615641	-2.22296	0.11 [0.01 - 1.11]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	2385713	34	0.558824	0.0106885	0.169738	-1.26101	0.755534	-0.278244	0.76 [0.13 - 4.36]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1732719	34	0.264706	0.264384	-	0.611356	0.624212	0.393343	1.48 [0.31 - 7.15]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219723_x_at	63	0.47619	0.29855	-	-0.35131	0.642486	-0.163905	0.85 [0.42 - 1.70]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	223182_s_at	63	0.571429	0.000916763	0.0236913	1.10152	0.0543008	0.355789	1.43 [0.99 - 2.05]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	224282_s_at	63	0.714286	0.00112328	0.028091	1.07233	0.126191	0.35155	1.42 [0.91 - 2.23]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	223183_at	63	0.396825	0.011053	0.174049	0.984664	0.0221837	0.682889	1.98 [1.10 - 3.55]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	223184_s_at	63	0.746032	9.07376e-05	0.0032147	1.28128	0.00785534	0.778791	2.18 [1.23 - 3.87]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225440_at	63	0.444444	0.0544561	-	0.687872	0.130696	0.320909	1.38 [0.91 - 2.09]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11611540_3p_a_at	28	0.642857	0.210624	-	-0.802445	0.834695	1.05038	2.86 [0.00 - 55035.10]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.284123.0.S1_3p_a_at	28	0.107143	0.077039	-	15.359	0.867428	0.0549268	1.06 [0.55 - 2.01]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13278926_3p_a_at	28	0.571429	0.0628517	-	1.03646	0.412699	0.413705	1.51 [0.56 - 4.07]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.284123.0.S3_3p_at	28	0.785714	0.236777	-	0.712793	0.876931	0.0739358	1.08 [0.42 - 2.74]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.173138.0.S1_3p_at	28	0.107143	0.0754021	-	-1.43211	0.90747	-0.0518098	0.95 [0.40 - 2.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219723_x_at	82	0.439024	0.00847588	0.142455	-0.887627	0.310116	-0.667854	0.51 [0.14 - 1.86]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219723_x_at	79	0.493671	0.184562	-	-0.3476	0.509387	-0.259822	0.77 [0.36 - 1.67]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219723_x_at	104	0.240385	0.0182446	0.251033	-0.801478	0.540238	-0.454165	0.63 [0.15 - 2.72]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P344711	117	0.393162	0.00243675	0.0532245	0.971974	0.0469274	0.5466	1.73 [1.01 - 2.96]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P218743	117	0.623932	0.000267645	0.00827752	1.00946	0.052893	0.491527	1.63 [0.99 - 2.69]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P356466	117	0.769231	0.00218751	0.0487419	0.881624	0.520584	0.208894	1.23 [0.65 - 2.33]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	223184_s_at	204	0.102941	0.289721	-	-0.51694	0.940067	-0.0427701	0.96 [0.31 - 2.92]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	223182_s_at	204	0.759804	0.271639	-	0.423013	0.691337	0.21939	1.25 [0.42 - 3.68]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	223183_at	204	0.102941	0.268349	-	-0.539233	0.49674	-0.328492	0.72 [0.28 - 1.86]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219723_x_at	204	0.534314	0.0402501	0.429384	0.760245	0.267014	0.751055	2.12 [0.56 - 7.98]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	224282_s_at	204	0.813725	0.0156193	0.224501	0.907919	0.100604	0.549448	1.73 [0.90 - 3.34]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225440_at	204	0.803922	0.0415228	0.437967	0.771213	0.337941	0.592605	1.81 [0.54 - 6.08]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	223184_s_at	204	0.102941	0.000952078	0.024456	-1.03538	0.275187	-0.48309	0.62 [0.26 - 1.47]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	223182_s_at	204	0.245098	0.166339	-	-0.402955	0.632582	-0.20207	0.82 [0.36 - 1.87]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	223183_at	204	0.112745	0.067166	-	-0.631431	0.120704	-0.575917	0.56 [0.27 - 1.16]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219723_x_at	204	0.166667	0.11412	-	0.726189	0.706222	0.184956	1.20 [0.46 - 3.15]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	224282_s_at	204	0.838235	0.00233525	0.051412	0.896239	0.12283	0.353317	1.42 [0.91 - 2.23]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225440_at	204	0.117647	0.0821463	-	-0.625393	0.862276	0.0819046	1.09 [0.43 - 2.74]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219723_x_at	178	0.207865	0.309869	-	0.257826	0.790118	0.0813911	1.08 [0.60 - 1.98]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200019086	41	0.341463	0.017917	0.247807	-0.957732	0.0505926	-0.991592	0.37 [0.14 - 1.00]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219723_x_at	111	0.234234	0.0139694	0.206967	-0.688248	0.224928	-0.238528	0.79 [0.54 - 1.16]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	223184_s_at	111	0.351351	0.109429	-	-0.430915	0.388575	-0.365867	0.69 [0.30 - 1.59]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	223182_s_at	111	0.594595	0.0926182	-	-0.4613	0.29248	-0.179595	0.84 [0.60 - 1.17]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	223183_at	111	0.207207	0.000111703	0.00386061	-1.07325	0.0303013	-0.850017	0.43 [0.20 - 0.92]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	224282_s_at	111	0.846847	0.0352919	0.394456	0.654828	0.107155	0.33131	1.39 [0.93 - 2.08]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225440_at	111	0.846847	0.11222	-	0.530764	0.418588	0.167278	1.18 [0.79 - 1.77]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219723_x_at	90	0.211111	0.00259344	0.0559891	1.90085	0.1614	0.951609	2.59 [0.68 - 9.81]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219723_x_at	90	0.244444	0.00677354	0.119934	1.75771	0.194642	1.01589	2.76 [0.59 - 12.82]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225440_at	138	0.224638	0.00637862	0.114481	0.987364	0.355191	0.142227	1.15 [0.85 - 1.56]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219723_x_at	138	0.268116	0.133386	-	0.434409	0.833545	-0.109415	0.90 [0.32 - 2.49]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	223182_s_at	138	0.615942	0.00326291	0.0673979	0.699169	0.359998	0.13019	1.14 [0.86 - 1.51]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	224282_s_at	138	0.427536	0.0128017	0.194103	0.627398	0.334258	0.263568	1.30 [0.76 - 2.22]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	223183_at	138	0.471014	0.010913	0.172399	0.634799	0.781374	0.0493035	1.05 [0.74 - 1.49]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	223184_s_at	138	0.543478	0.0833574	-	0.416134	0.88755	0.02911	1.03 [0.69 - 1.54]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219723_x_at	129	0.310078	0.0181595	0.250198	-0.594235	0.42871	-0.409829	0.66 [0.24 - 1.83]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22547	56	0.875	0.249117	-	0.623705	0.851994	-0.0762172	0.93 [0.42 - 2.06]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24169	56	0.125	0.135099	-	-0.674834	0.709746	-0.104271	0.90 [0.52 - 1.56]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22283	56	0.553571	0.0116044	0.180482	0.900512	0.139702	0.525999	1.69 [0.84 - 3.40]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22547	56	0.214286	0.15926	-	-0.534939	0.456389	-0.322258	0.72 [0.31 - 1.69]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22283	56	0.607143	0.0163045	0.23158	0.892148	0.51352	0.227779	1.26 [0.63 - 2.49]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24169	56	0.892857	0.0406302	0.431962	0.919282	0.816211	0.0675493	1.07 [0.61 - 1.89]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	223184_s_at	278	0.251799	0.0154984	0.22324	-0.49455	0.0900587	-0.24597	0.78 [0.59 - 1.04]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	223182_s_at	278	0.654676	0.0346034	0.389407	-0.444755	0.358678	-0.107954	0.90 [0.71 - 1.13]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	223183_at	278	0.374101	0.135724	-	-0.283844	0.920799	-0.012972	0.99 [0.76 - 1.27]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219723_x_at	278	0.143885	0.00155015	0.0367206	-0.751221	0.0835352	-0.482599	0.62 [0.36 - 1.07]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	224282_s_at	278	0.859712	0.0114444	0.178626	-0.736064	0.0195062	-0.593965	0.55 [0.34 - 0.91]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225440_at	278	0.208633	0.00104951	0.0265387	-0.684161	0.00927433	-0.386644	0.68 [0.51 - 0.91]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219723_x_at	133	0.699248	0.0540495	-	0.48395	0.194364	0.95488	2.60 [0.61 - 10.99]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14928	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219723_x_at	185	0.232432	0.224181	-	0.257798	0.660882	-0.123217	0.88 [0.51 - 1.53]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219723_x_at	185	0.254054	0.275083	-	0.201133	0.747557	-0.0806103	0.92 [0.56 - 1.51]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P356466	110	0.481818	0.0715149	-	0.415749	0.500246	0.124192	1.13 [0.79 - 1.62]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P344711	110	0.836364	0.0656849	-	0.621706	0.303899	0.297364	1.35 [0.76 - 2.37]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P218743	110	0.581818	0.00129944	0.0317202	0.732528	0.050115	0.423228	1.53 [1.00 - 2.33]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P356466	110	0.845455	0.00273719	0.058492	1.01244	0.334643	0.242658	1.27 [0.78 - 2.09]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P218743	110	0.381818	0.0102471	0.164452	0.897977	0.308191	0.25669	1.29 [0.79 - 2.12]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P344711	110	0.818182	0.0307258	0.359971	0.574681	0.216121	0.290259	1.34 [0.84 - 2.12]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219723_x_at	80	0.8875	0.0897878	-	0.849017	0.225294	0.395967	1.49 [0.78 - 2.82]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:113504	59	0.79661	0.148162	-	-1.37223	0.984736	0.0163248	1.02 [0.19 - 5.41]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:126995	59	0.559322	0.103848	-	-0.840213	0.64105	-0.47781	0.62 [0.08 - 4.62]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219723_x_at	38	0.263158	0.0520098	-	1.37841	0.316526	0.589117	1.80 [0.57 - 5.71]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	223184_s_at	38	0.789474	0.000552829	0.0154381	1.59522	0.0327708	0.954314	2.60 [1.08 - 6.24]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	223182_s_at	38	0.894737	1.05217e-05	0.000467846	2.41948	0.13404	0.701644	2.02 [0.81 - 5.05]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	223183_at	38	0.815789	7.50602e-05	0.00271873	1.77772	0.0343474	0.942456	2.57 [1.07 - 6.14]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	224282_s_at	38	0.815789	0.00409537	0.0808222	1.53932	0.0685218	0.611612	1.84 [0.95 - 3.56]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225440_at	38	0.736842	0.00730832	0.127173	1.32267	0.10382	0.78697	2.20 [0.85 - 5.67]
GENE	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219723_x_at	140	0.8	0.0183805	0.252366	-1.06629	0.0967074	-1.22309	0.29 [0.07 - 1.25]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216199_s_at	30	0.366667	0.0934957	-	-0.701248	0.264437	-0.41814	0.66 [0.32 - 1.37]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219693_at	30	0.766667	0.340797	-	0.418756	0.983254	-0.0131521	0.99 [0.29 - 3.37]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1732672	165	0.763636	0.223937	-	-0.384718	0.720399	-0.0627365	0.94 [0.67 - 1.32]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1732672	165	0.121212	0.11263	-	1.47463	0.58374	0.138262	1.15 [0.70 - 1.88]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219693_at	163	0.104294	0.195072	-	0.473094	0.539356	0.270463	1.31 [0.55 - 3.11]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216199_s_at	163	0.570552	0.18835	-	-0.264547	0.490574	0.136229	1.15 [0.78 - 1.69]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	228667_at	163	0.785276	0.00646196	0.11564	0.591007	0.128803	0.358746	1.43 [0.90 - 2.27]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	228667_at	79	0.835443	0.0432344	0.449282	0.737893	0.879689	-0.0411924	0.96 [0.56 - 1.64]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216199_s_at	79	0.848101	0.0168056	0.236686	0.829552	0.110018	0.618898	1.86 [0.87 - 3.97]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219693_at	79	0.78481	0.0480796	0.479972	0.654524	0.718623	0.152363	1.16 [0.51 - 2.67]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216199_s_at	58	0.551724	0.0119582	0.184555	-0.712099	0.0267269	-0.913758	0.40 [0.18 - 0.90]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219693_at	58	0.362069	0.306854	-	-0.289156	0.655829	0.0786043	1.08 [0.77 - 1.53]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216199_s_at	34	0.323529	0.0411563	0.43551	-0.819805	0.0330131	-1.0994	0.33 [0.12 - 0.92]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219693_at	34	0.294118	0.157921	-	0.618079	0.243035	0.308911	1.36 [0.81 - 2.29]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216199_s_at	158	0.85443	0.0864567	-	-0.667919	0.623591	-0.137356	0.87 [0.50 - 1.51]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219693_at	158	0.126582	0.045421	0.46337	-0.586023	0.0344847	-1.80713	0.16 [0.03 - 0.88]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219693_at	53	0.641509	0.087535	-	-0.634725	0.318644	-0.228201	0.80 [0.51 - 1.25]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216199_s_at	53	0.113208	0.277961	-	0.775891	0.55462	0.324241	1.38 [0.47 - 4.05]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219693_at	53	0.641509	0.0371258	0.407662	-0.847417	0.405277	-0.20427	0.82 [0.50 - 1.32]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216199_s_at	53	0.54717	0.246818	-	0.395865	0.668358	0.214957	1.24 [0.46 - 3.31]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216199_s_at	180	0.655556	0.106636	-	-0.388181	0.509269	-0.18186	0.83 [0.49 - 1.43]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219693_at	180	0.283333	0.125286	-	-0.340248	0.536818	0.0572717	1.06 [0.88 - 1.27]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	228667_at	180	0.111111	0.00593775	0.10828	-0.766093	0.296085	-0.0927422	0.91 [0.77 - 1.08]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	228667_at	559	0.547406	0.00889311	0.147757	0.533414	0.201706	0.140316	1.15 [0.93 - 1.43]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219693_at	559	0.350626	0.0477764	0.478106	0.447816	0.551487	0.0864983	1.09 [0.82 - 1.45]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216199_s_at	559	0.31127	0.0163637	0.232186	0.615868	0.15402	0.426378	1.53 [0.85 - 2.75]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216199_s_at	77	0.181818	2.45845e-05	0.0010054	-1.27767	0.318976	-0.342983	0.71 [0.36 - 1.39]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219693_at	77	0.623377	0.0832587	-	-0.460631	0.585849	-0.121343	0.89 [0.57 - 1.37]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	228667_at	77	0.779221	0.0440078	0.454311	-0.663104	0.103444	-0.419786	0.66 [0.40 - 1.09]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	228667_at	70	0.4	0.267316	-	0.298558	0.917188	0.0180316	1.02 [0.72 - 1.43]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216199_s_at	70	0.614286	0.250268	-	-0.323639	0.908286	-0.020746	0.98 [0.69 - 1.39]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219693_at	70	0.857143	0.399018	-	-0.338697	0.71131	0.132744	1.14 [0.57 - 2.31]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219693_at	74	0.135135	0.0441289	0.455093	1.01166	0.298062	0.222488	1.25 [0.82 - 1.90]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216199_s_at	74	0.810811	0.0221565	0.287916	0.758199	0.772659	0.142789	1.15 [0.44 - 3.04]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	228667_at	74	0.851351	0.00631995	0.113663	0.956667	0.690756	-0.122089	0.89 [0.49 - 1.62]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219693_at	67	0.58209	0.00792316	0.135305	-15.9878	0.0868476	-2.51971	0.08 [0.00 - 1.44]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	228667_at	67	0.462687	0.00695229	0.122371	-2.31361	0.0237834	-2.25868	0.10 [0.01 - 0.74]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216199_s_at	67	0.134328	0.00214199	0.0479114	-1.82335	0.128775	-1.11507	0.33 [0.08 - 1.38]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219693_at	115	0.686957	0.397897	-	-0.542759	0.948182	0.0449065	1.05 [0.27 - 4.05]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216199_s_at	115	0.121739	0.00415202	0.0817094	-1.46064	0.0504887	-1.63105	0.20 [0.04 - 1.00]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	228667_at	115	0.104348	0.000484084	0.0137838	-1.72219	0.188471	-0.908025	0.40 [0.10 - 1.56]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219693_at	204	0.632353	0.000225286	0.00712856	0.53672	0.0195941	0.174438	1.19 [1.03 - 1.38]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	228667_at	204	0.754902	0.0821771	-	0.282187	0.571254	0.0471774	1.05 [0.89 - 1.23]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216199_s_at	204	0.661765	0.221709	-	-0.178846	0.527833	-0.111563	0.89 [0.63 - 1.26]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216199_s_at	87	0.885057	0.155787	-	0.68765	0.548009	0.230044	1.26 [0.59 - 2.67]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	228667_at	87	0.735632	0.0525572	-	-1.00802	0.337754	-0.343559	0.71 [0.35 - 1.43]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	228667_at	87	0.735632	0.0525572	-	-1.00802	0.337754	-0.343559	0.71 [0.35 - 1.43]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216199_s_at	87	0.885057	0.155787	-	0.68765	0.548009	0.230044	1.26 [0.59 - 2.67]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219693_at	87	0.436782	0.0852901	-	-0.649302	0.573773	-0.241693	0.79 [0.34 - 1.82]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219693_at	87	0.436782	0.0852901	-	-0.649302	0.573773	-0.241693	0.79 [0.34 - 1.82]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	228667_at	77	0.155844	0.327647	-	-0.63671	0.694853	-0.343669	0.71 [0.13 - 3.95]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216199_s_at	77	0.727273	0.0731136	-	1.08093	0.350819	0.672658	1.96 [0.48 - 8.05]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	228667_at	77	0.155844	0.14985	-	-0.959504	0.828353	-0.213811	0.81 [0.12 - 5.58]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219693_at	77	0.12987	0.0450256	0.460851	-1.1439	0.974216	-0.0276365	0.97 [0.18 - 5.20]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216199_s_at	77	0.727273	0.310166	-	0.57119	0.882058	0.0960502	1.10 [0.31 - 3.92]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219693_at	77	0.896104	0.260632	-	0.862697	0.409555	0.740972	2.10 [0.36 - 12.21]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219693_at	136	0.323529	0.0782607	-	-0.787689	0.381097	-0.201801	0.82 [0.52 - 1.28]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216199_s_at	136	0.897059	0.139546	-	0.812386	0.464605	0.533108	1.70 [0.41 - 7.11]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219693_at	200	0.115	0.185143	-	-0.539083	0.755653	-0.056358	0.95 [0.66 - 1.35]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216199_s_at	200	0.87	0.164847	-	-0.807747	0.998851	0.000548426	1.00 [0.47 - 2.11]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11284	60	0.85	0.225527	-	-0.861301	0.853193	-0.0322708	0.97 [0.69 - 1.36]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11284	60	0.233333	0.0312308	0.363905	1.25021	0.126439	0.439779	1.55 [0.88 - 2.73]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219693_at	286	0.335664	0.00136066	0.032958	0.726496	0.00221117	0.374432	1.45 [1.14 - 1.85]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216199_s_at	286	0.34965	0.101182	-	0.347374	0.598145	0.142428	1.15 [0.68 - 1.96]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216199_s_at	159	0.465409	0.00914341	0.150901	-1.00515	0.208422	-0.641405	0.53 [0.19 - 1.43]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219693_at	159	0.63522	0.184548	-	-0.465624	0.579967	-0.101755	0.90 [0.63 - 1.30]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216199_s_at	159	0.465409	0.00139662	0.0336797	-1.05472	0.0390128	-0.886146	0.41 [0.18 - 0.96]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219693_at	159	0.836478	0.196568	-	0.553504	0.627099	-0.104711	0.90 [0.59 - 1.37]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219693_at	159	0.27044	0.224774	-	0.475692	0.721408	-0.0651383	0.94 [0.65 - 1.34]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216199_s_at	159	0.540881	0.00853843	0.143255	-0.900707	0.165032	-0.611917	0.54 [0.23 - 1.29]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228667_at	159	0.72956	0.0222013	0.288322	-1.04552	0.823381	-0.0402768	0.96 [0.67 - 1.37]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228667_at	159	0.72956	0.0230418	0.295876	-1.0395	0.182617	-0.241762	0.79 [0.55 - 1.12]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228667_at	159	0.72956	0.0730991	-	-0.931454	0.669531	-0.0903131	0.91 [0.60 - 1.38]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219693_at	54	0.611111	0.0267544	0.327894	1.62918	0.0967032	1.51111	4.53 [0.76 - 26.96]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216199_s_at	117	0.837607	0.150453	-	0.542586	0.716873	0.0941855	1.10 [0.66 - 1.83]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216199_s_at	117	0.846154	0.143813	-	0.628684	0.683842	0.12774	1.14 [0.61 - 2.10]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216199_s_at	117	0.846154	0.0633021	-	0.803635	0.632223	0.161603	1.18 [0.61 - 2.28]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216199_s_at	117	0.837607	0.150453	-	0.542586	0.716873	0.0941855	1.10 [0.66 - 1.83]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219693_at	117	0.128205	0.0149703	0.217689	-0.901006	0.202955	-0.565891	0.57 [0.24 - 1.36]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219693_at	117	0.888889	0.127894	-	-1.42681	0.264497	-0.585453	0.56 [0.20 - 1.56]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219693_at	117	0.888889	0.152074	-	-1.35504	0.389407	-0.480261	0.62 [0.21 - 1.85]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219693_at	117	0.128205	0.0149703	0.217689	-0.901006	0.202955	-0.565891	0.57 [0.24 - 1.36]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216199_s_at	236	0.432203	0.100143	-	0.468379	0.738465	0.143354	1.15 [0.50 - 2.68]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219693_at	236	0.144068	0.000383619	0.0112921	-1.03212	0.0898688	-0.298827	0.74 [0.53 - 1.05]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	228667_at	236	0.182203	0.0958222	-	-0.523957	0.321356	-0.160672	0.85 [0.62 - 1.17]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216199_s_at	249	0.401606	0.0180311	0.248934	0.545967	0.249458	0.396203	1.49 [0.76 - 2.92]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219693_at	249	0.160643	0.000383663	0.0112932	-0.837327	0.0961387	-0.232047	0.79 [0.60 - 1.04]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	228667_at	249	0.594378	0.0457795	0.465642	-0.447127	0.212225	-0.155347	0.86 [0.67 - 1.09]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219693_at	125	0.864	0.30332	-	-0.449248	0.8016	-0.0887923	0.92 [0.46 - 1.83]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219693_at	54	0.833333	0.155266	-	-1.42704	0.658747	-0.117208	0.89 [0.53 - 1.50]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216199_s_at	62	0.145161	0.0860347	-	-0.962627	0.46012	-0.189072	0.83 [0.50 - 1.37]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216199_s_at	125	0.456	0.123744	-	0.613574	0.746019	0.117485	1.12 [0.55 - 2.29]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219693_at	62	0.709677	0.066202	-	-1.05361	0.449493	-0.168517	0.84 [0.55 - 1.31]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216199_s_at	125	0.672	0.0259378	0.32103	0.64148	0.527175	0.175978	1.19 [0.69 - 2.06]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219693_at	125	0.864	0.174105	-	-0.967648	0.887783	0.0625651	1.06 [0.45 - 2.54]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216199_s_at	54	0.277778	0.329126	-	-0.626168	0.553339	-0.181773	0.83 [0.46 - 1.52]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219693_at	198	0.631313	0.0937657	-	0.359204	0.525195	0.0515847	1.05 [0.90 - 1.23]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216199_s_at	198	0.176768	0.0845104	-	-0.509769	0.258865	-0.2518	0.78 [0.50 - 1.20]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216199_s_at	198	0.479798	0.126847	-	-0.411105	0.354087	-0.20757	0.81 [0.52 - 1.26]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219693_at	198	0.106061	0.151103	-	0.729969	0.935404	-0.00770009	0.99 [0.82 - 1.20]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219693_at	198	0.106061	0.118968	-	0.897296	0.769582	0.0295192	1.03 [0.85 - 1.25]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216199_s_at	198	0.151515	0.0187058	0.255538	-0.613624	0.136136	-0.275943	0.76 [0.53 - 1.09]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219693_at	62	0.177419	0.0827526	-	15.3627	0.316332	1.06014	2.89 [0.36 - 22.96]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216199_s_at	51	0.117647	0.0358182	0.398282	-1.71284	0.22386	-1.17415	0.31 [0.05 - 2.05]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216199_s_at	62	0.66129	0.115129	-	-1.15775	0.632371	0.347957	1.42 [0.34 - 5.89]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219693_at	51	0.372549	0.247175	-	-1.01419	0.737587	-0.57417	0.56 [0.02 - 16.19]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	228667_at	145	0.6	0.0534037	-	0.636739	0.262879	0.544985	1.72 [0.66 - 4.48]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216199_s_at	177	0.19774	0.000714513	0.0191975	2.05705	0.00374143	1.31504	3.72 [1.53 - 9.06]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219693_at	177	0.819209	0.000677549	0.0183526	0.850188	0.00562384	1.02413	2.78 [1.35 - 5.75]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216199_s_at	145	0.737931	0.0461833	0.468187	0.671499	0.186179	0.71597	2.05 [0.71 - 5.92]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219693_at	145	0.896552	0.0102749	0.164787	0.98942	0.115689	0.835243	2.31 [0.81 - 6.53]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219693_at	177	0.819209	0.00019649	0.00632903	1.02445	0.0072095	1.14041	3.13 [1.36 - 7.19]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	228667_at	177	0.38983	0.0114125	0.178255	0.675811	0.0255416	0.70645	2.03 [1.09 - 3.77]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	228667_at	177	0.38983	0.00905529	0.149797	0.830322	0.0359046	0.757286	2.13 [1.05 - 4.33]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216199_s_at	177	0.19774	0.000108328	0.00375783	1.95682	0.000105675	1.5589	4.75 [2.16 - 10.45]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216199_s_at	226	0.477876	0.288087	-	0.31125	0.931632	-0.0398915	0.96 [0.39 - 2.39]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219693_at	226	0.876106	0.0173919	0.242587	0.792729	0.505653	0.0873594	1.09 [0.84 - 1.41]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	228667_at	226	0.787611	0.00782809	0.134061	0.776985	0.195342	0.14712	1.16 [0.93 - 1.45]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219693_at	55	0.418182	0.144969	-	0.760679	0.782483	0.181088	1.20 [0.33 - 4.33]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	228667_at	55	0.272727	0.052162	-	1.34541	0.506825	0.417971	1.52 [0.44 - 5.22]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219693_at	49	0.673469	0.0642287	-	1.03795	0.762706	0.235757	1.27 [0.27 - 5.85]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	228667_at	49	0.653061	0.115597	-	0.893172	0.486676	0.541441	1.72 [0.37 - 7.90]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216199_s_at	55	0.727273	0.011297	0.176908	1.15457	0.013418	1.68865	5.41 [1.42 - 20.64]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216199_s_at	49	0.693878	0.00199327	0.0451699	1.63803	0.031871	1.62414	5.07 [1.15 - 22.37]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	228667_at	55	0.581818	0.00574399	0.105514	1.22369	0.130966	0.82979	2.29 [0.78 - 6.73]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216199_s_at	55	0.672727	0.00961742	0.156782	1.1097	0.0313348	1.31765	3.73 [1.13 - 12.40]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219693_at	55	0.636364	0.0176486	0.245147	1.02945	0.2043	0.720488	2.06 [0.68 - 6.25]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	228667_at	63	0.587302	0.000891897	0.0231495	1.09126	0.0756628	0.250378	1.28 [0.97 - 1.69]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216199_s_at	63	0.825397	0.0229856	0.295374	0.85747	0.181427	0.285127	1.33 [0.88 - 2.02]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219693_at	63	0.142857	3.01973e-05	0.00120888	-1.54598	0.507083	0.601478	1.82 [0.31 - 10.79]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9910391_3p_at	28	0.535714	0.00545106	0.101282	1.53757	0.0935799	0.237933	1.27 [0.96 - 1.68]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.127958.0.A1_3p_at	28	0.142857	0.0685508	-	-1.19105	0.386058	-1.71986	0.18 [0.00 - 8.75]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219693_at	82	0.329268	0.1439	-	0.561437	0.943184	0.0307851	1.03 [0.44 - 2.40]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216199_s_at	82	0.195122	0.151376	-	-0.558979	0.462101	-0.278284	0.76 [0.36 - 1.59]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219693_at	79	0.35443	0.230686	-	0.333507	0.742967	0.11556	1.12 [0.56 - 2.24]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216199_s_at	79	0.658228	0.0650242	-	0.486135	0.305779	0.388513	1.47 [0.70 - 3.10]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216199_s_at	104	0.153846	0.0105953	0.168628	-0.895623	0.232439	-0.52894	0.59 [0.25 - 1.40]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219693_at	104	0.153846	0.240991	-	-0.462679	0.96365	-0.0244573	0.98 [0.34 - 2.79]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P58960	117	0.547009	0.0120134	0.185186	-0.761809	0.0263927	-0.432121	0.65 [0.44 - 0.95]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P141768	117	0.717949	0.000237074	0.00745136	-1.70745	0.0117847	-0.452357	0.64 [0.45 - 0.90]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219693_at	204	0.509804	0.00299214	0.0628571	1.16083	0.0408632	0.870331	2.39 [1.04 - 5.50]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	228667_at	204	0.803922	0.0480719	0.479925	-1.3452	0.841451	-0.0665419	0.94 [0.49 - 1.80]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219693_at	204	0.441176	0.0107273	0.170199	0.744207	0.0886802	0.46587	1.59 [0.93 - 2.72]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	228667_at	204	0.803922	0.0707071	-	-0.76408	0.980989	-0.00590746	0.99 [0.61 - 1.62]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216199_s_at	204	0.897059	0.14709	-	-1.36784	0.584254	-0.330442	0.72 [0.22 - 2.35]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216199_s_at	204	0.759804	0.123503	-	-0.555619	0.397084	-0.377886	0.69 [0.29 - 1.64]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216199_s_at	178	0.162921	0.0348193	0.390996	-0.503486	0.374239	-0.300414	0.74 [0.38 - 1.44]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219693_at	178	0.898876	0.0777731	-	-0.727364	0.949153	0.0175817	1.02 [0.59 - 1.75]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219693_at	111	0.783784	0.00344743	0.07044	0.822884	0.298566	0.152676	1.16 [0.87 - 1.55]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216199_s_at	111	0.594595	0.0210641	0.277906	0.597515	0.247616	0.487849	1.63 [0.71 - 3.72]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	228667_at	111	0.378378	0.0590797	-	0.550729	0.342886	0.136046	1.15 [0.86 - 1.52]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219693_at	90	0.711111	0.0690559	-	0.603242	0.327643	0.559218	1.75 [0.57 - 5.36]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219693_at	90	0.433333	0.0759386	-	0.698962	0.206243	0.798891	2.22 [0.64 - 7.67]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216199_s_at	90	0.555556	0.283504	-	-0.357514	0.897069	-0.0344582	0.97 [0.57 - 1.63]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216199_s_at	90	0.555556	0.195172	-	-0.503421	0.690914	-0.120287	0.89 [0.49 - 1.60]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219693_at	138	0.818841	0.0405336	0.431309	0.579865	0.159902	0.249278	1.28 [0.91 - 1.82]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216199_s_at	138	0.253623	0.0910581	-	0.505667	0.370409	0.172234	1.19 [0.81 - 1.73]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	228667_at	138	0.224638	0.000427574	0.0123941	-0.874406	0.609395	0.106013	1.11 [0.74 - 1.67]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216199_s_at	129	0.131783	0.128579	-	-0.501046	0.659415	0.142421	1.15 [0.61 - 2.17]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219693_at	129	0.643411	0.0830689	-	-0.468031	0.652581	-0.0597351	0.94 [0.73 - 1.22]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20389	56	0.446429	0.0593781	-	0.643317	0.480422	0.133353	1.14 [0.79 - 1.65]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22218	56	0.821429	0.184495	-	-0.640831	0.732321	0.0681235	1.07 [0.72 - 1.58]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20389	56	0.446429	0.0600337	-	0.670605	0.50081	0.132677	1.14 [0.78 - 1.68]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22218	56	0.107143	0.245471	-	0.690993	0.541289	0.122127	1.13 [0.76 - 1.67]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216199_s_at	278	0.697842	0.0858271	-	-0.381136	0.950453	-0.0110328	0.99 [0.70 - 1.40]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219693_at	278	0.388489	0.000131589	0.00445806	0.794759	0.00498007	0.449678	1.57 [1.15 - 2.15]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	228667_at	278	0.496403	0.0222305	0.288586	0.429487	0.0682724	0.216635	1.24 [0.98 - 1.57]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216199_s_at	133	0.887218	0.0448979	0.460036	-0.836968	0.0917372	-0.251716	0.78 [0.58 - 1.04]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219693_at	133	0.120301	0.00576435	0.105805	1.74326	0.626317	-0.170677	0.84 [0.42 - 1.68]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219693_at	185	0.167568	0.0109028	0.172278	0.631205	0.232288	0.293215	1.34 [0.83 - 2.17]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216199_s_at	185	0.313514	0.0636448	-	0.376609	0.272453	0.131261	1.14 [0.90 - 1.44]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219693_at	185	0.167568	0.00706599	0.123912	0.59919	0.126265	0.342654	1.41 [0.91 - 2.19]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216199_s_at	185	0.313514	0.206794	-	0.227872	0.453966	0.0804775	1.08 [0.88 - 1.34]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P329452	110	0.672727	0.00508198	0.0958611	-0.730007	0.127098	-0.315772	0.73 [0.49 - 1.09]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P141768	110	0.881818	0.219297	-	-0.6329	0.966658	-0.00739507	0.99 [0.70 - 1.40]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P329452	110	0.690909	0.00753381	0.130178	-1.05322	0.152702	-0.409525	0.66 [0.38 - 1.16]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P58960	110	0.890909	0.315239	-	-0.389411	0.756019	0.0444909	1.05 [0.79 - 1.38]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P141768	110	0.6	0.170855	-	-0.321682	0.815194	-0.0300237	0.97 [0.75 - 1.25]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P58960	110	0.536364	0.207163	-	-0.380988	0.959816	0.00984156	1.01 [0.69 - 1.48]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216199_s_at	80	0.8375	0.0537512	-	-15.306	0.661272	-0.157848	0.85 [0.42 - 1.73]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219693_at	80	0.8125	0.0689558	-	-15.3139	0.63397	-0.0978247	0.91 [0.61 - 1.36]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219693_at	38	0.368421	0.37587	-	0.461778	0.75277	0.125852	1.13 [0.52 - 2.48]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216199_s_at	38	0.789474	0.122439	-	-1.45945	0.775145	0.0858345	1.09 [0.60 - 1.96]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	228667_at	38	0.368421	0.0374294	0.409815	1.14958	0.469148	0.271882	1.31 [0.63 - 2.74]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216199_s_at	140	0.778571	1.86809e-05	0.000785523	1.19392	0.00160292	0.645764	1.91 [1.28 - 2.85]
GENE	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219693_at	140	0.771429	0.000137672	0.00463822	1.06588	0.000127847	1.31061	3.71 [1.90 - 7.25]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218096_at	30	0.233333	0.174864	-	-0.614615	0.837944	-0.0879738	0.92 [0.39 - 2.13]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1768029	165	0.709091	0.0348845	0.391474	0.526628	0.0677289	0.295755	1.34 [0.98 - 1.85]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1768029	165	0.69697	0.149367	-	0.514059	0.392228	0.200954	1.22 [0.77 - 1.94]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218096_at	163	0.662577	0.0552033	-	0.388915	0.443814	0.0983573	1.10 [0.86 - 1.42]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	232007_at	163	0.441718	0.271811	-	-0.215642	0.961967	-0.00822652	0.99 [0.71 - 1.39]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	232007_at	79	0.468354	0.0227449	0.293221	0.678605	0.275589	0.211799	1.24 [0.84 - 1.81]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218096_at	79	0.481013	0.0475582	0.47676	0.582965	0.558208	0.10343	1.11 [0.78 - 1.57]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218096_at	58	0.655172	0.355046	-	0.266871	0.762411	0.0774855	1.08 [0.65 - 1.79]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218096_at	34	0.705882	0.0242576	0.306596	0.921144	0.0891408	0.592123	1.81 [0.91 - 3.58]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218096_at	158	0.803797	0.0378574	0.412834	-0.693368	0.735025	-0.0613478	0.94 [0.66 - 1.34]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218096_at	53	0.113208	0.102701	-	1.51266	0.662245	0.191885	1.21 [0.51 - 2.87]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218096_at	53	0.264151	0.224518	-	-0.455009	0.935468	-0.0329018	0.97 [0.44 - 2.15]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218096_at	180	0.116667	0.00134954	0.032734	-0.885671	0.777607	-0.0596544	0.94 [0.62 - 1.43]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	232007_at	180	0.894444	0.0349024	0.391606	0.651907	0.706368	0.0645619	1.07 [0.76 - 1.49]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	232007_at	559	0.234347	0.104383	-	0.439751	0.415159	0.150631	1.16 [0.81 - 1.67]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218096_at	559	0.899821	0.115191	-	0.46538	0.517429	0.132784	1.14 [0.76 - 1.71]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218096_at	77	0.675325	0.00103768	0.0262878	0.885997	0.377801	0.447267	1.56 [0.58 - 4.23]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	232007_at	77	0.207792	0.281787	-	-0.334284	0.906436	-0.0376631	0.96 [0.51 - 1.80]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	232007_at	70	0.514286	0.138754	-	-0.398231	0.891588	-0.029483	0.97 [0.64 - 1.48]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218096_at	70	0.885714	0.225061	-	-0.568547	0.660265	-0.112309	0.89 [0.54 - 1.47]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218096_at	74	0.405405	0.00507821	0.0958053	-0.804192	0.00314055	-1.23685	0.29 [0.13 - 0.66]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	232007_at	74	0.324324	9.09561e-05	0.00322153	-1.12588	0.000241081	-1.15782	0.31 [0.17 - 0.58]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	232007_at	67	0.253731	0.0713451	-	15.5303	0.55038	0.905352	2.47 [0.13 - 48.27]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218096_at	67	0.223881	0.0723281	-	15.5084	0.617706	0.544517	1.72 [0.20 - 14.63]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218096_at	115	0.373913	0.00474688	0.0908472	-1.5212	0.0315731	-1.44467	0.24 [0.06 - 0.88]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	232007_at	115	0.521739	0.00676941	0.119877	-1.80981	0.181832	-0.804868	0.45 [0.14 - 1.46]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218096_at	204	0.784314	0.0147073	0.214897	0.415151	0.751066	0.0539014	1.06 [0.76 - 1.47]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	232007_at	204	0.887255	0.00113884	0.0284158	0.724486	0.482525	0.10362	1.11 [0.83 - 1.48]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	232007_at	87	0.137931	0.00815676	0.138345	-1.10457	0.126707	-0.57942	0.56 [0.27 - 1.18]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	232007_at	87	0.137931	0.00815676	0.138345	-1.10457	0.126707	-0.57942	0.56 [0.27 - 1.18]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218096_at	87	0.264368	0.0247111	0.310535	-0.834022	0.158163	-0.341056	0.71 [0.44 - 1.14]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218096_at	87	0.264368	0.0247111	0.310535	-0.834022	0.158163	-0.341056	0.71 [0.44 - 1.14]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	232007_at	77	0.727273	0.0783648	-	-1.64269	0.128179	-0.918321	0.40 [0.12 - 1.30]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	232007_at	77	0.727273	0.162201	-	-1.36612	0.442571	-0.451443	0.64 [0.20 - 2.02]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218096_at	77	0.116883	0.183871	-	15.2042	0.887426	-0.0550347	0.95 [0.44 - 2.03]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218096_at	77	0.324675	0.139317	-	1.43291	0.650895	0.189274	1.21 [0.53 - 2.74]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218096_at	136	0.220588	0.0304094	0.35749	-0.959098	0.587706	-0.276021	0.76 [0.28 - 2.06]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218096_at	200	0.215	0.0115444	0.179787	-0.776242	0.429905	-0.296757	0.74 [0.36 - 1.55]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5858	60	0.266667	0.0675993	-	-0.712626	0.0987604	-0.290179	0.75 [0.53 - 1.06]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4471	60	0.833333	0.25776	-	-0.678139	0.916284	-0.0271546	0.97 [0.59 - 1.61]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4471	60	0.133333	2.13772e-05	0.00088679	-1.75775	0.084075	-0.468808	0.63 [0.37 - 1.07]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5858	60	0.116667	0.161133	-	-0.688191	0.730792	-0.100445	0.90 [0.51 - 1.60]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218096_at	286	0.104895	0.0141834	0.209282	-0.637737	0.253264	-0.303694	0.74 [0.44 - 1.24]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218096_at	159	0.377358	0.0334227	0.380626	-0.774894	0.124961	-0.79838	0.45 [0.16 - 1.25]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218096_at	159	0.874214	0.102261	-	-1.12537	0.330039	-0.419974	0.66 [0.28 - 1.53]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218096_at	159	0.100629	0.00528517	0.0988583	-1.05419	0.0379316	-0.933163	0.39 [0.16 - 0.95]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232007_at	159	0.685535	0.00314832	0.0654877	-1.31634	0.060789	-0.649519	0.52 [0.26 - 1.03]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232007_at	159	0.465409	0.00208703	0.0469033	-0.998479	0.0591399	-0.659094	0.52 [0.26 - 1.03]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232007_at	159	0.465409	0.000366818	0.0108655	-1.42423	0.0235318	-0.924462	0.40 [0.18 - 0.88]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218096_at	54	0.648148	0.122604	-	0.995604	0.701196	0.169796	1.19 [0.50 - 2.82]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218096_at	117	0.128205	0.143009	-	1.01906	0.661952	0.0890258	1.09 [0.73 - 1.63]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218096_at	117	0.683761	0.103845	-	0.606414	0.485983	0.168192	1.18 [0.74 - 1.90]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218096_at	117	0.692308	0.158941	-	0.551184	0.353776	0.22792	1.26 [0.78 - 2.03]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218096_at	117	0.128205	0.143009	-	1.01906	0.661952	0.0890258	1.09 [0.73 - 1.63]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218096_at	236	0.169492	0.015971	0.228148	-0.714568	0.318569	-0.413013	0.66 [0.29 - 1.49]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	232007_at	236	0.75	0.0571732	-	-0.713302	0.573307	-0.19651	0.82 [0.41 - 1.63]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218096_at	249	0.172691	0.00517193	0.0971919	-0.666068	0.243554	-0.367022	0.69 [0.37 - 1.28]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	232007_at	249	0.445783	0.0920175	-	-0.354863	0.601471	-0.142512	0.87 [0.51 - 1.48]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218096_at	62	0.887097	0.0597708	-	-15.3214	0.299208	-0.385406	0.68 [0.33 - 1.41]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218096_at	125	0.512	0.361159	-	0.354019	0.914446	0.0324388	1.03 [0.57 - 1.87]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218096_at	125	0.224	0.0755539	-	-0.601413	0.427658	-0.184787	0.83 [0.53 - 1.31]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218096_at	54	0.296296	0.0402032	0.429064	-1.21028	0.213748	-0.571049	0.56 [0.23 - 1.39]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218096_at	198	0.727273	0.0482264	0.480873	-0.632161	0.351123	-0.193836	0.82 [0.55 - 1.24]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218096_at	198	0.727273	0.13578	-	-0.483741	0.388836	-0.186331	0.83 [0.54 - 1.27]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218096_at	198	0.80303	0.0121956	0.187265	-0.791412	0.18525	-0.221848	0.80 [0.58 - 1.11]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218096_at	51	0.176471	0.0112013	0.17579	-1.98121	0.117227	-1.01263	0.36 [0.10 - 1.29]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218096_at	62	0.774194	0.0418711	0.440291	-15.4875	0.451007	-0.325627	0.72 [0.31 - 1.68]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218096_at	177	0.124294	0.0434335	0.450581	-0.594094	0.258047	-0.211473	0.81 [0.56 - 1.17]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	232007_at	145	0.344828	0.0979243	-	-0.546557	0.428148	-0.276157	0.76 [0.38 - 1.50]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218096_at	145	0.103448	0.00644562	0.115413	-1.05293	0.0144087	-0.575072	0.56 [0.35 - 0.89]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	232007_at	177	0.80791	0.0924992	-	-0.713455	0.62136	-0.138879	0.87 [0.50 - 1.51]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218096_at	177	0.779661	0.00642717	0.115157	-1.31882	0.0461305	-0.4063	0.67 [0.45 - 0.99]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	232007_at	177	0.740113	0.0792861	-	-0.531736	0.741999	-0.0797503	0.92 [0.57 - 1.48]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218096_at	226	0.230089	0.000914575	0.0236437	-0.922879	0.0019552	-0.627173	0.53 [0.36 - 0.79]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	232007_at	226	0.309735	0.0542301	-	-0.543618	0.116352	-0.339326	0.71 [0.47 - 1.09]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	232007_at	55	0.690909	0.0107606	0.170594	-2.13551	0.532813	-0.307053	0.74 [0.28 - 1.93]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218096_at	55	0.727273	0.09198	-	-1.15918	0.462244	-0.297701	0.74 [0.34 - 1.64]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218096_at	49	0.244898	0.041376	0.436984	15.4967	0.904567	0.0530661	1.05 [0.44 - 2.51]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	232007_at	55	0.727273	0.0079283	0.135373	-2.23398	0.388937	-0.38615	0.68 [0.28 - 1.64]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	232007_at	49	0.306122	0.0507241	-	1.79827	0.867917	-0.0868063	0.92 [0.33 - 2.55]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218096_at	55	0.727273	0.0396958	0.425598	-1.41378	0.651569	-0.160426	0.85 [0.42 - 1.71]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	273144	34	0.147059	0.209441	-	-0.691544	0.811797	0.111773	1.12 [0.45 - 2.81]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	232007_at	63	0.873016	0.0028753	0.060868	1.43798	0.0294904	0.810064	2.25 [1.08 - 4.66]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218096_at	63	0.84127	0.0350718	0.392847	0.872978	0.31097	0.258683	1.30 [0.79 - 2.14]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.281895.0.S1_3p_x_at	28	0.25	0.0110027	0.173457	-1.40734	0.126048	-2.18543	0.11 [0.01 - 1.85]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8922941_3p_at	28	0.428571	0.0104017	0.166312	-1.45146	0.143471	-0.339647	0.71 [0.45 - 1.12]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.281895.0.S1_3p_at	28	0.571429	0.123424	-	-0.924564	0.340833	-1.86168	0.16 [0.00 - 7.16]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218096_at	82	0.865854	0.0848828	-	0.71137	0.72374	-0.144248	0.87 [0.39 - 1.93]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218096_at	79	0.556962	0.166458	-	0.361404	0.782625	0.0830833	1.09 [0.60 - 1.96]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218096_at	104	0.884615	0.0636828	-	0.755891	0.544214	0.219672	1.25 [0.61 - 2.53]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P216200	117	0.641026	0.00961564	0.15676	0.727066	0.0212517	0.458625	1.58 [1.07 - 2.34]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P29876	117	0.777778	0.00200835	0.0454497	0.901138	0.0472251	0.439611	1.55 [1.01 - 2.40]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	232007_at	204	0.367647	0.0816278	-	-0.626361	0.324492	-0.52243	0.59 [0.21 - 1.68]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218096_at	204	0.137255	0.224865	-	0.861858	0.785628	-0.153109	0.86 [0.28 - 2.59]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218096_at	204	0.416667	0.350069	-	0.262645	0.674243	0.170288	1.19 [0.54 - 2.62]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	232007_at	204	0.196078	0.300661	-	0.394012	0.800062	0.0973646	1.10 [0.52 - 2.34]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218096_at	178	0.516854	0.0328349	0.376197	-0.431474	0.294493	-0.262403	0.77 [0.47 - 1.26]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200003797	41	0.292683	0.153269	-	-0.606452	0.373875	-0.239597	0.79 [0.46 - 1.33]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218096_at	111	0.504505	0.0304992	0.358196	0.567817	0.251878	0.40354	1.50 [0.75 - 2.99]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	232007_at	111	0.801802	0.0690844	-	0.539741	0.5798	-0.103215	0.90 [0.63 - 1.30]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218096_at	90	0.755556	0.0610856	-	0.630594	0.330882	0.337131	1.40 [0.71 - 2.76]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218096_at	90	0.788889	0.084972	-	0.67897	0.387424	0.336232	1.40 [0.65 - 3.00]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3075	50	0.62	0.340824	-	0.456988	0.827906	-0.144865	0.87 [0.23 - 3.19]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218096_at	138	0.876812	0.0136688	0.203693	0.769589	0.119649	0.233562	1.26 [0.94 - 1.70]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	232007_at	138	0.891304	0.105448	-	0.54875	0.267364	0.215371	1.24 [0.85 - 1.81]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218096_at	129	0.736434	0.00546515	0.101487	0.705145	0.168317	0.593156	1.81 [0.78 - 4.21]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12005	56	0.839286	0.00368119	0.0742375	1.12388	0.0439744	0.430557	1.54 [1.01 - 2.34]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	448	56	0.589286	0.00575252	0.105636	0.939188	0.0230727	0.460701	1.59 [1.07 - 2.36]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12005	56	0.857143	0.000818184	0.0215265	1.37403	0.0606098	0.43922	1.55 [0.98 - 2.45]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	448	56	0.857143	0.000442417	0.0127619	1.41026	0.0158122	0.529929	1.70 [1.10 - 2.61]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	232007_at	278	0.776978	0.0151114	0.219179	-0.629491	0.883402	-0.0222701	0.98 [0.73 - 1.32]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218096_at	278	0.895683	0.057483	-	-0.656321	0.669075	-0.0554073	0.95 [0.73 - 1.22]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218096_at	133	0.233083	0.00173738	0.0403459	-0.776573	0.00408641	-0.437339	0.65 [0.48 - 0.87]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218096_at	185	0.87027	0.0637493	-	0.460117	0.473599	0.101822	1.11 [0.84 - 1.46]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218096_at	185	0.87027	0.0861485	-	0.403995	0.565288	0.0756683	1.08 [0.83 - 1.40]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P29876	110	0.872727	0.172091	-	0.518709	0.708841	0.0799288	1.08 [0.71 - 1.65]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P216200	110	0.790909	0.148228	-	0.384366	0.622555	0.0856382	1.09 [0.77 - 1.53]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P29876	110	0.363636	0.0568324	-	-0.445584	0.424672	-0.133908	0.87 [0.63 - 1.22]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P216200	110	0.263636	0.0479928	0.479438	-0.606333	0.864823	0.0378198	1.04 [0.67 - 1.61]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218096_at	80	0.7125	0.162928	-	0.619191	0.474582	0.214791	1.24 [0.69 - 2.23]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218096_at	38	0.631579	0.00620689	0.11208	1.30993	0.0937968	0.865215	2.38 [0.86 - 6.54]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	232007_at	38	0.315789	0.0342922	0.387108	1.17803	0.0952222	0.559816	1.75 [0.91 - 3.38]
GENE	AGPAT5	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218096_at	140	0.185714	0.0478766	0.478724	1.12191	0.314256	0.257353	1.29 [0.78 - 2.14]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205401_at	30	0.733333	0.00158877	0.0374754	1.58244	0.356791	0.473313	1.61 [0.59 - 4.39]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1750465	165	0.89697	0.0392	0.422188	0.693589	0.243846	0.261532	1.30 [0.84 - 2.02]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1750465	165	0.89697	0.00423141	0.0829477	1.16106	0.0638495	0.622174	1.86 [0.96 - 3.60]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205401_at	163	0.582822	0.304571	-	-0.208059	0.743216	0.0729829	1.08 [0.70 - 1.66]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225113_at	163	0.742331	0.208675	-	-0.301053	0.965295	-0.0103795	0.99 [0.62 - 1.58]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225114_at	163	0.889571	0.00221034	0.0491572	0.844297	0.0949823	0.251432	1.29 [0.96 - 1.73]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225108_at	163	0.865031	0.165807	-	0.387442	0.6778	0.0814972	1.08 [0.74 - 1.59]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205401_at	79	0.696203	2.69159e-08	1.87885e-06	1.61511	0.00868622	0.745038	2.11 [1.21 - 3.67]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225113_at	79	0.721519	0.103563	-	0.497618	0.195939	0.32331	1.38 [0.85 - 2.26]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225114_at	79	0.898734	1.68311e-05	0.000715118	1.61388	0.00446237	0.717841	2.05 [1.25 - 3.36]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225108_at	79	0.43038	0.199382	-	0.385815	0.657978	0.120195	1.13 [0.66 - 1.92]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205401_at	58	0.87931	0.149494	-	0.581342	0.384146	0.216495	1.24 [0.76 - 2.02]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205401_at	34	0.735294	0.111307	-	0.673655	0.625615	0.261971	1.30 [0.45 - 3.72]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205401_at	158	0.259494	0.0218599	0.285219	-0.562286	0.48875	-0.19669	0.82 [0.47 - 1.43]
GENE	AGPS	alkylglycerone phosphate synthase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205401_at	53	0.792453	0.11832	-	0.616357	0.879913	0.0731757	1.08 [0.42 - 2.78]
GENE	AGPS	alkylglycerone phosphate synthase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205401_at	53	0.169811	0.0709469	-	1.04602	0.486224	0.324126	1.38 [0.56 - 3.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205401_at	180	0.611111	0.090184	-	-0.373439	0.230418	-0.304877	0.74 [0.45 - 1.21]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225114_at	180	0.572222	0.108986	-	0.336414	0.63579	-0.116413	0.89 [0.55 - 1.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225108_at	180	0.233333	0.11698	-	0.419304	0.401711	0.281233	1.32 [0.69 - 2.56]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225113_at	180	0.522222	0.194982	-	-0.273287	0.632485	-0.045845	0.96 [0.79 - 1.15]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205401_at	559	0.563506	0.0027128	0.0580695	0.599862	0.00767123	0.83678	2.31 [1.25 - 4.27]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225113_at	559	0.821109	5.37023e-08	3.5903e-06	1.07831	0.118475	0.222007	1.25 [0.94 - 1.65]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225114_at	559	0.744186	0.0024401	0.053284	0.607946	0.0066674	0.79512	2.21 [1.25 - 3.93]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225108_at	559	0.872987	0.0609415	-	0.473449	0.864574	0.0361015	1.04 [0.68 - 1.57]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205401_at	77	0.701299	0.0847698	-	-0.510759	0.863501	-0.0583932	0.94 [0.48 - 1.84]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225114_at	77	0.623377	0.00281391	0.0598151	0.774914	0.226154	0.392912	1.48 [0.78 - 2.80]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225108_at	77	0.194805	6.71656e-05	0.00246397	-1.22216	0.00376915	-1.48395	0.23 [0.08 - 0.62]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225113_at	77	0.454545	0.029777	0.352495	-0.553762	0.171702	-0.361754	0.70 [0.41 - 1.17]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205401_at	70	0.7	0.347148	-	0.270391	0.936326	-0.0251718	0.98 [0.53 - 1.81]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225113_at	70	0.342857	0.225649	-	-0.331153	0.633939	-0.180291	0.84 [0.40 - 1.75]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225114_at	70	0.171429	0.00646336	0.115659	-0.879796	0.636611	-0.134213	0.87 [0.50 - 1.53]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225108_at	70	0.114286	0.106132	-	-0.66017	0.295841	-0.342908	0.71 [0.37 - 1.35]
GENE	AGPS	alkylglycerone phosphate synthase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39225_at	50	0.82	0.000731751	0.0195888	1.37554	0.0332574	1.03108	2.80 [1.09 - 7.25]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205401_at	74	0.202703	0.000323845	0.00975974	-1.12151	0.00170662	-0.895865	0.41 [0.23 - 0.71]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225108_at	74	0.148649	0.0864404	-	-0.630683	0.446238	-0.387683	0.68 [0.25 - 1.84]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225113_at	74	0.594595	0.0064093	0.114908	-0.848792	0.0410212	-0.700647	0.50 [0.25 - 0.97]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225114_at	74	0.891892	0.113784	-	0.684936	0.573206	0.309268	1.36 [0.46 - 4.00]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225113_at	67	0.164179	0.177226	-	-0.922806	0.994743	-0.00732011	0.99 [0.11 - 8.76]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205401_at	67	0.41791	0.0968332	-	1.26178	0.353992	0.78482	2.19 [0.42 - 11.52]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225114_at	67	0.41791	0.0409898	0.43439	1.88112	0.1586	0.892712	2.44 [0.71 - 8.45]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225108_at	67	0.373134	0.0463175	0.469031	-1.31426	0.159351	-1.32698	0.27 [0.04 - 1.68]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225113_at	115	0.2	0.197533	-	1.254	0.916798	-0.0510683	0.95 [0.36 - 2.48]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225114_at	115	0.252174	0.023576	0.300616	15.5086	0.189387	0.832882	2.30 [0.66 - 7.98]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225108_at	115	0.478261	0.0608823	-	-1.05584	0.131587	-0.816172	0.44 [0.15 - 1.28]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205401_at	115	0.191304	0.0587113	-	15.367	0.253141	0.693293	2.00 [0.61 - 6.57]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39225_at	158	0.265823	0.302499	-	0.36287	0.889332	0.0532442	1.05 [0.50 - 2.23]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39225_at	76	0.618421	0.00320572	0.0664465	1.56227	0.0469084	1.26112	3.53 [1.02 - 12.24]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225113_at	204	0.691176	0.0277142	0.33584	-0.336332	0.691125	-0.0431435	0.96 [0.77 - 1.18]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205401_at	204	0.803922	0.21406	-	-0.223562	0.868655	0.0174743	1.02 [0.83 - 1.25]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225114_at	204	0.764706	0.2228	-	-0.206159	0.955528	0.00612169	1.01 [0.81 - 1.25]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225108_at	204	0.627451	0.00979285	0.158934	-0.370345	0.108664	-0.174666	0.84 [0.68 - 1.04]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205401_at	87	0.287356	0.1072	-	0.845801	0.910668	-0.019	0.98 [0.70 - 1.37]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225113_at	87	0.126437	0.213354	-	1.19651	0.77044	0.0470088	1.05 [0.76 - 1.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225113_at	87	0.126437	0.213354	-	1.19651	0.77044	0.0470088	1.05 [0.76 - 1.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225114_at	87	0.873563	0.0786153	-	-1.6127	0.939718	0.0109198	1.01 [0.76 - 1.34]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225114_at	87	0.873563	0.0786153	-	-1.6127	0.939718	0.0109198	1.01 [0.76 - 1.34]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225108_at	87	0.413793	0.0559683	-	-0.717606	0.502723	-0.113634	0.89 [0.64 - 1.24]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225108_at	87	0.413793	0.0559683	-	-0.717606	0.502723	-0.113634	0.89 [0.64 - 1.24]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205401_at	87	0.287356	0.1072	-	0.845801	0.910668	-0.019	0.98 [0.70 - 1.37]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205401_at	77	0.480519	0.0867441	-	-0.989099	0.622128	-0.189546	0.83 [0.39 - 1.76]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225113_at	77	0.298701	0.0479602	0.479238	-1.05183	0.364128	-0.25329	0.78 [0.45 - 1.34]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225114_at	77	0.233766	0.0355331	0.396213	-1.11228	0.827894	-0.0533828	0.95 [0.59 - 1.53]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225108_at	77	0.519481	0.0487872	0.484298	-1.22061	0.310372	-0.305822	0.74 [0.41 - 1.33]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225113_at	77	0.246753	0.0541151	-	-1.15501	0.515537	-0.208444	0.81 [0.43 - 1.52]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225114_at	77	0.233766	0.0413009	0.436481	-1.21566	0.904429	-0.033923	0.97 [0.56 - 1.68]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225108_at	77	0.402597	0.0435388	0.451267	-1.30102	0.30671	-0.354572	0.70 [0.36 - 1.38]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205401_at	77	0.480519	0.0346216	0.389541	-1.52039	0.760885	-0.133318	0.88 [0.37 - 2.07]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205401_at	136	0.720588	0.0983923	-	0.743777	0.962257	-0.0182744	0.98 [0.46 - 2.09]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205401_at	200	0.27	0.159847	-	0.54032	0.834157	0.0588598	1.06 [0.61 - 1.84]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5365	60	0.8	0.0609265	-	0.776888	0.578025	0.121041	1.13 [0.74 - 1.73]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5365	60	0.533333	0.306593	-	0.388205	0.893749	-0.0340797	0.97 [0.59 - 1.59]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12654	155	0.380645	0.0678921	-	-0.508046	0.38921	-0.117714	0.89 [0.68 - 1.16]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205401_at	286	0.70979	0.0308382	0.360849	0.434733	0.454402	0.17284	1.19 [0.76 - 1.87]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205401_at	159	0.289308	0.076264	-	0.722238	0.839537	0.0765168	1.08 [0.51 - 2.26]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205401_at	159	0.522013	0.0355236	0.396144	0.674367	0.343536	0.354688	1.43 [0.68 - 2.97]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205401_at	159	0.522013	0.0151244	0.219316	0.940812	0.243488	0.515025	1.67 [0.70 - 3.98]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225108_at	159	0.157233	0.00053112	0.0149197	-1.27031	0.0685505	-0.565218	0.57 [0.31 - 1.04]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225113_at	159	0.251572	0.0102301	0.164246	-0.807386	0.153052	-0.190878	0.83 [0.64 - 1.07]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225113_at	159	0.264151	0.129977	-	-0.497609	0.95219	-0.00837834	0.99 [0.75 - 1.30]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225113_at	159	0.251572	0.136409	-	-0.574354	0.778046	-0.0464901	0.95 [0.69 - 1.32]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225114_at	159	0.616352	0.131256	-	0.473713	0.818532	0.0643308	1.07 [0.62 - 1.85]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225114_at	159	0.559748	0.0155798	0.22409	0.762352	0.154451	0.421877	1.52 [0.85 - 2.73]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225108_at	159	0.232704	0.000201199	0.00646091	-1.13193	0.0185022	-0.618043	0.54 [0.32 - 0.90]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225114_at	159	0.566038	0.0586269	-	0.699129	0.338705	0.321522	1.38 [0.71 - 2.67]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225108_at	159	0.157233	0.0019802	0.0449269	-1.02544	0.0623563	-0.501879	0.61 [0.36 - 1.03]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205401_at	54	0.462963	0.140916	-	1.12501	0.468084	0.244872	1.28 [0.66 - 2.48]
GENE	AGPS	alkylglycerone phosphate synthase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205401_at	117	0.478632	0.182159	-	-0.423662	0.68643	-0.0937448	0.91 [0.58 - 1.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205401_at	117	0.478632	0.0513158	-	-0.75131	0.673982	-0.117989	0.89 [0.51 - 1.54]
GENE	AGPS	alkylglycerone phosphate synthase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205401_at	117	0.581197	0.0846469	-	-0.746258	0.250005	-0.365293	0.69 [0.37 - 1.29]
GENE	AGPS	alkylglycerone phosphate synthase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205401_at	117	0.478632	0.182159	-	-0.423662	0.68643	-0.0937448	0.91 [0.58 - 1.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205401_at	236	0.868644	0.319488	-	-0.461873	0.867684	-0.0547843	0.95 [0.50 - 1.80]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225114_at	236	0.65678	0.406727	-	0.228733	0.927473	0.0217607	1.02 [0.64 - 1.63]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225108_at	236	0.148305	0.0132645	0.199249	-0.768447	0.141851	-0.41345	0.66 [0.38 - 1.15]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225113_at	236	0.487288	0.125397	-	0.422595	0.852676	0.0220032	1.02 [0.81 - 1.29]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205401_at	249	0.156627	0.213405	-	0.433951	0.43517	0.195755	1.22 [0.74 - 1.99]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225114_at	249	0.646586	0.331482	-	0.210869	0.754829	0.0581564	1.06 [0.74 - 1.53]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225108_at	249	0.899598	0.0340576	0.385367	0.608613	0.915662	-0.0253169	0.98 [0.61 - 1.56]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225113_at	249	0.104418	0.131418	-	0.680895	0.702421	0.0354952	1.04 [0.86 - 1.24]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205401_at	125	0.136	0.245613	-	0.59848	0.589104	-0.11199	0.89 [0.60 - 1.34]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205401_at	54	0.240741	0.0713855	-	15.3962	0.85542	-0.0461387	0.95 [0.58 - 1.57]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205401_at	62	0.548387	0.217806	-	-0.599084	0.669621	-0.0884818	0.92 [0.61 - 1.37]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205401_at	125	0.208	0.0561099	-	-0.761834	0.227953	-0.351192	0.70 [0.40 - 1.25]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205401_at	198	0.813131	0.108784	-	-0.495182	0.993759	-0.00102411	1.00 [0.77 - 1.29]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205401_at	198	0.484848	0.0527068	-	-0.50255	0.270683	-0.179114	0.84 [0.61 - 1.15]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205401_at	198	0.484848	0.0502083	-	-0.52748	0.334468	-0.163454	0.85 [0.61 - 1.18]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205401_at	62	0.193548	0.249707	-	1.13982	0.801185	0.132446	1.14 [0.41 - 3.20]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205401_at	51	0.352941	0.250939	-	-1.00523	0.999158	0.000880151	1.00 [0.20 - 5.13]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205401_at	145	0.765517	0.0315217	0.366156	-1.22014	0.649134	-0.140531	0.87 [0.47 - 1.59]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225114_at	145	0.268966	0.0268237	0.328472	-0.73339	0.122192	-0.614364	0.54 [0.25 - 1.18]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225108_at	145	0.144828	0.0291085	0.347159	-0.824483	0.304702	-0.407688	0.67 [0.31 - 1.45]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225113_at	145	0.634483	0.00378073	0.0758362	-1.21997	0.242977	-0.464776	0.63 [0.29 - 1.37]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205401_at	177	0.129944	0.0948582	-	0.756902	0.879158	0.0355785	1.04 [0.66 - 1.64]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225113_at	177	0.887006	0.319581	-	-0.421771	0.894034	-0.0399022	0.96 [0.53 - 1.73]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225113_at	177	0.887006	0.150236	-	-0.831037	0.987747	-0.0053321	0.99 [0.50 - 1.96]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225114_at	177	0.129944	0.251217	-	0.455882	0.854446	0.0532005	1.05 [0.60 - 1.86]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205401_at	177	0.101695	0.0682557	-	1.23449	0.82392	0.0605022	1.06 [0.62 - 1.81]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225108_at	177	0.135593	0.0054653	0.101489	-0.777503	0.817851	-0.0675637	0.93 [0.53 - 1.66]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225114_at	177	0.898305	0.162513	-	-0.968352	0.708857	-0.124901	0.88 [0.46 - 1.70]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225108_at	177	0.774011	0.0453384	0.462844	0.589272	0.660379	0.151463	1.16 [0.59 - 2.29]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225113_at	226	0.362832	0.00724725	0.126354	-0.744532	0.0303104	-0.532278	0.59 [0.36 - 0.95]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225114_at	226	0.10177	0.00536615	0.100044	-0.951836	0.0172302	-1.00013	0.37 [0.16 - 0.84]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225108_at	226	0.19469	0.0608323	-	-0.570803	0.904466	-0.0338174	0.97 [0.56 - 1.68]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205401_at	226	0.876106	0.0426787	0.445636	-1.35788	0.248155	-0.300421	0.74 [0.44 - 1.23]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225113_at	55	0.272727	0.0252861	0.315483	-1.05249	0.394912	-0.381354	0.68 [0.28 - 1.64]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225114_at	55	0.745455	0.183799	-	0.652138	0.377331	0.383807	1.47 [0.63 - 3.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225108_at	55	0.2	0.038674	0.418544	-0.995505	0.339592	-0.557274	0.57 [0.18 - 1.80]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225113_at	49	0.285714	0.186515	-	-0.758018	0.835805	-0.118054	0.89 [0.29 - 2.71]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205401_at	49	0.632653	0.183906	-	-0.862697	0.934429	-0.0469667	0.95 [0.31 - 2.92]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225114_at	49	0.571429	0.038867	0.419884	1.288	0.096551	0.852815	2.35 [0.86 - 6.42]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225108_at	49	0.142857	0.0192615	0.260907	-1.35408	0.31639	-0.741648	0.48 [0.11 - 2.03]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205401_at	55	0.836364	0.0452709	0.462416	0.944027	0.369249	0.412749	1.51 [0.61 - 3.72]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225113_at	55	0.727273	0.0489349	0.485196	0.863161	0.961468	0.0217332	1.02 [0.42 - 2.47]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225114_at	55	0.745455	0.0127709	0.193758	1.07425	0.0834252	0.688103	1.99 [0.91 - 4.34]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225108_at	55	0.272727	0.00706053	0.123839	-1.15224	0.148797	-0.803619	0.45 [0.15 - 1.33]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205401_at	55	0.163636	0.167817	-	1.28222	0.803865	-0.116495	0.89 [0.35 - 2.23]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	32969	34	0.176471	0.0189472	0.257878	2.05178	0.380257	0.38227	1.47 [0.62 - 3.44]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205401_at	63	0.365079	0.0606154	-	0.69092	0.333936	0.264937	1.30 [0.76 - 2.23]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225113_at	63	0.888889	0.306059	-	-0.610473	0.997677	0.000457192	1.00 [0.74 - 1.36]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225114_at	63	0.222222	0.0350451	0.392652	-0.735856	0.133686	-0.254622	0.78 [0.56 - 1.08]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225108_at	63	0.698413	0.0222698	0.288942	0.773135	0.503104	0.162185	1.18 [0.73 - 1.89]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.331666.0.S2_3p_at	28	0.642857	0.124855	-	-0.987091	0.658908	-3.9152	0.02 [0.00 - 707220.94]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4501992_3p_at	28	0.892857	0.163966	-	1.04443	0.14334	0.673275	1.96 [0.80 - 4.83]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.331666.0.S3_3p_at	28	0.642857	0.246293	-	0.629145	0.64039	0.14476	1.16 [0.63 - 2.12]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.331666.0.S1_3p_at	28	0.75	0.0827684	-	0.96889	0.252408	0.654971	1.93 [0.63 - 5.91]
GENE	AGPS	alkylglycerone phosphate synthase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205401_at	82	0.292683	0.0463259	0.469084	-0.67772	0.422131	-0.407998	0.66 [0.25 - 1.80]
GENE	AGPS	alkylglycerone phosphate synthase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	39225_at	84	0.583333	0.0102295	0.16424	0.733053	0.130567	0.823666	2.28 [0.78 - 6.63]
GENE	AGPS	alkylglycerone phosphate synthase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205401_at	79	0.620253	0.00335164	0.0688658	0.787131	0.0961381	0.770446	2.16 [0.87 - 5.35]
GENE	AGPS	alkylglycerone phosphate synthase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Y09443_at	86	0.116279	0.152431	-	-0.778421	0.824682	0.103349	1.11 [0.44 - 2.77]
GENE	AGPS	alkylglycerone phosphate synthase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205401_at	104	0.711538	0.0107254	0.170177	0.818279	0.138122	0.614738	1.85 [0.82 - 4.17]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P27706	117	0.290598	0.168117	-	0.484194	0.381365	0.253793	1.29 [0.73 - 2.28]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P368645	117	0.897436	0.0117926	0.182653	0.941897	0.0134521	0.697143	2.01 [1.16 - 3.49]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P902100	117	0.461538	0.00275355	0.0587748	0.916177	0.0345744	0.816179	2.26 [1.06 - 4.82]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225113_at	204	0.465686	2.43659e-05	0.00099738	2.142	0.000637829	2.32091	10.18 [2.69 - 38.59]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205401_at	204	0.661765	1.19236e-06	6.39916e-05	1.72323	0.000250626	1.59225	4.91 [2.10 - 11.53]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225114_at	204	0.362745	0.00134204	0.0325828	1.72935	0.0667311	1.03524	2.82 [0.93 - 8.52]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225108_at	204	0.22549	0.213868	-	0.656111	0.980271	-0.0165549	0.98 [0.26 - 3.65]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225113_at	204	0.362745	2.36588e-05	0.000971361	1.55396	0.00027504	1.82367	6.19 [2.32 - 16.55]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205401_at	204	0.338235	6.21381e-06	0.000290093	1.84989	1.61218e-05	1.40683	4.08 [2.15 - 7.74]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225114_at	204	0.705882	0.0208366	0.275795	0.629823	0.04821	0.83647	2.31 [1.01 - 5.29]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225108_at	204	0.411765	0.0818536	-	-0.469737	0.563528	-0.292893	0.75 [0.28 - 2.02]
GENE	AGPS	alkylglycerone phosphate synthase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205401_at	178	0.331461	0.0258509	0.320294	0.515539	0.511119	0.167714	1.18 [0.72 - 1.95]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200003165	41	0.560976	0.092408	-	0.691519	0.797768	0.080827	1.08 [0.58 - 2.01]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205401_at	111	0.378378	0.243139	-	0.321269	0.525982	0.2118	1.24 [0.64 - 2.38]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225113_at	111	0.783784	0.15278	-	-0.515023	0.942417	-0.00835436	0.99 [0.79 - 1.24]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225114_at	111	0.81982	0.0474273	0.47595	-0.833625	0.787231	-0.0665128	0.94 [0.58 - 1.52]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225108_at	111	0.108108	0.496176	-	-0.275451	0.58488	-0.138804	0.87 [0.53 - 1.43]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205401_at	90	0.888889	0.0407349	0.43267	0.834039	0.784746	0.088799	1.09 [0.58 - 2.07]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205401_at	90	0.888889	0.025501	0.317319	0.986417	0.540817	0.226871	1.25 [0.61 - 2.60]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2388	50	0.64	0.0660652	-	0.869081	0.178642	0.594334	1.81 [0.76 - 4.31]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205401_at	138	0.507246	0.00544835	0.101243	0.670691	0.0178004	0.257425	1.29 [1.05 - 1.60]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225113_at	138	0.188406	0.000390884	0.0114756	1.64071	0.0152342	0.414666	1.51 [1.08 - 2.12]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225114_at	138	0.347826	0.00776769	0.133267	0.732279	0.0369754	0.302866	1.35 [1.02 - 1.80]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225108_at	138	0.115942	0.208078	-	0.577664	0.904471	0.0150055	1.02 [0.79 - 1.30]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205401_at	129	0.821705	0.0237432	0.302089	0.672395	0.580216	0.234686	1.26 [0.55 - 2.90]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44276	56	0.428571	0.1027	-	0.638607	0.418307	0.169544	1.18 [0.79 - 1.79]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2491	56	0.375	0.187509	-	0.477087	0.594696	0.120878	1.13 [0.72 - 1.76]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11763	56	0.803571	0.0549325	-	0.749045	0.528745	0.139759	1.15 [0.74 - 1.78]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2491	56	0.375	0.132747	-	0.566881	0.420868	0.177938	1.19 [0.77 - 1.84]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44276	56	0.196429	0.206155	-	0.608048	0.852656	0.0369788	1.04 [0.70 - 1.53]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11763	56	0.803571	0.166655	-	0.534274	0.990109	-0.00267092	1.00 [0.65 - 1.52]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225113_at	278	0.115108	0.262864	-	0.368081	0.637567	0.0838048	1.09 [0.77 - 1.54]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205401_at	278	0.564748	0.132361	-	0.283284	0.745503	-0.0498054	0.95 [0.70 - 1.29]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225114_at	278	0.741007	0.117973	-	-0.3416	0.793601	-0.035376	0.97 [0.74 - 1.26]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225108_at	278	0.205036	0.0195077	0.263265	0.592456	0.0712854	0.270311	1.31 [0.98 - 1.76]
GENE	AGPS	alkylglycerone phosphate synthase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205401_at	133	0.473684	0.00109066	0.027407	-0.779985	0.0820688	-0.196486	0.82 [0.66 - 1.03]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4347	81	0.382716	0.12692	-	1.10454	0.666506	0.288311	1.33 [0.36 - 4.95]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205401_at	185	0.843243	0.137497	-	-0.355893	0.667009	-0.100733	0.90 [0.57 - 1.43]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205401_at	185	0.843243	0.0483068	0.481365	-0.553594	0.28219	-0.276134	0.76 [0.46 - 1.26]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P368645	110	0.736364	0.0367108	0.404704	0.649256	0.385856	0.192699	1.21 [0.78 - 1.87]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P902100	110	0.454545	0.0686291	-	0.55788	0.441744	0.176975	1.19 [0.76 - 1.87]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P368645	110	0.463636	0.259452	-	0.257665	0.876367	-0.0274816	0.97 [0.69 - 1.38]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P902100	110	0.636364	0.0308791	0.361168	-0.546537	0.477992	-0.116796	0.89 [0.64 - 1.23]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205401_at	80	0.375	0.0299814	0.354115	1.26923	0.530012	0.223573	1.25 [0.62 - 2.51]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_1011	281	0.779359	0.0552895	-	-0.34331	0.452473	-0.0655654	0.94 [0.79 - 1.11]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225113_at	38	0.894737	0.00736762	0.127966	1.61942	0.0141562	1.22971	3.42 [1.28 - 9.14]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225114_at	38	0.605263	0.000470986	0.0134642	1.68925	0.00427012	1.69426	5.44 [1.70 - 17.40]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225108_at	38	0.210526	0.0394259	0.423745	1.45389	0.0792239	0.78426	2.19 [0.91 - 5.26]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205401_at	38	0.789474	0.000747482	0.0199444	1.70644	0.0112166	1.01417	2.76 [1.26 - 6.04]
GENE	AGPS	alkylglycerone phosphate synthase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205401_at	140	0.821429	0.00164049	0.0384806	0.93504	0.0331682	0.626889	1.87 [1.05 - 3.33]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206957_at	30	0.233333	0.0327967	0.375908	-0.967153	0.400545	-0.668682	0.51 [0.11 - 2.44]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210326_at	30	0.666667	0.122348	-	0.640935	0.578577	0.387868	1.47 [0.38 - 5.79]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210327_s_at	30	0.566667	0.0474151	0.475875	0.796772	0.566008	0.409501	1.51 [0.37 - 6.10]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1709796	165	0.139394	0.345297	-	-0.301572	0.34077	-0.616893	0.54 [0.15 - 1.92]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1709796	165	0.412121	0.0677973	-	-0.639985	0.183905	-1.77958	0.17 [0.01 - 2.33]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210326_at	163	0.104294	0.235204	-	-0.364818	0.638727	-0.296638	0.74 [0.22 - 2.56]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210327_s_at	163	0.889571	0.013495	0.201788	0.666363	0.166328	0.491758	1.64 [0.81 - 3.28]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206957_at	163	0.871166	0.0124421	0.190059	0.658409	0.0978752	0.640161	1.90 [0.89 - 4.05]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210327_s_at	79	0.113924	0.0114791	0.179029	-0.956564	0.750774	0.112031	1.12 [0.56 - 2.23]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210326_at	79	0.696203	0.0161956	0.230463	-0.867873	0.157353	-1.30639	0.27 [0.04 - 1.66]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206957_at	79	0.405063	0.404272	-	0.251383	0.420714	0.47372	1.61 [0.51 - 5.09]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210327_s_at	58	0.551724	0.00753293	0.130167	0.754776	0.211268	0.14377	1.15 [0.92 - 1.45]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206957_at	58	0.793103	0.260956	-	0.368021	0.803791	0.0406768	1.04 [0.76 - 1.44]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210326_at	58	0.827586	0.0498363	0.490641	0.712117	0.805791	0.0526143	1.05 [0.69 - 1.60]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210327_s_at	34	0.882353	0.135682	-	-1.05456	0.767644	-0.104566	0.90 [0.45 - 1.80]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206957_at	34	0.882353	0.0269213	0.329284	1.17364	0.829744	-0.0502277	0.95 [0.60 - 1.50]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210326_at	34	0.117647	0.22254	-	0.87401	0.882713	-0.032237	0.97 [0.63 - 1.49]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210327_s_at	158	0.151899	0.0491315	0.486389	-0.560536	0.641704	-0.380517	0.68 [0.14 - 3.39]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206957_at	158	0.139241	0.124908	-	-0.452195	0.275478	-0.774516	0.46 [0.11 - 1.85]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210326_at	158	0.683544	0.0142936	0.210469	-0.678456	0.281333	-0.980613	0.38 [0.06 - 2.23]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210327_s_at	53	0.754717	0.373996	-	-0.375703	0.750878	-0.0676866	0.93 [0.62 - 1.42]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210326_at	53	0.641509	0.0362886	0.401676	0.757063	0.105981	0.523631	1.69 [0.89 - 3.19]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206957_at	53	0.830189	0.0510243	-	-1.12381	0.287595	-0.213961	0.81 [0.54 - 1.20]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210327_s_at	53	0.830189	0.408444	-	-0.442407	0.959708	-0.0115469	0.99 [0.63 - 1.55]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210326_at	53	0.603774	0.0305713	0.358762	0.732879	0.104975	0.479113	1.61 [0.90 - 2.88]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206957_at	53	0.830189	0.113489	-	-0.93191	0.392533	-0.185469	0.83 [0.54 - 1.27]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210327_s_at	180	0.455556	0.099784	-	-0.342451	0.379487	-0.104469	0.90 [0.71 - 1.14]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206957_at	180	0.616667	0.0584274	-	0.397426	0.127434	0.127652	1.14 [0.96 - 1.34]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210326_at	180	0.411111	0.0601412	-	0.412593	0.351575	0.104559	1.11 [0.89 - 1.38]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210327_s_at	559	0.320215	0.00735749	0.127831	-0.53283	0.0394131	-0.229234	0.80 [0.64 - 0.99]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210326_at	559	0.135957	0.175091	-	-0.344452	0.599232	-0.0827428	0.92 [0.68 - 1.25]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206957_at	559	0.254025	0.0518349	-	0.493202	0.377413	0.106642	1.11 [0.88 - 1.41]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206957_at	77	0.350649	0.0492919	0.487359	0.55547	0.175598	0.176605	1.19 [0.92 - 1.54]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210327_s_at	77	0.532468	0.0138501	0.20567	0.627396	0.262684	0.352051	1.42 [0.77 - 2.63]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210326_at	77	0.87013	0.207818	-	0.463883	0.674926	-0.0585926	0.94 [0.72 - 1.24]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210327_s_at	70	0.857143	0.000478226	0.0136411	1.21137	0.0744395	1.4991	4.48 [0.86 - 23.25]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210326_at	70	0.114286	0.017966	0.248292	-0.890757	0.492679	0.380206	1.46 [0.49 - 4.33]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206957_at	70	0.171429	0.0985828	-	0.665291	0.603239	0.522489	1.69 [0.24 - 12.10]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37880_at	50	0.14	0.0110953	0.174546	-1.05348	0.0425143	-0.777857	0.46 [0.22 - 0.97]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206957_at	74	0.310811	0.0541087	-	0.651708	0.332993	0.184892	1.20 [0.83 - 1.75]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210326_at	74	0.581081	0.00192346	0.0438677	-0.964905	0.219789	-0.325646	0.72 [0.43 - 1.21]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210327_s_at	74	0.5	0.000812709	0.0214049	0.983824	0.0629449	0.424505	1.53 [0.98 - 2.39]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210327_s_at	67	0.880597	0.198315	-	0.99357	0.692479	0.726399	2.07 [0.06 - 75.66]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210326_at	67	0.149254	0.0817276	-	-1.1798	0.605243	-1.20918	0.30 [0.00 - 29.25]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206957_at	67	0.58209	0.139611	-	-1.45832	0.550822	-1.8627	0.16 [0.00 - 70.63]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210327_s_at	115	0.652174	0.067496	-	0.956031	0.397099	0.498256	1.65 [0.52 - 5.21]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210326_at	115	0.652174	0.0861619	-	-1.22661	0.83706	0.10229	1.11 [0.42 - 2.94]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206957_at	115	0.686957	0.100235	-	0.851548	0.545882	0.334184	1.40 [0.47 - 4.13]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37880_at	158	0.253165	0.187035	-	-0.432275	0.822559	0.0687297	1.07 [0.59 - 1.95]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37880_at	76	0.315789	0.041572	0.438296	-1.0134	0.293657	-0.590751	0.55 [0.18 - 1.67]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210326_at	204	0.45098	0.0393701	0.42336	-0.297091	0.136471	-0.12274	0.88 [0.75 - 1.04]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206957_at	204	0.382353	0.027748	0.336118	0.322158	0.383675	0.059141	1.06 [0.93 - 1.21]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210327_s_at	204	0.735294	0.0885042	-	-0.272772	0.616525	-0.0340065	0.97 [0.85 - 1.10]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210327_s_at	87	0.873563	0.0938729	-	-1.54867	0.62461	-0.519005	0.60 [0.07 - 4.76]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210326_at	87	0.735632	0.162214	-	-0.677653	0.275492	-0.777185	0.46 [0.11 - 1.86]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210327_s_at	87	0.873563	0.0938729	-	-1.54867	0.62461	-0.519005	0.60 [0.07 - 4.76]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206957_at	87	0.137931	0.0652083	-	1.67569	0.994012	-0.0079824	0.99 [0.12 - 7.98]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210326_at	87	0.735632	0.162214	-	-0.677653	0.275492	-0.777185	0.46 [0.11 - 1.86]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206957_at	87	0.137931	0.0652083	-	1.67569	0.994012	-0.0079824	0.99 [0.12 - 7.98]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206957_at	77	0.12987	9.36352e-05	0.00330508	-2.08674	0.165041	-3.23924	0.04 [0.00 - 3.80]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210326_at	77	0.805195	0.230595	-	0.70587	0.317925	1.18859	3.28 [0.32 - 33.82]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206957_at	77	0.12987	0.00141876	0.0341223	-1.64334	0.169024	-2.77942	0.06 [0.00 - 3.26]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210327_s_at	77	0.207792	0.0110665	0.174207	-1.47701	0.714194	-0.631721	0.53 [0.02 - 15.63]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210326_at	77	0.506494	0.186862	-	-0.883067	0.585409	-0.724624	0.48 [0.04 - 6.55]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210327_s_at	77	0.896104	0.0544176	-	1.19579	0.75094	0.452506	1.57 [0.10 - 25.71]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210326_at	136	0.897059	0.0514899	-	1.05634	0.702946	0.115294	1.12 [0.62 - 2.03]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210327_s_at	136	0.764706	0.111945	-	0.714746	0.836197	-0.0507694	0.95 [0.59 - 1.54]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206957_at	136	0.294118	0.192718	-	-0.58145	0.954435	0.0125106	1.01 [0.66 - 1.56]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206957_at	200	0.86	0.00524754	0.0983056	0.934835	0.537937	0.106771	1.11 [0.79 - 1.56]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210326_at	200	0.185	0.0354434	0.39556	-0.708049	0.0670989	-0.3249	0.72 [0.51 - 1.02]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210327_s_at	200	0.81	0.162335	-	0.465044	0.659108	0.0725287	1.08 [0.78 - 1.48]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5183	60	0.366667	0.0792031	-	-0.660375	0.615018	-0.289202	0.75 [0.24 - 2.31]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5183	60	0.566667	0.00522125	0.0979189	-1.15849	0.339745	-0.508013	0.60 [0.21 - 1.71]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11195	155	0.2	0.000703942	0.0189566	-0.939361	0.0172352	-0.265476	0.77 [0.62 - 0.95]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206957_at	286	0.839161	0.0377999	0.412429	-0.649924	0.20332	-0.141302	0.87 [0.70 - 1.08]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210326_at	286	0.293706	6.32746e-06	0.000294915	-0.857051	0.0140994	-0.351194	0.70 [0.53 - 0.93]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210327_s_at	286	0.587413	0.137782	-	0.286372	0.699343	0.0523307	1.05 [0.81 - 1.37]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210326_at	159	0.710692	0.00908754	0.150202	0.807708	0.119422	0.374173	1.45 [0.91 - 2.33]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206957_at	159	0.100629	0.0296417	0.35142	-0.878538	0.806133	0.046733	1.05 [0.72 - 1.52]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206957_at	159	0.100629	0.0200499	0.268418	-1.02203	0.898299	-0.0276886	0.97 [0.64 - 1.49]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210326_at	159	0.874214	0.0140443	0.207778	0.90071	0.0999101	0.401184	1.49 [0.93 - 2.41]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210327_s_at	159	0.389937	0.0947569	-	-0.52249	0.288707	-0.271065	0.76 [0.46 - 1.26]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210327_s_at	159	0.188679	0.200051	-	-0.464329	0.339813	-0.237997	0.79 [0.48 - 1.28]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206957_at	159	0.849057	0.126378	-	-0.888351	0.581654	0.104631	1.11 [0.77 - 1.61]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210326_at	159	0.710692	0.0277698	0.336296	0.800831	0.278786	0.30695	1.36 [0.78 - 2.37]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210327_s_at	159	0.389937	0.105196	-	-0.5934	0.199174	-0.403934	0.67 [0.36 - 1.24]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210326_at	54	0.518519	0.128482	-	-1.15926	0.382724	-1.24782	0.29 [0.02 - 4.73]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210327_s_at	54	0.685185	0.114627	-	1.06648	0.850732	-0.23683	0.79 [0.07 - 9.30]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206957_at	54	0.203704	0.0576348	-	-1.25935	0.0905221	-6.10667	0.00 [0.00 - 2.62]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210327_s_at	117	0.34188	0.0151359	0.219437	0.928797	0.217602	0.262157	1.30 [0.86 - 1.97]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210327_s_at	117	0.435897	0.0154888	0.22314	1.01284	0.131851	0.316915	1.37 [0.91 - 2.07]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206957_at	117	0.649573	0.0217758	0.284451	0.714229	0.13961	0.564465	1.76 [0.83 - 3.72]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210327_s_at	117	0.324786	0.141394	-	0.675492	0.00192981	0.791739	2.21 [1.34 - 3.64]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206957_at	117	0.555556	0.425112	-	-0.313839	0.367825	0.434703	1.54 [0.60 - 3.98]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210327_s_at	117	0.34188	0.0151359	0.219437	0.928797	0.217602	0.262157	1.30 [0.86 - 1.97]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206957_at	117	0.692308	0.147429	-	0.580617	0.00775988	1.41373	4.11 [1.45 - 11.64]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206957_at	117	0.649573	0.0217758	0.284451	0.714229	0.13961	0.564465	1.76 [0.83 - 3.72]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210326_at	117	0.350427	0.0385171	0.417452	-0.651152	0.927837	-0.048638	0.95 [0.33 - 2.73]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210326_at	117	0.350427	0.0029151	0.0615476	-1.08578	0.815543	0.131069	1.14 [0.38 - 3.43]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210326_at	117	0.888889	0.0340373	0.385216	0.968093	0.158231	0.771189	2.16 [0.74 - 6.31]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210326_at	117	0.350427	0.0385171	0.417452	-0.651152	0.927837	-0.048638	0.95 [0.33 - 2.73]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210326_at	236	0.292373	0.108426	-	0.53498	0.243118	0.257297	1.29 [0.84 - 1.99]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210327_s_at	236	0.245763	0.125783	-	-0.4367	0.801718	-0.0709241	0.93 [0.54 - 1.62]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206957_at	236	0.432203	0.10753	-	-0.431712	0.441315	-0.131088	0.88 [0.63 - 1.22]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210327_s_at	249	0.104418	0.0221141	0.287531	1.11252	0.846328	0.0424336	1.04 [0.68 - 1.60]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206957_at	249	0.285141	0.00691072	0.121806	-0.582383	0.144266	-0.19598	0.82 [0.63 - 1.07]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210326_at	249	0.702811	0.145546	-	0.32219	0.607957	0.0920593	1.10 [0.77 - 1.56]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210327_s_at	62	0.241935	0.0872075	-	1.58932	0.975901	-0.0184793	0.98 [0.30 - 3.26]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210326_at	125	0.392	0.165822	-	-0.417778	0.372279	-0.445149	0.64 [0.24 - 1.70]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210326_at	54	0.888889	0.233572	-	0.786898	0.839465	-0.0463845	0.95 [0.61 - 1.50]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210327_s_at	125	0.64	0.215263	-	0.47219	0.619784	0.182182	1.20 [0.58 - 2.46]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206957_at	62	0.112903	0.207114	-	15.1693	0.674646	-0.128973	0.88 [0.48 - 1.61]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210327_s_at	125	0.64	0.286478	-	0.313226	0.945106	-0.0199218	0.98 [0.56 - 1.73]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206957_at	125	0.768	0.0530812	-	-1.32277	0.104707	-1.94727	0.14 [0.01 - 1.50]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210326_at	62	0.225806	0.296456	-	0.766641	0.753478	-0.0592956	0.94 [0.65 - 1.36]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206957_at	125	0.816	0.111576	-	-0.809794	0.46866	-0.64357	0.53 [0.09 - 3.00]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210327_s_at	54	0.240741	0.062716	-	15.424	0.971378	0.0265069	1.03 [0.24 - 4.37]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210326_at	125	0.12	0.201205	-	1.22539	0.684641	-0.260463	0.77 [0.22 - 2.71]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206957_at	54	0.277778	0.0494975	0.488601	15.4642	0.799693	-0.0939047	0.91 [0.44 - 1.88]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210326_at	198	0.267677	0.225198	-	0.307005	0.95873	0.00483277	1.00 [0.84 - 1.21]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206957_at	198	0.116162	0.0866444	-	-0.56436	0.349774	-0.0889368	0.91 [0.76 - 1.10]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210327_s_at	198	0.651515	0.256561	-	-0.33396	0.975596	0.00365445	1.00 [0.79 - 1.27]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206957_at	198	0.106061	0.0957187	-	-0.574583	0.541978	-0.0600977	0.94 [0.78 - 1.14]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210326_at	198	0.267677	0.0379971	0.413815	0.704502	0.147267	0.165286	1.18 [0.94 - 1.48]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210327_s_at	198	0.863636	0.035689	0.397345	0.56049	0.401489	0.0791786	1.08 [0.90 - 1.30]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210327_s_at	198	0.863636	0.25892	-	0.37478	0.845421	0.021945	1.02 [0.82 - 1.27]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210326_at	198	0.267677	0.112614	-	0.548614	0.464303	0.0876307	1.09 [0.86 - 1.38]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206957_at	198	0.550505	0.125463	-	-0.328969	0.613551	-0.0384654	0.96 [0.83 - 1.12]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210326_at	62	0.129032	0.243202	-	-0.759947	0.94217	-0.0813426	0.92 [0.10 - 8.30]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210327_s_at	62	0.467742	0.0327888	0.375848	-1.3261	0.285904	-1.86873	0.15 [0.00 - 4.78]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210327_s_at	51	0.156863	0.00174642	0.0405186	-2.31741	0.24716	-3.17594	0.04 [0.00 - 9.05]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206957_at	51	0.784314	0.223631	-	-15.421	0.659395	-0.618106	0.54 [0.03 - 8.42]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206957_at	62	0.16129	0.00189287	0.043294	-1.64335	0.248705	-1.0798	0.34 [0.05 - 2.13]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210326_at	51	0.254902	0.182248	-	15.4968	0.640078	0.75056	2.12 [0.09 - 49.24]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210326_at	145	0.42069	0.00844182	0.142019	-0.87364	0.0164917	-1.69931	0.18 [0.05 - 0.73]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206957_at	177	0.491525	0.00957023	0.1562	-0.614287	0.0533536	-1.31677	0.27 [0.07 - 1.02]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210327_s_at	177	0.214689	0.00145525	0.0348486	-0.884465	0.0247912	-1.34614	0.26 [0.08 - 0.84]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206957_at	145	0.868966	0.0522029	-	-1.74078	0.548092	-0.51534	0.60 [0.11 - 3.21]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210326_at	177	0.299435	0.00144746	0.034694	-0.842154	0.0139289	-1.46489	0.23 [0.07 - 0.74]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210327_s_at	177	0.214689	0.012709	0.193064	-0.638924	0.228495	-0.608763	0.54 [0.20 - 1.47]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206957_at	177	0.491525	0.0454809	0.46375	-0.543856	0.189055	-0.985523	0.37 [0.09 - 1.62]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210326_at	177	0.299435	0.0033112	0.0681979	-0.688538	0.0103558	-1.31679	0.27 [0.10 - 0.73]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210327_s_at	145	0.786207	0.00318344	0.0660749	-2.38531	0.129575	-1.16844	0.31 [0.07 - 1.41]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210326_at	226	0.190265	0.000399622	0.0116956	-1.00372	0.239401	-0.142506	0.87 [0.68 - 1.10]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206957_at	226	0.752212	0.0685907	-	0.547569	0.535661	0.0764244	1.08 [0.85 - 1.37]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210327_s_at	226	0.89823	0.0677053	-	0.695883	0.839742	-0.0247268	0.98 [0.77 - 1.24]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210326_at	49	0.22449	0.0422481	0.442793	-1.14937	0.0709291	-3.51331	0.03 [0.00 - 1.35]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206957_at	55	0.2	0.00444892	0.0863098	-1.33632	0.108159	-2.3599	0.09 [0.01 - 1.68]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206957_at	49	0.204082	0.00459602	0.0885594	-1.53213	0.018493	-3.99682	0.02 [0.00 - 0.51]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210327_s_at	55	0.2	0.174019	-	-0.652443	0.879041	0.135942	1.15 [0.20 - 6.60]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210327_s_at	55	0.4	0.100532	-	0.8699	0.408782	0.781623	2.19 [0.34 - 13.96]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210326_at	55	0.890909	0.0757417	-	0.956813	0.62237	-0.647253	0.52 [0.04 - 6.88]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210327_s_at	49	0.632653	0.207596	-	-0.819997	0.788809	-0.304984	0.74 [0.08 - 6.87]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206957_at	55	0.345455	0.0569724	-	-0.832756	0.0804065	-2.53507	0.08 [0.00 - 1.36]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210326_at	55	0.690909	0.0427779	0.446289	-1.36915	0.131788	-2.27737	0.10 [0.01 - 1.98]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206957_at	63	0.285714	0.00733174	0.127486	-0.900797	0.974548	-0.0414703	0.96 [0.08 - 12.26]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210327_s_at	63	0.142857	2.4455e-07	1.477e-05	-1.93818	0.546211	-0.406525	0.67 [0.18 - 2.49]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210326_at	63	0.190476	0.00095618	0.0245445	-1.16718	0.0601456	-22.1044	0.00 [0.00 - 2.57]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7706736_3p_at	28	0.321429	0.0691516	-	-1.03791	0.946474	-0.152632	0.86 [0.01 - 73.95]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g219432_3p_s_at	28	0.142857	0.0685508	-	-1.19105	0.37989	-5.01753	0.01 [0.00 - 483.99]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210326_at	82	0.195122	0.121764	-	0.800506	0.466747	0.374266	1.45 [0.53 - 3.98]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206957_at	82	0.256098	0.0609741	-	0.876622	0.176065	0.535511	1.71 [0.79 - 3.71]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210326_at	79	0.886076	0.103951	-	0.614215	0.836482	0.108712	1.11 [0.40 - 3.13]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206957_at	79	0.734177	0.125532	-	-0.490745	0.919052	0.0344003	1.03 [0.53 - 2.01]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206957_at	104	0.269231	0.0021594	0.0482296	1.65532	0.0165525	1.32606	3.77 [1.27 - 11.14]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210326_at	104	0.403846	0.00792793	0.135368	1.06143	0.024365	1.66797	5.30 [1.24 - 22.65]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P83590	117	0.880342	0.00214449	0.0479571	1.05573	0.233748	0.237683	1.27 [0.86 - 1.88]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P83514	117	0.393162	0.0114876	0.179128	-0.710537	0.0621723	-0.398097	0.67 [0.44 - 1.02]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210327_s_at	204	0.607843	0.0418503	0.440152	-0.85323	0.466715	-0.154697	0.86 [0.56 - 1.30]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210327_s_at	204	0.362745	0.19066	-	0.395076	0.989026	-0.00210592	1.00 [0.74 - 1.35]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210326_at	204	0.137255	0.0178648	0.247292	-0.943474	0.464567	0.17902	1.20 [0.74 - 1.93]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210326_at	204	0.147059	0.00421997	0.0827696	-0.863148	0.710368	0.0668284	1.07 [0.75 - 1.52]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206957_at	204	0.318627	0.0022523	0.0499177	1.92532	0.0304568	0.569197	1.77 [1.06 - 2.96]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206957_at	204	0.617647	0.156083	-	0.384933	0.603894	0.0841723	1.09 [0.79 - 1.50]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210326_at	178	0.898876	0.10963	-	0.490134	0.375822	0.395744	1.49 [0.62 - 3.57]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206957_at	178	0.207865	0.13152	-	-0.350365	0.622054	-0.116252	0.89 [0.56 - 1.41]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210326_at	111	0.702703	0.179756	-	0.365423	0.788096	0.0464715	1.05 [0.75 - 1.47]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206957_at	111	0.126126	0.0701318	-	-0.624178	0.637116	-0.0707708	0.93 [0.69 - 1.25]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210327_s_at	111	0.108108	0.0314553	0.365643	-0.772768	0.806697	0.0357437	1.04 [0.78 - 1.38]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210326_at	90	0.766667	0.00350238	0.0713383	-1.84917	0.951292	-0.031256	0.97 [0.36 - 2.64]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210326_at	90	0.766667	0.0156735	0.225066	-1.59744	0.990128	0.00717504	1.01 [0.32 - 3.14]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210327_s_at	90	0.655556	0.279567	-	0.405963	0.475043	0.640132	1.90 [0.33 - 10.99]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210327_s_at	90	0.288889	0.260111	-	0.427106	0.466143	0.580426	1.79 [0.38 - 8.51]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206957_at	90	0.6	0.156425	-	-0.503221	0.398267	0.659216	1.93 [0.42 - 8.92]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206957_at	90	0.822222	0.0578581	-	0.77319	0.164808	1.07085	2.92 [0.64 - 13.22]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2278	50	0.38	0.251844	-	-0.544913	0.829965	-0.0874432	0.92 [0.41 - 2.04]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210327_s_at	138	0.101449	0.00258397	0.0558231	-0.935592	0.399848	-2.93618	0.05 [0.00 - 49.38]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210326_at	138	0.297101	0.00243605	0.0532121	-0.722713	0.0445006	-14.2776	0.00 [0.00 - 0.70]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206957_at	138	0.73913	0.0387396	0.419	-0.633837	0.0870355	-7.90688	0.00 [0.00 - 3.16]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206957_at	129	0.186047	0.028392	0.341375	0.774056	0.245066	0.159797	1.17 [0.90 - 1.54]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210326_at	129	0.317829	0.0136545	0.203537	0.690467	0.14897	0.253709	1.29 [0.91 - 1.82]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210327_s_at	129	0.186047	0.16211	-	0.496386	0.926871	-0.0218856	0.98 [0.61 - 1.56]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43655	56	0.214286	0.00141935	0.0341342	-1.20187	0.483951	-0.39359	0.67 [0.22 - 2.03]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43655	56	0.160714	0.000678902	0.0183837	-1.41776	0.291244	-0.58353	0.56 [0.19 - 1.65]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206957_at	278	0.258993	0.00414646	0.0816224	-0.61383	0.0360212	-1.27948	0.28 [0.08 - 0.92]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210327_s_at	278	0.143885	0.0567818	-	0.651379	0.79876	-0.114597	0.89 [0.37 - 2.15]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210326_at	278	0.442446	0.208919	-	-0.240688	0.727824	-0.170953	0.84 [0.32 - 2.21]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206957_at	133	0.601504	0.0017523	0.040631	0.731392	0.0195514	1.50611	4.51 [1.27 - 15.97]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210326_at	133	0.654135	0.0036105	0.0730955	0.694252	0.0128374	5.20516	182.21 [3.02 - 10995.97]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210327_s_at	133	0.62406	0.00352399	0.0716905	0.686983	0.00359155	0.608584	1.84 [1.22 - 2.77]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17462	81	0.185185	0.0216268	0.283089	15.5124	0.181933	0.90263	2.47 [0.66 - 9.28]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10612	81	0.444444	0.378371	-	-0.458291	0.837025	0.0681351	1.07 [0.56 - 2.05]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206957_at	185	0.113514	0.102013	-	0.46202	0.609362	0.181363	1.20 [0.60 - 2.40]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210327_s_at	185	0.891892	0.0840909	-	0.45003	0.68431	0.221171	1.25 [0.43 - 3.62]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210326_at	185	0.135135	0.148119	-	0.338432	0.56628	-0.116579	0.89 [0.60 - 1.33]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210327_s_at	185	0.508108	0.0419951	0.441115	-0.359532	0.820821	-0.134577	0.87 [0.27 - 2.80]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206957_at	185	0.859459	0.15232	-	-0.349987	0.845372	0.0650051	1.07 [0.56 - 2.05]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210326_at	185	0.135135	0.147135	-	0.380345	0.600826	-0.118817	0.89 [0.57 - 1.39]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83590	110	0.390909	0.0168703	0.237341	-0.709997	0.694989	-0.123113	0.88 [0.48 - 1.64]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83514	110	0.309091	0.017025	0.238903	-0.718631	0.926915	0.0271493	1.03 [0.58 - 1.84]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83590	110	0.390909	0.120555	-	-0.360498	0.76866	-0.0654627	0.94 [0.61 - 1.45]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83514	110	0.690909	0.0187676	0.256138	0.557286	0.610498	0.11061	1.12 [0.73 - 1.71]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206957_at	80	0.15	0.0656751	-	15.29	0.973764	-0.00521012	0.99 [0.73 - 1.36]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210326_at	80	0.6625	0.172273	-	-0.694605	0.768008	-0.0544912	0.95 [0.66 - 1.36]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210327_s_at	80	0.45	0.0866385	-	0.865533	0.241628	0.200682	1.22 [0.87 - 1.71]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3160	281	0.142349	0.0531298	-	0.424608	0.744799	0.0171382	1.02 [0.92 - 1.13]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:214326	59	0.355932	0.0581807	-	1.32562	0.144803	1.44386	4.24 [0.61 - 29.51]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210326_at	38	0.236842	0.0661473	-	1.68763	0.832461	0.067832	1.07 [0.57 - 2.01]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206957_at	38	0.868421	0.0425406	0.444726	1.13834	0.560361	0.215158	1.24 [0.60 - 2.56]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210327_s_at	38	0.421053	0.0337085	0.382766	1.06358	0.216615	1.19263	3.30 [0.50 - 21.86]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210326_at	140	0.178571	0.117178	-	-0.57814	0.533479	-0.341679	0.71 [0.24 - 2.08]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210327_s_at	140	0.15	0.0143033	0.210573	-0.853642	0.203824	-1.1715	0.31 [0.05 - 1.89]
GENE	AGXT	alanine-glyoxylate aminotransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206957_at	140	0.542857	0.00399786	0.0792876	-0.895674	0.0748628	-3.05134	0.05 [0.00 - 1.36]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1783963	165	0.412121	0.0184053	0.252608	-0.563468	0.136179	-1.66614	0.19 [0.02 - 1.69]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1783963	165	0.581818	0.0123529	0.18905	-1.0252	0.134331	-2.41868	0.09 [0.00 - 2.11]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	229229_at	163	0.104294	0.00738539	0.128203	-0.763429	0.0803883	-1.72616	0.18 [0.03 - 1.23]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	229229_at	79	0.126582	0.233664	-	-0.484593	0.628899	-0.327739	0.72 [0.19 - 2.72]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	229229_at	180	0.355556	0.121437	-	-0.330544	0.625087	-0.0692742	0.93 [0.71 - 1.23]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	229229_at	559	0.384615	0.0333851	0.380344	-0.431424	0.172318	-0.221853	0.80 [0.58 - 1.10]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	229229_at	77	0.844156	0.105266	-	0.517769	0.517817	0.150634	1.16 [0.74 - 1.84]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	229229_at	70	0.428571	0.0701301	-	-0.483287	0.476697	-0.643823	0.53 [0.09 - 3.09]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	229229_at	74	0.405405	0.0386299	0.418237	0.627843	0.121687	0.399863	1.49 [0.90 - 2.47]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	229229_at	67	0.38806	0.0154141	0.222359	-1.73768	0.165817	-4.88441	0.01 [0.00 - 7.57]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	229229_at	115	0.452174	0.178253	-	0.773737	0.391282	0.829066	2.29 [0.34 - 15.25]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	229229_at	204	0.651961	0.0313381	0.364737	-0.327919	0.149499	-0.112523	0.89 [0.77 - 1.04]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	229229_at	87	0.655172	0.0118116	0.182873	0.924454	0.33617	0.629421	1.88 [0.52 - 6.77]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	229229_at	87	0.655172	0.0118116	0.182873	0.924454	0.33617	0.629421	1.88 [0.52 - 6.77]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	229229_at	77	0.805195	0.00745394	0.129117	1.38025	0.125609	2.09855	8.15 [0.56 - 119.58]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	229229_at	77	0.805195	0.10526	-	1.00334	0.528745	0.947511	2.58 [0.14 - 49.19]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15257	60	0.85	0.00837838	0.141204	1.18772	0.496436	0.233591	1.26 [0.64 - 2.48]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15257	60	0.25	8.29099e-05	0.00296861	-1.48177	0.00477703	-2.25058	0.11 [0.02 - 0.50]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2889	155	0.116129	1.14212e-06	6.15037e-05	-1.41234	0.165059	-0.254096	0.78 [0.54 - 1.11]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229229_at	159	0.207547	0.0269867	0.329829	-0.731021	0.266135	-0.324388	0.72 [0.41 - 1.28]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229229_at	159	0.100629	0.0374808	0.410178	-0.840923	0.696365	-0.111232	0.89 [0.51 - 1.56]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229229_at	159	0.144654	0.0880573	-	-0.724561	0.634356	-0.158578	0.85 [0.44 - 1.64]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	229229_at	236	0.885593	0.0537424	-	0.664056	0.699472	0.102818	1.11 [0.66 - 1.87]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	229229_at	249	0.2249	0.10339	-	-0.382222	0.668888	0.0885051	1.09 [0.73 - 1.64]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	229229_at	177	0.649718	0.00342425	0.07006	-0.98537	0.0914939	-1.15131	0.32 [0.08 - 1.20]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	229229_at	177	0.683616	0.00266028	0.0571567	-0.891178	0.0330572	-1.26822	0.28 [0.09 - 0.90]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	229229_at	145	0.57931	0.0270384	0.330259	-0.827238	0.34769	-0.778563	0.46 [0.09 - 2.33]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	229229_at	226	0.10177	0.169232	-	0.956302	0.583779	-0.0818959	0.92 [0.69 - 1.24]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	229229_at	55	0.763636	0.0757416	-	-1.24452	0.335096	-1.08328	0.34 [0.04 - 3.06]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	229229_at	55	0.763636	0.00649611	0.116113	-15.5763	0.0359094	-2.84604	0.06 [0.00 - 0.83]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	229229_at	49	0.734694	0.0312066	0.363717	-15.5359	0.0521622	-3.09493	0.05 [0.00 - 1.03]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	128949	34	0.529412	0.0136159	0.203114	1.09623	0.0756399	2.16283	8.70 [0.80 - 94.54]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	229229_at	63	0.190476	0.000287956	0.00881832	-1.26695	0.0345362	-17.5143	0.00 [0.00 - 0.28]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.193228.0.S1_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.163722	-6.6601	0.00 [0.00 - 15.08]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	229229_at	204	0.431373	0.0801748	-	-0.634683	0.393696	-0.170497	0.84 [0.57 - 1.25]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	229229_at	204	0.45098	0.0111499	0.175187	-0.689953	0.334524	-0.144391	0.87 [0.65 - 1.16]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	229229_at	111	0.756757	0.0497915	0.490372	0.55057	0.659806	0.0839941	1.09 [0.75 - 1.58]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4933	50	0.12	0.0303277	0.356848	-1.17099	0.768221	0.136212	1.15 [0.46 - 2.84]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	229229_at	138	0.318841	0.0264272	0.325155	-0.536641	0.195239	-4.24065	0.01 [0.00 - 8.81]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2066	56	0.642857	0.104202	-	0.587183	0.260393	0.581186	1.79 [0.65 - 4.92]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8081	56	0.232143	0.0160379	0.22884	-0.863333	0.118642	-0.599037	0.55 [0.26 - 1.17]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2066	56	0.642857	0.0218258	0.284908	0.777633	0.129654	0.769265	2.16 [0.80 - 5.84]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8081	56	0.232143	0.0110268	0.17374	-0.949424	0.108237	-0.68888	0.50 [0.22 - 1.16]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	229229_at	278	0.111511	0.0244625	0.308379	-0.6444	0.721673	-0.197899	0.82 [0.28 - 2.44]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P63468	110	0.709091	0.331033	-	0.317154	0.636794	-0.061776	0.94 [0.73 - 1.21]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P156076	110	0.136364	0.0684848	-	0.709139	0.58478	-0.0527917	0.95 [0.78 - 1.15]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P63468	110	0.290909	0.056731	-	0.521369	0.828148	-0.021432	0.98 [0.81 - 1.19]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P156076	110	0.154545	0.184254	-	0.621793	0.698593	-0.045901	0.96 [0.76 - 1.20]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:430214	59	0.898305	0.0842596	-	1.07035	0.217762	1.19832	3.31 [0.49 - 22.29]
GENE	AGXT2	alanine--glyoxylate aminotransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	229229_at	38	0.447368	0.221622	-	-0.573187	0.512741	-0.364401	0.69 [0.23 - 2.07]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AHCY	adenosylhomocysteinase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200903_s_at	30	0.866667	0.272218	-	-0.784272	0.770832	0.0961543	1.10 [0.58 - 2.10]
GENE	AHCY	adenosylhomocysteinase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1657862	165	0.145455	0.021687	0.28364	1.02276	0.317349	0.18032	1.20 [0.84 - 1.71]
GENE	AHCY	adenosylhomocysteinase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1657862	165	0.236364	0.213178	-	0.596901	0.567498	0.151932	1.16 [0.69 - 1.96]
GENE	AHCY	adenosylhomocysteinase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200903_s_at	163	0.533742	0.00359857	0.0729022	0.573083	0.189019	0.209182	1.23 [0.90 - 1.68]
GENE	AHCY	adenosylhomocysteinase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200903_s_at	79	0.392405	0.0107036	0.169918	0.798242	0.323231	0.23919	1.27 [0.79 - 2.04]
GENE	AHCY	adenosylhomocysteinase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200903_s_at	58	0.862069	0.0203436	0.271185	0.920011	0.775735	0.0991981	1.10 [0.56 - 2.19]
GENE	AHCY	adenosylhomocysteinase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200903_s_at	34	0.176471	0.138312	-	0.883233	0.660826	0.143243	1.15 [0.61 - 2.19]
GENE	AHCY	adenosylhomocysteinase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200903_s_at	158	0.892405	0.0198278	0.266314	-1.28889	0.109877	-0.284992	0.75 [0.53 - 1.07]
GENE	AHCY	adenosylhomocysteinase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200903_s_at	53	0.358491	0.00551929	0.102273	-0.983723	0.081253	-0.909273	0.40 [0.14 - 1.12]
GENE	AHCY	adenosylhomocysteinase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200903_s_at	53	0.358491	0.00720574	0.125797	-0.907452	0.11721	-0.781677	0.46 [0.17 - 1.22]
GENE	AHCY	adenosylhomocysteinase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200903_s_at	180	0.661111	0.0395178	0.424377	0.442107	0.135847	0.351465	1.42 [0.90 - 2.26]
GENE	AHCY	adenosylhomocysteinase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200903_s_at	559	0.470483	0.0188905	0.25733	0.477763	0.254208	0.189971	1.21 [0.87 - 1.68]
GENE	AHCY	adenosylhomocysteinase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200903_s_at	77	0.818182	2.52602e-05	0.00103016	1.37281	0.0246551	0.968499	2.63 [1.13 - 6.13]
GENE	AHCY	adenosylhomocysteinase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200903_s_at	70	0.314286	0.103359	-	-0.453364	0.290207	-0.317829	0.73 [0.40 - 1.31]
GENE	AHCY	adenosylhomocysteinase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40821_at	50	0.84	0.0041465	0.0816231	1.22952	0.124018	0.433488	1.54 [0.89 - 2.68]
GENE	AHCY	adenosylhomocysteinase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200903_s_at	74	0.837838	0.0471765	0.474395	0.700882	0.197949	0.600627	1.82 [0.73 - 4.55]
GENE	AHCY	adenosylhomocysteinase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200903_s_at	67	0.567164	0.00110411	0.0276895	2.64507	0.0803934	1.83279	6.25 [0.80 - 48.78]
GENE	AHCY	adenosylhomocysteinase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200903_s_at	115	0.417391	0.0033472	0.0687925	-1.69958	0.0424034	-1.78374	0.17 [0.03 - 0.94]
GENE	AHCY	adenosylhomocysteinase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40821_at	158	0.791139	0.0158735	0.22714	-1.08701	0.329573	-0.275084	0.76 [0.44 - 1.32]
GENE	AHCY	adenosylhomocysteinase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40821_at	76	0.881579	0.340449	-	0.606361	0.900206	-0.0703489	0.93 [0.31 - 2.80]
GENE	AHCY	adenosylhomocysteinase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200903_s_at	204	0.892157	0.204494	-	-0.281551	0.765039	-0.0474167	0.95 [0.70 - 1.30]
GENE	AHCY	adenosylhomocysteinase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200903_s_at	87	0.321839	0.0011773	0.029215	2.02217	0.00451628	1.03248	2.81 [1.38 - 5.73]
GENE	AHCY	adenosylhomocysteinase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200903_s_at	87	0.321839	0.0011773	0.029215	2.02217	0.00451628	1.03248	2.81 [1.38 - 5.73]
GENE	AHCY	adenosylhomocysteinase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200903_s_at	77	0.792208	0.0747812	-	1.09626	0.300272	0.653947	1.92 [0.56 - 6.63]
GENE	AHCY	adenosylhomocysteinase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200903_s_at	77	0.103896	0.19539	-	15.1945	0.415048	0.442027	1.56 [0.54 - 4.50]
GENE	AHCY	adenosylhomocysteinase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200903_s_at	136	0.720588	0.10237	-	0.740394	0.954344	0.029715	1.03 [0.37 - 2.85]
GENE	AHCY	adenosylhomocysteinase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200903_s_at	200	0.23	0.103464	-	0.698776	0.602063	-0.186905	0.83 [0.41 - 1.67]
GENE	AHCY	adenosylhomocysteinase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7732	60	0.433333	0.00335436	0.0689107	1.21973	0.0346229	0.546269	1.73 [1.04 - 2.87]
GENE	AHCY	adenosylhomocysteinase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7732	60	0.533333	0.0381562	0.414931	0.791936	0.284858	0.236998	1.27 [0.82 - 1.96]
GENE	AHCY	adenosylhomocysteinase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4624	155	0.896774	5.00582e-06	0.000238266	1.33434	0.000957203	0.325887	1.39 [1.14 - 1.68]
GENE	AHCY	adenosylhomocysteinase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200903_s_at	286	0.583916	0.00112826	0.028195	-0.681172	0.0433515	-0.438804	0.64 [0.42 - 0.99]
GENE	AHCY	adenosylhomocysteinase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200903_s_at	159	0.886792	0.020744	0.274932	0.885472	0.0751739	0.636742	1.89 [0.94 - 3.81]
GENE	AHCY	adenosylhomocysteinase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200903_s_at	159	0.886792	0.00433161	0.0845019	1.03684	0.0115459	0.875109	2.40 [1.22 - 4.73]
GENE	AHCY	adenosylhomocysteinase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200903_s_at	159	0.886792	0.00619471	0.111909	1.12772	0.012479	1.01762	2.77 [1.25 - 6.15]
GENE	AHCY	adenosylhomocysteinase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200903_s_at	54	0.166667	0.164175	-	15.3534	0.844038	0.0817712	1.09 [0.48 - 2.45]
GENE	AHCY	adenosylhomocysteinase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200903_s_at	117	0.25641	0.0283736	0.341225	-0.72289	0.304599	-0.261826	0.77 [0.47 - 1.27]
GENE	AHCY	adenosylhomocysteinase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200903_s_at	117	0.299145	0.0064603	0.115617	-0.991223	0.168356	-0.40558	0.67 [0.37 - 1.19]
GENE	AHCY	adenosylhomocysteinase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200903_s_at	117	0.25641	0.000562821	0.0156755	-1.27294	0.36348	-0.278135	0.76 [0.42 - 1.38]
GENE	AHCY	adenosylhomocysteinase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200903_s_at	117	0.25641	0.0283736	0.341225	-0.72289	0.304599	-0.261826	0.77 [0.47 - 1.27]
GENE	AHCY	adenosylhomocysteinase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200903_s_at	236	0.838983	0.000123243	0.00420896	1.0699	0.000343333	1.19189	3.29 [1.71 - 6.32]
GENE	AHCY	adenosylhomocysteinase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200903_s_at	249	0.835341	0.000481606	0.0137235	0.836969	0.00210431	0.821612	2.27 [1.35 - 3.84]
GENE	AHCY	adenosylhomocysteinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200903_s_at	125	0.12	0.0785524	-	1.2025	0.40927	0.158203	1.17 [0.80 - 1.71]
GENE	AHCY	adenosylhomocysteinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200903_s_at	54	0.759259	0.0498785	0.490894	1.10947	0.401744	0.415027	1.51 [0.57 - 4.00]
GENE	AHCY	adenosylhomocysteinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200903_s_at	62	0.774194	0.0272883	0.33233	1.04135	0.283379	0.428349	1.53 [0.70 - 3.36]
GENE	AHCY	adenosylhomocysteinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200903_s_at	125	0.16	0.0650897	-	1.6777	0.376316	0.221832	1.25 [0.76 - 2.04]
GENE	AHCY	adenosylhomocysteinase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200903_s_at	198	0.126263	0.22547	-	-0.362264	0.609634	0.0962311	1.10 [0.76 - 1.59]
GENE	AHCY	adenosylhomocysteinase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200903_s_at	198	0.121212	0.0235185	0.300108	-0.740408	0.346436	-0.216742	0.81 [0.51 - 1.26]
GENE	AHCY	adenosylhomocysteinase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200903_s_at	198	0.121212	0.0232775	0.297973	-0.74653	0.404096	-0.201994	0.82 [0.51 - 1.31]
GENE	AHCY	adenosylhomocysteinase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200903_s_at	62	0.693548	0.296796	-	-0.78795	0.955623	0.0172456	1.02 [0.55 - 1.87]
GENE	AHCY	adenosylhomocysteinase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200903_s_at	51	0.333333	0.0233478	0.298596	-2.11759	0.196135	-0.544479	0.58 [0.25 - 1.32]
GENE	AHCY	adenosylhomocysteinase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200903_s_at	177	0.457627	0.080412	-	-0.470473	0.270819	-0.298374	0.74 [0.44 - 1.26]
GENE	AHCY	adenosylhomocysteinase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200903_s_at	177	0.457627	0.100497	-	-0.383521	0.670729	-0.10047	0.90 [0.57 - 1.44]
GENE	AHCY	adenosylhomocysteinase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200903_s_at	145	0.331034	0.00605485	0.109939	-0.886194	0.133397	-0.519157	0.60 [0.30 - 1.17]
GENE	AHCY	adenosylhomocysteinase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200903_s_at	226	0.402655	0.0160778	0.229251	-0.669814	0.0495148	-0.487596	0.61 [0.38 - 1.00]
GENE	AHCY	adenosylhomocysteinase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200903_s_at	55	0.509091	0.146594	-	-0.668593	0.471309	-0.217054	0.80 [0.45 - 1.45]
GENE	AHCY	adenosylhomocysteinase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200903_s_at	55	0.872727	0.120806	-	0.810249	0.786477	0.102013	1.11 [0.53 - 2.32]
GENE	AHCY	adenosylhomocysteinase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200903_s_at	49	0.44898	0.124535	-	-0.875149	0.512626	-0.255071	0.77 [0.36 - 1.66]
GENE	AHCY	adenosylhomocysteinase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	840364	34	0.705882	0.0817158	-	0.757772	0.390388	0.458722	1.58 [0.56 - 4.51]
GENE	AHCY	adenosylhomocysteinase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200903_s_at	63	0.206349	0.121546	-	0.740815	0.363859	0.194076	1.21 [0.80 - 1.85]
GENE	AHCY	adenosylhomocysteinase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9951914_3p_a_at	28	0.178571	0.107985	-	1.52874	0.485811	-0.23151	0.79 [0.41 - 1.52]
GENE	AHCY	adenosylhomocysteinase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200903_s_at	82	0.548781	0.00374922	0.0753312	0.975741	0.0676181	0.719818	2.05 [0.95 - 4.45]
GENE	AHCY	adenosylhomocysteinase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40821_at	84	0.642857	0.00143055	0.0343573	0.930948	0.174217	0.483304	1.62 [0.81 - 3.26]
GENE	AHCY	adenosylhomocysteinase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200903_s_at	79	0.151899	0.12277	-	0.584171	0.966345	-0.0144343	0.99 [0.50 - 1.93]
GENE	AHCY	adenosylhomocysteinase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M61832_s_at	86	0.186047	0.0517473	-	-0.856353	0.820725	-0.133491	0.88 [0.28 - 2.78]
GENE	AHCY	adenosylhomocysteinase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200903_s_at	104	0.875	0.0385755	0.417859	0.810764	0.379099	0.38365	1.47 [0.62 - 3.45]
GENE	AHCY	adenosylhomocysteinase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P17575	117	0.82906	0.000502865	0.0142395	1.06446	0.000147236	0.906303	2.48 [1.55 - 3.95]
GENE	AHCY	adenosylhomocysteinase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P57367	117	0.717949	8.06255e-06	0.000367546	1.23315	0.000906626	0.80393	2.23 [1.39 - 3.59]
GENE	AHCY	adenosylhomocysteinase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200903_s_at	204	0.676471	0.01483	0.216202	0.864367	0.307141	0.504315	1.66 [0.63 - 4.36]
GENE	AHCY	adenosylhomocysteinase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200903_s_at	204	0.75	9.92233e-05	0.00347833	1.02828	0.000186206	1.28069	3.60 [1.84 - 7.05]
GENE	AHCY	adenosylhomocysteinase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200903_s_at	178	0.320225	0.0124945	0.190651	-0.499386	0.410199	-0.231319	0.79 [0.46 - 1.38]
GENE	AHCY	adenosylhomocysteinase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200008066	41	0.536585	0.0571086	-	0.795026	0.278982	0.238124	1.27 [0.82 - 1.95]
GENE	AHCY	adenosylhomocysteinase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200903_s_at	111	0.783784	0.143106	-	-0.527449	0.782101	-0.0595419	0.94 [0.62 - 1.44]
GENE	AHCY	adenosylhomocysteinase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200903_s_at	90	0.755556	0.156711	-	-0.621377	0.714826	-0.0826762	0.92 [0.59 - 1.43]
GENE	AHCY	adenosylhomocysteinase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200903_s_at	90	0.211111	0.296609	-	0.556008	0.834061	-0.0535781	0.95 [0.57 - 1.56]
GENE	AHCY	adenosylhomocysteinase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	206	50	0.8	0.174015	-	0.721802	0.489828	0.805401	2.24 [0.23 - 22.01]
GENE	AHCY	adenosylhomocysteinase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200903_s_at	138	0.152174	0.0627257	-	0.776142	0.781722	-0.0385361	0.96 [0.73 - 1.26]
GENE	AHCY	adenosylhomocysteinase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200903_s_at	129	0.124031	0.0882647	-	0.853074	0.133997	0.4396	1.55 [0.87 - 2.76]
GENE	AHCY	adenosylhomocysteinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8045	56	0.892857	0.00829179	0.14009	1.17164	0.426825	0.244366	1.28 [0.70 - 2.33]
GENE	AHCY	adenosylhomocysteinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3331	56	0.642857	0.102459	-	0.562796	0.558787	0.143109	1.15 [0.71 - 1.86]
GENE	AHCY	adenosylhomocysteinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8045	56	0.892857	0.00671829	0.119177	1.32304	0.487645	0.224601	1.25 [0.66 - 2.36]
GENE	AHCY	adenosylhomocysteinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3331	56	0.607143	0.119715	-	0.54859	0.708501	0.090394	1.09 [0.68 - 1.76]
GENE	AHCY	adenosylhomocysteinase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200903_s_at	278	0.899281	0.0951127	-	-0.603924	0.764452	0.0480468	1.05 [0.77 - 1.44]
GENE	AHCY	adenosylhomocysteinase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200903_s_at	133	0.255639	0.0364432	0.402787	-0.532711	0.310704	-0.140951	0.87 [0.66 - 1.14]
GENE	AHCY	adenosylhomocysteinase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16604	81	0.333333	0.0418231	0.439971	1.84119	0.263648	0.444463	1.56 [0.72 - 3.40]
GENE	AHCY	adenosylhomocysteinase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13026	81	0.703704	0.00831768	0.140424	1.28659	0.10347	0.76372	2.15 [0.86 - 5.38]
GENE	AHCY	adenosylhomocysteinase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200903_s_at	185	0.562162	0.028473	0.342032	-0.393957	0.425048	-0.07876	0.92 [0.76 - 1.12]
GENE	AHCY	adenosylhomocysteinase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200903_s_at	185	0.562162	0.0244639	0.308392	-0.371117	0.317021	-0.0891111	0.91 [0.77 - 1.09]
GENE	AHCY	adenosylhomocysteinase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P57367	110	0.181818	0.187543	-	-0.389364	0.718066	0.0591365	1.06 [0.77 - 1.46]
GENE	AHCY	adenosylhomocysteinase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P17575	110	0.681818	0.112171	-	0.486465	0.897983	0.0384055	1.04 [0.58 - 1.87]
GENE	AHCY	adenosylhomocysteinase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P57367	110	0.145455	0.041196	0.435777	-0.71346	0.790169	-0.0552558	0.95 [0.63 - 1.42]
GENE	AHCY	adenosylhomocysteinase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P17575	110	0.481818	0.117027	-	0.362237	0.510494	0.159056	1.17 [0.73 - 1.88]
GENE	AHCY	adenosylhomocysteinase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200903_s_at	80	0.8	0.0350465	0.392662	-1.87996	0.501058	-0.190925	0.83 [0.47 - 1.44]
GENE	AHCY	adenosylhomocysteinase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3730	281	0.540925	0.0335158	0.381324	0.297857	0.272415	0.13125	1.14 [0.90 - 1.44]
GENE	AHCY	adenosylhomocysteinase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:320818	59	0.762712	0.0332608	0.37941	-1.89876	0.153989	-1.1723	0.31 [0.06 - 1.55]
GENE	AHCY	adenosylhomocysteinase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:470496	59	0.254237	0.240737	-	0.85358	0.931133	-0.0561208	0.95 [0.26 - 3.38]
GENE	AHCY	adenosylhomocysteinase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200903_s_at	38	0.315789	0.00363384	0.0734731	1.92052	0.0233556	1.19994	3.32 [1.18 - 9.37]
GENE	AHCY	adenosylhomocysteinase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200903_s_at	140	0.214286	0.154841	-	0.574529	0.502431	0.177256	1.19 [0.71 - 2.00]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200848_at	30	0.533333	0.00220999	0.0491509	1.27632	0.0286002	0.793876	2.21 [1.09 - 4.50]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200850_s_at	30	0.4	0.0330611	0.377906	-0.872752	0.938724	-0.0531609	0.95 [0.24 - 3.68]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200849_s_at	30	0.5	0.0667722	-	0.742705	0.472939	0.44966	1.57 [0.46 - 5.35]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207464_at	30	0.166667	0.0944055	-	-0.868819	0.935923	0.061252	1.06 [0.24 - 4.73]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1770412	165	0.721212	0.0522846	-	-0.55655	0.06871	-0.547155	0.58 [0.32 - 1.04]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1770412	165	0.206061	0.0190496	0.258867	-0.849633	0.0336932	-0.9188	0.40 [0.17 - 0.93]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200849_s_at	163	0.766871	0.00912241	0.150638	0.567199	0.972638	-0.0063363	0.99 [0.69 - 1.43]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207464_at	163	0.705521	0.32038	-	-0.222521	0.924536	-0.0575028	0.94 [0.29 - 3.10]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200848_at	163	0.895706	0.0281571	0.339463	0.644003	0.989664	-0.00216529	1.00 [0.72 - 1.38]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200850_s_at	163	0.723926	0.0168868	0.237508	0.502749	0.484203	0.11462	1.12 [0.81 - 1.55]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200848_at	79	0.873418	0.0325203	0.37381	0.808079	0.62992	0.103102	1.11 [0.73 - 1.69]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207464_at	79	0.126582	0.0019367	0.0441155	-1.11995	0.198043	-0.993042	0.37 [0.08 - 1.68]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200850_s_at	79	0.860759	0.0979594	-	0.631813	0.703135	0.0918074	1.10 [0.68 - 1.76]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200849_s_at	79	0.835443	0.0156036	0.224337	0.840067	0.371864	0.217564	1.24 [0.77 - 2.00]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200848_at	58	0.758621	0.00389772	0.0777018	0.919649	0.0967	0.306585	1.36 [0.95 - 1.95]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200850_s_at	58	0.706897	0.000888399	0.0230731	0.991454	0.0271322	0.914495	2.50 [1.11 - 5.62]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200849_s_at	58	0.603448	0.0529937	-	0.538578	0.0532783	0.45869	1.58 [0.99 - 2.52]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207464_at	58	0.448276	0.0761449	-	-0.493018	0.461882	-0.10788	0.90 [0.67 - 1.20]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200848_at	34	0.588235	0.0779755	-	0.663822	0.270701	0.31564	1.37 [0.78 - 2.40]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200850_s_at	34	0.117647	0.207147	-	-0.692831	0.806553	-0.0661599	0.94 [0.55 - 1.59]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200849_s_at	34	0.176471	0.0760337	-	1.04694	0.47201	0.389541	1.48 [0.51 - 4.27]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207464_at	34	0.852941	0.109461	-	-1.12327	0.684194	0.115208	1.12 [0.64 - 1.95]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200848_at	158	0.892405	0.0128257	0.194371	0.868914	0.967205	0.0159781	1.02 [0.47 - 2.18]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200849_s_at	158	0.898734	0.0560073	-	0.643629	0.790057	0.115224	1.12 [0.48 - 2.62]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207464_at	158	0.670886	0.126079	-	0.368004	0.686864	0.386431	1.47 [0.22 - 9.63]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200850_s_at	158	0.253165	0.140321	-	0.404367	0.527859	0.250804	1.29 [0.59 - 2.80]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207464_at	53	0.867925	0.0291977	0.347874	0.978936	0.0610214	0.743623	2.10 [0.97 - 4.58]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200850_s_at	53	0.849057	0.014562	0.213347	0.976496	0.0702544	2.26034	9.59 [0.83 - 110.79]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200849_s_at	53	0.886792	4.46326e-05	0.00171367	1.86995	0.00878944	1.83068	6.24 [1.59 - 24.54]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207464_at	53	0.377358	0.0809122	-	0.647929	0.201982	0.475381	1.61 [0.78 - 3.34]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200848_at	53	0.132075	0.1721	-	-0.619269	0.544725	-0.334928	0.72 [0.24 - 2.11]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200850_s_at	53	0.886792	0.000917087	0.0236983	1.45469	0.0274234	3.03672	20.84 [1.40 - 309.66]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200849_s_at	53	0.886792	1.85423e-05	0.000780274	1.93785	0.0317008	1.57607	4.84 [1.15 - 20.37]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200848_at	53	0.584906	0.198598	-	0.439471	0.766393	0.153902	1.17 [0.42 - 3.22]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200848_at	180	0.122222	0.00143378	0.0344217	-0.836394	0.173359	-0.356707	0.70 [0.42 - 1.17]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200850_s_at	180	0.85	0.0760436	-	0.474361	0.984003	0.00947334	1.01 [0.40 - 2.55]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200849_s_at	180	0.111111	0.0675013	-	0.709843	0.5083	0.211741	1.24 [0.66 - 2.31]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207464_at	180	0.105556	0.0169883	0.238534	-0.738322	0.262486	-0.249797	0.78 [0.50 - 1.21]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200848_at	559	0.767442	0.00159081	0.0375152	-1.10769	0.208184	-0.234212	0.79 [0.55 - 1.14]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207464_at	559	0.375671	0.0779375	-	0.405646	0.505394	0.134833	1.14 [0.77 - 1.70]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200850_s_at	559	0.166369	0.000101675	0.00355391	-0.845228	0.000652684	-1.07294	0.34 [0.18 - 0.63]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200849_s_at	559	0.357782	0.00198545	0.0450245	-0.613666	0.0159485	-0.541674	0.58 [0.37 - 0.90]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200848_at	77	0.363636	0.0948411	-	-0.445851	0.382859	-0.200652	0.82 [0.52 - 1.28]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200850_s_at	77	0.441558	0.0305204	0.358362	-0.569674	0.266128	-0.279495	0.76 [0.46 - 1.24]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200849_s_at	77	0.467532	0.0206029	0.273615	-0.607229	0.253812	-0.265333	0.77 [0.49 - 1.21]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207464_at	77	0.857143	0.0373474	0.409234	0.704462	0.622928	0.11652	1.12 [0.71 - 1.79]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207464_at	70	0.528571	0.0155855	0.224149	0.65788	0.0940263	1.06981	2.91 [0.83 - 10.20]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200850_s_at	70	0.557143	0.000197874	0.00636783	1.03149	0.000243555	0.696443	2.01 [1.38 - 2.91]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200849_s_at	70	0.357143	0.00152472	0.0362213	0.947609	0.00215569	0.556644	1.74 [1.22 - 2.49]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200848_at	70	0.628571	0.00154296	0.0365796	0.871082	0.00141055	0.538593	1.71 [1.23 - 2.39]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34727_at	50	0.2	0.129657	-	-0.705853	0.547757	-0.149836	0.86 [0.53 - 1.40]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34792_at	50	0.22	0.0269814	0.329785	-0.922366	0.711386	-0.0816946	0.92 [0.60 - 1.42]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34728_g_at	50	0.28	0.0534098	-	-0.733404	0.716467	-0.0674296	0.93 [0.65 - 1.35]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41302_at	50	0.3	0.259571	-	-0.430301	0.644517	-0.0785549	0.92 [0.66 - 1.29]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200850_s_at	74	0.716216	0.00519526	0.0975359	-1.01123	0.0546284	-0.625035	0.54 [0.28 - 1.01]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200849_s_at	74	0.824324	0.0141504	0.208926	-1.11275	0.164716	-0.347129	0.71 [0.43 - 1.15]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207464_at	74	0.810811	0.00243916	0.0532673	-1.46299	0.0259624	-0.490501	0.61 [0.40 - 0.94]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200848_at	74	0.391892	0.000194662	0.00627772	-1.06539	0.000907004	-0.835201	0.43 [0.26 - 0.71]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200848_at	67	0.149254	0.259555	-	15.2213	0.955893	-0.0585568	0.94 [0.12 - 7.51]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207464_at	67	0.104478	0.161329	-	-1.07398	0.934587	-0.0944259	0.91 [0.10 - 8.68]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200850_s_at	67	0.164179	0.150492	-	-0.980496	0.686805	-0.498775	0.61 [0.05 - 6.86]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200849_s_at	67	0.880597	0.26527	-	-15.2372	0.92522	-0.108382	0.90 [0.09 - 8.63]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207464_at	115	0.852174	0.119386	-	0.893287	0.534694	0.711412	2.04 [0.22 - 19.25]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200850_s_at	115	0.895652	0.121436	-	0.966593	0.775364	-0.226741	0.80 [0.17 - 3.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200849_s_at	115	0.504348	0.027397	0.333228	-1.3375	0.278914	-0.776853	0.46 [0.11 - 1.88]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200848_at	115	0.104348	0.185285	-	-0.841309	0.621913	-0.395704	0.67 [0.14 - 3.24]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34727_at	158	0.246835	8.36481e-05	0.00299195	-1.11693	0.0390383	-0.452523	0.64 [0.41 - 0.98]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34792_at	158	0.56962	0.0144893	0.212569	-0.739949	0.0274549	-0.877548	0.42 [0.19 - 0.91]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34728_g_at	158	0.620253	0.0080392	0.136819	-0.827662	0.0579888	-0.615581	0.54 [0.29 - 1.02]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41302_at	158	0.208861	0.021614	0.282972	-0.747911	0.170676	-0.531832	0.59 [0.27 - 1.26]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34728_g_at	76	0.184211	0.0591615	-	-0.995937	0.481251	-0.431063	0.65 [0.20 - 2.16]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41302_at	76	0.144737	0.0806023	-	-0.987619	0.507833	-0.511916	0.60 [0.13 - 2.73]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34727_at	76	0.118421	0.115487	-	15.2556	0.363188	0.635844	1.89 [0.48 - 7.44]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34792_at	76	0.236842	0.0695716	-	-0.930493	0.46674	-0.557934	0.57 [0.13 - 2.57]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207464_at	204	0.338235	0.0075443	0.130317	-0.403827	0.326536	-0.0690511	0.93 [0.81 - 1.07]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200850_s_at	204	0.259804	0.00018044	0.00587597	-0.602883	0.00061928	-0.672368	0.51 [0.35 - 0.75]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200849_s_at	204	0.710784	0.00230065	0.0507902	-0.470463	0.0053578	-0.482732	0.62 [0.44 - 0.87]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200848_at	204	0.553922	0.00229162	0.0506275	-0.427159	0.00430795	-0.415093	0.66 [0.50 - 0.88]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200849_s_at	87	0.37931	0.00833722	0.140675	-0.971845	0.351864	-0.387029	0.68 [0.30 - 1.53]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207464_at	87	0.701149	0.207317	-	0.484	0.851203	-0.169243	0.84 [0.14 - 4.95]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200848_at	87	0.206897	0.113436	-	-0.651622	0.365177	-0.348354	0.71 [0.33 - 1.50]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200850_s_at	87	0.344828	0.00177706	0.0411033	-1.13305	0.182897	-0.552512	0.58 [0.26 - 1.30]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207464_at	87	0.701149	0.207317	-	0.484	0.851203	-0.169243	0.84 [0.14 - 4.95]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200849_s_at	87	0.37931	0.00833722	0.140675	-0.971845	0.351864	-0.387029	0.68 [0.30 - 1.53]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200850_s_at	87	0.344828	0.00177706	0.0411033	-1.13305	0.182897	-0.552512	0.58 [0.26 - 1.30]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200848_at	87	0.206897	0.113436	-	-0.651622	0.365177	-0.348354	0.71 [0.33 - 1.50]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207464_at	77	0.779221	0.170291	-	-1.3278	0.63289	-0.751995	0.47 [0.02 - 10.32]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200849_s_at	77	0.584416	0.0318357	0.368576	-1.9432	0.0879412	-1.19725	0.30 [0.08 - 1.19]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200850_s_at	77	0.194805	5.96171e-05	0.00221678	-1.94471	0.00574479	-1.60839	0.20 [0.06 - 0.63]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200848_at	77	0.363636	0.0138321	0.205474	-1.54308	0.217309	-0.650386	0.52 [0.19 - 1.47]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200849_s_at	77	0.233766	0.00159095	0.0375179	-1.59234	0.0132448	-1.61532	0.20 [0.06 - 0.71]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207464_at	77	0.116883	0.228288	-	15.2174	0.793249	-0.462555	0.63 [0.02 - 20.02]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200848_at	77	0.363636	0.000514812	0.0145279	-1.96203	0.0254539	-1.11964	0.33 [0.12 - 0.87]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200850_s_at	77	0.168831	0.000643381	0.0175643	-1.88858	0.0301719	-1.39652	0.25 [0.07 - 0.87]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200849_s_at	136	0.875	0.0401938	0.429	-15.3648	0.214382	-0.765908	0.46 [0.14 - 1.56]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207464_at	136	0.647059	0.169168	-	0.621469	0.37187	-0.224973	0.80 [0.49 - 1.31]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200848_at	136	0.102941	2.73324e-05	0.00110563	-1.84081	0.00310406	-1.10653	0.33 [0.16 - 0.69]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200850_s_at	136	0.205882	3.81829e-05	0.001491	-1.66293	0.00879452	-1.91218	0.15 [0.04 - 0.62]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200849_s_at	200	0.865	0.0236214	0.301016	-1.95927	0.189258	-0.687407	0.50 [0.18 - 1.40]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207464_at	200	0.84	0.0146471	0.214256	0.801702	0.266043	0.413551	1.51 [0.73 - 3.13]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200850_s_at	200	0.39	0.224637	-	0.380526	0.888451	-0.0788857	0.92 [0.31 - 2.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200848_at	200	0.12	0.00110459	0.0276996	-1.08207	0.0128665	-1.07829	0.34 [0.15 - 0.80]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8191	60	0.683333	0.015616	0.224467	-1.14885	0.0556994	-0.682436	0.51 [0.25 - 1.02]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1971	60	0.616667	0.222303	-	0.45995	0.278126	0.923886	2.52 [0.47 - 13.38]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8191	60	0.383333	0.00132423	0.0322228	-1.19104	0.014578	-0.980958	0.37 [0.17 - 0.82]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1971	60	0.833333	0.234513	-	-0.711187	0.31818	-0.762303	0.47 [0.10 - 2.08]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6841	155	0.767742	0.000618687	0.01699	0.932969	0.0447211	0.186576	1.21 [1.00 - 1.45]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200850_s_at	286	0.206294	2.42546e-05	0.000993289	-0.849606	0.00220724	-0.891378	0.41 [0.23 - 0.73]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200849_s_at	286	0.22028	0.000516114	0.0145593	-0.708666	0.00518748	-0.841727	0.43 [0.24 - 0.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207464_at	286	0.136364	0.0509307	-	-0.490761	0.402015	-0.159196	0.85 [0.59 - 1.24]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200848_at	286	0.262238	1.07019e-07	6.84018e-06	-1.00485	0.000207383	-0.748002	0.47 [0.32 - 0.70]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207464_at	159	0.672956	0.0103462	0.165645	0.79049	0.108453	0.700146	2.01 [0.86 - 4.74]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200848_at	159	0.654088	0.0137285	0.204344	-1.24638	0.150809	-0.602057	0.55 [0.24 - 1.25]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200850_s_at	159	0.899371	0.032949	0.37706	0.861871	0.738575	0.148144	1.16 [0.49 - 2.77]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200849_s_at	159	0.100629	1.3151e-06	7.00326e-05	-1.55968	0.0114508	-1.1221	0.33 [0.14 - 0.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200850_s_at	159	0.899371	0.0147646	0.215507	1.068	0.872466	-0.0850624	0.92 [0.33 - 2.59]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207464_at	159	0.691824	0.0107945	0.170996	0.787481	0.281201	0.451958	1.57 [0.69 - 3.58]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200848_at	159	0.45283	0.109097	-	0.526008	0.84256	0.0738473	1.08 [0.52 - 2.23]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200849_s_at	159	0.100629	0.00430116	0.0840305	-1.17169	0.125887	-0.768931	0.46 [0.17 - 1.24]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200850_s_at	159	0.283019	0.0333308	0.379937	-0.668051	0.642364	-0.211288	0.81 [0.33 - 1.97]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207464_at	159	0.691824	0.0621754	-	0.68338	0.412818	0.408069	1.50 [0.57 - 3.99]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200849_s_at	159	0.679245	0.0301566	0.3555	0.677764	0.804223	-0.103795	0.90 [0.40 - 2.05]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200848_at	159	0.169811	0.0118707	0.183551	-0.843231	0.0494981	-0.709655	0.49 [0.24 - 1.00]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207464_at	54	0.666667	0.0135649	0.202555	-15.9637	0.15854	-3.16847	0.04 [0.00 - 3.44]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200849_s_at	54	0.111111	0.2083	-	15.33	0.406864	0.537057	1.71 [0.48 - 6.09]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200850_s_at	54	0.185185	0.127541	-	15.3953	0.239693	0.686938	1.99 [0.63 - 6.25]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200848_at	54	0.648148	0.119176	-	1.00681	0.459383	0.391213	1.48 [0.52 - 4.17]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200848_at	117	0.709402	0.0599864	-	0.703877	0.466938	0.258257	1.29 [0.65 - 2.60]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200848_at	117	0.384615	0.162063	-	0.478544	0.765828	0.0898366	1.09 [0.61 - 1.98]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200850_s_at	117	0.880342	0.0270415	0.330284	0.98979	0.26136	0.493571	1.64 [0.69 - 3.88]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200850_s_at	117	0.376068	0.0649689	-	0.629695	0.305891	0.350951	1.42 [0.73 - 2.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200850_s_at	117	0.692308	0.0253547	0.316069	0.824691	0.117383	0.638848	1.89 [0.85 - 4.21]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200848_at	117	0.384615	0.162063	-	0.478544	0.765828	0.0898366	1.09 [0.61 - 1.98]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200848_at	117	0.709402	0.154536	-	0.567509	0.751194	0.12114	1.13 [0.53 - 2.39]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200849_s_at	117	0.102564	0.178385	-	0.948518	0.888314	0.0448038	1.05 [0.56 - 1.95]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200849_s_at	117	0.589744	0.219843	-	0.459907	0.556575	0.226208	1.25 [0.59 - 2.67]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200850_s_at	117	0.376068	0.0649689	-	0.629695	0.305891	0.350951	1.42 [0.73 - 2.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207464_at	117	0.376068	0.0537065	-	0.673035	0.57656	-0.626103	0.53 [0.06 - 4.81]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207464_at	117	0.102564	0.0599566	-	-0.842097	0.574706	-0.759454	0.47 [0.03 - 6.64]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200849_s_at	117	0.837607	0.0946729	-	0.72249	0.560168	0.237966	1.27 [0.57 - 2.83]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200849_s_at	117	0.102564	0.178385	-	0.948518	0.888314	0.0448038	1.05 [0.56 - 1.95]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207464_at	117	0.376068	0.0537065	-	0.673035	0.57656	-0.626103	0.53 [0.06 - 4.81]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207464_at	117	0.102564	0.102305	-	-0.787548	0.702491	-0.541044	0.58 [0.04 - 9.35]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207464_at	236	0.783898	0.111293	-	-0.600787	0.908148	0.0432453	1.04 [0.50 - 2.18]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200848_at	236	0.70339	0.0365122	0.403282	-0.716776	0.0906424	-0.73133	0.48 [0.21 - 1.12]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200850_s_at	236	0.165254	0.00315798	0.0656493	-0.870208	0.122258	-0.794779	0.45 [0.16 - 1.24]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200849_s_at	236	0.105932	0.022991	0.295423	-0.777552	0.601635	-0.25003	0.78 [0.30 - 1.99]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200850_s_at	249	0.172691	0.138466	-	-0.388735	0.548843	-0.2364	0.79 [0.36 - 1.71]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200848_at	249	0.104418	0.0704011	-	-0.539189	0.184059	-0.460888	0.63 [0.32 - 1.25]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200849_s_at	249	0.759036	0.152935	-	0.327305	0.828904	0.0787357	1.08 [0.53 - 2.21]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207464_at	249	0.871486	0.0642329	-	-0.712967	0.439872	0.235235	1.27 [0.70 - 2.30]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200849_s_at	125	0.408	0.046288	0.468846	-0.584407	0.304623	-0.370259	0.69 [0.34 - 1.40]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200850_s_at	125	0.312	0.027948	0.337756	1.26379	0.881211	0.0394962	1.04 [0.62 - 1.75]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200849_s_at	54	0.314815	0.0185179	0.253708	-1.31627	0.362532	-0.247556	0.78 [0.46 - 1.33]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207464_at	125	0.112	0.0810764	-	-0.707506	0.721879	-0.165733	0.85 [0.34 - 2.11]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200848_at	62	0.322581	0.073057	-	-0.851492	0.254392	-0.322406	0.72 [0.42 - 1.26]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207464_at	54	0.185185	0.0987766	-	15.3355	0.552184	-0.242256	0.78 [0.35 - 1.74]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200848_at	125	0.84	0.220752	-	-0.745075	0.39764	-0.358663	0.70 [0.30 - 1.60]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200850_s_at	62	0.193548	0.00655154	0.11688	-1.2502	0.214371	-0.428768	0.65 [0.33 - 1.28]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200848_at	125	0.424	0.0326078	0.374475	-0.611777	0.195403	-0.409069	0.66 [0.36 - 1.23]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200849_s_at	62	0.322581	0.052922	-	-0.923471	0.354132	-0.210099	0.81 [0.52 - 1.26]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200848_at	54	0.259259	0.0478417	0.478509	-1.12567	0.216817	-0.416412	0.66 [0.34 - 1.28]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200849_s_at	125	0.72	0.130519	-	-0.73209	0.553052	-0.283743	0.75 [0.29 - 1.92]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207464_at	62	0.887097	0.0578625	-	-15.3174	0.585325	-0.182063	0.83 [0.43 - 1.60]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200850_s_at	125	0.656	0.027615	0.335025	-0.735201	0.564058	-0.119453	0.89 [0.59 - 1.33]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207464_at	125	0.552	0.227413	-	0.47124	0.562311	0.348845	1.42 [0.44 - 4.61]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200850_s_at	54	0.111111	0.0024464	0.053396	-1.66721	0.167248	-0.554601	0.57 [0.26 - 1.26]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200849_s_at	198	0.227273	0.00246667	0.0537554	-0.68219	0.0863669	-0.319173	0.73 [0.50 - 1.05]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200848_at	198	0.207071	0.0112702	0.176595	-0.698866	0.0878845	-0.364558	0.69 [0.46 - 1.06]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200848_at	198	0.222222	0.0149536	0.217512	-0.697905	0.0851744	-0.387716	0.68 [0.44 - 1.06]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207464_at	198	0.358586	0.193627	-	0.295145	0.349934	0.102948	1.11 [0.89 - 1.38]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200850_s_at	198	0.737374	0.0549517	-	-0.685995	0.264954	-0.328311	0.72 [0.40 - 1.28]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200850_s_at	198	0.474747	0.171171	-	-0.288472	0.690519	-0.0907308	0.91 [0.58 - 1.43]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200849_s_at	198	0.222222	0.00562452	0.103795	-0.742232	0.0383089	-0.478337	0.62 [0.39 - 0.97]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200849_s_at	198	0.212121	0.00139274	0.033602	-0.879942	0.037031	-0.508061	0.60 [0.37 - 0.97]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207464_at	198	0.358586	0.207492	-	0.351042	0.786932	0.0346222	1.04 [0.81 - 1.33]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200848_at	198	0.207071	0.0209053	0.276433	-0.554112	0.306515	-0.180332	0.83 [0.59 - 1.18]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207464_at	198	0.358586	0.178574	-	0.395913	0.69629	0.052505	1.05 [0.81 - 1.37]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200850_s_at	198	0.752525	0.048961	0.485354	-0.698293	0.299382	-0.289161	0.75 [0.43 - 1.29]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200849_s_at	62	0.5	0.0725347	-	1.13549	0.889732	-0.0987528	0.91 [0.22 - 3.66]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207464_at	62	0.758065	0.110316	-	0.904725	0.372707	1.63299	5.12 [0.14 - 185.59]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200848_at	51	0.27451	0.174216	-	15.5127	0.952747	0.040711	1.04 [0.27 - 4.00]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200850_s_at	51	0.196078	0.228509	-	-1.0512	0.957537	-0.0425263	0.96 [0.20 - 4.59]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200848_at	62	0.177419	0.0990747	-	15.3295	0.804787	-0.113289	0.89 [0.36 - 2.19]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200849_s_at	51	0.882353	0.0310139	0.362219	1.74498	0.0436824	1.77406	5.89 [1.05 - 33.05]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200850_s_at	62	0.112903	0.194398	-	15.2147	0.866355	0.0880887	1.09 [0.39 - 3.05]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207464_at	51	0.54902	0.00863179	0.144446	16.5749	0.00899703	5.59376	268.74 [4.04 - 17871.50]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207464_at	145	0.77931	0.234724	-	-0.565863	0.953945	-0.0875463	0.92 [0.05 - 17.88]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200849_s_at	177	0.644068	0.0365421	0.403496	0.56275	0.272032	0.529658	1.70 [0.66 - 4.37]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200850_s_at	177	0.745763	0.106627	-	-0.476997	0.728728	0.14273	1.15 [0.51 - 2.58]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200848_at	177	0.175141	0.124124	-	0.709179	0.341171	0.376839	1.46 [0.67 - 3.17]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200849_s_at	177	0.655367	0.0723414	-	0.425388	0.521505	0.261291	1.30 [0.58 - 2.89]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200850_s_at	145	0.655172	0.00450135	0.0871137	-1.20496	0.920646	-0.053619	0.95 [0.33 - 2.72]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200848_at	177	0.451977	0.203235	-	0.307308	0.55046	0.201768	1.22 [0.63 - 2.37]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200849_s_at	145	0.137931	0.164286	-	0.974872	0.979117	-0.0143213	0.99 [0.34 - 2.88]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207464_at	177	0.632768	0.108666	-	0.438398	0.612994	0.525077	1.69 [0.22 - 12.93]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200848_at	145	0.337931	0.0525327	-	0.796355	0.99945	-0.000314934	1.00 [0.41 - 2.45]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200850_s_at	177	0.435028	0.0674953	-	0.5308	0.534915	0.29851	1.35 [0.52 - 3.46]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207464_at	177	0.271186	0.137144	-	-0.366543	0.773608	-0.279353	0.76 [0.11 - 5.07]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200850_s_at	226	0.526549	0.0177595	0.246248	-0.698079	0.375693	-0.364857	0.69 [0.31 - 1.56]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200849_s_at	226	0.115044	0.0776332	-	1.20092	0.852567	0.0707047	1.07 [0.51 - 2.26]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200848_at	226	0.420354	0.0508389	-	-0.548286	0.710802	-0.14069	0.87 [0.41 - 1.83]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207464_at	226	0.89823	0.0982885	-	-1.132	0.363559	0.228586	1.26 [0.77 - 2.06]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200850_s_at	55	0.145455	0.0439701	0.454066	15.3349	0.181527	0.976599	2.66 [0.63 - 11.13]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200849_s_at	55	0.709091	0.281063	-	0.501453	0.926842	0.0637753	1.07 [0.27 - 4.16]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200850_s_at	49	0.163265	0.096808	-	15.3384	0.258474	0.986674	2.68 [0.48 - 14.85]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200848_at	55	0.818182	0.00255896	0.0553841	1.33129	0.245253	0.672678	1.96 [0.63 - 6.09]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200849_s_at	55	0.836364	0.292755	-	0.591322	0.986787	0.0127197	1.01 [0.22 - 4.56]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200849_s_at	49	0.836735	0.185501	-	0.863042	0.859175	0.167243	1.18 [0.19 - 7.50]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200848_at	55	0.818182	0.00128746	0.0314765	1.57132	0.590604	0.355056	1.43 [0.39 - 5.20]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207464_at	55	0.290909	0.0472085	0.474594	-0.86819	0.203234	-2.32574	0.10 [0.00 - 3.51]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200848_at	49	0.857143	0.0144851	0.212524	1.39344	0.585831	0.404495	1.50 [0.35 - 6.42]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207464_at	55	0.818182	0.106137	-	-1.51666	0.184316	-2.63248	0.07 [0.00 - 3.50]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200850_s_at	55	0.872727	0.00538668	0.100344	1.35286	0.0988184	1.16163	3.20 [0.80 - 12.69]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207464_at	49	0.285714	0.0160286	0.228743	-1.31597	0.117959	-4.37391	0.01 [0.00 - 3.03]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200849_s_at	63	0.587302	0.374764	-	0.302942	0.987068	0.00326513	1.00 [0.68 - 1.49]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200848_at	63	0.714286	0.0457174	0.465248	-0.870346	0.479419	-0.134735	0.87 [0.60 - 1.27]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207464_at	63	0.238095	0.00105203	0.0265921	-1.1208	0.361321	-5.41367	0.00 [0.00 - 497.77]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200850_s_at	63	0.746032	0.00977431	0.158707	0.908833	0.859377	0.0426802	1.04 [0.65 - 1.67]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.4113.0.S2_3p_at	28	0.214286	0.0760583	-	-1.06351	0.362504	0.483583	1.62 [0.57 - 4.59]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5729723_3p_a_at	28	0.821429	0.0244579	0.30834	1.36151	0.391209	0.216891	1.24 [0.76 - 2.04]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.4113.0.S3_3p_a_at	28	0.285714	0.189575	-	-0.721818	0.795097	0.0790285	1.08 [0.60 - 1.96]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7662535_3p_at	28	0.785714	0.0416632	0.438905	-1.86914	0.790716	-0.331045	0.72 [0.06 - 8.28]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200849_s_at	82	0.317073	0.0296765	0.351696	-0.732764	0.116567	-0.718389	0.49 [0.20 - 1.20]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207464_at	82	0.658537	0.0314733	0.365783	-0.881437	0.62268	-0.338198	0.71 [0.19 - 2.74]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200850_s_at	82	0.670732	0.0091136	0.150528	-1.1878	0.0161093	-1.60589	0.20 [0.05 - 0.74]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200848_at	82	0.268293	0.0518391	-	-0.672126	0.0825118	-0.718593	0.49 [0.22 - 1.10]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34728_g_at	84	0.238095	0.178769	-	-0.429096	0.875666	-0.0573419	0.94 [0.46 - 1.94]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	41302_at	84	0.107143	0.129573	-	-0.615648	0.602977	-0.19992	0.82 [0.39 - 1.74]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34727_at	84	0.107143	0.256344	-	-0.467512	0.603166	-0.148804	0.86 [0.49 - 1.51]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34792_at	84	0.309524	0.336853	-	-0.292298	0.658946	-0.175391	0.84 [0.39 - 1.83]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200849_s_at	79	0.126582	0.0652556	-	0.839335	0.617362	-0.179137	0.84 [0.41 - 1.69]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207464_at	79	0.607595	0.0531365	-	-0.525514	0.444522	-0.46696	0.63 [0.19 - 2.08]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200848_at	79	0.898734	0.0544192	-	-0.96079	0.500462	-0.271878	0.76 [0.35 - 1.68]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200850_s_at	79	0.151899	0.0818295	-	0.737783	0.374038	-0.379805	0.68 [0.30 - 1.58]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200848_at	104	0.721154	0.043128	0.448586	0.664671	0.438249	0.39209	1.48 [0.55 - 3.99]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200849_s_at	104	0.125	0.00370646	0.0746443	-1.06584	0.522385	-0.320643	0.73 [0.27 - 1.94]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207464_at	104	0.355769	0.225693	-	-0.402303	0.495526	-0.605836	0.55 [0.10 - 3.12]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200850_s_at	104	0.105769	0.0458392	0.466019	-0.82018	0.746503	-0.197032	0.82 [0.25 - 2.71]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P11307	117	0.384615	0.0669672	-	0.577174	0.44893	0.182303	1.20 [0.75 - 1.92]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P368126	117	0.521368	0.292311	-	0.301899	0.823228	0.063304	1.07 [0.61 - 1.86]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207464_at	204	0.166667	0.0771897	-	-0.7193	0.646529	-0.137742	0.87 [0.48 - 1.57]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207464_at	204	0.348039	0.0618239	-	-0.506363	0.829247	-0.0499505	0.95 [0.60 - 1.50]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200850_s_at	204	0.598039	9.57611e-06	0.0004296	1.64626	0.00107718	2.512	12.33 [2.73 - 55.58]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200850_s_at	204	0.759804	0.000152161	0.00506297	1.0086	0.00236179	1.74857	5.75 [1.86 - 17.74]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200849_s_at	204	0.495098	7.58833e-05	0.00274509	1.72047	0.000168277	2.96	19.30 [4.13 - 90.20]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200849_s_at	204	0.794118	2.71883e-05	0.0011004	1.11645	0.000388592	2.03065	7.62 [2.48 - 23.40]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200848_at	204	0.558824	7.42175e-05	0.00269171	1.55214	0.00256749	2.06364	7.87 [2.06 - 30.12]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200848_at	204	0.558824	0.00046356	0.0132824	0.951889	0.0200783	1.16477	3.21 [1.20 - 8.56]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207464_at	178	0.741573	0.0661996	-	0.397619	0.226761	0.585304	1.80 [0.70 - 4.64]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200848_at	178	0.831461	0.0641502	-	-0.561742	0.411244	-0.247354	0.78 [0.43 - 1.41]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200850_s_at	178	0.117978	0.0665413	-	0.670961	0.985123	-0.00773848	0.99 [0.44 - 2.24]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200849_s_at	178	0.247191	0.107725	-	-0.352114	0.522153	-0.200081	0.82 [0.44 - 1.51]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207464_at	111	0.522523	0.218754	-	-0.327184	0.678858	-0.122726	0.88 [0.49 - 1.58]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200850_s_at	111	0.594595	0.0353208	0.394667	0.549961	0.195033	0.429029	1.54 [0.80 - 2.94]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200849_s_at	111	0.126126	0.0263534	0.324535	1.09944	0.68355	0.160305	1.17 [0.54 - 2.54]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200848_at	111	0.585586	0.218172	-	0.324915	0.769604	0.109455	1.12 [0.54 - 2.32]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200849_s_at	90	0.122222	0.122165	-	-0.637017	0.867946	-0.0643174	0.94 [0.44 - 2.00]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200849_s_at	90	0.122222	0.0197526	0.2656	-0.974594	0.180961	-0.616561	0.54 [0.22 - 1.33]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207464_at	90	0.211111	0.215115	-	0.655958	0.343461	0.831786	2.30 [0.41 - 12.84]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207464_at	90	0.5	0.0728845	-	-0.59481	0.970535	0.0330238	1.03 [0.18 - 5.96]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200850_s_at	90	0.888889	0.26418	-	0.49205	0.872718	-0.0565285	0.95 [0.47 - 1.89]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200850_s_at	90	0.422222	0.132754	-	-0.554943	0.243048	-0.435348	0.65 [0.31 - 1.34]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200848_at	90	0.122222	0.0718724	-	-0.739515	0.785801	0.091625	1.10 [0.57 - 2.12]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200848_at	90	0.111111	0.0192575	0.260869	-1.03362	0.625249	-0.194126	0.82 [0.38 - 1.79]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2170	50	0.38	0.00823878	0.139406	1.75895	0.0771763	0.980756	2.67 [0.90 - 7.91]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207464_at	138	0.355072	0.0145943	0.213692	-0.582029	0.132556	-7.88373	0.00 [0.00 - 10.91]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200850_s_at	138	0.565217	0.000381253	0.0112322	0.849936	0.189573	0.292777	1.34 [0.87 - 2.08]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200849_s_at	138	0.144928	0.105288	-	0.679981	0.290078	0.165835	1.18 [0.87 - 1.60]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200848_at	138	0.181159	0.0488055	0.484409	0.72654	0.233632	0.206375	1.23 [0.88 - 1.73]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200848_at	129	0.79845	0.070594	-	-0.670356	0.951705	0.0212622	1.02 [0.51 - 2.03]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200849_s_at	129	0.875969	0.009504	0.155383	0.843102	0.382175	0.351251	1.42 [0.65 - 3.12]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207464_at	129	0.426357	0.04806	0.479852	0.504425	0.193625	0.530607	1.70 [0.76 - 3.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200850_s_at	129	0.271318	0.168951	-	-0.36067	0.890144	0.0671955	1.07 [0.41 - 2.78]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40527	56	0.107143	0.0110736	0.174292	-1.31291	0.441299	-0.351653	0.70 [0.29 - 1.72]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29064	56	0.875	0.140207	-	-0.878624	0.757601	-0.134767	0.87 [0.37 - 2.06]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35414	56	0.517857	0.0379195	0.41327	-0.707149	0.292394	-0.454885	0.63 [0.27 - 1.48]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40527	56	0.107143	0.00166505	0.0389555	-1.62429	0.346721	-0.472558	0.62 [0.23 - 1.67]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35210	56	0.125	0.00106579	0.026883	-1.52594	0.208968	-0.594294	0.55 [0.22 - 1.39]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35414	56	0.464286	0.0235783	0.300636	-0.806414	0.134701	-0.687154	0.50 [0.20 - 1.24]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29064	56	0.875	0.208598	-	-0.744629	0.99406	0.00317703	1.00 [0.43 - 2.32]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35210	56	0.125	6.90913e-05	0.00252646	-1.867	0.148157	-0.751988	0.47 [0.17 - 1.31]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200849_s_at	278	0.57554	0.0609889	-	-0.37719	0.142467	-0.273314	0.76 [0.53 - 1.10]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200848_at	278	0.514389	0.114222	-	-0.298846	0.409088	-0.117542	0.89 [0.67 - 1.18]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207464_at	278	0.172662	0.000679637	0.0184005	-0.730839	0.0291165	-0.450836	0.64 [0.42 - 0.96]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200850_s_at	278	0.205036	0.00896242	0.148631	-0.545416	0.0323028	-0.445169	0.64 [0.43 - 0.96]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200850_s_at	133	0.24812	0.115645	-	-0.400793	0.662421	-0.0756149	0.93 [0.66 - 1.30]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200848_at	133	0.24812	0.00126183	0.030954	-0.781789	0.108985	-0.169445	0.84 [0.69 - 1.04]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200849_s_at	133	0.586466	0.144881	-	-0.349968	0.809826	-0.0389408	0.96 [0.70 - 1.32]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207464_at	133	0.360902	0.0121588	0.186846	0.652448	0.126597	0.488771	1.63 [0.87 - 3.05]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4036	81	0.333333	0.058548	-	-0.951619	0.602578	-0.317507	0.73 [0.22 - 2.41]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10762	81	0.111111	0.139357	-	15.2336	0.987069	0.00961264	1.01 [0.32 - 3.23]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200850_s_at	185	0.751351	0.0302087	0.355911	-0.446026	0.350554	-0.111244	0.89 [0.71 - 1.13]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200848_at	185	0.12973	0.145123	-	-0.351492	0.79022	-0.0360242	0.96 [0.74 - 1.26]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200849_s_at	185	0.351351	0.162941	-	-0.261459	0.768671	-0.0430138	0.96 [0.72 - 1.28]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207464_at	185	0.697297	0.214981	-	-0.225823	0.860288	0.0768185	1.08 [0.46 - 2.54]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200848_at	185	0.12973	0.0841183	-	-0.43905	0.878496	-0.0226075	0.98 [0.73 - 1.31]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200850_s_at	185	0.751351	0.00787572	0.134685	-0.503911	0.376846	-0.0952754	0.91 [0.74 - 1.12]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207464_at	185	0.243243	0.177092	-	0.287417	0.659308	0.210438	1.23 [0.48 - 3.15]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200849_s_at	185	0.416216	0.0405849	0.431655	-0.339421	0.539067	-0.0810611	0.92 [0.71 - 1.19]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P368126	110	0.745455	0.134234	-	-0.410507	0.909198	-0.0262918	0.97 [0.62 - 1.53]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P11307	110	0.118182	0.0623702	-	-0.603658	0.658282	-0.0848686	0.92 [0.63 - 1.34]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P368126	110	0.745455	0.113338	-	-0.584271	0.909425	-0.0327043	0.97 [0.55 - 1.70]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P11307	110	0.7	0.104747	-	-0.574571	0.381856	-0.210103	0.81 [0.51 - 1.30]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200848_at	80	0.3625	0.0138984	0.206196	-1.05533	0.215281	-0.628336	0.53 [0.20 - 1.44]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200850_s_at	80	0.2375	0.00408612	0.0806769	-1.27168	0.0510142	-0.997949	0.37 [0.14 - 1.00]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200849_s_at	80	0.325	0.0625792	-	-0.813863	0.266038	-0.47014	0.62 [0.27 - 1.43]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207464_at	80	0.4	0.124116	-	0.777704	0.665675	0.170418	1.19 [0.55 - 2.57]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5214	281	0.430605	0.00134864	0.0327158	0.459157	0.0464037	0.451213	1.57 [1.01 - 2.45]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200850_s_at	38	0.894737	0.0215268	0.282172	1.27386	0.223498	0.756172	2.13 [0.63 - 7.20]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200849_s_at	38	0.815789	0.00263907	0.056787	1.49738	0.0672768	1.16581	3.21 [0.92 - 11.18]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200848_at	38	0.894737	0.00734179	0.127621	1.44881	0.0116847	1.57913	4.85 [1.42 - 16.55]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207464_at	38	0.552632	0.0774169	-	-0.843809	0.854313	0.0874142	1.09 [0.43 - 2.77]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207464_at	140	0.828571	0.00299275	0.0628676	0.916492	0.0501405	1.70385	5.50 [1.00 - 30.23]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200850_s_at	140	0.307143	0.127874	-	0.51712	0.865165	0.0659884	1.07 [0.50 - 2.29]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200848_at	140	0.278571	0.0262538	0.323698	0.836741	0.798144	0.0888275	1.09 [0.55 - 2.16]
GENE	AHCYL1	adenosylhomocysteinase-like 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200849_s_at	140	0.821429	0.22019	-	-0.57203	0.87142	0.0638369	1.07 [0.49 - 2.31]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212814_at	30	0.133333	0.0200972	0.268865	-1.27275	0.413623	-0.750055	0.47 [0.08 - 2.85]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215672_s_at	30	0.7	0.0275626	0.334593	0.928537	0.102155	1.19357	3.30 [0.79 - 13.80]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212814_at	163	0.521472	0.0151761	0.219861	0.478874	0.0936098	0.525532	1.69 [0.92 - 3.13]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215672_s_at	163	0.226994	0.186224	-	0.33509	0.315431	0.756713	2.13 [0.49 - 9.34]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212814_at	79	0.202532	0.0811388	-	0.744962	0.0977391	0.583226	1.79 [0.90 - 3.57]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215672_s_at	79	0.886076	0.00333521	0.0685946	1.0955	0.143079	1.14228	3.13 [0.68 - 14.46]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215672_s_at	58	0.586207	0.157024	-	0.403739	0.78979	0.0438888	1.04 [0.76 - 1.44]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212814_at	58	0.741379	2.19722e-05	0.000908939	1.40276	0.00903799	0.895819	2.45 [1.25 - 4.80]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215672_s_at	34	0.5	0.0299713	0.354035	-0.927758	0.5806	-0.14165	0.87 [0.53 - 1.43]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212814_at	34	0.882353	0.0402856	0.429625	1.10077	0.507226	0.228379	1.26 [0.64 - 2.47]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215672_s_at	158	0.658228	0.0158961	0.227374	0.556861	0.0927639	1.16703	3.21 [0.82 - 12.53]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212814_at	158	0.234177	0.117258	-	0.472377	0.884946	-0.0780462	0.92 [0.32 - 2.66]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212814_at	53	0.716981	0.0876357	-	-0.762793	0.472551	-0.321321	0.73 [0.30 - 1.74]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215672_s_at	53	0.641509	0.0980009	-	-0.673145	0.715243	0.0974154	1.10 [0.65 - 1.86]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212814_at	53	0.679245	0.310555	-	-0.380705	0.870797	-0.0702867	0.93 [0.40 - 2.17]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215672_s_at	53	0.301887	0.0637488	-	0.771196	0.330317	0.250064	1.28 [0.78 - 2.12]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212814_at	180	0.744444	0.180334	-	0.303309	0.541133	0.187417	1.21 [0.66 - 2.20]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215672_s_at	180	0.261111	0.142716	-	-0.334727	0.891435	-0.0148246	0.99 [0.80 - 1.22]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212814_at	559	0.422182	0.0496213	0.489348	-0.39093	0.913572	0.0283444	1.03 [0.62 - 1.72]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215672_s_at	559	0.339893	0.00550753	0.102103	-0.566625	0.157937	-0.304523	0.74 [0.48 - 1.13]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215672_s_at	77	0.896104	0.0190941	0.259296	0.943996	0.323565	-0.212917	0.81 [0.53 - 1.23]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212814_at	77	0.805195	0.109997	-	0.483039	0.323644	-0.252818	0.78 [0.47 - 1.28]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212814_at	70	0.871429	0.0545666	-	0.705078	0.222349	0.29305	1.34 [0.84 - 2.15]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215672_s_at	70	0.885714	0.0488735	0.484823	0.750815	0.188091	0.626713	1.87 [0.74 - 4.76]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36066_at	50	0.12	0.000296828	0.00905269	-1.55759	0.234146	-0.415424	0.66 [0.33 - 1.31]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212814_at	74	0.72973	0.162554	-	-0.477246	0.995404	0.0019819	1.00 [0.51 - 1.97]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215672_s_at	74	0.378378	0.0136218	0.203178	-0.726765	0.0974313	-0.546309	0.58 [0.30 - 1.10]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215672_s_at	67	0.626866	0.107224	-	-1.5499	0.265284	-0.417682	0.66 [0.32 - 1.37]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212814_at	67	0.343284	0.0905238	-	-1.15628	0.27765	-0.490657	0.61 [0.25 - 1.48]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215672_s_at	115	0.895652	0.128414	-	0.949961	0.443094	0.861173	2.37 [0.26 - 21.37]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212814_at	115	0.191304	0.00113938	0.0284271	-1.57375	0.125186	-2.37982	0.09 [0.00 - 1.94]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36066_at	158	0.151899	0.00708298	0.124142	-0.875759	0.0298741	-0.658908	0.52 [0.29 - 0.94]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36066_at	76	0.276316	0.10352	-	-0.820236	0.722101	-0.162545	0.85 [0.35 - 2.08]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215672_s_at	204	0.740196	0.0182849	0.251429	-0.372886	0.170687	-0.154371	0.86 [0.69 - 1.07]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212814_at	204	0.372549	0.0293611	0.349182	-0.310428	0.153198	-0.26111	0.77 [0.54 - 1.10]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212814_at	87	0.413793	0.0802478	-	-0.651769	0.143218	-0.486036	0.62 [0.32 - 1.18]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215672_s_at	87	0.494253	0.0145234	0.212935	-0.953723	0.178216	-0.638997	0.53 [0.21 - 1.34]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212814_at	87	0.413793	0.0802478	-	-0.651769	0.143218	-0.486036	0.62 [0.32 - 1.18]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215672_s_at	87	0.494253	0.0145234	0.212935	-0.953723	0.178216	-0.638997	0.53 [0.21 - 1.34]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215672_s_at	77	0.246753	0.213482	-	-0.695779	0.705166	-0.420275	0.66 [0.07 - 5.79]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215672_s_at	77	0.246753	0.0437034	0.452337	-1.20447	0.17937	-1.7139	0.18 [0.01 - 2.20]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212814_at	77	0.116883	0.18202	-	15.2077	0.871419	-0.100162	0.90 [0.27 - 3.04]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212814_at	77	0.116883	0.247109	-	15.2026	0.805552	-0.175383	0.84 [0.21 - 3.39]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212814_at	136	0.860294	0.037817	0.412549	1.04729	0.330982	-0.516023	0.60 [0.21 - 1.69]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215672_s_at	136	0.808824	0.0256652	0.318717	-15.3727	0.807878	-0.0630089	0.94 [0.57 - 1.56]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212814_at	200	0.115	0.0012694	0.0311086	-1.06711	0.00124875	-1.29345	0.27 [0.13 - 0.60]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215672_s_at	200	0.155	5.66794e-05	0.00211952	-1.20094	0.00251777	-0.674588	0.51 [0.33 - 0.79]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20846	60	0.866667	0.00906461	0.149914	1.09571	0.169884	0.291535	1.34 [0.88 - 2.03]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20846	60	0.883333	0.00301333	0.0632159	1.32227	0.0888327	0.401388	1.49 [0.94 - 2.37]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212814_at	286	0.178322	0.0364853	0.403089	0.630708	0.369429	0.220884	1.25 [0.77 - 2.02]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215672_s_at	286	0.737762	0.189011	-	-0.306385	0.693292	-0.0591626	0.94 [0.70 - 1.26]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212814_at	159	0.106918	0.255981	-	-0.4986	0.793832	-0.134216	0.87 [0.32 - 2.39]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215672_s_at	159	0.874214	0.0111139	0.174764	1.05481	0.330275	0.341423	1.41 [0.71 - 2.80]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215672_s_at	159	0.874214	0.00161017	0.0378921	1.09874	0.257093	0.338643	1.40 [0.78 - 2.52]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212814_at	159	0.779874	0.0730996	-	0.597054	0.605157	0.268052	1.31 [0.47 - 3.61]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212814_at	159	0.106918	0.045247	0.462263	-0.890094	0.912651	-0.0660899	0.94 [0.29 - 3.05]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215672_s_at	159	0.874214	0.021303	0.280114	0.847676	0.531638	0.181727	1.20 [0.68 - 2.12]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212814_at	54	0.5	0.0318523	0.368704	1.95672	0.0233829	1.27787	3.59 [1.19 - 10.83]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215672_s_at	54	0.796296	0.0152288	0.220414	1.55881	0.0682282	1.38398	3.99 [0.90 - 17.66]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215672_s_at	117	0.102564	2.33143e-05	0.000958653	-1.55778	0.291323	-0.5927	0.55 [0.18 - 1.66]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215672_s_at	117	0.102564	0.000402597	0.0117703	-1.50685	0.564815	-0.374658	0.69 [0.19 - 2.46]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215672_s_at	117	0.102564	0.032885	0.376576	-1.13997	0.99925	0.000625269	1.00 [0.27 - 3.68]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215672_s_at	117	0.102564	2.33143e-05	0.000958653	-1.55778	0.291323	-0.5927	0.55 [0.18 - 1.66]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212814_at	117	0.709402	0.0288855	0.345366	-0.882065	0.24064	-0.40871	0.66 [0.34 - 1.32]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212814_at	117	0.162393	0.128634	-	1.06442	0.868134	-0.066197	0.94 [0.43 - 2.04]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212814_at	117	0.34188	0.255092	-	-0.448492	0.419178	-0.36229	0.70 [0.29 - 1.68]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212814_at	117	0.709402	0.0288855	0.345366	-0.882065	0.24064	-0.40871	0.66 [0.34 - 1.32]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212814_at	236	0.207627	0.121681	-	-0.465604	0.647407	-0.196139	0.82 [0.35 - 1.90]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215672_s_at	236	0.79661	0.0607984	-	0.561189	0.773676	-0.0848962	0.92 [0.52 - 1.64]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215672_s_at	249	0.578313	0.0128462	0.194601	0.523205	0.521594	0.150752	1.16 [0.73 - 1.84]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212814_at	249	0.188755	0.0370412	0.40706	-0.509724	0.481749	-0.237067	0.79 [0.41 - 1.53]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215672_s_at	62	0.806452	0.216627	-	-0.900644	0.693861	-0.0627453	0.94 [0.69 - 1.28]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212814_at	125	0.296	0.153299	-	-0.417952	0.39837	-0.427611	0.65 [0.24 - 1.76]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215672_s_at	125	0.632	0.422295	-	0.308742	0.900519	0.0620664	1.06 [0.40 - 2.82]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212814_at	54	0.777778	0.085805	-	-1.6429	0.59665	-0.111881	0.89 [0.59 - 1.35]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215672_s_at	125	0.784	0.238432	-	-0.415987	0.609194	-0.198984	0.82 [0.38 - 1.76]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215672_s_at	54	0.111111	0.13837	-	-1.12438	0.706761	-0.0732918	0.93 [0.63 - 1.36]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212814_at	62	0.806452	0.0286977	0.343851	-1.96316	0.65108	-0.0783005	0.92 [0.66 - 1.30]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212814_at	125	0.296	0.0892523	-	-0.642556	0.804789	-0.157272	0.85 [0.25 - 2.97]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215672_s_at	198	0.873737	0.0507429	-	0.622819	0.235311	0.163877	1.18 [0.90 - 1.54]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215672_s_at	198	0.873737	0.0487407	0.484015	0.652926	0.268329	0.162822	1.18 [0.88 - 1.57]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212814_at	198	0.888889	0.0095027	0.155367	-1.14374	0.332065	-0.159197	0.85 [0.62 - 1.18]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215672_s_at	198	0.106061	0.077739	-	0.738922	0.445359	0.0788755	1.08 [0.88 - 1.33]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212814_at	198	0.156566	0.0814206	-	0.792644	0.904819	-0.0251063	0.98 [0.65 - 1.47]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212814_at	198	0.156566	0.0680857	-	0.914435	0.952822	-0.0131834	0.99 [0.64 - 1.53]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212814_at	62	0.483871	0.0433429	0.44999	-1.26218	0.196247	-0.59169	0.55 [0.23 - 1.36]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215672_s_at	51	0.45098	0.00977345	0.158697	-16.5338	0.155176	-2.44684	0.09 [0.00 - 2.53]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215672_s_at	62	0.451613	0.0364613	0.402917	-1.30212	0.420976	-0.553112	0.58 [0.15 - 2.21]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212814_at	51	0.568627	0.0381677	0.415011	-16.0644	0.178977	-1.39477	0.25 [0.03 - 1.90]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215672_s_at	145	0.172414	0.138989	-	0.865382	0.966539	-0.0126211	0.99 [0.55 - 1.78]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215672_s_at	177	0.282486	0.124879	-	-0.434908	0.390208	-0.22654	0.80 [0.48 - 1.34]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212814_at	177	0.158192	0.103573	-	0.601834	0.777414	0.0403553	1.04 [0.79 - 1.38]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212814_at	177	0.158192	0.171805	-	0.583734	0.937333	0.0130045	1.01 [0.73 - 1.40]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215672_s_at	177	0.282486	0.226494	-	-0.305032	0.555755	-0.130885	0.88 [0.57 - 1.36]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212814_at	145	0.2	0.0492247	0.486953	1.12576	0.532695	0.124819	1.13 [0.77 - 1.68]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212814_at	226	0.393805	0.242955	-	-0.329686	0.993002	-0.00161768	1.00 [0.70 - 1.43]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215672_s_at	226	0.884956	0.0952768	-	0.605099	0.954802	0.0111534	1.01 [0.69 - 1.49]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212814_at	55	0.727273	0.0491467	0.48648	-1.32825	0.758216	-0.0792106	0.92 [0.56 - 1.53]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212814_at	49	0.367347	0.0639422	-	1.71768	0.684268	0.144408	1.16 [0.58 - 2.32]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212814_at	55	0.363636	0.191577	-	0.663002	0.904499	0.0298769	1.03 [0.63 - 1.68]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215672_s_at	55	0.345455	0.0688581	-	-0.794119	0.593039	-0.216917	0.80 [0.36 - 1.78]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215672_s_at	55	0.363636	0.0419845	0.441045	-0.934932	0.1527	-0.661073	0.52 [0.21 - 1.28]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215672_s_at	49	0.346939	0.058008	-	-1.05306	0.372903	-0.559984	0.57 [0.17 - 1.96]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	774198	34	0.147059	0.00307359	0.064233	-1.51654	0.476685	-0.303974	0.74 [0.32 - 1.70]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212814_at	63	0.111111	0.000120621	0.00413021	-1.66202	0.000120247	-0.510084	0.60 [0.46 - 0.78]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215672_s_at	63	0.365079	0.000265103	0.0082094	-1.18563	0.00110641	-0.381947	0.68 [0.54 - 0.86]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.4984.1.S1_3p_a_at	28	0.821429	0.310302	-	-0.76377	0.835259	-0.275384	0.76 [0.06 - 10.18]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.4984.0.S1_3p_at	28	0.107143	0.317589	-	-0.752764	0.95259	0.0154874	1.02 [0.61 - 1.69]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212814_at	82	0.292683	0.00492433	0.0935137	-0.933828	0.106783	-0.396917	0.67 [0.42 - 1.09]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215672_s_at	82	0.707317	0.0411036	0.435156	-0.951916	0.459625	-0.329634	0.72 [0.30 - 1.72]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36066_at	84	0.785714	0.00585766	0.107139	-1.23611	0.171677	-0.217885	0.80 [0.59 - 1.10]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212814_at	79	0.518987	0.0188639	0.257072	0.607693	0.133783	0.259285	1.30 [0.92 - 1.82]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215672_s_at	79	0.898734	0.0273969	0.333227	0.880877	0.0332813	0.595167	1.81 [1.05 - 3.14]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212814_at	104	0.278846	0.168115	-	0.542891	0.712314	0.0667548	1.07 [0.75 - 1.52]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215672_s_at	104	0.365385	0.00874939	0.14594	1.05588	0.612624	0.19277	1.21 [0.57 - 2.56]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P72518	117	0.290598	0.000425808	0.0123502	-0.975762	0.00962244	-0.284298	0.75 [0.61 - 0.93]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P252075	117	0.128205	0.00926596	0.152431	-0.900985	0.0713477	-0.259693	0.77 [0.58 - 1.02]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215672_s_at	204	0.740196	0.00803816	0.136805	-1.72075	0.0502807	-0.692586	0.50 [0.25 - 1.00]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215672_s_at	204	0.759804	0.00803226	0.136728	-1.09347	0.101352	-0.404315	0.67 [0.41 - 1.08]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212814_at	204	0.715686	0.000729816	0.0195449	-2.62152	0.00978855	-0.695066	0.50 [0.29 - 0.85]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212814_at	204	0.622549	0.00147066	0.0351543	-1.02998	0.00232243	-0.619622	0.54 [0.36 - 0.80]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212814_at	178	0.382022	0.0070358	0.123504	-0.533689	0.0935475	-0.184305	0.83 [0.67 - 1.03]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215672_s_at	178	0.196629	0.0388018	0.419432	-0.480182	0.22109	-0.262708	0.77 [0.50 - 1.17]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215672_s_at	111	0.522523	0.0892514	-	0.445189	0.0485713	0.5908	1.81 [1.00 - 3.25]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212814_at	111	0.810811	0.191839	-	-0.49157	0.936631	-0.0156625	0.98 [0.67 - 1.45]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212814_at	90	0.688889	0.064671	-	0.605007	0.766549	0.139511	1.15 [0.46 - 2.89]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212814_at	90	0.688889	0.0695795	-	0.67228	0.619564	0.257942	1.29 [0.47 - 3.58]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215672_s_at	90	0.211111	0.219482	-	0.540822	0.540364	0.419679	1.52 [0.40 - 5.83]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215672_s_at	90	0.788889	0.0809941	-	0.688349	0.279265	0.839756	2.32 [0.51 - 10.60]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212814_at	138	0.297101	0.0824459	-	0.49207	0.187411	0.111027	1.12 [0.95 - 1.32]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215672_s_at	138	0.594203	0.0227042	0.292856	0.543959	0.00975782	0.233312	1.26 [1.06 - 1.51]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212814_at	129	0.79845	0.037921	0.413281	-0.808081	0.194362	-0.340325	0.71 [0.43 - 1.19]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215672_s_at	129	0.496124	0.0735676	-	-0.444265	0.126417	-0.328913	0.72 [0.47 - 1.10]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215672_s_at	278	0.136691	0.00560466	0.103508	-0.668483	0.968098	-0.0109159	0.99 [0.58 - 1.69]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212814_at	278	0.280576	0.0902256	-	0.364033	0.285726	0.235964	1.27 [0.82 - 1.95]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215672_s_at	133	0.819549	0.0269681	0.329674	0.648929	0.37876	1.0939	2.99 [0.26 - 34.12]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212814_at	133	0.661654	0.0201177	0.269058	0.56362	0.950733	-0.0340589	0.97 [0.33 - 2.85]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215672_s_at	185	0.27027	0.00825689	0.13964	0.498467	0.418853	0.202084	1.22 [0.75 - 2.00]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212814_at	185	0.302703	0.00429987	0.0840105	0.566337	0.141409	0.672297	1.96 [0.80 - 4.80]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212814_at	185	0.302703	0.00041985	0.0122019	0.646539	0.0531622	0.813097	2.25 [0.99 - 5.14]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215672_s_at	185	0.27027	0.0186713	0.255202	0.485319	0.406475	0.228762	1.26 [0.73 - 2.16]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P252075	110	0.154545	0.0226084	0.291996	0.879203	0.420266	0.205798	1.23 [0.74 - 2.03]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P72518	110	0.454545	0.0519837	-	0.456426	0.647866	0.0972055	1.10 [0.73 - 1.67]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P252075	110	0.154545	0.304791	-	0.528828	0.934633	0.0278175	1.03 [0.53 - 2.00]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P72518	110	0.5	0.267615	-	0.330447	0.938332	0.0203571	1.02 [0.61 - 1.71]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212814_at	80	0.2	0.0346972	0.390098	1.8795	0.349134	0.405778	1.50 [0.64 - 3.51]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215672_s_at	80	0.5875	0.0829252	-	-0.822931	0.897939	-0.0249222	0.98 [0.67 - 1.43]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:35242	59	0.881356	0.00368322	0.0742702	1.75384	0.324324	-1.39265	0.25 [0.02 - 3.96]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212814_at	38	0.578947	0.0323338	0.37239	0.999848	0.53278	0.172197	1.19 [0.69 - 2.04]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215672_s_at	38	0.368421	0.00798126	0.136064	1.42062	0.108867	0.481616	1.62 [0.90 - 2.92]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212814_at	140	0.878571	0.0171309	0.23997	0.864358	0.554272	-0.362764	0.70 [0.21 - 2.32]
GENE	AHCYL2	adenosylhomocysteinase-like 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215672_s_at	140	0.128571	0.0194783	0.262985	-0.890832	0.930806	-0.0691412	0.93 [0.20 - 4.44]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219841_at	30	0.166667	0.0161175	0.229659	-1.24621	0.823421	-0.180569	0.83 [0.17 - 4.08]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1792434	165	0.575758	0.289163	-	-0.271217	0.447612	-0.685562	0.50 [0.09 - 2.96]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1792434	165	0.678788	0.199552	-	0.458885	0.906374	-0.14579	0.86 [0.08 - 9.81]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219841_at	163	0.233129	0.0803322	-	-0.391901	0.325601	-0.575753	0.56 [0.18 - 1.77]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	224499_s_at	163	0.693252	0.0461966	0.468272	-0.449517	0.0338529	-1.64708	0.19 [0.04 - 0.88]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	224499_s_at	79	0.708861	0.168305	-	-0.471144	0.458465	-0.625609	0.53 [0.10 - 2.80]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219841_at	79	0.898734	0.166792	-	-0.804759	0.549171	-0.412683	0.66 [0.17 - 2.55]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219841_at	58	0.810345	0.0187202	0.255678	0.82771	0.483658	0.0949937	1.10 [0.84 - 1.43]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219841_at	34	0.647059	0.0363643	0.40222	-0.880029	0.103188	-0.391372	0.68 [0.42 - 1.08]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219841_at	158	0.240506	0.091603	-	-0.419719	0.937254	-0.00657679	0.99 [0.84 - 1.17]
GENE	AICDA	activation-induced cytidine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219841_at	53	0.471698	0.0837337	-	0.639353	0.618636	0.0574006	1.06 [0.84 - 1.33]
GENE	AICDA	activation-induced cytidine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219841_at	53	0.471698	0.0188533	0.256969	0.815419	0.256696	0.126232	1.13 [0.91 - 1.41]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219841_at	180	0.166667	0.0603484	-	0.61976	0.31495	0.0571916	1.06 [0.95 - 1.18]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	224499_s_at	180	0.194444	0.170234	-	0.408211	0.355073	0.047865	1.05 [0.95 - 1.16]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	224499_s_at	559	0.134168	0.00821781	0.139135	-0.627841	0.393077	-0.0965631	0.91 [0.73 - 1.13]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219841_at	559	0.733453	0.0222458	0.288724	-0.548634	0.414164	-0.0993943	0.91 [0.71 - 1.15]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219841_at	77	0.87013	0.105069	-	-0.685329	0.446296	-0.113583	0.89 [0.67 - 1.20]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	224499_s_at	77	0.350649	0.0780874	-	0.490384	0.456126	0.107963	1.11 [0.84 - 1.48]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219841_at	70	0.785714	0.107798	-	0.49343	0.810017	0.338518	1.40 [0.09 - 22.16]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	224499_s_at	70	0.857143	0.111736	-	-0.67478	0.845847	-0.211239	0.81 [0.10 - 6.81]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219841_at	74	0.175676	0.0382267	0.415424	-0.68933	0.344315	-0.176847	0.84 [0.58 - 1.21]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	224499_s_at	74	0.891892	0.000227595	0.00719199	1.39834	0.399046	0.168052	1.18 [0.80 - 1.75]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	224499_s_at	67	0.179104	0.00785672	0.134436	-1.61678	0.253458	-3.72097	0.02 [0.00 - 14.37]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219841_at	67	0.61194	0.0646166	-	-1.73785	0.729224	-0.945821	0.39 [0.00 - 82.23]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219841_at	115	0.895652	0.00862902	0.14441	1.43586	0.315181	0.877344	2.40 [0.43 - 13.32]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	224499_s_at	115	0.565217	0.0937001	-	0.907138	0.31149	0.405359	1.50 [0.68 - 3.29]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	224499_s_at	204	0.740196	0.11629	-	0.250989	0.505453	0.0459174	1.05 [0.91 - 1.20]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219841_at	204	0.813725	0.144613	-	-0.27318	0.793413	-0.0150901	0.99 [0.88 - 1.10]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219841_at	87	0.367816	0.00208528	0.0468711	1.52248	0.732717	-0.156015	0.86 [0.35 - 2.09]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219841_at	87	0.367816	0.00208528	0.0468711	1.52248	0.732717	-0.156015	0.86 [0.35 - 2.09]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	224499_s_at	87	0.724138	0.0659017	-	-0.957696	0.529153	-0.435763	0.65 [0.17 - 2.51]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	224499_s_at	87	0.724138	0.0659017	-	-0.957696	0.529153	-0.435763	0.65 [0.17 - 2.51]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219841_at	77	0.415584	0.132816	-	1.12848	0.00323002	1.13633	3.12 [1.46 - 6.64]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	224499_s_at	77	0.896104	0.0879915	-	1.07216	0.00764673	0.767272	2.15 [1.23 - 3.79]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	224499_s_at	77	0.896104	0.0216916	0.283682	1.4545	0.00441163	0.866359	2.38 [1.31 - 4.32]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219841_at	77	0.597403	0.0158414	0.226808	1.34761	0.00352038	1.03633	2.82 [1.41 - 5.65]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219841_at	136	0.485294	0.15071	-	0.664399	0.595955	0.119948	1.13 [0.72 - 1.76]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219841_at	200	0.215	0.15734	-	0.60933	0.733398	0.0521378	1.05 [0.78 - 1.42]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18338	60	0.833333	0.025807	0.319922	0.958626	0.23188	0.413142	1.51 [0.77 - 2.98]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18338	60	0.25	0.0181359	0.249966	-0.916883	0.992682	0.00185449	1.00 [0.67 - 1.49]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17908	155	0.148387	0.000607323	0.0167243	-0.987467	0.180938	-0.159658	0.85 [0.67 - 1.08]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219841_at	286	0.856643	0.221129	-	-0.371936	0.750726	-0.0300255	0.97 [0.81 - 1.17]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219841_at	159	0.735849	0.0257604	0.319526	0.818378	0.372439	0.216393	1.24 [0.77 - 2.00]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219841_at	159	0.72327	0.00948586	0.155159	0.808191	0.263372	0.230069	1.26 [0.84 - 1.88]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219841_at	159	0.735849	0.0618268	-	0.600777	0.314741	0.191709	1.21 [0.83 - 1.76]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224499_s_at	159	0.132075	0.0306842	0.359646	1.89326	0.0368969	0.353079	1.42 [1.02 - 1.98]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224499_s_at	159	0.440252	0.158787	-	0.463278	0.112448	0.253626	1.29 [0.94 - 1.76]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224499_s_at	159	0.132075	0.0260374	0.321873	15.2542	0.0149736	0.46188	1.59 [1.09 - 2.30]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219841_at	54	0.833333	0.140022	-	-15.3778	0.367464	-1.59941	0.20 [0.01 - 6.55]
GENE	AICDA	activation-induced cytidine deaminase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219841_at	117	0.863248	0.0381713	0.415036	-1.39343	0.143191	-1.11325	0.33 [0.07 - 1.46]
GENE	AICDA	activation-induced cytidine deaminase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219841_at	117	0.811966	0.0572227	-	-1.30114	0.150615	-1.46682	0.23 [0.03 - 1.70]
GENE	AICDA	activation-induced cytidine deaminase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219841_at	117	0.384615	0.0789945	-	-0.676343	0.199411	-1.31085	0.27 [0.04 - 2.00]
GENE	AICDA	activation-induced cytidine deaminase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219841_at	117	0.863248	0.0381713	0.415036	-1.39343	0.143191	-1.11325	0.33 [0.07 - 1.46]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219841_at	236	0.283898	0.112973	-	0.529337	0.387496	0.160911	1.17 [0.82 - 1.69]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	224499_s_at	236	0.220339	0.148512	-	0.545971	0.895636	-0.0217472	0.98 [0.71 - 1.35]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219841_at	249	0.726908	0.122989	-	-0.395774	0.69493	0.0535489	1.06 [0.81 - 1.38]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	224499_s_at	249	0.594378	0.0157675	0.226042	-0.549682	0.144704	-0.190076	0.83 [0.64 - 1.07]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219841_at	62	0.709677	0.415347	-	-0.435333	0.587597	-0.128785	0.88 [0.55 - 1.40]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219841_at	125	0.456	0.167378	-	-0.53288	0.45068	-0.570587	0.57 [0.13 - 2.49]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219841_at	125	0.88	0.118805	-	-1.0782	0.421491	-0.472343	0.62 [0.20 - 1.97]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219841_at	54	0.740741	0.246151	-	-0.880949	0.601036	-0.150993	0.86 [0.49 - 1.51]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219841_at	198	0.19697	0.0262721	0.323852	-0.629124	0.373288	-0.0730876	0.93 [0.79 - 1.09]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219841_at	198	0.19697	0.0333028	0.379726	-0.623138	0.337874	-0.0813684	0.92 [0.78 - 1.09]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219841_at	198	0.19697	0.0788438	-	-0.430538	0.224988	-0.0812931	0.92 [0.81 - 1.05]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219841_at	51	0.843137	0.00287536	0.060869	2.23268	0.0684857	4.55191	94.81 [0.71 - 12697.07]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219841_at	62	0.177419	0.158346	-	-0.839427	0.853385	0.294533	1.34 [0.06 - 30.52]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	224499_s_at	177	0.242938	2.66167e-05	0.00107964	-1.11076	0.0289051	-1.98759	0.14 [0.02 - 0.82]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219841_at	177	0.666667	0.0226124	0.292032	-0.751672	0.506024	-0.545488	0.58 [0.12 - 2.89]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	224499_s_at	177	0.242938	4.71461e-06	0.000225598	-1.06069	0.0122595	-1.96928	0.14 [0.03 - 0.65]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219841_at	177	0.677966	0.0168492	0.237127	-0.680089	0.306813	-0.732937	0.48 [0.12 - 1.96]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	224499_s_at	145	0.117241	0.30808	-	0.725936	0.691726	-0.379464	0.68 [0.10 - 4.46]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219841_at	145	0.668966	0.061411	-	-0.769343	0.86658	-0.169942	0.84 [0.12 - 6.13]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	224499_s_at	226	0.207965	0.0145972	0.213723	1.20144	0.459093	0.0727976	1.08 [0.89 - 1.30]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219841_at	226	0.743363	0.15638	-	-0.51688	0.61382	-0.0527614	0.95 [0.77 - 1.16]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	224499_s_at	55	0.345455	0.0771651	-	0.95639	0.331379	1.30222	3.68 [0.27 - 50.90]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219841_at	55	0.818182	0.0714103	-	0.855634	0.961053	-0.0820542	0.92 [0.03 - 24.81]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	224499_s_at	55	0.290909	0.0652207	-	1.25875	0.211756	1.75828	5.80 [0.37 - 91.65]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219841_at	55	0.8	0.042653	0.445467	1.03055	0.877735	-0.282809	0.75 [0.02 - 27.67]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	224499_s_at	49	0.816327	0.00732122	0.127346	1.56847	0.11811	2.42388	11.29 [0.54 - 236.02]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219841_at	49	0.816327	0.0729287	-	1.05234	0.981202	0.0469126	1.05 [0.02 - 51.90]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	224499_s_at	63	0.222222	0.00929876	0.152839	-0.903241	0.486679	1.22805	3.41 [0.11 - 108.67]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219841_at	63	0.206349	4.83164e-05	0.00183907	-1.39089	0.00555359	-40.6448	0.00 [0.00 - 0.00]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g10190699_3p_at	28	0.535714	0.131953	-	-0.893374	0.786814	-0.381111	0.68 [0.04 - 10.81]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13623400_3p_s_at	28	0.107143	0.0156577	0.224901	-1.60217	0.221064	0.225375	1.25 [0.87 - 1.80]
GENE	AICDA	activation-induced cytidine deaminase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219841_at	82	0.890244	0.0727555	-	0.790594	0.520852	0.287673	1.33 [0.55 - 3.21]
GENE	AICDA	activation-induced cytidine deaminase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219841_at	79	0.632911	0.203083	-	0.335385	0.940186	-0.02271	0.98 [0.54 - 1.77]
GENE	AICDA	activation-induced cytidine deaminase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219841_at	104	0.480769	0.0399085	0.427054	0.711342	0.282344	0.401544	1.49 [0.72 - 3.11]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	224499_s_at	204	0.166667	0.0350578	0.392745	-0.817319	0.264689	-0.184943	0.83 [0.60 - 1.15]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219841_at	204	0.720588	0.0604222	-	-0.970331	0.676712	-0.0568474	0.94 [0.72 - 1.23]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	224499_s_at	204	0.848039	0.203737	-	-0.588255	0.808085	-0.0295424	0.97 [0.76 - 1.23]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219841_at	204	0.52451	0.0575333	-	0.52049	0.797848	0.0259177	1.03 [0.84 - 1.25]
GENE	AICDA	activation-induced cytidine deaminase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219841_at	178	0.651685	0.104491	-	0.32851	0.873671	-0.0279526	0.97 [0.69 - 1.37]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	224499_s_at	111	0.738739	0.236292	-	-0.37183	0.728317	-0.0474476	0.95 [0.73 - 1.25]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219841_at	111	0.837838	0.251558	-	0.382117	0.926187	0.0126647	1.01 [0.77 - 1.32]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219841_at	90	0.488889	0.0624393	-	-0.609526	0.648237	-0.298843	0.74 [0.21 - 2.68]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219841_at	90	0.488889	0.155808	-	-0.529506	0.815648	-0.171258	0.84 [0.20 - 3.56]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219841_at	138	0.181159	0.00333228	0.0685463	-0.764703	0.355298	-0.529752	0.59 [0.19 - 1.81]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	224499_s_at	138	0.195652	0.00101831	0.025876	-0.820675	0.421845	-0.265421	0.77 [0.40 - 1.47]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219841_at	129	0.813953	0.136935	-	0.434458	0.769765	0.0458135	1.05 [0.77 - 1.42]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43143	56	0.357143	0.233425	-	-0.420834	0.679474	-0.0622537	0.94 [0.70 - 1.26]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43143	56	0.696429	0.198968	-	-0.500192	0.594101	-0.0761371	0.93 [0.70 - 1.23]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	224499_s_at	278	0.755396	0.0468508	0.472368	0.404055	0.711726	0.0798963	1.08 [0.71 - 1.65]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219841_at	278	0.223022	0.129089	-	0.345444	0.86273	0.0510332	1.05 [0.59 - 1.88]
GENE	AICDA	activation-induced cytidine deaminase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219841_at	133	0.87218	0.00491491	0.0933728	0.881022	0.056902	3.04031	20.91 [0.91 - 478.16]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219841_at	185	0.254054	0.00146175	0.0349777	0.606881	0.0333931	0.530061	1.70 [1.04 - 2.77]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219841_at	185	0.254054	0.00173061	0.0402162	0.663781	0.0807797	0.475005	1.61 [0.94 - 2.74]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36641	110	0.854545	0.0919091	-	0.513062	0.915356	-0.0132895	0.99 [0.77 - 1.26]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36641	110	0.890909	0.00512576	0.0965096	1.0647	0.439297	0.126336	1.13 [0.82 - 1.56]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219841_at	80	0.8125	0.0193736	0.261982	1.01495	0.161571	0.230841	1.26 [0.91 - 1.74]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	224499_s_at	38	0.236842	0.0294903	0.350213	-1.09266	0.227753	-0.491126	0.61 [0.28 - 1.36]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219841_at	38	0.894737	0.0782472	-	-15.2666	0.586506	-0.239037	0.79 [0.33 - 1.86]
GENE	AICDA	activation-induced cytidine deaminase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219841_at	140	0.707143	0.12098	-	-0.529046	0.829394	-0.202823	0.82 [0.13 - 5.17]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AK1	adenylate kinase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202587_s_at	30	0.7	0.0828229	-	0.70371	0.924629	0.0296397	1.03 [0.56 - 1.90]
GENE	AK1	adenylate kinase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202588_at	30	0.6	0.033959	0.384634	-0.878137	0.638109	-0.396735	0.67 [0.13 - 3.51]
GENE	AK1	adenylate kinase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1779965	165	0.866667	0.0904352	-	-0.768099	0.828513	-0.0341544	0.97 [0.71 - 1.32]
GENE	AK1	adenylate kinase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1779965	165	0.472727	0.0342917	0.387104	0.787091	0.333813	0.222896	1.25 [0.80 - 1.96]
GENE	AK1	adenylate kinase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202588_at	163	0.865031	0.021845	0.285083	-0.781037	0.0493689	-1.39776	0.25 [0.06 - 1.00]
GENE	AK1	adenylate kinase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202587_s_at	163	0.171779	0.196015	-	-0.321127	0.124872	-0.303537	0.74 [0.50 - 1.09]
GENE	AK1	adenylate kinase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202587_s_at	79	0.139241	0.000468916	0.0134136	-1.19423	0.0339484	-0.4499	0.64 [0.42 - 0.97]
GENE	AK1	adenylate kinase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202588_at	79	0.708861	0.0282463	0.34019	-0.765438	0.140656	-0.969711	0.38 [0.10 - 1.38]
GENE	AK1	adenylate kinase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202587_s_at	58	0.413793	2.30371e-05	0.000948412	-1.24053	0.00343759	-0.377737	0.69 [0.53 - 0.88]
GENE	AK1	adenylate kinase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202588_at	58	0.431034	0.141907	-	-0.413894	0.407976	-0.182586	0.83 [0.54 - 1.28]
GENE	AK1	adenylate kinase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202587_s_at	34	0.852941	0.03206	0.370297	-1.45291	0.131836	-0.456789	0.63 [0.35 - 1.15]
GENE	AK1	adenylate kinase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202588_at	34	0.117647	0.0555441	-	-1.02005	0.722379	-0.0817045	0.92 [0.59 - 1.45]
GENE	AK1	adenylate kinase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202587_s_at	158	0.879747	0.0559429	-	0.579188	0.0537957	0.621102	1.86 [0.99 - 3.50]
GENE	AK1	adenylate kinase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202588_at	158	0.493671	0.0030834	0.0643981	0.690181	0.0380361	1.65413	5.23 [1.10 - 24.95]
GENE	AK1	adenylate kinase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202588_at	53	0.396226	0.0379269	0.413322	-0.743602	0.757782	0.103749	1.11 [0.57 - 2.14]
GENE	AK1	adenylate kinase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202587_s_at	53	0.773585	0.000273394	0.00843123	1.32664	0.0543742	0.705328	2.02 [0.99 - 4.15]
GENE	AK1	adenylate kinase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202588_at	53	0.377358	0.0582269	-	-0.642118	0.657069	0.140784	1.15 [0.62 - 2.14]
GENE	AK1	adenylate kinase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202587_s_at	53	0.773585	0.000129632	0.00439985	1.42417	0.0504302	0.769339	2.16 [1.00 - 4.67]
GENE	AK1	adenylate kinase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202587_s_at	180	0.322222	0.112939	-	-0.348736	0.65946	-0.11187	0.89 [0.54 - 1.47]
GENE	AK1	adenylate kinase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202588_at	180	0.844444	0.0218497	0.285125	0.585325	0.963706	-0.00539458	0.99 [0.79 - 1.25]
GENE	AK1	adenylate kinase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202588_at	559	0.54025	0.193789	-	-0.262588	0.734765	-0.0609645	0.94 [0.66 - 1.34]
GENE	AK1	adenylate kinase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202587_s_at	559	0.11449	0.0376147	0.411123	-0.547671	0.136111	-0.154156	0.86 [0.70 - 1.05]
GENE	AK1	adenylate kinase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202587_s_at	77	0.87013	7.04166e-05	0.00256933	1.32622	0.159626	0.304033	1.36 [0.89 - 2.07]
GENE	AK1	adenylate kinase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202588_at	77	0.896104	0.00254843	0.0551989	1.12234	0.297065	0.211307	1.24 [0.83 - 1.84]
GENE	AK1	adenylate kinase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202587_s_at	70	0.657143	0.170379	-	0.375159	0.559607	0.0718292	1.07 [0.84 - 1.37]
GENE	AK1	adenylate kinase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202588_at	70	0.171429	0.114842	-	-0.549828	0.917615	0.0676074	1.07 [0.30 - 3.85]
GENE	AK1	adenylate kinase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36997_at	50	0.36	0.0233518	0.298632	-0.792196	0.486131	-0.354839	0.70 [0.26 - 1.90]
GENE	AK1	adenylate kinase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202587_s_at	74	0.878378	0.00113495	0.0283347	1.2627	0.101666	0.641628	1.90 [0.88 - 4.10]
GENE	AK1	adenylate kinase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202588_at	74	0.810811	0.0892327	-	-0.727843	0.250712	-0.312913	0.73 [0.43 - 1.25]
GENE	AK1	adenylate kinase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202588_at	67	0.820895	0.178534	-	0.935121	0.958027	-0.0771759	0.93 [0.05 - 16.39]
GENE	AK1	adenylate kinase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202587_s_at	67	0.313433	0.0156985	0.225325	-1.55553	0.212249	-0.76225	0.47 [0.14 - 1.55]
GENE	AK1	adenylate kinase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202588_at	115	0.121739	0.220966	-	-0.780744	0.667152	0.376626	1.46 [0.26 - 8.11]
GENE	AK1	adenylate kinase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202587_s_at	115	0.191304	0.105429	-	-0.879713	0.538566	-0.432257	0.65 [0.16 - 2.57]
GENE	AK1	adenylate kinase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36997_at	158	0.835443	0.00416126	0.0818538	0.872378	0.125714	0.676875	1.97 [0.83 - 4.68]
GENE	AK1	adenylate kinase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36997_at	76	0.473684	0.0591115	-	-1.05989	0.537011	-0.323323	0.72 [0.26 - 2.02]
GENE	AK1	adenylate kinase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202587_s_at	204	0.553922	0.0067904	0.120165	-0.38778	0.522972	-0.114503	0.89 [0.63 - 1.27]
GENE	AK1	adenylate kinase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202588_at	204	0.323529	0.0146296	0.214069	0.365253	0.0360096	0.190798	1.21 [1.01 - 1.45]
GENE	AK1	adenylate kinase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202588_at	87	0.528736	0.0753319	-	0.675708	0.904354	0.0717789	1.07 [0.33 - 3.46]
GENE	AK1	adenylate kinase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202588_at	87	0.528736	0.0753319	-	0.675708	0.904354	0.0717789	1.07 [0.33 - 3.46]
GENE	AK1	adenylate kinase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202587_s_at	87	0.862069	0.0564793	-	0.810653	0.585857	0.177011	1.19 [0.63 - 2.26]
GENE	AK1	adenylate kinase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202587_s_at	87	0.862069	0.0564793	-	0.810653	0.585857	0.177011	1.19 [0.63 - 2.26]
GENE	AK1	adenylate kinase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202588_at	77	0.714286	0.016135	0.229839	1.43104	0.722251	0.37462	1.45 [0.18 - 11.48]
GENE	AK1	adenylate kinase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202587_s_at	77	0.155844	0.0758232	-	-1.02683	0.882358	-0.0751533	0.93 [0.34 - 2.51]
GENE	AK1	adenylate kinase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202587_s_at	77	0.155844	0.170684	-	-0.917552	0.912526	-0.0623758	0.94 [0.31 - 2.86]
GENE	AK1	adenylate kinase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202588_at	77	0.714286	0.00442842	0.0859947	1.48758	0.282003	0.976242	2.65 [0.45 - 15.72]
GENE	AK1	adenylate kinase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202588_at	136	0.801471	0.110975	-	-1.49365	0.639728	-0.147738	0.86 [0.46 - 1.60]
GENE	AK1	adenylate kinase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202587_s_at	136	0.882353	0.0754289	-	0.89044	0.651975	0.255076	1.29 [0.43 - 3.91]
GENE	AK1	adenylate kinase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202587_s_at	200	0.87	0.00603846	0.109707	0.954103	0.031551	0.80677	2.24 [1.07 - 4.67]
GENE	AK1	adenylate kinase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202588_at	200	0.155	0.0478764	0.478723	-0.698386	0.269699	-0.2689	0.76 [0.47 - 1.23]
GENE	AK1	adenylate kinase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17131	60	0.183333	0.0516424	-	-0.841926	0.558317	-0.175295	0.84 [0.47 - 1.51]
GENE	AK1	adenylate kinase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17131	60	0.133333	0.135277	-	1.40187	0.688723	0.157939	1.17 [0.54 - 2.54]
GENE	AK1	adenylate kinase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6888	155	0.225806	4.86072e-06	0.000231963	-1.21125	1.76283e-05	-0.597226	0.55 [0.42 - 0.72]
GENE	AK1	adenylate kinase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202587_s_at	286	0.122378	0.0496531	0.489539	-0.513846	0.656811	-0.117915	0.89 [0.53 - 1.50]
GENE	AK1	adenylate kinase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202588_at	286	0.734266	0.251198	-	0.238231	0.87674	0.0249895	1.03 [0.75 - 1.41]
GENE	AK1	adenylate kinase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202588_at	159	0.899371	0.217368	-	0.539989	0.734412	0.0972995	1.10 [0.63 - 1.93]
GENE	AK1	adenylate kinase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202587_s_at	159	0.427673	0.0346808	0.389977	-0.663763	0.55337	-0.260689	0.77 [0.33 - 1.82]
GENE	AK1	adenylate kinase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202587_s_at	159	0.427673	0.0992406	-	-0.606757	0.730407	-0.176682	0.84 [0.31 - 2.29]
GENE	AK1	adenylate kinase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202588_at	159	0.899371	0.000768042	0.0204072	1.20186	0.0241932	0.712808	2.04 [1.10 - 3.79]
GENE	AK1	adenylate kinase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202587_s_at	159	0.427673	0.0564975	-	-0.597799	0.832529	-0.0910014	0.91 [0.39 - 2.12]
GENE	AK1	adenylate kinase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202588_at	159	0.899371	0.0350898	0.392979	0.932669	0.127617	0.552313	1.74 [0.85 - 3.54]
GENE	AK1	adenylate kinase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202587_s_at	54	0.259259	0.0660574	-	15.5347	0.479907	0.396902	1.49 [0.49 - 4.47]
GENE	AK1	adenylate kinase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202588_at	54	0.333333	0.0740927	-	1.73175	0.647437	0.457451	1.58 [0.22 - 11.22]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202587_s_at	117	0.290598	0.0435136	0.451103	0.788208	0.134236	0.437982	1.55 [0.87 - 2.75]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202587_s_at	117	0.102564	0.167101	-	1.31157	0.199238	0.448268	1.57 [0.79 - 3.10]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202587_s_at	117	0.102564	0.217596	-	1.18698	0.679602	0.146557	1.16 [0.58 - 2.32]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202587_s_at	117	0.290598	0.0435136	0.451103	0.788208	0.134236	0.437982	1.55 [0.87 - 2.75]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202588_at	117	0.598291	0.0388962	0.420086	0.642514	0.710087	0.208439	1.23 [0.41 - 3.70]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202588_at	117	0.598291	0.0403903	0.430336	0.758404	0.564595	0.378823	1.46 [0.40 - 5.30]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202588_at	117	0.162393	0.182647	-	0.942411	0.859036	0.131127	1.14 [0.27 - 4.85]
GENE	AK1	adenylate kinase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202588_at	117	0.598291	0.0388962	0.420086	0.642514	0.710087	0.208439	1.23 [0.41 - 3.70]
GENE	AK1	adenylate kinase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202588_at	236	0.805085	0.0667125	-	0.548851	0.215914	0.364204	1.44 [0.81 - 2.56]
GENE	AK1	adenylate kinase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202587_s_at	236	0.423729	0.0064349	0.115264	0.820033	0.145331	0.495077	1.64 [0.84 - 3.19]
GENE	AK1	adenylate kinase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202587_s_at	249	0.481928	0.342063	-	-0.201116	0.957342	-0.0163449	0.98 [0.54 - 1.79]
GENE	AK1	adenylate kinase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202588_at	249	0.353414	0.144137	-	-0.313206	0.926708	-0.0204521	0.98 [0.63 - 1.51]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202588_at	125	0.112	0.042937	0.447334	-0.777662	0.764331	-0.131571	0.88 [0.37 - 2.07]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202588_at	54	0.425926	0.0411022	0.435146	1.86579	0.916442	-0.0265614	0.97 [0.59 - 1.60]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202587_s_at	62	0.870968	0.208526	-	-0.939392	0.796025	-0.0611783	0.94 [0.59 - 1.50]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202587_s_at	125	0.448	0.310325	-	0.393611	0.701797	0.136586	1.15 [0.57 - 2.31]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202588_at	62	0.16129	0.0696877	-	15.2829	0.787513	-0.0562208	0.95 [0.63 - 1.42]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202587_s_at	125	0.192	0.283987	-	0.41445	0.747783	0.0882577	1.09 [0.64 - 1.87]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202588_at	125	0.104	0.067302	-	-0.88223	0.668653	0.240024	1.27 [0.42 - 3.82]
GENE	AK1	adenylate kinase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202587_s_at	54	0.888889	0.355196	-	-0.950431	0.932549	-0.0241676	0.98 [0.56 - 1.71]
GENE	AK1	adenylate kinase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202588_at	198	0.116162	0.0628937	-	-0.52344	0.294446	-0.123808	0.88 [0.70 - 1.11]
GENE	AK1	adenylate kinase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202587_s_at	198	0.555556	0.179967	-	-0.358188	0.897472	-0.0294594	0.97 [0.62 - 1.52]
GENE	AK1	adenylate kinase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202587_s_at	198	0.60101	0.176949	-	-0.392436	0.754846	-0.0738009	0.93 [0.58 - 1.48]
GENE	AK1	adenylate kinase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202588_at	198	0.287879	0.122767	-	0.465325	0.981252	0.00333917	1.00 [0.76 - 1.33]
GENE	AK1	adenylate kinase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202588_at	198	0.29798	0.0732694	-	0.576195	0.737161	0.0501452	1.05 [0.78 - 1.41]
GENE	AK1	adenylate kinase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202587_s_at	198	0.121212	0.0969311	-	0.647083	0.975394	0.00568269	1.01 [0.70 - 1.44]
GENE	AK1	adenylate kinase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202588_at	62	0.822581	0.0688309	-	-15.401	0.42514	-0.623181	0.54 [0.12 - 2.48]
GENE	AK1	adenylate kinase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202587_s_at	51	0.235294	0.2141	-	15.4374	0.310445	0.354568	1.43 [0.72 - 2.83]
GENE	AK1	adenylate kinase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202587_s_at	62	0.451613	0.0287574	0.344333	1.53857	0.165172	0.328463	1.39 [0.87 - 2.21]
GENE	AK1	adenylate kinase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202588_at	51	0.803922	0.245835	-	-15.3875	0.764903	-0.346398	0.71 [0.07 - 6.85]
GENE	AK1	adenylate kinase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202588_at	177	0.429379	0.180237	-	0.390399	0.958829	0.0367817	1.04 [0.26 - 4.19]
GENE	AK1	adenylate kinase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202587_s_at	177	0.350282	0.00577639	0.105978	0.781085	0.103012	0.299082	1.35 [0.94 - 1.93]
GENE	AK1	adenylate kinase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202587_s_at	177	0.40113	0.00288559	0.0610439	0.940892	0.094647	0.354483	1.43 [0.94 - 2.16]
GENE	AK1	adenylate kinase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202588_at	177	0.225989	0.178427	-	-0.364728	0.922797	-0.0602162	0.94 [0.28 - 3.18]
GENE	AK1	adenylate kinase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202587_s_at	145	0.303448	0.182842	-	0.553781	0.897109	-0.0329076	0.97 [0.59 - 1.59]
GENE	AK1	adenylate kinase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202588_at	145	0.855172	0.184853	-	-0.782106	0.853027	-0.161168	0.85 [0.15 - 4.68]
GENE	AK1	adenylate kinase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202587_s_at	226	0.80531	0.174561	-	-0.58324	0.46087	-0.134154	0.87 [0.61 - 1.25]
GENE	AK1	adenylate kinase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202588_at	226	0.265487	0.118655	-	-0.462159	0.589241	-0.0902805	0.91 [0.66 - 1.27]
GENE	AK1	adenylate kinase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202587_s_at	49	0.673469	0.00227675	0.0503594	1.67356	0.0408298	0.788246	2.20 [1.03 - 4.68]
GENE	AK1	adenylate kinase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202587_s_at	55	0.690909	0.0115935	0.180356	1.08075	0.187088	0.35648	1.43 [0.84 - 2.43]
GENE	AK1	adenylate kinase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202588_at	55	0.381818	0.0293401	0.349014	1.1549	0.449193	0.597511	1.82 [0.39 - 8.54]
GENE	AK1	adenylate kinase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202588_at	55	0.6	0.111981	-	0.70375	0.822383	0.200937	1.22 [0.21 - 7.07]
GENE	AK1	adenylate kinase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202588_at	49	0.612245	0.00695324	0.122384	1.52136	0.168091	1.43729	4.21 [0.55 - 32.49]
GENE	AK1	adenylate kinase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202587_s_at	55	0.690909	0.0491357	0.486414	0.900107	0.155382	0.427137	1.53 [0.85 - 2.76]
GENE	AK1	adenylate kinase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202587_s_at	63	0.174603	0.0411323	0.435349	-0.780276	0.327415	-0.17534	0.84 [0.59 - 1.19]
GENE	AK1	adenylate kinase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202588_at	63	0.47619	0.0672798	-	-0.616505	0.49286	-0.421953	0.66 [0.20 - 2.19]
GENE	AK1	adenylate kinase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12654562_3p_a_at	28	0.464286	0.0624108	-	1.02877	0.254758	0.55633	1.74 [0.67 - 4.54]
GENE	AK1	adenylate kinase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502010_3p_at	28	0.178571	0.121662	-	1.47977	0.586964	-0.422376	0.66 [0.14 - 3.01]
GENE	AK1	adenylate kinase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202588_at	82	0.609756	0.0841936	-	-0.634291	0.421569	-0.325554	0.72 [0.33 - 1.60]
GENE	AK1	adenylate kinase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202587_s_at	82	0.878049	0.161586	-	-0.976119	0.977489	-0.00858511	0.99 [0.55 - 1.80]
GENE	AK1	adenylate kinase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202588_at	79	0.468354	0.0674613	-	-0.47435	0.412603	-0.281104	0.75 [0.39 - 1.48]
GENE	AK1	adenylate kinase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202587_s_at	79	0.518987	0.0276756	0.335523	-0.573883	0.250348	-0.215328	0.81 [0.56 - 1.16]
GENE	AK1	adenylate kinase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	J04809_rna1_at	86	0.302326	0.0666056	-	-0.741682	0.252164	-0.696137	0.50 [0.15 - 1.64]
GENE	AK1	adenylate kinase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202587_s_at	104	0.221154	0.0387045	0.418755	-0.70494	0.276527	-0.272774	0.76 [0.47 - 1.24]
GENE	AK1	adenylate kinase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202588_at	104	0.596154	0.0216955	0.283717	-0.824926	0.487465	-0.339262	0.71 [0.27 - 1.86]
GENE	AK1	adenylate kinase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P217088	117	0.111111	0.00135352	0.0328142	-1.13204	0.00134503	-0.450558	0.64 [0.48 - 0.84]
GENE	AK1	adenylate kinase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P278192	117	0.444444	0.000763802	0.0203119	-0.954392	0.00421247	-0.775007	0.46 [0.27 - 0.78]
GENE	AK1	adenylate kinase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202588_at	204	0.240196	0.0038428	0.0768279	-1.0237	0.00742532	-0.518254	0.60 [0.41 - 0.87]
GENE	AK1	adenylate kinase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202588_at	204	0.735294	0.000801445	0.0211543	-1.4466	0.00905853	-0.377427	0.69 [0.52 - 0.91]
GENE	AK1	adenylate kinase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202587_s_at	204	0.627451	0.00520702	0.0977093	-1.38779	0.0334127	-0.802787	0.45 [0.21 - 0.94]
GENE	AK1	adenylate kinase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202587_s_at	204	0.671569	0.0233726	0.298816	-0.74861	0.153989	-0.383126	0.68 [0.40 - 1.15]
GENE	AK1	adenylate kinase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202588_at	178	0.438202	0.0517899	-	-0.38189	0.14404	-0.357774	0.70 [0.43 - 1.13]
GENE	AK1	adenylate kinase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202587_s_at	178	0.685393	0.00814025	0.138131	-0.618097	0.030459	-0.369554	0.69 [0.49 - 0.97]
GENE	AK1	adenylate kinase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006268	41	0.878049	0.11449	-	-1.47779	0.397491	-0.225846	0.80 [0.47 - 1.35]
GENE	AK1	adenylate kinase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202587_s_at	111	0.108108	0.209522	-	-0.502384	0.652773	-0.0808997	0.92 [0.65 - 1.31]
GENE	AK1	adenylate kinase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202588_at	111	0.387387	0.0804177	-	0.491626	0.252133	0.230949	1.26 [0.85 - 1.87]
GENE	AK1	adenylate kinase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202588_at	90	0.833333	0.00371474	0.0747775	1.03797	0.301905	0.728142	2.07 [0.52 - 8.25]
GENE	AK1	adenylate kinase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202588_at	90	0.833333	0.00152897	0.0363049	1.21184	0.17756	1.05156	2.86 [0.62 - 13.20]
GENE	AK1	adenylate kinase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202587_s_at	90	0.411111	0.14999	-	0.487789	0.933234	0.0185109	1.02 [0.66 - 1.57]
GENE	AK1	adenylate kinase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202587_s_at	90	0.422222	0.18824	-	0.508837	0.840666	0.049993	1.05 [0.65 - 1.71]
GENE	AK1	adenylate kinase 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	2039	50	0.52	0.224544	-	-0.597142	0.716343	-0.12302	0.88 [0.46 - 1.72]
GENE	AK1	adenylate kinase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202588_at	138	0.181159	0.167695	-	-0.384052	0.602444	-0.103108	0.90 [0.61 - 1.33]
GENE	AK1	adenylate kinase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202587_s_at	138	0.101449	0.0412917	0.436419	1.14304	0.588802	0.0446474	1.05 [0.89 - 1.23]
GENE	AK1	adenylate kinase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202587_s_at	129	0.875969	0.0325568	0.374088	0.728715	0.712799	-0.136789	0.87 [0.42 - 1.81]
GENE	AK1	adenylate kinase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202588_at	129	0.565891	0.0902583	-	0.417481	0.584618	0.151388	1.16 [0.68 - 2.00]
GENE	AK1	adenylate kinase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1874	56	0.107143	0.0172778	0.241445	-1.04769	0.621386	-0.12475	0.88 [0.54 - 1.45]
GENE	AK1	adenylate kinase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19848	56	0.625	0.0769941	-	-0.673889	0.409898	-0.40323	0.67 [0.26 - 1.74]
GENE	AK1	adenylate kinase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16254	56	0.125	0.0704614	-	-0.758933	0.794902	-0.0619604	0.94 [0.59 - 1.50]
GENE	AK1	adenylate kinase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19848	56	0.625	0.149269	-	-0.582413	0.364677	-0.482196	0.62 [0.22 - 1.75]
GENE	AK1	adenylate kinase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1874	56	0.107143	0.0587278	-	-0.83705	0.837187	-0.0516576	0.95 [0.58 - 1.55]
GENE	AK1	adenylate kinase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16254	56	0.107143	0.0719985	-	-0.806291	0.586826	-0.131432	0.88 [0.55 - 1.41]
GENE	AK1	adenylate kinase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202588_at	278	0.769784	0.0152581	0.220722	-0.607138	0.136662	-0.40928	0.66 [0.39 - 1.14]
GENE	AK1	adenylate kinase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202587_s_at	278	0.888489	0.00100282	0.0255455	-1.40607	0.0351996	-0.247848	0.78 [0.62 - 0.98]
GENE	AK1	adenylate kinase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202587_s_at	133	0.894737	0.0011695	0.0290533	-2.53162	0.00654032	-0.243108	0.78 [0.66 - 0.93]
GENE	AK1	adenylate kinase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202588_at	133	0.105263	0.000337727	0.0101194	-1.10755	0.510071	-0.3899	0.68 [0.21 - 2.16]
GENE	AK1	adenylate kinase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11829	81	0.160494	0.16291	-	-0.937992	0.499822	-0.488243	0.61 [0.15 - 2.53]
GENE	AK1	adenylate kinase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202588_at	185	0.12973	0.0575426	-	0.462478	0.958738	-0.0133952	0.99 [0.59 - 1.64]
GENE	AK1	adenylate kinase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202587_s_at	185	0.102703	0.131736	-	0.421524	0.745399	0.0312646	1.03 [0.85 - 1.25]
GENE	AK1	adenylate kinase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202588_at	185	0.135135	0.051305	-	0.524756	0.77651	0.0806379	1.08 [0.62 - 1.89]
GENE	AK1	adenylate kinase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202587_s_at	185	0.832432	0.224003	-	0.274411	0.531863	0.0657832	1.07 [0.87 - 1.31]
GENE	AK1	adenylate kinase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217088	110	0.863636	0.0309711	0.361886	-0.888357	0.664519	-0.0599244	0.94 [0.72 - 1.23]
GENE	AK1	adenylate kinase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P278192	110	0.481818	0.03204	0.370143	-0.649441	0.190113	-0.51733	0.60 [0.27 - 1.29]
GENE	AK1	adenylate kinase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217088	110	0.863636	0.154471	-	-0.829387	0.997863	0.000479971	1.00 [0.70 - 1.42]
GENE	AK1	adenylate kinase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P278192	110	0.636364	0.00464135	0.0892489	-0.728171	0.190282	-0.394708	0.67 [0.37 - 1.22]
GENE	AK1	adenylate kinase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202587_s_at	80	0.1875	0.133531	-	-0.717875	0.553704	0.219561	1.25 [0.60 - 2.58]
GENE	AK1	adenylate kinase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202588_at	80	0.725	0.136725	-	0.662845	0.963246	-0.011574	0.99 [0.60 - 1.62]
GENE	AK1	adenylate kinase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0657	281	0.572954	0.0630131	-	0.259502	0.274983	0.108601	1.11 [0.92 - 1.35]
GENE	AK1	adenylate kinase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202587_s_at	38	0.842105	0.00200434	0.0453754	1.58927	0.0765246	0.629095	1.88 [0.94 - 3.76]
GENE	AK1	adenylate kinase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202588_at	38	0.315789	0.0529262	-	1.06154	0.221776	0.727619	2.07 [0.64 - 6.65]
GENE	AK1	adenylate kinase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202588_at	140	0.114286	0.00794206	0.135552	-0.915175	0.534884	-0.30708	0.74 [0.28 - 1.94]
GENE	AK1	adenylate kinase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202587_s_at	140	0.507143	0.0623276	-	-0.549617	0.682495	-0.0746323	0.93 [0.65 - 1.33]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AK2	adenylate kinase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205996_s_at	30	0.766667	0.00733286	0.127501	1.26279	0.139353	1.00314	2.73 [0.72 - 10.31]
GENE	AK2	adenylate kinase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212173_at	30	0.666667	0.031274	0.36424	0.915236	0.137171	1.5376	4.65 [0.61 - 35.34]
GENE	AK2	adenylate kinase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208967_s_at	30	0.733333	0.0179538	0.248171	1.02519	0.172088	0.741303	2.10 [0.72 - 6.08]
GENE	AK2	adenylate kinase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212174_at	30	0.633333	0.00652101	0.116458	1.1023	0.0683708	0.910479	2.49 [0.93 - 6.62]
GENE	AK2	adenylate kinase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212175_s_at	30	0.7	0.000484903	0.0138037	1.66835	0.169204	0.776583	2.17 [0.72 - 6.58]
GENE	AK2	adenylate kinase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1670542	165	0.89697	0.00867233	0.144961	0.876795	0.186184	0.311073	1.36 [0.86 - 2.16]
GENE	AK2	adenylate kinase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1670542	165	0.824242	0.00691563	0.121873	0.995298	0.104122	0.623923	1.87 [0.88 - 3.96]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208967_s_at	163	0.754601	0.0934208	-	0.363221	0.839647	-0.0285745	0.97 [0.74 - 1.28]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212174_at	163	0.865031	0.181781	-	-0.422359	0.961438	-0.00484065	1.00 [0.82 - 1.21]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212173_at	163	0.196319	0.00703946	0.123553	0.76228	0.456931	0.136738	1.15 [0.80 - 1.64]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212175_s_at	163	0.116564	0.133619	-	0.496526	0.555363	0.0649545	1.07 [0.86 - 1.32]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205996_s_at	163	0.883436	0.160134	-	-0.484925	0.913922	0.0137284	1.01 [0.79 - 1.30]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212174_at	79	0.620253	0.0369046	0.406087	0.605007	0.164364	0.207432	1.23 [0.92 - 1.65]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212173_at	79	0.683544	0.0408379	0.433366	0.603226	0.52218	0.123399	1.13 [0.78 - 1.65]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208967_s_at	79	0.696203	0.0758005	-	0.535836	0.37452	0.141411	1.15 [0.84 - 1.57]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205996_s_at	79	0.341772	0.0663506	-	0.593072	0.247148	0.180388	1.20 [0.88 - 1.63]
GENE	AK2	adenylate kinase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212175_s_at	79	0.481013	0.0402465	0.429359	0.60235	0.181732	0.205531	1.23 [0.91 - 1.66]
GENE	AK2	adenylate kinase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212175_s_at	58	0.896552	0.00621988	0.112263	1.17001	0.213089	0.371825	1.45 [0.81 - 2.60]
GENE	AK2	adenylate kinase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205996_s_at	58	0.689655	7.9215e-05	0.00285139	1.2075	0.00122437	1.01214	2.75 [1.49 - 5.08]
GENE	AK2	adenylate kinase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212173_at	58	0.206897	0.119114	-	0.527974	0.352718	0.145697	1.16 [0.85 - 1.57]
GENE	AK2	adenylate kinase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208967_s_at	58	0.206897	0.0399606	0.42741	0.713334	0.265426	0.286002	1.33 [0.80 - 2.20]
GENE	AK2	adenylate kinase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212174_at	58	0.275862	0.00012865	0.0043706	1.31459	0.00054188	1.4743	4.37 [1.89 - 10.07]
GENE	AK2	adenylate kinase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212175_s_at	34	0.617647	0.00635592	0.114165	1.00908	0.40923	0.36982	1.45 [0.60 - 3.48]
GENE	AK2	adenylate kinase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205996_s_at	34	0.147059	0.133852	-	-0.767692	0.610445	0.192759	1.21 [0.58 - 2.55]
GENE	AK2	adenylate kinase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212173_at	34	0.470588	0.131917	-	0.57719	0.975829	0.00781873	1.01 [0.61 - 1.67]
GENE	AK2	adenylate kinase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208967_s_at	34	0.5	0.0134271	0.201041	0.977538	0.506685	0.274191	1.32 [0.59 - 2.96]
GENE	AK2	adenylate kinase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212174_at	34	0.735294	0.179268	-	0.584835	0.612107	0.148163	1.16 [0.65 - 2.06]
GENE	AK2	adenylate kinase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212175_s_at	158	0.886076	0.115607	-	0.528952	0.783689	-0.0644159	0.94 [0.59 - 1.49]
GENE	AK2	adenylate kinase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205996_s_at	158	0.297468	0.0648905	-	-0.43612	0.41898	-0.246332	0.78 [0.43 - 1.42]
GENE	AK2	adenylate kinase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208967_s_at	158	0.120253	0.00255665	0.0553436	-0.874325	0.139399	-0.451558	0.64 [0.35 - 1.16]
GENE	AK2	adenylate kinase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212174_at	158	0.487342	0.074192	-	-0.418671	0.605923	-0.123561	0.88 [0.55 - 1.41]
GENE	AK2	adenylate kinase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212173_at	158	0.873418	0.042359	0.443527	-0.909256	0.333284	-0.803126	0.45 [0.09 - 2.28]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212174_at	53	0.773585	0.0601475	-	-0.975215	0.435728	-0.401245	0.67 [0.24 - 1.84]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208967_s_at	53	0.886792	0.129601	-	0.723082	0.799069	0.133784	1.14 [0.41 - 3.20]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212175_s_at	53	0.867925	0.151233	-	-1.00886	0.930021	-0.0595946	0.94 [0.25 - 3.56]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212174_at	53	0.773585	0.154322	-	-0.631702	0.954506	0.028319	1.03 [0.39 - 2.72]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205996_s_at	53	0.528302	0.201958	-	-0.473978	0.973047	0.0215948	1.02 [0.29 - 3.58]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212173_at	53	0.207547	0.0277814	0.336392	-0.835601	0.447559	-0.148077	0.86 [0.59 - 1.26]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212173_at	53	0.207547	0.0112785	0.176693	-0.97649	0.27572	-0.22225	0.80 [0.54 - 1.19]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212175_s_at	53	0.867925	0.24335	-	-0.692258	0.666845	0.273606	1.31 [0.38 - 4.57]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208967_s_at	53	0.886792	0.0746464	-	0.854456	0.989994	0.00712783	1.01 [0.33 - 3.07]
GENE	AK2	adenylate kinase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205996_s_at	53	0.886792	0.0985112	-	0.736482	0.299447	0.667871	1.95 [0.55 - 6.89]
GENE	AK2	adenylate kinase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205996_s_at	180	0.833333	0.0558495	-	-0.60614	0.234717	-0.378979	0.68 [0.37 - 1.28]
GENE	AK2	adenylate kinase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208967_s_at	180	0.155556	0.0900116	-	-0.470758	0.362081	-0.331738	0.72 [0.35 - 1.46]
GENE	AK2	adenylate kinase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212174_at	180	0.816667	0.03626	0.401471	0.521329	0.419404	0.382023	1.47 [0.58 - 3.70]
GENE	AK2	adenylate kinase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212173_at	180	0.861111	0.00422429	0.0828367	-1.07604	0.325603	-0.146328	0.86 [0.65 - 1.16]
GENE	AK2	adenylate kinase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212175_s_at	180	0.294444	0.0496546	0.489548	-0.43125	0.690992	-0.17111	0.84 [0.36 - 1.96]
GENE	AK2	adenylate kinase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212174_at	559	0.239714	0.000508206	0.0143686	1.1508	0.00575347	0.653891	1.92 [1.21 - 3.06]
GENE	AK2	adenylate kinase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212173_at	559	0.708408	0.0022828	0.0504686	0.610537	0.0142392	0.355798	1.43 [1.07 - 1.90]
GENE	AK2	adenylate kinase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208967_s_at	559	0.887299	6.1263e-05	0.002271	0.988111	0.0271647	0.589638	1.80 [1.07 - 3.04]
GENE	AK2	adenylate kinase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205996_s_at	559	0.169946	0.00171916	0.0399967	1.23982	0.0091399	0.617054	1.85 [1.17 - 2.95]
GENE	AK2	adenylate kinase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212175_s_at	559	0.899821	2.68492e-05	0.00108809	1.1003	0.018782	0.658891	1.93 [1.12 - 3.35]
GENE	AK2	adenylate kinase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212175_s_at	77	0.519481	0.000187984	0.00608963	0.966823	1.34451e-05	2.00907	7.46 [3.02 - 18.43]
GENE	AK2	adenylate kinase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205996_s_at	77	0.532468	0.000304379	0.00925129	0.911488	0.00936296	0.873133	2.39 [1.24 - 4.63]
GENE	AK2	adenylate kinase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212173_at	77	0.25974	0.00450943	0.0872375	0.919368	0.0260235	0.510211	1.67 [1.06 - 2.61]
GENE	AK2	adenylate kinase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208967_s_at	77	0.545455	6.40639e-05	0.00236285	1.03632	0.00652628	1.0233	2.78 [1.33 - 5.82]
GENE	AK2	adenylate kinase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212174_at	77	0.636364	0.0007068	0.0190218	0.858673	0.00267081	1.52544	4.60 [1.70 - 12.44]
GENE	AK2	adenylate kinase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212173_at	70	0.228571	0.00442982	0.0860162	-0.840051	0.268902	-0.418371	0.66 [0.31 - 1.38]
GENE	AK2	adenylate kinase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208967_s_at	70	0.671429	0.0408127	0.433196	0.56091	0.787902	0.114329	1.12 [0.49 - 2.58]
GENE	AK2	adenylate kinase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205996_s_at	70	0.457143	0.0930463	-	0.454386	0.964515	0.01647	1.02 [0.49 - 2.10]
GENE	AK2	adenylate kinase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212175_s_at	70	0.8	0.114102	-	0.496657	0.844325	0.079224	1.08 [0.49 - 2.39]
GENE	AK2	adenylate kinase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212174_at	70	0.842857	0.22836	-	-0.455471	0.635712	-0.127133	0.88 [0.52 - 1.49]
GENE	AK2	adenylate kinase 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40788_at	50	0.68	0.00725678	0.126482	0.976653	0.0658015	0.313192	1.37 [0.98 - 1.91]
GENE	AK2	adenylate kinase 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40789_at	50	0.26	0.0174835	0.243503	1.33792	0.182083	0.893337	2.44 [0.66 - 9.08]
GENE	AK2	adenylate kinase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212173_at	74	0.337838	0.195184	-	0.406589	0.417417	0.192301	1.21 [0.76 - 1.93]
GENE	AK2	adenylate kinase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208967_s_at	74	0.324324	0.0278778	0.337182	0.723126	0.455478	0.358749	1.43 [0.56 - 3.67]
GENE	AK2	adenylate kinase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212174_at	74	0.621622	0.0698056	-	-0.570378	0.49448	-0.256422	0.77 [0.37 - 1.61]
GENE	AK2	adenylate kinase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212175_s_at	74	0.635135	0.0235121	0.300051	-0.724235	0.388135	-0.420693	0.66 [0.25 - 1.71]
GENE	AK2	adenylate kinase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205996_s_at	74	0.72973	0.0572875	-	-0.690206	0.149436	-0.52694	0.59 [0.29 - 1.21]
GENE	AK2	adenylate kinase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212174_at	67	0.38806	0.195639	-	1.00208	0.894766	-0.133853	0.87 [0.12 - 6.36]
GENE	AK2	adenylate kinase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212173_at	67	0.58209	0.0416303	0.438685	-1.876	0.259306	-1.5724	0.21 [0.01 - 3.19]
GENE	AK2	adenylate kinase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208967_s_at	67	0.835821	0.00760987	0.131186	1.63239	0.943432	-0.0895258	0.91 [0.08 - 10.84]
GENE	AK2	adenylate kinase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205996_s_at	67	0.850746	0.0704014	-	1.21774	0.751855	0.325157	1.38 [0.18 - 10.39]
GENE	AK2	adenylate kinase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212175_s_at	67	0.865672	0.396666	-	0.671228	0.904665	0.13408	1.14 [0.13 - 10.26]
GENE	AK2	adenylate kinase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212173_at	115	0.330435	0.143442	-	-0.765505	0.937763	-0.0566355	0.94 [0.23 - 3.92]
GENE	AK2	adenylate kinase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208967_s_at	115	0.817391	0.0566135	-	1.01943	0.210297	0.92697	2.53 [0.59 - 10.78]
GENE	AK2	adenylate kinase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205996_s_at	115	0.634783	0.0860584	-	0.894925	0.216236	0.73374	2.08 [0.65 - 6.66]
GENE	AK2	adenylate kinase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212175_s_at	115	0.808696	0.0787942	-	0.945493	0.61615	0.381916	1.47 [0.33 - 6.52]
GENE	AK2	adenylate kinase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212174_at	115	0.147826	0.109308	-	-0.922997	0.884181	0.0907658	1.10 [0.32 - 3.71]
GENE	AK2	adenylate kinase 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40788_at	158	0.132911	0.207496	-	0.736513	0.830499	0.0918576	1.10 [0.47 - 2.54]
GENE	AK2	adenylate kinase 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40789_at	158	0.670886	0.0229008	0.294617	0.664786	0.813518	0.0672247	1.07 [0.61 - 1.87]
GENE	AK2	adenylate kinase 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40789_at	76	0.315789	0.04113	0.435333	-1.01469	0.236583	-0.613593	0.54 [0.20 - 1.50]
GENE	AK2	adenylate kinase 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40788_at	76	0.815789	0.25392	-	-1.12142	0.55553	-0.425322	0.65 [0.16 - 2.69]
GENE	AK2	adenylate kinase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208967_s_at	204	0.230392	0.0949169	-	-0.28163	0.594915	-0.0858847	0.92 [0.67 - 1.26]
GENE	AK2	adenylate kinase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205996_s_at	204	0.892157	0.00046386	0.0132897	0.798594	0.133031	0.19411	1.21 [0.94 - 1.56]
GENE	AK2	adenylate kinase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212175_s_at	204	0.710784	0.0836027	-	0.267288	0.768165	0.0460575	1.05 [0.77 - 1.42]
GENE	AK2	adenylate kinase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212174_at	204	0.784314	0.00652682	0.116538	0.464335	0.100595	0.229519	1.26 [0.96 - 1.65]
GENE	AK2	adenylate kinase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212173_at	204	0.818627	0.131272	-	0.279641	0.414128	0.0962448	1.10 [0.87 - 1.39]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212173_at	87	0.183908	0.0694974	-	-0.784192	0.149283	-0.717537	0.49 [0.18 - 1.29]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212174_at	87	0.149425	0.0770312	-	-0.798776	0.687121	-0.154388	0.86 [0.40 - 1.82]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208967_s_at	87	0.448276	0.0574547	-	-0.711342	0.0244579	-0.948911	0.39 [0.17 - 0.88]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212173_at	87	0.183908	0.0694974	-	-0.784192	0.149283	-0.717537	0.49 [0.18 - 1.29]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205996_s_at	87	0.149425	0.0400791	0.428218	-0.928288	0.719285	-0.15249	0.86 [0.37 - 1.97]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212175_s_at	87	0.896552	0.0612331	-	0.898417	0.516388	0.355768	1.43 [0.49 - 4.18]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208967_s_at	87	0.448276	0.0574547	-	-0.711342	0.0244579	-0.948911	0.39 [0.17 - 0.88]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212174_at	87	0.149425	0.0770312	-	-0.798776	0.687121	-0.154388	0.86 [0.40 - 1.82]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205996_s_at	87	0.149425	0.0400791	0.428218	-0.928288	0.719285	-0.15249	0.86 [0.37 - 1.97]
GENE	AK2	adenylate kinase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212175_s_at	87	0.896552	0.0612331	-	0.898417	0.516388	0.355768	1.43 [0.49 - 4.18]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205996_s_at	77	0.103896	0.0217812	0.2845	-1.45308	0.269918	-0.773365	0.46 [0.12 - 1.82]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212175_s_at	77	0.285714	0.0796041	-	-1.05993	0.2267	-0.847902	0.43 [0.11 - 1.69]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208967_s_at	77	0.324675	0.178787	-	0.992523	0.541272	0.354722	1.43 [0.46 - 4.45]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212174_at	77	0.792208	0.116023	-	0.976499	0.681255	-0.271579	0.76 [0.21 - 2.79]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205996_s_at	77	0.103896	1.86826e-05	0.000785588	-2.06899	0.0239596	-1.44074	0.24 [0.07 - 0.83]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212175_s_at	77	0.103896	0.00237632	0.0521474	-1.65363	0.00928171	-1.64837	0.19 [0.06 - 0.67]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212173_at	77	0.74026	0.226607	-	-1.2015	0.74443	-0.303856	0.74 [0.12 - 4.59]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212174_at	77	0.285714	0.021036	0.277646	-1.21278	0.216122	-0.778216	0.46 [0.13 - 1.58]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208967_s_at	77	0.324675	0.130111	-	1.46213	0.356663	0.626567	1.87 [0.49 - 7.09]
GENE	AK2	adenylate kinase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212173_at	77	0.636364	0.0955274	-	-1.20783	0.309414	-0.901322	0.41 [0.07 - 2.31]
GENE	AK2	adenylate kinase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208967_s_at	136	0.147059	0.0284259	0.34165	-1.02846	0.373813	-0.511699	0.60 [0.19 - 1.85]
GENE	AK2	adenylate kinase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212174_at	136	0.110294	0.00591877	0.10801	-1.25582	0.0136259	-1.4008	0.25 [0.08 - 0.75]
GENE	AK2	adenylate kinase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212173_at	136	0.786765	0.108839	-	0.73551	0.739201	0.101619	1.11 [0.61 - 2.01]
GENE	AK2	adenylate kinase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212175_s_at	136	0.411765	0.184896	-	-0.588842	0.667984	-0.396676	0.67 [0.11 - 4.12]
GENE	AK2	adenylate kinase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205996_s_at	136	0.205882	0.00168216	0.0392855	-1.31495	0.0101516	-0.771148	0.46 [0.26 - 0.83]
GENE	AK2	adenylate kinase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208967_s_at	200	0.48	0.249444	-	-0.343571	0.712389	-0.174732	0.84 [0.33 - 2.13]
GENE	AK2	adenylate kinase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212174_at	200	0.85	0.0754726	-	0.608199	0.673263	0.165567	1.18 [0.55 - 2.55]
GENE	AK2	adenylate kinase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212173_at	200	0.885	0.0307214	0.359937	0.827659	0.810806	0.0570544	1.06 [0.66 - 1.69]
GENE	AK2	adenylate kinase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212175_s_at	200	0.85	0.0424422	0.444077	0.690573	0.937684	0.0398025	1.04 [0.38 - 2.82]
GENE	AK2	adenylate kinase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205996_s_at	200	0.2	0.000124981	0.00426102	-1.14773	0.0994118	-0.655382	0.52 [0.24 - 1.13]
GENE	AK2	adenylate kinase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5495	60	0.816667	0.141875	-	-0.868991	0.675915	-0.190333	0.83 [0.34 - 2.02]
GENE	AK2	adenylate kinase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5495	60	0.316667	0.0496394	0.489456	-0.734536	0.67967	-0.237377	0.79 [0.26 - 2.43]
GENE	AK2	adenylate kinase 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	785	155	0.148387	0.0581312	-	1.28383	0.141755	0.379351	1.46 [0.88 - 2.42]
GENE	AK2	adenylate kinase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212173_at	286	0.615385	0.101619	-	0.3174	0.840948	0.0275039	1.03 [0.79 - 1.34]
GENE	AK2	adenylate kinase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208967_s_at	286	0.115385	2.55836e-05	0.00104199	-0.974636	0.00539108	-0.970038	0.38 [0.19 - 0.75]
GENE	AK2	adenylate kinase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212174_at	286	0.241259	0.0182749	0.251331	-0.490869	0.860623	0.0564011	1.06 [0.56 - 1.99]
GENE	AK2	adenylate kinase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212175_s_at	286	0.797203	0.000381381	0.0112355	0.735584	0.377062	0.287372	1.33 [0.70 - 2.52]
GENE	AK2	adenylate kinase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205996_s_at	286	0.527972	0.0764743	-	-0.348131	0.418489	-0.213023	0.81 [0.48 - 1.35]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212175_s_at	159	0.899371	0.00269579	0.0577744	1.2253	0.00583697	1.50209	4.49 [1.54 - 13.07]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212174_at	159	0.867925	0.0384005	0.416639	0.766475	0.243757	0.660062	1.93 [0.64 - 5.87]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205996_s_at	159	0.81761	8.60286e-05	0.00306701	1.37716	0.00145657	1.75642	5.79 [1.96 - 17.08]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208967_s_at	159	0.880503	0.00629489	0.113313	0.997097	0.00504484	1.19552	3.31 [1.43 - 7.62]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212173_at	159	0.421384	0.0110702	0.174251	0.897475	0.0664	0.449804	1.57 [0.97 - 2.53]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212173_at	159	0.855346	0.0145354	0.213062	0.977043	0.0971265	0.477666	1.61 [0.92 - 2.83]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212175_s_at	159	0.679245	0.00678235	0.120054	0.832422	0.0059039	1.28363	3.61 [1.45 - 9.00]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212174_at	159	0.867925	0.0012788	0.0313003	1.09084	0.100637	0.948049	2.58 [0.83 - 8.00]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205996_s_at	159	0.855346	0.00193471	0.0440783	1.05284	0.0118672	1.21574	3.37 [1.31 - 8.70]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208967_s_at	159	0.72956	0.00150105	0.0357551	1.12109	0.00112361	1.53016	4.62 [1.84 - 11.60]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212173_at	159	0.264151	0.0191664	0.259992	1.06877	0.0460658	0.491832	1.64 [1.01 - 2.65]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212174_at	159	0.672956	0.00363333	0.0734649	1.03947	0.0791356	1.12213	3.07 [0.88 - 10.75]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212175_s_at	159	0.893082	0.00282672	0.0600353	1.08173	0.02323	1.07435	2.93 [1.16 - 7.40]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208967_s_at	159	0.320755	0.00074832	0.0199633	1.60227	0.0048049	1.17745	3.25 [1.43 - 7.36]
GENE	AK2	adenylate kinase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205996_s_at	159	0.899371	0.00122974	0.0302966	1.16272	0.00431538	1.39912	4.05 [1.55 - 10.59]
GENE	AK2	adenylate kinase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212173_at	54	0.685185	0.103602	-	-1.57556	0.5343	-0.658385	0.52 [0.06 - 4.13]
GENE	AK2	adenylate kinase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208967_s_at	54	0.62963	0.000888967	0.0230855	2.21485	0.101175	1.24072	3.46 [0.78 - 15.25]
GENE	AK2	adenylate kinase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212174_at	54	0.203704	0.151818	-	15.3713	0.250743	0.612029	1.84 [0.65 - 5.24]
GENE	AK2	adenylate kinase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212172_at	54	0.740741	0.0335127	0.381301	-15.8471	0.156007	-1.70936	0.18 [0.02 - 1.92]
GENE	AK2	adenylate kinase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212175_s_at	54	0.537037	0.140505	-	1.00296	0.411512	0.527911	1.70 [0.48 - 5.98]
GENE	AK2	adenylate kinase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205996_s_at	54	0.537037	0.118886	-	-1.18524	0.9084	-0.0792578	0.92 [0.24 - 3.56]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212175_s_at	117	0.384615	0.16103	-	0.494209	0.391374	0.208226	1.23 [0.76 - 1.98]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212175_s_at	117	0.384615	0.240231	-	0.486256	0.675315	0.118478	1.13 [0.65 - 1.96]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205996_s_at	117	0.111111	0.058387	-	1.70435	0.459102	-0.209445	0.81 [0.47 - 1.41]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212173_at	117	0.760684	0.0639587	-	0.734824	0.561967	0.188673	1.21 [0.64 - 2.28]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205996_s_at	117	0.521368	0.0322429	0.371696	-0.841895	0.179016	-0.524492	0.59 [0.28 - 1.27]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212175_s_at	117	0.700855	0.275535	-	0.436569	0.763546	0.0934208	1.10 [0.60 - 2.02]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212173_at	117	0.760684	0.191467	-	0.509665	0.878982	-0.0504662	0.95 [0.50 - 1.82]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212175_s_at	117	0.384615	0.16103	-	0.494209	0.391374	0.208226	1.23 [0.76 - 1.98]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205996_s_at	117	0.504274	0.0165773	0.234367	-0.980257	0.137836	-0.632474	0.53 [0.23 - 1.22]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205996_s_at	117	0.111111	0.058387	-	1.70435	0.459102	-0.209445	0.81 [0.47 - 1.41]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208967_s_at	117	0.222222	0.0623898	-	-0.638204	0.642352	-0.138446	0.87 [0.49 - 1.56]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208967_s_at	117	0.247863	0.0884566	-	-0.660041	0.708302	-0.133561	0.87 [0.43 - 1.76]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212173_at	117	0.760684	0.0273218	0.332607	0.69912	0.310453	0.25846	1.29 [0.79 - 2.13]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212174_at	117	0.683761	0.0853853	-	-0.620733	0.464278	-0.148352	0.86 [0.58 - 1.28]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212174_at	117	0.837607	0.0835421	-	-1.19829	0.0928281	-0.41292	0.66 [0.41 - 1.07]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208967_s_at	117	0.264957	0.105945	-	-0.641997	0.887028	-0.0541935	0.95 [0.45 - 2.00]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208967_s_at	117	0.222222	0.0623898	-	-0.638204	0.642352	-0.138446	0.87 [0.49 - 1.56]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212173_at	117	0.760684	0.0273218	0.332607	0.69912	0.310453	0.25846	1.29 [0.79 - 2.13]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212174_at	117	0.683761	0.0853853	-	-0.620733	0.464278	-0.148352	0.86 [0.58 - 1.28]
GENE	AK2	adenylate kinase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212174_at	117	0.393162	0.0677392	-	-0.70626	0.11997	-0.406579	0.67 [0.40 - 1.11]
GENE	AK2	adenylate kinase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212174_at	236	0.898305	0.298916	-	0.418292	0.539242	0.283266	1.33 [0.54 - 3.28]
GENE	AK2	adenylate kinase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212173_at	236	0.805085	0.137651	-	0.456775	0.810347	0.0650782	1.07 [0.63 - 1.82]
GENE	AK2	adenylate kinase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212175_s_at	236	0.101695	0.0039423	0.0784091	-0.973591	0.848069	0.0969969	1.10 [0.41 - 2.97]
GENE	AK2	adenylate kinase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205996_s_at	236	0.792373	0.140953	-	-0.586982	0.833726	0.0905324	1.09 [0.47 - 2.55]
GENE	AK2	adenylate kinase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208967_s_at	236	0.139831	0.0349744	0.392134	1.18218	0.659527	0.224101	1.25 [0.46 - 3.39]
GENE	AK2	adenylate kinase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212173_at	249	0.895582	0.0638792	-	-0.914722	0.799562	-0.0524593	0.95 [0.63 - 1.42]
GENE	AK2	adenylate kinase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212175_s_at	249	0.116466	0.00503719	0.0951962	-0.758018	0.510189	-0.269521	0.76 [0.34 - 1.70]
GENE	AK2	adenylate kinase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205996_s_at	249	0.803213	0.0554674	-	-0.607012	0.380163	-0.288865	0.75 [0.39 - 1.43]
GENE	AK2	adenylate kinase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208967_s_at	249	0.273092	0.081298	-	0.446912	0.372381	0.365522	1.44 [0.65 - 3.22]
GENE	AK2	adenylate kinase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212174_at	249	0.783133	0.0581928	-	-0.561591	0.411789	-0.304672	0.74 [0.36 - 1.53]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208967_s_at	125	0.144	0.0486933	0.483725	1.32889	0.928183	-0.0193429	0.98 [0.64 - 1.49]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208967_s_at	54	0.111111	0.0783738	-	-1.31285	0.895519	0.0685627	1.07 [0.38 - 2.98]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212173_at	125	0.632	0.142105	-	-0.620151	0.734743	-0.160016	0.85 [0.34 - 2.15]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212175_s_at	62	0.370968	0.141496	-	-0.726173	0.715093	-0.102767	0.90 [0.52 - 1.57]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212174_at	125	0.184	0.0372948	0.408861	-0.71984	0.644011	-0.117074	0.89 [0.54 - 1.46]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205996_s_at	62	0.16129	0.000685935	0.018545	-1.60077	0.540288	-0.164475	0.85 [0.50 - 1.44]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212174_at	54	0.111111	0.00767374	0.13203	-1.56588	0.598968	-0.108329	0.90 [0.60 - 1.34]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212175_s_at	125	0.296	0.116966	-	0.827951	0.978049	0.0121995	1.01 [0.42 - 2.41]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205996_s_at	125	0.88	0.234129	-	-0.854965	0.784433	0.0806852	1.08 [0.61 - 1.93]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212173_at	62	0.290323	0.0261369	0.322713	-1.0758	0.49825	-0.156167	0.86 [0.54 - 1.34]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212175_s_at	125	0.896	0.107972	-	-0.932041	0.432505	-0.273942	0.76 [0.38 - 1.51]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208967_s_at	62	0.870968	0.211057	-	-1.21652	0.857834	-0.0765636	0.93 [0.40 - 2.14]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205996_s_at	125	0.896	0.203022	-	-0.659559	0.743646	-0.0763725	0.93 [0.59 - 1.46]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212175_s_at	54	0.851852	0.21664	-	0.753376	0.865783	-0.0580078	0.94 [0.48 - 1.85]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208967_s_at	125	0.152	0.0824891	-	1.596	0.652458	0.122813	1.13 [0.66 - 1.93]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205996_s_at	54	0.148148	0.0030024	0.0630309	-1.71417	0.707116	-0.121868	0.89 [0.47 - 1.67]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212174_at	62	0.112903	0.000625986	0.0171602	-1.59258	0.468312	-0.124468	0.88 [0.63 - 1.24]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212173_at	125	0.608	0.0670728	-	-0.580867	0.215821	-0.469498	0.63 [0.30 - 1.32]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212173_at	54	0.796296	0.069036	-	-1.74227	0.651098	-0.124322	0.88 [0.52 - 1.51]
GENE	AK2	adenylate kinase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212174_at	125	0.752	0.0334559	0.380876	0.794146	0.71238	0.117719	1.12 [0.60 - 2.10]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212173_at	198	0.883838	0.0106473	0.169247	-2.14431	0.770437	-0.0307991	0.97 [0.79 - 1.19]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212175_s_at	198	0.560606	0.00145917	0.0349266	-0.895444	0.0490613	-0.485626	0.62 [0.38 - 1.00]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208967_s_at	198	0.414141	0.0265385	0.326088	-0.463237	0.212336	-0.217226	0.80 [0.57 - 1.13]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205996_s_at	198	0.681818	0.135688	-	-0.449868	0.367332	-0.197497	0.82 [0.53 - 1.26]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212175_s_at	198	0.560606	0.00507205	0.095714	-0.822497	0.085677	-0.446097	0.64 [0.38 - 1.06]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205996_s_at	198	0.868687	0.13536	-	-0.758109	0.286594	-0.246998	0.78 [0.50 - 1.23]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212174_at	198	0.883838	0.0527012	-	-0.802528	0.416938	-0.133308	0.88 [0.63 - 1.21]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208967_s_at	198	0.136364	0.0073597	0.12786	-0.819714	0.0477555	-0.4139	0.66 [0.44 - 1.00]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212173_at	198	0.883838	0.00243339	0.0531648	-1.61843	0.8745	-0.0127261	0.99 [0.84 - 1.16]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208967_s_at	198	0.136364	0.00170268	0.0396803	-0.964672	0.0653949	-0.410847	0.66 [0.43 - 1.03]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212175_s_at	198	0.479798	0.0137232	0.204287	-0.521089	0.0974661	-0.337156	0.71 [0.48 - 1.06]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212174_at	198	0.515152	0.0254279	0.316695	-0.586081	0.207972	-0.26025	0.77 [0.51 - 1.16]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205996_s_at	198	0.323232	0.0786485	-	0.422342	0.955641	-0.0099382	0.99 [0.70 - 1.41]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212174_at	198	0.444444	0.0248051	0.311347	-0.599557	0.166543	-0.301714	0.74 [0.48 - 1.13]
GENE	AK2	adenylate kinase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212173_at	198	0.883838	0.00552459	0.10235	-2.2784	0.775486	-0.0286734	0.97 [0.80 - 1.18]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208967_s_at	62	0.16129	0.3433	-	0.953707	0.844277	0.12414	1.13 [0.33 - 3.91]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212173_at	51	0.137255	0.0502073	-	-1.61102	0.186382	-1.9879	0.14 [0.01 - 2.61]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212174_at	62	0.790323	0.241511	-	-1.15797	0.413746	-0.409192	0.66 [0.25 - 1.77]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212175_s_at	51	0.784314	0.254203	-	1.00032	0.705613	0.416728	1.52 [0.17 - 13.18]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205996_s_at	51	0.882353	0.393162	-	-15.2189	0.981702	0.0472307	1.05 [0.02 - 59.36]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212175_s_at	62	0.129032	0.140493	-	15.269	0.463346	0.547783	1.73 [0.40 - 7.48]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205996_s_at	62	0.403226	0.182513	-	-0.762849	0.440387	-1.1534	0.32 [0.02 - 5.91]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208967_s_at	51	0.647059	0.0975517	-	-15.7252	0.546747	-0.486476	0.61 [0.13 - 2.99]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212173_at	62	0.129032	0.128795	-	-0.975281	0.276528	-0.967234	0.38 [0.07 - 2.17]
GENE	AK2	adenylate kinase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212174_at	51	0.117647	0.010189	0.163751	-2.01724	0.0635595	-2.03213	0.13 [0.02 - 1.12]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208967_s_at	145	0.606897	0.00448926	0.0869287	-1.13722	0.0289243	-1.00615	0.37 [0.15 - 0.90]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205996_s_at	177	0.180791	0.102492	-	-0.440968	0.995822	-0.00154905	1.00 [0.56 - 1.78]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212174_at	177	0.723164	0.105367	-	0.451769	0.639223	0.13319	1.14 [0.65 - 1.99]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212175_s_at	177	0.559322	0.183608	-	-0.317086	0.563013	-0.151809	0.86 [0.51 - 1.44]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212174_at	177	0.158192	0.127149	-	-0.439768	0.788058	0.0664783	1.07 [0.66 - 1.74]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205996_s_at	145	0.489655	0.0105267	0.167808	-0.877865	0.207003	-0.52093	0.59 [0.26 - 1.33]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212173_at	177	0.768362	0.294065	-	-0.366206	0.918301	-0.0525195	0.95 [0.35 - 2.59]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212175_s_at	145	0.468966	0.00850465	0.142823	-0.887127	0.0712569	-0.655802	0.52 [0.25 - 1.06]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212174_at	145	0.144828	0.0290848	0.346968	-0.820798	0.385377	-0.304881	0.74 [0.37 - 1.47]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208967_s_at	177	0.80226	0.00631622	0.113611	-1.48348	0.0649678	-0.686091	0.50 [0.24 - 1.04]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212173_at	177	0.169492	0.0864587	-	-0.494487	0.558496	-0.266727	0.77 [0.31 - 1.87]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205996_s_at	177	0.740113	0.163271	-	0.400173	0.936768	0.0269664	1.03 [0.53 - 2.00]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208967_s_at	177	0.508475	0.0675965	-	-0.433892	0.260049	-0.369783	0.69 [0.36 - 1.31]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212173_at	145	0.462069	0.213058	-	0.42888	0.925647	0.0588559	1.06 [0.31 - 3.65]
GENE	AK2	adenylate kinase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212175_s_at	177	0.711864	0.0717764	-	-0.599046	0.319979	-0.296788	0.74 [0.41 - 1.33]
GENE	AK2	adenylate kinase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208967_s_at	226	0.287611	8.35977e-05	0.00299035	-1.06507	0.00333257	-1.00248	0.37 [0.19 - 0.72]
GENE	AK2	adenylate kinase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205996_s_at	226	0.115044	0.00311925	0.0650005	-0.948324	0.38602	-0.309896	0.73 [0.36 - 1.48]
GENE	AK2	adenylate kinase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212175_s_at	226	0.570796	0.00433679	0.0845819	-0.892209	0.0370266	-0.615617	0.54 [0.30 - 0.96]
GENE	AK2	adenylate kinase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212174_at	226	0.110619	0.00772053	0.132647	-0.889256	0.460106	-0.239694	0.79 [0.42 - 1.49]
GENE	AK2	adenylate kinase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212173_at	226	0.89823	0.00565804	0.104278	0.981334	0.46541	-0.114597	0.89 [0.66 - 1.21]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208967_s_at	49	0.673469	0.0637396	-	1.03356	0.744648	0.239171	1.27 [0.30 - 5.36]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212174_at	55	0.236364	0.106207	-	-0.740984	0.57375	-0.278767	0.76 [0.29 - 2.00]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205996_s_at	55	0.490909	0.0879449	-	-0.83902	0.217328	-0.79417	0.45 [0.13 - 1.60]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212175_s_at	55	0.109091	0.0948625	-	15.2316	0.562831	0.304596	1.36 [0.48 - 3.81]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205996_s_at	49	0.102041	0.0834468	-	-1.29714	0.416434	-0.605833	0.55 [0.13 - 2.35]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212175_s_at	49	0.897959	0.0449863	0.460601	1.26718	0.362	0.62844	1.87 [0.49 - 7.24]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212174_at	55	0.236364	0.0346978	0.390102	-1.04846	0.13164	-0.782262	0.46 [0.17 - 1.26]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212173_at	55	0.290909	0.000514775	0.014527	-1.45047	0.0757037	-1.70074	0.18 [0.03 - 1.19]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212174_at	49	0.244898	0.0465719	0.470626	-1.11474	0.329052	-0.669893	0.51 [0.13 - 1.96]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208967_s_at	55	0.618182	0.0951345	-	0.733204	0.947802	0.035865	1.04 [0.35 - 3.03]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212173_at	55	0.327273	2.49829e-05	0.00102001	-1.98825	0.00145686	-3.71019	0.02 [0.00 - 0.24]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212173_at	49	0.265306	0.0005373	0.0150676	-1.85472	0.0463366	-2.57579	0.08 [0.01 - 0.96]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208967_s_at	55	0.6	0.00842392	0.141789	1.28098	0.458544	0.44193	1.56 [0.48 - 5.01]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205996_s_at	55	0.836364	0.217698	-	0.628257	0.869828	-0.0995253	0.91 [0.28 - 2.98]
GENE	AK2	adenylate kinase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212175_s_at	55	0.854545	0.065059	-	0.925569	0.400005	0.434647	1.54 [0.56 - 4.25]
GENE	AK2	adenylate kinase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205996_s_at	63	0.111111	0.0308533	0.360967	-0.895972	0.254605	-0.295895	0.74 [0.45 - 1.24]
GENE	AK2	adenylate kinase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212175_s_at	63	0.238095	0.111929	-	-0.575371	0.308829	-0.212062	0.81 [0.54 - 1.22]
GENE	AK2	adenylate kinase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212174_at	63	0.365079	0.0657455	-	-0.622959	0.764991	-0.0473569	0.95 [0.70 - 1.30]
GENE	AK2	adenylate kinase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212173_at	63	0.111111	0.000438428	0.0126633	-1.45426	0.411264	0.711688	2.04 [0.37 - 11.13]
GENE	AK2	adenylate kinase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208967_s_at	63	0.777778	0.0705232	-	-0.854726	0.971982	-0.00695845	0.99 [0.67 - 1.46]
GENE	AK2	adenylate kinase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g1209686_3p_x_at	28	0.535714	0.0143345	0.210908	1.39272	0.260284	0.255106	1.29 [0.83 - 2.01]
GENE	AK2	adenylate kinase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.171811.2.A2_3p_at	28	0.892857	0.00875389	0.145997	1.97853	0.139344	1.7158	5.56 [0.57 - 54.10]
GENE	AK2	adenylate kinase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7524345_3p_a_at	28	0.75	0.0670028	-	-1.71735	0.245204	-2.12966	0.12 [0.00 - 4.32]
GENE	AK2	adenylate kinase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.171811.2.A3_3p_at	28	0.5	0.0505698	-	-1.15197	0.112454	-6.04186	0.00 [0.00 - 4.13]
GENE	AK2	adenylate kinase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g1209686_3p_a_at	28	0.892857	0.219776	-	-15.1822	0.484305	-0.325538	0.72 [0.29 - 1.80]
GENE	AK2	adenylate kinase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.171811.2.A1_3p_a_at	28	0.857143	0.00128253	0.0313762	1.97789	0.0615533	2.9438	18.99 [0.87 - 415.75]
GENE	AK2	adenylate kinase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208967_s_at	82	0.317073	0.030831	0.360793	-0.710008	0.641112	-0.317787	0.73 [0.19 - 2.77]
GENE	AK2	adenylate kinase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212174_at	82	0.329268	0.00466192	0.0895612	-0.937558	0.00736142	-1.1532	0.32 [0.14 - 0.73]
GENE	AK2	adenylate kinase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212173_at	82	0.597561	0.0568337	-	-0.696098	0.613522	-0.34465	0.71 [0.19 - 2.70]
GENE	AK2	adenylate kinase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212175_s_at	82	0.317073	0.0351545	0.393453	-0.699393	0.270491	-0.487651	0.61 [0.26 - 1.46]
GENE	AK2	adenylate kinase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205996_s_at	82	0.256098	0.0106554	0.169344	-0.872627	0.218621	-0.708045	0.49 [0.16 - 1.52]
GENE	AK2	adenylate kinase 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40789_at	84	0.464286	0.00154437	0.0366072	-0.929616	0.499053	-0.10759	0.90 [0.66 - 1.23]
GENE	AK2	adenylate kinase 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40788_at	84	0.130952	0.17081	-	0.643086	0.808939	0.0720717	1.07 [0.60 - 1.93]
GENE	AK2	adenylate kinase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208967_s_at	79	0.113924	0.0644903	-	0.84349	0.908301	-0.0438973	0.96 [0.45 - 2.02]
GENE	AK2	adenylate kinase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212174_at	79	0.101266	0.0312296	0.363895	-0.818039	0.309829	-0.274116	0.76 [0.45 - 1.29]
GENE	AK2	adenylate kinase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212175_s_at	79	0.797468	0.0592942	-	-0.672025	0.270537	-0.344269	0.71 [0.38 - 1.31]
GENE	AK2	adenylate kinase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205996_s_at	79	0.139241	0.141606	-	-0.510081	0.34164	-0.357115	0.70 [0.34 - 1.46]
GENE	AK2	adenylate kinase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212173_at	79	0.113924	0.0146215	0.213983	-0.88114	0.257249	-0.440023	0.64 [0.30 - 1.38]
GENE	AK2	adenylate kinase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205996_s_at	104	0.836538	0.00125288	0.030771	-15.4173	0.00762543	-1.5955	0.20 [0.06 - 0.65]
GENE	AK2	adenylate kinase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208967_s_at	104	0.288462	0.0559507	-	-0.650245	0.531675	-0.299516	0.74 [0.29 - 1.89]
GENE	AK2	adenylate kinase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212174_at	104	0.163462	0.00179065	0.0413619	-1.08526	0.00283819	-1.29888	0.27 [0.12 - 0.64]
GENE	AK2	adenylate kinase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212173_at	104	0.625	0.000543992	0.0152275	-1.36412	0.00609798	-1.61571	0.20 [0.06 - 0.63]
GENE	AK2	adenylate kinase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212175_s_at	104	0.788462	0.000449828	0.0129448	-2.6925	0.00524586	-1.32684	0.27 [0.10 - 0.67]
GENE	AK2	adenylate kinase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P207360	117	0.846154	0.032947	0.377045	-1.19922	0.290314	-0.259754	0.77 [0.48 - 1.25]
GENE	AK2	adenylate kinase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P179903	117	0.410256	0.0269773	0.32975	0.674332	0.0860398	0.415679	1.52 [0.94 - 2.44]
GENE	AK2	adenylate kinase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P500891	117	0.820513	0.108145	-	-0.741651	0.686705	-0.107123	0.90 [0.53 - 1.51]
GENE	AK2	adenylate kinase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P200404	117	0.521368	0.00995112	0.160866	0.737116	0.0306272	0.589746	1.80 [1.06 - 3.08]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212173_at	204	0.794118	0.249961	-	0.471291	0.701373	0.18816	1.21 [0.46 - 3.16]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212173_at	204	0.794118	0.00487775	0.0928163	0.79296	0.142979	0.515588	1.67 [0.84 - 3.34]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208967_s_at	204	0.303922	0.00232569	0.0512404	1.92113	0.0119389	1.20551	3.34 [1.30 - 8.55]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208967_s_at	204	0.289216	2.53465e-05	0.00103332	2.09763	0.000158246	1.34814	3.85 [1.91 - 7.75]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205996_s_at	204	0.112745	0.0154317	0.222542	-0.96309	0.280297	-0.605679	0.55 [0.18 - 1.64]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212175_s_at	204	0.210784	0.116498	-	0.922343	0.388105	0.416887	1.52 [0.59 - 3.91]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205996_s_at	204	0.112745	0.067446	-	-0.630622	0.947123	0.0276124	1.03 [0.45 - 2.32]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212175_s_at	204	0.892157	0.00660989	0.117686	0.888996	0.218355	0.449027	1.57 [0.77 - 3.20]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212174_at	204	0.357843	0.0451651	0.461741	-0.718119	0.191377	-0.682548	0.51 [0.18 - 1.41]
GENE	AK2	adenylate kinase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212174_at	204	0.357843	0.165245	-	-0.379744	0.657207	-0.174931	0.84 [0.39 - 1.82]
GENE	AK2	adenylate kinase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212174_at	178	0.117978	0.0372739	0.408713	-0.596257	0.131765	-0.315235	0.73 [0.48 - 1.10]
GENE	AK2	adenylate kinase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212175_s_at	178	0.426966	0.0452284	0.462145	-0.398587	0.0921144	-0.464353	0.63 [0.37 - 1.08]
GENE	AK2	adenylate kinase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205996_s_at	178	0.101124	0.0149447	0.217418	-0.691952	0.127619	-0.477807	0.62 [0.34 - 1.15]
GENE	AK2	adenylate kinase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212173_at	178	0.47191	0.0286	0.343061	-0.433282	0.0983634	-0.405013	0.67 [0.41 - 1.08]
GENE	AK2	adenylate kinase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208967_s_at	178	0.668539	0.041977	0.440995	-0.435411	0.121261	-0.519253	0.59 [0.31 - 1.15]
GENE	AK2	adenylate kinase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208967_s_at	111	0.720721	0.0223926	0.290052	0.637462	0.109762	0.474052	1.61 [0.90 - 2.87]
GENE	AK2	adenylate kinase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205996_s_at	111	0.306306	0.36113	-	-0.247459	0.747191	0.115573	1.12 [0.56 - 2.27]
GENE	AK2	adenylate kinase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212175_s_at	111	0.774775	0.0914387	-	0.504733	0.783981	0.0827002	1.09 [0.60 - 1.96]
GENE	AK2	adenylate kinase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212174_at	111	0.108108	0.0603499	-	-0.702854	0.985795	0.00576119	1.01 [0.53 - 1.90]
GENE	AK2	adenylate kinase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212173_at	111	0.882883	0.0544996	-	0.688806	0.553057	0.111574	1.12 [0.77 - 1.62]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208967_s_at	90	0.877778	0.105786	-	0.666377	0.513372	0.273072	1.31 [0.58 - 2.98]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208967_s_at	90	0.877778	0.0712763	-	0.807507	0.290654	0.489695	1.63 [0.66 - 4.05]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212174_at	90	0.222222	0.121996	-	0.726562	0.605815	-0.147821	0.86 [0.49 - 1.51]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212174_at	90	0.8	0.137958	-	-0.878296	0.547442	-0.19699	0.82 [0.43 - 1.56]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212173_at	90	0.577778	0.0769555	-	0.650522	0.365911	0.69872	2.01 [0.44 - 9.15]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212173_at	90	0.577778	0.0742792	-	0.573881	0.793841	0.181734	1.20 [0.31 - 4.69]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212175_s_at	90	0.377778	0.0323614	0.3726	0.796602	0.709748	0.0972534	1.10 [0.66 - 1.84]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212175_s_at	90	0.4	0.0333283	0.379918	0.895066	0.82984	0.0649529	1.07 [0.59 - 1.93]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205996_s_at	90	0.744444	0.319695	-	-0.394695	0.657715	-0.193462	0.82 [0.35 - 1.94]
GENE	AK2	adenylate kinase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205996_s_at	90	0.488889	0.104144	-	0.626001	0.946466	0.0327583	1.03 [0.40 - 2.69]
GENE	AK2	adenylate kinase 2	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3984	50	0.88	0.0886338	-	-15.255	0.958745	-0.0221403	0.98 [0.42 - 2.26]
GENE	AK2	adenylate kinase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212173_at	138	0.847826	0.00142488	0.0342444	0.888101	0.0741215	0.245155	1.28 [0.98 - 1.67]
GENE	AK2	adenylate kinase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208967_s_at	138	0.405797	0.00109313	0.0274591	0.855622	0.0131255	0.522511	1.69 [1.12 - 2.55]
GENE	AK2	adenylate kinase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205996_s_at	138	0.652174	0.00247623	0.0539249	0.717097	0.258891	0.151321	1.16 [0.89 - 1.51]
GENE	AK2	adenylate kinase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212175_s_at	138	0.34058	0.118698	-	0.418804	0.409164	0.157303	1.17 [0.81 - 1.70]
GENE	AK2	adenylate kinase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212174_at	138	0.572464	0.0565848	-	0.456466	0.285712	0.125606	1.13 [0.90 - 1.43]
GENE	AK2	adenylate kinase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205996_s_at	129	0.604651	0.0428909	0.447032	-0.529713	0.55267	-0.235109	0.79 [0.36 - 1.72]
GENE	AK2	adenylate kinase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208967_s_at	129	0.44186	0.0288032	0.344703	0.559346	0.25438	0.641203	1.90 [0.63 - 5.72]
GENE	AK2	adenylate kinase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212174_at	129	0.620155	0.0533319	-	-0.519508	0.437102	-0.285931	0.75 [0.37 - 1.55]
GENE	AK2	adenylate kinase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212173_at	129	0.620155	0.0500856	-	-0.518415	0.194851	-0.270465	0.76 [0.51 - 1.15]
GENE	AK2	adenylate kinase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212175_s_at	129	0.465116	0.0732094	-	0.450604	0.843621	0.0768634	1.08 [0.50 - 2.32]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21686	56	0.392857	0.138608	-	-0.533704	0.776292	-0.106802	0.90 [0.43 - 1.88]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28803	56	0.589286	0.139096	-	0.497825	0.323951	0.442414	1.56 [0.65 - 3.75]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7453	56	0.232143	0.119108	-	-0.564494	0.911437	0.057567	1.06 [0.38 - 2.92]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38584	56	0.285714	0.141506	-	0.639621	0.652563	0.208794	1.23 [0.50 - 3.06]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8497	56	0.517857	0.0528274	-	0.705124	0.698427	0.212076	1.24 [0.42 - 3.61]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21938	56	0.125	0.0513904	-	-0.866541	0.725229	-0.180482	0.83 [0.31 - 2.28]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28803	56	0.160714	0.0469151	0.472769	-0.992505	0.317899	0.486533	1.63 [0.63 - 4.23]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7453	56	0.875	0.130013	-	0.730755	0.770099	0.163568	1.18 [0.39 - 3.53]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21686	56	0.392857	0.214425	-	-0.433364	0.672171	-0.150898	0.86 [0.43 - 1.73]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21938	56	0.125	0.079545	-	-0.788652	0.971899	-0.0189276	0.98 [0.34 - 2.81]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38584	56	0.160714	0.165105	-	-0.678667	0.766531	0.13093	1.14 [0.48 - 2.71]
GENE	AK2	adenylate kinase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8497	56	0.464286	0.0967928	-	0.575366	0.895436	0.0657623	1.07 [0.40 - 2.85]
GENE	AK2	adenylate kinase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205996_s_at	278	0.809353	0.109981	-	0.340677	0.66882	0.0558654	1.06 [0.82 - 1.37]
GENE	AK2	adenylate kinase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212175_s_at	278	0.748201	0.18676	-	0.275512	0.965149	0.00692282	1.01 [0.74 - 1.37]
GENE	AK2	adenylate kinase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212174_at	278	0.830935	0.148637	-	0.344183	0.930566	0.0107041	1.01 [0.79 - 1.29]
GENE	AK2	adenylate kinase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212173_at	278	0.71223	0.212593	-	0.256145	0.655903	0.0637934	1.07 [0.81 - 1.41]
GENE	AK2	adenylate kinase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208967_s_at	278	0.118705	0.237944	-	0.361145	0.654463	0.069257	1.07 [0.79 - 1.45]
GENE	AK2	adenylate kinase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212173_at	133	0.578947	0.0162938	0.23147	0.562402	0.859802	0.0215801	1.02 [0.80 - 1.30]
GENE	AK2	adenylate kinase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212175_s_at	133	0.81203	0.0395329	0.42448	-0.693953	0.785978	0.0383834	1.04 [0.79 - 1.37]
GENE	AK2	adenylate kinase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205996_s_at	133	0.721804	0.0107211	0.170125	0.633161	0.042091	0.355103	1.43 [1.01 - 2.01]
GENE	AK2	adenylate kinase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208967_s_at	133	0.849624	0.0640777	-	-0.685886	0.949409	0.00824256	1.01 [0.78 - 1.30]
GENE	AK2	adenylate kinase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212174_at	133	0.75188	0.0651438	-	0.47316	0.379517	0.0976862	1.10 [0.89 - 1.37]
GENE	AK2	adenylate kinase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7907	81	0.185185	0.0524526	-	-0.988707	0.69587	-0.222123	0.80 [0.26 - 2.44]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212174_at	185	0.627027	0.0222979	0.289196	0.378406	0.335285	0.119835	1.13 [0.88 - 1.44]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205996_s_at	185	0.221622	0.135435	-	0.327482	0.962281	-0.0106904	0.99 [0.64 - 1.54]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212175_s_at	185	0.481081	0.0683274	-	0.323358	0.279985	0.143663	1.15 [0.89 - 1.50]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212173_at	185	0.313514	0.0975157	-	0.293242	0.529268	0.172024	1.19 [0.69 - 2.03]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212174_at	185	0.627027	0.00844357	0.142041	0.466799	0.296864	0.140498	1.15 [0.88 - 1.50]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208967_s_at	185	0.318919	0.0257753	0.319653	-0.38304	0.779574	-0.0354642	0.97 [0.75 - 1.24]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212173_at	185	0.567568	0.196445	-	0.228975	0.778173	0.08434	1.09 [0.61 - 1.96]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205996_s_at	185	0.221622	0.124429	-	0.305934	0.948352	-0.0133987	0.99 [0.66 - 1.48]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212175_s_at	185	0.481081	0.027379	0.333079	0.362996	0.1776	0.165726	1.18 [0.93 - 1.50]
GENE	AK2	adenylate kinase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208967_s_at	185	0.318919	0.0118027	0.18277	-0.462441	0.458602	-0.103016	0.90 [0.69 - 1.18]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P207360	110	0.636364	0.00463678	0.0891794	0.654832	0.0815866	0.323674	1.38 [0.96 - 1.99]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P179903	110	0.272727	0.0214378	0.281354	0.973108	0.215401	0.28737	1.33 [0.85 - 2.10]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P500891	110	0.836364	0.00377215	0.0756988	0.787452	0.184677	0.26776	1.31 [0.88 - 1.94]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P207360	110	0.636364	0.130757	-	0.451719	0.382869	0.205478	1.23 [0.77 - 1.95]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P200404	110	0.3	0.00746807	0.129305	0.742148	0.109838	0.315488	1.37 [0.93 - 2.02]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P500891	110	0.754545	0.0565137	-	0.602188	0.312252	0.264806	1.30 [0.78 - 2.18]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P179903	110	0.390909	0.0201311	0.269185	0.579072	0.119563	0.300247	1.35 [0.93 - 1.97]
GENE	AK2	adenylate kinase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P200404	110	0.218182	0.0235618	0.30049	1.13	0.177893	0.318867	1.38 [0.87 - 2.19]
GENE	AK2	adenylate kinase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205996_s_at	80	0.7875	0.0817103	-	0.82604	0.745091	0.131211	1.14 [0.52 - 2.51]
GENE	AK2	adenylate kinase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212173_at	80	0.2375	0.0206512	0.274067	-0.985572	0.179984	-0.265801	0.77 [0.52 - 1.13]
GENE	AK2	adenylate kinase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208967_s_at	80	0.4625	0.243893	-	-0.507647	0.831836	-0.0761876	0.93 [0.46 - 1.87]
GENE	AK2	adenylate kinase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212174_at	80	0.725	0.0103897	0.166168	1.08578	0.227663	0.512955	1.67 [0.73 - 3.84]
GENE	AK2	adenylate kinase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212175_s_at	80	0.875	0.0286707	0.343633	1.08725	0.743906	0.12251	1.13 [0.54 - 2.36]
GENE	AK2	adenylate kinase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208967_s_at	38	0.447368	0.00521599	0.0978414	1.50647	0.0235848	1.04465	2.84 [1.15 - 7.02]
GENE	AK2	adenylate kinase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205996_s_at	38	0.894737	0.000534247	0.0149946	1.94989	0.0577932	1.14132	3.13 [0.96 - 10.18]
GENE	AK2	adenylate kinase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212175_s_at	38	0.894737	0.000221848	0.00703394	2.42113	0.117468	0.910308	2.49 [0.80 - 7.77]
GENE	AK2	adenylate kinase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212174_at	38	0.894737	0.206689	-	0.951264	0.472559	0.395046	1.48 [0.51 - 4.36]
GENE	AK2	adenylate kinase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212173_at	38	0.263158	0.00360339	0.0729803	1.96019	0.0658831	0.630187	1.88 [0.96 - 3.68]
GENE	AK2	adenylate kinase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212174_at	140	0.264286	0.000217861	0.00692394	-1.04863	0.102683	-0.530695	0.59 [0.31 - 1.11]
GENE	AK2	adenylate kinase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212173_at	140	0.735714	0.00846099	0.142264	0.772328	0.280273	0.453678	1.57 [0.69 - 3.59]
GENE	AK2	adenylate kinase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212175_s_at	140	0.735714	0.00662207	0.117854	0.784895	0.174524	0.469093	1.60 [0.81 - 3.15]
GENE	AK2	adenylate kinase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205996_s_at	140	0.3	0.0356692	0.397201	-0.61935	0.32492	-0.4618	0.63 [0.25 - 1.58]
GENE	AK2	adenylate kinase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208967_s_at	140	0.835714	0.00040223	0.0117611	1.11111	0.096703	0.521013	1.68 [0.91 - 3.11]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AK3	adenylate kinase 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1778173	165	0.29697	0.0234273	0.299301	-0.555777	0.13397	-0.342391	0.71 [0.45 - 1.11]
GENE	AK3	adenylate kinase 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1778173	165	0.393939	0.00845624	0.142203	-0.916782	0.0833993	-0.573588	0.56 [0.29 - 1.08]
GENE	AK3	adenylate kinase 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	224151_s_at	163	0.736196	0.0012856	0.0314386	0.677824	0.0228805	0.380595	1.46 [1.05 - 2.03]
GENE	AK3	adenylate kinase 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	224655_at	163	0.644172	0.0125194	0.190932	0.49955	0.0641029	0.254244	1.29 [0.99 - 1.69]
GENE	AK3	adenylate kinase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	224655_at	79	0.822785	0.102265	-	0.57522	0.49992	0.199275	1.22 [0.68 - 2.18]
GENE	AK3	adenylate kinase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	224151_s_at	79	0.316456	0.0703564	-	0.598514	0.334249	0.245061	1.28 [0.78 - 2.10]
GENE	AK3	adenylate kinase 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	224655_at	180	0.211111	0.0451685	0.461763	-0.475883	0.802618	-0.0974701	0.91 [0.42 - 1.95]
GENE	AK3	adenylate kinase 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	224151_s_at	180	0.488889	0.0128336	0.194459	0.527109	0.831174	0.0559521	1.06 [0.63 - 1.77]
GENE	AK3	adenylate kinase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	224151_s_at	559	0.629696	0.0314778	0.365818	-0.484747	0.49549	-0.152911	0.86 [0.55 - 1.33]
GENE	AK3	adenylate kinase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	224655_at	559	0.899821	0.0630854	-	-0.764802	0.221825	-0.341023	0.71 [0.41 - 1.23]
GENE	AK3	adenylate kinase 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	224655_at	77	0.87013	0.0149051	0.216999	0.861073	0.191611	0.376032	1.46 [0.83 - 2.56]
GENE	AK3	adenylate kinase 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	224151_s_at	77	0.766234	0.0122173	0.187512	0.718685	0.273894	0.269476	1.31 [0.81 - 2.12]
GENE	AK3	adenylate kinase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	224655_at	70	0.471429	0.0253333	0.315887	0.604387	0.250416	0.30736	1.36 [0.81 - 2.30]
GENE	AK3	adenylate kinase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	224151_s_at	70	0.228571	0.190163	-	0.438272	0.658836	0.111865	1.12 [0.68 - 1.84]
GENE	AK3	adenylate kinase 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	224151_s_at	74	0.662162	0.106264	-	-0.532715	0.362226	-0.316515	0.73 [0.37 - 1.44]
GENE	AK3	adenylate kinase 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	224655_at	74	0.878378	0.100031	-	0.673518	0.687921	0.175113	1.19 [0.51 - 2.80]
GENE	AK3	adenylate kinase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	224151_s_at	67	0.80597	0.119957	-	-15.387	0.615517	-0.376716	0.69 [0.16 - 2.98]
GENE	AK3	adenylate kinase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	224655_at	67	0.761194	0.082073	-	-15.4942	0.796451	-0.308933	0.73 [0.07 - 7.68]
GENE	AK3	adenylate kinase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	224151_s_at	115	0.895652	0.186254	-	-15.1878	0.934416	0.0699636	1.07 [0.20 - 5.68]
GENE	AK3	adenylate kinase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	224655_at	115	0.504348	0.299361	-	-0.571252	0.900061	-0.105703	0.90 [0.17 - 4.68]
GENE	AK3	adenylate kinase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	224151_s_at	204	0.519608	0.119349	-	-0.223606	0.844564	-0.032793	0.97 [0.70 - 1.34]
GENE	AK3	adenylate kinase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	224655_at	204	0.20098	0.194735	-	-0.230971	0.604836	-0.108893	0.90 [0.59 - 1.35]
GENE	AK3	adenylate kinase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	224151_s_at	87	0.390805	0.0294359	0.34978	-0.806465	0.483749	-0.264909	0.77 [0.37 - 1.61]
GENE	AK3	adenylate kinase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	224655_at	87	0.436782	0.0328306	0.376165	-0.797395	0.177799	-0.655171	0.52 [0.20 - 1.35]
GENE	AK3	adenylate kinase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	224655_at	87	0.436782	0.0328306	0.376165	-0.797395	0.177799	-0.655171	0.52 [0.20 - 1.35]
GENE	AK3	adenylate kinase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	224151_s_at	87	0.390805	0.0294359	0.34978	-0.806465	0.483749	-0.264909	0.77 [0.37 - 1.61]
GENE	AK3	adenylate kinase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	224151_s_at	77	0.337662	0.0535127	-	-1.1778	0.611023	-0.300241	0.74 [0.23 - 2.36]
GENE	AK3	adenylate kinase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	224655_at	77	0.350649	0.0704446	-	-1.11034	0.340447	-0.609535	0.54 [0.16 - 1.90]
GENE	AK3	adenylate kinase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	224151_s_at	77	0.402597	0.0707872	-	-0.989798	0.476949	-0.366806	0.69 [0.25 - 1.90]
GENE	AK3	adenylate kinase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	224655_at	77	0.350649	0.0983893	-	-0.890236	0.288451	-0.596528	0.55 [0.18 - 1.66]
GENE	AK3	adenylate kinase 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11471	60	0.15	0.0832016	-	-0.784125	0.361804	-0.369734	0.69 [0.31 - 1.53]
GENE	AK3	adenylate kinase 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11471	60	0.116667	0.197728	-	-0.682269	0.278364	-0.568388	0.57 [0.20 - 1.58]
GENE	AK3	adenylate kinase 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6080	155	0.825806	0.00217869	0.0485813	0.881643	0.0089934	0.572971	1.77 [1.15 - 2.73]
GENE	AK3	adenylate kinase 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224151_s_at	159	0.484277	0.00559617	0.103386	-0.904789	0.145357	-0.464925	0.63 [0.34 - 1.17]
GENE	AK3	adenylate kinase 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224151_s_at	159	0.484277	0.0159169	0.22759	-0.779735	0.164392	-0.45178	0.64 [0.34 - 1.20]
GENE	AK3	adenylate kinase 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224151_s_at	159	0.446541	0.00328048	0.0676892	-1.12144	0.0682435	-0.664236	0.51 [0.25 - 1.05]
GENE	AK3	adenylate kinase 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224655_at	159	0.352201	0.0282504	0.340223	-0.680759	0.326414	-0.428191	0.65 [0.28 - 1.53]
GENE	AK3	adenylate kinase 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224655_at	159	0.748428	0.0942441	-	-0.725381	0.485157	-0.310874	0.73 [0.31 - 1.75]
GENE	AK3	adenylate kinase 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224655_at	159	0.352201	0.0142193	0.209669	-0.886397	0.169174	-0.696452	0.50 [0.18 - 1.35]
GENE	AK3	adenylate kinase 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	224655_at	236	0.466102	0.000741082	0.0197999	-0.926779	0.0220201	-0.996829	0.37 [0.16 - 0.87]
GENE	AK3	adenylate kinase 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	224151_s_at	236	0.75	0.0290314	0.346539	-0.857491	0.0475151	-0.672815	0.51 [0.26 - 0.99]
GENE	AK3	adenylate kinase 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	224655_at	249	0.526104	0.00445505	0.0864039	-0.619718	0.0700899	-0.60321	0.55 [0.28 - 1.05]
GENE	AK3	adenylate kinase 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	224151_s_at	249	0.13253	0.112332	-	-0.435382	0.230245	-0.320516	0.73 [0.43 - 1.23]
GENE	AK3	adenylate kinase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	224151_s_at	177	0.101695	0.0894737	-	1.15866	0.437215	0.26849	1.31 [0.66 - 2.57]
GENE	AK3	adenylate kinase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	224655_at	177	0.898305	0.0144338	0.211975	0.756404	0.247128	0.363933	1.44 [0.78 - 2.67]
GENE	AK3	adenylate kinase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	224655_at	177	0.152542	0.0987717	-	0.834554	0.453517	0.269447	1.31 [0.65 - 2.65]
GENE	AK3	adenylate kinase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	224151_s_at	177	0.898305	0.00371599	0.0747976	0.876305	0.107964	0.493436	1.64 [0.90 - 2.99]
GENE	AK3	adenylate kinase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	224655_at	145	0.289655	0.164428	-	-0.478462	0.685548	-0.171579	0.84 [0.37 - 1.93]
GENE	AK3	adenylate kinase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	224151_s_at	145	0.503448	0.0518827	-	-0.654019	0.330024	-0.391902	0.68 [0.31 - 1.49]
GENE	AK3	adenylate kinase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	224655_at	226	0.393805	0.305185	-	-0.291008	0.941932	-0.0267866	0.97 [0.47 - 2.00]
GENE	AK3	adenylate kinase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	224151_s_at	226	0.314159	0.147087	-	-0.419998	0.6244	-0.178429	0.84 [0.41 - 1.71]
GENE	AK3	adenylate kinase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	224655_at	55	0.890909	0.15135	-	0.783979	0.341264	-0.518823	0.60 [0.20 - 1.73]
GENE	AK3	adenylate kinase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	224151_s_at	55	0.290909	0.0821954	-	1.04297	0.199852	0.40715	1.50 [0.81 - 2.80]
GENE	AK3	adenylate kinase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	224151_s_at	55	0.509091	0.0236751	0.301489	1.1323	0.0404823	0.781456	2.18 [1.03 - 4.61]
GENE	AK3	adenylate kinase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	224655_at	55	0.781818	0.0240384	0.304681	1.02636	0.738437	-0.198506	0.82 [0.26 - 2.63]
GENE	AK3	adenylate kinase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	224151_s_at	49	0.163265	0.0791177	-	15.3837	0.194061	0.519017	1.68 [0.77 - 3.68]
GENE	AK3	adenylate kinase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	224655_at	49	0.102041	0.0252745	0.315383	-1.38821	0.202537	-0.865956	0.42 [0.11 - 1.59]
GENE	AK3	adenylate kinase 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	289402	34	0.588235	0.0572006	-	-0.892847	0.302249	-0.600191	0.55 [0.18 - 1.72]
GENE	AK3	adenylate kinase 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	2296257	34	0.852941	0.0176422	0.245083	-15.4291	0.0452353	-1.98749	0.14 [0.02 - 0.96]
GENE	AK3	adenylate kinase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	224151_s_at	63	0.492063	0.0428454	0.446732	-0.695544	0.241808	-0.219086	0.80 [0.56 - 1.16]
GENE	AK3	adenylate kinase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	224655_at	63	0.47619	0.298744	-	-0.351528	0.828245	-0.038271	0.96 [0.68 - 1.36]
GENE	AK3	adenylate kinase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.43436.1.S3_3p_x_at	28	0.285714	0.00697601	0.122693	2.45911	0.181829	0.226286	1.25 [0.90 - 1.75]
GENE	AK3	adenylate kinase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9963776_3p_a_at	28	0.678571	0.0932252	-	-1.07055	0.176014	-1.15065	0.32 [0.06 - 1.68]
GENE	AK3	adenylate kinase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.43436.1.S3_3p_at	28	0.428571	0.15131	-	0.837111	0.310063	0.175012	1.19 [0.85 - 1.67]
GENE	AK3	adenylate kinase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P247106	117	0.444444	0.06133	-	0.554939	0.223099	0.273678	1.31 [0.85 - 2.04]
GENE	AK3	adenylate kinase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	224151_s_at	204	0.602941	0.0133335	0.200011	-1.14984	0.0625103	-1.16935	0.31 [0.09 - 1.06]
GENE	AK3	adenylate kinase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	224655_at	204	0.897059	0.0528815	-	0.857546	0.406634	0.707047	2.03 [0.38 - 10.77]
GENE	AK3	adenylate kinase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	224151_s_at	204	0.220588	2.26538e-05	0.000934226	-1.11107	0.000474684	-1.63319	0.20 [0.08 - 0.49]
GENE	AK3	adenylate kinase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	224655_at	204	0.877451	0.00562421	0.103791	0.878682	0.929624	0.0573051	1.06 [0.30 - 3.78]
GENE	AK3	adenylate kinase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	224151_s_at	111	0.612613	0.179826	-	0.355682	0.920162	0.0292348	1.03 [0.58 - 1.82]
GENE	AK3	adenylate kinase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	224655_at	111	0.846847	0.0902299	-	0.567409	0.629363	-0.169384	0.84 [0.42 - 1.68]
GENE	AK3	adenylate kinase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	224151_s_at	138	0.275362	0.160646	-	0.398649	0.101739	0.302391	1.35 [0.94 - 1.94]
GENE	AK3	adenylate kinase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	224655_at	138	0.101449	0.235123	-	0.545379	0.174792	0.263515	1.30 [0.89 - 1.90]
GENE	AK3	adenylate kinase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7876	56	0.25	0.141282	-	0.768106	0.642461	0.109099	1.12 [0.70 - 1.77]
GENE	AK3	adenylate kinase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28274	56	0.303571	0.227958	-	0.485418	0.879553	0.0363631	1.04 [0.65 - 1.66]
GENE	AK3	adenylate kinase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24877	56	0.321429	0.190861	-	0.525283	0.878205	0.0381583	1.04 [0.64 - 1.69]
GENE	AK3	adenylate kinase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28274	56	0.375	0.0950237	-	0.670758	0.789572	0.0679231	1.07 [0.65 - 1.76]
GENE	AK3	adenylate kinase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7876	56	0.196429	0.308394	-	0.538398	0.803915	0.05434	1.06 [0.69 - 1.62]
GENE	AK3	adenylate kinase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24877	56	0.357143	0.102359	-	0.686119	0.742176	0.0869139	1.09 [0.65 - 1.83]
GENE	AK3	adenylate kinase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	224151_s_at	278	0.866906	0.0189142	0.257558	-0.791462	0.0997496	-0.223164	0.80 [0.61 - 1.04]
GENE	AK3	adenylate kinase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	224655_at	278	0.841727	0.00214372	0.047943	-1.01821	0.00976142	-0.390866	0.68 [0.50 - 0.91]
GENE	AK3	adenylate kinase 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4763	81	0.679012	0.247759	-	-0.692403	0.795592	-0.0936733	0.91 [0.45 - 1.85]
GENE	AK3	adenylate kinase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P247106	110	0.3	0.0939255	-	0.641586	0.385872	0.158398	1.17 [0.82 - 1.68]
GENE	AK3	adenylate kinase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P247106	110	0.745455	0.157049	-	-0.382888	0.457652	-0.115471	0.89 [0.66 - 1.21]
GENE	AK3	adenylate kinase 3	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:142585	59	0.271186	0.0140255	0.207574	-1.15858	0.121716	-1.77166	0.17 [0.02 - 1.60]
GENE	AK3	adenylate kinase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	224151_s_at	38	0.289474	0.0340995	0.385679	1.27175	0.277278	0.525273	1.69 [0.66 - 4.36]
GENE	AK3	adenylate kinase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	224655_at	38	0.868421	0.14343	-	0.949157	0.414484	0.409456	1.51 [0.56 - 4.03]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AK4	adenylate kinase 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204348_s_at	30	0.866667	0.0121867	0.187164	1.36716	0.10911	0.357376	1.43 [0.92 - 2.21]
GENE	AK4	adenylate kinase 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1686522	165	0.860606	0.0979527	-	0.522135	0.742384	0.0455548	1.05 [0.80 - 1.37]
GENE	AK4	adenylate kinase 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1686522	165	0.10303	0.24939	-	-0.556798	0.937687	-0.0156736	0.98 [0.66 - 1.46]
GENE	AK4	adenylate kinase 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204348_s_at	163	0.895706	0.052915	-	0.570425	0.43059	0.280334	1.32 [0.66 - 2.66]
GENE	AK4	adenylate kinase 4	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225342_at	163	0.214724	0.028694	0.343821	-0.488327	0.582057	0.113289	1.12 [0.75 - 1.68]
GENE	AK4	adenylate kinase 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225342_at	79	0.759494	0.0061092	0.110706	0.842456	0.0432695	0.334311	1.40 [1.01 - 1.93]
GENE	AK4	adenylate kinase 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204348_s_at	79	0.873418	2.09519e-06	0.000107441	1.62859	0.00308769	0.560581	1.75 [1.21 - 2.54]
GENE	AK4	adenylate kinase 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204348_s_at	58	0.327586	0.259774	-	0.331579	0.917954	0.0176661	1.02 [0.73 - 1.42]
GENE	AK4	adenylate kinase 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204348_s_at	34	0.823529	0.0610241	-	-1.14118	0.147833	-0.388581	0.68 [0.40 - 1.15]
GENE	AK4	adenylate kinase 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204348_s_at	158	0.791139	0.0967303	-	0.432841	0.572408	0.0866588	1.09 [0.81 - 1.47]
GENE	AK4	adenylate kinase 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204348_s_at	53	0.150943	0.0177955	0.246605	2.04097	0.129937	0.325982	1.39 [0.91 - 2.11]
GENE	AK4	adenylate kinase 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204348_s_at	53	0.113208	0.114523	-	1.09611	0.521543	0.127826	1.14 [0.77 - 1.68]
GENE	AK4	adenylate kinase 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204348_s_at	180	0.55	0.236637	-	-0.250751	0.644942	-0.0610773	0.94 [0.73 - 1.22]
GENE	AK4	adenylate kinase 4	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225342_at	180	0.788889	0.105804	-	0.387626	0.878878	-0.0336981	0.97 [0.63 - 1.49]
GENE	AK4	adenylate kinase 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225342_at	559	0.851521	0.273722	-	-0.306477	0.907605	-0.0253213	0.97 [0.64 - 1.50]
GENE	AK4	adenylate kinase 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204348_s_at	559	0.105546	0.0622635	-	1.04715	0.393011	0.133875	1.14 [0.84 - 1.55]
GENE	AK4	adenylate kinase 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204348_s_at	77	0.454545	0.00213158	0.0477208	0.807575	0.0148212	0.595982	1.81 [1.12 - 2.93]
GENE	AK4	adenylate kinase 4	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225342_at	77	0.181818	0.00901162	0.149249	0.932084	0.128463	0.296454	1.35 [0.92 - 1.97]
GENE	AK4	adenylate kinase 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225342_at	70	0.314286	0.00251318	0.0545779	0.894989	0.0134615	0.381485	1.46 [1.08 - 1.98]
GENE	AK4	adenylate kinase 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204348_s_at	70	0.671429	0.00685052	0.120986	0.745555	0.0425505	0.372646	1.45 [1.01 - 2.08]
GENE	AK4	adenylate kinase 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204348_s_at	74	0.310811	0.00957367	0.156243	0.899442	0.029443	0.603037	1.83 [1.06 - 3.15]
GENE	AK4	adenylate kinase 4	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225342_at	74	0.567568	0.00031646	0.00956743	1.08284	0.00205983	0.755576	2.13 [1.32 - 3.44]
GENE	AK4	adenylate kinase 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204348_s_at	67	0.80597	0.0492322	0.486998	1.24924	0.980792	-0.0156621	0.98 [0.28 - 3.52]
GENE	AK4	adenylate kinase 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225342_at	67	0.746269	0.0329664	0.377192	1.33249	0.468974	0.438612	1.55 [0.47 - 5.08]
GENE	AK4	adenylate kinase 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204348_s_at	115	0.895652	0.0167871	0.236499	1.31409	0.385594	0.425864	1.53 [0.58 - 4.01]
GENE	AK4	adenylate kinase 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225342_at	115	0.895652	0.0167871	0.236499	1.31409	0.61749	0.263124	1.30 [0.46 - 3.65]
GENE	AK4	adenylate kinase 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204348_s_at	204	0.730392	0.00279899	0.0595585	0.473622	0.030338	0.199421	1.22 [1.02 - 1.46]
GENE	AK4	adenylate kinase 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225342_at	204	0.813725	0.00252879	0.0548532	0.555785	0.0629044	0.171465	1.19 [0.99 - 1.42]
GENE	AK4	adenylate kinase 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204348_s_at	87	0.37931	0.158762	-	0.583126	0.811693	0.0411413	1.04 [0.74 - 1.46]
GENE	AK4	adenylate kinase 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204348_s_at	87	0.37931	0.158762	-	0.583126	0.811693	0.0411413	1.04 [0.74 - 1.46]
GENE	AK4	adenylate kinase 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225342_at	87	0.747126	0.079833	-	-1.02587	0.74322	-0.047423	0.95 [0.72 - 1.27]
GENE	AK4	adenylate kinase 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225342_at	87	0.747126	0.079833	-	-1.02587	0.74322	-0.047423	0.95 [0.72 - 1.27]
GENE	AK4	adenylate kinase 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225342_at	77	0.350649	0.0772912	-	-1.08667	0.142793	-0.35659	0.70 [0.43 - 1.13]
GENE	AK4	adenylate kinase 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204348_s_at	77	0.337662	0.117113	-	-0.846987	0.267596	-0.245082	0.78 [0.51 - 1.21]
GENE	AK4	adenylate kinase 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204348_s_at	77	0.337662	0.237422	-	-0.731313	0.505959	-0.170214	0.84 [0.51 - 1.39]
GENE	AK4	adenylate kinase 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225342_at	77	0.350649	0.0353328	0.394754	-1.13808	0.0629042	-0.39095	0.68 [0.45 - 1.02]
GENE	AK4	adenylate kinase 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204348_s_at	136	0.205882	0.0540854	-	-0.876946	0.784056	-0.0988329	0.91 [0.45 - 1.84]
GENE	AK4	adenylate kinase 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204348_s_at	200	0.625	0.229351	-	-0.376692	0.698979	-0.101142	0.90 [0.54 - 1.51]
GENE	AK4	adenylate kinase 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19791	60	0.783333	0.12655	-	0.637452	0.834502	0.0265723	1.03 [0.80 - 1.32]
GENE	AK4	adenylate kinase 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3952	60	0.866667	0.0506725	-	0.886128	0.251319	0.166419	1.18 [0.89 - 1.57]
GENE	AK4	adenylate kinase 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19791	60	0.283333	0.0738794	-	-0.687272	0.692411	0.0572475	1.06 [0.80 - 1.41]
GENE	AK4	adenylate kinase 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3952	60	0.833333	0.0179548	0.248181	0.978918	0.255831	0.177899	1.19 [0.88 - 1.62]
GENE	AK4	adenylate kinase 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204348_s_at	286	0.839161	0.102853	-	0.403635	0.916487	-0.016964	0.98 [0.72 - 1.35]
GENE	AK4	adenylate kinase 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204348_s_at	159	0.383648	0.104778	-	-0.594561	0.406147	-0.215216	0.81 [0.49 - 1.34]
GENE	AK4	adenylate kinase 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204348_s_at	159	0.264151	0.0720731	-	-0.579508	0.30243	-0.226897	0.80 [0.52 - 1.23]
GENE	AK4	adenylate kinase 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204348_s_at	159	0.358491	0.00132966	0.0323326	-0.988202	0.0227527	-0.491623	0.61 [0.40 - 0.93]
GENE	AK4	adenylate kinase 4	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225342_at	159	0.358491	0.0140889	0.208261	-0.760434	0.355088	-0.273096	0.76 [0.43 - 1.36]
GENE	AK4	adenylate kinase 4	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225342_at	159	0.886792	0.0139026	0.206242	1.02363	0.99604	-0.00169539	1.00 [0.51 - 1.95]
GENE	AK4	adenylate kinase 4	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225342_at	159	0.245283	0.089786	-	-0.555384	0.75387	-0.091023	0.91 [0.52 - 1.61]
GENE	AK4	adenylate kinase 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204348_s_at	54	0.481481	0.028393	0.341383	-1.59299	0.910021	-0.042701	0.96 [0.46 - 2.01]
GENE	AK4	adenylate kinase 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204347_at	54	0.277778	0.21653	-	1.23191	0.980231	0.0160261	1.02 [0.29 - 3.61]
GENE	AK4	adenylate kinase 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204348_s_at	117	0.205128	0.144484	-	0.685036	0.908033	-0.0186023	0.98 [0.72 - 1.35]
GENE	AK4	adenylate kinase 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204348_s_at	117	0.205128	0.150182	-	0.853419	0.693217	-0.0775278	0.93 [0.63 - 1.36]
GENE	AK4	adenylate kinase 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204348_s_at	117	0.726496	0.125641	-	-0.809752	0.592234	-0.109842	0.90 [0.60 - 1.34]
GENE	AK4	adenylate kinase 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204348_s_at	117	0.205128	0.144484	-	0.685036	0.908033	-0.0186023	0.98 [0.72 - 1.35]
GENE	AK4	adenylate kinase 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204348_s_at	236	0.254237	0.0192948	0.261227	0.868653	0.0479694	0.484753	1.62 [1.00 - 2.63]
GENE	AK4	adenylate kinase 4	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225342_at	236	0.889831	0.00190974	0.0436105	1.00983	0.014699	0.584049	1.79 [1.12 - 2.87]
GENE	AK4	adenylate kinase 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204348_s_at	249	0.248996	0.0342911	0.387099	0.57709	0.150556	0.275049	1.32 [0.90 - 1.92]
GENE	AK4	adenylate kinase 4	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225342_at	249	0.811245	0.0193478	0.261735	0.578708	0.0557747	0.35615	1.43 [0.99 - 2.06]
GENE	AK4	adenylate kinase 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204348_s_at	62	0.83871	0.204045	-	0.665381	0.71066	-0.0738158	0.93 [0.63 - 1.37]
GENE	AK4	adenylate kinase 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204348_s_at	125	0.272	0.0746031	-	-0.682957	0.457518	-0.205632	0.81 [0.47 - 1.40]
GENE	AK4	adenylate kinase 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204348_s_at	125	0.896	0.19756	-	-0.751977	0.707455	-0.0801636	0.92 [0.61 - 1.40]
GENE	AK4	adenylate kinase 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204348_s_at	54	0.481481	0.150104	-	-0.92172	0.562842	-0.141351	0.87 [0.54 - 1.40]
GENE	AK4	adenylate kinase 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204348_s_at	198	0.328283	0.153245	-	0.411893	0.875793	0.0216057	1.02 [0.78 - 1.34]
GENE	AK4	adenylate kinase 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204348_s_at	198	0.777778	0.300178	-	-0.360047	0.977094	0.00418789	1.00 [0.75 - 1.34]
GENE	AK4	adenylate kinase 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204348_s_at	198	0.80303	0.132367	-	-0.435321	0.683848	0.0458794	1.05 [0.84 - 1.31]
GENE	AK4	adenylate kinase 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204348_s_at	51	0.666667	0.207061	-	1.09655	0.322899	1.14371	3.14 [0.32 - 30.31]
GENE	AK4	adenylate kinase 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204348_s_at	62	0.435484	0.261865	-	-0.646053	0.754457	-0.213823	0.81 [0.21 - 3.08]
GENE	AK4	adenylate kinase 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204348_s_at	145	0.131034	0.300722	-	-0.45914	0.997387	0.000722771	1.00 [0.65 - 1.54]
GENE	AK4	adenylate kinase 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225342_at	177	0.118644	0.100382	-	-0.532721	0.826607	-0.0264348	0.97 [0.77 - 1.23]
GENE	AK4	adenylate kinase 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204348_s_at	177	0.152542	0.0370512	0.407131	-0.672332	0.479595	-0.128731	0.88 [0.62 - 1.26]
GENE	AK4	adenylate kinase 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204348_s_at	177	0.152542	0.0324567	0.373326	-0.612956	0.706612	-0.0596436	0.94 [0.69 - 1.29]
GENE	AK4	adenylate kinase 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225342_at	145	0.165517	0.199216	-	0.756293	0.622942	0.0866546	1.09 [0.77 - 1.54]
GENE	AK4	adenylate kinase 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225342_at	177	0.20904	0.137542	-	-0.459446	0.684856	-0.0558051	0.95 [0.72 - 1.24]
GENE	AK4	adenylate kinase 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225342_at	226	0.584071	0.126725	-	-0.452052	0.491889	-0.106524	0.90 [0.66 - 1.22]
GENE	AK4	adenylate kinase 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204348_s_at	226	0.340708	0.103032	-	0.534423	0.528148	-0.090923	0.91 [0.69 - 1.21]
GENE	AK4	adenylate kinase 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225342_at	55	0.872727	0.0635614	-	1.00315	0.827762	-0.0484792	0.95 [0.62 - 1.47]
GENE	AK4	adenylate kinase 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225342_at	49	0.877551	0.00684868	0.120961	1.66454	0.642089	0.166375	1.18 [0.59 - 2.38]
GENE	AK4	adenylate kinase 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204348_s_at	55	0.890909	0.257964	-	0.697029	0.690801	0.118568	1.13 [0.63 - 2.02]
GENE	AK4	adenylate kinase 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225342_at	55	0.872727	0.00370468	0.0746157	1.63437	0.321657	0.271184	1.31 [0.77 - 2.24]
GENE	AK4	adenylate kinase 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204348_s_at	55	0.890909	0.0324261	0.373093	1.3068	0.190795	0.446985	1.56 [0.80 - 3.05]
GENE	AK4	adenylate kinase 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204348_s_at	49	0.285714	0.265338	-	-0.682847	0.740908	0.1485	1.16 [0.48 - 2.80]
GENE	AK4	adenylate kinase 4	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	209735	34	0.323529	0.315067	-	-0.45129	0.995008	0.00367748	1.00 [0.32 - 3.18]
GENE	AK4	adenylate kinase 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225342_at	63	0.587302	0.00162164	0.0381151	1.03838	0.0131617	0.332128	1.39 [1.07 - 1.81]
GENE	AK4	adenylate kinase 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204348_s_at	63	0.539683	8.96996e-05	0.00318224	1.31894	0.0238471	0.35227	1.42 [1.05 - 1.93]
GENE	AK4	adenylate kinase 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.10862.0.S1_3p_at	28	0.285714	0.00553508	0.102502	15.7785	0.763153	0.0675106	1.07 [0.69 - 1.66]
GENE	AK4	adenylate kinase 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8051578_3p_a_at	28	0.25	0.0356661	0.397179	1.91108	0.404493	0.172945	1.19 [0.79 - 1.79]
GENE	AK4	adenylate kinase 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204348_s_at	82	0.207317	0.00113871	0.028413	2.55675	0.140283	0.295123	1.34 [0.91 - 1.99]
GENE	AK4	adenylate kinase 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204348_s_at	79	0.417722	0.0166018	0.234616	0.678484	0.0520239	0.397409	1.49 [1.00 - 2.22]
GENE	AK4	adenylate kinase 4	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X60673_rna1_at	86	0.372093	0.00447433	0.0866998	1.59235	0.0491537	0.543535	1.72 [1.00 - 2.96]
GENE	AK4	adenylate kinase 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204348_s_at	104	0.846154	0.377125	-	0.366905	0.972768	0.00866076	1.01 [0.61 - 1.66]
GENE	AK4	adenylate kinase 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P108655	117	0.367521	0.0808068	-	0.558373	0.535747	0.053196	1.05 [0.89 - 1.25]
GENE	AK4	adenylate kinase 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P200524	117	0.470085	0.00497686	0.094298	0.846268	0.119193	0.140429	1.15 [0.96 - 1.37]
GENE	AK4	adenylate kinase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204348_s_at	204	0.803922	0.000140138	0.00471094	1.31192	0.000565802	0.774805	2.17 [1.40 - 3.37]
GENE	AK4	adenylate kinase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204348_s_at	204	0.705882	6.86708e-08	4.51901e-06	1.37234	9.29985e-07	0.820276	2.27 [1.64 - 3.15]
GENE	AK4	adenylate kinase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225342_at	204	0.617647	2.78525e-05	0.00112446	1.57094	0.000398774	0.730477	2.08 [1.39 - 3.11]
GENE	AK4	adenylate kinase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225342_at	204	0.681373	9.5651e-08	6.15935e-06	1.37169	1.05588e-07	0.849069	2.34 [1.71 - 3.20]
GENE	AK4	adenylate kinase 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204348_s_at	178	0.58427	0.000532696	0.0149575	0.681249	0.0472034	0.265879	1.30 [1.00 - 1.70]
GENE	AK4	adenylate kinase 4	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300010202	41	0.829268	0.0817174	-	0.860255	0.830134	0.0357855	1.04 [0.75 - 1.44]
GENE	AK4	adenylate kinase 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204348_s_at	111	0.891892	0.00226845	0.0502095	1.07648	0.0830994	0.296882	1.35 [0.96 - 1.88]
GENE	AK4	adenylate kinase 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225342_at	111	0.315315	0.135417	-	0.445809	0.249965	0.237318	1.27 [0.85 - 1.90]
GENE	AK4	adenylate kinase 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204348_s_at	90	0.255556	0.247233	-	-0.402266	0.815467	-0.045003	0.96 [0.66 - 1.40]
GENE	AK4	adenylate kinase 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204348_s_at	90	0.744444	0.173749	-	0.526017	0.961345	-0.0105919	0.99 [0.64 - 1.52]
GENE	AK4	adenylate kinase 4	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4635	50	0.86	0.155414	-	0.812792	0.752376	-0.162089	0.85 [0.31 - 2.33]
GENE	AK4	adenylate kinase 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204348_s_at	138	0.384058	0.000125694	0.00428235	1.05313	0.000440332	0.273606	1.31 [1.13 - 1.53]
GENE	AK4	adenylate kinase 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225342_at	138	0.326087	0.00173842	0.0403657	0.933105	0.00693275	0.210733	1.23 [1.06 - 1.44]
GENE	AK4	adenylate kinase 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204348_s_at	129	0.379845	0.0847071	-	0.454022	0.184044	0.335678	1.40 [0.85 - 2.30]
GENE	AK4	adenylate kinase 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225342_at	278	0.276978	0.107385	-	-0.330307	0.804244	0.0240821	1.02 [0.85 - 1.24]
GENE	AK4	adenylate kinase 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204348_s_at	278	0.330935	0.0724426	-	-0.35486	0.690255	-0.0448478	0.96 [0.77 - 1.19]
GENE	AK4	adenylate kinase 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204348_s_at	133	0.706767	0.0226622	0.292479	-0.652841	0.0571998	-0.182272	0.83 [0.69 - 1.01]
GENE	AK4	adenylate kinase 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204348_s_at	185	0.275676	0.261945	-	0.202996	0.919854	0.012337	1.01 [0.80 - 1.29]
GENE	AK4	adenylate kinase 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204348_s_at	185	0.216216	0.207301	-	-0.250093	0.807465	-0.0326615	0.97 [0.74 - 1.26]
GENE	AK4	adenylate kinase 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P108655	110	0.863636	0.0341706	0.386206	0.690059	0.380095	0.128203	1.14 [0.85 - 1.51]
GENE	AK4	adenylate kinase 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P108655	110	0.863636	0.0945258	-	0.642039	0.455957	0.141181	1.15 [0.79 - 1.67]
GENE	AK4	adenylate kinase 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204348_s_at	80	0.8875	0.178346	-	0.749704	0.8716	0.0599013	1.06 [0.51 - 2.20]
GENE	AK4	adenylate kinase 4	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0989	281	0.88968	0.0183295	0.251866	-0.606199	0.0944814	-0.106168	0.90 [0.79 - 1.02]
GENE	AK4	adenylate kinase 4	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:41339	59	0.762712	0.162505	-	-1.01285	0.604136	-0.500158	0.61 [0.09 - 4.02]
GENE	AK4	adenylate kinase 4	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:146168	59	0.118644	0.211552	-	-0.788888	0.677527	0.332041	1.39 [0.29 - 6.67]
GENE	AK4	adenylate kinase 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225342_at	38	0.105263	0.0226574	0.292436	15.6468	0.0434065	0.555707	1.74 [1.02 - 2.99]
GENE	AK4	adenylate kinase 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204348_s_at	38	0.236842	0.0588069	-	1.35007	0.285301	0.308032	1.36 [0.77 - 2.39]
GENE	AK4	adenylate kinase 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204348_s_at	140	0.871429	0.0389293	0.420316	0.71949	0.466494	0.148879	1.16 [0.78 - 1.73]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AK5	adenylate kinase 5	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219308_s_at	30	0.166667	0.00250255	0.0543902	-1.67361	0.814712	0.16894	1.18 [0.29 - 4.86]
GENE	AK5	adenylate kinase 5	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1656593	165	0.254545	0.157596	-	-0.363163	0.756637	-0.198088	0.82 [0.23 - 2.87]
GENE	AK5	adenylate kinase 5	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1656593	165	0.175758	0.217553	-	-0.49927	0.681243	0.345709	1.41 [0.27 - 7.35]
GENE	AK5	adenylate kinase 5	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219308_s_at	163	0.895706	0.0604266	-	0.570633	0.317426	0.350698	1.42 [0.71 - 2.82]
GENE	AK5	adenylate kinase 5	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222862_s_at	163	0.141104	0.0386345	0.418269	0.676597	0.211511	0.159664	1.17 [0.91 - 1.51]
GENE	AK5	adenylate kinase 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222862_s_at	79	0.848101	0.00746292	0.129236	0.91209	0.11775	0.269423	1.31 [0.93 - 1.83]
GENE	AK5	adenylate kinase 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219308_s_at	79	0.708861	0.044949	0.460363	0.589993	0.114162	0.358613	1.43 [0.92 - 2.23]
GENE	AK5	adenylate kinase 5	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219308_s_at	58	0.103448	0.00946604	0.154914	-1.11507	0.178463	-0.255002	0.77 [0.53 - 1.12]
GENE	AK5	adenylate kinase 5	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219308_s_at	34	0.352941	0.0993733	-	-0.670932	0.618248	-0.161959	0.85 [0.45 - 1.61]
GENE	AK5	adenylate kinase 5	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219308_s_at	158	0.481013	0.0109792	0.17318	-0.593402	0.152015	-1.03516	0.36 [0.09 - 1.46]
GENE	AK5	adenylate kinase 5	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219308_s_at	53	0.528302	0.0164067	0.232626	-0.909581	0.10988	-0.286134	0.75 [0.53 - 1.07]
GENE	AK5	adenylate kinase 5	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219308_s_at	53	0.528302	0.0331186	0.37834	-0.741685	0.20475	-0.216466	0.81 [0.58 - 1.13]
GENE	AK5	adenylate kinase 5	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219308_s_at	180	0.766667	0.046594	0.470764	0.465407	0.972484	-0.00464325	1.00 [0.76 - 1.30]
GENE	AK5	adenylate kinase 5	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222862_s_at	180	0.266667	0.0117307	0.18194	-0.54949	0.445578	-0.0788631	0.92 [0.75 - 1.13]
GENE	AK5	adenylate kinase 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222862_s_at	559	0.876565	0.233594	-	0.303484	0.90796	-0.0150437	0.99 [0.76 - 1.27]
GENE	AK5	adenylate kinase 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219308_s_at	559	0.794275	0.00138313	0.0334094	0.651641	0.0594191	0.231741	1.26 [0.99 - 1.60]
GENE	AK5	adenylate kinase 5	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219308_s_at	77	0.896104	0.0199216	0.267204	-1.29377	0.107007	-0.175439	0.84 [0.68 - 1.04]
GENE	AK5	adenylate kinase 5	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222862_s_at	77	0.896104	0.00736814	0.127973	-1.49217	0.712321	-0.0365393	0.96 [0.79 - 1.17]
GENE	AK5	adenylate kinase 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222862_s_at	70	0.2	0.160742	-	-0.469159	0.916644	-0.0143574	0.99 [0.75 - 1.29]
GENE	AK5	adenylate kinase 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219308_s_at	70	0.885714	0.202365	-	-0.54589	0.630531	-0.0836366	0.92 [0.65 - 1.29]
GENE	AK5	adenylate kinase 5	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219308_s_at	74	0.621622	0.0312931	0.364388	0.613661	0.189402	0.14241	1.15 [0.93 - 1.43]
GENE	AK5	adenylate kinase 5	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222862_s_at	74	0.445946	0.0077625	0.133199	0.795888	0.0299312	0.239258	1.27 [1.02 - 1.58]
GENE	AK5	adenylate kinase 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222862_s_at	67	0.104478	0.00642708	0.115155	-1.76648	0.298464	-2.53872	0.08 [0.00 - 9.46]
GENE	AK5	adenylate kinase 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219308_s_at	67	0.835821	0.121513	-	-15.4021	0.279887	-1.99035	0.14 [0.00 - 5.05]
GENE	AK5	adenylate kinase 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222862_s_at	115	0.669565	0.0298206	0.352841	-1.93442	0.104363	-0.569312	0.57 [0.28 - 1.12]
GENE	AK5	adenylate kinase 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219308_s_at	115	0.573913	0.00445571	0.0864141	-2.36051	0.0592651	-0.800412	0.45 [0.20 - 1.03]
GENE	AK5	adenylate kinase 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222862_s_at	204	0.691176	0.0259391	0.321041	-0.332987	0.266642	-0.0584474	0.94 [0.85 - 1.05]
GENE	AK5	adenylate kinase 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219308_s_at	204	0.75	0.00465779	0.0894985	-0.453418	0.0152288	-0.147754	0.86 [0.77 - 0.97]
GENE	AK5	adenylate kinase 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222862_s_at	87	0.494253	0.000428578	0.012419	-1.42557	0.010252	-0.369054	0.69 [0.52 - 0.92]
GENE	AK5	adenylate kinase 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222862_s_at	87	0.494253	0.000428578	0.012419	-1.42557	0.010252	-0.369054	0.69 [0.52 - 0.92]
GENE	AK5	adenylate kinase 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219308_s_at	87	0.586207	0.0115796	0.180194	-1.10712	0.0494926	-0.315486	0.73 [0.53 - 1.00]
GENE	AK5	adenylate kinase 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219308_s_at	87	0.586207	0.0115796	0.180194	-1.10712	0.0494926	-0.315486	0.73 [0.53 - 1.00]
GENE	AK5	adenylate kinase 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219308_s_at	77	0.142857	0.0043378	0.0845975	-1.65736	0.0973146	-0.80572	0.45 [0.17 - 1.16]
GENE	AK5	adenylate kinase 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222862_s_at	77	0.376623	0.0320349	0.370105	-1.15947	0.143864	-0.399568	0.67 [0.39 - 1.15]
GENE	AK5	adenylate kinase 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222862_s_at	77	0.649351	0.0710537	-	-1.69549	0.231292	-0.369887	0.69 [0.38 - 1.27]
GENE	AK5	adenylate kinase 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219308_s_at	77	0.168831	0.0099551	0.160915	-1.36834	0.0714728	-0.730545	0.48 [0.22 - 1.07]
GENE	AK5	adenylate kinase 5	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219308_s_at	136	0.654412	0.205265	-	-0.696749	0.527121	0.151122	1.16 [0.73 - 1.86]
GENE	AK5	adenylate kinase 5	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219308_s_at	200	0.505	0.000388736	0.0114214	-1.13302	0.0242443	-0.369057	0.69 [0.50 - 0.95]
GENE	AK5	adenylate kinase 5	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21967	60	0.25	0.172657	-	-0.553103	0.739343	-0.0637697	0.94 [0.64 - 1.37]
GENE	AK5	adenylate kinase 5	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21967	60	0.483333	0.236574	-	-0.454006	0.738155	0.0681047	1.07 [0.72 - 1.60]
GENE	AK5	adenylate kinase 5	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15171	155	0.122581	6.6551e-05	0.00244399	-1.15309	0.000254046	-0.484884	0.62 [0.47 - 0.80]
GENE	AK5	adenylate kinase 5	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219308_s_at	286	0.741259	0.00706336	0.123877	-0.683093	0.247731	-0.126525	0.88 [0.71 - 1.09]
GENE	AK5	adenylate kinase 5	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219308_s_at	159	0.72327	0.00546538	0.10149	-1.35822	0.025227	-0.445049	0.64 [0.43 - 0.95]
GENE	AK5	adenylate kinase 5	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219308_s_at	159	0.704403	0.00243891	0.0532629	-1.46423	0.00261035	-0.603771	0.55 [0.37 - 0.81]
GENE	AK5	adenylate kinase 5	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219308_s_at	159	0.704403	0.0115201	0.179505	-1.41919	0.0280381	-0.510393	0.60 [0.38 - 0.95]
GENE	AK5	adenylate kinase 5	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222862_s_at	159	0.213836	0.00086798	0.0226257	-1.03039	0.00356396	-0.388531	0.68 [0.52 - 0.88]
GENE	AK5	adenylate kinase 5	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222862_s_at	159	0.213836	0.000426748	0.0123736	-1.08677	0.00206185	-0.41438	0.66 [0.51 - 0.86]
GENE	AK5	adenylate kinase 5	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222862_s_at	159	0.213836	7.59629e-05	0.00274763	-1.36445	0.00293951	-0.468146	0.63 [0.46 - 0.85]
GENE	AK5	adenylate kinase 5	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219308_s_at	54	0.111111	0.000146807	0.00490673	-2.58912	0.0900129	-1.82076	0.16 [0.02 - 1.33]
GENE	AK5	adenylate kinase 5	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219308_s_at	117	0.82906	0.0424967	0.444437	0.706751	0.423785	0.135685	1.15 [0.82 - 1.60]
GENE	AK5	adenylate kinase 5	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219308_s_at	117	0.102564	0.127624	-	-0.743841	0.995034	-0.00144092	1.00 [0.63 - 1.57]
GENE	AK5	adenylate kinase 5	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219308_s_at	117	0.82906	0.0424967	0.444437	0.706751	0.423785	0.135685	1.15 [0.82 - 1.60]
GENE	AK5	adenylate kinase 5	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219308_s_at	117	0.871795	0.00645112	0.115489	1.08643	0.168414	0.242128	1.27 [0.90 - 1.80]
GENE	AK5	adenylate kinase 5	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219308_s_at	236	0.347458	0.0277723	0.336317	-0.587223	0.411544	-0.150337	0.86 [0.60 - 1.23]
GENE	AK5	adenylate kinase 5	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222862_s_at	236	0.605932	0.0621104	-	-0.548061	0.587906	-0.0592203	0.94 [0.76 - 1.17]
GENE	AK5	adenylate kinase 5	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219308_s_at	249	0.35743	0.00228469	0.0505027	-0.637676	0.0763342	-0.250992	0.78 [0.59 - 1.03]
GENE	AK5	adenylate kinase 5	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222862_s_at	249	0.606426	0.040137	0.428613	-0.465449	0.380475	-0.0754713	0.93 [0.78 - 1.10]
GENE	AK5	adenylate kinase 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219308_s_at	125	0.512	0.11048	-	-0.478617	0.532948	-0.1844	0.83 [0.47 - 1.48]
GENE	AK5	adenylate kinase 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219308_s_at	125	0.736	0.0343213	0.387322	-1.10758	0.528613	-0.246243	0.78 [0.36 - 1.68]
GENE	AK5	adenylate kinase 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219308_s_at	54	0.351852	0.0061467	0.111234	-1.64436	0.232653	-0.273872	0.76 [0.48 - 1.19]
GENE	AK5	adenylate kinase 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219308_s_at	62	0.741935	0.0165798	0.234393	-1.65634	0.240224	-0.218924	0.80 [0.56 - 1.16]
GENE	AK5	adenylate kinase 5	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219308_s_at	198	0.69697	0.177309	-	-0.31617	0.932349	-0.00590836	0.99 [0.87 - 1.14]
GENE	AK5	adenylate kinase 5	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219308_s_at	198	0.69697	0.00366142	0.0739187	-0.939524	0.130977	-0.120092	0.89 [0.76 - 1.04]
GENE	AK5	adenylate kinase 5	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219308_s_at	198	0.69697	0.00176578	0.0408883	-1.1351	0.16149	-0.114762	0.89 [0.76 - 1.05]
GENE	AK5	adenylate kinase 5	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219308_s_at	51	0.882353	0.0380387	0.414107	1.68786	0.225059	2.3141	10.12 [0.24 - 425.27]
GENE	AK5	adenylate kinase 5	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219308_s_at	62	0.887097	0.0201579	0.269437	1.4354	0.922214	-0.137513	0.87 [0.06 - 13.77]
GENE	AK5	adenylate kinase 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219308_s_at	177	0.418079	0.0159049	0.227466	0.606931	0.214914	0.800422	2.23 [0.63 - 7.89]
GENE	AK5	adenylate kinase 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222862_s_at	145	0.365517	0.0598142	-	0.741607	0.698915	0.310846	1.36 [0.28 - 6.59]
GENE	AK5	adenylate kinase 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219308_s_at	145	0.57931	0.0321783	0.371202	0.709115	0.202824	1.17402	3.23 [0.53 - 19.70]
GENE	AK5	adenylate kinase 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222862_s_at	177	0.881356	0.360535	-	0.333024	0.901886	-0.0833079	0.92 [0.24 - 3.46]
GENE	AK5	adenylate kinase 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219308_s_at	177	0.474576	0.0257927	0.319801	0.623201	0.145393	1.1011	3.01 [0.68 - 13.24]
GENE	AK5	adenylate kinase 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222862_s_at	177	0.819209	0.0916358	-	-0.592556	0.342912	-0.544926	0.58 [0.19 - 1.79]
GENE	AK5	adenylate kinase 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222862_s_at	226	0.774336	0.000105958	0.00368538	1.05356	0.0346251	0.278125	1.32 [1.02 - 1.71]
GENE	AK5	adenylate kinase 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219308_s_at	226	0.668142	0.0019579	0.0445113	0.857082	0.07319	0.28658	1.33 [0.97 - 1.82]
GENE	AK5	adenylate kinase 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222862_s_at	55	0.309091	0.0554604	-	-0.90017	0.105314	-2.74614	0.06 [0.00 - 1.78]
GENE	AK5	adenylate kinase 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219308_s_at	55	0.581818	0.0132128	0.198677	-1.44369	0.242702	-1.18284	0.31 [0.04 - 2.23]
GENE	AK5	adenylate kinase 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222862_s_at	49	0.469388	0.0943459	-	-0.987933	0.396364	-1.9297	0.15 [0.00 - 12.55]
GENE	AK5	adenylate kinase 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219308_s_at	49	0.55102	0.0309705	0.361881	-1.52176	0.373976	-1.03636	0.35 [0.04 - 3.48]
GENE	AK5	adenylate kinase 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222862_s_at	55	0.509091	0.0139725	0.207	-1.19895	0.0258709	-3.7161	0.02 [0.00 - 0.64]
GENE	AK5	adenylate kinase 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219308_s_at	55	0.490909	0.0514752	-	-0.885792	0.343392	-0.931136	0.39 [0.06 - 2.70]
GENE	AK5	adenylate kinase 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219308_s_at	63	0.111111	0.00805905	0.137077	-1.13782	0.31968	0.155423	1.17 [0.86 - 1.59]
GENE	AK5	adenylate kinase 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222862_s_at	63	0.396825	0.021642	0.283227	-0.761699	0.159948	0.264259	1.30 [0.90 - 1.88]
GENE	AK5	adenylate kinase 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6912231_3p_a_at	28	0.25	0.0183719	0.252282	-1.41629	0.207241	-2.62866	0.07 [0.00 - 4.29]
GENE	AK5	adenylate kinase 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.18268.0.S1_3p_a_at	28	0.892857	0.0998963	-	1.2303	0.354072	0.494697	1.64 [0.58 - 4.67]
GENE	AK5	adenylate kinase 5	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219308_s_at	79	0.202532	0.00404132	0.0799727	-0.853979	0.078723	-0.314231	0.73 [0.51 - 1.04]
GENE	AK5	adenylate kinase 5	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219308_s_at	104	0.153846	0.380112	-	0.461176	0.515361	0.162176	1.18 [0.72 - 1.92]
GENE	AK5	adenylate kinase 5	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P200015	117	0.119658	0.2371	-	0.607943	0.735887	0.0309283	1.03 [0.86 - 1.23]
GENE	AK5	adenylate kinase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222862_s_at	204	0.897059	0.297197	-	-0.75427	0.705851	-0.0742578	0.93 [0.63 - 1.37]
GENE	AK5	adenylate kinase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219308_s_at	204	0.730392	0.0276829	0.335583	0.790622	0.301741	0.25817	1.29 [0.79 - 2.11]
GENE	AK5	adenylate kinase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222862_s_at	204	0.519608	0.015836	0.226752	0.667679	0.130897	0.206145	1.23 [0.94 - 1.61]
GENE	AK5	adenylate kinase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219308_s_at	204	0.642157	0.0985158	-	0.448754	0.439698	0.141737	1.15 [0.80 - 1.65]
GENE	AK5	adenylate kinase 5	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219308_s_at	178	0.331461	0.0193101	0.261373	0.507499	0.127947	0.239423	1.27 [0.93 - 1.73]
GENE	AK5	adenylate kinase 5	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300020542	41	0.463415	0.0948648	-	0.717378	0.672268	0.165615	1.18 [0.55 - 2.54]
GENE	AK5	adenylate kinase 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219308_s_at	111	0.585586	0.0403134	0.429814	0.534316	0.919762	-0.0142863	0.99 [0.75 - 1.30]
GENE	AK5	adenylate kinase 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222862_s_at	111	0.81982	0.24886	-	-0.435548	0.932635	0.014694	1.01 [0.72 - 1.43]
GENE	AK5	adenylate kinase 5	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219308_s_at	90	0.466667	0.0823626	-	-0.644627	0.526261	-0.683612	0.50 [0.06 - 4.18]
GENE	AK5	adenylate kinase 5	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219308_s_at	90	0.466667	0.0545191	-	-0.622545	0.278962	-1.02127	0.36 [0.06 - 2.29]
GENE	AK5	adenylate kinase 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219308_s_at	138	0.173913	0.0187095	0.255574	-0.638392	0.0265608	1.01232	2.75 [1.12 - 6.73]
GENE	AK5	adenylate kinase 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222862_s_at	138	0.884058	0.00467912	0.089822	0.856619	0.0318874	1.65232	5.22 [1.15 - 23.61]
GENE	AK5	adenylate kinase 5	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219308_s_at	129	0.364341	0.170053	-	0.372329	0.972844	0.00842379	1.01 [0.62 - 1.64]
GENE	AK5	adenylate kinase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37432	56	0.535714	0.00848066	0.142516	0.898842	0.0520223	0.319638	1.38 [1.00 - 1.90]
GENE	AK5	adenylate kinase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15663	56	0.660714	0.221559	-	-0.47112	0.95408	0.0427573	1.04 [0.24 - 4.47]
GENE	AK5	adenylate kinase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37432	56	0.535714	0.00450653	0.0871931	1.05165	0.0280958	0.396019	1.49 [1.04 - 2.12]
GENE	AK5	adenylate kinase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1001	56	0.232143	0.0128337	0.194461	1.17109	0.0979189	0.291171	1.34 [0.95 - 1.89]
GENE	AK5	adenylate kinase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15663	56	0.571429	0.0936179	-	-0.617441	0.620809	-0.37173	0.69 [0.16 - 3.01]
GENE	AK5	adenylate kinase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1001	56	0.232143	0.0126176	0.192038	1.28197	0.0746744	0.343739	1.41 [0.97 - 2.06]
GENE	AK5	adenylate kinase 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222862_s_at	278	0.845324	1.96326e-05	0.00082144	0.917034	0.0108841	0.541658	1.72 [1.13 - 2.61]
GENE	AK5	adenylate kinase 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219308_s_at	278	0.758993	0.00380868	0.0762831	0.585556	0.00651078	0.534574	1.71 [1.16 - 2.51]
GENE	AK5	adenylate kinase 5	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219308_s_at	133	0.699248	0.00299986	0.0629879	0.721534	0.0289497	1.78097	5.94 [1.20 - 29.35]
GENE	AK5	adenylate kinase 5	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219308_s_at	185	0.378378	0.00148803	0.035498	0.606545	0.170336	0.345851	1.41 [0.86 - 2.32]
GENE	AK5	adenylate kinase 5	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219308_s_at	185	0.291892	0.0022673	0.0501888	0.562628	0.219443	0.283314	1.33 [0.84 - 2.09]
GENE	AK5	adenylate kinase 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P200015	110	0.545455	0.236551	-	0.275564	0.718697	0.0231969	1.02 [0.90 - 1.16]
GENE	AK5	adenylate kinase 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P342632	110	0.509091	0.0214744	0.28169	-0.709767	0.186966	-0.240281	0.79 [0.55 - 1.12]
GENE	AK5	adenylate kinase 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P200015	110	0.8	0.206176	-	-0.548069	0.561927	-0.0507608	0.95 [0.80 - 1.13]
GENE	AK5	adenylate kinase 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P342632	110	0.427273	0.0563493	-	-0.438628	0.202402	-0.183363	0.83 [0.63 - 1.10]
GENE	AK5	adenylate kinase 5	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219308_s_at	80	0.1375	0.049412	0.488085	-0.990103	0.305915	-0.194416	0.82 [0.57 - 1.19]
GENE	AK5	adenylate kinase 5	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:728079	59	0.830508	0.311472	-	0.534958	0.353928	0.830482	2.29 [0.40 - 13.28]
GENE	AK5	adenylate kinase 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219308_s_at	38	0.763158	0.00327576	0.0676111	1.32779	0.0742123	1.00154	2.72 [0.91 - 8.18]
GENE	AK5	adenylate kinase 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222862_s_at	38	0.763158	5.05778e-05	0.00191546	1.85695	0.0101533	0.547833	1.73 [1.14 - 2.63]
GENE	AK5	adenylate kinase 5	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219308_s_at	140	0.621429	0.0271545	0.331222	0.628459	0.347649	0.671924	1.96 [0.48 - 7.96]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AK7	adenylate kinase 7	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1684305	165	0.478788	0.0604884	-	-0.452092	0.393502	-0.46532	0.63 [0.22 - 1.83]
GENE	AK7	adenylate kinase 7	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1684305	165	0.478788	0.018891	0.257334	-0.849743	0.830489	-0.175654	0.84 [0.17 - 4.19]
GENE	AK7	adenylate kinase 7	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	241326_at	163	0.349693	0.0359553	0.399273	-0.423837	0.380164	-0.881175	0.41 [0.06 - 2.96]
GENE	AK7	adenylate kinase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1569699_at	79	0.341772	0.0286956	0.343834	-0.647947	0.151762	-1.0466	0.35 [0.08 - 1.47]
GENE	AK7	adenylate kinase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1569700_s_at	79	0.240506	0.0520252	-	-0.613771	0.0902634	-1.28279	0.28 [0.06 - 1.22]
GENE	AK7	adenylate kinase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1553734_at	79	0.151899	0.0596275	-	-0.691707	0.114355	-0.864429	0.42 [0.14 - 1.23]
GENE	AK7	adenylate kinase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	241326_at	79	0.772152	0.0544347	-	0.605696	0.557024	-0.498761	0.61 [0.11 - 3.21]
GENE	AK7	adenylate kinase 7	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	241326_at	180	0.227778	0.0920968	-	-0.401049	0.413393	-0.109225	0.90 [0.69 - 1.16]
GENE	AK7	adenylate kinase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	241326_at	559	0.880143	0.0655569	-	0.486171	0.335373	0.121769	1.13 [0.88 - 1.45]
GENE	AK7	adenylate kinase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1569699_at	559	0.701252	0.0687702	-	-0.429478	0.229838	-0.193427	0.82 [0.60 - 1.13]
GENE	AK7	adenylate kinase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1569700_s_at	559	0.352415	0.120491	-	0.368797	0.889699	-0.0233233	0.98 [0.70 - 1.36]
GENE	AK7	adenylate kinase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1553734_at	559	0.225403	0.0314688	0.365748	0.781575	0.162908	0.176296	1.19 [0.93 - 1.53]
GENE	AK7	adenylate kinase 7	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	241326_at	77	0.688312	0.0770766	-	-0.509634	0.621994	-0.115034	0.89 [0.56 - 1.41]
GENE	AK7	adenylate kinase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1569699_at	70	0.4	0.136347	-	-0.394925	0.204327	-1.18069	0.31 [0.05 - 1.90]
GENE	AK7	adenylate kinase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1569700_s_at	70	0.257143	0.194901	-	-0.380519	0.983766	0.0199759	1.02 [0.15 - 6.99]
GENE	AK7	adenylate kinase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1553734_at	70	0.2	0.0454662	0.463657	-0.621605	0.984472	-0.0106976	0.99 [0.34 - 2.91]
GENE	AK7	adenylate kinase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	241326_at	70	0.628571	0.349957	-	0.252683	0.814248	0.244564	1.28 [0.17 - 9.82]
GENE	AK7	adenylate kinase 7	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	241326_at	74	0.891892	0.000245958	0.00769302	1.35815	0.764854	0.104357	1.11 [0.56 - 2.20]
GENE	AK7	adenylate kinase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1553734_at	67	0.223881	0.119453	-	15.4274	0.451528	1.71528	5.56 [0.06 - 483.38]
GENE	AK7	adenylate kinase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1569699_at	67	0.104478	0.00167801	0.0392055	-2.48287	0.378384	-2.50649	0.08 [0.00 - 21.55]
GENE	AK7	adenylate kinase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1569700_s_at	67	0.328358	0.0644352	-	-1.18429	0.673839	-0.754771	0.47 [0.01 - 15.80]
GENE	AK7	adenylate kinase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	241326_at	67	0.671642	0.0309035	0.361358	-15.6937	0.238611	-3.27255	0.04 [0.00 - 8.76]
GENE	AK7	adenylate kinase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	241326_at	115	0.434783	0.0182481	0.251068	1.61858	0.280804	0.586939	1.80 [0.62 - 5.23]
GENE	AK7	adenylate kinase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1569699_at	115	0.452174	0.0576578	-	1.16799	0.239227	1.07201	2.92 [0.49 - 17.41]
GENE	AK7	adenylate kinase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1569700_s_at	115	0.817391	0.246791	-	-1.13981	0.941422	-0.0981495	0.91 [0.07 - 12.43]
GENE	AK7	adenylate kinase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1553734_at	115	0.452174	0.037291	0.408834	-1.16489	0.132226	-0.437598	0.65 [0.37 - 1.14]
GENE	AK7	adenylate kinase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1553734_at	204	0.79902	0.152005	-	-0.250784	0.279633	-0.0605363	0.94 [0.84 - 1.05]
GENE	AK7	adenylate kinase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	241326_at	204	0.897059	0.317214	-	-0.231487	0.776367	-0.0220759	0.98 [0.84 - 1.14]
GENE	AK7	adenylate kinase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1569699_at	204	0.897059	0.00615396	0.111337	-0.630358	0.779191	-0.0184365	0.98 [0.86 - 1.12]
GENE	AK7	adenylate kinase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1569700_s_at	204	0.161765	0.0464083	0.469601	-0.381411	0.632823	-0.0342966	0.97 [0.84 - 1.11]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	241326_at	87	0.678161	0.00916081	0.151119	0.951694	0.102279	1.63808	5.15 [0.72 - 36.71]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1569699_at	87	0.264368	0.223527	-	0.592222	0.740848	0.302725	1.35 [0.23 - 8.14]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1569699_at	87	0.264368	0.223527	-	0.592222	0.740848	0.302725	1.35 [0.23 - 8.14]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1569700_s_at	87	0.666667	0.0352368	0.394054	0.776837	0.263285	0.734042	2.08 [0.58 - 7.54]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1569700_s_at	87	0.666667	0.0352368	0.394054	0.776837	0.263285	0.734042	2.08 [0.58 - 7.54]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1553734_at	87	0.896552	0.00027681	0.0085223	1.50396	0.0336272	0.651498	1.92 [1.05 - 3.50]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1553734_at	87	0.896552	0.00027681	0.0085223	1.50396	0.0336272	0.651498	1.92 [1.05 - 3.50]
GENE	AK7	adenylate kinase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	241326_at	87	0.678161	0.00916081	0.151119	0.951694	0.102279	1.63808	5.15 [0.72 - 36.71]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	241326_at	77	0.584416	0.1055	-	0.893409	0.673163	0.610045	1.84 [0.11 - 31.33]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569699_at	77	0.857143	0.00389221	0.0776144	1.50183	0.706009	0.379954	1.46 [0.20 - 10.53]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569700_s_at	77	0.415584	0.1174	-	-0.866011	0.982057	-0.0334215	0.97 [0.05 - 17.80]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553734_at	77	0.12987	0.00216942	0.0484123	-1.58569	0.0241042	-3.03558	0.05 [0.00 - 0.67]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	241326_at	77	0.584416	0.218742	-	0.774665	0.980661	0.0418613	1.04 [0.04 - 30.77]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569699_at	77	0.857143	0.120977	-	1.02483	0.755705	-0.367853	0.69 [0.07 - 7.03]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569700_s_at	77	0.415584	0.0461604	0.468044	-1.28646	0.561541	-0.964509	0.38 [0.01 - 9.89]
GENE	AK7	adenylate kinase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553734_at	77	0.493506	0.0332981	0.379691	-1.53055	0.0400107	-3.20887	0.04 [0.00 - 0.86]
GENE	AK7	adenylate kinase 7	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3719	60	0.833333	0.0120312	0.18539	1.07372	0.436443	0.358858	1.43 [0.58 - 3.53]
GENE	AK7	adenylate kinase 7	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3719	60	0.116667	0.00119434	0.0295675	-1.33699	0.0655284	-0.935074	0.39 [0.15 - 1.06]
GENE	AK7	adenylate kinase 7	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241326_at	159	0.748428	0.0250702	0.313631	0.823085	0.250128	0.43678	1.55 [0.74 - 3.26]
GENE	AK7	adenylate kinase 7	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241326_at	159	0.742138	0.0463539	0.469259	0.64116	0.357027	0.285925	1.33 [0.72 - 2.45]
GENE	AK7	adenylate kinase 7	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241326_at	159	0.716981	0.101862	-	0.528428	0.238439	0.376701	1.46 [0.78 - 2.73]
GENE	AK7	adenylate kinase 7	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	241326_at	236	0.682203	0.0566258	-	-0.63166	0.647643	-0.14069	0.87 [0.48 - 1.59]
GENE	AK7	adenylate kinase 7	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	241326_at	249	0.86747	0.0825464	-	-0.670278	0.62604	-0.12269	0.88 [0.54 - 1.45]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1569699_at	177	0.621469	0.0563095	-	-0.482618	0.44497	-0.321272	0.73 [0.32 - 1.65]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	241326_at	177	0.367232	0.112545	-	0.469243	0.599917	0.450681	1.57 [0.29 - 8.46]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1569699_at	177	0.248588	0.298369	-	0.350021	0.852026	-0.0893903	0.91 [0.36 - 2.34]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1569700_s_at	177	0.581921	0.0120827	0.185979	-0.638491	0.483	-0.447854	0.64 [0.18 - 2.23]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1553734_at	177	0.531073	0.0746632	-	-0.429199	0.644992	-0.1797	0.84 [0.39 - 1.79]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1569700_s_at	177	0.581921	0.182337	-	-0.376137	0.920497	0.0703538	1.07 [0.27 - 4.27]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	241326_at	177	0.367232	0.0496673	0.489624	0.504073	0.533208	0.463672	1.59 [0.37 - 6.84]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1553734_at	177	0.610169	0.345362	-	-0.266892	0.881867	-0.0663208	0.94 [0.39 - 2.24]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1569699_at	145	0.875862	0.200296	-	0.568105	0.797993	0.152519	1.16 [0.36 - 3.75]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1569700_s_at	145	0.455172	0.100839	-	-0.547909	0.854268	-0.157432	0.85 [0.16 - 4.58]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1553734_at	145	0.117241	0.147296	-	1.01189	0.255108	0.611356	1.84 [0.64 - 5.28]
GENE	AK7	adenylate kinase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	241326_at	145	0.710345	0.231035	-	-0.47689	0.972749	0.035694	1.04 [0.13 - 8.03]
GENE	AK7	adenylate kinase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1569699_at	226	0.707965	0.054897	-	-0.725882	0.194323	-0.238254	0.79 [0.55 - 1.13]
GENE	AK7	adenylate kinase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1569700_s_at	226	0.876106	0.0157839	0.226212	0.808046	0.353839	0.112476	1.12 [0.88 - 1.42]
GENE	AK7	adenylate kinase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1553734_at	226	0.163717	0.102881	-	0.82778	0.350037	0.119088	1.13 [0.88 - 1.45]
GENE	AK7	adenylate kinase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	241326_at	226	0.588496	0.0159815	0.228257	-0.759224	0.227765	-0.291893	0.75 [0.46 - 1.20]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1569699_at	55	0.363636	0.000239429	0.00751555	-1.57682	0.0834367	-1.97509	0.14 [0.01 - 1.30]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1569700_s_at	55	0.4	0.152111	-	0.686432	0.933611	-0.135726	0.87 [0.04 - 21.28]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1553734_at	55	0.563636	0.0298065	0.352729	-1.07337	0.0972763	-1.53899	0.21 [0.03 - 1.32]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	241326_at	55	0.472727	0.0658009	-	-0.839139	0.610072	-0.87224	0.42 [0.01 - 11.94]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	241326_at	55	0.672727	0.0801404	-	0.835681	0.372517	1.57458	4.83 [0.15 - 153.75]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1569699_at	55	0.872727	0.0630547	-	-15.288	0.198131	-1.51204	0.22 [0.02 - 2.21]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1569700_s_at	55	0.109091	0.243017	-	-0.597645	0.644797	-0.850258	0.43 [0.01 - 15.87]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1553734_at	55	0.109091	0.00233157	0.051346	-1.49128	0.0481845	-2.14673	0.12 [0.01 - 0.98]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	241326_at	49	0.204082	0.0922805	-	-0.956824	0.326281	-2.15696	0.12 [0.00 - 8.58]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1569699_at	49	0.285714	0.00270876	0.0579994	-1.65089	0.133403	-2.27169	0.10 [0.01 - 2.00]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1569700_s_at	49	0.102041	0.222493	-	-0.794113	0.622186	-1.04413	0.35 [0.01 - 22.40]
GENE	AK7	adenylate kinase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1553734_at	49	0.510204	0.180236	-	-0.80149	0.42183	-0.97349	0.38 [0.04 - 4.06]
GENE	AK7	adenylate kinase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1569699_at	63	0.111111	0.0029868	0.0627666	-1.22278	0.161749	-12.8186	0.00 [0.00 - 170.31]
GENE	AK7	adenylate kinase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1569700_s_at	63	0.253968	0.0116049	0.180488	-0.862366	0.779654	-1.7286	0.18 [0.00 - 32259.69]
GENE	AK7	adenylate kinase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1553734_at	63	0.619048	0.00189252	0.0432873	-1.23903	0.0281992	-14.033	0.00 [0.00 - 0.22]
GENE	AK7	adenylate kinase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	241326_at	63	0.206349	0.000147285	0.00492071	-1.31078	0.815186	-0.678584	0.51 [0.00 - 150.14]
GENE	AK7	adenylate kinase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.330253.1.S1_3p_s_at	28	0.714286	0.0499211	0.49115	-1.42805	0.204362	-11.9214	0.00 [0.00 - 657.36]
GENE	AK7	adenylate kinase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.143883.0.A1_3p_s_at	28	0.642857	0.116773	-	-1.00635	0.22588	-6.48975	0.00 [0.00 - 55.34]
GENE	AK7	adenylate kinase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.143883.1.S1_3p_at	28	0.285714	0.0191692	0.260019	-1.31879	0.329097	-0.850083	0.43 [0.08 - 2.36]
GENE	AK7	adenylate kinase 7	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P105963	117	0.145299	0.0395951	0.424907	-0.69342	0.674877	-0.0436787	0.96 [0.78 - 1.17]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	241326_at	204	0.343137	0.00389417	0.0776454	-0.768308	0.0259243	-0.379682	0.68 [0.49 - 0.96]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1569699_at	204	0.446078	0.0388416	0.419708	0.596506	0.285564	0.180427	1.20 [0.86 - 1.67]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1569700_s_at	204	0.823529	0.0181816	0.250415	0.703618	0.509024	-0.123737	0.88 [0.61 - 1.28]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1553734_at	204	0.112745	6.80566e-05	0.00249291	-1.23244	0.0249365	-0.348969	0.71 [0.52 - 0.96]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	241326_at	204	0.838235	0.010549	0.168075	-15.3192	0.155858	-0.338848	0.71 [0.45 - 1.14]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1569699_at	204	0.397059	0.065148	-	0.776776	0.211194	0.297863	1.35 [0.84 - 2.15]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1569700_s_at	204	0.661765	0.00164604	0.038588	1.1154	0.4284	0.25648	1.29 [0.69 - 2.44]
GENE	AK7	adenylate kinase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1553734_at	204	0.112745	0.0003861	0.0113548	-1.36654	0.0690281	-0.370612	0.69 [0.46 - 1.03]
GENE	AK7	adenylate kinase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	241326_at	111	0.117117	0.196302	-	0.659508	0.821779	0.0593467	1.06 [0.63 - 1.78]
GENE	AK7	adenylate kinase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1569699_at	111	0.810811	0.136349	-	0.454815	0.867423	0.0433756	1.04 [0.63 - 1.74]
GENE	AK7	adenylate kinase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1569700_s_at	111	0.117117	0.0105125	0.167639	-0.813421	0.665511	0.0756475	1.08 [0.77 - 1.52]
GENE	AK7	adenylate kinase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1553734_at	111	0.36036	0.0432411	0.449326	-0.533303	0.285297	-0.153018	0.86 [0.65 - 1.14]
GENE	AK7	adenylate kinase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	241326_at	138	0.15942	0.023652	0.301286	-0.623363	0.328162	-4.13347	0.02 [0.00 - 63.55]
GENE	AK7	adenylate kinase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1569699_at	138	0.15942	0.00974689	0.158372	-0.713763	0.411845	-2.89621	0.06 [0.00 - 55.75]
GENE	AK7	adenylate kinase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1569700_s_at	138	0.442029	0.00461849	0.0889014	-0.679488	0.204681	-3.71474	0.02 [0.00 - 7.58]
GENE	AK7	adenylate kinase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1553734_at	138	0.152174	0.0961232	-	-0.507893	0.70661	0.0908471	1.10 [0.68 - 1.76]
GENE	AK7	adenylate kinase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14469	56	0.732143	0.00188258	0.0431004	1.1321	0.0884969	0.373759	1.45 [0.95 - 2.23]
GENE	AK7	adenylate kinase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14469	56	0.678571	0.0152732	0.220882	0.813218	0.180967	0.273939	1.32 [0.88 - 1.96]
GENE	AK7	adenylate kinase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1553734_at	278	0.453237	2.78803e-05	0.00112546	-0.782771	0.000421661	-0.485612	0.62 [0.47 - 0.81]
GENE	AK7	adenylate kinase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	241326_at	278	0.863309	0.00278794	0.0593682	-1.1116	0.00614156	-1.10068	0.33 [0.15 - 0.73]
GENE	AK7	adenylate kinase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1569699_at	278	0.194245	0.181277	-	0.341928	0.701666	0.135125	1.14 [0.57 - 2.29]
GENE	AK7	adenylate kinase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1569700_s_at	278	0.205036	0.168496	-	-0.294987	0.937704	-0.0353177	0.97 [0.40 - 2.34]
GENE	AK7	adenylate kinase 7	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P105963	110	0.7	0.00173875	0.040372	-1.30142	0.0130614	-0.34894	0.71 [0.54 - 0.93]
GENE	AK7	adenylate kinase 7	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P105963	110	0.418182	0.000647785	0.0176663	-0.776204	0.00620482	-0.270546	0.76 [0.63 - 0.93]
GENE	AK7	adenylate kinase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	241326_at	38	0.657895	0.0927155	-	-0.838656	0.740614	0.126714	1.14 [0.54 - 2.40]
GENE	AK7	adenylate kinase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1569699_at	38	0.868421	0.000830099	0.0217907	1.68671	0.884298	0.0888914	1.09 [0.33 - 3.62]
GENE	AK7	adenylate kinase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1569700_s_at	38	0.842105	0.0391897	0.422116	-1.86464	0.290479	-0.477749	0.62 [0.26 - 1.50]
GENE	AK7	adenylate kinase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1553734_at	38	0.473684	0.000588785	0.0162891	-1.62967	0.12752	-0.395752	0.67 [0.40 - 1.12]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201900_s_at	30	0.766667	0.0522844	-	0.919433	0.824164	0.14464	1.16 [0.32 - 4.14]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1728047	165	0.793939	0.000538872	0.0151052	0.878331	0.0413838	0.609021	1.84 [1.02 - 3.30]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1728047	165	0.781818	0.0106186	0.168905	0.904709	0.0716714	0.798141	2.22 [0.93 - 5.29]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201900_s_at	163	0.515337	0.0187788	0.256247	0.463506	0.2157	0.199262	1.22 [0.89 - 1.67]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	241978_at	163	0.490798	0.0574058	-	0.375726	0.156967	1.02709	2.79 [0.67 - 11.58]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	241978_at	79	0.860759	0.00995651	0.160932	0.895224	0.288083	1.03148	2.81 [0.42 - 18.81]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201900_s_at	79	0.708861	0.020881	0.276207	0.689518	0.113218	0.353248	1.42 [0.92 - 2.20]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201900_s_at	58	0.706897	0.0210935	0.278178	0.673936	0.124002	0.546141	1.73 [0.86 - 3.46]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201900_s_at	34	0.117647	0.128951	-	1.06847	0.462556	0.312304	1.37 [0.59 - 3.14]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201900_s_at	158	0.398734	0.0211436	0.278642	-0.529952	0.104697	-0.493625	0.61 [0.34 - 1.11]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201900_s_at	53	0.886792	0.0495568	0.488959	-1.76509	0.953906	-0.0348901	0.97 [0.30 - 3.15]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201900_s_at	53	0.207547	0.0546755	-	0.987163	0.804987	0.138879	1.15 [0.38 - 3.46]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201900_s_at	180	0.65	0.00152937	0.0363127	0.661015	0.0621383	0.607999	1.84 [0.97 - 3.48]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	241978_at	180	0.455556	0.039624	0.425106	0.439037	0.147057	0.470202	1.60 [0.85 - 3.02]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	241978_at	559	0.105546	0.156115	-	0.639869	0.801877	0.082546	1.09 [0.57 - 2.07]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201900_s_at	559	0.633274	0.00932985	0.153225	-0.628386	0.0269754	-0.67308	0.51 [0.28 - 0.93]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201900_s_at	77	0.38961	0.0159466	0.227897	0.658228	0.122098	0.715605	2.05 [0.83 - 5.07]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	241978_at	77	0.428571	0.110372	-	-0.425574	0.984205	0.00745047	1.01 [0.48 - 2.11]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	241978_at	70	0.842857	0.0538396	-	-0.815172	0.217259	-1.04829	0.35 [0.07 - 1.85]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201900_s_at	70	0.885714	0.132317	-	-0.762795	0.835683	-0.066644	0.94 [0.50 - 1.76]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38780_at	50	0.6	0.115989	-	0.56142	0.239788	0.344202	1.41 [0.79 - 2.50]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201900_s_at	74	0.189189	0.0645465	-	0.788591	0.218059	0.665222	1.94 [0.67 - 5.61]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	241978_at	74	0.851351	0.131893	-	-0.700996	0.500586	-0.370698	0.69 [0.23 - 2.03]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201900_s_at	67	0.283582	0.0814081	-	-1.11995	0.458504	-0.749834	0.47 [0.07 - 3.43]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	241978_at	67	0.179104	0.00963299	0.156973	-1.586	0.305467	-1.9667	0.14 [0.00 - 6.02]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201900_s_at	115	0.843478	0.00167914	0.0392273	1.53736	0.908148	-0.0891643	0.91 [0.20 - 4.16]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	241978_at	115	0.347826	0.0219612	0.286142	2.01497	0.0496013	2.37387	10.74 [1.00 - 114.85]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38780_at	158	0.297468	0.0797416	-	-0.510605	0.891809	-0.0561344	0.95 [0.42 - 2.12]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38780_at	76	0.118421	0.0182968	0.251546	-1.29495	0.214472	-1.17425	0.31 [0.05 - 1.97]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201900_s_at	204	0.156863	0.101925	-	-0.317926	0.927529	-0.0163892	0.98 [0.69 - 1.40]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	241978_at	204	0.519608	0.0708276	-	-0.259475	0.568516	-0.0875103	0.92 [0.68 - 1.24]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	241978_at	87	0.252874	0.144714	-	0.706338	0.395213	0.606436	1.83 [0.45 - 7.42]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	241978_at	87	0.252874	0.144714	-	0.706338	0.395213	0.606436	1.83 [0.45 - 7.42]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201900_s_at	87	0.103448	0.0508814	-	-0.940122	0.287577	-0.486966	0.61 [0.25 - 1.51]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201900_s_at	87	0.103448	0.0508814	-	-0.940122	0.287577	-0.486966	0.61 [0.25 - 1.51]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201900_s_at	77	0.142857	0.135917	-	15.2541	0.769939	0.170357	1.19 [0.38 - 3.71]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	241978_at	77	0.220779	0.0718573	-	15.4593	0.381692	1.45553	4.29 [0.16 - 111.80]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201900_s_at	77	0.181818	0.129038	-	15.335	0.789631	0.17711	1.19 [0.32 - 4.39]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	241978_at	77	0.597403	0.0121273	0.186487	1.39651	0.124656	2.32231	10.20 [0.53 - 197.67]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201900_s_at	136	0.117647	0.00455402	0.0879191	-1.3948	0.75381	-0.184059	0.83 [0.26 - 2.63]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201900_s_at	200	0.23	0.0811441	-	-0.538794	0.269819	-0.496953	0.61 [0.25 - 1.47]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12047	60	0.783333	0.174721	-	0.563869	0.918048	0.058139	1.06 [0.35 - 3.21]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12047	60	0.133333	0.245504	-	0.827585	0.839109	0.168312	1.18 [0.23 - 6.01]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17192	155	0.593548	0.101538	-	0.447153	0.776274	-0.0631519	0.94 [0.61 - 1.45]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201900_s_at	286	0.412587	0.0447062	0.458809	-0.386461	0.791674	-0.0860443	0.92 [0.48 - 1.74]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201900_s_at	159	0.899371	0.0280676	0.338733	0.885917	0.370242	0.365	1.44 [0.65 - 3.20]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201900_s_at	159	0.157233	0.0687587	-	-0.653279	0.583694	0.228621	1.26 [0.55 - 2.85]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201900_s_at	159	0.899371	0.0121827	0.187118	1.09533	0.280704	0.508063	1.66 [0.66 - 4.18]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241978_at	159	0.471698	0.07529	-	0.699641	0.800414	0.180014	1.20 [0.30 - 4.83]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241978_at	159	0.100629	0.00899396	0.149027	-0.99342	0.155996	-0.792201	0.45 [0.15 - 1.35]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241978_at	159	0.471698	0.166366	-	0.448292	0.512899	0.369801	1.45 [0.48 - 4.38]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201900_s_at	54	0.425926	0.177235	-	1.05174	0.64653	0.3365	1.40 [0.33 - 5.90]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201900_s_at	117	0.102564	0.13368	-	1.04179	0.445675	0.304326	1.36 [0.62 - 2.96]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201900_s_at	117	0.102564	0.331155	-	0.699435	0.758898	0.145131	1.16 [0.46 - 2.92]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201900_s_at	117	0.435897	0.310249	-	-0.400332	0.830589	-0.104326	0.90 [0.35 - 2.34]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201900_s_at	117	0.102564	0.13368	-	1.04179	0.445675	0.304326	1.36 [0.62 - 2.96]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201900_s_at	236	0.614407	0.0814753	-	0.465842	0.491342	0.282128	1.33 [0.59 - 2.96]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	241978_at	236	0.487288	0.00850236	0.142794	0.73119	0.119151	0.809253	2.25 [0.81 - 6.22]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201900_s_at	249	0.899598	0.0117178	0.181792	0.741523	0.091827	0.526909	1.69 [0.92 - 3.13]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	241978_at	249	0.654619	0.1049	-	0.35152	0.377652	0.356627	1.43 [0.65 - 3.15]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201900_s_at	125	0.896	0.0827407	-	0.633408	0.966291	-0.0125722	0.99 [0.55 - 1.77]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201900_s_at	54	0.111111	0.0258541	0.320322	-1.41991	0.422062	-0.439622	0.64 [0.22 - 1.88]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201900_s_at	62	0.112903	0.214838	-	-0.774687	0.389842	-0.378177	0.69 [0.29 - 1.62]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201900_s_at	125	0.112	0.0538489	-	15.2142	0.777585	0.10794	1.11 [0.53 - 2.36]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201900_s_at	198	0.535354	0.028245	0.34018	-0.47756	0.365927	-0.190742	0.83 [0.55 - 1.25]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201900_s_at	198	0.747475	0.150486	-	-0.475435	0.561824	-0.14781	0.86 [0.52 - 1.42]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201900_s_at	198	0.888889	0.12971	-	-0.87215	0.604066	-0.137798	0.87 [0.52 - 1.47]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201900_s_at	62	0.112903	0.0829782	-	-1.10096	0.500905	-0.504622	0.60 [0.14 - 2.62]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201900_s_at	51	0.117647	0.0206202	0.273777	-1.85388	0.223547	-1.28225	0.28 [0.04 - 2.19]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	241978_at	177	0.310734	0.0101015	0.162693	-0.694729	0.461119	-0.613008	0.54 [0.11 - 2.77]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201900_s_at	145	0.241379	0.0128787	0.194964	-0.828079	0.0565266	-0.980758	0.38 [0.14 - 1.03]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	241978_at	177	0.310734	0.00605816	0.109986	-0.645725	0.536157	-0.44565	0.64 [0.16 - 2.63]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201900_s_at	177	0.20904	0.198947	-	-0.387831	0.484862	-0.286721	0.75 [0.34 - 1.68]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	241978_at	145	0.827586	0.148824	-	-0.847216	0.898537	-0.126529	0.88 [0.13 - 6.16]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201900_s_at	177	0.163842	0.0534715	-	-0.52953	0.335701	-0.34216	0.71 [0.35 - 1.43]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201900_s_at	226	0.610619	0.000343033	0.0102562	-1.23934	0.0172038	-0.827705	0.44 [0.22 - 0.86]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	241978_at	226	0.190265	0.0475106	0.476466	0.992366	0.311249	0.368332	1.45 [0.71 - 2.95]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201900_s_at	49	0.571429	0.0538555	-	1.1302	0.360039	0.911849	2.49 [0.35 - 17.54]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	241978_at	55	0.4	0.0331123	0.378292	-1.00003	0.207213	-2.48953	0.08 [0.00 - 3.97]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	241978_at	55	0.4	0.067594	-	-0.801381	0.571741	-1.03649	0.35 [0.01 - 12.88]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	241978_at	49	0.387755	0.119655	-	-0.883442	0.510925	-1.51864	0.22 [0.00 - 20.27]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201900_s_at	55	0.527273	0.00802971	0.136695	1.22834	0.162179	0.914053	2.49 [0.69 - 8.99]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201900_s_at	55	0.763636	0.135721	-	0.717184	0.582406	0.385958	1.47 [0.37 - 5.82]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	241978_at	63	0.603175	0.00489357	0.0930532	-1.08206	0.180514	-1.80486	0.16 [0.01 - 2.31]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201900_s_at	63	0.206349	0.174702	-	-0.520932	0.718407	-0.0891109	0.91 [0.56 - 1.48]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5174390_3p_a_at	28	0.357143	0.168822	-	-0.723107	0.758921	-0.0998188	0.91 [0.48 - 1.71]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.186939.0.S1_3p_at	28	0.25	0.0468457	0.472336	-1.13531	0.584737	-5.01523	0.01 [0.00 - 430359.42]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201900_s_at	82	0.390244	0.00763448	0.131511	-0.879233	0.0392893	-1.04327	0.35 [0.13 - 0.95]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38780_at	84	0.833333	0.122055	-	-0.664862	0.556977	0.235013	1.26 [0.58 - 2.77]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201900_s_at	79	0.810127	0.274724	-	-0.376958	0.501845	-0.376963	0.69 [0.23 - 2.06]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	J04794_at	86	0.581395	0.00934608	0.153427	-1.32653	0.041389	-1.84411	0.16 [0.03 - 0.93]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201900_s_at	104	0.355769	0.119728	-	-0.501976	0.594408	-0.261283	0.77 [0.29 - 2.01]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P79750	117	0.880342	0.0103045	0.165144	0.884457	0.292288	0.411063	1.51 [0.70 - 3.24]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P79755	117	0.888889	0.0914479	-	0.642755	0.680121	0.109781	1.12 [0.66 - 1.88]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201900_s_at	204	0.20098	0.00421809	0.0827403	15.3928	0.0279994	1.66515	5.29 [1.20 - 23.35]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201900_s_at	204	0.259804	0.000392571	0.0115181	1.64976	0.00157161	1.76911	5.87 [1.96 - 17.57]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	241978_at	204	0.137255	0.0930134	-	1.54909	0.311092	0.695841	2.01 [0.52 - 7.71]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	241978_at	204	0.127451	0.0115412	0.179749	2.12608	0.356095	0.461848	1.59 [0.60 - 4.23]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201900_s_at	178	0.134831	0.141739	-	0.485113	0.958202	0.0201998	1.02 [0.48 - 2.17]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300019715	41	0.463415	0.00149568	0.0356491	1.41693	0.133705	0.482131	1.62 [0.86 - 3.04]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201900_s_at	111	0.756757	0.173072	-	-0.438548	0.516072	-0.248709	0.78 [0.37 - 1.65]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	241978_at	111	0.864865	0.0792575	-	-0.803313	0.580219	-0.179706	0.84 [0.44 - 1.58]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201900_s_at	90	0.888889	0.248714	-	0.508098	0.640868	0.207747	1.23 [0.51 - 2.95]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201900_s_at	90	0.6	0.296906	-	0.385301	0.820228	0.115311	1.12 [0.42 - 3.03]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201900_s_at	138	0.869565	0.211697	-	-0.497234	0.924357	-0.0209784	0.98 [0.64 - 1.51]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	241978_at	138	0.210145	0.0625261	-	-0.498203	0.748971	-0.268489	0.76 [0.15 - 3.96]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201900_s_at	129	0.449612	0.00389491	0.0776573	-0.714225	0.47588	-0.30051	0.74 [0.32 - 1.69]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18907	56	0.178571	0.032693	0.375122	1.09297	0.94949	-0.0205226	0.98 [0.52 - 1.85]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26849	56	0.25	0.0818418	-	0.713174	0.944227	0.023161	1.02 [0.53 - 1.96]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13297	56	0.392857	0.214229	-	0.443928	0.746656	0.118081	1.13 [0.55 - 2.30]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18907	56	0.178571	0.0375358	0.410566	1.07403	0.930691	-0.0297502	0.97 [0.50 - 1.90]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42653	56	0.892857	0.0800593	-	-1.22007	0.780193	-0.0987703	0.91 [0.45 - 1.81]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13297	56	0.428571	0.105001	-	0.58911	0.563574	0.221162	1.25 [0.59 - 2.64]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26849	56	0.232143	0.0809336	-	0.732246	0.915191	0.0334726	1.03 [0.56 - 1.91]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42653	56	0.892857	0.0397466	0.425946	-1.84726	0.760522	-0.112914	0.89 [0.43 - 1.85]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	241978_at	278	0.899281	0.0193525	0.26178	0.611164	0.439333	0.284769	1.33 [0.65 - 2.74]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201900_s_at	278	0.320144	0.000101891	0.00356056	-0.73675	0.126117	-0.345874	0.71 [0.45 - 1.10]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201900_s_at	133	0.278196	0.00166127	0.0388824	-0.788984	0.0255935	-0.378352	0.68 [0.49 - 0.95]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12316	81	0.555556	0.179235	-	-0.73097	0.705161	-0.229493	0.79 [0.24 - 2.61]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17357	81	0.283951	0.182347	-	-0.69818	0.763928	-0.180967	0.83 [0.26 - 2.72]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201900_s_at	185	0.875676	0.0253369	0.315918	-0.560551	0.352792	-0.121182	0.89 [0.69 - 1.14]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201900_s_at	185	0.254054	0.0570354	-	-0.383896	0.357148	-0.133831	0.87 [0.66 - 1.16]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P79750	110	0.109091	0.0630801	-	-0.622853	0.739999	-0.0991949	0.91 [0.50 - 1.63]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P79755	110	0.372727	0.0826213	-	-0.406438	0.622325	-0.108406	0.90 [0.58 - 1.38]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P79750	110	0.163636	0.0190068	0.258454	-0.86932	0.547133	-0.234939	0.79 [0.37 - 1.70]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P79755	110	0.372727	0.0579728	-	-0.558851	0.345401	-0.254463	0.78 [0.46 - 1.32]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201900_s_at	80	0.4625	0.00476563	0.0911301	-1.29928	0.00950395	-1.69706	0.18 [0.05 - 0.66]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3497	281	0.75089	0.0143516	0.211093	-0.408955	0.39731	-0.132815	0.88 [0.64 - 1.19]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:268786	59	0.322034	7.08677e-05	0.00258389	-1.80723	0.0110599	-1.3142	0.27 [0.10 - 0.74]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201900_s_at	38	0.263158	0.103378	-	-0.765926	0.565425	-0.345933	0.71 [0.22 - 2.30]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	241978_at	38	0.894737	0.00618046	0.111709	1.48601	0.122197	1.3484	3.85 [0.70 - 21.29]
GENE	AKR1A1	aldo-keto reductase family 1, member A1 (aldehyde reductase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201900_s_at	140	0.457143	0.0400988	0.428353	0.625757	0.113685	0.718929	2.05 [0.84 - 5.00]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201272_at	30	0.433333	0.140079	-	0.61774	0.298835	0.21599	1.24 [0.83 - 1.87]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1701731	165	0.890909	0.059034	-	0.641435	0.596866	0.0530316	1.05 [0.87 - 1.28]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1701731	165	0.193939	0.00341191	0.0698575	15.3847	0.015548	0.3948	1.48 [1.08 - 2.04]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201272_at	163	0.834356	0.000670754	0.0181964	0.796429	0.0224691	0.337507	1.40 [1.05 - 1.87]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201272_at	79	0.227848	0.0229571	0.29512	0.90662	0.082958	0.351572	1.42 [0.96 - 2.11]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201272_at	58	0.862069	0.154109	-	0.549372	0.473428	0.266313	1.31 [0.63 - 2.70]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201272_at	34	0.323529	0.211405	-	-0.522112	0.546064	-0.424355	0.65 [0.16 - 2.59]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201272_at	158	0.487342	0.00593403	0.108227	-0.642046	0.0299312	-0.433028	0.65 [0.44 - 0.96]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201272_at	53	0.830189	0.129446	-	-0.894718	0.479371	-0.328736	0.72 [0.29 - 1.79]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201272_at	53	0.830189	0.168737	-	-0.718398	0.972313	-0.0153415	0.98 [0.41 - 2.34]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201272_at	180	0.866667	0.00248736	0.0541217	0.801357	0.0843303	0.530864	1.70 [0.93 - 3.11]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201272_at	559	0.422182	0.000151722	0.00505018	0.814648	0.0188803	0.445591	1.56 [1.08 - 2.26]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201272_at	77	0.883117	7.66182e-05	0.00276859	1.46827	0.837489	0.0744658	1.08 [0.53 - 2.19]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201272_at	70	0.714286	0.0246013	0.309584	-0.719141	0.361269	-0.249086	0.78 [0.46 - 1.33]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36589_at	50	0.36	0.137301	-	0.549915	0.354712	0.298057	1.35 [0.72 - 2.53]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201272_at	74	0.108108	0.0070679	0.123938	2.23445	0.0243635	1.33584	3.80 [1.19 - 12.17]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201272_at	67	0.716418	0.248621	-	-1.16145	0.679216	-0.420984	0.66 [0.09 - 4.83]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201272_at	115	0.686957	0.00825305	0.13959	-15.6674	0.159775	-1.0035	0.37 [0.09 - 1.49]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36589_at	158	0.892405	0.0238422	0.30296	0.862731	0.304229	0.358661	1.43 [0.72 - 2.84]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36589_at	76	0.605263	0.0301016	0.355066	-1.50246	0.572179	-0.294796	0.74 [0.27 - 2.07]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201272_at	204	0.833333	0.265253	-	-0.20933	0.698088	-0.0580331	0.94 [0.70 - 1.27]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201272_at	87	0.137931	0.0845511	-	-0.787192	0.0562398	-0.460782	0.63 [0.39 - 1.01]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201272_at	87	0.137931	0.0845511	-	-0.787192	0.0562398	-0.460782	0.63 [0.39 - 1.01]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201272_at	77	0.857143	0.033122	0.378365	1.20784	0.0889762	0.909259	2.48 [0.87 - 7.08]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201272_at	77	0.857143	0.127448	-	1.00927	0.303071	0.617591	1.85 [0.57 - 6.01]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201272_at	136	0.139706	0.00714989	0.125045	-1.27164	0.27626	-0.555918	0.57 [0.21 - 1.56]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201272_at	200	0.105	0.0115772	0.180166	-0.95429	0.073331	-0.815759	0.44 [0.18 - 1.08]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13928	60	0.283333	0.208106	-	-0.486811	0.694632	-0.0825298	0.92 [0.61 - 1.39]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13928	60	0.366667	0.119991	-	0.664332	0.527684	0.15943	1.17 [0.72 - 1.92]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	804	155	0.264516	0.000382121	0.0112542	-0.983405	0.019968	-0.429933	0.65 [0.45 - 0.93]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201272_at	286	0.548951	0.206728	-	-0.248623	0.986961	0.00408828	1.00 [0.61 - 1.64]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201272_at	159	0.245283	0.0578144	-	-0.619113	0.115384	-0.875854	0.42 [0.14 - 1.24]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201272_at	159	0.245283	0.0633943	-	-0.606482	0.678002	-0.216212	0.81 [0.29 - 2.24]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201272_at	159	0.245283	0.118346	-	-0.601195	0.200648	-0.833089	0.43 [0.12 - 1.56]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201272_at	54	0.111111	0.0756153	-	-1.35246	0.713099	-0.193661	0.82 [0.29 - 2.31]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201272_at	117	0.769231	0.0197548	0.265621	0.746187	0.472838	0.197679	1.22 [0.71 - 2.09]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201272_at	117	0.376068	0.0467087	0.471481	-0.737211	0.888255	-0.0450687	0.96 [0.51 - 1.79]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201272_at	117	0.376068	0.0469121	0.47275	-0.76742	0.58136	-0.185333	0.83 [0.43 - 1.61]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201272_at	117	0.769231	0.0197548	0.265621	0.746187	0.472838	0.197679	1.22 [0.71 - 2.09]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201272_at	236	0.834746	0.113028	-	-0.728137	0.206431	-0.621984	0.54 [0.20 - 1.41]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201272_at	249	0.851406	0.063981	-	-0.673798	0.439067	-0.286098	0.75 [0.36 - 1.55]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201272_at	125	0.464	0.000804737	0.0212276	-0.958489	0.0598104	-0.438986	0.64 [0.41 - 1.02]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201272_at	54	0.166667	0.107567	-	-0.956695	0.795895	-0.0602313	0.94 [0.60 - 1.49]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201272_at	62	0.193548	0.293916	-	-0.547959	0.683118	-0.0797195	0.92 [0.63 - 1.35]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201272_at	125	0.296	0.000191088	0.00617718	-1.32808	0.0301887	-0.698303	0.50 [0.26 - 0.94]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201272_at	198	0.358586	0.141454	-	-0.315611	0.836867	-0.036342	0.96 [0.68 - 1.36]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201272_at	198	0.358586	0.21244	-	-0.321724	0.81789	-0.0497057	0.95 [0.62 - 1.45]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201272_at	198	0.358586	0.144944	-	-0.391496	0.633133	-0.105333	0.90 [0.58 - 1.39]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201272_at	62	0.612903	0.142453	-	0.834848	0.490744	0.231918	1.26 [0.65 - 2.44]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201272_at	51	0.411765	0.0608799	-	-1.83103	0.317517	-0.937809	0.39 [0.06 - 2.46]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201272_at	177	0.242938	0.0969635	-	0.49078	0.276949	0.226021	1.25 [0.83 - 1.88]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201272_at	145	0.896552	0.00567893	0.104579	1.07167	0.0128371	0.768262	2.16 [1.18 - 3.95]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201272_at	177	0.661017	0.0428472	0.446745	0.542967	0.267567	0.265973	1.30 [0.82 - 2.09]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201272_at	226	0.477876	0.00237921	0.0521992	0.925834	0.0379012	0.5722	1.77 [1.03 - 3.04]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201272_at	55	0.563636	0.00340374	0.0697233	1.42081	0.0465212	0.656687	1.93 [1.01 - 3.68]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201272_at	49	0.795918	0.0910899	-	0.954814	0.378802	0.360727	1.43 [0.64 - 3.20]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201272_at	55	0.618182	0.00520692	0.0977079	1.20925	0.0112142	0.825266	2.28 [1.21 - 4.32]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201272_at	63	0.174603	0.0231321	0.29668	-0.857561	0.405115	-0.232081	0.79 [0.46 - 1.37]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502048_3p_at	28	0.214286	0.0295206	0.350455	-1.15684	0.505258	-0.108169	0.90 [0.65 - 1.23]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201272_at	82	0.182927	0.0343613	0.387619	-0.787388	0.774683	-0.0702346	0.93 [0.58 - 1.51]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36589_at	84	0.690476	0.0113469	0.177491	0.734165	0.116514	0.374131	1.45 [0.91 - 2.32]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201272_at	79	0.772152	0.00379199	0.0760165	0.830961	0.0612831	0.381778	1.46 [0.98 - 2.19]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X15414_at	86	0.651163	0.116853	-	-0.770455	0.629406	-0.169479	0.84 [0.42 - 1.68]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201272_at	104	0.615385	0.125382	-	-0.538767	0.700412	0.0877825	1.09 [0.70 - 1.71]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P258190	117	0.136752	0.00215475	0.0481446	-1.01321	0.841256	-0.0312569	0.97 [0.71 - 1.32]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201272_at	204	0.377451	0.00026196	0.00812503	2.20287	0.00898797	0.970273	2.64 [1.27 - 5.46]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201272_at	204	0.377451	0.000196161	0.00631981	1.27359	0.00754493	0.746942	2.11 [1.22 - 3.65]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201272_at	178	0.651685	0.0871825	-	0.347279	0.730997	0.0672762	1.07 [0.73 - 1.57]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006069	41	0.292683	0.0962872	-	-0.705908	0.844397	-0.0679445	0.93 [0.47 - 1.84]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201272_at	111	0.738739	0.046916	0.472775	-0.65416	0.429605	-0.142649	0.87 [0.61 - 1.24]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201272_at	90	0.566667	0.207695	-	0.406267	0.952264	0.0131657	1.01 [0.66 - 1.56]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201272_at	90	0.566667	0.0981613	-	0.608462	0.719483	0.0900783	1.09 [0.67 - 1.79]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201272_at	138	0.717391	0.0111501	0.17519	0.626694	0.245163	0.111428	1.12 [0.93 - 1.35]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201272_at	129	0.775194	0.0247781	0.311113	0.594434	0.374204	0.211385	1.24 [0.78 - 1.97]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38295	56	0.25	0.123083	-	-0.582414	0.633291	-0.0559035	0.95 [0.75 - 1.19]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38295	56	0.464286	0.298903	-	0.378193	0.924755	0.0114475	1.01 [0.80 - 1.28]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201272_at	278	0.273381	0.0372753	0.408723	0.48187	0.090576	0.232126	1.26 [0.96 - 1.65]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201272_at	133	0.879699	0.0484875	0.48247	0.621774	0.703115	0.043366	1.04 [0.84 - 1.31]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16418	81	0.567901	0.00497594	0.0942843	1.4047	0.0701395	0.437528	1.55 [0.96 - 2.49]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17630	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201272_at	185	0.513514	0.107235	-	0.284417	0.971068	0.00434031	1.00 [0.79 - 1.27]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201272_at	185	0.513514	0.148278	-	0.235282	0.888899	0.0150601	1.02 [0.82 - 1.25]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258190	110	0.109091	0.0257638	0.319555	-0.778773	0.849663	0.0269378	1.03 [0.78 - 1.36]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258190	110	0.109091	0.0218299	0.284945	-0.711904	0.799735	0.0361899	1.04 [0.78 - 1.37]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201272_at	80	0.8625	0.085736	-	-1.59554	0.908903	0.0350475	1.04 [0.57 - 1.89]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_0657	281	0.843416	0.0341638	0.386156	0.403713	0.604064	0.0559888	1.06 [0.86 - 1.31]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:340628	59	0.779661	0.0495216	0.488747	-1.78164	0.115269	-1.3336	0.26 [0.05 - 1.39]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201272_at	38	0.842105	0.00166214	0.0388994	1.67092	0.0436329	1.10601	3.02 [1.03 - 8.85]
GENE	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201272_at	140	0.892857	0.00515701	0.0969716	1.00179	0.00852817	0.959333	2.61 [1.28 - 5.33]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204151_x_at	30	0.7	0.361449	-	0.379571	0.808429	0.034418	1.04 [0.78 - 1.37]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216594_x_at	30	0.8	0.325765	-	0.454607	0.701919	0.0584602	1.06 [0.79 - 1.43]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1662507	165	0.2	0.117328	-	-0.435047	0.438672	-0.423974	0.65 [0.22 - 1.91]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1662507	165	0.478788	0.00850828	0.14287	-0.965751	0.0942735	-1.79077	0.17 [0.02 - 1.36]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204151_x_at	163	0.748466	0.039297	0.422857	-0.49946	0.170948	-0.248518	0.78 [0.55 - 1.11]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216594_x_at	163	0.883436	0.0663194	-	-0.630962	0.195264	-0.279041	0.76 [0.50 - 1.15]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216594_x_at	79	0.518987	0.0134962	0.201802	-0.730224	0.0934446	-0.306995	0.74 [0.51 - 1.05]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1562102_at	79	0.683544	0.11527	-	0.47154	0.446856	0.420387	1.52 [0.52 - 4.50]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204151_x_at	79	0.56962	0.0497896	0.49036	-0.590802	0.0825313	-0.275993	0.76 [0.56 - 1.04]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216594_x_at	58	0.896552	0.0447648	0.459184	-0.92694	0.176738	-0.371725	0.69 [0.40 - 1.18]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204151_x_at	58	0.155172	0.0419602	0.440883	-0.769403	0.0311557	-0.402057	0.67 [0.46 - 0.96]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216594_x_at	34	0.735294	0.0182834	0.251415	-1.13062	0.14715	-0.520716	0.59 [0.29 - 1.20]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204151_x_at	34	0.735294	0.0182834	0.251415	-1.13062	0.129938	-0.418008	0.66 [0.38 - 1.13]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216594_x_at	158	0.563291	0.19608	-	0.297651	0.875847	0.095875	1.10 [0.33 - 3.66]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204151_x_at	158	0.297468	0.0616477	-	-0.442193	0.582077	-0.349278	0.71 [0.20 - 2.45]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204151_x_at	53	0.849057	0.100751	-	0.745523	0.530444	0.253159	1.29 [0.58 - 2.84]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216594_x_at	53	0.792453	0.087191	-	0.67461	0.643625	0.213337	1.24 [0.50 - 3.06]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204151_x_at	53	0.849057	0.226322	-	0.543862	0.982022	-0.00905962	0.99 [0.45 - 2.18]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216594_x_at	53	0.792453	0.103767	-	0.608409	0.969927	-0.016326	0.98 [0.42 - 2.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204151_x_at	180	0.127778	0.0460784	0.467528	-0.580564	0.739949	-0.0580135	0.94 [0.67 - 1.33]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216594_x_at	180	0.4	0.187152	-	-0.281257	0.869927	0.02923	1.03 [0.73 - 1.46]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216594_x_at	559	0.640429	0.0950418	-	0.339695	0.514762	0.0957662	1.10 [0.83 - 1.47]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204151_x_at	559	0.561717	0.0525901	-	0.385598	0.535832	0.100152	1.11 [0.81 - 1.52]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1562102_at	559	0.112701	0.11485	-	0.652567	0.499949	0.0707276	1.07 [0.87 - 1.32]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216594_x_at	77	0.558442	0.0023508	0.0516909	-0.799881	0.039131	-0.378798	0.68 [0.48 - 0.98]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204151_x_at	77	0.532468	0.000461859	0.0132407	-0.902612	0.0140376	-0.374585	0.69 [0.51 - 0.93]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216594_x_at	70	0.6	0.0174216	0.242884	-0.656706	0.240001	-0.31872	0.73 [0.43 - 1.24]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204151_x_at	70	0.842857	0.037622	0.411175	-0.817658	0.155747	-0.297002	0.74 [0.49 - 1.12]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1562102_at	70	0.3	0.0707397	-	-0.512231	0.365718	-0.916743	0.40 [0.05 - 2.91]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32805_at	50	0.4	0.000102774	0.00358772	-1.33986	0.0348008	-0.384864	0.68 [0.48 - 0.97]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204151_x_at	74	0.486486	0.000107445	0.00373087	-1.14116	0.0036231	-0.648672	0.52 [0.34 - 0.81]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216594_x_at	74	0.662162	0.00305154	0.0638614	-0.967033	0.0172796	-0.622456	0.54 [0.32 - 0.90]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216594_x_at	67	0.298507	0.0332583	0.379392	15.6786	0.406581	0.427304	1.53 [0.56 - 4.21]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204151_x_at	67	0.328358	0.0274154	0.33338	15.7214	0.376797	0.367794	1.44 [0.64 - 3.27]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1562102_at	67	0.761194	0.0628677	-	1.18075	0.368291	0.442349	1.56 [0.59 - 4.08]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216594_x_at	115	0.165217	0.0275546	0.334527	-1.16377	0.19153	-0.579978	0.56 [0.23 - 1.34]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204151_x_at	115	0.121739	0.0299317	0.353721	-1.21964	0.156768	-0.731207	0.48 [0.17 - 1.32]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1562102_at	115	0.243478	0.0750283	-	-0.927464	0.141176	-0.790515	0.45 [0.16 - 1.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32805_at	158	0.898734	0.000820044	0.0215678	1.13057	0.000431279	0.370756	1.45 [1.18 - 1.78]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32805_at	76	0.368421	0.240362	-	-0.605641	0.673342	-0.0898044	0.91 [0.60 - 1.39]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204151_x_at	204	0.77451	0.000161172	0.00532423	0.650473	0.0155746	0.151572	1.16 [1.03 - 1.32]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1562102_at	204	0.897059	0.00604797	0.109842	0.630683	0.587125	0.0366156	1.04 [0.91 - 1.18]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216594_x_at	204	0.823529	0.000886573	0.0230331	0.622232	0.00950977	0.159941	1.17 [1.04 - 1.32]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1562102_at	87	0.482759	0.0197595	0.265665	-0.913094	0.441018	0.521897	1.69 [0.45 - 6.36]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1562102_at	87	0.482759	0.0197595	0.265665	-0.913094	0.441018	0.521897	1.69 [0.45 - 6.36]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204151_x_at	87	0.137931	0.0779619	-	-0.799959	0.952504	-0.00930637	0.99 [0.73 - 1.35]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216594_x_at	87	0.712644	0.190779	-	-0.635146	0.989623	0.00234337	1.00 [0.70 - 1.43]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204151_x_at	87	0.137931	0.0779619	-	-0.799959	0.952504	-0.00930637	0.99 [0.73 - 1.35]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216594_x_at	87	0.712644	0.190779	-	-0.635146	0.989623	0.00234337	1.00 [0.70 - 1.43]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204151_x_at	77	0.766234	0.154341	-	-1.373	0.521092	-0.21124	0.81 [0.42 - 1.54]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1562102_at	77	0.831169	0.127097	-	0.888246	0.968329	-0.0445687	0.96 [0.11 - 8.63]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1562102_at	77	0.155844	0.138928	-	-0.98413	0.552749	-1.1409	0.32 [0.01 - 13.82]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216594_x_at	77	0.844156	0.145664	-	-15.3123	0.379233	-0.502104	0.61 [0.20 - 1.85]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204151_x_at	77	0.766234	0.0626667	-	-15.4867	0.414575	-0.3348	0.72 [0.32 - 1.60]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216594_x_at	77	0.844156	0.0945857	-	-15.3179	0.380823	-0.418325	0.66 [0.26 - 1.68]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204151_x_at	136	0.492647	0.0192121	0.260432	-1.12146	0.194989	-0.332715	0.72 [0.43 - 1.19]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216594_x_at	136	0.375	0.0367583	0.405043	-0.93118	0.0900097	-0.547584	0.58 [0.31 - 1.09]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204151_x_at	200	0.555	0.0411548	0.4355	0.602924	0.761772	0.046725	1.05 [0.77 - 1.42]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216594_x_at	200	0.385	0.0736861	-	0.592103	0.919709	0.0166486	1.02 [0.74 - 1.41]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2655	60	0.766667	0.136454	-	0.59546	0.273873	0.187813	1.21 [0.86 - 1.69]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2655	60	0.483333	0.316055	-	-0.381119	0.973211	-0.00528921	0.99 [0.73 - 1.35]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3983	155	0.690323	1.55908e-06	8.19006e-05	1.26819	0.00119544	0.301992	1.35 [1.13 - 1.62]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204151_x_at	286	0.248252	0.0234563	0.299558	-0.466271	0.117781	-0.192789	0.82 [0.65 - 1.05]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216594_x_at	286	0.402098	0.0237436	0.302093	-0.433691	0.196853	-0.18412	0.83 [0.63 - 1.10]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204151_x_at	159	0.314465	0.038372	0.41644	-0.647497	0.529943	-0.115276	0.89 [0.62 - 1.28]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216594_x_at	159	0.27044	0.0259699	0.321302	-0.809541	0.693042	-0.0964864	0.91 [0.56 - 1.47]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216594_x_at	159	0.704403	0.216712	-	-0.48378	0.903703	-0.0241228	0.98 [0.66 - 1.44]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204151_x_at	159	0.314465	0.0113448	0.177466	-0.78229	0.188722	-0.253336	0.78 [0.53 - 1.13]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204151_x_at	159	0.314465	0.00312364	0.0650741	-1.05516	0.348393	-0.210338	0.81 [0.52 - 1.26]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216594_x_at	159	0.484277	0.0702041	-	-0.583163	0.556003	-0.123736	0.88 [0.59 - 1.33]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216594_x_at	54	0.111111	0.174581	-	-1.06129	0.455298	0.147475	1.16 [0.79 - 1.71]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217626_at	54	0.796296	0.493682	-	-0.714654	0.418943	0.147447	1.16 [0.81 - 1.66]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204151_x_at	54	0.111111	0.0756712	-	-1.35409	0.692916	0.0841464	1.09 [0.72 - 1.65]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216594_x_at	117	0.316239	0.145969	-	0.545497	0.707663	0.0427147	1.04 [0.83 - 1.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216594_x_at	117	0.367521	0.0627611	-	0.833822	0.464102	0.0947858	1.10 [0.85 - 1.42]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216594_x_at	117	0.794872	0.0544717	-	0.770142	0.381189	0.115672	1.12 [0.87 - 1.45]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216594_x_at	117	0.316239	0.145969	-	0.545497	0.707663	0.0427147	1.04 [0.83 - 1.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204151_x_at	117	0.717949	0.188644	-	0.43395	0.664033	0.0471086	1.05 [0.85 - 1.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204151_x_at	117	0.786325	0.103513	-	0.649375	0.468526	0.0903054	1.09 [0.86 - 1.40]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204151_x_at	117	0.786325	0.0183037	0.251614	0.915982	0.23908	0.144338	1.16 [0.91 - 1.47]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204151_x_at	117	0.717949	0.188644	-	0.43395	0.664033	0.0471086	1.05 [0.85 - 1.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204151_x_at	236	0.677966	0.0315779	0.366591	-0.709314	0.256428	-0.23093	0.79 [0.53 - 1.18]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216594_x_at	236	0.699153	0.0304209	0.357581	-0.739664	0.254024	-0.307547	0.74 [0.43 - 1.25]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216594_x_at	249	0.248996	0.0397434	0.425924	-0.470967	0.640856	-0.0928242	0.91 [0.62 - 1.35]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204151_x_at	249	0.325301	0.0350923	0.392998	-0.454496	0.572375	-0.0872676	0.92 [0.68 - 1.24]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216594_x_at	62	0.129032	0.0173726	0.242394	-1.31625	0.118183	-0.367136	0.69 [0.44 - 1.10]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204151_x_at	125	0.352	0.098973	-	0.546434	0.420679	0.104776	1.11 [0.86 - 1.43]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216594_x_at	125	0.424	0.0279294	0.337604	-0.827633	0.364724	-0.246838	0.78 [0.46 - 1.33]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204151_x_at	54	0.481481	0.00626775	0.112933	-1.77755	0.130879	-0.393736	0.67 [0.40 - 1.12]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216594_x_at	125	0.656	0.11703	-	0.451006	0.435027	0.12629	1.13 [0.83 - 1.56]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216594_x_at	54	0.12963	0.01791	0.247738	-1.58169	0.200378	-0.371004	0.69 [0.39 - 1.22]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204151_x_at	62	0.516129	0.000849228	0.0222132	-1.82598	0.0601998	-0.399253	0.67 [0.44 - 1.02]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204151_x_at	125	0.496	0.181304	-	-0.506703	0.55736	-0.116868	0.89 [0.60 - 1.31]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216594_x_at	198	0.868687	0.0955753	-	0.533081	0.359987	0.0832999	1.09 [0.91 - 1.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216594_x_at	198	0.878788	0.029843	0.353018	0.721423	0.177995	0.124613	1.13 [0.94 - 1.36]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204151_x_at	198	0.89899	0.0510143	-	0.579204	0.650519	0.0321988	1.03 [0.90 - 1.19]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216594_x_at	198	0.878788	0.0975739	-	0.465472	0.480026	0.053713	1.06 [0.91 - 1.22]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204151_x_at	198	0.89899	0.0421261	0.441985	0.692836	0.485385	0.0592126	1.06 [0.90 - 1.25]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204151_x_at	198	0.883838	0.0411981	0.435791	0.704631	0.272756	0.0955243	1.10 [0.93 - 1.31]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204151_x_at	62	0.596774	0.0932337	-	0.949015	0.871957	0.0441159	1.05 [0.61 - 1.79]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216594_x_at	51	0.823529	0.142055	-	1.25729	0.408301	0.353287	1.42 [0.62 - 3.29]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216594_x_at	62	0.209677	0.0714637	-	-1.0135	0.82317	0.0722957	1.07 [0.57 - 2.03]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204151_x_at	51	0.647059	0.177227	-	1.1669	0.306645	0.386886	1.47 [0.70 - 3.09]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1562102_at	145	0.806897	0.062873	-	-1.07257	0.336132	-1.30527	0.27 [0.02 - 3.88]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204151_x_at	145	0.668966	0.0447174	0.45888	0.658597	0.585295	0.147617	1.16 [0.68 - 1.97]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216594_x_at	177	0.491525	0.0650697	-	0.506786	0.770262	0.0636304	1.07 [0.70 - 1.63]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204151_x_at	177	0.485876	0.0155206	0.223472	0.673947	0.57729	0.117952	1.13 [0.74 - 1.70]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216594_x_at	177	0.440678	0.07913	-	0.425933	0.893125	0.0261132	1.03 [0.70 - 1.50]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216594_x_at	145	0.868966	0.11203	-	0.658899	0.988673	-0.00414677	1.00 [0.56 - 1.77]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1562102_at	177	0.333333	0.124919	-	-0.366644	0.496963	-0.406831	0.67 [0.21 - 2.15]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1562102_at	177	0.265537	0.0952126	-	-0.471074	0.577556	-0.35636	0.70 [0.20 - 2.45]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204151_x_at	177	0.542373	0.033024	0.377626	0.497648	0.76031	0.0591314	1.06 [0.73 - 1.55]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216594_x_at	226	0.712389	0.0984512	-	0.478697	0.510702	0.116971	1.12 [0.79 - 1.59]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204151_x_at	226	0.628319	0.0618913	-	0.524266	0.972057	0.0057226	1.01 [0.73 - 1.39]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1562102_at	226	0.10177	0.17996	-	-0.543587	0.828338	-0.0328708	0.97 [0.72 - 1.30]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1562102_at	55	0.709091	0.0634308	-	-1.3006	0.282672	-1.63593	0.19 [0.01 - 3.85]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1562102_at	49	0.387755	0.21033	-	-0.719562	0.350431	-1.75116	0.17 [0.00 - 6.85]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216594_x_at	55	0.618182	0.00773852	0.132884	1.15596	0.421011	0.3334	1.40 [0.62 - 3.14]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204151_x_at	55	0.654545	0.0107021	0.169899	1.09572	0.24101	0.473412	1.61 [0.73 - 3.54]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1562102_at	55	0.436364	0.183201	-	-0.590656	0.449901	-1.0649	0.34 [0.02 - 5.46]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216594_x_at	55	0.618182	0.0337293	0.382921	0.987707	0.207378	0.556684	1.74 [0.73 - 4.15]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216594_x_at	49	0.632653	0.013061	0.196994	1.41087	0.605804	0.281299	1.32 [0.46 - 3.86]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204151_x_at	55	0.872727	0.0949652	-	0.943946	0.343186	0.42475	1.53 [0.64 - 3.68]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204151_x_at	49	0.673469	0.0854437	-	0.964289	0.518224	0.351468	1.42 [0.49 - 4.13]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	196992	34	0.764706	0.0127135	0.193115	-1.70983	0.0946348	-0.332796	0.72 [0.49 - 1.06]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216594_x_at	63	0.761905	0.00564134	0.104038	0.966903	0.418493	0.188096	1.21 [0.77 - 1.90]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204151_x_at	63	0.825397	0.120004	-	0.621926	0.620189	0.0625748	1.06 [0.83 - 1.36]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1562102_at	63	0.587302	0.0699015	-	-0.649477	0.840099	-0.394839	0.67 [0.01 - 31.21]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.348647.1.S1_3p_at	28	0.464286	0.0448138	0.459498	-1.09659	0.895309	-0.0416766	0.96 [0.52 - 1.78]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	216594_3p_x_at	28	0.321429	0.0580389	-	-1.00143	0.587357	-0.226805	0.80 [0.35 - 1.81]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306098.1.S1_3p_s_at	28	0.535714	0.12508	-	0.854857	0.416531	0.0636874	1.07 [0.91 - 1.24]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5453542_3p_s_at	28	0.464286	0.138906	-	0.826474	0.442486	0.0624412	1.06 [0.91 - 1.25]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306098.1.S1_3p_x_at	28	0.107143	0.0601728	-	-1.42222	0.151071	0.418541	1.52 [0.86 - 2.69]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	204151_3p_x_at	28	0.714286	0.163506	-	0.793763	0.689202	0.0533144	1.05 [0.81 - 1.37]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306098.1.S1_3p_at	28	0.607143	0.1416	-	-0.855987	0.38378	-0.699647	0.50 [0.10 - 2.40]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204151_x_at	82	0.756098	0.186823	-	0.475048	0.566922	0.0733278	1.08 [0.84 - 1.38]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216594_x_at	82	0.756098	0.186823	-	0.475048	0.51043	0.0878375	1.09 [0.84 - 1.42]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32805_at	84	0.27381	0.0614765	-	-0.558713	0.704604	-0.0280621	0.97 [0.84 - 1.12]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204151_x_at	79	0.658228	0.00033854	0.0101404	0.962133	0.00196498	0.303353	1.35 [1.12 - 1.64]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216594_x_at	79	0.658228	0.00033854	0.0101404	0.962133	0.00250463	0.312413	1.37 [1.12 - 1.67]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204151_x_at	104	0.201923	0.0779133	-	-0.613997	0.451477	-0.101854	0.90 [0.69 - 1.18]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216594_x_at	104	0.192308	0.105939	-	-0.579861	0.524196	-0.0905112	0.91 [0.69 - 1.21]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P312578	117	0.102564	0.000371112	0.0109749	-1.24592	0.439971	-0.0906807	0.91 [0.73 - 1.15]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P152968	117	0.162393	0.0102366	0.164326	-0.810474	0.737671	-0.0303179	0.97 [0.81 - 1.16]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P257971	117	0.213675	0.000784046	0.0207659	-0.961451	0.733475	-0.0404488	0.96 [0.76 - 1.21]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P220947	117	0.435897	0.00432207	0.0843542	-0.808593	0.841297	-0.0210241	0.98 [0.80 - 1.20]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216594_x_at	204	0.137255	0.000636063	0.0173945	-1.01919	0.45128	-0.100052	0.90 [0.70 - 1.17]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204151_x_at	204	0.862745	0.020164	0.269495	0.927612	0.206471	0.233361	1.26 [0.88 - 1.81]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204151_x_at	204	0.107843	0.00309264	0.0645535	-0.964799	0.250592	-0.162922	0.85 [0.64 - 1.12]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1562102_at	204	0.784314	0.117161	-	0.598375	0.445574	0.115858	1.12 [0.83 - 1.51]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1562102_at	204	0.534314	0.0411032	0.435154	-0.574334	0.359377	-0.114308	0.89 [0.70 - 1.14]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216594_x_at	204	0.887255	0.00183564	0.042215	1.21595	0.110596	0.265133	1.30 [0.94 - 1.81]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204151_x_at	178	0.106742	0.0123638	0.189174	-0.669465	0.839389	-0.0146336	0.99 [0.86 - 1.14]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216594_x_at	178	0.117978	0.037871	0.412929	-0.545244	0.894421	-0.0102129	0.99 [0.85 - 1.15]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204151_x_at	111	0.306306	0.00986374	0.159801	-0.682011	0.209777	-0.0980489	0.91 [0.78 - 1.06]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1562102_at	111	0.693694	0.0844424	-	-0.516225	0.550454	-0.0484417	0.95 [0.81 - 1.12]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216594_x_at	111	0.378378	0.0233497	0.298613	-0.592387	0.211883	-0.0965224	0.91 [0.78 - 1.06]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204151_x_at	90	0.355556	0.0426651	0.445547	-0.651931	0.724375	-0.0296062	0.97 [0.82 - 1.14]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204151_x_at	90	0.355556	0.0106562	0.169353	-0.919342	0.478687	-0.0680664	0.93 [0.77 - 1.13]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216594_x_at	90	0.355556	0.139406	-	-0.481713	0.782735	-0.0249181	0.98 [0.82 - 1.16]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216594_x_at	90	0.355556	0.047143	0.474187	-0.722861	0.563006	-0.060212	0.94 [0.77 - 1.15]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	527	50	0.82	0.0150098	0.218106	1.18357	0.0436068	0.458641	1.58 [1.01 - 2.47]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204151_x_at	138	0.789855	0.0890818	-	-0.574557	0.393552	-0.0328262	0.97 [0.90 - 1.04]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1562102_at	138	0.362319	0.000760402	0.0202355	-0.794955	0.138709	-0.0699185	0.93 [0.85 - 1.02]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216594_x_at	138	0.724638	0.0285998	0.343059	-0.662412	0.417881	-0.0325438	0.97 [0.89 - 1.05]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204151_x_at	129	0.713178	0.0128832	0.195014	0.623241	0.525823	0.0580213	1.06 [0.89 - 1.27]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216594_x_at	129	0.674419	0.031111	0.362974	0.533822	0.392084	0.0771197	1.08 [0.91 - 1.29]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36808	56	0.214286	0.0598078	-	-0.722949	0.273885	-0.073459	0.93 [0.81 - 1.06]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31046	56	0.196429	0.0493118	0.48748	-0.752206	0.242948	-0.0771306	0.93 [0.81 - 1.05]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36808	56	0.892857	0.161235	-	-0.988446	0.770378	-0.0215553	0.98 [0.85 - 1.13]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13689	56	0.232143	0.0329919	0.377384	-0.791533	0.394206	-0.0589004	0.94 [0.82 - 1.08]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31046	56	0.857143	0.158348	-	-0.836734	0.687493	-0.0295083	0.97 [0.84 - 1.12]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13689	56	0.232143	0.193385	-	-0.53075	0.907899	-0.0085863	0.99 [0.86 - 1.15]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216594_x_at	278	0.866906	0.0236167	0.300975	0.534431	0.174013	0.162726	1.18 [0.93 - 1.49]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204151_x_at	278	0.881295	0.00190763	0.043571	0.731688	0.0772019	0.171346	1.19 [0.98 - 1.44]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1562102_at	278	0.176259	0.00377176	0.0756925	-0.630358	0.106919	-1.08195	0.34 [0.09 - 1.26]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216594_x_at	133	0.721804	0.00147284	0.0351975	-1.0374	0.0113835	-0.417342	0.66 [0.48 - 0.91]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204151_x_at	133	0.834586	0.00111844	0.0279896	-1.39753	0.0165859	-0.292072	0.75 [0.59 - 0.95]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2435	81	0.876543	0.102377	-	-15.2739	0.436813	-0.159039	0.85 [0.57 - 1.27]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	546	81	0.790123	0.0804532	-	-1.62859	0.404967	-0.353961	0.70 [0.31 - 1.61]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216594_x_at	185	0.794595	0.00990166	0.160263	0.518875	0.0749802	0.27355	1.31 [0.97 - 1.78]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204151_x_at	185	0.87027	0.0825807	-	0.411781	0.118053	0.219931	1.25 [0.95 - 1.64]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216594_x_at	185	0.794595	0.0638543	-	0.41135	0.133379	0.248452	1.28 [0.93 - 1.77]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204151_x_at	185	0.875676	0.113007	-	0.40522	0.190605	0.198657	1.22 [0.91 - 1.64]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P152968	110	0.772727	0.000461948	0.0132428	1.02747	0.0798262	0.224818	1.25 [0.97 - 1.61]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P257971	110	0.8	0.0132542	0.199135	0.64988	0.214533	0.0891481	1.09 [0.95 - 1.26]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P312578	110	0.790909	0.0460874	0.467584	0.667655	0.607903	0.0811629	1.08 [0.80 - 1.48]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P220947	110	0.472727	0.0705614	-	0.416838	0.237447	0.0702302	1.07 [0.95 - 1.21]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P257971	110	0.8	0.0314648	0.365717	0.722525	0.262039	0.10575	1.11 [0.92 - 1.34]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P152968	110	0.654545	0.000123037	0.00420276	0.870461	0.0135882	0.232354	1.26 [1.05 - 1.52]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P220947	110	0.763636	0.0612272	-	0.616448	0.302473	0.08061	1.08 [0.93 - 1.26]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P312578	110	0.763636	0.00767067	0.131989	0.665057	0.4732	0.0867292	1.09 [0.86 - 1.38]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204151_x_at	80	0.525	0.0560274	-	0.861546	0.993964	-0.00134201	1.00 [0.71 - 1.41]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216594_x_at	80	0.5375	0.0905763	-	0.749277	0.851181	-0.0427907	0.96 [0.61 - 1.50]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_1037	281	0.13879	0.033442	0.380771	-0.396318	0.722932	0.0323508	1.03 [0.86 - 1.24]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1562102_at	38	0.210526	0.301867	-	0.757671	0.782971	0.0918832	1.10 [0.57 - 2.11]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216594_x_at	38	0.868421	0.226149	-	-1.17765	0.815125	-0.0435973	0.96 [0.66 - 1.38]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204151_x_at	38	0.789474	0.162681	-	-1.00354	0.962933	-0.0102737	0.99 [0.64 - 1.53]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204151_x_at	140	0.664286	9.10721e-05	0.00322516	-1.65581	0.00501164	-0.26114	0.77 [0.64 - 0.92]
GENE	AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216594_x_at	140	0.657143	0.000304727	0.00926043	-1.44808	0.00496241	-0.297577	0.74 [0.60 - 0.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210558_at	30	0.866667	0.276258	-	0.587718	0.455208	0.791541	2.21 [0.28 - 17.62]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1668880	165	0.630303	0.012219	0.187531	-0.679019	0.846124	-0.0855771	0.92 [0.39 - 2.18]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1668880	165	0.284848	0.0361837	0.400921	1.06846	0.769778	0.157367	1.17 [0.41 - 3.36]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210558_at	163	0.680982	0.0284152	0.341563	0.441686	0.417414	0.643372	1.90 [0.40 - 9.01]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210558_at	79	0.886076	0.0316589	0.367215	-1.43062	0.316723	-0.819509	0.44 [0.09 - 2.19]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210558_at	58	0.551724	0.2187	-	0.339742	0.87992	-0.0222607	0.98 [0.73 - 1.31]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210558_at	34	0.382353	0.221202	-	-0.474395	0.853495	-0.0573787	0.94 [0.51 - 1.74]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210558_at	158	0.208861	0.16559	-	0.448753	0.683914	0.292752	1.34 [0.33 - 5.49]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210558_at	53	0.830189	0.00783222	0.134115	1.00572	0.140851	0.321404	1.38 [0.90 - 2.12]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210558_at	53	0.754717	0.0237234	0.301916	0.838551	0.196349	0.288619	1.33 [0.86 - 2.07]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210558_at	180	0.605556	0.13001	-	-0.333521	0.535718	-0.0532814	0.95 [0.80 - 1.12]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210558_at	559	0.751342	0.131254	-	0.313828	0.60213	0.0596228	1.06 [0.85 - 1.33]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210558_at	77	0.818182	0.0425086	0.444515	-0.754389	0.926531	0.0140119	1.01 [0.75 - 1.37]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210558_at	70	0.685714	0.115144	-	-0.465138	0.88954	-0.115875	0.89 [0.17 - 4.57]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35482_at	50	0.16	0.00921542	0.151801	-1.12178	0.124434	-1.33456	0.26 [0.05 - 1.44]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210558_at	74	0.351351	0.00232023	0.0511424	-0.863082	0.0288086	-0.364083	0.69 [0.50 - 0.96]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210558_at	67	0.432836	0.051353	-	-1.44282	0.490523	-2.2394	0.11 [0.00 - 61.97]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210558_at	115	0.278261	0.0483623	0.481704	-1.01415	0.0494714	-1.25045	0.29 [0.08 - 1.00]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35482_at	158	0.632911	0.0627939	-	0.526291	0.88409	0.0332891	1.03 [0.66 - 1.62]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35482_at	76	0.131579	0.38994	-	0.863727	0.659954	-0.208531	0.81 [0.32 - 2.06]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210558_at	204	0.877451	0.106312	-	0.34646	0.482788	0.0460243	1.05 [0.92 - 1.19]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210558_at	87	0.689655	0.108245	-	0.60561	0.477341	0.706285	2.03 [0.29 - 14.22]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210558_at	87	0.689655	0.108245	-	0.60561	0.477341	0.706285	2.03 [0.29 - 14.22]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210558_at	77	0.714286	0.0346561	0.389794	-15.609	0.326601	-1.8969	0.15 [0.00 - 6.64]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210558_at	77	0.194805	0.254403	-	1.1261	0.877541	0.231128	1.26 [0.07 - 23.83]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210558_at	136	0.102941	0.0124563	0.19022	-1.22864	0.4237	-0.177839	0.84 [0.54 - 1.29]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210558_at	200	0.16	0.113635	-	0.913669	0.481757	0.138986	1.15 [0.78 - 1.69]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21351	60	0.766667	0.245666	-	-0.616052	0.731629	-0.261494	0.77 [0.17 - 3.43]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21351	60	0.816667	0.0344905	0.388574	0.835305	0.110288	0.729309	2.07 [0.85 - 5.08]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1981	155	0.780645	0.00355438	0.0721851	0.819139	0.0555015	0.336815	1.40 [0.99 - 1.98]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210558_at	286	0.601399	0.0497019	0.489832	-0.402141	0.548022	-0.0720986	0.93 [0.74 - 1.18]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210558_at	159	0.522013	0.223329	-	0.387384	0.646684	0.0806544	1.08 [0.77 - 1.53]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210558_at	159	0.176101	0.213942	-	-0.533992	0.97624	-0.00611357	0.99 [0.66 - 1.49]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210558_at	159	0.742138	0.0685736	-	0.586608	0.588081	0.0978789	1.10 [0.77 - 1.57]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210558_at	54	0.277778	0.153018	-	1.40132	0.853915	-0.276861	0.76 [0.04 - 14.44]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210558_at	117	0.649573	0.0919136	-	-0.628373	0.165087	-1.44451	0.24 [0.03 - 1.81]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210558_at	117	0.649573	0.124668	-	-0.693712	0.678315	-0.461691	0.63 [0.07 - 5.58]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210558_at	117	0.649573	0.174336	-	-0.622897	0.913669	-0.120135	0.89 [0.10 - 7.78]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210558_at	117	0.649573	0.0919136	-	-0.628373	0.165087	-1.44451	0.24 [0.03 - 1.81]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210558_at	236	0.110169	0.0010236	0.0259886	-1.00204	0.556938	-0.103573	0.90 [0.64 - 1.27]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210558_at	249	0.11245	0.0023116	0.0509872	-0.801425	0.337348	-0.133329	0.88 [0.67 - 1.15]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210558_at	62	0.709677	0.119015	-	-0.882398	0.588452	-0.275449	0.76 [0.28 - 2.06]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210558_at	125	0.232	0.168916	-	0.821524	0.598431	0.278461	1.32 [0.47 - 3.72]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210558_at	125	0.704	0.121767	-	0.449825	0.967265	0.0169223	1.02 [0.45 - 2.28]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210558_at	54	0.425926	0.0464647	0.469954	1.82694	0.790979	-0.16201	0.85 [0.26 - 2.82]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210558_at	198	0.292929	0.0477549	0.477974	0.627043	0.175057	0.139239	1.15 [0.94 - 1.41]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210558_at	198	0.292929	0.0775346	-	0.585716	0.275063	0.117842	1.13 [0.91 - 1.39]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210558_at	198	0.318182	0.000569168	0.015826	0.919402	0.0140447	0.213439	1.24 [1.04 - 1.47]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210558_at	51	0.54902	0.0426879	0.445697	-16.0218	0.136064	-6.21779	0.00 [0.00 - 7.08]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210558_at	62	0.758065	0.047443	0.476048	-15.4632	0.151315	-3.2046	0.04 [0.00 - 3.23]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210558_at	177	0.19209	0.0339984	0.384927	-0.653817	0.662139	0.107694	1.11 [0.69 - 1.81]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210558_at	177	0.19209	0.0858432	-	-0.486872	0.980421	-0.00559433	0.99 [0.64 - 1.55]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210558_at	145	0.724138	0.084591	-	-0.754112	0.394098	-0.316866	0.73 [0.35 - 1.51]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210558_at	226	0.792035	0.0777808	-	-0.750794	0.481171	-0.0764038	0.93 [0.75 - 1.15]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210558_at	55	0.218182	0.0349449	0.391917	-0.933245	0.308192	-0.825947	0.44 [0.09 - 2.14]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210558_at	55	0.218182	0.0191133	0.259481	-1.11081	0.977484	0.0152606	1.02 [0.35 - 2.93]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210558_at	49	0.693878	0.0660778	-	-1.71043	0.408869	-0.935033	0.39 [0.04 - 3.61]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210558_at	63	0.142857	0.000100693	0.00352366	-1.56237	0.0594517	-8.25385	0.00 [0.00 - 1.39]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9186907_3p_at	28	0.178571	0.0757846	-	-1.05061	0.969167	-0.0349288	0.97 [0.16 - 5.68]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210558_at	82	0.109756	0.0547269	-	1.72898	0.669112	0.093245	1.10 [0.72 - 1.68]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210558_at	79	0.455696	0.00044866	0.012916	0.958963	0.0694234	0.276637	1.32 [0.98 - 1.78]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210558_at	104	0.682692	0.0498209	0.490548	-0.796631	0.768108	-0.0803595	0.92 [0.54 - 1.57]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210558_at	204	0.102941	0.00449762	0.0870566	-0.962076	0.0394214	-0.29858	0.74 [0.56 - 0.99]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210558_at	204	0.102941	0.028853	0.345104	-0.962462	0.505331	-0.135677	0.87 [0.59 - 1.30]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210558_at	178	0.230337	0.00196892	0.0447168	0.821439	0.161615	0.130529	1.14 [0.95 - 1.37]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300002854	41	0.487805	0.101206	-	0.70449	0.703062	0.0825724	1.09 [0.71 - 1.66]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210558_at	111	0.684685	0.0547578	-	-0.57581	0.412205	-0.0981906	0.91 [0.72 - 1.15]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210558_at	90	0.411111	0.0400769	0.428204	0.723657	0.318726	0.278261	1.32 [0.76 - 2.28]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210558_at	90	0.411111	0.0711675	-	0.736415	0.331675	0.292587	1.34 [0.74 - 2.42]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210558_at	138	0.731884	0.00520994	0.0977524	-0.900027	0.0484141	-1.34772	0.26 [0.07 - 0.99]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210558_at	129	0.581395	0.00173898	0.0403764	0.777812	0.00209319	0.45135	1.57 [1.18 - 2.09]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43333	56	0.821429	0.0411596	0.435532	-1.37691	0.325842	-0.278519	0.76 [0.43 - 1.32]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10351	56	0.875	0.141715	-	0.786141	0.617205	0.231778	1.26 [0.51 - 3.13]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43333	56	0.25	0.0605831	-	-0.731761	0.17164	-0.433508	0.65 [0.35 - 1.21]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10351	56	0.25	0.050804	-	-0.710029	0.965667	0.0205016	1.02 [0.40 - 2.60]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210558_at	278	0.539568	0.0072552	0.126461	-0.514542	0.0983504	-0.976641	0.38 [0.12 - 1.20]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210558_at	133	0.729323	0.00127737	0.0312712	0.788069	0.0234779	1.05853	2.88 [1.15 - 7.20]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16625	81	0.432099	0.0538398	-	-1.01973	0.164296	-0.314103	0.73 [0.47 - 1.14]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210558_at	185	0.12973	0.18766	-	-0.318202	0.592358	-0.276381	0.76 [0.28 - 2.09]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210558_at	185	0.643243	0.294136	-	-0.196315	0.961022	-0.0270824	0.97 [0.33 - 2.88]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P149926	110	0.454545	0.0875399	-	-0.397922	0.313858	-0.156896	0.85 [0.63 - 1.16]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P149926	110	0.490909	0.122658	-	-0.470472	0.549301	-0.125587	0.88 [0.58 - 1.33]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210558_at	80	0.675	0.00474138	0.0907641	1.25049	0.195247	0.251456	1.29 [0.88 - 1.88]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_0230	281	0.124555	0.0782629	-	0.422503	0.635927	-0.0766493	0.93 [0.67 - 1.27]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:85981	59	0.864407	0.0210884	0.278131	1.28905	0.282901	1.00033	2.72 [0.44 - 16.88]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210558_at	38	0.552632	0.108367	-	-0.767434	0.338544	-0.189401	0.83 [0.56 - 1.22]
GENE	AKR1C4	aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210558_at	140	0.207143	3.91041e-06	0.000190206	-1.27062	3.93233e-05	-4.18382	0.02 [0.00 - 0.11]

